
PMID- 29621227
OWN - NLM
STAT- In-Data-Review
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 4
DP  - 2018 Apr 5
TI  - Involving undergraduates in genomics research to narrow the education-research
      gap.
PG  - 369-371
LID - 10.1038/nbt.4113 [doi]
FAU - Mangul, Serghei
AU  - Mangul S
AD  - Department of Computer Science, University of California, Los Angeles, Los
      Angeles, California, USA.
AD  - Institute for Quantitative and Computational Biosciences, University of
      California, Los Angeles, Los Angeles, California, USA.
FAU - Martin, Lana S
AU  - Martin LS
AD  - Department of Computer Science, University of California, Los Angeles, Los
      Angeles, California, USA.
FAU - Eskin, Eleazar
AU  - Eskin E
AD  - Department of Computer Science, University of California, Los Angeles, Los
      Angeles, California, USA.
AD  - Department of Human Genetics, University of California, Los Angeles, Los Angeles,
      California, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/04/06 06:00
MHDA- 2018/04/06 06:00
CRDT- 2018/04/06 06:00
PHST- 2018/04/06 06:00 [entrez]
PHST- 2018/04/06 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt.4113 [pii]
AID - 10.1038/nbt.4113 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Apr 5;36(4):369-371. doi: 10.1038/nbt.4113.

PMID- 29621226
OWN - NLM
STAT- In-Data-Review
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 4
DP  - 2018 Apr 5
TI  - FDA approves stroke-detecting AI software.
PG  - 290
LID - 10.1038/nbt0418-290 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/04/06 06:00
MHDA- 2018/04/06 06:00
CRDT- 2018/04/06 06:00
PHST- 2018/04/06 06:00 [entrez]
PHST- 2018/04/06 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt0418-290 [pii]
AID - 10.1038/nbt0418-290 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Apr 5;36(4):290. doi: 10.1038/nbt0418-290.

PMID- 29621225
OWN - NLM
STAT- In-Data-Review
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 4
DP  - 2018 Apr 5
TI  - Roche pays $1.9 billion for Flatiron's army of electronic health record curators.
PG  - 289-290
LID - 10.1038/nbt0418-289 [doi]
FAU - Petrone, Justin
AU  - Petrone J
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/04/06 06:00
MHDA- 2018/04/06 06:00
CRDT- 2018/04/06 06:00
PHST- 2018/04/06 06:00 [entrez]
PHST- 2018/04/06 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt0418-289 [pii]
AID - 10.1038/nbt0418-289 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Apr 5;36(4):289-290. doi: 10.1038/nbt0418-289.

PMID- 29621224
OWN - NLM
STAT- In-Data-Review
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 4
DP  - 2018 Apr 5
TI  - Critics say 'right to try' wrong for patients.
PG  - 294-295
LID - 10.1038/nbt0418-294 [doi]
FAU - Morrison, Christopher
AU  - Morrison C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/04/06 06:00
MHDA- 2018/04/06 06:00
CRDT- 2018/04/06 06:00
PHST- 2018/04/06 06:00 [entrez]
PHST- 2018/04/06 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt0418-294 [pii]
AID - 10.1038/nbt0418-294 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Apr 5;36(4):294-295. doi: 10.1038/nbt0418-294.

PMID- 29621223
OWN - NLM
STAT- In-Data-Review
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 4
DP  - 2018 Apr 5
TI  - Around the world in a month.
PG  - 296
LID - 10.1038/nbt0418-296 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/04/06 06:00
MHDA- 2018/04/06 06:00
CRDT- 2018/04/06 06:00
PHST- 2018/04/06 06:00 [entrez]
PHST- 2018/04/06 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt0418-296 [pii]
AID - 10.1038/nbt0418-296 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Apr 5;36(4):296. doi: 10.1038/nbt0418-296.

PMID- 29621222
OWN - NLM
STAT- In-Data-Review
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 4
DP  - 2018 Apr 5
TI  - Metabolomics activity screening for identifying metabolites that modulate
      phenotype.
PG  - 316-320
LID - 10.1038/nbt.4101 [doi]
AB  - Metabolomics, in which small-molecule metabolites (the metabolome) are identified
      and quantified, is broadly acknowledged to be the omics discipline that is
      closest to the phenotype. Although appreciated for its role in biomarker
      discovery programs, metabolomics can also be used to identify metabolites that
      could alter a cell's or an organism's phenotype. Metabolomics activity screening 
      (MAS) as described here integrates metabolomics data with metabolic pathways and 
      systems biology information, including proteomics and transcriptomics data, to
      produce a set of endogenous metabolites that can be tested for functionality in
      altering phenotypes. A growing literature reports the use of metabolites to
      modulate diverse processes, such as stem cell differentiation, oligodendrocyte
      maturation, insulin signaling, T-cell survival and macrophage immune responses.
      This opens up the possibility of identifying and applying metabolites to affect
      phenotypes. Unlike genes or proteins, metabolites are often readily available,
      which means that MAS is broadly amenable to high-throughput screening of
      virtually any biological system.
FAU - Guijas, Carlos
AU  - Guijas C
AUID- ORCID: http://orcid.org/0000-0001-7993-3388
AD  - The Scripps Research Institute, Scripps Center for Metabolomics and Mass
      Spectrometry, La Jolla, California, USA.
FAU - Montenegro-Burke, J Rafael
AU  - Montenegro-Burke JR
AUID- ORCID: http://orcid.org/0000-0001-7787-3414
AD  - The Scripps Research Institute, Scripps Center for Metabolomics and Mass
      Spectrometry, La Jolla, California, USA.
FAU - Warth, Benedikt
AU  - Warth B
AD  - The Scripps Research Institute, Scripps Center for Metabolomics and Mass
      Spectrometry, La Jolla, California, USA.
AD  - University of Vienna, Department of Food Chemistry and Toxicology, Vienna,
      Austria.
FAU - Spilker, Mary E
AU  - Spilker ME
AD  - The Scripps Research Institute, Scripps Center for Metabolomics and Mass
      Spectrometry, La Jolla, California, USA.
FAU - Siuzdak, Gary
AU  - Siuzdak G
AUID- ORCID: http://orcid.org/0000-0002-4749-0014
AD  - The Scripps Research Institute, Scripps Center for Metabolomics and Mass
      Spectrometry, La Jolla, California, USA.
AD  - The Scripps Research Institute, Department of Integrative and Computational
      Biology, La Jolla, California, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/04/06 06:00
MHDA- 2018/04/06 06:00
CRDT- 2018/04/06 06:00
PHST- 2017/06/28 00:00 [received]
PHST- 2018/02/14 00:00 [accepted]
PHST- 2018/04/06 06:00 [entrez]
PHST- 2018/04/06 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt.4101 [pii]
AID - 10.1038/nbt.4101 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Apr 5;36(4):316-320. doi: 10.1038/nbt.4101.

PMID- 29621221
OWN - NLM
STAT- In-Data-Review
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 4
DP  - 2018 Apr 5
TI  - New drug for multidrug-resistant HIV.
PG  - 291
LID - 10.1038/nbt0418-291b [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/04/06 06:00
MHDA- 2018/04/06 06:00
CRDT- 2018/04/06 06:00
PHST- 2018/04/06 06:00 [entrez]
PHST- 2018/04/06 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt0418-291b [pii]
AID - 10.1038/nbt0418-291b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Apr 5;36(4):291. doi: 10.1038/nbt0418-291b.

PMID- 29621220
OWN - NLM
STAT- In-Data-Review
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 4
DP  - 2018 Apr 5
TI  - Patching the retina with stem cells.
PG  - 311-313
LID - 10.1038/nbt.4118 [doi]
FAU - Bharti, Kapil
AU  - Bharti K
AD  - Ocular Stem Cell and Translational Research Unit at the National Eye Institute,
      NIH, Bethesda, Maryland, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/04/06 06:00
MHDA- 2018/04/06 06:00
CRDT- 2018/04/06 06:00
PHST- 2018/04/06 06:00 [entrez]
PHST- 2018/04/06 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt.4118 [pii]
AID - 10.1038/nbt.4118 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Apr 5;36(4):311-313. doi: 10.1038/nbt.4118.

PMID- 29621218
OWN - NLM
STAT- In-Data-Review
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 4
DP  - 2018 Apr 5
TI  - Portable gene expression guaranteed.
PG  - 313-314
LID - 10.1038/nbt.4119 [doi]
FAU - Tomazou, Marios
AU  - Tomazou M
AD  - Department of Bioengineering & the Imperial College Centre for Synthetic Biology 
      at Imperial College, London, UK.
FAU - Stan, Guy-Bart
AU  - Stan GB
AUID- ORCID: http://orcid.org/0000-0002-5560-902X
AD  - Department of Bioengineering & the Imperial College Centre for Synthetic Biology 
      at Imperial College, London, UK.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/04/06 06:00
MHDA- 2018/04/06 06:00
CRDT- 2018/04/06 06:00
PHST- 2018/04/06 06:00 [entrez]
PHST- 2018/04/06 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt.4119 [pii]
AID - 10.1038/nbt.4119 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Apr 5;36(4):313-314. doi: 10.1038/nbt.4119.

PMID- 29621217
OWN - NLM
STAT- In-Data-Review
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 4
DP  - 2018 Apr 5
TI  - Nature Biotechnology's academic spinouts of 2017.
PG  - 297-306
LID - 10.1038/nbt.4121 [doi]
FAU - Branca, Malorye Allison
AU  - Branca MA
FAU - Garber, Ken
AU  - Garber K
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/04/06 06:00
MHDA- 2018/04/06 06:00
CRDT- 2018/04/06 06:00
PHST- 2018/04/06 06:00 [entrez]
PHST- 2018/04/06 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt.4121 [pii]
AID - 10.1038/nbt.4121 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Apr 5;36(4):297-306. doi: 10.1038/nbt.4121.

PMID- 29621216
OWN - NLM
STAT- In-Data-Review
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 4
DP  - 2018 Apr 5
TI  - Low-molecular-weight albumin drug touted for severe osteoarthritis.
PG  - 293
LID - 10.1038/nbt0418-293 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/04/06 06:00
MHDA- 2018/04/06 06:00
CRDT- 2018/04/06 06:00
PHST- 2018/04/06 06:00 [entrez]
PHST- 2018/04/06 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt0418-293 [pii]
AID - 10.1038/nbt0418-293 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Apr 5;36(4):293. doi: 10.1038/nbt0418-293.

PMID- 29621215
OWN - NLM
STAT- In-Data-Review
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 4
DP  - 2018 Apr 5
TI  - Rollout of high-priced cell and gene therapies forces payer rethink.
PG  - 291-292
LID - 10.1038/nbt0418-291a [doi]
FAU - Senior, Melanie
AU  - Senior M
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/04/06 06:00
MHDA- 2018/04/06 06:00
CRDT- 2018/04/06 06:00
PHST- 2018/04/06 06:00 [entrez]
PHST- 2018/04/06 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt0418-291a [pii]
AID - 10.1038/nbt0418-291a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Apr 5;36(4):291-292. doi: 10.1038/nbt0418-291a.

PMID- 29621214
OWN - NLM
STAT- In-Data-Review
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 4
DP  - 2018 Apr 5
TI  - Epigenome editing to the rescue.
PG  - 315
LID - 10.1038/nbt.4116 [doi]
FAU - Elsner, Markus
AU  - Elsner M
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/04/06 06:00
MHDA- 2018/04/06 06:00
CRDT- 2018/04/06 06:00
PHST- 2018/04/06 06:00 [entrez]
PHST- 2018/04/06 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt.4116 [pii]
AID - 10.1038/nbt.4116 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Apr 5;36(4):315. doi: 10.1038/nbt.4116.

PMID- 29621213
OWN - NLM
STAT- In-Data-Review
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 4
DP  - 2018 Apr 5
TI  - Recent patents in tumor detection and treatment.
PG  - 310
LID - 10.1038/nbt.4123 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/04/06 06:00
MHDA- 2018/04/06 06:00
CRDT- 2018/04/06 06:00
PHST- 2018/04/06 06:00 [entrez]
PHST- 2018/04/06 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt.4123 [pii]
AID - 10.1038/nbt.4123 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Apr 5;36(4):310. doi: 10.1038/nbt.4123.

PMID- 29621212
OWN - NLM
STAT- In-Data-Review
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 4
DP  - 2018 Apr 5
TI  - The long view on sequencing.
PG  - 287
LID - 10.1038/nbt.4125 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/04/06 06:00
MHDA- 2018/04/06 06:00
CRDT- 2018/04/06 06:00
PHST- 2018/04/06 06:00 [entrez]
PHST- 2018/04/06 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt.4125 [pii]
AID - 10.1038/nbt.4125 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Apr 5;36(4):287. doi: 10.1038/nbt.4125.

PMID- 29621210
OWN - NLM
STAT- In-Data-Review
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 4
DP  - 2018 Apr 5
TI  - Gender differences in obtaining and maintaining patent rights.
PG  - 307-309
LID - 10.1038/nbt.4120 [doi]
FAU - Jensen, Kyle
AU  - Jensen K
AUID- ORCID: http://orcid.org/0000-0001-8075-0861
AD  - Yale School of Management, Yale University, New Haven, Connecticut, USA.
FAU - Kovacs, Balazs
AU  - Kovacs B
AD  - Yale School of Management, Yale University, New Haven, Connecticut, USA.
FAU - Sorenson, Olav
AU  - Sorenson O
AD  - Yale School of Management, Yale University, New Haven, Connecticut, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/04/06 06:00
MHDA- 2018/04/06 06:00
CRDT- 2018/04/06 06:00
PHST- 2018/04/06 06:00 [entrez]
PHST- 2018/04/06 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt.4120 [pii]
AID - 10.1038/nbt.4120 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Apr 5;36(4):307-309. doi: 10.1038/nbt.4120.

PMID- 29608179
OWN - NLM
STAT- Publisher
LR  - 20180402
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
DP  - 2018 Apr 2
TI  - Integrating single-cell transcriptomic data across different conditions,
      technologies, and species.
LID - 10.1038/nbt.4096 [doi]
AB  - Computational single-cell RNA-seq (scRNA-seq) methods have been successfully
      applied to experiments representing a single condition, technology, or species to
      discover and define cellular phenotypes. However, identifying subpopulations of
      cells that are present across multiple data sets remains challenging. Here, we
      introduce an analytical strategy for integrating scRNA-seq data sets based on
      common sources of variation, enabling the identification of shared populations
      across data sets and downstream comparative analysis. We apply this approach,
      implemented in our R toolkit Seurat (http://satijalab.org/seurat/), to align
      scRNA-seq data sets of peripheral blood mononuclear cells under resting and
      stimulated conditions, hematopoietic progenitors sequenced using two profiling
      technologies, and pancreatic cell 'atlases' generated from human and mouse
      islets. In each case, we learn distinct or transitional cell states jointly
      across data sets, while boosting statistical power through integrated analysis.
      Our approach facilitates general comparisons of scRNA-seq data sets, potentially 
      deepening our understanding of how distinct cell states respond to perturbation, 
      disease, and evolution.
FAU - Butler, Andrew
AU  - Butler A
AD  - New York Genome Center, New York, New York, USA.
AD  - Center for Genomics and Systems Biology, New York University, New York, New York,
      USA.
FAU - Hoffman, Paul
AU  - Hoffman P
AD  - New York Genome Center, New York, New York, USA.
FAU - Smibert, Peter
AU  - Smibert P
AD  - New York Genome Center, New York, New York, USA.
FAU - Papalexi, Efthymia
AU  - Papalexi E
AD  - New York Genome Center, New York, New York, USA.
AD  - Center for Genomics and Systems Biology, New York University, New York, New York,
      USA.
FAU - Satija, Rahul
AU  - Satija R
AUID- ORCID: http://orcid.org/0000-0001-9448-8833
AD  - New York Genome Center, New York, New York, USA.
AD  - Center for Genomics and Systems Biology, New York University, New York, New York,
      USA.
LA  - eng
PT  - Journal Article
DEP - 20180402
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/04/03 06:00
MHDA- 2018/04/03 06:00
CRDT- 2018/04/03 06:00
PHST- 2017/07/04 00:00 [received]
PHST- 2018/02/09 00:00 [accepted]
PHST- 2018/04/03 06:00 [entrez]
PHST- 2018/04/03 06:00 [pubmed]
PHST- 2018/04/03 06:00 [medline]
AID - nbt.4096 [pii]
AID - 10.1038/nbt.4096 [doi]
PST - aheadofprint
SO  - Nat Biotechnol. 2018 Apr 2. pii: nbt.4096. doi: 10.1038/nbt.4096.

PMID- 29608177
OWN - NLM
STAT- Publisher
LR  - 20180402
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
DP  - 2018 Apr 2
TI  - Batch effects in single-cell RNA-sequencing data are corrected by matching mutual
      nearest neighbors.
LID - 10.1038/nbt.4091 [doi]
AB  - Large-scale single-cell RNA sequencing (scRNA-seq) data sets that are produced in
      different laboratories and at different times contain batch effects that may
      compromise the integration and interpretation of the data. Existing scRNA-seq
      analysis methods incorrectly assume that the composition of cell populations is
      either known or identical across batches. We present a strategy for batch
      correction based on the detection of mutual nearest neighbors (MNNs) in the
      high-dimensional expression space. Our approach does not rely on predefined or
      equal population compositions across batches; instead, it requires only that a
      subset of the population be shared between batches. We demonstrate the
      superiority of our approach compared with existing methods by using both
      simulated and real scRNA-seq data sets. Using multiple droplet-based scRNA-seq
      data sets, we demonstrate that our MNN batch-effect-correction method can be
      scaled to large numbers of cells.
FAU - Haghverdi, Laleh
AU  - Haghverdi L
AD  - European Molecular Biology Laboratory, European Bioinformatics Institute
      (EMBL-EBI), Cambridge, UK.
AD  - Institute of Computational Biology, Helmholtz Zentrum Munchen, Munich, Germany.
FAU - Lun, Aaron T L
AU  - Lun ATL
AUID- ORCID: http://orcid.org/0000-0002-3564-4813
AD  - Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
FAU - Morgan, Michael D
AU  - Morgan MD
AUID- ORCID: http://orcid.org/0000-0003-0757-0711
AD  - Wellcome Trust Sanger Institute, Cambridge, UK.
FAU - Marioni, John C
AU  - Marioni JC
AD  - European Molecular Biology Laboratory, European Bioinformatics Institute
      (EMBL-EBI), Cambridge, UK.
AD  - Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
AD  - Wellcome Trust Sanger Institute, Cambridge, UK.
LA  - eng
PT  - Journal Article
DEP - 20180402
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/04/03 06:00
MHDA- 2018/04/03 06:00
CRDT- 2018/04/03 06:00
PHST- 2017/07/03 00:00 [received]
PHST- 2018/02/01 00:00 [accepted]
PHST- 2018/04/03 06:00 [entrez]
PHST- 2018/04/03 06:00 [pubmed]
PHST- 2018/04/03 06:00 [medline]
AID - nbt.4091 [pii]
AID - 10.1038/nbt.4091 [doi]
PST - aheadofprint
SO  - Nat Biotechnol. 2018 Apr 2. pii: nbt.4091. doi: 10.1038/nbt.4091.

PMID- 29553577
OWN - NLM
STAT- In-Data-Review
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 4
DP  - 2018 Apr
TI  - Phase 1 clinical study of an embryonic stem cell-derived retinal pigment
      epithelium patch in age-related macular degeneration.
PG  - 328-337
LID - 10.1038/nbt.4114 [doi]
AB  - Age-related macular degeneration (AMD) remains a major cause of blindness, with
      dysfunction and loss of retinal pigment epithelium (RPE) central to disease
      progression. We engineered an RPE patch comprising a fully differentiated, human 
      embryonic stem cell (hESC)-derived RPE monolayer on a coated, synthetic basement 
      membrane. We delivered the patch, using a purpose-designed microsurgical tool,
      into the subretinal space of one eye in each of two patients with severe
      exudative AMD. Primary endpoints were incidence and severity of adverse events
      and proportion of subjects with improved best-corrected visual acuity of 15
      letters or more. We report successful delivery and survival of the RPE patch by
      biomicroscopy and optical coherence tomography, and a visual acuity gain of 29
      and 21 letters in the two patients, respectively, over 12 months. Only local
      immunosuppression was used long-term. We also present the preclinical surgical,
      cell safety and tumorigenicity studies leading to trial approval. This work
      supports the feasibility and safety of hESC-RPE patch transplantation as a
      regenerative strategy for AMD.
FAU - da Cruz, Lyndon
AU  - da Cruz L
AD  - The London Project to Cure Blindness, ORBIT, Institute of Ophthalmology,
      University College London (UCL), London, UK.
AD  - NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, 
      UCL Institute of Ophthalmology, London, UK.
AD  - Moorfields Eye Hospital NHS Foundation Trust, London, UK.
AD  - Wellcome/EPSRC Centre for Interventional & Surgical Sciences (WEISS), Charles
      Bell House, London, UK.
FAU - Fynes, Kate
AU  - Fynes K
AD  - The London Project to Cure Blindness, ORBIT, Institute of Ophthalmology,
      University College London (UCL), London, UK.
FAU - Georgiadis, Odysseas
AU  - Georgiadis O
AD  - The London Project to Cure Blindness, ORBIT, Institute of Ophthalmology,
      University College London (UCL), London, UK.
AD  - NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, 
      UCL Institute of Ophthalmology, London, UK.
AD  - Moorfields Eye Hospital NHS Foundation Trust, London, UK.
FAU - Kerby, Julie
AU  - Kerby J
AD  - Pfizer, Granta Park, Cambridge, UK.
AD  - Cell and Gene Therapy Catapult, London, UK.
FAU - Luo, Yvonne H
AU  - Luo YH
AD  - The London Project to Cure Blindness, ORBIT, Institute of Ophthalmology,
      University College London (UCL), London, UK.
AD  - NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, 
      UCL Institute of Ophthalmology, London, UK.
AD  - Moorfields Eye Hospital NHS Foundation Trust, London, UK.
FAU - Ahmado, Ahmad
AU  - Ahmado A
AD  - The London Project to Cure Blindness, ORBIT, Institute of Ophthalmology,
      University College London (UCL), London, UK.
FAU - Vernon, Amanda
AU  - Vernon A
AD  - Cells for Sight, Transplantation & Research Program, UCL Institute of
      Ophthalmology, London, UK.
FAU - Daniels, Julie T
AU  - Daniels JT
AD  - Cells for Sight, Transplantation & Research Program, UCL Institute of
      Ophthalmology, London, UK.
FAU - Nommiste, Britta
AU  - Nommiste B
AD  - The London Project to Cure Blindness, ORBIT, Institute of Ophthalmology,
      University College London (UCL), London, UK.
FAU - Hasan, Shazeen M
AU  - Hasan SM
AD  - The London Project to Cure Blindness, ORBIT, Institute of Ophthalmology,
      University College London (UCL), London, UK.
FAU - Gooljar, Sakina B
AU  - Gooljar SB
AD  - The London Project to Cure Blindness, ORBIT, Institute of Ophthalmology,
      University College London (UCL), London, UK.
FAU - Carr, Amanda-Jayne F
AU  - Carr AF
AUID- ORCID: http://orcid.org/0000-0002-5469-0030
AD  - The London Project to Cure Blindness, ORBIT, Institute of Ophthalmology,
      University College London (UCL), London, UK.
FAU - Vugler, Anthony
AU  - Vugler A
AD  - The London Project to Cure Blindness, ORBIT, Institute of Ophthalmology,
      University College London (UCL), London, UK.
FAU - Ramsden, Conor M
AU  - Ramsden CM
AD  - The London Project to Cure Blindness, ORBIT, Institute of Ophthalmology,
      University College London (UCL), London, UK.
AD  - Moorfields Eye Hospital NHS Foundation Trust, London, UK.
FAU - Bictash, Magda
AU  - Bictash M
AD  - Pfizer, Granta Park, Cambridge, UK.
FAU - Fenster, Mike
AU  - Fenster M
AD  - Pfizer, Granta Park, Cambridge, UK.
FAU - Steer, Juliette
AU  - Steer J
AD  - Pfizer, Granta Park, Cambridge, UK.
FAU - Harbinson, Tricia
AU  - Harbinson T
AD  - Pfizer, Granta Park, Cambridge, UK.
FAU - Wilbrey, Anna
AU  - Wilbrey A
AD  - Pfizer, Granta Park, Cambridge, UK.
FAU - Tufail, Adnan
AU  - Tufail A
AD  - NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, 
      UCL Institute of Ophthalmology, London, UK.
AD  - Moorfields Eye Hospital NHS Foundation Trust, London, UK.
FAU - Feng, Gang
AU  - Feng G
AD  - Pfizer, Granta Park, Cambridge, UK.
FAU - Whitlock, Mark
AU  - Whitlock M
AD  - Pfizer, Granta Park, Cambridge, UK.
FAU - Robson, Anthony G
AU  - Robson AG
AD  - NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, 
      UCL Institute of Ophthalmology, London, UK.
AD  - Moorfields Eye Hospital NHS Foundation Trust, London, UK.
FAU - Holder, Graham E
AU  - Holder GE
AD  - NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, 
      UCL Institute of Ophthalmology, London, UK.
AD  - Moorfields Eye Hospital NHS Foundation Trust, London, UK.
FAU - Sagoo, Mandeep S
AU  - Sagoo MS
AD  - NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, 
      UCL Institute of Ophthalmology, London, UK.
AD  - Moorfields Eye Hospital NHS Foundation Trust, London, UK.
FAU - Loudon, Peter T
AU  - Loudon PT
AD  - Pfizer, Granta Park, Cambridge, UK.
FAU - Whiting, Paul
AU  - Whiting P
AD  - Pfizer, Granta Park, Cambridge, UK.
AD  - UCL Institute of Neurology, Queen Square, London, UK.
FAU - Coffey, Peter J
AU  - Coffey PJ
AD  - The London Project to Cure Blindness, ORBIT, Institute of Ophthalmology,
      University College London (UCL), London, UK.
AD  - NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, 
      UCL Institute of Ophthalmology, London, UK.
AD  - Center for Stem Cell Biology and Engineering, NRI, UC, Santa Barbara, California,
      USA.
LA  - eng
PT  - Journal Article
DEP - 20180319
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/03/20 06:00
MHDA- 2018/03/20 06:00
CRDT- 2018/03/20 06:00
PHST- 2016/11/06 00:00 [received]
PHST- 2018/02/28 00:00 [accepted]
PHST- 2018/03/20 06:00 [pubmed]
PHST- 2018/03/20 06:00 [medline]
PHST- 2018/03/20 06:00 [entrez]
AID - nbt.4114 [pii]
AID - 10.1038/nbt.4114 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Apr;36(4):328-337. doi: 10.1038/nbt.4114. Epub 2018 Mar 19.

PMID- 29553576
OWN - NLM
STAT- In-Data-Review
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 4
DP  - 2018 Apr
TI  - Engineered promoters enable constant gene expression at any copy number in
      bacteria.
PG  - 352-358
LID - 10.1038/nbt.4111 [doi]
AB  - The internal environment of growing cells is variable and dynamic, making it
      difficult to introduce reliable parts, such as promoters, for genetic
      engineering. Here, we applied control-theoretic ideas to design promoters that
      maintained constant levels of expression at any copy number. Theory predicts that
      independence to copy number can be achieved by using an incoherent feedforward
      loop (iFFL) if the negative regulation is perfectly non-cooperative. We
      engineered iFFLs into Escherichia coli promoters using
      transcription-activator-like effectors (TALEs). These promoters had
      near-identical expression in different genome locations and plasmids, even when
      their copy number was perturbed by genomic mutations or changes in growth medium 
      composition. We applied the stabilized promoters to show that a three-gene
      metabolic pathway to produce deoxychromoviridans could retain function without
      re-tuning when the stabilized-promoter-driven genes were moved from a plasmid
      into the genome.
FAU - Segall-Shapiro, Thomas H
AU  - Segall-Shapiro TH
AUID- ORCID: http://orcid.org/0000-0001-9364-6537
AD  - Synthetic Biology Center, Department of Biological Engineering, Massachusetts
      Institute of Technology, Cambridge, Massachusetts, USA.
FAU - Sontag, Eduardo D
AU  - Sontag ED
AUID- ORCID: http://orcid.org/0000-0001-8020-5783
AD  - Department of Bioengineering and Department of Electrical and Computer
      Engineering, Northeastern University, Boston, Massachusetts, USA.
FAU - Voigt, Christopher A
AU  - Voigt CA
AD  - Synthetic Biology Center, Department of Biological Engineering, Massachusetts
      Institute of Technology, Cambridge, Massachusetts, USA.
LA  - eng
PT  - Journal Article
DEP - 20180319
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/03/20 06:00
MHDA- 2018/03/20 06:00
CRDT- 2018/03/20 06:00
PHST- 2017/10/16 00:00 [received]
PHST- 2018/02/23 00:00 [accepted]
PHST- 2018/03/20 06:00 [pubmed]
PHST- 2018/03/20 06:00 [medline]
PHST- 2018/03/20 06:00 [entrez]
AID - nbt.4111 [pii]
AID - 10.1038/nbt.4111 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Apr;36(4):352-358. doi: 10.1038/nbt.4111. Epub 2018 Mar 19.

PMID- 29553575
OWN - NLM
STAT- In-Data-Review
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 4
DP  - 2018 Apr
TI  - Cultivation and sequencing of rumen microbiome members from the Hungate1000
      Collection.
PG  - 359-367
LID - 10.1038/nbt.4110 [doi]
AB  - Productivity of ruminant livestock depends on the rumen microbiota, which ferment
      indigestible plant polysaccharides into nutrients used for growth. Understanding 
      the functions carried out by the rumen microbiota is important for reducing
      greenhouse gas production by ruminants and for developing biofuels from
      lignocellulose. We present 410 cultured bacteria and archaea, together with their
      reference genomes, representing every cultivated rumen-associated archaeal and
      bacterial family. We evaluate polysaccharide degradation, short-chain fatty acid 
      production and methanogenesis pathways, and assign specific taxa to functions. A 
      total of 336 organisms were present in available rumen metagenomic data sets, and
      134 were present in human gut microbiome data sets. Comparison with the human
      microbiome revealed rumen-specific enrichment for genes encoding de novo
      synthesis of vitamin B12, ongoing evolution by gene loss and potential vertical
      inheritance of the rumen microbiome based on underrepresentation of markers of
      environmental stress. We estimate that our Hungate genome resource represents
      approximately 75% of the genus-level bacterial and archaeal taxa present in the
      rumen.
FAU - Seshadri, Rekha
AU  - Seshadri R
AUID- ORCID: http://orcid.org/0000-0003-3219-2900
AD  - Department of Energy, Joint Genome Institute, Walnut Creek, California, USA.
FAU - Leahy, Sinead C
AU  - Leahy SC
AUID- ORCID: http://orcid.org/0000-0002-5461-6738
AD  - AgResearch Limited, Grasslands Research Centre, Palmerston North, New Zealand.
FAU - Attwood, Graeme T
AU  - Attwood GT
AD  - AgResearch Limited, Grasslands Research Centre, Palmerston North, New Zealand.
FAU - Teh, Koon Hoong
AU  - Teh KH
AD  - AgResearch Limited, Grasslands Research Centre, Palmerston North, New Zealand.
FAU - Lambie, Suzanne C
AU  - Lambie SC
AD  - AgResearch Limited, Grasslands Research Centre, Palmerston North, New Zealand.
FAU - Cookson, Adrian L
AU  - Cookson AL
AD  - AgResearch Limited, Grasslands Research Centre, Palmerston North, New Zealand.
FAU - Eloe-Fadrosh, Emiley A
AU  - Eloe-Fadrosh EA
AD  - Department of Energy, Joint Genome Institute, Walnut Creek, California, USA.
FAU - Pavlopoulos, Georgios A
AU  - Pavlopoulos GA
AD  - Department of Energy, Joint Genome Institute, Walnut Creek, California, USA.
FAU - Hadjithomas, Michalis
AU  - Hadjithomas M
AD  - Department of Energy, Joint Genome Institute, Walnut Creek, California, USA.
FAU - Varghese, Neha J
AU  - Varghese NJ
AD  - Department of Energy, Joint Genome Institute, Walnut Creek, California, USA.
FAU - Paez-Espino, David
AU  - Paez-Espino D
AUID- ORCID: http://orcid.org/0000-0002-2939-5398
AD  - Department of Energy, Joint Genome Institute, Walnut Creek, California, USA.
CN  - Hungate1000 project collaborators
FAU - Perry, Rechelle
AU  - Perry R
AD  - AgResearch Limited, Grasslands Research Centre, Palmerston North, New Zealand.
FAU - Henderson, Gemma
AU  - Henderson G
AD  - AgResearch Limited, Grasslands Research Centre, Palmerston North, New Zealand.
FAU - Creevey, Christopher J
AU  - Creevey CJ
AD  - Institute of Biological, Environmental and Rural Sciences, Aberystwyth
      University, Aberystwyth, Wales, UK.
FAU - Terrapon, Nicolas
AU  - Terrapon N
AUID- ORCID: http://orcid.org/0000-0002-3693-6017
AD  - Architecture et Fonction des Macromolecules Biologiques, Aix-Marseille
      Universite, Marseille, France.
AD  - Institut National de la Recherche Agronomique, Marseille, France.
FAU - Lapebie, Pascal
AU  - Lapebie P
AD  - Architecture et Fonction des Macromolecules Biologiques, Aix-Marseille
      Universite, Marseille, France.
AD  - Institut National de la Recherche Agronomique, Marseille, France.
FAU - Drula, Elodie
AU  - Drula E
AD  - Architecture et Fonction des Macromolecules Biologiques, Aix-Marseille
      Universite, Marseille, France.
AD  - Institut National de la Recherche Agronomique, Marseille, France.
FAU - Lombard, Vincent
AU  - Lombard V
AD  - Architecture et Fonction des Macromolecules Biologiques, Aix-Marseille
      Universite, Marseille, France.
AD  - Institut National de la Recherche Agronomique, Marseille, France.
FAU - Rubin, Edward
AU  - Rubin E
AD  - Department of Energy, Joint Genome Institute, Walnut Creek, California, USA.
FAU - Kyrpides, Nikos C
AU  - Kyrpides NC
AD  - Department of Energy, Joint Genome Institute, Walnut Creek, California, USA.
FAU - Henrissat, Bernard
AU  - Henrissat B
AD  - Architecture et Fonction des Macromolecules Biologiques, Aix-Marseille
      Universite, Marseille, France.
AD  - Institut National de la Recherche Agronomique, Marseille, France.
AD  - Department of Biological Sciences, King Abdulaziz University, Jeddah, Saudi
      Arabia.
FAU - Woyke, Tanja
AU  - Woyke T
AUID- ORCID: http://orcid.org/0000-0002-9485-5637
AD  - Department of Energy, Joint Genome Institute, Walnut Creek, California, USA.
FAU - Ivanova, Natalia N
AU  - Ivanova NN
AD  - Department of Energy, Joint Genome Institute, Walnut Creek, California, USA.
FAU - Kelly, William J
AU  - Kelly WJ
AUID- ORCID: http://orcid.org/0000-0001-8982-066X
AD  - AgResearch Limited, Grasslands Research Centre, Palmerston North, New Zealand.
LA  - eng
PT  - Journal Article
DEP - 20180319
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
IR  - Palevich N
FIR - Palevich, Nikola
IR  - Janssen PH
FIR - Janssen, Peter H
IR  - Ronimus RS
FIR - Ronimus, Ron S
IR  - Noel S
FIR - Noel, Samantha
IR  - Soni P
FIR - Soni, Priya
IR  - Reilly K
FIR - Reilly, Kerri
IR  - Atherly T
FIR - Atherly, Todd
IR  - Ziemer C
FIR - Ziemer, Cherie
IR  - Wright AD
FIR - Wright, Andre-Denis
IR  - Ishaq S
FIR - Ishaq, Suzanne
IR  - Cotta M
FIR - Cotta, Michael
IR  - Thompson S
FIR - Thompson, Stephanie
IR  - Crosley K
FIR - Crosley, Katie
IR  - McKain N
FIR - McKain, Nest
IR  - Wallace RJ
FIR - Wallace, R John
IR  - Flint HJ
FIR - Flint, Harry J
IR  - Martin JC
FIR - Martin, Jennifer C
IR  - Forster RJ
FIR - Forster, Robert J
IR  - Gruninger RJ
FIR - Gruninger, Robert J
IR  - McAllister T
FIR - McAllister, Tim
IR  - Gilbert R
FIR - Gilbert, Rosalind
IR  - Ouwerkerk D
FIR - Ouwerkerk, Diane
IR  - Klieve A
FIR - Klieve, Athol
IR  - Jassim RA
FIR - Jassim, Rafat Al
IR  - Denman S
FIR - Denman, Stuart
IR  - McSweeney C
FIR - McSweeney, Chris
IR  - Rosewarne C
FIR - Rosewarne, Carly
IR  - Koike S
FIR - Koike, Satoshi
IR  - Kobayashi Y
FIR - Kobayashi, Yasuo
IR  - Mitsumori M
FIR - Mitsumori, Makoto
IR  - Shinkai T
FIR - Shinkai, Takumi
IR  - Cravero S
FIR - Cravero, Silvio
IR  - Cucchi MC
FIR - Cucchi, Maria Ceron
EDAT- 2018/03/20 06:00
MHDA- 2018/03/20 06:00
CRDT- 2018/03/20 06:00
PHST- 2017/08/16 00:00 [received]
PHST- 2018/02/23 00:00 [accepted]
PHST- 2018/03/20 06:00 [pubmed]
PHST- 2018/03/20 06:00 [medline]
PHST- 2018/03/20 06:00 [entrez]
AID - nbt.4110 [pii]
AID - 10.1038/nbt.4110 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Apr;36(4):359-367. doi: 10.1038/nbt.4110. Epub 2018 Mar 19.

PMID- 29553574
OWN - NLM
STAT- In-Data-Review
LR  - 20180407
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 4
DP  - 2018 Apr
TI  - Linear assembly of a human centromere on the Y chromosome.
PG  - 321-323
LID - 10.1038/nbt.4109 [doi]
AB  - The human genome reference sequence remains incomplete owing to the challenge of 
      assembling long tracts of near-identical tandem repeats in centromeres. We
      implemented a nanopore sequencing strategy to generate high-quality reads that
      span hundreds of kilobases of highly repetitive DNA in a human Y chromosome
      centromere. Combining these data with short-read variant validation, we assembled
      and characterized the centromeric region of a human Y chromosome.
FAU - Jain, Miten
AU  - Jain M
AUID- ORCID: http://orcid.org/0000-0002-4571-3982
AD  - UC Santa Cruz Genomics Institute, University of California, Santa Cruz,
      California, USA.
FAU - Olsen, Hugh E
AU  - Olsen HE
AD  - UC Santa Cruz Genomics Institute, University of California, Santa Cruz,
      California, USA.
FAU - Turner, Daniel J
AU  - Turner DJ
AD  - Oxford Nanopore Technologies, Oxford, UK.
FAU - Stoddart, David
AU  - Stoddart D
AD  - Oxford Nanopore Technologies, Oxford, UK.
FAU - Bulazel, Kira V
AU  - Bulazel KV
AD  - Duke Institute for Genome Sciences and Policy, Duke University, Durham, North
      Carolina, USA.
FAU - Paten, Benedict
AU  - Paten B
AD  - UC Santa Cruz Genomics Institute, University of California, Santa Cruz,
      California, USA.
FAU - Haussler, David
AU  - Haussler D
AD  - UC Santa Cruz Genomics Institute, University of California, Santa Cruz,
      California, USA.
FAU - Willard, Huntington F
AU  - Willard HF
AD  - Duke Institute for Genome Sciences and Policy, Duke University, Durham, North
      Carolina, USA.
AD  - Geisinger National, Bethesda, Maryland, USA.
FAU - Akeson, Mark
AU  - Akeson M
AD  - UC Santa Cruz Genomics Institute, University of California, Santa Cruz,
      California, USA.
FAU - Miga, Karen H
AU  - Miga KH
AD  - UC Santa Cruz Genomics Institute, University of California, Santa Cruz,
      California, USA.
AD  - Duke Institute for Genome Sciences and Policy, Duke University, Durham, North
      Carolina, USA.
LA  - eng
GR  - R01 HG007827/HG/NHGRI NIH HHS/United States
GR  - U54 HG007990/HG/NHGRI NIH HHS/United States
PT  - Journal Article
DEP - 20180319
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
PMC - PMC5886786
MID - NIHMS945766
EDAT- 2018/03/20 06:00
MHDA- 2018/03/20 06:00
CRDT- 2018/03/20 06:00
PMCR- 2018/09/19 00:00
PHST- 2017/08/08 00:00 [received]
PHST- 2018/02/22 00:00 [accepted]
PHST- 2018/09/19 00:00 [pmc-release]
PHST- 2018/03/20 06:00 [pubmed]
PHST- 2018/03/20 06:00 [medline]
PHST- 2018/03/20 06:00 [entrez]
AID - nbt.4109 [pii]
AID - 10.1038/nbt.4109 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Apr;36(4):321-323. doi: 10.1038/nbt.4109. Epub 2018 Mar 19.

PMID- 29553573
OWN - NLM
STAT- In-Data-Review
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 4
DP  - 2018 Apr
TI  - Base editing with a Cpf1-cytidine deaminase fusion.
PG  - 324-327
LID - 10.1038/nbt.4102 [doi]
AB  - The targeting range of CRISPR-Cas9 base editors (BEs) is limited by their
      G/C-rich protospacer-adjacent motif (PAM) sequences. To overcome this limitation,
      we developed a CRISPR-Cpf1-based BE by fusing the rat cytosine deaminase APOBEC1 
      to a catalytically inactive version of Lachnospiraceae bacterium Cpf1. The base
      editor recognizes a T-rich PAM sequence and catalyzes C-to-T conversion in human 
      cells, while inducing low levels of indels, non-C-to-T substitutions and
      off-target editing.
FAU - Li, Xiaosa
AU  - Li X
AD  - School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
AD  - Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences,
      Shanghai, China.
AD  - University of Chinese Academy of Sciences, Beijing, China.
FAU - Wang, Ying
AU  - Wang Y
AD  - Key Laboratory of Computational Biology, CAS-MPG Partner Institute for
      Computational Biology, Shanghai Institutes for Biological Sciences, University of
      Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.
FAU - Liu, Yajing
AU  - Liu Y
AD  - School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
AD  - Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences,
      Shanghai, China.
AD  - University of Chinese Academy of Sciences, Beijing, China.
FAU - Yang, Bei
AU  - Yang B
AUID- ORCID: http://orcid.org/0000-0001-5389-3859
AD  - Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, 
      Shanghai, China.
FAU - Wang, Xiao
AU  - Wang X
AD  - School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
AD  - Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences,
      Shanghai, China.
AD  - University of Chinese Academy of Sciences, Beijing, China.
FAU - Wei, Jia
AU  - Wei J
AD  - Key Laboratory of Computational Biology, CAS-MPG Partner Institute for
      Computational Biology, Shanghai Institutes for Biological Sciences, University of
      Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.
FAU - Lu, Zongyang
AU  - Lu Z
AD  - School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
AD  - Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences,
      Shanghai, China.
AD  - University of Chinese Academy of Sciences, Beijing, China.
FAU - Zhang, Yuxi
AU  - Zhang Y
AD  - School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
FAU - Wu, Jing
AU  - Wu J
AD  - School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
FAU - Huang, Xingxu
AU  - Huang X
AD  - School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
FAU - Yang, Li
AU  - Yang L
AUID- ORCID: http://orcid.org/0000-0001-8833-7473
AD  - Key Laboratory of Computational Biology, CAS-MPG Partner Institute for
      Computational Biology, Shanghai Institutes for Biological Sciences, University of
      Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.
FAU - Chen, Jia
AU  - Chen J
AUID- ORCID: http://orcid.org/0000-0002-4242-2899
AD  - School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
LA  - eng
PT  - Journal Article
DEP - 20180319
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/03/20 06:00
MHDA- 2018/03/20 06:00
CRDT- 2018/03/20 06:00
PHST- 2017/09/13 00:00 [received]
PHST- 2018/02/15 00:00 [accepted]
PHST- 2018/03/20 06:00 [pubmed]
PHST- 2018/03/20 06:00 [medline]
PHST- 2018/03/20 06:00 [entrez]
AID - nbt.4102 [pii]
AID - 10.1038/nbt.4102 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Apr;36(4):324-327. doi: 10.1038/nbt.4102. Epub 2018 Mar 19.

PMID- 29505028
OWN - NLM
STAT- In-Data-Review
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 4
DP  - 2018 Apr
TI  - IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and
      CAR-T cell survival in the tumor.
PG  - 346-351
LID - 10.1038/nbt.4086 [doi]
AB  - Infiltration, accumulation, and survival of chimeric antigen receptor T (CAR-T)
      cells in solid tumors is crucial for tumor clearance. We engineered CAR-T cells
      to express interleukin (IL)-7 and CCL19 (7 x 19 CAR-T cells), as these factors
      are essential for the maintenance of T-cell zones in lymphoid organs. In mice, 7 
      x 19 CAR-T cells achieved complete regression of pre-established solid tumors and
      prolonged mouse survival, with superior anti-tumor activity compared to
      conventional CAR-T cells. Histopathological analyses showed increased
      infiltration of dendritic cells (DC) and T cells into tumor tissues following 7 x
      19 CAR-T cell therapy. Depletion of recipient T cells before 7 x 19 CAR-T cell
      administration dampened the therapeutic effects of 7 x 19 CAR-T cell treatment,
      suggesting that CAR-T cells and recipient immune cells collaborated to exert
      anti-tumor activity. Following treatment of mice with 7 x 19 CAR-T cells, both
      recipient conventional T cells and administered CAR-T cells generated memory
      responses against tumors.
FAU - Adachi, Keishi
AU  - Adachi K
AD  - Department of Immunology, Yamaguchi University Graduate School of Medicine, Ube, 
      Japan.
FAU - Kano, Yosuke
AU  - Kano Y
AD  - Department of Immunology, Yamaguchi University Graduate School of Medicine, Ube, 
      Japan.
FAU - Nagai, Tomohiko
AU  - Nagai T
AD  - Department of Immunology, Yamaguchi University Graduate School of Medicine, Ube, 
      Japan.
FAU - Okuyama, Namiko
AU  - Okuyama N
AD  - Department of Immunology, Yamaguchi University Graduate School of Medicine, Ube, 
      Japan.
FAU - Sakoda, Yukimi
AU  - Sakoda Y
AD  - Department of Immunology, Yamaguchi University Graduate School of Medicine, Ube, 
      Japan.
FAU - Tamada, Koji
AU  - Tamada K
AD  - Department of Immunology, Yamaguchi University Graduate School of Medicine, Ube, 
      Japan.
LA  - eng
PT  - Journal Article
DEP - 20180305
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/03/06 06:00
MHDA- 2018/03/06 06:00
CRDT- 2018/03/06 06:00
PHST- 2017/01/14 00:00 [received]
PHST- 2018/01/30 00:00 [accepted]
PHST- 2018/03/06 06:00 [pubmed]
PHST- 2018/03/06 06:00 [medline]
PHST- 2018/03/06 06:00 [entrez]
AID - nbt.4086 [pii]
AID - 10.1038/nbt.4086 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Apr;36(4):346-351. doi: 10.1038/nbt.4086. Epub 2018 Mar 5.

PMID- 29431738
OWN - NLM
STAT- In-Data-Review
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 4
DP  - 2018 Apr
TI  - Nanopore sequencing and assembly of a human genome with ultra-long reads.
PG  - 338-345
LID - 10.1038/nbt.4060 [doi]
AB  - We report the sequencing and assembly of a reference genome for the human GM12878
      Utah/Ceph cell line using the MinION (Oxford Nanopore Technologies) nanopore
      sequencer. 91.2 Gb of sequence data, representing approximately 30x theoretical
      coverage, were produced. Reference-based alignment enabled detection of large
      structural variants and epigenetic modifications. De novo assembly of nanopore
      reads alone yielded a contiguous assembly (NG50 approximately 3 Mb). We developed
      a protocol to generate ultra-long reads (N50 > 100 kb, read lengths up to 882
      kb). Incorporating an additional 5x coverage of these ultra-long reads more than 
      doubled the assembly contiguity (NG50 approximately 6.4 Mb). The final assembled 
      genome was 2,867 million bases in size, covering 85.8% of the reference. Assembly
      accuracy, after incorporating complementary short-read sequencing data, exceeded 
      99.8%. Ultra-long reads enabled assembly and phasing of the 4-Mb major
      histocompatibility complex (MHC) locus in its entirety, measurement of telomere
      repeat length, and closure of gaps in the reference human genome assembly GRCh38.
FAU - Jain, Miten
AU  - Jain M
AUID- ORCID: http://orcid.org/0000-0002-4571-3982
AD  - UC Santa Cruz Genomics Institute, University of California, Santa Cruz,
      California, USA.
FAU - Koren, Sergey
AU  - Koren S
AD  - Genome Informatics Section, Computational and Statistical Genomics Branch,
      National Human Genome Research Institute, Bethesda, Maryland, USA.
FAU - Miga, Karen H
AU  - Miga KH
AD  - UC Santa Cruz Genomics Institute, University of California, Santa Cruz,
      California, USA.
FAU - Quick, Josh
AU  - Quick J
AD  - Institute of Microbiology and Infection, University of Birmingham, Birmingham,
      UK.
FAU - Rand, Arthur C
AU  - Rand AC
AD  - UC Santa Cruz Genomics Institute, University of California, Santa Cruz,
      California, USA.
FAU - Sasani, Thomas A
AU  - Sasani TA
AUID- ORCID: http://orcid.org/0000-0003-2317-1374
AD  - Department of Human Genetics, University of Utah, Salt Lake City, Utah, USA.
AD  - USTAR Center for Genetic Discovery, University of Utah, Salt Lake City, Utah,
      USA.
FAU - Tyson, John R
AU  - Tyson JR
AD  - Michael Smith Laboratories and Djavad Mowafaghian Centre for Brain Health,
      University of British Columbia, Vancouver, Canada.
FAU - Beggs, Andrew D
AU  - Beggs AD
AUID- ORCID: http://orcid.org/0000-0003-0784-2967
AD  - Surgical Research Laboratory, Institute of Cancer & Genomic Science, University
      of Birmingham, UK.
FAU - Dilthey, Alexander T
AU  - Dilthey AT
AUID- ORCID: http://orcid.org/0000-0002-6394-4581
AD  - Genome Informatics Section, Computational and Statistical Genomics Branch,
      National Human Genome Research Institute, Bethesda, Maryland, USA.
FAU - Fiddes, Ian T
AU  - Fiddes IT
AD  - UC Santa Cruz Genomics Institute, University of California, Santa Cruz,
      California, USA.
FAU - Malla, Sunir
AU  - Malla S
AD  - DeepSeq, School of Life Sciences, University of Nottingham, UK.
FAU - Marriott, Hannah
AU  - Marriott H
AD  - DeepSeq, School of Life Sciences, University of Nottingham, UK.
FAU - Nieto, Tom
AU  - Nieto T
AD  - Surgical Research Laboratory, Institute of Cancer & Genomic Science, University
      of Birmingham, UK.
FAU - O'Grady, Justin
AU  - O'Grady J
AUID- ORCID: http://orcid.org/0000-0001-5412-7152
AD  - Norwich Medical School, University of East Anglia, Norwich, UK.
FAU - Olsen, Hugh E
AU  - Olsen HE
AD  - UC Santa Cruz Genomics Institute, University of California, Santa Cruz,
      California, USA.
FAU - Pedersen, Brent S
AU  - Pedersen BS
AD  - Department of Human Genetics, University of Utah, Salt Lake City, Utah, USA.
AD  - USTAR Center for Genetic Discovery, University of Utah, Salt Lake City, Utah,
      USA.
FAU - Rhie, Arang
AU  - Rhie A
AUID- ORCID: http://orcid.org/0000-0002-9809-8127
AD  - Genome Informatics Section, Computational and Statistical Genomics Branch,
      National Human Genome Research Institute, Bethesda, Maryland, USA.
FAU - Richardson, Hollian
AU  - Richardson H
AD  - Norwich Medical School, University of East Anglia, Norwich, UK.
FAU - Quinlan, Aaron R
AU  - Quinlan AR
AUID- ORCID: http://orcid.org/0000-0003-1756-0859
AD  - Department of Human Genetics, University of Utah, Salt Lake City, Utah, USA.
AD  - USTAR Center for Genetic Discovery, University of Utah, Salt Lake City, Utah,
      USA.
AD  - Department of Biomedical Informatics, University of Utah, Salt Lake City, Utah,
      USA.
FAU - Snutch, Terrance P
AU  - Snutch TP
AD  - Michael Smith Laboratories and Djavad Mowafaghian Centre for Brain Health,
      University of British Columbia, Vancouver, Canada.
FAU - Tee, Louise
AU  - Tee L
AD  - Surgical Research Laboratory, Institute of Cancer & Genomic Science, University
      of Birmingham, UK.
FAU - Paten, Benedict
AU  - Paten B
AD  - UC Santa Cruz Genomics Institute, University of California, Santa Cruz,
      California, USA.
FAU - Phillippy, Adam M
AU  - Phillippy AM
AD  - Genome Informatics Section, Computational and Statistical Genomics Branch,
      National Human Genome Research Institute, Bethesda, Maryland, USA.
FAU - Simpson, Jared T
AU  - Simpson JT
AD  - Ontario Institute for Cancer Research, Toronto, Canada.
AD  - Department of Computer Science, University of Toronto, Toronto, Canada.
FAU - Loman, Nicholas J
AU  - Loman NJ
AD  - Institute of Microbiology and Infection, University of Birmingham, Birmingham,
      UK.
FAU - Loose, Matthew
AU  - Loose M
AUID- ORCID: http://orcid.org/0000-0002-5264-0929
AD  - DeepSeq, School of Life Sciences, University of Nottingham, UK.
LA  - eng
GR  - U41 HG007234/HG/NHGRI NIH HHS/United States
GR  - U54 HG007990/HG/NHGRI NIH HHS/United States
PT  - Journal Article
DEP - 20180129
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/02/13 06:00
MHDA- 2018/02/13 06:00
CRDT- 2018/02/13 06:00
PHST- 2017/04/20 00:00 [received]
PHST- 2017/12/11 00:00 [accepted]
PHST- 2018/02/13 06:00 [pubmed]
PHST- 2018/02/13 06:00 [medline]
PHST- 2018/02/13 06:00 [entrez]
AID - nbt.4060 [pii]
AID - 10.1038/nbt.4060 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Apr;36(4):338-345. doi: 10.1038/nbt.4060. Epub 2018 Jan 29.

PMID- 29608178
OWN - NLM
STAT- Publisher
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
DP  - 2018 Mar 28
TI  - Simultaneous single-cell profiling of lineages and cell types in the vertebrate
      brain.
LID - 10.1038/nbt.4103 [doi]
AB  - The lineage relationships among the hundreds of cell types generated during
      development are difficult to reconstruct. A recent method, GESTALT, used
      CRISPR-Cas9 barcode editing for large-scale lineage tracing, but was restricted
      to early development and did not identify cell types. Here we present scGESTALT, 
      which combines the lineage recording capabilities of GESTALT with cell-type
      identification by single-cell RNA sequencing. The method relies on an inducible
      system that enables barcodes to be edited at multiple time points, capturing
      lineage information from later stages of development. Sequencing of approximately
      60,000 transcriptomes from the juvenile zebrafish brain identified >100 cell
      types and marker genes. Using these data, we generate lineage trees with hundreds
      of branches that help uncover restrictions at the level of cell types, brain
      regions, and gene expression cascades during differentiation. scGESTALT can be
      applied to other multicellular organisms to simultaneously characterize molecular
      identities and lineage histories of thousands of cells during development and
      disease.
FAU - Raj, Bushra
AU  - Raj B
AUID- ORCID: http://orcid.org/0000-0002-5833-0251
AD  - Department of Molecular and Cellular Biology, Harvard University, Cambridge,
      Massachusetts, USA.
AD  - Allen Discovery Center for Cell Lineage Tracing, Seattle, Washington, USA.
FAU - Wagner, Daniel E
AU  - Wagner DE
AD  - Department of Systems Biology, Harvard Medical School, Boston, Massachusetts,
      USA.
FAU - McKenna, Aaron
AU  - McKenna A
AUID- ORCID: http://orcid.org/0000-0001-8277-6512
AD  - Allen Discovery Center for Cell Lineage Tracing, Seattle, Washington, USA.
AD  - Department of Genome Sciences, University of Washington, Seattle, Washington,
      USA.
FAU - Pandey, Shristi
AU  - Pandey S
AD  - Department of Molecular and Cellular Biology, Harvard University, Cambridge,
      Massachusetts, USA.
FAU - Klein, Allon M
AU  - Klein AM
AUID- ORCID: http://orcid.org/0000-0001-8913-7879
AD  - Department of Systems Biology, Harvard Medical School, Boston, Massachusetts,
      USA.
FAU - Shendure, Jay
AU  - Shendure J
AUID- ORCID: http://orcid.org/0000-0002-1516-1865
AD  - Allen Discovery Center for Cell Lineage Tracing, Seattle, Washington, USA.
AD  - Department of Genome Sciences, University of Washington, Seattle, Washington,
      USA.
AD  - Howard Hughes Medical Institute, Seattle, Washington, USA.
FAU - Gagnon, James A
AU  - Gagnon JA
AUID- ORCID: http://orcid.org/0000-0003-3978-6058
AD  - Department of Molecular and Cellular Biology, Harvard University, Cambridge,
      Massachusetts, USA.
AD  - Allen Discovery Center for Cell Lineage Tracing, Seattle, Washington, USA.
AD  - Department of Biology, University of Utah, Salt Lake City, Utah, USA.
FAU - Schier, Alexander F
AU  - Schier AF
AUID- ORCID: http://orcid.org/0000-0001-7645-5325
AD  - Department of Molecular and Cellular Biology, Harvard University, Cambridge,
      Massachusetts, USA.
AD  - Allen Discovery Center for Cell Lineage Tracing, Seattle, Washington, USA.
AD  - Biozentrum, University of Basel, Switzerland.
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
AD  - Harvard Stem Cell Institute, Harvard University, Cambridge, Massachusetts, USA.
AD  - Center for Brain Science, Harvard University, Cambridge, Massachusetts, USA.
LA  - eng
GR  - DP1 HD094764/HD/NICHD NIH HHS/United States
GR  - DP1 HG007811/HG/NHGRI NIH HHS/United States
GR  - R01 HD085905/HD/NICHD NIH HHS/United States
GR  - U01 MH105960/MH/NIMH NIH HHS/United States
PT  - Journal Article
DEP - 20180328
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/04/03 06:00
MHDA- 2018/04/03 06:00
CRDT- 2018/04/03 06:00
PHST- 2017/10/03 00:00 [received]
PHST- 2018/02/15 00:00 [accepted]
PHST- 2018/04/03 06:00 [entrez]
PHST- 2018/04/03 06:00 [pubmed]
PHST- 2018/04/03 06:00 [medline]
AID - nbt.4103 [pii]
AID - 10.1038/nbt.4103 [doi]
PST - aheadofprint
SO  - Nat Biotechnol. 2018 Mar 28. pii: nbt.4103. doi: 10.1038/nbt.4103.

PMID- 29509746
OWN - NLM
STAT- In-Data-Review
LR  - 20180306
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 3
DP  - 2018 Mar 6
TI  - Recent patents in DNA sequencing.
PG  - 233
LID - 10.1038/nbt.4105 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/03/07 06:00
MHDA- 2018/03/07 06:00
CRDT- 2018/03/07 06:00
PHST- 2018/03/07 06:00 [entrez]
PHST- 2018/03/07 06:00 [pubmed]
PHST- 2018/03/07 06:00 [medline]
AID - nbt.4105 [pii]
AID - 10.1038/nbt.4105 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Mar 6;36(3):233. doi: 10.1038/nbt.4105.

PMID- 29509745
OWN - NLM
STAT- In-Data-Review
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 3
DP  - 2018 Mar 6
TI  - Driving T-cell immunotherapy to solid tumors.
PG  - 215-219
LID - 10.1038/nbt.4090 [doi]
FAU - Garber, Ken
AU  - Garber K
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/03/07 06:00
MHDA- 2018/03/07 06:00
CRDT- 2018/03/07 06:00
PHST- 2018/03/07 06:00 [entrez]
PHST- 2018/03/07 06:00 [pubmed]
PHST- 2018/03/07 06:00 [medline]
AID - nbt.4090 [pii]
AID - 10.1038/nbt.4090 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Mar 6;36(3):215-219. doi: 10.1038/nbt.4090.

PMID- 29509744
OWN - NLM
STAT- In-Data-Review
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 3
DP  - 2018 Mar 6
TI  - Smart cancer therapy with DNA origami.
PG  - 234-235
LID - 10.1038/nbt.4095 [doi]
FAU - Tasciotti, Ennio
AU  - Tasciotti E
AD  - Center for Biomimetic Medicine and Center for Musculoskeletal Regeneration,
      Houston Methodist Orthopedic and Sports Medicine, Houston Methodist Hospital,
      Houston Methodist Research Institute, Houston, Texas, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/03/07 06:00
MHDA- 2018/03/07 06:00
CRDT- 2018/03/07 06:00
PHST- 2018/03/07 06:00 [entrez]
PHST- 2018/03/07 06:00 [pubmed]
PHST- 2018/03/07 06:00 [medline]
AID - nbt.4095 [pii]
AID - 10.1038/nbt.4095 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Mar 6;36(3):234-235. doi: 10.1038/nbt.4095.

PMID- 29509743
OWN - NLM
STAT- In-Data-Review
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 3
DP  - 2018 Mar 6
TI  - FDA makes drug data public.
PG  - 212
LID - 10.1038/nbt0318-212b [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/03/07 06:00
MHDA- 2018/03/07 06:00
CRDT- 2018/03/07 06:00
PHST- 2018/03/07 06:00 [entrez]
PHST- 2018/03/07 06:00 [pubmed]
PHST- 2018/03/07 06:00 [medline]
AID - nbt0318-212b [pii]
AID - 10.1038/nbt0318-212b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Mar 6;36(3):212. doi: 10.1038/nbt0318-212b.

PMID- 29509742
OWN - NLM
STAT- In-Data-Review
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 3
DP  - 2018 Mar 6
TI  - All MiNDS on the brain.
PG  - 238
LID - 10.1038/nbt.4094 [doi]
FAU - Jarchum, Irene
AU  - Jarchum I
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/03/07 06:00
MHDA- 2018/03/07 06:00
CRDT- 2018/03/07 06:00
PHST- 2018/03/07 06:00 [entrez]
PHST- 2018/03/07 06:00 [pubmed]
PHST- 2018/03/07 06:00 [medline]
AID - nbt.4094 [pii]
AID - 10.1038/nbt.4094 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Mar 6;36(3):238. doi: 10.1038/nbt.4094.

PMID- 29509741
OWN - NLM
STAT- In-Data-Review
LR  - 20180407
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 3
DP  - 2018 Mar 6
TI  - The NIEHS TaRGET II Consortium and environmental epigenomics.
PG  - 225-227
LID - 10.1038/nbt.4099 [doi]
FAU - Wang, Ting
AU  - Wang T
AUID- ORCID: http://orcid.org/0000-0002-6800-242X
AD  - Department of Genetics, Washington University School of Medicine, St. Louis,
      Missouri, USA.
AD  - The Edison Family Center for Genome Sciences and Systems Biology, Washington
      University School of Medicine, St. Louis, Missouri, USA.
FAU - Pehrsson, Erica C
AU  - Pehrsson EC
AD  - Department of Genetics, Washington University School of Medicine, St. Louis,
      Missouri, USA.
AD  - The Edison Family Center for Genome Sciences and Systems Biology, Washington
      University School of Medicine, St. Louis, Missouri, USA.
FAU - Purushotham, Deepak
AU  - Purushotham D
AD  - Department of Genetics, Washington University School of Medicine, St. Louis,
      Missouri, USA.
AD  - The Edison Family Center for Genome Sciences and Systems Biology, Washington
      University School of Medicine, St. Louis, Missouri, USA.
FAU - Li, Daofeng
AU  - Li D
AD  - Department of Genetics, Washington University School of Medicine, St. Louis,
      Missouri, USA.
AD  - The Edison Family Center for Genome Sciences and Systems Biology, Washington
      University School of Medicine, St. Louis, Missouri, USA.
FAU - Zhuo, Xiaoyu
AU  - Zhuo X
AUID- ORCID: http://orcid.org/0000-0002-1400-5609
AD  - Department of Genetics, Washington University School of Medicine, St. Louis,
      Missouri, USA.
AD  - The Edison Family Center for Genome Sciences and Systems Biology, Washington
      University School of Medicine, St. Louis, Missouri, USA.
FAU - Zhang, Bo
AU  - Zhang B
AD  - Center for Regenerative Medicine, Washington University School of Medicine, St.
      Louis, Missouri, USA.
FAU - Lawson, Heather A
AU  - Lawson HA
AD  - Department of Genetics, Washington University School of Medicine, St. Louis,
      Missouri, USA.
FAU - Province, Michael A
AU  - Province MA
AD  - Department of Genetics, Washington University School of Medicine, St. Louis,
      Missouri, USA.
FAU - Krapp, Christopher
AU  - Krapp C
AD  - Epigenetics Institute, Center for Excellence in Environmental Toxicology,
      Department of Cell and Developmental Biology, Perelman School of Medicine,
      University of Pennsylvania, Philadelphia, Pennsylvania, USA.
FAU - Lan, Yemin
AU  - Lan Y
AD  - Epigenetics Institute, Center for Excellence in Environmental Toxicology,
      Department of Cell and Developmental Biology, Perelman School of Medicine,
      University of Pennsylvania, Philadelphia, Pennsylvania, USA.
FAU - Coarfa, Cristian
AU  - Coarfa C
AD  - Center for Precision Environmental Health, Departments of Molecular & Cellular
      Biology and Medicine, Baylor College of Medicine, Houston, Texas, USA.
FAU - Katz, Tiffany A
AU  - Katz TA
AD  - Center for Precision Environmental Health, Departments of Molecular & Cellular
      Biology and Medicine, Baylor College of Medicine, Houston, Texas, USA.
FAU - Tang, Wan Yee
AU  - Tang WY
AD  - Department of Environmental Health Sciences, Johns Hopkins School of Public
      Health, Baltimore, Maryland, USA.
FAU - Wang, Zhibin
AU  - Wang Z
AUID- ORCID: http://orcid.org/0000-0001-9406-6913
AD  - Department of Environmental Health Sciences, Johns Hopkins School of Public
      Health, Baltimore, Maryland, USA.
FAU - Biswal, Shyam
AU  - Biswal S
AD  - Department of Environmental Health Sciences, Johns Hopkins School of Public
      Health, Baltimore, Maryland, USA.
FAU - Rajagopalan, Sanjay
AU  - Rajagopalan S
AD  - Department of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
FAU - Colacino, Justin A
AU  - Colacino JA
AD  - Department of Environmental Health Sciences and Nutritional Sciences, University 
      of Michigan School of Public Health, Ann Arbor, Michigan, USA.
FAU - Tsai, Zing Tsung-Yeh
AU  - Tsai ZT
AUID- ORCID: http://orcid.org/0000-0002-4006-1559
AD  - Department of Environmental Health Sciences and Nutritional Sciences, University 
      of Michigan School of Public Health, Ann Arbor, Michigan, USA.
FAU - Sartor, Maureen A
AU  - Sartor MA
AD  - Department of Environmental Health Sciences and Nutritional Sciences, University 
      of Michigan School of Public Health, Ann Arbor, Michigan, USA.
FAU - Neier, Kari
AU  - Neier K
AD  - Department of Environmental Health Sciences and Nutritional Sciences, University 
      of Michigan School of Public Health, Ann Arbor, Michigan, USA.
FAU - Dolinoy, Dana C
AU  - Dolinoy DC
AD  - Department of Environmental Health Sciences and Nutritional Sciences, University 
      of Michigan School of Public Health, Ann Arbor, Michigan, USA.
FAU - Pinto, Jayant
AU  - Pinto J
AD  - Department of Medicine, The University of Chicago, Chicago, Illinois, USA.
FAU - Hamanaka, Robert B
AU  - Hamanaka RB
AD  - Department of Medicine, The University of Chicago, Chicago, Illinois, USA.
FAU - Mutlu, Gokhan M
AU  - Mutlu GM
AD  - Department of Medicine, The University of Chicago, Chicago, Illinois, USA.
FAU - Patisaul, Heather B
AU  - Patisaul HB
AD  - Department of Biological Sciences, Center for Human Health and the Environment,
      Bioinformatics Research Center, North Carolina State University, Raleigh, North
      Carolina, USA.
FAU - Aylor, David L
AU  - Aylor DL
AD  - Department of Biological Sciences, Center for Human Health and the Environment,
      Bioinformatics Research Center, North Carolina State University, Raleigh, North
      Carolina, USA.
FAU - Crawford, Gregory E
AU  - Crawford GE
AD  - Center for Genomic & Computational Biology, Division of Medical Genetics,
      Department of Pediatrics, Duke University, Durham, North Carolina, USA.
FAU - Wiltshire, Tim
AU  - Wiltshire T
AD  - Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of
      Pharmacy, Chapel Hill, North Carolina, USA.
FAU - Chadwick, Lisa H
AU  - Chadwick LH
AD  - Genes Environment and Health Branch, Division of Extramural Research and
      Training, National Institute of Environmental Health Sciences, Research Triangle 
      Park, North Carolina, USA.
FAU - Duncan, Christopher G
AU  - Duncan CG
AUID- ORCID: http://orcid.org/0000-0001-7205-2414
AD  - Genes Environment and Health Branch, Division of Extramural Research and
      Training, National Institute of Environmental Health Sciences, Research Triangle 
      Park, North Carolina, USA.
FAU - Garton, Amanda E
AU  - Garton AE
AD  - Genes Environment and Health Branch, Division of Extramural Research and
      Training, National Institute of Environmental Health Sciences, Research Triangle 
      Park, North Carolina, USA.
FAU - McAllister, Kimberly A
AU  - McAllister KA
AD  - Genes Environment and Health Branch, Division of Extramural Research and
      Training, National Institute of Environmental Health Sciences, Research Triangle 
      Park, North Carolina, USA.
CN  - TaRGET II Consortium
FAU - Bartolomei, Marisa S
AU  - Bartolomei MS
AD  - Epigenetics Institute, Center for Excellence in Environmental Toxicology,
      Department of Cell and Developmental Biology, Perelman School of Medicine,
      University of Pennsylvania, Philadelphia, Pennsylvania, USA.
FAU - Walker, Cheryl L
AU  - Walker CL
AD  - Center for Precision Environmental Health, Departments of Molecular & Cellular
      Biology and Medicine, Baylor College of Medicine, Houston, Texas, USA.
FAU - Tyson, Frederick L
AU  - Tyson FL
AD  - Genes Environment and Health Branch, Division of Extramural Research and
      Training, National Institute of Environmental Health Sciences, Research Triangle 
      Park, North Carolina, USA.
LA  - eng
GR  - U24 ES026699/ES/NIEHS NIH HHS/United States
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/03/07 06:00
MHDA- 2018/03/07 06:00
CRDT- 2018/03/07 06:00
PHST- 2018/03/07 06:00 [entrez]
PHST- 2018/03/07 06:00 [pubmed]
PHST- 2018/03/07 06:00 [medline]
AID - nbt.4099 [pii]
AID - 10.1038/nbt.4099 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Mar 6;36(3):225-227. doi: 10.1038/nbt.4099.

PMID- 29509740
OWN - NLM
STAT- In-Data-Review
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 3
DP  - 2018 Mar 6
TI  - An archive written in DNA.
PG  - 236-237
LID - 10.1038/nbt.4093 [doi]
FAU - Heckel, Reinhard
AU  - Heckel R
AD  - Department of Electrical and Computer Engineering, Rice University, Houston,
      Texas, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/03/07 06:00
MHDA- 2018/03/07 06:00
CRDT- 2018/03/07 06:00
PHST- 2018/03/07 06:00 [entrez]
PHST- 2018/03/07 06:00 [pubmed]
PHST- 2018/03/07 06:00 [medline]
AID - nbt.4093 [pii]
AID - 10.1038/nbt.4093 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Mar 6;36(3):236-237. doi: 10.1038/nbt.4093.

PMID- 29509739
OWN - NLM
STAT- In-Data-Review
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 3
DP  - 2018 Mar 6
TI  - The alphabet soup of agreements.
PG  - 220-224
LID - 10.1038/nbt.4088 [doi]
FAU - Chitale, Sadhana
AU  - Chitale S
AD  - Office of Industrial Liaison, NYU Langone Medical Center, New York, New York,
      USA.
FAU - Lawler, Colm
AU  - Lawler C
AD  - Partners HealthCare, Innovation, Cambridge, Massachusetts, USA.
FAU - Macfarlane, Scott
AU  - Macfarlane S
AD  - Office of Technology Transfer, SUNY Upstate Medical University, Syracuse, New
      York, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/03/07 06:00
MHDA- 2018/03/07 06:00
CRDT- 2018/03/07 06:00
PHST- 2018/03/07 06:00 [entrez]
PHST- 2018/03/07 06:00 [pubmed]
PHST- 2018/03/07 06:00 [medline]
AID - nbt.4088 [pii]
AID - 10.1038/nbt.4088 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Mar 6;36(3):220-224. doi: 10.1038/nbt.4088.

PMID- 29509738
OWN - NLM
STAT- In-Data-Review
LR  - 20180306
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 3
DP  - 2018 Mar 6
TI  - Correction.
PG  - 214
LID - 10.1038/nbt0318-214a [doi]
AB  - This corrects the article DOI: 10.1038/nbt0218-126.
LA  - eng
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2018 Feb 6;36(2):126-127. PMID: 29406505
EDAT- 2018/03/07 06:00
MHDA- 2018/03/07 06:00
CRDT- 2018/03/07 06:00
PHST- 2018/03/07 06:00 [entrez]
PHST- 2018/03/07 06:00 [pubmed]
PHST- 2018/03/07 06:00 [medline]
AID - nbt0318-214a [pii]
AID - 10.1038/nbt0318-214a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Mar 6;36(3):214. doi: 10.1038/nbt0318-214a.

PMID- 29509737
OWN - NLM
STAT- In-Data-Review
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 3
DP  - 2018 Mar 6
TI  - The evidence gap.
PG  - 228-232
LID - 10.1038/nbt.4097 [doi]
FAU - Seyfert-Margolis, Vicki
AU  - Seyfert-Margolis V
AD  - My Own Med, Inc., Bethesda, Maryland, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/03/07 06:00
MHDA- 2018/03/07 06:00
CRDT- 2018/03/07 06:00
PHST- 2018/03/07 06:00 [entrez]
PHST- 2018/03/07 06:00 [pubmed]
PHST- 2018/03/07 06:00 [medline]
AID - nbt.4097 [pii]
AID - 10.1038/nbt.4097 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Mar 6;36(3):228-232. doi: 10.1038/nbt.4097.

PMID- 29509736
OWN - NLM
STAT- In-Data-Review
LR  - 20180306
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 3
DP  - 2018 Mar 6
TI  - Amazon's cloud on the healthcare horizon.
PG  - 205
LID - 10.1038/nbt.4107 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/03/07 06:00
MHDA- 2018/03/07 06:00
CRDT- 2018/03/07 06:00
PHST- 2018/03/07 06:00 [entrez]
PHST- 2018/03/07 06:00 [pubmed]
PHST- 2018/03/07 06:00 [medline]
AID - nbt.4107 [pii]
AID - 10.1038/nbt.4107 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Mar 6;36(3):205. doi: 10.1038/nbt.4107.

PMID- 29509734
OWN - NLM
STAT- In-Data-Review
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 3
DP  - 2018 Mar 6
TI  - EPO revokes Broad's CRISPR patent.
PG  - 209
LID - 10.1038/nbt0318-209b [doi]
FAU - Harrison, Charlotte
AU  - Harrison C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/03/07 06:00
MHDA- 2018/03/07 06:00
CRDT- 2018/03/07 06:00
PHST- 2018/03/07 06:00 [entrez]
PHST- 2018/03/07 06:00 [pubmed]
PHST- 2018/03/07 06:00 [medline]
AID - nbt0318-209b [pii]
AID - 10.1038/nbt0318-209b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Mar 6;36(3):209. doi: 10.1038/nbt0318-209b.

PMID- 29509733
OWN - NLM
STAT- In-Data-Review
LR  - 20180306
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 3
DP  - 2018 Mar 6
TI  - Preprint wipes millions off CRISPR companies' stocks.
PG  - 211
LID - 10.1038/nbt0318-211 [doi]
FAU - von Schaper, Eva
AU  - von Schaper E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/03/07 06:00
MHDA- 2018/03/07 06:00
CRDT- 2018/03/07 06:00
PHST- 2018/03/07 06:00 [entrez]
PHST- 2018/03/07 06:00 [pubmed]
PHST- 2018/03/07 06:00 [medline]
AID - nbt0318-211 [pii]
AID - 10.1038/nbt0318-211 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Mar 6;36(3):211. doi: 10.1038/nbt0318-211.

PMID- 29509732
OWN - NLM
STAT- In-Data-Review
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 3
DP  - 2018 Mar 6
TI  - Evidence for a mental health crisis in graduate education.
PG  - 282-284
LID - 10.1038/nbt.4089 [doi]
FAU - Evans, Teresa M
AU  - Evans TM
AD  - Graduate School of Biomedical Sciences and Department of Pharmacology, UT Health 
      San Antonio, San Antonio, Texas, USA.
FAU - Bira, Lindsay
AU  - Bira L
AD  - Department of Psychiatry, UT Health San Antonio, San Antonio, Texas, USA.
FAU - Gastelum, Jazmin Beltran
AU  - Gastelum JB
AD  - Department of Biology, St. Mary's University, San Antonio, Texas, USA.
FAU - Weiss, L Todd
AU  - Weiss LT
AD  - Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA.
FAU - Vanderford, Nathan L
AU  - Vanderford NL
AD  - Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA.
AD  - Department of Toxicology & Cancer Biology, University of Kentucky College of
      Medicine, Lexington, Kentucky, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/03/07 06:00
MHDA- 2018/03/07 06:00
CRDT- 2018/03/07 06:00
PHST- 2018/03/07 06:00 [entrez]
PHST- 2018/03/07 06:00 [pubmed]
PHST- 2018/03/07 06:00 [medline]
AID - nbt.4089 [pii]
AID - 10.1038/nbt.4089 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Mar 6;36(3):282-284. doi: 10.1038/nbt.4089.

PMID- 29509731
OWN - NLM
STAT- In-Data-Review
LR  - 20180306
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 3
DP  - 2018 Mar 6
TI  - Around the world in a month.
PG  - 214
LID - 10.1038/nbt0318-214b [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/03/07 06:00
MHDA- 2018/03/07 06:00
CRDT- 2018/03/07 06:00
PHST- 2018/03/07 06:00 [entrez]
PHST- 2018/03/07 06:00 [pubmed]
PHST- 2018/03/07 06:00 [medline]
AID - nbt0318-214b [pii]
AID - 10.1038/nbt0318-214b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Mar 6;36(3):214. doi: 10.1038/nbt0318-214b.

PMID- 29509730
OWN - NLM
STAT- In-Data-Review
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 3
DP  - 2018 Mar 6
TI  - Jury out on liquid biopsies for cancer.
PG  - 209-210
LID - 10.1038/nbt0318-209a [doi]
FAU - Ratner, Mark
AU  - Ratner M
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/03/07 06:00
MHDA- 2018/03/07 06:00
CRDT- 2018/03/07 06:00
PHST- 2018/03/07 06:00 [entrez]
PHST- 2018/03/07 06:00 [pubmed]
PHST- 2018/03/07 06:00 [medline]
AID - nbt0318-209a [pii]
AID - 10.1038/nbt0318-209a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Mar 6;36(3):209-210. doi: 10.1038/nbt0318-209a.

PMID- 29509728
OWN - NLM
STAT- In-Data-Review
LR  - 20180306
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 3
DP  - 2018 Mar 6
TI  - First Rounders podcast: Jeffrey Leiden.
PG  - 224
LID - 10.1038/nbt.4087 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/03/07 06:00
MHDA- 2018/03/07 06:00
CRDT- 2018/03/07 06:00
PHST- 2018/03/07 06:00 [entrez]
PHST- 2018/03/07 06:00 [pubmed]
PHST- 2018/03/07 06:00 [medline]
AID - nbt.4087 [pii]
AID - 10.1038/nbt.4087 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Mar 6;36(3):224. doi: 10.1038/nbt.4087.

PMID- 29509727
OWN - NLM
STAT- In-Data-Review
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 3
DP  - 2018 Mar 6
TI  - First off-the-shelf mesenchymal stem cell therapy nears European approval.
PG  - 212-214
LID - 10.1038/nbt0318-212a [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/03/07 06:00
MHDA- 2018/03/07 06:00
CRDT- 2018/03/07 06:00
PHST- 2018/03/07 06:00 [entrez]
PHST- 2018/03/07 06:00 [pubmed]
PHST- 2018/03/07 06:00 [medline]
AID - nbt0318-212a [pii]
AID - 10.1038/nbt0318-212a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Mar 6;36(3):212-214. doi: 10.1038/nbt0318-212a.

PMID- 29509726
OWN - NLM
STAT- In-Data-Review
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 3
DP  - 2018 Mar 6
TI  - Migraine drug race turns its final corner, FDA decisions in sight.
PG  - 207-208
LID - 10.1038/nbt0318-207 [doi]
FAU - Dolgin, Elie
AU  - Dolgin E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/03/07 06:00
MHDA- 2018/03/07 06:00
CRDT- 2018/03/07 06:00
PHST- 2018/03/07 06:00 [entrez]
PHST- 2018/03/07 06:00 [pubmed]
PHST- 2018/03/07 06:00 [medline]
AID - nbt0318-207 [pii]
AID - 10.1038/nbt0318-207 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Mar 6;36(3):207-208. doi: 10.1038/nbt0318-207.

PMID- 29457795
OWN - NLM
STAT- In-Data-Review
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 3
DP  - 2018 Mar
TI  - Random access in large-scale DNA data storage.
PG  - 242-248
LID - 10.1038/nbt.4079 [doi]
AB  - Synthetic DNA is durable and can encode digital data with high density, making it
      an attractive medium for data storage. However, recovering stored data on a
      large-scale currently requires all the DNA in a pool to be sequenced, even if
      only a subset of the information needs to be extracted. Here, we encode and store
      35 distinct files (over 200 MB of data), in more than 13 million DNA
      oligonucleotides, and show that we can recover each file individually and with no
      errors, using a random access approach. We design and validate a large library of
      primers that enable individual recovery of all files stored within the DNA. We
      also develop an algorithm that greatly reduces the sequencing read coverage
      required for error-free decoding by maximizing information from all sequence
      reads. These advances demonstrate a viable, large-scale system for DNA data
      storage and retrieval.
FAU - Organick, Lee
AU  - Organick L
AD  - Paul G. Allen School of Computer Science and Engineering, University of
      Washington, Seattle, Washington, USA.
FAU - Ang, Siena Dumas
AU  - Ang SD
AD  - Microsoft Research, Redmond, Washington, USA.
FAU - Chen, Yuan-Jyue
AU  - Chen YJ
AD  - Microsoft Research, Redmond, Washington, USA.
FAU - Lopez, Randolph
AU  - Lopez R
AD  - Department of Bioengineering Department, University of Washington, Seattle,
      Washington, USA.
FAU - Yekhanin, Sergey
AU  - Yekhanin S
AD  - Microsoft Research, Redmond, Washington, USA.
FAU - Makarychev, Konstantin
AU  - Makarychev K
AD  - Microsoft Research, Redmond, Washington, USA.
FAU - Racz, Miklos Z
AU  - Racz MZ
AD  - Microsoft Research, Redmond, Washington, USA.
FAU - Kamath, Govinda
AU  - Kamath G
AD  - Microsoft Research, Redmond, Washington, USA.
FAU - Gopalan, Parikshit
AU  - Gopalan P
AD  - Microsoft Research, Redmond, Washington, USA.
FAU - Nguyen, Bichlien
AU  - Nguyen B
AD  - Microsoft Research, Redmond, Washington, USA.
FAU - Takahashi, Christopher N
AU  - Takahashi CN
AD  - Paul G. Allen School of Computer Science and Engineering, University of
      Washington, Seattle, Washington, USA.
FAU - Newman, Sharon
AU  - Newman S
AD  - Paul G. Allen School of Computer Science and Engineering, University of
      Washington, Seattle, Washington, USA.
FAU - Parker, Hsing-Yeh
AU  - Parker HY
AD  - Microsoft Research, Redmond, Washington, USA.
FAU - Rashtchian, Cyrus
AU  - Rashtchian C
AD  - Microsoft Research, Redmond, Washington, USA.
FAU - Stewart, Kendall
AU  - Stewart K
AD  - Paul G. Allen School of Computer Science and Engineering, University of
      Washington, Seattle, Washington, USA.
FAU - Gupta, Gagan
AU  - Gupta G
AD  - Microsoft Research, Redmond, Washington, USA.
FAU - Carlson, Robert
AU  - Carlson R
AD  - Microsoft Research, Redmond, Washington, USA.
FAU - Mulligan, John
AU  - Mulligan J
AD  - Microsoft Research, Redmond, Washington, USA.
FAU - Carmean, Douglas
AU  - Carmean D
AD  - Microsoft Research, Redmond, Washington, USA.
FAU - Seelig, Georg
AU  - Seelig G
AD  - Paul G. Allen School of Computer Science and Engineering, University of
      Washington, Seattle, Washington, USA.
AD  - Department of Electrical Engineering, University of Washington, Seattle,
      Washington, USA.
FAU - Ceze, Luis
AU  - Ceze L
AD  - Paul G. Allen School of Computer Science and Engineering, University of
      Washington, Seattle, Washington, USA.
FAU - Strauss, Karin
AU  - Strauss K
AD  - Microsoft Research, Redmond, Washington, USA.
LA  - eng
PT  - Journal Article
DEP - 20180219
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/02/20 06:00
MHDA- 2018/02/20 06:00
CRDT- 2018/02/20 06:00
PHST- 2017/07/13 00:00 [received]
PHST- 2018/01/11 00:00 [accepted]
PHST- 2018/02/20 06:00 [pubmed]
PHST- 2018/02/20 06:00 [medline]
PHST- 2018/02/20 06:00 [entrez]
AID - nbt.4079 [pii]
AID - 10.1038/nbt.4079 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Mar;36(3):242-248. doi: 10.1038/nbt.4079. Epub 2018 Feb 19.

PMID- 29457794
OWN - NLM
STAT- In-Data-Review
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 3
DP  - 2018 Mar
TI  - Recon3D enables a three-dimensional view of gene variation in human metabolism.
PG  - 272-281
LID - 10.1038/nbt.4072 [doi]
AB  - Genome-scale network reconstructions have helped uncover the molecular basis of
      metabolism. Here we present Recon3D, a computational resource that includes
      three-dimensional (3D) metabolite and protein structure data and enables
      integrated analyses of metabolic functions in humans. We use Recon3D to
      functionally characterize mutations associated with disease, and identify
      metabolic response signatures that are caused by exposure to certain drugs.
      Recon3D represents the most comprehensive human metabolic network model to date, 
      accounting for 3,288 open reading frames (representing 17% of functionally
      annotated human genes), 13,543 metabolic reactions involving 4,140 unique
      metabolites, and 12,890 protein structures. These data provide a unique resource 
      for investigating molecular mechanisms of human metabolism. Recon3D is available 
      at http://vmh.life.
FAU - Brunk, Elizabeth
AU  - Brunk E
AUID- ORCID: http://orcid.org/0000-0001-8578-8658
AD  - Department of Bioengineering, University of California, San Diego, San
      Diego,California, USA.
AD  - The Novo Nordisk Foundation Center for Biosustainability, Technical University of
      Denmark, Lyngby, Denmark.
FAU - Sahoo, Swagatika
AU  - Sahoo S
AD  - Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Campus
      Belval, Esch-Sur-Alzette, Luxembourg.
FAU - Zielinski, Daniel C
AU  - Zielinski DC
AD  - Department of Bioengineering, University of California, San Diego, San
      Diego,California, USA.
FAU - Altunkaya, Ali
AU  - Altunkaya A
AUID- ORCID: http://orcid.org/0000-0002-0430-6715
AD  - RCSB Protein Data Bank, San Diego Supercomputer Center, University of California,
      San Diego, La Jolla, California, USA.
AD  - Department of Computer Science, Arizona State University, Tempe, AZ 85281,
      Arizona, USA.
FAU - Drager, Andreas
AU  - Drager A
AUID- ORCID: http://orcid.org/0000-0002-1240-5553
AD  - Applied Bioinformatics Group, Center for Bioinformatics Tubingen (ZBIT),
      University of Tubingen, Tubingen, Germany.
FAU - Mih, Nathan
AU  - Mih N
AD  - Department of Bioengineering, University of California, San Diego, San
      Diego,California, USA.
FAU - Gatto, Francesco
AU  - Gatto F
AUID- ORCID: http://orcid.org/0000-0002-9031-9562
AD  - Department of Bioengineering, University of California, San Diego, San
      Diego,California, USA.
AD  - Department of Biology and Biological Engineering, Chalmers University of
      Technology, Gothenburg,Sweden.
FAU - Nilsson, Avlant
AU  - Nilsson A
AUID- ORCID: http://orcid.org/0000-0002-9476-4516
AD  - Department of Biology and Biological Engineering, Chalmers University of
      Technology, Gothenburg,Sweden.
FAU - Preciat Gonzalez, German Andres
AU  - Preciat Gonzalez GA
AUID- ORCID: http://orcid.org/0000-0003-4903-9515
AD  - Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Campus
      Belval, Esch-Sur-Alzette, Luxembourg.
FAU - Aurich, Maike Kathrin
AU  - Aurich MK
AD  - Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Campus
      Belval, Esch-Sur-Alzette, Luxembourg.
FAU - Prlic, Andreas
AU  - Prlic A
AD  - RCSB Protein Data Bank, San Diego Supercomputer Center, University of California,
      San Diego, La Jolla, California, USA.
FAU - Sastry, Anand
AU  - Sastry A
AD  - Department of Bioengineering, University of California, San Diego, San
      Diego,California, USA.
FAU - Danielsdottir, Anna D
AU  - Danielsdottir AD
AD  - Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Campus
      Belval, Esch-Sur-Alzette, Luxembourg.
FAU - Heinken, Almut
AU  - Heinken A
AD  - Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Campus
      Belval, Esch-Sur-Alzette, Luxembourg.
FAU - Noronha, Alberto
AU  - Noronha A
AD  - Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Campus
      Belval, Esch-Sur-Alzette, Luxembourg.
FAU - Rose, Peter W
AU  - Rose PW
AD  - RCSB Protein Data Bank, San Diego Supercomputer Center, University of California,
      San Diego, La Jolla, California, USA.
FAU - Burley, Stephen K
AU  - Burley SK
AD  - RCSB Protein Data Bank, San Diego Supercomputer Center, University of California,
      San Diego, La Jolla, California, USA.
AD  - Department of Chemistry and Chemical Biology, Center for Integrative Proteomics
      Research, Institute for Quantitative Biomedicine, and Rutgers Cancer Institute of
      New Jersey, Rutgers, The State University of New Jersey, Piscataway, New Jersey, 
      USA.
FAU - Fleming, Ronan M T
AU  - Fleming RMT
AUID- ORCID: http://orcid.org/0000-0001-5346-9812
AD  - Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Campus
      Belval, Esch-Sur-Alzette, Luxembourg.
AD  - Division of Analytical Biosciences, Leiden Academic Centre for Drug Research,
      Faculty of Science, University of Leiden, Leiden, the Netherlands.
FAU - Nielsen, Jens
AU  - Nielsen J
AUID- ORCID: http://orcid.org/0000-0002-9955-6003
AD  - The Novo Nordisk Foundation Center for Biosustainability, Technical University of
      Denmark, Lyngby, Denmark.
AD  - Department of Biology and Biological Engineering, Chalmers University of
      Technology, Gothenburg,Sweden.
FAU - Thiele, Ines
AU  - Thiele I
AUID- ORCID: http://orcid.org/0000-0002-8071-7110
AD  - Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Campus
      Belval, Esch-Sur-Alzette, Luxembourg.
FAU - Palsson, Bernhard O
AU  - Palsson BO
AUID- ORCID: http://orcid.org/0000-0003-2357-6785
AD  - Department of Bioengineering, University of California, San Diego, San
      Diego,California, USA.
AD  - The Novo Nordisk Foundation Center for Biosustainability, Technical University of
      Denmark, Lyngby, Denmark.
AD  - Department of Pediatrics, University of California, San Diego, La Jolla, CA, USA.
LA  - eng
GR  - R01 GM057089/GM/NIGMS NIH HHS/United States
PT  - Journal Article
DEP - 20180219
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
PMC - PMC5840010
MID - NIHMS934074
EDAT- 2018/02/20 06:00
MHDA- 2018/02/20 06:00
CRDT- 2018/02/20 06:00
PMCR- 2018/08/19 00:00
PHST- 2016/06/19 00:00 [received]
PHST- 2018/01/10 00:00 [accepted]
PHST- 2018/08/19 00:00 [pmc-release]
PHST- 2018/02/20 06:00 [pubmed]
PHST- 2018/02/20 06:00 [medline]
PHST- 2018/02/20 06:00 [entrez]
AID - nbt.4072 [pii]
AID - 10.1038/nbt.4072 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Mar;36(3):272-281. doi: 10.1038/nbt.4072. Epub 2018 Feb 19.

PMID- 29431741
OWN - NLM
STAT- In-Data-Review
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 3
DP  - 2018 Mar
TI  - Sugar release and growth of biofuel crops are improved by downregulation of
      pectin biosynthesis.
PG  - 249-257
LID - 10.1038/nbt.4067 [doi]
AB  - Cell walls in crops and trees have been engineered for production of biofuels and
      commodity chemicals, but engineered varieties often fail multi-year field trials 
      and are not commercialized. We engineered reduced expression of a pectin
      biosynthesis gene (Galacturonosyltransferase 4, GAUT4) in switchgrass and poplar,
      and find that this improves biomass yields and sugar release from biomass
      processing. Both traits were maintained in a 3-year field trial of
      GAUT4-knockdown switchgrass, with up to sevenfold increased saccharification and 
      ethanol production and sixfold increased biomass yield compared with control
      plants. We show that GAUT4 is an alpha-1,4-galacturonosyltransferase that
      synthesizes homogalacturonan (HG). Downregulation of GAUT4 reduces HG and
      rhamnogalacturonan II (RGII), reduces wall calcium and boron, and increases
      extractability of cell wall sugars. Decreased recalcitrance in biomass processing
      and increased growth are likely due to reduced HG and RGII cross-linking in the
      cell wall.
FAU - Biswal, Ajaya K
AU  - Biswal AK
AD  - Department of Biochemistry and Molecular Biology, University of Georgia, Athens, 
      Georgia, USA.
AD  - Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia,
      USA.
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
FAU - Atmodjo, Melani A
AU  - Atmodjo MA
AUID- ORCID: http://orcid.org/0000-0001-5176-0008
AD  - Department of Biochemistry and Molecular Biology, University of Georgia, Athens, 
      Georgia, USA.
AD  - Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia,
      USA.
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
FAU - Li, Mi
AU  - Li M
AUID- ORCID: http://orcid.org/0000-0001-7523-1266
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA.
AD  - UT-ORNL Joint Institute for Biological Sciences, Oak Ridge, Tennessee, USA.
FAU - Baxter, Holly L
AU  - Baxter HL
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - Department of Plant Sciences, University of Tennessee, Knoxville, Tennessee, USA.
FAU - Yoo, Chang Geun
AU  - Yoo CG
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA.
AD  - UT-ORNL Joint Institute for Biological Sciences, Oak Ridge, Tennessee, USA.
FAU - Pu, Yunqiao
AU  - Pu Y
AUID- ORCID: http://orcid.org/0000-0003-2554-1447
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA.
AD  - UT-ORNL Joint Institute for Biological Sciences, Oak Ridge, Tennessee, USA.
FAU - Lee, Yi-Ching
AU  - Lee YC
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - Noble Research Institute, Ardmore, Oklahoma, USA.
FAU - Mazarei, Mitra
AU  - Mazarei M
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - Department of Plant Sciences, University of Tennessee, Knoxville, Tennessee, USA.
FAU - Black, Ian M
AU  - Black IM
AD  - Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia,
      USA.
FAU - Zhang, Ji-Yi
AU  - Zhang JY
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - Noble Research Institute, Ardmore, Oklahoma, USA.
FAU - Ramanna, Hema
AU  - Ramanna H
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - Noble Research Institute, Ardmore, Oklahoma, USA.
FAU - Bray, Adam L
AU  - Bray AL
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - Institute of Plant Breeding, Genetics and Genomics, University of Georgia,
      Athens, Georgia, USA.
FAU - King, Zachary R
AU  - King ZR
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - Institute of Plant Breeding, Genetics and Genomics, University of Georgia,
      Athens, Georgia, USA.
FAU - LaFayette, Peter R
AU  - LaFayette PR
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - Institute of Plant Breeding, Genetics and Genomics, University of Georgia,
      Athens, Georgia, USA.
FAU - Pattathil, Sivakumar
AU  - Pattathil S
AD  - Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia,
      USA.
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
FAU - Donohoe, Bryon S
AU  - Donohoe BS
AUID- ORCID: http://orcid.org/0000-0002-2272-5059
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - National Renewable Energy Laboratory, Golden, Colorado, USA.
FAU - Mohanty, Sushree S
AU  - Mohanty SS
AD  - Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia,
      USA.
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
FAU - Ryno, David
AU  - Ryno D
AD  - Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia,
      USA.
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
FAU - Yee, Kelsey
AU  - Yee K
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA.
FAU - Thompson, Olivia A
AU  - Thompson OA
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA.
FAU - Rodriguez, Miguel Jr.
AU  - Rodriguez M Jr.
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA.
FAU - Dumitrache, Alexandru
AU  - Dumitrache A
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA.
FAU - Natzke, Jace
AU  - Natzke J
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA.
FAU - Winkeler, Kim
AU  - Winkeler K
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - ArborGen, Inc., Ridgeville, South Carolina, USA.
FAU - Collins, Cassandra
AU  - Collins C
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - ArborGen, Inc., Ridgeville, South Carolina, USA.
FAU - Yang, Xiaohan
AU  - Yang X
AUID- ORCID: http://orcid.org/0000-0001-5207-4210
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA.
FAU - Tan, Li
AU  - Tan L
AD  - Department of Biochemistry and Molecular Biology, University of Georgia, Athens, 
      Georgia, USA.
AD  - Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia,
      USA.
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
FAU - Sykes, Robert W
AU  - Sykes RW
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - National Renewable Energy Laboratory, Golden, Colorado, USA.
FAU - Gjersing, Erica L
AU  - Gjersing EL
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - National Renewable Energy Laboratory, Golden, Colorado, USA.
FAU - Ziebell, Angela
AU  - Ziebell A
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - National Renewable Energy Laboratory, Golden, Colorado, USA.
FAU - Turner, Geoffrey B
AU  - Turner GB
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - National Renewable Energy Laboratory, Golden, Colorado, USA.
FAU - Decker, Stephen R
AU  - Decker SR
AUID- ORCID: http://orcid.org/0000-0001-7002-9034
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - National Renewable Energy Laboratory, Golden, Colorado, USA.
FAU - Hahn, Michael G
AU  - Hahn MG
AUID- ORCID: http://orcid.org/0000-0003-2136-5191
AD  - Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia,
      USA.
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - Department of Plant Biology, University of Georgia, Athens, Georgia, USA.
FAU - Davison, Brian H
AU  - Davison BH
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA.
FAU - Udvardi, Michael K
AU  - Udvardi MK
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - Noble Research Institute, Ardmore, Oklahoma, USA.
FAU - Mielenz, Jonathan R
AU  - Mielenz JR
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA.
FAU - Davis, Mark F
AU  - Davis MF
AUID- ORCID: http://orcid.org/0000-0003-4541-9852
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - National Renewable Energy Laboratory, Golden, Colorado, USA.
FAU - Nelson, Richard S
AU  - Nelson RS
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - Noble Research Institute, Ardmore, Oklahoma, USA.
FAU - Parrott, Wayne A
AU  - Parrott WA
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - Institute of Plant Breeding, Genetics and Genomics, University of Georgia,
      Athens, Georgia, USA.
FAU - Ragauskas, Arthur J
AU  - Ragauskas AJ
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA.
AD  - UT-ORNL Joint Institute for Biological Sciences, Oak Ridge, Tennessee, USA.
AD  - Department of Chemical and Biomolecular Engineering & Department of Forestry,
      Wildlife, and Fisheries, University of Tennessee, Knoxville, Tennessee, USA.
FAU - Neal Stewart, C Jr
AU  - Neal Stewart C Jr
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
AD  - Department of Plant Sciences, University of Tennessee, Knoxville, Tennessee, USA.
FAU - Mohnen, Debra
AU  - Mohnen D
AD  - Department of Biochemistry and Molecular Biology, University of Georgia, Athens, 
      Georgia, USA.
AD  - Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia,
      USA.
AD  - DOE-BioEnergy Science Center (BESC), Oak Ridge National Laboratory, Oak Ridge,
      Tennessee, USA.
LA  - eng
PT  - Journal Article
DEP - 20180212
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/02/13 06:00
MHDA- 2018/02/13 06:00
CRDT- 2018/02/13 06:00
PHST- 2017/06/14 00:00 [received]
PHST- 2018/01/02 00:00 [accepted]
PHST- 2018/02/13 06:00 [pubmed]
PHST- 2018/02/13 06:00 [medline]
PHST- 2018/02/13 06:00 [entrez]
AID - nbt.4067 [pii]
AID - 10.1038/nbt.4067 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Mar;36(3):249-257. doi: 10.1038/nbt.4067. Epub 2018 Feb 12.

PMID- 29431740
OWN - NLM
STAT- In-Data-Review
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 3
DP  - 2018 Mar
TI  - Deep learning improves prediction of CRISPR-Cpf1 guide RNA activity.
PG  - 239-241
LID - 10.1038/nbt.4061 [doi]
AB  - We present two algorithms to predict the activity of AsCpf1 guide RNAs. Indel
      frequencies for 15,000 target sequences were used in a deep-learning framework
      based on a convolutional neural network to train Seq-deepCpf1. We then
      incorporated chromatin accessibility information to create the better-performing 
      DeepCpf1 algorithm for cell lines for which such information is available and
      show that both algorithms outperform previous machine learning algorithms on our 
      own and published data sets.
FAU - Kim, Hui Kwon
AU  - Kim HK
AD  - Department of Pharmacology, Yonsei University College of Medicine, Seoul,
      Republic of Korea.
AD  - Brain Korea 21 Plus Project for Medical Sciences, Yonsei University College of
      Medicine, Seoul, Republic of Korea.
FAU - Min, Seonwoo
AU  - Min S
AD  - Electrical and Computer Engineering, Seoul National University, Seoul, Republic
      of Korea.
FAU - Song, Myungjae
AU  - Song M
AD  - Department of Pharmacology, Yonsei University College of Medicine, Seoul,
      Republic of Korea.
AD  - Graduate School of Biomedical Science and Engineering, Hanyang University, Seoul,
      Republic of Korea.
FAU - Jung, Soobin
AU  - Jung S
AD  - Department of Pharmacology, Yonsei University College of Medicine, Seoul,
      Republic of Korea.
AD  - Brain Korea 21 Plus Project for Medical Sciences, Yonsei University College of
      Medicine, Seoul, Republic of Korea.
FAU - Choi, Jae Woo
AU  - Choi JW
AD  - Department of Pharmacology, Yonsei University College of Medicine, Seoul,
      Republic of Korea.
AD  - Severance Biomedical Science Institute, Yonsei University College of Medicine,
      Seoul, Republic of Korea.
FAU - Kim, Younggwang
AU  - Kim Y
AD  - Department of Pharmacology, Yonsei University College of Medicine, Seoul,
      Republic of Korea.
AD  - Brain Korea 21 Plus Project for Medical Sciences, Yonsei University College of
      Medicine, Seoul, Republic of Korea.
FAU - Lee, Sangeun
AU  - Lee S
AD  - Department of Pharmacology, Yonsei University College of Medicine, Seoul,
      Republic of Korea.
AD  - Brain Korea 21 Plus Project for Medical Sciences, Yonsei University College of
      Medicine, Seoul, Republic of Korea.
FAU - Yoon, Sungroh
AU  - Yoon S
AUID- ORCID: http://orcid.org/0000-0002-2367-197X
AD  - Electrical and Computer Engineering, Seoul National University, Seoul, Republic
      of Korea.
AD  - Interdisciplinary Program in Bioinformatics, Seoul National University, Seoul,
      Republic of Korea.
FAU - Kim, Hyongbum Henry
AU  - Kim HH
AUID- ORCID: http://orcid.org/0000-0002-4693-738X
AD  - Department of Pharmacology, Yonsei University College of Medicine, Seoul,
      Republic of Korea.
AD  - Brain Korea 21 Plus Project for Medical Sciences, Yonsei University College of
      Medicine, Seoul, Republic of Korea.
AD  - Severance Biomedical Science Institute, Yonsei University College of Medicine,
      Seoul, Republic of Korea.
AD  - Center for Nanomedicine, Institute for Basic Science (IBS), Seoul, Republic of
      Korea.
AD  - Yonsei-IBS Institute, Yonsei University, Seoul, Republic of Korea.
LA  - eng
PT  - Journal Article
DEP - 20180129
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/02/13 06:00
MHDA- 2018/02/13 06:00
CRDT- 2018/02/13 06:00
PHST- 2017/05/24 00:00 [received]
PHST- 2017/12/08 00:00 [accepted]
PHST- 2018/02/13 06:00 [pubmed]
PHST- 2018/02/13 06:00 [medline]
PHST- 2018/02/13 06:00 [entrez]
AID - nbt.4061 [pii]
AID - 10.1038/nbt.4061 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Mar;36(3):239-241. doi: 10.1038/nbt.4061. Epub 2018 Jan 29.

PMID- 29431739
OWN - NLM
STAT- In-Data-Review
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 3
DP  - 2018 Mar
TI  - A highly specific SpCas9 variant is identified by in vivo screening in yeast.
PG  - 265-271
LID - 10.1038/nbt.4066 [doi]
AB  - Despite the utility of CRISPR-Cas9 nucleases for genome editing, the potential
      for off-target activity limits their application, especially for therapeutic
      purposes. We developed a yeast-based assay to identify optimized Streptococcus
      pyogenes Cas9 (SpCas9) variants that enables simultaneous evaluation of on- and
      off-target activity. We screened a library of SpCas9 variants carrying random
      mutations in the REC3 domain and identified mutations that increased editing
      accuracy while maintaining editing efficiency. We combined four beneficial
      mutations to generate evoCas9, a variant that has fidelity exceeding both
      wild-type (79-fold improvement) and rationally designed Cas9 variants (fourfold
      average improvement), while maintaining near wild-type on-target editing
      efficiency (90% median residual activity). Evaluating evoCas9 on endogenous
      genomic loci, we demonstrated a substantially improved specificity and observed
      no off-target sites for four of the eight single guide RNAs (sgRNAs) tested.
      Finally, we showed that following long-term expression (40 d), evoCas9 strongly
      limited the nonspecific cleavage of a difficult-to-discriminate off-target site
      and fully abrogated the cleavage of two additional off-target sites.
FAU - Casini, Antonio
AU  - Casini A
AUID- ORCID: http://orcid.org/0000-0001-7709-4955
AD  - Centre for Integrative Biology (CIBIO), University of Trento, Laboratory of
      Molecular Virology, Trento, Italy.
FAU - Olivieri, Michele
AU  - Olivieri M
AUID- ORCID: http://orcid.org/0000-0002-0257-998X
AD  - Centre for Integrative Biology (CIBIO), University of Trento, Laboratory of
      Molecular Virology, Trento, Italy.
FAU - Petris, Gianluca
AU  - Petris G
AUID- ORCID: http://orcid.org/0000-0002-2420-6359
AD  - Centre for Integrative Biology (CIBIO), University of Trento, Laboratory of
      Molecular Virology, Trento, Italy.
FAU - Montagna, Claudia
AU  - Montagna C
AD  - Centre for Integrative Biology (CIBIO), University of Trento, Laboratory of
      Molecular Virology, Trento, Italy.
FAU - Reginato, Giordano
AU  - Reginato G
AD  - Centre for Integrative Biology (CIBIO), University of Trento, Laboratory of
      Molecular Virology, Trento, Italy.
FAU - Maule, Giulia
AU  - Maule G
AD  - Centre for Integrative Biology (CIBIO), University of Trento, Laboratory of
      Molecular Virology, Trento, Italy.
FAU - Lorenzin, Francesca
AU  - Lorenzin F
AD  - Centre for Integrative Biology (CIBIO), University of Trento, Laboratory of
      Computational Oncology, Trento, Italy.
FAU - Prandi, Davide
AU  - Prandi D
AD  - Centre for Integrative Biology (CIBIO), University of Trento, Laboratory of
      Computational Oncology, Trento, Italy.
FAU - Romanel, Alessandro
AU  - Romanel A
AUID- ORCID: http://orcid.org/0000-0003-4855-8620
AD  - Centre for Integrative Biology (CIBIO), University of Trento, Laboratory of
      Computational Oncology, Trento, Italy.
FAU - Demichelis, Francesca
AU  - Demichelis F
AD  - Centre for Integrative Biology (CIBIO), University of Trento, Laboratory of
      Computational Oncology, Trento, Italy.
FAU - Inga, Alberto
AU  - Inga A
AD  - Centre for Integrative Biology (CIBIO), Laboratory of Transcriptional Networks,
      Trento, Italy.
FAU - Cereseto, Anna
AU  - Cereseto A
AD  - Centre for Integrative Biology (CIBIO), University of Trento, Laboratory of
      Molecular Virology, Trento, Italy.
LA  - eng
PT  - Journal Article
DEP - 20180129
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/02/13 06:00
MHDA- 2018/02/13 06:00
CRDT- 2018/02/13 06:00
PHST- 2017/03/14 00:00 [received]
PHST- 2017/12/22 00:00 [accepted]
PHST- 2018/02/13 06:00 [pubmed]
PHST- 2018/02/13 06:00 [medline]
PHST- 2018/02/13 06:00 [entrez]
AID - nbt.4066 [pii]
AID - 10.1038/nbt.4066 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Mar;36(3):265-271. doi: 10.1038/nbt.4066. Epub 2018 Jan 29.

PMID- 29431737
OWN - NLM
STAT- In-Data-Review
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 3
DP  - 2018 Mar
TI  - A DNA nanorobot functions as a cancer therapeutic in response to a molecular
      trigger in vivo.
PG  - 258-264
LID - 10.1038/nbt.4071 [doi]
AB  - Nanoscale robots have potential as intelligent drug delivery systems that respond
      to molecular triggers. Using DNA origami we constructed an autonomous DNA robot
      programmed to transport payloads and present them specifically in tumors. Our
      nanorobot is functionalized on the outside with a DNA aptamer that binds
      nucleolin, a protein specifically expressed on tumor-associated endothelial
      cells, and the blood coagulation protease thrombin within its inner cavity. The
      nucleolin-targeting aptamer serves both as a targeting domain and as a molecular 
      trigger for the mechanical opening of the DNA nanorobot. The thrombin inside is
      thus exposed and activates coagulation at the tumor site. Using tumor-bearing
      mouse models, we demonstrate that intravenously injected DNA nanorobots deliver
      thrombin specifically to tumor-associated blood vessels and induce intravascular 
      thrombosis, resulting in tumor necrosis and inhibition of tumor growth. The
      nanorobot proved safe and immunologically inert in mice and Bama miniature pigs. 
      Our data show that DNA nanorobots represent a promising strategy for precise drug
      delivery in cancer therapy.
FAU - Li, Suping
AU  - Li S
AD  - CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, CAS Key 
      Laboratory of Nanosystem and Hierarchical Fabrication, CAS Center for Excellence 
      in Nanoscience, National Center for Nanoscience and Technology, China, Beijing,
      China.
AD  - University of Chinese Academy of Sciences, Beijing, China.
FAU - Jiang, Qiao
AU  - Jiang Q
AD  - CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, CAS Key 
      Laboratory of Nanosystem and Hierarchical Fabrication, CAS Center for Excellence 
      in Nanoscience, National Center for Nanoscience and Technology, China, Beijing,
      China.
FAU - Liu, Shaoli
AU  - Liu S
AD  - CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, CAS Key 
      Laboratory of Nanosystem and Hierarchical Fabrication, CAS Center for Excellence 
      in Nanoscience, National Center for Nanoscience and Technology, China, Beijing,
      China.
AD  - University of Chinese Academy of Sciences, Beijing, China.
FAU - Zhang, Yinlong
AU  - Zhang Y
AD  - CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, CAS Key 
      Laboratory of Nanosystem and Hierarchical Fabrication, CAS Center for Excellence 
      in Nanoscience, National Center for Nanoscience and Technology, China, Beijing,
      China.
AD  - College of Pharmaceutical Science, Jilin University, Changchun, China.
FAU - Tian, Yanhua
AU  - Tian Y
AD  - CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, CAS Key 
      Laboratory of Nanosystem and Hierarchical Fabrication, CAS Center for Excellence 
      in Nanoscience, National Center for Nanoscience and Technology, China, Beijing,
      China.
AD  - Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary 
      Studies, Peking University, Beijing, China.
FAU - Song, Chen
AU  - Song C
AD  - CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, CAS Key 
      Laboratory of Nanosystem and Hierarchical Fabrication, CAS Center for Excellence 
      in Nanoscience, National Center for Nanoscience and Technology, China, Beijing,
      China.
FAU - Wang, Jing
AU  - Wang J
AD  - CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, CAS Key 
      Laboratory of Nanosystem and Hierarchical Fabrication, CAS Center for Excellence 
      in Nanoscience, National Center for Nanoscience and Technology, China, Beijing,
      China.
FAU - Zou, Yiguo
AU  - Zou Y
AD  - CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, CAS Key 
      Laboratory of Nanosystem and Hierarchical Fabrication, CAS Center for Excellence 
      in Nanoscience, National Center for Nanoscience and Technology, China, Beijing,
      China.
FAU - Anderson, Gregory J
AU  - Anderson GJ
AD  - QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
FAU - Han, Jing-Yan
AU  - Han JY
AD  - Department of Integration of Chinese and Western Medicine, School of Basic
      Medical Sciences, Peking University, Beijing, China.
FAU - Chang, Yung
AU  - Chang Y
AD  - School of Molecular Sciences, Center for Molecular Design and Biomimetics; School
      of Life Sciences, Center for Immunotherapy, Vaccines, and Virotherapy at the
      Biodesign Institute, Arizona State University, Tempe, Arizona, USA.
FAU - Liu, Yan
AU  - Liu Y
AUID- ORCID: http://orcid.org/0000-0003-0906-2606
AD  - School of Molecular Sciences, Center for Molecular Design and Biomimetics; School
      of Life Sciences, Center for Immunotherapy, Vaccines, and Virotherapy at the
      Biodesign Institute, Arizona State University, Tempe, Arizona, USA.
FAU - Zhang, Chen
AU  - Zhang C
AD  - Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
FAU - Chen, Liang
AU  - Chen L
AD  - Institute of Life and Health Engineering, College of Life Science and Technology,
      Jinan University, Guangzhou, China.
FAU - Zhou, Guangbiao
AU  - Zhou G
AD  - Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
FAU - Nie, Guangjun
AU  - Nie G
AD  - CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, CAS Key 
      Laboratory of Nanosystem and Hierarchical Fabrication, CAS Center for Excellence 
      in Nanoscience, National Center for Nanoscience and Technology, China, Beijing,
      China.
AD  - University of Chinese Academy of Sciences, Beijing, China.
FAU - Yan, Hao
AU  - Yan H
AD  - School of Molecular Sciences, Center for Molecular Design and Biomimetics; School
      of Life Sciences, Center for Immunotherapy, Vaccines, and Virotherapy at the
      Biodesign Institute, Arizona State University, Tempe, Arizona, USA.
FAU - Ding, Baoquan
AU  - Ding B
AD  - CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, CAS Key 
      Laboratory of Nanosystem and Hierarchical Fabrication, CAS Center for Excellence 
      in Nanoscience, National Center for Nanoscience and Technology, China, Beijing,
      China.
AD  - University of Chinese Academy of Sciences, Beijing, China.
FAU - Zhao, Yuliang
AU  - Zhao Y
AUID- ORCID: http://orcid.org/0000-0002-9586-9360
AD  - CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, CAS Key 
      Laboratory of Nanosystem and Hierarchical Fabrication, CAS Center for Excellence 
      in Nanoscience, National Center for Nanoscience and Technology, China, Beijing,
      China.
AD  - University of Chinese Academy of Sciences, Beijing, China.
LA  - eng
PT  - Journal Article
DEP - 20180212
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/02/13 06:00
MHDA- 2018/02/13 06:00
CRDT- 2018/02/13 06:00
PHST- 2016/06/16 00:00 [received]
PHST- 2018/01/09 00:00 [accepted]
PHST- 2018/02/13 06:00 [pubmed]
PHST- 2018/02/13 06:00 [medline]
PHST- 2018/02/13 06:00 [entrez]
AID - nbt.4071 [pii]
AID - 10.1038/nbt.4071 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Mar;36(3):258-264. doi: 10.1038/nbt.4071. Epub 2018 Feb 12.

PMID- 29406517
OWN - NLM
STAT- In-Data-Review
LR  - 20180206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 2
DP  - 2018 Feb 6
TI  - A less than ideal Deal.
PG  - 117
LID - 10.1038/nbt.4084 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/02/07 06:00
MHDA- 2018/02/07 06:00
CRDT- 2018/02/07 06:00
PHST- 2018/02/07 06:00 [entrez]
PHST- 2018/02/07 06:00 [pubmed]
PHST- 2018/02/07 06:00 [medline]
AID - nbt.4084 [pii]
AID - 10.1038/nbt.4084 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Feb 6;36(2):117. doi: 10.1038/nbt.4084.

PMID- 29406516
OWN - NLM
STAT- In-Data-Review
LR  - 20180209
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 2
DP  - 2018 Feb 6
TI  - Corrigendum: Minimum information about a single amplified genome (MISAG) and a
      metagenome-assembled genome (MIMAG) of bacteria and archaea.
PG  - 196
LID - 10.1038/nbt0218-196a [doi]
FAU - Bowers, Robert M
AU  - Bowers RM
FAU - Kyrpides, Nikos C
AU  - Kyrpides NC
FAU - Stepanauskas, Ramunas
AU  - Stepanauskas R
FAU - Harmon-Smith, Miranda
AU  - Harmon-Smith M
FAU - Doud, Devin
AU  - Doud D
FAU - Reddy, T B K
AU  - Reddy TBK
FAU - Schulz, Frederik
AU  - Schulz F
FAU - Jarett, Jessica
AU  - Jarett J
FAU - Rivers, Adam R
AU  - Rivers AR
FAU - Eloe-Fadrosh, Emiley A
AU  - Eloe-Fadrosh EA
FAU - Tringe, Susannah G
AU  - Tringe SG
FAU - Ivanova, Natalia N
AU  - Ivanova NN
FAU - Copeland, Alex
AU  - Copeland A
FAU - Clum, Alicia
AU  - Clum A
FAU - Becraft, Eric D
AU  - Becraft ED
FAU - Malmstrom, Rex R
AU  - Malmstrom RR
FAU - Birren, Bruce
AU  - Birren B
FAU - Podar, Mircea
AU  - Podar M
FAU - Bork, Peer
AU  - Bork P
FAU - Weinstock, George M
AU  - Weinstock GM
FAU - Garrity, George M
AU  - Garrity GM
FAU - Dodsworth, Jeremy A
AU  - Dodsworth JA
FAU - Yooseph, Shibu
AU  - Yooseph S
FAU - Sutton, Granger
AU  - Sutton G
FAU - Glockner, Frank O
AU  - Glockner FO
FAU - Gilbert, Jack A
AU  - Gilbert JA
FAU - Nelson, William C
AU  - Nelson WC
FAU - Hallam, Steven J
AU  - Hallam SJ
FAU - Jungbluth, Sean P
AU  - Jungbluth SP
FAU - Ettema, Thijs J G
AU  - Ettema TJG
FAU - Tighe, Scott
AU  - Tighe S
FAU - Konstantinidis, Konstantinos T
AU  - Konstantinidis KT
FAU - Liu, Wen-Tso
AU  - Liu WT
FAU - Baker, Brett J
AU  - Baker BJ
FAU - Rattei, Thomas
AU  - Rattei T
FAU - Eisen, Jonathan A
AU  - Eisen JA
FAU - Hedlund, Brian
AU  - Hedlund B
FAU - McMahon, Katherine D
AU  - McMahon KD
FAU - Fierer, Noah
AU  - Fierer N
FAU - Knight, Rob
AU  - Knight R
FAU - Finn, Rob
AU  - Finn R
FAU - Cochrane, Guy
AU  - Cochrane G
FAU - Karsch-Mizrachi, Ilene
AU  - Karsch-Mizrachi I
FAU - Tyson, Gene W
AU  - Tyson GW
FAU - Rinke, Christian
AU  - Rinke C
CN  - Genome Standards Consortium
FAU - Lapidus, Alla
AU  - Lapidus A
FAU - Meyer, Folker
AU  - Meyer F
FAU - Yilmaz, Pelin
AU  - Yilmaz P
FAU - Parks, Donovan H
AU  - Parks DH
FAU - Eren, A Murat
AU  - Eren AM
FAU - Schriml, Lynn
AU  - Schriml L
FAU - Banfield, Jillian F
AU  - Banfield JF
FAU - Hugenholtz, Philip
AU  - Hugenholtz P
FAU - Woyke, Tanja
AU  - Woyke T
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/02/07 06:00
MHDA- 2018/02/07 06:00
CRDT- 2018/02/07 06:00
PHST- 2018/02/07 06:00 [entrez]
PHST- 2018/02/07 06:00 [pubmed]
PHST- 2018/02/07 06:00 [medline]
AID - nbt0218-196a [pii]
AID - 10.1038/nbt0218-196a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Feb 6;36(2):196. doi: 10.1038/nbt0218-196a.

PMID- 29406515
OWN - NLM
STAT- In-Data-Review
LR  - 20180206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 2
DP  - 2018 Feb 6
TI  - No research in Correspondence.
PG  - 117
LID - 10.1038/nbt.4085 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/02/07 06:00
MHDA- 2018/02/07 06:00
CRDT- 2018/02/07 06:00
PHST- 2018/02/07 06:00 [entrez]
PHST- 2018/02/07 06:00 [pubmed]
PHST- 2018/02/07 06:00 [medline]
AID - nbt.4085 [pii]
AID - 10.1038/nbt.4085 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Feb 6;36(2):117. doi: 10.1038/nbt.4085.

PMID- 29406514
OWN - NLM
STAT- In-Data-Review
LR  - 20180209
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 2
DP  - 2018 Feb 6
TI  - An alternative proposal to the destruction of abandoned human embryos.
PG  - 139-141
LID - 10.1038/nbt.4070 [doi]
FAU - Gleicher, Norbert
AU  - Gleicher N
AD  - The Center for Human Reproduction, New York, New York, USA.
AD  - The Foundation for Reproductive Medicine, New York, New York, USA.
AD  - The Rockefeller University, New York, New York, USA.
AD  - Department of Obstetrics and Gynecology, University of Vienna School of Medicine,
      Vienna, Austria.
FAU - Caplan, Arthur L
AU  - Caplan AL
AD  - New York University Langone Medical Center, Division of Medical Ethics, New York,
      New York, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/02/07 06:00
MHDA- 2018/02/07 06:00
CRDT- 2018/02/07 06:00
PHST- 2018/02/07 06:00 [entrez]
PHST- 2018/02/07 06:00 [pubmed]
PHST- 2018/02/07 06:00 [medline]
AID - nbt.4070 [pii]
AID - 10.1038/nbt.4070 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Feb 6;36(2):139-141. doi: 10.1038/nbt.4070.

PMID- 29406513
OWN - NLM
STAT- In-Data-Review
LR  - 20180206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 2
DP  - 2018 Feb 6
TI  - Erratum: Increasing the efficiency of homology-directed repair for
      CRISPR-Cas9-induced precise gene editing in mammalian cells.
PG  - 196
LID - 10.1038/nbt0218-196d [doi]
FAU - Van Chu, Trung
AU  - Van Chu T
FAU - Weber, Timm
AU  - Weber T
FAU - Wefers, Benedikt
AU  - Wefers B
FAU - Wurst, Wolfgang
AU  - Wurst W
FAU - Sander, Sandrine
AU  - Sander S
FAU - Rajewsky, Klaus
AU  - Rajewsky K
FAU - Kuhn, Ralf
AU  - Kuhn R
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/02/07 06:00
MHDA- 2018/02/07 06:00
CRDT- 2018/02/07 06:00
PHST- 2018/02/07 06:00 [entrez]
PHST- 2018/02/07 06:00 [pubmed]
PHST- 2018/02/07 06:00 [medline]
AID - nbt0218-196d [pii]
AID - 10.1038/nbt0218-196d [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Feb 6;36(2):196. doi: 10.1038/nbt0218-196d.

PMID- 29406512
OWN - NLM
STAT- In-Data-Review
LR  - 20180206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 2
DP  - 2018 Feb 6
TI  - FDA warns public of dangers of DIY gene therapy.
PG  - 119-120
LID - 10.1038/nbt0218-119 [doi]
FAU - Smalley, Eric
AU  - Smalley E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/02/07 06:00
MHDA- 2018/02/07 06:00
CRDT- 2018/02/07 06:00
PHST- 2018/02/07 06:00 [entrez]
PHST- 2018/02/07 06:00 [pubmed]
PHST- 2018/02/07 06:00 [medline]
AID - nbt0218-119 [pii]
AID - 10.1038/nbt0218-119 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Feb 6;36(2):119-120. doi: 10.1038/nbt0218-119.

PMID- 29406511
OWN - NLM
STAT- In-Data-Review
LR  - 20180324
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 2
DP  - 2018 Feb 6
TI  - Making brain proteomics true to type.
PG  - 149-150
LID - 10.1038/nbt.4077 [doi]
FAU - Wilson, Rashaun S
AU  - Wilson RS
AD  - Department of Psychiatry, Yale School of Medicine, Connecticut Mental Health
      Center, New Haven, Connecticut, USA.
FAU - Nairn, Angus C
AU  - Nairn AC
AUID- ORCID: http://orcid.org/0000-0002-7075-0195
AD  - Department of Psychiatry, Yale School of Medicine, Connecticut Mental Health
      Center, New Haven, Connecticut, USA.
LA  - eng
GR  - P30 DA018343/DA/NIDA NIH HHS/United States
GR  - P50 AG047270/AG/NIA NIH HHS/United States
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/02/07 06:00
MHDA- 2018/02/07 06:00
CRDT- 2018/02/07 06:00
PHST- 2018/02/07 06:00 [entrez]
PHST- 2018/02/07 06:00 [pubmed]
PHST- 2018/02/07 06:00 [medline]
AID - nbt.4077 [pii]
AID - 10.1038/nbt.4077 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Feb 6;36(2):149-150. doi: 10.1038/nbt.4077.

PMID- 29406510
OWN - NLM
STAT- In-Data-Review
LR  - 20180209
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 2
DP  - 2018 Feb 6
TI  - PrePAIRing Cas9s for screening success.
PG  - 147-148
LID - 10.1038/nbt.4075 [doi]
FAU - Zhou, Zhuo
AU  - Zhou Z
AD  - Biodynamics Optical Imaging Center (BIOPIC), Beijing Advanced Innovation Center
      for Genomics, Peking-Tsinghua Center for Life Sciences, State Key Laboratory of
      Protein and Plant Gene Research, and School of Life Sciences, Peking University, 
      Beijing, China.
FAU - Wei, Wensheng
AU  - Wei W
AD  - Biodynamics Optical Imaging Center (BIOPIC), Beijing Advanced Innovation Center
      for Genomics, Peking-Tsinghua Center for Life Sciences, State Key Laboratory of
      Protein and Plant Gene Research, and School of Life Sciences, Peking University, 
      Beijing, China.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/02/07 06:00
MHDA- 2018/02/07 06:00
CRDT- 2018/02/07 06:00
PHST- 2018/02/07 06:00 [entrez]
PHST- 2018/02/07 06:00 [pubmed]
PHST- 2018/02/07 06:00 [medline]
AID - nbt.4075 [pii]
AID - 10.1038/nbt.4075 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Feb 6;36(2):147-148. doi: 10.1038/nbt.4075.

PMID- 29406509
OWN - NLM
STAT- In-Data-Review
LR  - 20180206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 2
DP  - 2018 Feb 6
TI  - Drug pipeline: 4Q17.
PG  - 130
LID - 10.1038/nbt.4073 [doi]
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/02/07 06:00
MHDA- 2018/02/07 06:00
CRDT- 2018/02/07 06:00
PHST- 2018/02/07 06:00 [entrez]
PHST- 2018/02/07 06:00 [pubmed]
PHST- 2018/02/07 06:00 [medline]
AID - nbt.4073 [pii]
AID - 10.1038/nbt.4073 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Feb 6;36(2):130. doi: 10.1038/nbt.4073.

PMID- 29406508
OWN - NLM
STAT- In-Data-Review
LR  - 20180209
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 2
DP  - 2018 Feb 6
TI  - Tertiary patenting on drug-device combination products in the United States.
PG  - 142-145
LID - 10.1038/nbt.4078 [doi]
FAU - Beall, Reed F
AU  - Beall RF
AD  - Program On Regulation, Therapeutics, And Law (PORTAL), Division of
      Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and
      Harvard Medical School, Boston, Massachusetts, USA.
FAU - Kesselheim, Aaron S
AU  - Kesselheim AS
AD  - Program On Regulation, Therapeutics, And Law (PORTAL), Division of
      Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and
      Harvard Medical School, Boston, Massachusetts, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/02/07 06:00
MHDA- 2018/02/07 06:00
CRDT- 2018/02/07 06:00
PHST- 2018/02/07 06:00 [entrez]
PHST- 2018/02/07 06:00 [pubmed]
PHST- 2018/02/07 06:00 [medline]
AID - nbt.4078 [pii]
AID - 10.1038/nbt.4078 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Feb 6;36(2):142-145. doi: 10.1038/nbt.4078.

PMID- 29406507
OWN - NLM
STAT- In-Data-Review
LR  - 20180209
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 2
DP  - 2018 Feb 6
TI  - Corrigendum: Reproducing with DNA.
PG  - 196
LID - 10.1038/nbt0218-196c [doi]
FAU - Branca, Malorye Allison
AU  - Branca MA
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/02/07 06:00
MHDA- 2018/02/07 06:00
CRDT- 2018/02/07 06:00
PHST- 2018/02/07 06:00 [entrez]
PHST- 2018/02/07 06:00 [pubmed]
PHST- 2018/02/07 06:00 [medline]
AID - nbt0218-196c [pii]
AID - 10.1038/nbt0218-196c [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Feb 6;36(2):196. doi: 10.1038/nbt0218-196c.

PMID- 29406506
OWN - NLM
STAT- In-Data-Review
LR  - 20180209
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 2
DP  - 2018 Feb 6
TI  - Corrigendum: Assisted reproductive technologies to prevent human mitochondrial
      disease transmission.
PG  - 196
LID - 10.1038/nbt0218-196b [doi]
FAU - Greenfield, Andy
AU  - Greenfield A
FAU - Braude, Peter
AU  - Braude P
FAU - Flinter, Frances
AU  - Flinter F
FAU - Lovell-Badge, Robin
AU  - Lovell-Badge R
FAU - Ogilvie, Caroline
AU  - Ogilvie C
FAU - Perry, Anthony C F
AU  - Perry ACF
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/02/07 06:00
MHDA- 2018/02/07 06:00
CRDT- 2018/02/07 06:00
PHST- 2018/02/07 06:00 [entrez]
PHST- 2018/02/07 06:00 [pubmed]
PHST- 2018/02/07 06:00 [medline]
AID - nbt0218-196b [pii]
AID - 10.1038/nbt0218-196b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Feb 6;36(2):196. doi: 10.1038/nbt0218-196b.

PMID- 29406505
OWN - NLM
STAT- In-Data-Review
LR  - 20180306
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 2
DP  - 2018 Feb 6
TI  - California voters and CIRM-will lightning strike twice?
PG  - 126-127
LID - 10.1038/nbt0218-126 [doi]
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EIN - Nat Biotechnol. 2018 Mar 6;36(3):214. PMID: 29509738
EDAT- 2018/02/07 06:00
MHDA- 2018/02/07 06:00
CRDT- 2018/02/07 06:00
PHST- 2018/02/07 06:00 [entrez]
PHST- 2018/02/07 06:00 [pubmed]
PHST- 2018/02/07 06:00 [medline]
AID - nbt0218-126 [pii]
AID - 10.1038/nbt0218-126 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Feb 6;36(2):126-127. doi: 10.1038/nbt0218-126.

PMID- 29406503
OWN - NLM
STAT- In-Data-Review
LR  - 20180206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 2
DP  - 2018 Feb 6
TI  - 2017-venture funding goes into overdrive.
PG  - 129
LID - 10.1038/nbt.4081 [doi]
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/02/07 06:00
MHDA- 2018/02/07 06:00
CRDT- 2018/02/07 06:00
PHST- 2018/02/07 06:00 [entrez]
PHST- 2018/02/07 06:00 [pubmed]
PHST- 2018/02/07 06:00 [medline]
AID - nbt.4081 [pii]
AID - 10.1038/nbt.4081 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Feb 6;36(2):129. doi: 10.1038/nbt.4081.

PMID- 29406502
OWN - NLM
STAT- In-Data-Review
LR  - 20180209
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 2
DP  - 2018 Feb 6
TI  - US tax reform may jeopardize orphans.
PG  - 128
LID - 10.1038/nbt0218-128 [doi]
FAU - Morrison, Chris
AU  - Morrison C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/02/07 06:00
MHDA- 2018/02/07 06:00
CRDT- 2018/02/07 06:00
PHST- 2018/02/07 06:00 [entrez]
PHST- 2018/02/07 06:00 [pubmed]
PHST- 2018/02/07 06:00 [medline]
AID - nbt0218-128 [pii]
AID - 10.1038/nbt0218-128 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Feb 6;36(2):128. doi: 10.1038/nbt0218-128.

PMID- 29406501
OWN - NLM
STAT- In-Data-Review
LR  - 20180206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 2
DP  - 2018 Feb 6
TI  - Recent patents in neoantigens and neoepitopes.
PG  - 146
LID - 10.1038/nbt.4083 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/02/07 06:00
MHDA- 2018/02/07 06:00
CRDT- 2018/02/07 06:00
PHST- 2018/02/07 06:00 [entrez]
PHST- 2018/02/07 06:00 [pubmed]
PHST- 2018/02/07 06:00 [medline]
AID - nbt.4083 [pii]
AID - 10.1038/nbt.4083 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Feb 6;36(2):146. doi: 10.1038/nbt.4083.

PMID- 29406500
OWN - NLM
STAT- In-Data-Review
LR  - 20180206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 2
DP  - 2018 Feb 6
TI  - Rationalizing governance of genetically modified products in developing
      countries.
PG  - 137-139
LID - 10.1038/nbt.4069 [doi]
FAU - Adenle, Ademola A
AU  - Adenle AA
AD  - School of Global Environmental Sustainability, Colorado State University, Fort
      Collins, Colorado, USA.
FAU - Morris, E Jane
AU  - Morris EJ
AD  - School of Biology, University of Leeds, Leeds, UK.
FAU - Murphy, Denis J
AU  - Murphy DJ
AUID- ORCID: http://orcid.org/0000-0002-5291-2445
AD  - University of South Wales, Pontypridd, UK.
FAU - Phillips, Peter W B
AU  - Phillips PWB
AD  - Centre for the Study of Science and Innovation Policy (CSIP), University of
      Saskatchewan, Saskatoon, Canada.
FAU - Trigo, Eduardo
AU  - Trigo E
AD  - Grupo CEO SA, Buenos Aires, Argentina.
FAU - Kearns, Peter
AU  - Kearns P
AUID- ORCID: http://orcid.org/0000-0001-7967-0274
AD  - Biosafety and Environment Programme, the Organisation for Economic Co-operation
      and Development (OECD), Paris, France.
FAU - Li, Yun-He
AU  - Li YH
AD  - Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing,
      China.
FAU - Quemada, Hector
AU  - Quemada H
AD  - Donald Danforth Plant Science Center, St Louis, Missouri, USA.
FAU - Falck-Zepeda, Jose
AU  - Falck-Zepeda J
AD  - Program for Biosafety Systems Policy, International Food Policy Research
      Institute (IFPRI), Washington, DC, USA.
FAU - Komen, John
AU  - Komen J
AD  - Komen Bioscience Consultancy, Haarlem, Netherlands.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/02/07 06:00
MHDA- 2018/02/07 06:00
CRDT- 2018/02/07 06:00
PHST- 2018/02/07 06:00 [entrez]
PHST- 2018/02/07 06:00 [pubmed]
PHST- 2018/02/07 06:00 [medline]
AID - nbt.4069 [pii]
AID - 10.1038/nbt.4069 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Feb 6;36(2):137-139. doi: 10.1038/nbt.4069.

PMID- 29406499
OWN - NLM
STAT- In-Data-Review
LR  - 20180209
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 2
DP  - 2018 Feb 6
TI  - Gut bacteria link to immunotherapy sparks interest.
PG  - 121-123
LID - 10.1038/nbt0218-121 [doi]
FAU - Owens, Brian
AU  - Owens B
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/02/07 06:00
MHDA- 2018/02/07 06:00
CRDT- 2018/02/07 06:00
PHST- 2018/02/07 06:00 [entrez]
PHST- 2018/02/07 06:00 [pubmed]
PHST- 2018/02/07 06:00 [medline]
AID - nbt0218-121 [pii]
AID - 10.1038/nbt0218-121 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Feb 6;36(2):121-123. doi: 10.1038/nbt0218-121.

PMID- 29406498
OWN - NLM
STAT- In-Data-Review
LR  - 20180206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 2
DP  - 2018 Feb 6
TI  - Around the world in a month.
PG  - 127
LID - 10.1038/nbt0218-127 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/02/07 06:00
MHDA- 2018/02/07 06:00
CRDT- 2018/02/07 06:00
PHST- 2018/02/07 06:00 [entrez]
PHST- 2018/02/07 06:00 [pubmed]
PHST- 2018/02/07 06:00 [medline]
AID - nbt0218-127 [pii]
AID - 10.1038/nbt0218-127 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Feb 6;36(2):127. doi: 10.1038/nbt0218-127.

PMID- 29406497
OWN - NLM
STAT- In-Data-Review
LR  - 20180209
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 2
DP  - 2018 Feb 6
TI  - Roche pays $1.7 billion to target tumors' genetic signatures.
PG  - 123
LID - 10.1038/nbt0218-123 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/02/07 06:00
MHDA- 2018/02/07 06:00
CRDT- 2018/02/07 06:00
PHST- 2018/02/07 06:00 [entrez]
PHST- 2018/02/07 06:00 [pubmed]
PHST- 2018/02/07 06:00 [medline]
AID - nbt0218-123 [pii]
AID - 10.1038/nbt0218-123 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Feb 6;36(2):123. doi: 10.1038/nbt0218-123.

PMID- 29406495
OWN - NLM
STAT- In-Data-Review
LR  - 20180206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 2
DP  - 2018 Feb 6
TI  - Spark's gene therapy price tag: $850,000.
PG  - 122
LID - 10.1038/nbt0218-122 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/02/07 06:00
MHDA- 2018/02/07 06:00
CRDT- 2018/02/07 06:00
PHST- 2018/02/07 06:00 [entrez]
PHST- 2018/02/07 06:00 [pubmed]
PHST- 2018/02/07 06:00 [medline]
AID - nbt0218-122 [pii]
AID - 10.1038/nbt0218-122 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Feb 6;36(2):122. doi: 10.1038/nbt0218-122.

PMID- 29406494
OWN - NLM
STAT- In-Data-Review
LR  - 20180209
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 2
DP  - 2018 Feb 6
TI  - Approval of first tumor gene panel sends shockwaves through labs.
PG  - 124-125
LID - 10.1038/nbt0218-124 [doi]
FAU - Ratner, Mark
AU  - Ratner M
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/02/07 06:00
MHDA- 2018/02/07 06:00
CRDT- 2018/02/07 06:00
PHST- 2018/02/07 06:00 [entrez]
PHST- 2018/02/07 06:00 [pubmed]
PHST- 2018/02/07 06:00 [medline]
AID - nbt0218-124 [pii]
AID - 10.1038/nbt0218-124 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Feb 6;36(2):124-125. doi: 10.1038/nbt0218-124.

PMID- 29406493
OWN - NLM
STAT- In-Data-Review
LR  - 20180209
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 2
DP  - 2018 Feb 6
TI  - Putting a number on neoepitope quality.
PG  - 151
LID - 10.1038/nbt.4074 [doi]
FAU - Jarchum, Irene
AU  - Jarchum I
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/02/07 06:00
MHDA- 2018/02/07 06:00
CRDT- 2018/02/07 06:00
PHST- 2018/02/07 06:00 [entrez]
PHST- 2018/02/07 06:00 [pubmed]
PHST- 2018/02/07 06:00 [medline]
AID - nbt.4074 [pii]
AID - 10.1038/nbt.4074 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Feb 6;36(2):151. doi: 10.1038/nbt.4074.

PMID- 29334370
OWN - NLM
STAT- In-Data-Review
LR  - 20180209
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 2
DP  - 2018 Feb
TI  - Scaffolds that mimic antigen-presenting cells enable ex vivo expansion of primary
      T cells.
PG  - 160-169
LID - 10.1038/nbt.4047 [doi]
AB  - Therapeutic ex vivo T-cell expansion is limited by low rates and T-cell products 
      of limited functionality. Here we describe a system that mimics natural
      antigen-presenting cells (APCs) and consists of a fluid lipid bilayer supported
      by mesoporous silica micro-rods. The lipid bilayer presents membrane-bound cues
      for T-cell receptor stimulation and costimulation, while the micro-rods enable
      sustained release of soluble paracrine cues. Using anti-CD3, anti-CD28, and
      interleukin-2, we show that the APC-mimetic scaffolds (APC-ms) promote two- to
      tenfold greater polyclonal expansion of primary mouse and human T cells compared 
      with commercial expansion beads (Dynabeads). The efficiency of expansion depends 
      on the density of stimulatory cues and the amount of material in the starting
      culture. Following a single stimulation, APC-ms enables antigen-specific
      expansion of rare cytotoxic T-cell subpopulations at a greater magnitude than
      autologous monocyte-derived dendritic cells after 2 weeks. APC-ms support over
      fivefold greater expansion of restimulated CD19 CAR-T cells than Dynabeads, with 
      similar efficacy in a xenograft lymphoma model.
FAU - Cheung, Alexander S
AU  - Cheung AS
AUID- ORCID: http://orcid.org/0000-0002-7139-1665
AD  - John A. Paulson School of Engineering and Applied Sciences, Harvard University,
      Cambridge, Massachusetts, USA.
AD  - The Wyss Institute for Biologically Inspired Engineering Harvard University,
      Cambridge, Massachusetts, USA.
FAU - Zhang, David K Y
AU  - Zhang DKY
AUID- ORCID: http://orcid.org/0000-0002-6999-6454
AD  - John A. Paulson School of Engineering and Applied Sciences, Harvard University,
      Cambridge, Massachusetts, USA.
AD  - The Wyss Institute for Biologically Inspired Engineering Harvard University,
      Cambridge, Massachusetts, USA.
FAU - Koshy, Sandeep T
AU  - Koshy ST
AUID- ORCID: http://orcid.org/0000-0003-2836-5813
AD  - John A. Paulson School of Engineering and Applied Sciences, Harvard University,
      Cambridge, Massachusetts, USA.
AD  - The Wyss Institute for Biologically Inspired Engineering Harvard University,
      Cambridge, Massachusetts, USA.
AD  - Harvard-MIT Division of Health Sciences and Technology, Cambridge, Massachusetts,
      USA.
FAU - Mooney, David J
AU  - Mooney DJ
AD  - John A. Paulson School of Engineering and Applied Sciences, Harvard University,
      Cambridge, Massachusetts, USA.
AD  - The Wyss Institute for Biologically Inspired Engineering Harvard University,
      Cambridge, Massachusetts, USA.
LA  - eng
GR  - R01 EB015498/EB/NIBIB NIH HHS/United States
GR  - UL1 TR001102/TR/NCATS NIH HHS/United States
PT  - Journal Article
DEP - 20180115
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
PMC - PMC5801009
MID - NIHMS925039
EDAT- 2018/01/16 06:00
MHDA- 2018/01/16 06:00
CRDT- 2018/01/16 06:00
PMCR- 2018/07/15 00:00
PHST- 2016/12/22 00:00 [received]
PHST- 2017/12/01 00:00 [accepted]
PHST- 2018/07/15 00:00 [pmc-release]
PHST- 2018/01/16 06:00 [pubmed]
PHST- 2018/01/16 06:00 [medline]
PHST- 2018/01/16 06:00 [entrez]
AID - nbt.4047 [pii]
AID - 10.1038/nbt.4047 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Feb;36(2):160-169. doi: 10.1038/nbt.4047. Epub 2018 Jan 15.

PMID- 29334369
OWN - NLM
STAT- In-Data-Review
LR  - 20180328
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 2
DP  - 2018 Feb
TI  - Dual gene activation and knockout screen reveals directional dependencies in
      genetic networks.
PG  - 170-178
LID - 10.1038/nbt.4062 [doi]
AB  - Understanding the direction of information flow is essential for characterizing
      how genetic networks affect phenotypes. However, methods to find genetic
      interactions largely fail to reveal directional dependencies. We combine two
      orthogonal Cas9 proteins from Streptococcus pyogenes and Staphylococcus aureus to
      carry out a dual screen in which one gene is activated while a second gene is
      deleted in the same cell. We analyze the quantitative effects of activation and
      knockout to calculate genetic interaction and directionality scores for each gene
      pair. Based on the results from over 100,000 perturbed gene pairs, we reconstruct
      a directional dependency network for human K562 leukemia cells and demonstrate
      how our approach allows the determination of directionality in activating genetic
      interactions. Our interaction network connects previously uncharacterized genes
      to well-studied pathways and identifies targets relevant for therapeutic
      intervention.
FAU - Boettcher, Michael
AU  - Boettcher M
AUID- ORCID: http://orcid.org/0000-0003-0986-4465
AD  - Department of Microbiology and Immunology, University of California San Francisco
      Diabetes Center, WM Keck Center for Noncoding RNAs, University of California, San
      Francisco, San Francisco, California, USA.
FAU - Tian, Ruilin
AU  - Tian R
AD  - Institute for Neurodegenerative Diseases, Department of Biochemistry and
      Biophysics, University of California, San Francisco and Chan Zuckerberg Biohub,
      San Francisco, California, USA.
FAU - Blau, James A
AU  - Blau JA
AD  - Department of Microbiology and Immunology, University of California San Francisco
      Diabetes Center, WM Keck Center for Noncoding RNAs, University of California, San
      Francisco, San Francisco, California, USA.
FAU - Markegard, Evan
AU  - Markegard E
AD  - Helen Diller Family Comprehensive Cancer Center, Department of Microbiology and
      Immunology, University of California, San Francisco, San Francisco, California,
      USA.
FAU - Wagner, Ryan T
AU  - Wagner RT
AD  - Department of Microbiology and Immunology, University of California San Francisco
      Diabetes Center, WM Keck Center for Noncoding RNAs, University of California, San
      Francisco, San Francisco, California, USA.
FAU - Wu, David
AU  - Wu D
AD  - Department of Microbiology and Immunology, University of California San Francisco
      Diabetes Center, WM Keck Center for Noncoding RNAs, University of California, San
      Francisco, San Francisco, California, USA.
FAU - Mo, Xiulei
AU  - Mo X
AD  - Department of Pharmacology and Emory Chemical Biology Discovery Center, Emory
      University School of Medicine, Atlanta, Georgia, USA.
FAU - Biton, Anne
AU  - Biton A
AD  - Department of Medicine, Lung Biology Center, University of California, San
      Francisco, San Francisco, California, USA.
AD  - Centre de Bioinformatique, Biostatistique et Biologie Integrative (C3BI, USR 3756
      Institut Pasteur et CNRS), Paris, France.
FAU - Zaitlen, Noah
AU  - Zaitlen N
AD  - Department of Medicine, Lung Biology Center, University of California, San
      Francisco, San Francisco, California, USA.
FAU - Fu, Haian
AU  - Fu H
AUID- ORCID: http://orcid.org/0000-0002-2362-7979
AD  - Department of Pharmacology and Emory Chemical Biology Discovery Center, Emory
      University School of Medicine, Atlanta, Georgia, USA.
FAU - McCormick, Frank
AU  - McCormick F
AD  - Helen Diller Family Comprehensive Cancer Center, Department of Microbiology and
      Immunology, University of California, San Francisco, San Francisco, California,
      USA.
FAU - Kampmann, Martin
AU  - Kampmann M
AUID- ORCID: http://orcid.org/0000-0002-3819-7019
AD  - Institute for Neurodegenerative Diseases, Department of Biochemistry and
      Biophysics, University of California, San Francisco and Chan Zuckerberg Biohub,
      San Francisco, California, USA.
FAU - McManus, Michael T
AU  - McManus MT
AUID- ORCID: http://orcid.org/0000-0003-3013-6569
AD  - Department of Microbiology and Immunology, University of California San Francisco
      Diabetes Center, WM Keck Center for Noncoding RNAs, University of California, San
      Francisco, San Francisco, California, USA.
LA  - eng
GR  - DP2 GM119139/GM/NIGMS NIH HHS/United States
GR  - K99 CA181494/CA/NCI NIH HHS/United States
GR  - R00 CA181494/CA/NCI NIH HHS/United States
PT  - Journal Article
DEP - 20180115
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/01/16 06:00
MHDA- 2018/01/16 06:00
CRDT- 2018/01/16 06:00
PHST- 2017/08/14 00:00 [received]
PHST- 2017/12/20 00:00 [accepted]
PHST- 2018/01/16 06:00 [pubmed]
PHST- 2018/01/16 06:00 [medline]
PHST- 2018/01/16 06:00 [entrez]
AID - nbt.4062 [pii]
AID - 10.1038/nbt.4062 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Feb;36(2):170-178. doi: 10.1038/nbt.4062. Epub 2018 Jan 15.

PMID- 29334368
OWN - NLM
STAT- In-Data-Review
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 2
DP  - 2018 Feb
TI  - Visualizing detailed postdoctoral employment trends using a new career outcome
      taxonomy.
PG  - 197-202
LID - 10.1038/nbt.4059 [doi]
FAU - Xu, Hong
AU  - Xu H
AUID- ORCID: http://orcid.org/0000-0003-1995-4675
AD  - Career Development, National Institute of Environmental Health Sciences, National
      Institutes of Health, Research Triangle Park, North Carolina, USA.
AD  - Department of Biostatistics, Graduate School of Public Health, University of
      Pittsburgh, Pittsburgh, Pennsylvania, USA.
FAU - Gilliam, Richard S T
AU  - Gilliam RST
AD  - Career Development, National Institute of Environmental Health Sciences, National
      Institutes of Health, Research Triangle Park, North Carolina, USA.
FAU - Peddada, Shyamal D
AU  - Peddada SD
AD  - Department of Biostatistics, Graduate School of Public Health, University of
      Pittsburgh, Pittsburgh, Pennsylvania, USA.
FAU - Buchold, Gregory M
AU  - Buchold GM
AD  - Sheikh Khalifa Zayed Al Nahyan Institute for Personalized Cancer Therapy, The
      University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
FAU - Collins, Tammy R L
AU  - Collins TRL
AUID- ORCID: http://orcid.org/0000-0002-8023-256X
AD  - Career Development, National Institute of Environmental Health Sciences, National
      Institutes of Health, Research Triangle Park, North Carolina, USA.
LA  - eng
GR  - Z99 ES999999/Intramural NIH HHS/United States
PT  - Journal Article
DEP - 20180115
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
PMC - PMC5872819
MID - NIHMS945237
EDAT- 2018/01/16 06:00
MHDA- 2018/01/16 06:00
CRDT- 2018/01/16 06:00
PMCR- 2018/08/01 00:00
PHST- 2017/06/10 00:00 [received]
PHST- 2017/09/21 00:00 [accepted]
PHST- 2018/08/01 00:00 [pmc-release]
PHST- 2018/01/16 06:00 [pubmed]
PHST- 2018/01/16 06:00 [medline]
PHST- 2018/01/16 06:00 [entrez]
AID - nbt.4059 [pii]
AID - 10.1038/nbt.4059 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Feb;36(2):197-202. doi: 10.1038/nbt.4059. Epub 2018 Jan 15.

PMID- 29309060
OWN - NLM
STAT- In-Data-Review
LR  - 20180209
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 2
DP  - 2018 Feb
TI  - Functional interrogation and mining of natively paired human VH:VL antibody
      repertoires.
PG  - 152-155
LID - 10.1038/nbt.4052 [doi]
AB  - We present a technology to screen millions of B cells for natively paired human
      antibody repertoires. Libraries of natively paired, variable region heavy and
      light (VH:VL) amplicons are expressed in a yeast display platform that is
      optimized for human Fab surface expression. Using our method we identify HIV-1
      broadly neutralizing antibodies (bNAbs) from an HIV-1 slow progressor and
      high-affinity neutralizing antibodies against Ebola virus glycoprotein and
      influenza hemagglutinin.
FAU - Wang, Bo
AU  - Wang B
AD  - Department of Chemical Engineering, The University of Texas at Austin, Austin,
      Texas, USA.
FAU - DeKosky, Brandon J
AU  - DeKosky BJ
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases,
      Bethesda, Maryland, USA.
AD  - Department of Chemical & Petroleum Engineering, The University of Kansas,
      Lawrence, Kansas, USA.
AD  - Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence,
      Kansas, USA.
FAU - Timm, Morgan R
AU  - Timm MR
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases,
      Bethesda, Maryland, USA.
FAU - Lee, Jiwon
AU  - Lee J
AD  - Department of Chemical Engineering, The University of Texas at Austin, Austin,
      Texas, USA.
FAU - Normandin, Erica
AU  - Normandin E
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases,
      Bethesda, Maryland, USA.
FAU - Misasi, John
AU  - Misasi J
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases,
      Bethesda, Maryland, USA.
FAU - Kong, Rui
AU  - Kong R
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases,
      Bethesda, Maryland, USA.
FAU - McDaniel, Jonathan R
AU  - McDaniel JR
AD  - Department of Chemical Engineering, The University of Texas at Austin, Austin,
      Texas, USA.
FAU - Delidakis, George
AU  - Delidakis G
AUID- ORCID: http://orcid.org/0000-0002-4330-9476
AD  - Department of Chemical Engineering, The University of Texas at Austin, Austin,
      Texas, USA.
FAU - Leigh, Kendra E
AU  - Leigh KE
AUID- ORCID: http://orcid.org/0000-0002-6467-3330
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases,
      Bethesda, Maryland, USA.
FAU - Niezold, Thomas
AU  - Niezold T
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases,
      Bethesda, Maryland, USA.
FAU - Choi, Chang W
AU  - Choi CW
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases,
      Bethesda, Maryland, USA.
FAU - Viox, Elise G
AU  - Viox EG
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases,
      Bethesda, Maryland, USA.
FAU - Fahad, Ahmed
AU  - Fahad A
AD  - Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence,
      Kansas, USA.
FAU - Cagigi, Alberto
AU  - Cagigi A
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases,
      Bethesda, Maryland, USA.
FAU - Ploquin, Aurelie
AU  - Ploquin A
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases,
      Bethesda, Maryland, USA.
FAU - Leung, Kwanyee
AU  - Leung K
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases,
      Bethesda, Maryland, USA.
FAU - Yang, Eun Sung
AU  - Yang ES
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases,
      Bethesda, Maryland, USA.
FAU - Kong, Wing-Pui
AU  - Kong WP
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases,
      Bethesda, Maryland, USA.
FAU - Voss, William N
AU  - Voss WN
AD  - Department of Chemical Engineering, The University of Texas at Austin, Austin,
      Texas, USA.
FAU - Schmidt, Aaron G
AU  - Schmidt AG
AD  - Laboratory of Molecular Medicine, Boston Children's Hospital, Harvard Medical
      School, Boston, Massachusetts, USA.
FAU - Moody, M Anthony
AU  - Moody MA
AD  - Duke Human Vaccine Institute, Duke University Medical School, Durham, North
      Carolina, USA.
AD  - Department of Pediatrics, Duke University Medical School, Durham, North Carolina,
      USA.
FAU - Ambrozak, David R
AU  - Ambrozak DR
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases,
      Bethesda, Maryland, USA.
FAU - Henry, Amy R
AU  - Henry AR
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases,
      Bethesda, Maryland, USA.
FAU - Laboune, Farida
AU  - Laboune F
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases,
      Bethesda, Maryland, USA.
FAU - Ledgerwood, Julie E
AU  - Ledgerwood JE
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases,
      Bethesda, Maryland, USA.
FAU - Graham, Barney S
AU  - Graham BS
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases,
      Bethesda, Maryland, USA.
FAU - Connors, Mark
AU  - Connors M
AD  - National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
FAU - Douek, Daniel C
AU  - Douek DC
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases,
      Bethesda, Maryland, USA.
FAU - Sullivan, Nancy J
AU  - Sullivan NJ
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases,
      Bethesda, Maryland, USA.
FAU - Ellington, Andrew D
AU  - Ellington AD
AD  - Center for Systems and Synthetic Biology, The University of Texas at Austin,
      Austin, Texas, USA.
AD  - Department of Molecular Biosciences, The University of Texas at Austin, Austin,
      Texas, USA.
FAU - Mascola, John R
AU  - Mascola JR
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases,
      Bethesda, Maryland, USA.
FAU - Georgiou, George
AU  - Georgiou G
AD  - Department of Chemical Engineering, The University of Texas at Austin, Austin,
      Texas, USA.
AD  - Center for Systems and Synthetic Biology, The University of Texas at Austin,
      Austin, Texas, USA.
AD  - Department of Molecular Biosciences, The University of Texas at Austin, Austin,
      Texas, USA.
AD  - Department of Bioengineering, The University of Texas at Austin, Austin, Texas,
      USA.
LA  - eng
GR  - DP5 OD023118/OD/NIH HHS/United States
GR  - R21 CA191239/CA/NCI NIH HHS/United States
GR  - R56 AI106006/AI/NIAID NIH HHS/United States
PT  - Journal Article
DEP - 20180108
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
PMC - PMC5801115
MID - NIHMS925655
EDAT- 2018/01/09 06:00
MHDA- 2018/01/09 06:00
CRDT- 2018/01/09 06:00
PMCR- 2018/07/08 00:00
PHST- 2017/06/14 00:00 [received]
PHST- 2017/12/06 00:00 [accepted]
PHST- 2018/07/08 00:00 [pmc-release]
PHST- 2018/01/09 06:00 [pubmed]
PHST- 2018/01/09 06:00 [medline]
PHST- 2018/01/09 06:00 [entrez]
AID - nbt.4052 [pii]
AID - 10.1038/nbt.4052 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Feb;36(2):152-155. doi: 10.1038/nbt.4052. Epub 2018 Jan 8.

PMID- 29291348
OWN - NLM
STAT- In-Data-Review
LR  - 20180209
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 2
DP  - 2018 Feb
TI  - Retrieval of a million high-quality, full-length microbial 16S and 18S rRNA gene 
      sequences without primer bias.
PG  - 190-195
LID - 10.1038/nbt.4045 [doi]
AB  - Small subunit ribosomal RNA (SSU rRNA) genes, 16S in bacteria and 18S in
      eukaryotes, have been the standard phylogenetic markers used to characterize
      microbial diversity and evolution for decades. However, the reference databases
      of full-length SSU rRNA gene sequences are skewed to well-studied ecosystems and 
      subject to primer bias and chimerism, which results in an incomplete view of the 
      diversity present in a sample. We combine poly(A)-tailing and reverse
      transcription of SSU rRNA molecules with synthetic long-read sequencing to
      generate high-quality, full-length SSU rRNA sequences, without primer bias, at
      high throughput. We apply our approach to samples from seven different ecosystems
      and obtain more than a million SSU rRNA sequences from all domains of life, with 
      an estimated raw error rate of 0.17%. We observe a large proportion of novel
      diversity, including several deeply branching phylum-level lineages putatively
      related to the Asgard Archaea. Our approach will enable expansion of the SSU rRNA
      reference databases by orders of magnitude, and contribute to a comprehensive
      census of the tree of life.
FAU - Karst, Soren M
AU  - Karst SM
AD  - Center for Microbial Communities, Department of Chemistry and Bioscience, Aalborg
      University, Denmark.
FAU - Dueholm, Morten S
AU  - Dueholm MS
AUID- ORCID: http://orcid.org/0000-0003-4135-2670
AD  - Center for Microbial Communities, Department of Chemistry and Bioscience, Aalborg
      University, Denmark.
FAU - McIlroy, Simon J
AU  - McIlroy SJ
AUID- ORCID: http://orcid.org/0000-0003-3749-8730
AD  - Center for Microbial Communities, Department of Chemistry and Bioscience, Aalborg
      University, Denmark.
FAU - Kirkegaard, Rasmus H
AU  - Kirkegaard RH
AUID- ORCID: http://orcid.org/0000-0003-3349-3617
AD  - Center for Microbial Communities, Department of Chemistry and Bioscience, Aalborg
      University, Denmark.
FAU - Nielsen, Per H
AU  - Nielsen PH
AUID- ORCID: http://orcid.org/0000-0002-6402-1877
AD  - Center for Microbial Communities, Department of Chemistry and Bioscience, Aalborg
      University, Denmark.
FAU - Albertsen, Mads
AU  - Albertsen M
AUID- ORCID: http://orcid.org/0000-0002-6151-190X
AD  - Center for Microbial Communities, Department of Chemistry and Bioscience, Aalborg
      University, Denmark.
LA  - eng
PT  - Journal Article
DEP - 20180101
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/01/02 06:00
MHDA- 2018/01/02 06:00
CRDT- 2018/01/02 06:00
PHST- 2016/12/08 00:00 [received]
PHST- 2017/11/22 00:00 [accepted]
PHST- 2018/01/02 06:00 [pubmed]
PHST- 2018/01/02 06:00 [medline]
PHST- 2018/01/02 06:00 [entrez]
AID - nbt.4045 [pii]
AID - 10.1038/nbt.4045 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Feb;36(2):190-195. doi: 10.1038/nbt.4045. Epub 2018 Jan 1.

PMID- 29251727
OWN - NLM
STAT- In-Data-Review
LR  - 20180209
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 2
DP  - 2018 Feb
TI  - Labeling and identifying cell-specific proteomes in the mouse brain.
PG  - 156-159
LID - 10.1038/nbt.4056 [doi]
AB  - We develop an approach to tag proteomes synthesized by specific cell types in
      dissociated cortex, brain slices, and the brains of live mice. By viral-mediated 
      expression of an orthogonal pyrrolysyl-tRNA synthetase-tRNAXXX pair in a cell
      type of interest and providing a non-canonical amino acid with a chemical handle,
      we selectively label neuronal or glial proteomes. The method enables the
      identification of proteins from spatially and genetically defined regions of the 
      brain.
FAU - Krogager, Toke P
AU  - Krogager TP
AD  - Medical Research Council Laboratory of Molecular Biology, Cambridge, England, UK.
FAU - Ernst, Russell J
AU  - Ernst RJ
AD  - Medical Research Council Laboratory of Molecular Biology, Cambridge, England, UK.
FAU - Elliott, Thomas S
AU  - Elliott TS
AD  - Medical Research Council Laboratory of Molecular Biology, Cambridge, England, UK.
FAU - Calo, Laura
AU  - Calo L
AD  - Department of Clinical Neurosciences, University of Cambridge, Cambridge,
      England, UK.
FAU - Beranek, Vaclav
AU  - Beranek V
AD  - Medical Research Council Laboratory of Molecular Biology, Cambridge, England, UK.
FAU - Ciabatti, Ernesto
AU  - Ciabatti E
AD  - Medical Research Council Laboratory of Molecular Biology, Cambridge, England, UK.
FAU - Spillantini, Maria Grazia
AU  - Spillantini MG
AD  - Department of Clinical Neurosciences, University of Cambridge, Cambridge,
      England, UK.
FAU - Tripodi, Marco
AU  - Tripodi M
AD  - Medical Research Council Laboratory of Molecular Biology, Cambridge, England, UK.
FAU - Hastings, Michael H
AU  - Hastings MH
AUID- ORCID: http://orcid.org/0000-0001-8576-6651
AD  - Medical Research Council Laboratory of Molecular Biology, Cambridge, England, UK.
FAU - Chin, Jason W
AU  - Chin JW
AUID- ORCID: http://orcid.org/0000-0003-1219-4757
AD  - Medical Research Council Laboratory of Molecular Biology, Cambridge, England, UK.
LA  - eng
GR  - G-1102/Parkinson's UK/United Kingdom
GR  - MC_UP_A024_1008/Medical Research Council/United Kingdom
PT  - Journal Article
DEP - 20171218
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/12/19 06:00
MHDA- 2017/12/19 06:00
CRDT- 2017/12/19 06:00
PHST- 2017/01/10 00:00 [received]
PHST- 2017/12/08 00:00 [accepted]
PHST- 2017/12/19 06:00 [pubmed]
PHST- 2017/12/19 06:00 [medline]
PHST- 2017/12/19 06:00 [entrez]
AID - nbt.4056 [pii]
AID - 10.1038/nbt.4056 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Feb;36(2):156-159. doi: 10.1038/nbt.4056. Epub 2017 Dec 18.

PMID- 29251726
OWN - NLM
STAT- In-Data-Review
LR  - 20180209
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 2
DP  - 2018 Feb
TI  - Orthologous CRISPR-Cas9 enzymes for combinatorial genetic screens.
PG  - 179-189
LID - 10.1038/nbt.4048 [doi]
AB  - Combinatorial genetic screening using CRISPR-Cas9 is a useful approach to uncover
      redundant genes and to explore complex gene networks. However, current methods
      suffer from interference between the single-guide RNAs (sgRNAs) and from limited 
      gene targeting activity. To increase the efficiency of combinatorial screening,
      we employ orthogonal Cas9 enzymes from Staphylococcus aureus and Streptococcus
      pyogenes. We used machine learning to establish S. aureus Cas9 sgRNA design rules
      and paired S. aureus Cas9 with S. pyogenes Cas9 to achieve dual targeting in a
      high fraction of cells. We also developed a lentiviral vector and cloning
      strategy to generate high-complexity pooled dual-knockout libraries to identify
      synthetic lethal and buffering gene pairs across multiple cell types, including
      MAPK pathway genes and apoptotic genes. Our orthologous approach also enabled a
      screen combining gene knockouts with transcriptional activation, which revealed
      genetic interactions with TP53. The "Big Papi" (paired aureus and pyogenes for
      interactions) approach described here will be widely applicable for the study of 
      combinatorial phenotypes.
FAU - Najm, Fadi J
AU  - Najm FJ
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
AD  - Department of Pathology, Massachusetts General Hospital and Harvard Medical
      School, Boston, Massachusetts, USA.
AD  - Center for Cancer Research, Massachusetts General Hospital and Harvard Medical
      School, Boston, Massachusetts, USA.
FAU - Strand, Christine
AU  - Strand C
AUID- ORCID: http://orcid.org/0000-0001-5783-6667
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Donovan, Katherine F
AU  - Donovan KF
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Hegde, Mudra
AU  - Hegde M
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Sanson, Kendall R
AU  - Sanson KR
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Vaimberg, Emma W
AU  - Vaimberg EW
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Sullender, Meagan E
AU  - Sullender ME
AUID- ORCID: http://orcid.org/0000-0001-6666-8650
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Hartenian, Ella
AU  - Hartenian E
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Kalani, Zohra
AU  - Kalani Z
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Fusi, Nicolo
AU  - Fusi N
AUID- ORCID: http://orcid.org/0000-0002-4102-0169
AD  - Microsoft Research New England, Cambridge, Massachusetts, USA.
FAU - Listgarten, Jennifer
AU  - Listgarten J
AUID- ORCID: http://orcid.org/0000-0002-6600-1431
AD  - Microsoft Research New England, Cambridge, Massachusetts, USA.
FAU - Younger, Scott T
AU  - Younger ST
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Bernstein, Bradley E
AU  - Bernstein BE
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
AD  - Department of Pathology, Massachusetts General Hospital and Harvard Medical
      School, Boston, Massachusetts, USA.
AD  - Center for Cancer Research, Massachusetts General Hospital and Harvard Medical
      School, Boston, Massachusetts, USA.
FAU - Root, David E
AU  - Root DE
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Doench, John G
AU  - Doench JG
AUID- ORCID: http://orcid.org/0000-0002-3707-9889
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
LA  - eng
GR  - DP1 CA216873/CA/NCI NIH HHS/United States
GR  - T32 GM007226/GM/NIGMS NIH HHS/United States
PT  - Journal Article
DEP - 20171218
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
PMC - PMC5800952
MID - NIHMS925040
EDAT- 2017/12/19 06:00
MHDA- 2017/12/19 06:00
CRDT- 2017/12/19 06:00
PMCR- 2018/06/18 00:00
PHST- 2017/03/13 00:00 [received]
PHST- 2017/11/04 00:00 [accepted]
PHST- 2018/06/18 00:00 [pmc-release]
PHST- 2017/12/19 06:00 [pubmed]
PHST- 2017/12/19 06:00 [medline]
PHST- 2017/12/19 06:00 [entrez]
AID - nbt.4048 [pii]
AID - 10.1038/nbt.4048 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Feb;36(2):179-189. doi: 10.1038/nbt.4048. Epub 2017 Dec 18.

PMID- 29355851
OWN - NLM
STAT- Publisher
LR  - 20180402
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
DP  - 2018 Jan 22
TI  - Fresh from the biotech pipeline-2017.
LID - 10.1038/nbt.4068 [doi]
FAU - Morrison, Chris
AU  - Morrison C
LA  - eng
PT  - Journal Article
DEP - 20180122
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/01/23 06:00
MHDA- 2018/01/23 06:00
CRDT- 2018/01/23 06:00
PHST- 2018/01/23 06:00 [pubmed]
PHST- 2018/01/23 06:00 [medline]
PHST- 2018/01/23 06:00 [entrez]
AID - nbt.4068 [pii]
AID - 10.1038/nbt.4068 [doi]
PST - aheadofprint
SO  - Nat Biotechnol. 2018 Jan 22. pii: nbt.4068. doi: 10.1038/nbt.4068.

PMID- 29319700
OWN - NLM
STAT- In-Data-Review
LR  - 20180115
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 1
DP  - 2018 Jan 10
TI  - DNA makes an appearance.
PG  - 14-17
LID - 10.1038/nbt.4057 [doi]
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/01/11 06:00
MHDA- 2018/01/11 06:00
CRDT- 2018/01/11 06:00
PHST- 2018/01/11 06:00 [entrez]
PHST- 2018/01/11 06:00 [pubmed]
PHST- 2018/01/11 06:00 [medline]
AID - nbt.4057 [pii]
AID - 10.1038/nbt.4057 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Jan 10;36(1):14-17. doi: 10.1038/nbt.4057.

PMID- 29319699
OWN - NLM
STAT- In-Data-Review
LR  - 20180115
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 1
DP  - 2018 Jan 10
TI  - Precision oncology in the age of integrative genomics.
PG  - 46-60
LID - 10.1038/nbt.4017 [doi]
AB  - Precision oncology applies genomic and other molecular analyses of tumor biopsies
      to improve the diagnosis and treatment of cancers. In addition to identifying
      therapeutic options, precision oncology tracks the response of a tumor to an
      intervention at the molecular level and detects drug resistance and the
      mechanisms by which it occurs. Integrative genomics can include sequencing
      specific panels of genes, exomes, or the entire triad of the patient's germline, 
      tumor exome, and tumor transcriptome. Although the capabilities of sequencing
      technologies continue to improve, widespread adoption of genomics-driven
      precision oncology in the clinic has been held back by logistical, regulatory,
      financial, and ethical considerations. Nevertheless, integrative clinical
      sequencing programs applied at the point of care have the potential to improve
      the clinical management of cancer patients.
FAU - Kumar-Sinha, Chandan
AU  - Kumar-Sinha C
AD  - Michigan Center for Translational Pathology, Ann Arbor, Michigan, USA.
AD  - Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
FAU - Chinnaiyan, Arul M
AU  - Chinnaiyan AM
AD  - Michigan Center for Translational Pathology, Ann Arbor, Michigan, USA.
AD  - Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
AD  - Department of Computational Medicine and Bioinformatics, University of Michigan, 
      Ann Arbor, Michigan, USA.
AD  - Howard Hughes Medical Institute, University of Michigan Medical School, Ann
      Arbor, Michigan, USA.
AD  - Department of Urology, University of Michigan, Ann Arbor, Michigan, USA.
AD  - Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor,
      Michigan, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/01/11 06:00
MHDA- 2018/01/11 06:00
CRDT- 2018/01/11 06:00
PHST- 2016/09/28 00:00 [received]
PHST- 2017/10/20 00:00 [accepted]
PHST- 2018/01/11 06:00 [entrez]
PHST- 2018/01/11 06:00 [pubmed]
PHST- 2018/01/11 06:00 [medline]
AID - nbt.4017 [pii]
AID - 10.1038/nbt.4017 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Jan 10;36(1):46-60. doi: 10.1038/nbt.4017.

PMID- 29319697
OWN - NLM
STAT- In-Data-Review
LR  - 20180115
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 1
DP  - 2018 Jan 10
TI  - FDA approves hereditary blindness gene therapy.
PG  - 6
LID - 10.1038/nbt0118-6a [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/01/11 06:00
MHDA- 2018/01/11 06:00
CRDT- 2018/01/11 06:00
PHST- 2018/01/11 06:00 [entrez]
PHST- 2018/01/11 06:00 [pubmed]
PHST- 2018/01/11 06:00 [medline]
AID - nbt0118-6a [pii]
AID - 10.1038/nbt0118-6a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Jan 10;36(1):6. doi: 10.1038/nbt0118-6a.

PMID- 29319696
OWN - NLM
STAT- In-Data-Review
LR  - 20180115
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 1
DP  - 2018 Jan 10
TI  - RNA-targeting CRISPR comes of age.
PG  - 44-45
LID - 10.1038/nbt.4054 [doi]
FAU - Kim, V Narry
AU  - Kim VN
AD  - Center for RNA Research, Institute for Basic Science, Seoul, Korea, and School of
      Biological Sciences, Seoul National University, Seoul, Korea.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/01/11 06:00
MHDA- 2018/01/11 06:00
CRDT- 2018/01/11 06:00
PHST- 2018/01/11 06:00 [entrez]
PHST- 2018/01/11 06:00 [pubmed]
PHST- 2018/01/11 06:00 [medline]
AID - nbt.4054 [pii]
AID - 10.1038/nbt.4054 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Jan 10;36(1):44-45. doi: 10.1038/nbt.4054.

PMID- 29319695
OWN - NLM
STAT- In-Data-Review
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 1
DP  - 2018 Jan 10
TI  - PODCAST: First rounders: Susan Windham-Bannister.
PG  - 11
LID - 10.1038/nbt.4053 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/01/11 06:00
MHDA- 2018/01/11 06:00
CRDT- 2018/01/11 06:00
PHST- 2018/01/11 06:00 [entrez]
PHST- 2018/01/11 06:00 [pubmed]
PHST- 2018/01/11 06:00 [medline]
AID - nbt.4053 [pii]
AID - 10.1038/nbt.4053 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Jan 10;36(1):11. doi: 10.1038/nbt.4053.

PMID- 29319694
OWN - NLM
STAT- In-Data-Review
LR  - 20180115
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 1
DP  - 2018 Jan 10
TI  - With a free pass, CRISPR-edited plants reach market in record time.
PG  - 6-7
LID - 10.1038/nbt0118-6b [doi]
FAU - Waltz, Emily
AU  - Waltz E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/01/11 06:00
MHDA- 2018/01/11 06:00
CRDT- 2018/01/11 06:00
PHST- 2018/01/11 06:00 [entrez]
PHST- 2018/01/11 06:00 [pubmed]
PHST- 2018/01/11 06:00 [medline]
AID - nbt0118-6b [pii]
AID - 10.1038/nbt0118-6b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Jan 10;36(1):6-7. doi: 10.1038/nbt0118-6b.

PMID- 29319693
OWN - NLM
STAT- In-Data-Review
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 1
DP  - 2018 Jan 10
TI  - AI for your heart, on your wrist.
PG  - 5
LID - 10.1038/nbt0118-5a [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/01/11 06:00
MHDA- 2018/01/11 06:00
CRDT- 2018/01/11 06:00
PHST- 2018/01/11 06:00 [entrez]
PHST- 2018/01/11 06:00 [pubmed]
PHST- 2018/01/11 06:00 [medline]
AID - nbt0118-5a [pii]
AID - 10.1038/nbt0118-5a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Jan 10;36(1):5. doi: 10.1038/nbt0118-5a.

PMID- 29319692
OWN - NLM
STAT- In-Data-Review
LR  - 20180115
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 1
DP  - 2018 Jan 10
TI  - FDA to relax grip on at-home genetic tests, but concerns linger.
PG  - 10-11
LID - 10.1038/nbt0118-10 [doi]
FAU - Ratner, Mark
AU  - Ratner M
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/01/11 06:00
MHDA- 2018/01/11 06:00
CRDT- 2018/01/11 06:00
PHST- 2018/01/11 06:00 [entrez]
PHST- 2018/01/11 06:00 [pubmed]
PHST- 2018/01/11 06:00 [medline]
AID - nbt0118-10 [pii]
AID - 10.1038/nbt0118-10 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Jan 10;36(1):10-11. doi: 10.1038/nbt0118-10.

PMID- 29319691
OWN - NLM
STAT- In-Data-Review
LR  - 20180115
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 1
DP  - 2018 Jan 10
TI  - Drugmakers cling to dual IL-13/IL-4 blockbuster hopes.
PG  - 3-5
LID - 10.1038/nbt0118-3 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/01/11 06:00
MHDA- 2018/01/11 06:00
CRDT- 2018/01/11 06:00
PHST- 2018/01/11 06:00 [entrez]
PHST- 2018/01/11 06:00 [pubmed]
PHST- 2018/01/11 06:00 [medline]
AID - nbt0118-3 [pii]
AID - 10.1038/nbt0118-3 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Jan 10;36(1):3-5. doi: 10.1038/nbt0118-3.

PMID- 29319690
OWN - NLM
STAT- In-Data-Review
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 1
DP  - 2018 Jan 10
TI  - Texas displays 'Silicon Valley' credentials to lure Brazilian biotechs.
PG  - 12-13
LID - 10.1038/nbt0118-12 [doi]
FAU - Senior, Melanie
AU  - Senior M
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/01/11 06:00
MHDA- 2018/01/11 06:00
CRDT- 2018/01/11 06:00
PHST- 2018/01/11 06:00 [entrez]
PHST- 2018/01/11 06:00 [pubmed]
PHST- 2018/01/11 06:00 [medline]
AID - nbt0118-12 [pii]
AID - 10.1038/nbt0118-12 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Jan 10;36(1):12-13. doi: 10.1038/nbt0118-12.

PMID- 29319689
OWN - NLM
STAT- In-Data-Review
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 1
DP  - 2018 Jan 10
TI  - Recent patents in proteomics.
PG  - 40
LID - 10.1038/nbt.4064 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/01/11 06:00
MHDA- 2018/01/11 06:00
CRDT- 2018/01/11 06:00
PHST- 2018/01/11 06:00 [entrez]
PHST- 2018/01/11 06:00 [pubmed]
PHST- 2018/01/11 06:00 [medline]
AID - nbt.4064 [pii]
AID - 10.1038/nbt.4064 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Jan 10;36(1):40. doi: 10.1038/nbt.4064.

PMID- 29319688
OWN - NLM
STAT- In-Data-Review
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 1
DP  - 2018 Jan 10
TI  - Around the world in a month.
PG  - 13
LID - 10.1038/nbt0118-13 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/01/11 06:00
MHDA- 2018/01/11 06:00
CRDT- 2018/01/11 06:00
PHST- 2018/01/11 06:00 [entrez]
PHST- 2018/01/11 06:00 [pubmed]
PHST- 2018/01/11 06:00 [medline]
AID - nbt0118-13 [pii]
AID - 10.1038/nbt0118-13 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Jan 10;36(1):13. doi: 10.1038/nbt0118-13.

PMID- 29319687
OWN - NLM
STAT- In-Data-Review
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 1
DP  - 2018 Jan 10
TI  - First in vivo human genome editing trial.
PG  - 5
LID - 10.1038/nbt0118-5b [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/01/11 06:00
MHDA- 2018/01/11 06:00
CRDT- 2018/01/11 06:00
PHST- 2018/01/11 06:00 [entrez]
PHST- 2018/01/11 06:00 [pubmed]
PHST- 2018/01/11 06:00 [medline]
AID - nbt0118-5b [pii]
AID - 10.1038/nbt0118-5b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Jan 10;36(1):5. doi: 10.1038/nbt0118-5b.

PMID- 29319686
OWN - NLM
STAT- In-Data-Review
LR  - 20180115
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 1
DP  - 2018 Jan 10
TI  - Strength in numbers from integrated single-cell neuroscience.
PG  - 41-42
LID - 10.1038/nbt.4055 [doi]
FAU - Satija, Rahul
AU  - Satija R
AD  - New York Genome Center, New York, New York, USA, and New York University, Center 
      for Genomics and Systems Biology, New York, New York, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/01/11 06:00
MHDA- 2018/01/11 06:00
CRDT- 2018/01/11 06:00
PHST- 2018/01/11 06:00 [entrez]
PHST- 2018/01/11 06:00 [pubmed]
PHST- 2018/01/11 06:00 [medline]
AID - nbt.4055 [pii]
AID - 10.1038/nbt.4055 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Jan 10;36(1):41-42. doi: 10.1038/nbt.4055.

PMID- 29319685
OWN - NLM
STAT- In-Data-Review
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 1
DP  - 2018 Jan 10
TI  - China's fledgling biotech sector fizzes into life.
PG  - 8-9
LID - 10.1038/nbt0118-8 [doi]
FAU - Ellis, Shannon
AU  - Ellis S
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/01/11 06:00
MHDA- 2018/01/11 06:00
CRDT- 2018/01/11 06:00
PHST- 2018/01/11 06:00 [entrez]
PHST- 2018/01/11 06:00 [pubmed]
PHST- 2018/01/11 06:00 [medline]
AID - nbt0118-8 [pii]
AID - 10.1038/nbt0118-8 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Jan 10;36(1):8-9. doi: 10.1038/nbt0118-8.

PMID- 29319684
OWN - NLM
STAT- In-Data-Review
LR  - 20180115
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 1
DP  - 2018 Jan 10
TI  - Mapping the global influence of published research on industry and innovation.
PG  - 31-39
LID - 10.1038/nbt.4049 [doi]
FAU - Jefferson, Osmat A
AU  - Jefferson OA
AUID- ORCID: http://orcid.org/0000-0002-0607-8728
AD  - Queensland University of Technology (QUT), Brisbane, Queensland, Australia.
AD  - Cambia, Canberra, Australia.
FAU - Jaffe, Adam
AU  - Jaffe A
AD  - Queensland University of Technology (QUT), Brisbane, Queensland, Australia.
AD  - Motu Economic and Public Policy Research, Wellington, New Zealand.
FAU - Ashton, Doug
AU  - Ashton D
AD  - Cambia, Canberra, Australia.
FAU - Warren, Ben
AU  - Warren B
AD  - Cambia, Canberra, Australia.
FAU - Koellhofer, Deniz
AU  - Koellhofer D
AD  - Cambia, Canberra, Australia.
FAU - Dulleck, Uwe
AU  - Dulleck U
AD  - Queensland University of Technology (QUT), Brisbane, Queensland, Australia.
AD  - ANU, Research Services Division, Canberra, Australia.
AD  - CESifo Ludwig-Maximilians-Universitat, Center for Economic Studies, Munich,
      Germany.
FAU - Ballagh, Aaron
AU  - Ballagh A
AD  - ANU, Research Services Division, Canberra, Australia.
FAU - Moe, John
AU  - Moe J
AD  - National Library of Medicine, National Institutes of Health, Bethesda, Maryland, 
      USA.
FAU - DiCuccio, Michael
AU  - DiCuccio M
AD  - National Library of Medicine, National Institutes of Health, Bethesda, Maryland, 
      USA.
FAU - Ward, Karl
AU  - Ward K
AD  - Crossref Oxfordw Centre for Innovation, New Road, Oxford, United Kingdom.
FAU - Bilder, Geoff
AU  - Bilder G
AD  - Crossref Oxfordw Centre for Innovation, New Road, Oxford, United Kingdom.
FAU - Dolby, Kevin
AU  - Dolby K
AD  - Medical Research Council, London, United Kingdom.
FAU - Jefferson, Richard A
AU  - Jefferson RA
AD  - Queensland University of Technology (QUT), Brisbane, Queensland, Australia.
AD  - Cambia, Canberra, Australia.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/01/11 06:00
MHDA- 2018/01/11 06:00
CRDT- 2018/01/11 06:00
PHST- 2018/01/11 06:00 [entrez]
PHST- 2018/01/11 06:00 [pubmed]
PHST- 2018/01/11 06:00 [medline]
AID - nbt.4049 [pii]
AID - 10.1038/nbt.4049 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Jan 10;36(1):31-39. doi: 10.1038/nbt.4049.

PMID- 29319683
OWN - NLM
STAT- In-Data-Review
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 1
DP  - 2018 Jan 10
TI  - Why the European Union needs a national GMO opt-in mechanism.
PG  - 18-19
LID - 10.1038/nbt.4051 [doi]
FAU - Eriksson, Dennis
AU  - Eriksson D
AD  - Department of Plant Breeding, Swedish University of Agricultural Sciences,
      Alnarp, Sweden.
FAU - de Andrade, Eugenia
AU  - de Andrade E
AD  - Research Unit for Agricultural and Forestry Systems and Plant Health, National
      Institute for Agricultural and Veterinarian Research, Oeiras, Portugal.
FAU - Bohanec, Borut
AU  - Bohanec B
AD  - University of Ljubljana, Biotechnical Faculty, Ljubljana, Slovenia.
FAU - Chatzopolou, Sevasti
AU  - Chatzopolou S
AD  - Department of Social Sciences and Business, Roskilde School of Governance,
      Roskilde, Denmark.
FAU - Defez, Roberto
AU  - Defez R
AD  - IBBR, National Research Council, Naples, Italy.
FAU - Eriksson, Nelida Leiva
AU  - Eriksson NL
AD  - Department of Pure and Applied Biochemistry, Lund University (LTH), Lund, Sweden.
FAU - van der Meer, Piet
AU  - van der Meer P
AUID- ORCID: http://orcid.org/0000-0001-6991-5493
AD  - Department of Plant Biotechnology and Bio-Informatics, Faculty of Sciences, and
      Department of European, Public and International Law, Faculty of Law, Ghent
      University, Belgium.
AD  - Faculty of Science and Bio-Engineering Sciences, Free University Brussels (VUB), 
      Belgium.
FAU - van der Meulen, Bernd
AU  - van der Meulen B
AD  - Law & Governance Group, Wageningen University, Wageningen, the Netherlands.
FAU - Ritala, Anneli
AU  - Ritala A
AD  - VTT Technical Research Centre of Finland Ltd., Espoo, Finland.
FAU - Sagi, Laszlo
AU  - Sagi L
AUID- ORCID: http://orcid.org/0000-0002-6497-7174
AD  - Centre for Agricultural Research, Hungarian Academy of Sciences, Martonvasar,
      Hungary.
FAU - Schiemann, Joachim
AU  - Schiemann J
AD  - Institute for Biosafety in Plant Biotechnology, Julius Kuhn-Institut, Federal
      Research Centre for Cultivated Plants, Quedlinburg, Germany.
FAU - Twardowski, Tomasz
AU  - Twardowski T
AD  - Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland.
FAU - Vanek, Tomas
AU  - Vanek T
AD  - Laboratory of Plant Biotechnologies, Institute of Experimental Botany AS CR,
      Prague, Czech Republic.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/01/11 06:00
MHDA- 2018/01/11 06:00
CRDT- 2018/01/11 06:00
PHST- 2018/01/11 06:00 [entrez]
PHST- 2018/01/11 06:00 [pubmed]
PHST- 2018/01/11 06:00 [medline]
AID - nbt.4051 [pii]
AID - 10.1038/nbt.4051 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Jan 10;36(1):18-19. doi: 10.1038/nbt.4051.

PMID- 29319682
OWN - NLM
STAT- In-Data-Review
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 1
DP  - 2018 Jan 10
TI  - Bluebird's BCMA CAR-T impresses at ASH.
PG  - 11
LID - 10.1038/nbt0118-11 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2018/01/11 06:00
MHDA- 2018/01/11 06:00
CRDT- 2018/01/11 06:00
PHST- 2018/01/11 06:00 [entrez]
PHST- 2018/01/11 06:00 [pubmed]
PHST- 2018/01/11 06:00 [medline]
AID - nbt0118-11 [pii]
AID - 10.1038/nbt0118-11 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Jan 10;36(1):11. doi: 10.1038/nbt0118-11.

PMID- 29251732
OWN - NLM
STAT- In-Data-Review
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 1
DP  - 2018 Jan
TI  - Aligning stars of all colors.
PG  - 1
LID - 10.1038/nbt.4050 [doi]
LA  - eng
PT  - Editorial
DEP - 20171218
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/12/19 06:00
MHDA- 2017/12/19 06:00
CRDT- 2017/12/19 06:00
PHST- 2017/12/19 06:00 [pubmed]
PHST- 2017/12/19 06:00 [medline]
PHST- 2017/12/19 06:00 [entrez]
AID - nbt.4050 [pii]
AID - 10.1038/nbt.4050 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Jan;36(1):1. doi: 10.1038/nbt.4050. Epub 2017 Dec 18.

PMID- 29251731
OWN - NLM
STAT- In-Data-Review
LR  - 20180111
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 1
DP  - 2018 Jan
TI  - Mentoring for diversity in technology.
PG  - 113-115
LID - 10.1038/nbt.4025 [doi]
FAU - Werner-Washburne, Maggie
AU  - Werner-Washburne M
AD  - Department of Biology at the University of New Mexico, Albuquerque, New Mexico,
      USA.
LA  - eng
PT  - Journal Article
DEP - 20171218
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/12/19 06:00
MHDA- 2017/12/19 06:00
CRDT- 2017/12/19 06:00
PHST- 2017/12/19 06:00 [pubmed]
PHST- 2017/12/19 06:00 [medline]
PHST- 2017/12/19 06:00 [entrez]
AID - nbt.4025 [pii]
AID - 10.1038/nbt.4025 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Jan;36(1):113-115. doi: 10.1038/nbt.4025. Epub 2017 Dec 18.

PMID- 29251730
OWN - NLM
STAT- In-Data-Review
LR  - 20180111
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 1
DP  - 2018 Jan
TI  - Biotech's pale shadow.
PG  - 20-30
LID - 10.1038/nbt.4046 [doi]
FAU - Huggett, Brady
AU  - Huggett B
AD  - Nature Biotechnology. Photo at top of page is Ted Love, CEO of Global Blood
      Therapeutics.
LA  - eng
PT  - Journal Article
DEP - 20171218
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/12/19 06:00
MHDA- 2017/12/19 06:00
CRDT- 2017/12/19 06:00
PHST- 2017/12/19 06:00 [pubmed]
PHST- 2017/12/19 06:00 [medline]
PHST- 2017/12/19 06:00 [entrez]
AID - nbt.4046 [pii]
AID - 10.1038/nbt.4046 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Jan;36(1):20-30. doi: 10.1038/nbt.4046. Epub 2017 Dec 18.

PMID- 29251729
OWN - NLM
STAT- In-Data-Review
LR  - 20180111
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 1
DP  - 2018 Jan
TI  - Virus stamping for targeted single-cell infection in vitro and in vivo.
PG  - 81-88
LID - 10.1038/nbt.4034 [doi]
AB  - Genetic engineering by viral infection of single cells is useful to study complex
      systems such as the brain. However, available methods for infecting single cells 
      have drawbacks that limit their applications. Here we describe 'virus stamping', 
      in which viruses are reversibly bound to a delivery vehicle-a functionalized
      glass pipette tip or magnetic nanoparticles in a pipette-that is brought into
      physical contact with the target cell on a surface or in tissue, using mechanical
      or magnetic forces. Different single cells in the same tissue can be infected
      with different viruses and an individual cell can be simultaneously infected with
      different viruses. We use rabies, lenti, herpes simplex, and adeno-associated
      viruses to drive expression of fluorescent markers or a calcium indicator in
      target cells in cell culture, mouse retina, human brain organoid, and the brains 
      of live mice. Virus stamping provides a versatile solution for targeted
      single-cell infection of diverse cell types, both in vitro and in vivo.
FAU - Schubert, Rajib
AU  - Schubert R
AUID- ORCID: http://orcid.org/0000-0002-7071-0134
AD  - Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
FAU - Trenholm, Stuart
AU  - Trenholm S
AD  - Neural Circuit Laboratories, Friedrich Miescher Institute for Biomedical
      Research, Basel, Switzerland.
FAU - Balint, Kamill
AU  - Balint K
AD  - Neural Circuit Laboratories, Friedrich Miescher Institute for Biomedical
      Research, Basel, Switzerland.
AD  - University of Basel, Basel, Switzerland.
FAU - Kosche, Georg
AU  - Kosche G
AD  - Neural Circuit Laboratories, Friedrich Miescher Institute for Biomedical
      Research, Basel, Switzerland.
FAU - Cowan, Cameron S
AU  - Cowan CS
AD  - Neural Circuit Laboratories, Friedrich Miescher Institute for Biomedical
      Research, Basel, Switzerland.
FAU - Mohr, Manuel A
AU  - Mohr MA
AUID- ORCID: http://orcid.org/0000-0002-5189-541X
AD  - Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
FAU - Munz, Martin
AU  - Munz M
AD  - Neural Circuit Laboratories, Friedrich Miescher Institute for Biomedical
      Research, Basel, Switzerland.
FAU - Martinez-Martin, David
AU  - Martinez-Martin D
AD  - Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
FAU - Flaschner, Gotthold
AU  - Flaschner G
AUID- ORCID: http://orcid.org/0000-0001-6707-6905
AD  - Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
FAU - Newton, Richard
AU  - Newton R
AD  - Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
FAU - Krol, Jacek
AU  - Krol J
AD  - Neural Circuit Laboratories, Friedrich Miescher Institute for Biomedical
      Research, Basel, Switzerland.
FAU - Scherf, Brigitte Gross
AU  - Scherf BG
AD  - Neural Circuit Laboratories, Friedrich Miescher Institute for Biomedical
      Research, Basel, Switzerland.
FAU - Yonehara, Keisuke
AU  - Yonehara K
AD  - Neural Circuit Laboratories, Friedrich Miescher Institute for Biomedical
      Research, Basel, Switzerland.
FAU - Wertz, Adrian
AU  - Wertz A
AD  - Neural Circuit Laboratories, Friedrich Miescher Institute for Biomedical
      Research, Basel, Switzerland.
FAU - Ponti, Aaron
AU  - Ponti A
AD  - Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
FAU - Ghanem, Alexander
AU  - Ghanem A
AD  - Max von Pettenkofer-Institute & Gene Center, Faculty of Medicine,
      Ludwig-Maximilians-University Munich, Munich, Germany.
FAU - Hillier, Daniel
AU  - Hillier D
AD  - Neural Circuit Laboratories, Friedrich Miescher Institute for Biomedical
      Research, Basel, Switzerland.
FAU - Conzelmann, Karl-Klaus
AU  - Conzelmann KK
AUID- ORCID: http://orcid.org/0000-0002-8614-3656
AD  - Max von Pettenkofer-Institute & Gene Center, Faculty of Medicine,
      Ludwig-Maximilians-University Munich, Munich, Germany.
FAU - Muller, Daniel J
AU  - Muller DJ
AUID- ORCID: http://orcid.org/0000-0003-3075-0665
AD  - Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
FAU - Roska, Botond
AU  - Roska B
AUID- ORCID: http://orcid.org/0000-0002-9559-1450
AD  - Neural Circuit Laboratories, Friedrich Miescher Institute for Biomedical
      Research, Basel, Switzerland.
AD  - Department of Ophthalmology, University of Basel, Basel, Switzerland.
LA  - eng
PT  - Journal Article
DEP - 20171218
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/12/19 06:00
MHDA- 2017/12/19 06:00
CRDT- 2017/12/19 06:00
PHST- 2017/08/29 00:00 [received]
PHST- 2017/11/13 00:00 [accepted]
PHST- 2017/12/19 06:00 [pubmed]
PHST- 2017/12/19 06:00 [medline]
PHST- 2017/12/19 06:00 [entrez]
AID - nbt.4034 [pii]
AID - 10.1038/nbt.4034 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Jan;36(1):81-88. doi: 10.1038/nbt.4034. Epub 2017 Dec 18.

PMID- 29251728
OWN - NLM
STAT- In-Data-Review
LR  - 20180111
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 1
DP  - 2018 Jan
TI  - Viruses leave their stamp on single cells.
PG  - 42-44
LID - 10.1038/nbt.4043 [doi]
FAU - Rancz, Ede A
AU  - Rancz EA
AUID- ORCID: http://orcid.org/0000-0002-7951-1385
AD  - Cortical Circuits Laboratory, Francis Crick Institute, London, UK.
FAU - Schaefer, Andreas T
AU  - Schaefer AT
AD  - Neurophysiology of Behaviour Laboratory, Francis Crick Institute, London, UK, and
      the Department of Neuroscience, Physiology & Pharmacology, University College
      London, London, UK.
LA  - eng
PT  - Journal Article
DEP - 20171218
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/12/19 06:00
MHDA- 2017/12/19 06:00
CRDT- 2017/12/19 06:00
PHST- 2017/12/19 06:00 [pubmed]
PHST- 2017/12/19 06:00 [medline]
PHST- 2017/12/19 06:00 [entrez]
AID - nbt.4043 [pii]
AID - 10.1038/nbt.4043 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Jan;36(1):42-44. doi: 10.1038/nbt.4043. Epub 2017 Dec 18.

PMID- 29227470
OWN - NLM
STAT- In-Data-Review
LR  - 20180220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 1
DP  - 2018 Jan
TI  - Multiplexed droplet single-cell RNA-sequencing using natural genetic variation.
PG  - 89-94
LID - 10.1038/nbt.4042 [doi]
AB  - Droplet single-cell RNA-sequencing (dscRNA-seq) has enabled rapid, massively
      parallel profiling of transcriptomes. However, assessing differential expression 
      across multiple individuals has been hampered by inefficient sample processing
      and technical batch effects. Here we describe a computational tool, demuxlet,
      that harnesses natural genetic variation to determine the sample identity of each
      droplet containing a single cell (singlet) and detect droplets containing two
      cells (doublets). These capabilities enable multiplexed dscRNA-seq experiments in
      which cells from unrelated individuals are pooled and captured at higher
      throughput than in standard workflows. Using simulated data, we show that 50
      single-nucleotide polymorphisms (SNPs) per cell are sufficient to assign 97% of
      singlets and identify 92% of doublets in pools of up to 64 individuals. Given
      genotyping data for each of eight pooled samples, demuxlet correctly recovers the
      sample identity of >99% of singlets and identifies doublets at rates consistent
      with previous estimates. We apply demuxlet to assess cell-type-specific changes
      in gene expression in 8 pooled lupus patient samples treated with interferon
      (IFN)-beta and perform eQTL analysis on 23 pooled samples.
FAU - Kang, Hyun Min
AU  - Kang HM
AD  - Department of Biostatistics and Center for Statistical Genetics, University of
      Michigan School of Public Health, Ann Arbor, Michigan, USA.
FAU - Subramaniam, Meena
AU  - Subramaniam M
AD  - Biological and Medical Informatics Graduate Program, University of California,
      San Francisco, San Francisco, California, USA.
AD  - Institute for Human Genetics (IHG), University of California, San Francisco, San 
      Francisco, California, USA.
AD  - Institute for Computational Health Sciences, University of California, San
      Francisco, San Francisco, California, USA.
AD  - Department of Epidemiology and Biostatistics, University of California, San
      Francisco, San Francisco, California, USA.
AD  - Department of Bioengineering and Therapeutic Sciences, University of California, 
      San Francisco, San Francisco, California, USA.
FAU - Targ, Sasha
AU  - Targ S
AD  - Biological and Medical Informatics Graduate Program, University of California,
      San Francisco, San Francisco, California, USA.
AD  - Institute for Human Genetics (IHG), University of California, San Francisco, San 
      Francisco, California, USA.
AD  - Institute for Computational Health Sciences, University of California, San
      Francisco, San Francisco, California, USA.
AD  - Department of Epidemiology and Biostatistics, University of California, San
      Francisco, San Francisco, California, USA.
AD  - Department of Bioengineering and Therapeutic Sciences, University of California, 
      San Francisco, San Francisco, California, USA.
AD  - Medical Scientist Training Program (MSTP), University of California, San
      Francisco, San Francisco, California, USA.
FAU - Nguyen, Michelle
AU  - Nguyen M
AD  - Department of Microbiology and Immunology, University of California, San
      Francisco, San Francisco, California, USA.
AD  - Diabetes Center, University of California, San Francisco, San Francisco,
      California, USA.
AD  - Innovative Genomics Institute, University of California, Berkeley, Berkeley,
      California, USA.
FAU - Maliskova, Lenka
AU  - Maliskova L
AD  - Institute for Human Genetics (IHG), University of California, San Francisco, San 
      Francisco, California, USA.
AD  - Department of Neurology, University of California, San Francisco, San Francisco, 
      California, USA.
FAU - McCarthy, Elizabeth
AU  - McCarthy E
AD  - Medical Scientist Training Program (MSTP), University of California, San
      Francisco, San Francisco, California, USA.
FAU - Wan, Eunice
AU  - Wan E
AD  - Institute for Human Genetics (IHG), University of California, San Francisco, San 
      Francisco, California, USA.
FAU - Wong, Simon
AU  - Wong S
AD  - Institute for Human Genetics (IHG), University of California, San Francisco, San 
      Francisco, California, USA.
FAU - Byrnes, Lauren
AU  - Byrnes L
AD  - Developmental and Stem Cell Biology Graduate Program, University of California,
      San Francisco, San Francisco, California, USA.
FAU - Lanata, Cristina M
AU  - Lanata CM
AD  - Department of Medicine, University of California, San Francisco, San Francisco,
      California, USA.
AD  - Rosalind Russell/Ephraim P Engleman Rheumatology Research Center, University of
      California, San Francisco, San Francisco, California, USA.
FAU - Gate, Rachel E
AU  - Gate RE
AD  - Biological and Medical Informatics Graduate Program, University of California,
      San Francisco, San Francisco, California, USA.
AD  - Institute for Human Genetics (IHG), University of California, San Francisco, San 
      Francisco, California, USA.
AD  - Institute for Computational Health Sciences, University of California, San
      Francisco, San Francisco, California, USA.
AD  - Department of Epidemiology and Biostatistics, University of California, San
      Francisco, San Francisco, California, USA.
AD  - Department of Bioengineering and Therapeutic Sciences, University of California, 
      San Francisco, San Francisco, California, USA.
FAU - Mostafavi, Sara
AU  - Mostafavi S
AD  - Department of Statistics, University of British Columbia, Vancouver, British
      Columbia, Canada.
FAU - Marson, Alexander
AU  - Marson A
AD  - Department of Microbiology and Immunology, University of California, San
      Francisco, San Francisco, California, USA.
AD  - Diabetes Center, University of California, San Francisco, San Francisco,
      California, USA.
AD  - Innovative Genomics Institute, University of California, Berkeley, Berkeley,
      California, USA.
AD  - Department of Medicine, University of California, San Francisco, San Francisco,
      California, USA.
AD  - UCSF Helen Diller Family Comprehensive Cancer Center, University of California,
      San Francisco, San Francisco, California, USA.
AD  - Chan Zuckerberg Biohub, San Francisco, California, USA.
FAU - Zaitlen, Noah
AU  - Zaitlen N
AD  - Institute for Human Genetics (IHG), University of California, San Francisco, San 
      Francisco, California, USA.
AD  - Department of Medicine, University of California, San Francisco, San Francisco,
      California, USA.
AD  - Lung Biology Center, University of California, San Francisco, San Francisco,
      California, USA.
FAU - Criswell, Lindsey A
AU  - Criswell LA
AD  - Institute for Human Genetics (IHG), University of California, San Francisco, San 
      Francisco, California, USA.
AD  - Department of Medicine, University of California, San Francisco, San Francisco,
      California, USA.
AD  - Rosalind Russell/Ephraim P Engleman Rheumatology Research Center, University of
      California, San Francisco, San Francisco, California, USA.
AD  - Department of Orofacial Sciences, University of California, San Francisco, San
      Francisco, USA.
FAU - Ye, Chun Jimmie
AU  - Ye CJ
AD  - Institute for Human Genetics (IHG), University of California, San Francisco, San 
      Francisco, California, USA.
AD  - Institute for Computational Health Sciences, University of California, San
      Francisco, San Francisco, California, USA.
AD  - Department of Epidemiology and Biostatistics, University of California, San
      Francisco, San Francisco, California, USA.
AD  - Department of Bioengineering and Therapeutic Sciences, University of California, 
      San Francisco, San Francisco, California, USA.
LA  - eng
GR  - F30 DK115167/DK/NIDDK NIH HHS/United States
GR  - R03 DE025665/DE/NIDCR NIH HHS/United States
GR  - R21 AI133337/AI/NIAID NIH HHS/United States
GR  - R01 AR071522/AR/NIAMS NIH HHS/United States
GR  - U01 HL137182/HL/NHLBI NIH HHS/United States
GR  - K25 HL121295/HL/NHLBI NIH HHS/United States
PT  - Journal Article
DEP - 20171211
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
PMC - PMC5784859
MID - NIHMS921103
EDAT- 2017/12/12 06:00
MHDA- 2017/12/12 06:00
CRDT- 2017/12/12 06:00
PMCR- 2018/06/11 00:00
PHST- 2017/03/20 00:00 [received]
PHST- 2017/11/16 00:00 [accepted]
PHST- 2018/06/11 00:00 [pmc-release]
PHST- 2017/12/12 06:00 [pubmed]
PHST- 2017/12/12 06:00 [medline]
PHST- 2017/12/12 06:00 [entrez]
AID - nbt.4042 [pii]
AID - 10.1038/nbt.4042 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Jan;36(1):89-94. doi: 10.1038/nbt.4042. Epub 2017 Dec 11.

PMID- 29227469
OWN - NLM
STAT- In-Data-Review
LR  - 20180404
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 1
DP  - 2018 Jan
TI  - Integrative single-cell analysis of transcriptional and epigenetic states in the 
      human adult brain.
PG  - 70-80
LID - 10.1038/nbt.4038 [doi]
AB  - Detailed characterization of the cell types in the human brain requires scalable 
      experimental approaches to examine multiple aspects of the molecular state of
      individual cells, as well as computational integration of the data to produce
      unified cell-state annotations. Here we report improved high-throughput methods
      for single-nucleus droplet-based sequencing (snDrop-seq) and single-cell
      transposome hypersensitive site sequencing (scTHS-seq). We used each method to
      acquire nuclear transcriptomic and DNA accessibility maps for >60,000 single
      cells from human adult visual cortex, frontal cortex, and cerebellum. Integration
      of these data revealed regulatory elements and transcription factors that
      underlie cell-type distinctions, providing a basis for the study of complex
      processes in the brain, such as genetic programs that coordinate adult
      remyelination. We also mapped disease-associated risk variants to specific
      cellular populations, which provided insights into normal and pathogenic cellular
      processes in the human brain. This integrative multi-omics approach permits more 
      detailed single-cell interrogation of complex organs and tissues.
FAU - Lake, Blue B
AU  - Lake BB
AD  - Department of Bioengineering, University of California San Diego, La Jolla,
      California, USA.
FAU - Chen, Song
AU  - Chen S
AD  - Department of Bioengineering, University of California San Diego, La Jolla,
      California, USA.
FAU - Sos, Brandon C
AU  - Sos BC
AD  - Department of Bioengineering, University of California San Diego, La Jolla,
      California, USA.
AD  - UC San Diego School of Medicine, La Jolla, California, USA.
FAU - Fan, Jean
AU  - Fan J
AUID- ORCID: http://orcid.org/0000-0002-0212-5451
AD  - Department of Biomedical Informatics, Harvard Medical School, Boston,
      Massachusetts, USA.
FAU - Kaeser, Gwendolyn E
AU  - Kaeser GE
AD  - UC San Diego School of Medicine, La Jolla, California, USA.
AD  - Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA.
FAU - Yung, Yun C
AU  - Yung YC
AUID- ORCID: http://orcid.org/0000-0001-8973-7612
AD  - Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA.
FAU - Duong, Thu E
AU  - Duong TE
AD  - Department of Bioengineering, University of California San Diego, La Jolla,
      California, USA.
AD  - Department of Pediatric Respiratory Medicine, University of California San Diego,
      La Jolla, California, USA.
FAU - Gao, Derek
AU  - Gao D
AD  - Department of Bioengineering, University of California San Diego, La Jolla,
      California, USA.
FAU - Chun, Jerold
AU  - Chun J
AD  - Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA.
FAU - Kharchenko, Peter V
AU  - Kharchenko PV
AD  - Department of Biomedical Informatics, Harvard Medical School, Boston,
      Massachusetts, USA.
FAU - Zhang, Kun
AU  - Zhang K
AUID- ORCID: http://orcid.org/0000-0002-7596-5224
AD  - Department of Bioengineering, University of California San Diego, La Jolla,
      California, USA.
LA  - eng
GR  - P50 AG005131/AG/NIA NIH HHS/United States
GR  - U01 MH098977/MH/NIMH NIH HHS/United States
GR  - R01 HL131768/HL/NHLBI NIH HHS/United States
GR  - K12 HD000850/HD/NICHD NIH HHS/United States
GR  - T32 AG000216/AG/NIA NIH HHS/United States
GR  - P50 MH106933/MH/NIMH NIH HHS/United States
PT  - Journal Article
DEP - 20171211
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/12/12 06:00
MHDA- 2017/12/12 06:00
CRDT- 2017/12/12 06:00
PHST- 2017/04/14 00:00 [received]
PHST- 2017/11/15 00:00 [accepted]
PHST- 2017/12/12 06:00 [pubmed]
PHST- 2017/12/12 06:00 [medline]
PHST- 2017/12/12 06:00 [entrez]
AID - nbt.4038 [pii]
AID - 10.1038/nbt.4038 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Jan;36(1):70-80. doi: 10.1038/nbt.4038. Epub 2017 Dec 11.

PMID- 29227468
OWN - NLM
STAT- In-Data-Review
LR  - 20180113
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 1
DP  - 2018 Jan
TI  - Metagenomic binning and association of plasmids with bacterial host genomes using
      DNA methylation.
PG  - 61-69
LID - 10.1038/nbt.4037 [doi]
AB  - Shotgun metagenomics methods enable characterization of microbial communities in 
      human microbiome and environmental samples. Assembly of metagenome sequences does
      not output whole genomes, so computational binning methods have been developed to
      cluster sequences into genome 'bins'. These methods exploit sequence composition,
      species abundance, or chromosome organization but cannot fully distinguish
      closely related species and strains. We present a binning method that
      incorporates bacterial DNA methylation signatures, which are detected using
      single-molecule real-time sequencing. Our method takes advantage of these
      endogenous epigenetic barcodes to resolve individual reads and assembled contigs 
      into species- and strain-level bins. We validate our method using synthetic and
      real microbiome sequences. In addition to genome binning, we show that our method
      links plasmids and other mobile genetic elements to their host species in a real 
      microbiome sample. Incorporation of DNA methylation information into shotgun
      metagenomics analyses will complement existing methods to enable more accurate
      sequence binning.
FAU - Beaulaurier, John
AU  - Beaulaurier J
AUID- ORCID: http://orcid.org/0000-0003-1536-888X
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
AD  - Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at 
      Mount Sinai, New York, New York, USA.
FAU - Zhu, Shijia
AU  - Zhu S
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
AD  - Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at 
      Mount Sinai, New York, New York, USA.
FAU - Deikus, Gintaras
AU  - Deikus G
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
AD  - Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at 
      Mount Sinai, New York, New York, USA.
FAU - Mogno, Ilaria
AU  - Mogno I
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
AD  - Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at 
      Mount Sinai, New York, New York, USA.
AD  - Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New
      York, USA.
FAU - Zhang, Xue-Song
AU  - Zhang XS
AD  - Department of Medicine, New York University School of Medicine, New York, New
      York, USA.
FAU - Davis-Richardson, Austin
AU  - Davis-Richardson A
AD  - Department of Microbiology and Cell Science, Institute of Food and Agricultural
      Sciences, University of Florida, Gainesville, Florida, USA.
FAU - Canepa, Ronald
AU  - Canepa R
AD  - Department of Microbiology and Cell Science, Institute of Food and Agricultural
      Sciences, University of Florida, Gainesville, Florida, USA.
FAU - Triplett, Eric W
AU  - Triplett EW
AD  - Department of Microbiology and Cell Science, Institute of Food and Agricultural
      Sciences, University of Florida, Gainesville, Florida, USA.
FAU - Faith, Jeremiah J
AU  - Faith JJ
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
AD  - Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at 
      Mount Sinai, New York, New York, USA.
AD  - Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New
      York, USA.
FAU - Sebra, Robert
AU  - Sebra R
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
AD  - Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at 
      Mount Sinai, New York, New York, USA.
AD  - Sema4, a Mount Sinai venture, Stamford, Connecticut, USA.
FAU - Schadt, Eric E
AU  - Schadt EE
AUID- ORCID: http://orcid.org/0000-0002-7892-8808
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
AD  - Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at 
      Mount Sinai, New York, New York, USA.
AD  - Sema4, a Mount Sinai venture, Stamford, Connecticut, USA.
FAU - Fang, Gang
AU  - Fang G
AUID- ORCID: http://orcid.org/0000-0002-2462-9124
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
AD  - Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at 
      Mount Sinai, New York, New York, USA.
LA  - eng
GR  - R01 GM114472/GM/NIGMS NIH HHS/United States
PT  - Journal Article
DEP - 20171211
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
PMC - PMC5762413
MID - NIHMS920168
EDAT- 2017/12/12 06:00
MHDA- 2017/12/12 06:00
CRDT- 2017/12/12 06:00
PMCR- 2018/06/11 00:00
PHST- 2016/09/13 00:00 [received]
PHST- 2017/11/13 00:00 [accepted]
PHST- 2018/06/11 00:00 [pmc-release]
PHST- 2017/12/12 06:00 [pubmed]
PHST- 2017/12/12 06:00 [medline]
PHST- 2017/12/12 06:00 [entrez]
AID - nbt.4037 [pii]
AID - 10.1038/nbt.4037 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Jan;36(1):61-69. doi: 10.1038/nbt.4037. Epub 2017 Dec 11.

PMID- 29176614
OWN - NLM
STAT- In-Data-Review
LR  - 20180113
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 1
DP  - 2018 Jan
TI  - Inhibition of 53BP1 favors homology-dependent DNA repair and increases
      CRISPR-Cas9 genome-editing efficiency.
PG  - 95-102
LID - 10.1038/nbt.4021 [doi]
AB  - Programmable nucleases, such as Cas9, are used for precise genome editing by
      homology-dependent repair (HDR). However, HDR efficiency is constrained by
      competition from other double-strand break (DSB) repair pathways, including
      non-homologous end-joining (NHEJ). We report the discovery of a genetically
      encoded inhibitor of 53BP1 that increases the efficiency of HDR-dependent genome 
      editing in human and mouse cells. 53BP1 is a key regulator of DSB repair pathway 
      choice in eukaryotic cells and functions to favor NHEJ over HDR by suppressing
      end resection, which is the rate-limiting step in the initiation of HDR. We
      screened an existing combinatorial library of engineered ubiquitin variants for
      inhibitors of 53BP1. Expression of one variant, named i53 (inhibitor of 53BP1),
      in human and mouse cells, blocked accumulation of 53BP1 at sites of DNA damage
      and improved gene targeting and chromosomal gene conversion with either
      double-stranded DNA or single-stranded oligonucleotide donors by up to 5.6-fold. 
      Inhibition of 53BP1 is a robust method to increase efficiency of HDR-based
      precise genome editing.
FAU - Canny, Marella D
AU  - Canny MD
AD  - The Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto,
      Ontario, Canada.
FAU - Moatti, Nathalie
AU  - Moatti N
AD  - The Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto,
      Ontario, Canada.
FAU - Wan, Leo C K
AU  - Wan LCK
AD  - The Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto,
      Ontario, Canada.
AD  - Department of Molecular Genetics, University of Toronto, Ontario, Canada.
FAU - Fradet-Turcotte, Amelie
AU  - Fradet-Turcotte A
AD  - The Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto,
      Ontario, Canada.
FAU - Krasner, Danielle
AU  - Krasner D
AD  - Department of Molecular Microbiology and Immunology, Keck School of Medicine,
      University of Southern California, Los Angeles, California, USA.
FAU - Mateos-Gomez, Pedro A
AU  - Mateos-Gomez PA
AD  - Skirball Institute of Biomolecular Medicine, Department of Cell Biology, NYU
      Langone Medical Center, New York, New York, USA.
FAU - Zimmermann, Michal
AU  - Zimmermann M
AD  - The Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto,
      Ontario, Canada.
FAU - Orthwein, Alexandre
AU  - Orthwein A
AD  - The Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto,
      Ontario, Canada.
FAU - Juang, Yu-Chi
AU  - Juang YC
AD  - The Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto,
      Ontario, Canada.
FAU - Zhang, Wei
AU  - Zhang W
AD  - The Donnelly Centre for Cellular and Biomolecular Research, Banting and Best
      Department of Medical Research, University of Toronto, Ontario, Canada.
FAU - Noordermeer, Sylvie M
AU  - Noordermeer SM
AUID- ORCID: http://orcid.org/0000-0003-2737-9690
AD  - The Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto,
      Ontario, Canada.
FAU - Seclen, Eduardo
AU  - Seclen E
AD  - Department of Molecular Microbiology and Immunology, Keck School of Medicine,
      University of Southern California, Los Angeles, California, USA.
FAU - Wilson, Marcus D
AU  - Wilson MD
AD  - The Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto,
      Ontario, Canada.
FAU - Vorobyov, Andrew
AU  - Vorobyov A
AD  - The Donnelly Centre for Cellular and Biomolecular Research, Banting and Best
      Department of Medical Research, University of Toronto, Ontario, Canada.
FAU - Munro, Meagan
AU  - Munro M
AD  - The Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto,
      Ontario, Canada.
FAU - Ernst, Andreas
AU  - Ernst A
AD  - The Donnelly Centre for Cellular and Biomolecular Research, Banting and Best
      Department of Medical Research, University of Toronto, Ontario, Canada.
FAU - Ng, Timothy F
AU  - Ng TF
AD  - The Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto,
      Ontario, Canada.
AD  - Department of Molecular Genetics, University of Toronto, Ontario, Canada.
FAU - Cho, Tiffany
AU  - Cho T
AD  - The Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto,
      Ontario, Canada.
AD  - Department of Molecular Genetics, University of Toronto, Ontario, Canada.
FAU - Cannon, Paula M
AU  - Cannon PM
AD  - Department of Molecular Microbiology and Immunology, Keck School of Medicine,
      University of Southern California, Los Angeles, California, USA.
FAU - Sidhu, Sachdev S
AU  - Sidhu SS
AD  - Department of Molecular Genetics, University of Toronto, Ontario, Canada.
AD  - The Donnelly Centre for Cellular and Biomolecular Research, Banting and Best
      Department of Medical Research, University of Toronto, Ontario, Canada.
FAU - Sicheri, Frank
AU  - Sicheri F
AD  - The Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto,
      Ontario, Canada.
AD  - Department of Molecular Genetics, University of Toronto, Ontario, Canada.
FAU - Durocher, Daniel
AU  - Durocher D
AUID- ORCID: http://orcid.org/0000-0003-3863-8635
AD  - The Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto,
      Ontario, Canada.
AD  - Department of Molecular Genetics, University of Toronto, Ontario, Canada.
LA  - eng
GR  - U19 HL129902/HL/NHLBI NIH HHS/United States
PT  - Journal Article
DEP - 20171127
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
PMC - PMC5762392
MID - NIHMS914739
EDAT- 2017/11/28 06:00
MHDA- 2017/11/28 06:00
CRDT- 2017/11/28 06:00
PMCR- 2018/05/27 00:00
PHST- 2016/03/28 00:00 [received]
PHST- 2017/10/20 00:00 [accepted]
PHST- 2018/05/27 00:00 [pmc-release]
PHST- 2017/11/28 06:00 [pubmed]
PHST- 2017/11/28 06:00 [medline]
PHST- 2017/11/28 06:00 [entrez]
AID - nbt.4021 [pii]
AID - 10.1038/nbt.4021 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Jan;36(1):95-102. doi: 10.1038/nbt.4021. Epub 2017 Nov 27.

PMID- 29176613
OWN - NLM
STAT- In-Data-Review
LR  - 20180113
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 36
IP  - 1
DP  - 2018 Jan
TI  - Global landscape of cell envelope protein complexes in Escherichia coli.
PG  - 103-112
LID - 10.1038/nbt.4024 [doi]
AB  - Bacterial cell envelope protein (CEP) complexes mediate a range of processes,
      including membrane assembly, antibiotic resistance and metabolic coordination.
      However, only limited characterization of relevant macromolecules has been
      reported to date. Here we present a proteomic survey of 1,347 CEPs encompassing
      90% inner- and outer-membrane and periplasmic proteins of Escherichia coli. After
      extraction with non-denaturing detergents, we affinity-purified 785 endogenously 
      tagged CEPs and identified stably associated polypeptides by precision mass
      spectrometry. The resulting high-quality physical interaction network, comprising
      77% of targeted CEPs, revealed many previously uncharacterized heteromeric
      complexes. We found that the secretion of autotransporters requires translocation
      and the assembly module TamB to nucleate proper folding from periplasm to cell
      surface through a cooperative mechanism involving the beta-barrel assembly
      machinery. We also establish that an ABC transporter of unknown function, YadH,
      together with the Mla system preserves outer membrane lipid asymmetry. This E.
      coli CEP 'interactome' provides insights into the functional landscape governing 
      CE systems essential to bacterial growth, metabolism and drug resistance.
FAU - Babu, Mohan
AU  - Babu M
AUID- ORCID: http://orcid.org/0000-0003-4118-6406
AD  - Department of Biochemistry, University of Regina, Regina, Saskatchewan, Canada.
FAU - Bundalovic-Torma, Cedoljub
AU  - Bundalovic-Torma C
AUID- ORCID: http://orcid.org/0000-0001-8741-4457
AD  - Hospital for Sick Children, Toronto, Ontario, Canada.
AD  - Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.
FAU - Calmettes, Charles
AU  - Calmettes C
AD  - Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.
AD  - INRS-Institut Armand Frappier, Laval, Quebec, Canada.
FAU - Phanse, Sadhna
AU  - Phanse S
AD  - Department of Biochemistry, University of Regina, Regina, Saskatchewan, Canada.
AD  - Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.
FAU - Zhang, Qingzhou
AU  - Zhang Q
AD  - Department of Biochemistry, University of Regina, Regina, Saskatchewan, Canada.
FAU - Jiang, Yue
AU  - Jiang Y
AD  - Hospital for Sick Children, Toronto, Ontario, Canada.
FAU - Minic, Zoran
AU  - Minic Z
AD  - Department of Biochemistry, University of Regina, Regina, Saskatchewan, Canada.
FAU - Kim, Sunyoung
AU  - Kim S
AD  - Department of Biochemistry, University of Regina, Regina, Saskatchewan, Canada.
FAU - Mehla, Jitender
AU  - Mehla J
AD  - Virginia Commonwealth University, Richmond, Virginia, USA.
FAU - Gagarinova, Alla
AU  - Gagarinova A
AD  - Department of Biochemistry, University of Saskatchewan, Saskatoon, Canada.
FAU - Rodionova, Irina
AU  - Rodionova I
AD  - Department of Molecular Biology, UC San Diego, La Jolla, California, USA.
FAU - Kumar, Ashwani
AU  - Kumar A
AD  - Department of Computer Science, University of Regina, Regina, Saskatchewan,
      Canada.
FAU - Guo, Hongbo
AU  - Guo H
AD  - Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.
FAU - Kagan, Olga
AU  - Kagan O
AD  - Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.
FAU - Pogoutse, Oxana
AU  - Pogoutse O
AD  - Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.
FAU - Aoki, Hiroyuki
AU  - Aoki H
AD  - Department of Biochemistry, University of Regina, Regina, Saskatchewan, Canada.
FAU - Deineko, Viktor
AU  - Deineko V
AD  - Department of Biochemistry, University of Regina, Regina, Saskatchewan, Canada.
FAU - Caufield, J Harry
AU  - Caufield JH
AUID- ORCID: http://orcid.org/0000-0001-5705-7831
AD  - Virginia Commonwealth University, Richmond, Virginia, USA.
FAU - Holtzapple, Erik
AU  - Holtzapple E
AD  - Department of Biochemistry, University of Saskatchewan, Saskatoon, Canada.
AD  - Department of Molecular Biology, UC San Diego, La Jolla, California, USA.
FAU - Zhang, Zhongge
AU  - Zhang Z
AD  - Department of Molecular Biology, UC San Diego, La Jolla, California, USA.
FAU - Vastermark, Ake
AU  - Vastermark A
AUID- ORCID: http://orcid.org/0000-0001-8649-7553
AD  - Department of Molecular Biology, UC San Diego, La Jolla, California, USA.
FAU - Pandya, Yogee
AU  - Pandya Y
AD  - Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.
FAU - Lai, Christine Chieh-Lin
AU  - Lai CC
AD  - Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.
FAU - El Bakkouri, Majida
AU  - El Bakkouri M
AD  - Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.
FAU - Hooda, Yogesh
AU  - Hooda Y
AD  - Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.
FAU - Shah, Megha
AU  - Shah M
AD  - Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.
FAU - Burnside, Dan
AU  - Burnside D
AD  - Department of Biology, Carleton University, Ottawa, Ontario, Canada.
FAU - Hooshyar, Mohsen
AU  - Hooshyar M
AD  - Department of Biology, Carleton University, Ottawa, Ontario, Canada.
FAU - Vlasblom, James
AU  - Vlasblom J
AD  - Department of Biochemistry, University of Regina, Regina, Saskatchewan, Canada.
FAU - Rajagopala, Sessandra V
AU  - Rajagopala SV
AD  - J. Craig Venter Institute, Rockville, Maryland, USA.
FAU - Golshani, Ashkan
AU  - Golshani A
AD  - Department of Biology, Carleton University, Ottawa, Ontario, Canada.
FAU - Wuchty, Stefan
AU  - Wuchty S
AD  - Department of Computer Science and Department of Biology, University of Miami,
      Coral Gables, Florida, USA.
FAU - F Greenblatt, Jack
AU  - F Greenblatt J
AD  - Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.
AD  - Department of Molecular Genetics, University of Toronto, Toronto, Ontario,
      Canada.
FAU - Saier, Milton
AU  - Saier M
AD  - Department of Molecular Biology, UC San Diego, La Jolla, California, USA.
FAU - Uetz, Peter
AU  - Uetz P
AUID- ORCID: http://orcid.org/0000-0001-6194-4927
AD  - Virginia Commonwealth University, Richmond, Virginia, USA.
FAU - F Moraes, Trevor
AU  - F Moraes T
AD  - Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.
FAU - Parkinson, John
AU  - Parkinson J
AD  - Hospital for Sick Children, Toronto, Ontario, Canada.
AD  - Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.
AD  - Department of Molecular Genetics, University of Toronto, Toronto, Ontario,
      Canada.
FAU - Emili, Andrew
AU  - Emili A
AUID- ORCID: http://orcid.org/0000-0001-8995-246X
AD  - Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.
AD  - Department of Molecular Genetics, University of Toronto, Toronto, Ontario,
      Canada.
AD  - Department of Biology and Biochemistry, Boston University, Boston, Massachusetts,
      USA.
LA  - eng
GR  - R01 GM077402/GM/NIGMS NIH HHS/United States
PT  - Journal Article
DEP - 20171127
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/11/28 06:00
MHDA- 2017/11/28 06:00
CRDT- 2017/11/28 06:00
PHST- 2017/04/17 00:00 [received]
PHST- 2017/11/01 00:00 [accepted]
PHST- 2017/11/28 06:00 [pubmed]
PHST- 2017/11/28 06:00 [medline]
PHST- 2017/11/28 06:00 [entrez]
AID - nbt.4024 [pii]
AID - 10.1038/nbt.4024 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2018 Jan;36(1):103-112. doi: 10.1038/nbt.4024. Epub 2017 Nov 27.

PMID- 29220038
OWN - NLM
STAT- In-Data-Review
LR  - 20171208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 12
DP  - 2017 Dec 8
TI  - Top 20 translational researchers of 2016.
PG  - 1126
LID - 10.1038/nbt.4028 [doi]
FAU - Huggett, Brady
AU  - Huggett B
AD  - Nature Biotechnology.
FAU - Paisner, Kathryn
AU  - Paisner K
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/12/09 06:00
MHDA- 2017/12/09 06:00
CRDT- 2017/12/09 06:00
PHST- 2017/12/09 06:00 [entrez]
PHST- 2017/12/09 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt.4028 [pii]
AID - 10.1038/nbt.4028 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Dec 8;35(12):1126. doi: 10.1038/nbt.4028.

PMID- 29220037
OWN - NLM
STAT- In-Data-Review
LR  - 20180202
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 12
DP  - 2017 Dec 8
TI  - Corrections.
PG  - 1124
LID - 10.1038/nbt1217-1124b [doi]
LA  - eng
PT  - Journal Article
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2017 Sep 11;35(9):808-809. PMID: 28898216
EDAT- 2017/12/09 06:00
MHDA- 2017/12/09 06:00
CRDT- 2017/12/09 06:00
PHST- 2017/12/09 06:00 [entrez]
PHST- 2017/12/09 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt1217-1124b [pii]
AID - 10.1038/nbt1217-1124b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Dec 8;35(12):1124. doi: 10.1038/nbt1217-1124b.

PMID- 29220036
OWN - NLM
STAT- In-Data-Review
LR  - 20171220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 12
DP  - 2017 Dec 8
TI  - The international MAQC Society launches to enhance reproducibility of
      high-throughput technologies.
PG  - 1127-1128
LID - 10.1038/nbt.4029 [doi]
FAU - Shi, Leming
AU  - Shi L
AD  - State Key Laboratory of Genetic Engineering, School of Life Sciences and Shanghai
      Cancer Center, Fudan University, Shanghai, China.
AD  - Collaborative Innovation Center for Genetics and Development, Fudan University,
      Shanghai, China.
FAU - Kusko, Rebecca
AU  - Kusko R
AD  - Immuneering Corporation, Cambridge, Massachusetts, USA.
FAU - Wolfinger, Russell D
AU  - Wolfinger RD
AD  - SAS Institute Inc., Cary, North Carolina, USA.
FAU - Haibe-Kains, Benjamin
AU  - Haibe-Kains B
AD  - Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
AD  - Departments of Medical Biophysics and Computer Science, University of Toronto,
      Toronto, Ontario, Canada.
AD  - Ontario Cancer Research Institute, Toronto, Ontario, Canada.
FAU - Fischer, Matthias
AU  - Fischer M
AD  - Department of Experimental Pediatric Oncology, University Children's Hospital of 
      Cologne, Medical Faculty, Cologne, Germany.
AD  - Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne,
      Germany.
FAU - Sansone, Susanna-Assunta
AU  - Sansone SA
AUID- ORCID: http://orcid.org/0000-0001-5306-5690
AD  - Oxford e-Research Centre, Engineering Science Department, University of Oxford,
      Oxford, UK.
FAU - Mason, Christopher E
AU  - Mason CE
AUID- ORCID: http://orcid.org/0000-0002-1850-1642
AD  - Weill Cornell Medicine, New York, New York, USA.
FAU - Furlanello, Cesare
AU  - Furlanello C
AUID- ORCID: http://orcid.org/0000-0002-5384-3605
AD  - Fondazione Bruno Kessler, Trento, Italy.
FAU - Jones, Wendell D
AU  - Jones WD
AUID- ORCID: http://orcid.org/0000-0002-9676-5387
AD  - Q2 Solutions, Morrisville, North Carolina, USA.
FAU - Ning, Baitang
AU  - Ning B
AD  - National Center for Toxicological Research, US Food and Drug Administration,
      Jefferson, Arkansas, USA.
FAU - Tong, Weida
AU  - Tong W
AD  - National Center for Toxicological Research, US Food and Drug Administration,
      Jefferson, Arkansas, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/12/09 06:00
MHDA- 2017/12/09 06:00
CRDT- 2017/12/09 06:00
PHST- 2017/12/09 06:00 [entrez]
PHST- 2017/12/09 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt.4029 [pii]
AID - 10.1038/nbt.4029 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Dec 8;35(12):1127-1128. doi: 10.1038/nbt.4029.

PMID- 29220035
OWN - NLM
STAT- In-Data-Review
LR  - 20171208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 12
DP  - 2017 Dec 8
TI  - The Broad and Johns Hopkins lure deep-pocketed investors.
PG  - 1123
LID - 10.1038/nbt1217-1123 [doi]
FAU - von Schaper, Eva
AU  - von Schaper E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/12/09 06:00
MHDA- 2017/12/09 06:00
CRDT- 2017/12/09 06:00
PHST- 2017/12/09 06:00 [entrez]
PHST- 2017/12/09 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt1217-1123 [pii]
AID - 10.1038/nbt1217-1123 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Dec 8;35(12):1123. doi: 10.1038/nbt1217-1123.

PMID- 29220033
OWN - NLM
STAT- In-Data-Review
LR  - 20180222
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 12
DP  - 2017 Dec 8
TI  - Challenges and recommendations for epigenomics in precision health.
PG  - 1128-1132
LID - 10.1038/nbt.4030 [doi]
FAU - Carter, Ava C
AU  - Carter AC
AD  - Center for Personal Dynamic Regulomes, Stanford University, Stanford, California,
      USA.
FAU - Chang, Howard Y
AU  - Chang HY
AUID- ORCID: http://orcid.org/0000-0002-9459-4393
AD  - Center for Personal Dynamic Regulomes, Stanford University, Stanford, California,
      USA.
FAU - Church, George
AU  - Church G
AD  - Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA, and
      Wyss Institute, Boston, Massachusetts, USA.
FAU - Dombkowski, Ashley
AU  - Dombkowski A
AD  - BEFORE Brands, Menlo Park, California, USA.
FAU - Ecker, Joseph R
AU  - Ecker JR
AD  - The Salk Institute for Biological Studies, La Jolla, California, USA, and Howard 
      Hughes Medical Institute.
FAU - Gil, Elad
AU  - Gil E
AD  - Color Genomics, Burlingame, California, USA.
FAU - Giresi, Paul G
AU  - Giresi PG
AD  - Epinomics, Menlo Park, California, USA.
FAU - Greely, Henry
AU  - Greely H
AD  - Center for Law and the Biosciences, Stanford University, Stanford, California,
      USA.
FAU - Greenleaf, William J
AU  - Greenleaf WJ
AUID- ORCID: http://orcid.org/0000-0003-1409-3095
AD  - Center for Personal Dynamic Regulomes, Stanford University, Stanford, California,
      USA.
AD  - Department of Genetics, Stanford University, Stanford, California, USA.
FAU - Hacohen, Nir
AU  - Hacohen N
AD  - Massachusetts General Hospital, Boston, Massachusetts, USA.
FAU - He, Chuan
AU  - He C
AD  - University of Chicago, Chicago, Illinois, USA, & Howard Hughes Medical Institute.
FAU - Hill, David
AU  - Hill D
AD  - Center for Cancer Systems Biology, Dana Farber Cancer Institute, Boston,
      Massachusetts, USA.
FAU - Ko, Justin
AU  - Ko J
AD  - Department of Dermatology, Stanford University, Stanford, California, USA.
FAU - Kohane, Isaac
AU  - Kohane I
AD  - Department of Medical Informatics, Harvard Medical School, Boston, Massachusetts,
      USA.
FAU - Kundaje, Anshul
AU  - Kundaje A
AD  - Departments of Genetics and Computer Science, Stanford University, Stanford,
      California, USA.
FAU - Palmer, Megan
AU  - Palmer M
AD  - Center for International Security and Cooperation, Stanford University, Stanford,
      California, USA.
FAU - Snyder, Michael P
AU  - Snyder MP
AD  - Center for Personal Dynamic Regulomes, Stanford University, Stanford, California,
      USA.
AD  - Department of Genetics, Stanford University, Stanford, California, USA.
FAU - Tung, Joyce
AU  - Tung J
AD  - 23andMe, Mountain View, California, USA.
FAU - Urban, Alexander
AU  - Urban A
AD  - Center for Personal Dynamic Regulomes, Stanford University, Stanford, California,
      USA.
AD  - Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, 
      California, USA.
FAU - Vidal, Marc
AU  - Vidal M
AD  - Center for Cancer Systems Biology, Dana Farber Cancer Institute, Boston,
      Massachusetts, USA.
FAU - Wong, Wing
AU  - Wong W
AD  - Center for Personal Dynamic Regulomes, Stanford University, Stanford, California,
      USA.
AD  - Department of Statistics, Stanford University, Stanford, California, USA.
LA  - eng
GR  - RM1 HG008935/HG/NHGRI NIH HHS/United States
GR  - P50 HG005550/HG/NHGRI NIH HHS/United States
GR  - RM1 HG008525/HG/NHGRI NIH HHS/United States
GR  - P50 HG004233/HG/NHGRI NIH HHS/United States
GR  - P50 HG007735/HG/NHGRI NIH HHS/United States
GR  - R01 HG007834/HG/NHGRI NIH HHS/United States
GR  - P50 MH106933/MH/NIMH NIH HHS/United States
GR  - P50 HG002357/HG/NHGRI NIH HHS/United States
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
PMC - PMC5821229
MID - NIHMS940528
EDAT- 2017/12/09 06:00
MHDA- 2017/12/09 06:00
CRDT- 2017/12/09 06:00
PHST- 2017/12/09 06:00 [entrez]
PHST- 2017/12/09 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt.4030 [pii]
AID - 10.1038/nbt.4030 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Dec 8;35(12):1128-1132. doi: 10.1038/nbt.4030.

PMID- 29220032
OWN - NLM
STAT- In-Data-Review
LR  - 20171220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 12
DP  - 2017 Dec 8
TI  - Institutional culture is the key to team science.
PG  - 1212-1214
LID - 10.1038/nbt.4026 [doi]
FAU - Lee, Sandra Soo-Jin
AU  - Lee SS
AD  - Stanford Center for Biomedical Ethics, Stanford University School of Medicine,
      Stanford, California, USA.
FAU - Jabloner, Anna
AU  - Jabloner A
AD  - Center for Research on the Ethical, Legal and Social Implications of Psychiatric,
      Neurologic and Behavioral Genetics, Columbia University Medical Center, New York,
      New York, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/12/09 06:00
MHDA- 2017/12/09 06:00
CRDT- 2017/12/09 06:00
PHST- 2017/12/09 06:00 [entrez]
PHST- 2017/12/09 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt.4026 [pii]
AID - 10.1038/nbt.4026 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Dec 8;35(12):1212-1214. doi: 10.1038/nbt.4026.

PMID- 29220031
OWN - NLM
STAT- In-Data-Review
LR  - 20171208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 12
DP  - 2017 Dec 8
TI  - Activists bury India's GM mustard hopes.
PG  - 1124
LID - 10.1038/nbt1217-1124a [doi]
FAU - Jayaraman, Killugudi
AU  - Jayaraman K
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/12/09 06:00
MHDA- 2017/12/09 06:00
CRDT- 2017/12/09 06:00
PHST- 2017/12/09 06:00 [entrez]
PHST- 2017/12/09 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt1217-1124a [pii]
AID - 10.1038/nbt1217-1124a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Dec 8;35(12):1124. doi: 10.1038/nbt1217-1124a.

PMID- 29220030
OWN - NLM
STAT- In-Data-Review
LR  - 20171208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 12
DP  - 2017 Dec 8
TI  - Methods, preprints and papers.
PG  - 1113
LID - 10.1038/nbt.4044 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/12/09 06:00
MHDA- 2017/12/09 06:00
CRDT- 2017/12/09 06:00
PHST- 2017/12/09 06:00 [entrez]
PHST- 2017/12/09 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt.4044 [pii]
AID - 10.1038/nbt.4044 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Dec 8;35(12):1113. doi: 10.1038/nbt.4044.

PMID- 29220029
OWN - NLM
STAT- In-Data-Review
LR  - 20171220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 12
DP  - 2017 Dec 8
TI  - Corrigendum: Shotgun metagenomics, from sampling to analysis.
PG  - 1211
LID - 10.1038/nbt1217-1211b [doi]
AB  - This corrects the article DOI: 10.1038/nbt.3935.
FAU - Quince, Christopher
AU  - Quince C
FAU - Walker, Alan W
AU  - Walker AW
FAU - Simpson, Jared T
AU  - Simpson JT
FAU - Loman, Nicholas J
AU  - Loman NJ
FAU - Segata, Nicola
AU  - Segata N
LA  - eng
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2017 Sep 12;35(9):833-844. PMID: 28898207
EDAT- 2017/12/09 06:00
MHDA- 2017/12/09 06:00
CRDT- 2017/12/09 06:00
PHST- 2017/12/09 06:00 [entrez]
PHST- 2017/12/09 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt1217-1211b [pii]
AID - 10.1038/nbt1217-1211b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Dec 8;35(12):1211. doi: 10.1038/nbt1217-1211b.

PMID- 29220028
OWN - NLM
STAT- In-Data-Review
LR  - 20171220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 12
DP  - 2017 Dec 8
TI  - Erratum: Revisiting the Warnock rule.
PG  - 1211
LID - 10.1038/nbt1217-1211d [doi]
AB  - This corrects the article DOI: 10.1038/nbt.4015.
FAU - Hurlbut, J Benjamin
AU  - Hurlbut JB
FAU - Hyun, Insoo
AU  - Hyun I
FAU - Levine, Aaron D
AU  - Levine AD
FAU - Lovell-Badge, Robin
AU  - Lovell-Badge R
FAU - Lunshof, Jeantine E
AU  - Lunshof JE
FAU - Matthews, Kirstin R W
AU  - Matthews KRW
FAU - Mills, Peter
AU  - Mills P
FAU - Murdoch, Alison
AU  - Murdoch A
FAU - Pera, Martin F
AU  - Pera MF
FAU - Scott, Christopher Thomas
AU  - Scott CT
FAU - Tizzard, Juliet
AU  - Tizzard J
FAU - Warnock, Mary
AU  - Warnock M
FAU - Zernicka-Goetz, Magdalena
AU  - Zernicka-Goetz M
FAU - Zhou, Qi
AU  - Zhou Q
FAU - Zoloth, Laurie
AU  - Zoloth L
LA  - eng
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2017 Nov 9;35(11):1029-1042. PMID: 29121021
EDAT- 2017/12/09 06:00
MHDA- 2017/12/09 06:00
CRDT- 2017/12/09 06:00
PHST- 2017/12/09 06:00 [entrez]
PHST- 2017/12/09 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt1217-1211d [pii]
AID - 10.1038/nbt1217-1211d [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Dec 8;35(12):1211. doi: 10.1038/nbt1217-1211d.

PMID- 29220027
OWN - NLM
STAT- In-Data-Review
LR  - 20171220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 12
DP  - 2017 Dec 8
TI  - When pig organs will fly.
PG  - 1133-1138
LID - 10.1038/nbt.4027 [doi]
FAU - Waltz, Emily
AU  - Waltz E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/12/09 06:00
MHDA- 2017/12/09 06:00
CRDT- 2017/12/09 06:00
PHST- 2017/12/09 06:00 [entrez]
PHST- 2017/12/09 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt.4027 [pii]
AID - 10.1038/nbt.4027 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Dec 8;35(12):1133-1138. doi: 10.1038/nbt.4027.

PMID- 29220026
OWN - NLM
STAT- In-Data-Review
LR  - 20171220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 12
DP  - 2017 Dec 8
TI  - A new crop of microbe startups raises big bucks, takes on the establishment.
PG  - 1120-1122
LID - 10.1038/nbt1217-1120 [doi]
FAU - Waltz, Emily
AU  - Waltz E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/12/09 06:00
MHDA- 2017/12/09 06:00
CRDT- 2017/12/09 06:00
PHST- 2017/12/09 06:00 [entrez]
PHST- 2017/12/09 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt1217-1120 [pii]
AID - 10.1038/nbt1217-1120 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Dec 8;35(12):1120-1122. doi: 10.1038/nbt1217-1120.

PMID- 29220025
OWN - NLM
STAT- In-Data-Review
LR  - 20171220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 12
DP  - 2017 Dec 8
TI  - California cracks down on stem cell cowboys.
PG  - 1119
LID - 10.1038/nbt1217-1119 [doi]
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/12/09 06:00
MHDA- 2017/12/09 06:00
CRDT- 2017/12/09 06:00
PHST- 2017/12/09 06:00 [entrez]
PHST- 2017/12/09 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt1217-1119 [pii]
AID - 10.1038/nbt1217-1119 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Dec 8;35(12):1119. doi: 10.1038/nbt1217-1119.

PMID- 29220024
OWN - NLM
STAT- In-Data-Review
LR  - 20171220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 12
DP  - 2017 Dec 8
TI  - MAGE in yeast is a go.
PG  - 1147-1148
LID - 10.1038/nbt.4033 [doi]
FAU - Jones, Susan
AU  - Jones S
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/12/09 06:00
MHDA- 2017/12/09 06:00
CRDT- 2017/12/09 06:00
PHST- 2017/12/09 06:00 [entrez]
PHST- 2017/12/09 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt.4033 [pii]
AID - 10.1038/nbt.4033 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Dec 8;35(12):1147-1148. doi: 10.1038/nbt.4033.

PMID- 29220023
OWN - NLM
STAT- In-Data-Review
LR  - 20180202
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 12
DP  - 2017 Dec 8
TI  - Corrigendum: Development and function of human innate immune cells in a humanized
      mouse model.
PG  - 1211
LID - 10.1038/nbt1217-1211c [doi]
FAU - Rongvaux, Anthony
AU  - Rongvaux A
FAU - Willinger, Tim
AU  - Willinger T
FAU - Martinek, Jan
AU  - Martinek J
FAU - Strowig, Till
AU  - Strowig T
FAU - Gearty, Sofia V
AU  - Gearty SV
FAU - Teichmann, Lino L
AU  - Teichmann LL
FAU - Saito, Yasuyuki
AU  - Saito Y
FAU - Marches, Florentina
AU  - Marches F
FAU - Halene, Stephanie
AU  - Halene S
FAU - Palucka, A Karolina
AU  - Palucka AK
FAU - Manz, Markus G
AU  - Manz MG
FAU - Flavell, Richard A
AU  - Flavell RA
LA  - eng
PT  - Journal Article
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2014 Apr;32(4):364-72. PMID: 24633240
EDAT- 2017/12/09 06:00
MHDA- 2017/12/09 06:00
CRDT- 2017/12/09 06:00
PHST- 2017/12/09 06:00 [entrez]
PHST- 2017/12/09 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt1217-1211c [pii]
AID - 10.1038/nbt1217-1211c [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Dec 8;35(12):1211. doi: 10.1038/nbt1217-1211c.

PMID- 29220022
OWN - NLM
STAT- In-Data-Review
LR  - 20171208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 12
DP  - 2017 Dec 8
TI  - Around the world in a month.
PG  - 1122
LID - 10.1038/nbt1217-1122 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/12/09 06:00
MHDA- 2017/12/09 06:00
CRDT- 2017/12/09 06:00
PHST- 2017/12/09 06:00 [entrez]
PHST- 2017/12/09 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt1217-1122 [pii]
AID - 10.1038/nbt1217-1122 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Dec 8;35(12):1122. doi: 10.1038/nbt1217-1122.

PMID- 29220019
OWN - NLM
STAT- In-Data-Review
LR  - 20171220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 12
DP  - 2017 Dec 8
TI  - Amgen cholesterol antibody feud could kill key IP rule.
PG  - 1118-1119
LID - 10.1038/nbt1217-1118 [doi]
FAU - Ratner, Mark
AU  - Ratner M
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/12/09 06:00
MHDA- 2017/12/09 06:00
CRDT- 2017/12/09 06:00
PHST- 2017/12/09 06:00 [entrez]
PHST- 2017/12/09 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt1217-1118 [pii]
AID - 10.1038/nbt1217-1118 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Dec 8;35(12):1118-1119. doi: 10.1038/nbt1217-1118.

PMID- 29220018
OWN - NLM
STAT- In-Data-Review
LR  - 20171220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 12
DP  - 2017 Dec 8
TI  - Ablynx's nanobody fragments go places antibodies cannot.
PG  - 1115-1117
LID - 10.1038/nbt1217-1115 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/12/09 06:00
MHDA- 2017/12/09 06:00
CRDT- 2017/12/09 06:00
PHST- 2017/12/09 06:00 [entrez]
PHST- 2017/12/09 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt1217-1115 [pii]
AID - 10.1038/nbt1217-1115 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Dec 8;35(12):1115-1117. doi: 10.1038/nbt1217-1115.

PMID- 29220017
OWN - NLM
STAT- In-Data-Review
LR  - 20171220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 12
DP  - 2017 Dec 8
TI  - Will inter partes review speed US generic drug entry?
PG  - 1139-1141
LID - 10.1038/nbt.4036 [doi]
FAU - Darrow, Jonathan J
AU  - Darrow JJ
AD  - Program On Regulation, Therapeutics, And Law (PORTAL), Division of
      Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and
      Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
FAU - Beall, Reed F
AU  - Beall RF
AD  - Program On Regulation, Therapeutics, And Law (PORTAL), Division of
      Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and
      Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
FAU - Kesselheim, Aaron S
AU  - Kesselheim AS
AD  - Program On Regulation, Therapeutics, And Law (PORTAL), Division of
      Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and
      Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/12/09 06:00
MHDA- 2017/12/09 06:00
CRDT- 2017/12/09 06:00
PHST- 2017/12/09 06:00 [entrez]
PHST- 2017/12/09 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt.4036 [pii]
AID - 10.1038/nbt.4036 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Dec 8;35(12):1139-1141. doi: 10.1038/nbt.4036.

PMID- 29220016
OWN - NLM
STAT- In-Data-Review
LR  - 20171208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 12
DP  - 2017 Dec 8
TI  - Recent patents in xenotransplantation.
PG  - 1142
LID - 10.1038/nbt.4040 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/12/09 06:00
MHDA- 2017/12/09 06:00
CRDT- 2017/12/09 06:00
PHST- 2017/12/09 06:00 [entrez]
PHST- 2017/12/09 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt.4040 [pii]
AID - 10.1038/nbt.4040 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Dec 8;35(12):1142. doi: 10.1038/nbt.4040.

PMID- 29220015
OWN - NLM
STAT- In-Data-Review
LR  - 20171208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 12
DP  - 2017 Dec 8
TI  - Drug pipeline 3Q17.
PG  - 1125
LID - 10.1038/nbt.4032 [doi]
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/12/09 06:00
MHDA- 2017/12/09 06:00
CRDT- 2017/12/09 06:00
PHST- 2017/12/09 06:00 [entrez]
PHST- 2017/12/09 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt.4032 [pii]
AID - 10.1038/nbt.4032 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Dec 8;35(12):1125. doi: 10.1038/nbt.4032.

PMID- 29220013
OWN - NLM
STAT- In-Data-Review
LR  - 20171220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 12
DP  - 2017 Dec 8
TI  - Corrigendum: In vivo genome editing and organoid transplantation models of
      colorectal cancer and metastasis.
PG  - 1211
LID - 10.1038/nbt1217-1211a [doi]
AB  - This corrects the article DOI: 10.1038/nbt.3836.
FAU - Roper, Jatin
AU  - Roper J
FAU - Tammela, Tuomas
AU  - Tammela T
FAU - Cetinbas, Naniye Malli
AU  - Cetinbas NM
FAU - Akkad, Adam
AU  - Akkad A
FAU - Roghanian, Ali
AU  - Roghanian A
FAU - Rickelt, Steffen
AU  - Rickelt S
FAU - Almeqdadi, Mohammad
AU  - Almeqdadi M
FAU - Wu, Katherine
AU  - Wu K
FAU - Oberli, Matthias A
AU  - Oberli MA
FAU - Sanchez-Rivera, Francisco
AU  - Sanchez-Rivera F
FAU - Park, Yoona K
AU  - Park YK
FAU - Liang, Xu
AU  - Liang X
FAU - Eng, George
AU  - Eng G
FAU - Taylor, Martin S
AU  - Taylor MS
FAU - Azimi, Roxana
AU  - Azimi R
FAU - Kedrin, Dmitriy
AU  - Kedrin D
FAU - Neupane, Rachit
AU  - Neupane R
FAU - Beyaz, Semir
AU  - Beyaz S
FAU - Sicinska, Ewa T
AU  - Sicinska ET
FAU - Suarez, Yvelisse
AU  - Suarez Y
FAU - Yoo, James
AU  - Yoo J
FAU - Chen, Lillian
AU  - Chen L
FAU - Zukerberg, Lawrence
AU  - Zukerberg L
FAU - Katajisto, Pekka
AU  - Katajisto P
FAU - Deshpande, Vikram
AU  - Deshpande V
FAU - Bass, Adam J
AU  - Bass AJ
FAU - Tsichlis, Philip N
AU  - Tsichlis PN
FAU - Lees, Jacqueline
AU  - Lees J
FAU - Langer, Robert
AU  - Langer R
FAU - Hynes, Richard O
AU  - Hynes RO
FAU - Chen, Jianzhu
AU  - Chen J
FAU - Bhutkar, Arjun
AU  - Bhutkar A
FAU - Jacks, Tyler
AU  - Jacks T
FAU - Yilmaz, Omer H
AU  - Yilmaz OH
LA  - eng
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2017 Jun;35(6):569-576. PMID: 28459449
EDAT- 2017/12/09 06:00
MHDA- 2017/12/09 06:00
CRDT- 2017/12/09 06:00
PHST- 2017/12/09 06:00 [entrez]
PHST- 2017/12/09 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt1217-1211a [pii]
AID - 10.1038/nbt1217-1211a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Dec 8;35(12):1211. doi: 10.1038/nbt1217-1211a.

PMID- 29220034
OWN - NLM
STAT- MEDLINE
DCOM- 20171219
LR  - 20171220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 12
DP  - 2017 Dec
TI  - Just how good an investment is the biopharmaceutical sector?
PG  - 1149-1157
LID - 10.1038/nbt.4023 [doi]
AB  - Uncertainty surrounding the risk and reward of investments in biopharmaceutical
      companies poses a challenge to those interested in funding such enterprises.
      Using data on publicly traded stocks, we track the performance of 1,066
      biopharmaceutical companies from 1930 to 2015-the most comprehensive financial
      analysis of this sector to date. Our systematic exploration of methods for
      distinguishing biotech and pharmaceutical companies yields a dynamic, more
      accurate classification method. We find that the performance of the biotech
      sector is highly sensitive to the presence of a few outlier companies, and
      confirm that nearly all biotech companies are loss-making enterprises, exhibiting
      high stock volatility. In contrast, since 2000, pharmaceutical companies have
      become increasingly profitable, with risk-adjusted returns consistently
      outperforming the market. The performance of all biopharmaceutical companies is
      subject not only to factors arising from their drug pipelines (idiosyncratic
      risk), but also from general economic conditions (systematic risk). The risk
      associated with returns has profound implications both for patterns of investment
      and for funding innovation in biomedical R&D.
FAU - Thakor, Richard T
AU  - Thakor RT
AD  - Carlson School of Management, University of Minnesota, Minneapolis, Minnesota,
      USA.
FAU - Anaya, Nicholas
AU  - Anaya N
AD  - MIT Sloan School of Management and Laboratory for Financial Engineering,
      Cambridge, Massachusetts, USA.
FAU - Zhang, Yuwei
AU  - Zhang Y
AD  - MIT Sloan School of Management and Laboratory for Financial Engineering,
      Cambridge, Massachusetts, USA.
FAU - Vilanilam, Christian
AU  - Vilanilam C
AD  - MIT Sloan School of Management and Laboratory for Financial Engineering,
      Cambridge, Massachusetts, USA.
FAU - Siah, Kien Wei
AU  - Siah KW
AD  - MIT Sloan School of Management and Laboratory for Financial Engineering,
      Cambridge, Massachusetts, USA.
AD  - MIT Department of Electrical Engineering and Computer Science, Cambridge,
      Massachusetts, USA.
FAU - Wong, Chi Heem
AU  - Wong CH
AD  - MIT Sloan School of Management and Laboratory for Financial Engineering,
      Cambridge, Massachusetts, USA.
AD  - MIT Computer Science and Artificial Intelligence Laboratory, Cambridge,
      Massachusetts, USA.
FAU - Lo, Andrew W
AU  - Lo AW
AUID- ORCID: http://orcid.org/0000-0003-2944-7773
AD  - MIT Sloan School of Management and Laboratory for Financial Engineering,
      Cambridge, Massachusetts, USA.
AD  - MIT Department of Electrical Engineering and Computer Science, Cambridge,
      Massachusetts, USA.
AD  - MIT Computer Science and Artificial Intelligence Laboratory, Cambridge,
      Massachusetts, USA.
AD  - AlphaSimplex Group, LLC, Cambridge, Massachusetts, USA.
LA  - eng
PT  - Journal Article
DEP - 20171208
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Biotechnology/economics/organization & administration/statistics & numerical
      data
MH  - *Drug Industry/economics/organization & administration/statistics & numerical
      data
MH  - Humans
MH  - *Investments/economics/statistics & numerical data
MH  - Research
MH  - Risk
EDAT- 2017/12/09 06:00
MHDA- 2017/12/20 06:00
CRDT- 2017/12/09 06:00
PHST- 2016/05/31 00:00 [received]
PHST- 2017/10/31 00:00 [accepted]
PHST- 2017/12/09 06:00 [entrez]
PHST- 2017/12/09 06:00 [pubmed]
PHST- 2017/12/20 06:00 [medline]
AID - nbt.4023 [pii]
AID - 10.1038/nbt.4023 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Dec;35(12):1149-1157. doi: 10.1038/nbt.4023. Epub 2017 Dec
      8.

PMID- 29220020
OWN - NLM
STAT- MEDLINE
DCOM- 20171219
LR  - 20171220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 12
DP  - 2017 Dec
TI  - Microbial synthesis of medium-chain chemicals from renewables.
PG  - 1158-1166
LID - 10.1038/nbt.4022 [doi]
AB  - Linear, medium-chain (C8-C12) hydrocarbons are important components of fuels as
      well as commodity and specialty chemicals. As industrial microbes do not contain 
      pathways to produce medium-chain chemicals, approaches such as overexpression of 
      endogenous enzymes or deletion of competing pathways are not available to the
      metabolic engineer; instead, fatty acid synthesis and reversed beta-oxidation are
      manipulated to synthesize medium-chain chemical precursors. Even so, chain
      lengths remain difficult to control, which means that purification must be used
      to obtain the desired products, titers of which are typically low and rarely
      exceed milligrams per liter. By engineering the substrate specificity and
      activity of the pathway enzymes that generate the fatty acyl intermediates and
      chain-tailoring enzymes, researchers can boost the type and yield of medium-chain
      chemicals. Development of technologies to both manipulate chain-tailoring enzymes
      and to assay for products promises to enable the generation of g/L yields of
      medium-chain chemicals.
FAU - Sarria, Stephen
AU  - Sarria S
AD  - School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta,
      Georgia, USA.
FAU - Kruyer, Nicholas S
AU  - Kruyer NS
AD  - School of Chemical and Biomolecular, Georgia Institute of Technology, Atlanta,
      Georgia, USA.
AD  - Renewable Bioproducts Institute, Georgia Institute of Technology, Atlanta,
      Georgia, USA.
FAU - Peralta-Yahya, Pamela
AU  - Peralta-Yahya P
AD  - School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta,
      Georgia, USA.
AD  - School of Chemical and Biomolecular, Georgia Institute of Technology, Atlanta,
      Georgia, USA.
AD  - Renewable Bioproducts Institute, Georgia Institute of Technology, Atlanta,
      Georgia, USA.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20171208
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Biofuels)
RN  - 0 (Fatty Acids)
RN  - 0 (Hydrocarbons)
RN  - 11132-73-3 (lignocellulose)
RN  - 9005-53-2 (Lignin)
SB  - IM
MH  - *Biofuels
MH  - *Biomass
MH  - Escherichia coli
MH  - Fatty Acids/*metabolism
MH  - Hydrocarbons/*metabolism
MH  - Lignin
MH  - Metabolic Engineering/*methods
MH  - Saccharomyces cerevisiae
EDAT- 2017/12/09 06:00
MHDA- 2017/12/20 06:00
CRDT- 2017/12/09 06:00
PHST- 2017/03/21 00:00 [received]
PHST- 2017/10/31 00:00 [accepted]
PHST- 2017/12/09 06:00 [entrez]
PHST- 2017/12/09 06:00 [pubmed]
PHST- 2017/12/20 06:00 [medline]
AID - nbt.4022 [pii]
AID - 10.1038/nbt.4022 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Dec;35(12):1158-1166. doi: 10.1038/nbt.4022. Epub 2017 Dec
      8.

PMID- 29131149
OWN - NLM
STAT- MEDLINE
DCOM- 20171219
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 12
DP  - 2017 Dec
TI  - Three-dimensional map of nonhematopoietic bone and bone-marrow cells and
      molecules.
PG  - 1202-1210
LID - 10.1038/nbt.4006 [doi]
AB  - The bone marrow (BM) microenvironment contains many types of cells and molecules 
      with roles in hematopoiesis, osteogenesis, angiogenesis and metabolism. The
      spatial distribution of the different bone and BM cell types remains elusive,
      owing to technical challenges associated with bone imaging. To map
      nonhematopoietic cells and structures in bone and BM, we performed multicolor 3D 
      imaging of osteoblastic, vascular, perivascular, neuronal and marrow stromal
      cells, and extracellular-matrix proteins in whole mouse femurs. We analyzed
      potential interactions between cells and molecules on the basis of colocalization
      of markers. Our results shed light on the markers expressed by different
      osteolineage cell types; the heterogeneity of vascular and perivascular cells;
      the neural subtypes innervating marrow and bone; the diversity of stromal cells; 
      and the distribution of extracellular-matrix components. Our complete imaging
      data set is available for download and can be used in research in bone biology,
      hematology, vascular biology, neuroscience and extracellular-matrix biology.
FAU - Coutu, Daniel L
AU  - Coutu DL
AUID- ORCID: http://orcid.org/0000-0002-4641-0115
AD  - Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
FAU - Kokkaliaris, Konstantinos D
AU  - Kokkaliaris KD
AD  - Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
FAU - Kunz, Leo
AU  - Kunz L
AD  - Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
FAU - Schroeder, Timm
AU  - Schroeder T
AD  - Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
LA  - eng
PT  - Journal Article
DEP - 20171113
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Biomarkers)
SB  - IM
MH  - Animals
MH  - Biomarkers/analysis/chemistry
MH  - Bone Marrow Cells/*chemistry/*cytology
MH  - Endothelial Cells/chemistry/cytology
MH  - Femur/*cytology
MH  - Immunohistochemistry
MH  - Male
MH  - Mice
MH  - Models, Biological
MH  - Neurons/chemistry/cytology
MH  - Osteoblasts/chemistry/cytology
EDAT- 2017/11/14 06:00
MHDA- 2017/12/20 06:00
CRDT- 2017/11/14 06:00
PHST- 2016/08/03 00:00 [received]
PHST- 2017/10/09 00:00 [accepted]
PHST- 2017/11/14 06:00 [pubmed]
PHST- 2017/12/20 06:00 [medline]
PHST- 2017/11/14 06:00 [entrez]
AID - nbt.4006 [pii]
AID - 10.1038/nbt.4006 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Dec;35(12):1202-1210. doi: 10.1038/nbt.4006. Epub 2017 Nov
      13.

PMID- 29131148
OWN - NLM
STAT- MEDLINE
DCOM- 20171219
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 12
DP  - 2017 Dec
TI  - Structure-guided chemical modification of guide RNA enables potent non-viral in
      vivo genome editing.
PG  - 1179-1187
LID - 10.1038/nbt.4005 [doi]
AB  - Efficient genome editing with Cas9-sgRNA in vivo has required the use of viral
      delivery systems, which have limitations for clinical applications. Translational
      efforts to develop other RNA therapeutics have shown that judicious chemical
      modification of RNAs can improve therapeutic efficacy by reducing susceptibility 
      to nuclease degradation. Guided by the structure of the Cas9-sgRNA complex, we
      identify regions of sgRNA that can be modified while maintaining or enhancing
      genome-editing activity, and we develop an optimal set of chemical modifications 
      for in vivo applications. Using lipid nanoparticle formulations of these enhanced
      sgRNAs (e-sgRNA) and mRNA encoding Cas9, we show that a single intravenous
      injection into mice induces >80% editing of Pcsk9 in the liver. Serum Pcsk9 is
      reduced to undetectable levels, and cholesterol levels are significantly lowered 
      about 35% to 40% in animals. This strategy may enable non-viral, Cas9-based
      genome editing in the liver in clinical settings.
FAU - Yin, Hao
AU  - Yin H
AD  - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
FAU - Song, Chun-Qing
AU  - Song CQ
AD  - RNA Therapeutics Institute, University of Massachusetts Medical School,
      Worcester, Massachusetts, USA.
FAU - Suresh, Sneha
AU  - Suresh S
AD  - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
FAU - Wu, Qiongqiong
AU  - Wu Q
AD  - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
FAU - Walsh, Stephen
AU  - Walsh S
AD  - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
FAU - Rhym, Luke Hyunsik
AU  - Rhym LH
AD  - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Chemical Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Mintzer, Esther
AU  - Mintzer E
AD  - Department of Molecular, Cell and Cancer Biology, University of Massachusetts
      Medical School, Worcester, Massachusetts, USA.
FAU - Bolukbasi, Mehmet Fatih
AU  - Bolukbasi MF
AUID- ORCID: http://orcid.org/0000-0002-5612-3881
AD  - Department of Molecular, Cell and Cancer Biology, University of Massachusetts
      Medical School, Worcester, Massachusetts, USA.
AD  - Department of Biochemistry and Molecular Pharmacology, University of
      Massachusetts Medical School, Worcester, Massachusetts, USA.
FAU - Zhu, Lihua Julie
AU  - Zhu LJ
AUID- ORCID: http://orcid.org/0000-0001-7416-0590
AD  - Department of Molecular, Cell and Cancer Biology, University of Massachusetts
      Medical School, Worcester, Massachusetts, USA.
AD  - Program in Bioinformatics and Integrative Biology, University of Massachusetts
      Medical School, Worcester, Massachusetts, USA.
AD  - Department of Molecular Medicine, University of Massachusetts Medical School,
      Worcester, Massachusetts, USA.
FAU - Kauffman, Kevin
AU  - Kauffman K
AD  - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Chemical Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Mou, Haiwei
AU  - Mou H
AD  - RNA Therapeutics Institute, University of Massachusetts Medical School,
      Worcester, Massachusetts, USA.
FAU - Oberholzer, Alicia
AU  - Oberholzer A
AD  - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
FAU - Ding, Junmei
AU  - Ding J
AD  - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
FAU - Kwan, Suet-Yan
AU  - Kwan SY
AD  - RNA Therapeutics Institute, University of Massachusetts Medical School,
      Worcester, Massachusetts, USA.
FAU - Bogorad, Roman L
AU  - Bogorad RL
AD  - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
FAU - Zatsepin, Timofei
AU  - Zatsepin T
AUID- ORCID: http://orcid.org/0000-0003-0030-9174
AD  - Center of Translational Biomedicine, Skolkovo Institute of Science and
      Technology, Skolkovo, Moscow, Russia.
AD  - Department of Chemistry, Lomonosov Moscow State University, Moscow, Russia.
FAU - Koteliansky, Victor
AU  - Koteliansky V
AD  - Center of Translational Biomedicine, Skolkovo Institute of Science and
      Technology, Skolkovo, Moscow, Russia.
FAU - Wolfe, Scot A
AU  - Wolfe SA
AD  - Department of Molecular, Cell and Cancer Biology, University of Massachusetts
      Medical School, Worcester, Massachusetts, USA.
AD  - Department of Biochemistry and Molecular Pharmacology, University of
      Massachusetts Medical School, Worcester, Massachusetts, USA.
FAU - Xue, Wen
AU  - Xue W
AUID- ORCID: http://orcid.org/0000-0002-9797-8042
AD  - RNA Therapeutics Institute, University of Massachusetts Medical School,
      Worcester, Massachusetts, USA.
AD  - Department of Molecular, Cell and Cancer Biology, University of Massachusetts
      Medical School, Worcester, Massachusetts, USA.
AD  - Department of Molecular Medicine, University of Massachusetts Medical School,
      Worcester, Massachusetts, USA.
FAU - Langer, Robert
AU  - Langer R
AD  - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Chemical Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
AD  - Harvard-MIT Division of Health Sciences & Technology, Cambridge, Massachusetts,
      USA.
AD  - Institute of Medical Engineering and Science, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
FAU - Anderson, Daniel G
AU  - Anderson DG
AD  - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Chemical Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
AD  - Harvard-MIT Division of Health Sciences & Technology, Cambridge, Massachusetts,
      USA.
AD  - Institute of Medical Engineering and Science, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
LA  - eng
GR  - DP2 HL137167/HL/NHLBI NIH HHS/United States
GR  - P01 HL131471/HL/NHLBI NIH HHS/United States
GR  - R00 CA169512/CA/NCI NIH HHS/United States
PT  - Journal Article
DEP - 20171113
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (RNA, Guide)
RN  - EC 3.4.21.- (Pcsk9 protein, mouse)
RN  - EC 3.4.21.- (Proprotein Convertase 9)
SB  - IM
MH  - Animals
MH  - CRISPR-Cas Systems/genetics
MH  - Gene Editing/*methods
MH  - *Gene Transfer Techniques
MH  - Liver/*metabolism
MH  - Mice
MH  - Nanoparticles/chemistry
MH  - Nucleic Acid Conformation
MH  - Proprotein Convertase 9/genetics
MH  - RNA, Guide/*genetics
EDAT- 2017/11/14 06:00
MHDA- 2017/12/20 06:00
CRDT- 2017/11/14 06:00
PHST- 2016/11/29 00:00 [received]
PHST- 2017/10/09 00:00 [accepted]
PHST- 2017/11/14 06:00 [pubmed]
PHST- 2017/12/20 06:00 [medline]
PHST- 2017/11/14 06:00 [entrez]
AID - nbt.4005 [pii]
AID - 10.1038/nbt.4005 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Dec;35(12):1179-1187. doi: 10.1038/nbt.4005. Epub 2017 Nov
      13.

PMID- 29131147
OWN - NLM
STAT- MEDLINE
DCOM- 20171219
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 12
DP  - 2017 Dec
TI  - Accurate assembly of transcripts through phase-preserving graph decomposition.
PG  - 1167-1169
LID - 10.1038/nbt.4020 [doi]
AB  - We introduce Scallop, an accurate reference-based transcript assembler that
      improves reconstruction of multi-exon and lowly expressed transcripts. Scallop
      preserves long-range phasing paths extracted from reads, while producing a
      parsimonious set of transcripts and minimizing coverage deviation. On 10 human
      RNA-seq samples, Scallop produces 34.5% and 36.3% more correct multi-exon
      transcripts than StringTie and TransComb, and respectively identifies 67.5% and
      52.3% more lowly expressed transcripts. Scallop achieves higher sensitivity and
      precision than previous approaches over a wide range of coverage thresholds.
FAU - Shao, Mingfu
AU  - Shao M
AD  - Computational Biology Department, School of Computer Science, Carnegie Mellon
      University, Pittsburgh, Pennsylvania, USA.
FAU - Kingsford, Carl
AU  - Kingsford C
AD  - Computational Biology Department, School of Computer Science, Carnegie Mellon
      University, Pittsburgh, Pennsylvania, USA.
LA  - eng
GR  - R01 GM122935/GM/NIGMS NIH HHS/United States
GR  - R01 HG007104/HG/NHGRI NIH HHS/United States
PT  - Journal Article
DEP - 20171113
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 63231-63-0 (RNA)
SB  - IM
MH  - *Algorithms
MH  - Humans
MH  - *RNA/analysis/genetics/metabolism
MH  - Sequence Alignment/*methods
MH  - Sequence Analysis, RNA/*methods
MH  - *Software
PMC - PMC5722698
MID - NIHMS914740
EDAT- 2017/11/14 06:00
MHDA- 2017/12/20 06:00
CRDT- 2017/11/14 06:00
PMCR- 2018/05/13 00:00
PHST- 2017/04/11 00:00 [received]
PHST- 2017/10/20 00:00 [accepted]
PHST- 2018/05/13 00:00 [pmc-release]
PHST- 2017/11/14 06:00 [pubmed]
PHST- 2017/12/20 06:00 [medline]
PHST- 2017/11/14 06:00 [entrez]
AID - nbt.4020 [pii]
AID - 10.1038/nbt.4020 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Dec;35(12):1167-1169. doi: 10.1038/nbt.4020. Epub 2017 Nov
      13.

PMID- 29106410
OWN - NLM
STAT- MEDLINE
DCOM- 20171219
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 12
DP  - 2017 Dec
TI  - Generation of higher affinity T cell receptors by antigen-driven differentiation 
      of progenitor T cells in vitro.
PG  - 1188-1195
LID - 10.1038/nbt.4004 [doi]
AB  - Many promising targets for T-cell-based cancer immunotherapies are self-antigens.
      During thymic selection, T cells bearing T cell receptors (TCRs) with high
      affinity for self-antigen are eliminated. The affinity of the remaining
      low-avidity TCRs can be improved to increase their antitumor efficacy, but
      conventional saturation mutagenesis approaches are labor intensive, and the
      resulting TCRs may be cross-reactive. Here we describe the in vitro maturation
      and selection of mouse and human T cells on antigen-expressing feeder cells to
      develop higher-affinity TCRs. The approach takes advantage of natural Tcrb gene
      rearrangement to generate diversity in the length and composition of CDR3beta. In
      vitro differentiation of progenitors transduced with a known Tcra gene in the
      presence of antigen drives differentiation of cells with a distinct
      agonist-selected phenotype. We purified these cells to generate TCRbeta chain
      libraries pre-enriched for target antigen specificity. Several TCRbeta chains
      paired with a transgenic TCRalpha chain to produce a TCR with higher affinity
      than the parental TCR for target antigen, without evidence of cross-reactivity.
FAU - Schmitt, Thomas M
AU  - Schmitt TM
AUID- ORCID: http://orcid.org/0000-0002-0736-4195
AD  - Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
FAU - Aggen, David H
AU  - Aggen DH
AD  - Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana,
      Illinois, USA.
FAU - Ishida-Tsubota, Kumiko
AU  - Ishida-Tsubota K
AD  - Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
FAU - Ochsenreither, Sebastian
AU  - Ochsenreither S
AD  - Department of Hematology, Oncology, and Tumor Immunology, Charite Campus Benjamin
      Franklin, Berlin, Germany.
FAU - Kranz, David M
AU  - Kranz DM
AD  - Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana,
      Illinois, USA.
FAU - Greenberg, Philip D
AU  - Greenberg PD
AD  - Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
AD  - Departments of Immunology and Medicine, University of Washington, Seattle,
      Washington, USA.
LA  - eng
GR  - P01 CA018029/CA/NCI NIH HHS/United States
GR  - R01 CA033084/CA/NCI NIH HHS/United States
GR  - R01 CA178844/CA/NCI NIH HHS/United States
PT  - Journal Article
DEP - 20171106
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Autoantigens)
RN  - 0 (Receptors, Antigen, T-Cell)
SB  - IM
MH  - Animals
MH  - Autoantigens/*metabolism
MH  - Cell Differentiation/*genetics
MH  - Cell Line
MH  - Flow Cytometry
MH  - Genes, T-Cell Receptor beta/genetics
MH  - Humans
MH  - Mice
MH  - *Precursor Cells, T-Lymphoid/cytology/metabolism
MH  - Protein Binding
MH  - Receptors, Antigen, T-Cell/*genetics/*metabolism
PMC - PMC5722674
MID - NIHMS913219
EDAT- 2017/11/07 06:00
MHDA- 2017/12/20 06:00
CRDT- 2017/11/07 06:00
PMCR- 2018/05/06 00:00
PHST- 2017/06/13 00:00 [received]
PHST- 2017/10/13 00:00 [accepted]
PHST- 2018/05/06 00:00 [pmc-release]
PHST- 2017/11/07 06:00 [pubmed]
PHST- 2017/12/20 06:00 [medline]
PHST- 2017/11/07 06:00 [entrez]
AID - nbt.4004 [pii]
AID - 10.1038/nbt.4004 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Dec;35(12):1188-1195. doi: 10.1038/nbt.4004. Epub 2017 Nov
      6.

PMID- 29106409
OWN - NLM
STAT- In-Data-Review
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 12
DP  - 2017 Dec
TI  - DNA sequencing at ultra-high fidelity.
PG  - 1143-1144
LID - 10.1038/nbt.4001 [doi]
FAU - Sebra, Robert
AU  - Sebra R
AD  - Department of Genetics & Genomic Sciences & Icahn Institute for Genomics &
      Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, New York, 
      USA, and at Sema4, a Mount Sinai venture, Stamford, Connecticut, USA.
LA  - eng
PT  - Journal Article
DEP - 20171030
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/11/07 06:00
MHDA- 2017/11/07 06:00
CRDT- 2017/11/07 06:00
PHST- 2017/11/07 06:00 [pubmed]
PHST- 2017/11/07 06:00 [medline]
PHST- 2017/11/07 06:00 [entrez]
AID - nbt.4001 [pii]
AID - 10.1038/nbt.4001 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Dec;35(12):1143-1144. doi: 10.1038/nbt.4001. Epub 2017 Oct
      30.

PMID- 29106408
OWN - NLM
STAT- MEDLINE
DCOM- 20171219
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 12
DP  - 2017 Dec
TI  - Cell-type-specific metabolic labeling of nascent proteomes in vivo.
PG  - 1196-1201
LID - 10.1038/nbt.4016 [doi]
AB  - Although advances in protein labeling methods have made it possible to measure
      the proteome of mixed cell populations, it has not been possible to isolate
      cell-type-specific proteomes in vivo. This is because the existing methods for
      metabolic protein labeling in vivo access all cell types. We report the
      development of a transgenic mouse line where Cre-recombinase-induced expression
      of a mutant methionyl-tRNA synthetase (L274G) enables the cell-type-specific
      labeling of nascent proteins with a non-canonical amino-acid and click chemistry.
      Using immunoblotting, imaging and mass spectrometry, we use our transgenic mouse 
      to label and analyze proteins in excitatory principal neurons and Purkinje
      neurons in vitro (brain slices) and in vivo. We discover more than 200 proteins
      that are differentially regulated in hippocampal excitatory neurons by exposing
      mice to an environment with enriched sensory cues. Our approach can be used to
      isolate, analyze and quantitate cell-type-specific proteomes and their dynamics
      in healthy and diseased tissues.
FAU - Alvarez-Castelao, Beatriz
AU  - Alvarez-Castelao B
AD  - Max Planck Institute for Brain Research, Frankfurt, Germany.
FAU - Schanzenbacher, Christoph T
AU  - Schanzenbacher CT
AD  - Max Planck Institute for Brain Research, Frankfurt, Germany.
AD  - Max Planck Institute of Biophysics, Frankfurt, Germany.
FAU - Hanus, Cyril
AU  - Hanus C
AD  - Max Planck Institute for Brain Research, Frankfurt, Germany.
FAU - Glock, Caspar
AU  - Glock C
AD  - Max Planck Institute for Brain Research, Frankfurt, Germany.
FAU - Tom Dieck, Susanne
AU  - Tom Dieck S
AD  - Max Planck Institute for Brain Research, Frankfurt, Germany.
FAU - Dorrbaum, Aline R
AU  - Dorrbaum AR
AD  - Max Planck Institute for Brain Research, Frankfurt, Germany.
AD  - Max Planck Institute of Biophysics, Frankfurt, Germany.
FAU - Bartnik, Ina
AU  - Bartnik I
AD  - Max Planck Institute for Brain Research, Frankfurt, Germany.
FAU - Nassim-Assir, Belquis
AU  - Nassim-Assir B
AD  - Max Planck Institute for Brain Research, Frankfurt, Germany.
FAU - Ciirdaeva, Elena
AU  - Ciirdaeva E
AD  - Max Planck Institute for Brain Research, Frankfurt, Germany.
FAU - Mueller, Anke
AU  - Mueller A
AD  - Institute for Pharmacology and Toxicology, Otto von Guericke University,
      Magdeburg, Germany; Leibniz Institute for Neurobiology, Magdeburg, Germany; and
      Center for Behavioral Brain Sciences, Magdeburg, Germany.
FAU - Dieterich, Daniela C
AU  - Dieterich DC
AD  - Institute for Pharmacology and Toxicology, Otto von Guericke University,
      Magdeburg, Germany; Leibniz Institute for Neurobiology, Magdeburg, Germany; and
      Center for Behavioral Brain Sciences, Magdeburg, Germany.
FAU - Tirrell, David A
AU  - Tirrell DA
AD  - Division of Chemistry and Chemical Engineering, California Institute of
      Technology, Pasadena, California, USA.
FAU - Langer, Julian D
AU  - Langer JD
AD  - Max Planck Institute for Brain Research, Frankfurt, Germany.
AD  - Max Planck Institute of Biophysics, Frankfurt, Germany.
FAU - Schuman, Erin M
AU  - Schuman EM
AD  - Max Planck Institute for Brain Research, Frankfurt, Germany.
LA  - eng
PT  - Journal Article
DEP - 20171106
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Amino Acids)
RN  - 0 (Proteome)
RN  - EC 2.7.7.- (Cre recombinase)
RN  - EC 2.7.7.- (Integrases)
RN  - EC 6.1.1.10 (Methionine-tRNA Ligase)
SB  - IM
MH  - Amino Acids/analysis/chemistry/metabolism
MH  - Animals
MH  - Click Chemistry
MH  - Female
MH  - Gene Expression Regulation/*genetics/physiology
MH  - Integrases/genetics/metabolism
MH  - Male
MH  - Methionine-tRNA Ligase/metabolism
MH  - Mice
MH  - Mice, Transgenic
MH  - Neurons/chemistry/metabolism
MH  - Proteome/analysis/chemistry/*genetics/*metabolism
MH  - Proteomics/*methods
EDAT- 2017/11/07 06:00
MHDA- 2017/12/20 06:00
CRDT- 2017/11/07 06:00
PHST- 2016/12/12 00:00 [received]
PHST- 2017/10/19 00:00 [accepted]
PHST- 2017/11/07 06:00 [pubmed]
PHST- 2017/12/20 06:00 [medline]
PHST- 2017/11/07 06:00 [entrez]
AID - nbt.4016 [pii]
AID - 10.1038/nbt.4016 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Dec;35(12):1196-1201. doi: 10.1038/nbt.4016. Epub 2017 Nov
      6.

PMID- 29106407
OWN - NLM
STAT- MEDLINE
DCOM- 20171219
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 12
DP  - 2017 Dec
TI  - Highly accurate fluorogenic DNA sequencing with information theory-based error
      correction.
PG  - 1170-1178
LID - 10.1038/nbt.3982 [doi]
AB  - Eliminating errors in next-generation DNA sequencing has proved challenging. Here
      we present error-correction code (ECC) sequencing, a method to greatly improve
      sequencing accuracy by combining fluorogenic sequencing-by-synthesis (SBS) with
      an information theory-based error-correction algorithm. ECC embeds redundancy in 
      sequencing reads by creating three orthogonal degenerate sequences, generated by 
      alternate dual-base reactions. This is similar to encoding and decoding
      strategies that have proved effective in detecting and correcting errors in
      information communication and storage. We show that, when combined with a
      fluorogenic SBS chemistry with raw accuracy of 98.1%, ECC sequencing provides
      single-end, error-free sequences up to 200 bp. ECC approaches should enable
      accurate identification of extremely rare genomic variations in various
      applications in biology and medicine.
FAU - Chen, Zitian
AU  - Chen Z
AD  - Beijing Advanced Innovation Center for Genomics (ICG), Peking University,
      Beijing, China.
AD  - Biodynamic Optical Imaging Center (BIOPIC), Peking University, Beijing, China.
AD  - College of Engineering, Peking University, Beijing, China.
AD  - School of Life Sciences, Peking University, Beijing, China.
FAU - Zhou, Wenxiong
AU  - Zhou W
AD  - Beijing Advanced Innovation Center for Genomics (ICG), Peking University,
      Beijing, China.
AD  - Biodynamic Optical Imaging Center (BIOPIC), Peking University, Beijing, China.
AD  - School of Life Sciences, Peking University, Beijing, China.
FAU - Qiao, Shuo
AU  - Qiao S
AD  - Beijing Advanced Innovation Center for Genomics (ICG), Peking University,
      Beijing, China.
AD  - Biodynamic Optical Imaging Center (BIOPIC), Peking University, Beijing, China.
AD  - School of Life Sciences, Peking University, Beijing, China.
FAU - Kang, Li
AU  - Kang L
AD  - Beijing Advanced Innovation Center for Genomics (ICG), Peking University,
      Beijing, China.
AD  - Biodynamic Optical Imaging Center (BIOPIC), Peking University, Beijing, China.
AD  - School of Life Sciences, Peking University, Beijing, China.
FAU - Duan, Haifeng
AU  - Duan H
AD  - Beijing Advanced Innovation Center for Genomics (ICG), Peking University,
      Beijing, China.
AD  - Biodynamic Optical Imaging Center (BIOPIC), Peking University, Beijing, China.
AD  - School of Life Sciences, Peking University, Beijing, China.
FAU - Xie, X Sunney
AU  - Xie XS
AD  - Beijing Advanced Innovation Center for Genomics (ICG), Peking University,
      Beijing, China.
AD  - Biodynamic Optical Imaging Center (BIOPIC), Peking University, Beijing, China.
AD  - School of Life Sciences, Peking University, Beijing, China.
FAU - Huang, Yanyi
AU  - Huang Y
AUID- ORCID: http://orcid.org/0000-0002-7297-1266
AD  - Beijing Advanced Innovation Center for Genomics (ICG), Peking University,
      Beijing, China.
AD  - Biodynamic Optical Imaging Center (BIOPIC), Peking University, Beijing, China.
AD  - College of Engineering, Peking University, Beijing, China.
AD  - School of Life Sciences, Peking University, Beijing, China.
AD  - Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China.
LA  - eng
PT  - Journal Article
DEP - 20171106
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Fluorescent Dyes)
SB  - IM
MH  - *Algorithms
MH  - Fluorescent Dyes
MH  - High-Throughput Nucleotide Sequencing/*methods
MH  - *Information Theory
MH  - Reproducibility of Results
MH  - Sequence Analysis, DNA/*methods
EDAT- 2017/11/07 06:00
MHDA- 2017/12/20 06:00
CRDT- 2017/11/07 06:00
PHST- 2016/11/10 00:00 [received]
PHST- 2017/08/30 00:00 [accepted]
PHST- 2017/11/07 06:00 [pubmed]
PHST- 2017/12/20 06:00 [medline]
PHST- 2017/11/07 06:00 [entrez]
AID - nbt.3982 [pii]
AID - 10.1038/nbt.3982 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Dec;35(12):1170-1178. doi: 10.1038/nbt.3982. Epub 2017 Nov
      6.

PMID- 29106406
OWN - NLM
STAT- In-Data-Review
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 12
DP  - 2017 Dec
TI  - Tuning up T-cell receptors.
PG  - 1145-1146
LID - 10.1038/nbt.4009 [doi]
FAU - Rappazzo, C Garrett
AU  - Rappazzo CG
AD  - Department of Biological Engineering, Koch Institute for Integrative Cancer
      Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
FAU - Birnbaum, Michael E
AU  - Birnbaum ME
AUID- ORCID: http://orcid.org/0000-0002-2281-3518
AD  - Department of Biological Engineering, Koch Institute for Integrative Cancer
      Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
LA  - eng
PT  - Journal Article
DEP - 20171106
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/11/07 06:00
MHDA- 2017/11/07 06:00
CRDT- 2017/11/07 06:00
PHST- 2017/11/07 06:00 [pubmed]
PHST- 2017/11/07 06:00 [medline]
PHST- 2017/11/07 06:00 [entrez]
AID - nbt.4009 [pii]
AID - 10.1038/nbt.4009 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Dec;35(12):1145-1146. doi: 10.1038/nbt.4009. Epub 2017 Nov
      6.

PMID- 29121031
OWN - NLM
STAT- In-Data-Review
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 11
DP  - 2017 Nov 9
TI  - Better beings?
PG  - 1006-1011
LID - 10.1038/nbt.3998 [doi]
FAU - Dance, Amber
AU  - Dance A
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/11/10 06:00
MHDA- 2017/11/10 06:00
CRDT- 2017/11/10 06:00
PHST- 2017/11/10 06:00 [entrez]
PHST- 2017/11/10 06:00 [pubmed]
PHST- 2017/11/10 06:00 [medline]
AID - nbt.3998 [pii]
AID - 10.1038/nbt.3998 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Nov 9;35(11):1006-1011. doi: 10.1038/nbt.3998.

PMID- 29121029
OWN - NLM
STAT- In-Data-Review
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 11
DP  - 2017 Nov 9
TI  - Coiled coils unspring protein origami.
PG  - 1044-1045
LID - 10.1038/nbt.4003 [doi]
FAU - Hura, Greg L
AU  - Hura GL
AD  - MBIB Division, Lawrence Berkeley National Lab, Berkeley, Califoria, USA, and.
FAU - Tainer, John A
AU  - Tainer JA
AD  - Department of Molecular and Cellular Oncology, The University of Texas, MD
      Anderson Cancer Center, Houston, Texas, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/11/10 06:00
MHDA- 2017/11/10 06:00
CRDT- 2017/11/10 06:00
PHST- 2017/11/10 06:00 [entrez]
PHST- 2017/11/10 06:00 [pubmed]
PHST- 2017/11/10 06:00 [medline]
AID - nbt.4003 [pii]
AID - 10.1038/nbt.4003 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Nov 9;35(11):1044-1045. doi: 10.1038/nbt.4003.

PMID- 29121028
OWN - NLM
STAT- In-Data-Review
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 11
DP  - 2017 Nov 9
TI  - With Alnylam's amyloidosis success, RNAi approval hopes soar.
PG  - 995-997
LID - 10.1038/nbt1117-995 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/11/10 06:00
MHDA- 2017/11/10 06:00
CRDT- 2017/11/10 06:00
PHST- 2017/11/10 06:00 [entrez]
PHST- 2017/11/10 06:00 [pubmed]
PHST- 2017/11/10 06:00 [medline]
AID - nbt1117-995 [pii]
AID - 10.1038/nbt1117-995 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Nov 9;35(11):995-997. doi: 10.1038/nbt1117-995.

PMID- 29121027
OWN - NLM
STAT- In-Data-Review
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 11
DP  - 2017 Nov 9
TI  - Age-related macular degeneration foils drugmakers.
PG  - 1000-1001
LID - 10.1038/nbt1117-1000 [doi]
FAU - Dolgin, Elie
AU  - Dolgin E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/11/10 06:00
MHDA- 2017/11/10 06:00
CRDT- 2017/11/10 06:00
PHST- 2017/11/10 06:00 [entrez]
PHST- 2017/11/10 06:00 [pubmed]
PHST- 2017/11/10 06:00 [medline]
AID - nbt1117-1000 [pii]
AID - 10.1038/nbt1117-1000 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Nov 9;35(11):1000-1001. doi: 10.1038/nbt1117-1000.

PMID- 29121026
OWN - NLM
STAT- In-Data-Review
LR  - 20171109
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 11
DP  - 2017 Nov 9
TI  - Humans 2.0.
PG  - 993
LID - 10.1038/nbt.4018 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/11/10 06:00
MHDA- 2017/11/10 06:00
CRDT- 2017/11/10 06:00
PHST- 2017/11/10 06:00 [entrez]
PHST- 2017/11/10 06:00 [pubmed]
PHST- 2017/11/10 06:00 [medline]
AID - nbt.4018 [pii]
AID - 10.1038/nbt.4018 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Nov 9;35(11):993. doi: 10.1038/nbt.4018.

PMID- 29121025
OWN - NLM
STAT- In-Data-Review
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 11
DP  - 2017 Nov 9
TI  - Query the merits of embryo editing for reproductive research now.
PG  - 1023-1025
LID - 10.1038/nbt.4000 [doi]
FAU - Hyun, Insoo
AU  - Hyun I
AD  - Department of Bioethics, Case Western Reserve University School of Medicine,
      Cleveland, Ohio, USA.
FAU - Osborn, Catherine
AU  - Osborn C
AD  - Department of Anthropology and Dittrick Medical History Center, Case Western
      Reserve University, Cleveland, Ohio, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/11/10 06:00
MHDA- 2017/11/10 06:00
CRDT- 2017/11/10 06:00
PHST- 2017/11/10 06:00 [entrez]
PHST- 2017/11/10 06:00 [pubmed]
PHST- 2017/11/10 06:00 [medline]
AID - nbt.4000 [pii]
AID - 10.1038/nbt.4000 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Nov 9;35(11):1023-1025. doi: 10.1038/nbt.4000.

PMID- 29121024
OWN - NLM
STAT- In-Data-Review
LR  - 20171109
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 11
DP  - 2017 Nov 9
TI  - Ethical principles for the use of human cellular biotechnologies.
PG  - 1050-1058
LID - 10.1038/nbt.4007 [doi]
FAU - Wolpe, Paul Root
AU  - Wolpe PR
AD  - Center for Ethics, Emory University, Atlanta, Georgia, USA.
FAU - Rommelfanger, Karen S
AU  - Rommelfanger KS
AD  - Center for Ethics, Emory University, Atlanta, Georgia, USA.
CN  - Drafting and Reviewing Delegates of the BEINGS Working Groups
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/11/10 06:00
MHDA- 2017/11/10 06:00
CRDT- 2017/11/10 06:00
PHST- 2017/11/10 06:00 [entrez]
PHST- 2017/11/10 06:00 [pubmed]
PHST- 2017/11/10 06:00 [medline]
AID - nbt.4007 [pii]
AID - 10.1038/nbt.4007 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Nov 9;35(11):1050-1058. doi: 10.1038/nbt.4007.

PMID- 29121023
OWN - NLM
STAT- In-Data-Review
LR  - 20171109
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 11
DP  - 2017 Nov 9
TI  - Corrections.
PG  - 1004
LID - 10.1038/nbt1117-1004c [doi]
AB  - This corrects the article DOI: 10.1038/nbt0617-493.
LA  - eng
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2017 Jun 7;35(6):493-494. PMID: 28591114
EDAT- 2017/11/10 06:00
MHDA- 2017/11/10 06:00
CRDT- 2017/11/10 06:00
PHST- 2017/11/10 06:00 [entrez]
PHST- 2017/11/10 06:00 [pubmed]
PHST- 2017/11/10 06:00 [medline]
AID - nbt1117-1004c [pii]
AID - 10.1038/nbt1117-1004c [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Nov 9;35(11):1004. doi: 10.1038/nbt1117-1004c.

PMID- 29121022
OWN - NLM
STAT- In-Data-Review
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 11
DP  - 2017 Nov 9
TI  - Public views on gene editing and its uses.
PG  - 1021-1023
LID - 10.1038/nbt.3958 [doi]
FAU - Gaskell, George
AU  - Gaskell G
AUID- ORCID: http://orcid.org/0000-0001-6135-9496
AD  - Department of Methodology, London School of Economics, London, UK.
FAU - Bard, Imre
AU  - Bard I
AUID- ORCID: http://orcid.org/0000-0001-6395-0335
AD  - Department of Methodology, London School of Economics, London, UK.
FAU - Allansdottir, Agnes
AU  - Allansdottir A
AUID- ORCID: http://orcid.org/0000-0003-0961-2380
AD  - Toscana Life Sciences Foundation, Siena, Italy.
FAU - da Cunha, Rui Vieira
AU  - da Cunha RV
AD  - Institute of Molecular and Cellular Biology, Porto, Portugal.
FAU - Eduard, Peter
AU  - Eduard P
AD  - Experimentarium, Science Communication Centre, Copenhagen, Denmark.
FAU - Hampel, Juergen
AU  - Hampel J
AD  - Center for Interdisciplinary Risk and Innovation Studies, Stuttgart University,
      Stuttgart, Germany.
FAU - Hildt, Elisabeth
AU  - Hildt E
AUID- ORCID: http://orcid.org/0000-0003-1314-5527
AD  - Center for the Study of Ethics in the Professions, Illinois Institute of
      Technology, Chicago, Illinois, USA.
FAU - Hofmaier, Christian
AU  - Hofmaier C
AD  - Center for Interdisciplinary Risk and Innovation Studies, Stuttgart University,
      Stuttgart, Germany.
FAU - Kronberger, Nicole
AU  - Kronberger N
AD  - Department of Social and Economic Psychology Johannes Kepler University, Linz,
      Austria.
FAU - Laursen, Sheena
AU  - Laursen S
AD  - Experimentarium, Science Communication Centre, Copenhagen, Denmark.
FAU - Meijknecht, Anna
AU  - Meijknecht A
AD  - Tilburg Institute for Law, Technology, and Society, Tilburg University, Tilburg, 
      The Netherlands.
FAU - Nordal, Salvor
AU  - Nordal S
AD  - Centre for Ethics University of Iceland, Reykjavik, Iceland.
FAU - Quintanilha, Alexandre
AU  - Quintanilha A
AD  - Institute of Molecular and Cellular Biology, Porto, Portugal.
FAU - Revuelta, Gema
AU  - Revuelta G
AUID- ORCID: http://orcid.org/0000-0002-0701-2026
AD  - Centre on Science, Communication and Society Universitat Pompeu Fabra, Barcelona,
      Spain.
FAU - Saladie, Nuria
AU  - Saladie N
AD  - Centre on Science, Communication and Society Universitat Pompeu Fabra, Barcelona,
      Spain.
FAU - Sandor, Judit
AU  - Sandor J
AD  - The Center for Ethics and Law in Biomedicine Central European University,
      Budapest, Hungary.
FAU - Santos, Julio Borlido
AU  - Santos JB
AD  - Institute of Molecular and Cellular Biology, Porto, Portugal.
FAU - Seyringer, Simone
AU  - Seyringer S
AD  - Department of Social and Economic Psychology Johannes Kepler University, Linz,
      Austria.
FAU - Singh, Ilina
AU  - Singh I
AUID- ORCID: http://orcid.org/0000-0003-4497-3587
AD  - Department of Psychiatry and Oxford Uehiro Centre University of Oxford, Oxford,
      UK.
FAU - Somsen, Han
AU  - Somsen H
AD  - Tilburg Institute for Law, Technology, and Society, Tilburg University, Tilburg, 
      The Netherlands.
FAU - Toonders, Winnie
AU  - Toonders W
AD  - Institute for Science, Innovation and Society Radboud University of Nijmegen,
      Nijmegen, The Netherlands.
FAU - Torgersen, Helge
AU  - Torgersen H
AD  - Institute of Technology Assessment Austrian Academy of Sciences, Vienna, Austria.
FAU - Torre, Vincent
AU  - Torre V
AD  - Centre for Neurobiology, International School for Advanced Studies, Trieste,
      Italy.
FAU - Varju, Marton
AU  - Varju M
AD  - The Center for Ethics and Law in Biomedicine Central European University,
      Budapest, Hungary.
FAU - Zwart, Hub
AU  - Zwart H
AD  - Institute for Science, Innovation and Society Radboud University of Nijmegen,
      Nijmegen, The Netherlands.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/11/10 06:00
MHDA- 2017/11/10 06:00
CRDT- 2017/11/10 06:00
PHST- 2017/11/10 06:00 [entrez]
PHST- 2017/11/10 06:00 [pubmed]
PHST- 2017/11/10 06:00 [medline]
AID - nbt.3958 [pii]
AID - 10.1038/nbt.3958 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Nov 9;35(11):1021-1023. doi: 10.1038/nbt.3958.

PMID- 29121021
OWN - NLM
STAT- In-Data-Review
LR  - 20180202
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 11
DP  - 2017 Nov 9
TI  - Revisiting the Warnock rule.
PG  - 1029-1042
LID - 10.1038/nbt.4015 [doi]
FAU - Hurlbut, J Benjamin
AU  - Hurlbut JB
AD  - School of Life Sciences, Center for Biology and Society and School for the Future
      of Innovation in Society, Arizona State University, Tempe, Arizona, USA.
FAU - Hyun, Insoo
AU  - Hyun I
AD  - Department of Bioethics, Case Western Reserve University School of Medicine,
      Cleveland, Ohio, USA.
FAU - Levine, Aaron D
AU  - Levine AD
AD  - School of Public Policy, Petit Institute for Bioengineering and Bioscience,
      Georgia Institute of Technology, Atlanta, Georgia, USA.
FAU - Lovell-Badge, Robin
AU  - Lovell-Badge R
AD  - The Francis Crick Institute, London, UK.
FAU - Lunshof, Jeantine E
AU  - Lunshof JE
AD  - Department of Genetics, University of Groningen, University Medical Center
      Groningen (UMCG), Groningen, The Netherlands, and Department of Genetics, Church 
      laboratory, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Matthews, Kirstin R W
AU  - Matthews KRW
AD  - Baker Institute Center for Health and Biosciences, Rice University, Houston, TX, 
      USA.
FAU - Mills, Peter
AU  - Mills P
AD  - Nuffield Council on Bioethics, London, UK.
FAU - Murdoch, Alison
AU  - Murdoch A
AD  - Department of Reproductive Medicine, International Centre for Life, Newcastle
      upon Tyne, UK.
FAU - Pera, Martin F
AU  - Pera MF
AD  - The Jackson Laboratory, Bar Harbor, Maine, USA.
FAU - Scott, Christopher Thomas
AU  - Scott CT
AD  - Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston,
      TX, USA.
FAU - Tizzard, Juliet
AU  - Tizzard J
AD  - The Human Fertilisation and Embryology Authority, London, UK.
FAU - Warnock, Mary
AU  - Warnock M
AD  - Honorary Fellow, Hertford College, University of Oxford, Catte Street, Oxford,
      UK.
FAU - Zernicka-Goetz, Magdalena
AU  - Zernicka-Goetz M
AD  - Department of Physiology, Development and Neuroscience, University of Cambridge, 
      Cambridge, UK.
FAU - Zhou, Qi
AU  - Zhou Q
AD  - The State Key Laboratory of Stem cell and Reproductive Biology, Institute of
      Zoology, Chinese Academy of Sciences, Beijing, China.
FAU - Zoloth, Laurie
AU  - Zoloth L
AD  - University of Chicago Divinity School, Chicago, Illinois, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EIN - Nat Biotechnol. 2017 Dec 8;35(12 ):1211. PMID: 29220028
EDAT- 2017/11/10 06:00
MHDA- 2017/11/10 06:00
CRDT- 2017/11/10 06:00
PHST- 2017/11/10 06:00 [entrez]
PHST- 2017/11/10 06:00 [pubmed]
PHST- 2017/11/10 06:00 [medline]
AID - nbt.4015 [pii]
AID - 10.1038/nbt.4015 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Nov 9;35(11):1029-1042. doi: 10.1038/nbt.4015.

PMID- 29121020
OWN - NLM
STAT- In-Data-Review
LR  - 20171109
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 11
DP  - 2017 Nov 9
TI  - First rounders: Stelios Papadopoulos.
PG  - 1004
LID - 10.1038/nbt.3995 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/11/10 06:00
MHDA- 2017/11/10 06:00
CRDT- 2017/11/10 06:00
PHST- 2017/11/10 06:00 [entrez]
PHST- 2017/11/10 06:00 [pubmed]
PHST- 2017/11/10 06:00 [medline]
AID - nbt.3995 [pii]
AID - 10.1038/nbt.3995 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Nov 9;35(11):1004. doi: 10.1038/nbt.3995.

PMID- 29121019
OWN - NLM
STAT- In-Data-Review
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 11
DP  - 2017 Nov 9
TI  - Duchenne drug clings on for FDA nod.
PG  - 999
LID - 10.1038/nbt1117-999 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/11/10 06:00
MHDA- 2017/11/10 06:00
CRDT- 2017/11/10 06:00
PHST- 2017/11/10 06:00 [entrez]
PHST- 2017/11/10 06:00 [pubmed]
PHST- 2017/11/10 06:00 [medline]
AID - nbt1117-999 [pii]
AID - 10.1038/nbt1117-999 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Nov 9;35(11):999. doi: 10.1038/nbt1117-999.

PMID- 29121018
OWN - NLM
STAT- In-Data-Review
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 11
DP  - 2017 Nov 9
TI  - When replacement becomes reversion.
PG  - 1012-1015
LID - 10.1038/nbt.3996 [doi]
FAU - Connor, Steve
AU  - Connor S
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/11/10 06:00
MHDA- 2017/11/10 06:00
CRDT- 2017/11/10 06:00
PHST- 2017/11/10 06:00 [entrez]
PHST- 2017/11/10 06:00 [pubmed]
PHST- 2017/11/10 06:00 [medline]
AID - nbt.3996 [pii]
AID - 10.1038/nbt.3996 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Nov 9;35(11):1012-1015. doi: 10.1038/nbt.3996.

PMID- 29121017
OWN - NLM
STAT- In-Data-Review
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 11
DP  - 2017 Nov 9
TI  - Reproducing with DNA.
PG  - 1016-1020
LID - 10.1038/nbt.4002 [doi]
FAU - Branca, Malorye Allison
AU  - Branca MA
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/11/10 06:00
MHDA- 2017/11/10 06:00
CRDT- 2017/11/10 06:00
PHST- 2017/11/10 06:00 [entrez]
PHST- 2017/11/10 06:00 [pubmed]
PHST- 2017/11/10 06:00 [medline]
AID - nbt.4002 [pii]
AID - 10.1038/nbt.4002 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Nov 9;35(11):1016-1020. doi: 10.1038/nbt.4002.

PMID- 29121016
OWN - NLM
STAT- In-Data-Review
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 11
DP  - 2017 Nov 9
TI  - Spanish group defeats Shkreli in Chagas voucher race.
PG  - 1003
LID - 10.1038/nbt1117-1003 [doi]
FAU - Melton, Lisa
AU  - Melton L
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/11/10 06:00
MHDA- 2017/11/10 06:00
CRDT- 2017/11/10 06:00
PHST- 2017/11/10 06:00 [entrez]
PHST- 2017/11/10 06:00 [pubmed]
PHST- 2017/11/10 06:00 [medline]
AID - nbt1117-1003 [pii]
AID - 10.1038/nbt1117-1003 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Nov 9;35(11):1003. doi: 10.1038/nbt1117-1003.

PMID- 29121015
OWN - NLM
STAT- In-Data-Review
LR  - 20171109
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 11
DP  - 2017 Nov 9
TI  - 3Q17-Funding and partnership into overdrive.
PG  - 1005
LID - 10.1038/nbt.4012 [doi]
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/11/10 06:00
MHDA- 2017/11/10 06:00
CRDT- 2017/11/10 06:00
PHST- 2017/11/10 06:00 [entrez]
PHST- 2017/11/10 06:00 [pubmed]
PHST- 2017/11/10 06:00 [medline]
AID - nbt.4012 [pii]
AID - 10.1038/nbt.4012 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Nov 9;35(11):1005. doi: 10.1038/nbt.4012.

PMID- 29121014
OWN - NLM
STAT- In-Data-Review
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 11
DP  - 2017 Nov 9
TI  - First AAV gene therapy poised for landmark approval.
PG  - 998-999
LID - 10.1038/nbt1117-998 [doi]
FAU - Smalley, Eric
AU  - Smalley E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/11/10 06:00
MHDA- 2017/11/10 06:00
CRDT- 2017/11/10 06:00
PHST- 2017/11/10 06:00 [entrez]
PHST- 2017/11/10 06:00 [pubmed]
PHST- 2017/11/10 06:00 [medline]
AID - nbt1117-998 [pii]
AID - 10.1038/nbt1117-998 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Nov 9;35(11):998-999. doi: 10.1038/nbt1117-998.

PMID- 29121013
OWN - NLM
STAT- In-Data-Review
LR  - 20171109
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 11
DP  - 2017 Nov 9
TI  - Recent patents related to germline modification.
PG  - 1043
LID - 10.1038/nbt.4013 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/11/10 06:00
MHDA- 2017/11/10 06:00
CRDT- 2017/11/10 06:00
PHST- 2017/11/10 06:00 [entrez]
PHST- 2017/11/10 06:00 [pubmed]
PHST- 2017/11/10 06:00 [medline]
AID - nbt.4013 [pii]
AID - 10.1038/nbt.4013 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Nov 9;35(11):1043. doi: 10.1038/nbt.4013.

PMID- 29121012
OWN - NLM
STAT- In-Data-Review
LR  - 20171109
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 11
DP  - 2017 Nov 9
TI  - RET-oncogene-targeting drugs draw notice.
PG  - 996
LID - 10.1038/nbt1117-996 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/11/10 06:00
MHDA- 2017/11/10 06:00
CRDT- 2017/11/10 06:00
PHST- 2017/11/10 06:00 [entrez]
PHST- 2017/11/10 06:00 [pubmed]
PHST- 2017/11/10 06:00 [medline]
AID - nbt1117-996 [pii]
AID - 10.1038/nbt1117-996 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Nov 9;35(11):996. doi: 10.1038/nbt1117-996.

PMID- 29121011
OWN - NLM
STAT- Publisher
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 11
DP  - 2017 Nov 9
TI  - Assisted reproductive technologies to prevent human mitochondrial disease
      transmission.
PG  - 1059-1068
LID - 10.1038/nbt.3997 [doi]
AB  - Mitochondria are essential cytoplasmic organelles that generate energy (ATP) by
      oxidative phosphorylation and mediate key cellular processes such as apoptosis.
      They are maternally inherited and in humans contain a 16,569-base-pair circular
      genome (mtDNA) encoding 37 genes required for oxidative phosphorylation.
      Mutations in mtDNA cause a range of pathologies, commonly affecting
      energy-demanding tissues such as muscle and brain. Because mitochondrial diseases
      are incurable, attention has focused on limiting the inheritance of pathogenic
      mtDNA by mitochondrial replacement therapy (MRT). MRT aims to avoid pathogenic
      mtDNA transmission between generations by maternal spindle transfer, pronuclear
      transfer or polar body transfer: all involve the transfer of nuclear DNA from an 
      egg or zygote containing defective mitochondria to a corresponding egg or zygote 
      with normal mitochondria. Here we review recent developments in animal and human 
      models of MRT and the underlying biology. These have led to potential clinical
      applications; we identify challenges to their technical refinement.
FAU - Greenfield, Andy
AU  - Greenfield A
AD  - MRC Harwell Institute, Mammalian Genetics Unit, Harwell Campus, Harwell,
      Oxfordshire, UK.
FAU - Braude, Peter
AU  - Braude P
AD  - Division of Women's Health, King's College, London, UK.
FAU - Flinter, Frances
AU  - Flinter F
AD  - Clinical Genetics Department, Guy's Hospital, Great Maze Pond, London, UK.
FAU - Lovell-Badge, Robin
AU  - Lovell-Badge R
AUID- ORCID: http://orcid.org/0000-0001-9364-4179
AD  - The Francis Crick Institute, London, UK.
FAU - Ogilvie, Caroline
AU  - Ogilvie C
AD  - Genetics Department, Guy's & St Thomas' NHS Foundation Trust and Division of
      Women's Health, King's College, London, UK.
FAU - Perry, Anthony C F
AU  - Perry ACF
AD  - Laboratory of Mammalian Molecular Embryology, Department of Biology and
      Biochemistry, University of Bath, Bath, UK.
LA  - eng
PT  - Journal Article
DEP - 20171109
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/11/10 06:00
MHDA- 2017/11/10 06:00
CRDT- 2017/11/10 06:00
PHST- 2017/08/02 00:00 [received]
PHST- 2017/10/02 00:00 [accepted]
PHST- 2017/11/10 06:00 [entrez]
PHST- 2017/11/10 06:00 [pubmed]
PHST- 2017/11/10 06:00 [medline]
AID - nbt.3997 [pii]
AID - 10.1038/nbt.3997 [doi]
PST - aheadofprint
SO  - Nat Biotechnol. 2017 Nov 9;35(11):1059-1068. doi: 10.1038/nbt.3997.

PMID- 29121010
OWN - NLM
STAT- In-Data-Review
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 11
DP  - 2017 Nov 9
TI  - Allergan's Mohawk evergreening patent deal draws criticism, but ultimately may
      flop.
PG  - 1002
LID - 10.1038/nbt1117-1002 [doi]
FAU - von Schaper, Eva
AU  - von Schaper E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/11/10 06:00
MHDA- 2017/11/10 06:00
CRDT- 2017/11/10 06:00
PHST- 2017/11/10 06:00 [entrez]
PHST- 2017/11/10 06:00 [pubmed]
PHST- 2017/11/10 06:00 [medline]
AID - nbt1117-1002 [pii]
AID - 10.1038/nbt1117-1002 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Nov 9;35(11):1002. doi: 10.1038/nbt1117-1002.

PMID- 29121009
OWN - NLM
STAT- In-Data-Review
LR  - 20171109
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 11
DP  - 2017 Nov 9
TI  - Around the world in a month.
PG  - 1004
LID - 10.1038/nbt1117-1004 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/11/10 06:00
MHDA- 2017/11/10 06:00
CRDT- 2017/11/10 06:00
PHST- 2017/11/10 06:00 [entrez]
PHST- 2017/11/10 06:00 [pubmed]
PHST- 2017/11/10 06:00 [medline]
AID - nbt1117-1004 [pii]
AID - 10.1038/nbt1117-1004 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Nov 9;35(11):1004. doi: 10.1038/nbt1117-1004.

PMID- 29121007
OWN - NLM
STAT- In-Data-Review
LR  - 20171109
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 11
DP  - 2017 Nov 9
TI  - Third-quarter biotech job picture.
PG  - 1111
LID - 10.1038/nbt.4008 [doi]
FAU - Francisco, Michael
AU  - Francisco M
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/11/10 06:00
MHDA- 2017/11/10 06:00
CRDT- 2017/11/10 06:00
PHST- 2017/11/10 06:00 [entrez]
PHST- 2017/11/10 06:00 [pubmed]
PHST- 2017/11/10 06:00 [medline]
AID - nbt.4008 [pii]
AID - 10.1038/nbt.4008 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Nov 9;35(11):1111. doi: 10.1038/nbt.4008.

PMID- 29035374
OWN - NLM
STAT- MEDLINE
DCOM- 20171120
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 11
DP  - 2017 Nov
TI  - Design of coiled-coil protein-origami cages that self-assemble in vitro and in
      vivo.
PG  - 1094-1101
LID - 10.1038/nbt.3994 [doi]
AB  - Polypeptides and polynucleotides are natural programmable biopolymers that can
      self-assemble into complex tertiary structures. We describe a system analogous to
      designed DNA nanostructures in which protein coiled-coil (CC) dimers serve as
      building blocks for modular de novo design of polyhedral protein cages that
      efficiently self-assemble in vitro and in vivo. We produced and characterized >20
      single-chain protein cages in three shapes-tetrahedron, four-sided pyramid, and
      triangular prism-with the largest containing >700 amino-acid residues and
      measuring 11 nm in diameter. Their stability and folding kinetics were similar to
      those of natural proteins. Solution small-angle X-ray scattering (SAXS), electron
      microscopy (EM), and biophysical analysis confirmed agreement of the expressed
      structures with the designs. We also demonstrated self-assembly of a tetrahedral 
      structure in bacteria, mammalian cells, and mice without evidence of
      inflammation. A semi-automated computational design platform and a toolbox of CC 
      building modules are provided to enable the design of protein cages in any
      polyhedral shape.
FAU - Ljubetic, Ajasja
AU  - Ljubetic A
AD  - Department of Synthetic Biology and Immunology, National Institute of Chemistry, 
      Ljubljana, Slovenia.
FAU - Lapenta, Fabio
AU  - Lapenta F
AD  - Department of Synthetic Biology and Immunology, National Institute of Chemistry, 
      Ljubljana, Slovenia.
AD  - Graduate School of Biomedicine, University of Ljubljana, Ljubljana, Slovenia.
FAU - Gradisar, Helena
AU  - Gradisar H
AD  - Department of Synthetic Biology and Immunology, National Institute of Chemistry, 
      Ljubljana, Slovenia.
AD  - EN-FIST Centre of Excellence, Ljubljana, Slovenia.
FAU - Drobnak, Igor
AU  - Drobnak I
AD  - Department of Synthetic Biology and Immunology, National Institute of Chemistry, 
      Ljubljana, Slovenia.
FAU - Aupic, Jana
AU  - Aupic J
AD  - Department of Synthetic Biology and Immunology, National Institute of Chemistry, 
      Ljubljana, Slovenia.
AD  - Doctoral Study Programme in Chemical Sciences, University of Ljubljana,
      Ljubljana, Slovenia.
FAU - Strmsek, Ziga
AU  - Strmsek Z
AD  - Department of Synthetic Biology and Immunology, National Institute of Chemistry, 
      Ljubljana, Slovenia.
FAU - Lainscek, Dusko
AU  - Lainscek D
AD  - Department of Synthetic Biology and Immunology, National Institute of Chemistry, 
      Ljubljana, Slovenia.
FAU - Hafner-Bratkovic, Iva
AU  - Hafner-Bratkovic I
AD  - Department of Synthetic Biology and Immunology, National Institute of Chemistry, 
      Ljubljana, Slovenia.
AD  - EN-FIST Centre of Excellence, Ljubljana, Slovenia.
FAU - Majerle, Andreja
AU  - Majerle A
AD  - Department of Synthetic Biology and Immunology, National Institute of Chemistry, 
      Ljubljana, Slovenia.
FAU - Krivec, Nusa
AU  - Krivec N
AD  - Department of Synthetic Biology and Immunology, National Institute of Chemistry, 
      Ljubljana, Slovenia.
FAU - Bencina, Mojca
AU  - Bencina M
AD  - Department of Synthetic Biology and Immunology, National Institute of Chemistry, 
      Ljubljana, Slovenia.
FAU - Pisanski, Tomaz
AU  - Pisanski T
AD  - FAMINT, University of Primorska, Koper and Institute of Mathematics and Physics, 
      Ljubljana, Slovenia.
FAU - Velickovic, Tanja Cirkovic
AU  - Velickovic TC
AD  - Center of Excellence for Molecular Food Sciences, Faculty of Chemistry,
      University of Belgrade, Serbia.
FAU - Round, Adam
AU  - Round A
AD  - The European Synchrotron Radiation Facility (ESRF), Grenoble, France.
AD  - School of Chemical and Physical Sciences, Keele Univerity, Keele, Staffordshire, 
      UK.
FAU - Carazo, Jose Maria
AU  - Carazo JM
AD  - Centro Nacional de Biotecnologia (CNB-CSIC), Madrid, Spain.
FAU - Melero, Roberto
AU  - Melero R
AD  - Centro Nacional de Biotecnologia (CNB-CSIC), Madrid, Spain.
FAU - Jerala, Roman
AU  - Jerala R
AUID- ORCID: http://orcid.org/0000-0002-6337-5251
AD  - Department of Synthetic Biology and Immunology, National Institute of Chemistry, 
      Ljubljana, Slovenia.
AD  - EN-FIST Centre of Excellence, Ljubljana, Slovenia.
LA  - eng
PT  - Journal Article
DEP - 20171016
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Proteins)
SB  - IM
MH  - Models, Molecular
MH  - Nanostructures
MH  - *Protein Engineering
MH  - Protein Folding
MH  - Protein Multimerization
MH  - Protein Structure, Secondary
MH  - Proteins/*chemistry
EDAT- 2017/10/17 06:00
MHDA- 2017/11/29 06:00
CRDT- 2017/10/17 06:00
PHST- 2016/10/04 00:00 [received]
PHST- 2017/09/25 00:00 [accepted]
PHST- 2017/10/17 06:00 [pubmed]
PHST- 2017/11/29 06:00 [medline]
PHST- 2017/10/17 06:00 [entrez]
AID - nbt.3994 [pii]
AID - 10.1038/nbt.3994 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Nov;35(11):1094-1101. doi: 10.1038/nbt.3994. Epub 2017 Oct
      16.

PMID- 29035373
OWN - NLM
STAT- MEDLINE
DCOM- 20171120
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 11
DP  - 2017 Nov
TI  - Molecular afterglow imaging with bright, biodegradable polymer nanoparticles.
PG  - 1102-1110
LID - 10.1038/nbt.3987 [doi]
AB  - Afterglow optical agents, which emit light long after cessation of excitation,
      hold promise for ultrasensitive in vivo imaging because they eliminate tissue
      autofluorescence. However, afterglow imaging has been limited by its reliance on 
      inorganic nanoparticles with relatively low brightness and short-near-infrared
      (NIR) emission. Here we present semiconducting polymer nanoparticles (SPNs) <40
      nm in diameter that store photon energy via chemical defects and emit long-NIR
      afterglow luminescence at 780 nm with a half-life of approximately 6 min. In
      vivo, the afterglow intensity of SPNs is more than 100-fold brighter than that of
      inorganic afterglow agents, and the signal is detectable through the body of a
      live mouse. High-contrast lymph node and tumor imaging in living mice is
      demonstrated with a signal-to-background ratio up to 127-times higher than that
      obtained by NIR fluorescence imaging. Moreover, we developed an afterglow probe, 
      activated only in the presence of biothiols, for early detection of drug-induced 
      hepatotoxicity in living mice.
FAU - Miao, Qingqing
AU  - Miao Q
AD  - School of Chemical and Biomedical Engineering, Nanyang Technological University, 
      Singapore.
FAU - Xie, Chen
AU  - Xie C
AD  - School of Chemical and Biomedical Engineering, Nanyang Technological University, 
      Singapore.
FAU - Zhen, Xu
AU  - Zhen X
AD  - School of Chemical and Biomedical Engineering, Nanyang Technological University, 
      Singapore.
FAU - Lyu, Yan
AU  - Lyu Y
AD  - School of Chemical and Biomedical Engineering, Nanyang Technological University, 
      Singapore.
FAU - Duan, Hongwei
AU  - Duan H
AD  - School of Chemical and Biomedical Engineering, Nanyang Technological University, 
      Singapore.
FAU - Liu, Xiaogang
AU  - Liu X
AD  - Department of Chemistry, National University of Singapore, Singapore.
FAU - Jokerst, Jesse V
AU  - Jokerst JV
AD  - Department of NanoEngineering, University of California San Diego, La Jolla,
      California, USA.
FAU - Pu, Kanyi
AU  - Pu K
AUID- ORCID: http://orcid.org/0000-0002-8064-6009
AD  - School of Chemical and Biomedical Engineering, Nanyang Technological University, 
      Singapore.
LA  - eng
PT  - Journal Article
DEP - 20171016
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Biodegradable Plastics)
RN  - 0 (Luminescent Agents)
RN  - 0 (Polymers)
SB  - IM
MH  - Animals
MH  - *Biodegradable Plastics
MH  - Diagnostic Imaging
MH  - HeLa Cells
MH  - Humans
MH  - *Light
MH  - Luminescent Agents
MH  - Mice
MH  - Mice, Nude
MH  - Neoplasms, Experimental
MH  - *Polymers
MH  - Quantum Dots/*chemistry
EDAT- 2017/10/17 06:00
MHDA- 2017/11/29 06:00
CRDT- 2017/10/17 06:00
PHST- 2017/02/11 00:00 [received]
PHST- 2017/09/14 00:00 [accepted]
PHST- 2017/10/17 06:00 [pubmed]
PHST- 2017/11/29 06:00 [medline]
PHST- 2017/10/17 06:00 [entrez]
AID - nbt.3987 [pii]
AID - 10.1038/nbt.3987 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Nov;35(11):1102-1110. doi: 10.1038/nbt.3987. Epub 2017 Oct
      16.

PMID- 29035372
OWN - NLM
STAT- In-Data-Review
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 11
DP  - 2017 Nov
TI  - MMseqs2 enables sensitive protein sequence searching for the analysis of massive 
      data sets.
PG  - 1026-1028
LID - 10.1038/nbt.3988 [doi]
FAU - Steinegger, Martin
AU  - Steinegger M
AUID- ORCID: http://orcid.org/0000-0001-8781-9753
AD  - Quantitative and Computational Biology group, Max-Planck Institute for
      Biophysical Chemistry, Gottingen, Germany.
AD  - Department for Bioinformatics and Computational Biology, Technische Universitat
      Munchen, Garching, Germany.
FAU - Soding, Johannes
AU  - Soding J
AUID- ORCID: http://orcid.org/0000-0001-9642-8244
AD  - Quantitative and Computational Biology group, Max-Planck Institute for
      Biophysical Chemistry, Gottingen, Germany.
LA  - eng
PT  - Journal Article
DEP - 20171016
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/10/17 06:00
MHDA- 2017/10/17 06:00
CRDT- 2017/10/17 06:00
PHST- 2017/10/17 06:00 [pubmed]
PHST- 2017/10/17 06:00 [medline]
PHST- 2017/10/17 06:00 [entrez]
AID - nbt.3988 [pii]
AID - 10.1038/nbt.3988 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Nov;35(11):1026-1028. doi: 10.1038/nbt.3988. Epub 2017 Oct
      16.

PMID- 28991269
OWN - NLM
STAT- In-Data-Review
LR  - 20171113
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 11
DP  - 2017 Nov
TI  - Engineered bacteria self-organize to sense pressure.
PG  - 1045-1047
LID - 10.1038/nbt.3992 [doi]
FAU - Morales, Neydis Moreno
AU  - Morales NM
AD  - Department of Biomedical Engineering, University of Wisconsin-Madison, Madison,
      Wisconsin, USA.
AD  - Biophysics Graduate Program, University of Wisconsin-Madison, Madison, Wisconsin,
      USA.
FAU - McClean, Megan N
AU  - McClean MN
AUID- ORCID: http://orcid.org/0000-0002-1141-4802
AD  - Department of Biomedical Engineering, University of Wisconsin-Madison, Madison,
      Wisconsin, USA.
LA  - eng
PT  - Journal Article
DEP - 20171009
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/10/11 06:00
MHDA- 2017/10/11 06:00
CRDT- 2017/10/10 06:00
PHST- 2017/10/11 06:00 [pubmed]
PHST- 2017/10/11 06:00 [medline]
PHST- 2017/10/10 06:00 [entrez]
AID - nbt.3992 [pii]
AID - 10.1038/nbt.3992 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Nov;35(11):1045-1047. doi: 10.1038/nbt.3992. Epub 2017 Oct
      9.

PMID- 28991268
OWN - NLM
STAT- MEDLINE
DCOM- 20171120
LR  - 20171212
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 11
DP  - 2017 Nov
TI  - Programmable assembly of pressure sensors using pattern-forming bacteria.
PG  - 1087-1093
LID - 10.1038/nbt.3978 [doi]
AB  - Biological systems can generate microstructured materials that combine organic
      and inorganic components and possess diverse physical and chemical properties.
      However, these natural processes in materials fabrication are not readily
      programmable. Here, we use a synthetic-biology approach to assemble patterned
      materials. We demonstrate programmable fabrication of three-dimensional (3D)
      materials by printing engineered self-patterning bacteria on permeable membranes 
      that serve as a structural scaffold. Application of gold nanoparticles to the
      colonies creates hybrid organic-inorganic dome structures. The dynamics of the
      dome structures' response to pressure is determined by their geometry (colony
      size, dome height, and pattern), which is easily modified by varying the
      properties of the membrane (e.g., pore size and hydrophobicity). We generate
      resettable pressure sensors that process signals in response to varying pressure 
      intensity and duration.
FAU - Cao, Yangxiaolu
AU  - Cao Y
AD  - Department of Biomedical Engineering, Duke University, Durham, North Carolina,
      USA.
FAU - Feng, Yaying
AU  - Feng Y
AD  - Department of Mechanical Engineering and Materials Science, Duke University,
      Durham, North Carolina, USA.
FAU - Ryser, Marc D
AU  - Ryser MD
AD  - Department of Mathematics, Duke University, Durham, North Carolina, USA.
AD  - Department of Surgery, Division of Advanced Oncologic and GI Surgery, Duke
      University School of Medicine, Durham, North Carolina, USA.
FAU - Zhu, Kui
AU  - Zhu K
AD  - Department of Biomedical Engineering, Duke University, Durham, North Carolina,
      USA.
FAU - Herschlag, Gregory
AU  - Herschlag G
AD  - Department of Biomedical Engineering, Duke University, Durham, North Carolina,
      USA.
AD  - Department of Mathematics, Duke University, Durham, North Carolina, USA.
FAU - Cao, Changyong
AU  - Cao C
AD  - Department of Mechanical Engineering and Materials Science, Duke University,
      Durham, North Carolina, USA.
AD  - School of Packaging, Department of Mechanical Engineering, Michigan State
      University, East Lansing, Michigan, USA.
FAU - Marusak, Katherine
AU  - Marusak K
AD  - Department of Mechanical Engineering and Materials Science, Duke University,
      Durham, North Carolina, USA.
FAU - Zauscher, Stefan
AU  - Zauscher S
AD  - Department of Biomedical Engineering, Duke University, Durham, North Carolina,
      USA.
AD  - Department of Mechanical Engineering and Materials Science, Duke University,
      Durham, North Carolina, USA.
AD  - Department of Chemistry, Duke University, Durham, North Carolina, USA.
FAU - You, Lingchong
AU  - You L
AD  - Department of Biomedical Engineering, Duke University, Durham, North Carolina,
      USA.
AD  - Center for Genomic and Computational Biology, Duke University, Durham, North
      Carolina, USA.
AD  - Department of Molecular Genetics and Microbiology, Duke University School of
      Medicine, Durham, North Carolina, USA.
LA  - eng
GR  - K99 CA207872/CA/NCI NIH HHS/United States
GR  - R01 GM096190/GM/NIGMS NIH HHS/United States
GR  - R01 GM098642/GM/NIGMS NIH HHS/United States
PT  - Journal Article
DEP - 20171009
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 7440-57-5 (Gold)
SB  - IM
MH  - *Biosensing Techniques
MH  - Escherichia coli/genetics/*physiology
MH  - Gold
MH  - Metal Nanoparticles
MH  - Pressure
EDAT- 2017/10/11 06:00
MHDA- 2017/11/29 06:00
CRDT- 2017/10/10 06:00
PHST- 2016/11/28 00:00 [received]
PHST- 2017/09/01 00:00 [accepted]
PHST- 2017/10/11 06:00 [pubmed]
PHST- 2017/11/29 06:00 [medline]
PHST- 2017/10/10 06:00 [entrez]
AID - nbt.3978 [pii]
AID - 10.1038/nbt.3978 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Nov;35(11):1087-1093. doi: 10.1038/nbt.3978. Epub 2017 Oct
      9.

PMID- 28967887
OWN - NLM
STAT- MEDLINE
DCOM- 20171120
LR  - 20171128
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 11
DP  - 2017 Nov
TI  - Towards standards for human fecal sample processing in metagenomic studies.
PG  - 1069-1076
LID - 10.1038/nbt.3960 [doi]
AB  - Technical variation in metagenomic analysis must be minimized to confidently
      assess the contributions of microbiota to human health. Here we tested 21
      representative DNA extraction protocols on the same fecal samples and quantified 
      differences in observed microbial community composition. We compared them with
      differences due to library preparation and sample storage, which we contrasted
      with observed biological variation within the same specimen or within an
      individual over time. We found that DNA extraction had the largest effect on the 
      outcome of metagenomic analysis. To rank DNA extraction protocols, we considered 
      resulting DNA quantity and quality, and we ascertained biases in estimates of
      community diversity and the ratio between Gram-positive and Gram-negative
      bacteria. We recommend a standardized DNA extraction method for human fecal
      samples, for which transferability across labs was established and which was
      further benchmarked using a mock community of known composition. Its adoption
      will improve comparability of human gut microbiome studies and facilitate
      meta-analyses.
FAU - Costea, Paul I
AU  - Costea PI
AUID- ORCID: http://orcid.org/0000-0003-1645-3947
AD  - Structural and Computational Biology, European Molecular Biology Laboratory,
      Heidelberg, Germany.
FAU - Zeller, Georg
AU  - Zeller G
AD  - Structural and Computational Biology, European Molecular Biology Laboratory,
      Heidelberg, Germany.
FAU - Sunagawa, Shinichi
AU  - Sunagawa S
AUID- ORCID: http://orcid.org/0000-0003-3065-0314
AD  - Structural and Computational Biology, European Molecular Biology Laboratory,
      Heidelberg, Germany.
AD  - Department of Biology, Institute of Microbiology, ETH Zurich, Zurich,
      Switzerland.
FAU - Pelletier, Eric
AU  - Pelletier E
AD  - CEA - Institut Francois Jacob - Genoscope, Evry, France.
AD  - CNRS UMR-8030, Evry, France.
AD  - Universite Evry Val d'Essonne, Evry, France.
FAU - Alberti, Adriana
AU  - Alberti A
AUID- ORCID: http://orcid.org/0000-0003-3372-9423
AD  - CEA - Institut Francois Jacob - Genoscope, Evry, France.
FAU - Levenez, Florence
AU  - Levenez F
AD  - Metagenopolis, Institut National de la Recherche Agronomique, Jouy en Josas,
      France.
FAU - Tramontano, Melanie
AU  - Tramontano M
AD  - Structural and Computational Biology, European Molecular Biology Laboratory,
      Heidelberg, Germany.
FAU - Driessen, Marja
AU  - Driessen M
AD  - Structural and Computational Biology, European Molecular Biology Laboratory,
      Heidelberg, Germany.
FAU - Hercog, Rajna
AU  - Hercog R
AD  - Structural and Computational Biology, European Molecular Biology Laboratory,
      Heidelberg, Germany.
FAU - Jung, Ferris-Elias
AU  - Jung FE
AD  - Structural and Computational Biology, European Molecular Biology Laboratory,
      Heidelberg, Germany.
FAU - Kultima, Jens Roat
AU  - Kultima JR
AD  - Structural and Computational Biology, European Molecular Biology Laboratory,
      Heidelberg, Germany.
FAU - Hayward, Matthew R
AU  - Hayward MR
AD  - Structural and Computational Biology, European Molecular Biology Laboratory,
      Heidelberg, Germany.
FAU - Coelho, Luis Pedro
AU  - Coelho LP
AUID- ORCID: http://orcid.org/0000-0002-9280-7885
AD  - Structural and Computational Biology, European Molecular Biology Laboratory,
      Heidelberg, Germany.
FAU - Allen-Vercoe, Emma
AU  - Allen-Vercoe E
AD  - Department of Molecular and Cellular Biology, The University of Guelph, Guelph,
      Ontario, Canada.
FAU - Bertrand, Laurie
AU  - Bertrand L
AD  - CEA - Institut Francois Jacob - Genoscope, Evry, France.
FAU - Blaut, Michael
AU  - Blaut M
AD  - Department of Gastrointestinal Microbiology, German Institute of Human Nutrition 
      Potsdam-Rehbruecke, Nuthetal, Germany.
FAU - Brown, Jillian R M
AU  - Brown JRM
AD  - School of Microbiology & APC Microbiome Institute, University College Cork, Cork,
      Ireland.
FAU - Carton, Thomas
AU  - Carton T
AD  - Biofortis, Merieux NutriSciences, Nantes, France.
FAU - Cools-Portier, Stephanie
AU  - Cools-Portier S
AD  - Danone Nutricia Research, Palaiseau, France.
FAU - Daigneault, Michelle
AU  - Daigneault M
AD  - Metagenopolis, Institut National de la Recherche Agronomique, Jouy en Josas,
      France.
FAU - Derrien, Muriel
AU  - Derrien M
AD  - Danone Nutricia Research, Palaiseau, France.
FAU - Druesne, Anne
AU  - Druesne A
AD  - Danone Nutricia Research, Palaiseau, France.
FAU - de Vos, Willem M
AU  - de Vos WM
AUID- ORCID: http://orcid.org/0000-0002-0273-3166
AD  - Laboratory of Microbiology, Wageningen University & Research, Wageningen, the
      Netherlands.
AD  - Immunobiology Research Program, Department of Bacteriology and Immunology,
      University of Helsinki, Helsinki, Finland.
FAU - Finlay, B Brett
AU  - Finlay BB
AD  - Michael Smith Laboratories, University of British Columbia, Vancouver, British
      Columbia, Canada.
FAU - Flint, Harry J
AU  - Flint HJ
AD  - Rowett Institute of Nutrition and Health, University of Aberdeen, Aberdeen, UK.
FAU - Guarner, Francisco
AU  - Guarner F
AD  - Digestive System Research Unit, Vall d'Hebron Research Institute, Barcelona,
      Spain.
FAU - Hattori, Masahira
AU  - Hattori M
AD  - Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan.
AD  - Graduate School of Advanced Science and Engineering, Waseda University, Tokyo,
      Japan.
FAU - Heilig, Hans
AU  - Heilig H
AD  - Laboratory of Microbiology, Wageningen University & Research, Wageningen, the
      Netherlands.
FAU - Luna, Ruth Ann
AU  - Luna RA
AUID- ORCID: http://orcid.org/0000-0001-6104-0872
AD  - Texas Children's Hospital, Feigin Center, Houston, Texas, USA.
FAU - van Hylckama Vlieg, Johan
AU  - van Hylckama Vlieg J
AD  - Danone Nutricia Research, Palaiseau, France.
FAU - Junick, Jana
AU  - Junick J
AD  - Department of Gastrointestinal Microbiology, German Institute of Human Nutrition 
      Potsdam-Rehbruecke, Nuthetal, Germany.
FAU - Klymiuk, Ingeborg
AU  - Klymiuk I
AD  - Center for Medical Research, Medical University of Graz, Graz, Austria.
FAU - Langella, Philippe
AU  - Langella P
AD  - Metagenopolis, Institut National de la Recherche Agronomique, Jouy en Josas,
      France.
FAU - Le Chatelier, Emmanuelle
AU  - Le Chatelier E
AD  - Metagenopolis, Institut National de la Recherche Agronomique, Jouy en Josas,
      France.
FAU - Mai, Volker
AU  - Mai V
AD  - Department of Epidemiology, College of Public Health and Health Professions and
      College of Medicine, Emerging Pathogens Institute, University of Florida,
      Gainesville, Florida, USA.
FAU - Manichanh, Chaysavanh
AU  - Manichanh C
AD  - Digestive System Research Unit, Vall d'Hebron Research Institute, Barcelona,
      Spain.
FAU - Martin, Jennifer C
AU  - Martin JC
AD  - Rowett Institute of Nutrition and Health, University of Aberdeen, Aberdeen, UK.
FAU - Mery, Clementine
AU  - Mery C
AD  - Biofortis, Merieux NutriSciences, Nantes, France.
FAU - Morita, Hidetoshi
AU  - Morita H
AD  - Graduate School of Environmental and Life Science, Okayama University, Okayama,
      Japan.
FAU - O'Toole, Paul W
AU  - O'Toole PW
AD  - School of Microbiology & APC Microbiome Institute, University College Cork, Cork,
      Ireland.
FAU - Orvain, Celine
AU  - Orvain C
AD  - CEA - Institut Francois Jacob - Genoscope, Evry, France.
FAU - Patil, Kiran Raosaheb
AU  - Patil KR
AD  - Structural and Computational Biology, European Molecular Biology Laboratory,
      Heidelberg, Germany.
FAU - Penders, John
AU  - Penders J
AD  - School of Nutrition and Translational Research in Metabolism (NUTRIM) and Care
      and Public Health Research Institute (Caphri), Department of Medical
      Microbiology, Maastricht University Medical Center, Maastricht, the Netherlands.
FAU - Persson, Soren
AU  - Persson S
AD  - Unit of Foodborne Infections, Department of Bacteria, Parasites & Fungi, Statens 
      Serum Institut, Copenhagen, Denmark.
FAU - Pons, Nicolas
AU  - Pons N
AD  - Metagenopolis, Institut National de la Recherche Agronomique, Jouy en Josas,
      France.
FAU - Popova, Milena
AU  - Popova M
AD  - Biofortis, Merieux NutriSciences, Nantes, France.
FAU - Salonen, Anne
AU  - Salonen A
AD  - Immunobiology Research Program, Department of Bacteriology and Immunology,
      University of Helsinki, Helsinki, Finland.
FAU - Saulnier, Delphine
AU  - Saulnier D
AD  - Department of Gastrointestinal Microbiology, German Institute of Human Nutrition 
      Potsdam-Rehbruecke, Nuthetal, Germany.
FAU - Scott, Karen P
AU  - Scott KP
AD  - Rowett Institute of Nutrition and Health, University of Aberdeen, Aberdeen, UK.
FAU - Singh, Bhagirath
AU  - Singh B
AD  - Centre for Human Immunology, Department of Microbiology & Immunology and Robarts 
      Research Institute, University of Western Ontario, London, Ontario, Canada.
FAU - Slezak, Kathleen
AU  - Slezak K
AD  - Department of Gastrointestinal Microbiology, German Institute of Human Nutrition 
      Potsdam-Rehbruecke, Nuthetal, Germany.
FAU - Veiga, Patrick
AU  - Veiga P
AD  - Danone Nutricia Research, Palaiseau, France.
FAU - Versalovic, James
AU  - Versalovic J
AD  - Texas Children's Hospital, Feigin Center, Houston, Texas, USA.
FAU - Zhao, Liping
AU  - Zhao L
AD  - Ministry of Education Key Laboratory for Systems Biomedicine, Shanghai Centre for
      Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, PR China.
FAU - Zoetendal, Erwin G
AU  - Zoetendal EG
AD  - Laboratory of Microbiology, Wageningen University & Research, Wageningen, the
      Netherlands.
FAU - Ehrlich, S Dusko
AU  - Ehrlich SD
AD  - Metagenopolis, Institut National de la Recherche Agronomique, Jouy en Josas,
      France.
AD  - King's College London, Centre for Host-Microbiome Interactions, Dental Institute 
      Central Office, Guy's Hospital, London, UK.
FAU - Dore, Joel
AU  - Dore J
AD  - Metagenopolis, Institut National de la Recherche Agronomique, Jouy en Josas,
      France.
FAU - Bork, Peer
AU  - Bork P
AD  - Structural and Computational Biology, European Molecular Biology Laboratory,
      Heidelberg, Germany.
AD  - Department of Bioinformatics, Biocenter, University of Wurzburg, Wurzburg,
      Germany.
AD  - Molecular Medicine Partnership Unit, Heidelberg, Germany.
AD  - Max-Delbruck-Centre for Molecular Medicine, Berlin, Germany.
LA  - eng
PT  - Journal Article
DEP - 20171002
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 9007-49-2 (DNA)
SB  - IM
MH  - Bacteria/genetics
MH  - Chemical Fractionation/*methods
MH  - Computational Biology
MH  - DNA/*chemistry
MH  - Feces/*chemistry
MH  - Humans
MH  - *Metagenomics
MH  - Quality Control
MH  - Species Specificity
EDAT- 2017/10/03 06:00
MHDA- 2017/11/29 06:00
CRDT- 2017/10/03 06:00
PHST- 2016/07/08 00:00 [received]
PHST- 2017/08/11 00:00 [accepted]
PHST- 2017/10/03 06:00 [pubmed]
PHST- 2017/11/29 06:00 [medline]
PHST- 2017/10/03 06:00 [entrez]
AID - nbt.3960 [pii]
AID - 10.1038/nbt.3960 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Nov;35(11):1069-1076. doi: 10.1038/nbt.3960. Epub 2017 Oct
      2.

PMID- 28967886
OWN - NLM
STAT- In-Data-Review
LR  - 20171113
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 11
DP  - 2017 Nov
TI  - The ecological landscape of microbiome science.
PG  - 1047-1049
LID - 10.1038/nbt.3983 [doi]
FAU - Gohl, Daryl M
AU  - Gohl DM
AUID- ORCID: http://orcid.org/0000-0002-4434-2788
AD  - University of Minnesota Genomics Center, Minneapolis, Minnesota, USA.
LA  - eng
PT  - Journal Article
DEP - 20171002
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/10/03 06:00
MHDA- 2017/10/03 06:00
CRDT- 2017/10/03 06:00
PHST- 2017/10/03 06:00 [pubmed]
PHST- 2017/10/03 06:00 [medline]
PHST- 2017/10/03 06:00 [entrez]
AID - nbt.3983 [pii]
AID - 10.1038/nbt.3983 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Nov;35(11):1047-1049. doi: 10.1038/nbt.3983. Epub 2017 Oct
      2.

PMID- 28967885
OWN - NLM
STAT- MEDLINE
DCOM- 20171120
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 11
DP  - 2017 Nov
TI  - Assessment of variation in microbial community amplicon sequencing by the
      Microbiome Quality Control (MBQC) project consortium.
PG  - 1077-1086
LID - 10.1038/nbt.3981 [doi]
AB  - In order for human microbiome studies to translate into actionable outcomes for
      health, meta-analysis of reproducible data from population-scale cohorts is
      needed. Achieving sufficient reproducibility in microbiome research has proven
      challenging. We report a baseline investigation of variability in taxonomic
      profiling for the Microbiome Quality Control (MBQC) project baseline study
      (MBQC-base). Blinded specimen sets from human stool, chemostats, and artificial
      microbial communities were sequenced by 15 laboratories and analyzed using nine
      bioinformatics protocols. Variability depended most on biospecimen type and
      origin, followed by DNA extraction, sample handling environment, and
      bioinformatics. Analysis of artificial community specimens revealed differences
      in extraction efficiency and bioinformatic classification. These results may
      guide researchers in experimental design choices for gut microbiome studies.
FAU - Sinha, Rashmi
AU  - Sinha R
AD  - Division of Cancer Epidemiology and Genetics, National Cancer Institute,
      Bethesda, Maryland, USA.
FAU - Abu-Ali, Galeb
AU  - Abu-Ali G
AD  - Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, 
      USA.
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
FAU - Vogtmann, Emily
AU  - Vogtmann E
AUID- ORCID: http://orcid.org/0000-0003-1355-5593
AD  - Division of Cancer Epidemiology and Genetics, National Cancer Institute,
      Bethesda, Maryland, USA.
FAU - Fodor, Anthony A
AU  - Fodor AA
AD  - Bioinformatics and Genomics, University of North Carolina, Charlotte, Charlotte, 
      North Carolina, USA.
FAU - Ren, Boyu
AU  - Ren B
AD  - Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, 
      USA.
FAU - Amir, Amnon
AU  - Amir A
AD  - Pediatrics, University of California, San Diego, La Jolla, California, USA.
FAU - Schwager, Emma
AU  - Schwager E
AUID- ORCID: http://orcid.org/0000-0002-7385-8994
AD  - Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, 
      USA.
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
FAU - Crabtree, Jonathan
AU  - Crabtree J
AD  - Institute for Genome Sciences, University of Maryland School of Medicine,
      Baltimore, Maryland, USA.
FAU - Ma, Siyuan
AU  - Ma S
AD  - Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, 
      USA.
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
CN  - Microbiome Quality Control Project Consortium
FAU - Abnet, Christian C
AU  - Abnet CC
AUID- ORCID: http://orcid.org/0000-0002-3008-7843
AD  - Division of Cancer Epidemiology and Genetics, National Cancer Institute,
      Bethesda, Maryland, USA.
FAU - Knight, Rob
AU  - Knight R
AUID- ORCID: http://orcid.org/0000-0002-0975-9019
AD  - Pediatrics, University of California, San Diego, La Jolla, California, USA.
AD  - Computer Science and Engineering and Center for Microbiome Innovation, University
      of California, San Diego, La Jolla, California, USA.
FAU - White, Owen
AU  - White O
AD  - Institute for Genome Sciences, University of Maryland School of Medicine,
      Baltimore, Maryland, USA.
FAU - Huttenhower, Curtis
AU  - Huttenhower C
AUID- ORCID: http://orcid.org/0000-0002-1110-0096
AD  - Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, 
      USA.
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
LA  - eng
GR  - P30 DK043351/DK/NIDDK NIH HHS/United States
GR  - U01 HG006537/HG/NHGRI NIH HHS/United States
GR  - U01 HG004866/HG/NHGRI NIH HHS/United States
GR  - U54 DE023798/DE/NIDCR NIH HHS/United States
GR  - R01 HG005220/HG/NHGRI NIH HHS/United States
GR  - R01 HG004872/HG/NHGRI NIH HHS/United States
GR  - R01 HG005969/HG/NHGRI NIH HHS/United States
GR  - R01 CA179243/CA/NCI NIH HHS/United States
PT  - Journal Article
DEP - 20171002
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (DNA, Bacterial)
SB  - IM
MH  - Bacteria/*genetics
MH  - DNA, Bacterial/*chemistry/*genetics
MH  - Gastrointestinal Microbiome/*genetics
MH  - Humans
MH  - *Microbiota
MH  - Nucleic Acid Amplification Techniques/*methods/*standards
MH  - Reference Standards
MH  - Research Design
PMC - PMC5839636
MID - NIHMS919295
EDAT- 2017/10/03 06:00
MHDA- 2017/11/29 06:00
CRDT- 2017/10/03 06:00
PHST- 2016/07/16 00:00 [received]
PHST- 2017/09/11 00:00 [accepted]
PHST- 2017/10/03 06:00 [pubmed]
PHST- 2017/11/29 06:00 [medline]
PHST- 2017/10/03 06:00 [entrez]
AID - nbt.3981 [pii]
AID - 10.1038/nbt.3981 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Nov;35(11):1077-1086. doi: 10.1038/nbt.3981. Epub 2017 Oct
      2.

PMID- 29020007
OWN - NLM
STAT- In-Data-Review
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 10
DP  - 2017 Oct 11
TI  - Novartis trial validates inflammasome as chronic disease driver.
PG  - 893-894
LID - 10.1038/nbt1017-893 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/10/12 06:00
MHDA- 2017/10/12 06:00
CRDT- 2017/10/12 06:00
PHST- 2017/10/12 06:00 [entrez]
PHST- 2017/10/12 06:00 [pubmed]
PHST- 2017/10/12 06:00 [medline]
AID - nbt1017-893 [pii]
AID - 10.1038/nbt1017-893 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Oct 11;35(10):893-894. doi: 10.1038/nbt1017-893.

PMID- 29020006
OWN - NLM
STAT- MEDLINE
DCOM- 20171023
LR  - 20171116
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 10
DP  - 2017 Oct 11
TI  - Surge in insect resistance to transgenic crops and prospects for sustainability.
PG  - 926-935
LID - 10.1038/nbt.3974 [doi]
AB  - Transgenic crops have revolutionized insect pest control, but their effectiveness
      has been reduced by evolution of resistance in pests. We analyzed global
      monitoring data reported during the first two decades of transgenic crops, with
      each case representing the responses of one pest species in one country to one
      insecticidal protein from Bacillus thuringiensis (Bt). The cases of pest
      resistance to Bt crystalline (Cry) proteins produced by transgenic crops
      increased from 3 in 2005 to 16 in 2016. By contrast, in 17 other cases there was 
      no decrease in pest susceptibility to Bt crops, including the recently introduced
      transgenic corn that produces a Bt vegetative insecticidal protein (Vip).
      Recessive inheritance of pest resistance has favored sustained susceptibility,
      but even when inheritance is not recessive, abundant refuges of non-Bt host
      plants have substantially delayed resistance. These insights may inform
      resistance management strategies to increase the durability of current and future
      transgenic crops.
FAU - Tabashnik, Bruce E
AU  - Tabashnik BE
AUID- ORCID: http://orcid.org/0000-0002-2430-2367
AD  - Department of Entomology, University of Arizona, Tucson, Arizona, USA.
FAU - Carriere, Yves
AU  - Carriere Y
AD  - Department of Entomology, University of Arizona, Tucson, Arizona, USA.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - Bacillus thuringiensis/physiology
MH  - *Conservation of Natural Resources
MH  - Geography
MH  - Insecta/*physiology
MH  - Pest Control, Biological
MH  - Plants, Genetically Modified/*parasitology
EDAT- 2017/10/12 06:00
MHDA- 2017/10/24 06:00
CRDT- 2017/10/12 06:00
PHST- 2017/05/04 00:00 [received]
PHST- 2017/08/25 00:00 [accepted]
PHST- 2017/10/12 06:00 [entrez]
PHST- 2017/10/12 06:00 [pubmed]
PHST- 2017/10/24 06:00 [medline]
AID - nbt.3974 [pii]
AID - 10.1038/nbt.3974 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Oct 11;35(10):926-935. doi: 10.1038/nbt.3974.

PMID- 29020005
OWN - NLM
STAT- In-Data-Review
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 10
DP  - 2017 Oct 11
TI  - Antigen receptor repertoire profiling from RNA-seq data.
PG  - 908-911
LID - 10.1038/nbt.3979 [doi]
FAU - Bolotin, Dmitriy A
AU  - Bolotin DA
AD  - MiLaboratory LLC, Skolkovo Innovation Center, Moscow, Russia.
AD  - Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.
AD  - Pirogov Russian National Research Medical University, Moscow, Russia.
FAU - Poslavsky, Stanislav
AU  - Poslavsky S
AD  - MiLaboratory LLC, Skolkovo Innovation Center, Moscow, Russia.
AD  - Pirogov Russian National Research Medical University, Moscow, Russia.
FAU - Davydov, Alexey N
AU  - Davydov AN
AD  - Central European Institute of Technology, Brno, Czech Republic.
FAU - Frenkel, Felix E
AU  - Frenkel FE
AD  - BostonGene LLC, Lincoln, Massachusetts, USA.
FAU - Fanchi, Lorenzo
AU  - Fanchi L
AD  - Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The
      Netherlands.
FAU - Zolotareva, Olga I
AU  - Zolotareva OI
AUID- ORCID: http://orcid.org/0000-0002-9424-8052
AD  - BostonGene LLC, Lincoln, Massachusetts, USA.
FAU - Hemmers, Saskia
AU  - Hemmers S
AD  - Howard Hughes Medical Institute and Immunology Program, Memorial Sloan-Kettering 
      Cancer Center, New York, New York, USA.
FAU - Putintseva, Ekaterina V
AU  - Putintseva EV
AD  - Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.
AD  - Centre for Genomic Regulation, The Barcelona Institute for Science and
      Technology, Barcelona, Spain.
FAU - Obraztsova, Anna S
AU  - Obraztsova AS
AD  - Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.
AD  - Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, 
      Moscow, Russia.
FAU - Shugay, Mikhail
AU  - Shugay M
AUID- ORCID: http://orcid.org/0000-0001-7826-7942
AD  - MiLaboratory LLC, Skolkovo Innovation Center, Moscow, Russia.
AD  - Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.
AD  - Pirogov Russian National Research Medical University, Moscow, Russia.
AD  - Nizhny Novgorod State Medical Academy, Nizhny Novgorod, Russia.
AD  - Center for Data-Intensive Biomedicine and Biotechnology, Skolkovo Institute of
      Science and Technology, Moscow, Russia.
FAU - Ataullakhanov, Ravshan I
AU  - Ataullakhanov RI
AD  - BostonGene LLC, Lincoln, Massachusetts, USA.
AD  - Institute of Immunology FMBA, Moscow, Russia.
AD  - Faculties for Physics and Biology, Lomonosov Moscow State University, Moscow,
      Russia.
FAU - Rudensky, Alexander Y
AU  - Rudensky AY
AD  - Howard Hughes Medical Institute and Immunology Program, Memorial Sloan-Kettering 
      Cancer Center, New York, New York, USA.
AD  - Ludwig Center at Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering
      Cancer Center, New York, New York, USA.
FAU - Schumacher, Ton N
AU  - Schumacher TN
AD  - Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The
      Netherlands.
FAU - Chudakov, Dmitriy M
AU  - Chudakov DM
AUID- ORCID: http://orcid.org/0000-0003-0430-790X
AD  - Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.
AD  - Pirogov Russian National Research Medical University, Moscow, Russia.
AD  - Central European Institute of Technology, Brno, Czech Republic.
AD  - Nizhny Novgorod State Medical Academy, Nizhny Novgorod, Russia.
AD  - Center for Data-Intensive Biomedicine and Biotechnology, Skolkovo Institute of
      Science and Technology, Moscow, Russia.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/10/12 06:00
MHDA- 2017/10/12 06:00
CRDT- 2017/10/12 06:00
PHST- 2017/10/12 06:00 [entrez]
PHST- 2017/10/12 06:00 [pubmed]
PHST- 2017/10/12 06:00 [medline]
AID - nbt.3979 [pii]
AID - 10.1038/nbt.3979 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Oct 11;35(10):908-911. doi: 10.1038/nbt.3979.

PMID- 29020004
OWN - NLM
STAT- In-Data-Review
LR  - 20171220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 10
DP  - 2017 Oct 11
TI  - iML1515, a knowledgebase that computes Escherichia coli traits.
PG  - 904-908
LID - 10.1038/nbt.3956 [doi]
FAU - Monk, Jonathan M
AU  - Monk JM
AD  - Department of Bioengineering, University of California, San Diego, La Jolla,
      California, USA.
FAU - Lloyd, Colton J
AU  - Lloyd CJ
AD  - Department of Bioengineering, University of California, San Diego, La Jolla,
      California, USA.
FAU - Brunk, Elizabeth
AU  - Brunk E
AUID- ORCID: http://orcid.org/0000-0001-8578-8658
AD  - Department of Bioengineering, University of California, San Diego, La Jolla,
      California, USA.
FAU - Mih, Nathan
AU  - Mih N
AD  - Department of Bioengineering, University of California, San Diego, La Jolla,
      California, USA.
FAU - Sastry, Anand
AU  - Sastry A
AD  - Department of Bioengineering, University of California, San Diego, La Jolla,
      California, USA.
FAU - King, Zachary
AU  - King Z
AUID- ORCID: http://orcid.org/0000-0003-1238-1499
AD  - Department of Bioengineering, University of California, San Diego, La Jolla,
      California, USA.
FAU - Takeuchi, Rikiya
AU  - Takeuchi R
AD  - Graduate School of Biological Sciences Nara Institute of Science and Technology
      Ikoma, Nara, Japan.
FAU - Nomura, Wataru
AU  - Nomura W
AD  - Graduate School of Biological Sciences Nara Institute of Science and Technology
      Ikoma, Nara, Japan.
FAU - Zhang, Zhen
AU  - Zhang Z
AD  - Department of Bioengineering, University of California, San Diego, La Jolla,
      California, USA.
FAU - Mori, Hirotada
AU  - Mori H
AD  - Graduate School of Biological Sciences Nara Institute of Science and Technology
      Ikoma, Nara, Japan.
FAU - Feist, Adam M
AU  - Feist AM
AUID- ORCID: http://orcid.org/0000-0002-8630-4800
AD  - Department of Bioengineering, University of California, San Diego, La Jolla,
      California, USA.
AD  - The NNF Center for Biosustainability, The Technical University of Denmark,
      Lyngby, Denmark.
FAU - Palsson, Bernhard O
AU  - Palsson BO
AUID- ORCID: http://orcid.org/0000-0003-2357-6785
AD  - Department of Bioengineering, University of California, San Diego, La Jolla,
      California, USA.
AD  - The NNF Center for Biosustainability, The Technical University of Denmark,
      Lyngby, Denmark.
LA  - eng
GR  - U01 AI124316/AI/NIAID NIH HHS/United States
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/10/12 06:00
MHDA- 2017/10/12 06:00
CRDT- 2017/10/12 06:00
PHST- 2017/10/12 06:00 [entrez]
PHST- 2017/10/12 06:00 [pubmed]
PHST- 2017/10/12 06:00 [medline]
AID - nbt.3956 [pii]
AID - 10.1038/nbt.3956 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Oct 11;35(10):904-908. doi: 10.1038/nbt.3956.

PMID- 29020003
OWN - NLM
STAT- In-Data-Review
LR  - 20171011
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 10
DP  - 2017 Oct 11
TI  - Around the world in a month.
PG  - 899
LID - 10.1038/nbt1017-899 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/10/12 06:00
MHDA- 2017/10/12 06:00
CRDT- 2017/10/12 06:00
PHST- 2017/10/12 06:00 [entrez]
PHST- 2017/10/12 06:00 [pubmed]
PHST- 2017/10/12 06:00 [medline]
AID - nbt1017-899 [pii]
AID - 10.1038/nbt1017-899 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Oct 11;35(10):899. doi: 10.1038/nbt1017-899.

PMID- 29020002
OWN - NLM
STAT- In-Data-Review
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 10
DP  - 2017 Oct 11
TI  - First metabolic oncology inhibitor gets FDA green light, with record price tag.
PG  - 895
LID - 10.1038/nbt1017-895 [doi]
FAU - Garber, Ken
AU  - Garber K
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/10/12 06:00
MHDA- 2017/10/12 06:00
CRDT- 2017/10/12 06:00
PHST- 2017/10/12 06:00 [entrez]
PHST- 2017/10/12 06:00 [pubmed]
PHST- 2017/10/12 06:00 [medline]
AID - nbt1017-895 [pii]
AID - 10.1038/nbt1017-895 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Oct 11;35(10):895. doi: 10.1038/nbt1017-895.

PMID- 29020001
OWN - NLM
STAT- In-Data-Review
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 10
DP  - 2017 Oct 11
TI  - 23andMe wades further into drug discovery.
PG  - 897
LID - 10.1038/nbt1017-897 [doi]
FAU - Petrone, Justin
AU  - Petrone J
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/10/12 06:00
MHDA- 2017/10/12 06:00
CRDT- 2017/10/12 06:00
PHST- 2017/10/12 06:00 [entrez]
PHST- 2017/10/12 06:00 [pubmed]
PHST- 2017/10/12 06:00 [medline]
AID - nbt1017-897 [pii]
AID - 10.1038/nbt1017-897 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Oct 11;35(10):897. doi: 10.1038/nbt1017-897.

PMID- 29020000
OWN - NLM
STAT- In-Data-Review
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 10
DP  - 2017 Oct 11
TI  - GM moths with autocidal gene tested outdoors in New York state.
PG  - 896
LID - 10.1038/nbt1017-896 [doi]
FAU - Waltz, Emily
AU  - Waltz E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/10/12 06:00
MHDA- 2017/10/12 06:00
CRDT- 2017/10/12 06:00
PHST- 2017/10/12 06:00 [entrez]
PHST- 2017/10/12 06:00 [pubmed]
PHST- 2017/10/12 06:00 [medline]
AID - nbt1017-896 [pii]
AID - 10.1038/nbt1017-896 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Oct 11;35(10):896. doi: 10.1038/nbt1017-896.

PMID- 29019999
OWN - NLM
STAT- In-Data-Review
LR  - 20171011
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 10
DP  - 2017 Oct 11
TI  - The Supreme Court's interpretation of the biosimilars statute and the value of
      certainty.
PG  - 916-919
LID - 10.1038/nbt.3977 [doi]
FAU - Royzman, Irena
AU  - Royzman I
AD  - Patterson Belknap Webb &Tyler, New York, New York, USA.
FAU - Monroe-Yavneh, Nathan
AU  - Monroe-Yavneh N
AD  - Patterson Belknap Webb &Tyler, New York, New York, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/10/12 06:00
MHDA- 2017/10/12 06:00
CRDT- 2017/10/12 06:00
PHST- 2017/10/12 06:00 [entrez]
PHST- 2017/10/12 06:00 [pubmed]
PHST- 2017/10/12 06:00 [medline]
AID - nbt.3977 [pii]
AID - 10.1038/nbt.3977 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Oct 11;35(10):916-919. doi: 10.1038/nbt.3977.

PMID- 29019997
OWN - NLM
STAT- In-Data-Review
LR  - 20171011
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 10
DP  - 2017 Oct 11
TI  - Recent patents related to the manufacture and repair of organs and organoids.
PG  - 920
LID - 10.1038/nbt.3991 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/10/12 06:00
MHDA- 2017/10/12 06:00
CRDT- 2017/10/12 06:00
PHST- 2017/10/12 06:00 [entrez]
PHST- 2017/10/12 06:00 [pubmed]
PHST- 2017/10/12 06:00 [medline]
AID - nbt.3991 [pii]
AID - 10.1038/nbt.3991 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Oct 11;35(10):920. doi: 10.1038/nbt.3991.

PMID- 29019996
OWN - NLM
STAT- In-Data-Review
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 10
DP  - 2017 Oct 11
TI  - Speed and oversight: FDA Commissioner Gottlieb acts on pledges.
PG  - 898-899
LID - 10.1038/nbt1017-898 [doi]
FAU - Morrison, Chris
AU  - Morrison C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/10/12 06:00
MHDA- 2017/10/12 06:00
CRDT- 2017/10/12 06:00
PHST- 2017/10/12 06:00 [entrez]
PHST- 2017/10/12 06:00 [pubmed]
PHST- 2017/10/12 06:00 [medline]
AID - nbt1017-898 [pii]
AID - 10.1038/nbt1017-898 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Oct 11;35(10):898-899. doi: 10.1038/nbt1017-898.

PMID- 29019995
OWN - NLM
STAT- In-Data-Review
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 10
DP  - 2017 Oct 11
TI  - Epic $12 billion deal and FDA's approval raise CAR-T to new heights.
PG  - 891-892
LID - 10.1038/nbt1017-891 [doi]
FAU - Dolgin, Elie
AU  - Dolgin E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/10/12 06:00
MHDA- 2017/10/12 06:00
CRDT- 2017/10/12 06:00
PHST- 2017/10/12 06:00 [entrez]
PHST- 2017/10/12 06:00 [pubmed]
PHST- 2017/10/12 06:00 [medline]
AID - nbt1017-891 [pii]
AID - 10.1038/nbt1017-891 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Oct 11;35(10):891-892. doi: 10.1038/nbt1017-891.

PMID- 29019993
OWN - NLM
STAT- In-Data-Review
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 10
DP  - 2017 Oct 11
TI  - The key to unlocking CARs.
PG  - 889
LID - 10.1038/nbt.3993 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/10/12 06:00
MHDA- 2017/10/12 06:00
CRDT- 2017/10/12 06:00
PHST- 2017/10/12 06:00 [entrez]
PHST- 2017/10/12 06:00 [pubmed]
PHST- 2017/10/12 06:00 [medline]
AID - nbt.3993 [pii]
AID - 10.1038/nbt.3993 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Oct 11;35(10):889. doi: 10.1038/nbt.3993.

PMID- 29019992
OWN - NLM
STAT- In-Data-Review
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 10
DP  - 2017 Oct 11
TI  - The grand challenge of cellulosic biofuels.
PG  - 912-915
LID - 10.1038/nbt.3976 [doi]
FAU - Lynd, Lee R
AU  - Lynd LR
AD  - Paul and Joan Queneau Distinguished Professor of Engineering and adjunct
      professor of Biology at Dartmouth College, Hanover, New Hampshire, USA. A
      co-founder of two cellulosic biofuel start-ups, he is focus area lead for biomass
      deconstruction and conversion for the DOE Bioenergy Science Center, and executive
      committee chairman of the Global Sustainable Bioenergy Initiative.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/10/12 06:00
MHDA- 2017/10/12 06:00
CRDT- 2017/10/12 06:00
PHST- 2017/10/12 06:00 [entrez]
PHST- 2017/10/12 06:00 [pubmed]
PHST- 2017/10/12 06:00 [medline]
AID - nbt.3976 [pii]
AID - 10.1038/nbt.3976 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Oct 11;35(10):912-915. doi: 10.1038/nbt.3976.

PMID- 29019991
OWN - NLM
STAT- In-Data-Review
LR  - 20171011
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 10
DP  - 2017 Oct 11
TI  - Scientists need data visualization training.
PG  - 990-991
LID - 10.1038/nbt.3986 [doi]
FAU - Elgendi, Mohamed
AU  - Elgendi M
AD  - School of Electrical and Computer Engineering, University of British Columbia,
      Vancouver, Canada and the Department of Obstetrics &Gynecology, University of
      British Columbia and BC Children's &Women's Hospital, Vancouver, Canada.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/10/12 06:00
MHDA- 2017/10/12 06:00
CRDT- 2017/10/12 06:00
PHST- 2017/10/12 06:00 [entrez]
PHST- 2017/10/12 06:00 [pubmed]
PHST- 2017/10/12 06:00 [medline]
AID - nbt.3986 [pii]
AID - 10.1038/nbt.3986 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Oct 11;35(10):990-991. doi: 10.1038/nbt.3986.

PMID- 29019990
OWN - NLM
STAT- In-Data-Review
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 10
DP  - 2017 Oct 11
TI  - Genetics of a hardy crop.
PG  - 922-924
LID - 10.1038/nbt.3984 [doi]
FAU - Krasileva, Ksenia V
AU  - Krasileva KV
AD  - Earlham Institute, Norwich Research Park, Norwich, UK, and The Sainsbury
      Laboratory, Norwich Research Park, Norwich, UK.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/10/12 06:00
MHDA- 2017/10/12 06:00
CRDT- 2017/10/12 06:00
PHST- 2017/10/12 06:00 [entrez]
PHST- 2017/10/12 06:00 [pubmed]
PHST- 2017/10/12 06:00 [medline]
AID - nbt.3984 [pii]
AID - 10.1038/nbt.3984 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Oct 11;35(10):922-924. doi: 10.1038/nbt.3984.

PMID- 29019989
OWN - NLM
STAT- In-Data-Review
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 10
DP  - 2017 Oct 11
TI  - A successful founder off the beaten path.
PG  - 900-903
LID - 10.1038/nbt.3975 [doi]
FAU - Hoerr, Ingmar
AU  - Hoerr I
AD  - CureVac, Tubingen, Germany.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/10/12 06:00
MHDA- 2017/10/12 06:00
CRDT- 2017/10/12 06:00
PHST- 2017/10/12 06:00 [entrez]
PHST- 2017/10/12 06:00 [pubmed]
PHST- 2017/10/12 06:00 [medline]
AID - nbt.3975 [pii]
AID - 10.1038/nbt.3975 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Oct 11;35(10):900-903. doi: 10.1038/nbt.3975.

PMID- 29019988
OWN - NLM
STAT- In-Data-Review
LR  - 20171219
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 10
DP  - 2017 Oct 11
TI  - Mosaic mice ace functional genomics.
PG  - 924
LID - 10.1038/nbt.3980 [doi]
FAU - Elsner, Markus
AU  - Elsner M
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/10/12 06:00
MHDA- 2017/10/12 06:00
CRDT- 2017/10/12 06:00
PHST- 2017/10/12 06:00 [entrez]
PHST- 2017/10/12 06:00 [pubmed]
PHST- 2017/10/12 06:00 [medline]
AID - nbt.3980 [pii]
AID - 10.1038/nbt.3980 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Oct 11;35(10):924. doi: 10.1038/nbt.3980.

PMID- 28922347
OWN - NLM
STAT- MEDLINE
DCOM- 20171023
LR  - 20171023
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 10
DP  - 2017 Oct
TI  - Pearl millet genome sequence provides a resource to improve agronomic traits in
      arid environments.
PG  - 969-976
LID - 10.1038/nbt.3943 [doi]
AB  - Pearl millet [Cenchrus americanus (L.) Morrone] is a staple food for more than 90
      million farmers in arid and semi-arid regions of sub-Saharan Africa, India and
      South Asia. We report the approximately 1.79 Gb draft whole genome sequence of
      reference genotype Tift 23D2B1-P1-P5, which contains an estimated 38,579 genes.
      We highlight the substantial enrichment for wax biosynthesis genes, which may
      contribute to heat and drought tolerance in this crop. We resequenced and
      analyzed 994 pearl millet lines, enabling insights into population structure,
      genetic diversity and domestication. We use these resequencing data to establish 
      marker trait associations for genomic selection, to define heterotic pools, and
      to predict hybrid performance. We believe that these resources should empower
      researchers and breeders to improve this important staple crop.
FAU - Varshney, Rajeev K
AU  - Varshney RK
AUID- ORCID: http://orcid.org/0000-0002-4562-9131
AD  - International Crops Research Institute for the Semi-Arid Tropics (ICRISAT),
      Hyderabad, Telangana State, India.
FAU - Shi, Chengcheng
AU  - Shi C
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Thudi, Mahendar
AU  - Thudi M
AD  - International Crops Research Institute for the Semi-Arid Tropics (ICRISAT),
      Hyderabad, Telangana State, India.
FAU - Mariac, Cedric
AU  - Mariac C
AD  - Institut de recherche pour le developpement (IRD), Montpellier, France.
FAU - Wallace, Jason
AU  - Wallace J
AD  - University of Georgia, Athens, Georgia, USA.
FAU - Qi, Peng
AU  - Qi P
AD  - University of Georgia, Athens, Georgia, USA.
FAU - Zhang, He
AU  - Zhang H
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Zhao, Yusheng
AU  - Zhao Y
AD  - Leibniz Institute of Plant Genetics and Crop Plant Research (IPK), Gatersleben,
      Germany.
FAU - Wang, Xiyin
AU  - Wang X
AD  - University of Georgia, Athens, Georgia, USA.
FAU - Rathore, Abhishek
AU  - Rathore A
AUID- ORCID: http://orcid.org/0000-0001-6887-4095
AD  - International Crops Research Institute for the Semi-Arid Tropics (ICRISAT),
      Hyderabad, Telangana State, India.
FAU - Srivastava, Rakesh K
AU  - Srivastava RK
AD  - International Crops Research Institute for the Semi-Arid Tropics (ICRISAT),
      Hyderabad, Telangana State, India.
FAU - Chitikineni, Annapurna
AU  - Chitikineni A
AD  - International Crops Research Institute for the Semi-Arid Tropics (ICRISAT),
      Hyderabad, Telangana State, India.
FAU - Fan, Guangyi
AU  - Fan G
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Bajaj, Prasad
AU  - Bajaj P
AD  - International Crops Research Institute for the Semi-Arid Tropics (ICRISAT),
      Hyderabad, Telangana State, India.
FAU - Punnuri, Somashekhar
AU  - Punnuri S
AD  - Fort Valley State University, Fort Valley, Georgia, USA.
FAU - Gupta, S K
AU  - Gupta SK
AD  - International Crops Research Institute for the Semi-Arid Tropics (ICRISAT),
      Hyderabad, Telangana State, India.
FAU - Wang, Hao
AU  - Wang H
AD  - Cornell University, Ithaca, New York, USA.
FAU - Jiang, Yong
AU  - Jiang Y
AUID- ORCID: http://orcid.org/0000-0002-2824-677X
AD  - Leibniz Institute of Plant Genetics and Crop Plant Research (IPK), Gatersleben,
      Germany.
FAU - Couderc, Marie
AU  - Couderc M
AD  - Institut de recherche pour le developpement (IRD), Montpellier, France.
FAU - Katta, Mohan A V S K
AU  - Katta MAVSK
AD  - International Crops Research Institute for the Semi-Arid Tropics (ICRISAT),
      Hyderabad, Telangana State, India.
FAU - Paudel, Dev R
AU  - Paudel DR
AUID- ORCID: http://orcid.org/0000-0002-0739-4343
AD  - University of Florida, Gainesville, Florida, USA.
FAU - Mungra, K D
AU  - Mungra KD
AD  - Junagadh Agricultural University, Jamnagar, Gujarat, India.
FAU - Chen, Wenbin
AU  - Chen W
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Harris-Shultz, Karen R
AU  - Harris-Shultz KR
AD  - United States Department of Agriculture-Agricultural Research Service (USDA-ARS),
      Tifton, Georgia, USA.
FAU - Garg, Vanika
AU  - Garg V
AD  - International Crops Research Institute for the Semi-Arid Tropics (ICRISAT),
      Hyderabad, Telangana State, India.
FAU - Desai, Neetin
AU  - Desai N
AD  - Department of Ecogenomics and Systems Biology, University of Vienna, Vienna,
      Austria.
AD  - Amity University, Mumbai, Maharashtra, India.
FAU - Doddamani, Dadakhalandar
AU  - Doddamani D
AD  - International Crops Research Institute for the Semi-Arid Tropics (ICRISAT),
      Hyderabad, Telangana State, India.
FAU - Kane, Ndjido Ardo
AU  - Kane NA
AD  - Institut Senegalais de Recherches Agricoles (ISRA), Dakar, Senegal.
FAU - Conner, Joann A
AU  - Conner JA
AD  - University of Georgia, Tifton, Georgia, USA.
FAU - Ghatak, Arindam
AU  - Ghatak A
AD  - Department of Ecogenomics and Systems Biology, University of Vienna, Vienna,
      Austria.
AD  - School of Bioinformatics and Biotechnology, D.Y. Patil University, Mumbai,
      Maharashtra, India.
FAU - Chaturvedi, Palak
AU  - Chaturvedi P
AUID- ORCID: http://orcid.org/0000-0002-5856-0348
AD  - Department of Ecogenomics and Systems Biology, University of Vienna, Vienna,
      Austria.
FAU - Subramaniam, Sabarinath
AU  - Subramaniam S
AD  - University of Arizona, Tucson, Arizona, USA.
AD  - Phoenix Bioinformatics, Redwood City, California, USA.
FAU - Yadav, Om Parkash
AU  - Yadav OP
AD  - Indian Council of Agricultural Research (ICAR)-Central Arid Zone Research
      Institute (CAZRI), Jodhpur, Rajasthan, India.
FAU - Berthouly-Salazar, Cecile
AU  - Berthouly-Salazar C
AD  - Institut de recherche pour le developpement (IRD), Montpellier, France.
AD  - Laboratoire Mixte International Adaptation des Plantes et Microorganismes
      Associes aux Stress Environnementaux, Centre de Recherche de Bel Air, Dakar,
      Senegal.
FAU - Hamidou, Falalou
AU  - Hamidou F
AD  - ICRISAT Sahelian Center, Niamey, Niger.
AD  - Faculty of Sciences and Techniques, University Abdou Moumouni, Niamey, Niger.
FAU - Wang, Jianping
AU  - Wang J
AUID- ORCID: http://orcid.org/0000-0002-0259-1508
AD  - University of Florida, Gainesville, Florida, USA.
FAU - Liang, Xinming
AU  - Liang X
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Clotault, Jeremy
AU  - Clotault J
AD  - Institut de recherche pour le developpement (IRD), Montpellier, France.
AD  - University of Montpellier, Montpellier, France.
FAU - Upadhyaya, Hari D
AU  - Upadhyaya HD
AD  - International Crops Research Institute for the Semi-Arid Tropics (ICRISAT),
      Hyderabad, Telangana State, India.
FAU - Cubry, Philippe
AU  - Cubry P
AUID- ORCID: http://orcid.org/0000-0003-1561-8949
AD  - Institut de recherche pour le developpement (IRD), Montpellier, France.
FAU - Rhone, Benedicte
AU  - Rhone B
AD  - Institut de recherche pour le developpement (IRD), Montpellier, France.
AD  - Laboratoire de biometrie et Biologie Evolutive, Universite Lyon 1, Villeurbanne, 
      France.
FAU - Gueye, Mame Codou
AU  - Gueye MC
AD  - Institut Senegalais de Recherches Agricoles (ISRA), Dakar, Senegal.
FAU - Sunkar, Ramanjulu
AU  - Sunkar R
AD  - Oklahoma State University, Stillwater, Oklahoma, USA.
FAU - Dupuy, Christian
AU  - Dupuy C
AD  - Institut des Mondes Africains (IMAf), Paris, France.
FAU - Sparvoli, Francesca
AU  - Sparvoli F
AUID- ORCID: http://orcid.org/0000-0002-3304-7548
AD  - CNR-Consiglio Nazionale delle Ricerche, Istituto di Biologia e Biotecnologia
      Agraria, Milan, Italy.
FAU - Cheng, Shifeng
AU  - Cheng S
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Mahala, R S
AU  - Mahala RS
AD  - Pioneer Hi-Bred Private Limited, Hyderabad, Telangana State, India.
FAU - Singh, Bharat
AU  - Singh B
AD  - Fort Valley State University, Fort Valley, Georgia, USA.
FAU - Yadav, Rattan S
AU  - Yadav RS
AD  - Institute of Biological, Environmental and Rural Sciences, Aberystwyth
      University, Ceredigion, UK.
FAU - Lyons, Eric
AU  - Lyons E
AD  - University of Arizona, Tucson, Arizona, USA.
FAU - Datta, Swapan K
AU  - Datta SK
AD  - Visva-Bharati, Santiniketan, West Bengal, India.
FAU - Hash, C Tom
AU  - Hash CT
AUID- ORCID: http://orcid.org/0000-0003-3138-9234
AD  - ICRISAT Sahelian Center, Niamey, Niger.
FAU - Devos, Katrien M
AU  - Devos KM
AD  - University of Georgia, Athens, Georgia, USA.
FAU - Buckler, Edward
AU  - Buckler E
AUID- ORCID: http://orcid.org/0000-0002-3100-371X
AD  - Cornell University, Ithaca, New York, USA.
AD  - USDA-ARS, Ithaca, New York, USA.
FAU - Bennetzen, Jeffrey L
AU  - Bennetzen JL
AD  - University of Georgia, Athens, Georgia, USA.
FAU - Paterson, Andrew H
AU  - Paterson AH
AD  - University of Georgia, Athens, Georgia, USA.
FAU - Ozias-Akins, Peggy
AU  - Ozias-Akins P
AD  - University of Georgia, Tifton, Georgia, USA.
FAU - Grando, Stefania
AU  - Grando S
AD  - International Crops Research Institute for the Semi-Arid Tropics (ICRISAT),
      Hyderabad, Telangana State, India.
FAU - Wang, Jun
AU  - Wang J
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Mohapatra, Trilochan
AU  - Mohapatra T
AD  - Indian Council of Agricultural Research (ICAR), New Delhi, India.
FAU - Weckwerth, Wolfram
AU  - Weckwerth W
AD  - Department of Ecogenomics and Systems Biology, University of Vienna, Vienna,
      Austria.
AD  - Vienna Metabolomics Center (VIME), University of Vienna, Vienna, Austria.
FAU - Reif, Jochen C
AU  - Reif JC
AUID- ORCID: http://orcid.org/0000-0002-6742-265X
AD  - Leibniz Institute of Plant Genetics and Crop Plant Research (IPK), Gatersleben,
      Germany.
FAU - Liu, Xin
AU  - Liu X
AD  - BGI-Shenzhen, Shenzhen, China.
AD  - BGI-Qingdao, Qingdao, China.
FAU - Vigouroux, Yves
AU  - Vigouroux Y
AD  - Institut de recherche pour le developpement (IRD), Montpellier, France.
AD  - University of Montpellier, Montpellier, France.
FAU - Xu, Xun
AU  - Xu X
AD  - BGI-Shenzhen, Shenzhen, China.
AD  - BGI-Qingdao, Qingdao, China.
AD  - China National GeneBank (CNGB), Shenzen, China.
LA  - eng
PT  - Journal Article
DEP - 20170918
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Agriculture
MH  - Base Sequence
MH  - Conserved Sequence
MH  - *Desert Climate
MH  - Genes, Plant
MH  - Genetic Variation
MH  - *Genome, Plant
MH  - Genome-Wide Association Study
MH  - Hybridization, Genetic
MH  - Molecular Sequence Annotation
MH  - Pennisetum/*genetics
MH  - *Quantitative Trait, Heritable
EDAT- 2017/09/19 06:00
MHDA- 2017/10/24 06:00
CRDT- 2017/09/19 06:00
PHST- 2017/04/18 00:00 [received]
PHST- 2017/07/17 00:00 [accepted]
PHST- 2017/09/19 06:00 [pubmed]
PHST- 2017/10/24 06:00 [medline]
PHST- 2017/09/19 06:00 [entrez]
AID - nbt.3943 [pii]
AID - 10.1038/nbt.3943 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Oct;35(10):969-976. doi: 10.1038/nbt.3943. Epub 2017 Sep 18.

PMID- 28922346
OWN - NLM
STAT- MEDLINE
DCOM- 20171023
LR  - 20180326
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 10
DP  - 2017 Oct
TI  - GRID-seq reveals the global RNA-chromatin interactome.
PG  - 940-950
LID - 10.1038/nbt.3968 [doi]
AB  - Higher eukaryotic genomes are bound by a large number of coding and non-coding
      RNAs, but approaches to comprehensively map the identity and binding sites of
      these RNAs are lacking. Here we report a method to capture in situ global RNA
      interactions with DNA by deep sequencing (GRID-seq), which enables the
      comprehensive identification of the entire repertoire of chromatin-interacting
      RNAs and their respective binding sites. In human, mouse, and Drosophila cells,
      we detected a large set of tissue-specific coding and non-coding RNAs that are
      bound to active promoters and enhancers, especially super-enhancers. Assuming
      that most mRNA-chromatin interactions indicate the physical proximity of a
      promoter and an enhancer, we constructed a three-dimensional global connectivity 
      map of promoters and enhancers, revealing transcription-activity-linked genomic
      interactions in the nucleus.
FAU - Li, Xiao
AU  - Li X
AUID- ORCID: http://orcid.org/0000-0001-8527-4438
AD  - Department of Cellular and Molecular Medicine, University of California, San
      Diego, La Jolla, California, USA.
FAU - Zhou, Bing
AU  - Zhou B
AUID- ORCID: http://orcid.org/0000-0003-2846-1813
AD  - Department of Cellular and Molecular Medicine, University of California, San
      Diego, La Jolla, California, USA.
FAU - Chen, Liang
AU  - Chen L
AD  - Department of Cellular and Molecular Medicine, University of California, San
      Diego, La Jolla, California, USA.
FAU - Gou, Lan-Tao
AU  - Gou LT
AD  - Department of Cellular and Molecular Medicine, University of California, San
      Diego, La Jolla, California, USA.
FAU - Li, Hairi
AU  - Li H
AD  - Department of Cellular and Molecular Medicine, University of California, San
      Diego, La Jolla, California, USA.
FAU - Fu, Xiang-Dong
AU  - Fu XD
AUID- ORCID: http://orcid.org/0000-0001-5499-8732
AD  - Department of Cellular and Molecular Medicine, University of California, San
      Diego, La Jolla, California, USA.
AD  - Institute of Genomic Medicine, University of California, San Diego, La Jolla,
      California, USA.
LA  - eng
PT  - Journal Article
DEP - 20170918
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Chromatin)
RN  - 63231-63-0 (RNA)
RN  - 9007-49-2 (DNA)
SB  - IM
CIN - Nat Rev Genet. 2017 Nov;18(11):640-641. PMID: 28970587
MH  - Animals
MH  - Cell Line, Tumor
MH  - Chromatin/*metabolism
MH  - DNA/*isolation & purification
MH  - Drosophila
MH  - Enhancer Elements, Genetic
MH  - High-Throughput Nucleotide Sequencing/*methods
MH  - Humans
MH  - Promoter Regions, Genetic
MH  - RNA/*metabolism
MH  - Reproducibility of Results
EDAT- 2017/09/19 06:00
MHDA- 2017/10/24 06:00
CRDT- 2017/09/19 06:00
PHST- 2017/03/21 00:00 [received]
PHST- 2017/08/21 00:00 [accepted]
PHST- 2017/09/19 06:00 [pubmed]
PHST- 2017/10/24 06:00 [medline]
PHST- 2017/09/19 06:00 [entrez]
AID - nbt.3968 [pii]
AID - 10.1038/nbt.3968 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Oct;35(10):940-950. doi: 10.1038/nbt.3968. Epub 2017 Sep 18.

PMID- 28892078
OWN - NLM
STAT- MEDLINE
DCOM- 20171023
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 10
DP  - 2017 Oct
TI  - Detection of dysregulated protein-association networks by high-throughput
      proteomics predicts cancer vulnerabilities.
PG  - 983-989
LID - 10.1038/nbt.3955 [doi]
AB  - The formation of protein complexes and the co-regulation of the cellular
      concentrations of proteins are essential mechanisms for cellular signaling and
      for maintaining homeostasis. Here we use isobaric-labeling multiplexed proteomics
      to analyze protein co-regulation and show that this allows the identification of 
      protein-protein associations with high accuracy. We apply this 'interactome
      mapping by high-throughput quantitative proteome analysis' (IMAHP) method to a
      panel of 41 breast cancer cell lines and show that deviations of the observed
      protein co-regulations in specific cell lines from the consensus network affects 
      cellular fitness. Furthermore, these aberrant interactions serve as biomarkers
      that predict the drug sensitivity of cell lines in screens across 195 drugs. We
      expect that IMAHP can be broadly used to gain insight into how changing
      landscapes of protein-protein associations affect the phenotype of biological
      systems.
FAU - Lapek, John D Jr
AU  - Lapek JD Jr
AD  - Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard 
      Medical School, Charlestown, Massachusetts, USA.
FAU - Greninger, Patricia
AU  - Greninger P
AD  - Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard 
      Medical School, Charlestown, Massachusetts, USA.
FAU - Morris, Robert
AU  - Morris R
AD  - Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard 
      Medical School, Charlestown, Massachusetts, USA.
FAU - Amzallag, Arnaud
AU  - Amzallag A
AD  - Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard 
      Medical School, Charlestown, Massachusetts, USA.
FAU - Pruteanu-Malinici, Iulian
AU  - Pruteanu-Malinici I
AD  - Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard 
      Medical School, Charlestown, Massachusetts, USA.
FAU - Benes, Cyril H
AU  - Benes CH
AD  - Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard 
      Medical School, Charlestown, Massachusetts, USA.
FAU - Haas, Wilhelm
AU  - Haas W
AD  - Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard 
      Medical School, Charlestown, Massachusetts, USA.
LA  - eng
GR  - Wellcome Trust/United Kingdom
GR  - 102696HABER/Wellcome Trust/United Kingdom
GR  - K12 GM068524/GM/NIGMS NIH HHS/United States
GR  - U54 HG006097/HG/NHGRI NIH HHS/United States
PT  - Journal Article
DEP - 20170911
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Breast Neoplasms/metabolism
MH  - Cell Line, Tumor
MH  - Female
MH  - High-Throughput Screening Assays/*methods
MH  - Humans
MH  - Neoplasms/*metabolism
MH  - *Protein Interaction Maps
MH  - Proteomics/*methods
PMC - PMC5683351
MID - EMS73743
EDAT- 2017/09/12 06:00
MHDA- 2017/10/24 06:00
CRDT- 2017/09/12 06:00
PHST- 2017/04/20 00:00 [received]
PHST- 2017/08/08 00:00 [accepted]
PHST- 2017/09/12 06:00 [pubmed]
PHST- 2017/10/24 06:00 [medline]
PHST- 2017/09/12 06:00 [entrez]
AID - nbt.3955 [pii]
AID - 10.1038/nbt.3955 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Oct;35(10):983-989. doi: 10.1038/nbt.3955. Epub 2017 Sep 11.

PMID- 28892077
OWN - NLM
STAT- In-Data-Review
LR  - 20171014
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 10
DP  - 2017 Oct
TI  - Mapping the secrets of the antibody pool.
PG  - 921-922
LID - 10.1038/nbt.3972 [doi]
FAU - McDaniel, Jonathan R
AU  - McDaniel JR
AD  - Department of Chemical Engineering at the University of Texas at Austin, Austin, 
      Texas, USA.
FAU - Ippolito, Gregory C
AU  - Ippolito GC
AD  - Department of Molecular Biosciences at the University of Texas at Austin, Austin,
      Texas, USA.
FAU - Georgiou, George
AU  - Georgiou G
AD  - Department of Chemical Engineering at the University of Texas at Austin, Austin, 
      Texas, USA.
LA  - eng
PT  - Journal Article
DEP - 20170911
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/09/12 06:00
MHDA- 2017/09/12 06:00
CRDT- 2017/09/12 06:00
PHST- 2017/09/12 06:00 [pubmed]
PHST- 2017/09/12 06:00 [medline]
PHST- 2017/09/12 06:00 [entrez]
AID - nbt.3972 [pii]
AID - 10.1038/nbt.3972 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Oct;35(10):921-922. doi: 10.1038/nbt.3972. Epub 2017 Sep 11.

PMID- 28892076
OWN - NLM
STAT- MEDLINE
DCOM- 20171023
LR  - 20171023
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 10
DP  - 2017 Oct
TI  - Single-cell deep phenotyping of IgG-secreting cells for high-resolution immune
      monitoring.
PG  - 977-982
LID - 10.1038/nbt.3964 [doi]
AB  - Studies of the dynamics of the antibody-mediated immune response have been
      hampered by the absence of quantitative, high-throughput systems to analyze
      individual antibody-secreting cells. Here we describe a simple microfluidic
      system, DropMap, in which single cells are compartmentalized in tens of thousands
      of 40-pL droplets and analyzed in two-dimensional droplet arrays using a
      fluorescence relocation-based immunoassay. Using DropMap, we characterized
      antibody-secreting cells in mice immunized with tetanus toxoid (TT) over a 7-week
      protocol, simultaneously analyzing the secretion rate and affinity of IgG from
      over 0.5 million individual cells enriched from spleen and bone marrow.
      Immunization resulted in dramatic increases in the range of both single-cell
      secretion rates and affinities, which spanned at maximum 3 and 4 logs,
      respectively. We observed differences over time in dynamics of secretion rate and
      affinity within and between anatomical compartments. This system will not only
      enable immune monitoring and optimization of immunization and vaccination
      protocols but also potentiate antibody screening.
FAU - Eyer, Klaus
AU  - Eyer K
AD  - Laboratoire Colloides et Materiaux Divises (LCMD), ESPCI Paris, PSL Research
      University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.
FAU - Doineau, Raphael C L
AU  - Doineau RCL
AD  - Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS
      UMR8231 Chimie Biologie Innovation, Paris, France.
AD  - HiFiBio SAS Paris, France.
FAU - Castrillon, Carlos E
AU  - Castrillon CE
AD  - Unit of Antibodies in Therapy and Pathology, Department of Immunology, Institut
      Pasteur, Paris, France.
AD  - INSERM, Paris, France.
FAU - Briseno-Roa, Luis
AU  - Briseno-Roa L
AUID- ORCID: http://orcid.org/0000-0002-8326-3329
AD  - HiFiBio SAS Paris, France.
FAU - Menrath, Vera
AU  - Menrath V
AD  - HiFiBio SAS Paris, France.
FAU - Mottet, Guillaume
AU  - Mottet G
AD  - Unit of Antibodies in Therapy and Pathology, Department of Immunology, Institut
      Pasteur, Paris, France.
AD  - INSERM, Paris, France.
FAU - England, Patrick
AU  - England P
AD  - Laboratoire Colloides et Materiaux Divises (LCMD), ESPCI Paris, PSL Research
      University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.
FAU - Godina, Alexei
AU  - Godina A
AD  - Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS
      UMR8231 Chimie Biologie Innovation, Paris, France.
FAU - Brient-Litzler, Elodie
AU  - Brient-Litzler E
AD  - Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS
      UMR8231 Chimie Biologie Innovation, Paris, France.
FAU - Nizak, Clement
AU  - Nizak C
AUID- ORCID: http://orcid.org/0000-0002-4591-8240
AD  - Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS
      UMR8231 Chimie Biologie Innovation, Paris, France.
FAU - Jensen, Allan
AU  - Jensen A
AD  - HiFiBio SAS Paris, France.
FAU - Griffiths, Andrew D
AU  - Griffiths AD
AD  - Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS
      UMR8231 Chimie Biologie Innovation, Paris, France.
FAU - Bibette, Jerome
AU  - Bibette J
AD  - Laboratoire Colloides et Materiaux Divises (LCMD), ESPCI Paris, PSL Research
      University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.
FAU - Bruhns, Pierre
AU  - Bruhns P
AUID- ORCID: http://orcid.org/0000-0002-4709-8936
AD  - Unit of Antibodies in Therapy and Pathology, Department of Immunology, Institut
      Pasteur, Paris, France.
AD  - INSERM, Paris, France.
FAU - Baudry, Jean
AU  - Baudry J
AUID- ORCID: http://orcid.org/0000-0002-5526-499X
AD  - Laboratoire Colloides et Materiaux Divises (LCMD), ESPCI Paris, PSL Research
      University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.
LA  - eng
PT  - Journal Article
DEP - 20170911
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Immunoglobulin G)
SB  - IM
MH  - Animals
MH  - CHO Cells
MH  - Calibration
MH  - Cricetinae
MH  - Cricetulus
MH  - Immunization
MH  - Immunoglobulin G/*metabolism
MH  - Mice, Inbred C57BL
MH  - Monitoring, Immunologic/*methods
MH  - Phenotype
MH  - Single-Cell Analysis/*methods
MH  - Time Factors
EDAT- 2017/09/12 06:00
MHDA- 2017/10/24 06:00
CRDT- 2017/09/12 06:00
PHST- 2016/10/12 00:00 [received]
PHST- 2017/08/17 00:00 [accepted]
PHST- 2017/09/12 06:00 [pubmed]
PHST- 2017/10/24 06:00 [medline]
PHST- 2017/09/12 06:00 [entrez]
AID - nbt.3964 [pii]
AID - 10.1038/nbt.3964 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Oct;35(10):977-982. doi: 10.1038/nbt.3964. Epub 2017 Sep 11.

PMID- 28892075
OWN - NLM
STAT- MEDLINE
DCOM- 20171023
LR  - 20171023
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 10
DP  - 2017 Oct
TI  - Analysis of somatic microsatellite indels identifies driver events in human
      tumors.
PG  - 951-959
LID - 10.1038/nbt.3966 [doi]
AB  - Microsatellites (MSs) are tracts of variable-length repeats of short DNA motifs
      that exhibit high rates of mutation in the form of insertions or deletions
      (indels) of the repeated motif. Despite their prevalence, the contribution of
      somatic MS indels to cancer has been largely unexplored, owing to difficulties in
      detecting them in short-read sequencing data. Here we present two tools:
      MSMuTect, for accurate detection of somatic MS indels, and MSMutSig, for
      identification of genes containing MS indels at a higher frequency than expected 
      by chance. Applying MSMuTect to whole-exome data from 6,747 human tumors
      representing 20 tumor types, we identified >1,000 previously undescribed MS
      indels in cancer genes. Additionally, we demonstrate that the number and pattern 
      of MS indels can accurately distinguish microsatellite-stable tumors from tumors 
      with microsatellite instability, thus potentially improving classification of
      clinically relevant subgroups. Finally, we identified seven MS indel driver
      hotspots: four in known cancer genes (ACVR2A, RNF43, JAK1, and MSH3) and three in
      genes not previously implicated as cancer drivers (ESRP1, PRDM2, and DOCK3).
FAU - Maruvka, Yosef E
AU  - Maruvka YE
AD  - Massachusetts General Hospital Center for Cancer Research, Charlestown,
      Massachusetts, USA.
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Mouw, Kent W
AU  - Mouw KW
AD  - Harvard Medical School, Boston, Massachusetts, USA.
AD  - Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber
      Cancer Institute, Boston, Massachusetts, USA.
FAU - Karlic, Rosa
AU  - Karlic R
AUID- ORCID: http://orcid.org/0000-0002-1291-2897
AD  - Bioinformatics Group, Division of Molecular Biology,Department of Biology,
      Faculty of Science, University of Zagreb, Zagreb, Croatia.
FAU - Parasuraman, Prasanna
AU  - Parasuraman P
AD  - Massachusetts General Hospital Center for Cancer Research, Charlestown,
      Massachusetts, USA.
FAU - Kamburov, Atanas
AU  - Kamburov A
AD  - Massachusetts General Hospital Center for Cancer Research, Charlestown,
      Massachusetts, USA.
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Polak, Paz
AU  - Polak P
AUID- ORCID: http://orcid.org/0000-0002-2153-4488
AD  - Massachusetts General Hospital Center for Cancer Research, Charlestown,
      Massachusetts, USA.
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Haradhvala, Nicholas J
AU  - Haradhvala NJ
AD  - Massachusetts General Hospital Center for Cancer Research, Charlestown,
      Massachusetts, USA.
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Hess, Julian M
AU  - Hess JM
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Rheinbay, Esther
AU  - Rheinbay E
AD  - Massachusetts General Hospital Center for Cancer Research, Charlestown,
      Massachusetts, USA.
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Brody, Yehuda
AU  - Brody Y
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Koren, Amnon
AU  - Koren A
AD  - Department of Molecular Biology and Genetics, Cornell University, Ithaca, New
      York, USA.
FAU - Braunstein, Lior Z
AU  - Braunstein LZ
AD  - Massachusetts General Hospital Center for Cancer Research, Charlestown,
      Massachusetts, USA.
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - D'Andrea, Alan
AU  - D'Andrea A
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
AD  - Harvard Medical School, Boston, Massachusetts, USA.
AD  - Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber
      Cancer Institute, Boston, Massachusetts, USA.
FAU - Lawrence, Michael S
AU  - Lawrence MS
AD  - Massachusetts General Hospital Center for Cancer Research, Charlestown,
      Massachusetts, USA.
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Bass, Adam
AU  - Bass A
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
AD  - Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
FAU - Bernards, Andre
AU  - Bernards A
AD  - Massachusetts General Hospital Center for Cancer Research, Charlestown,
      Massachusetts, USA.
FAU - Michor, Franziska
AU  - Michor F
AUID- ORCID: http://orcid.org/0000-0003-4869-8842
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
AD  - Harvard Medical School, Boston, Massachusetts, USA.
AD  - Department of Biostatistics and Computational Biology, Dana-Farber Cancer
      Institute, Boston, Massachusetts, USA.
AD  - Department of Stem Cells and Regenerative Biology, Harvard University, Cambridge,
      Massachusetts, USA.
FAU - Getz, Gad
AU  - Getz G
AUID- ORCID: http://orcid.org/0000-0002-0936-0753
AD  - Massachusetts General Hospital Center for Cancer Research, Charlestown,
      Massachusetts, USA.
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
AD  - Harvard Medical School, Boston, Massachusetts, USA.
AD  - Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts,
      USA.
LA  - eng
PT  - Journal Article
DEP - 20170911
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (ESRP1 protein, human)
RN  - 0 (RNA, Messenger)
RN  - 0 (RNA-Binding Proteins)
SB  - IM
MH  - Exome/genetics
MH  - Genes, Neoplasm
MH  - High-Throughput Nucleotide Sequencing
MH  - Humans
MH  - INDEL Mutation/*genetics
MH  - Microsatellite Instability
MH  - Microsatellite Repeats/*genetics
MH  - Mutation/genetics
MH  - Neoplasms/*genetics
MH  - RNA, Messenger/genetics/metabolism
MH  - RNA-Binding Proteins/genetics/metabolism
EDAT- 2017/09/12 06:00
MHDA- 2017/10/24 06:00
CRDT- 2017/09/12 06:00
PHST- 2016/11/14 00:00 [received]
PHST- 2017/08/18 00:00 [accepted]
PHST- 2017/09/12 06:00 [pubmed]
PHST- 2017/10/24 06:00 [medline]
PHST- 2017/09/12 06:00 [entrez]
AID - nbt.3966 [pii]
AID - 10.1038/nbt.3966 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Oct;35(10):951-959. doi: 10.1038/nbt.3966. Epub 2017 Sep 11.

PMID- 28892074
OWN - NLM
STAT- MEDLINE
DCOM- 20171023
LR  - 20171023
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 10
DP  - 2017 Oct
TI  - Replacing reprogramming factors with antibodies selected from combinatorial
      antibody libraries.
PG  - 960-968
LID - 10.1038/nbt.3963 [doi]
AB  - The reprogramming of differentiated cells into induced pluripotent stem cells
      (iPSCs) is usually achieved by exogenous induction of transcription by factors
      acting in the nucleus. In contrast, during development, signaling pathways
      initiated at the membrane induce differentiation. The central idea of this study 
      is to identify antibodies that can catalyze cellular de-differentiation and
      nuclear reprogramming by acting at the cell surface. We screen a lentiviral
      library encoding approximately 100 million secreted and membrane-bound
      single-chain antibodies and identify antibodies that can replace either Sox2 and 
      Myc (c-Myc) or Oct4 during reprogramming of mouse embryonic fibroblasts into
      iPSCs. We show that one Sox2-replacing antibody antagonizes the
      membrane-associated protein Basp1, thereby de-repressing nuclear factors WT1,
      Esrrb and Lin28a (Lin28) independent of Sox2. By manipulating this pathway, we
      identify three methods to generate iPSCs. Our results establish unbiased
      selection from autocrine combinatorial antibody libraries as a robust method to
      discover new biologics and uncover membrane-to-nucleus signaling pathways that
      regulate pluripotency and cell fate.
FAU - Blanchard, Joel W
AU  - Blanchard JW
AD  - Department of Molecular and Cellular Neuroscience, Dorris Neuroscience Center,
      The Scripps Research Institute, La Jolla, California, USA.
FAU - Xie, Jia
AU  - Xie J
AD  - Department of Cell and Molecular Biology, The Scripps Research Institute, La
      Jolla, California, USA.
FAU - El-Mecharrafie, Nadja
AU  - El-Mecharrafie N
AD  - Department of Molecular and Cellular Neuroscience, Dorris Neuroscience Center,
      The Scripps Research Institute, La Jolla, California, USA.
FAU - Gross, Simon
AU  - Gross S
AD  - Department of Molecular and Cellular Neuroscience, Dorris Neuroscience Center,
      The Scripps Research Institute, La Jolla, California, USA.
FAU - Lee, Sohyon
AU  - Lee S
AD  - Department of Molecular and Cellular Neuroscience, Dorris Neuroscience Center,
      The Scripps Research Institute, La Jolla, California, USA.
FAU - Lerner, Richard A
AU  - Lerner RA
AD  - Department of Cell and Molecular Biology, The Scripps Research Institute, La
      Jolla, California, USA.
FAU - Baldwin, Kristin K
AU  - Baldwin KK
AD  - Department of Molecular and Cellular Neuroscience, Dorris Neuroscience Center,
      The Scripps Research Institute, La Jolla, California, USA.
LA  - eng
PT  - Journal Article
DEP - 20170911
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antibodies)
RN  - 0 (Basp1 protein, mouse)
RN  - 0 (Calmodulin-Binding Proteins)
RN  - 0 (Cytoskeletal Proteins)
RN  - 0 (Nerve Tissue Proteins)
RN  - 0 (Proto-Oncogene Proteins c-myc)
RN  - 0 (SOXB1 Transcription Factors)
RN  - 0 (Smad Proteins)
RN  - 0 (Transforming Growth Factor beta)
SB  - IM
MH  - Animals
MH  - Antibodies/*metabolism
MH  - Autocrine Communication
MH  - Blastocyst/cytology
MH  - Calmodulin-Binding Proteins/metabolism
MH  - *Cellular Reprogramming/drug effects
MH  - Clone Cells
MH  - *Combinatorial Chemistry Techniques
MH  - Cytoskeletal Proteins/metabolism
MH  - Fibroblasts/cytology/drug effects
MH  - Induced Pluripotent Stem Cells/cytology/drug effects
MH  - Mice, Inbred C57BL
MH  - Nerve Tissue Proteins/metabolism
MH  - Phosphorylation/drug effects
MH  - Protein Binding/drug effects
MH  - Proto-Oncogene Proteins c-myc/metabolism
MH  - Reproducibility of Results
MH  - SOXB1 Transcription Factors/metabolism
MH  - Smad Proteins/metabolism
MH  - Transforming Growth Factor beta/pharmacology
MH  - Up-Regulation/drug effects
EDAT- 2017/09/12 06:00
MHDA- 2017/10/24 06:00
CRDT- 2017/09/12 06:00
PHST- 2016/11/03 00:00 [received]
PHST- 2017/08/16 00:00 [accepted]
PHST- 2017/09/12 06:00 [pubmed]
PHST- 2017/10/24 06:00 [medline]
PHST- 2017/09/12 06:00 [entrez]
AID - nbt.3963 [pii]
AID - 10.1038/nbt.3963 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Oct;35(10):960-968. doi: 10.1038/nbt.3963. Epub 2017 Sep 11.

PMID- 28854175
OWN - NLM
STAT- MEDLINE
DCOM- 20171023
LR  - 20171023
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 10
DP  - 2017 Oct
TI  - Multiplexed quantification of proteins and transcripts in single cells.
PG  - 936-939
LID - 10.1038/nbt.3973 [doi]
AB  - We present a tool to measure gene and protein expression levels in single cells
      with DNA-labeled antibodies and droplet microfluidics. Using the RNA expression
      and protein sequencing assay (REAP-seq), we quantified proteins with 82 barcoded 
      antibodies and >20,000 genes in a single workflow. We used REAP-seq to assess the
      costimulatory effects of a CD27 agonist on human CD8(+) lymphocytes and to
      identify and characterize an unknown cell type.
FAU - Peterson, Vanessa M
AU  - Peterson VM
AD  - Genetics &Pharmacogenomics, Department of Translational Medicine, Merck &Co.,
      Inc., Boston, Massachusetts, USA.
FAU - Zhang, Kelvin Xi
AU  - Zhang KX
AD  - Informatics IT, Merck &Co., Inc., Boston, Massachusetts, USA.
FAU - Kumar, Namit
AU  - Kumar N
AD  - Genetics &Pharmacogenomics, Department of Translational Medicine, Merck &Co.,
      Inc., Boston, Massachusetts, USA.
FAU - Wong, Jerelyn
AU  - Wong J
AD  - Department of Profiling and Expression, Merck &Co., Inc., Palo Alto, California, 
      USA.
FAU - Li, Lixia
AU  - Li L
AD  - Genetics &Pharmacogenomics, Department of Translational Medicine, Merck &Co.,
      Inc., Boston, Massachusetts, USA.
FAU - Wilson, Douglas C
AU  - Wilson DC
AD  - Department of Profiling and Expression, Merck &Co., Inc., Palo Alto, California, 
      USA.
FAU - Moore, Renee
AU  - Moore R
AD  - Protein Sciences, Department of Biologics, Merck &Co., Inc., Boston,
      Massachusetts, USA.
FAU - McClanahan, Terrill K
AU  - McClanahan TK
AD  - Department of Profiling and Expression, Merck &Co., Inc., Palo Alto, California, 
      USA.
FAU - Sadekova, Svetlana
AU  - Sadekova S
AD  - Department of Profiling and Expression, Merck &Co., Inc., Palo Alto, California, 
      USA.
FAU - Klappenbach, Joel A
AU  - Klappenbach JA
AD  - Genetics &Pharmacogenomics, Department of Translational Medicine, Merck &Co.,
      Inc., Boston, Massachusetts, USA.
LA  - eng
PT  - Journal Article
DEP - 20170830
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Proteins)
RN  - 0 (RNA, Messenger)
SB  - IM
MH  - CD4-Positive T-Lymphocytes/metabolism
MH  - Humans
MH  - Lymphocyte Activation/immunology
MH  - Proteins/*metabolism
MH  - RNA, Messenger/genetics/metabolism
MH  - Sequence Analysis, Protein
MH  - Sequence Analysis, RNA
MH  - Single-Cell Analysis/*methods
EDAT- 2017/08/31 06:00
MHDA- 2017/10/24 06:00
CRDT- 2017/08/31 06:00
PHST- 2017/06/14 00:00 [received]
PHST- 2017/08/24 00:00 [accepted]
PHST- 2017/08/31 06:00 [pubmed]
PHST- 2017/10/24 06:00 [medline]
PHST- 2017/08/31 06:00 [entrez]
AID - nbt.3973 [pii]
AID - 10.1038/nbt.3973 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Oct;35(10):936-939. doi: 10.1038/nbt.3973. Epub 2017 Aug 30.

PMID- 28898207
OWN - NLM
STAT- MEDLINE
DCOM- 20170927
LR  - 20171220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 9
DP  - 2017 Sep 12
TI  - Shotgun metagenomics, from sampling to analysis.
PG  - 833-844
LID - 10.1038/nbt.3935 [doi]
AB  - Diverse microbial communities of bacteria, archaea, viruses and single-celled
      eukaryotes have crucial roles in the environment and in human health. However,
      microbes are frequently difficult to culture in the laboratory, which can
      confound cataloging of members and understanding of how communities function.
      High-throughput sequencing technologies and a suite of computational pipelines
      have been combined into shotgun metagenomics methods that have transformed
      microbiology. Still, computational approaches to overcome the challenges that
      affect both assembly-based and mapping-based metagenomic profiling, particularly 
      of high-complexity samples or environments containing organisms with limited
      similarity to sequenced genomes, are needed. Understanding the functions and
      characterizing specific strains of these communities offers biotechnological
      promise in therapeutic discovery and innovative ways to synthesize products using
      microbial factories and can pinpoint the contributions of microorganisms to
      planetary, animal and human health.
FAU - Quince, Christopher
AU  - Quince C
AD  - Warwick Medical School, University of Warwick, Warwick, UK.
FAU - Walker, Alan W
AU  - Walker AW
AUID- ORCID: http://orcid.org/0000-0001-5099-8495
AD  - Microbiology Group, The Rowett Institute, University of Aberdeen, Aberdeen, UK.
FAU - Simpson, Jared T
AU  - Simpson JT
AD  - Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
AD  - Department of Computer Science, University of Toronto, Toronto, Ontario, Canada.
FAU - Loman, Nicholas J
AU  - Loman NJ
AD  - Institute for Microbiology and Infection, University of Birmingham, Birmingham,
      UK.
FAU - Segata, Nicola
AU  - Segata N
AUID- ORCID: http://orcid.org/0000-0002-1583-5794
AD  - Centre for Integrative Biology, University of Trento, Trento, Italy.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EIN - Nat Biotechnol. 2017 Dec 8;35(12 ):1211. PMID: 29220029
MH  - Animals
MH  - Biomedical Research
MH  - *High-Throughput Nucleotide Sequencing
MH  - Humans
MH  - *Metagenomics
MH  - *Microbiota/genetics/physiology
EDAT- 2017/09/13 06:00
MHDA- 2017/09/28 06:00
CRDT- 2017/09/13 06:00
PHST- 2015/08/17 00:00 [received]
PHST- 2017/07/12 00:00 [accepted]
PHST- 2017/09/13 06:00 [entrez]
PHST- 2017/09/13 06:00 [pubmed]
PHST- 2017/09/28 06:00 [medline]
AID - nbt.3935 [pii]
AID - 10.1038/nbt.3935 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Sep 12;35(9):833-844. doi: 10.1038/nbt.3935.

PMID- 28898230
OWN - NLM
STAT- In-Data-Review
LR  - 20170915
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 9
DP  - 2017 Sep 11
TI  - Massachusetts injects more cash into jobs.
PG  - 809
LID - 10.1038/nbt0917-809 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/09/13 06:00
MHDA- 2017/09/13 06:00
CRDT- 2017/09/13 06:00
PHST- 2017/09/13 06:00 [entrez]
PHST- 2017/09/13 06:00 [pubmed]
PHST- 2017/09/13 06:00 [medline]
AID - nbt0917-809 [pii]
AID - 10.1038/nbt0917-809 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Sep 11;35(9):809. doi: 10.1038/nbt0917-809.

PMID- 28898229
OWN - NLM
STAT- In-Data-Review
LR  - 20170915
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 9
DP  - 2017 Sep 11
TI  - What faculty hiring committees want.
PG  - 885-887
LID - 10.1038/nbt.3962 [doi]
FAU - Wright, Charles B
AU  - Wright CB
AD  - Office of the Scientific Director, National Eye Institute, Bethesda, Maryland,
      USA.
FAU - Vanderford, Nathan L
AU  - Vanderford NL
AD  - Department of Toxicology and Cancer Biology and the Markey Cancer Center,
      University of Kentucky, Lexington, Kentucky, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/09/13 06:00
MHDA- 2017/09/13 06:00
CRDT- 2017/09/13 06:00
PHST- 2017/09/13 06:00 [entrez]
PHST- 2017/09/13 06:00 [pubmed]
PHST- 2017/09/13 06:00 [medline]
AID - nbt.3962 [pii]
AID - 10.1038/nbt.3962 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Sep 11;35(9):885-887. doi: 10.1038/nbt.3962.

PMID- 28898228
OWN - NLM
STAT- In-Data-Review
LR  - 20170915
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 9
DP  - 2017 Sep 11
TI  - Vertex CF data wow Wall Street.
PG  - 807
LID - 10.1038/nbt0917-807 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/09/13 06:00
MHDA- 2017/09/13 06:00
CRDT- 2017/09/13 06:00
PHST- 2017/09/13 06:00 [entrez]
PHST- 2017/09/13 06:00 [pubmed]
PHST- 2017/09/13 06:00 [medline]
AID - nbt0917-807 [pii]
AID - 10.1038/nbt0917-807 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Sep 11;35(9):807. doi: 10.1038/nbt0917-807.

PMID- 28898227
OWN - NLM
STAT- In-Data-Review
LR  - 20170915
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 9
DP  - 2017 Sep 11
TI  - Challenges in the gene therapy commercial ecosystem.
PG  - 813-815
LID - 10.1038/nbt.3931 [doi]
FAU - Kapoor, Rahul
AU  - Kapoor R
AD  - The Wharton School, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
FAU - Klueter, Thomas
AU  - Klueter T
AD  - IESE Business School, Barcelona, Spain.
FAU - Wilson, James M
AU  - Wilson JM
AD  - Department of Pathology and Laboratory Medicine, Perelman School of Medicine,
      University of Pennsylvania, Philadelphia, Pennsylvania, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/09/13 06:00
MHDA- 2017/09/13 06:00
CRDT- 2017/09/13 06:00
PHST- 2017/09/13 06:00 [entrez]
PHST- 2017/09/13 06:00 [pubmed]
PHST- 2017/09/13 06:00 [medline]
AID - nbt.3931 [pii]
AID - 10.1038/nbt.3931 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Sep 11;35(9):813-815. doi: 10.1038/nbt.3931.

PMID- 28898226
OWN - NLM
STAT- In-Data-Review
LR  - 20170915
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 9
DP  - 2017 Sep 11
TI  - After Myriad, what makes a gene patent claim 'markedly different' from nature?
PG  - 820-825
LID - 10.1038/nbt.3953 [doi]
FAU - Aboy, Mateo
AU  - Aboy M
AD  - Centre for Law, Medicine, and Life Sciences (LML), Faculty of Law, University of 
      Cambridge, Cambridge, UK.
FAU - Liddicoat, Johnathon
AU  - Liddicoat J
AD  - Centre for Law, Medicine, and Life Sciences (LML), Faculty of Law, University of 
      Cambridge, Cambridge, UK.
FAU - Liddell, Kathleen
AU  - Liddell K
AD  - Centre for Law, Medicine, and Life Sciences (LML), Faculty of Law, University of 
      Cambridge, Cambridge, UK.
FAU - Jordan, Matthew
AU  - Jordan M
AD  - Centre for Law, Medicine, and Life Sciences (LML), Faculty of Law, University of 
      Cambridge, Cambridge, UK.
FAU - Crespo, Cristina
AU  - Crespo C
AD  - Centre for Law, Medicine, and Life Sciences (LML), Faculty of Law, University of 
      Cambridge, Cambridge, UK.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/09/13 06:00
MHDA- 2017/09/13 06:00
CRDT- 2017/09/13 06:00
PHST- 2017/09/13 06:00 [entrez]
PHST- 2017/09/13 06:00 [pubmed]
PHST- 2017/09/13 06:00 [medline]
AID - nbt.3953 [pii]
AID - 10.1038/nbt.3953 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Sep 11;35(9):820-825. doi: 10.1038/nbt.3953.

PMID- 28898225
OWN - NLM
STAT- In-Data-Review
LR  - 20170915
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 9
DP  - 2017 Sep 11
TI  - Adenosine checkpoint agent blazes a trail, joins immunotherapy roster.
PG  - 805-807
LID - 10.1038/nbt0917-805 [doi]
FAU - Garber, Ken
AU  - Garber K
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/09/13 06:00
MHDA- 2017/09/13 06:00
CRDT- 2017/09/13 06:00
PHST- 2017/09/13 06:00 [entrez]
PHST- 2017/09/13 06:00 [pubmed]
PHST- 2017/09/13 06:00 [medline]
AID - nbt0917-805 [pii]
AID - 10.1038/nbt0917-805 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Sep 11;35(9):805-807. doi: 10.1038/nbt0917-805.

PMID- 28898224
OWN - NLM
STAT- In-Data-Review
LR  - 20170915
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 9
DP  - 2017 Sep 11
TI  - Buying time for transplants.
PG  - 801
LID - 10.1038/nbt.3971 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/09/13 06:00
MHDA- 2017/09/13 06:00
CRDT- 2017/09/13 06:00
PHST- 2017/09/13 06:00 [entrez]
PHST- 2017/09/13 06:00 [pubmed]
PHST- 2017/09/13 06:00 [medline]
AID - nbt.3971 [pii]
AID - 10.1038/nbt.3971 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Sep 11;35(9):801. doi: 10.1038/nbt.3971.

PMID- 28898223
OWN - NLM
STAT- In-Data-Review
LR  - 20170912
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 9
DP  - 2017 Sep 11
TI  - Recent patents related to clinical applications of sequencing.
PG  - 826
LID - 10.1038/nbt.3970 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/09/13 06:00
MHDA- 2017/09/13 06:00
CRDT- 2017/09/13 06:00
PHST- 2017/09/13 06:00 [entrez]
PHST- 2017/09/13 06:00 [pubmed]
PHST- 2017/09/13 06:00 [medline]
AID - nbt.3970 [pii]
AID - 10.1038/nbt.3970 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Sep 11;35(9):826. doi: 10.1038/nbt.3970.

PMID- 28898222
OWN - NLM
STAT- In-Data-Review
LR  - 20170912
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 9
DP  - 2017 Sep 11
TI  - Around the world in a month.
PG  - 811
LID - 10.1038/nbt0917-811 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/09/13 06:00
MHDA- 2017/09/13 06:00
CRDT- 2017/09/13 06:00
PHST- 2017/09/13 06:00 [entrez]
PHST- 2017/09/13 06:00 [pubmed]
PHST- 2017/09/13 06:00 [medline]
AID - nbt0917-811 [pii]
AID - 10.1038/nbt0917-811 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Sep 11;35(9):811. doi: 10.1038/nbt0917-811.

PMID- 28898221
OWN - NLM
STAT- In-Data-Review
LR  - 20170915
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 9
DP  - 2017 Sep 11
TI  - Go-ahead for first anti-IL-23 mAb to treat psoriasis.
PG  - 806
LID - 10.1038/nbt0917-806 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/09/13 06:00
MHDA- 2017/09/13 06:00
CRDT- 2017/09/13 06:00
PHST- 2017/09/13 06:00 [entrez]
PHST- 2017/09/13 06:00 [pubmed]
PHST- 2017/09/13 06:00 [medline]
AID - nbt0917-806 [pii]
AID - 10.1038/nbt0917-806 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Sep 11;35(9):806. doi: 10.1038/nbt0917-806.

PMID- 28898220
OWN - NLM
STAT- In-Data-Review
LR  - 20170912
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 9
DP  - 2017 Sep 11
TI  - Podcast: First rounders: Greg Winter.
PG  - 811
LID - 10.1038/nbt.3950 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/09/13 06:00
MHDA- 2017/09/13 06:00
CRDT- 2017/09/13 06:00
PHST- 2017/09/13 06:00 [entrez]
PHST- 2017/09/13 06:00 [pubmed]
PHST- 2017/09/13 06:00 [medline]
AID - nbt.3950 [pii]
AID - 10.1038/nbt.3950 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Sep 11;35(9):811. doi: 10.1038/nbt.3950.

PMID- 28898219
OWN - NLM
STAT- In-Data-Review
LR  - 20170915
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 9
DP  - 2017 Sep 11
TI  - Nestle moves into gut microbiome tests.
PG  - 808
LID - 10.1038/nbt0917-808a [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/09/13 06:00
MHDA- 2017/09/13 06:00
CRDT- 2017/09/13 06:00
PHST- 2017/09/13 06:00 [entrez]
PHST- 2017/09/13 06:00 [pubmed]
PHST- 2017/09/13 06:00 [medline]
AID - nbt0917-808a [pii]
AID - 10.1038/nbt0917-808a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Sep 11;35(9):808. doi: 10.1038/nbt0917-808a.

PMID- 28898218
OWN - NLM
STAT- In-Data-Review
LR  - 20170915
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 9
DP  - 2017 Sep 11
TI  - Greener revolutions for all require transparency and diversity, not secrecy.
PG  - 817-818
LID - 10.1038/nbt.3951 [doi]
FAU - Larsen, Morten Hedegaard
AU  - Larsen MH
AUID- ORCID: http://orcid.org/0000-0002-7233-6406
AD  - Department of Planning Foodscapes, Innovation and Networks, Aalborg University,
      A.C. Meyers Vaenge 15, 2450, Copenhagen, Denmark.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/09/13 06:00
MHDA- 2017/09/13 06:00
CRDT- 2017/09/13 06:00
PHST- 2017/09/13 06:00 [entrez]
PHST- 2017/09/13 06:00 [pubmed]
PHST- 2017/09/13 06:00 [medline]
AID - nbt.3951 [pii]
AID - 10.1038/nbt.3951 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Sep 11;35(9):817-818. doi: 10.1038/nbt.3951.

PMID- 28898216
OWN - NLM
STAT- In-Data-Review
LR  - 20180202
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 9
DP  - 2017 Sep 11
TI  - CRISPR patent estate splinters.
PG  - 808-809
LID - 10.1038/nbt0917-808b [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EIN - Nat Biotechnol. 2017 Dec 8;35(12 ):1124. PMID: 29220037
EDAT- 2017/09/13 06:00
MHDA- 2017/09/13 06:00
CRDT- 2017/09/13 06:00
PHST- 2017/09/13 06:00 [entrez]
PHST- 2017/09/13 06:00 [pubmed]
PHST- 2017/09/13 06:00 [medline]
AID - nbt0917-808b [pii]
AID - 10.1038/nbt0917-808b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Sep 11;35(9):808-809. doi: 10.1038/nbt0917-808b.

PMID- 28898215
OWN - NLM
STAT- In-Data-Review
LR  - 20170915
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 9
DP  - 2017 Sep 11
TI  - Mouse phenotyping sheds light on rare disease.
PG  - 831
LID - 10.1038/nbt.3959 [doi]
FAU - Perry, Sarah
AU  - Perry S
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/09/13 06:00
MHDA- 2017/09/13 06:00
CRDT- 2017/09/13 06:00
PHST- 2017/09/13 06:00 [entrez]
PHST- 2017/09/13 06:00 [pubmed]
PHST- 2017/09/13 06:00 [medline]
AID - nbt.3959 [pii]
AID - 10.1038/nbt.3959 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Sep 11;35(9):831. doi: 10.1038/nbt.3959.

PMID- 28898214
OWN - NLM
STAT- In-Data-Review
LR  - 20170915
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 9
DP  - 2017 Sep 11
TI  - Blood feud erupts over Roche's bispecific antibody for hemophilia.
PG  - 803-804
LID - 10.1038/nbt0917-803 [doi]
FAU - Dolgin, Elie
AU  - Dolgin E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/09/13 06:00
MHDA- 2017/09/13 06:00
CRDT- 2017/09/13 06:00
PHST- 2017/09/13 06:00 [entrez]
PHST- 2017/09/13 06:00 [pubmed]
PHST- 2017/09/13 06:00 [medline]
AID - nbt0917-803 [pii]
AID - 10.1038/nbt0917-803 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Sep 11;35(9):803-804. doi: 10.1038/nbt0917-803.

PMID- 28898213
OWN - NLM
STAT- In-Data-Review
LR  - 20170912
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 9
DP  - 2017 Sep 11
TI  - 2Q17-Biotech stages a recovery.
PG  - 812
LID - 10.1038/nbt.3949 [doi]
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
AD  - Nature Biotechnology.
FAU - Huggett, Brady
AU  - Huggett B
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/09/13 06:00
MHDA- 2017/09/13 06:00
CRDT- 2017/09/13 06:00
PHST- 2017/09/13 06:00 [entrez]
PHST- 2017/09/13 06:00 [pubmed]
PHST- 2017/09/13 06:00 [medline]
AID - nbt.3949 [pii]
AID - 10.1038/nbt.3949 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Sep 11;35(9):812. doi: 10.1038/nbt.3949.

PMID- 28898212
OWN - NLM
STAT- In-Data-Review
LR  - 20170915
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 9
DP  - 2017 Sep 11
TI  - Precision editing in the human embryo.
PG  - 832
LID - 10.1038/nbt.3965 [doi]
FAU - Aschheim, Kathy
AU  - Aschheim K
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/09/13 06:00
MHDA- 2017/09/13 06:00
CRDT- 2017/09/13 06:00
PHST- 2017/09/13 06:00 [entrez]
PHST- 2017/09/13 06:00 [pubmed]
PHST- 2017/09/13 06:00 [medline]
AID - nbt.3965 [pii]
AID - 10.1038/nbt.3965 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Sep 11;35(9):832. doi: 10.1038/nbt.3965.

PMID- 28898210
OWN - NLM
STAT- In-Data-Review
LR  - 20170912
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 9
DP  - 2017 Sep 11
TI  - What's app? Helix wants you to quiz your genome-some of it for fun.
PG  - 810
LID - 10.1038/nbt0917-810 [doi]
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/09/13 06:00
MHDA- 2017/09/13 06:00
CRDT- 2017/09/13 06:00
PHST- 2017/09/13 06:00 [entrez]
PHST- 2017/09/13 06:00 [pubmed]
PHST- 2017/09/13 06:00 [medline]
AID - nbt0917-810 [pii]
AID - 10.1038/nbt0917-810 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Sep 11;35(9):810. doi: 10.1038/nbt0917-810.

PMID- 28898209
OWN - NLM
STAT- In-Data-Review
LR  - 20170915
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 9
DP  - 2017 Sep 11
TI  - Neoantigen prediction and the need for validation.
PG  - 815-817
LID - 10.1038/nbt.3932 [doi]
FAU - Vitiello, Antonella
AU  - Vitiello A
AD  - PersImmune, Inc., San Diego, California, USA.
FAU - Zanetti, Maurizio
AU  - Zanetti M
AD  - The Laboratory of Immunology, Department of Medicine and Moores Cancer Center,
      University of California San Diego, La Jolla, California, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/09/13 06:00
MHDA- 2017/09/13 06:00
CRDT- 2017/09/13 06:00
PHST- 2017/09/13 06:00 [entrez]
PHST- 2017/09/13 06:00 [pubmed]
PHST- 2017/09/13 06:00 [medline]
AID - nbt.3932 [pii]
AID - 10.1038/nbt.3932 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Sep 11;35(9):815-817. doi: 10.1038/nbt.3932.

PMID- 28898208
OWN - NLM
STAT- In-Data-Review
LR  - 20170915
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 9
DP  - 2017 Sep 11
TI  - Interpreting the T-cell receptor repertoire.
PG  - 829-830
LID - 10.1038/nbt.3957 [doi]
FAU - Holt, Robert A
AU  - Holt RA
AD  - British Columbia Cancer Agency Genome Sciences Centre, University of British
      Columbia Department of Medical Genetics, Simon Fraser University Department of
      Biochemistry &Molecular Biology Vancouver, British Columbia, Canada.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/09/13 06:00
MHDA- 2017/09/13 06:00
CRDT- 2017/09/13 06:00
PHST- 2017/09/13 06:00 [entrez]
PHST- 2017/09/13 06:00 [pubmed]
PHST- 2017/09/13 06:00 [medline]
AID - nbt.3957 [pii]
AID - 10.1038/nbt.3957 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Sep 11;35(9):829-830. doi: 10.1038/nbt.3957.

PMID- 28898206
OWN - NLM
STAT- In-Data-Review
LR  - 20170915
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 9
DP  - 2017 Sep 11
TI  - Reply: Greener revolutions for all require transparency and diversity, not
      secrecy.
PG  - 818-819
LID - 10.1038/nbt.3952 [doi]
FAU - Flavell, Richard B
AU  - Flavell RB
AD  - International Wheat Yield Partnership, Texas A&M University, College State
      Station, Texas, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/09/13 06:00
MHDA- 2017/09/13 06:00
CRDT- 2017/09/13 06:00
PHST- 2017/09/13 06:00 [entrez]
PHST- 2017/09/13 06:00 [pubmed]
PHST- 2017/09/13 06:00 [medline]
AID - nbt.3952 [pii]
AID - 10.1038/nbt.3952 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Sep 11;35(9):818-819. doi: 10.1038/nbt.3952.

PMID- 28898205
OWN - NLM
STAT- In-Data-Review
LR  - 20170915
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 9
DP  - 2017 Sep 11
TI  - Tagging activated neurons with light.
PG  - 827-828
LID - 10.1038/nbt.3954 [doi]
FAU - Roy, Dheeraj S
AU  - Roy DS
AD  - RIKEN-MIT Center for Neural Circuit Genetics at the Picower Institute for
      Learning and Memory, Department of Biology and Department of Brain and Cognitive 
      Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
FAU - Okuyama, Teruhiro
AU  - Okuyama T
AD  - RIKEN-MIT Center for Neural Circuit Genetics at the Picower Institute for
      Learning and Memory, Department of Biology and Department of Brain and Cognitive 
      Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
FAU - Tonegawa, Susumu
AU  - Tonegawa S
AD  - RIKEN-MIT Center for Neural Circuit Genetics at the Picower Institute for
      Learning and Memory, Department of Biology and Department of Brain and Cognitive 
      Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
AD  - Howard Hughes Medical Institute, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/09/13 06:00
MHDA- 2017/09/13 06:00
CRDT- 2017/09/13 06:00
PHST- 2017/09/13 06:00 [entrez]
PHST- 2017/09/13 06:00 [pubmed]
PHST- 2017/09/13 06:00 [medline]
AID - nbt.3954 [pii]
AID - 10.1038/nbt.3954 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Sep 11;35(9):827-828. doi: 10.1038/nbt.3954.

PMID- 28829439
OWN - NLM
STAT- MEDLINE
DCOM- 20170927
LR  - 20180301
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 9
DP  - 2017 Sep
TI  - An integrated expression atlas of miRNAs and their promoters in human and mouse.
PG  - 872-878
LID - 10.1038/nbt.3947 [doi]
AB  - MicroRNAs (miRNAs) are short non-coding RNAs with key roles in cellular
      regulation. As part of the fifth edition of the Functional Annotation of
      Mammalian Genome (FANTOM5) project, we created an integrated expression atlas of 
      miRNAs and their promoters by deep-sequencing 492 short RNA (sRNA) libraries,
      with matching Cap Analysis Gene Expression (CAGE) data, from 396 human and 47
      mouse RNA samples. Promoters were identified for 1,357 human and 804 mouse miRNAs
      and showed strong sequence conservation between species. We also found that
      primary and mature miRNA expression levels were correlated, allowing us to use
      the primary miRNA measurements as a proxy for mature miRNA levels in a total of
      1,829 human and 1,029 mouse CAGE libraries. We thus provide a broad atlas of
      miRNA expression and promoters in primary mammalian cells, establishing a
      foundation for detailed analysis of miRNA expression patterns and transcriptional
      control regions.
FAU - de Rie, Derek
AU  - de Rie D
AD  - Division of Genomic Technologies, RIKEN Center for Life Science Technologies,
      Yokohama, Japan.
AD  - Centre for Integrative Bioinformatics (IBIVU), VU University Amsterdam,
      Amsterdam, the Netherlands.
FAU - Abugessaisa, Imad
AU  - Abugessaisa I
AUID- ORCID: http://orcid.org/0000-0001-7458-801X
AD  - Division of Genomic Technologies, RIKEN Center for Life Science Technologies,
      Yokohama, Japan.
FAU - Alam, Tanvir
AU  - Alam T
AD  - Computational Bioscience Research Center, Computer, Electrical and Mathematical
      Sciences and Engineering Division, King Abdullah University of Science and
      Technology (KAUST), Thuwal, Saudi Arabia.
FAU - Arner, Erik
AU  - Arner E
AD  - Division of Genomic Technologies, RIKEN Center for Life Science Technologies,
      Yokohama, Japan.
AD  - RIKEN Omics Science Center (OSC), Yokohama, Japan.
FAU - Arner, Peter
AU  - Arner P
AD  - Department of Medicine, Karolinska Institutet at Karolinska University Hospital, 
      Huddinge, Sweden.
FAU - Ashoor, Haitham
AU  - Ashoor H
AD  - Computational Bioscience Research Center, Computer, Electrical and Mathematical
      Sciences and Engineering Division, King Abdullah University of Science and
      Technology (KAUST), Thuwal, Saudi Arabia.
FAU - Astrom, Gaby
AU  - Astrom G
AD  - Department of Medicine, Karolinska Institutet at Karolinska University Hospital, 
      Huddinge, Sweden.
FAU - Babina, Magda
AU  - Babina M
AD  - Department of Dermatology and Allergy, Charite Campus Mitte, Universitatsmedizin 
      Berlin, Berlin, Germany.
FAU - Bertin, Nicolas
AU  - Bertin N
AUID- ORCID: http://orcid.org/0000-0002-9835-9606
AD  - Division of Genomic Technologies, RIKEN Center for Life Science Technologies,
      Yokohama, Japan.
AD  - RIKEN Omics Science Center (OSC), Yokohama, Japan.
AD  - Cancer Science Institute of Singapore, National University of Singapore,
      Singapore.
FAU - Burroughs, A Maxwell
AU  - Burroughs AM
AD  - Division of Genomic Technologies, RIKEN Center for Life Science Technologies,
      Yokohama, Japan.
AD  - RIKEN Omics Science Center (OSC), Yokohama, Japan.
AD  - National Center for Biotechnology Information, National Library of Medicine,
      National Institutes of Health, Bethesda, Maryland, USA.
FAU - Carlisle, Ailsa J
AU  - Carlisle AJ
AD  - The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of
      Edinburgh, Edinburgh, UK.
FAU - Daub, Carsten O
AU  - Daub CO
AUID- ORCID: http://orcid.org/0000-0002-3295-8729
AD  - Division of Genomic Technologies, RIKEN Center for Life Science Technologies,
      Yokohama, Japan.
AD  - RIKEN Omics Science Center (OSC), Yokohama, Japan.
FAU - Detmar, Michael
AU  - Detmar M
AUID- ORCID: http://orcid.org/0000-0002-5351-5054
AD  - Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology (ETH)
      Zurich, Zurich, Switzerland.
FAU - Deviatiiarov, Ruslan
AU  - Deviatiiarov R
AD  - Division of Genomic Technologies, RIKEN Center for Life Science Technologies,
      Yokohama, Japan.
AD  - Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan,
      Russia.
FAU - Fort, Alexandre
AU  - Fort A
AD  - Division of Genomic Technologies, RIKEN Center for Life Science Technologies,
      Yokohama, Japan.
AD  - RIKEN Omics Science Center (OSC), Yokohama, Japan.
FAU - Gebhard, Claudia
AU  - Gebhard C
AD  - Department of Internal Medicine III, University Hospital Regensburg, Regensburg, 
      Germany.
AD  - Regensburg Centre for Interventional Immunology (RCI), Regensburg, Germany.
FAU - Goldowitz, Daniel
AU  - Goldowitz D
AD  - Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics,
      Child and Family Research Institute, University of British Columbia, Vancouver,
      British Columbia, Canada.
FAU - Guhl, Sven
AU  - Guhl S
AD  - Department of Dermatology and Allergy, Charite Campus Mitte, Universitatsmedizin 
      Berlin, Berlin, Germany.
FAU - Ha, Thomas J
AU  - Ha TJ
AD  - Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics,
      Child and Family Research Institute, University of British Columbia, Vancouver,
      British Columbia, Canada.
FAU - Harshbarger, Jayson
AU  - Harshbarger J
AUID- ORCID: http://orcid.org/0000-0002-5188-2045
AD  - Division of Genomic Technologies, RIKEN Center for Life Science Technologies,
      Yokohama, Japan.
AD  - RIKEN Omics Science Center (OSC), Yokohama, Japan.
FAU - Hasegawa, Akira
AU  - Hasegawa A
AD  - Division of Genomic Technologies, RIKEN Center for Life Science Technologies,
      Yokohama, Japan.
AD  - RIKEN Omics Science Center (OSC), Yokohama, Japan.
FAU - Hashimoto, Kosuke
AU  - Hashimoto K
AD  - Division of Genomic Technologies, RIKEN Center for Life Science Technologies,
      Yokohama, Japan.
AD  - RIKEN Omics Science Center (OSC), Yokohama, Japan.
FAU - Herlyn, Meenhard
AU  - Herlyn M
AD  - Melanoma Research Center, The Wistar Institute, Philadelphia, Pennsylvania, USA.
FAU - Heutink, Peter
AU  - Heutink P
AUID- ORCID: http://orcid.org/0000-0001-5218-1737
AD  - German Center for Neurodegenerative Diseases (DZNE), Tubingen, Germany.
FAU - Hitchens, Kelly J
AU  - Hitchens KJ
AD  - Australian Infectious Diseases Research Centre (AID), University of Queensland,
      Brisbane, Queensland, Australia.
FAU - Hon, Chung Chau
AU  - Hon CC
AUID- ORCID: http://orcid.org/0000-0002-3741-7577
AD  - Division of Genomic Technologies, RIKEN Center for Life Science Technologies,
      Yokohama, Japan.
FAU - Huang, Edward
AU  - Huang E
AD  - The University of Melbourne Centre for Stem Cell Systems, School of Biomedical
      Sciences, The University of Melbourne, Victoria, Australia.
AD  - Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria,
      Australia.
FAU - Ishizu, Yuri
AU  - Ishizu Y
AD  - Division of Genomic Technologies, RIKEN Center for Life Science Technologies,
      Yokohama, Japan.
AD  - RIKEN Omics Science Center (OSC), Yokohama, Japan.
FAU - Kai, Chieko
AU  - Kai C
AD  - Laboratory Animal Research Center, Institute of Medical Science, The University
      of Tokyo, Tokyo, Japan.
FAU - Kasukawa, Takeya
AU  - Kasukawa T
AD  - Division of Genomic Technologies, RIKEN Center for Life Science Technologies,
      Yokohama, Japan.
FAU - Klinken, Peter
AU  - Klinken P
AD  - Harry Perkins Institute of Medical Research, and the Centre for Medical Research,
      University of Western Australia, QEII Medical Centre, Perth, Western Australia,
      Australia.
FAU - Lassmann, Timo
AU  - Lassmann T
AD  - Division of Genomic Technologies, RIKEN Center for Life Science Technologies,
      Yokohama, Japan.
AD  - RIKEN Omics Science Center (OSC), Yokohama, Japan.
AD  - Telethon Kids Institute, The University of Western Australia, Subiaco, Western
      Australia, Australia.
FAU - Lecellier, Charles-Henri
AU  - Lecellier CH
AD  - Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics,
      Child and Family Research Institute, University of British Columbia, Vancouver,
      British Columbia, Canada.
AD  - Institute of Molecular Genetics of Montpellier, Montpellier, France.
FAU - Lee, Weonju
AU  - Lee W
AD  - Department of Dermatology, Kyungpook National University School of Medicine,
      Daegu, South Korea.
FAU - Lizio, Marina
AU  - Lizio M
AUID- ORCID: http://orcid.org/0000-0001-7337-7325
AD  - Division of Genomic Technologies, RIKEN Center for Life Science Technologies,
      Yokohama, Japan.
AD  - RIKEN Omics Science Center (OSC), Yokohama, Japan.
FAU - Makeev, Vsevolod
AU  - Makeev V
AUID- ORCID: http://orcid.org/0000-0001-9405-9748
AD  - Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow,
      Russia.
AD  - Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow,
      Russia.
AD  - Moscow Institute of Physics and Technology, Dolgoprudny, Russia.
FAU - Mathelier, Anthony
AU  - Mathelier A
AUID- ORCID: http://orcid.org/0000-0001-5127-5459
AD  - Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics,
      Child and Family Research Institute, University of British Columbia, Vancouver,
      British Columbia, Canada.
FAU - Medvedeva, Yulia A
AU  - Medvedeva YA
AD  - Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow,
      Russia.
AD  - IMPPC, Institute of Predictive and Personalized Medicine of Cancer, Ctra. de Can 
      Ruti, Badalona, Spain.
AD  - Institute of Bioengineering, Research Center of Biotechnology, Moscow, Russia.
FAU - Mejhert, Niklas
AU  - Mejhert N
AD  - Department of Medicine, Karolinska Institutet at Karolinska University Hospital, 
      Huddinge, Sweden.
FAU - Mungall, Christopher J
AU  - Mungall CJ
AD  - Environmental Genomics and Systems Biology Division, Lawrence Berkeley National
      Laboratory, Berkeley, California, USA.
FAU - Noma, Shohei
AU  - Noma S
AD  - Division of Genomic Technologies, RIKEN Center for Life Science Technologies,
      Yokohama, Japan.
AD  - RIKEN Omics Science Center (OSC), Yokohama, Japan.
FAU - Ohshima, Mitsuhiro
AU  - Ohshima M
AD  - Department of Biochemistry, Ohu University School of Pharmaceutical Sciences,
      Koriyama, Japan.
FAU - Okada-Hatakeyama, Mariko
AU  - Okada-Hatakeyama M
AD  - Laboratory of Cell Systems, Institute for Protein Research, Osaka University,
      Osaka, Japan.
AD  - RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
FAU - Persson, Helena
AU  - Persson H
AUID- ORCID: http://orcid.org/0000-0002-5187-6446
AD  - Division of Oncology and Pathology, Department of Clinical Sciences, Lund
      University, Lund, Sweden.
FAU - Rizzu, Patrizia
AU  - Rizzu P
AD  - German Center for Neurodegenerative Diseases (DZNE), Tubingen, Germany.
FAU - Roudnicky, Filip
AU  - Roudnicky F
AUID- ORCID: http://orcid.org/0000-0001-7156-2383
AD  - Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology (ETH)
      Zurich, Zurich, Switzerland.
FAU - Saetrom, Pal
AU  - Saetrom P
AUID- ORCID: http://orcid.org/0000-0001-8142-7441
AD  - Department of Computer and Information Science, Norwegian University of Science
      and Technology, Trondheim, Norway.
FAU - Sato, Hiroki
AU  - Sato H
AD  - Laboratory Animal Research Center, Institute of Medical Science, The University
      of Tokyo, Tokyo, Japan.
FAU - Severin, Jessica
AU  - Severin J
AD  - Division of Genomic Technologies, RIKEN Center for Life Science Technologies,
      Yokohama, Japan.
AD  - RIKEN Omics Science Center (OSC), Yokohama, Japan.
FAU - Shin, Jay W
AU  - Shin JW
AD  - Division of Genomic Technologies, RIKEN Center for Life Science Technologies,
      Yokohama, Japan.
AD  - RIKEN Omics Science Center (OSC), Yokohama, Japan.
FAU - Swoboda, Rolf K
AU  - Swoboda RK
AD  - Melanoma Research Center, The Wistar Institute, Philadelphia, Pennsylvania, USA.
FAU - Tarui, Hiroshi
AU  - Tarui H
AD  - Division of Genomic Technologies, RIKEN Center for Life Science Technologies,
      Yokohama, Japan.
AD  - RIKEN Omics Science Center (OSC), Yokohama, Japan.
FAU - Toyoda, Hiroo
AU  - Toyoda H
AD  - Department of Clinical Molecular Genetics, School of Pharmacy, Tokyo University
      of Pharmacy and Life Sciences, Tokyo, Japan.
FAU - Vitting-Seerup, Kristoffer
AU  - Vitting-Seerup K
AD  - The Bioinformatics Centre, Department of Biology, and Biotech Research and
      Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.
FAU - Winteringham, Louise
AU  - Winteringham L
AD  - Harry Perkins Institute of Medical Research, and the Centre for Medical Research,
      University of Western Australia, QEII Medical Centre, Perth, Western Australia,
      Australia.
FAU - Yamaguchi, Yoko
AU  - Yamaguchi Y
AD  - Department of Biochemistry, Nihon University School of Dentistry, Tokyo, Japan.
FAU - Yasuzawa, Kayoko
AU  - Yasuzawa K
AD  - Division of Genomic Technologies, RIKEN Center for Life Science Technologies,
      Yokohama, Japan.
FAU - Yoneda, Misako
AU  - Yoneda M
AD  - Laboratory Animal Research Center, Institute of Medical Science, The University
      of Tokyo, Tokyo, Japan.
FAU - Yumoto, Noriko
AU  - Yumoto N
AD  - RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
FAU - Zabierowski, Susan
AU  - Zabierowski S
AD  - The SKI Stem Cell Research Facility, The Center for Stem Cell Biology and
      Developmental Biology Program, Sloan Kettering Institute, New York, New York,
      USA.
FAU - Zhang, Peter G
AU  - Zhang PG
AD  - Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics,
      Child and Family Research Institute, University of British Columbia, Vancouver,
      British Columbia, Canada.
FAU - Wells, Christine A
AU  - Wells CA
AUID- ORCID: http://orcid.org/0000-0003-3133-3628
AD  - The University of Melbourne Centre for Stem Cell Systems, School of Biomedical
      Sciences, The University of Melbourne, Victoria, Australia.
AD  - Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria,
      Australia.
FAU - Summers, Kim M
AU  - Summers KM
AD  - The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of
      Edinburgh, Edinburgh, UK.
AD  - Mater Research Institute-University of Queensland, Translational Research
      Institute, Brisbane, Australia.
FAU - Kawaji, Hideya
AU  - Kawaji H
AD  - Division of Genomic Technologies, RIKEN Center for Life Science Technologies,
      Yokohama, Japan.
AD  - RIKEN Omics Science Center (OSC), Yokohama, Japan.
AD  - RIKEN Preventive Medicine and Diagnosis Innovation Program, Wako, Japan.
FAU - Sandelin, Albin
AU  - Sandelin A
AUID- ORCID: http://orcid.org/0000-0002-7109-7378
AD  - The Bioinformatics Centre, Department of Biology, and Biotech Research and
      Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.
FAU - Rehli, Michael
AU  - Rehli M
AD  - Department of Internal Medicine III, University Hospital Regensburg, Regensburg, 
      Germany.
AD  - Regensburg Centre for Interventional Immunology (RCI), Regensburg, Germany.
CN  - FANTOM Consortium
FAU - Hayashizaki, Yoshihide
AU  - Hayashizaki Y
AD  - RIKEN Omics Science Center (OSC), Yokohama, Japan.
AD  - RIKEN Preventive Medicine and Diagnosis Innovation Program, Wako, Japan.
FAU - Carninci, Piero
AU  - Carninci P
AUID- ORCID: http://orcid.org/0000-0001-7202-7243
AD  - Division of Genomic Technologies, RIKEN Center for Life Science Technologies,
      Yokohama, Japan.
AD  - RIKEN Omics Science Center (OSC), Yokohama, Japan.
FAU - Forrest, Alistair R R
AU  - Forrest ARR
AD  - Division of Genomic Technologies, RIKEN Center for Life Science Technologies,
      Yokohama, Japan.
AD  - RIKEN Omics Science Center (OSC), Yokohama, Japan.
AD  - Harry Perkins Institute of Medical Research, and the Centre for Medical Research,
      University of Western Australia, QEII Medical Centre, Perth, Western Australia,
      Australia.
FAU - de Hoon, Michiel J L
AU  - de Hoon MJL
AD  - Division of Genomic Technologies, RIKEN Center for Life Science Technologies,
      Yokohama, Japan.
AD  - RIKEN Omics Science Center (OSC), Yokohama, Japan.
LA  - eng
GR  - P30 CA010815/CA/NCI NIH HHS/United States
PT  - Journal Article
DEP - 20170821
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (MicroRNAs)
SB  - IM
MH  - Animals
MH  - Cells, Cultured
MH  - Gene Expression Profiling/*methods
MH  - Gene Library
MH  - High-Throughput Nucleotide Sequencing
MH  - Humans
MH  - Mice
MH  - MicroRNAs/*genetics/metabolism
MH  - *Molecular Sequence Annotation
MH  - Promoter Regions, Genetic/*genetics
PMC - PMC5767576
MID - NIHMS931914
EDAT- 2017/08/23 06:00
MHDA- 2017/09/28 06:00
CRDT- 2017/08/23 06:00
PHST- 2016/05/02 00:00 [received]
PHST- 2017/07/25 00:00 [accepted]
PHST- 2017/08/23 06:00 [pubmed]
PHST- 2017/09/28 06:00 [medline]
PHST- 2017/08/23 06:00 [entrez]
AID - nbt.3947 [pii]
AID - 10.1038/nbt.3947 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Sep;35(9):872-878. doi: 10.1038/nbt.3947. Epub 2017 Aug 21.

PMID- 28829438
OWN - NLM
STAT- MEDLINE
DCOM- 20170927
LR  - 20180221
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 9
DP  - 2017 Sep
TI  - An atlas of B-cell clonal distribution in the human body.
PG  - 879-884
LID - 10.1038/nbt.3942 [doi]
AB  - B-cell responses result in clonal expansion, and can occur in a variety of
      tissues. To define how B-cell clones are distributed in the body, we sequenced
      933,427 B-cell clonal lineages and mapped them to eight different anatomic
      compartments in six human organ donors. We show that large B-cell clones
      partition into two broad networks-one spans the blood, bone marrow, spleen and
      lung, while the other is restricted to tissues within the gastrointestinal (GI)
      tract (jejunum, ileum and colon). Notably, GI tract clones display extensive
      sharing of sequence variants among different portions of the tract and have
      higher frequencies of somatic hypermutation, suggesting extensive and serial
      rounds of clonal expansion and selection. Our findings provide an anatomic atlas 
      of B-cell clonal lineages, their properties and tissue connections. This resource
      serves as a foundation for studies of tissue-based immunity, including vaccine
      responses, infections, autoimmunity and cancer.
FAU - Meng, Wenzhao
AU  - Meng W
AD  - Department of Pathology and Laboratory Medicine, Perelman School of Medicine,
      University of Pennsylvania, Philadelphia, Pennsylvania, USA.
FAU - Zhang, Bochao
AU  - Zhang B
AD  - School of Biomedical Engineering, Science and Health Systems, Drexel University, 
      Philadelphia, Pennsylvania, USA.
FAU - Schwartz, Gregory W
AU  - Schwartz GW
AD  - School of Biomedical Engineering, Science and Health Systems, Drexel University, 
      Philadelphia, Pennsylvania, USA.
FAU - Rosenfeld, Aaron M
AU  - Rosenfeld AM
AD  - School of Biomedical Engineering, Science and Health Systems, Drexel University, 
      Philadelphia, Pennsylvania, USA.
FAU - Ren, Daqiu
AU  - Ren D
AD  - Department of Pathology and Laboratory Medicine, Perelman School of Medicine,
      University of Pennsylvania, Philadelphia, Pennsylvania, USA.
FAU - Thome, Joseph J C
AU  - Thome JJC
AD  - Columbia Center for Translational Immunology, Columbia University Medical Center,
      New York, New York, USA.
FAU - Carpenter, Dustin J
AU  - Carpenter DJ
AUID- ORCID: http://orcid.org/0000-0001-6008-5868
AD  - Columbia Center for Translational Immunology, Columbia University Medical Center,
      New York, New York, USA.
FAU - Matsuoka, Nobuhide
AU  - Matsuoka N
AD  - Columbia Center for Translational Immunology, Columbia University Medical Center,
      New York, New York, USA.
FAU - Lerner, Harvey
AU  - Lerner H
AD  - LiveOnNY, New York, New York, USA.
FAU - Friedman, Amy L
AU  - Friedman AL
AD  - LiveOnNY, New York, New York, USA.
FAU - Granot, Tomer
AU  - Granot T
AD  - Columbia Center for Translational Immunology, Columbia University Medical Center,
      New York, New York, USA.
FAU - Farber, Donna L
AU  - Farber DL
AD  - Columbia Center for Translational Immunology, Columbia University Medical Center,
      New York, New York, USA.
AD  - Department of Surgery and Department of Microbiology and Immunology, Columbia
      University School of Medicine, New York, New York, USA.
FAU - Shlomchik, Mark J
AU  - Shlomchik MJ
AD  - Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania,
      USA.
FAU - Hershberg, Uri
AU  - Hershberg U
AD  - School of Biomedical Engineering, Science and Health Systems, Drexel University, 
      Philadelphia, Pennsylvania, USA.
AD  - Department of Microbiology and Immunology, Drexel College of Medicine, Drexel
      University, Philadelphia, Pennsylvania, USA.
FAU - Luning Prak, Eline T
AU  - Luning Prak ET
AUID- ORCID: http://orcid.org/0000-0002-9478-9211
AD  - Department of Pathology and Laboratory Medicine, Perelman School of Medicine,
      University of Pennsylvania, Philadelphia, Pennsylvania, USA.
LA  - eng
GR  - F31 AG047003/AG/NIA NIH HHS/United States
GR  - P01 AI106697/AI/NIAID NIH HHS/United States
GR  - P30 CA016520/CA/NCI NIH HHS/United States
PT  - Journal Article
DEP - 20170821
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Adult
MH  - B-Lymphocytes/*cytology
MH  - Cell Lineage/*genetics
MH  - Clone Cells
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Organ Specificity/*genetics
MH  - Young Adult
PMC - PMC5679700
MID - NIHMS892926
EDAT- 2017/08/23 06:00
MHDA- 2017/09/28 06:00
CRDT- 2017/08/23 06:00
PHST- 2016/12/20 00:00 [received]
PHST- 2017/07/13 00:00 [accepted]
PHST- 2017/08/23 06:00 [pubmed]
PHST- 2017/09/28 06:00 [medline]
PHST- 2017/08/23 06:00 [entrez]
AID - nbt.3942 [pii]
AID - 10.1038/nbt.3942 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Sep;35(9):879-884. doi: 10.1038/nbt.3942. Epub 2017 Aug 21.

PMID- 28829437
OWN - NLM
STAT- MEDLINE
DCOM- 20170927
LR  - 20170927
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 9
DP  - 2017 Sep
TI  - Control of phosphorothioate stereochemistry substantially increases the efficacy 
      of antisense oligonucleotides.
PG  - 845-851
LID - 10.1038/nbt.3948 [doi]
AB  - Whereas stereochemical purity in drugs has become the standard for small
      molecules, stereoisomeric mixtures containing as many as a half million
      components persist in antisense oligonucleotide (ASO) therapeutics because it has
      been feasible neither to separate the individual stereoisomers, nor to synthesize
      stereochemically pure ASOs. Here we report the development of a scalable
      synthetic process that yields therapeutic ASOs having high stereochemical and
      chemical purity. Using this method, we synthesized rationally designed stereopure
      components of mipomersen, a drug comprising 524,288 stereoisomers. We demonstrate
      that phosphorothioate (PS) stereochemistry substantially affects the
      pharmacologic properties of ASOs. We report that Sp-configured PS linkages are
      stabilized relative to Rp, providing stereochemical protection from pharmacologic
      inactivation of the drug. Further, we elucidated a triplet stereochemical code in
      the stereopure ASOs, 3'-SpSpRp, that promotes target RNA cleavage by RNase H1 in 
      vitro and provides a more durable response in mice than stereorandom ASOs.
FAU - Iwamoto, Naoki
AU  - Iwamoto N
AD  - Wave Life Sciences, Cambridge, Massachusetts, USA.
FAU - Butler, David C D
AU  - Butler DCD
AD  - Wave Life Sciences, Cambridge, Massachusetts, USA.
FAU - Svrzikapa, Nenad
AU  - Svrzikapa N
AD  - Wave Life Sciences, Cambridge, Massachusetts, USA.
FAU - Mohapatra, Susovan
AU  - Mohapatra S
AD  - Wave Life Sciences, Cambridge, Massachusetts, USA.
FAU - Zlatev, Ivan
AU  - Zlatev I
AD  - Wave Life Sciences, Cambridge, Massachusetts, USA.
FAU - Sah, Dinah W Y
AU  - Sah DWY
AD  - Wave Life Sciences, Cambridge, Massachusetts, USA.
FAU - Meena
AU  - Meena
AD  - Wave Life Sciences, Cambridge, Massachusetts, USA.
FAU - Standley, Stephany M
AU  - Standley SM
AD  - Wave Life Sciences, Cambridge, Massachusetts, USA.
FAU - Lu, Genliang
AU  - Lu G
AD  - Wave Life Sciences, Cambridge, Massachusetts, USA.
FAU - Apponi, Luciano H
AU  - Apponi LH
AD  - Wave Life Sciences, Cambridge, Massachusetts, USA.
FAU - Frank-Kamenetsky, Maria
AU  - Frank-Kamenetsky M
AD  - Wave Life Sciences, Cambridge, Massachusetts, USA.
FAU - Zhang, Jason Jingxin
AU  - Zhang JJ
AD  - Wave Life Sciences, Cambridge, Massachusetts, USA.
FAU - Vargeese, Chandra
AU  - Vargeese C
AD  - Wave Life Sciences, Cambridge, Massachusetts, USA.
FAU - Verdine, Gregory L
AU  - Verdine GL
AD  - Wave Life Sciences, Cambridge, Massachusetts, USA.
AD  - Department of Stem Cell and Regenerative Biology, Department of Chemistry and
      Chemical Biology, Harvard University and Harvard Medical School, Cambridge,
      Massachusetts, USA.
LA  - eng
PT  - Journal Article
DEP - 20170821
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Oligonucleotides)
RN  - 0 (Oligonucleotides, Antisense)
RN  - 0 (Phosphorothioate Oligonucleotides)
RN  - 9GJ8S4GU0M (mipomersen)
RN  - EC 3.1.26.4 (Ribonuclease H)
RN  - EC 3.1.26.4 (ribonuclease HI)
SB  - IM
MH  - Animals
MH  - Drug Stability
MH  - Female
MH  - Genetic Therapy/*methods
MH  - Humans
MH  - Hydrophobic and Hydrophilic Interactions
MH  - Male
MH  - Mice
MH  - Mice, Inbred C57BL
MH  - Mice, Transgenic
MH  - Oligonucleotides
MH  - Oligonucleotides, Antisense/*chemistry/*pharmacokinetics/therapeutic use
MH  - Phosphorothioate Oligonucleotides/*chemistry
MH  - Rats
MH  - Rats, Sprague-Dawley
MH  - Ribonuclease H/metabolism
MH  - Stereoisomerism
EDAT- 2017/08/23 06:00
MHDA- 2017/09/28 06:00
CRDT- 2017/08/23 06:00
PHST- 2016/09/22 00:00 [received]
PHST- 2017/07/26 00:00 [accepted]
PHST- 2017/08/23 06:00 [pubmed]
PHST- 2017/09/28 06:00 [medline]
PHST- 2017/08/23 06:00 [entrez]
AID - nbt.3948 [pii]
AID - 10.1038/nbt.3948 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Sep;35(9):845-851. doi: 10.1038/nbt.3948. Epub 2017 Aug 21.

PMID- 28650462
OWN - NLM
STAT- MEDLINE
DCOM- 20170927
LR  - 20170927
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 9
DP  - 2017 Sep
TI  - Haplotype phasing of whole human genomes using bead-based barcode partitioning in
      a single tube.
PG  - 852-857
LID - 10.1038/nbt.3897 [doi]
AB  - Haplotype-resolved genome sequencing promises to unlock a wealth of information
      in population and medical genetics. However, for the vast majority of genomes
      sequenced to date, haplotypes have not been determined because of cumbersome
      haplotyping workflows that require fractions of the genome to be sequenced in a
      large number of compartments. Here we demonstrate barcode partitioning of long
      DNA molecules in a single compartment using "on-bead" barcoded tagmentation. The 
      key to the method that we call "contiguity preserving transposition" sequencing
      on beads (CPTv2-seq) is transposon-mediated transfer of homogenous populations of
      barcodes from beads to individual long DNA molecules that get fragmented at the
      same time (tagmentation). These are then processed to sequencing libraries
      wherein all sequencing reads originating from each long DNA molecule share a
      common barcode. Single-tube, bulk processing of long DNA molecules with
      approximately 150,000 different barcoded bead types provides a barcode-linked
      read structure that reveals long-range molecular contiguity. This technology
      provides a simple, rapid, plate-scalable and automatable route to accurate,
      haplotype-resolved sequencing, and phasing of structural variants of the genome.
FAU - Zhang, Fan
AU  - Zhang F
AD  - Advanced Research Department, Illumina, San Diego, California, USA.
FAU - Christiansen, Lena
AU  - Christiansen L
AD  - Advanced Research Department, Illumina, San Diego, California, USA.
FAU - Thomas, Jerushah
AU  - Thomas J
AD  - Advanced Research Department, Illumina, San Diego, California, USA.
FAU - Pokholok, Dmitry
AU  - Pokholok D
AD  - Advanced Research Department, Illumina, San Diego, California, USA.
FAU - Jackson, Ros
AU  - Jackson R
AD  - Technology Development Department, Illumina, Little Chesterford, Essex, UK.
FAU - Morrell, Natalie
AU  - Morrell N
AD  - Technology Development Department, Illumina, Little Chesterford, Essex, UK.
FAU - Zhao, Yannan
AU  - Zhao Y
AD  - Technology Development, Illumina, San Diego, California, USA.
FAU - Wiley, Melissa
AU  - Wiley M
AD  - Technology Development, Illumina, San Diego, California, USA.
FAU - Welch, Emily
AU  - Welch E
AD  - Technology Development, Illumina, San Diego, California, USA.
FAU - Jaeger, Erich
AU  - Jaeger E
AD  - Gene Expression Department, Illumina, San Francisco, California, USA.
FAU - Granat, Ana
AU  - Granat A
AD  - Gene Expression Department, Illumina, San Francisco, California, USA.
FAU - Norberg, Steven J
AU  - Norberg SJ
AD  - Advanced Research Department, Illumina, San Diego, California, USA.
FAU - Halpern, Aaron
AU  - Halpern A
AD  - Gene Expression Department, Illumina, San Francisco, California, USA.
FAU - C Rogert, Maria
AU  - C Rogert M
AUID- ORCID: http://orcid.org/0000-0002-2977-1517
AD  - Technology Development, Illumina, San Diego, California, USA.
FAU - Ronaghi, Mostafa
AU  - Ronaghi M
AD  - Advanced Research Department, Illumina, San Diego, California, USA.
FAU - Shendure, Jay
AU  - Shendure J
AD  - Department of Genome Sciences, University of Washington, Seattle, Washington,
      USA.
FAU - Gormley, Niall
AU  - Gormley N
AD  - Technology Development Department, Illumina, Little Chesterford, Essex, UK.
FAU - Gunderson, Kevin L
AU  - Gunderson KL
AD  - Encodia, Inc., San Diego, California, USA.
FAU - Steemers, Frank J
AU  - Steemers FJ
AD  - Advanced Research Department, Illumina, San Diego, California, USA.
LA  - eng
PT  - Journal Article
DEP - 20170626
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - DNA Barcoding, Taxonomic/*methods
MH  - Genome, Human/*genetics
MH  - Genomics/*methods
MH  - Haplotypes/*genetics
MH  - High-Throughput Nucleotide Sequencing/methods
MH  - Humans
EDAT- 2017/06/27 06:00
MHDA- 2017/09/28 06:00
CRDT- 2017/06/27 06:00
PHST- 2016/10/14 00:00 [received]
PHST- 2017/05/10 00:00 [accepted]
PHST- 2017/06/27 06:00 [pubmed]
PHST- 2017/09/28 06:00 [medline]
PHST- 2017/06/27 06:00 [entrez]
AID - nbt.3897 [pii]
AID - 10.1038/nbt.3897 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Sep;35(9):852-857. doi: 10.1038/nbt.3897. Epub 2017 Jun 26.

PMID- 28650461
OWN - NLM
STAT- MEDLINE
DCOM- 20170927
LR  - 20171226
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 9
DP  - 2017 Sep
TI  - A light- and calcium-gated transcription factor for imaging and manipulating
      activated neurons.
PG  - 864-871
LID - 10.1038/nbt.3909 [doi]
AB  - Activity remodels neurons, altering their molecular, structural, and electrical
      characteristics. To enable the selective characterization and manipulation of
      these neurons, we present FLARE, an engineered transcription factor that drives
      expression of fluorescent proteins, opsins, and other genetically encoded tools
      only in the subset of neurons that experienced activity during a user-defined
      time window. FLARE senses the coincidence of elevated cytosolic calcium and
      externally applied blue light, which together produce translocation of a
      membrane-anchored transcription factor to the nucleus to drive expression of any 
      transgene. In cultured rat neurons, FLARE gives a light-to-dark signal ratio of
      120 and a high- to low-calcium signal ratio of 10 after 10 min of stimulation.
      Opsin expression permitted functional manipulation of FLARE-marked neurons. In
      adult mice, FLARE also gave light- and motor-activity-dependent transcription in 
      the cortex. Due to its modular design, minute-scale temporal resolution, and
      minimal dark-state leak, FLARE should be useful for the study of
      activity-dependent processes in neurons and other cells that signal with calcium.
FAU - Wang, Wenjing
AU  - Wang W
AD  - Departments of Genetics, Biology, and Chemistry, Stanford University, Stanford,
      California, USA.
AD  - Department of Chemistry, Massachusetts Institute of Technology, Cambridge,
      Massachusetts, USA.
FAU - Wildes, Craig P
AU  - Wildes CP
AD  - Picower Institute for Learning and Memory and Department of Brain and Cognitive
      Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
FAU - Pattarabanjird, Tanyaporn
AU  - Pattarabanjird T
AD  - Department of Chemistry, Massachusetts Institute of Technology, Cambridge,
      Massachusetts, USA.
FAU - Sanchez, Mateo I
AU  - Sanchez MI
AD  - Departments of Genetics, Biology, and Chemistry, Stanford University, Stanford,
      California, USA.
AD  - Department of Chemistry, Massachusetts Institute of Technology, Cambridge,
      Massachusetts, USA.
FAU - Glober, Gordon F
AU  - Glober GF
AD  - Picower Institute for Learning and Memory and Department of Brain and Cognitive
      Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
FAU - Matthews, Gillian A
AU  - Matthews GA
AD  - Picower Institute for Learning and Memory and Department of Brain and Cognitive
      Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
FAU - Tye, Kay M
AU  - Tye KM
AD  - Picower Institute for Learning and Memory and Department of Brain and Cognitive
      Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
FAU - Ting, Alice Y
AU  - Ting AY
AD  - Departments of Genetics, Biology, and Chemistry, Stanford University, Stanford,
      California, USA.
AD  - Department of Chemistry, Massachusetts Institute of Technology, Cambridge,
      Massachusetts, USA.
LA  - eng
GR  - DP2 DK102256/DK/NIDDK NIH HHS/United States
GR  - R01 MH102441/MH/NIMH NIH HHS/United States
PT  - Journal Article
DEP - 20170626
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Transcription Factors)
RN  - SY7Q814VUP (Calcium)
SB  - IM
MH  - Animals
MH  - Calcium/*metabolism
MH  - Cells, Cultured
MH  - Genetic Engineering
MH  - Mice
MH  - Molecular Imaging/*methods
MH  - Neurons/chemistry/cytology/*metabolism
MH  - Optogenetics/*methods
MH  - Rats
MH  - Transcription Factors/*genetics/*metabolism
PMC - PMC5595644
MID - NIHMS878815
EDAT- 2017/06/27 06:00
MHDA- 2017/09/28 06:00
CRDT- 2017/06/27 06:00
PHST- 2016/11/16 00:00 [received]
PHST- 2017/05/22 00:00 [accepted]
PHST- 2017/06/27 06:00 [pubmed]
PHST- 2017/09/28 06:00 [medline]
PHST- 2017/06/27 06:00 [entrez]
AID - nbt.3909 [pii]
AID - 10.1038/nbt.3909 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Sep;35(9):864-871. doi: 10.1038/nbt.3909. Epub 2017 Jun 26.

PMID- 28650460
OWN - NLM
STAT- MEDLINE
DCOM- 20170927
LR  - 20170927
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 9
DP  - 2017 Sep
TI  - A calcium- and light-gated switch to induce gene expression in activated neurons.
PG  - 858-863
LID - 10.1038/nbt.3902 [doi]
AB  - Despite recent advances in optogenetics, it remains challenging to manipulate
      gene expression in specific populations of neurons. We present a dual-protein
      switch system, Cal-Light, that translates neuronal-activity-mediated calcium
      signaling into gene expression in a light-dependent manner. In cultured neurons
      and brain slices, we show that Cal-Light drives expression of the reporter EGFP
      with high spatiotemporal resolution only in the presence of both blue light and
      calcium. Delivery of the Cal-Light components to the motor cortex of mice by
      viral vectors labels a subset of excitatory and inhibitory neurons related to
      learned lever-pressing behavior. By using Cal-Light to drive expression of the
      inhibitory receptor halorhodopsin (eNpHR), which responds to yellow light, we
      temporarily inhibit the lever-pressing behavior, confirming that the labeled
      neurons mediate the behavior. Thus, Cal-Light enables dissection of neural
      circuits underlying complex mammalian behaviors with high spatiotemporal
      precision.
FAU - Lee, Dongmin
AU  - Lee D
AD  - Max Planck Florida Institute for Neuroscience, Jupiter, Florida, USA.
AD  - Department of Anatomy, College of Medicine, Korea University, Seoul, Republic of 
      Korea.
AD  - Department of Biomedical Science, Brain Korea 21 PLUS, College of Medicine, Korea
      University, Seoul, Republic of Korea.
FAU - Hyun, Jung Ho
AU  - Hyun JH
AUID- ORCID: http://orcid.org/0000-0003-0185-5943
AD  - Max Planck Florida Institute for Neuroscience, Jupiter, Florida, USA.
FAU - Jung, Kanghoon
AU  - Jung K
AD  - Max Planck Florida Institute for Neuroscience, Jupiter, Florida, USA.
FAU - Hannan, Patrick
AU  - Hannan P
AD  - Max Planck Florida Institute for Neuroscience, Jupiter, Florida, USA.
FAU - Kwon, Hyung-Bae
AU  - Kwon HB
AD  - Max Planck Florida Institute for Neuroscience, Jupiter, Florida, USA.
AD  - Max Planck Institute of Neurobiology, Martinsried, Germany.
LA  - eng
PT  - Journal Article
DEP - 20170626
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Halorhodopsins)
RN  - SY7Q814VUP (Calcium)
SB  - IM
MH  - Animals
MH  - Calcium/metabolism
MH  - Gene Expression/*genetics/physiology
MH  - Halorhodopsins/genetics/metabolism
MH  - Mice
MH  - Neurons/cytology/*metabolism/physiology
MH  - Optogenetics/*methods
EDAT- 2017/06/27 06:00
MHDA- 2017/09/28 06:00
CRDT- 2017/06/27 06:00
PHST- 2016/11/28 00:00 [received]
PHST- 2017/05/17 00:00 [accepted]
PHST- 2017/06/27 06:00 [pubmed]
PHST- 2017/09/28 06:00 [medline]
PHST- 2017/06/27 06:00 [entrez]
AID - nbt.3902 [pii]
AID - 10.1038/nbt.3902 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Sep;35(9):858-863. doi: 10.1038/nbt.3902. Epub 2017 Jun 26.

PMID- 28787428
OWN - NLM
STAT- In-Data-Review
LR  - 20170808
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug 8
TI  - Innovation drive seizes Indian biotech.
PG  - 698
LID - 10.1038/nbt0817-698 [doi]
FAU - Jayaraman, Killugudi
AU  - Jayaraman K
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/08/09 06:00
MHDA- 2017/08/09 06:00
CRDT- 2017/08/09 06:00
PHST- 2017/08/09 06:00 [entrez]
PHST- 2017/08/09 06:00 [pubmed]
PHST- 2017/08/09 06:00 [medline]
AID - nbt0817-698 [pii]
AID - 10.1038/nbt0817-698 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug 8;35(8):698. doi: 10.1038/nbt0817-698.

PMID- 28787427
OWN - NLM
STAT- In-Data-Review
LR  - 20170810
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug 8
TI  - Policy implications for post-Brexit biotech.
PG  - 710-711
LID - 10.1038/nbt.3930 [doi]
FAU - Annaloro, John
AU  - Annaloro J
AD  - University of California San Diego, School of Medicine, Global Public Health and 
      Anesthesiology, San Diego, California, USA.
FAU - Mackey, Tim K
AU  - Mackey TK
AUID- ORCID: http://orcid.org/0000-0002-2191-7833
AD  - University of California San Diego, School of Medicine, Global Public Health and 
      Anesthesiology, San Diego, California, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/08/09 06:00
MHDA- 2017/08/09 06:00
CRDT- 2017/08/09 06:00
PHST- 2017/08/09 06:00 [entrez]
PHST- 2017/08/09 06:00 [pubmed]
PHST- 2017/08/09 06:00 [medline]
AID - nbt.3930 [pii]
AID - 10.1038/nbt.3930 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug 8;35(8):710-711. doi: 10.1038/nbt.3930.

PMID- 28787426
OWN - NLM
STAT- MEDLINE
DCOM- 20170821
LR  - 20170821
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug 8
TI  - Characterization of noncoding regulatory DNA in the human genome.
PG  - 732-746
LID - 10.1038/nbt.3863 [doi]
AB  - Genetic variants associated with common diseases are usually located in noncoding
      parts of the human genome. Delineation of the full repertoire of functional
      noncoding elements, together with efficient methods for probing their biological 
      roles, is therefore of crucial importance. Over the past decade, DNA
      accessibility and various epigenetic modifications have been associated with
      regulatory functions. Mapping these features across the genome has enabled
      researchers to begin to document the full complement of putative regulatory
      elements. High-throughput reporter assays to probe the functions of regulatory
      regions have also been developed but these methods separate putative regulatory
      elements from the chromosome so that any effects of chromatin context and
      long-range regulatory interactions are lost. Definitive assignment of function(s)
      to putative cis-regulatory elements requires perturbation of these elements.
      Genome-editing technologies are now transforming our ability to perturb
      regulatory elements across entire genomes. Interpretation of high-throughput
      genetic screens that incorporate genome editors might enable the construction of 
      an unbiased map of functional noncoding elements in the human genome.
FAU - Elkon, Ran
AU  - Elkon R
AD  - Department of Human Molecular Genetics and Biochemistry, Sackler School of
      Medicine, Tel Aviv, Israel.
AD  - Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
FAU - Agami, Reuven
AU  - Agami R
AD  - Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The
      Netherlands.
AD  - Erasmus MC, Rotterdam University, The Netherlands.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 9007-49-2 (DNA)
SB  - IM
MH  - Chromosome Mapping
MH  - DNA/*genetics
MH  - Epigenomics
MH  - Genome, Human/*genetics
MH  - Genomics/*methods
MH  - Humans
MH  - Regulatory Sequences, Nucleic Acid/*genetics
EDAT- 2017/08/09 06:00
MHDA- 2017/08/22 06:00
CRDT- 2017/08/09 06:00
PHST- 2016/06/01 00:00 [received]
PHST- 2017/03/31 00:00 [accepted]
PHST- 2017/08/09 06:00 [entrez]
PHST- 2017/08/09 06:00 [pubmed]
PHST- 2017/08/22 06:00 [medline]
AID - nbt.3863 [pii]
AID - 10.1038/nbt.3863 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug 8;35(8):732-746. doi: 10.1038/nbt.3863.

PMID- 28787425
OWN - NLM
STAT- In-Data-Review
LR  - 20170808
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug 8
TI  - Engineering the animal out of animal products.
PG  - 704-707
LID - 10.1038/nbt.3933 [doi]
FAU - Dance, Amber
AU  - Dance A
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/08/09 06:00
MHDA- 2017/08/09 06:00
CRDT- 2017/08/09 06:00
PHST- 2017/08/09 06:00 [entrez]
PHST- 2017/08/09 06:00 [pubmed]
PHST- 2017/08/09 06:00 [medline]
AID - nbt.3933 [pii]
AID - 10.1038/nbt.3933 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug 8;35(8):704-707. doi: 10.1038/nbt.3933.

PMID- 28787424
OWN - NLM
STAT- MEDLINE
DCOM- 20170821
LR  - 20180113
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug 8
TI  - Minimum information about a single amplified genome (MISAG) and a
      metagenome-assembled genome (MIMAG) of bacteria and archaea.
PG  - 725-731
LID - 10.1038/nbt.3893 [doi]
AB  - We present two standards developed by the Genomic Standards Consortium (GSC) for 
      reporting bacterial and archaeal genome sequences. Both are extensions of the
      Minimum Information about Any (x) Sequence (MIxS). The standards are the Minimum 
      Information about a Single Amplified Genome (MISAG) and the Minimum Information
      about a Metagenome-Assembled Genome (MIMAG), including, but not limited to,
      assembly quality, and estimates of genome completeness and contamination. These
      standards can be used in combination with other GSC checklists, including the
      Minimum Information about a Genome Sequence (MIGS), Minimum Information about a
      Metagenomic Sequence (MIMS), and Minimum Information about a Marker Gene Sequence
      (MIMARKS). Community-wide adoption of MISAG and MIMAG will facilitate more robust
      comparative genomic analyses of bacterial and archaeal diversity.
FAU - Bowers, Robert M
AU  - Bowers RM
AD  - Department of Energy Joint Genome Institute, Walnut Creek, California, USA.
FAU - Kyrpides, Nikos C
AU  - Kyrpides NC
AD  - Department of Energy Joint Genome Institute, Walnut Creek, California, USA.
FAU - Stepanauskas, Ramunas
AU  - Stepanauskas R
AUID- ORCID: http://orcid.org/0000-0003-4458-3108
AD  - Bigelow Laboratory for Ocean Sciences, East Boothbay, Maine, USA.
FAU - Harmon-Smith, Miranda
AU  - Harmon-Smith M
AD  - Department of Energy Joint Genome Institute, Walnut Creek, California, USA.
FAU - Doud, Devin
AU  - Doud D
AD  - Department of Energy Joint Genome Institute, Walnut Creek, California, USA.
FAU - Reddy, T B K
AU  - Reddy TBK
AD  - Department of Energy Joint Genome Institute, Walnut Creek, California, USA.
FAU - Schulz, Frederik
AU  - Schulz F
AUID- ORCID: http://orcid.org/0000-0002-4932-4677
AD  - Department of Energy Joint Genome Institute, Walnut Creek, California, USA.
FAU - Jarett, Jessica
AU  - Jarett J
AD  - Department of Energy Joint Genome Institute, Walnut Creek, California, USA.
FAU - Rivers, Adam R
AU  - Rivers AR
AD  - Department of Energy Joint Genome Institute, Walnut Creek, California, USA.
AD  - United States Department of Agriculture, Agricultural Research Service, Genomics 
      and Bioinformatics Research Unit, Gainesville, Florida, USA.
FAU - Eloe-Fadrosh, Emiley A
AU  - Eloe-Fadrosh EA
AD  - Department of Energy Joint Genome Institute, Walnut Creek, California, USA.
FAU - Tringe, Susannah G
AU  - Tringe SG
AUID- ORCID: http://orcid.org/0000-0001-6479-8427
AD  - Department of Energy Joint Genome Institute, Walnut Creek, California, USA.
AD  - School of Natural Sciences, University of California Merced, Merced, California, 
      USA.
FAU - Ivanova, Natalia N
AU  - Ivanova NN
AD  - Department of Energy Joint Genome Institute, Walnut Creek, California, USA.
FAU - Copeland, Alex
AU  - Copeland A
AD  - Department of Energy Joint Genome Institute, Walnut Creek, California, USA.
FAU - Clum, Alicia
AU  - Clum A
AD  - Department of Energy Joint Genome Institute, Walnut Creek, California, USA.
FAU - Becraft, Eric D
AU  - Becraft ED
AD  - Bigelow Laboratory for Ocean Sciences, East Boothbay, Maine, USA.
FAU - Malmstrom, Rex R
AU  - Malmstrom RR
AD  - Department of Energy Joint Genome Institute, Walnut Creek, California, USA.
FAU - Birren, Bruce
AU  - Birren B
AD  - Broad Institute, Cambridge, Massachusetts, USA.
FAU - Podar, Mircea
AU  - Podar M
AD  - Biosciences Division, Oak Ridge National Laboratory, Oakridge Tennessee, USA.
FAU - Bork, Peer
AU  - Bork P
AD  - Structural and Computational Biology Unit, European Molecular Biology Laboratory,
      Heidelberg, Germany.
FAU - Weinstock, George M
AU  - Weinstock GM
AD  - The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, USA.
FAU - Garrity, George M
AU  - Garrity GM
AD  - Department of Microbiology &Molecular Genetics, Biomedical Physical Sciences,
      Michigan State University, East Lansing, Michigan, USA.
FAU - Dodsworth, Jeremy A
AU  - Dodsworth JA
AD  - Department of Biology, California State University, San Bernardino, California,
      USA.
FAU - Yooseph, Shibu
AU  - Yooseph S
AD  - J. Craig Venter Institute, San Diego, California, USA.
FAU - Sutton, Granger
AU  - Sutton G
AUID- ORCID: http://orcid.org/0000-0001-7498-8048
AD  - J. Craig Venter Institute, Rockville, Maryland, USA.
FAU - Glockner, Frank O
AU  - Glockner FO
AD  - Microbial Genomics and Bioinformatics Research Group, Max Planck Institute for
      Marine Microbiology, Bremen, Germany.
FAU - Gilbert, Jack A
AU  - Gilbert JA
AD  - Biosciences Division, Argonne National Laboratory, Argonne, Illinois, USA.
AD  - Department of Surgery, University of Chicago, Chicago, Illinois, USA.
FAU - Nelson, William C
AU  - Nelson WC
AD  - Biological Sciences Division, Earth and Biological Sciences Directorate, Pacific 
      Northwest National Laboratory, Richland, Washington, USA.
FAU - Hallam, Steven J
AU  - Hallam SJ
AD  - Department of Microbiology &Immunology, University of British Columbia,
      Vancouver, British Columbia, Canada.
FAU - Jungbluth, Sean P
AU  - Jungbluth SP
AUID- ORCID: http://orcid.org/0000-0001-9265-8341
AD  - Department of Energy Joint Genome Institute, Walnut Creek, California, USA.
AD  - Center for Dark Energy Biosphere Investigation, University of Southern
      California, Los Angeles, California, USA.
FAU - Ettema, Thijs J G
AU  - Ettema TJG
AD  - Department of Cell and Molecular Biology, Science for Life Laboratory, Uppsala
      University, Uppsala, Sweden.
FAU - Tighe, Scott
AU  - Tighe S
AD  - Advanced Genomics Lab, University of Vermont Cancer Center, Burlington Vermont,
      USA.
FAU - Konstantinidis, Konstantinos T
AU  - Konstantinidis KT
AD  - Georgia Institute of Technology, School of Civil and Environmental Engineering,
      Atlanta, Georgia, USA.
FAU - Liu, Wen-Tso
AU  - Liu WT
AD  - Department of Civil and Environmental Engineering, University of Illinois at
      Urbana-Champaign, Urbana, Illinois, USA.
FAU - Baker, Brett J
AU  - Baker BJ
AD  - Department of Marine Science, University of Texas-Austin, Marine Science
      Institute, Austin, Texas, USA.
FAU - Rattei, Thomas
AU  - Rattei T
AD  - Department of Microbiology and Ecosystem Science, University of Vienna, Vienna,
      Austria.
FAU - Eisen, Jonathan A
AU  - Eisen JA
AD  - Genome Center, University of California, Davis, California, USA.
FAU - Hedlund, Brian
AU  - Hedlund B
AD  - School of Life Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, USA.
AD  - Nevada Institute of Personalized Medicine, University of Nevada Las Vegas, Las
      Vegas, Nevada, USA.
FAU - McMahon, Katherine D
AU  - McMahon KD
AD  - Department of Civil and Environmental Engineering, University of
      Wisconsin-Madison, Madison, Wisconsin, USA.
AD  - Department of Bacteriology, University of Wisconsin-Madison, Madison, Wisconsin, 
      USA.
FAU - Fierer, Noah
AU  - Fierer N
AD  - Cooperative Institute for Research in Environmental Sciences, University of
      Colorado, Boulder, Colorado, USA.
AD  - Department of Ecology and Evolutionary Biology, University of Colorado, Boulder, 
      Colorado, USA.
FAU - Knight, Rob
AU  - Knight R
AUID- ORCID: http://orcid.org/0000-0002-0975-9019
AD  - Center for Microbiome Innovation, and Departments of Pediatrics and Computer
      Science &Engineering, University of California San Diego, La Jolla, California,
      USA.
FAU - Finn, Rob
AU  - Finn R
AD  - European Molecular Biology Laboratory, European Bioinformatics Institute
      (EMBL-EBI), Welcome Trust Genome Campus, Hinxton, Cambridge, UK.
FAU - Cochrane, Guy
AU  - Cochrane G
AD  - European Molecular Biology Laboratory, European Bioinformatics Institute
      (EMBL-EBI), Welcome Trust Genome Campus, Hinxton, Cambridge, UK.
FAU - Karsch-Mizrachi, Ilene
AU  - Karsch-Mizrachi I
AD  - National Center for Biotechnology Information, National Library of Medicine,
      National Institutes of Health, Bethesda, Maryland, USA.
FAU - Tyson, Gene W
AU  - Tyson GW
AD  - Australian Centre for Ecogenomics, School of Chemistry and Molecular Biosciences,
      The University of Queensland, Brisbane, Queensland, Australia.
FAU - Rinke, Christian
AU  - Rinke C
AUID- ORCID: http://orcid.org/0000-0003-4632-1187
AD  - Australian Centre for Ecogenomics, School of Chemistry and Molecular Biosciences,
      The University of Queensland, Brisbane, Queensland, Australia.
CN  - Genome Standards Consortium
FAU - Lapidus, Alla
AU  - Lapidus A
AUID- ORCID: http://orcid.org/0000-0003-0427-8731
AD  - Centre for Algorithmic Biotechnology, ITBM, St. Petersburg State University, St. 
      Petersburg, Russia.
FAU - Meyer, Folker
AU  - Meyer F
AD  - Biosciences Division, Argonne National Laboratory, Argonne, Illinois, USA.
FAU - Yilmaz, Pelin
AU  - Yilmaz P
AUID- ORCID: http://orcid.org/0000-0003-4724-323X
AD  - Microbial Genomics and Bioinformatics Research Group, Max Planck Institute for
      Marine Microbiology, Bremen, Germany.
FAU - Parks, Donovan H
AU  - Parks DH
AUID- ORCID: http://orcid.org/0000-0001-6662-9010
AD  - Australian Centre for Ecogenomics, School of Chemistry and Molecular Biosciences,
      The University of Queensland, Brisbane, Queensland, Australia.
FAU - Eren, A M
AU  - Eren AM
AUID- ORCID: http://orcid.org/0000-0001-9013-4827
AD  - Knapp Center for Biomedical Discovery, Chicago, Illinois, USA.
FAU - Schriml, Lynn
AU  - Schriml L
AD  - National Cancer Institute, Frederick, Maryland, USA.
FAU - Banfield, Jillian F
AU  - Banfield JF
AD  - Department of Earth and Planetary Science, University of California, Berkeley,
      California, USA.
FAU - Hugenholtz, Philip
AU  - Hugenholtz P
AD  - Australian Centre for Ecogenomics, School of Chemistry and Molecular Biosciences,
      The University of Queensland, Brisbane, Queensland, Australia.
FAU - Woyke, Tanja
AU  - Woyke T
AD  - Department of Energy Joint Genome Institute, Walnut Creek, California, USA.
AD  - School of Natural Sciences, University of California Merced, Merced, California, 
      USA.
LA  - eng
GR  - R01 AI123037/AI/NIAID NIH HHS/United States
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Genome, Archaeal/*genetics
MH  - Genome, Bacterial/genetics
MH  - Genomics/*methods/standards
MH  - Metagenomics/*methods/standards
MH  - Sequence Analysis, DNA
IR  - Kyrpides NC
FIR - Kyrpides, Nikos C
IR  - Schriml L
FIR - Schriml, Lynn
IR  - Garrity GM
FIR - Garrity, George M
IR  - Hugenholtz P
FIR - Hugenholtz, Philip
IR  - Sutton G
FIR - Sutton, Granger
IR  - Yilmaz P
FIR - Yilmaz, Pelin
IR  - Meyer F
FIR - Meyer, Folker
IR  - Glockner FO
FIR - Glockner, Frank O
IR  - Gilbert JA
FIR - Gilbert, Jack A
IR  - Knight R
FIR - Knight, Rob
IR  - Finn R
FIR - Finn, Rob
IR  - Cochrane G
FIR - Cochrane, Guy
IR  - Karsch-Mizrachi I
FIR - Karsch-Mizrachi, Ilene
EDAT- 2017/08/09 06:00
MHDA- 2017/08/22 06:00
CRDT- 2017/08/09 06:00
PHST- 2016/11/10 00:00 [received]
PHST- 2017/04/27 00:00 [accepted]
PHST- 2017/08/09 06:00 [entrez]
PHST- 2017/08/09 06:00 [pubmed]
PHST- 2017/08/22 06:00 [medline]
AID - nbt.3893 [pii]
AID - 10.1038/nbt.3893 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug 8;35(8):725-731. doi: 10.1038/nbt.3893.

PMID- 28787423
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug 8
TI  - Retraction: DNA-guided genome editing using the Natronobacterium gregoryi
      Argonaute.
PG  - 797
LID - 10.1038/nbt0817-797a [doi]
FAU - Gao, Feng
AU  - Gao F
FAU - Shen, Xiao Z
AU  - Shen XZ
FAU - Jiang, Feng
AU  - Jiang F
FAU - Wu, Yongqiang
AU  - Wu Y
FAU - Han, Chunyu
AU  - Han C
LA  - eng
PT  - Journal Article
PT  - Retraction of Publication
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
ROF - Nat Biotechnol. 2016 Jul;34(7):768-73. PMID: 27136078
EDAT- 2017/08/09 06:00
MHDA- 2017/08/09 06:01
CRDT- 2017/08/09 06:00
PHST- 2017/08/09 06:00 [entrez]
PHST- 2017/08/09 06:00 [pubmed]
PHST- 2017/08/09 06:01 [medline]
AID - nbt0817-797a [pii]
AID - 10.1038/nbt0817-797a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug 8;35(8):797. doi: 10.1038/nbt0817-797a.

PMID- 28787422
OWN - NLM
STAT- In-Data-Review
LR  - 20170808
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug 8
TI  - Recent patents in synthetic biology.
PG  - 719
LID - 10.1038/nbt.3946 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/08/09 06:00
MHDA- 2017/08/09 06:00
CRDT- 2017/08/09 06:00
PHST- 2017/08/09 06:00 [entrez]
PHST- 2017/08/09 06:00 [pubmed]
PHST- 2017/08/09 06:00 [medline]
AID - nbt.3946 [pii]
AID - 10.1038/nbt.3946 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug 8;35(8):719. doi: 10.1038/nbt.3946.

PMID- 28787421
OWN - NLM
STAT- In-Data-Review
LR  - 20170808
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug 8
TI  - LifeArc splashes out, fuelled by Keytruda.
PG  - 693
LID - 10.1038/nbt0817-693 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/08/09 06:00
MHDA- 2017/08/09 06:00
CRDT- 2017/08/09 06:00
PHST- 2017/08/09 06:00 [entrez]
PHST- 2017/08/09 06:00 [pubmed]
PHST- 2017/08/09 06:00 [medline]
AID - nbt0817-693 [pii]
AID - 10.1038/nbt0817-693 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug 8;35(8):693. doi: 10.1038/nbt0817-693.

PMID- 28787419
OWN - NLM
STAT- In-Data-Review
LR  - 20170927
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug 8
TI  - Big data opens a window onto wellness.
PG  - 720-721
LID - 10.1038/nbt.3934 [doi]
FAU - Butte, Atul J
AU  - Butte AJ
AUID- ORCID: http://orcid.org/0000-0002-7433-2740
AD  - Institute for Computational Health Sciences, University of California, San
      Francisco, USA.
LA  - eng
GR  - OT2 OD024611/OD/NIH HHS/United States
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/08/09 06:00
MHDA- 2017/08/09 06:00
CRDT- 2017/08/09 06:00
PHST- 2017/08/09 06:00 [entrez]
PHST- 2017/08/09 06:00 [pubmed]
PHST- 2017/08/09 06:00 [medline]
AID - nbt.3934 [pii]
AID - 10.1038/nbt.3934 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug 8;35(8):720-721. doi: 10.1038/nbt.3934.

PMID- 28787418
OWN - NLM
STAT- In-Data-Review
LR  - 20170810
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug 8
TI  - Erratum: Nature Biotechnology's academic spinouts of 2016.
PG  - 797
LID - 10.1038/nbt0817-797b [doi]
FAU - Bouchie, Aaron
AU  - Bouchie A
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
FAU - Sheridan, Cormac
AU  - Sheridan C
FAU - Webb, Sarah
AU  - Webb S
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/08/09 06:00
MHDA- 2017/08/09 06:00
CRDT- 2017/08/09 06:00
PHST- 2017/08/09 06:00 [entrez]
PHST- 2017/08/09 06:00 [pubmed]
PHST- 2017/08/09 06:00 [medline]
AID - nbt0817-797b [pii]
AID - 10.1038/nbt0817-797b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug 8;35(8):797. doi: 10.1038/nbt0817-797b.

PMID- 28787417
OWN - NLM
STAT- In-Data-Review
LR  - 20170824
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug 8
TI  - Pluripotent stem cells that evade the immune radar.
PG  - 722-723
LID - 10.1038/nbt.3940 [doi]
FAU - Kim, Steven C
AU  - Kim SC
AD  - Emory Transplant Center, Emory University School of Medicine, Atlanta, Georgia,
      USA.
FAU - Adams, Andrew B
AU  - Adams AB
AD  - Emory Transplant Center, Emory University School of Medicine, Atlanta, Georgia,
      USA.
LA  - eng
GR  - R01 AI126322/AI/NIAID NIH HHS/United States
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/08/09 06:00
MHDA- 2017/08/09 06:00
CRDT- 2017/08/09 06:00
PHST- 2017/08/09 06:00 [entrez]
PHST- 2017/08/09 06:00 [pubmed]
PHST- 2017/08/09 06:00 [medline]
AID - nbt.3940 [pii]
AID - 10.1038/nbt.3940 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug 8;35(8):722-723. doi: 10.1038/nbt.3940.

PMID- 28787416
OWN - NLM
STAT- In-Data-Review
LR  - 20170808
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug 8
TI  - Drug pipeline 2Q17.
PG  - 703
LID - 10.1038/nbt.3941 [doi]
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/08/09 06:00
MHDA- 2017/08/09 06:00
CRDT- 2017/08/09 06:00
PHST- 2017/08/09 06:00 [entrez]
PHST- 2017/08/09 06:00 [pubmed]
PHST- 2017/08/09 06:00 [medline]
AID - nbt.3941 [pii]
AID - 10.1038/nbt.3941 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug 8;35(8):703. doi: 10.1038/nbt.3941.

PMID- 28787415
OWN - NLM
STAT- In-Data-Review
LR  - 20180307
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug 8
TI  - Rules of the road for insect gene drive research and testing.
PG  - 716-718
LID - 10.1038/nbt.3926 [doi]
FAU - Adelman, Zach
AU  - Adelman Z
AD  - Texas A&M University, College Station, Texas, USA.
FAU - Akbari, Omar
AU  - Akbari O
AD  - University of California Riverside, Riverside, California, USA.
FAU - Bauer, John
AU  - Bauer J
AD  - University of California San Diego, La Jolla, California, USA.
FAU - Bier, Ethan
AU  - Bier E
AD  - University of California San Diego, La Jolla, California, USA.
FAU - Bloss, Cinnamon
AU  - Bloss C
AD  - University of California San Diego, La Jolla, California, USA.
FAU - Carter, Sarah R
AU  - Carter SR
AD  - Science Policy Consulting LLC, Arlington, Virginia, USA.
FAU - Callender, Craig
AU  - Callender C
AD  - University of California San Diego, La Jolla, California, USA.
FAU - Denis, Adriana Costero-Saint
AU  - Denis AC
AD  - NIAID, National Institutes of Health, Bethesda, Maryland. USA.
FAU - Cowhey, Peter
AU  - Cowhey P
AD  - University of California San Diego, La Jolla, California, USA.
FAU - Dass, Brinda
AU  - Dass B
AD  - US Food and Drug Administration, Rockville, Maryland, USA.
FAU - Delborne, Jason
AU  - Delborne J
AD  - North Carolina State University, Raleigh, North Carolina, USA.
FAU - Devereaux, Mary
AU  - Devereaux M
AD  - University of California San Diego, La Jolla, California, USA.
FAU - Ellsworth, Peter
AU  - Ellsworth P
AD  - Legler Benbough Foundation, San Diego, California, USA.
FAU - Friedman, Robert M
AU  - Friedman RM
AD  - J. Craig Venter Institute, San Diego, California, USA.
FAU - Gantz, Valentino
AU  - Gantz V
AD  - University of California San Diego, La Jolla, California, USA.
FAU - Gibson, Clark
AU  - Gibson C
AD  - University of California San Diego, La Jolla, California, USA.
FAU - Hay, Bruce A
AU  - Hay BA
AD  - California Institute of Technology, Pasadena, California, USA.
FAU - Hoddle, Mark
AU  - Hoddle M
AD  - University of California Riverside, Riverside, California, USA.
FAU - James, Anthony A
AU  - James AA
AD  - University of California Irvine, Irvine, California, USA.
FAU - James, Stephanie
AU  - James S
AD  - Foundation for NIH, Rockville, Maryland, USA.
FAU - Jorgenson, Lyric
AU  - Jorgenson L
AD  - Office of Science Policy, National Institutes of Health, Bethesda, Maryland, USA.
FAU - Kalichman, Michael
AU  - Kalichman M
AD  - University of California San Diego, La Jolla, California, USA.
FAU - Marshall, John
AU  - Marshall J
AD  - University of California Berkeley, Berkeley, California, USA.
FAU - McGinnis, William
AU  - McGinnis W
AD  - University of California San Diego, La Jolla, California, USA.
FAU - Newman, Jack
AU  - Newman J
AD  - Zagaya Foundation, Emeryville, California, USA.
FAU - Pearson, Alan
AU  - Pearson A
AD  - Animal Plant Health Inspection Service, US Department of Agriculture, Washington,
      DC, USA.
FAU - Quemada, Hector
AU  - Quemada H
AD  - Donald Danforth Plant Science Center, St. Louis, Missouri, USA.
FAU - Rudenko, Larisa
AU  - Rudenko L
AD  - US Food and Drug Administration, Rockville, Maryland, USA.
FAU - Shelton, Anthony
AU  - Shelton A
AD  - Cornell University, Geneva, New York, USA.
FAU - Vinetz, Joseph M
AU  - Vinetz JM
AD  - University of California San Diego, La Jolla, California, USA.
FAU - Weisman, Jennifer
AU  - Weisman J
AD  - Strategic Analysis, Inc., Arlington, Virginia, USA.
FAU - Wong, Brenda
AU  - Wong B
AD  - University of California San Diego, La Jolla, California, USA.
FAU - Wozniak, Chris
AU  - Wozniak C
AD  - US Environmental Protection Agency, Washington, DC, USA.
LA  - eng
GR  - R01 GM117321/GM/NIGMS NIH HHS/United States
GR  - R56 AI070654/AI/NIAID NIH HHS/United States
GR  - R56 NS029870/NS/NINDS NIH HHS/United States
GR  - U19 AI089681/AI/NIAID NIH HHS/United States
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
PMC - PMC5831321
MID - NIHMS941701
EDAT- 2017/08/09 06:00
MHDA- 2017/08/09 06:00
CRDT- 2017/08/09 06:00
PHST- 2017/08/09 06:00 [entrez]
PHST- 2017/08/09 06:00 [pubmed]
PHST- 2017/08/09 06:00 [medline]
AID - nbt.3926 [pii]
AID - 10.1038/nbt.3926 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug 8;35(8):716-718. doi: 10.1038/nbt.3926.

PMID- 28787414
OWN - NLM
STAT- In-Data-Review
LR  - 20170808
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug 8
TI  - Around the world in a month.
PG  - 702
LID - 10.1038/nbt0817-702 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/08/09 06:00
MHDA- 2017/08/09 06:00
CRDT- 2017/08/09 06:00
PHST- 2017/08/09 06:00 [entrez]
PHST- 2017/08/09 06:00 [pubmed]
PHST- 2017/08/09 06:00 [medline]
AID - nbt0817-702 [pii]
AID - 10.1038/nbt0817-702 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug 8;35(8):702. doi: 10.1038/nbt0817-702.

PMID- 28787413
OWN - NLM
STAT- In-Data-Review
LR  - 20170808
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug 8
TI  - Plant breeders test drive first open-source seed bank.
PG  - 700
LID - 10.1038/nbt0817-700 [doi]
FAU - Laursen, Lucas
AU  - Laursen L
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/08/09 06:00
MHDA- 2017/08/09 06:00
CRDT- 2017/08/09 06:00
PHST- 2017/08/09 06:00 [entrez]
PHST- 2017/08/09 06:00 [pubmed]
PHST- 2017/08/09 06:00 [medline]
AID - nbt0817-700 [pii]
AID - 10.1038/nbt0817-700 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug 8;35(8):700. doi: 10.1038/nbt0817-700.

PMID- 28787412
OWN - NLM
STAT- In-Data-Review
LR  - 20170808
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug 8
TI  - What the roll out of EU data legislation means for you.
PG  - 712-713
LID - 10.1038/nbt.3928 [doi]
FAU - Neethu, Rajam
AU  - Neethu R
AD  - Center for Information and Innovation, Faculty of Law, University of Copenhagen, 
      Copenhagen, Denmark.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/08/09 06:00
MHDA- 2017/08/09 06:00
CRDT- 2017/08/09 06:00
PHST- 2017/08/09 06:00 [entrez]
PHST- 2017/08/09 06:00 [pubmed]
PHST- 2017/08/09 06:00 [medline]
AID - nbt.3928 [pii]
AID - 10.1038/nbt.3928 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug 8;35(8):712-713. doi: 10.1038/nbt.3928.

PMID- 28787411
OWN - NLM
STAT- In-Data-Review
LR  - 20170810
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug 8
TI  - First new drug approval for AML in 15 years.
PG  - 696-698
LID - 10.1038/nbt0817-696 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/08/09 06:00
MHDA- 2017/08/09 06:00
CRDT- 2017/08/09 06:00
PHST- 2017/08/09 06:00 [entrez]
PHST- 2017/08/09 06:00 [pubmed]
PHST- 2017/08/09 06:00 [medline]
AID - nbt0817-696 [pii]
AID - 10.1038/nbt0817-696 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug 8;35(8):696-698. doi: 10.1038/nbt0817-696.

PMID- 28787410
OWN - NLM
STAT- In-Data-Review
LR  - 20180202
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug 8
TI  - Erratum: Genome-wide target specificities of CRISPR RNA-guided programmable
      deaminases.
PG  - 797
LID - 10.1038/nbt0817-797d [doi]
FAU - Kim, Daesik
AU  - Kim D
FAU - Lim, Kayeong
AU  - Lim K
FAU - Kim, Sang-Tae
AU  - Kim ST
FAU - Yoon, Sun-Heui
AU  - Yoon SH
FAU - Kim, Kyoungmi
AU  - Kim K
FAU - Ryu, Seuk-Min
AU  - Ryu SM
FAU - Kim, Jin-Soo
AU  - Kim JS
LA  - eng
PT  - Journal Article
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2017 May;35(5):475-480. PMID: 28398345
EDAT- 2017/08/09 06:00
MHDA- 2017/08/09 06:00
CRDT- 2017/08/09 06:00
PHST- 2017/08/09 06:00 [entrez]
PHST- 2017/08/09 06:00 [pubmed]
PHST- 2017/08/09 06:00 [medline]
AID - nbt0817-797d [pii]
AID - 10.1038/nbt0817-797d [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug 8;35(8):797. doi: 10.1038/nbt0817-797d.

PMID- 28787409
OWN - NLM
STAT- In-Data-Review
LR  - 20170810
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug 8
TI  - Google, Novartis back Medicxi's ambitions.
PG  - 701
LID - 10.1038/nbt0817-701 [doi]
FAU - Senior, Melanie
AU  - Senior M
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/08/09 06:00
MHDA- 2017/08/09 06:00
CRDT- 2017/08/09 06:00
PHST- 2017/08/09 06:00 [entrez]
PHST- 2017/08/09 06:00 [pubmed]
PHST- 2017/08/09 06:00 [medline]
AID - nbt0817-701 [pii]
AID - 10.1038/nbt0817-701 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug 8;35(8):701. doi: 10.1038/nbt0817-701.

PMID- 28787408
OWN - NLM
STAT- In-Data-Review
LR  - 20170810
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug 8
TI  - First approval in sight for Novartis' CAR-T therapy after panel vote.
PG  - 691-693
LID - 10.1038/nbt0817-691 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/08/09 06:00
MHDA- 2017/08/09 06:00
CRDT- 2017/08/09 06:00
PHST- 2017/08/09 06:00 [entrez]
PHST- 2017/08/09 06:00 [pubmed]
PHST- 2017/08/09 06:00 [medline]
AID - nbt0817-691 [pii]
AID - 10.1038/nbt0817-691 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug 8;35(8):691-693. doi: 10.1038/nbt0817-691.

PMID- 28787407
OWN - NLM
STAT- In-Data-Review
LR  - 20170808
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug 8
TI  - Second-quarter biotech job picture.
PG  - 798
LID - 10.1038/nbt.3937 [doi]
FAU - Francisco, Michael
AU  - Francisco M
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/08/09 06:00
MHDA- 2017/08/09 06:00
CRDT- 2017/08/09 06:00
PHST- 2017/08/09 06:00 [entrez]
PHST- 2017/08/09 06:00 [pubmed]
PHST- 2017/08/09 06:00 [medline]
AID - nbt.3937 [pii]
AID - 10.1038/nbt.3937 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug 8;35(8):798. doi: 10.1038/nbt.3937.

PMID- 28787406
OWN - NLM
STAT- In-Data-Review
LR  - 20170808
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug 8
TI  - Ethical lessons from a tale of two genetically modified insects.
PG  - 713-716
LID - 10.1038/nbt.3927 [doi]
FAU - Neuhaus, Carolyn P
AU  - Neuhaus CP
AUID- ORCID: http://orcid.org/0000-0002-8563-5632
AD  - Division of Medical Ethics, NYU School of Medicine, New York, New York, USA.
AD  - The Hastings Center, Garrison, New York, USA.
FAU - Caplan, Arthur L
AU  - Caplan AL
AD  - Division of Medical Ethics, NYU School of Medicine, New York, New York, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/08/09 06:00
MHDA- 2017/08/09 06:00
CRDT- 2017/08/09 06:00
PHST- 2017/08/09 06:00 [entrez]
PHST- 2017/08/09 06:00 [pubmed]
PHST- 2017/08/09 06:00 [medline]
AID - nbt.3927 [pii]
AID - 10.1038/nbt.3927 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug 8;35(8):713-716. doi: 10.1038/nbt.3927.

PMID- 28787405
OWN - NLM
STAT- In-Data-Review
LR  - 20170810
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug 8
TI  - First multi-gene NGS diagnostic kit approved.
PG  - 699
LID - 10.1038/nbt0817-699 [doi]
FAU - Ratner, Mark
AU  - Ratner M
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/08/09 06:00
MHDA- 2017/08/09 06:00
CRDT- 2017/08/09 06:00
PHST- 2017/08/09 06:00 [entrez]
PHST- 2017/08/09 06:00 [pubmed]
PHST- 2017/08/09 06:00 [medline]
AID - nbt0817-699 [pii]
AID - 10.1038/nbt0817-699 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug 8;35(8):699. doi: 10.1038/nbt0817-699.

PMID- 28787404
OWN - NLM
STAT- In-Data-Review
LR  - 20170810
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug 8
TI  - Turning silver dust into electronics.
PG  - 723
LID - 10.1038/nbt.3939 [doi]
FAU - Jarchum, Irene
AU  - Jarchum I
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/08/09 06:00
MHDA- 2017/08/09 06:00
CRDT- 2017/08/09 06:00
PHST- 2017/08/09 06:00 [entrez]
PHST- 2017/08/09 06:00 [pubmed]
PHST- 2017/08/09 06:00 [medline]
AID - nbt.3939 [pii]
AID - 10.1038/nbt.3939 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug 8;35(8):723. doi: 10.1038/nbt.3939.

PMID- 28787403
OWN - NLM
STAT- In-Data-Review
LR  - 20170810
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug 8
TI  - Loxo TRK inhibitor data wows oncologists.
PG  - 694-695
LID - 10.1038/nbt0817-694 [doi]
FAU - Dolgin, Elie
AU  - Dolgin E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/08/09 06:00
MHDA- 2017/08/09 06:00
CRDT- 2017/08/09 06:00
PHST- 2017/08/09 06:00 [entrez]
PHST- 2017/08/09 06:00 [pubmed]
PHST- 2017/08/09 06:00 [medline]
AID - nbt0817-694 [pii]
AID - 10.1038/nbt0817-694 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug 8;35(8):694-695. doi: 10.1038/nbt0817-694.

PMID- 28787402
OWN - NLM
STAT- In-Data-Review
LR  - 20180202
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug 8
TI  - Erratum: Making individualized drugs a reality.
PG  - 797
LID - 10.1038/nbt0817-797c [doi]
FAU - Schellekens, Huub
AU  - Schellekens H
FAU - Aldosari, Mohammed
AU  - Aldosari M
FAU - Talsma, Herre
AU  - Talsma H
FAU - Mastrobattista, Enrico
AU  - Mastrobattista E
LA  - eng
PT  - Journal Article
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2017 Jun;35(6):507-513. PMID: 28581491
EDAT- 2017/08/09 06:00
MHDA- 2017/08/09 06:00
CRDT- 2017/08/09 06:00
PHST- 2017/08/09 06:00 [entrez]
PHST- 2017/08/09 06:00 [pubmed]
PHST- 2017/08/09 06:00 [medline]
AID - nbt0817-797c [pii]
AID - 10.1038/nbt0817-797c [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug 8;35(8):797. doi: 10.1038/nbt0817-797c.

PMID- 28767642
OWN - NLM
STAT- In-Data-Review
LR  - 20170810
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug
TI  - Time for the data to speak.
PG  - 689
LID - 10.1038/nbt.3938 [doi]
LA  - eng
PT  - Editorial
DEP - 20170802
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/08/03 06:00
MHDA- 2017/08/03 06:00
CRDT- 2017/08/03 06:00
PHST- 2017/08/03 06:00 [pubmed]
PHST- 2017/08/03 06:00 [medline]
PHST- 2017/08/03 06:00 [entrez]
AID - nbt.3938 [pii]
AID - 10.1038/nbt.3938 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug;35(8):689. doi: 10.1038/nbt.3938. Epub 2017 Aug 2.

PMID- 28714966
OWN - NLM
STAT- MEDLINE
DCOM- 20170821
LR  - 20180117
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug
TI  - Nanoscale imaging of clinical specimens using pathology-optimized expansion
      microscopy.
PG  - 757-764
LID - 10.1038/nbt.3892 [doi]
AB  - Expansion microscopy (ExM), a method for improving the resolution of light
      microscopy by physically expanding a specimen, has not been applied to clinical
      tissue samples. Here we report a clinically optimized form of ExM that supports
      nanoscale imaging of human tissue specimens that have been fixed with formalin,
      embedded in paraffin, stained with hematoxylin and eosin, and/or fresh frozen.
      The method, which we call expansion pathology (ExPath), converts clinical samples
      into an ExM-compatible state, then applies an ExM protocol with protein anchoring
      and mechanical homogenization steps optimized for clinical samples. ExPath
      enables approximately 70-nm-resolution imaging of diverse biomolecules in intact 
      tissues using conventional diffraction-limited microscopes and standard antibody 
      and fluorescent DNA in situ hybridization reagents. We use ExPath for optical
      diagnosis of kidney minimal-change disease, a process that previously required
      electron microscopy, and we demonstrate high-fidelity computational
      discrimination between early breast neoplastic lesions for which pathologists
      often disagree in classification. ExPath may enable the routine use of nanoscale 
      imaging in pathology and clinical research.
FAU - Zhao, Yongxin
AU  - Zhao Y
AD  - MIT Media Lab, Massachusetts Institute of Technology, Cambridge, Massachusetts,
      USA.
FAU - Bucur, Octavian
AU  - Bucur O
AD  - Department of Pathology and Cancer Research Institute, Beth Israel Deaconess
      Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
AD  - Ludwig Center at Harvard Medical School, Boston, Massachusetts, USA.
AD  - Institute of Biochemistry of the Romanian Academy, Bucharest, Romania.
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
FAU - Irshad, Humayun
AU  - Irshad H
AD  - Department of Pathology and Cancer Research Institute, Beth Israel Deaconess
      Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
AD  - Ludwig Center at Harvard Medical School, Boston, Massachusetts, USA.
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
FAU - Chen, Fei
AU  - Chen F
AD  - MIT Media Lab, Massachusetts Institute of Technology, Cambridge, Massachusetts,
      USA.
AD  - Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
AD  - McGovern Institute, Massachusetts Institute of Technology, Cambridge,
      Massachusetts, USA.
FAU - Weins, Astrid
AU  - Weins A
AD  - Department of Pathology, Brigham and Women's Hospital, Harvard Medical School,
      Boston, Massachusetts, USA.
AD  - Department of Medicine, Renal Division, Brigham and Women's Hospital, Harvard
      Medical School, Boston, Massachusetts, USA.
FAU - Stancu, Andreea L
AU  - Stancu AL
AD  - Department of Pathology and Cancer Research Institute, Beth Israel Deaconess
      Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
FAU - Oh, Eun-Young
AU  - Oh EY
AD  - Department of Pathology and Cancer Research Institute, Beth Israel Deaconess
      Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
FAU - DiStasio, Marcello
AU  - DiStasio M
AD  - Department of Pathology and Cancer Research Institute, Beth Israel Deaconess
      Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Torous, Vanda
AU  - Torous V
AD  - Department of Pathology and Cancer Research Institute, Beth Israel Deaconess
      Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Glass, Benjamin
AU  - Glass B
AD  - Department of Pathology and Cancer Research Institute, Beth Israel Deaconess
      Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Stillman, Isaac E
AU  - Stillman IE
AD  - Department of Pathology and Cancer Research Institute, Beth Israel Deaconess
      Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Schnitt, Stuart J
AU  - Schnitt SJ
AD  - Department of Pathology and Cancer Research Institute, Beth Israel Deaconess
      Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Beck, Andrew H
AU  - Beck AH
AD  - Department of Pathology and Cancer Research Institute, Beth Israel Deaconess
      Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
AD  - Ludwig Center at Harvard Medical School, Boston, Massachusetts, USA.
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
FAU - Boyden, Edward S
AU  - Boyden ES
AD  - MIT Media Lab, Massachusetts Institute of Technology, Cambridge, Massachusetts,
      USA.
AD  - Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
AD  - McGovern Institute, Massachusetts Institute of Technology, Cambridge,
      Massachusetts, USA.
AD  - Department of Brain and Cognitive Sciences, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
LA  - eng
GR  - R21 CA187642/CA/NCI NIH HHS/United States
GR  - U01 MH106011/MH/NIMH NIH HHS/United States
GR  - R01 EY023173/EY/NEI NIH HHS/United States
GR  - R01 GM104948/GM/NIGMS NIH HHS/United States
GR  - DP1 NS087724/NS/NINDS NIH HHS/United States
GR  - UL1 TR001102/TR/NCATS NIH HHS/United States
GR  - R01 MH110932/MH/NIMH NIH HHS/United States
PT  - Journal Article
DEP - 20170717
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biopsy
MH  - Breast/diagnostic imaging/pathology/ultrastructure
MH  - Female
MH  - Histological Techniques
MH  - Humans
MH  - Image Processing, Computer-Assisted/*methods
MH  - Kidney/diagnostic imaging/pathology/ultrastructure
MH  - Microscopy/*methods
MH  - Molecular Imaging/*methods
MH  - Nanomedicine/*methods
MH  - Nephrosis, Lipoid/diagnostic imaging/pathology
PMC - PMC5548617
MID - NIHMS872468
EDAT- 2017/07/18 06:00
MHDA- 2017/08/22 06:00
CRDT- 2017/07/18 06:00
PHST- 2016/06/29 00:00 [received]
PHST- 2017/04/28 00:00 [accepted]
PHST- 2017/07/18 06:00 [pubmed]
PHST- 2017/08/22 06:00 [medline]
PHST- 2017/07/18 06:00 [entrez]
AID - nbt.3892 [pii]
AID - 10.1038/nbt.3892 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug;35(8):757-764. doi: 10.1038/nbt.3892. Epub 2017 Jul 17.

PMID- 28714965
OWN - NLM
STAT- MEDLINE
DCOM- 20170821
LR  - 20180213
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug
TI  - A wellness study of 108 individuals using personal, dense, dynamic data clouds.
PG  - 747-756
LID - 10.1038/nbt.3870 [doi]
AB  - Personal data for 108 individuals were collected during a 9-month period,
      including whole genome sequences; clinical tests, metabolomes, proteomes, and
      microbiomes at three time points; and daily activity tracking. Using all of these
      data, we generated a correlation network that revealed communities of related
      analytes associated with physiology and disease. Connectivity within analyte
      communities enabled the identification of known and candidate biomarkers (e.g.,
      gamma-glutamyltyrosine was densely interconnected with clinical analytes for
      cardiometabolic disease). We calculated polygenic scores from genome-wide
      association studies (GWAS) for 127 traits and diseases, and used these to
      discover molecular correlates of polygenic risk (e.g., genetic risk for
      inflammatory bowel disease was negatively correlated with plasma cystine).
      Finally, behavioral coaching informed by personal data helped participants to
      improve clinical biomarkers. Our results show that measurement of personal data
      clouds over time can improve our understanding of health and disease, including
      early transitions to disease states.
FAU - Price, Nathan D
AU  - Price ND
AD  - Institute for Systems Biology, Seattle, Washington, USA.
AD  - Arivale, Seattle, Washington, USA.
FAU - Magis, Andrew T
AU  - Magis AT
AD  - Arivale, Seattle, Washington, USA.
FAU - Earls, John C
AU  - Earls JC
AD  - Arivale, Seattle, Washington, USA.
FAU - Glusman, Gustavo
AU  - Glusman G
AUID- ORCID: http://orcid.org/0000-0001-8060-5955
AD  - Institute for Systems Biology, Seattle, Washington, USA.
FAU - Levy, Roie
AU  - Levy R
AD  - Institute for Systems Biology, Seattle, Washington, USA.
FAU - Lausted, Christopher
AU  - Lausted C
AD  - Institute for Systems Biology, Seattle, Washington, USA.
FAU - McDonald, Daniel T
AU  - McDonald DT
AD  - Institute for Systems Biology, Seattle, Washington, USA.
FAU - Kusebauch, Ulrike
AU  - Kusebauch U
AD  - Institute for Systems Biology, Seattle, Washington, USA.
FAU - Moss, Christopher L
AU  - Moss CL
AD  - Institute for Systems Biology, Seattle, Washington, USA.
FAU - Zhou, Yong
AU  - Zhou Y
AD  - Institute for Systems Biology, Seattle, Washington, USA.
FAU - Qin, Shizhen
AU  - Qin S
AD  - Institute for Systems Biology, Seattle, Washington, USA.
FAU - Moritz, Robert L
AU  - Moritz RL
AUID- ORCID: http://orcid.org/0000-0002-3216-9447
AD  - Institute for Systems Biology, Seattle, Washington, USA.
FAU - Brogaard, Kristin
AU  - Brogaard K
AD  - Arivale, Seattle, Washington, USA.
FAU - Omenn, Gilbert S
AU  - Omenn GS
AD  - Institute for Systems Biology, Seattle, Washington, USA.
AD  - Department of Computational Medicine and Bioinformatics, University of Michigan, 
      Ann Arbor, Michigan, USA.
FAU - Lovejoy, Jennifer C
AU  - Lovejoy JC
AD  - Institute for Systems Biology, Seattle, Washington, USA.
AD  - Arivale, Seattle, Washington, USA.
FAU - Hood, Leroy
AU  - Hood L
AD  - Institute for Systems Biology, Seattle, Washington, USA.
AD  - Providence St. Joseph Health, Seattle, Washington, USA.
LA  - eng
GR  - P30 ES017885/ES/NIEHS NIH HHS/United States
GR  - P50 GM076547/GM/NIGMS NIH HHS/United States
GR  - RC2 HG005805/HG/NHGRI NIH HHS/United States
GR  - U24 CA210967/CA/NCI NIH HHS/United States
PT  - Journal Article
DEP - 20170717
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Biomarkers)
RN  - 0 (Proteome)
SB  - IM
MH  - *Biomarkers/analysis/blood
MH  - Computational Biology/*methods
MH  - *Databases, Factual
MH  - Exercise/physiology
MH  - Genome-Wide Association Study/*methods
MH  - Humans
MH  - Longitudinal Studies
MH  - Metabolome
MH  - Microbiota
MH  - Models, Statistical
MH  - Monitoring, Physiologic
MH  - Neoplasms/genetics/metabolism
MH  - Nutritional Status
MH  - Proteome
PMC - PMC5568837
MID - NIHMS867769
EDAT- 2017/07/18 06:00
MHDA- 2017/08/22 06:00
CRDT- 2017/07/18 06:00
PHST- 2016/10/16 00:00 [received]
PHST- 2017/04/11 00:00 [accepted]
PHST- 2017/07/18 06:00 [pubmed]
PHST- 2017/08/22 06:00 [medline]
PHST- 2017/07/18 06:00 [entrez]
AID - nbt.3870 [pii]
AID - 10.1038/nbt.3870 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug;35(8):747-756. doi: 10.1038/nbt.3870. Epub 2017 Jul 17.

PMID- 28671662
OWN - NLM
STAT- MEDLINE
DCOM- 20170821
LR  - 20170927
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug
TI  - Long time-lapse nanoscopy with spontaneously blinking membrane probes.
PG  - 773-780
LID - 10.1038/nbt.3876 [doi]
AB  - Imaging cellular structures and organelles in living cells by long time-lapse
      super-resolution microscopy is challenging, as it requires dense labeling, bright
      and highly photostable dyes, and non-toxic conditions. We introduce a set of
      high-density, environment-sensitive (HIDE) membrane probes, based on the
      membrane-permeable silicon-rhodamine dye HMSiR, that assemble in situ and enable 
      long time-lapse, live-cell nanoscopy of discrete cellular structures and
      organelles with high spatiotemporal resolution. HIDE-enabled nanoscopy movies
      span tens of minutes, whereas movies obtained with labeled proteins span tens of 
      seconds. Our data reveal 2D dynamics of the mitochondria, plasma membrane and
      filopodia, and the 2D and 3D dynamics of the endoplasmic reticulum, in living
      cells. HIDE probes also facilitate acquisition of live-cell, two-color,
      super-resolution images, expanding the utility of nanoscopy to visualize dynamic 
      processes and structures in living cells.
FAU - Takakura, Hideo
AU  - Takakura H
AD  - Department of Cell Biology, Yale University School of Medicine, New Haven,
      Connecticut, USA.
FAU - Zhang, Yongdeng
AU  - Zhang Y
AUID- ORCID: http://orcid.org/0000-0002-4569-8137
AD  - Department of Cell Biology, Yale University School of Medicine, New Haven,
      Connecticut, USA.
FAU - Erdmann, Roman S
AU  - Erdmann RS
AD  - Department of Cell Biology, Yale University School of Medicine, New Haven,
      Connecticut, USA.
AD  - Department of Chemistry, Yale University, New Haven, Connecticut, USA.
FAU - Thompson, Alexander D
AU  - Thompson AD
AD  - Department of Chemistry, Yale University, New Haven, Connecticut, USA.
FAU - Lin, Yu
AU  - Lin Y
AD  - Department of Cell Biology, Yale University School of Medicine, New Haven,
      Connecticut, USA.
FAU - McNellis, Brian
AU  - McNellis B
AD  - Department of Cell Biology, Yale University School of Medicine, New Haven,
      Connecticut, USA.
FAU - Rivera-Molina, Felix
AU  - Rivera-Molina F
AD  - Department of Cell Biology, Yale University School of Medicine, New Haven,
      Connecticut, USA.
FAU - Uno, Shin-Nosuke
AU  - Uno SN
AD  - Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan.
FAU - Kamiya, Mako
AU  - Kamiya M
AD  - Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan.
AD  - PRESTO, Japan Science and Technology Agency, Kawaguchi, Saitama, Japan.
FAU - Urano, Yasuteru
AU  - Urano Y
AD  - Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan.
AD  - Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo-ku,
      Japan.
AD  - CREST, Japan Agency for Medical Research and Development (AMED), Chiyoda-ku,
      Tokyo, Japan.
FAU - Rothman, James E
AU  - Rothman JE
AD  - Department of Cell Biology, Yale University School of Medicine, New Haven,
      Connecticut, USA.
FAU - Bewersdorf, Joerg
AU  - Bewersdorf J
AUID- ORCID: http://orcid.org/0000-0002-4085-7020
AD  - Department of Cell Biology, Yale University School of Medicine, New Haven,
      Connecticut, USA.
AD  - Department of Biomedical Engineering, Yale University, New Haven, Connecticut,
      USA.
FAU - Schepartz, Alanna
AU  - Schepartz A
AD  - Department of Chemistry, Yale University, New Haven, Connecticut, USA.
AD  - Department of Molecular, Cellular, and Developmental Biology, Yale University,
      New Haven, Connecticut, USA.
FAU - Toomre, Derek
AU  - Toomre D
AD  - Department of Cell Biology, Yale University School of Medicine, New Haven,
      Connecticut, USA.
LA  - eng
GR  - F31 GM119259/GM/NIGMS NIH HHS/United States
GR  - R01 GM118486/GM/NIGMS NIH HHS/United States
GR  - P30 DK045735/DK/NIDDK NIH HHS/United States
GR  - R01 GM083257/GM/NIGMS NIH HHS/United States
GR  - Wellcome Trust/United Kingdom
PT  - Journal Article
DEP - 20170703
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Fluorescent Dyes)
SB  - IM
MH  - Cellular Structures/*ultrastructure
MH  - Fluorescent Dyes/*analysis/*chemistry
MH  - HeLa Cells
MH  - Humans
MH  - Microscopy, Fluorescence/*methods
MH  - Nanotechnology/*methods
PMC - PMC5609855
MID - NIHMS893131
EDAT- 2017/07/04 06:00
MHDA- 2017/08/22 06:00
CRDT- 2017/07/04 06:00
PHST- 2016/12/22 00:00 [received]
PHST- 2017/04/13 00:00 [accepted]
PHST- 2017/07/04 06:00 [pubmed]
PHST- 2017/08/22 06:00 [medline]
PHST- 2017/07/04 06:00 [entrez]
AID - nbt.3876 [pii]
AID - 10.1038/nbt.3876 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug;35(8):773-780. doi: 10.1038/nbt.3876. Epub 2017 Jul 3.

PMID- 28604659
OWN - NLM
STAT- MEDLINE
DCOM- 20170821
LR  - 20171212
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug
TI  - Inference and quantification of peptidoforms in large sample cohorts by SWATH-MS.
PG  - 781-788
LID - 10.1038/nbt.3908 [doi]
AB  - Consistent detection and quantification of protein post-translational
      modifications (PTMs) across sample cohorts is a prerequisite for functional
      analysis of biological processes. Data-independent acquisition (DIA) is a
      bottom-up mass spectrometry approach that provides complete information on
      precursor and fragment ions. However, owing to the convoluted structure of DIA
      data sets, confident, systematic identification and quantification of
      peptidoforms has remained challenging. Here, we present inference of peptidoforms
      (IPF), a fully automated algorithm that uses spectral libraries to query,
      validate and quantify peptidoforms in DIA data sets. The method was developed on 
      data acquired by the DIA method SWATH-MS and benchmarked using a synthetic
      phosphopeptide reference data set and phosphopeptide-enriched samples. IPF
      reduced false site-localization by more than sevenfold compared with previous
      approaches, while recovering 85.4% of the true signals. Using IPF, we quantified 
      peptidoforms in DIA data acquired from >200 samples of blood plasma of a human
      twin cohort and assessed the contribution of heritable, environmental and
      longitudinal effects on their PTMs.
FAU - Rosenberger, George
AU  - Rosenberger G
AUID- ORCID: http://orcid.org/0000-0002-1655-6789
AD  - Department of Biology, Institute of Molecular Systems Biology, ETH Zurich,
      Zurich, Switzerland.
AD  - PhD Program in Systems Biology, University of Zurich and ETH Zurich, Zurich,
      Switzerland.
FAU - Liu, Yansheng
AU  - Liu Y
AUID- ORCID: http://orcid.org/0000-0002-2626-3912
AD  - Department of Biology, Institute of Molecular Systems Biology, ETH Zurich,
      Zurich, Switzerland.
FAU - Rost, Hannes L
AU  - Rost HL
AUID- ORCID: http://orcid.org/0000-0003-0990-7488
AD  - Department of Biology, Institute of Molecular Systems Biology, ETH Zurich,
      Zurich, Switzerland.
AD  - Department of Genetics, Stanford University, Stanford, California, USA.
FAU - Ludwig, Christina
AU  - Ludwig C
AD  - Department of Biology, Institute of Molecular Systems Biology, ETH Zurich,
      Zurich, Switzerland.
AD  - Bavarian Biomolecular Mass Spectrometry Center (BayBioMS), Technical University
      Munich, Freising, Germany.
FAU - Buil, Alfonso
AU  - Buil A
AUID- ORCID: http://orcid.org/0000-0002-1863-164X
AD  - Research Institute of Biological Psychiatry, Mental Health Center Sct. Hans,
      Roskilde, Denmark.
FAU - Bensimon, Ariel
AU  - Bensimon A
AD  - Department of Biology, Institute of Molecular Systems Biology, ETH Zurich,
      Zurich, Switzerland.
FAU - Soste, Martin
AU  - Soste M
AD  - Department of Biology, Institute of Biochemistry, ETH Zurich, Zurich,
      Switzerland.
FAU - Spector, Tim D
AU  - Spector TD
AD  - Department of Twin Research and Genetic Epidemiology, King's College London, St
      Thomas' Hospital Campus, London, UK.
FAU - Dermitzakis, Emmanouil T
AU  - Dermitzakis ET
AD  - Department of Genetic Medicine and Development, University of Geneva Medical
      School, Geneva, Switzerland.
FAU - Collins, Ben C
AU  - Collins BC
AUID- ORCID: http://orcid.org/0000-0003-0827-3495
AD  - Department of Biology, Institute of Molecular Systems Biology, ETH Zurich,
      Zurich, Switzerland.
FAU - Malmstrom, Lars
AU  - Malmstrom L
AUID- ORCID: http://orcid.org/0000-0001-9885-9312
AD  - Department of Biology, Institute of Molecular Systems Biology, ETH Zurich,
      Zurich, Switzerland.
AD  - S3IT, University of Zurich, Zurich, Switzerland.
FAU - Aebersold, Ruedi
AU  - Aebersold R
AD  - Department of Biology, Institute of Molecular Systems Biology, ETH Zurich,
      Zurich, Switzerland.
AD  - Faculty of Science, University of Zurich, Zurich, Switzerland.
LA  - eng
GR  - Wellcome Trust/United Kingdom
PT  - Journal Article
DEP - 20170612
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (APOA1 protein, human)
RN  - 0 (Apolipoprotein A-I)
RN  - 0 (Peptides)
RN  - 0 (Phosphopeptides)
SB  - IM
MH  - Algorithms
MH  - Apolipoprotein A-I/chemistry
MH  - Humans
MH  - Mass Spectrometry/*methods
MH  - Peptides/*blood/*chemistry
MH  - Phosphopeptides/blood/chemistry
MH  - *Protein Processing, Post-Translational
MH  - Proteomics/*methods
MH  - Twins
PMC - PMC5593115
MID - EMS72902
EDAT- 2017/06/13 06:00
MHDA- 2017/08/22 06:00
CRDT- 2017/06/13 06:00
PHST- 2016/11/15 00:00 [received]
PHST- 2017/05/22 00:00 [accepted]
PHST- 2017/06/13 06:00 [pubmed]
PHST- 2017/08/22 06:00 [medline]
PHST- 2017/06/13 06:00 [entrez]
AID - nbt.3908 [pii]
AID - 10.1038/nbt.3908 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug;35(8):781-788. doi: 10.1038/nbt.3908. Epub 2017 Jun 12.

PMID- 28581492
OWN - NLM
STAT- MEDLINE
DCOM- 20170821
LR  - 20171205
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug
TI  - Engineered Cpf1 variants with altered PAM specificities.
PG  - 789-792
LID - 10.1038/nbt.3900 [doi]
AB  - The RNA-guided endonuclease Cpf1 is a promising tool for genome editing in
      eukaryotic cells. However, the utility of the commonly used Acidaminococcus sp.
      BV3L6 Cpf1 (AsCpf1) and Lachnospiraceae bacterium ND2006 Cpf1 (LbCpf1) is limited
      by their requirement of a TTTV protospacer adjacent motif (PAM) in the DNA
      substrate. To address this limitation, we performed a structure-guided
      mutagenesis screen to increase the targeting range of Cpf1. We engineered two
      AsCpf1 variants carrying the mutations S542R/K607R and S542R/K548V/N552R, which
      recognize TYCV and TATV PAMs, respectively, with enhanced activities in vitro and
      in human cells. Genome-wide assessment of off-target activity using BLISS
      indicated that these variants retain high DNA-targeting specificity, which we
      further improved by introducing an additional non-PAM-interacting mutation.
      Introducing the identified PAM-interacting mutations at their corresponding
      positions in LbCpf1 similarly altered its PAM specificity. Together, these
      variants increase the targeting range of Cpf1 by approximately threefold in human
      coding sequences to one cleavage site per approximately 11 bp.
FAU - Gao, Linyi
AU  - Gao L
AUID- ORCID: http://orcid.org/0000-0002-3579-0327
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
AD  - Department of Biological Engineering, Massachusetts Institute of Technology
      Cambridge, Massachusetts, USA.
FAU - Cox, David B T
AU  - Cox DBT
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
AD  - Department of Biology, Massachusetts Institute of Technology, Cambridge,
      Massachusetts, USA.
AD  - Harvard-MIT Division of Health Sciences and Technology, Harvard Medical School,
      Boston, Massachusetts, USA.
FAU - Yan, Winston X
AU  - Yan WX
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
AD  - Harvard-MIT Division of Health Sciences and Technology, Harvard Medical School,
      Boston, Massachusetts, USA.
AD  - Graduate Program in Biophysics, Harvard Medical School, Boston, Massachusetts,
      USA.
FAU - Manteiga, John C
AU  - Manteiga JC
AD  - Department of Biology, Massachusetts Institute of Technology, Cambridge,
      Massachusetts, USA.
FAU - Schneider, Martin W
AU  - Schneider MW
AUID- ORCID: http://orcid.org/0000-0001-9760-6292
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
FAU - Yamano, Takashi
AU  - Yamano T
AD  - Department of Biological Sciences, Graduate School of Science, The University of 
      Tokyo, Tokyo, Japan.
FAU - Nishimasu, Hiroshi
AU  - Nishimasu H
AD  - Department of Biological Sciences, Graduate School of Science, The University of 
      Tokyo, Tokyo, Japan.
AD  - JST, PRESTO, Tokyo, Japan.
FAU - Nureki, Osamu
AU  - Nureki O
AD  - Department of Biological Sciences, Graduate School of Science, The University of 
      Tokyo, Tokyo, Japan.
FAU - Crosetto, Nicola
AU  - Crosetto N
AD  - Science for Life Laboratory, Division of Translational Medicine and Chemical
      Biology, Department of Medical Biochemistry and Biophysics, Karolinska
      Institutet, Stockholm, Sweden.
FAU - Zhang, Feng
AU  - Zhang F
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
AD  - Department of Biological Engineering, Massachusetts Institute of Technology
      Cambridge, Massachusetts, USA.
AD  - McGovern Institute for Brain Research, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
AD  - Department of Brain and Cognitive Sciences, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
LA  - eng
GR  - DP1 MH100706/MH/NIMH NIH HHS/United States
GR  - R01 MH110049/MH/NIMH NIH HHS/United States
GR  - T32 GM007287/GM/NIGMS NIH HHS/United States
GR  - T32 GM007753/GM/NIGMS NIH HHS/United States
PT  - Journal Article
DEP - 20170605
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Bacterial Proteins)
RN  - EC 3.1.- (Endonucleases)
SB  - IM
MH  - Acidaminococcus/enzymology/genetics
MH  - Bacterial Proteins/*genetics
MH  - Endonucleases/*genetics
MH  - Genetic Engineering/*methods
MH  - Genetic Variation/*genetics
MH  - HEK293 Cells
MH  - Humans
MH  - Mutagenesis, Site-Directed/*methods
PMC - PMC5548640
MID - NIHMS877403
EDAT- 2017/06/06 06:00
MHDA- 2017/08/22 06:00
CRDT- 2017/06/06 06:00
PHST- 2016/11/27 00:00 [received]
PHST- 2017/05/16 00:00 [accepted]
PHST- 2017/06/06 06:00 [pubmed]
PHST- 2017/08/22 06:00 [medline]
PHST- 2017/06/06 06:00 [entrez]
AID - nbt.3900 [pii]
AID - 10.1038/nbt.3900 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug;35(8):789-792. doi: 10.1038/nbt.3900. Epub 2017 Jun 5.

PMID- 28504668
OWN - NLM
STAT- MEDLINE
DCOM- 20170821
LR  - 20171115
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug
TI  - HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by 
      NK cells.
PG  - 765-772
LID - 10.1038/nbt.3860 [doi]
AB  - Polymorphisms in the human leukocyte antigen (HLA) class I genes can cause the
      rejection of pluripotent stem cell (PSC)-derived products in allogeneic
      recipients. Disruption of the Beta-2 Microglobulin (B2M) gene eliminates surface 
      expression of all class I molecules, but leaves the cells vulnerable to lysis by 
      natural killer (NK) cells. Here we show that this 'missing-self' response can be 
      prevented by forced expression of minimally polymorphic HLA-E molecules. We use
      adeno-associated virus (AAV)-mediated gene editing to knock in HLA-E genes at the
      B2M locus in human PSCs in a manner that confers inducible, regulated, surface
      expression of HLA-E single-chain dimers (fused to B2M) or trimers (fused to B2M
      and a peptide antigen), without surface expression of HLA-A, B or C. These
      HLA-engineered PSCs and their differentiated derivatives are not recognized as
      allogeneic by CD8(+) T cells, do not bind anti-HLA antibodies and are resistant
      to NK-mediated lysis. Our approach provides a potential source of universal donor
      cells for applications where the differentiated derivatives lack HLA class II
      expression.
FAU - Gornalusse, German G
AU  - Gornalusse GG
AD  - Department of Medicine, University of Washington, Seattle, Washington, USA.
FAU - Hirata, Roli K
AU  - Hirata RK
AD  - Department of Medicine, University of Washington, Seattle, Washington, USA.
FAU - Funk, Sarah E
AU  - Funk SE
AD  - Department of Medicine, University of Washington, Seattle, Washington, USA.
FAU - Riolobos, Laura
AU  - Riolobos L
AD  - Department of Medicine, University of Washington, Seattle, Washington, USA.
FAU - Lopes, Vanda S
AU  - Lopes VS
AD  - Center for Stem Cell Biology and Engineering, Department of Molecular, Cellular, 
      and Developmental Biology, University of California, Santa Barbara, USA.
FAU - Manske, Gabriel
AU  - Manske G
AD  - Department of Medicine, University of Washington, Seattle, Washington, USA.
FAU - Prunkard, Donna
AU  - Prunkard D
AD  - Department of Medicine, University of Washington, Seattle, Washington, USA.
FAU - Colunga, Aric G
AU  - Colunga AG
AD  - Department of Medicine, University of Washington, Seattle, Washington, USA.
FAU - Hanafi, Laila-Aicha
AU  - Hanafi LA
AD  - Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle,
      Washington, USA.
FAU - Clegg, Dennis O
AU  - Clegg DO
AD  - Center for Stem Cell Biology and Engineering, Department of Molecular, Cellular, 
      and Developmental Biology, University of California, Santa Barbara, USA.
FAU - Turtle, Cameron
AU  - Turtle C
AD  - Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle,
      Washington, USA.
FAU - Russell, David W
AU  - Russell DW
AD  - Department of Medicine, University of Washington, Seattle, Washington, USA.
AD  - Department of Biochemistry, University of Washington, Seattle, Washington, USA.
LA  - eng
GR  - R01 DK055759/DK/NIDDK NIH HHS/United States
GR  - R01 HL130770/HL/NHLBI NIH HHS/United States
GR  - T32 HL007093/HL/NHLBI NIH HHS/United States
GR  - U54 DK106829/DK/NIDDK NIH HHS/United States
PT  - Journal Article
DEP - 20170515
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (HLA Antigens)
SB  - IM
MH  - Animals
MH  - Female
MH  - Graft Rejection/immunology
MH  - HLA Antigens/chemistry/genetics/*immunology
MH  - Humans
MH  - Killer Cells, Natural/*immunology
MH  - Mice
MH  - Pluripotent Stem Cells/chemistry/cytology/*immunology
MH  - Transplants/chemistry/cytology/*immunology
PMC - PMC5548598
MID - NIHMS863048
EDAT- 2017/05/16 06:00
MHDA- 2017/08/22 06:00
CRDT- 2017/05/16 06:00
PHST- 2016/05/09 00:00 [received]
PHST- 2017/03/24 00:00 [accepted]
PHST- 2017/05/16 06:00 [pubmed]
PHST- 2017/08/22 06:00 [medline]
PHST- 2017/05/16 06:00 [entrez]
AID - nbt.3860 [pii]
AID - 10.1038/nbt.3860 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug;35(8):765-772. doi: 10.1038/nbt.3860. Epub 2017 May 15.

PMID- 28504667
OWN - NLM
STAT- MEDLINE
DCOM- 20170821
LR  - 20170821
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 8
DP  - 2017 Aug
TI  - Rapid cloning of genes in hexaploid wheat using cultivar-specific long-range
      chromosome assembly.
PG  - 793-796
LID - 10.1038/nbt.3877 [doi]
AB  - Cereal crops such as wheat and maize have large repeat-rich genomes that make
      cloning of individual genes challenging. Moreover, gene order and gene sequences 
      often differ substantially between cultivars of the same crop species. A major
      bottleneck for gene cloning in cereals is the generation of high-quality sequence
      information from a cultivar of interest. In order to accelerate gene cloning from
      any cropping line, we report 'targeted chromosome-based cloning via long-range
      assembly' (TACCA). TACCA combines lossless genome-complexity reduction via
      chromosome flow sorting with Chicago long-range linkage to assemble complex
      genomes. We applied TACCA to produce a high-quality (N50 of 9.76 Mb) de novo
      chromosome assembly of the wheat line CH Campala Lr22a in only 4 months. Using
      this assembly we cloned the broad-spectrum Lr22a leaf-rust resistance gene, using
      molecular marker information and ethyl methanesulfonate (EMS) mutants, and found 
      that Lr22a encodes an intracellular immune receptor homologous to the Arabidopsis
      thaliana RPM1 protein.
FAU - Thind, Anupriya Kaur
AU  - Thind AK
AD  - Department of Plant and Microbial Biology, University of Zurich, Zurich,
      Switzerland.
FAU - Wicker, Thomas
AU  - Wicker T
AD  - Department of Plant and Microbial Biology, University of Zurich, Zurich,
      Switzerland.
FAU - Simkova, Hana
AU  - Simkova H
AD  - Institute of Experimental Botany, Centre of the Region Hana for Biotechnological 
      and Agricultural Research, Olomouc, Czech Republic.
FAU - Fossati, Dario
AU  - Fossati D
AD  - Institute for Plant Production Sciences, Agroscope, Switzerland.
FAU - Moullet, Odile
AU  - Moullet O
AD  - Institute for Plant Production Sciences, Agroscope, Switzerland.
FAU - Brabant, Cecile
AU  - Brabant C
AD  - Institute for Plant Production Sciences, Agroscope, Switzerland.
FAU - Vrana, Jan
AU  - Vrana J
AD  - Institute of Experimental Botany, Centre of the Region Hana for Biotechnological 
      and Agricultural Research, Olomouc, Czech Republic.
FAU - Dolezel, Jaroslav
AU  - Dolezel J
AUID- ORCID: http://orcid.org/0000-0002-6263-0492
AD  - Institute of Experimental Botany, Centre of the Region Hana for Biotechnological 
      and Agricultural Research, Olomouc, Czech Republic.
FAU - Krattinger, Simon G
AU  - Krattinger SG
AD  - Department of Plant and Microbial Biology, University of Zurich, Zurich,
      Switzerland.
LA  - eng
PT  - Journal Article
DEP - 20170515
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology
MH  - Cloning, Molecular/*methods
MH  - Edible Grain/*genetics
MH  - Genes, Plant/*genetics
MH  - Genetic Linkage
MH  - Triticum/*genetics
EDAT- 2017/05/16 06:00
MHDA- 2017/08/22 06:00
CRDT- 2017/05/16 06:00
PHST- 2016/10/21 00:00 [received]
PHST- 2017/04/11 00:00 [accepted]
PHST- 2017/05/16 06:00 [pubmed]
PHST- 2017/08/22 06:00 [medline]
PHST- 2017/05/16 06:00 [entrez]
AID - nbt.3877 [pii]
AID - 10.1038/nbt.3877 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Aug;35(8):793-796. doi: 10.1038/nbt.3877. Epub 2017 May 15.

PMID- 28700562
OWN - NLM
STAT- In-Data-Review
LR  - 20170715
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 7
DP  - 2017 Jul 12
TI  - Single-cell genomics for the masses.
PG  - 635-636
LID - 10.1038/nbt.3914 [doi]
FAU - Tringe, Susannah G
AU  - Tringe SG
AUID- ORCID: http://orcid.org/0000-0001-6479-8427
AD  - DOE Joint Genome Institute, Walnut Creek, California, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/07/13 06:00
MHDA- 2017/07/13 06:00
CRDT- 2017/07/13 06:00
PHST- 2017/07/13 06:00 [entrez]
PHST- 2017/07/13 06:00 [pubmed]
PHST- 2017/07/13 06:00 [medline]
AID - nbt.3914 [pii]
AID - 10.1038/nbt.3914 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jul 12;35(7):635-636. doi: 10.1038/nbt.3914.

PMID- 28700561
OWN - NLM
STAT- In-Data-Review
LR  - 20170712
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 7
DP  - 2017 Jul 12
TI  - Recent patents in optogenetics and optochemistry.
PG  - 634
LID - 10.1038/nbt.3922 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/07/13 06:00
MHDA- 2017/07/13 06:00
CRDT- 2017/07/13 06:00
PHST- 2017/07/13 06:00 [entrez]
PHST- 2017/07/13 06:00 [pubmed]
PHST- 2017/07/13 06:00 [medline]
AID - nbt.3922 [pii]
AID - 10.1038/nbt.3922 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jul 12;35(7):634. doi: 10.1038/nbt.3922.

PMID- 28700560
OWN - NLM
STAT- In-Data-Review
LR  - 20170715
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 7
DP  - 2017 Jul 12
TI  - AI-powered drug discovery captures pharma interest.
PG  - 604-605
LID - 10.1038/nbt0717-604 [doi]
FAU - Smalley, Eric
AU  - Smalley E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/07/13 06:00
MHDA- 2017/07/13 06:00
CRDT- 2017/07/13 06:00
PHST- 2017/07/13 06:00 [entrez]
PHST- 2017/07/13 06:00 [pubmed]
PHST- 2017/07/13 06:00 [medline]
AID - nbt0717-604 [pii]
AID - 10.1038/nbt0717-604 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jul 12;35(7):604-605. doi: 10.1038/nbt0717-604.

PMID- 28700558
OWN - NLM
STAT- In-Data-Review
LR  - 20170715
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 7
DP  - 2017 Jul 12
TI  - Algal oil productivity gets a fat bonus.
PG  - 636-638
LID - 10.1038/nbt.3920 [doi]
FAU - Posewitz, Matthew C
AU  - Posewitz MC
AD  - Department of Chemistry, Colorado School of Mines, Golden, Colorado, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/07/13 06:00
MHDA- 2017/07/13 06:00
CRDT- 2017/07/13 06:00
PHST- 2017/07/13 06:00 [entrez]
PHST- 2017/07/13 06:00 [pubmed]
PHST- 2017/07/13 06:00 [medline]
AID - nbt.3920 [pii]
AID - 10.1038/nbt.3920 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jul 12;35(7):636-638. doi: 10.1038/nbt.3920.

PMID- 28700557
OWN - NLM
STAT- In-Data-Review
LR  - 20170712
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 7
DP  - 2017 Jul 12
TI  - Around the world in a month.
PG  - 607
LID - 10.1038/nbt0717-607 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/07/13 06:00
MHDA- 2017/07/13 06:00
CRDT- 2017/07/13 06:00
PHST- 2017/07/13 06:00 [entrez]
PHST- 2017/07/13 06:00 [pubmed]
PHST- 2017/07/13 06:00 [medline]
AID - nbt0717-607 [pii]
AID - 10.1038/nbt0717-607 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jul 12;35(7):607. doi: 10.1038/nbt0717-607.

PMID- 28700556
OWN - NLM
STAT- In-Data-Review
LR  - 20170714
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 7
DP  - 2017 Jul 12
TI  - Permeability rules for antibiotic design.
PG  - 639
LID - 10.1038/nbt.3919 [doi]
FAU - Jones, Susan
AU  - Jones S
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/07/13 06:00
MHDA- 2017/07/13 06:00
CRDT- 2017/07/13 06:00
PHST- 2017/07/13 06:00 [entrez]
PHST- 2017/07/13 06:00 [pubmed]
PHST- 2017/07/13 06:00 [medline]
AID - nbt.3919 [pii]
AID - 10.1038/nbt.3919 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jul 12;35(7):639. doi: 10.1038/nbt.3919.

PMID- 28700555
OWN - NLM
STAT- In-Data-Review
LR  - 20170714
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 7
DP  - 2017 Jul 12
TI  - An emerging model for life sciences commercialization.
PG  - 608-613
LID - 10.1038/nbt.3911 [doi]
FAU - Stevens, Ashley J
AU  - Stevens AJ
AD  - Focus IP Group, Winchester, Massachusetts, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/07/13 06:00
MHDA- 2017/07/13 06:00
CRDT- 2017/07/13 06:00
PHST- 2017/07/13 06:00 [entrez]
PHST- 2017/07/13 06:00 [pubmed]
PHST- 2017/07/13 06:00 [medline]
AID - nbt.3911 [pii]
AID - 10.1038/nbt.3911 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jul 12;35(7):608-613. doi: 10.1038/nbt.3911.

PMID- 28700554
OWN - NLM
STAT- In-Data-Review
LR  - 20170712
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 7
DP  - 2017 Jul 12
TI  - Faster, deeper, smaller-the rise of antibody-like scaffolds.
PG  - 602-603
LID - 10.1038/nbt0717-602 [doi]
FAU - Owens, Brian
AU  - Owens B
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/07/13 06:00
MHDA- 2017/07/13 06:00
CRDT- 2017/07/13 06:00
PHST- 2017/07/13 06:00 [entrez]
PHST- 2017/07/13 06:00 [pubmed]
PHST- 2017/07/13 06:00 [medline]
AID - nbt0717-602 [pii]
AID - 10.1038/nbt0717-602 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jul 12;35(7):602-603. doi: 10.1038/nbt0717-602.

PMID- 28700553
OWN - NLM
STAT- In-Data-Review
LR  - 20170712
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 7
DP  - 2017 Jul 12
TI  - First rounders: Jan Vilcek.
PG  - 613
LID - 10.1038/nbt.3910 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/07/13 06:00
MHDA- 2017/07/13 06:00
CRDT- 2017/07/13 06:00
PHST- 2017/07/13 06:00 [entrez]
PHST- 2017/07/13 06:00 [pubmed]
PHST- 2017/07/13 06:00 [medline]
AID - nbt.3910 [pii]
AID - 10.1038/nbt.3910 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jul 12;35(7):613. doi: 10.1038/nbt.3910.

PMID- 28700552
OWN - NLM
STAT- In-Data-Review
LR  - 20170715
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 7
DP  - 2017 Jul 12
TI  - First state-approved embryonic stem cell trials in China.
PG  - 600
LID - 10.1038/nbt0717-600 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/07/13 06:00
MHDA- 2017/07/13 06:00
CRDT- 2017/07/13 06:00
PHST- 2017/07/13 06:00 [entrez]
PHST- 2017/07/13 06:00 [pubmed]
PHST- 2017/07/13 06:00 [medline]
AID - nbt0717-600 [pii]
AID - 10.1038/nbt0717-600 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jul 12;35(7):600. doi: 10.1038/nbt0717-600.

PMID- 28700551
OWN - NLM
STAT- In-Data-Review
LR  - 20170715
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 7
DP  - 2017 Jul 12
TI  - Unlocking Big Data for better health.
PG  - 684-686
LID - 10.1038/nbt.3918 [doi]
FAU - Munevar, Steven
AU  - Munevar S
AD  - Helix Bioscience Institute, Cambridge, Massachusetts, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/07/13 06:00
MHDA- 2017/07/13 06:00
CRDT- 2017/07/13 06:00
PHST- 2017/07/13 06:00 [entrez]
PHST- 2017/07/13 06:00 [pubmed]
PHST- 2017/07/13 06:00 [medline]
AID - nbt.3918 [pii]
AID - 10.1038/nbt.3918 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jul 12;35(7):684-686. doi: 10.1038/nbt.3918.

PMID- 28700550
OWN - NLM
STAT- In-Data-Review
LR  - 20170715
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 7
DP  - 2017 Jul 12
TI  - CAR-Ts move beyond B-cell cancers to myeloma.
PG  - 599-601
LID - 10.1038/nbt0717-599 [doi]
FAU - Dolgin, Elie
AU  - Dolgin E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/07/13 06:00
MHDA- 2017/07/13 06:00
CRDT- 2017/07/13 06:00
PHST- 2017/07/13 06:00 [entrez]
PHST- 2017/07/13 06:00 [pubmed]
PHST- 2017/07/13 06:00 [medline]
AID - nbt0717-599 [pii]
AID - 10.1038/nbt0717-599 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jul 12;35(7):599-601. doi: 10.1038/nbt0717-599.

PMID- 28700549
OWN - NLM
STAT- In-Data-Review
LR  - 20170714
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 7
DP  - 2017 Jul 12
TI  - CRISPR-Cas9 claim sets and the potential to stifle innovation.
PG  - 630-633
LID - 10.1038/nbt.3913 [doi]
FAU - Gray, Benjamin N
AU  - Gray BN
AD  - Benson Hill Biosystems, Durham, North Carolina, USA.
FAU - Spruill, W Murray
AU  - Spruill WM
AD  - Benson Hill Biosystems, Durham, North Carolina, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/07/13 06:00
MHDA- 2017/07/13 06:00
CRDT- 2017/07/13 06:00
PHST- 2017/07/13 06:00 [entrez]
PHST- 2017/07/13 06:00 [pubmed]
PHST- 2017/07/13 06:00 [medline]
AID - nbt.3913 [pii]
AID - 10.1038/nbt.3913 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jul 12;35(7):630-633. doi: 10.1038/nbt.3913.

PMID- 28700548
OWN - NLM
STAT- In-Data-Review
LR  - 20170712
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 7
DP  - 2017 Jul 12
TI  - FDA is the wrong agency to regulate genetically engineered animals.
PG  - 620-622
LID - 10.1038/nbt.3915 [doi]
FAU - Cohrssen, John J
AU  - Cohrssen JJ
AD  - Attorney at Law, Arlington, Virginia, USA.
FAU - Miller, Henry I
AU  - Miller HI
AD  - Hoover Institution, Stanford University, Stanford, California, USA.
AD  - Competitive Enterprise Institute, Washington, DC, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/07/13 06:00
MHDA- 2017/07/13 06:00
CRDT- 2017/07/13 06:00
PHST- 2017/07/13 06:00 [entrez]
PHST- 2017/07/13 06:00 [pubmed]
PHST- 2017/07/13 06:00 [medline]
AID - nbt.3915 [pii]
AID - 10.1038/nbt.3915 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jul 12;35(7):620-622. doi: 10.1038/nbt.3915.

PMID- 28700547
OWN - NLM
STAT- In-Data-Review
LR  - 20170715
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 7
DP  - 2017 Jul 12
TI  - Public biotech in 2016-the numbers.
PG  - 623-629
LID - 10.1038/nbt.3917 [doi]
FAU - Morrison, Chris
AU  - Morrison C
FAU - Lahteenmaki, Riku
AU  - Lahteenmaki R
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/07/13 06:00
MHDA- 2017/07/13 06:00
CRDT- 2017/07/13 06:00
PHST- 2017/07/13 06:00 [entrez]
PHST- 2017/07/13 06:00 [pubmed]
PHST- 2017/07/13 06:00 [medline]
AID - nbt.3917 [pii]
AID - 10.1038/nbt.3917 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jul 12;35(7):623-629. doi: 10.1038/nbt.3917.

PMID- 28700546
OWN - NLM
STAT- In-Data-Review
LR  - 20170712
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 7
DP  - 2017 Jul 12
TI  - Wanted: biotech for an aging population.
PG  - 597
LID - 10.1038/nbt.3925 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/07/13 06:00
MHDA- 2017/07/13 06:00
CRDT- 2017/07/13 06:00
PHST- 2017/07/13 06:00 [entrez]
PHST- 2017/07/13 06:00 [pubmed]
PHST- 2017/07/13 06:00 [medline]
AID - nbt.3925 [pii]
AID - 10.1038/nbt.3925 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jul 12;35(7):597. doi: 10.1038/nbt.3925.

PMID- 28700545
OWN - NLM
STAT- In-Data-Review
LR  - 20170715
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 7
DP  - 2017 Jul 12
TI  - FDA deems in vitro data on mutations sufficient to expand cystic fibrosis drug
      label.
PG  - 606
LID - 10.1038/nbt0717-606 [doi]
FAU - Ratner, Mark
AU  - Ratner M
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/07/13 06:00
MHDA- 2017/07/13 06:00
CRDT- 2017/07/13 06:00
PHST- 2017/07/13 06:00 [entrez]
PHST- 2017/07/13 06:00 [pubmed]
PHST- 2017/07/13 06:00 [medline]
AID - nbt0717-606 [pii]
AID - 10.1038/nbt0717-606 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jul 12;35(7):606. doi: 10.1038/nbt0717-606.

PMID- 28700544
OWN - NLM
STAT- In-Data-Review
LR  - 20170812
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 7
DP  - 2017 Jul 12
TI  - Payer coverage policies for multigene tests.
PG  - 614-617
LID - 10.1038/nbt.3912 [doi]
FAU - Phillips, Kathryn A
AU  - Phillips KA
AD  - Department of Clinical Pharmacy, Center for Translational and Policy Research on 
      Personalized Medicine (TRANSPERS), University of California San Francisco, San
      Francisco, California, USA.
AD  - Philip R. Lee Institute for Health Policy, University of California San
      Francisco, San Francisco, California, USA.
AD  - Helen Diller Family Comprehensive Cancer Center, University of California San
      Francisco, San Francisco, California, USA.
FAU - Deverka, Patricia A
AU  - Deverka PA
AD  - American Institutes for Research, Chapel Hill, North Carolina, USA.
AD  - University of North Carolina, Eshelman School of Pharmacy, Center for
      Pharmacogenomics and Individualized Therapy, Chapel Hill, North Carolina, USA.
FAU - Trosman, Julia R
AU  - Trosman JR
AD  - Department of Clinical Pharmacy, Center for Translational and Policy Research on 
      Personalized Medicine (TRANSPERS), University of California San Francisco, San
      Francisco, California, USA.
AD  - Center for Business Models in Healthcare, Chicago, Illinois, USA.
AD  - Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
FAU - Douglas, Michael P
AU  - Douglas MP
AD  - Department of Clinical Pharmacy, Center for Translational and Policy Research on 
      Personalized Medicine (TRANSPERS), University of California San Francisco, San
      Francisco, California, USA.
FAU - Chambers, James D
AU  - Chambers JD
AD  - The Center for the Evaluation of Value and Risk in Health, Institute for Clinical
      Research and Health Policy Studies.
AD  - Tufts Medical Center, Boston, Massachusetts, USA.
FAU - Weldon, Christine B
AU  - Weldon CB
AD  - Center for Business Models in Healthcare, Chicago, Illinois, USA.
AD  - Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
FAU - Dervan, Andrew P
AU  - Dervan AP
AD  - Division of Medical Genetics, Department of Medicine, University of Washington,
      Seattle, Washington, USA.
LA  - eng
GR  - R01 HG007063/HG/NHGRI NIH HHS/United States
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
PMC - PMC5553867
MID - NIHMS892806
EDAT- 2017/07/13 06:00
MHDA- 2017/07/13 06:00
CRDT- 2017/07/13 06:00
PHST- 2017/07/13 06:00 [entrez]
PHST- 2017/07/13 06:00 [pubmed]
PHST- 2017/07/13 06:00 [medline]
AID - nbt.3912 [pii]
AID - 10.1038/nbt.3912 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jul 12;35(7):614-617. doi: 10.1038/nbt.3912.

PMID- 28700542
OWN - NLM
STAT- In-Data-Review
LR  - 20170715
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 7
DP  - 2017 Jul 12
TI  - Consent and engagement, security, and authentic living using wearable and mobile 
      health technology.
PG  - 617-620
LID - 10.1038/nbt.3887 [doi]
FAU - Kreitmair, Karola V
AU  - Kreitmair KV
AD  - Stanford Center for Biomedical Ethics, Stanford, California, USA.
FAU - Cho, Mildred K
AU  - Cho MK
AD  - Stanford Center for Biomedical Ethics, Department of Pediatrics, Stanford
      University, Stanford, California, USA.
FAU - Magnus, David C
AU  - Magnus DC
AD  - Stanford Center for Biomedical Ethics, Department of Medicine, Stanford
      University, Stanford, California, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/07/13 06:00
MHDA- 2017/07/13 06:00
CRDT- 2017/07/13 06:00
PHST- 2017/07/13 06:00 [entrez]
PHST- 2017/07/13 06:00 [pubmed]
PHST- 2017/07/13 06:00 [medline]
AID - nbt.3887 [pii]
AID - 10.1038/nbt.3887 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jul 12;35(7):617-620. doi: 10.1038/nbt.3887.

PMID- 28700541
OWN - NLM
STAT- In-Data-Review
LR  - 20170712
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 7
DP  - 2017 Jul 12
TI  - Merck KGaA, F-Star shake on immune-oncology bispecifics.
PG  - 601
LID - 10.1038/nbt0717-601 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/07/13 06:00
MHDA- 2017/07/13 06:00
CRDT- 2017/07/13 06:00
PHST- 2017/07/13 06:00 [entrez]
PHST- 2017/07/13 06:00 [pubmed]
PHST- 2017/07/13 06:00 [medline]
AID - nbt0717-601 [pii]
AID - 10.1038/nbt0717-601 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jul 12;35(7):601. doi: 10.1038/nbt0717-601.

PMID- 28628130
OWN - NLM
STAT- MEDLINE
DCOM- 20170818
LR  - 20170818
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 7
DP  - 2017 Jul
TI  - Lipid production in Nannochloropsis gaditana is doubled by decreasing expression 
      of a single transcriptional regulator.
PG  - 647-652
LID - 10.1038/nbt.3865 [doi]
AB  - Lipid production in the industrial microalga Nannochloropsis gaditana exceeds
      that of model algal species and can be maximized by nutrient starvation in batch 
      culture. However, starvation halts growth, thereby decreasing productivity.
      Efforts to engineer N. gaditana strains that can accumulate biomass and
      overproduce lipids have previously met with little success. We identified 20
      transcription factors as putative negative regulators of lipid production by
      using RNA-seq analysis of N. gaditana during nitrogen deprivation. Application of
      a CRISPR-Cas9 reverse-genetics pipeline enabled insertional mutagenesis of 18 of 
      these 20 transcription factors. Knocking out a homolog of fungal
      Zn(II)2Cys6-encoding genes improved partitioning of total carbon to lipids from
      20% (wild type) to 40-55% (mutant) in nutrient-replete conditions. Knockout
      mutants grew poorly, but attenuation of Zn(II)2Cys6 expression yielded strains
      producing twice as much lipid ( approximately 5.0 g m(-2) d(-1)) as that in the
      wild type ( approximately 2.5 g m(-2) d(-1)) under semicontinuous growth
      conditions and had little effect on growth.
FAU - Ajjawi, Imad
AU  - Ajjawi I
AD  - Synthetic Genomics Inc., La Jolla, California, USA.
FAU - Verruto, John
AU  - Verruto J
AD  - Synthetic Genomics Inc., La Jolla, California, USA.
FAU - Aqui, Moena
AU  - Aqui M
AD  - Synthetic Genomics Inc., La Jolla, California, USA.
FAU - Soriaga, Leah B
AU  - Soriaga LB
AD  - Synthetic Genomics Inc., La Jolla, California, USA.
FAU - Coppersmith, Jennifer
AU  - Coppersmith J
AD  - Synthetic Genomics Inc., La Jolla, California, USA.
FAU - Kwok, Kathleen
AU  - Kwok K
AD  - Synthetic Genomics Inc., La Jolla, California, USA.
FAU - Peach, Luke
AU  - Peach L
AD  - Synthetic Genomics Inc., La Jolla, California, USA.
FAU - Orchard, Elizabeth
AU  - Orchard E
AD  - Synthetic Genomics Inc., La Jolla, California, USA.
FAU - Kalb, Ryan
AU  - Kalb R
AD  - Synthetic Genomics Inc., La Jolla, California, USA.
FAU - Xu, Weidong
AU  - Xu W
AD  - Synthetic Genomics Inc., La Jolla, California, USA.
FAU - Carlson, Tom J
AU  - Carlson TJ
AD  - Synthetic Genomics Inc., La Jolla, California, USA.
FAU - Francis, Kristie
AU  - Francis K
AD  - Synthetic Genomics Inc., La Jolla, California, USA.
FAU - Konigsfeld, Katie
AU  - Konigsfeld K
AD  - Synthetic Genomics Inc., La Jolla, California, USA.
FAU - Bartalis, Judit
AU  - Bartalis J
AD  - Synthetic Genomics Inc., La Jolla, California, USA.
FAU - Schultz, Andrew
AU  - Schultz A
AD  - Synthetic Genomics Inc., La Jolla, California, USA.
FAU - Lambert, William
AU  - Lambert W
AD  - Synthetic Genomics Inc., La Jolla, California, USA.
FAU - Schwartz, Ariel S
AU  - Schwartz AS
AD  - Synthetic Genomics Inc., La Jolla, California, USA.
FAU - Brown, Robert
AU  - Brown R
AD  - Synthetic Genomics Inc., La Jolla, California, USA.
FAU - Moellering, Eric R
AU  - Moellering ER
AD  - Synthetic Genomics Inc., La Jolla, California, USA.
LA  - eng
PT  - Journal Article
DEP - 20170619
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Algal Proteins)
RN  - 0 (Lipids)
RN  - 0 (Transcription Factors)
SB  - IM
MH  - Algal Proteins/genetics
MH  - Down-Regulation/genetics
MH  - Gene Knockout Techniques
MH  - Genetic Enhancement/*methods
MH  - Lipid Metabolism/*genetics
MH  - Lipids/*biosynthesis/genetics
MH  - Regulatory Elements, Transcriptional/*genetics
MH  - Stramenopiles/*genetics/growth & development
MH  - Transcription Factors/*genetics
EDAT- 2017/06/20 06:00
MHDA- 2017/08/19 06:00
CRDT- 2017/06/20 06:00
PHST- 2016/11/08 00:00 [received]
PHST- 2017/04/05 00:00 [accepted]
PHST- 2017/06/20 06:00 [pubmed]
PHST- 2017/08/19 06:00 [medline]
PHST- 2017/06/20 06:00 [entrez]
AID - nbt.3865 [pii]
AID - 10.1038/nbt.3865 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jul;35(7):647-652. doi: 10.1038/nbt.3865. Epub 2017 Jun 19.

PMID- 28604661
OWN - NLM
STAT- MEDLINE
DCOM- 20170818
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 7
DP  - 2017 Jul
TI  - Computational design of trimeric influenza-neutralizing proteins targeting the
      hemagglutinin receptor binding site.
PG  - 667-671
LID - 10.1038/nbt.3907 [doi]
AB  - Many viral surface glycoproteins and cell surface receptors are homo-oligomers,
      and thus can potentially be targeted by geometrically matched homo-oligomers that
      engage all subunits simultaneously to attain high avidity and/or lock subunits
      together. The adaptive immune system cannot generally employ this strategy since 
      the individual antibody binding sites are not arranged with appropriate geometry 
      to simultaneously engage multiple sites in a single target homo-oligomer. We
      describe a general strategy for the computational design of homo-oligomeric
      protein assemblies with binding functionality precisely matched to
      homo-oligomeric target sites. In the first step, a small protein is designed that
      binds a single site on the target. In the second step, the designed protein is
      assembled into a homo-oligomer such that the designed binding sites are aligned
      with the target sites. We use this approach to design high-avidity trimeric
      proteins that bind influenza A hemagglutinin (HA) at its conserved receptor
      binding site. The designed trimers can both capture and detect HA in a
      paper-based diagnostic format, neutralizes influenza in cell culture, and
      completely protects mice when given as a single dose 24 h before or after
      challenge with influenza.
FAU - Strauch, Eva-Maria
AU  - Strauch EM
AD  - Department of Biochemistry, University of Washington, Seattle, Washington, USA.
AD  - Institute for Protein Design, Department of Biochemistry, University of
      Washington, Seattle, Washington, USA.
FAU - Bernard, Steffen M
AU  - Bernard SM
AD  - Department of Integrative Structural and Computational Biology, The Scripps
      Research Institute, La Jolla, California, USA.
FAU - La, David
AU  - La D
AD  - Department of Biochemistry, University of Washington, Seattle, Washington, USA.
FAU - Bohn, Alan J
AU  - Bohn AJ
AD  - Department of Microbiology, University of Washington, Seattle, Washington, USA.
FAU - Lee, Peter S
AU  - Lee PS
AD  - Department of Integrative Structural and Computational Biology, The Scripps
      Research Institute, La Jolla, California, USA.
FAU - Anderson, Caitlin E
AU  - Anderson CE
AD  - Department of Bioengineering, University of Washington, Seattle, Washington, USA.
FAU - Nieusma, Travis
AU  - Nieusma T
AD  - Department of Integrative Structural and Computational Biology, The Scripps
      Research Institute, La Jolla, California, USA.
FAU - Holstein, Carly A
AU  - Holstein CA
AD  - Department of Bioengineering, University of Washington, Seattle, Washington, USA.
FAU - Garcia, Natalie K
AU  - Garcia NK
AD  - Department of Medicinal Chemistry, University of Washington, Seattle, Washington,
      USA.
FAU - Hooper, Kathryn A
AU  - Hooper KA
AD  - Division of Basic Sciences and Computational Biology Program, Fred Hutchinson
      Cancer Research Center, Seattle, Washington, USA.
FAU - Ravichandran, Rashmi
AU  - Ravichandran R
AD  - Institute for Protein Design, Department of Biochemistry, University of
      Washington, Seattle, Washington, USA.
FAU - Nelson, Jorgen W
AU  - Nelson JW
AD  - Department of Biochemistry, University of Washington, Seattle, Washington, USA.
FAU - Sheffler, William
AU  - Sheffler W
AD  - Department of Biochemistry, University of Washington, Seattle, Washington, USA.
FAU - Bloom, Jesse D
AU  - Bloom JD
AUID- ORCID: http://orcid.org/0000-0003-1267-3408
AD  - Division of Basic Sciences and Computational Biology Program, Fred Hutchinson
      Cancer Research Center, Seattle, Washington, USA.
FAU - Lee, Kelly K
AU  - Lee KK
AD  - Department of Medicinal Chemistry, University of Washington, Seattle, Washington,
      USA.
FAU - Ward, Andrew B
AU  - Ward AB
AD  - Department of Integrative Structural and Computational Biology, The Scripps
      Research Institute, La Jolla, California, USA.
FAU - Yager, Paul
AU  - Yager P
AD  - Department of Bioengineering, University of Washington, Seattle, Washington, USA.
FAU - Fuller, Deborah H
AU  - Fuller DH
AD  - Department of Microbiology, University of Washington, Seattle, Washington, USA.
AD  - Washington National Primate Research Center, University of Washington, Seattle,
      Washington, USA.
FAU - Wilson, Ian A
AU  - Wilson IA
AUID- ORCID: http://orcid.org/0000-0002-6469-2419
AD  - Department of Integrative Structural and Computational Biology, The Scripps
      Research Institute, La Jolla, California, USA.
FAU - Baker, David
AU  - Baker D
AD  - Department of Biochemistry, University of Washington, Seattle, Washington, USA.
AD  - Institute for Protein Design, Department of Biochemistry, University of
      Washington, Seattle, Washington, USA.
AD  - Howard Hughes Medical Institute, University of Washington, Seattle, Washington,
      USA.
LA  - eng
GR  - T32 AI007354/AI/NIAID NIH HHS/United States
GR  - P51 OD010425/OD/NIH HHS/United States
GR  - R01 AI096184/AI/NIAID NIH HHS/United States
GR  - R01 GM099989/GM/NIGMS NIH HHS/United States
GR  - T32 GM007270/GM/NIGMS NIH HHS/United States
GR  - Howard Hughes Medical Institute/United States
GR  - R56 AI117675/AI/NIAID NIH HHS/United States
GR  - R21 AI119258/AI/NIAID NIH HHS/United States
GR  - R01 GM102198/GM/NIGMS NIH HHS/United States
GR  - P41 GM103393/GM/NIGMS NIH HHS/United States
PT  - Journal Article
DEP - 20170612
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Hemagglutinin Glycoproteins, Influenza Virus)
SB  - IM
MH  - Binding Sites
MH  - Hemagglutinin Glycoproteins, Influenza Virus/*chemistry/*ultrastructure
MH  - *Models, Chemical
MH  - *Molecular Docking Simulation
MH  - Protein Binding
MH  - Protein Engineering/*methods
MH  - *Protein Multimerization
PMC - PMC5512607
MID - HHMIMS878279
EDAT- 2017/06/13 06:00
MHDA- 2017/08/19 06:00
CRDT- 2017/06/13 06:00
PHST- 2016/10/05 00:00 [received]
PHST- 2017/05/19 00:00 [accepted]
PHST- 2017/06/13 06:00 [pubmed]
PHST- 2017/08/19 06:00 [medline]
PHST- 2017/06/13 06:00 [entrez]
AID - nbt.3907 [pii]
AID - 10.1038/nbt.3907 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jul;35(7):667-671. doi: 10.1038/nbt.3907. Epub 2017 Jun 12.

PMID- 28604660
OWN - NLM
STAT- MEDLINE
DCOM- 20170818
LR  - 20170818
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 7
DP  - 2017 Jul
TI  - 1,003 reference genomes of bacterial and archaeal isolates expand coverage of the
      tree of life.
PG  - 676-683
LID - 10.1038/nbt.3886 [doi]
AB  - We present 1,003 reference genomes that were sequenced as part of the Genomic
      Encyclopedia of Bacteria and Archaea (GEBA) initiative, selected to maximize
      sequence coverage of phylogenetic space. These genomes double the number of
      existing type strains and expand their overall phylogenetic diversity by 25%.
      Comparative analyses with previously available finished and draft genomes reveal 
      a 10.5% increase in novel protein families as a function of phylogenetic
      diversity. The GEBA genomes recruit 25 million previously unassigned metagenomic 
      proteins from 4,650 samples, improving their phylogenetic and functional
      interpretation. We identify numerous biosynthetic clusters and experimentally
      validate a divergent phenazine cluster with potential new chemical structure and 
      antimicrobial activity. This Resource is the largest single release of reference 
      genomes to date. Bacterial and archaeal isolate sequence space is still far from 
      saturated, and future endeavors in this direction will continue to be a valuable 
      resource for scientific discovery.
FAU - Mukherjee, Supratim
AU  - Mukherjee S
AD  - Department of Energy, Joint Genome Institute, Walnut Creek, California, USA.
FAU - Seshadri, Rekha
AU  - Seshadri R
AD  - Department of Energy, Joint Genome Institute, Walnut Creek, California, USA.
FAU - Varghese, Neha J
AU  - Varghese NJ
AD  - Department of Energy, Joint Genome Institute, Walnut Creek, California, USA.
FAU - Eloe-Fadrosh, Emiley A
AU  - Eloe-Fadrosh EA
AD  - Department of Energy, Joint Genome Institute, Walnut Creek, California, USA.
FAU - Meier-Kolthoff, Jan P
AU  - Meier-Kolthoff JP
AUID- ORCID: http://orcid.org/0000-0001-9105-9814
AD  - Leibniz Institute DSMZ - German Collection of Microorganisms and Cell Cultures,
      Braunschweig, Germany.
FAU - Goker, Markus
AU  - Goker M
AUID- ORCID: http://orcid.org/0000-0002-5144-6200
AD  - Leibniz Institute DSMZ - German Collection of Microorganisms and Cell Cultures,
      Braunschweig, Germany.
FAU - Coates, R Cameron
AU  - Coates RC
AD  - Department of Energy, Joint Genome Institute, Walnut Creek, California, USA.
FAU - Hadjithomas, Michalis
AU  - Hadjithomas M
AD  - Department of Energy, Joint Genome Institute, Walnut Creek, California, USA.
FAU - Pavlopoulos, Georgios A
AU  - Pavlopoulos GA
AUID- ORCID: http://orcid.org/0000-0002-4577-8276
AD  - Department of Energy, Joint Genome Institute, Walnut Creek, California, USA.
FAU - Paez-Espino, David
AU  - Paez-Espino D
AUID- ORCID: http://orcid.org/0000-0002-2939-5398
AD  - Department of Energy, Joint Genome Institute, Walnut Creek, California, USA.
FAU - Yoshikuni, Yasuo
AU  - Yoshikuni Y
AD  - Department of Energy, Joint Genome Institute, Walnut Creek, California, USA.
FAU - Visel, Axel
AU  - Visel A
AUID- ORCID: http://orcid.org/0000-0002-4130-7784
AD  - Department of Energy, Joint Genome Institute, Walnut Creek, California, USA.
FAU - Whitman, William B
AU  - Whitman WB
AD  - Department of Microbiology, University of Georgia, Athens, Georgia, USA.
FAU - Garrity, George M
AU  - Garrity GM
AD  - Department of Microbiology and Molecular Genetics, Michigan State University,
      East Lansing, Michigan, USA.
AD  - NamesforLife, LLC, East Lansing, Michigan, USA.
FAU - Eisen, Jonathan A
AU  - Eisen JA
AD  - University of California Davis Genome Center, Davis, California, USA.
FAU - Hugenholtz, Philip
AU  - Hugenholtz P
AUID- ORCID: http://orcid.org/0000-0001-5386-7925
AD  - Australian Centre for Ecogenomics, The University of Queensland, Brisbane,
      Queensland, Australia.
FAU - Pati, Amrita
AU  - Pati A
AD  - Department of Energy, Joint Genome Institute, Walnut Creek, California, USA.
FAU - Ivanova, Natalia N
AU  - Ivanova NN
AD  - Department of Energy, Joint Genome Institute, Walnut Creek, California, USA.
FAU - Woyke, Tanja
AU  - Woyke T
AD  - Department of Energy, Joint Genome Institute, Walnut Creek, California, USA.
FAU - Klenk, Hans-Peter
AU  - Klenk HP
AD  - School of Biology, Newcastle University, Newcastle upon, Tyne, UK.
FAU - Kyrpides, Nikos C
AU  - Kyrpides NC
AD  - Department of Energy, Joint Genome Institute, Walnut Creek, California, USA.
LA  - eng
PT  - Journal Article
DEP - 20170612
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Chromosome Mapping/*standards
MH  - Database Management Systems
MH  - *Databases, Genetic
MH  - Datasets as Topic
MH  - Encyclopedias as Topic
MH  - Genome, Archaeal/*genetics
MH  - Genome, Bacterial/*genetics
MH  - High-Throughput Nucleotide Sequencing/*standards
MH  - *Knowledge Bases
MH  - Reference Values
EDAT- 2017/06/13 06:00
MHDA- 2017/08/19 06:00
CRDT- 2017/06/13 06:00
PHST- 2016/11/08 00:00 [received]
PHST- 2017/04/21 00:00 [accepted]
PHST- 2017/06/13 06:00 [pubmed]
PHST- 2017/08/19 06:00 [medline]
PHST- 2017/06/13 06:00 [entrez]
AID - nbt.3886 [pii]
AID - 10.1038/nbt.3886 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jul;35(7):676-683. doi: 10.1038/nbt.3886. Epub 2017 Jun 12.

PMID- 28562594
OWN - NLM
STAT- MEDLINE
DCOM- 20170818
LR  - 20180225
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 7
DP  - 2017 Jul
TI  - Guided self-organization and cortical plate formation in human brain organoids.
PG  - 659-666
LID - 10.1038/nbt.3906 [doi]
AB  - Three-dimensional cell culture models have either relied on the self-organizing
      properties of mammalian cells or used bioengineered constructs to arrange cells
      in an organ-like configuration. While self-organizing organoids excel at
      recapitulating early developmental events, bioengineered constructs reproducibly 
      generate desired tissue architectures. Here, we combine these two approaches to
      reproducibly generate human forebrain tissue while maintaining its
      self-organizing capacity. We use poly(lactide-co-glycolide) copolymer (PLGA)
      fiber microfilaments as a floating scaffold to generate elongated embryoid
      bodies. Microfilament-engineered cerebral organoids (enCORs) display enhanced
      neuroectoderm formation and improved cortical development. Furthermore,
      reconstitution of the basement membrane leads to characteristic cortical tissue
      architecture, including formation of a polarized cortical plate and radial units.
      Thus, enCORs model the distinctive radial organization of the cerebral cortex and
      allow for the study of neuronal migration. Our data demonstrate that combining 3D
      cell culture with bioengineering can increase reproducibility and improve tissue 
      architecture.
FAU - Lancaster, Madeline A
AU  - Lancaster MA
AUID- ORCID: http://orcid.org/0000-0003-2324-8853
AD  - IMBA-Institute of Molecular Biotechnology of the Austrian Academy of Science,
      Vienna, Austria.
AD  - MRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Cambridge, UK.
FAU - Corsini, Nina S
AU  - Corsini NS
AD  - IMBA-Institute of Molecular Biotechnology of the Austrian Academy of Science,
      Vienna, Austria.
FAU - Wolfinger, Simone
AU  - Wolfinger S
AD  - IMBA-Institute of Molecular Biotechnology of the Austrian Academy of Science,
      Vienna, Austria.
FAU - Gustafson, E Hilary
AU  - Gustafson EH
AUID- ORCID: http://orcid.org/0000-0003-3978-8088
AD  - IMBA-Institute of Molecular Biotechnology of the Austrian Academy of Science,
      Vienna, Austria.
FAU - Phillips, Alex W
AU  - Phillips AW
AD  - MRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Cambridge, UK.
FAU - Burkard, Thomas R
AU  - Burkard TR
AD  - IMBA-Institute of Molecular Biotechnology of the Austrian Academy of Science,
      Vienna, Austria.
AD  - IMP-Institute of Molecular Pathology, Vienna, Austria.
FAU - Otani, Tomoki
AU  - Otani T
AD  - Gurdon Institute and Department of Biochemistry, University of Cambridge, Tennis 
      Court Road, Cambridge, UK.
FAU - Livesey, Frederick J
AU  - Livesey FJ
AD  - Gurdon Institute and Department of Biochemistry, University of Cambridge, Tennis 
      Court Road, Cambridge, UK.
FAU - Knoblich, Juergen A
AU  - Knoblich JA
AD  - IMBA-Institute of Molecular Biotechnology of the Austrian Academy of Science,
      Vienna, Austria.
LA  - eng
GR  - MC_UP_1201/9/Medical Research Council/United Kingdom
PT  - Journal Article
DEP - 20170531
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Batch Cell Culture Techniques/*methods
MH  - Cells, Cultured
MH  - Guided Tissue Regeneration/methods
MH  - Humans
MH  - Neural Stem Cells/cytology/*physiology
MH  - Neurogenesis/*physiology
MH  - Organ Culture Techniques/methods
MH  - Organoids/cytology/*growth & development
MH  - Prosencephalon/cytology/*growth & development
MH  - Tissue Engineering/*methods
PMC - PMC5824977
MID - EMS76188
EDAT- 2017/06/01 06:00
MHDA- 2017/08/19 06:00
CRDT- 2017/06/01 06:00
PHST- 2017/04/23 00:00 [received]
PHST- 2017/05/18 00:00 [accepted]
PHST- 2017/06/01 06:00 [pubmed]
PHST- 2017/08/19 06:00 [medline]
PHST- 2017/06/01 06:00 [entrez]
AID - nbt.3906 [pii]
AID - 10.1038/nbt.3906 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jul;35(7):659-666. doi: 10.1038/nbt.3906. Epub 2017 May 31.

PMID- 28553942
OWN - NLM
STAT- MEDLINE
DCOM- 20170818
LR  - 20170818
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 7
DP  - 2017 Jul
TI  - Digital-to-biological converter for on-demand production of biologics.
PG  - 672-675
LID - 10.1038/nbt.3859 [doi]
AB  - Manufacturing processes for biological molecules in the research laboratory have 
      failed to keep pace with the rapid advances in automization and parellelization. 
      We report the development of a digital-to-biological converter for fully
      automated, versatile and demand-based production of functional biologics starting
      from DNA sequence information. Specifically, DNA templates, RNA molecules,
      proteins and viral particles were produced in an automated fashion from digitally
      transmitted DNA sequences without human intervention.
FAU - Boles, Kent S
AU  - Boles KS
AD  - Synthetic Genomics, Inc., La Jolla, California, USA.
FAU - Kannan, Krishna
AU  - Kannan K
AD  - Synthetic Genomics, Inc., La Jolla, California, USA.
FAU - Gill, John
AU  - Gill J
AD  - Synthetic Genomics, Inc., La Jolla, California, USA.
FAU - Felderman, Martina
AU  - Felderman M
AD  - Synthetic Genomics, Inc., La Jolla, California, USA.
FAU - Gouvis, Heather
AU  - Gouvis H
AD  - Synthetic Genomics, Inc., La Jolla, California, USA.
FAU - Hubby, Bolyn
AU  - Hubby B
AD  - Synthetic Genomics, Inc., La Jolla, California, USA.
FAU - Kamrud, Kurt I
AU  - Kamrud KI
AD  - Synthetic Genomics, Inc., La Jolla, California, USA.
FAU - Venter, J Craig
AU  - Venter JC
AD  - Synthetic Genomics, Inc., La Jolla, California, USA.
FAU - Gibson, Daniel G
AU  - Gibson DG
AD  - Synthetic Genomics, Inc., La Jolla, California, USA.
LA  - eng
PT  - Journal Article
PT  - Video-Audio Media
DEP - 20170529
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Biological Products)
RN  - 0 (Biopolymers)
SB  - IM
MH  - Biological Products/*chemistry
MH  - Biopolymers/*chemistry
MH  - Equipment Design
MH  - Equipment Failure Analysis
MH  - Genetic Engineering/*instrumentation
MH  - High-Throughput Nucleotide Sequencing/*instrumentation
MH  - Robotics/*instrumentation
MH  - Synthetic Biology/*instrumentation
EDAT- 2017/05/30 06:00
MHDA- 2017/08/19 06:00
CRDT- 2017/05/30 06:00
PHST- 2016/08/05 00:00 [received]
PHST- 2017/03/24 00:00 [accepted]
PHST- 2017/05/30 06:00 [pubmed]
PHST- 2017/08/19 06:00 [medline]
PHST- 2017/05/30 06:00 [entrez]
AID - nbt.3859 [pii]
AID - 10.1038/nbt.3859 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jul;35(7):672-675. doi: 10.1038/nbt.3859. Epub 2017 May 29.

PMID- 28553941
OWN - NLM
STAT- MEDLINE
DCOM- 20170818
LR  - 20180101
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 7
DP  - 2017 Jul
TI  - Engineered bacteria can function in the mammalian gut long-term as live
      diagnostics of inflammation.
PG  - 653-658
LID - 10.1038/nbt.3879 [doi]
AB  - Bacteria can be engineered to function as diagnostics or therapeutics in the
      mammalian gut but commercial translation of technologies to accomplish this has
      been hindered by the susceptibility of synthetic genetic circuits to mutation and
      unpredictable function during extended gut colonization. Here, we report stable, 
      engineered bacterial strains that maintain their function for 6 months in the
      mouse gut. We engineered a commensal murine Escherichia coli strain to detect
      tetrathionate, which is produced during inflammation. Using our engineered
      diagnostic strain, which retains memory of exposure in the gut for analysis by
      fecal testing, we detected tetrathionate in both infection-induced and genetic
      mouse models of inflammation over 6 months. The synthetic genetic circuits in the
      engineered strain were genetically stable and functioned as intended over time.
      The durable performance of these strains confirms the potential of engineered
      bacteria as living diagnostics.
FAU - Riglar, David T
AU  - Riglar DT
AD  - Department of Systems Biology, Harvard Medical School, Boston, Massachusetts,
      USA.
AD  - Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston,
      Massachusetts, USA.
FAU - Giessen, Tobias W
AU  - Giessen TW
AD  - Department of Systems Biology, Harvard Medical School, Boston, Massachusetts,
      USA.
AD  - Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston,
      Massachusetts, USA.
FAU - Baym, Michael
AU  - Baym M
AUID- ORCID: http://orcid.org/0000-0003-1303-5598
AD  - Department of Systems Biology, Harvard Medical School, Boston, Massachusetts,
      USA.
AD  - Department of Biomedical Informatics, Harvard Medical School, Boston,
      Massachusetts, USA.
FAU - Kerns, S Jordan
AU  - Kerns SJ
AD  - Department of Systems Biology, Harvard Medical School, Boston, Massachusetts,
      USA.
AD  - Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston,
      Massachusetts, USA.
FAU - Niederhuber, Matthew J
AU  - Niederhuber MJ
AD  - Department of Systems Biology, Harvard Medical School, Boston, Massachusetts,
      USA.
AD  - Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston,
      Massachusetts, USA.
FAU - Bronson, Roderick T
AU  - Bronson RT
AD  - Department of Microbiology and Immunology, Harvard Medical School, Boston,
      Massachusetts, USA.
FAU - Kotula, Jonathan W
AU  - Kotula JW
AD  - Department of Systems Biology, Harvard Medical School, Boston, Massachusetts,
      USA.
AD  - Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston,
      Massachusetts, USA.
FAU - Gerber, Georg K
AU  - Gerber GK
AUID- ORCID: http://orcid.org/0000-0002-9149-5509
AD  - Massachusetts Host-Microbiome Center, Department of Pathology, Brigham and
      Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Way, Jeffrey C
AU  - Way JC
AD  - Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston,
      Massachusetts, USA.
FAU - Silver, Pamela A
AU  - Silver PA
AD  - Department of Systems Biology, Harvard Medical School, Boston, Massachusetts,
      USA.
AD  - Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston,
      Massachusetts, USA.
LA  - eng
GR  - P30 CA006516/CA/NCI NIH HHS/United States
PT  - Journal Article
DEP - 20170529
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 8V1L8R19JH (Tetrathionic Acid)
SB  - IM
MH  - Animals
MH  - Cell Survival
MH  - Escherichia coli/*genetics/isolation & purification/*metabolism
MH  - Female
MH  - Gastroenteritis/*diagnosis/*microbiology
MH  - *Gastrointestinal Microbiome
MH  - Genetic Engineering/methods
MH  - Intestines
MH  - Mice
MH  - Mice, Inbred C57BL
MH  - Tetrathionic Acid/*metabolism
PMC - PMC5658125
MID - NIHMS906000
EDAT- 2017/05/30 06:00
MHDA- 2017/08/19 06:00
CRDT- 2017/05/30 06:00
PHST- 2016/09/20 00:00 [received]
PHST- 2017/04/07 00:00 [accepted]
PHST- 2017/05/30 06:00 [pubmed]
PHST- 2017/08/19 06:00 [medline]
PHST- 2017/05/30 06:00 [entrez]
AID - nbt.3879 [pii]
AID - 10.1038/nbt.3879 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jul;35(7):653-658. doi: 10.1038/nbt.3879. Epub 2017 May 29.

PMID- 28553940
OWN - NLM
STAT- MEDLINE
DCOM- 20170818
LR  - 20171129
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 7
DP  - 2017 Jul
TI  - Single-cell genome sequencing at ultra-high-throughput with microfluidic droplet 
      barcoding.
PG  - 640-646
LID - 10.1038/nbt.3880 [doi]
AB  - The application of single-cell genome sequencing to large cell populations has
      been hindered by technical challenges in isolating single cells during genome
      preparation. Here we present single-cell genomic sequencing (SiC-seq), which uses
      droplet microfluidics to isolate, fragment, and barcode the genomes of single
      cells, followed by Illumina sequencing of pooled DNA. We demonstrate
      ultra-high-throughput sequencing of >50,000 cells per run in a synthetic
      community of Gram-negative and Gram-positive bacteria and fungi. The sequenced
      genomes can be sorted in silico based on characteristic sequences. We use this
      approach to analyze the distributions of antibiotic-resistance genes, virulence
      factors, and phage sequences in microbial communities from an environmental
      sample. The ability to routinely sequence large populations of single cells will 
      enable the de-convolution of genetic heterogeneity in diverse cell populations.
FAU - Lan, Freeman
AU  - Lan F
AD  - Department of Bioengineering and Therapeutic Sciences, California Institute for
      Quantitative Biosciences, University of California, San Francisco, California,
      USA.
AD  - UC Berkeley-UCSF Graduate Program in Bioengineering, University of California,
      San Francisco, California, USA.
FAU - Demaree, Benjamin
AU  - Demaree B
AD  - Department of Bioengineering and Therapeutic Sciences, California Institute for
      Quantitative Biosciences, University of California, San Francisco, California,
      USA.
AD  - UC Berkeley-UCSF Graduate Program in Bioengineering, University of California,
      San Francisco, California, USA.
FAU - Ahmed, Noorsher
AU  - Ahmed N
AUID- ORCID: http://orcid.org/0000-0003-1701-3994
AD  - Department of Bioengineering and Therapeutic Sciences, California Institute for
      Quantitative Biosciences, University of California, San Francisco, California,
      USA.
FAU - Abate, Adam R
AU  - Abate AR
AD  - Department of Bioengineering and Therapeutic Sciences, California Institute for
      Quantitative Biosciences, University of California, San Francisco, California,
      USA.
AD  - UC Berkeley-UCSF Graduate Program in Bioengineering, University of California,
      San Francisco, California, USA.
AD  - Chan Zuckerberg Biohub, San Francisco, California, USA.
LA  - eng
GR  - DP2 AR068129/AR/NIAMS NIH HHS/United States
GR  - R01 EB019453/EB/NIBIB NIH HHS/United States
GR  - R01 HG008978/HG/NHGRI NIH HHS/United States
GR  - R21 HG007233/HG/NHGRI NIH HHS/United States
PT  - Evaluation Studies
PT  - Journal Article
DEP - 20170529
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Cell Separation/instrumentation
MH  - Chromosome Mapping/*instrumentation
MH  - DNA Barcoding, Taxonomic/*instrumentation
MH  - Equipment Design
MH  - Equipment Failure Analysis
MH  - Genome/*genetics
MH  - High-Throughput Nucleotide Sequencing/*instrumentation
MH  - *Lab-On-A-Chip Devices
MH  - Tissue Array Analysis/*instrumentation
PMC - PMC5531050
MID - NIHMS865786
EDAT- 2017/05/30 06:00
MHDA- 2017/08/19 06:00
CRDT- 2017/05/30 06:00
PHST- 2016/08/23 00:00 [received]
PHST- 2017/04/04 00:00 [accepted]
PHST- 2017/05/30 06:00 [pubmed]
PHST- 2017/08/19 06:00 [medline]
PHST- 2017/05/30 06:00 [entrez]
AID - nbt.3880 [pii]
AID - 10.1038/nbt.3880 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jul;35(7):640-646. doi: 10.1038/nbt.3880. Epub 2017 May 29.

PMID- 28591128
OWN - NLM
STAT- MEDLINE
DCOM- 20180405
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 6
DP  - 2017 Jun 7
TI  - After Glybera's withdrawal, what's next for gene therapy?
PG  - 491-492
LID - 10.1038/nbt0617-491 [doi]
FAU - Senior, Melanie
AU  - Senior M
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - EC 3.1.1.34 (Lipoprotein Lipase)
SB  - IM
MH  - Drug Approval/*economics
MH  - Genetic Therapy/*economics
MH  - Humans
MH  - Lipoprotein Lipase/deficiency/therapeutic use
MH  - Pancreatitis/*drug therapy/economics
EDAT- 2017/06/08 06:00
MHDA- 2018/04/06 06:00
CRDT- 2017/06/08 06:00
PHST- 2017/06/08 06:00 [entrez]
PHST- 2017/06/08 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt0617-491 [pii]
AID - 10.1038/nbt0617-491 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jun 7;35(6):491-492. doi: 10.1038/nbt0617-491.

PMID- 28591127
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 6
DP  - 2017 Jun 7
TI  - Eat a water bottle or two.
PG  - 495
LID - 10.1038/nbt0617-495a [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/06/08 06:00
MHDA- 2017/06/08 06:01
CRDT- 2017/06/08 06:00
PHST- 2017/06/08 06:00 [entrez]
PHST- 2017/06/08 06:00 [pubmed]
PHST- 2017/06/08 06:01 [medline]
AID - nbt0617-495a [pii]
AID - 10.1038/nbt0617-495a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jun 7;35(6):495. doi: 10.1038/nbt0617-495a.

PMID- 28591126
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 6
DP  - 2017 Jun 7
TI  - Around the world in a month.
PG  - 495
LID - 10.1038/nbt0617-495b [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/06/08 06:00
MHDA- 2017/06/08 06:01
CRDT- 2017/06/08 06:00
PHST- 2017/06/08 06:00 [entrez]
PHST- 2017/06/08 06:00 [pubmed]
PHST- 2017/06/08 06:01 [medline]
AID - nbt0617-495b [pii]
AID - 10.1038/nbt0617-495b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jun 7;35(6):495. doi: 10.1038/nbt0617-495b.

PMID- 28591125
OWN - NLM
STAT- MEDLINE
DCOM- 20170818
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 6
DP  - 2017 Jun 7
TI  - Open-source, community-driven microfluidics with Metafluidics.
PG  - 523-529
LID - 10.1038/nbt.3873 [doi]
AB  - Microfluidic devices have the potential to automate and miniaturize biological
      experiments, but open-source sharing of device designs has lagged behind sharing 
      of other resources such as software. Synthetic biologists have used microfluidics
      for DNA assembly, cell-free expression, and cell culture, but a combination of
      expense, device complexity, and reliance on custom set-ups hampers their
      widespread adoption. We present Metafluidics, an open-source, community-driven
      repository that hosts digital design files, assembly specifications, and
      open-source software to enable users to build, configure, and operate a
      microfluidic device. We use Metafluidics to share designs and fabrication
      instructions for both a microfluidic ring-mixer device and a 32-channel tabletop 
      microfluidic controller. This device and controller are applied to build genetic 
      circuits using standard DNA assembly methods including ligation, Gateway, Gibson,
      and Golden Gate. Metafluidics is intended to enable a broad community of
      engineers, DIY enthusiasts, and other nontraditional participants with limited
      fabrication skills to contribute to microfluidic research.
FAU - Kong, David S
AU  - Kong DS
AD  - Massachusetts Institute of Technology Lincoln Laboratory, Lexington,
      Massachusetts, USA.
FAU - Thorsen, Todd A
AU  - Thorsen TA
AD  - Massachusetts Institute of Technology Lincoln Laboratory, Lexington,
      Massachusetts, USA.
FAU - Babb, Jonathan
AU  - Babb J
AD  - Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Wick, Scott T
AU  - Wick ST
AD  - Massachusetts Institute of Technology Lincoln Laboratory, Lexington,
      Massachusetts, USA.
FAU - Gam, Jeremy J
AU  - Gam JJ
AD  - Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Weiss, Ron
AU  - Weiss R
AD  - Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
AD  - Department of Electrical Engineering &Computer Science, Massachusetts Institute
      of Technology, Cambridge, Massachusetts, USA.
FAU - Carr, Peter A
AU  - Carr PA
AUID- ORCID: 0000-0002-4078-8846
AD  - Massachusetts Institute of Technology Lincoln Laboratory, Lexington,
      Massachusetts, USA.
LA  - eng
GR  - R01 CA173712/CA/NCI NIH HHS/United States
GR  - P50 GM098792/GM/NIGMS NIH HHS/United States
PT  - Journal Article
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PT  - Research Support, N.I.H., Extramural
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 9007-49-2 (DNA)
SB  - IM
MH  - Algorithms
MH  - DNA/*genetics
MH  - Databases, Factual
MH  - Gene Regulatory Networks/*genetics
MH  - Genetic Engineering/*instrumentation
MH  - Signal Processing, Computer-Assisted/*instrumentation
MH  - *Software
MH  - Synthetic Biology/*instrumentation
EDAT- 2017/06/08 06:00
MHDA- 2017/08/19 06:00
CRDT- 2017/06/08 06:00
PHST- 2016/08/05 00:00 [received]
PHST- 2017/04/11 00:00 [accepted]
PHST- 2017/06/08 06:00 [entrez]
PHST- 2017/06/08 06:00 [pubmed]
PHST- 2017/08/19 06:00 [medline]
AID - nbt.3873 [pii]
AID - 10.1038/nbt.3873 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jun 7;35(6):523-529. doi: 10.1038/nbt.3873.

PMID- 28591124
OWN - NLM
STAT- MEDLINE
DCOM- 20180405
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 6
DP  - 2017 Jun 7
TI  - Patient-centered drug manufacture.
PG  - 485
LID - 10.1038/nbt.3901 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Proteins)
SB  - IM
MH  - *Drug Industry
MH  - Humans
MH  - Patients
MH  - *Precision Medicine
MH  - Proteins/*therapeutic use
EDAT- 2017/06/08 06:00
MHDA- 2018/04/06 06:00
CRDT- 2017/06/08 06:00
PHST- 2017/06/08 06:00 [entrez]
PHST- 2017/06/08 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt.3901 [pii]
AID - 10.1038/nbt.3901 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jun 7;35(6):485. doi: 10.1038/nbt.3901.

PMID- 28591123
OWN - NLM
STAT- MEDLINE
DCOM- 20180330
LR  - 20180330
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 6
DP  - 2017 Jun 7
TI  - Building the human inner ear in an organoid.
PG  - 518-520
LID - 10.1038/nbt.3899 [doi]
FAU - Munnamalai, Vidhya
AU  - Munnamalai V
AUID- ORCID: 0000-0002-4985-8265
AD  - Department of Biological Sciences, Purdue University, West Lafayette, Indiana,
      USA.
FAU - Fekete, Donna M
AU  - Fekete DM
AD  - Department of Biological Sciences, Purdue University, West Lafayette, Indiana,
      USA.
LA  - eng
GR  - R01 DC002756/DC/NIDCD NIH HHS/United States
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2017 Jun;35(6):583-589. PMID: 28459451
MH  - *Ear, Inner
MH  - Humans
MH  - *Organoids
EDAT- 2017/06/08 06:00
MHDA- 2018/03/31 06:00
CRDT- 2017/06/08 06:00
PHST- 2017/06/08 06:00 [entrez]
PHST- 2017/06/08 06:00 [pubmed]
PHST- 2018/03/31 06:00 [medline]
AID - nbt.3899 [pii]
AID - 10.1038/nbt.3899 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jun 7;35(6):518-520. doi: 10.1038/nbt.3899.

PMID- 28591122
OWN - NLM
STAT- MEDLINE
DCOM- 20180405
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 6
DP  - 2017 Jun 7
TI  - CAR-T death strikes Kite.
PG  - 492
LID - 10.1038/nbt0617-492 [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Receptors, Antigen, T-Cell)
SB  - IM
MH  - Brain Edema/chemically induced/*mortality
MH  - Humans
MH  - Immunotherapy/*adverse effects
MH  - Lymphoma, Non-Hodgkin/drug therapy/immunology/*mortality
MH  - Receptors, Antigen, T-Cell/*immunology
EDAT- 2017/06/08 06:00
MHDA- 2018/04/06 06:00
CRDT- 2017/06/08 06:00
PHST- 2017/06/08 06:00 [entrez]
PHST- 2017/06/08 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt0617-492 [pii]
AID - 10.1038/nbt0617-492 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jun 7;35(6):492. doi: 10.1038/nbt0617-492.

PMID- 28591121
OWN - NLM
STAT- MEDLINE
DCOM- 20180330
LR  - 20180330
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 6
DP  - 2017 Jun 7
TI  - A spring collection of designer yeast chromosomes.
PG  - 522
LID - 10.1038/nbt.3890 [doi]
FAU - Marcinkiewicz, Katarzyna
AU  - Marcinkiewicz K
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Science. 2017 Mar 10;355(6329):1040-1044. PMID: 28280199
MH  - *Chromosomes
MH  - Saccharomyces cerevisiae/*genetics
EDAT- 2017/06/08 06:00
MHDA- 2018/03/31 06:00
CRDT- 2017/06/08 06:00
PHST- 2017/06/08 06:00 [entrez]
PHST- 2017/06/08 06:00 [pubmed]
PHST- 2018/03/31 06:00 [medline]
AID - nbt.3890 [pii]
AID - 10.1038/nbt.3890 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jun 7;35(6):522. doi: 10.1038/nbt.3890.

PMID- 28591119
OWN - NLM
STAT- MEDLINE
DCOM- 20180330
LR  - 20180330
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 6
DP  - 2017 Jun 7
TI  - Manufacture of CAR-T cells in the body.
PG  - 520-521
LID - 10.1038/nbt.3898 [doi]
FAU - Olweus, Johanna
AU  - Olweus J
AD  - Department of Cancer Immunology, Institute for Cancer Research, Oslo University
      Hospital Radiumhospitalet and K.G. Jebsen Center for Cancer Immunotherapy,
      University of Oslo, Oslo, Norway.
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Receptors, Antigen, T-Cell)
SB  - IM
CON - Nat Nanotechnol. 2017 Aug;12 (8):813-820. PMID: 28416815
MH  - Humans
MH  - *Immunotherapy, Adoptive
MH  - *Receptors, Antigen, T-Cell
MH  - T-Lymphocytes
EDAT- 2017/06/08 06:00
MHDA- 2018/03/31 06:00
CRDT- 2017/06/08 06:00
PHST- 2017/06/08 06:00 [entrez]
PHST- 2017/06/08 06:00 [pubmed]
PHST- 2018/03/31 06:00 [medline]
AID - nbt.3898 [pii]
AID - 10.1038/nbt.3898 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jun 7;35(6):520-521. doi: 10.1038/nbt.3898.

PMID- 28591118
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 6
DP  - 2017 Jun 7
TI  - Hanging on a thread.
PG  - 496-499
LID - 10.1038/nbt.3894 [doi]
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/06/08 06:00
MHDA- 2017/06/08 06:01
CRDT- 2017/06/08 06:00
PHST- 2017/06/08 06:00 [entrez]
PHST- 2017/06/08 06:00 [pubmed]
PHST- 2017/06/08 06:01 [medline]
AID - nbt.3894 [pii]
AID - 10.1038/nbt.3894 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jun 7;35(6):496-499. doi: 10.1038/nbt.3894.

PMID- 28591117
OWN - NLM
STAT- MEDLINE
DCOM- 20180405
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 6
DP  - 2017 Jun 7
TI  - The illusion of control in germline-engineering policy.
PG  - 502-506
LID - 10.1038/nbt.3884 [doi]
FAU - Konig, Harald
AU  - Konig H
AD  - Karlsruhe Institute of Technology, Institute for Technology Assessment and
      Systems Analysis (ITAS), Karlsruhe, Germany.
LA  - eng
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - CRISPR-Cas Systems/genetics
MH  - Gene Editing/*ethics/trends
MH  - Genetic Engineering/*ethics
MH  - *Germ Cells
MH  - Humans
EDAT- 2017/06/08 06:00
MHDA- 2018/04/06 06:00
CRDT- 2017/06/08 06:00
PHST- 2017/06/08 06:00 [entrez]
PHST- 2017/06/08 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt.3884 [pii]
AID - 10.1038/nbt.3884 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jun 7;35(6):502-506. doi: 10.1038/nbt.3884.

PMID- 28591116
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 6
DP  - 2017 Jun 7
TI  - A synthetic biology approach to integrative high school STEM training.
PG  - 591-595
LID - 10.1038/nbt.3896 [doi]
FAU - Dube, Sutherland
AU  - Dube S
AD  - Department of Chemistry and Biochemistry, University of Lethbridge, Lethbridge,
      Alberta, Canada.
FAU - Orr, Doug
AU  - Orr D
AD  - Teaching Centre, University of Lethbridge, Lethbridge, Alberta, Canada.
FAU - Dempsey, Brian
AU  - Dempsey B
AD  - Department of Chemistry and Biochemistry, University of Lethbridge, Lethbridge,
      Alberta, Canada.
AD  - Alberta RNA Research and Training Institute, University of Lethbridge,
      Lethbridge, Alberta, Canada.
FAU - Wieden, Hans-Joachim
AU  - Wieden HJ
AD  - Department of Chemistry and Biochemistry, University of Lethbridge, Lethbridge,
      Alberta, Canada.
AD  - Alberta RNA Research and Training Institute, University of Lethbridge,
      Lethbridge, Alberta, Canada.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/06/08 06:00
MHDA- 2017/06/08 06:01
CRDT- 2017/06/08 06:00
PHST- 2017/06/08 06:00 [entrez]
PHST- 2017/06/08 06:00 [pubmed]
PHST- 2017/06/08 06:01 [medline]
AID - nbt.3896 [pii]
AID - 10.1038/nbt.3896 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jun 7;35(6):591-595. doi: 10.1038/nbt.3896.

PMID- 28591115
OWN - NLM
STAT- MEDLINE
DCOM- 20180405
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 6
DP  - 2017 Jun 7
TI  - Alternative drug sensitivity metrics improve preclinical cancer pharmacogenomics.
PG  - 500-502
LID - 10.1038/nbt.3882 [doi]
FAU - Hafner, Marc
AU  - Hafner M
AUID- ORCID: 0000-0003-1337-7598
AD  - HMS LINCS Center, Laboratory of Systems Pharmacology, Department of Systems
      Biology, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Niepel, Mario
AU  - Niepel M
AUID- ORCID: 0000-0003-1415-6295
AD  - HMS LINCS Center, Laboratory of Systems Pharmacology, Department of Systems
      Biology, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Sorger, Peter K
AU  - Sorger PK
AD  - HMS LINCS Center, Laboratory of Systems Pharmacology, Department of Systems
      Biology, Harvard Medical School, Boston, Massachusetts, USA.
LA  - eng
GR  - U54 HL127365/HL/NHLBI NIH HHS/United States
PT  - Letter
PT  - Research Support, N.I.H., Extramural
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Cell Line, Tumor/drug effects
MH  - *Dose-Response Relationship, Drug
MH  - Humans
MH  - Neoplasms/*drug therapy/genetics
MH  - *Pharmacogenetics
PMC - PMC5668135
MID - NIHMS913802
EDAT- 2017/06/08 06:00
MHDA- 2018/04/06 06:00
CRDT- 2017/06/08 06:00
PMCR- 2018/06/07 00:00
PHST- 2018/06/07 00:00 [pmc-release]
PHST- 2017/06/08 06:00 [entrez]
PHST- 2017/06/08 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt.3882 [pii]
AID - 10.1038/nbt.3882 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jun 7;35(6):500-502. doi: 10.1038/nbt.3882.

PMID- 28591114
OWN - NLM
STAT- MEDLINE
DCOM- 20180405
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 6
DP  - 2017 Jun 7
TI  - First deuterated drug approved.
PG  - 493-494
LID - 10.1038/nbt0617-493 [doi]
FAU - Schmidt, Charles
AU  - Schmidt C
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (deutetrabenazine)
RN  - AR09D82C7G (Deuterium)
RN  - Z9O08YRN8O (Tetrabenazine)
SB  - IM
EIN - Nat Biotechnol. 2017 Nov 9;35(11):1004. PMID: 29121023
MH  - Deuterium/chemistry/*therapeutic use
MH  - Drug Approval
MH  - Drug Industry/economics
MH  - Humans
MH  - Huntington Disease/*drug therapy
MH  - Tetrabenazine/*analogs & derivatives/therapeutic use
MH  - United States
MH  - United States Food and Drug Administration
EDAT- 2017/06/08 06:00
MHDA- 2018/04/06 06:00
CRDT- 2017/06/08 06:00
PHST- 2017/06/08 06:00 [entrez]
PHST- 2017/06/08 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt0617-493 [pii]
AID - 10.1038/nbt0617-493 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jun 7;35(6):493-494. doi: 10.1038/nbt0617-493.

PMID- 28591113
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 6
DP  - 2017 Jun 7
TI  - Recent patents in microbiomes and microbial genomics.
PG  - 517
LID - 10.1038/nbt.3905 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/06/08 06:00
MHDA- 2017/06/08 06:01
CRDT- 2017/06/08 06:00
PHST- 2017/06/08 06:00 [entrez]
PHST- 2017/06/08 06:00 [pubmed]
PHST- 2017/06/08 06:01 [medline]
AID - nbt.3905 [pii]
AID - 10.1038/nbt.3905 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jun 7;35(6):517. doi: 10.1038/nbt.3905.

PMID- 28591112
OWN - NLM
STAT- MEDLINE
DCOM- 20170818
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 6
DP  - 2017 Jun 7
TI  - The promise of organ and tissue preservation to transform medicine.
PG  - 530-542
LID - 10.1038/nbt.3889 [doi]
AB  - The ability to replace organs and tissues on demand could save or improve
      millions of lives each year globally and create public health benefits on par
      with curing cancer. Unmet needs for organ and tissue preservation place enormous 
      logistical limitations on transplantation, regenerative medicine, drug discovery,
      and a variety of rapidly advancing areas spanning biomedicine. A growing
      coalition of researchers, clinicians, advocacy organizations, academic
      institutions, and other stakeholders has assembled to address the unmet need for 
      preservation advances, outlining remaining challenges and identifying areas of
      underinvestment and untapped opportunities. Meanwhile, recent discoveries provide
      proofs of principle for breakthroughs in a family of research areas surrounding
      biopreservation. These developments indicate that a new paradigm, integrating
      multiple existing preservation approaches and new technologies that have
      flourished in the past 10 years, could transform preservation research.
      Capitalizing on these opportunities will require engagement across many research 
      areas and stakeholder groups. A coordinated effort is needed to expedite
      preservation advances that can transform several areas of medicine and medical
      science.
FAU - Giwa, Sebastian
AU  - Giwa S
AD  - Organ Preservation Alliance, NASA Research Park, Moffett Field, California, USA.
AD  - Sylvatica Biotech, Inc., Charleston, South Carolina, USA.
AD  - Ossium Health, San Francisco, California, USA.
FAU - Lewis, Jedediah K
AU  - Lewis JK
AD  - Organ Preservation Alliance, NASA Research Park, Moffett Field, California, USA.
FAU - Alvarez, Luis
AU  - Alvarez L
AD  - Regenerative Biology Research Group, Cancer and Developmental Biology Laboratory,
      National Cancer Institute, Bethesda, Maryland, USA.
AD  - Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
AD  - Department of Chemistry and Life Science, United States Military Academy, West
      Point, New York, USA.
FAU - Langer, Robert
AU  - Langer R
AD  - Department of Chemical Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Roth, Alvin E
AU  - Roth AE
AD  - Department of Economics, Stanford University, Stanford, California, USA.
FAU - Church, George M
AU  - Church GM
AD  - Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Markmann, James F
AU  - Markmann JF
AD  - Division of Transplant Surgery, Department of Surgery, Massachusetts General
      Hospital, Boston, Massachusetts, USA.
FAU - Sachs, David H
AU  - Sachs DH
AD  - Columbia Center for Translational Immunology, Columbia University Medical Center,
      New York, New York, USA.
FAU - Chandraker, Anil
AU  - Chandraker A
AD  - American Society of Transplantation, Mt. Laurel, New Jersey, USA.
AD  - Transplantation Research Center, Renal Division, Brigham and Women's Hospital,
      Harvard Medical School, Boston, Massachusetts, USA.
FAU - Wertheim, Jason A
AU  - Wertheim JA
AUID- ORCID: 0000-0001-5680-1067
AD  - American Society of Transplant Surgeons, Arlington Virginia, USA.
AD  - Comprehensive Transplant Center, Northwestern University Feinberg School of
      Medicine, Chicago, Illinois, USA.
FAU - Rothblatt, Martine
AU  - Rothblatt M
AD  - United Therapeutics, Silver Spring, Maryland, USA.
FAU - Boyden, Edward S
AU  - Boyden ES
AD  - MIT Media Lab and McGovern Institute, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Eidbo, Elling
AU  - Eidbo E
AD  - Association of Organ Procurement Organizations, Vienna, Virginia, USA.
FAU - Lee, W P Andrew
AU  - Lee WPA
AD  - Department of Plastic and Reconstructive Surgery, Johns Hopkins University School
      of Medicine, Baltimore, Maryland, USA.
FAU - Pomahac, Bohdan
AU  - Pomahac B
AD  - Department of Surgery, Division of Plastic Surgery, Brigham and Women's
      Hospital/Harvard Medical School, Boston, Massachusetts, USA.
FAU - Brandacher, Gerald
AU  - Brandacher G
AD  - Department of Plastic and Reconstructive Surgery, Johns Hopkins University School
      of Medicine, Baltimore, Maryland, USA.
FAU - Weinstock, David M
AU  - Weinstock DM
AD  - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical
      School, Boston, Massachusetts, USA.
FAU - Elliott, Gloria
AU  - Elliott G
AD  - Department of Mechanical Engineering and Engineering Science, University of North
      Carolina at Charlotte, Charlotte, North Carolina, USA.
FAU - Nelson, David
AU  - Nelson D
AD  - Department of Transplant Medicine, Nazih Zuhdi Transplant Institute, Integris
      Baptist Medical Center, Oklahoma City, Oklahoma, USA.
FAU - Acker, Jason P
AU  - Acker JP
AD  - Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton,
      Alberta, Canada.
AD  - Society for Cryobiology, Baltimore, Maryland, USA.
FAU - Uygun, Korkut
AU  - Uygun K
AD  - Department of Surgery, Center for Engineering in Medicine, Massachusetts General 
      Hospital, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Schmalz, Boris
AU  - Schmalz B
AD  - Organ Preservation Alliance, NASA Research Park, Moffett Field, California, USA.
AD  - Max Planck Institute of Psychiatry, Munich, Germany.
FAU - Weegman, Brad P
AU  - Weegman BP
AD  - Organ Preservation Alliance, NASA Research Park, Moffett Field, California, USA.
AD  - Sylvatica Biotech, Inc., Charleston, South Carolina, USA.
FAU - Tocchio, Alessandro
AU  - Tocchio A
AD  - Organ Preservation Alliance, NASA Research Park, Moffett Field, California, USA.
AD  - Department of Radiology, Stanford School of Medicine, Stanford, California, USA.
FAU - Fahy, Greg M
AU  - Fahy GM
AD  - 21st Century Medicine, Fontana, California, USA.
FAU - Storey, Kenneth B
AU  - Storey KB
AD  - Institute of Biochemistry, Carleton University, Ottawa, Ontario, Canada.
FAU - Rubinsky, Boris
AU  - Rubinsky B
AD  - Department of Mechanical Engineering, University of California Berkeley,
      Berkeley, California, USA.
FAU - Bischof, John
AU  - Bischof J
AD  - Department of Mechanical Engineering, University of Minnesota, Minneapolis,
      Minnesota, USA.
FAU - Elliott, Janet A W
AU  - Elliott JAW
AD  - Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton,
      Alberta, Canada.
AD  - Department of Chemical and Materials Engineering, University of Alberta,
      Edmonton, Alberta, Canada.
FAU - Woodruff, Teresa K
AU  - Woodruff TK
AUID- ORCID: 0000-0002-1197-3399
AD  - Division of Obstetrics and Gynecology-Reproductive Science in Medicine,
      Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
FAU - Morris, G John
AU  - Morris GJ
AD  - Asymptote Ltd., Cambridge, UK.
FAU - Demirci, Utkan
AU  - Demirci U
AD  - Department of Radiology, Stanford School of Medicine, Stanford, California, USA.
AD  - Department of Electrical Engineering (by courtesy), Stanford, California, USA.
FAU - Brockbank, Kelvin G M
AU  - Brockbank KGM
AD  - Department of Bioengineering, Clemson University, Clemson, South Carolina, USA.
FAU - Woods, Erik J
AU  - Woods EJ
AD  - Ossium Health, San Francisco, California, USA.
AD  - Society for Cryobiology, Baltimore, Maryland, USA.
AD  - Department of Microbiology and Immunology, Indiana University School of Medicine,
      Indianapolis, Indiana, USA.
FAU - Ben, Robert N
AU  - Ben RN
AD  - Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, 
      Ontario, Canada.
FAU - Baust, John G
AU  - Baust JG
AD  - Department of Biological Sciences, Binghamton University, State University of New
      York, Binghamton, New York, USA.
FAU - Gao, Dayong
AU  - Gao D
AD  - Society for Cryobiology, Baltimore, Maryland, USA.
AD  - Department of Mechanical Engineering, University of Washington, Seattle,
      Washington, USA.
FAU - Fuller, Barry
AU  - Fuller B
AD  - Division of Surgery &Interventional Science, University College Medical School,
      Royal Free Hospital Campus, London, UK.
FAU - Rabin, Yoed
AU  - Rabin Y
AD  - Department of Mechanical Engineering, Carnegie Mellon University, Pittsburgh,
      Pennsylvania, USA.
FAU - Kravitz, David C
AU  - Kravitz DC
AD  - Organ Recovery Systems, Chicago, Illinois, USA.
FAU - Taylor, Michael J
AU  - Taylor MJ
AUID- ORCID: 0000-0002-8406-134X
AD  - Sylvatica Biotech, Inc., Charleston, South Carolina, USA.
AD  - Department of Mechanical Engineering, Carnegie Mellon University, Pittsburgh,
      Pennsylvania, USA.
AD  - Department of Surgery, University of Arizona, Tucson, Arizona, USA.
FAU - Toner, Mehmet
AU  - Toner M
AD  - Department of Surgery, Center for Engineering in Medicine, Massachusetts General 
      Hospital, Harvard Medical School, Boston, Massachusetts, USA.
LA  - eng
GR  - P01 AI045897/AI/NIAID NIH HHS/United States
GR  - R01 DK107875/DK/NIDDK NIH HHS/United States
GR  - R01 EB015776/EB/NIBIB NIH HHS/United States
GR  - UL1 TR001422/TR/NCATS NIH HHS/United States
PT  - Journal Article
PT  - Review
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Cryopreservation/*trends
MH  - Forecasting
MH  - Humans
MH  - Organ Culture Techniques/*trends
MH  - Organ Preservation/*trends
MH  - Organ Transplantation/*trends
MH  - Regenerative Medicine/*trends
MH  - Tissue Preservation/trends
PMC - PMC5724041
MID - NIHMS921041
EDAT- 2017/06/08 06:00
MHDA- 2017/08/19 06:00
CRDT- 2017/06/08 06:00
PHST- 2016/10/31 00:00 [received]
PHST- 2017/04/28 00:00 [accepted]
PHST- 2017/06/08 06:00 [entrez]
PHST- 2017/06/08 06:00 [pubmed]
PHST- 2017/08/19 06:00 [medline]
AID - nbt.3889 [pii]
AID - 10.1038/nbt.3889 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jun 7;35(6):530-542. doi: 10.1038/nbt.3889.

PMID- 28591111
OWN - NLM
STAT- MEDLINE
DCOM- 20180405
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 6
DP  - 2017 Jun 7
TI  - Verily chases a perfectly healthy human.
PG  - 490
LID - 10.1038/nbt0617-490 [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biosensing Techniques/*instrumentation
MH  - Drug Industry
MH  - Humans
MH  - Monitoring, Physiologic/*instrumentation
MH  - Parkinson Disease/*diagnosis/physiopathology
EDAT- 2017/06/08 06:00
MHDA- 2018/04/06 06:00
CRDT- 2017/06/08 06:00
PHST- 2017/06/08 06:00 [entrez]
PHST- 2017/06/08 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt0617-490 [pii]
AID - 10.1038/nbt0617-490 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jun 7;35(6):490. doi: 10.1038/nbt0617-490.

PMID- 28591110
OWN - NLM
STAT- MEDLINE
DCOM- 20180405
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 6
DP  - 2017 Jun 7
TI  - Patents as collateral for securitization.
PG  - 514-516
LID - 10.1038/nbt.3891 [doi]
FAU - Deshpande, Nishad
AU  - Deshpande N
AD  - CSIR Unit for Research and Development of Information Products and Symbiosis
      International University, Pune, India.
FAU - Nagendra, Asha
AU  - Nagendra A
AD  - Symbiosis Institute of Management Studies, Symbiosis International University,
      Pune, India.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*economics
MH  - Capital Financing/*economics
MH  - Humans
MH  - Investments/*economics
MH  - *Patents as Topic
EDAT- 2017/06/08 06:00
MHDA- 2018/04/06 06:00
CRDT- 2017/06/08 06:00
PHST- 2017/06/08 06:00 [entrez]
PHST- 2017/06/08 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt.3891 [pii]
AID - 10.1038/nbt.3891 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jun 7;35(6):514-516. doi: 10.1038/nbt.3891.

PMID- 28591109
OWN - NLM
STAT- MEDLINE
DCOM- 20180405
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 6
DP  - 2017 Jun 7
TI  - Interest rekindles in drug cocktails that reprogram cells.
PG  - 489-490
LID - 10.1038/nbt0617-489 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Cellular Reprogramming/genetics
MH  - *Drug Industry
MH  - Hair Cells, Auditory/*drug effects/pathology
MH  - Hearing Loss/pathology/*therapy
MH  - Humans
MH  - Regeneration/genetics
EDAT- 2017/06/08 06:00
MHDA- 2018/04/06 06:00
CRDT- 2017/06/08 06:00
PHST- 2017/06/08 06:00 [entrez]
PHST- 2017/06/08 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt0617-489 [pii]
AID - 10.1038/nbt0617-489 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jun 7;35(6):489-490. doi: 10.1038/nbt0617-489.

PMID- 28591107
OWN - NLM
STAT- MEDLINE
DCOM- 20180405
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 6
DP  - 2017 Jun 7
TI  - Industry 'road tests' new wave of immune checkpoints.
PG  - 487-488
LID - 10.1038/nbt0617-487 [doi]
FAU - Garber, Ken
AU  - Garber K
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (CTLA-4 Antigen)
RN  - 0 (PDCD1 protein, human)
RN  - 0 (Programmed Cell Death 1 Receptor)
RN  - 0 (Receptors, Antigen, T-Cell)
SB  - IM
MH  - CTLA-4 Antigen/antagonists & inhibitors/immunology
MH  - *Drug Industry
MH  - Humans
MH  - Neoplasms/immunology/*therapy
MH  - Programmed Cell Death 1 Receptor/antagonists & inhibitors/immunology
MH  - Receptors, Antigen, T-Cell/antagonists & inhibitors/*immunology
MH  - T-Lymphocytes/*drug effects/immunology
EDAT- 2017/06/08 06:00
MHDA- 2018/04/06 06:00
CRDT- 2017/06/08 06:00
PHST- 2017/06/08 06:00 [entrez]
PHST- 2017/06/08 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt0617-487 [pii]
AID - 10.1038/nbt0617-487 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jun 7;35(6):487-488. doi: 10.1038/nbt0617-487.

PMID- 28581491
OWN - NLM
STAT- MEDLINE
DCOM- 20180402
LR  - 20180402
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 6
DP  - 2017 Jun
TI  - Making individualized drugs a reality.
PG  - 507-513
LID - 10.1038/nbt.3888 [doi]
FAU - Schellekens, Huub
AU  - Schellekens H
AD  - Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University,
      The Netherlands.
FAU - Aldosari, Mohammed
AU  - Aldosari M
AD  - Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University,
      The Netherlands, and the Saudi Food and Drug Administration, Riyadh, Saudi
      Arabia.
FAU - Talsma, Herre
AU  - Talsma H
AD  - Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University,
      The Netherlands.
FAU - Mastrobattista, Enrico
AU  - Mastrobattista E
AD  - Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University,
      The Netherlands.
LA  - eng
PT  - Journal Article
DEP - 20170605
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EIN - Nat Biotechnol. 2017 Aug 8;35(8):797. PMID: 28787402
MH  - Drug Discovery/*trends
MH  - Humans
MH  - Precision Medicine/*trends
EDAT- 2017/06/06 06:00
MHDA- 2018/04/03 06:00
CRDT- 2017/06/06 06:00
PHST- 2017/06/06 06:00 [pubmed]
PHST- 2018/04/03 06:00 [medline]
PHST- 2017/06/06 06:00 [entrez]
AID - nbt.3888 [pii]
AID - 10.1038/nbt.3888 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jun;35(6):507-513. doi: 10.1038/nbt.3888. Epub 2017 Jun 5.

PMID- 28459452
OWN - NLM
STAT- MEDLINE
DCOM- 20170818
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 6
DP  - 2017 Jun
TI  - Targeting genomic rearrangements in tumor cells through Cas9-mediated insertion
      of a suicide gene.
PG  - 543-550
LID - 10.1038/nbt.3843 [doi]
AB  - Specifically targeting genomic rearrangements and mutations in tumor cells
      remains an elusive goal in cancer therapy. Here, we used Cas9-based genome
      editing to introduce the gene encoding the prodrug-converting enzyme herpes
      simplex virus type 1 thymidine kinase (HSV1-tk) into the genomes of cancer cells 
      carrying unique sequences resulting from genome rearrangements. Specifically, we 
      targeted the breakpoints of TMEM135-CCDC67 and MAN2A1-FER fusions in human
      prostate cancer or hepatocellular carcinoma cells in vitro and in mouse
      xenografts. We designed one adenovirus to deliver the nickase Cas9(D10A) and
      guide RNAs targeting the breakpoint sequences, and another to deliver an
      EGFP-HSV1-tk construct flanked by sequences homologous to those surrounding the
      breakpoint. Infection with both viruses resulted in breakpoint-dependent
      expression of EGFP-tk and ganciclovir-mediated apoptosis. When mouse xenografts
      were treated with adenoviruses and ganciclovir, all animals showed decreased
      tumor burden and no mortality during the study. Thus, Cas9-mediated suicide-gene 
      insertion may be a viable genotype-specific cancer therapy.
FAU - Chen, Zhang-Hui
AU  - Chen ZH
AD  - Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh,
      Pennsylvania, USA.
FAU - Yu, Yan P
AU  - Yu YP
AD  - Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh,
      Pennsylvania, USA.
FAU - Zuo, Ze-Hua
AU  - Zuo ZH
AD  - Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh,
      Pennsylvania, USA.
FAU - Nelson, Joel B
AU  - Nelson JB
AD  - Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh,
      Pennsylvania, USA.
FAU - Michalopoulos, George K
AU  - Michalopoulos GK
AUID- ORCID: 0000-0001-9922-6920
AD  - Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh,
      Pennsylvania, USA.
FAU - Monga, Satdatshan
AU  - Monga S
AD  - Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh,
      Pennsylvania, USA.
FAU - Liu, Silvia
AU  - Liu S
AD  - Department of Biostatistics, University of Pittsburgh School of Medicine,
      Pittsburgh, Pennsylvania, USA.
FAU - Tseng, George
AU  - Tseng G
AD  - Department of Biostatistics, University of Pittsburgh School of Medicine,
      Pittsburgh, Pennsylvania, USA.
FAU - Luo, Jian-Hua
AU  - Luo JH
AD  - Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh,
      Pennsylvania, USA.
LA  - eng
GR  - R01 CA098249/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, N.I.H., Extramural
DEP - 20170501
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Bacterial Proteins)
RN  - EC 3.1.- (Cas9 endonuclease Streptococcus pyogenes)
RN  - EC 3.1.- (Endonucleases)
SB  - IM
MH  - Animals
MH  - Apoptosis/genetics
MH  - Bacterial Proteins/*genetics
MH  - Cell Line, Tumor
MH  - Clustered Regularly Interspaced Short Palindromic Repeats/*genetics
MH  - Endonucleases/*genetics
MH  - Gene Rearrangement/*genetics
MH  - Gene Targeting/methods
MH  - Genes, Transgenic, Suicide/*genetics
MH  - Genetic Therapy/*methods
MH  - Humans
MH  - Male
MH  - Mice
MH  - Mice, SCID
MH  - Neoplasms, Experimental/*genetics/pathology/*therapy
PMC - PMC5462845
MID - NIHMS858772
EDAT- 2017/05/02 06:00
MHDA- 2017/08/19 06:00
CRDT- 2017/05/02 06:00
PHST- 2016/06/30 00:00 [received]
PHST- 2017/03/08 00:00 [accepted]
PHST- 2017/05/02 06:00 [pubmed]
PHST- 2017/08/19 06:00 [medline]
PHST- 2017/05/02 06:00 [entrez]
AID - nbt.3843 [pii]
AID - 10.1038/nbt.3843 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jun;35(6):543-550. doi: 10.1038/nbt.3843. Epub 2017 May 1.

PMID- 28459451
OWN - NLM
STAT- MEDLINE
DCOM- 20170818
LR  - 20180330
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 6
DP  - 2017 Jun
TI  - Generation of inner ear organoids containing functional hair cells from human
      pluripotent stem cells.
PG  - 583-589
LID - 10.1038/nbt.3840 [doi]
AB  - The derivation of human inner ear tissue from pluripotent stem cells would enable
      in vitro screening of drug candidates for the treatment of hearing and balance
      dysfunction and may provide a source of cells for cell-based therapies of the
      inner ear. Here we report a method for differentiating human pluripotent stem
      cells to inner ear organoids that harbor functional hair cells. Using a
      three-dimensional culture system, we modulate TGF, BMP, FGF, and WNT signaling to
      generate multiple otic-vesicle-like structures from a single stem-cell aggregate.
      Over 2 months, the vesicles develop into inner ear organoids with sensory
      epithelia that are innervated by sensory neurons. Additionally, using
      CRISPR-Cas9, we generate an ATOH1-2A-eGFP cell line to detect hair cell induction
      and demonstrate that derived hair cells exhibit electrophysiological properties
      similar to those of native sensory hair cells. Our culture system should
      facilitate the study of human inner ear development and research on therapies for
      diseases of the inner ear.
FAU - Koehler, Karl R
AU  - Koehler KR
AD  - Department of Otolaryngology-Head and Neck Surgery, Indiana University School of 
      Medicine, Indianapolis, Indiana, USA.
FAU - Nie, Jing
AU  - Nie J
AD  - Department of Otolaryngology-Head and Neck Surgery, Indiana University School of 
      Medicine, Indianapolis, Indiana, USA.
FAU - Longworth-Mills, Emma
AU  - Longworth-Mills E
AD  - Department of Otolaryngology-Head and Neck Surgery, Indiana University School of 
      Medicine, Indianapolis, Indiana, USA.
AD  - Department of Anatomy and Cell Biology, Indiana University School of Medicine,
      Indianapolis, Indiana, USA.
FAU - Liu, Xiao-Ping
AU  - Liu XP
AD  - Departments of Otolaryngology and Neurology, F.M. Kirby Neurobiology Center
      Boston Children's Hospital, and Harvard Medical School, Boston, Massachusetts,
      USA.
FAU - Lee, Jiyoon
AU  - Lee J
AD  - Department of Otolaryngology-Head and Neck Surgery, Indiana University School of 
      Medicine, Indianapolis, Indiana, USA.
FAU - Holt, Jeffrey R
AU  - Holt JR
AD  - Departments of Otolaryngology and Neurology, F.M. Kirby Neurobiology Center
      Boston Children's Hospital, and Harvard Medical School, Boston, Massachusetts,
      USA.
FAU - Hashino, Eri
AU  - Hashino E
AD  - Department of Otolaryngology-Head and Neck Surgery, Indiana University School of 
      Medicine, Indianapolis, Indiana, USA.
AD  - Stark Neurosciences Research Institute, Indiana University School of Medicine,
      Indianapolis, Indiana, USA.
LA  - eng
GR  - R03 DC015624/DC/NIDCD NIH HHS/United States
GR  - F31 DC015968/DC/NIDCD NIH HHS/United States
GR  - R01 DC013294/DC/NIDCD NIH HHS/United States
GR  - UL1 TR001108/TR/NCATS NIH HHS/United States
GR  - C06 RR020128/RR/NCRR NIH HHS/United States
GR  - U54 HD090255/HD/NICHD NIH HHS/United States
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, N.I.H., Extramural
DEP - 20170501
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CIN - Nat Biotechnol. 2017 Jun 7;35(6):518-520. PMID: 28591123
MH  - Cells, Cultured
MH  - Ear, Inner/cytology/*growth & development
MH  - Hair Cells, Auditory, Inner/cytology/*physiology
MH  - Humans
MH  - Organogenesis/*physiology
MH  - Organoids/cytology/*growth & development
MH  - Pluripotent Stem Cells/*physiology
MH  - Tissue Engineering/*methods
PMC - PMC5462862
MID - NIHMS858768
EDAT- 2017/05/02 06:00
MHDA- 2017/08/19 06:00
CRDT- 2017/05/02 06:00
PHST- 2016/07/31 00:00 [received]
PHST- 2017/03/08 00:00 [accepted]
PHST- 2017/05/02 06:00 [pubmed]
PHST- 2017/08/19 06:00 [medline]
PHST- 2017/05/02 06:00 [entrez]
AID - nbt.3840 [pii]
AID - 10.1038/nbt.3840 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jun;35(6):583-589. doi: 10.1038/nbt.3840. Epub 2017 May 1.

PMID- 28459450
OWN - NLM
STAT- MEDLINE
DCOM- 20170818
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 6
DP  - 2017 Jun
TI  - Transplantation of engineered organoids enables rapid generation of metastatic
      mouse models of colorectal cancer.
PG  - 577-582
LID - 10.1038/nbt.3837 [doi]
AB  - Colorectal cancer (CRC) is a leading cause of death in the developed world, yet
      facile preclinical models that mimic the natural stages of CRC progression are
      lacking. Through the orthotopic engraftment of colon organoids we describe a
      broadly usable immunocompetent CRC model that recapitulates the entire
      adenoma-adenocarcinoma-metastasis axis in vivo. The engraftment procedure takes
      less than 5 minutes, shows efficient tumor engraftment in two-thirds of mice, and
      can be achieved using organoids derived from genetically engineered mouse models 
      (GEMMs), wild-type organoids engineered ex vivo, or from patient-derived human
      CRC organoids. In this model, we describe the genotype and time-dependent
      progression of CRCs from adenocarcinoma (6 weeks), to local disseminated disease 
      (11-12 weeks), and spontaneous metastasis (>20 weeks). Further, we use the system
      to show that loss of dysregulated Wnt signaling is critical for the progression
      of disseminated CRCs. Thus, our approach provides a fast and flexible means to
      produce tailored CRC mouse models for genetic studies and pre-clinical
      investigation.
FAU - O'Rourke, Kevin P
AU  - O'Rourke KP
AD  - Weill Cornell Medicine/Rockefeller University/Sloan Kettering Tri-Institutional
      MD-PhD Program, New York, New York, USA.
AD  - Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New 
      York, New York, USA.
FAU - Loizou, Evangelia
AU  - Loizou E
AD  - Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New 
      York, New York, USA.
AD  - Weill Cornell Graduate School of Medical Sciences, New York, New York, USA.
FAU - Livshits, Geulah
AU  - Livshits G
AD  - Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New 
      York, New York, USA.
FAU - Schatoff, Emma M
AU  - Schatoff EM
AD  - Weill Cornell Medicine/Rockefeller University/Sloan Kettering Tri-Institutional
      MD-PhD Program, New York, New York, USA.
AD  - Meyer Cancer Center, Hematology &Medical Oncology Division, Department of
      Medicine, Weill Cornell Medicine, New York, New York, USA.
FAU - Baslan, Timour
AU  - Baslan T
AD  - Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New 
      York, New York, USA.
FAU - Manchado, Eusebio
AU  - Manchado E
AD  - Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New 
      York, New York, USA.
FAU - Simon, Janelle
AU  - Simon J
AD  - Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New 
      York, New York, USA.
FAU - Romesser, Paul B
AU  - Romesser PB
AD  - Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New 
      York, New York, USA.
AD  - Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York,
      USA.
FAU - Leach, Benjamin
AU  - Leach B
AD  - Meyer Cancer Center, Hematology &Medical Oncology Division, Department of
      Medicine, Weill Cornell Medicine, New York, New York, USA.
FAU - Han, Teng
AU  - Han T
AD  - Weill Cornell Graduate School of Medical Sciences, New York, New York, USA.
AD  - Meyer Cancer Center, Hematology &Medical Oncology Division, Department of
      Medicine, Weill Cornell Medicine, New York, New York, USA.
FAU - Pauli, Chantal
AU  - Pauli C
AD  - Meyer Cancer Center, Hematology &Medical Oncology Division, Department of
      Medicine, Weill Cornell Medicine, New York, New York, USA.
AD  - Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell
      Medicine, New York, New York, USA.
FAU - Beltran, Himisha
AU  - Beltran H
AD  - Meyer Cancer Center, Hematology &Medical Oncology Division, Department of
      Medicine, Weill Cornell Medicine, New York, New York, USA.
AD  - Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell
      Medicine, New York, New York, USA.
FAU - Rubin, Mark A
AU  - Rubin MA
AUID- ORCID: 0000-0002-8321-9950
AD  - Meyer Cancer Center, Hematology &Medical Oncology Division, Department of
      Medicine, Weill Cornell Medicine, New York, New York, USA.
AD  - Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell
      Medicine, New York, New York, USA.
FAU - Dow, Lukas E
AU  - Dow LE
AD  - Meyer Cancer Center, Hematology &Medical Oncology Division, Department of
      Medicine, Weill Cornell Medicine, New York, New York, USA.
FAU - Lowe, Scott W
AU  - Lowe SW
AD  - Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New 
      York, New York, USA.
AD  - Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New
      York, New York, USA.
LA  - eng
GR  - U54 OD020355/OD/NIH HHS/United States
GR  - K22 CA181280/CA/NCI NIH HHS/United States
GR  - P50 CA092629/CA/NCI NIH HHS/United States
GR  - F30 CA200110/CA/NCI NIH HHS/United States
GR  - P30 CA008748/CA/NCI NIH HHS/United States
GR  - R01 CA187069/CA/NCI NIH HHS/United States
GR  - T32 GM007739/GM/NIGMS NIH HHS/United States
GR  - R01 CA195787/CA/NCI NIH HHS/United States
GR  - R24 CA083084/CA/NCI NIH HHS/United States
GR  - K12 CA184746/CA/NCI NIH HHS/United States
GR  - HHMI/Howard Hughes Medical Institute/United States
PT  - Journal Article
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, N.I.H., Extramural
DEP - 20170501
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CIN - Nat Rev Cancer. 2017 Jul;17 (7):395. PMID: 28642600
MH  - Animals
MH  - Carcinogenesis/genetics
MH  - Cell Line, Tumor
MH  - Clustered Regularly Interspaced Short Palindromic Repeats/genetics
MH  - Colorectal Neoplasms/*genetics
MH  - *Disease Models, Animal
MH  - Female
MH  - Gene Editing/*methods
MH  - Genes, Neoplasm/*genetics
MH  - Liver Neoplasms/*genetics/*secondary
MH  - Male
MH  - Mice
MH  - Mice, Transgenic
MH  - Neoplasm Metastasis
MH  - Organ Transplantation/*methods
PMC - PMC5462850
MID - NIHMS855610
EDAT- 2017/05/02 06:00
MHDA- 2017/08/19 06:00
CRDT- 2017/05/02 06:00
PHST- 2016/07/08 00:00 [received]
PHST- 2017/02/24 00:00 [accepted]
PHST- 2017/05/02 06:00 [pubmed]
PHST- 2017/08/19 06:00 [medline]
PHST- 2017/05/02 06:00 [entrez]
AID - nbt.3837 [pii]
AID - 10.1038/nbt.3837 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jun;35(6):577-582. doi: 10.1038/nbt.3837. Epub 2017 May 1.

PMID- 28459449
OWN - NLM
STAT- MEDLINE
DCOM- 20170818
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 6
DP  - 2017 Jun
TI  - In vivo genome editing and organoid transplantation models of colorectal cancer
      and metastasis.
PG  - 569-576
LID - 10.1038/nbt.3836 [doi]
AB  - In vivo interrogation of the function of genes implicated in tumorigenesis is
      limited by the need to generate and cross germline mutant mice. Here we describe 
      approaches to model colorectal cancer (CRC) and metastasis, which rely on in situ
      gene editing and orthotopic organoid transplantation in mice without
      cancer-predisposing mutations. Autochthonous tumor formation is induced by
      CRISPR-Cas9-based editing of the Apc and Trp53 tumor suppressor genes in colon
      epithelial cells and by orthotopic transplantation of Apc-edited colon organoids.
      ApcDelta/Delta;Kras(G12D/+);Trp53Delta/Delta (AKP) mouse colon organoids and
      human CRC organoids engraft in the distal colon and metastasize to the liver.
      Finally, we apply the orthotopic transplantation model to characterize the clonal
      dynamics of Lgr5(+) stem cells and demonstrate sequential activation of an
      oncogene in established colon adenomas. These experimental systems enable rapid
      in vivo characterization of cancer-associated genes and reproduce the entire
      spectrum of tumor progression and metastasis.
FAU - Roper, Jatin
AU  - Roper J
AUID- ORCID: 0000-0002-8851-1352
AD  - The David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge,
      Massachusetts, USA.
AD  - Division of Gastroenterology, Tufts Medical Center, Boston, Massachusetts, USA.
AD  - Molecular Oncology Research Institute, Tufts Medical Center, Boston,
      Massachusetts, USA.
FAU - Tammela, Tuomas
AU  - Tammela T
AD  - The David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge,
      Massachusetts, USA.
FAU - Cetinbas, Naniye Malli
AU  - Cetinbas NM
AD  - The David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge,
      Massachusetts, USA.
FAU - Akkad, Adam
AU  - Akkad A
AD  - The David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge,
      Massachusetts, USA.
FAU - Roghanian, Ali
AU  - Roghanian A
AD  - The David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge,
      Massachusetts, USA.
AD  - Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton
      General Hospital, Southampton, United Kingdom.
FAU - Rickelt, Steffen
AU  - Rickelt S
AD  - The David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge,
      Massachusetts, USA.
FAU - Almeqdadi, Mohammad
AU  - Almeqdadi M
AUID- ORCID: 0000-0002-5503-2371
AD  - The David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge,
      Massachusetts, USA.
FAU - Wu, Katherine
AU  - Wu K
AD  - The David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge,
      Massachusetts, USA.
FAU - Oberli, Matthias A
AU  - Oberli MA
AD  - The David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge,
      Massachusetts, USA.
FAU - Sanchez-Rivera, Francisco J
AU  - Sanchez-Rivera FJ
AD  - The David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge,
      Massachusetts, USA.
FAU - Park, Yoona K
AU  - Park YK
AD  - The David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge,
      Massachusetts, USA.
FAU - Liang, Xu
AU  - Liang X
AD  - The David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge,
      Massachusetts, USA.
FAU - Eng, George
AU  - Eng G
AD  - The David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge,
      Massachusetts, USA.
AD  - Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts,
      USA.
FAU - Taylor, Martin S
AU  - Taylor MS
AUID- ORCID: 0000-0003-1560-9276
AD  - Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts,
      USA.
FAU - Azimi, Roxana
AU  - Azimi R
AD  - The David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge,
      Massachusetts, USA.
FAU - Kedrin, Dmitriy
AU  - Kedrin D
AD  - The David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge,
      Massachusetts, USA.
FAU - Neupane, Rachit
AU  - Neupane R
AD  - The David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge,
      Massachusetts, USA.
FAU - Beyaz, Semir
AU  - Beyaz S
AD  - The David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge,
      Massachusetts, USA.
FAU - Sicinska, Ewa T
AU  - Sicinska ET
AD  - Department of Medical Oncology, Dana Farber Cancer Institute, Boston,
      Massachusetts, USA.
FAU - Suarez, Yvelisse
AU  - Suarez Y
AUID- ORCID: 0000-0002-0456-3260
AD  - Department of Pathology, Tufts Medical Center, Boston, Massachusetts, USA.
FAU - Yoo, James
AU  - Yoo J
AD  - Molecular Oncology Research Institute, Tufts Medical Center, Boston,
      Massachusetts, USA.
AD  - Department of Surgery, Tufts Medical Center, Boston, Massachusetts, USA.
FAU - Chen, Lillian
AU  - Chen L
AD  - Department of Surgery, Tufts Medical Center, Boston, Massachusetts, USA.
FAU - Zukerberg, Lawrence
AU  - Zukerberg L
AD  - Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts,
      USA.
FAU - Katajisto, Pekka
AU  - Katajisto P
AD  - Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
AD  - Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm,
      Sweden.
FAU - Deshpande, Vikram
AU  - Deshpande V
AD  - Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts,
      USA.
FAU - Bass, Adam J
AU  - Bass AJ
AD  - Department of Medical Oncology, Dana Farber Cancer Institute, Boston,
      Massachusetts, USA.
FAU - Tsichlis, Philip N
AU  - Tsichlis PN
AD  - Molecular Oncology Research Institute, Tufts Medical Center, Boston,
      Massachusetts, USA.
FAU - Lees, Jacqueline
AU  - Lees J
AD  - The David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge,
      Massachusetts, USA.
FAU - Langer, Robert
AU  - Langer R
AD  - The David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge,
      Massachusetts, USA.
FAU - Hynes, Richard O
AU  - Hynes RO
AD  - The David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge,
      Massachusetts, USA.
AD  - Howard Hughes Medical Institute, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Chen, Jianzhu
AU  - Chen J
AD  - The David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge,
      Massachusetts, USA.
FAU - Bhutkar, Arjun
AU  - Bhutkar A
AD  - The David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge,
      Massachusetts, USA.
FAU - Jacks, Tyler
AU  - Jacks T
AD  - The David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge,
      Massachusetts, USA.
AD  - Howard Hughes Medical Institute, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Yilmaz, Omer H
AU  - Yilmaz OH
AD  - The David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge,
      Massachusetts, USA.
AD  - Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts,
      USA.
LA  - eng
GR  - P30 DK043351/DK/NIDDK NIH HHS/United States
GR  - K99 CA187317/CA/NCI NIH HHS/United States
GR  - K99 AG045144/AG/NIA NIH HHS/United States
GR  - P30 CA014051/CA/NCI NIH HHS/United States
GR  - R01 CA017007/CA/NCI NIH HHS/United States
GR  - K08 CA198002/CA/NCI NIH HHS/United States
GR  - R00 AG045144/AG/NIA NIH HHS/United States
GR  - R01 CA120198/CA/NCI NIH HHS/United States
GR  - R01 AI050631/AI/NIAID NIH HHS/United States
GR  - R01 CA034992/CA/NCI NIH HHS/United States
GR  - R01 CA211184/CA/NCI NIH HHS/United States
GR  - R01 AI040146/AI/NIAID NIH HHS/United States
GR  - C06 CA062520/CA/NCI NIH HHS/United States
GR  - P30 CA147882/CA/NCI NIH HHS/United States
GR  - R01 CA184956/CA/NCI NIH HHS/United States
GR  - HHMI/Howard Hughes Medical Institute/United States
GR  - U54 CA163109/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, N.I.H., Extramural
DEP - 20170501
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CIN - Nat Rev Cancer. 2017 Jul;17 (7):395. PMID: 28642600
EIN - Nat Biotechnol. 2017 Dec 8;35(12 ):1211. PMID: 29220013
MH  - Animals
MH  - Carcinogenesis/genetics
MH  - Cell Line, Tumor
MH  - Clustered Regularly Interspaced Short Palindromic Repeats/genetics
MH  - Colorectal Neoplasms/*genetics
MH  - *Disease Models, Animal
MH  - Female
MH  - Gene Editing/*methods
MH  - Genes, Neoplasm/*genetics
MH  - Liver Neoplasms/*genetics/*secondary
MH  - Male
MH  - Mice
MH  - Mice, Transgenic
MH  - Neoplasm Metastasis
MH  - Organ Transplantation/*methods
PMC - PMC5462879
MID - NIHMS856821
EDAT- 2017/05/02 06:00
MHDA- 2017/08/19 06:00
CRDT- 2017/05/02 06:00
PHST- 2016/07/08 00:00 [received]
PHST- 2017/03/01 00:00 [accepted]
PHST- 2017/05/02 06:00 [pubmed]
PHST- 2017/08/19 06:00 [medline]
PHST- 2017/05/02 06:00 [entrez]
AID - nbt.3836 [pii]
AID - 10.1038/nbt.3836 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jun;35(6):569-576. doi: 10.1038/nbt.3836. Epub 2017 May 1.

PMID- 28459448
OWN - NLM
STAT- MEDLINE
DCOM- 20170818
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 6
DP  - 2017 Jun
TI  - Single-cell topological RNA-seq analysis reveals insights into cellular
      differentiation and development.
PG  - 551-560
LID - 10.1038/nbt.3854 [doi]
AB  - Transcriptional programs control cellular lineage commitment and differentiation 
      during development. Understanding of cell fate has been advanced by studying
      single-cell RNA-sequencing (RNA-seq) but is limited by the assumptions of current
      analytic methods regarding the structure of data. We present single-cell
      topological data analysis (scTDA), an algorithm for topology-based computational 
      analyses to study temporal, unbiased transcriptional regulation. Unlike other
      methods, scTDA is a nonlinear, model-independent, unsupervised statistical
      framework that can characterize transient cellular states. We applied scTDA to
      the analysis of murine embryonic stem cell (mESC) differentiation in vitro in
      response to inducers of motor neuron differentiation. scTDA resolved asynchrony
      and continuity in cellular identity over time and identified four transient
      states (pluripotent, precursor, progenitor, and fully differentiated cells) based
      on changes in stage-dependent combinations of transcription factors, RNA-binding 
      proteins, and long noncoding RNAs (lncRNAs). scTDA can be applied to study
      asynchronous cellular responses to either developmental cues or environmental
      perturbations.
FAU - Rizvi, Abbas H
AU  - Rizvi AH
AD  - Department of Biochemistry and Molecular Biophysics, Columbia University Medical 
      Center, New York, New York, USA.
AD  - The Mortimer B. Zuckerman Mind Brain Behavior Institute, Columbia University, New
      York, New York, USA.
FAU - Camara, Pablo G
AU  - Camara PG
AD  - Department of Systems Biology, Columbia University Medical Center, New York, New 
      York, USA.
AD  - Department of Biomedical Informatics, Columbia University Medical Center, New
      York, New York, USA.
FAU - Kandror, Elena K
AU  - Kandror EK
AD  - Department of Biochemistry and Molecular Biophysics, Columbia University Medical 
      Center, New York, New York, USA.
AD  - The Mortimer B. Zuckerman Mind Brain Behavior Institute, Columbia University, New
      York, New York, USA.
FAU - Roberts, Thomas J
AU  - Roberts TJ
AD  - Department of Biochemistry and Molecular Biophysics, Columbia University Medical 
      Center, New York, New York, USA.
AD  - The Mortimer B. Zuckerman Mind Brain Behavior Institute, Columbia University, New
      York, New York, USA.
AD  - Department of Biomedical Informatics, Columbia University Medical Center, New
      York, New York, USA.
FAU - Schieren, Ira
AU  - Schieren I
AD  - The Mortimer B. Zuckerman Mind Brain Behavior Institute, Columbia University, New
      York, New York, USA.
AD  - Howard Hughes Medical Institute, Columbia University Medical Center, New York,
      New York, USA.
FAU - Maniatis, Tom
AU  - Maniatis T
AD  - Department of Biochemistry and Molecular Biophysics, Columbia University Medical 
      Center, New York, New York, USA.
AD  - The Mortimer B. Zuckerman Mind Brain Behavior Institute, Columbia University, New
      York, New York, USA.
FAU - Rabadan, Raul
AU  - Rabadan R
AD  - Department of Systems Biology, Columbia University Medical Center, New York, New 
      York, USA.
AD  - Department of Biomedical Informatics, Columbia University Medical Center, New
      York, New York, USA.
LA  - eng
GR  - DP1 NS082099/NS/NINDS NIH HHS/United States
GR  - R01 GM117591/GM/NIGMS NIH HHS/United States
GR  - U54 CA193313/CA/NCI NIH HHS/United States
GR  - R21 NS088992/NS/NINDS NIH HHS/United States
GR  - T32 GM008224/GM/NIGMS NIH HHS/United States
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, N.I.H., Extramural
DEP - 20170501
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 63231-63-0 (RNA)
SB  - IM
MH  - *Algorithms
MH  - Animals
MH  - Cell Differentiation/*genetics
MH  - Cells, Cultured
MH  - Embryonic Stem Cells/cytology/*physiology
MH  - Gene Expression Regulation/genetics
MH  - Mice
MH  - Motor Neurons/cytology/physiology
MH  - RNA/*genetics
MH  - Sequence Analysis, RNA/*methods
MH  - Single-Cell Analysis/methods
MH  - Transcription, Genetic/*genetics
MH  - Transcriptional Activation/genetics
PMC - PMC5569300
MID - NIHMS862038
EDAT- 2017/05/02 06:00
MHDA- 2017/08/19 06:00
CRDT- 2017/05/02 06:00
PHST- 2016/09/25 00:00 [received]
PHST- 2017/03/20 00:00 [accepted]
PHST- 2017/05/02 06:00 [pubmed]
PHST- 2017/08/19 06:00 [medline]
PHST- 2017/05/02 06:00 [entrez]
AID - nbt.3854 [pii]
AID - 10.1038/nbt.3854 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jun;35(6):551-560. doi: 10.1038/nbt.3854. Epub 2017 May 1.

PMID- 28369033
OWN - NLM
STAT- MEDLINE
DCOM- 20170818
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 6
DP  - 2017 Jun
TI  - CRISPR-Cas9 epigenome editing enables high-throughput screening for functional
      regulatory elements in the human genome.
PG  - 561-568
LID - 10.1038/nbt.3853 [doi]
AB  - Large genome-mapping consortia and thousands of genome-wide association studies
      have identified non-protein-coding elements in the genome as having a central
      role in various biological processes. However, decoding the functions of the
      millions of putative regulatory elements discovered in these studies remains
      challenging. CRISPR-Cas9-based epigenome editing technologies have enabled
      precise perturbation of the activity of specific regulatory elements. Here we
      describe CRISPR-Cas9-based epigenomic regulatory element screening (CERES) for
      improved high-throughput screening of regulatory element activity in the native
      genomic context. Using dCas9(KRAB) repressor and dCas9(p300) activator constructs
      and lentiviral single guide RNA libraries to target DNase I hypersensitive sites 
      surrounding a gene of interest, we carried out both loss- and gain-of-function
      screens to identify regulatory elements for the beta-globin and HER2 loci in
      human cells. CERES readily identified known and previously unidentified
      regulatory elements, some of which were dependent on cell type or direction of
      perturbation. This technology allows the high-throughput functional annotation of
      putative regulatory elements in their native chromosomal context.
FAU - Klann, Tyler S
AU  - Klann TS
AD  - Department of Biomedical Engineering, Duke University, Durham, North Carolina,
      USA.
AD  - Center for Genomic and Computational Biology, Duke University, Durham, North
      Carolina, USA.
FAU - Black, Joshua B
AU  - Black JB
AD  - Department of Biomedical Engineering, Duke University, Durham, North Carolina,
      USA.
AD  - Center for Genomic and Computational Biology, Duke University, Durham, North
      Carolina, USA.
FAU - Chellappan, Malathi
AU  - Chellappan M
AD  - Department of Biomedical Engineering, Duke University, Durham, North Carolina,
      USA.
AD  - Center for Genomic and Computational Biology, Duke University, Durham, North
      Carolina, USA.
FAU - Safi, Alexias
AU  - Safi A
AD  - Center for Genomic and Computational Biology, Duke University, Durham, North
      Carolina, USA.
FAU - Song, Lingyun
AU  - Song L
AD  - Center for Genomic and Computational Biology, Duke University, Durham, North
      Carolina, USA.
FAU - Hilton, Isaac B
AU  - Hilton IB
AUID- ORCID: 0000-0002-3064-8532
AD  - Department of Biomedical Engineering, Duke University, Durham, North Carolina,
      USA.
AD  - Center for Genomic and Computational Biology, Duke University, Durham, North
      Carolina, USA.
FAU - Crawford, Gregory E
AU  - Crawford GE
AD  - Center for Genomic and Computational Biology, Duke University, Durham, North
      Carolina, USA.
AD  - Department of Pediatrics, Division of Medical Genetics, Duke University Medical
      Center, Durham, North Carolina, USA.
FAU - Reddy, Timothy E
AU  - Reddy TE
AUID- ORCID: 0000-0002-7629-061X
AD  - Department of Biomedical Engineering, Duke University, Durham, North Carolina,
      USA.
AD  - Center for Genomic and Computational Biology, Duke University, Durham, North
      Carolina, USA.
AD  - Department of Biostatistics and Bioinformatics, Duke University Medical Center,
      Durham, North Carolina, USA.
FAU - Gersbach, Charles A
AU  - Gersbach CA
AD  - Department of Biomedical Engineering, Duke University, Durham, North Carolina,
      USA.
AD  - Center for Genomic and Computational Biology, Duke University, Durham, North
      Carolina, USA.
AD  - Department of Orthopaedic Surgery, Duke University Medical Center, Durham, North 
      Carolina, USA.
LA  - eng
GR  - T32 GM008555/GM/NIGMS NIH HHS/United States
GR  - DP2 OD008586/OD/NIH HHS/United States
GR  - R01 DA036865/DA/NIDA NIH HHS/United States
GR  - U01 HG007900/HG/NHGRI NIH HHS/United States
GR  - R41 GM119914/GM/NIGMS NIH HHS/United States
GR  - P30 AR066527/AR/NIAMS NIH HHS/United States
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PT  - Research Support, N.I.H., Extramural
DEP - 20170403
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (CRISPR-Associated Proteins)
SB  - IM
MH  - CRISPR-Associated Proteins/*genetics
MH  - *CRISPR-Cas Systems
MH  - Chromosome Mapping/methods
MH  - Clustered Regularly Interspaced Short Palindromic Repeats/*genetics
MH  - Epigenomics/methods
MH  - Gene Editing/*methods
MH  - Genome, Human/*genetics
MH  - High-Throughput Nucleotide Sequencing/*methods
MH  - Humans
MH  - Regulatory Elements, Transcriptional/*genetics
MH  - Sequence Analysis, DNA/*methods
PMC - PMC5462860
MID - NIHMS861702
EDAT- 2017/04/04 06:00
MHDA- 2017/08/19 06:00
CRDT- 2017/04/04 06:00
PHST- 2016/09/19 00:00 [received]
PHST- 2017/03/17 00:00 [accepted]
PHST- 2017/04/04 06:00 [pubmed]
PHST- 2017/08/19 06:00 [medline]
PHST- 2017/04/04 06:00 [entrez]
AID - nbt.3853 [pii]
AID - 10.1038/nbt.3853 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jun;35(6):561-568. doi: 10.1038/nbt.3853. Epub 2017 Apr 3.

PMID- 28486470
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May 9
TI  - Erratum: An optical probe of synaptic plasticity.
PG  - 481
LID - 10.1038/nbt0517-481c [doi]
FAU - Laviv, Tal
AU  - Laviv T
FAU - Yasuda, Ryohei
AU  - Yasuda R
LA  - eng
PT  - Journal Article
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2017 Jan 10;35(1):26-27. PMID: 28072770
EDAT- 2017/05/10 06:00
MHDA- 2017/05/10 06:01
CRDT- 2017/05/10 06:00
PHST- 2017/05/10 06:00 [entrez]
PHST- 2017/05/10 06:00 [pubmed]
PHST- 2017/05/10 06:01 [medline]
AID - nbt0517-481c [pii]
AID - 10.1038/nbt0517-481c [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May 9;35(5):481. doi: 10.1038/nbt0517-481c.

PMID- 28486469
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May 9
TI  - Digital farming attracts cash to agtech startups.
PG  - 397-398
LID - 10.1038/nbt0517-397 [doi]
FAU - Waltz, Emily
AU  - Waltz E
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/05/10 06:00
MHDA- 2017/05/10 06:01
CRDT- 2017/05/10 06:00
PHST- 2017/05/10 06:00 [entrez]
PHST- 2017/05/10 06:00 [pubmed]
PHST- 2017/05/10 06:01 [medline]
AID - nbt0517-397 [pii]
AID - 10.1038/nbt0517-397 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May 9;35(5):397-398. doi: 10.1038/nbt0517-397.

PMID- 28486468
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May 9
TI  - Recent patents in plant organogenesis.
PG  - 425
LID - 10.1038/nbt.3883 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/05/10 06:00
MHDA- 2017/05/10 06:01
CRDT- 2017/05/10 06:00
PHST- 2017/05/10 06:00 [entrez]
PHST- 2017/05/10 06:00 [pubmed]
PHST- 2017/05/10 06:01 [medline]
AID - nbt.3883 [pii]
AID - 10.1038/nbt.3883 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May 9;35(5):425. doi: 10.1038/nbt.3883.

PMID- 28486467
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May 9
TI  - Academic partnerships 2016.
PG  - 404-405
LID - 10.1038/nbt.3861 [doi]
FAU - Huggett, Brady
AU  - Huggett B
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/05/10 06:00
MHDA- 2017/05/10 06:01
CRDT- 2017/05/10 06:00
PHST- 2017/05/10 06:00 [entrez]
PHST- 2017/05/10 06:00 [pubmed]
PHST- 2017/05/10 06:01 [medline]
AID - nbt.3861 [pii]
AID - 10.1038/nbt.3861 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May 9;35(5):404-405. doi: 10.1038/nbt.3861.

PMID- 28486466
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May 9
TI  - Erratum: Drugging the gut microbiome.
PG  - 481
LID - 10.1038/nbt0517-481b [doi]
FAU - Garber, Ken
AU  - Garber K
LA  - eng
PT  - Journal Article
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2015 Mar;33(3):228-31. PMID: 25748907
EDAT- 2017/05/10 06:00
MHDA- 2017/05/10 06:01
CRDT- 2017/05/10 06:00
PHST- 2017/05/10 06:00 [entrez]
PHST- 2017/05/10 06:00 [pubmed]
PHST- 2017/05/10 06:01 [medline]
AID - nbt0517-481b [pii]
AID - 10.1038/nbt0517-481b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May 9;35(5):481. doi: 10.1038/nbt0517-481b.

PMID- 28486465
OWN - NLM
STAT- MEDLINE
DCOM- 20180405
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May 9
TI  - FDA approves PARP inhibitor for ovarian cancer.
PG  - 398
LID - 10.1038/nbt0517-398 [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Poly(ADP-ribose) Polymerase Inhibitors)
SB  - IM
MH  - *Drug Approval
MH  - Female
MH  - Humans
MH  - Ovarian Neoplasms/*drug therapy
MH  - Poly(ADP-ribose) Polymerase Inhibitors/*therapeutic use
MH  - United States
MH  - United States Food and Drug Administration
EDAT- 2017/05/10 06:00
MHDA- 2018/04/06 06:00
CRDT- 2017/05/10 06:00
PHST- 2017/05/10 06:00 [entrez]
PHST- 2017/05/10 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt0517-398 [pii]
AID - 10.1038/nbt0517-398 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May 9;35(5):398. doi: 10.1038/nbt0517-398.

PMID- 28486464
OWN - NLM
STAT- MEDLINE
DCOM- 20180405
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May 9
TI  - Discovering and linking public omics data sets using the Omics Discovery Index.
PG  - 406-409
LID - 10.1038/nbt.3790 [doi]
FAU - Perez-Riverol, Yasset
AU  - Perez-Riverol Y
AUID- ORCID: 0000-0001-6579-6941
AD  - European Molecular Biology Laboratory, European Bioinformatics Institute
      (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, United Kingdom.
FAU - Bai, Mingze
AU  - Bai M
AUID- ORCID: 0000-0002-9782-2056
AD  - European Molecular Biology Laboratory, European Bioinformatics Institute
      (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, United Kingdom.
AD  - Institute of Bioinformatics, Chongqing University of Posts and
      Telecommunications, Chongqing, China.
AD  - Beijing Proteome Research Center, National Center for Protein Sciences Beijing,
      Beijing, China.
FAU - da Veiga Leprevost, Felipe
AU  - da Veiga Leprevost F
AUID- ORCID: 0000-0002-8228-5374
AD  - Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
FAU - Squizzato, Silvano
AU  - Squizzato S
AUID- ORCID: 0000-0001-7433-0991
AD  - European Molecular Biology Laboratory, European Bioinformatics Institute
      (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, United Kingdom.
FAU - Park, Young Mi
AU  - Park YM
AUID- ORCID: 0000-0001-6587-6562
AD  - European Molecular Biology Laboratory, European Bioinformatics Institute
      (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, United Kingdom.
FAU - Haug, Kenneth
AU  - Haug K
AUID- ORCID: 0000-0003-3168-4145
AD  - European Molecular Biology Laboratory, European Bioinformatics Institute
      (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, United Kingdom.
FAU - Carroll, Adam J
AU  - Carroll AJ
AD  - Research School of Biology, Australian National University, Canberra, Australian 
      Capital Territory, Australia.
FAU - Spalding, Dylan
AU  - Spalding D
AUID- ORCID: 0000-0002-4285-2493
AD  - European Molecular Biology Laboratory, European Bioinformatics Institute
      (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, United Kingdom.
FAU - Paschall, Justin
AU  - Paschall J
AD  - European Molecular Biology Laboratory, European Bioinformatics Institute
      (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, United Kingdom.
FAU - Wang, Mingxun
AU  - Wang M
AD  - Department of Computer Science and Engineering, University of California, San
      Diego, La Jolla, California, USA.
FAU - Del-Toro, Noemi
AU  - Del-Toro N
AD  - European Molecular Biology Laboratory, European Bioinformatics Institute
      (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, United Kingdom.
FAU - Ternent, Tobias
AU  - Ternent T
AD  - European Molecular Biology Laboratory, European Bioinformatics Institute
      (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, United Kingdom.
FAU - Zhang, Peng
AU  - Zhang P
AD  - Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
AD  - Commonwealth Scientific and Industrial Research Organization, Canberra,
      Australian Capital Territory, Australia.
FAU - Buso, Nicola
AU  - Buso N
AUID- ORCID: 0000-0002-0555-0226
AD  - European Molecular Biology Laboratory, European Bioinformatics Institute
      (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, United Kingdom.
FAU - Bandeira, Nuno
AU  - Bandeira N
AD  - Department of Computer Science and Engineering, University of California, San
      Diego, La Jolla, California, USA.
FAU - Deutsch, Eric W
AU  - Deutsch EW
AD  - Institute for Systems Biology, Seattle, Washington, USA.
FAU - Campbell, David S
AU  - Campbell DS
AD  - Institute for Systems Biology, Seattle, Washington, USA.
FAU - Beavis, Ronald C
AU  - Beavis RC
AD  - Biochemistry &Medical Genetics, University of Manitoba, Winnipeg, Manitoba,
      Canada.
FAU - Salek, Reza M
AU  - Salek RM
AUID- ORCID: 0000-0001-8604-1732
AD  - European Molecular Biology Laboratory, European Bioinformatics Institute
      (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, United Kingdom.
FAU - Sarkans, Ugis
AU  - Sarkans U
AUID- ORCID: 0000-0001-9227-8488
AD  - European Molecular Biology Laboratory, European Bioinformatics Institute
      (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, United Kingdom.
FAU - Petryszak, Robert
AU  - Petryszak R
AD  - European Molecular Biology Laboratory, European Bioinformatics Institute
      (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, United Kingdom.
FAU - Keays, Maria
AU  - Keays M
AD  - European Molecular Biology Laboratory, European Bioinformatics Institute
      (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, United Kingdom.
FAU - Fahy, Eoin
AU  - Fahy E
AD  - Department of Bioengineering, University of California, San Diego, La Jolla,
      California, USA.
FAU - Sud, Manish
AU  - Sud M
AD  - Department of Bioengineering, University of California, San Diego, La Jolla,
      California, USA.
FAU - Subramaniam, Shankar
AU  - Subramaniam S
AD  - Department of Bioengineering, University of California, San Diego, La Jolla,
      California, USA.
FAU - Barbera, Ariana
AU  - Barbera A
AD  - Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
FAU - Jimenez, Rafael C
AU  - Jimenez RC
AD  - ELIXIR Hub, Wellcome Genome Campus, Hinxton, United Kingdom.
FAU - Nesvizhskii, Alexey I
AU  - Nesvizhskii AI
AUID- ORCID: 0000-0002-2806-7819
AD  - Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
FAU - Sansone, Susanna-Assunta
AU  - Sansone SA
AD  - Oxford e-Research Centre, University of Oxford, Oxford, United Kingdom.
FAU - Steinbeck, Christoph
AU  - Steinbeck C
AUID- ORCID: 0000-0001-6966-0814
AD  - European Molecular Biology Laboratory, European Bioinformatics Institute
      (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, United Kingdom.
FAU - Lopez, Rodrigo
AU  - Lopez R
AUID- ORCID: 0000-0003-1256-7306
AD  - European Molecular Biology Laboratory, European Bioinformatics Institute
      (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, United Kingdom.
FAU - Vizcaino, Juan A
AU  - Vizcaino JA
AUID- ORCID: 0000-0002-3905-4335
AD  - European Molecular Biology Laboratory, European Bioinformatics Institute
      (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, United Kingdom.
FAU - Ping, Peipei
AU  - Ping P
AD  - Department of Physiology and Department of Medicine, Division of Cardiology,
      David Geffen School of Medicine at UCLA, University of California, Los Angeles,
      Los Angeles, California, USA.
AD  - Department of Medicine, Division of Cardiology, David Geffen School of Medicine
      at UCLA, University of California, Los Angeles, Los Angeles, California, USA.
FAU - Hermjakob, Henning
AU  - Hermjakob H
AUID- ORCID: 0000-0001-8479-0262
AD  - European Molecular Biology Laboratory, European Bioinformatics Institute
      (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, United Kingdom.
AD  - Beijing Proteome Research Center, National Center for Protein Sciences Beijing,
      Beijing, China.
LA  - eng
GR  - U01 CA198941/CA/NCI NIH HHS/United States
GR  - U24 AI117966/AI/NIAID NIH HHS/United States
GR  - U01 DK097430/DK/NIDDK NIH HHS/United States
GR  - P41 GM103484/GM/NIGMS NIH HHS/United States
GR  - U54 GM114833/GM/NIGMS NIH HHS/United States
GR  - R01 GM094231/GM/NIGMS NIH HHS/United States
GR  - Wellcome Trust/United Kingdom
GR  - BB/K01997X/1/Biotechnology and Biological Sciences Research Council/United
      Kingdom
GR  - WT101477MA/Wellcome Trust/United Kingdom
GR  - BB/L024225/1/Biotechnology and Biological Sciences Research Council/United
      Kingdom
PT  - Letter
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Computational Biology
MH  - Data Mining/*methods
MH  - *Genomics
MH  - Humans
MH  - Information Storage and Retrieval/*methods
MH  - *Proteomics
PMC - PMC5831141
MID - NIHMS944263
EDAT- 2017/05/10 06:00
MHDA- 2018/04/06 06:00
CRDT- 2017/05/10 06:00
PHST- 2017/05/10 06:00 [entrez]
PHST- 2017/05/10 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt.3790 [pii]
AID - 10.1038/nbt.3790 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May 9;35(5):406-409. doi: 10.1038/nbt.3790.

PMID- 28486463
OWN - NLM
STAT- MEDLINE
DCOM- 20180405
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May 9
TI  - First eczema biologic debuts but price could restrict use.
PG  - 391-392
LID - 10.1038/nbt0517-391 [doi]
FAU - Dolgin, Elie
AU  - Dolgin E
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antibodies, Monoclonal)
RN  - 0 (IL4R protein, human)
RN  - 0 (Interleukin-4 Receptor alpha Subunit)
RN  - 0 (SAR231893)
SB  - IM
MH  - Antibodies, Monoclonal/economics/*therapeutic use
MH  - Drug Approval/*economics
MH  - Eczema/*drug therapy/economics
MH  - Humans
MH  - Interleukin-4 Receptor alpha Subunit/antagonists & inhibitors/genetics
MH  - United States
MH  - United States Food and Drug Administration/economics
EDAT- 2017/05/10 06:00
MHDA- 2018/04/06 06:00
CRDT- 2017/05/10 06:00
PHST- 2017/05/10 06:00 [entrez]
PHST- 2017/05/10 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt0517-391 [pii]
AID - 10.1038/nbt0517-391 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May 9;35(5):391-392. doi: 10.1038/nbt0517-391.

PMID- 28486462
OWN - NLM
STAT- MEDLINE
DCOM- 20180405
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May 9
TI  - Living in a microbial world.
PG  - 401-403
LID - 10.1038/nbt.3868 [doi]
FAU - Schmidt, Charles
AU  - Schmidt C
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Bacteria/genetics/*isolation & purification
MH  - *Cell Phone
MH  - Ecological Parameter Monitoring
MH  - Fungi/genetics/*isolation & purification
MH  - Humans
MH  - *Metagenomics
EDAT- 2017/05/10 06:00
MHDA- 2018/04/06 06:00
CRDT- 2017/05/10 06:00
PHST- 2017/05/10 06:00 [entrez]
PHST- 2017/05/10 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt.3868 [pii]
AID - 10.1038/nbt.3868 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May 9;35(5):401-403. doi: 10.1038/nbt.3868.

PMID- 28486460
OWN - NLM
STAT- MEDLINE
DCOM- 20180405
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May 9
TI  - Astex shapes CDK4/6 inhibitor for approval.
PG  - 395-396
LID - 10.1038/nbt0517-395 [doi]
FAU - Peplow, Mark
AU  - Peplow M
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Aminopyridines)
RN  - 0 (Purines)
RN  - EC 2.7.11.22 (Cyclin-Dependent Kinase 4)
RN  - EC 2.7.11.22 (Cyclin-Dependent Kinase 6)
RN  - TK8ERE8P56 (ribociclib)
SB  - IM
MH  - Aminopyridines/*therapeutic use
MH  - Breast Neoplasms/*drug therapy/epidemiology
MH  - Cyclin-Dependent Kinase 4/antagonists & inhibitors
MH  - Cyclin-Dependent Kinase 6/antagonists & inhibitors
MH  - *Drug Approval
MH  - Drug Industry
MH  - Female
MH  - Humans
MH  - Purines/*therapeutic use
MH  - United States
MH  - United States Food and Drug Administration
EDAT- 2017/05/10 06:00
MHDA- 2018/04/06 06:00
CRDT- 2017/05/10 06:00
PHST- 2017/05/10 06:00 [entrez]
PHST- 2017/05/10 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt0517-395 [pii]
AID - 10.1038/nbt0517-395 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May 9;35(5):395-396. doi: 10.1038/nbt0517-395.

PMID- 28486459
OWN - NLM
STAT- MEDLINE
DCOM- 20180405
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May 9
TI  - Genentech's Ocrevus heralds new chapter in MS treatment.
PG  - 393-394
LID - 10.1038/nbt0517-393 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antibodies, Monoclonal, Humanized)
RN  - A10SJL62JY (ocrelizumab)
SB  - IM
MH  - Antibodies, Monoclonal, Humanized/*therapeutic use
MH  - Drug Industry
MH  - Humans
MH  - Multiple Sclerosis/*drug therapy/immunology/pathology
MH  - Myelin Sheath/drug effects/pathology
EDAT- 2017/05/10 06:00
MHDA- 2018/04/06 06:00
CRDT- 2017/05/10 06:00
PHST- 2017/05/10 06:00 [entrez]
PHST- 2017/05/10 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt0517-393 [pii]
AID - 10.1038/nbt0517-393 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May 9;35(5):393-394. doi: 10.1038/nbt0517-393.

PMID- 28486458
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May 9
TI  - First-quarter biotech job picture.
PG  - 482
LID - 10.1038/nbt.3875 [doi]
FAU - Francisco, Michael
AU  - Francisco M
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/05/10 06:00
MHDA- 2017/05/10 06:01
CRDT- 2017/05/10 06:00
PHST- 2017/05/10 06:00 [entrez]
PHST- 2017/05/10 06:00 [pubmed]
PHST- 2017/05/10 06:01 [medline]
AID - nbt.3875 [pii]
AID - 10.1038/nbt.3875 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May 9;35(5):482. doi: 10.1038/nbt.3875.

PMID- 28486457
OWN - NLM
STAT- MEDLINE
DCOM- 20180330
LR  - 20180330
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May 9
TI  - Base editing on the rise.
PG  - 428-429
LID - 10.1038/nbt.3871 [doi]
FAU - May, Andrew
AU  - May A
AD  - Chan Zuckerberg Biohub, San Francisco, California, USA.
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2017 May;35(5):438-440. PMID: 28244994
CON - Nat Biotechnol. 2017 May;35(5):435-437. PMID: 28244995
CON - Nat Biotechnol. 2017 May;35(5):441-443. PMID: 28346401
CON - Nat Biotechnol. 2017 May;35(5):475-480. PMID: 28398345
CON - Nat Biotechnol. 2017 Apr;35(4):371-376. PMID: 28191901
MH  - *CRISPR-Cas Systems
MH  - *RNA Editing
EDAT- 2017/05/10 06:00
MHDA- 2018/03/31 06:00
CRDT- 2017/05/10 06:00
PHST- 2017/05/10 06:00 [entrez]
PHST- 2017/05/10 06:00 [pubmed]
PHST- 2018/03/31 06:00 [medline]
AID - nbt.3871 [pii]
AID - 10.1038/nbt.3871 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May 9;35(5):428-429. doi: 10.1038/nbt.3871.

PMID- 28486456
OWN - NLM
STAT- MEDLINE
DCOM- 20180405
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May 9
TI  - Genomics pioneer gets its first drug.
PG  - 399
LID - 10.1038/nbt0517-399 [doi]
FAU - Ratner, Mark
AU  - Ratner M
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Pyrimidines)
RN  - 381V4FCV2Z (telotristat)
RN  - 47E5O17Y3R (Phenylalanine)
RN  - EC 1.14.16.4 (Tryptophan Hydroxylase)
SB  - IM
MH  - Drug Industry/*trends
MH  - *Genomics
MH  - Humans
MH  - Phenylalanine/*analogs & derivatives/therapeutic use
MH  - Pyrimidines/*therapeutic use
MH  - Tryptophan Hydroxylase/antagonists & inhibitors/*therapeutic use
EDAT- 2017/05/10 06:00
MHDA- 2018/04/06 06:00
CRDT- 2017/05/10 06:00
PHST- 2017/05/10 06:00 [entrez]
PHST- 2017/05/10 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt0517-399 [pii]
AID - 10.1038/nbt0517-399 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May 9;35(5):399. doi: 10.1038/nbt0517-399.

PMID- 28486455
OWN - NLM
STAT- MEDLINE
DCOM- 20180405
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May 9
TI  - UC granted CRISPR patents in Europe, appeals in US.
PG  - 396
LID - 10.1038/nbt0517-396 [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *CRISPR-Cas Systems
MH  - Europe
MH  - Humans
MH  - Patents as Topic/*legislation & jurisprudence
MH  - United States
EDAT- 2017/05/10 06:00
MHDA- 2018/04/06 06:00
CRDT- 2017/05/10 06:00
PHST- 2017/05/10 06:00 [entrez]
PHST- 2017/05/10 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt0517-396 [pii]
AID - 10.1038/nbt0517-396 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May 9;35(5):396. doi: 10.1038/nbt0517-396.

PMID- 28486454
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May 9
TI  - Corrigendum: Response to "Railroading at the FDA".
PG  - 481
LID - 10.1038/nbt0517-481d [doi]
FAU - Muntoni, Francesco
AU  - Muntoni F
FAU - Fletcher, Sue
AU  - Fletcher S
FAU - Wilton, Steve
AU  - Wilton S
LA  - eng
PT  - Journal Article
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2017 Mar 7;35(3):207-209. PMID: 28267731
EDAT- 2017/05/10 06:00
MHDA- 2017/05/10 06:01
CRDT- 2017/05/10 06:00
PHST- 2017/05/10 06:00 [entrez]
PHST- 2017/05/10 06:00 [pubmed]
PHST- 2017/05/10 06:01 [medline]
AID - nbt0517-481d [pii]
AID - 10.1038/nbt0517-481d [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May 9;35(5):481. doi: 10.1038/nbt0517-481d.

PMID- 28486453
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May 9
TI  - Addendum: Editorial Expression of Concern: DNA-guided genome editing using the
      Natronobacterium gregoryi Argonaute.
PG  - 481
LID - 10.1038/nbt0517-481a [doi]
FAU - Gao, Feng
AU  - Gao F
FAU - Shen, Xiao Z
AU  - Shen XZ
FAU - Jiang, Feng
AU  - Jiang F
FAU - Wu, Yongqiang
AU  - Wu Y
FAU - Han, Chunyu
AU  - Han C
LA  - eng
PT  - Journal Article
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2016 Jul;34(7):768-73. PMID: 27136078
EDAT- 2017/05/10 06:00
MHDA- 2017/05/10 06:01
CRDT- 2017/05/10 06:00
PHST- 2017/05/10 06:00 [entrez]
PHST- 2017/05/10 06:00 [pubmed]
PHST- 2017/05/10 06:01 [medline]
AID - nbt0517-481a [pii]
AID - 10.1038/nbt0517-481a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May 9;35(5):481. doi: 10.1038/nbt0517-481a.

PMID- 28486452
OWN - NLM
STAT- MEDLINE
DCOM- 20180330
LR  - 20180330
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May 9
TI  - Genome organization by the slice.
PG  - 430
LID - 10.1038/nbt.3866 [doi]
FAU - Elsner, Markus
AU  - Elsner M
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nature. 2017 Mar 23;543(7646):519-524. PMID: 28273065
MH  - *Genome
MH  - *Organ Culture Techniques
EDAT- 2017/05/10 06:00
MHDA- 2018/03/31 06:00
CRDT- 2017/05/10 06:00
PHST- 2017/05/10 06:00 [entrez]
PHST- 2017/05/10 06:00 [pubmed]
PHST- 2018/03/31 06:00 [medline]
AID - nbt.3866 [pii]
AID - 10.1038/nbt.3866 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May 9;35(5):430. doi: 10.1038/nbt.3866.

PMID- 28486451
OWN - NLM
STAT- MEDLINE
DCOM- 20180405
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May 9
TI  - Biotech's wellspring-a survey of the health of the private sector in 2016.
PG  - 413-420
LID - 10.1038/nbt.3867 [doi]
FAU - Lawrence, Stacy
AU  - Lawrence S
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*economics
MH  - Humans
MH  - Investments/*economics
MH  - Private Sector/*economics
MH  - Surveys and Questionnaires
EDAT- 2017/05/10 06:00
MHDA- 2018/04/06 06:00
CRDT- 2017/05/10 06:00
PHST- 2017/05/10 06:00 [entrez]
PHST- 2017/05/10 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt.3867 [pii]
AID - 10.1038/nbt.3867 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May 9;35(5):413-420. doi: 10.1038/nbt.3867.

PMID- 28486449
OWN - NLM
STAT- MEDLINE
DCOM- 20180405
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May 9
TI  - Drug pipeline: 1Q17.
PG  - 400
LID - 10.1038/nbt.3874 [doi]
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Drug Approval
MH  - Drug Industry/*economics
MH  - Humans
MH  - United States
MH  - United States Food and Drug Administration
EDAT- 2017/05/10 06:00
MHDA- 2018/04/06 06:00
CRDT- 2017/05/10 06:00
PHST- 2017/05/10 06:00 [entrez]
PHST- 2017/05/10 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt.3874 [pii]
AID - 10.1038/nbt.3874 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May 9;35(5):400. doi: 10.1038/nbt.3874.

PMID- 28486448
OWN - NLM
STAT- MEDLINE
DCOM- 20180330
LR  - 20180330
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May 9
TI  - Reprogramming the diseased brain.
PG  - 426-428
LID - 10.1038/nbt.3869 [doi]
FAU - Dunnett, Stephen B
AU  - Dunnett SB
AD  - The Brain Repair Group, Cardiff University School of Biosciences, Cardiff, Wales,
      UK.
FAU - Rosser, Anne E
AU  - Rosser AE
AD  - The Brain Repair Group, Cardiff University School of Biosciences, Cardiff, Wales,
      UK.
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2017 May;35(5):444-452. PMID: 28398344
MH  - *Brain
MH  - *Cellular Reprogramming
MH  - Humans
EDAT- 2017/05/10 06:00
MHDA- 2018/03/31 06:00
CRDT- 2017/05/10 06:00
PHST- 2017/05/10 06:00 [entrez]
PHST- 2017/05/10 06:00 [pubmed]
PHST- 2018/03/31 06:00 [medline]
AID - nbt.3869 [pii]
AID - 10.1038/nbt.3869 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May 9;35(5):426-428. doi: 10.1038/nbt.3869.

PMID- 28486447
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May 9
TI  - Corrigendum: A FRET sensor enables quantitative measurements of membrane charges 
      in live cells.
PG  - 481
LID - 10.1038/nbt0517-481e [doi]
FAU - Ma, Yuanqing
AU  - Ma Y
FAU - Yamamoto, Yui
AU  - Yamamoto Y
FAU - Nicovich, Philip R
AU  - Nicovich PR
FAU - Goyette, Jesse
AU  - Goyette J
FAU - Rossy, Jeremie
AU  - Rossy J
FAU - Gooding, J Justin
AU  - Gooding JJ
FAU - Gaus, Katharina
AU  - Gaus K
LA  - eng
PT  - Journal Article
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2017 Apr;35(4):363-370. PMID: 28288102
EDAT- 2017/05/10 06:00
MHDA- 2017/05/10 06:01
CRDT- 2017/05/10 06:00
PHST- 2017/05/10 06:00 [entrez]
PHST- 2017/05/10 06:00 [pubmed]
PHST- 2017/05/10 06:01 [medline]
AID - nbt0517-481e [pii]
AID - 10.1038/nbt0517-481e [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May 9;35(5):481. doi: 10.1038/nbt0517-481e.

PMID- 28486446
OWN - NLM
STAT- MEDLINE
DCOM- 20180405
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May 9
TI  - Firmiana: towards a one-stop proteomic cloud platform for data processing and
      analysis.
PG  - 409-412
LID - 10.1038/nbt.3825 [doi]
FAU - Feng, Jinwen
AU  - Feng J
AD  - State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing
      Institute of Radiation Medicine, National Center for Protein Sciences (The
      PHOENIX Center, Beijing), Beijing, China.
AD  - The Center for Bioinformatics and Computational Biology, Shanghai Key Laboratory 
      of Regulatory Biology, Institute of Biomedical Sciences and School of Life
      Sciences, East China Normal University, Shanghai, China.
FAU - Ding, Chen
AU  - Ding C
AD  - State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing
      Institute of Radiation Medicine, National Center for Protein Sciences (The
      PHOENIX Center, Beijing), Beijing, China.
AD  - State Key Laboratory of Genetic Engineering and Collaborative Innovation Center
      for Genetics and Development, School of Life Sciences, Institutes of Biomedical
      Sciences, Fudan University, Shanghai, China.
FAU - Qiu, Naiqi
AU  - Qiu N
AD  - State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing
      Institute of Radiation Medicine, National Center for Protein Sciences (The
      PHOENIX Center, Beijing), Beijing, China.
AD  - The Center for Bioinformatics and Computational Biology, Shanghai Key Laboratory 
      of Regulatory Biology, Institute of Biomedical Sciences and School of Life
      Sciences, East China Normal University, Shanghai, China.
FAU - Ni, Xiaotian
AU  - Ni X
AD  - State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing
      Institute of Radiation Medicine, National Center for Protein Sciences (The
      PHOENIX Center, Beijing), Beijing, China.
AD  - The Center for Bioinformatics and Computational Biology, Shanghai Key Laboratory 
      of Regulatory Biology, Institute of Biomedical Sciences and School of Life
      Sciences, East China Normal University, Shanghai, China.
FAU - Zhan, Dongdong
AU  - Zhan D
AD  - State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing
      Institute of Radiation Medicine, National Center for Protein Sciences (The
      PHOENIX Center, Beijing), Beijing, China.
AD  - The Center for Bioinformatics and Computational Biology, Shanghai Key Laboratory 
      of Regulatory Biology, Institute of Biomedical Sciences and School of Life
      Sciences, East China Normal University, Shanghai, China.
FAU - Liu, Wanlin
AU  - Liu W
AD  - State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing
      Institute of Radiation Medicine, National Center for Protein Sciences (The
      PHOENIX Center, Beijing), Beijing, China.
FAU - Xia, Xia
AU  - Xia X
AD  - State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing
      Institute of Radiation Medicine, National Center for Protein Sciences (The
      PHOENIX Center, Beijing), Beijing, China.
FAU - Li, Peng
AU  - Li P
AD  - The Center for Bioinformatics and Computational Biology, Shanghai Key Laboratory 
      of Regulatory Biology, Institute of Biomedical Sciences and School of Life
      Sciences, East China Normal University, Shanghai, China.
FAU - Lu, Bingxin
AU  - Lu B
AD  - The Center for Bioinformatics and Computational Biology, Shanghai Key Laboratory 
      of Regulatory Biology, Institute of Biomedical Sciences and School of Life
      Sciences, East China Normal University, Shanghai, China.
FAU - Zhao, Qi
AU  - Zhao Q
AD  - State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen
      University, Guangzhou, China.
FAU - Nie, Peng
AU  - Nie P
AD  - State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen
      University, Guangzhou, China.
FAU - Song, Lei
AU  - Song L
AD  - State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing
      Institute of Radiation Medicine, National Center for Protein Sciences (The
      PHOENIX Center, Beijing), Beijing, China.
FAU - Zhou, Quan
AU  - Zhou Q
AD  - State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing
      Institute of Radiation Medicine, National Center for Protein Sciences (The
      PHOENIX Center, Beijing), Beijing, China.
FAU - Lai, Mi
AU  - Lai M
AD  - State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing
      Institute of Radiation Medicine, National Center for Protein Sciences (The
      PHOENIX Center, Beijing), Beijing, China.
FAU - Guo, Gaigai
AU  - Guo G
AD  - State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing
      Institute of Radiation Medicine, National Center for Protein Sciences (The
      PHOENIX Center, Beijing), Beijing, China.
FAU - Zhu, Weimin
AU  - Zhu W
AD  - State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing
      Institute of Radiation Medicine, National Center for Protein Sciences (The
      PHOENIX Center, Beijing), Beijing, China.
FAU - Ren, Jian
AU  - Ren J
AUID- ORCID: 0000-0002-4161-1292
AD  - State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen
      University, Guangzhou, China.
FAU - Shi, Tieliu
AU  - Shi T
AD  - The Center for Bioinformatics and Computational Biology, Shanghai Key Laboratory 
      of Regulatory Biology, Institute of Biomedical Sciences and School of Life
      Sciences, East China Normal University, Shanghai, China.
FAU - Qin, Jun
AU  - Qin J
AD  - State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing
      Institute of Radiation Medicine, National Center for Protein Sciences (The
      PHOENIX Center, Beijing), Beijing, China.
AD  - State Key Laboratory of Genetic Engineering and Collaborative Innovation Center
      for Genetics and Development, School of Life Sciences, Institutes of Biomedical
      Sciences, Fudan University, Shanghai, China.
LA  - eng
PT  - Letter
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Cloud Computing
MH  - Data Mining/methods
MH  - Humans
MH  - Proteomics/*methods
MH  - *Software
EDAT- 2017/05/10 06:00
MHDA- 2018/04/06 06:00
CRDT- 2017/05/10 06:00
PHST- 2017/05/10 06:00 [entrez]
PHST- 2017/05/10 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt.3825 [pii]
AID - 10.1038/nbt.3825 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May 9;35(5):409-412. doi: 10.1038/nbt.3825.

PMID- 28486445
OWN - NLM
STAT- MEDLINE
DCOM- 20180405
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May 9
TI  - Who reads patents?
PG  - 421-424
LID - 10.1038/nbt.3864 [doi]
FAU - Ouellette, Lisa Larrimore
AU  - Ouellette LL
AD  - Stanford Law School, Stanford University, Stanford, California, USA.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*legislation & jurisprudence
MH  - Chemistry/legislation & jurisprudence
MH  - Humans
MH  - Patents as Topic/*legislation & jurisprudence
MH  - Research/*legislation & jurisprudence
MH  - Supreme Court Decisions
MH  - United States
EDAT- 2017/05/10 06:00
MHDA- 2018/04/06 06:00
CRDT- 2017/05/10 06:00
PHST- 2017/05/10 06:00 [entrez]
PHST- 2017/05/10 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt.3864 [pii]
AID - 10.1038/nbt.3864 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May 9;35(5):421-424. doi: 10.1038/nbt.3864.

PMID- 28486444
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May 9
TI  - First Rounders: Rachel Haurwitz.
PG  - 405
LID - 10.1038/nbt.3861 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/05/10 06:00
MHDA- 2017/05/10 06:01
CRDT- 2017/05/10 06:00
PHST- 2017/05/10 06:00 [entrez]
PHST- 2017/05/10 06:00 [pubmed]
PHST- 2017/05/10 06:01 [medline]
AID - nbt.3862 [pii]
AID - 10.1038/nbt.3861 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May 9;35(5):405. doi: 10.1038/nbt.3861.

PMID- 28486443
OWN - NLM
STAT- MEDLINE
DCOM- 20180405
LR  - 20180405
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May 9
TI  - CRISPR catch-up.
PG  - 389
LID - 10.1038/nbt.3885 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - EC 3.1.- (Transcription Activator-Like Effector Nucleases)
SB  - IM
MH  - CRISPR-Cas Systems/*genetics
MH  - *Gene Editing
MH  - *Genetic Therapy
MH  - Humans
MH  - Transcription Activator-Like Effector Nucleases/genetics/*therapeutic use
EDAT- 2017/05/10 06:00
MHDA- 2018/04/06 06:00
CRDT- 2017/05/10 06:00
PHST- 2017/05/10 06:00 [entrez]
PHST- 2017/05/10 06:00 [pubmed]
PHST- 2018/04/06 06:00 [medline]
AID - nbt.3885 [pii]
AID - 10.1038/nbt.3885 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May 9;35(5):389. doi: 10.1038/nbt.3885.

PMID- 28398345
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May
TI  - Genome-wide target specificities of CRISPR RNA-guided programmable deaminases.
PG  - 475-480
LID - 10.1038/nbt.3852 [doi]
AB  - Cas9-linked deaminases, also called base editors, enable targeted mutation of
      single nucleotides in eukaryotic genomes. However, their off-target activity is
      largely unknown. Here we modify digested-genome sequencing (Digenome-seq) to
      assess the specificity of a programmable deaminase composed of a Cas9 nickase
      (nCas9) and the deaminase APOBEC1 in the human genome. Genomic DNA is treated
      with the base editor and a mixture of DNA-modifying enzymes in vitro to produce
      DNA double-strand breaks (DSBs) at uracil-containing sites. Off-target sites are 
      then computationally identified from whole genome sequencing data. Testing seven 
      different single guide RNAs (sgRNAs), we find that the rAPOBEC1-nCas9 base editor
      is highly specific, inducing cytosine-to-uracil conversions at only 18 +/- 9
      sites in the human genome for each sgRNA. Digenome-seq is sensitive enough to
      capture off-target sites with a substitution frequency of 0.1%. Notably,
      off-target sites of the base editors are often different from those of Cas9
      alone, calling for independent assessment of their genome-wide specificities.
FAU - Kim, Daesik
AU  - Kim D
AD  - Department of Chemistry, Seoul National University, Seoul, Republic of Korea.
FAU - Lim, Kayeong
AU  - Lim K
AD  - Department of Chemistry, Seoul National University, Seoul, Republic of Korea.
AD  - Center for Genome Engineering, Institute for Basic Science (IBS), Seoul, Republic
      of Korea.
FAU - Kim, Sang-Tae
AU  - Kim ST
AD  - Center for Genome Engineering, Institute for Basic Science (IBS), Seoul, Republic
      of Korea.
FAU - Yoon, Sun-Heui
AU  - Yoon SH
AD  - Department of Chemistry, Seoul National University, Seoul, Republic of Korea.
FAU - Kim, Kyoungmi
AU  - Kim K
AD  - Center for Genome Engineering, Institute for Basic Science (IBS), Seoul, Republic
      of Korea.
FAU - Ryu, Seuk-Min
AU  - Ryu SM
AD  - Department of Chemistry, Seoul National University, Seoul, Republic of Korea.
AD  - Center for Genome Engineering, Institute for Basic Science (IBS), Seoul, Republic
      of Korea.
FAU - Kim, Jin-Soo
AU  - Kim JS
AD  - Department of Chemistry, Seoul National University, Seoul, Republic of Korea.
AD  - Center for Genome Engineering, Institute for Basic Science (IBS), Seoul, Republic
      of Korea.
AD  - Department of Functional Genomics, University of Science and Technology, Daejeon,
      Republic of Korea.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20170410
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Bacterial Proteins)
RN  - 0 (CRISPR-Associated Proteins)
RN  - 0 (Recombinant Fusion Proteins)
RN  - 63231-63-0 (RNA)
RN  - EC 3.1.- (Cas9 endonuclease Streptococcus pyogenes)
RN  - EC 3.1.- (Endonucleases)
RN  - EC 3.5.4.36 (APOBEC-1 Deaminase)
RN  - EC 3.5.4.36 (APOBEC1 protein, human)
RN  - EC 3.5.4.5 (Cytidine Deaminase)
SB  - IM
CIN - Nat Biotechnol. 2017 May 9;35(5):428-429. PMID: 28486457
EIN - Nat Biotechnol. 2017 Aug 8;35(8):797. PMID: 28787410
MH  - APOBEC-1 Deaminase/genetics
MH  - Bacterial Proteins/*genetics
MH  - Base Pairing/genetics
MH  - CRISPR-Associated Proteins/*genetics
MH  - Clustered Regularly Interspaced Short Palindromic Repeats/*genetics
MH  - Cytidine Deaminase/genetics
MH  - Endonucleases/*genetics
MH  - Gene Editing/*methods
MH  - Genome, Human/*genetics
MH  - Humans
MH  - Mutagenesis, Site-Directed/*methods
MH  - Point Mutation/genetics
MH  - RNA/*genetics
MH  - Recombinant Fusion Proteins/genetics
EDAT- 2017/04/12 06:00
MHDA- 2017/06/07 06:00
CRDT- 2017/04/12 06:00
PHST- 2017/01/11 00:00 [received]
PHST- 2017/03/17 00:00 [accepted]
PHST- 2017/04/12 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2017/04/12 06:00 [entrez]
AID - nbt.3852 [pii]
AID - 10.1038/nbt.3852 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May;35(5):475-480. doi: 10.1038/nbt.3852. Epub 2017 Apr 10.

PMID- 28398344
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May
TI  - Induction of functional dopamine neurons from human astrocytes in vitro and mouse
      astrocytes in a Parkinson's disease model.
PG  - 444-452
LID - 10.1038/nbt.3835 [doi]
AB  - Cell replacement therapies for neurodegenerative disease have focused on
      transplantation of the cell types affected by the pathological process. Here we
      describe an alternative strategy for Parkinson's disease in which dopamine
      neurons are generated by direct conversion of astrocytes. Using three
      transcription factors, NEUROD1, ASCL1 and LMX1A, and the microRNA miR218,
      collectively designated NeAL218, we reprogram human astrocytes in vitro, and
      mouse astrocytes in vivo, into induced dopamine neurons (iDANs). Reprogramming
      efficiency in vitro is improved by small molecules that promote chromatin
      remodeling and activate the TGFbeta, Shh and Wnt signaling pathways. The
      reprogramming efficiency of human astrocytes reaches up to 16%, resulting in
      iDANs with appropriate midbrain markers and excitability. In a mouse model of
      Parkinson's disease, NeAL218 alone reprograms adult striatal astrocytes into
      iDANs that are excitable and correct some aspects of motor behavior in vivo,
      including gait impairments. With further optimization, this approach may enable
      clinical therapies for Parkinson's disease by delivery of genes rather than
      cells.
FAU - Rivetti di Val Cervo, Pia
AU  - Rivetti di Val Cervo P
AD  - Laboratory of Molecular Neurobiology, Department of Medical Biochemistry and
      Biophysics, Karolinska Institutet, Stockholm, Sweden.
FAU - Romanov, Roman A
AU  - Romanov RA
AD  - Department of Molecular Neurosciences, Center for Brain Research, Medical
      University of Vienna, Vienna, Austria.
AD  - Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
FAU - Spigolon, Giada
AU  - Spigolon G
AD  - Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
FAU - Masini, Debora
AU  - Masini D
AD  - Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
FAU - Martin-Montanez, Elisa
AU  - Martin-Montanez E
AD  - Laboratory of Molecular Neurobiology, Department of Medical Biochemistry and
      Biophysics, Karolinska Institutet, Stockholm, Sweden.
AD  - Department of Pharmacology, Faculty of Medicine, Biomedical Research Institute of
      Malaga (IBIMA), Malaga University, Malaga, Spain.
FAU - Toledo, Enrique M
AU  - Toledo EM
AUID- ORCID: 0000-0002-1460-4708
AD  - Laboratory of Molecular Neurobiology, Department of Medical Biochemistry and
      Biophysics, Karolinska Institutet, Stockholm, Sweden.
FAU - La Manno, Gioele
AU  - La Manno G
AD  - Laboratory of Molecular Neurobiology, Department of Medical Biochemistry and
      Biophysics, Karolinska Institutet, Stockholm, Sweden.
FAU - Feyder, Michael
AU  - Feyder M
AUID- ORCID: 0000-0001-5849-905X
AD  - Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
FAU - Pifl, Christian
AU  - Pifl C
AD  - Department of Molecular Neurosciences, Center for Brain Research, Medical
      University of Vienna, Vienna, Austria.
FAU - Ng, Yi-Han
AU  - Ng YH
AD  - Institute for Stem Cell Biology and Regenerative Medicine, Stanford University,
      Stanford, California, USA.
FAU - Sanchez, Sara Padrell
AU  - Sanchez SP
AD  - Laboratory of Molecular Neurobiology, Department of Medical Biochemistry and
      Biophysics, Karolinska Institutet, Stockholm, Sweden.
FAU - Linnarsson, Sten
AU  - Linnarsson S
AD  - Laboratory of Molecular Neurobiology, Department of Medical Biochemistry and
      Biophysics, Karolinska Institutet, Stockholm, Sweden.
FAU - Wernig, Marius
AU  - Wernig M
AD  - Institute for Stem Cell Biology and Regenerative Medicine, Stanford University,
      Stanford, California, USA.
FAU - Harkany, Tibor
AU  - Harkany T
AD  - Department of Molecular Neurosciences, Center for Brain Research, Medical
      University of Vienna, Vienna, Austria.
AD  - Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
FAU - Fisone, Gilberto
AU  - Fisone G
AD  - Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
FAU - Arenas, Ernest
AU  - Arenas E
AUID- ORCID: 0000-0003-0197-6577
AD  - Laboratory of Molecular Neurobiology, Department of Medical Biochemistry and
      Biophysics, Karolinska Institutet, Stockholm, Sweden.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, N.I.H., Extramural
DEP - 20170410
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CIN - Nat Biotechnol. 2017 May 9;35(5):426-428. PMID: 28486448
MH  - Animals
MH  - Astrocytes/cytology/*transplantation
MH  - Cell Differentiation/genetics
MH  - Cells, Cultured
MH  - Cellular Reprogramming Techniques/*methods
MH  - Dopaminergic Neurons/*cytology
MH  - Humans
MH  - Mice
MH  - Movement Disorders/etiology/pathology/*prevention & control
MH  - Parkinson Disease/complications/*pathology/*therapy
MH  - Treatment Outcome
EDAT- 2017/04/12 06:00
MHDA- 2017/06/07 06:00
CRDT- 2017/04/12 06:00
PHST- 2016/07/15 00:00 [received]
PHST- 2017/02/22 00:00 [accepted]
PHST- 2017/04/12 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2017/04/12 06:00 [entrez]
AID - nbt.3835 [pii]
AID - 10.1038/nbt.3835 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May;35(5):444-452. doi: 10.1038/nbt.3835. Epub 2017 Apr 10.

PMID- 28346402
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May
TI  - Large-scale design of robust genetic circuits with multiple inputs and outputs
      for mammalian cells.
PG  - 453-462
LID - 10.1038/nbt.3805 [doi]
AB  - Engineered genetic circuits for mammalian cells often require extensive
      fine-tuning to perform as intended. We present a robust, general, scalable
      system, called 'Boolean logic and arithmetic through DNA excision' (BLADE), to
      engineer genetic circuits with multiple inputs and outputs in mammalian cells
      with minimal optimization. The reliability of BLADE arises from its reliance on
      recombinases under the control of a single promoter, which integrates circuit
      signals on a single transcriptional layer. We used BLADE to build 113 circuits in
      human embryonic kidney and Jurkat T cells and devised a quantitative,
      vector-proximity metric to evaluate their performance. Of 113 circuits analyzed, 
      109 functioned (96.5%) as intended without optimization. The circuits, which are 
      available through Addgene, include a 3-input, two-output full adder; a 6-input,
      one-output Boolean logic look-up table; circuits with small-molecule-inducible
      control; and circuits that incorporate CRISPR-Cas9 to regulate endogenous genes. 
      BLADE enables execution of sophisticated cellular computation in mammalian cells,
      with applications in cell and tissue engineering.
FAU - Weinberg, Benjamin H
AU  - Weinberg BH
AD  - Department of Biomedical Engineering and Biological Design Center, Boston
      University, Boston, Massachusetts, USA.
FAU - Pham, N T Hang
AU  - Pham NTH
AD  - Department of Biomedical Engineering and Biological Design Center, Boston
      University, Boston, Massachusetts, USA.
FAU - Caraballo, Leidy D
AU  - Caraballo LD
AD  - Department of Biomedical Engineering and Biological Design Center, Boston
      University, Boston, Massachusetts, USA.
FAU - Lozanoski, Thomas
AU  - Lozanoski T
AD  - Department of Biomedical Engineering and Biological Design Center, Boston
      University, Boston, Massachusetts, USA.
FAU - Engel, Adrien
AU  - Engel A
AD  - Department of Biomedical Engineering and Biological Design Center, Boston
      University, Boston, Massachusetts, USA.
AD  - Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
FAU - Bhatia, Swapnil
AU  - Bhatia S
AUID- ORCID: 0000-0003-1079-7570
AD  - Department of Electrical and Computer Engineering, Boston University, Boston,
      Massachusetts, USA.
FAU - Wong, Wilson W
AU  - Wong WW
AD  - Department of Biomedical Engineering and Biological Design Center, Boston
      University, Boston, Massachusetts, USA.
LA  - eng
GR  - DP2 CA186574/CA/NCI NIH HHS/United States
GR  - T32 GM008764/GM/NIGMS NIH HHS/United States
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PT  - Research Support, N.I.H., Extramural
DEP - 20170327
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Proteome)
SB  - IM
MH  - Cellular Reprogramming Techniques/*methods
MH  - Computer Simulation
MH  - Computers, Molecular
MH  - Gene Regulatory Networks/*genetics
MH  - Genetic Engineering/*methods
MH  - Humans
MH  - Jurkat Cells
MH  - *Models, Genetic
MH  - Proteome/*genetics
MH  - Signal Transduction/*genetics
PMC - PMC5423837
MID - NIHMS847626
EDAT- 2017/03/28 06:00
MHDA- 2017/06/07 06:00
CRDT- 2017/03/28 06:00
PHST- 2016/06/20 00:00 [received]
PHST- 2017/01/27 00:00 [accepted]
PHST- 2017/03/28 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2017/03/28 06:00 [entrez]
AID - nbt.3805 [pii]
AID - 10.1038/nbt.3805 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May;35(5):453-462. doi: 10.1038/nbt.3805. Epub 2017 Mar 27.

PMID- 28346401
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May
TI  - Targeted base editing in rice and tomato using a CRISPR-Cas9 cytidine deaminase
      fusion.
PG  - 441-443
LID - 10.1038/nbt.3833 [doi]
AB  - We applied a fusion of CRISPR-Cas9 and activation-induced cytidine deaminase
      (Target-AID) for point mutagenesis at genomic regions specified by single guide
      RNAs (sgRNAs) in two crop plants. In rice, we induced multiple
      herbicide-resistance point mutations by multiplexed editing using herbicide
      selection, while in tomato we generated marker-free plants with homozygous
      heritable DNA substitutions, demonstrating the feasibility of base editing for
      crop improvement.
FAU - Shimatani, Zenpei
AU  - Shimatani Z
AD  - Graduate School of Science, Technology and Innovation, Kobe University, Kobe,
      Japan.
FAU - Kashojiya, Sachiko
AU  - Kashojiya S
AD  - Faculty of Life and Environmental Sciences, University of Tsukuba, Gene Research 
      Center, Tsukuba, Japan.
FAU - Takayama, Mariko
AU  - Takayama M
AD  - Faculty of Life and Environmental Sciences, University of Tsukuba, Gene Research 
      Center, Tsukuba, Japan.
FAU - Terada, Rie
AU  - Terada R
AD  - Laboratory of Genetics and Breeding Science, Faculty of Agriculture, Meijo
      University, Nagoya, Japan.
FAU - Arazoe, Takayuki
AU  - Arazoe T
AD  - Graduate School of Science, Technology and Innovation, Kobe University, Kobe,
      Japan.
FAU - Ishii, Hisaki
AU  - Ishii H
AD  - Graduate School of Science, Technology and Innovation, Kobe University, Kobe,
      Japan.
FAU - Teramura, Hiroshi
AU  - Teramura H
AD  - Graduate School of Science, Technology and Innovation, Kobe University, Kobe,
      Japan.
FAU - Yamamoto, Tsuyoshi
AU  - Yamamoto T
AD  - Faculty of Life and Environmental Sciences, University of Tsukuba, Gene Research 
      Center, Tsukuba, Japan.
FAU - Komatsu, Hiroki
AU  - Komatsu H
AD  - Faculty of Life and Environmental Sciences, University of Tsukuba, Gene Research 
      Center, Tsukuba, Japan.
FAU - Miura, Kenji
AU  - Miura K
AD  - Faculty of Life and Environmental Sciences, University of Tsukuba, Gene Research 
      Center, Tsukuba, Japan.
FAU - Ezura, Hiroshi
AU  - Ezura H
AD  - Faculty of Life and Environmental Sciences, University of Tsukuba, Gene Research 
      Center, Tsukuba, Japan.
FAU - Nishida, Keiji
AU  - Nishida K
AUID- ORCID: 0000-0002-9371-4971
AD  - Graduate School of Science, Technology and Innovation, Kobe University, Kobe,
      Japan.
FAU - Ariizumi, Tohru
AU  - Ariizumi T
AD  - Faculty of Life and Environmental Sciences, University of Tsukuba, Gene Research 
      Center, Tsukuba, Japan.
FAU - Kondo, Akihiko
AU  - Kondo A
AUID- ORCID: 0000-0003-1527-5288
AD  - Graduate School of Science, Technology and Innovation, Kobe University, Kobe,
      Japan.
AD  - Department of Chemical Science and Engineering, Graduate School of Engineering,
      Kobe University, Kobe, Japan.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20170327
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (CRISPR-Associated Proteins)
RN  - 0 (DNA, Plant)
RN  - 0 (Recombinant Fusion Proteins)
RN  - EC 3.5.4.5 (Cytidine Deaminase)
SB  - IM
CIN - Nat Biotechnol. 2017 May 9;35(5):428-429. PMID: 28486457
MH  - Base Pairing/genetics
MH  - CRISPR-Associated Proteins/*genetics
MH  - Clustered Regularly Interspaced Short Palindromic Repeats/genetics
MH  - Cytidine Deaminase/genetics
MH  - DNA, Plant/*genetics
MH  - Gene Editing/*methods
MH  - Genes, Plant/genetics
MH  - Lycopersicon esculentum/*genetics
MH  - Mutagenesis, Site-Directed/*methods
MH  - Oryza/*genetics
MH  - Plants, Genetically Modified/genetics
MH  - Point Mutation/genetics
MH  - Recombinant Fusion Proteins/genetics
EDAT- 2017/03/28 06:00
MHDA- 2017/06/07 06:00
CRDT- 2017/03/28 06:00
PHST- 2016/10/31 00:00 [received]
PHST- 2017/02/21 00:00 [accepted]
PHST- 2017/03/28 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2017/03/28 06:00 [entrez]
AID - nbt.3833 [pii]
AID - 10.1038/nbt.3833 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May;35(5):441-443. doi: 10.1038/nbt.3833. Epub 2017 Mar 27.

PMID- 28319085
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May
TI  - Synergistic drug combinations for cancer identified in a CRISPR screen for
      pairwise genetic interactions.
PG  - 463-474
LID - 10.1038/nbt.3834 [doi]
AB  - Identification of effective combination therapies is critical to address the
      emergence of drug-resistant cancers, but direct screening of all possible drug
      combinations is infeasible. Here we introduce a CRISPR-based double knockout
      (CDKO) system that improves the efficiency of combinatorial genetic screening
      using an effective strategy for cloning and sequencing paired single guide RNA
      (sgRNA) libraries and a robust statistical scoring method for calculating genetic
      interactions (GIs) from CRISPR-deleted gene pairs. We applied CDKO to generate a 
      large-scale human GI map, comprising 490,000 double-sgRNAs directed against
      21,321 pairs of drug targets in K562 leukemia cells and identified synthetic
      lethal drug target pairs for which corresponding drugs exhibit synergistic
      killing. These included the BCL2L1 and MCL1 combination, which was also effective
      in imatinib-resistant cells. We further validated this system by identifying
      known and previously unidentified GIs between modifiers of ricin toxicity. This
      work provides an effective strategy to screen synergistic drug combinations in
      high-throughput and a CRISPR-based tool to dissect functional GI networks.
FAU - Han, Kyuho
AU  - Han K
AD  - Department of Genetics, Stanford University, Stanford, California, USA.
FAU - Jeng, Edwin E
AU  - Jeng EE
AD  - Department of Genetics, Stanford University, Stanford, California, USA.
AD  - Program in Cancer Biology, Stanford University, Stanford, California, USA.
FAU - Hess, Gaelen T
AU  - Hess GT
AD  - Department of Genetics, Stanford University, Stanford, California, USA.
FAU - Morgens, David W
AU  - Morgens DW
AD  - Department of Genetics, Stanford University, Stanford, California, USA.
FAU - Li, Amy
AU  - Li A
AD  - Department of Genetics, Stanford University, Stanford, California, USA.
FAU - Bassik, Michael C
AU  - Bassik MC
AD  - Department of Genetics, Stanford University, Stanford, California, USA.
AD  - Chemistry, Engineering, and Medicine for Human Health (ChEM-H), Stanford
      University, Stanford, California, USA.
LA  - eng
GR  - DP2 HD084069/HD/NICHD NIH HHS/United States
GR  - T32 CA009302/CA/NCI NIH HHS/United States
GR  - T32 HG000044/HG/NHGRI NIH HHS/United States
GR  - U01 CA199216/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, N.I.H., Extramural
DEP - 20170320
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Neoplasm Proteins)
SB  - IM
CIN - Nat Rev Drug Discov. 2017 May;16(5):314. PMID: 28417987
CIN - Nat Rev Genet. 2017 May;18(5):272-273. PMID: 28366937
MH  - Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
MH  - Clustered Regularly Interspaced Short Palindromic Repeats/*genetics
MH  - Drug Screening Assays, Antitumor/*methods
MH  - Drug Synergism
MH  - Humans
MH  - K562 Cells
MH  - Neoplasm Proteins/*genetics
MH  - Neoplasms, Experimental/*drug therapy/*genetics
PMC - PMC5557292
MID - NIHMS855046
EDAT- 2017/03/21 06:00
MHDA- 2017/06/07 06:00
CRDT- 2017/03/21 06:00
PHST- 2016/10/04 00:00 [received]
PHST- 2017/02/22 00:00 [accepted]
PHST- 2017/03/21 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2017/03/21 06:00 [entrez]
AID - nbt.3834 [pii]
AID - 10.1038/nbt.3834 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May;35(5):463-474. doi: 10.1038/nbt.3834. Epub 2017 Mar 20.

PMID- 28244995
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May
TI  - Highly efficient RNA-guided base editing in mouse embryos.
PG  - 435-437
LID - 10.1038/nbt.3816 [doi]
AB  - Base editors (BEs) composed of a cytidine deaminase fused to CRISPR-Cas9 convert 
      cytidine to uridine, leading to single-base-pair substitutions in eukaryotic
      cells. We delivered BE mRNA or ribonucleoproteins targeting the Dmd or Tyr gene
      via electroporation or microinjection into mouse zygotes. F0 mice showed nonsense
      mutations with an efficiency of 44-57% and allelic frequencies of up to 100%,
      demonstrating an efficient method to generate mice with targeted point mutations.
FAU - Kim, Kyoungmi
AU  - Kim K
AD  - Center for Genome Engineering, Institute for Basic Science, Seoul, Republic of
      Korea.
FAU - Ryu, Seuk-Min
AU  - Ryu SM
AD  - Center for Genome Engineering, Institute for Basic Science, Seoul, Republic of
      Korea.
AD  - Department of Chemistry, Seoul National University, Seoul, Republic of Korea.
FAU - Kim, Sang-Tae
AU  - Kim ST
AD  - Center for Genome Engineering, Institute for Basic Science, Seoul, Republic of
      Korea.
FAU - Baek, Gayoung
AU  - Baek G
AD  - Center for Genome Engineering, Institute for Basic Science, Seoul, Republic of
      Korea.
FAU - Kim, Daesik
AU  - Kim D
AD  - Department of Chemistry, Seoul National University, Seoul, Republic of Korea.
FAU - Lim, Kayeong
AU  - Lim K
AD  - Center for Genome Engineering, Institute for Basic Science, Seoul, Republic of
      Korea.
AD  - Department of Chemistry, Seoul National University, Seoul, Republic of Korea.
FAU - Chung, Eugene
AU  - Chung E
AD  - Center for Genome Engineering, Institute for Basic Science, Seoul, Republic of
      Korea.
AD  - Department of Chemistry, Seoul National University, Seoul, Republic of Korea.
FAU - Kim, Sunghyun
AU  - Kim S
AD  - Center for Genome Engineering, Institute for Basic Science, Seoul, Republic of
      Korea.
AD  - Department of Chemistry, Seoul National University, Seoul, Republic of Korea.
FAU - Kim, Jin-Soo
AU  - Kim JS
AD  - Center for Genome Engineering, Institute for Basic Science, Seoul, Republic of
      Korea.
AD  - Department of Chemistry, Seoul National University, Seoul, Republic of Korea.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20170227
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (CRISPR-Associated Proteins)
RN  - 0 (Recombinant Fusion Proteins)
RN  - 63231-63-0 (RNA)
RN  - EC 3.5.4.5 (Cytidine Deaminase)
SB  - IM
CIN - Nat Biotechnol. 2017 May 9;35(5):428-429. PMID: 28486457
MH  - Animals
MH  - Base Pairing/genetics
MH  - CRISPR-Associated Proteins/*genetics
MH  - Clustered Regularly Interspaced Short Palindromic Repeats/*genetics
MH  - Cytidine Deaminase/genetics
MH  - Embryo, Mammalian/embryology/*physiology
MH  - Gene Editing/*methods
MH  - Mice
MH  - Mice, Inbred C57BL
MH  - Mice, Inbred ICR
MH  - Mutagenesis, Site-Directed/*methods
MH  - Point Mutation/genetics
MH  - RNA/*genetics
MH  - Recombinant Fusion Proteins/genetics
EDAT- 2017/03/01 06:00
MHDA- 2017/06/07 06:00
CRDT- 2017/03/01 06:00
PHST- 2016/12/19 00:00 [received]
PHST- 2017/02/08 00:00 [accepted]
PHST- 2017/03/01 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2017/03/01 06:00 [entrez]
AID - nbt.3816 [pii]
AID - 10.1038/nbt.3816 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May;35(5):435-437. doi: 10.1038/nbt.3816. Epub 2017 Feb 27.

PMID- 28244994
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May
TI  - Precise base editing in rice, wheat and maize with a Cas9-cytidine deaminase
      fusion.
PG  - 438-440
LID - 10.1038/nbt.3811 [doi]
AB  - Targeted base editing in plants without the need for a foreign DNA donor or
      double-stranded DNA cleavage would accelerate genome modification and breeding in
      a wide array of crops. We used a CRISPR-Cas9 nickase-cytidine deaminase fusion to
      achieve targeted conversion of cytosine to thymine from position 3 to 9 within
      the protospacer in both protoplasts and regenerated rice, wheat and maize plants 
      at frequencies of up to 43.48%.
FAU - Zong, Yuan
AU  - Zong Y
AD  - State Key Laboratory of Plant Cell and Chromosome Engineering, Institute of
      Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China.
AD  - University of Chinese Academy of Sciences, Beijing, China.
FAU - Wang, Yanpeng
AU  - Wang Y
AD  - State Key Laboratory of Plant Cell and Chromosome Engineering, Institute of
      Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China.
AD  - University of Chinese Academy of Sciences, Beijing, China.
FAU - Li, Chao
AU  - Li C
AD  - State Key Laboratory of Plant Cell and Chromosome Engineering, Institute of
      Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China.
AD  - University of Chinese Academy of Sciences, Beijing, China.
FAU - Zhang, Rui
AU  - Zhang R
AD  - State Key Laboratory of Plant Cell and Chromosome Engineering, Institute of
      Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China.
FAU - Chen, Kunling
AU  - Chen K
AD  - State Key Laboratory of Plant Cell and Chromosome Engineering, Institute of
      Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China.
FAU - Ran, Yidong
AU  - Ran Y
AD  - Genovo Biotechnology Co., Ltd, Tianjin, China.
FAU - Qiu, Jin-Long
AU  - Qiu JL
AD  - State Key Laboratory of Plant Genomics, Institute of Microbiology, Chinese
      Academy of Sciences, Beijing, China.
FAU - Wang, Daowen
AU  - Wang D
AD  - State Key Laboratory of Plant Cell and Chromosome Engineering, Institute of
      Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China.
FAU - Gao, Caixia
AU  - Gao C
AD  - State Key Laboratory of Plant Cell and Chromosome Engineering, Institute of
      Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20170227
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (CRISPR-Associated Proteins)
RN  - 0 (DNA, Plant)
RN  - 0 (Recombinant Fusion Proteins)
RN  - EC 3.5.4.5 (Cytidine Deaminase)
SB  - IM
CIN - Nat Biotechnol. 2017 May 9;35(5):428-429. PMID: 28486457
MH  - Base Pairing/genetics
MH  - CRISPR-Associated Proteins/*genetics
MH  - Clustered Regularly Interspaced Short Palindromic Repeats/*genetics
MH  - Cytidine Deaminase/genetics
MH  - DNA, Plant/*genetics
MH  - Gene Editing/*methods
MH  - Genes, Plant/genetics
MH  - Mutagenesis, Site-Directed/*methods
MH  - Oryza/genetics
MH  - Plants/*genetics
MH  - Plants, Genetically Modified/genetics
MH  - Point Mutation/genetics
MH  - Recombinant Fusion Proteins/genetics
MH  - Triticum/genetics
MH  - Zea mays/genetics
EDAT- 2017/03/01 06:00
MHDA- 2017/06/07 06:00
CRDT- 2017/03/01 06:00
PHST- 2016/10/31 00:00 [received]
PHST- 2017/02/05 00:00 [accepted]
PHST- 2017/03/01 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2017/03/01 06:00 [entrez]
AID - nbt.3811 [pii]
AID - 10.1038/nbt.3811 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May;35(5):438-440. doi: 10.1038/nbt.3811. Epub 2017 Feb 27.

PMID- 28191903
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 5
DP  - 2017 May
TI  - Efficient genome editing in the mouse brain by local delivery of engineered Cas9 
      ribonucleoprotein complexes.
PG  - 431-434
LID - 10.1038/nbt.3806 [doi]
AB  - We demonstrate editing of post-mitotic neurons in the adult mouse brain following
      injection of Cas9 ribonucleoprotein (RNP) complexes in the hippocampus, striatum 
      and cortex. Engineered variants of Cas9 with multiple SV40 nuclear localization
      sequences enabled a tenfold increase in the efficiency of neuronal editing in
      vivo. These advances indicate the potential of genome editing in the brain to
      correct or inactivate the underlying genetic causes of neurological diseases.
FAU - Staahl, Brett T
AU  - Staahl BT
AD  - Department of Molecular and Cell Biology, University of California, Berkeley,
      California, USA.
FAU - Benekareddy, Madhurima
AU  - Benekareddy M
AD  - Roche Pharma Research and Early Development, Basel, Switzerland.
FAU - Coulon-Bainier, Claire
AU  - Coulon-Bainier C
AD  - Roche Pharma Research and Early Development, Basel, Switzerland.
FAU - Banfal, Ashwin A
AU  - Banfal AA
AD  - Department of Molecular and Cell Biology, University of California, Berkeley,
      California, USA.
FAU - Floor, Stephen N
AU  - Floor SN
AD  - Department of Molecular and Cell Biology, University of California, Berkeley,
      California, USA.
FAU - Sabo, Jennifer K
AU  - Sabo JK
AD  - Department of Molecular and Cell Biology, University of California, Berkeley,
      California, USA.
FAU - Urnes, Cole
AU  - Urnes C
AD  - Department of Molecular and Cell Biology, University of California, Berkeley,
      California, USA.
FAU - Munares, Gabriela Acevedo
AU  - Munares GA
AD  - Department of Molecular and Cell Biology, University of California, Berkeley,
      California, USA.
FAU - Ghosh, Anirvan
AU  - Ghosh A
AD  - Roche Pharma Research and Early Development, Basel, Switzerland.
AD  - E-Scape Bio, San Francisco, California, USA.
FAU - Doudna, Jennifer A
AU  - Doudna JA
AD  - Department of Molecular and Cell Biology, University of California, Berkeley,
      California, USA.
AD  - Howard Hughes Medical Institute, University of California, Berkeley, California, 
      USA.
AD  - Innovative Genomics Institute, University of California, Berkeley, California,
      USA.
AD  - MBIB Division, Lawrence Berkeley National Laboratory, Berkeley, California, USA.
AD  - Department of Chemistry, University of California, Berkeley, California, USA.
LA  - eng
GR  - HHMI/Howard Hughes Medical Institute/United States
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20170213
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Bacterial Proteins)
RN  - 0 (CRISPR-Associated Proteins)
RN  - 0 (Nerve Tissue Proteins)
RN  - 0 (Ribonucleoproteins)
RN  - EC 3.1.- (Cas9 endonuclease Streptococcus pyogenes)
RN  - EC 3.1.- (Endonucleases)
SB  - IM
MH  - Animals
MH  - Bacterial Proteins/*genetics
MH  - Brain/*physiology
MH  - CRISPR-Associated Proteins/administration & dosage/*genetics
MH  - Clustered Regularly Interspaced Short Palindromic Repeats/genetics
MH  - Endonucleases/*genetics
MH  - Gene Editing/*methods
MH  - Gene Targeting/methods
MH  - Male
MH  - Mice
MH  - Nerve Tissue Proteins/*physiology
MH  - Protein Engineering/methods
MH  - Ribonucleoproteins/*genetics
EDAT- 2017/02/14 06:00
MHDA- 2017/06/07 06:00
CRDT- 2017/02/14 06:00
PHST- 2016/08/22 00:00 [received]
PHST- 2017/01/31 00:00 [accepted]
PHST- 2017/02/14 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2017/02/14 06:00 [entrez]
AID - nbt.3806 [pii]
AID - 10.1038/nbt.3806 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 May;35(5):431-434. doi: 10.1038/nbt.3806. Epub 2017 Feb 13.

PMID- 28398333
OWN - NLM
STAT- MEDLINE
DCOM- 20180309
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr 11
TI  - Top heart-failure contender serelaxin flops.
PG  - 297
LID - 10.1038/nbt0417-297b [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (RLN2 protein, human)
RN  - 0 (Recombinant Proteins)
RN  - 0 (serelaxin protein, human)
RN  - 9002-69-1 (Relaxin)
SB  - IM
MH  - Clinical Trials as Topic
MH  - Heart Failure/*drug therapy/genetics/pathology
MH  - Humans
MH  - Recombinant Proteins/*adverse effects/therapeutic use
MH  - Relaxin/*adverse effects/therapeutic use
EDAT- 2017/04/12 06:00
MHDA- 2018/03/10 06:00
CRDT- 2017/04/12 06:00
PHST- 2017/04/12 06:00 [entrez]
PHST- 2017/04/12 06:00 [pubmed]
PHST- 2018/03/10 06:00 [medline]
AID - nbt0417-297b [pii]
AID - 10.1038/nbt0417-297b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr 11;35(4):297. doi: 10.1038/nbt0417-297b.

PMID- 28398332
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180301
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr 11
TI  - Drugmakers accused of exploiting orphan drug incentives, fueling price problem.
PG  - 301
LID - 10.1038/nbt0417-301 [doi]
FAU - Huggett, Brady
AU  - Huggett B
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/04/12 06:00
MHDA- 2017/04/12 06:01
CRDT- 2017/04/12 06:00
PHST- 2017/04/12 06:00 [entrez]
PHST- 2017/04/12 06:00 [pubmed]
PHST- 2017/04/12 06:01 [medline]
AID - nbt0417-301 [pii]
AID - 10.1038/nbt0417-301 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr 11;35(4):301. doi: 10.1038/nbt0417-301.

PMID- 28398331
OWN - NLM
STAT- MEDLINE
DCOM- 20180302
LR  - 20180302
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr 11
TI  - With all due respect to Maholo, lab automation isn't anthropomorphic.
PG  - 312-314
LID - 10.1038/nbt.3795 [doi]
FAU - McClymont, David W
AU  - McClymont DW
AD  - The London DNA Foundry, UK Synthetic Biology Innovation, Commercialisation and
      Industrial Translation Centre, London, UK.
FAU - Freemont, Paul S
AU  - Freemont PS
AD  - The London DNA Foundry, UK Synthetic Biology Innovation, Commercialisation and
      Industrial Translation Centre, London, UK.
AD  - Centre for Synthetic Biology and Innovation, Department of Medicine, South
      Kensington Campus, Imperial College London, London, UK.
LA  - eng
PT  - Letter
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2017 Apr 11;35(4):310-312. PMID: 28398329
MH  - *Automation
EDAT- 2017/04/12 06:00
MHDA- 2018/03/03 06:00
CRDT- 2017/04/12 06:00
PHST- 2017/04/12 06:00 [entrez]
PHST- 2017/04/12 06:00 [pubmed]
PHST- 2018/03/03 06:00 [medline]
AID - nbt.3795 [pii]
AID - 10.1038/nbt.3795 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr 11;35(4):312-314. doi: 10.1038/nbt.3795.

PMID- 28398330
OWN - NLM
STAT- MEDLINE
DCOM- 20180309
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr 11
TI  - Remote detection of buried landmines using a bacterial sensor.
PG  - 308-310
LID - 10.1038/nbt.3791 [doi]
FAU - Belkin, Shimshon
AU  - Belkin S
AD  - Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem,
      Israel.
FAU - Yagur-Kroll, Sharon
AU  - Yagur-Kroll S
AD  - Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem,
      Israel.
FAU - Kabessa, Yossef
AU  - Kabessa Y
AD  - Applied Physics and the Brojde Center for Innovative Engineering and Computer
      Science, The Hebrew University of Jerusalem, Jerusalem, Israel.
FAU - Korouma, Victor
AU  - Korouma V
AD  - Applied Physics and the Brojde Center for Innovative Engineering and Computer
      Science, The Hebrew University of Jerusalem, Jerusalem, Israel.
FAU - Septon, Tali
AU  - Septon T
AD  - Applied Physics and the Brojde Center for Innovative Engineering and Computer
      Science, The Hebrew University of Jerusalem, Jerusalem, Israel.
FAU - Anati, Yonatan
AU  - Anati Y
AD  - Applied Physics and the Brojde Center for Innovative Engineering and Computer
      Science, The Hebrew University of Jerusalem, Jerusalem, Israel.
FAU - Zohar-Perez, Cheinat
AU  - Zohar-Perez C
AD  - Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew
      University of Jerusalem, Rehovot, Israel.
FAU - Rabinovitz, Zahi
AU  - Rabinovitz Z
AD  - Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew
      University of Jerusalem, Rehovot, Israel.
FAU - Nussinovitch, Amos
AU  - Nussinovitch A
AD  - Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew
      University of Jerusalem, Rehovot, Israel.
FAU - Agranat, Aharon J
AU  - Agranat AJ
AD  - Applied Physics and the Brojde Center for Innovative Engineering and Computer
      Science, The Hebrew University of Jerusalem, Jerusalem, Israel.
LA  - eng
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 118-96-7 (Trinitrotoluene)
SB  - IM
MH  - *Biosensing Techniques
MH  - Humans
MH  - Pseudomonas putida/chemistry/genetics
MH  - Trinitrotoluene/chemistry/*isolation & purification
MH  - Weapons
EDAT- 2017/04/12 06:00
MHDA- 2018/03/10 06:00
CRDT- 2017/04/12 06:00
PHST- 2017/04/12 06:00 [entrez]
PHST- 2017/04/12 06:00 [pubmed]
PHST- 2018/03/10 06:00 [medline]
AID - nbt.3791 [pii]
AID - 10.1038/nbt.3791 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr 11;35(4):308-310. doi: 10.1038/nbt.3791.

PMID- 28398329
OWN - NLM
STAT- MEDLINE
DCOM- 20180309
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr 11
TI  - Robotic crowd biology with Maholo LabDroids.
PG  - 310-312
LID - 10.1038/nbt.3758 [doi]
FAU - Yachie, Nozomu
AU  - Yachie N
AUID- ORCID: 0000-0003-1582-6027
AD  - Research Center for Advanced Science and Technology, the University of Tokyo,
      Tokyo, Japan.
AD  - Department of Biological Sciences, Graduate School of Science, the University of 
      Tokyo, Tokyo, Japan.
AD  - Institute for Advanced Biosciences, Keio University, Tsuruoka, Japan.
AD  - PRESTO, Japan Science and Technology Agency, Tokyo, Japan.
AD  - Spiber, Inc., Tsuruoka, Japan.
CN  - Robotic Biology Consortium
FAU - Natsume, Tohru
AU  - Natsume T
AD  - Molecular Profiling Research Center for Drug Discovery, National Institute of
      Advanced Industrial Science and Technology, Tokyo, Japan.
AD  - Robotic Biology Institute, Inc., Tokyo, Japan.
LA  - eng
PT  - Letter
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CIN - Nat Biotechnol. 2017 Apr 11;35(4):312-314. PMID: 28398331
MH  - Biological Science Disciplines/*trends
MH  - Humans
MH  - Robotics/*trends
IR  - Takahashi K
FIR - Takahashi, Koichi
IR  - Katayama T
FIR - Katayama, Toshiaki
IR  - Sakurada T
FIR - Sakurada, Takeshi
IR  - Kanda GN
FIR - Kanda, Genki N
IR  - Takagi E
FIR - Takagi, Eiji
IR  - Hirose T
FIR - Hirose, Takako
IR  - Katsura T
FIR - Katsura, Tatsuo
IR  - Moriya T
FIR - Moriya, Tetsuo
IR  - Kitano H
FIR - Kitano, Hiroaki
IR  - Tsujii J
FIR - Tsujii, Junichi
IR  - Shiraki T
FIR - Shiraki, Tomoyuki
IR  - Kariyazaki H
FIR - Kariyazaki, Hirokazu
IR  - Kamei M
FIR - Kamei, Motohisa
IR  - Abe N
FIR - Abe, Noriko
IR  - Fukuda T
FIR - Fukuda, Takuya
IR  - Sawada Y
FIR - Sawada, Yukiko
IR  - Hashiguchi Y
FIR - Hashiguchi, Yukio
IR  - Matsukuma K
FIR - Matsukuma, Kenji
IR  - Murai S
FIR - Murai, Shinji
IR  - Sasaki N
FIR - Sasaki, Naoyuki
IR  - Ipposhi T
FIR - Ipposhi, Tatsuro
IR  - Urabe H
FIR - Urabe, Hideo
IR  - Kudo T
FIR - Kudo, Taku
IR  - Umeno M
FIR - Umeno, Makoto
IR  - Ono S
FIR - Ono, Seiki
IR  - Miyauchi K
FIR - Miyauchi, Kohei
IR  - Nakamura M
FIR - Nakamura, Miki
IR  - Kizaki T
FIR - Kizaki, Takahiro
IR  - Suyama T
FIR - Suyama, Takashi
IR  - Hatta T
FIR - Hatta, Tomohisa
IR  - Natsume T
FIR - Natsume, Tohru
IR  - Ohta T
FIR - Ohta, Tazro
IR  - Ozawa Y
FIR - Ozawa, Yosuke
IR  - Ihara S
FIR - Ihara, Shoji
IR  - Tamaki S
FIR - Tamaki, Satoshi
IR  - Antezana E
FIR - Antezana, Erick
IR  - Garcia-Castro A
FIR - Garcia-Castro, Alexander
IR  - Perret JL
FIR - Perret, Jean-Luc
IR  - Ishiguro S
FIR - Ishiguro, Soh
IR  - Mori H
FIR - Mori, Hideto
IR  - Evans-Yamamoto D
FIR - Evans-Yamamoto, Daniel
IR  - Masuyama N
FIR - Masuyama, Nanami
IR  - Tomita M
FIR - Tomita, Masaru
IR  - Katayama T
FIR - Katayama, Toshiaki
IR  - Matsumoto M
FIR - Matsumoto, Masaki
IR  - Nakayama H
FIR - Nakayama, Hiroshi
IR  - Shirasawa A
FIR - Shirasawa, Ayaka
IR  - Shimbo K
FIR - Shimbo, Kazutaka
IR  - Yamada N
FIR - Yamada, Naoyuki
IR  - Nakayama KI
FIR - Nakayama, Keiichi I
IR  - Shimizu T
FIR - Shimizu, Takatsune
IR  - Saya H
FIR - Saya, Hideyuki
IR  - Yamashita S
FIR - Yamashita, Satoshi
IR  - Matsushima T
FIR - Matsushima, Takahide
IR  - Asahara H
FIR - Asahara, Hiroshi
IR  - Eguchi H
FIR - Eguchi, Hidetoshi
IR  - Mikamori M
FIR - Mikamori, Manabu
IR  - Mori M
FIR - Mori, Masaki
EDAT- 2017/04/12 06:00
MHDA- 2018/03/10 06:00
CRDT- 2017/04/12 06:00
PHST- 2017/04/12 06:00 [entrez]
PHST- 2017/04/12 06:00 [pubmed]
PHST- 2018/03/10 06:00 [medline]
AID - nbt.3758 [pii]
AID - 10.1038/nbt.3758 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr 11;35(4):310-312. doi: 10.1038/nbt.3758.

PMID- 28398328
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180301
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr 11
TI  - Around the world in a month.
PG  - 300
LID - 10.1038/nbt0417-300 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/04/12 06:00
MHDA- 2017/04/12 06:01
CRDT- 2017/04/12 06:00
PHST- 2017/04/12 06:00 [entrez]
PHST- 2017/04/12 06:00 [pubmed]
PHST- 2017/04/12 06:01 [medline]
AID - nbt0417-300 [pii]
AID - 10.1038/nbt0417-300 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr 11;35(4):300. doi: 10.1038/nbt0417-300.

PMID- 28398327
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180301
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr 11
TI  - Recent patents in epigenetic targeting.
PG  - 336
LID - 10.1038/nbt.3858 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/04/12 06:00
MHDA- 2017/04/12 06:01
CRDT- 2017/04/12 06:00
PHST- 2017/04/12 06:00 [entrez]
PHST- 2017/04/12 06:00 [pubmed]
PHST- 2017/04/12 06:01 [medline]
AID - nbt.3858 [pii]
AID - 10.1038/nbt.3858 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr 11;35(4):336. doi: 10.1038/nbt.3858.

PMID- 28398325
OWN - NLM
STAT- MEDLINE
DCOM- 20180302
LR  - 20180302
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr 11
TI  - Single-minded CRISPR screening.
PG  - 339-340
LID - 10.1038/nbt.3849 [doi]
FAU - Lanning, Bryan R
AU  - Lanning BR
AD  - Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA.
FAU - Vakoc, Christopher R
AU  - Vakoc CR
AD  - Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA.
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Nuclear Proteins)
SB  - IM
CON - Cell. 2016 Dec 15;167(7):1867-1882.e21. PMID: 27984733
CON - Cell. 2016 Dec 15;167(7):1853-1866.e17. PMID: 27984732
CON - Cell. 2016 Dec 15;167(7):1883-1896.e15. PMID: 27984734
CON - Nat Methods. 2017 Mar;14 (3):297-301. PMID: 28099430
MH  - Animals
MH  - *Clustered Regularly Interspaced Short Palindromic Repeats
MH  - *Drosophila
MH  - Humans
MH  - Nuclear Proteins/genetics
EDAT- 2017/04/12 06:00
MHDA- 2018/03/03 06:00
CRDT- 2017/04/12 06:00
PHST- 2017/04/12 06:00 [entrez]
PHST- 2017/04/12 06:00 [pubmed]
PHST- 2018/03/03 06:00 [medline]
AID - nbt.3849 [pii]
AID - 10.1038/nbt.3849 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr 11;35(4):339-340. doi: 10.1038/nbt.3849.

PMID- 28398324
OWN - NLM
STAT- MEDLINE
DCOM- 20180309
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr 11
TI  - National Academies report has broad support.
PG  - 304-306
LID - 10.1038/nbt.3842 [doi]
FAU - Vincelli, Paul
AU  - Vincelli P
AD  - Sustainable Agriculture Research and Education Program (SARE) and the University 
      of Kentucky, Lexington, Kentucky, USA.
FAU - Jackson-Smith, Douglas
AU  - Jackson-Smith D
AD  - Rural Sociological Society and School of Environment and Natural Resources, The
      Ohio State University, Columbus, Ohio, USA.
FAU - Holsapple, Michael
AU  - Holsapple M
AD  - Society of Toxicology, Center for Research on Ingredient Safety (CRIS) and
      Department of Food Science and Human Nutrition, Michigan State University, East
      Lansing, Michigan, USA.
FAU - Grusak, Michael A
AU  - Grusak MA
AD  - Crop Science Society of America, USDA-ARS Children's Nutrition Research Center
      and Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
FAU - Harsh, Matthew
AU  - Harsh M
AD  - Society for Social Studies of Science and Centre for Engineering in Society,
      Concordia University, Montreal, Quebec, Canada.
FAU - Klein, Theodore
AU  - Klein T
AD  - Society for In Vitro Biology and Meristematic, Inc., San Francisco, California,
      USA.
FAU - Lambert, James
AU  - Lambert J
AD  - Society for Risk Analysis and University of Virginia, Charlottesville, Virginia, 
      USA.
FAU - Lange, B Markus
AU  - Lange BM
AD  - Phytochemical Society of North America and Institute of Biological Chemistry,
      Washington State University, Pullman, Washington, USA.
FAU - Lodge, David M
AU  - Lodge DM
AD  - Ecological Society of America and Atkinson Center for a Sustainable Future,
      Cornell University, Ithaca, New York, USA.
FAU - McCluskey, Jill
AU  - McCluskey J
AD  - School of Economic Sciences, Washington State University, Pullman, Washington,
      USA.
FAU - Murphy, Angus
AU  - Murphy A
AD  - Department of Plant Sciences and Landscape Architecture, University of Maryland, 
      College Park, Maryland, USA.
FAU - Neuhouser, Marian L
AU  - Neuhouser ML
AD  - American Society for Nutrition and Cancer Prevention Program, Fred Hutchinson
      Cancer Research Center, Seattle, Washington, USA.
FAU - Pray, Carl
AU  - Pray C
AD  - International Consortium for Applied Bioeconomy Research and Department of
      Agriculture, Food, and Resource Economics, Rutgers University, New Brunswick, New
      Jersey, USA.
FAU - Weller, Susan
AU  - Weller S
AD  - Entomological Society of America and University of Nebraska State Museum,
      Lincoln, Nebraska, USA.
LA  - eng
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Bacterial Proteins)
RN  - 0 (Herbicides)
RN  - 0 (Insecticides)
RN  - 0 (cryIG protein, Bacillus thuringiensis)
SB  - IM
CIN - Nat Biotechnol. 2017 Apr 11;35(4):306-308. PMID: 28398310
MH  - Academies and Institutes/*trends
MH  - Bacterial Proteins/genetics
MH  - Herbicides/toxicity
MH  - Humans
MH  - Insecticides/toxicity
MH  - Plants, Genetically Modified/*genetics
MH  - United States
EDAT- 2017/04/12 06:00
MHDA- 2018/03/10 06:00
CRDT- 2017/04/12 06:00
PHST- 2017/04/12 06:00 [entrez]
PHST- 2017/04/12 06:00 [pubmed]
PHST- 2018/03/10 06:00 [medline]
AID - nbt.3842 [pii]
AID - 10.1038/nbt.3842 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr 11;35(4):304-306. doi: 10.1038/nbt.3842.

PMID- 28398323
OWN - NLM
STAT- MEDLINE
DCOM- 20180309
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr 11
TI  - Nature Biotechnology's academic spinouts of 2016.
PG  - 322-333
LID - 10.1038/nbt.3847 [doi]
FAU - Bouchie, Aaron
AU  - Bouchie A
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
AD  - Nature Biotechnology.
FAU - Sheridan, Cormac
AU  - Sheridan C
FAU - Webb, Sarah
AU  - Webb S
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (CD47 Antigen)
SB  - IM
MH  - Biotechnology/*trends
MH  - CD47 Antigen/antagonists & inhibitors/*therapeutic use
MH  - Drug Industry/trends
MH  - Humans
MH  - *Molecular Targeted Therapy
MH  - Neoplasms/*drug therapy
EDAT- 2017/04/12 06:00
MHDA- 2018/03/10 06:00
CRDT- 2017/04/12 06:00
PHST- 2017/04/12 06:00 [entrez]
PHST- 2017/04/12 06:00 [pubmed]
PHST- 2018/03/10 06:00 [medline]
AID - nbt.3847 [pii]
AID - 10.1038/nbt.3847 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr 11;35(4):322-333. doi: 10.1038/nbt.3847.

PMID- 28398322
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20180302
LR  - 20180302
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr 11
TI  - The best spot to park a CAR.
PG  - 341
LID - 10.1038/nbt.3848 [doi]
FAU - Marcinkiewicz, Katarzyna
AU  - Marcinkiewicz K
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
CON - Nature. 2017 Mar 2;543(7643):113-117. PMID: 28225754
EDAT- 2017/04/12 06:00
MHDA- 2017/04/12 06:01
CRDT- 2017/04/12 06:00
PHST- 2017/04/12 06:00 [entrez]
PHST- 2017/04/12 06:00 [pubmed]
PHST- 2017/04/12 06:01 [medline]
AID - nbt.3848 [pii]
AID - 10.1038/nbt.3848 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr 11;35(4):341. doi: 10.1038/nbt.3848.

PMID- 28398320
OWN - NLM
STAT- MEDLINE
DCOM- 20180309
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr 11
TI  - National Academies relax stance on germline edits.
PG  - 295-296
LID - 10.1038/nbt0417-295 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Academies and Institutes
MH  - CRISPR-Cas Systems/*genetics
MH  - Gene Editing/*trends
MH  - Genome, Human/*genetics
MH  - Germ Cells/pathology
MH  - Humans
EDAT- 2017/04/12 06:00
MHDA- 2018/03/10 06:00
CRDT- 2017/04/12 06:00
PHST- 2017/04/12 06:00 [entrez]
PHST- 2017/04/12 06:00 [pubmed]
PHST- 2018/03/10 06:00 [medline]
AID - nbt0417-295 [pii]
AID - 10.1038/nbt0417-295 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr 11;35(4):295-296. doi: 10.1038/nbt0417-295.

PMID- 28398319
OWN - NLM
STAT- MEDLINE
DCOM- 20180309
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr 11
TI  - A futile cycle in cell therapy.
PG  - 291
LID - 10.1038/nbt.3857 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Adult Stem Cells/transplantation
MH  - Cell- and Tissue-Based Therapy/*adverse effects
MH  - Clinical Trials as Topic
MH  - Heart Diseases/epidemiology/*therapy
MH  - Humans
EDAT- 2017/04/12 06:00
MHDA- 2018/03/10 06:00
CRDT- 2017/04/12 06:00
PHST- 2017/04/12 06:00 [entrez]
PHST- 2017/04/12 06:00 [pubmed]
PHST- 2018/03/10 06:00 [medline]
AID - nbt.3857 [pii]
AID - 10.1038/nbt.3857 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr 11;35(4):291. doi: 10.1038/nbt.3857.

PMID- 28398318
OWN - NLM
STAT- MEDLINE
DCOM- 20180302
LR  - 20180302
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr 11
TI  - Elevating the conversation about GE crops.
PG  - 302-304
LID - 10.1038/nbt.3841 [doi]
FAU - Gould, Fred
AU  - Gould F
AD  - North Carolina State, Dept. of Entomology and Plant Pathology, Genetic
      Engineering and Society Center, Raleigh, North Carolina, USA.
FAU - Amasino, Richard M
AU  - Amasino RM
AD  - University of Wisconsin-Madison, Dept. of Biochemistry, Madison, Wisconsin, USA.
FAU - Brossard, Dominique
AU  - Brossard D
AUID- ORCID: 0000-0002-9188-8388
AD  - University of Wisconsin-Madison, Dept. of Life Sciences Communication, Madison,
      Wisconsin, USA.
FAU - Buell, C Robin
AU  - Buell CR
AD  - Michigan State University, Dept. of Plant Biology, East Lansing, Michigan, USA.
FAU - Dixon, Richard A
AU  - Dixon RA
AUID- ORCID: 0000-0001-8393-9408
AD  - University of North Texas, Dept. of Biological Sciences, Denton, Texas, USA.
FAU - Falck-Zepeda, Jose B
AU  - Falck-Zepeda JB
AD  - International Food Policy Research Institute, Environment and Production
      Technology Division, Washington, DC, USA.
FAU - Gallo, Michael A
AU  - Gallo MA
AD  - Rutgers University, Environmental and Occupational Health Sciences Institute and 
      CounterACT Research Center of Excellence, Piscataway, New Jersey, USA.
FAU - Giller, Ken E
AU  - Giller KE
AUID- ORCID: 0000-0002-5998-4652
AD  - Wageningen University, Plant Production Systems, Wageningen, The Netherlands.
FAU - Glenna, Leland L
AU  - Glenna LL
AD  - Pennsylvania State University, Dept. of Agricultural Economics, Sociology and
      Education, University Park, Pennsylvania, USA.
FAU - Griffin, Timothy
AU  - Griffin T
AD  - Tufts University, Friedman School of Nutrition Science and Policy, Jaharis Family
      Center for Biomedical and Nutrition Sciences, Boston, Massachusetts, USA.
FAU - Hamaker, Bruce R
AU  - Hamaker BR
AUID- ORCID: 0000-0001-6591-942X
AD  - Purdue University, Dept. of Food Science, West Lafayette, Indiana, USA.
FAU - Kareiva, Peter M
AU  - Kareiva PM
AD  - University of California, Los Angeles, Institute of the Environment and
      Sustainability, Los Angeles, California, USA.
FAU - Magraw, Daniel
AU  - Magraw D
AD  - Johns Hopkins University School of Advanced International Studies, Washington,
      DC, USA.
FAU - Mallory-Smith, Carol
AU  - Mallory-Smith C
AD  - Oregon State University, Dept. of Crop and Soil Science, Corvallis, Oregon, USA.
FAU - Pixley, Kevin V
AU  - Pixley KV
AD  - CIMMYT (Centro Internacional de Mejoramiento de Maiz y Trigo), Texcoco CP, Edo.
      de Mexico, Mexico.
FAU - Ransom, Elizabeth P
AU  - Ransom EP
AD  - University of Richmond, Dept. of Sociology and Anthropology, University of
      Richmond, Virginia, USA.
FAU - Rodemeyer, Michael
AU  - Rodemeyer M
AD  - University of Virginia, Dept. of Engineering and Society, Charlottesville,
      Charlottesville, Virginia, USA.
FAU - Stelly, David M
AU  - Stelly DM
AUID- ORCID: 0000-0002-3468-4119
AD  - Texas A&M University, Dept. of Soil and Crop Sciences, College Station, Texas,
      USA.
FAU - Stewart, C Neal Jr
AU  - Stewart CN Jr
AD  - University of Tennessee, Dept. of Plant Sciences, Knoxville, Tennessee, USA.
FAU - Whitaker, Robert J
AU  - Whitaker RJ
AD  - Produce Marketing Association (PMA), Newark, Delaware, USA.
LA  - eng
PT  - Letter
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2016 Dec 7;34(12 ):1226-1228. PMID: 27926716
CIN - Nat Biotechnol. 2017 Apr 11;35(4):306-308. PMID: 28398310
MH  - *Crops, Agricultural
MH  - *Food, Genetically Modified
EDAT- 2017/04/12 06:00
MHDA- 2018/03/03 06:00
CRDT- 2017/04/12 06:00
PHST- 2017/04/12 06:00 [entrez]
PHST- 2017/04/12 06:00 [pubmed]
PHST- 2018/03/03 06:00 [medline]
AID - nbt.3841 [pii]
AID - 10.1038/nbt.3841 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr 11;35(4):302-304. doi: 10.1038/nbt.3841.

PMID- 28398317
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180301
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr 11
TI  - Allergan dives into CRISPR-Cas9.
PG  - 296
LID - 10.1038/nbt0417-296 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/04/12 06:00
MHDA- 2017/04/12 06:01
CRDT- 2017/04/12 06:00
PHST- 2017/04/12 06:00 [entrez]
PHST- 2017/04/12 06:00 [pubmed]
PHST- 2017/04/12 06:01 [medline]
AID - nbt0417-296 [pii]
AID - 10.1038/nbt0417-296 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr 11;35(4):296. doi: 10.1038/nbt0417-296.

PMID- 28398316
OWN - NLM
STAT- MEDLINE
DCOM- 20180302
LR  - 20180302
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr 11
TI  - mHealth advances clinical research, bit by bit.
PG  - 337-339
LID - 10.1038/nbt.3851 [doi]
FAU - Kvedar, Joseph C
AU  - Kvedar JC
AD  - Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts,
      USA, and Harvard Medical School, Boston, Massachusetts, USA, and Partners
      Connected Health, Partners Healthcare, Boston, Massachusetts, USA.
FAU - Fogel, Alexander L
AU  - Fogel AL
AD  - Stanford University School of Medicine, Stanford, California.
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2017 Apr;35(4):354-362. PMID: 28288104
MH  - Humans
MH  - *Telemedicine
EDAT- 2017/04/12 06:00
MHDA- 2018/03/03 06:00
CRDT- 2017/04/12 06:00
PHST- 2017/04/12 06:00 [entrez]
PHST- 2017/04/12 06:00 [pubmed]
PHST- 2018/03/03 06:00 [medline]
AID - nbt.3851 [pii]
AID - 10.1038/nbt.3851 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr 11;35(4):337-339. doi: 10.1038/nbt.3851.

PMID- 28398315
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180301
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr 11
TI  - Trade groups laud Gottlieb FDA choice, silent on NIH cutback.
PG  - 293-294
LID - 10.1038/nbt0417-293 [doi]
FAU - Ratner, Mark
AU  - Ratner M
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/04/12 06:00
MHDA- 2017/04/12 06:01
CRDT- 2017/04/12 06:00
PHST- 2017/04/12 06:00 [entrez]
PHST- 2017/04/12 06:00 [pubmed]
PHST- 2017/04/12 06:01 [medline]
AID - nbt0417-293 [pii]
AID - 10.1038/nbt0417-293 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr 11;35(4):293-294. doi: 10.1038/nbt0417-293.

PMID- 28398314
OWN - NLM
STAT- MEDLINE
DCOM- 20180309
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr 11
TI  - Toil enables reproducible, open source, big biomedical data analyses.
PG  - 314-316
LID - 10.1038/nbt.3772 [doi]
FAU - Vivian, John
AU  - Vivian J
AD  - Computational Genomics Lab, UC Santa Cruz Genomics Institute, University of
      California Santa Cruz, Santa Cruz, California, USA.
FAU - Rao, Arjun Arkal
AU  - Rao AA
AD  - Computational Genomics Lab, UC Santa Cruz Genomics Institute, University of
      California Santa Cruz, Santa Cruz, California, USA.
FAU - Nothaft, Frank Austin
AU  - Nothaft FA
AD  - AMP Lab, University of California Berkeley, Berkeley, California, USA.
AD  - UC Berkeley ASPIRE Lab, Berkeley, Berkeley, California, USA.
FAU - Ketchum, Christopher
AU  - Ketchum C
AD  - Computational Genomics Lab, UC Santa Cruz Genomics Institute, University of
      California Santa Cruz, Santa Cruz, California, USA.
FAU - Armstrong, Joel
AU  - Armstrong J
AD  - Computational Genomics Lab, UC Santa Cruz Genomics Institute, University of
      California Santa Cruz, Santa Cruz, California, USA.
FAU - Novak, Adam
AU  - Novak A
AUID- ORCID: 0000-0001-5828-047X
AD  - Computational Genomics Lab, UC Santa Cruz Genomics Institute, University of
      California Santa Cruz, Santa Cruz, California, USA.
FAU - Pfeil, Jacob
AU  - Pfeil J
AD  - Computational Genomics Lab, UC Santa Cruz Genomics Institute, University of
      California Santa Cruz, Santa Cruz, California, USA.
FAU - Narkizian, Jake
AU  - Narkizian J
AD  - Computational Genomics Lab, UC Santa Cruz Genomics Institute, University of
      California Santa Cruz, Santa Cruz, California, USA.
FAU - Deran, Alden D
AU  - Deran AD
AD  - Computational Genomics Lab, UC Santa Cruz Genomics Institute, University of
      California Santa Cruz, Santa Cruz, California, USA.
FAU - Musselman-Brown, Audrey
AU  - Musselman-Brown A
AD  - Computational Genomics Lab, UC Santa Cruz Genomics Institute, University of
      California Santa Cruz, Santa Cruz, California, USA.
FAU - Schmidt, Hannes
AU  - Schmidt H
AD  - Computational Genomics Lab, UC Santa Cruz Genomics Institute, University of
      California Santa Cruz, Santa Cruz, California, USA.
FAU - Amstutz, Peter
AU  - Amstutz P
AD  - Curoverse, Somerville, Massachusetts, USA.
FAU - Craft, Brian
AU  - Craft B
AD  - Computational Genomics Lab, UC Santa Cruz Genomics Institute, University of
      California Santa Cruz, Santa Cruz, California, USA.
FAU - Goldman, Mary
AU  - Goldman M
AD  - Computational Genomics Lab, UC Santa Cruz Genomics Institute, University of
      California Santa Cruz, Santa Cruz, California, USA.
FAU - Rosenbloom, Kate
AU  - Rosenbloom K
AD  - Computational Genomics Lab, UC Santa Cruz Genomics Institute, University of
      California Santa Cruz, Santa Cruz, California, USA.
FAU - Cline, Melissa
AU  - Cline M
AD  - Computational Genomics Lab, UC Santa Cruz Genomics Institute, University of
      California Santa Cruz, Santa Cruz, California, USA.
FAU - O'Connor, Brian
AU  - O'Connor B
AD  - Computational Genomics Lab, UC Santa Cruz Genomics Institute, University of
      California Santa Cruz, Santa Cruz, California, USA.
FAU - Hanna, Megan
AU  - Hanna M
AD  - Broad Institute of Harvard and Massachusetts Institute of Technology (MIT),
      Cambridge, Massachusetts, USA.
FAU - Birger, Chet
AU  - Birger C
AD  - Broad Institute of Harvard and Massachusetts Institute of Technology (MIT),
      Cambridge, Massachusetts, USA.
FAU - Kent, W James
AU  - Kent WJ
AD  - Computational Genomics Lab, UC Santa Cruz Genomics Institute, University of
      California Santa Cruz, Santa Cruz, California, USA.
FAU - Patterson, David A
AU  - Patterson DA
AD  - AMP Lab, University of California Berkeley, Berkeley, California, USA.
AD  - UC Berkeley ASPIRE Lab, Berkeley, Berkeley, California, USA.
FAU - Joseph, Anthony D
AU  - Joseph AD
AD  - AMP Lab, University of California Berkeley, Berkeley, California, USA.
AD  - UC Berkeley ASPIRE Lab, Berkeley, Berkeley, California, USA.
FAU - Zhu, Jingchun
AU  - Zhu J
AD  - Computational Genomics Lab, UC Santa Cruz Genomics Institute, University of
      California Santa Cruz, Santa Cruz, California, USA.
FAU - Zaranek, Sasha
AU  - Zaranek S
AD  - Curoverse, Somerville, Massachusetts, USA.
FAU - Getz, Gad
AU  - Getz G
AUID- ORCID: 0000-0002-0936-0753
AD  - Broad Institute of Harvard and Massachusetts Institute of Technology (MIT),
      Cambridge, Massachusetts, USA.
FAU - Haussler, David
AU  - Haussler D
AD  - Computational Genomics Lab, UC Santa Cruz Genomics Institute, University of
      California Santa Cruz, Santa Cruz, California, USA.
FAU - Paten, Benedict
AU  - Paten B
AD  - Computational Genomics Lab, UC Santa Cruz Genomics Institute, University of
      California Santa Cruz, Santa Cruz, California, USA.
LA  - eng
GR  - U41 HG002371/HG/NHGRI NIH HHS/United States
GR  - U24 CA180951/CA/NCI NIH HHS/United States
GR  - U24 CA210974/CA/NCI NIH HHS/United States
GR  - U24 CA143858/CA/NCI NIH HHS/United States
GR  - U54 HG007990/HG/NHGRI NIH HHS/United States
PT  - Letter
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Automatic Data Processing/*methods
MH  - Biomedical Research/*instrumentation
MH  - Humans
MH  - *Software
PMC - PMC5546205
MID - NIHMS887759
EDAT- 2017/04/12 06:00
MHDA- 2018/03/10 06:00
CRDT- 2017/04/12 06:00
PHST- 2017/04/12 06:00 [entrez]
PHST- 2017/04/12 06:00 [pubmed]
PHST- 2018/03/10 06:00 [medline]
AID - nbt.3772 [pii]
AID - 10.1038/nbt.3772 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr 11;35(4):314-316. doi: 10.1038/nbt.3772.

PMID- 28398313
OWN - NLM
STAT- MEDLINE
DCOM- 20180309
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr 11
TI  - Oncologists await historic first: a pan-tumor predictive marker, for
      immunotherapy.
PG  - 297-298
LID - 10.1038/nbt0417-297a [doi]
FAU - Garber, Ken
AU  - Garber K
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antibodies, Monoclonal, Humanized)
RN  - 0 (Biomarkers, Tumor)
RN  - DPT0O3T46P (pembrolizumab)
SB  - IM
MH  - Antibodies, Monoclonal, Humanized/immunology/*therapeutic use
MH  - Biomarkers, Tumor/immunology/therapeutic use
MH  - DNA Mismatch Repair/genetics/immunology
MH  - Drug Approval
MH  - Humans
MH  - *Immunotherapy
MH  - *Microsatellite Instability
MH  - Mutation
MH  - Neoplasms/genetics/immunology/*therapy
EDAT- 2017/04/12 06:00
MHDA- 2018/03/10 06:00
CRDT- 2017/04/12 06:00
PHST- 2017/04/12 06:00 [entrez]
PHST- 2017/04/12 06:00 [pubmed]
PHST- 2018/03/10 06:00 [medline]
AID - nbt0417-297a [pii]
AID - 10.1038/nbt0417-297a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr 11;35(4):297-298. doi: 10.1038/nbt0417-297a.

PMID- 28398311
OWN - NLM
STAT- MEDLINE
DCOM- 20180309
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr 11
TI  - Nextflow enables reproducible computational workflows.
PG  - 316-319
LID - 10.1038/nbt.3820 [doi]
FAU - Di Tommaso, Paolo
AU  - Di Tommaso P
AUID- ORCID: 0000-0002-5431-190X
AD  - Centre for Genomic Regulation (CRG), The Barcelona Institute for Science and
      Technology, Barcelona, Spain.
FAU - Chatzou, Maria
AU  - Chatzou M
AD  - Centre for Genomic Regulation (CRG), The Barcelona Institute for Science and
      Technology, Barcelona, Spain.
AD  - Universitat Pompeu Fabra (UPF), Barcelona, Spain.
FAU - Floden, Evan W
AU  - Floden EW
AD  - Centre for Genomic Regulation (CRG), The Barcelona Institute for Science and
      Technology, Barcelona, Spain.
AD  - Universitat Pompeu Fabra (UPF), Barcelona, Spain.
FAU - Barja, Pablo Prieto
AU  - Barja PP
AD  - Centre for Genomic Regulation (CRG), The Barcelona Institute for Science and
      Technology, Barcelona, Spain.
AD  - Universitat Pompeu Fabra (UPF), Barcelona, Spain.
FAU - Palumbo, Emilio
AU  - Palumbo E
AD  - Centre for Genomic Regulation (CRG), The Barcelona Institute for Science and
      Technology, Barcelona, Spain.
FAU - Notredame, Cedric
AU  - Notredame C
AD  - Centre for Genomic Regulation (CRG), The Barcelona Institute for Science and
      Technology, Barcelona, Spain.
LA  - eng
PT  - Letter
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Automatic Data Processing
MH  - Computational Biology/*methods
MH  - *Genomics
MH  - *Software
MH  - Workflow
EDAT- 2017/04/12 06:00
MHDA- 2018/03/10 06:00
CRDT- 2017/04/12 06:00
PHST- 2017/04/12 06:00 [entrez]
PHST- 2017/04/12 06:00 [pubmed]
PHST- 2018/03/10 06:00 [medline]
AID - nbt.3820 [pii]
AID - 10.1038/nbt.3820 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr 11;35(4):316-319. doi: 10.1038/nbt.3820.

PMID- 28398310
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20180302
LR  - 20180302
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr 11
TI  - Response to Gould et al. and Vincelli et al.
PG  - 306-308
LID - 10.1038/nbt.3844 [doi]
LA  - eng
PT  - Letter
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
CON - Nat Biotechnol. 2017 Apr 11;35(4):304-306. PMID: 28398324
CON - Nat Biotechnol. 2017 Apr 11;35(4):302-304. PMID: 28398318
EDAT- 2017/04/12 06:00
MHDA- 2017/04/12 06:01
CRDT- 2017/04/12 06:00
PHST- 2017/04/12 06:00 [entrez]
PHST- 2017/04/12 06:00 [pubmed]
PHST- 2017/04/12 06:01 [medline]
AID - nbt.3844 [pii]
AID - 10.1038/nbt.3844 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr 11;35(4):306-308. doi: 10.1038/nbt.3844.

PMID- 28398309
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180301
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr 11
TI  - 'Tinder' for startups.
PG  - 294
LID - 10.1038/nbt0417-294 [doi]
FAU - Marshall, Andrew
AU  - Marshall A
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/04/12 06:00
MHDA- 2017/04/12 06:01
CRDT- 2017/04/12 06:00
PHST- 2017/04/12 06:00 [entrez]
PHST- 2017/04/12 06:00 [pubmed]
PHST- 2017/04/12 06:01 [medline]
AID - nbt0417-294 [pii]
AID - 10.1038/nbt0417-294 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr 11;35(4):294. doi: 10.1038/nbt0417-294.

PMID- 28398308
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180301
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr 11
TI  - Biotech startups woo increasing numbers of crowdfunders.
PG  - 299-300
LID - 10.1038/nbt0417-299 [doi]
FAU - Moran, Nuala
AU  - Moran N
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/04/12 06:00
MHDA- 2017/04/12 06:01
CRDT- 2017/04/12 06:00
PHST- 2017/04/12 06:00 [entrez]
PHST- 2017/04/12 06:00 [pubmed]
PHST- 2017/04/12 06:01 [medline]
AID - nbt0417-299 [pii]
AID - 10.1038/nbt0417-299 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr 11;35(4):299-300. doi: 10.1038/nbt0417-299.

PMID- 28398307
OWN - NLM
STAT- MEDLINE
DCOM- 20180309
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr 11
TI  - Reproducible RNA-seq analysis using recount2.
PG  - 319-321
LID - 10.1038/nbt.3838 [doi]
FAU - Collado-Torres, Leonardo
AU  - Collado-Torres L
AUID- ORCID: 0000-0003-2140-308X
AD  - Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health,
      Baltimore, Maryland, USA.
AD  - Center for Computational Biology, Johns Hopkins University, Baltimore, Maryland, 
      USA.
AD  - Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, 
      Maryland, USA.
FAU - Nellore, Abhinav
AU  - Nellore A
AD  - Department of Biomedical Engineering, Oregon Health &Science University,
      Portland, Oregon, USA.
AD  - Department of Surgery, Oregon Health &Science University, Portland, Oregon, USA.
AD  - Computational Biology Program, Oregon Health &Science University, Portland,
      Oregon, USA.
FAU - Kammers, Kai
AU  - Kammers K
AD  - Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health,
      Baltimore, Maryland, USA.
AD  - Center for Computational Biology, Johns Hopkins University, Baltimore, Maryland, 
      USA.
AD  - Division of Biostatistics and Bioinformatics, Department of Oncology, Sidney
      Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, 
      Baltimore, Maryland, USA.
FAU - Ellis, Shannon E
AU  - Ellis SE
AD  - Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health,
      Baltimore, Maryland, USA.
AD  - Center for Computational Biology, Johns Hopkins University, Baltimore, Maryland, 
      USA.
FAU - Taub, Margaret A
AU  - Taub MA
AD  - Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health,
      Baltimore, Maryland, USA.
AD  - Center for Computational Biology, Johns Hopkins University, Baltimore, Maryland, 
      USA.
FAU - Hansen, Kasper D
AU  - Hansen KD
AUID- ORCID: 0000-0003-0086-0687
AD  - Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health,
      Baltimore, Maryland, USA.
AD  - Center for Computational Biology, Johns Hopkins University, Baltimore, Maryland, 
      USA.
AD  - McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University,
      Baltimore, Maryland, USA.
FAU - Jaffe, Andrew E
AU  - Jaffe AE
AUID- ORCID: 0000-0001-6886-1454
AD  - Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health,
      Baltimore, Maryland, USA.
AD  - Center for Computational Biology, Johns Hopkins University, Baltimore, Maryland, 
      USA.
AD  - Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, 
      Maryland, USA.
AD  - Department of Mental Health, Johns Hopkins University, Baltimore, Maryland, USA.
FAU - Langmead, Ben
AU  - Langmead B
AD  - Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health,
      Baltimore, Maryland, USA.
AD  - Center for Computational Biology, Johns Hopkins University, Baltimore, Maryland, 
      USA.
AD  - Department of Computer Science, Johns Hopkins University, Baltimore, Maryland,
      USA.
FAU - Leek, Jeffrey T
AU  - Leek JT
AD  - Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health,
      Baltimore, Maryland, USA.
AD  - Center for Computational Biology, Johns Hopkins University, Baltimore, Maryland, 
      USA.
LA  - eng
GR  - HHSN268201000029C/HL/NHLBI NIH HHS/United States
GR  - HHSN261200800001E/CA/NCI NIH HHS/United States
GR  - R01 DA006227/DA/NIDA NIH HHS/United States
GR  - R01 DA033684/DA/NIDA NIH HHS/United States
GR  - R01 MH090941/MH/NIMH NIH HHS/United States
GR  - R01 MH101814/MH/NIMH NIH HHS/United States
GR  - R01 MH090951/MH/NIMH NIH HHS/United States
GR  - R01 MH090937/MH/NIMH NIH HHS/United States
GR  - R01 MH101820/MH/NIMH NIH HHS/United States
GR  - R01 MH101825/MH/NIMH NIH HHS/United States
GR  - R01 MH090936/MH/NIMH NIH HHS/United States
GR  - R01 MH101819/MH/NIMH NIH HHS/United States
GR  - R01 MH090948/MH/NIMH NIH HHS/United States
GR  - R01 MH101782/MH/NIMH NIH HHS/United States
GR  - R01 MH101810/MH/NIMH NIH HHS/United States
GR  - R01 MH101822/MH/NIMH NIH HHS/United States
GR  - R01 GM105705/GM/NIGMS NIH HHS/United States
GR  - R21 MH109956/MH/NIMH NIH HHS/United States
PT  - Letter
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 63231-63-0 (RNA)
SB  - IM
MH  - *Databases, Genetic
MH  - Gene Expression/*genetics
MH  - Humans
MH  - RNA/analysis/*genetics
MH  - Sequence Analysis, RNA/*methods
EDAT- 2017/04/12 06:00
MHDA- 2018/03/10 06:00
CRDT- 2017/04/12 06:00
PHST- 2017/04/12 06:00 [entrez]
PHST- 2017/04/12 06:00 [pubmed]
PHST- 2018/03/10 06:00 [medline]
AID - nbt.3838 [pii]
AID - 10.1038/nbt.3838 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr 11;35(4):319-321. doi: 10.1038/nbt.3838.

PMID- 28398306
OWN - NLM
STAT- MEDLINE
DCOM- 20180309
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr 11
TI  - Real world points to SGLT-2 blockers advantage.
PG  - 297
LID - 10.1038/nbt0417-297c [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0
      (2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-t
      riol)
RN  - 0 (Benzhydryl Compounds)
RN  - 0 (Glucosides)
RN  - 0 (SLC5A2 protein, human)
RN  - 0 (Sodium-Glucose Transporter 2)
RN  - 0SAC974Z85 (Canagliflozin)
RN  - IY9XDZ35W2 (Glucose)
SB  - IM
MH  - Benzhydryl Compounds/*therapeutic use
MH  - Canagliflozin/therapeutic use
MH  - Cardiovascular Abnormalities/blood/etiology/*prevention & control
MH  - Diabetes Mellitus, Type 2/blood/complications/*prevention & control
MH  - Glucose/metabolism
MH  - Glucosides/*therapeutic use
MH  - Humans
MH  - Kidney Tubules, Proximal/drug effects
MH  - Sodium-Glucose Transporter 2/*antagonists & inhibitors/therapeutic use
EDAT- 2017/04/12 06:00
MHDA- 2018/03/10 06:00
CRDT- 2017/04/12 06:00
PHST- 2017/04/12 06:00 [entrez]
PHST- 2017/04/12 06:00 [pubmed]
PHST- 2018/03/10 06:00 [medline]
AID - nbt0417-297c [pii]
AID - 10.1038/nbt0417-297c [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr 11;35(4):297. doi: 10.1038/nbt0417-297c.

PMID- 28398305
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180301
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr 11
TI  - Continuous positive compensation trends indicate a healthy private life sciences 
      sector.
PG  - 383-386
LID - 10.1038/nbt.3850 [doi]
FAU - Rychlik, Bruce
AU  - Rychlik B
AD  - Park Square Executive Search LLC, Boston, Massachusetts, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/04/12 06:00
MHDA- 2017/04/12 06:01
CRDT- 2017/04/12 06:00
PHST- 2017/04/12 06:00 [entrez]
PHST- 2017/04/12 06:00 [pubmed]
PHST- 2017/04/12 06:01 [medline]
AID - nbt.3850 [pii]
AID - 10.1038/nbt.3850 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr 11;35(4):383-386. doi: 10.1038/nbt.3850.

PMID- 28398312
OWN - NLM
STAT- MEDLINE
DCOM- 20180305
LR  - 20180305
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr 7
TI  - Differing diagnoses for European and US patents.
PG  - 334-335
LID - 10.1038/nbt.3839 [doi]
FAU - Amos, Brian
AU  - Amos B
AD  - Amster, Rothstein &Ebenstein, LLP, New York, New York, USA.
FAU - Miller, Alan D
AU  - Miller AD
AD  - Amster, Rothstein &Ebenstein, LLP, New York, New York, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Biomarkers)
SB  - IM
MH  - Biomarkers/analysis
MH  - *Diagnosis, Differential
MH  - Humans
MH  - Patents as Topic/*legislation & jurisprudence
MH  - Supreme Court Decisions
MH  - Translational Medical Research/*legislation & jurisprudence
MH  - United States
EDAT- 2017/04/12 06:00
MHDA- 2018/03/06 06:00
CRDT- 2017/04/12 06:00
PHST- 2017/04/12 06:00 [entrez]
PHST- 2017/04/12 06:00 [pubmed]
PHST- 2018/03/06 06:00 [medline]
AID - nbt.3839 [pii]
AID - 10.1038/nbt.3839 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr 7;35(4):334-335. doi: 10.1038/nbt.3839.

PMID- 28288105
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20180301
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr
TI  - Reduction of antinutritional glucosinolates in Brassica oilseeds by mutation of
      genes encoding transporters.
PG  - 377-382
LID - 10.1038/nbt.3823 [doi]
AB  - The nutritional value of Brassica seed meals is reduced by the presence of
      glucosinolates, which are toxic compounds involved in plant defense. Mutation of 
      the genes encoding two glucosinolate transporters (GTRs) eliminated
      glucosinolates from Arabidopsis thaliana seeds, but translation of
      loss-of-function phenotypes into Brassica crops is challenging because Brassica
      is polyploid. We mutated one of seven and four of 12 GTR orthologs and reduced
      glucosinolate levels in seeds by 60-70% in two different Brassica species
      (Brassica rapa and Brassica juncea). Reduction in seed glucosinolates was stably 
      inherited over multiple generations and maintained in field trials of two mutant 
      populations at three locations. Successful translation of the gtr
      loss-of-function phenotype from model plant to two Brassica crops suggests that
      our transport engineering approach could be broadly applied to reduce seed
      glucosinolate content in other oilseed crops, such as Camelina sativa or Crambe
      abyssinica.
FAU - Nour-Eldin, Hussam Hassan
AU  - Nour-Eldin HH
AUID- ORCID: 0000-0001-6660-0509
AD  - DynaMo Center, Department of Plant and Environmental Sciences, Faculty of
      Science, University of Copenhagen, Frederiksberg, Denmark.
AD  - Copenhagen Plant Science Center, Department of Plant and Environmental Sciences, 
      Faculty of Science, University of Copenhagen, Frederiksberg, Denmark.
FAU - Madsen, Svend Roesen
AU  - Madsen SR
AD  - DynaMo Center, Department of Plant and Environmental Sciences, Faculty of
      Science, University of Copenhagen, Frederiksberg, Denmark.
AD  - Copenhagen Plant Science Center, Department of Plant and Environmental Sciences, 
      Faculty of Science, University of Copenhagen, Frederiksberg, Denmark.
FAU - Engelen, Steven
AU  - Engelen S
AD  - Bayer CropScience NV, Innovation Center, Zwijnaarde, Belgium.
FAU - Jorgensen, Morten Egevang
AU  - Jorgensen ME
AUID- ORCID: 0000-0001-6503-0495
AD  - DynaMo Center, Department of Plant and Environmental Sciences, Faculty of
      Science, University of Copenhagen, Frederiksberg, Denmark.
AD  - Copenhagen Plant Science Center, Department of Plant and Environmental Sciences, 
      Faculty of Science, University of Copenhagen, Frederiksberg, Denmark.
FAU - Olsen, Carl Erik
AU  - Olsen CE
AD  - Department of Plant and Environmental Sciences, Faculty of Science, University of
      Copenhagen, Frederiksberg, Denmark.
FAU - Andersen, Jonathan Sonne
AU  - Andersen JS
AD  - DynaMo Center, Department of Plant and Environmental Sciences, Faculty of
      Science, University of Copenhagen, Frederiksberg, Denmark.
AD  - Copenhagen Plant Science Center, Department of Plant and Environmental Sciences, 
      Faculty of Science, University of Copenhagen, Frederiksberg, Denmark.
FAU - Seynnaeve, David
AU  - Seynnaeve D
AD  - Bayer CropScience NV, Innovation Center, Zwijnaarde, Belgium.
FAU - Verhoye, Thalia
AU  - Verhoye T
AD  - Bayer CropScience NV, Innovation Center, Zwijnaarde, Belgium.
FAU - Fulawka, Rudy
AU  - Fulawka R
AD  - Bayer CropScience Inc., Seed Quality Lab, Saskatoon, Saskatchewan, Canada.
FAU - Denolf, Peter
AU  - Denolf P
AD  - Bayer CropScience NV, Innovation Center, Zwijnaarde, Belgium.
FAU - Halkier, Barbara Ann
AU  - Halkier BA
AD  - DynaMo Center, Department of Plant and Environmental Sciences, Faculty of
      Science, University of Copenhagen, Frederiksberg, Denmark.
AD  - Copenhagen Plant Science Center, Department of Plant and Environmental Sciences, 
      Faculty of Science, University of Copenhagen, Frederiksberg, Denmark.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20170313
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Glucosinolates)
RN  - 0 (Monosaccharide Transport Proteins)
RN  - 0 (Plant Oils)
SB  - IM
MH  - Brassica/*genetics
MH  - Genetic Enhancement/*methods
MH  - Glucosinolates/analysis/*metabolism
MH  - Monosaccharide Transport Proteins/*genetics
MH  - Mutation
MH  - Plant Oils/analysis/*chemistry
MH  - Plants, Genetically Modified/genetics/metabolism
MH  - Seeds/chemistry/*genetics
EDAT- 2017/03/14 06:00
MHDA- 2017/06/07 06:00
CRDT- 2017/03/14 06:00
PHST- 2016/06/10 00:00 [received]
PHST- 2017/01/27 00:00 [accepted]
PHST- 2017/03/14 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2017/03/14 06:00 [entrez]
AID - nbt.3823 [pii]
AID - 10.1038/nbt.3823 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr;35(4):377-382. doi: 10.1038/nbt.3823. Epub 2017 Mar 13.

PMID- 28288104
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20180401
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr
TI  - The Asthma Mobile Health Study, a large-scale clinical observational study using 
      ResearchKit.
PG  - 354-362
LID - 10.1038/nbt.3826 [doi]
AB  - The feasibility of using mobile health applications to conduct observational
      clinical studies requires rigorous validation. Here, we report initial findings
      from the Asthma Mobile Health Study, a research study, including recruitment,
      consent, and enrollment, conducted entirely remotely by smartphone. We achieved
      secure bidirectional data flow between investigators and 7,593 participants from 
      across the United States, including many with severe asthma. Our platform enabled
      prospective collection of longitudinal, multidimensional data (e.g., surveys,
      devices, geolocation, and air quality) in a subset of users over the 6-month
      study period. Consistent trending and correlation of interrelated variables
      support the quality of data obtained via this method. We detected increased
      reporting of asthma symptoms in regions affected by heat, pollen, and wildfires. 
      Potential challenges with this technology include selection bias, low retention
      rates, reporting bias, and data security. These issues require attention to
      realize the full potential of mobile platforms in research and patient care.
FAU - Chan, Yu-Feng Yvonne
AU  - Chan YY
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
AD  - Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New
      York, New York, USA.
FAU - Wang, Pei
AU  - Wang P
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
FAU - Rogers, Linda
AU  - Rogers L
AD  - Department of Medicine, Pulmonary, Critical Care and Sleep Medicine, Icahn School
      of Medicine at Mount Sinai, New York, New York, USA.
FAU - Tignor, Nicole
AU  - Tignor N
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
FAU - Zweig, Micol
AU  - Zweig M
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
FAU - Hershman, Steven G
AU  - Hershman SG
AUID- ORCID: http://orcid.org/0000-0001-9167-7380
AD  - LifeMap Solutions, Inc., New York, New York, USA.
FAU - Genes, Nicholas
AU  - Genes N
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
AD  - Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New
      York, New York, USA.
FAU - Scott, Erick R
AU  - Scott ER
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
FAU - Krock, Eric
AU  - Krock E
AD  - LifeMap Solutions, Inc., New York, New York, USA.
FAU - Badgeley, Marcus
AU  - Badgeley M
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
FAU - Edgar, Ron
AU  - Edgar R
AD  - LifeMap Solutions, Inc., New York, New York, USA.
FAU - Violante, Samantha
AU  - Violante S
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
FAU - Wright, Rosalind
AU  - Wright R
AD  - Department of Medicine, Pulmonary, Critical Care and Sleep Medicine, Icahn School
      of Medicine at Mount Sinai, New York, New York, USA.
AD  - Department of Pediatrics, Pulmonary and Critical Care, Icahn School of Medicine
      at Mount Sinai, New York, New York, USA.
AD  - Department of Environmental Medicine &Public Health, Icahn School of Medicine at 
      Mount Sinai, New York, New York, USA.
FAU - Powell, Charles A
AU  - Powell CA
AUID- ORCID: http://orcid.org/0000-0003-3509-891X
AD  - Department of Medicine, Pulmonary, Critical Care and Sleep Medicine, Icahn School
      of Medicine at Mount Sinai, New York, New York, USA.
FAU - Dudley, Joel T
AU  - Dudley JT
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
AD  - Department of Population Health Science and Policy, Icahn School of Medicine at
      Mount Sinai, New York, New York, USA.
FAU - Schadt, Eric E
AU  - Schadt EE
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
LA  - eng
GR  - T32 GM007280/GM/NIGMS NIH HHS/United States
GR  - UL1 TR001433/TR/NCATS NIH HHS/United States
PT  - Journal Article
PT  - Observational Study
DEP - 20170313
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CIN - Nat Biotechnol. 2017 Apr 11;35(4):337-339. PMID: 28398316
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Asthma/diagnosis/*epidemiology
MH  - Female
MH  - Health Services Research/*organization & administration
MH  - Health Surveys/methods/*statistics & numerical data
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - New York/epidemiology
MH  - Observational Studies as Topic/methods
MH  - Patient Selection
MH  - Population Surveillance/*methods
MH  - Prevalence
MH  - *Research Design
MH  - Risk Factors
MH  - Telemedicine/*utilization
MH  - Young Adult
PMC - PMC5559298
MID - NIHMS885868
EDAT- 2017/03/14 06:00
MHDA- 2017/06/07 06:00
CRDT- 2017/03/14 06:00
PHST- 2016/04/15 00:00 [received]
PHST- 2017/02/13 00:00 [accepted]
PHST- 2017/03/14 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2017/03/14 06:00 [entrez]
AID - nbt.3826 [pii]
AID - 10.1038/nbt.3826 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr;35(4):354-362. doi: 10.1038/nbt.3826. Epub 2017 Mar 13.

PMID- 28288103
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20180301
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr
TI  - Reproducibility of computational workflows is automated using continuous
      analysis.
PG  - 342-346
LID - 10.1038/nbt.3780 [doi]
AB  - Replication, validation and extension of experiments are crucial for scientific
      progress. Computational experiments are scriptable and should be easy to
      reproduce. However, computational analyses are designed and run in a specific
      computing environment, which may be difficult or impossible to match using
      written instructions. We report the development of continuous analysis, a
      workflow that enables reproducible computational analyses. Continuous analysis
      combines Docker, a container technology akin to virtual machines, with continuous
      integration, a software development technique, to automatically rerun a
      computational analysis whenever updates or improvements are made to source code
      or data. This enables researchers to reproduce results without contacting the
      study authors. Continuous analysis allows reviewers, editors or readers to verify
      reproducibility without manually downloading and rerunning code and can provide
      an audit trail for analyses of data that cannot be shared.
FAU - Beaulieu-Jones, Brett K
AU  - Beaulieu-Jones BK
AD  - Genomics and Computational Biology Graduate Group, Perelman School of Medicine,
      University of Pennsylvania, Philadelphia, Pennsylvania, USA.
FAU - Greene, Casey S
AU  - Greene CS
AUID- ORCID: 0000-0001-8713-9213
AD  - Department of Systems Pharmacology and Translational Therapeutics, Perelman
      School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
LA  - eng
GR  - R01 AI116794/AI/NIAID NIH HHS/United States
GR  - R01 LM010098/LM/NLM NIH HHS/United States
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, N.I.H., Extramural
DEP - 20170313
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Computational Biology/*methods
MH  - Gene Expression Profiling/*methods
MH  - *Machine Learning
MH  - Reproducibility of Results
MH  - Sensitivity and Specificity
MH  - *Software
MH  - *User-Computer Interface
MH  - *Workflow
EDAT- 2017/03/14 06:00
MHDA- 2017/06/07 06:00
CRDT- 2017/03/14 06:00
PHST- 2016/06/10 00:00 [received]
PHST- 2016/12/22 00:00 [accepted]
PHST- 2017/03/14 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2017/03/14 06:00 [entrez]
AID - nbt.3780 [pii]
AID - 10.1038/nbt.3780 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr;35(4):342-346. doi: 10.1038/nbt.3780. Epub 2017 Mar 13.

PMID- 28288102
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr
TI  - A FRET sensor enables quantitative measurements of membrane charges in live
      cells.
PG  - 363-370
LID - 10.1038/nbt.3828 [doi]
AB  - Membrane charge has a critical role in protein trafficking and signaling.
      However, quantification of the effective electrostatic potential of cellular
      membranes has remained challenging. We developed a fluorescence membrane charge
      sensor (MCS) that reports changes in the membrane charge of live cells via
      Forster resonance energy transfer (FRET). MCS is permanently attached to the
      inner leaflet of the plasma membrane and shows a linear, reversible and fast
      response to changes of the electrostatic potential. The sensor can monitor a wide
      range of cellular treatments that alter the electrostatic potential, such as
      incorporation and redistribution of charged lipids and alterations in cytosolic
      ion concentration. Applying the sensor to T cell biology, we used it to identify 
      charged membrane domains in the immunological synapse. Further, we found that
      electrostatic interactions prevented spontaneous phosphorylation of the T cell
      receptor and contributed to the formation of signaling clusters in T cells.
FAU - Ma, Yuanqing
AU  - Ma Y
AD  - EMBL Australia Node in Single Molecule Science, School of Medical Sciences,
      University of New South Wales, Sydney, New South Wales, Australia.
AD  - ARC Centre of Excellence in Advanced Molecular Imaging, University of New South
      Wales, Sydney, New South Wales, Australia.
FAU - Yamamoto, Yui
AU  - Yamamoto Y
AD  - EMBL Australia Node in Single Molecule Science, School of Medical Sciences,
      University of New South Wales, Sydney, New South Wales, Australia.
AD  - ARC Centre of Excellence in Advanced Molecular Imaging, University of New South
      Wales, Sydney, New South Wales, Australia.
FAU - Nicovich, Philip R
AU  - Nicovich PR
AD  - EMBL Australia Node in Single Molecule Science, School of Medical Sciences,
      University of New South Wales, Sydney, New South Wales, Australia.
AD  - ARC Centre of Excellence in Advanced Molecular Imaging, University of New South
      Wales, Sydney, New South Wales, Australia.
FAU - Goyette, Jesse
AU  - Goyette J
AD  - EMBL Australia Node in Single Molecule Science, School of Medical Sciences,
      University of New South Wales, Sydney, New South Wales, Australia.
AD  - ARC Centre of Excellence in Advanced Molecular Imaging, University of New South
      Wales, Sydney, New South Wales, Australia.
FAU - Rossy, Jeremie
AU  - Rossy J
AD  - EMBL Australia Node in Single Molecule Science, School of Medical Sciences,
      University of New South Wales, Sydney, New South Wales, Australia.
FAU - Gooding, J Justin
AU  - Gooding JJ
AD  - School of Chemistry and Australian Centre of NanoMedicine, University of New
      South Wales, Sydney, New South Wales, Australia.
AD  - ARC Centre of Excellence in Convergent Bio-Nano Science and Technology,
      University of New South Wales, Sydney, New South Wales, Australia.
FAU - Gaus, Katharina
AU  - Gaus K
AD  - EMBL Australia Node in Single Molecule Science, School of Medical Sciences,
      University of New South Wales, Sydney, New South Wales, Australia.
AD  - ARC Centre of Excellence in Advanced Molecular Imaging, University of New South
      Wales, Sydney, New South Wales, Australia.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20170313
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Luminescent Proteins)
RN  - 0 (Membrane Proteins)
SB  - IM
EIN - Nat Biotechnol. 2017 May 9;35(5):481. PMID: 28486447
MH  - Cell Membrane/*physiology
MH  - Fluorescence Resonance Energy Transfer/*methods
MH  - Humans
MH  - Jurkat Cells
MH  - Luminescent Proteins/*metabolism
MH  - Membrane Potentials/*physiology
MH  - Membrane Proteins/*physiology
MH  - Reproducibility of Results
MH  - Sensitivity and Specificity
MH  - *Static Electricity
EDAT- 2017/03/14 06:00
MHDA- 2017/06/07 06:00
CRDT- 2017/03/14 06:00
PHST- 2015/09/15 00:00 [received]
PHST- 2017/02/15 00:00 [accepted]
PHST- 2017/03/14 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2017/03/14 06:00 [entrez]
AID - nbt.3828 [pii]
AID - 10.1038/nbt.3828 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr;35(4):363-370. doi: 10.1038/nbt.3828. Epub 2017 Mar 13.

PMID- 28263296
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20180301
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr
TI  - GuideScan software for improved single and paired CRISPR guide RNA design.
PG  - 347-349
LID - 10.1038/nbt.3804 [doi]
AB  - We present GuideScan software for the design of CRISPR guide RNA libraries that
      can be used to edit coding and noncoding genomic regions. GuideScan produces
      high-density sets of guide RNAs (gRNAs) for single- and paired-gRNA genome-wide
      screens. We also show that the trie data structure of GuideScan enables the
      design of gRNAs that are more specific than those designed by existing tools.
FAU - Perez, Alexendar R
AU  - Perez AR
AD  - Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, 
      New York, USA.
AD  - Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New 
      York, New York, USA.
AD  - Weill Cornell Graduate School of Medical Sciences of Cornell University, New
      York, New York, USA.
FAU - Pritykin, Yuri
AU  - Pritykin Y
AD  - Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, 
      New York, USA.
FAU - Vidigal, Joana A
AU  - Vidigal JA
AUID- ORCID: 0000-0003-2765-6985
AD  - Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New 
      York, New York, USA.
FAU - Chhangawala, Sagar
AU  - Chhangawala S
AD  - Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, 
      New York, USA.
AD  - Weill Cornell Graduate School of Medical Sciences of Cornell University, New
      York, New York, USA.
FAU - Zamparo, Lee
AU  - Zamparo L
AD  - Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, 
      New York, USA.
FAU - Leslie, Christina S
AU  - Leslie CS
AD  - Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, 
      New York, USA.
FAU - Ventura, Andrea
AU  - Ventura A
AD  - Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New 
      York, New York, USA.
LA  - eng
GR  - P30 CA008748/CA/NCI NIH HHS/United States
GR  - U01 HG007033/HG/NHGRI NIH HHS/United States
GR  - U01 HG007893/HG/NHGRI NIH HHS/United States
GR  - U01 HG009395/HG/NHGRI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, N.I.H., Extramural
DEP - 20170306
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (RNA, Small Interfering)
SB  - IM
MH  - *Algorithms
MH  - CRISPR-Cas Systems/genetics
MH  - Chromosome Mapping/methods
MH  - Clustered Regularly Interspaced Short Palindromic Repeats/*genetics
MH  - *Gene Silencing
MH  - *Machine Learning
MH  - RNA, Small Interfering/*genetics
MH  - Sequence Analysis, RNA/methods
MH  - *Software
PMC - PMC5607865
MID - NIHMS847627
EDAT- 2017/03/07 06:00
MHDA- 2017/06/07 06:00
CRDT- 2017/03/07 06:00
PHST- 2016/08/22 00:00 [received]
PHST- 2017/01/27 00:00 [accepted]
PHST- 2017/03/07 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2017/03/07 06:00 [entrez]
AID - nbt.3804 [pii]
AID - 10.1038/nbt.3804 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr;35(4):347-349. doi: 10.1038/nbt.3804. Epub 2017 Mar 6.

PMID- 28263295
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20180301
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr
TI  - Prediction of potent shRNAs with a sequential classification algorithm.
PG  - 350-353
LID - 10.1038/nbt.3807 [doi]
AB  - We present SplashRNA, a sequential classifier to predict potent microRNA-based
      short hairpin RNAs (shRNAs). Trained on published and novel data sets, SplashRNA 
      outperforms previous algorithms and reliably predicts the most efficient shRNAs
      for a given gene. Combined with an optimized miR-E backbone, >90% of high-scoring
      SplashRNA predictions trigger >85% protein knockdown when expressed from a single
      genomic integration. SplashRNA can significantly improve the accuracy of
      loss-of-function genetics studies and facilitates the generation of compact shRNA
      libraries.
FAU - Pelossof, Raphael
AU  - Pelossof R
AD  - Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, 
      New York, USA.
FAU - Fairchild, Lauren
AU  - Fairchild L
AD  - Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, 
      New York, USA.
AD  - Tri-Institutional Training Program in Computational Biology and Medicine, New
      York, New York, USA.
FAU - Huang, Chun-Hao
AU  - Huang CH
AD  - Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer
      Center, New York, New York, USA.
AD  - Cell and Developmental Biology Program, Weill Graduate School of Medical
      Sciences, Cornell University, New York, New York, USA.
FAU - Widmer, Christian
AU  - Widmer C
AD  - Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, 
      New York, USA.
AD  - Machine Learning Group, Department of Computer Science, Berlin Institute of
      Technology, Berlin, Germany.
FAU - Sreedharan, Vipin T
AU  - Sreedharan VT
AD  - Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, 
      New York, USA.
FAU - Sinha, Nishi
AU  - Sinha N
AD  - Mirimus Inc., Woodbury, New York, USA.
FAU - Lai, Dan-Yu
AU  - Lai DY
AD  - Mirimus Inc., Woodbury, New York, USA.
FAU - Guan, Yuanzhe
AU  - Guan Y
AD  - Mirimus Inc., Woodbury, New York, USA.
FAU - Premsrirut, Prem K
AU  - Premsrirut PK
AD  - Mirimus Inc., Woodbury, New York, USA.
FAU - Tschaharganeh, Darjus F
AU  - Tschaharganeh DF
AD  - Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer
      Center, New York, New York, USA.
FAU - Hoffmann, Thomas
AU  - Hoffmann T
AD  - Research Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria.
FAU - Thapar, Vishal
AU  - Thapar V
AD  - Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer
      Center, New York, New York, USA.
FAU - Xiang, Qing
AU  - Xiang Q
AD  - RNAi Core, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
FAU - Garippa, Ralph J
AU  - Garippa RJ
AD  - RNAi Core, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
FAU - Ratsch, Gunnar
AU  - Ratsch G
AD  - Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, 
      New York, USA.
AD  - Department of Computer Science, ETH Zurich, Zurich, Switzerland.
FAU - Zuber, Johannes
AU  - Zuber J
AD  - Research Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria.
FAU - Lowe, Scott W
AU  - Lowe SW
AD  - Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer
      Center, New York, New York, USA.
AD  - Cell and Developmental Biology Program, Weill Graduate School of Medical
      Sciences, Cornell University, New York, New York, USA.
AD  - Howard Hughes Medical Institute and Memorial Sloan Kettering Cancer Center, New
      York, New York, USA.
FAU - Leslie, Christina S
AU  - Leslie CS
AD  - Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, 
      New York, USA.
FAU - Fellmann, Christof
AU  - Fellmann C
AD  - Mirimus Inc., Woodbury, New York, USA.
AD  - Department of Molecular and Cell Biology, University of California, Berkeley,
      Berkeley, California, USA.
LA  - eng
GR  - U01 HG007033/HG/NHGRI NIH HHS/United States
GR  - U01 HG007893/HG/NHGRI NIH HHS/United States
GR  - P30 CA008748/CA/NCI NIH HHS/United States
GR  - K99 GM118909/GM/NIGMS NIH HHS/United States
GR  - U01 CA164190/CA/NCI NIH HHS/United States
GR  - P01 CA013106/CA/NCI NIH HHS/United States
GR  - R44 CA188154/CA/NCI NIH HHS/United States
GR  - HHMI/Howard Hughes Medical Institute/United States
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, N.I.H., Extramural
DEP - 20170306
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (RNA, Small Interfering)
SB  - IM
MH  - *Algorithms
MH  - CRISPR-Cas Systems/genetics
MH  - Chromosome Mapping/methods
MH  - Clustered Regularly Interspaced Short Palindromic Repeats/*genetics
MH  - *Gene Silencing
MH  - *Machine Learning
MH  - RNA, Small Interfering/*genetics
MH  - Sequence Analysis, RNA/methods
MH  - *Software
PMC - PMC5416823
MID - NIHMS845086
EDAT- 2017/03/07 06:00
MHDA- 2017/06/07 06:00
CRDT- 2017/03/07 06:00
PHST- 2016/10/21 00:00 [received]
PHST- 2017/01/18 00:00 [accepted]
PHST- 2017/03/07 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2017/03/07 06:00 [entrez]
AID - nbt.3807 [pii]
AID - 10.1038/nbt.3807 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr;35(4):350-353. doi: 10.1038/nbt.3807. Epub 2017 Mar 6.

PMID- 28191901
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 4
DP  - 2017 Apr
TI  - Increasing the genome-targeting scope and precision of base editing with
      engineered Cas9-cytidine deaminase fusions.
PG  - 371-376
LID - 10.1038/nbt.3803 [doi]
AB  - Base editing induces single-nucleotide changes in the DNA of living cells using a
      fusion protein containing a catalytically defective Streptococcus pyogenes Cas9, 
      a cytidine deaminase, and an inhibitor of base excision repair. This genome
      editing approach has the advantage that it does not require formation of
      double-stranded DNA breaks or provision of a donor DNA template. Here we report
      the development of five C to T (or G to A) base editors that use natural and
      engineered Cas9 variants with different protospacer-adjacent motif (PAM)
      specificities to expand the number of sites that can be targeted by base editing 
      2.5-fold. Additionally, we engineered base editors containing mutated cytidine
      deaminase domains that narrow the width of the editing window from approximately 
      5 nucleotides to as little as 1-2 nucleotides. We thereby enabled discrimination 
      of neighboring C nucleotides, which would otherwise be edited with similar
      efficiency, and doubled the number of disease-associated target Cs able to be
      corrected preferentially over nearby non-target Cs.
FAU - Kim, Y Bill
AU  - Kim YB
AD  - Department of Chemistry and Chemical Biology, Harvard University, Cambridge,
      Massachusetts, USA.
AD  - Howard Hughes Medical Institute, Harvard University, Cambridge, Massachusetts,
      USA.
FAU - Komor, Alexis C
AU  - Komor AC
AD  - Department of Chemistry and Chemical Biology, Harvard University, Cambridge,
      Massachusetts, USA.
AD  - Howard Hughes Medical Institute, Harvard University, Cambridge, Massachusetts,
      USA.
FAU - Levy, Jonathan M
AU  - Levy JM
AUID- ORCID: 0000-0002-8061-7953
AD  - Department of Chemistry and Chemical Biology, Harvard University, Cambridge,
      Massachusetts, USA.
AD  - Howard Hughes Medical Institute, Harvard University, Cambridge, Massachusetts,
      USA.
FAU - Packer, Michael S
AU  - Packer MS
AD  - Department of Chemistry and Chemical Biology, Harvard University, Cambridge,
      Massachusetts, USA.
AD  - Howard Hughes Medical Institute, Harvard University, Cambridge, Massachusetts,
      USA.
FAU - Zhao, Kevin T
AU  - Zhao KT
AD  - Department of Chemistry and Chemical Biology, Harvard University, Cambridge,
      Massachusetts, USA.
AD  - Howard Hughes Medical Institute, Harvard University, Cambridge, Massachusetts,
      USA.
FAU - Liu, David R
AU  - Liu DR
AD  - Department of Chemistry and Chemical Biology, Harvard University, Cambridge,
      Massachusetts, USA.
AD  - Howard Hughes Medical Institute, Harvard University, Cambridge, Massachusetts,
      USA.
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
LA  - eng
GR  - R35 GM118062/GM/NIGMS NIH HHS/United States
GR  - HHMI/Howard Hughes Medical Institute/United States
GR  - R01 GM065400/GM/NIGMS NIH HHS/United States
GR  - F32 GM112366/GM/NIGMS NIH HHS/United States
GR  - T32 GM008313/GM/NIGMS NIH HHS/United States
GR  - R01 EB022376/EB/NIBIB NIH HHS/United States
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20170213
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Bacterial Proteins)
RN  - 0 (Recombinant Fusion Proteins)
RN  - EC 3.1.- (Cas9 endonuclease Streptococcus pyogenes)
RN  - EC 3.1.- (Endonucleases)
RN  - EC 3.5.4.5 (Cytidine Deaminase)
SB  - IM
CIN - Nat Biotechnol. 2017 May 9;35(5):428-429. PMID: 28486457
MH  - Bacterial Proteins/*genetics
MH  - Base Composition/genetics
MH  - Clustered Regularly Interspaced Short Palindromic Repeats/*genetics
MH  - Cytidine Deaminase/*genetics
MH  - Endonucleases/*genetics
MH  - Gene Editing/*methods
MH  - Genome/*genetics
MH  - Recombinant Fusion Proteins/*genetics
PMC - PMC5388574
MID - NIHMS847628
EDAT- 2017/02/14 06:00
MHDA- 2017/06/07 06:00
CRDT- 2017/02/14 06:00
PHST- 2016/10/23 00:00 [received]
PHST- 2017/01/27 00:00 [accepted]
PHST- 2017/02/14 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2017/02/14 06:00 [entrez]
AID - nbt.3803 [pii]
AID - 10.1038/nbt.3803 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Apr;35(4):371-376. doi: 10.1038/nbt.3803. Epub 2017 Feb 13.

PMID- 28267741
OWN - NLM
STAT- MEDLINE
DCOM- 20180302
LR  - 20180302
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 3
DP  - 2017 Mar 7
TI  - Hearing in the mouse of Usher.
PG  - 216-218
LID - 10.1038/nbt.3815 [doi]
FAU - Brigande, John V
AU  - Brigande JV
AD  - Oregon Hearing Research Center, Department of Otolaryngology, Oregon Health
      &Science University, Portland, Oregon, USA.
LA  - eng
GR  - R01 DC014160/DC/NIDCD NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2017 Mar;35(3):280-284. PMID: 28165475
CON - Nat Biotechnol. 2017 Mar;35(3):264-272. PMID: 28165476
MH  - Animals
MH  - *Hearing Loss, Sensorineural
MH  - Mice
MH  - *Mutation
MH  - Usher Syndromes
PMC - PMC5467449
MID - NIHMS866122
EDAT- 2017/03/08 06:00
MHDA- 2018/03/03 06:00
CRDT- 2017/03/08 06:00
PHST- 2017/03/08 06:00 [entrez]
PHST- 2017/03/08 06:00 [pubmed]
PHST- 2018/03/03 06:00 [medline]
AID - nbt.3815 [pii]
AID - 10.1038/nbt.3815 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Mar 7;35(3):216-218. doi: 10.1038/nbt.3815.

PMID- 28267740
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180301
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 3
DP  - 2017 Mar 7
TI  - New York spreads the news with $1.15 billion biotech plan.
PG  - 191
LID - 10.1038/nbt0317-191 [doi]
FAU - Naik, Gautam
AU  - Naik G
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/03/08 06:00
MHDA- 2017/03/08 06:01
CRDT- 2017/03/08 06:00
PHST- 2017/03/08 06:00 [entrez]
PHST- 2017/03/08 06:00 [pubmed]
PHST- 2017/03/08 06:01 [medline]
AID - nbt0317-191 [pii]
AID - 10.1038/nbt0317-191 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Mar 7;35(3):191. doi: 10.1038/nbt0317-191.

PMID- 28267738
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180301
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 3
DP  - 2017 Mar 7
TI  - Around the world in a month.
PG  - 192
LID - 10.1038/nbt0317-192 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/03/08 06:00
MHDA- 2017/03/08 06:01
CRDT- 2017/03/08 06:00
PHST- 2017/03/08 06:00 [entrez]
PHST- 2017/03/08 06:00 [pubmed]
PHST- 2017/03/08 06:01 [medline]
AID - nbt0317-192 [pii]
AID - 10.1038/nbt0317-192 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Mar 7;35(3):192. doi: 10.1038/nbt0317-192.

PMID- 28267737
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180301
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 3
DP  - 2017 Mar 7
TI  - Recent patents in chimeric antigen receptors.
PG  - 215
LID - 10.1038/nbt.3832 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/03/08 06:00
MHDA- 2017/03/08 06:01
CRDT- 2017/03/08 06:00
PHST- 2017/03/08 06:00 [entrez]
PHST- 2017/03/08 06:00 [pubmed]
PHST- 2017/03/08 06:01 [medline]
AID - nbt.3832 [pii]
AID - 10.1038/nbt.3832 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Mar 7;35(3):215. doi: 10.1038/nbt.3832.

PMID- 28267736
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180301
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 3
DP  - 2017 Mar 7
TI  - Gender tokenism and bias prevail in biotech boardrooms.
PG  - 185-186
LID - 10.1038/nbt0317-185 [doi]
FAU - Dolgin, Elie
AU  - Dolgin E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/03/08 06:00
MHDA- 2017/03/08 06:01
CRDT- 2017/03/08 06:00
PHST- 2017/03/08 06:00 [entrez]
PHST- 2017/03/08 06:00 [pubmed]
PHST- 2017/03/08 06:01 [medline]
AID - nbt0317-185 [pii]
AID - 10.1038/nbt0317-185 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Mar 7;35(3):185-186. doi: 10.1038/nbt0317-185.

PMID- 28267735
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180301
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 3
DP  - 2017 Mar 7
TI  - First Rounders podcast: Stephen Quake.
PG  - 192
LID - 10.1038/nbt.3808 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/03/08 06:00
MHDA- 2017/03/08 06:01
CRDT- 2017/03/08 06:00
PHST- 2017/03/08 06:00 [entrez]
PHST- 2017/03/08 06:00 [pubmed]
PHST- 2017/03/08 06:01 [medline]
AID - nbt.3808 [pii]
AID - 10.1038/nbt.3808 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Mar 7;35(3):192. doi: 10.1038/nbt.3808.

PMID- 28267734
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180301
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 3
DP  - 2017 Mar 7
TI  - International mentoring as a new educational approach to alleviate brain drain,
      empower young talent, and internationalize higher education.
PG  - 285-288
LID - 10.1038/nbt.3822 [doi]
FAU - Soriano-Carot, Maria
AU  - Soriano-Carot M
AD  - International Mentoring Foundation for the Advancement of Higher Education,
      Dedham, Massachusetts, USA.
FAU - Breton-Romero, Rosa
AU  - Breton-Romero R
AD  - International Mentoring Foundation for the Advancement of Higher Education,
      Dedham, Massachusetts, USA.
FAU - Lopez-Herraiz, Joaquin
AU  - Lopez-Herraiz J
AD  - International Mentoring Foundation for the Advancement of Higher Education,
      Dedham, Massachusetts, USA.
FAU - Lopez-Diego, Rocio
AU  - Lopez-Diego R
AD  - International Mentoring Foundation for the Advancement of Higher Education,
      Dedham, Massachusetts, USA.
FAU - Suarez-Fueyo, Abel
AU  - Suarez-Fueyo A
AD  - International Mentoring Foundation for the Advancement of Higher Education,
      Dedham, Massachusetts, USA.
FAU - Prades, Gemma Pellissa
AU  - Prades GP
AD  - International Mentoring Foundation for the Advancement of Higher Education,
      Dedham, Massachusetts, USA.
FAU - Fernandez-Godino, Rosario
AU  - Fernandez-Godino R
AD  - International Mentoring Foundation for the Advancement of Higher Education,
      Dedham, Massachusetts, USA.
FAU - Navarro-Gomez, Daniel
AU  - Navarro-Gomez D
AD  - International Mentoring Foundation for the Advancement of Higher Education,
      Dedham, Massachusetts, USA.
FAU - Saguar, Amaranta
AU  - Saguar A
AD  - International Mentoring Foundation for the Advancement of Higher Education,
      Dedham, Massachusetts, USA.
FAU - Nieto, David
AU  - Nieto D
AD  - International Mentoring Foundation for the Advancement of Higher Education,
      Dedham, Massachusetts, USA.
FAU - Sanchez-Garcia, Laura
AU  - Sanchez-Garcia L
AD  - International Mentoring Foundation for the Advancement of Higher Education,
      Dedham, Massachusetts, USA.
FAU - Peropadre, Borja
AU  - Peropadre B
AD  - International Mentoring Foundation for the Advancement of Higher Education,
      Dedham, Massachusetts, USA.
FAU - Castano, Zafira
AU  - Castano Z
AD  - International Mentoring Foundation for the Advancement of Higher Education,
      Dedham, Massachusetts, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/03/08 06:00
MHDA- 2017/03/08 06:01
CRDT- 2017/03/08 06:00
PHST- 2017/03/08 06:00 [entrez]
PHST- 2017/03/08 06:00 [pubmed]
PHST- 2017/03/08 06:01 [medline]
AID - nbt.3822 [pii]
AID - 10.1038/nbt.3822 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Mar 7;35(3):285-288. doi: 10.1038/nbt.3822.

PMID- 28267733
OWN - NLM
STAT- MEDLINE
DCOM- 20180309
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 3
DP  - 2017 Mar 7
TI  - US immigration order strikes against biotech.
PG  - 204-206
LID - 10.1038/nbt.3824 [doi]
FAU - Levin, Jeremy M
AU  - Levin JM
AD  - Ovid Therapeutics, New York, New York, USA.
FAU - Holtzman, Steven H
AU  - Holtzman SH
AD  - Decibel Therapeutics, Cambridge, Massachusetts, USA.
FAU - Maraganore, John
AU  - Maraganore J
AD  - Alnylam Pharmaceuticals, Cambridge, Massachusetts, USA.
FAU - Hastings, Paul J
AU  - Hastings PJ
AD  - OncoMed Pharmaceuticals, Redwood City, California, USA.
FAU - Cohen, Ron
AU  - Cohen R
AD  - Acorda Therapeutics, Inc., Ardsley, New York, USA.
FAU - Dahiyat, Bassil
AU  - Dahiyat B
AD  - Xencor, Monrovia, California, USA.
FAU - Adams, Julian
AU  - Adams J
AD  - Clal Biotechnology Industries (CBI), Cambridge, Massachusetts, USA.
FAU - Adams, Chris
AU  - Adams C
AD  - Cydan Development Inc., Cambridge, Massachusetts, USA.
FAU - Ahrens, Brett
AU  - Ahrens B
AD  - Canaan Partners, Menlo Park, California, USA.
FAU - Albers, Jeff
AU  - Albers J
AD  - Blueprint Medicines, Cambridge, Massachusetts, USA.
FAU - Aspinall, Mara G
AU  - Aspinall MG
AD  - Health Catalysts, Tucson, Arizona, USA.
FAU - Audia, James E
AU  - Audia JE
AD  - Constellation Pharmaceuticals, Inc., Cambridge, Massachusetts, USA.
FAU - Babler, Martin
AU  - Babler M
AD  - Principia Biopharma, South San Francisco, California, USA.
FAU - Barrett, Peter
AU  - Barrett P
AD  - Atlas Venture, Cambridge, Massachusetts, USA.
FAU - Barry, Zoe
AU  - Barry Z
AD  - ZappRx, Boston, Massachusetts, USA.
FAU - Bermingham, Nessan
AU  - Bermingham N
AD  - Intellia Therapeutics, Cambridge, Massachusetts, USA.
FAU - Bloch, Stephen
AU  - Bloch S
AD  - Canaan Partners, Westport, Connecticut, USA.
FAU - Blum, Robert I
AU  - Blum RI
AD  - Cytokinetics, Inc., South San Francisco, California, USA.
FAU - Bolno, Paul B
AU  - Bolno PB
AD  - Wave Life Sciences, Cambridge, Massachusetts, USA.
FAU - Bonney, Michael W
AU  - Bonney MW
AD  - Alnylam Pharmaceuticals, Cambridge, Massachusetts, USA.
FAU - Booth, Bruce
AU  - Booth B
AD  - Atlas Venture, Cambridge, Massachusetts, USA.
FAU - Bradbury, Daniel M
AU  - Bradbury DM
AD  - Amylin Pharmaceuticals, San Diego, California, USA.
FAU - Brauer, Steven K
AU  - Brauer SK
AD  - Salus Discovery LLC, San Diego, California, USA.
FAU - Byers, Brook
AU  - Byers B
AD  - Biotech Venture Capitalist since 1978, Menlo Park, California, USA.
FAU - Cagnoni, Pablo J
AU  - Cagnoni PJ
AD  - Tizona Therapeutics, Inc., South San Francisco, California, USA.
FAU - Cali, Brian M
AU  - Cali BM
AD  - Ironwood Pharmaceuticals, Cambridge, Massachusetts, USA.
FAU - Ciechanover, Isaac
AU  - Ciechanover I
AD  - Atara Bio, South San Francisco, California, USA.
FAU - Clark, Chip
AU  - Clark C
AD  - Genocea Biosciences, Inc., Cambridge, Massachusetts, USA.
FAU - Clayman, Michael D
AU  - Clayman MD
AD  - Flexion Therapeutics, Burlington, Massachusetts, USA.
FAU - Cleland, Jeff L
AU  - Cleland JL
AD  - Graybug Vision, Redwood City, California, USA.
FAU - Cobb, Paula
AU  - Cobb P
AD  - Decibel Therapeutics, Cambridge, Massachusetts, USA.
FAU - Cooper, Ron
AU  - Cooper R
AD  - Albireo Pharma Inc., Boston, Massachusetts, USA.
FAU - Currie, Mark G
AU  - Currie MG
AD  - Ironwood Pharmaceuticals, Cambridge, Massachusetts, USA.
FAU - Diekman, John
AU  - Diekman J
AD  - 5AM Ventures, Boston, Massachusetts, USA.
FAU - Dobmeier, Eric L
AU  - Dobmeier EL
AD  - Seattle Genetics, Bothell, Washington, USA.
FAU - Doerfler, Doug
AU  - Doerfler D
AD  - MaxCyte, Inc., Gaithersburg, Maryland, USA.
FAU - Donley, Elizabeth Lr
AU  - Donley EL
AD  - NeuroPoint Dx, Madison, Wisconsin, USA.
FAU - Dunsire, Deborah
AU  - Dunsire D
AD  - Southern Cross Biotech Consulting, Waltham, Massachusetts, USA.
FAU - During, Matthew
AU  - During M
AD  - Ovid Therapeutics, New York, New York, USA.
FAU - Eckstein, Jens W
AU  - Eckstein JW
AD  - SR One, Conshohocken, Pennsylvania, USA.
FAU - Elenko, Eric
AU  - Elenko E
AD  - PureTech Health, Boston, Massachusetts, USA.
FAU - Exter, Neil A
AU  - Exter NA
AD  - Third Rock Ventures, Boston, Massachusetts, USA.
FAU - Fleming, Jonathan J
AU  - Fleming JJ
AD  - Q-State Biosciences, Cambridge, Massachusetts, USA.
FAU - Flesher, Gregory J
AU  - Flesher GJ
AD  - OticPharma Inc., Irvine, California, USA.
FAU - Formela, Jean-Francois
AU  - Formela JF
AD  - Atlas Venture, Cambridge, Massachusetts, USA.
FAU - Forrester, Robert
AU  - Forrester R
AD  - Verastem Inc., Needham, Massachusetts, USA.
FAU - Francois, Cedric
AU  - Francois C
AD  - Apellis Pharmaceuticals, Crestwood, Kentucky, USA.
FAU - Franklin, Heather
AU  - Franklin H
AD  - Blaze Bioscience Inc., Seattle, Washington, USA.
FAU - Freeman, Mason W
AU  - Freeman MW
AD  - 5AM Ventures, Boston, Massachusetts, USA.
FAU - Furst, Howard
AU  - Furst H
AD  - Deerfield Management, New York, New York, USA.
FAU - Gage, Leonard Patrick
AU  - Gage LP
AD  - Tetraphase, Watertown, Massachusetts, USA.
FAU - Galakatos, Nicholas
AU  - Galakatos N
AD  - Clarus, Cambridge, Massachusetts, USA.
FAU - Gallagher, Brian M
AU  - Gallagher BM
AD  - SR One, Ltd., Cambridge, Massachusetts, USA.
FAU - Geraghty, James A
AU  - Geraghty JA
AD  - Juniper Pharmaceuticals, Boston, Massachusetts, USA.
FAU - Gill, Simba
AU  - Gill S
AD  - Evelo Biosciences, Cambridge, Massachusetts, USA.
FAU - Goeddel, David V
AU  - Goeddel DV
AD  - The Column Group, San Francisco, California, USA.
FAU - Goldsmith, Mark A
AU  - Goldsmith MA
AD  - Revolution Medicines, Inc., Redwood City, California, USA.
FAU - Gowen, Maxine
AU  - Gowen M
AD  - Trevena Inc., King of Prussia, Pennsylvania, USA.
FAU - Goyal, Vikas
AU  - Goyal V
AD  - SR One, Ltd., Cambridge, Massachusetts, USA.
FAU - Graney, Tom
AU  - Graney T
AD  - Ironwood Pharmaceuticals, Cambridge, Massachusetts, USA.
FAU - Grayzel, David
AU  - Grayzel D
AD  - Atlas Venture, Cambridge, Massachusetts, USA.
FAU - Greene, Barry
AU  - Greene B
AD  - Alnylam Pharmaceuticals, Cambridge, Massachusetts, USA.
FAU - Grint, Paul
AU  - Grint P
AD  - Regulus Therapeutics, San Diego, California, USA.
FAU - Gutierrez-Ramos, J C
AU  - Gutierrez-Ramos JC
AD  - Synlogic, Cambridge, Massachusetts, USA.
FAU - Haney, Bill
AU  - Haney B
AD  - Dragonfly Therapeutics, Inc., Cambridge, Massachusetts, USA.
FAU - Ha-Ngoc, Tuan
AU  - Ha-Ngoc T
AD  - KEW, Inc., Cambridge, Massachusetts, USA.
FAU - Harris, Tim
AU  - Harris T
AD  - SV Life Sciences, Boston, Massachusetts, USA.
FAU - Hasnain, Faheem
AU  - Hasnain F
AD  - FSG Biotech, San Diego, California, USA.
FAU - Hata, Yujiro Steve
AU  - Hata YS
AD  - IDEAYA Biosciences, South San Francisco, California, USA.
FAU - Hecht, Peter
AU  - Hecht P
AD  - Ironwood Pharmaceuticals, Cambridge, Massachusetts, USA.
FAU - Henshaw, Leslie
AU  - Henshaw L
AD  - Deerfield Management, New York, New York, USA.
FAU - Heyman, Rich
AU  - Heyman R
AD  - Metacrine, Inc., San Diego, California, USA.
FAU - Hoppenot, Herve
AU  - Hoppenot H
AD  - Incyte, Wilmington, Delaware, USA.
FAU - Horvitz, H Robert
AU  - Horvitz HR
AD  - Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
FAU - Hughes, Thomas E
AU  - Hughes TE
AD  - Zafgen, Inc., Boston, Massachusetts, USA.
FAU - Hutton, Wende S
AU  - Hutton WS
AD  - Canaan Partners, Menlo Park, California, USA.
FAU - Isaacs, Stephen T
AU  - Isaacs ST
AD  - Aduro Biotech, Berkley, California, USA.
FAU - Jenkins, Annalisa
AU  - Jenkins A
AD  - Dimension Therapeutics, Cambridge, Massachusetts, USA.
FAU - Jonker, Jeff
AU  - Jonker J
AD  - NGM Biopharmaceuticals, Inc., South San Francisco, California, USA.
FAU - Kaplan, Jeff
AU  - Kaplan J
AD  - Deerfield Management, New York, New York, USA.
FAU - Karsen, Perry
AU  - Karsen P
AD  - Intellia Therapeutics, Cambridge, Massachusetts, USA.
FAU - Keiper, Jeb
AU  - Keiper J
AD  - Nimbus Therapeutics, Cambridge, Massachusetts, USA.
FAU - Kim, Jean
AU  - Kim J
AD  - Deerfield Management, New York, New York, USA.
FAU - Kindler, Jeff
AU  - Kindler J
AD  - Centrexion Therapeutics Inc., Boston, Massachusetts, USA.
FAU - King, Rachel
AU  - King R
AD  - GlycoMimetics, Inc., Rockville, Maryland, USA.
FAU - King, Vanessa
AU  - King V
AD  - Luc Therapeutics, Inc., Cambridge, Massachusetts, USA.
FAU - Kjellson, Nina
AU  - Kjellson N
AD  - Canaan Partners, Menlo Park, California, USA.
FAU - Koenig, Scott
AU  - Koenig S
AD  - MacroGenics, Inc., Rockville, Maryland, USA.
FAU - Koenig, Gerhard
AU  - Koenig G
AD  - Quartet Medicine, Cambridge, Massachusetts, USA.
FAU - Kolchinsky, Peter
AU  - Kolchinsky P
AD  - RA Capital Management, LLC, Boston, Massachusetts, USA.
FAU - Laikind, Paul
AU  - Laikind P
AD  - ViaCyte, Inc., San Diego, California, USA.
FAU - Langer, Robert Bob
AU  - Langer RB
AD  - Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
FAU - Lee, John J
AU  - Lee JJ
AD  - Decibel Therapeutics, Cambridge, Massachusetts, USA.
FAU - Leff, Jonathan S
AU  - Leff JS
AD  - Deerfield Management, New York, New York, USA.
FAU - Leicher, Bruce A
AU  - Leicher BA
AD  - Momenta Pharmaceuticals, Inc., Cambridge, Massachusetts, USA.
FAU - Leschly, Nick
AU  - Leschly N
AD  - Bluebird Bio, Cambridge, Massachusetts, USA.
FAU - Levin, Andrew
AU  - Levin A
AD  - RA Capital Management, LLC, Boston, Massachusetts, USA.
FAU - Levin, Mark
AU  - Levin M
AD  - Third Rock Ventures, Boston, Massachusetts, USA.
FAU - Levine, Arnold J
AU  - Levine AJ
AD  - Institute for Advanced Study, Princeton, New Jersey, USA.
FAU - Levy, Alan
AU  - Levy A
AD  - Chrono Therapeutics, Hayward, California, USA.
FAU - Liu, David R
AU  - Liu DR
AD  - Editas Medicine, Cambridge, Massachusetts, USA.
FAU - Lodish, Harvey F
AU  - Lodish HF
AD  - Whitehead Institute MIT, Cambridge, Massachusetts, USA.
FAU - Lopatin, Uri
AU  - Lopatin U
AD  - Assembly Biosciences, Carmel, Indiana, USA.
FAU - Love, Ted W
AU  - Love TW
AD  - Global Blood Therapeutics, South San Francisco, California, USA.
FAU - Macdonald, Guy
AU  - Macdonald G
AD  - Tetraphase, Watertown, Massachusetts, USA.
FAU - Maderis, Gail J
AU  - Maderis GJ
AD  - Antiva Biosciences, Inc., South San Francisco, California, USA.
FAU - Mahadevia, Ankit
AU  - Mahadevia A
AD  - Spero Therapeutics, Cambridge, Massachusetts, USA.
FAU - Mahanthappa, Nagesh K
AU  - Mahanthappa NK
AD  - Scholar Rock, Cambridge, Massachusetts, USA.
FAU - Martin, Joel F
AU  - Martin JF
AD  - Dauntless Pharmaceuticals, Inc., San Diego, California, USA.
FAU - Martin, Alex
AU  - Martin A
AD  - Realm Therapeutics, Malvern, Pennsylvania, USA.
FAU - Martucci, W Eddie
AU  - Martucci WE
AD  - Akili Interactive, Boston, Massachusetts, USA.
FAU - McArthur, James G
AU  - McArthur JG
AD  - Imara, Cambridge, Massachusetts, USA.
FAU - McCann, Corey M
AU  - McCann CM
AD  - Pear Therapeutics, Boston, Massachusetts, USA.
FAU - McCarthy, Sean A
AU  - McCarthy SA
AD  - CytomX, South San Francisco, California, USA.
FAU - McDonough, C Geoffrey
AU  - McDonough CG
AD  - Sobi, Waltham, Massachusetts, USA.
FAU - Mendlein, John
AU  - Mendlein J
AD  - aTyr Pharma, San Diego, California, USA.
FAU - Miller, Larry
AU  - Miller L
AD  - Macrolide Pharmaceuticals, Watertown, Massachusetts, USA.
FAU - Miralles, Diego
AU  - Miralles D
AD  - Adaptive Biotechnologies, Seattle, Washington, USA.
FAU - Moch, Kenneth I
AU  - Moch KI
AD  - Cognition Therapeutics, Inc., Pittsburgh, Pennsylvania, USA.
FAU - More, Bob
AU  - More B
AD  - Alta Partners, San Francisco, California, USA.
FAU - Myers, Andrew G
AU  - Myers AG
AD  - Harvard University, Cambridge, Massachusetts, USA.
FAU - Narachi, Michael A
AU  - Narachi MA
AD  - Orexigen Therapeutics, La Jolla, California, USA.
FAU - Nashat, Amir
AU  - Nashat A
AD  - Polaris Partners, Boston, Massachusetts, USA.
FAU - Nelson, Wendy
AU  - Nelson W
AD  - Boston Biotech Forum, Cambridge, Massachusetts, USA.
FAU - Newell, William J
AU  - Newell WJ
AD  - Sutro Biopharma, Inc., South San Francisco, California, USA.
FAU - Olle, Bernat
AU  - Olle B
AD  - Vedanta Biosciences, Inc., Cambridge, Massachusetts, USA.
FAU - Osborn, John E
AU  - Osborn JE
AD  - Egalet, Wayne, Pennsylvania, USA.
FAU - Owens, Julia C
AU  - Owens JC
AD  - Millendo Therapeutics, Inc., Ann Arbor, Michigan, USA.
FAU - Pande, Atul
AU  - Pande A
AD  - Verity BioConsulting, San Diego, California, USA.
FAU - Papadopoulos, Stelios
AU  - Papadopoulos S
AD  - Biogen Inc., Exelixis Inc. &Regulus Therapeutics Inc., Great Neck, New York, USA.
FAU - Parker, H Stewart
AU  - Parker HS
AD  - Parker BioConsulting, Seattle, Washington, USA.
FAU - Parmar, Kush M
AU  - Parmar KM
AD  - 5AM Ventures, Boston, Massachusetts, USA.
FAU - Patterson, Matthew R
AU  - Patterson MR
AD  - Audentes Therapeutics, Inc., San Francisco, California, USA.
FAU - Paul, Steve M
AU  - Paul SM
AD  - Voyager Therapeutics, Inc., Cambridge, Massachusetts, USA.
FAU - Perez, Rob
AU  - Perez R
AD  - Life Science Cares, Boston, Massachusetts, USA.
FAU - Perry, Matthew
AU  - Perry M
AD  - BVF Partners, LP, San Francisco, California, USA.
FAU - Pfeffer, Cary G
AU  - Pfeffer CG
AD  - Third Rock Ventures, Boston, Massachusetts, USA.
FAU - Powell, Mike
AU  - Powell M
AD  - Sofinnova Ventures, Menlo Park, California, USA.
FAU - Pruzanski, Mark
AU  - Pruzanski M
AD  - Intercept Pharma, New York, New York, USA.
FAU - Purcell, Dennis J
AU  - Purcell DJ
AD  - Aisling Capital, New York, New York, USA.
FAU - Rakhit, Amit
AU  - Rakhit A
AD  - Ovid Therapeutics, New York, New York, USA.
FAU - Ramamoorthi, Kartik
AU  - Ramamoorthi K
AD  - Encoded Genomics, South San Francisco, California, USA.
FAU - Rastetter, William
AU  - Rastetter W
AD  - Neurocrine Biosciences Inc., San Diego, California, USA.
FAU - Rawcliffe, Adrian Ad
AU  - Rawcliffe AA
AD  - Adaptimmune, Philadelphia, Pennsylvania, USA.
FAU - Reid, Laurence E
AU  - Reid LE
AD  - Warp Drive Bio, Cambridge, Massachusetts, USA.
FAU - Renaud, Ron C
AU  - Renaud RC
AD  - RaNa Therapeutics, Cambridge, Massachusetts, USA.
FAU - Rhodes, Jason P
AU  - Rhodes JP
AD  - Atlas Venture, Cambridge, Massachusetts, USA.
FAU - Rieflin, William J
AU  - Rieflin WJ
AD  - NGM Biopharmaceuticals, Inc., South San Francisco, California, USA.
FAU - Robins, Chad
AU  - Robins C
AD  - Adaptive Biotechnologies, Seattle, Washington, USA.
FAU - Rocklage, Scott M
AU  - Rocklage SM
AD  - 5AM Ventures, San Francisco, California, USA.
FAU - Rosenblatt, Michael
AU  - Rosenblatt M
AD  - Flagship Pioneering, Cambridge, Massachusetts, USA.
FAU - Rosin, Jonathan G
AU  - Rosin JG
AD  - Ironwood Pharmaceuticals, Cambridge, Massachusetts, USA.
FAU - Rutter, William J
AU  - Rutter WJ
AD  - Synergenics, LLC, San Francisco, California, USA.
FAU - Saha, Saurabh
AU  - Saha S
AD  - Delinia, Cambridge, Massachusetts, USA.
FAU - Samuels, Camille
AU  - Samuels C
AD  - Venrock, Palo Alto, California, USA.
FAU - Sato, Vicki L
AU  - Sato VL
AD  - Harvard Business School, Cambridge, Massachusetts, USA.
FAU - Scangos, George
AU  - Scangos G
AD  - Vir Bio, San Francisco, California, USA.
FAU - Scarlett, John A
AU  - Scarlett JA
AD  - Geron Corporation, Menlo Park, California, USA.
FAU - Schenkein, David
AU  - Schenkein D
AD  - Agios, Cambridge, Massachusetts, USA.
FAU - Schreiber, Stuart L
AU  - Schreiber SL
AD  - Broad Institute, Cambridge, Massachusetts, USA.
FAU - Schwab, Andrew
AU  - Schwab A
AD  - 5AM Ventures, San Francisco, California, USA.
FAU - Sekhri, Paul
AU  - Sekhri P
AD  - Lycera Corporation, New York, New York, USA.
FAU - Shah, Rajeev
AU  - Shah R
AD  - RA Capital Management, LLC, Boston, Massachusetts, USA.
FAU - Shenk, Thomas
AU  - Shenk T
AD  - Lewis Thomas Laboratory, Princeton, New Jersey, USA.
FAU - Siegall, Clay B
AU  - Siegall CB
AD  - Seattle Genetics, Bothell, Washington, USA.
FAU - Simon, Nick J
AU  - Simon NJ
AD  - Clarus Ventures LLC, South San Francisco, California, USA.
FAU - Simonian, Nancy
AU  - Simonian N
AD  - Syros Pharmaceuticals, Cambridge, Massachusetts, USA.
FAU - Stein, Jeff
AU  - Stein J
AD  - Cidara Therapeutics, San Diego, California, USA.
FAU - Su, Michael
AU  - Su M
AD  - Decibel Therapeutics, Cambridge, Massachusetts, USA.
FAU - Szela, Mary T
AU  - Szela MT
AD  - Novelion Therapeutics, Vancouver, British Columbia, USA.
FAU - Taglietti, Marco
AU  - Taglietti M
AD  - SCYNEXIS, Inc., Jersey City, New Jersey, USA.
FAU - Tandon, Nina
AU  - Tandon N
AD  - EpiBone, Inc., New York, New York, USA.
FAU - Termeer, Henri
AU  - Termeer H
AD  - Genzyme Corporation (former CEO), Cambridge, Massachusetts, USA.
FAU - Thornberry, Nancy A
AU  - Thornberry NA
AD  - Kallyope, New York, New York, USA.
FAU - Tolar, Martin
AU  - Tolar M
AD  - Alzheon, Framingham, Massachusetts, USA.
FAU - Ulevitch, Richard
AU  - Ulevitch R
AD  - 5AM Ventures, La Jolla, California, USA.
FAU - Vaishnaw, Akshay K
AU  - Vaishnaw AK
AD  - Alnylam Pharmaceuticals, Cambridge, Massachusetts, USA.
FAU - VanLent, Anne
AU  - VanLent A
AD  - AMV Advisors, Princeton, New Jersey, USA.
FAU - Varsavsky, Martin
AU  - Varsavsky M
AD  - Prelude Fertility, Inc., Atlanta, Georgia, USA.
FAU - Vlasuk, George P
AU  - Vlasuk GP
AD  - Navitor Pharmaceuticals, Inc., Cambridge, Massachusetts, USA.
FAU - Vounatsos, Michel
AU  - Vounatsos M
AD  - Biogen, Cambridge, Massachusetts, USA.
FAU - Waksal, Samuel G
AU  - Waksal SG
AD  - MeiraGTx, New York, New York, USA.
FAU - Warma, Neil
AU  - Warma N
AD  - Opexa Therapeutics, Inc., The Woodlands, Texas, USA.
FAU - Watts, Ryan J
AU  - Watts RJ
AD  - Denali Therapeutics Inc., South San Francisco, California, USA.
FAU - Werber, Yaron
AU  - Werber Y
AD  - Ovid Therapeutics, New York, New York, USA.
FAU - Westphal, Christoph
AU  - Westphal C
AD  - Flex Pharma, Boston, Massachusetts, USA.
FAU - Wierenga, Wendell
AU  - Wierenga W
AD  - Crinetics Pharmaceuticals, San Diego, California, USA.
FAU - Williams, Doug E
AU  - Williams DE
AD  - Codiak BioSciences, Cambridge, Massachusetts, USA.
FAU - Williams, Lewis Rusty
AU  - Williams LR
AD  - Five Prime Therapeutics, Inc., South San Francisco, California, USA.
FAU - Xanthopoulos, Kleanthis G
AU  - Xanthopoulos KG
AD  - Cerus, La Jolla, California, USA.
FAU - Zohar, Daphne
AU  - Zohar D
AD  - PureTech Health, Boston, Massachusetts, USA.
FAU - Zweifach, Sandford Sandy
AU  - Zweifach SS
AD  - Nuvelution Pharmaceuticals, Inc., South San Francisco, California, USA.
LA  - eng
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*legislation & jurisprudence
MH  - Emigration and Immigration/*legislation & jurisprudence
MH  - Humans
MH  - Population Dynamics
MH  - Public Policy/*legislation & jurisprudence
EDAT- 2017/03/08 06:00
MHDA- 2018/03/10 06:00
CRDT- 2017/03/08 06:00
PHST- 2017/03/08 06:00 [entrez]
PHST- 2017/03/08 06:00 [pubmed]
PHST- 2018/03/10 06:00 [medline]
AID - nbt.3824 [pii]
AID - 10.1038/nbt.3824 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Mar 7;35(3):204-206. doi: 10.1038/nbt.3824.

PMID- 28267732
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180301
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 3
DP  - 2017 Mar 7
TI  - Merck KGaA lands four Vertex cancer programs.
PG  - 186
LID - 10.1038/nbt0317-186 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/03/08 06:00
MHDA- 2017/03/08 06:01
CRDT- 2017/03/08 06:00
PHST- 2017/03/08 06:00 [entrez]
PHST- 2017/03/08 06:00 [pubmed]
PHST- 2017/03/08 06:01 [medline]
AID - nbt0317-186 [pii]
AID - 10.1038/nbt0317-186 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Mar 7;35(3):186. doi: 10.1038/nbt0317-186.

PMID- 28267731
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20180302
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 3
DP  - 2017 Mar 7
TI  - Response to "Railroading at the FDA".
PG  - 207-209
LID - 10.1038/nbt.3819 [doi]
FAU - Muntoni, Francesco
AU  - Muntoni F
AD  - Dubowitz Neuromuscular Centre, Great Ormond Street Hospital for Children, Great
      Ormond Street, London, UK.
FAU - Fletcher, Sue
AU  - Fletcher S
AD  - Centre for Comparative Genomics, Murdoch University, Perth, Western Australia,
      Australia.
FAU - Wilton, Steve
AU  - Wilton S
AD  - Centre for Comparative Genomics, Murdoch University, Perth, Western Australia,
      Australia.
LA  - eng
PT  - Research Support, Non-U.S. Gov't
PT  - Letter
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
CON - Nat Biotechnol. 2016 Nov 8;34(11):1078. PMID: 27824847
EIN - Nat Biotechnol. 2017 May 9;35(5):481. PMID: 28486454
EDAT- 2017/03/08 06:00
MHDA- 2017/03/08 06:01
CRDT- 2017/03/08 06:00
PHST- 2017/03/08 06:00 [entrez]
PHST- 2017/03/08 06:00 [pubmed]
PHST- 2017/03/08 06:01 [medline]
AID - nbt.3819 [pii]
AID - 10.1038/nbt.3819 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Mar 7;35(3):207-209. doi: 10.1038/nbt.3819.

PMID- 28267730
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180301
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 3
DP  - 2017 Mar 7
TI  - Biogen pays Forward in Tecfidera dispute.
PG  - 189
LID - 10.1038/nbt0317-189c [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/03/08 06:00
MHDA- 2017/03/08 06:01
CRDT- 2017/03/08 06:00
PHST- 2017/03/08 06:00 [entrez]
PHST- 2017/03/08 06:00 [pubmed]
PHST- 2017/03/08 06:01 [medline]
AID - nbt0317-189c [pii]
AID - 10.1038/nbt0317-189c [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Mar 7;35(3):189. doi: 10.1038/nbt0317-189c.

PMID- 28267729
OWN - NLM
STAT- MEDLINE
DCOM- 20180302
LR  - 20180302
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 3
DP  - 2017 Mar 7
TI  - Fleeting factors, turning back time.
PG  - 218-220
LID - 10.1038/nbt.3817 [doi]
FAU - Rando, Thomas A
AU  - Rando TA
AD  - Glenn Center for the Biology of Aging at Stanford University, Stanford,
      California, USA.
LA  - eng
GR  - P01 AG036695/AG/NIA NIH HHS/United States
GR  - R01 AG047820/AG/NIA NIH HHS/United States
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Cell. 2016 Dec 15;167(7):1719-1733.e12. PMID: 27984723
MH  - Aging/*physiology
MH  - Animals
MH  - Gene Expression
MH  - Humans
MH  - Mice
EDAT- 2017/03/08 06:00
MHDA- 2018/03/03 06:00
CRDT- 2017/03/08 06:00
PHST- 2017/03/08 06:00 [entrez]
PHST- 2017/03/08 06:00 [pubmed]
PHST- 2018/03/03 06:00 [medline]
AID - nbt.3817 [pii]
AID - 10.1038/nbt.3817 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Mar 7;35(3):218-220. doi: 10.1038/nbt.3817.

PMID- 28267728
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180301
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 3
DP  - 2017 Mar 7
TI  - The alleles of a tasty tomato.
PG  - 220-221
LID - 10.1038/nbt.3814 [doi]
FAU - Marcinkiewicz, Katarzyna
AU  - Marcinkiewicz K
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/03/08 06:00
MHDA- 2017/03/08 06:01
CRDT- 2017/03/08 06:00
PHST- 2017/03/08 06:00 [entrez]
PHST- 2017/03/08 06:00 [pubmed]
PHST- 2017/03/08 06:01 [medline]
AID - nbt.3814 [pii]
AID - 10.1038/nbt.3814 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Mar 7;35(3):220-221. doi: 10.1038/nbt.3814.

PMID- 28267727
OWN - NLM
STAT- MEDLINE
DCOM- 20180309
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 3
DP  - 2017 Mar 7
TI  - Why axing TPP was a lost opportunity for biotech.
PG  - 206-207
LID - 10.1038/nbt.3821 [doi]
FAU - Noonan, Kevin E
AU  - Noonan KE
AD  - McDonnell Boehnen Hulbert &Berghoff, Chicago, Illinois, USA, and
      www.patentdocs.org.
LA  - eng
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/economics/*legislation & jurisprudence
MH  - Humans
MH  - International Cooperation/*legislation & jurisprudence
MH  - Public Policy/economics/*legislation & jurisprudence
MH  - United States
EDAT- 2017/03/08 06:00
MHDA- 2018/03/10 06:00
CRDT- 2017/03/08 06:00
PHST- 2017/03/08 06:00 [entrez]
PHST- 2017/03/08 06:00 [pubmed]
PHST- 2018/03/10 06:00 [medline]
AID - nbt.3821 [pii]
AID - 10.1038/nbt.3821 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Mar 7;35(3):206-207. doi: 10.1038/nbt.3821.

PMID- 28267726
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180301
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 3
DP  - 2017 Mar 7
TI  - Trump's pick rallies biosimilar makers.
PG  - 189
LID - 10.1038/nbt0317-189b [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/03/08 06:00
MHDA- 2017/03/08 06:01
CRDT- 2017/03/08 06:00
PHST- 2017/03/08 06:00 [entrez]
PHST- 2017/03/08 06:00 [pubmed]
PHST- 2017/03/08 06:01 [medline]
AID - nbt0317-189b [pii]
AID - 10.1038/nbt0317-189b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Mar 7;35(3):189. doi: 10.1038/nbt0317-189b.

PMID- 28267725
OWN - NLM
STAT- MEDLINE
DCOM- 20180309
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 3
DP  - 2017 Mar 7
TI  - Solithromycin rejection chills antibiotic sector.
PG  - 187-188
LID - 10.1038/nbt0317-187 [doi]
FAU - Owens, Brian
AU  - Owens B
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Anti-Bacterial Agents)
RN  - 0 (Macrolides)
RN  - 0 (Triazoles)
RN  - 9U1ETH79CK (solithromycin)
SB  - IM
MH  - Anti-Bacterial Agents/*adverse effects/therapeutic use
MH  - Chemical and Drug Induced Liver Injury/*pathology
MH  - Humans
MH  - Macrolides/*adverse effects/therapeutic use
MH  - Triazoles/*adverse effects/therapeutic use
MH  - United States
MH  - United States Food and Drug Administration
EDAT- 2017/03/08 06:00
MHDA- 2018/03/10 06:00
CRDT- 2017/03/08 06:00
PHST- 2017/03/08 06:00 [entrez]
PHST- 2017/03/08 06:00 [pubmed]
PHST- 2018/03/10 06:00 [medline]
AID - nbt0317-187 [pii]
AID - 10.1038/nbt0317-187 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Mar 7;35(3):187-188. doi: 10.1038/nbt0317-187.

PMID- 28267724
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180301
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 3
DP  - 2017 Mar 7
TI  - Billion-dollar deals end eras of Ariad and Actelion.
PG  - 183-184
LID - 10.1038/nbt0317-183 [doi]
FAU - Senior, Melanie
AU  - Senior M
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/03/08 06:00
MHDA- 2017/03/08 06:01
CRDT- 2017/03/08 06:00
PHST- 2017/03/08 06:00 [entrez]
PHST- 2017/03/08 06:00 [pubmed]
PHST- 2017/03/08 06:01 [medline]
AID - nbt0317-183 [pii]
AID - 10.1038/nbt0317-183 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Mar 7;35(3):183-184. doi: 10.1038/nbt0317-183.

PMID- 28267723
OWN - NLM
STAT- MEDLINE
DCOM- 20180309
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 3
DP  - 2017 Mar 7
TI  - Celgene eyes 'inverse vaccines' in Anokion and Delinia deals.
PG  - 189-190
LID - 10.1038/nbt0317-189a [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Immunologic Factors)
RN  - 0 (Vaccines)
SB  - IM
MH  - Autoimmune Diseases/*drug therapy
MH  - Drug Industry
MH  - Humans
MH  - Immune Tolerance/*drug effects/immunology
MH  - Immunologic Factors/*therapeutic use
MH  - Vaccines/therapeutic use
EDAT- 2017/03/08 06:00
MHDA- 2018/03/10 06:00
CRDT- 2017/03/08 06:00
PHST- 2017/03/08 06:00 [entrez]
PHST- 2017/03/08 06:00 [pubmed]
PHST- 2018/03/10 06:00 [medline]
AID - nbt0317-189a [pii]
AID - 10.1038/nbt0317-189a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Mar 7;35(3):189-190. doi: 10.1038/nbt0317-189a.

PMID- 28267722
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180301
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 3
DP  - 2017 Mar 7
TI  - CRISPR patents belong to Broad, says USPTO.
PG  - 184
LID - 10.1038/nbt0317-184 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/03/08 06:00
MHDA- 2017/03/08 06:01
CRDT- 2017/03/08 06:00
PHST- 2017/03/08 06:00 [entrez]
PHST- 2017/03/08 06:00 [pubmed]
PHST- 2017/03/08 06:01 [medline]
AID - nbt0317-184 [pii]
AID - 10.1038/nbt0317-184 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Mar 7;35(3):184. doi: 10.1038/nbt0317-184.

PMID- 28267720
OWN - NLM
STAT- MEDLINE
DCOM- 20180309
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 3
DP  - 2017 Mar 7
TI  - Evidence of insufficient quality of reporting in patent landscapes in the life
      sciences.
PG  - 210-214
LID - 10.1038/nbt.3809 [doi]
FAU - Smith, James A
AU  - Smith JA
AD  - Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences,
      University of Oxford, Oxford, UK.
AD  - The Oxford-UCL Centre for the Advancement of Sustainable Medical Innovation,
      University of Oxford, Oxford, UK.
FAU - Arshad, Zeeshaan
AU  - Arshad Z
AD  - The Oxford-UCL Centre for the Advancement of Sustainable Medical Innovation,
      University of Oxford, Oxford, UK.
AD  - School of Medicine, University of St. Andrews, St. Andrews, UK.
FAU - Thomas, Hannah
AU  - Thomas H
AD  - School of Medicine, University of St. Andrews, St. Andrews, UK.
FAU - Carr, Andrew J
AU  - Carr AJ
AD  - Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences,
      University of Oxford, Oxford, UK.
FAU - Brindley, David A
AU  - Brindley DA
AD  - The Oxford-UCL Centre for the Advancement of Sustainable Medical Innovation,
      University of Oxford, Oxford, UK.
AD  - Department of Paediatrics, University of Oxford, Oxford, UK.
LA  - eng
GR  - MC_PC_12020/Medical Research Council/United Kingdom
GR  - MC_PC_14103/Medical Research Council/United Kingdom
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biological Science Disciplines/*legislation & jurisprudence
MH  - Humans
MH  - Patents as Topic/*legislation & jurisprudence
EDAT- 2017/03/08 06:00
MHDA- 2018/03/10 06:00
CRDT- 2017/03/08 06:00
PHST- 2017/03/08 06:00 [entrez]
PHST- 2017/03/08 06:00 [pubmed]
PHST- 2018/03/10 06:00 [medline]
AID - nbt.3809 [pii]
AID - 10.1038/nbt.3809 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Mar 7;35(3):210-214. doi: 10.1038/nbt.3809.

PMID- 28267719
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180301
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 3
DP  - 2017 Mar 7
TI  - Top US universities, institutes for life sciences in 2015.
PG  - 203
LID - 10.1038/nbt.3818 [doi]
FAU - Huggett, Brady
AU  - Huggett B
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/03/08 06:00
MHDA- 2017/03/08 06:01
CRDT- 2017/03/08 06:00
PHST- 2017/03/08 06:00 [entrez]
PHST- 2017/03/08 06:00 [pubmed]
PHST- 2017/03/08 06:01 [medline]
AID - nbt.3818 [pii]
AID - 10.1038/nbt.3818 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Mar 7;35(3):203. doi: 10.1038/nbt.3818.

PMID- 28244998
OWN - NLM
STAT- MEDLINE
DCOM- 20180309
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 3
DP  - 2017 Mar
TI  - Worth the RISC?
PG  - 198-202
LID - 10.1038/nbt.3810 [doi]
FAU - Garber, Ken
AU  - Garber K
LA  - eng
PT  - News
DEP - 20170227
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (RNA, Small Interfering)
RN  - 0 (RNA-Induced Silencing Complex)
RN  - Amyloidosis, Hereditary, Transthyretin-Related
SB  - IM
MH  - Amyloid Neuropathies, Familial/genetics/*therapy
MH  - Humans
MH  - RNA, Small Interfering/genetics/*therapeutic use
MH  - RNA-Induced Silencing Complex/*genetics/immunology
EDAT- 2017/03/01 06:00
MHDA- 2018/03/10 06:00
CRDT- 2017/03/01 06:00
PHST- 2017/03/01 06:00 [pubmed]
PHST- 2018/03/10 06:00 [medline]
PHST- 2017/03/01 06:00 [entrez]
AID - nbt.3810 [pii]
AID - 10.1038/nbt.3810 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Mar;35(3):198-202. doi: 10.1038/nbt.3810. Epub 2017 Feb 27.

PMID- 28244997
OWN - NLM
STAT- MEDLINE
DCOM- 20180309
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 3
DP  - 2017 Mar
TI  - The commercial tipping point.
PG  - 708-709
LID - 10.1038/nbt.3829 [doi]
FAU - Huggett, Brady
AU  - Huggett B
AD  - Nature Biotechnology.
FAU - Paisner, Kathryn
AU  - Paisner K
LA  - eng
PT  - Editorial
DEP - 20170227
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Oligonucleotides, Antisense)
RN  - 0 (RNA, Small Interfering)
SB  - IM
MH  - Drug Discovery/trends
MH  - Drug Industry/*trends
MH  - Humans
MH  - Oligonucleotides, Antisense/*therapeutic use
MH  - RNA, Small Interfering/*therapeutic use
EDAT- 2017/03/01 06:00
MHDA- 2018/03/10 06:00
CRDT- 2017/03/01 06:00
PHST- 2017/03/01 06:00 [pubmed]
PHST- 2018/03/10 06:00 [medline]
PHST- 2017/03/01 06:00 [entrez]
AID - nbt.3829 [pii]
AID - 10.1038/nbt.3829 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Mar;35(3):708-709. doi: 10.1038/nbt.3829. Epub 2017 Feb 27.

PMID- 28244996
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 3
DP  - 2017 Mar
TI  - Cellular uptake and trafficking of antisense oligonucleotides.
PG  - 230-237
LID - 10.1038/nbt.3779 [doi]
AB  - Antisense oligonucleotides (ASOs) modified with phosphorothioate (PS) linkages
      and different 2' modifications can be used either as drugs (e.g., to treat
      homozygous familial hypercholesterolemia and spinal muscular atrophy) or as
      research tools to alter gene expression. PS-ASOs can enter cells without
      additional modification or formulation and can be designed to mediate
      sequence-specific cleavage of different types of RNA (including mRNA and
      non-coding RNA) targeted by endogenous RNase H1. Although PS-ASOs function in
      both the cytoplasm and nucleus, localization to different subcellular regions can
      affect their therapeutic potency. Cellular uptake and intracellular distribution 
      of PS ASOs are mediated by protein interactions. The main proteins involved in
      these processes have been identified, and intracellular sites in which PS ASOs
      are active, or inactive, cataloged.
FAU - Crooke, Stanley T
AU  - Crooke ST
AD  - Department of Core Antisense Research, Ionis Pharmaceuticals, Inc., Carlsbad,
      California, USA.
FAU - Wang, Shiyu
AU  - Wang S
AD  - Department of Core Antisense Research, Ionis Pharmaceuticals, Inc., Carlsbad,
      California, USA.
FAU - Vickers, Timothy A
AU  - Vickers TA
AD  - Department of Core Antisense Research, Ionis Pharmaceuticals, Inc., Carlsbad,
      California, USA.
FAU - Shen, Wen
AU  - Shen W
AD  - Department of Core Antisense Research, Ionis Pharmaceuticals, Inc., Carlsbad,
      California, USA.
FAU - Liang, Xue-Hai
AU  - Liang XH
AUID- ORCID: http://orcid.org/0000-0001-9333-8622
AD  - Department of Core Antisense Research, Ionis Pharmaceuticals, Inc., Carlsbad,
      California, USA.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20170227
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Oligonucleotides, Antisense)
SB  - IM
MH  - Animals
MH  - Cell Membrane/metabolism
MH  - Genetic Therapy/*methods
MH  - Humans
MH  - Oligonucleotides, Antisense/genetics/*pharmacokinetics/*therapeutic use
MH  - Structure-Activity Relationship
MH  - Subcellular Fractions/*metabolism
EDAT- 2017/03/01 06:00
MHDA- 2017/06/07 06:00
CRDT- 2017/03/01 06:00
PHST- 2016/06/07 00:00 [received]
PHST- 2016/12/22 00:00 [accepted]
PHST- 2017/03/01 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2017/03/01 06:00 [entrez]
AID - nbt.3779 [pii]
AID - 10.1038/nbt.3779 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Mar;35(3):230-237. doi: 10.1038/nbt.3779. Epub 2017 Feb 27.

PMID- 28244993
OWN - NLM
STAT- MEDLINE
DCOM- 20180309
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 3
DP  - 2017 Mar
TI  - The 'anti-hype' vaccine.
PG  - 193-197
LID - 10.1038/nbt.3812 [doi]
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
LA  - eng
PT  - News
DEP - 20170227
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Rabies Vaccines)
RN  - 0 (Vaccines)
RN  - 63231-63-0 (RNA)
SB  - IM
MH  - Clinical Trials as Topic
MH  - Humans
MH  - *Immunotherapy
MH  - RNA/genetics/*therapeutic use
MH  - Rabies/immunology/pathology/*therapy
MH  - Rabies Vaccines/therapeutic use
MH  - Vaccines/immunology/*therapeutic use
EDAT- 2017/03/01 06:00
MHDA- 2018/03/10 06:00
CRDT- 2017/03/01 06:00
PHST- 2017/03/01 06:00 [pubmed]
PHST- 2018/03/10 06:00 [medline]
PHST- 2017/03/01 06:00 [entrez]
AID - nbt.3812 [pii]
AID - 10.1038/nbt.3812 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Mar;35(3):193-197. doi: 10.1038/nbt.3812. Epub 2017 Feb 27.

PMID- 28244992
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 3
DP  - 2017 Mar
TI  - Overcoming cellular barriers for RNA therapeutics.
PG  - 222-229
LID - 10.1038/nbt.3802 [doi]
AB  - RNA-based therapeutics, such as small-interfering (siRNAs), microRNAs (miRNAs),
      antisense oligonucleotides (ASOs), aptamers, synthetic mRNAs and CRISPR-Cas9,
      have great potential to target a large part of the currently undruggable genes
      and gene products and to generate entirely new therapeutic paradigms in disease, 
      ranging from cancer to pandemic influenza to Alzheimer's disease. However, for
      these RNA modalities to reach their full potential, they first need to overcome a
      billion years of evolutionary defenses that have kept RNAs on the outside of
      cells from invading the inside of cells. Overcoming the lipid bilayer to deliver 
      RNA into cells has remained the major problem to solve for widespread development
      of RNA therapeutics, but recent chemistry advances have begun to penetrate this
      evolutionary armor.
FAU - Dowdy, Steven F
AU  - Dowdy SF
AD  - Department of Cellular and Molecular Medicine, University of California, San
      Diego, School of Medicine, La Jolla, California, USA.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20170227
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Nanocapsules)
RN  - 63231-63-0 (RNA)
SB  - IM
MH  - Animals
MH  - Cell Membrane/*metabolism
MH  - Humans
MH  - Molecular Targeted Therapy/*methods
MH  - Nanocapsules/*chemistry/ultrastructure
MH  - RNA/*administration & dosage/*pharmacokinetics
MH  - RNA Interference
MH  - RNAi Therapeutics/*methods
EDAT- 2017/03/01 06:00
MHDA- 2017/06/07 06:00
CRDT- 2017/03/01 06:00
PHST- 2016/06/22 00:00 [received]
PHST- 2017/01/19 00:00 [accepted]
PHST- 2017/03/01 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2017/03/01 06:00 [entrez]
AID - nbt.3802 [pii]
AID - 10.1038/nbt.3802 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Mar;35(3):222-229. doi: 10.1038/nbt.3802. Epub 2017 Feb 27.

PMID- 28244991
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20180301
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 3
DP  - 2017 Mar
TI  - Oligonucleotide therapies for disorders of the nervous system.
PG  - 249-263
LID - 10.1038/nbt.3784 [doi]
AB  - Oligonucleotide therapies are currently experiencing a resurgence driven by
      advances in backbone chemistry and discoveries of novel therapeutic pathways that
      can be uniquely and efficiently modulated by the oligonucleotide drugs. A quarter
      of a century has passed since oligonucleotides were first applied in living
      mammalian brain to modulate gene expression. Despite challenges in delivery to
      the brain, multiple oligonucleotide-based compounds are now being developed for
      treatment of human brain disorders by direct delivery inside the blood brain
      barrier (BBB). Notably, the first new central nervous system (CNS)-targeted
      oligonucleotide-based drug (nusinersen/Spinraza) was approved by US Food and Drug
      Administration (FDA) in late 2016 and several other compounds are in advanced
      clinical trials. Human testing of brain-targeted oligonucleotides has highlighted
      unusual pharmacokinetic and pharmacodynamic properties of these compounds,
      including complex active uptake mechanisms, low systemic exposure, extremely long
      half-lives, accumulation and gradual release from subcellular depots. Further
      work on oligonucleotide uptake, development of formulations for delivery across
      the BBB and relevant disease biology studies are required for further
      optimization of the oligonucleotide drug development process for brain
      applications.
FAU - Khorkova, Olga
AU  - Khorkova O
AD  - OPKO Health Inc., Miramar, Florida, USA.
FAU - Wahlestedt, Claes
AU  - Wahlestedt C
AD  - Center for Therapeutic Innovation and the Department of Psychiatry and Behavioral
      Sciences, University of Miami Miller School of Medicine, Miami, Florida, USA.
LA  - eng
GR  - R21 DA035592/DA/NIDA NIH HHS/United States
GR  - P50 NS071674/NS/NINDS NIH HHS/United States
GR  - R01 AA023781/AA/NIAAA NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20170227
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Oligonucleotides)
SB  - IM
MH  - Animals
MH  - Brain Diseases/*metabolism/*therapy
MH  - Evidence-Based Medicine
MH  - Genetic Therapy/*methods
MH  - Humans
MH  - Oligonucleotides/*pharmacokinetics/*therapeutic use
MH  - Treatment Outcome
EDAT- 2017/03/01 06:00
MHDA- 2017/06/07 06:00
CRDT- 2017/03/01 06:00
PHST- 2016/07/08 00:00 [received]
PHST- 2017/01/09 00:00 [accepted]
PHST- 2017/03/01 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2017/03/01 06:00 [entrez]
AID - nbt.3784 [pii]
AID - 10.1038/nbt.3784 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Mar;35(3):249-263. doi: 10.1038/nbt.3784. Epub 2017 Feb 27.

PMID- 28244990
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20170902
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 3
DP  - 2017 Mar
TI  - The chemical evolution of oligonucleotide therapies of clinical utility.
PG  - 238-248
LID - 10.1038/nbt.3765 [doi]
AB  - After nearly 40 years of development, oligonucleotide therapeutics are nearing
      meaningful clinical productivity. One of the key advantages of oligonucleotide
      drugs is that their delivery and potency are derived primarily from the chemical 
      structure of the oligonucleotide whereas their target is defined by the base
      sequence. Thus, as oligonucleotides with a particular chemical design show
      appropriate distribution and safety profiles for clinical gene silencing in a
      particular tissue, this will open the door to the rapid development of additional
      drugs targeting other disease-associated genes in the same tissue. To achieve
      clinical productivity, the chemical architecture of the oligonucleotide needs to 
      be optimized with a combination of sugar, backbone, nucleobase, and 3'- and
      5'-terminal modifications. A portfolio of chemistries can be used to confer
      drug-like properties onto the oligonucleotide as a whole, with minor chemical
      changes often translating into major improvements in clinical efficacy. One
      outstanding challenge in oligonucleotide chemical development is the optimization
      of chemical architectures to ensure long-term safety. There are multiple designs 
      that enable effective targeting of the liver, but a second challenge is to
      develop architectures that enable robust clinical efficacy in additional tissues.
FAU - Khvorova, Anastasia
AU  - Khvorova A
AD  - RNA Therapeutics Institute, University of Massachusetts Medical School,
      Worcester, Massachusetts, USA.
AD  - Program in Molecular Medicine, University of Massachusetts Medical School,
      Worcester, Massachusetts, USA.
FAU - Watts, Jonathan K
AU  - Watts JK
AD  - RNA Therapeutics Institute, University of Massachusetts Medical School,
      Worcester, Massachusetts, USA.
AD  - Department of Biochemistry and Molecular Pharmacology, University of
      Massachusetts Medical School, Worcester, Massachusetts, USA.
LA  - eng
GR  - R01 GM108803/GM/NIGMS NIH HHS/United States
GR  - R01 HD086111/HD/NICHD NIH HHS/United States
GR  - UH3 TR000888/TR/NCATS NIH HHS/United States
PT  - Journal Article
PT  - Review
DEP - 20170227
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Oligonucleotides, Antisense)
RN  - 63231-63-0 (RNA)
SB  - IM
MH  - Animals
MH  - Drug Design
MH  - Humans
MH  - Molecular Targeted Therapy/methods
MH  - Oligonucleotides, Antisense/*genetics/*therapeutic use
MH  - RNA/*genetics/*therapeutic use
MH  - RNAi Therapeutics/*methods
PMC - PMC5517098
MID - NIHMS874289
EDAT- 2017/03/01 06:00
MHDA- 2017/06/07 06:00
CRDT- 2017/03/01 06:00
PHST- 2016/08/18 00:00 [received]
PHST- 2016/12/12 00:00 [accepted]
PHST- 2017/03/01 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2017/03/01 06:00 [entrez]
AID - nbt.3765 [pii]
AID - 10.1038/nbt.3765 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Mar;35(3):238-248. doi: 10.1038/nbt.3765. Epub 2017 Feb 27.

PMID- 28191902
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20180301
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 3
DP  - 2017 Mar
TI  - Dynamic regulation of metabolic flux in engineered bacteria using a
      pathway-independent quorum-sensing circuit.
PG  - 273-279
LID - 10.1038/nbt.3796 [doi]
AB  - Metabolic engineering of microorganisms to produce desirable products on an
      industrial scale can result in unbalanced cellular metabolic networks that reduce
      productivity and yield. Metabolic fluxes can be rebalanced using dynamic pathway 
      regulation, but few broadly applicable tools are available to achieve this. We
      present a pathway-independent genetic control module that can be used to
      dynamically regulate the expression of target genes. We apply our module to
      identify the optimal point to redirect glycolytic flux into heterologous
      engineered pathways in Escherichia coli, resulting in titers of myo-inositol
      increased 5.5-fold and titers of glucaric acid increased from unmeasurable to
      >0.8 g/L, compared to the parent strains lacking dynamic flux control. Scaled-up 
      production of these strains in benchtop bioreactors resulted in almost ten- and
      fivefold increases in specific titers of myo-inositol and glucaric acid,
      respectively. We also used our module to control flux into aromatic amino acid
      biosynthesis to increase titers of shikimate in E. coli from unmeasurable to >100
      mg/L.
FAU - Gupta, Apoorv
AU  - Gupta A
AD  - Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
AD  - Synthetic Biology Engineering Research Center (SynBERC), Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
FAU - Reizman, Irene M Brockman
AU  - Reizman IM
AUID- ORCID: 0000-0003-0585-2213
AD  - Department of Chemical Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Reisch, Christopher R
AU  - Reisch CR
AD  - Department of Chemical Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Prather, Kristala L J
AU  - Prather KL
AUID- ORCID: 0000-0003-0437-3157
AD  - Synthetic Biology Engineering Research Center (SynBERC), Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Chemical Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
LA  - eng
GR  - T32 GM008334/GM/NIGMS NIH HHS/United States
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20170213
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Escherichia coli Proteins)
SB  - IM
MH  - Computer Simulation
MH  - Escherichia coli/*physiology
MH  - Escherichia coli Proteins/genetics/*metabolism
MH  - Gene Expression Regulation, Bacterial/physiology
MH  - Metabolic Engineering/*methods
MH  - Metabolic Flux Analysis/*methods
MH  - Metabolome/physiology
MH  - *Models, Biological
MH  - Quorum Sensing/*physiology
MH  - Signal Transduction/physiology
PMC - PMC5340623
MID - NIHMS843850
EDAT- 2017/02/14 06:00
MHDA- 2017/06/07 06:00
CRDT- 2017/02/14 06:00
PHST- 2016/08/31 00:00 [received]
PHST- 2017/01/13 00:00 [accepted]
PHST- 2017/02/14 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2017/02/14 06:00 [entrez]
AID - nbt.3796 [pii]
AID - 10.1038/nbt.3796 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Mar;35(3):273-279. doi: 10.1038/nbt.3796. Epub 2017 Feb 13.

PMID- 28165476
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20180301
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 3
DP  - 2017 Mar
TI  - Gene therapy restores auditory and vestibular function in a mouse model of Usher 
      syndrome type 1c.
PG  - 264-272
LID - 10.1038/nbt.3801 [doi]
AB  - Because there are currently no biological treatments for hearing loss, we sought 
      to advance gene therapy approaches to treat genetic deafness. We focused on Usher
      syndrome, a devastating genetic disorder that causes blindness, balance disorders
      and profound deafness, and studied a knock-in mouse model, Ush1c c.216G>A, for
      Usher syndrome type IC (USH1C). As restoration of complex auditory and balance
      function is likely to require gene delivery systems that target auditory and
      vestibular sensory cells with high efficiency, we delivered wild-type Ush1c into 
      the inner ear of Ush1c c.216G>A mice using a synthetic adeno-associated viral
      vector, Anc80L65, shown to transduce 80-90% of sensory hair cells. We demonstrate
      recovery of gene and protein expression, restoration of sensory cell function,
      rescue of complex auditory function and recovery of hearing and balance behavior 
      to near wild-type levels. The data represent unprecedented recovery of inner ear 
      function and suggest that biological therapies to treat deafness may be suitable 
      for translation to humans with genetic inner ear disorders.
FAU - Pan, Bifeng
AU  - Pan B
AUID- ORCID: 0000-0001-9746-3420
AD  - Department of Otolaryngology, F.M. Kirby Center for Neurobiology, Boston
      Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Askew, Charles
AU  - Askew C
AUID- ORCID: 0000-0002-6131-6602
AD  - Department of Otolaryngology, F.M. Kirby Center for Neurobiology, Boston
      Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Galvin, Alice
AU  - Galvin A
AD  - Department of Otolaryngology, F.M. Kirby Center for Neurobiology, Boston
      Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Heman-Ackah, Selena
AU  - Heman-Ackah S
AD  - Department of Otolaryngology, F.M. Kirby Center for Neurobiology, Boston
      Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Asai, Yukako
AU  - Asai Y
AD  - Department of Otolaryngology, F.M. Kirby Center for Neurobiology, Boston
      Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Indzhykulian, Artur A
AU  - Indzhykulian AA
AD  - Department of Neurobiology, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Jodelka, Francine M
AU  - Jodelka FM
AD  - Department of Cell Biology &Anatomy, Chicago Medical School, Rosalind Franklin
      University of Medicine and Science, Chicago, Illinois, USA.
FAU - Hastings, Michelle L
AU  - Hastings ML
AD  - Department of Cell Biology &Anatomy, Chicago Medical School, Rosalind Franklin
      University of Medicine and Science, Chicago, Illinois, USA.
FAU - Lentz, Jennifer J
AU  - Lentz JJ
AD  - Department of Otorhinolaryngology &Bio-communications and Neuroscience Center,
      LSU Health Sciences Center, New Orleans, Louisiana, USA.
FAU - Vandenberghe, Luk H
AU  - Vandenberghe LH
AUID- ORCID: 0000-0002-3508-4924
AD  - Department of Ophthalmology, Grousbeck Gene Therapy Center, Schepens Eye Research
      Institute and Massachusetts Eye and Ear, Harvard Medical School, Boston,
      Massachusetts, USA.
FAU - Holt, Jeffrey R
AU  - Holt JR
AD  - Department of Otolaryngology, F.M. Kirby Center for Neurobiology, Boston
      Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
AD  - Department of Neurology, F.M. Kirby Center for Neurobiology, Boston Children's
      Hospital, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Geleoc, Gwenaelle S
AU  - Geleoc GS
AD  - Department of Otolaryngology, F.M. Kirby Center for Neurobiology, Boston
      Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
LA  - eng
GR  - R01 DC012596/DC/NIDCD NIH HHS/United States
GR  - R01 DC000304/DC/NIDCD NIH HHS/United States
GR  - U54 GM104940/GM/NIGMS NIH HHS/United States
GR  - P30 HD018655/HD/NICHD NIH HHS/United States
GR  - P30 EY012196/EY/NEI NIH HHS/United States
GR  - DP1 EY023177/EY/NEI NIH HHS/United States
GR  - HHMI/Howard Hughes Medical Institute/United States
GR  - U54 HD090255/HD/NICHD NIH HHS/United States
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, N.I.H., Extramural
DEP - 20170206
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Carrier Proteins)
RN  - 0 (Ush1c protein, mouse)
SB  - IM
CIN - Nat Biotechnol. 2017 Mar 7;35(3):216-218. PMID: 28267741
MH  - Animals
MH  - Carrier Proteins/*genetics
MH  - Female
MH  - Gene Knock-In Techniques
MH  - Genetic Therapy/*methods
MH  - Hearing Loss, Sensorineural/diagnosis/genetics/*therapy
MH  - Male
MH  - Mice
MH  - Mice, Inbred C57BL
MH  - Plasmids/administration & dosage/genetics
MH  - Recovery of Function/genetics
MH  - Treatment Outcome
MH  - Usher Syndromes/*genetics/*therapy
MH  - Vestibular Diseases/diagnosis/genetics/*therapy
PMC - PMC5340578
MID - NIHMS846200
EDAT- 2017/02/07 06:00
MHDA- 2017/06/07 06:00
CRDT- 2017/02/07 06:00
PHST- 2016/05/27 00:00 [received]
PHST- 2017/01/23 00:00 [accepted]
PHST- 2017/02/07 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2017/02/07 06:00 [entrez]
AID - nbt.3801 [pii]
AID - 10.1038/nbt.3801 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Mar;35(3):264-272. doi: 10.1038/nbt.3801. Epub 2017 Feb 6.

PMID- 28165475
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20180301
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 3
DP  - 2017 Mar
TI  - A synthetic AAV vector enables safe and efficient gene transfer to the mammalian 
      inner ear.
PG  - 280-284
LID - 10.1038/nbt.3781 [doi]
AB  - Efforts to develop gene therapies for hearing loss have been hampered by the lack
      of safe, efficient, and clinically relevant delivery modalities. Here we
      demonstrate the safety and efficiency of Anc80L65, a rationally designed
      synthetic vector, for transgene delivery to the mouse cochlea. Ex vivo
      transduction of mouse organotypic explants identified Anc80L65 from a set of
      other adeno-associated virus (AAV) vectors as a potent vector for the cochlear
      cell targets. Round window membrane injection resulted in highly efficient
      transduction of inner and outer hair cells in mice, a substantial improvement
      over conventional AAV vectors. Anc80L65 round window injection was well
      tolerated, as indicated by sensory cell function, hearing and vestibular
      function, and immunologic parameters. The ability of Anc80L65 to target outer
      hair cells at high rates, a requirement for restoration of complex auditory
      function, may enable future gene therapies for hearing and balance disorders.
FAU - Landegger, Lukas D
AU  - Landegger LD
AUID- ORCID: 0000-0002-9660-2625
AD  - Eaton Peabody Laboratories, Department of Otolaryngology, Massachusetts Eye and
      Ear, Boston, Massachusetts, USA.
AD  - Department of Otolaryngology, Harvard Medical School, Boston, Massachusetts, USA.
AD  - Department of Otolaryngology, Vienna General Hospital, Medical University of
      Vienna, Vienna, Austria.
FAU - Pan, Bifeng
AU  - Pan B
AUID- ORCID: 0000-0001-9746-3420
AD  - Department of Otolaryngology, Harvard Medical School, Boston, Massachusetts, USA.
AD  - Department of Otolaryngology, F.M. Kirby Neurobiology Center, Boston Children's
      Hospital, Boston, Massachusetts, USA.
FAU - Askew, Charles
AU  - Askew C
AUID- ORCID: 0000-0002-6131-6602
AD  - Department of Otolaryngology, Harvard Medical School, Boston, Massachusetts, USA.
AD  - Department of Otolaryngology, F.M. Kirby Neurobiology Center, Boston Children's
      Hospital, Boston, Massachusetts, USA.
FAU - Wassmer, Sarah J
AU  - Wassmer SJ
AD  - Grousbeck Gene Therapy Center, Schepens Eye Research Institute and Massachusetts 
      Eye and Ear, Boston, Massachusetts, USA.
AD  - Ocular Genomics Institute, Department of Ophthalmology, Harvard Medical School,
      Boston, Massachusetts, USA.
FAU - Gluck, Sarah D
AU  - Gluck SD
AD  - Department of Otolaryngology, Harvard Medical School, Boston, Massachusetts, USA.
AD  - Department of Otolaryngology, F.M. Kirby Neurobiology Center, Boston Children's
      Hospital, Boston, Massachusetts, USA.
AD  - Harvard Program in Speech and Hearing Bioscience and Technology, Boston,
      Massachusetts, USA.
FAU - Galvin, Alice
AU  - Galvin A
AD  - Department of Otolaryngology, F.M. Kirby Neurobiology Center, Boston Children's
      Hospital, Boston, Massachusetts, USA.
FAU - Taylor, Ruth
AU  - Taylor R
AD  - Center for Auditory Research, UCL Ear Institute, London, UK.
FAU - Forge, Andrew
AU  - Forge A
AD  - Center for Auditory Research, UCL Ear Institute, London, UK.
FAU - Stankovic, Konstantina M
AU  - Stankovic KM
AD  - Eaton Peabody Laboratories, Department of Otolaryngology, Massachusetts Eye and
      Ear, Boston, Massachusetts, USA.
AD  - Department of Otolaryngology, Harvard Medical School, Boston, Massachusetts, USA.
AD  - Harvard Program in Speech and Hearing Bioscience and Technology, Boston,
      Massachusetts, USA.
FAU - Holt, Jeffrey R
AU  - Holt JR
AD  - Department of Otolaryngology, Harvard Medical School, Boston, Massachusetts, USA.
AD  - Department of Otolaryngology, F.M. Kirby Neurobiology Center, Boston Children's
      Hospital, Boston, Massachusetts, USA.
AD  - Department of Neurology, Boston Children's Hospital and Harvard Medical School,
      Boston, Massachusetts, USA.
FAU - Vandenberghe, Luk H
AU  - Vandenberghe LH
AUID- ORCID: 0000-0002-3508-4924
AD  - Grousbeck Gene Therapy Center, Schepens Eye Research Institute and Massachusetts 
      Eye and Ear, Boston, Massachusetts, USA.
AD  - Ocular Genomics Institute, Department of Ophthalmology, Harvard Medical School,
      Boston, Massachusetts, USA.
AD  - Harvard Stem Cell Institute, Harvard University, Cambridge, Massachusetts, USA.
LA  - eng
GR  - DP1 EY023177/EY/NEI NIH HHS/United States
GR  - DP1 OD008267/OD/NIH HHS/United States
GR  - R01 DC015824/DC/NIDCD NIH HHS/United States
GR  - U54 HD090255/HD/NICHD NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20170206
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CIN - Nat Biotechnol. 2017 Mar 7;35(3):216-218. PMID: 28267741
MH  - Animals
MH  - Cochlea/*physiology/virology
MH  - Dependovirus/*genetics
MH  - Genetic Therapy/*methods
MH  - Genetic Vectors/*genetics
MH  - Mice
MH  - Mice, Inbred C57BL
MH  - Plasmids/administration & dosage/*genetics
MH  - Transduction, Genetic/*methods
PMC - PMC5340646
MID - NIHMS840965
EDAT- 2017/02/07 06:00
MHDA- 2017/06/07 06:00
CRDT- 2017/02/07 06:00
PHST- 2016/02/26 00:00 [received]
PHST- 2017/01/04 00:00 [accepted]
PHST- 2017/02/07 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2017/02/07 06:00 [entrez]
AID - nbt.3781 [pii]
AID - 10.1038/nbt.3781 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Mar;35(3):280-284. doi: 10.1038/nbt.3781. Epub 2017 Feb 6.

PMID- 28178263
OWN - NLM
STAT- MEDLINE
DCOM- 20180207
LR  - 20180207
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 2
DP  - 2017 Feb 8
TI  - Novartis snaps up Selexys for sickle cell.
PG  - 106
LID - 10.1038/nbt0217-106 [doi]
FAU - Morrison, Chris
AU  - Morrison C
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antibodies, Monoclonal)
RN  - 0 (critznlizumab)
SB  - IM
MH  - Anemia, Sickle Cell/*drug therapy
MH  - *Antibodies, Monoclonal
MH  - Clinical Trials, Phase II as Topic
MH  - *Drug Industry/economics/organization & administration
MH  - Humans
EDAT- 2017/02/09 06:00
MHDA- 2018/02/08 06:00
CRDT- 2017/02/09 06:00
PHST- 2017/02/09 06:00 [entrez]
PHST- 2017/02/09 06:00 [pubmed]
PHST- 2018/02/08 06:00 [medline]
AID - nbt0217-106 [pii]
AID - 10.1038/nbt0217-106 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Feb 8;35(2):106. doi: 10.1038/nbt0217-106.

PMID- 28178262
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 2
DP  - 2017 Feb 8
TI  - Correction.
PG  - 105
LID - 10.1038/nbt0217-105a [doi]
LA  - eng
PT  - Journal Article
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2017 Jan 10;35(1):9. PMID: 28072776
EDAT- 2017/02/09 06:00
MHDA- 2017/02/09 06:01
CRDT- 2017/02/09 06:00
PHST- 2017/02/09 06:00 [entrez]
PHST- 2017/02/09 06:00 [pubmed]
PHST- 2017/02/09 06:01 [medline]
AID - nbt0217-105a [pii]
AID - 10.1038/nbt0217-105a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Feb 8;35(2):105. doi: 10.1038/nbt0217-105a.

PMID- 28178261
OWN - NLM
STAT- MEDLINE
DCOM- 20180207
LR  - 20180207
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 2
DP  - 2017 Feb 8
TI  - The problem with neoantigen prediction.
PG  - 97
LID - 10.1038/nbt.3800 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antigens, Neoplasm)
RN  - 0 (Cancer Vaccines)
SB  - IM
MH  - *Antigens, Neoplasm
MH  - Biomedical Research
MH  - *Cancer Vaccines
MH  - *Computational Biology
MH  - Humans
MH  - *Models, Statistical
MH  - Neoplasms/immunology/prevention & control
MH  - Software
EDAT- 2017/02/09 06:00
MHDA- 2018/02/08 06:00
CRDT- 2017/02/09 06:00
PHST- 2017/02/09 06:00 [entrez]
PHST- 2017/02/09 06:00 [pubmed]
PHST- 2018/02/08 06:00 [medline]
AID - nbt.3800 [pii]
AID - 10.1038/nbt.3800 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Feb 8;35(2):97. doi: 10.1038/nbt.3800.

PMID- 28178260
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 2
DP  - 2017 Feb 8
TI  - Fourth-quarter biotech job picture.
PG  - 179
LID - 10.1038/nbt.3794 [doi]
FAU - Francisco, Michael
AU  - Francisco M
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/02/09 06:00
MHDA- 2017/02/09 06:01
CRDT- 2017/02/09 06:00
PHST- 2017/02/09 06:00 [entrez]
PHST- 2017/02/09 06:00 [pubmed]
PHST- 2017/02/09 06:01 [medline]
AID - nbt.3794 [pii]
AID - 10.1038/nbt.3794 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Feb 8;35(2):179. doi: 10.1038/nbt.3794.

PMID- 28178259
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 2
DP  - 2017 Feb 8
TI  - Roche breaks with PacBio, opts for Genia.
PG  - 100
LID - 10.1038/nbt0217-100 [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/02/09 06:00
MHDA- 2017/02/09 06:01
CRDT- 2017/02/09 06:00
PHST- 2017/02/09 06:00 [entrez]
PHST- 2017/02/09 06:00 [pubmed]
PHST- 2017/02/09 06:01 [medline]
AID - nbt0217-100 [pii]
AID - 10.1038/nbt0217-100 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Feb 8;35(2):100. doi: 10.1038/nbt0217-100.

PMID- 28178258
OWN - NLM
STAT- MEDLINE
DCOM- 20180207
LR  - 20180208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 2
DP  - 2017 Feb 8
TI  - Industrializing rare disease therapy discovery and development.
PG  - 117-118
LID - 10.1038/nbt.3787 [doi]
FAU - Ekins, Sean
AU  - Ekins S
AUID- ORCID: 0000-0002-5691-5790
AD  - Collaborations Pharmaceuticals, Inc., Fuquay Varina, North Carolina, USA; Phoenix
      Nest, Brooklyn, New York, USA; and Hereditary Neuropathy Foundation, New York,
      New York, USA.
LA  - eng
GR  - R42 NS089061/NS/NINDS NIH HHS/United States
PT  - Letter
PT  - Research Support, N.I.H., Extramural
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Clinical Trials as Topic
MH  - Drug Discovery
MH  - *Drug Industry
MH  - *Genetic Therapy
MH  - Giant Axonal Neuropathy/therapy
MH  - Humans
MH  - Rare Diseases/*therapy
PMC - PMC5320585
MID - NIHMS852269
EDAT- 2017/02/09 06:00
MHDA- 2018/02/08 06:00
CRDT- 2017/02/09 06:00
PHST- 2017/02/09 06:00 [entrez]
PHST- 2017/02/09 06:00 [pubmed]
PHST- 2018/02/08 06:00 [medline]
AID - nbt.3787 [pii]
AID - 10.1038/nbt.3787 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Feb 8;35(2):117-118. doi: 10.1038/nbt.3787.

PMID- 28178257
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 2
DP  - 2017 Feb 8
TI  - Drug pipeline: 4Q16.
PG  - 107
LID - 10.1038/nbt.3797 [doi]
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/02/09 06:00
MHDA- 2017/02/09 06:01
CRDT- 2017/02/09 06:00
PHST- 2017/02/09 06:00 [entrez]
PHST- 2017/02/09 06:00 [pubmed]
PHST- 2017/02/09 06:01 [medline]
AID - nbt.3797 [pii]
AID - 10.1038/nbt.3797 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Feb 8;35(2):107. doi: 10.1038/nbt.3797.

PMID- 28178256
OWN - NLM
STAT- MEDLINE
DCOM- 20180207
LR  - 20180207
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 2
DP  - 2017 Feb 8
TI  - Jun Wang's iCarbonX heads consortium using AI in health and wellness.
PG  - 103-105
LID - 10.1038/nbt0217-103a [doi]
FAU - Cyranoski, David
AU  - Cyranoski D
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Artificial Intelligence
MH  - China
MH  - *Computational Biology/economics/organization & administration
MH  - Humans
MH  - *Medical Informatics/economics/organization & administration
MH  - Software
EDAT- 2017/02/09 06:00
MHDA- 2018/02/08 06:00
CRDT- 2017/02/09 06:00
PHST- 2017/02/09 06:00 [entrez]
PHST- 2017/02/09 06:00 [pubmed]
PHST- 2018/02/08 06:00 [medline]
AID - nbt0217-103a [pii]
AID - 10.1038/nbt0217-103a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Feb 8;35(2):103-105. doi: 10.1038/nbt0217-103a.

PMID- 28178255
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 2
DP  - 2017 Feb 8
TI  - GE to boost yields with Synpromics' synthetic promoters.
PG  - 105
LID - 10.1038/nbt0217-105b [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/02/09 06:00
MHDA- 2017/02/09 06:01
CRDT- 2017/02/09 06:00
PHST- 2017/02/09 06:00 [entrez]
PHST- 2017/02/09 06:00 [pubmed]
PHST- 2017/02/09 06:01 [medline]
AID - nbt0217-105b [pii]
AID - 10.1038/nbt0217-105b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Feb 8;35(2):105. doi: 10.1038/nbt0217-105b.

PMID- 28178254
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 2
DP  - 2017 Feb 8
TI  - AACR makes public 19,000 cancer genomes.
PG  - 104
LID - 10.1038/nbt0217-104 [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/02/09 06:00
MHDA- 2017/02/09 06:01
CRDT- 2017/02/09 06:00
PHST- 2017/02/09 06:00 [entrez]
PHST- 2017/02/09 06:00 [pubmed]
PHST- 2017/02/09 06:01 [medline]
AID - nbt0217-104 [pii]
AID - 10.1038/nbt0217-104 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Feb 8;35(2):104. doi: 10.1038/nbt0217-104.

PMID- 28178253
OWN - NLM
STAT- MEDLINE
DCOM- 20180131
LR  - 20180201
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 2
DP  - 2017 Feb 8
TI  - Core promoters across the genome.
PG  - 123-124
LID - 10.1038/nbt.3788 [doi]
FAU - Cvetesic, Nevena
AU  - Cvetesic N
AD  - Institute of Clinical Sciences, Faculty of Medicine, Imperial College London,
      London, UK, and the MRC London Institute of Medical Sciences, London, UK.
FAU - Lenhard, Boris
AU  - Lenhard B
AUID- ORCID: 0000-0002-1114-1509
AD  - Institute of Clinical Sciences, Faculty of Medicine, Imperial College London,
      London, UK, and the MRC London Institute of Medical Sciences, London, UK.
LA  - eng
GR  - MC_UP_1102/1/Medical Research Council/United Kingdom
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2017 Feb;35(2):145-153. PMID: 28024146
CON - Nat Biotechnol. 2017 Feb;35(2):136-144. PMID: 28024147
MH  - *Genome
MH  - Humans
MH  - *Promoter Regions, Genetic
EDAT- 2017/02/09 06:00
MHDA- 2018/02/01 06:00
CRDT- 2017/02/09 06:00
PHST- 2017/02/09 06:00 [entrez]
PHST- 2017/02/09 06:00 [pubmed]
PHST- 2018/02/01 06:00 [medline]
AID - nbt.3788 [pii]
AID - 10.1038/nbt.3788 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Feb 8;35(2):123-124. doi: 10.1038/nbt.3788.

PMID- 28178252
OWN - NLM
STAT- MEDLINE
DCOM- 20180207
LR  - 20180207
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 2
DP  - 2017 Feb 8
TI  - Situating brain regions among patent rights and moral risks.
PG  - 119-121
LID - 10.1038/nbt.3782 [doi]
FAU - Roskams-Edris, Dylan
AU  - Roskams-Edris D
AD  - National Core for Neuroethics, Division of Neurology, Faculty of Medicine, The
      University of British Columbia, Vancouver, British Columbia, Canada.
FAU - Anderson-Redick, Stacey
AU  - Anderson-Redick S
AD  - Article One Partners, New York, New York, USA.
FAU - Kiss, Zelma H
AU  - Kiss ZH
AD  - Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of
      Calgary, Calgary, Alberta, Canada.
FAU - Illes, Judy
AU  - Illes J
AD  - National Core for Neuroethics, Division of Neurology, Faculty of Medicine, The
      University of British Columbia, Vancouver, British Columbia, Canada.
LA  - eng
GR  - EOG-120257 /CIHR/Canada
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biomedical Technology/*ethics
MH  - Brain/physiology
MH  - Deep Brain Stimulation/ethics
MH  - Humans
MH  - Neurosciences/*ethics
MH  - Patents as Topic/ethics
MH  - *Patient Rights
MH  - Transcranial Magnetic Stimulation/ethics
EDAT- 2017/02/09 06:00
MHDA- 2018/02/08 06:00
CRDT- 2017/02/09 06:00
PHST- 2017/02/09 06:00 [entrez]
PHST- 2017/02/09 06:00 [pubmed]
PHST- 2018/02/08 06:00 [medline]
AID - nbt.3782 [pii]
AID - 10.1038/nbt.3782 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Feb 8;35(2):119-121. doi: 10.1038/nbt.3782.

PMID- 28178251
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 2
DP  - 2017 Feb 8
TI  - Recent patents in single-cell analysis and microfluidics.
PG  - 122
LID - 10.1038/nbt.3792 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/02/09 06:00
MHDA- 2017/02/09 06:01
CRDT- 2017/02/09 06:00
PHST- 2017/02/09 06:00 [entrez]
PHST- 2017/02/09 06:00 [pubmed]
PHST- 2017/02/09 06:01 [medline]
AID - nbt.3792 [pii]
AID - 10.1038/nbt.3792 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Feb 8;35(2):122. doi: 10.1038/nbt.3792.

PMID- 28178250
OWN - NLM
STAT- MEDLINE
DCOM- 20180207
LR  - 20180207
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 2
DP  - 2017 Feb 8
TI  - Spinal muscular atrophy approval boosts antisense drugs.
PG  - 99-100
LID - 10.1038/nbt0217-99 [doi]
FAU - Dolgin, Elie
AU  - Dolgin E
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Oligonucleotides, Antisense)
SB  - IM
MH  - Drug Approval
MH  - Drug Industry/economics/legislation & jurisprudence
MH  - Humans
MH  - Muscular Atrophy, Spinal/*drug therapy
MH  - *Oligonucleotides, Antisense/economics/therapeutic use
MH  - United States
MH  - United States Food and Drug Administration
EDAT- 2017/02/09 06:00
MHDA- 2018/02/08 06:00
CRDT- 2017/02/09 06:00
PHST- 2017/02/09 06:00 [entrez]
PHST- 2017/02/09 06:00 [pubmed]
PHST- 2018/02/08 06:00 [medline]
AID - nbt0217-99 [pii]
AID - 10.1038/nbt0217-99 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Feb 8;35(2):99-100. doi: 10.1038/nbt0217-99.

PMID- 28178248
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20180205
LR  - 20180205
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 2
DP  - 2017 Feb 8
TI  - Stretching sensors by confinement.
PG  - 127
LID - 10.1038/nbt.3789 [doi]
FAU - Jarchum, Irene
AU  - Jarchum I
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
CON - Science. 2017 Jan 6;355(6320):59-64. PMID: 28059762
EDAT- 2017/02/09 06:00
MHDA- 2017/02/09 06:01
CRDT- 2017/02/09 06:00
PHST- 2017/02/09 06:00 [entrez]
PHST- 2017/02/09 06:00 [pubmed]
PHST- 2017/02/09 06:01 [medline]
AID - nbt.3789 [pii]
AID - 10.1038/nbt.3789 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Feb 8;35(2):127. doi: 10.1038/nbt.3789.

PMID- 28178247
OWN - NLM
STAT- MEDLINE
DCOM- 20180131
LR  - 20180131
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 2
DP  - 2017 Feb 8
TI  - Exploring protein sequence-function landscapes.
PG  - 125-126
LID - 10.1038/nbt.3786 [doi]
FAU - Starr, Tyler N
AU  - Starr TN
AD  - Graduate Program in Biochemistry and Molecular Biophysics, University of Chicago,
      Chicago, Illinois, USA.
FAU - Thornton, Joseph W
AU  - Thornton JW
AD  - Departments of Ecology &Evolution and Human Genetics, University of Chicago,
      Chicago, Illinois, USA.
LA  - eng
GR  - R01 GM104397/GM/NIGMS NIH HHS/United States
GR  - T32 GM007183/GM/NIGMS NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Proteins)
SB  - IM
CON - Nat Biotechnol. 2017 Feb;35(2):128-135. PMID: 28092658
MH  - *Amino Acid Sequence
MH  - Humans
MH  - *Proteins
EDAT- 2017/02/09 06:00
MHDA- 2018/02/01 06:00
CRDT- 2017/02/09 06:00
PHST- 2017/02/09 06:00 [entrez]
PHST- 2017/02/09 06:00 [pubmed]
PHST- 2018/02/01 06:00 [medline]
AID - nbt.3786 [pii]
AID - 10.1038/nbt.3786 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Feb 8;35(2):125-126. doi: 10.1038/nbt.3786.

PMID- 28178246
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 2
DP  - 2017 Feb 8
TI  - Erratum: Multiplex gene editing by CRISPR-Cpf1 using a single crRNA array.
PG  - 178
LID - 10.1038/nbt0217-178b [doi]
FAU - Zetsche, Bernd
AU  - Zetsche B
FAU - Heidenreich, Matthias
AU  - Heidenreich M
FAU - Mohanraju, Prarthana
AU  - Mohanraju P
FAU - Fedorova, Iana
AU  - Fedorova I
FAU - Kneppers, Jeroen
AU  - Kneppers J
FAU - DeGennaro, Ellen M
AU  - DeGennaro EM
FAU - Winblad, Nerges
AU  - Winblad N
FAU - Choudhury, Sourav R
AU  - Choudhury SR
FAU - Abudayyeh, Omar O
AU  - Abudayyeh OO
FAU - Gootenberg, Jonathan S
AU  - Gootenberg JS
FAU - Wu, Wen Y
AU  - Wu WY
FAU - Scott, David A
AU  - Scott DA
FAU - Severinov, Konstantin
AU  - Severinov K
FAU - van der Oost, John
AU  - van der Oost J
FAU - Zhang, Feng
AU  - Zhang F
LA  - eng
PT  - Journal Article
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2017 Jan;35(1):31-34. PMID: 27918548
EDAT- 2017/02/09 06:00
MHDA- 2017/02/09 06:01
CRDT- 2017/02/09 06:00
PHST- 2017/02/09 06:00 [entrez]
PHST- 2017/02/09 06:00 [pubmed]
PHST- 2017/02/09 06:01 [medline]
AID - nbt0217-178b [pii]
AID - 10.1038/nbt0217-178b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Feb 8;35(2):178. doi: 10.1038/nbt0217-178b.

PMID- 28178245
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 2
DP  - 2017 Feb 8
TI  - So you want to be a student entrepreneur?
PG  - 113-116
LID - 10.1038/nbt.3778 [doi]
FAU - Jones, Charles H
AU  - Jones CH
AD  - Abcombi Biosciences Inc., Buffalo, New York, USA.
FAU - Hill, Andrew
AU  - Hill A
AD  - Abcombi Biosciences Inc., Buffalo, New York, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/02/09 06:00
MHDA- 2017/02/09 06:01
CRDT- 2017/02/09 06:00
PHST- 2017/02/09 06:00 [entrez]
PHST- 2017/02/09 06:00 [pubmed]
PHST- 2017/02/09 06:01 [medline]
AID - nbt.3778 [pii]
AID - 10.1038/nbt.3778 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Feb 8;35(2):113-116. doi: 10.1038/nbt.3778.

PMID- 28178244
OWN - NLM
STAT- MEDLINE
DCOM- 20180207
LR  - 20180207
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 2
DP  - 2017 Feb 8
TI  - Grail to pour $1 billion into blood test to detect early cancer.
PG  - 101-102
LID - 10.1038/nbt0217-101 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Biomarkers, Tumor)
RN  - 0 (Circulating Tumor DNA)
SB  - IM
MH  - Biomarkers, Tumor/*blood
MH  - Circulating Tumor DNA/*blood
MH  - *Early Detection of Cancer/economics/methods
MH  - *Genomics/economics/methods
MH  - Humans
MH  - Liquid Biopsy
MH  - *Neoplasms/blood/diagnosis/genetics/therapy
EDAT- 2017/02/09 06:00
MHDA- 2018/02/08 06:00
CRDT- 2017/02/09 06:00
PHST- 2017/02/09 06:00 [entrez]
PHST- 2017/02/09 06:00 [pubmed]
PHST- 2018/02/08 06:00 [medline]
AID - nbt0217-101 [pii]
AID - 10.1038/nbt0217-101 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Feb 8;35(2):101-102. doi: 10.1038/nbt0217-101.

PMID- 28178243
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 2
DP  - 2017 Feb 8
TI  - Erratum: The cancer bloodhounds.
PG  - 178
LID - 10.1038/nbt0217-178c [doi]
FAU - Webb, Sarah
AU  - Webb S
LA  - eng
PT  - Journal Article
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2016 Nov 8;34(11):1090-1094. PMID: 27824838
EDAT- 2017/02/09 06:00
MHDA- 2017/02/09 06:01
CRDT- 2017/02/09 06:00
PHST- 2017/02/09 06:00 [entrez]
PHST- 2017/02/09 06:00 [pubmed]
PHST- 2017/02/09 06:01 [medline]
AID - nbt0217-178c [pii]
AID - 10.1038/nbt0217-178c [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Feb 8;35(2):178. doi: 10.1038/nbt0217-178c.

PMID- 28178242
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 2
DP  - 2017 Feb 8
TI  - Shire divests mRNA platform to RaNa.
PG  - 103
LID - 10.1038/nbt0217-103b [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/02/09 06:00
MHDA- 2017/02/09 06:01
CRDT- 2017/02/09 06:00
PHST- 2017/02/09 06:00 [entrez]
PHST- 2017/02/09 06:00 [pubmed]
PHST- 2017/02/09 06:01 [medline]
AID - nbt0217-103b [pii]
AID - 10.1038/nbt0217-103b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Feb 8;35(2):103. doi: 10.1038/nbt0217-103b.

PMID- 28178241
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 2
DP  - 2017 Feb 8
TI  - Erratum: Innovative academic startups 2016.
PG  - 178
LID - 10.1038/nbt0217-178a [doi]
FAU - Huggett, Brady
AU  - Huggett B
LA  - eng
PT  - Journal Article
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2017 Jan 10;35(1):16. PMID: 28072790
EDAT- 2017/02/09 06:00
MHDA- 2017/02/09 06:01
CRDT- 2017/02/09 06:00
PHST- 2017/02/09 06:00 [entrez]
PHST- 2017/02/09 06:00 [pubmed]
PHST- 2017/02/09 06:01 [medline]
AID - nbt0217-178a [pii]
AID - 10.1038/nbt0217-178a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Feb 8;35(2):178. doi: 10.1038/nbt0217-178a.

PMID- 28135234
OWN - NLM
STAT- MEDLINE
DCOM- 20180207
LR  - 20180207
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 2
DP  - 2017 Feb
TI  - Fresh from the biotech pipeline-2016.
PG  - 108-112
LID - 10.1038/nbt.3783 [doi]
FAU - Morrison, Chris
AU  - Morrison C
LA  - eng
PT  - News
DEP - 20170130
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Anti-Infective Agents)
RN  - 0 (Biosimilar Pharmaceuticals)
RN  - 63231-63-0 (RNA)
SB  - IM
MH  - Anti-Infective Agents/therapeutic use
MH  - *Biosimilar Pharmaceuticals
MH  - *Biotechnology
MH  - *Drug Industry
MH  - Humans
MH  - RNA/therapeutic use
MH  - United States
MH  - United States Food and Drug Administration
EDAT- 2017/01/31 06:00
MHDA- 2018/02/08 06:00
CRDT- 2017/01/31 06:00
PHST- 2017/01/31 06:00 [pubmed]
PHST- 2018/02/08 06:00 [medline]
PHST- 2017/01/31 06:00 [entrez]
AID - nbt.3783 [pii]
AID - 10.1038/nbt.3783 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Feb;35(2):108-112. doi: 10.1038/nbt.3783. Epub 2017 Jan 30.

PMID- 28112759
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 2
DP  - 2017 Feb
TI  - Combined small-molecule inhibition accelerates the derivation of functional
      cortical neurons from human pluripotent stem cells.
PG  - 154-163
LID - 10.1038/nbt.3777 [doi]
AB  - Considerable progress has been made in converting human pluripotent stem cells
      (hPSCs) into functional neurons. However, the protracted timing of human neuron
      specification and functional maturation remains a key challenge that hampers the 
      routine application of hPSC-derived lineages in disease modeling and regenerative
      medicine. Using a combinatorial small-molecule screen, we previously identified
      conditions to rapidly differentiate hPSCs into peripheral sensory neurons. Here
      we generalize the approach to central nervous system (CNS) fates by developing a 
      small-molecule approach for accelerated induction of early-born cortical neurons.
      Combinatorial application of six pathway inhibitors induces post-mitotic cortical
      neurons with functional electrophysiological properties by day 16 of
      differentiation, in the absence of glial cell co-culture. The resulting neurons, 
      transplanted at 8 d of differentiation into the postnatal mouse cortex, are
      functional and establish long-distance projections, as shown using iDISCO
      whole-brain imaging. Accelerated differentiation into cortical neuron fates
      should facilitate hPSC-based strategies for disease modeling and cell therapy in 
      CNS disorders.
FAU - Qi, Yuchen
AU  - Qi Y
AD  - Developmental Biology, Sloan-Kettering Institute, New York, New York, USA.
AD  - Center of Stem Cell Biology, Sloan-Kettering Institute, New York, New York, USA.
AD  - Weill Cornell Graduate School, New York, New York, USA.
FAU - Zhang, Xin-Jun
AU  - Zhang XJ
AD  - Developmental Biology, Sloan-Kettering Institute, New York, New York, USA.
AD  - Center of Stem Cell Biology, Sloan-Kettering Institute, New York, New York, USA.
FAU - Renier, Nicolas
AU  - Renier N
AD  - Laboratory of Brain Development and Repair, The Rockefeller University, New York,
      New York, USA.
FAU - Wu, Zhuhao
AU  - Wu Z
AD  - Laboratory of Brain Development and Repair, The Rockefeller University, New York,
      New York, USA.
FAU - Atkin, Talia
AU  - Atkin T
AD  - Department of Physiology, Columbia University, New York, New York, USA.
FAU - Sun, Ziyi
AU  - Sun Z
AD  - Department of Physiology, Columbia University, New York, New York, USA.
FAU - Ozair, M Zeeshan
AU  - Ozair MZ
AD  - Laboratory of Stem Cell Biology and Molecular Embryology, The Rockefeller
      University, New York, New York, USA.
FAU - Tchieu, Jason
AU  - Tchieu J
AD  - Developmental Biology, Sloan-Kettering Institute, New York, New York, USA.
AD  - Center of Stem Cell Biology, Sloan-Kettering Institute, New York, New York, USA.
FAU - Zimmer, Bastian
AU  - Zimmer B
AD  - Developmental Biology, Sloan-Kettering Institute, New York, New York, USA.
AD  - Center of Stem Cell Biology, Sloan-Kettering Institute, New York, New York, USA.
FAU - Fattahi, Faranak
AU  - Fattahi F
AD  - Developmental Biology, Sloan-Kettering Institute, New York, New York, USA.
AD  - Center of Stem Cell Biology, Sloan-Kettering Institute, New York, New York, USA.
AD  - Weill Cornell Graduate School, New York, New York, USA.
FAU - Ganat, Yosif
AU  - Ganat Y
AD  - Developmental Biology, Sloan-Kettering Institute, New York, New York, USA.
AD  - Center of Stem Cell Biology, Sloan-Kettering Institute, New York, New York, USA.
FAU - Azevedo, Ricardo
AU  - Azevedo R
AD  - Laboratory of Brain Development and Repair, The Rockefeller University, New York,
      New York, USA.
FAU - Zeltner, Nadja
AU  - Zeltner N
AD  - Developmental Biology, Sloan-Kettering Institute, New York, New York, USA.
AD  - Center of Stem Cell Biology, Sloan-Kettering Institute, New York, New York, USA.
FAU - Brivanlou, Ali H
AU  - Brivanlou AH
AD  - Laboratory of Stem Cell Biology and Molecular Embryology, The Rockefeller
      University, New York, New York, USA.
FAU - Karayiorgou, Maria
AU  - Karayiorgou M
AD  - Department of Physiology, Columbia University, New York, New York, USA.
FAU - Gogos, Joseph
AU  - Gogos J
AD  - Department of Physiology and Department of Neuroscience, Columbia University, New
      York, New York, USA.
FAU - Tomishima, Mark
AU  - Tomishima M
AD  - Developmental Biology, Sloan-Kettering Institute, New York, New York, USA.
AD  - Center of Stem Cell Biology, Sloan-Kettering Institute, New York, New York, USA.
AD  - SKI Stem Cell Core facility, Sloan-Kettering Institute, New York, New York, USA.
FAU - Tessier-Lavigne, Marc
AU  - Tessier-Lavigne M
AD  - Laboratory of Brain Development and Repair, The Rockefeller University, New York,
      New York, USA.
FAU - Shi, Song-Hai
AU  - Shi SH
AD  - Developmental Biology, Sloan-Kettering Institute, New York, New York, USA.
AD  - Center of Stem Cell Biology, Sloan-Kettering Institute, New York, New York, USA.
FAU - Studer, Lorenz
AU  - Studer L
AD  - Developmental Biology, Sloan-Kettering Institute, New York, New York, USA.
AD  - Center of Stem Cell Biology, Sloan-Kettering Institute, New York, New York, USA.
LA  - eng
GR  - P30 CA008748/CA/NCI NIH HHS/United States
GR  - R01 NS072381/NS/NINDS NIH HHS/United States
GR  - R21 NS084334/NS/NINDS NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20170123
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Central Nervous System Agents)
SB  - IM
MH  - Batch Cell Culture Techniques/methods
MH  - Cell Differentiation/drug effects/*physiology
MH  - Cells, Cultured
MH  - Central Nervous System Agents/*administration & dosage
MH  - Dose-Response Relationship, Drug
MH  - Drug Evaluation, Preclinical/methods
MH  - Humans
MH  - Neurogenesis/drug effects/physiology
MH  - Neurons/*cytology/drug effects/*physiology
MH  - Pluripotent Stem Cells/*cytology/drug effects/*physiology
PMC - PMC5516899
MID - NIHMS837429
EDAT- 2017/01/24 06:00
MHDA- 2017/06/07 06:00
CRDT- 2017/01/24 06:00
PHST- 2016/08/26 00:00 [received]
PHST- 2016/12/16 00:00 [accepted]
PHST- 2017/01/24 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2017/01/24 06:00 [entrez]
AID - nbt.3777 [pii]
AID - 10.1038/nbt.3777 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Feb;35(2):154-163. doi: 10.1038/nbt.3777. Epub 2017 Jan 23.

PMID- 28092658
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 2
DP  - 2017 Feb
TI  - Mutation effects predicted from sequence co-variation.
PG  - 128-135
LID - 10.1038/nbt.3769 [doi]
AB  - Many high-throughput experimental technologies have been developed to assess the 
      effects of large numbers of mutations (variation) on phenotypes. However,
      designing functional assays for these methods is challenging, and systematic
      testing of all combinations is impossible, so robust methods to predict the
      effects of genetic variation are needed. Most prediction methods exploit
      evolutionary sequence conservation but do not consider the interdependencies of
      residues or bases. We present EVmutation, an unsupervised statistical method for 
      predicting the effects of mutations that explicitly captures residue dependencies
      between positions. We validate EVmutation by comparing its predictions with
      outcomes of high-throughput mutagenesis experiments and measurements of human
      disease mutations and show that it outperforms methods that do not account for
      epistasis. EVmutation can be used to assess the quantitative effects of mutations
      in genes of any organism. We provide pre-computed predictions for approximately
      7,000 human proteins at http://evmutation.org/.
FAU - Hopf, Thomas A
AU  - Hopf TA
AD  - Department of Systems Biology, Harvard Medical School, Boston, Massachusetts,
      USA.
AD  - Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.
AD  - Department of Informatics, Technische Universitat Munchen, Garching, Germany.
FAU - Ingraham, John B
AU  - Ingraham JB
AD  - Department of Systems Biology, Harvard Medical School, Boston, Massachusetts,
      USA.
FAU - Poelwijk, Frank J
AU  - Poelwijk FJ
AUID- ORCID: 0000-0002-5696-4357
AD  - cBio Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
FAU - Scharfe, Charlotta P I
AU  - Scharfe CP
AD  - Department of Systems Biology, Harvard Medical School, Boston, Massachusetts,
      USA.
AD  - Applied Bioinformatics, Department of Computer Science, University of Tubingen,
      Tubingen, Germany.
FAU - Springer, Michael
AU  - Springer M
AD  - Department of Systems Biology, Harvard Medical School, Boston, Massachusetts,
      USA.
FAU - Sander, Chris
AU  - Sander C
AD  - Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.
AD  - cBio Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
FAU - Marks, Debora S
AU  - Marks DS
AD  - Department of Systems Biology, Harvard Medical School, Boston, Massachusetts,
      USA.
LA  - eng
GR  - R01 GM106303/GM/NIGMS NIH HHS/United States
PT  - Journal Article
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20170116
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Proteome)
SB  - IM
CIN - Nat Rev Genet. 2017 Mar;18(3):144-145. PMID: 28138145
CIN - Nat Biotechnol. 2017 Feb 8;35(2):125-126. PMID: 28178247
MH  - Amino Acid Sequence/genetics
MH  - Conserved Sequence/*genetics
MH  - DNA Mutational Analysis/*methods
MH  - Epistasis, Genetic/*genetics
MH  - Evolution, Molecular
MH  - Genetic Variation/*genetics
MH  - High-Throughput Nucleotide Sequencing/*methods
MH  - Humans
MH  - Molecular Sequence Data
MH  - Mutation/genetics
MH  - Proteome/chemistry/*genetics
PMC - PMC5383098
MID - NIHMS852897
EDAT- 2017/01/17 06:00
MHDA- 2017/06/07 06:00
CRDT- 2017/01/17 06:00
PHST- 2016/06/10 00:00 [received]
PHST- 2016/12/09 00:00 [accepted]
PHST- 2017/01/17 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2017/01/17 06:00 [entrez]
AID - nbt.3769 [pii]
AID - 10.1038/nbt.3769 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Feb;35(2):128-135. doi: 10.1038/nbt.3769. Epub 2017 Jan 16.

PMID- 28092657
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 2
DP  - 2017 Feb
TI  - Lipid production in Yarrowia lipolytica is maximized by engineering cytosolic
      redox metabolism.
PG  - 173-177
LID - 10.1038/nbt.3763 [doi]
AB  - Microbial factories have been engineered to produce lipids from carbohydrate
      feedstocks for production of biofuels and oleochemicals. However, even the best
      yields obtained to date are insufficient for commercial lipid production. To
      maximize the capture of electrons generated from substrate catabolism and thus
      increase substrate-to-product yields, we engineered 13 strains of Yarrowia
      lipolytica with synthetic pathways converting glycolytic NADH into the lipid
      biosynthetic precursors NADPH or acetyl-CoA. A quantitative model was established
      and identified the yield of the lipid pathway as a crucial determinant of overall
      process yield. The best engineered strain achieved a productivity of 1.2 g/L/h
      and a process yield of 0.27 g-fatty acid methyl esters/g-glucose, which
      constitutes a 25% improvement over previously engineered yeast strains. Oxygen
      requirements of our highest producer were reduced owing to decreased NADH
      oxidization by aerobic respiration. We show that redox engineering could enable
      commercialization of microbial carbohydrate-based lipid production.
FAU - Qiao, Kangjian
AU  - Qiao K
AD  - Department of Chemical Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Wasylenko, Thomas M
AU  - Wasylenko TM
AD  - Department of Chemical Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Zhou, Kang
AU  - Zhou K
AD  - Department of Chemical Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Xu, Peng
AU  - Xu P
AUID- ORCID: 0000-0002-4857-9483
AD  - Department of Chemical Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Stephanopoulos, Gregory
AU  - Stephanopoulos G
AD  - Department of Chemical Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
LA  - eng
PT  - Journal Article
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20170116
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Fungal Proteins)
RN  - 0 (Lipids)
SB  - IM
MH  - Computer Simulation
MH  - Cytosol/metabolism
MH  - Fungal Proteins/genetics/*metabolism
MH  - Genetic Enhancement/*methods
MH  - Lipids/*biosynthesis/*genetics
MH  - Models, Biological
MH  - Oxidation-Reduction
MH  - Yarrowia/*physiology
EDAT- 2017/01/17 06:00
MHDA- 2017/06/07 06:00
CRDT- 2017/01/17 06:00
PHST- 2016/04/04 00:00 [received]
PHST- 2016/12/08 00:00 [accepted]
PHST- 2017/01/17 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2017/01/17 06:00 [entrez]
AID - nbt.3763 [pii]
AID - 10.1038/nbt.3763 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Feb;35(2):173-177. doi: 10.1038/nbt.3763. Epub 2017 Jan 16.

PMID- 28092656
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 2
DP  - 2017 Feb
TI  - Influence of node abundance on signaling network state and dynamics analyzed by
      mass cytometry.
PG  - 164-172
LID - 10.1038/nbt.3770 [doi]
AB  - Signaling networks are key regulators of cellular function. Although the
      concentrations of signaling proteins are perturbed in disease states, such as
      cancer, and are modulated by drug therapies, our understanding of how such
      changes shape the properties of signaling networks is limited. Here we couple
      mass-cytometry-based single-cell analysis with overexpression of tagged signaling
      proteins to study the dependence of signaling relationships and dynamics on
      protein node abundance. Focusing on the epidermal growth factor receptor (EGFR)
      signaling network in HEK293T cells, we analyze 20 signaling proteins during a 1-h
      EGF stimulation time course using a panel of 35 antibodies. Data analysis with
      BP-R(2), a measure that quantifies complex signaling relationships, reveals
      abundance-dependent network states and identifies novel signaling relationships. 
      Further, we show that upstream signaling proteins have abundance-dependent
      effects on downstream signaling dynamics. Our approach elucidates the influence
      of node abundance on signal transduction networks and will further our
      understanding of signaling in health and disease.
FAU - Lun, Xiao-Kang
AU  - Lun XK
AD  - Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
AD  - Molecular Life Science PhD Program, Life Science Zurich Graduate School, ETH
      Zurich and University of Zurich, Zurich, Switzerland.
FAU - Zanotelli, Vito R T
AU  - Zanotelli VR
AD  - Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
AD  - Systems Biology PhD Program, Life Science Zurich Graduate School, ETH Zurich and 
      University of Zurich, Zurich, Switzerland.
FAU - Wade, James D
AU  - Wade JD
AD  - Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
AD  - Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of
      Technology and Emory University, Atlanta, Georgia, USA.
FAU - Schapiro, Denis
AU  - Schapiro D
AD  - Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
AD  - Systems Biology PhD Program, Life Science Zurich Graduate School, ETH Zurich and 
      University of Zurich, Zurich, Switzerland.
FAU - Tognetti, Marco
AU  - Tognetti M
AD  - Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
AD  - Molecular Life Science PhD Program, Life Science Zurich Graduate School, ETH
      Zurich and University of Zurich, Zurich, Switzerland.
AD  - Institute of Biochemistry, ETH Zurich, Zurich, Switzerland.
FAU - Dobberstein, Nadine
AU  - Dobberstein N
AD  - Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
FAU - Bodenmiller, Bernd
AU  - Bodenmiller B
AD  - Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
LA  - eng
PT  - Journal Article
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PT  - Research Support, Non-U.S. Gov't
DEP - 20170116
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Proteome)
RN  - 62229-50-9 (Epidermal Growth Factor)
RN  - EC 2.7.10.1 (EGFR protein, human)
RN  - EC 2.7.10.1 (Receptor, Epidermal Growth Factor)
SB  - IM
MH  - Computer Simulation
MH  - Epidermal Growth Factor/*metabolism
MH  - Flow Cytometry/*methods
MH  - Gene Expression Profiling/methods
MH  - Gene Expression Regulation/*physiology
MH  - HEK293 Cells
MH  - Humans
MH  - *Models, Biological
MH  - Proteome/*metabolism
MH  - Receptor, Epidermal Growth Factor/*metabolism
MH  - Signal Transduction
PMC - PMC5617104
MID - EMS70815
EDAT- 2017/01/17 06:00
MHDA- 2017/06/07 06:00
CRDT- 2017/01/17 06:00
PHST- 2016/07/28 00:00 [received]
PHST- 2016/12/15 00:00 [accepted]
PHST- 2017/01/17 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2017/01/17 06:00 [entrez]
AID - nbt.3770 [pii]
AID - 10.1038/nbt.3770 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Feb;35(2):164-172. doi: 10.1038/nbt.3770. Epub 2017 Jan 16.

PMID- 28024147
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20180328
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 2
DP  - 2017 Feb
TI  - Genome-wide assessment of sequence-intrinsic enhancer responsiveness at
      single-base-pair resolution.
PG  - 136-144
LID - 10.1038/nbt.3739 [doi]
AB  - Gene expression is controlled by enhancers that activate transcription from the
      core promoters of their target genes. Although a key function of core promoters
      is to convert enhancer activities into gene transcription, whether and how
      strongly they activate transcription in response to enhancers has not been
      systematically assessed on a genome-wide level. Here we describe
      self-transcribing active core promoter sequencing (STAP-seq), a method to
      determine the responsiveness of genomic sequences to enhancers, and apply it to
      the Drosophila melanogaster genome. We cloned candidate fragments at the position
      of the core promoter (also called minimal promoter) in reporter plasmids with or 
      without a strong enhancer, transfected the resulting library into cells, and
      quantified the transcripts that initiated from each candidate for each setup by
      deep sequencing. In the presence of a single strong enhancer, the enhancer
      responsiveness of different sequences differs by several orders of magnitude, and
      different levels of responsiveness are associated with genes of different
      functions. We also identify sequence features that predict enhancer
      responsiveness and discuss how different core promoters are employed for the
      regulation of gene expression.
FAU - Arnold, Cosmas D
AU  - Arnold CD
AD  - Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, 
      Austria.
FAU - Zabidi, Muhammad A
AU  - Zabidi MA
AD  - Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, 
      Austria.
FAU - Pagani, Michaela
AU  - Pagani M
AD  - Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, 
      Austria.
FAU - Rath, Martina
AU  - Rath M
AD  - Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, 
      Austria.
FAU - Schernhuber, Katharina
AU  - Schernhuber K
AD  - Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, 
      Austria.
FAU - Kazmar, Tomas
AU  - Kazmar T
AD  - Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, 
      Austria.
FAU - Stark, Alexander
AU  - Stark A
AD  - Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, 
      Austria.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20161226
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CIN - Nat Biotechnol. 2017 Feb 8;35(2):123-124. PMID: 28178253
MH  - Algorithms
MH  - Animals
MH  - Base Pairing/*genetics
MH  - Chromosome Mapping/*methods
MH  - Drosophila melanogaster
MH  - Enhancer Elements, Genetic/*genetics
MH  - Gene Expression Regulation/*genetics
MH  - Promoter Regions, Genetic/genetics
MH  - Sequence Analysis, DNA/*methods
MH  - Software
MH  - *Transcription Initiation, Genetic
PMC - PMC5870828
MID - EMS76735
EDAT- 2016/12/27 06:00
MHDA- 2017/06/07 06:00
CRDT- 2016/12/27 06:00
PHST- 2016/04/12 00:00 [received]
PHST- 2016/11/08 00:00 [accepted]
PHST- 2016/12/27 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2016/12/27 06:00 [entrez]
AID - nbt.3739 [pii]
AID - 10.1038/nbt.3739 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Feb;35(2):136-144. doi: 10.1038/nbt.3739. Epub 2016 Dec 26.

PMID- 28024146
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 2
DP  - 2017 Feb
TI  - Genome-wide mapping of autonomous promoter activity in human cells.
PG  - 145-153
LID - 10.1038/nbt.3754 [doi]
AB  - Previous methods to systematically characterize sequence-intrinsic activity of
      promoters have been limited by relatively low throughput and the length of the
      sequences that could be tested. Here we present 'survey of regulatory elements'
      (SuRE), a method that assays more than 10(8) DNA fragments, each 0.2-2 kb in
      size, for their ability to drive transcription autonomously. In SuRE, a plasmid
      library of random genomic fragments upstream of a 20-bp barcode is constructed,
      and decoded by paired-end sequencing. This library is used to transfect cells,
      and barcodes in transcribed RNA are quantified by high-throughput sequencing.
      When applied to the human genome, we achieve 55-fold genome coverage, allowing us
      to map autonomous promoter activity genome-wide in K562 cells. By computational
      modeling we delineate subregions within promoters that are relevant for their
      activity. We show that antisense promoter transcription is generally dependent on
      the sense core promoter sequences, and that most enhancers and several families
      of repetitive elements act as autonomous transcription initiation sites.
FAU - van Arensbergen, Joris
AU  - van Arensbergen J
AD  - Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, the
      Netherlands.
FAU - FitzPatrick, Vincent D
AU  - FitzPatrick VD
AD  - Department of Biological Sciences, Columbia University, New York, New York, USA.
AD  - Department of Systems Biology, Columbia University Medical Center, New York, New 
      York, USA.
FAU - de Haas, Marcel
AU  - de Haas M
AD  - Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, the
      Netherlands.
FAU - Pagie, Ludo
AU  - Pagie L
AD  - Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, the
      Netherlands.
FAU - Sluimer, Jasper
AU  - Sluimer J
AD  - Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, the
      Netherlands.
FAU - Bussemaker, Harmen J
AU  - Bussemaker HJ
AUID- ORCID: 0000-0002-7274-5277
AD  - Department of Biological Sciences, Columbia University, New York, New York, USA.
AD  - Department of Systems Biology, Columbia University Medical Center, New York, New 
      York, USA.
FAU - van Steensel, Bas
AU  - van Steensel B
AD  - Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, the
      Netherlands.
LA  - eng
GR  - 293662/European Research Council/International
GR  - R01 HG003008/HG/NHGRI NIH HHS/United States
GR  - T32 GM008281/GM/NIGMS NIH HHS/United States
GR  - T32 GM008798/GM/NIGMS NIH HHS/United States
GR  - S10 OD021764/OD/NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20161226
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 9007-49-2 (DNA)
SB  - IM
CIN - Nat Biotechnol. 2017 Feb 8;35(2):123-124. PMID: 28178253
MH  - Chromosome Mapping/*methods
MH  - DNA/genetics
MH  - Gene Library
MH  - Genome, Human/*genetics
MH  - Humans
MH  - K562 Cells
MH  - Promoter Regions, Genetic/*genetics
MH  - Sequence Analysis, DNA/*methods
MH  - *Transcription Initiation, Genetic
MH  - Transcriptional Activation/*genetics
PMC - PMC5498152
MID - NIHMS869116
EDAT- 2016/12/27 06:00
MHDA- 2017/06/07 06:00
CRDT- 2016/12/27 06:00
PHST- 2016/05/04 00:00 [received]
PHST- 2016/12/01 00:00 [accepted]
PHST- 2016/12/27 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2016/12/27 06:00 [entrez]
AID - nbt.3754 [pii]
AID - 10.1038/nbt.3754 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Feb;35(2):145-153. doi: 10.1038/nbt.3754. Epub 2016 Dec 26.

PMID- 28072792
OWN - NLM
STAT- In-Data-Review
LR  - 20170111
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 1
DP  - 2017 Jan 10
TI  - The rise of the ethical license.
PG  - 22-24
LID - 10.1038/nbt.3756 [doi]
FAU - Guerrini, Christi J
AU  - Guerrini CJ
AD  - Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston,
      Texas, USA, and.
FAU - Curnutte, Margaret A
AU  - Curnutte MA
AD  - Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston,
      Texas, USA, and.
FAU - Sherkow, Jacob S
AU  - Sherkow JS
AD  - Innovation Center for Law and Technology, New York Law School, New York, New
      York, USA.
FAU - Scott, Christopher T
AU  - Scott CT
AD  - Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston,
      Texas, USA, and.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/01/11 06:00
MHDA- 2017/01/11 06:00
CRDT- 2017/01/11 06:00
PHST- 2017/01/11 06:00 [entrez]
PHST- 2017/01/11 06:00 [pubmed]
PHST- 2017/01/11 06:00 [medline]
AID - nbt.3756 [pii]
AID - 10.1038/nbt.3756 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jan 10;35(1):22-24. doi: 10.1038/nbt.3756.

PMID- 28072791
OWN - NLM
STAT- MEDLINE
DCOM- 20170818
LR  - 20170818
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 1
DP  - 2017 Jan 10
TI  - First mitochondrial DNA transfer go-ahead.
PG  - 7
LID - 10.1038/nbt0117-7 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (DNA, Mitochondrial)
SB  - IM
MH  - DNA, Mitochondrial/*genetics
MH  - Female
MH  - Fertilization in Vitro/*methods
MH  - Humans
MH  - Mitochondria/*genetics/*transplantation
MH  - Pregnancy
MH  - Transfection/*methods
MH  - United Kingdom
MH  - United States
EDAT- 2017/01/11 06:00
MHDA- 2017/08/19 06:00
CRDT- 2017/01/11 06:00
PHST- 2017/01/11 06:00 [entrez]
PHST- 2017/01/11 06:00 [pubmed]
PHST- 2017/08/19 06:00 [medline]
AID - nbt0117-7 [pii]
AID - 10.1038/nbt0117-7 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jan 10;35(1):7. doi: 10.1038/nbt0117-7.

PMID- 28072790
OWN - NLM
STAT- In-Data-Review
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 1
DP  - 2017 Jan 10
TI  - Innovative academic startups 2016.
PG  - 16
LID - 10.1038/nbt.3760 [doi]
FAU - Huggett, Brady
AU  - Huggett B
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EIN - Nat Biotechnol. 2017 Feb 8;35(2):178. PMID: 28178241
EDAT- 2017/01/11 06:00
MHDA- 2017/01/11 06:00
CRDT- 2017/01/11 06:00
PHST- 2017/01/11 06:00 [entrez]
PHST- 2017/01/11 06:00 [pubmed]
PHST- 2017/01/11 06:00 [medline]
AID - nbt.3760 [pii]
AID - 10.1038/nbt.3760 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jan 10;35(1):16. doi: 10.1038/nbt.3760.

PMID- 28072789
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20170818
LR  - 20170818
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 1
DP  - 2017 Jan 10
TI  - Ganymed's Claudin win.
PG  - 5
LID - 10.1038/nbt0117-5b [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/01/11 06:00
MHDA- 2017/01/11 06:01
CRDT- 2017/01/11 06:00
PHST- 2017/01/11 06:00 [entrez]
PHST- 2017/01/11 06:00 [pubmed]
PHST- 2017/01/11 06:01 [medline]
AID - nbt0117-5b [pii]
AID - 10.1038/nbt0117-5b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jan 10;35(1):5. doi: 10.1038/nbt0117-5b.

PMID- 28072788
OWN - NLM
STAT- MEDLINE
DCOM- 20170818
LR  - 20170818
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 1
DP  - 2017 Jan 10
TI  - CRISPR therapeutics push into human testing.
PG  - 3-5
LID - 10.1038/nbt0117-3 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biomedical Research/trends
MH  - Biotechnology/*trends
MH  - Clinical Trials as Topic/*methods
MH  - Clustered Regularly Interspaced Short Palindromic Repeats/*genetics
MH  - Gene Editing/*trends
MH  - Genetic Therapy/*trends
MH  - Humans
MH  - Immunotherapy/*trends
MH  - Translational Medical Research/trends
EDAT- 2017/01/11 06:00
MHDA- 2017/08/19 06:00
CRDT- 2017/01/11 06:00
PHST- 2017/01/11 06:00 [entrez]
PHST- 2017/01/11 06:00 [pubmed]
PHST- 2017/08/19 06:00 [medline]
AID - nbt0117-3 [pii]
AID - 10.1038/nbt0117-3 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jan 10;35(1):3-5. doi: 10.1038/nbt0117-3.

PMID- 28072787
OWN - NLM
STAT- MEDLINE
DCOM- 20170818
LR  - 20170818
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 1
DP  - 2017 Jan 10
TI  - Obama signs 21st Century Cures Act.
PG  - 6
LID - 10.1038/nbt0117-6a [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biomedical Research/*economics/legislation & jurisprudence
MH  - Drug Industry/*education/legislation & jurisprudence
MH  - Financing, Government/*economics/*legislation & jurisprudence
MH  - Financing, Organized/*economics/*legislation & jurisprudence
MH  - Government Regulation
MH  - National Institutes of Health (U.S.)/*economics/legislation & jurisprudence
MH  - United States
EDAT- 2017/01/11 06:00
MHDA- 2017/08/19 06:00
CRDT- 2017/01/11 06:00
PHST- 2017/01/11 06:00 [entrez]
PHST- 2017/01/11 06:00 [pubmed]
PHST- 2017/08/19 06:00 [medline]
AID - nbt0117-6a [pii]
AID - 10.1038/nbt0117-6a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jan 10;35(1):6. doi: 10.1038/nbt0117-6a.

PMID- 28072785
OWN - NLM
STAT- In-Data-Review
LR  - 20170111
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 1
DP  - 2017 Jan 10
TI  - Mining ancient proteins for next-generation drugs.
PG  - 28-29
LID - 10.1038/nbt.3762 [doi]
FAU - Lazarus, Robert A
AU  - Lazarus RA
AD  - Department of Early Discovery Biochemistry, Genentech, Inc., South San Francisco,
      California, USA, and.
FAU - Scheiflinger, Friedrich
AU  - Scheiflinger F
AD  - Research EU, Shire, Vienna, Austria.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/01/11 06:00
MHDA- 2017/01/11 06:00
CRDT- 2017/01/11 06:00
PHST- 2017/01/11 06:00 [entrez]
PHST- 2017/01/11 06:00 [pubmed]
PHST- 2017/01/11 06:00 [medline]
AID - nbt.3762 [pii]
AID - 10.1038/nbt.3762 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jan 10;35(1):28-29. doi: 10.1038/nbt.3762.

PMID- 28072784
OWN - NLM
STAT- MEDLINE
DCOM- 20170818
LR  - 20170818
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 1
DP  - 2017 Jan 10
TI  - Concerns over Cures.
PG  - 1
LID - 10.1038/nbt.3773 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biomedical Research/*economics/legislation & jurisprudence
MH  - Financing, Government/*economics/*legislation & jurisprudence
MH  - Financing, Organized/*economics/*legislation & jurisprudence
MH  - Government Regulation
MH  - National Institutes of Health (U.S.)/*economics/legislation & jurisprudence
MH  - United States
EDAT- 2017/01/11 06:00
MHDA- 2017/08/19 06:00
CRDT- 2017/01/11 06:00
PHST- 2017/01/11 06:00 [entrez]
PHST- 2017/01/11 06:00 [pubmed]
PHST- 2017/08/19 06:00 [medline]
AID - nbt.3773 [pii]
AID - 10.1038/nbt.3773 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jan 10;35(1):1. doi: 10.1038/nbt.3773.

PMID- 28072783
OWN - NLM
STAT- In-Data-Review
LR  - 20170111
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 1
DP  - 2017 Jan 10
TI  - After Theranos.
PG  - 11-15
LID - 10.1038/nbt.3761 [doi]
FAU - Waltz, Emily
AU  - Waltz E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/01/11 06:00
MHDA- 2017/01/11 06:00
CRDT- 2017/01/11 06:00
PHST- 2017/01/11 06:00 [entrez]
PHST- 2017/01/11 06:00 [pubmed]
PHST- 2017/01/11 06:00 [medline]
AID - nbt.3761 [pii]
AID - 10.1038/nbt.3761 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jan 10;35(1):11-15. doi: 10.1038/nbt.3761.

PMID- 28072781
OWN - NLM
STAT- MEDLINE
DCOM- 20170818
LR  - 20170818
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 1
DP  - 2017 Jan 10
TI  - Where are the data?
PG  - 1
LID - 10.1038/nbt.3774 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/standards
MH  - *Data Accuracy
MH  - Datasets as Topic/*standards
MH  - *Editorial Policies
MH  - Periodicals as Topic/*standards
MH  - Publishing/*standards
MH  - United States
MH  - Writing/*standards
EDAT- 2017/01/11 06:00
MHDA- 2017/08/19 06:00
CRDT- 2017/01/11 06:00
PHST- 2017/01/11 06:00 [entrez]
PHST- 2017/01/11 06:00 [pubmed]
PHST- 2017/08/19 06:00 [medline]
AID - nbt.3774 [pii]
AID - 10.1038/nbt.3774 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jan 10;35(1):1. doi: 10.1038/nbt.3774.

PMID- 28072780
OWN - NLM
STAT- In-Data-Review
LR  - 20170111
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 1
DP  - 2017 Jan 10
TI  - Recent patents in metagenomics.
PG  - 25
LID - 10.1038/nbt.3775 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/01/11 06:00
MHDA- 2017/01/11 06:00
CRDT- 2017/01/11 06:00
PHST- 2017/01/11 06:00 [entrez]
PHST- 2017/01/11 06:00 [pubmed]
PHST- 2017/01/11 06:00 [medline]
AID - nbt.3775 [pii]
AID - 10.1038/nbt.3775 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jan 10;35(1):25. doi: 10.1038/nbt.3775.

PMID- 28072779
OWN - NLM
STAT- In-Data-Review
LR  - 20170111
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 1
DP  - 2017 Jan 10
TI  - Will a Trump administration let sleeping cells lie?
PG  - 20-21
LID - 10.1038/nbt.3768 [doi]
FAU - Moreno, Jonathan D
AU  - Moreno JD
AD  - University of Pennsylvania, Center for Bioethics, Philadelphia, Pennsylvania,
      USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/01/11 06:00
MHDA- 2017/01/11 06:00
CRDT- 2017/01/11 06:00
PHST- 2017/01/11 06:00 [entrez]
PHST- 2017/01/11 06:00 [pubmed]
PHST- 2017/01/11 06:00 [medline]
AID - nbt.3768 [pii]
AID - 10.1038/nbt.3768 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jan 10;35(1):20-21. doi: 10.1038/nbt.3768.

PMID- 28072777
OWN - NLM
STAT- MEDLINE
DCOM- 20170818
LR  - 20170818
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 1
DP  - 2017 Jan 10
TI  - Pancreatic islets find a new transplant home in the omentum.
PG  - 8
LID - 10.1038/nbt0117-8 [doi]
FAU - Schmidt, Charles
AU  - Schmidt C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - Diabetes Mellitus/*therapy
MH  - Humans
MH  - Islets of Langerhans Transplantation/*instrumentation/*methods
MH  - Omentum/*surgery
MH  - Rats
EDAT- 2017/01/11 06:00
MHDA- 2017/08/19 06:00
CRDT- 2017/01/11 06:00
PHST- 2017/01/11 06:00 [entrez]
PHST- 2017/01/11 06:00 [pubmed]
PHST- 2017/08/19 06:00 [medline]
AID - nbt0117-8 [pii]
AID - 10.1038/nbt0117-8 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jan 10;35(1):8. doi: 10.1038/nbt0117-8.

PMID- 28072776
OWN - NLM
STAT- In-Data-Review
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 1
DP  - 2017 Jan 10
TI  - Gut microbiome profiling tests propelled by customer demand.
PG  - 9
LID - 10.1038/nbt0117-9 [doi]
FAU - Shankar, Vijay
AU  - Shankar V
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EIN - Nat Biotechnol. 2017 Feb 8;35(2):105. PMID: 28178262
EDAT- 2017/01/11 06:00
MHDA- 2017/01/11 06:00
CRDT- 2017/01/11 06:00
PHST- 2017/01/11 06:00 [entrez]
PHST- 2017/01/11 06:00 [pubmed]
PHST- 2017/01/11 06:00 [medline]
AID - nbt0117-9 [pii]
AID - 10.1038/nbt0117-9 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jan 10;35(1):9. doi: 10.1038/nbt0117-9.

PMID- 28072775
OWN - NLM
STAT- MEDLINE
DCOM- 20170818
LR  - 20170818
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 1
DP  - 2017 Jan 10
TI  - BMS in microbiome immuno-oncology deal.
PG  - 5
LID - 10.1038/nbt0117-5a [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*organization & administration
MH  - *Drug Discovery
MH  - Drug Industry/*organization & administration
MH  - *Genetic Testing
MH  - Humans
MH  - Immunotherapy/*methods
MH  - Internationality
MH  - Microbiota/*physiology
MH  - Neoplasms/*therapy
EDAT- 2017/01/11 06:00
MHDA- 2017/08/19 06:00
CRDT- 2017/01/11 06:00
PHST- 2017/01/11 06:00 [entrez]
PHST- 2017/01/11 06:00 [pubmed]
PHST- 2017/08/19 06:00 [medline]
AID - nbt0117-5a [pii]
AID - 10.1038/nbt0117-5a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jan 10;35(1):5. doi: 10.1038/nbt0117-5a.

PMID- 28072774
OWN - NLM
STAT- MEDLINE
DCOM- 20170818
LR  - 20170818
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 1
DP  - 2017 Jan 10
TI  - CAR-T's forge ahead, despite Juno deaths.
PG  - 6-7
LID - 10.1038/nbt0117-6b [doi]
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antineoplastic Agents)
SB  - IM
MH  - Antineoplastic Agents/*therapeutic use
MH  - *Clinical Trials as Topic
MH  - *Drug Discovery
MH  - Drug Industry/*trends
MH  - Humans
MH  - Precursor Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy/*mortality
MH  - Survival Rate
MH  - Treatment Outcome
EDAT- 2017/01/11 06:00
MHDA- 2017/08/19 06:00
CRDT- 2017/01/11 06:00
PHST- 2017/01/11 06:00 [entrez]
PHST- 2017/01/11 06:00 [pubmed]
PHST- 2017/08/19 06:00 [medline]
AID - nbt0117-6b [pii]
AID - 10.1038/nbt0117-6b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jan 10;35(1):6-7. doi: 10.1038/nbt0117-6b.

PMID- 28072773
OWN - NLM
STAT- In-Data-Review
LR  - 20170111
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 1
DP  - 2017 Jan 10
TI  - Photosynthesis gets a boost.
PG  - 30
LID - 10.1038/nbt.3764 [doi]
FAU - Jarchum, Irene
AU  - Jarchum I
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/01/11 06:00
MHDA- 2017/01/11 06:00
CRDT- 2017/01/11 06:00
PHST- 2017/01/11 06:00 [entrez]
PHST- 2017/01/11 06:00 [pubmed]
PHST- 2017/01/11 06:00 [medline]
AID - nbt.3764 [pii]
AID - 10.1038/nbt.3764 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jan 10;35(1):30. doi: 10.1038/nbt.3764.

PMID- 28072771
OWN - NLM
STAT- In-Data-Review
LR  - 20170111
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 1
DP  - 2017 Jan 10
TI  - Should you profit from your genome?
PG  - 18-20
LID - 10.1038/nbt.3757 [doi]
FAU - Roberts, Jessica L
AU  - Roberts JL
AD  - University of Houston Law Center, Houston, Texas, USA.
FAU - Pereira, Stacey
AU  - Pereira S
AD  - Baylor College of Medicine, Houston, Texas, USA.
FAU - McGuire, Amy L
AU  - McGuire AL
AD  - Baylor College of Medicine, Houston, Texas, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/01/11 06:00
MHDA- 2017/01/11 06:00
CRDT- 2017/01/11 06:00
PHST- 2017/01/11 06:00 [entrez]
PHST- 2017/01/11 06:00 [pubmed]
PHST- 2017/01/11 06:00 [medline]
AID - nbt.3757 [pii]
AID - 10.1038/nbt.3757 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jan 10;35(1):18-20. doi: 10.1038/nbt.3757.

PMID- 28072770
OWN - NLM
STAT- In-Data-Review
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 1
DP  - 2017 Jan 10
TI  - An optical probe of synaptic plasticity.
PG  - 26-27
LID - 10.1038/nbt.3767 [doi]
FAU - Laviv, Tal
AU  - Laviv T
AD  - Max Planck Florida Institute for Neuroscience, Jupiter, Florida, USA.
FAU - Yasuda, Ryohei
AU  - Yasuda R
AD  - Max Planck Florida Institute for Neuroscience, Jupiter, Florida, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EIN - Nat Biotechnol. 2017 May 9;35(5):481. PMID: 28486470
EDAT- 2017/01/11 06:00
MHDA- 2017/01/11 06:00
CRDT- 2017/01/11 06:00
PHST- 2017/01/11 06:00 [entrez]
PHST- 2017/01/11 06:00 [pubmed]
PHST- 2017/01/11 06:00 [medline]
AID - nbt.3767 [pii]
AID - 10.1038/nbt.3767 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jan 10;35(1):26-27. doi: 10.1038/nbt.3767.

PMID- 28072769
OWN - NLM
STAT- In-Data-Review
LR  - 20170111
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 1
DP  - 2017 Jan 10
TI  - The impact of postdoctoral training on early careers in biomedicine.
PG  - 90-94
LID - 10.1038/nbt.3766 [doi]
FAU - Kahn, Shulamit
AU  - Kahn S
AUID- ORCID: http://orcid.org/0000-0002-6553-0219
AD  - Markets, Public Policy and Law Department, Questrom School of Business, Boston
      University, Boston, Massachusetts, USA.
FAU - Ginther, Donna K
AU  - Ginther DK
AD  - Department of Economics and Center for Science, Technology &Economic Policy,
      University of Kansas, Lawrence, Kansas, USA, and National Bureau of Economic
      Research, Cambridge, Massachusetts, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/01/11 06:00
MHDA- 2017/01/11 06:00
CRDT- 2017/01/11 06:00
PHST- 2017/01/11 06:00 [entrez]
PHST- 2017/01/11 06:00 [pubmed]
PHST- 2017/01/11 06:00 [medline]
AID - nbt.3766 [pii]
AID - 10.1038/nbt.3766 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jan 10;35(1):90-94. doi: 10.1038/nbt.3766.

PMID- 28072786
OWN - NLM
STAT- In-Data-Review
LR  - 20170111
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 1
DP  - 2017 Jan
TI  - First Rounders Podcast: Jeremy Levin.
PG  - 10
LID - 10.1038/nbt0117-10b [doi]
LA  - eng
PT  - Journal Article
DEP - 20161222
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2017/01/11 06:00
MHDA- 2017/01/11 06:00
CRDT- 2017/01/11 06:00
PHST- 2017/01/11 06:00 [entrez]
PHST- 2017/01/11 06:00 [pubmed]
PHST- 2017/01/11 06:00 [medline]
AID - nbt0117-10b [pii]
AID - 10.1038/nbt0117-10b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jan;35(1):10. doi: 10.1038/nbt0117-10b. Epub 2016 Dec 22.

PMID- 27941803
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 1
DP  - 2017 Jan
TI  - Genome-wide mapping of mutations at single-nucleotide resolution for protein,
      metabolic and genome engineering.
PG  - 48-55
LID - 10.1038/nbt.3718 [doi]
AB  - Improvements in DNA synthesis and sequencing have underpinned comprehensive
      assessment of gene function in bacteria and eukaryotes. Genome-wide analyses
      require high-throughput methods to generate mutations and analyze their
      phenotypes, but approaches to date have been unable to efficiently link the
      effects of mutations in coding regions or promoter elements in a highly parallel 
      fashion. We report that CRISPR-Cas9 gene editing in combination with massively
      parallel oligomer synthesis can enable trackable editing on a genome-wide scale. 
      Our method, CRISPR-enabled trackable genome engineering (CREATE), links each
      guide RNA to homologous repair cassettes that both edit loci and function as
      barcodes to track genotype-phenotype relationships. We apply CREATE to site
      saturation mutagenesis for protein engineering, reconstruction of adaptive
      laboratory evolution experiments, and identification of stress tolerance and
      antibiotic resistance genes in bacteria. We provide preliminary evidence that
      CREATE will work in yeast. We also provide a webtool to design multiplex CREATE
      libraries.
FAU - Garst, Andrew D
AU  - Garst AD
AD  - Department of Chemical and Biological Engineering, University of Colorado
      Boulder, Boulder, Colorado, USA.
AD  - Muse Biotechnology Inc., Boulder, Colorado, USA.
FAU - Bassalo, Marcelo C
AU  - Bassalo MC
AD  - Department of Chemical and Biological Engineering, University of Colorado
      Boulder, Boulder, Colorado, USA.
AD  - Department of Molecular, Cellular and Developmental Biology, University of
      Colorado Boulder, Boulder, Colorado, USA.
FAU - Pines, Gur
AU  - Pines G
AD  - Department of Chemical and Biological Engineering, University of Colorado
      Boulder, Boulder, Colorado, USA.
FAU - Lynch, Sean A
AU  - Lynch SA
AD  - Department of Chemical and Biological Engineering, University of Colorado
      Boulder, Boulder, Colorado, USA.
FAU - Halweg-Edwards, Andrea L
AU  - Halweg-Edwards AL
AD  - Department of Chemical and Biological Engineering, University of Colorado
      Boulder, Boulder, Colorado, USA.
AD  - Muse Biotechnology Inc., Boulder, Colorado, USA.
FAU - Liu, Rongming
AU  - Liu R
AD  - Department of Chemical and Biological Engineering, University of Colorado
      Boulder, Boulder, Colorado, USA.
FAU - Liang, Liya
AU  - Liang L
AD  - Department of Chemical and Biological Engineering, University of Colorado
      Boulder, Boulder, Colorado, USA.
FAU - Wang, Zhiwen
AU  - Wang Z
AD  - Department of Chemical and Biological Engineering, University of Colorado
      Boulder, Boulder, Colorado, USA.
AD  - Department of Biochemical Engineering, School of Chemical Engineering and
      Technology, Tianjin University, Tianjin, People's Republic of China.
AD  - SynBio Research Platform, Collaborative Innovation Center of Chemical Science and
      Engineering (Tianjin), Tianjin University, Tianjin, People's Republic of China.
AD  - Key Laboratory of Systems Bioengineering (Ministry of Education), Tianjin
      University, Tianjin, People's Republic of China.
FAU - Zeitoun, Ramsey
AU  - Zeitoun R
AD  - Department of Chemical and Biological Engineering, University of Colorado
      Boulder, Boulder, Colorado, USA.
FAU - Alexander, William G
AU  - Alexander WG
AD  - Muse Biotechnology Inc., Boulder, Colorado, USA.
FAU - Gill, Ryan T
AU  - Gill RT
AD  - Department of Chemical and Biological Engineering, University of Colorado
      Boulder, Boulder, Colorado, USA.
LA  - eng
PT  - Journal Article
DEP - 20161212
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Nucleotides)
RN  - 0 (Proteome)
SB  - IM
MH  - Algorithms
MH  - Chromosome Mapping/*methods
MH  - DNA Mutational Analysis/*methods
MH  - Gene Editing/*methods
MH  - Genome, Bacterial/genetics
MH  - Genome, Fungal/genetics
MH  - High-Throughput Nucleotide Sequencing
MH  - Metabolic Engineering/*methods
MH  - Metabolome/genetics
MH  - Nucleotides/genetics
MH  - Polymorphism, Single Nucleotide/*genetics
MH  - Protein Engineering/*methods
MH  - Proteome/genetics
MH  - Reproducibility of Results
MH  - Sensitivity and Specificity
MH  - Software
EDAT- 2016/12/13 06:00
MHDA- 2017/06/07 06:00
CRDT- 2016/12/13 06:00
PHST- 2016/01/11 00:00 [received]
PHST- 2016/10/05 00:00 [accepted]
PHST- 2016/12/13 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2016/12/13 06:00 [entrez]
AID - nbt.3718 [pii]
AID - 10.1038/nbt.3718 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jan;35(1):48-55. doi: 10.1038/nbt.3718. Epub 2016 Dec 12.

PMID- 27941802
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20170714
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 1
DP  - 2017 Jan
TI  - Influence of donor age on induced pluripotent stem cells.
PG  - 69-74
LID - 10.1038/nbt.3749 [doi]
AB  - Induced pluripotent stem cells (iPSCs) are being pursued as a source of cells for
      autologous therapies, many of which will be aimed at aged patients. To explore
      the impact of age on iPSC quality, we produced iPSCs from blood cells of 16
      donors aged 21-100. We find that iPSCs from older donors retain an epigenetic
      signature of age, which can be reduced through passaging. Clonal expansion via
      reprogramming also enables the discovery of somatic mutations present in
      individual donor cells, which are missed by bulk sequencing methods. We show that
      exomic mutations in iPSCs increase linearly with age, and all iPSC lines analyzed
      carry at least one gene-disrupting mutation, several of which have been
      associated with cancer or dysfunction. Unexpectedly, elderly donors (>90 yrs)
      harbor fewer mutations than predicted, likely due to a contracted blood
      progenitor pool. These studies establish that donor age is associated with an
      increased risk of abnormalities in iPSCs and will inform clinical development of 
      reprogramming technology.
FAU - Lo Sardo, Valentina
AU  - Lo Sardo V
AD  - Department of Molecular and Cellular Neuroscience, The Scripps Research
      Institute, La Jolla, California, USA.
FAU - Ferguson, William
AU  - Ferguson W
AUID- ORCID: http://orcid.org/0000-0001-5848-0340
AD  - Department of Molecular and Cellular Neuroscience, The Scripps Research
      Institute, La Jolla, California, USA.
FAU - Erikson, Galina A
AU  - Erikson GA
AD  - The Scripps Translational Science Institute, Scripps Health and The Scripps
      Research Institute, La Jolla, California, USA.
FAU - Topol, Eric J
AU  - Topol EJ
AD  - The Scripps Translational Science Institute, Scripps Health and The Scripps
      Research Institute, La Jolla, California, USA.
FAU - Baldwin, Kristin K
AU  - Baldwin KK
AD  - Department of Molecular and Cellular Neuroscience, The Scripps Research
      Institute, La Jolla, California, USA.
FAU - Torkamani, Ali
AU  - Torkamani A
AD  - The Scripps Translational Science Institute, Scripps Health and The Scripps
      Research Institute, La Jolla, California, USA.
LA  - eng
GR  - U01 HG006476/HG/NHGRI NIH HHS/United States
GR  - UL1 TR001114/TR/NCATS NIH HHS/United States
GR  - U54 GM114833/GM/NIGMS NIH HHS/United States
GR  - UL1 RR025774/RR/NCRR NIH HHS/United States
GR  - U01 HL107436/HL/NHLBI NIH HHS/United States
GR  - DP1 AG055944/AG/NIA NIH HHS/United States
GR  - UL1 TR000109/TR/NCATS NIH HHS/United States
PT  - Journal Article
DEP - 20161212
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aging/*genetics/*pathology
MH  - Cell Differentiation/genetics
MH  - Cells, Cultured
MH  - *Chromosome Aberrations
MH  - Epigenesis, Genetic/*genetics
MH  - Female
MH  - Humans
MH  - Induced Pluripotent Stem Cells/*pathology/*physiology
MH  - Male
MH  - Middle Aged
MH  - Stem Cell Transplantation
MH  - Tissue Donors
MH  - Young Adult
PMC - PMC5505172
MID - NIHMS869319
EDAT- 2016/12/13 06:00
MHDA- 2017/06/07 06:00
CRDT- 2016/12/13 06:00
PHST- 2016/03/15 00:00 [received]
PHST- 2016/11/14 00:00 [accepted]
PHST- 2016/12/13 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2016/12/13 06:00 [entrez]
AID - nbt.3749 [pii]
AID - 10.1038/nbt.3749 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jan;35(1):69-74. doi: 10.1038/nbt.3749. Epub 2016 Dec 12.

PMID- 27941801
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 1
DP  - 2017 Jan
TI  - Sinoatrial node cardiomyocytes derived from human pluripotent cells function as a
      biological pacemaker.
PG  - 56-68
LID - 10.1038/nbt.3745 [doi]
AB  - The sinoatrial node (SAN) is the primary pacemaker of the heart and controls
      heart rate throughout life. Failure of SAN function due to congenital disease or 
      aging results in slowing of the heart rate and inefficient blood circulation, a
      condition treated by implantation of an electronic pacemaker. The ability to
      produce pacemaker cells in vitro could lead to an alternative, biological
      pacemaker therapy in which the failing SAN is replaced through cell
      transplantation. Here we describe a transgene-independent method for the
      generation of SAN-like pacemaker cells (SANLPCs) from human pluripotent stem
      cells by stage-specific manipulation of developmental signaling pathways. SANLPCs
      are identified as NKX2-5(-) cardiomyocytes that express markers of the SAN
      lineage and display typical pacemaker action potentials, ion current profiles and
      chronotropic responses. When transplanted into the apex of rat hearts, SANLPCs
      are able to pace the host tissue, demonstrating their capacity to function as a
      biological pacemaker.
FAU - Protze, Stephanie I
AU  - Protze SI
AD  - McEwen Centre for Regenerative Medicine and Princess Margaret Cancer Center,
      University Health Network, Toronto, Ontario, Canada.
AD  - Department of Medical Biophysics, University of Toronto, Ontario, Canada.
FAU - Liu, Jie
AU  - Liu J
AD  - Department of Biology, York University, Toronto, Ontario, Canada.
AD  - Division of Cardiology and the Peter Munk Cardiac Centre, University Health
      Network, Toronto, Ontario, Canada.
FAU - Nussinovitch, Udi
AU  - Nussinovitch U
AD  - The Sohnis Laboratory for Cardiac Electrophysiology and Regenerative Medicine,
      Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute
      of Technology, Haifa, Israel.
AD  - Department of Internal Medicine A, Rappaport Faculty of Medicine and Research
      Institute and Rambam Health Care Campus, Technion-Israel Institute of Technology,
      Haifa, Israel.
FAU - Ohana, Lily
AU  - Ohana L
AD  - Department of Biology, York University, Toronto, Ontario, Canada.
AD  - Division of Cardiology and the Peter Munk Cardiac Centre, University Health
      Network, Toronto, Ontario, Canada.
FAU - Backx, Peter H
AU  - Backx PH
AD  - Department of Biology, York University, Toronto, Ontario, Canada.
AD  - Division of Cardiology and the Peter Munk Cardiac Centre, University Health
      Network, Toronto, Ontario, Canada.
FAU - Gepstein, Lior
AU  - Gepstein L
AD  - The Sohnis Laboratory for Cardiac Electrophysiology and Regenerative Medicine,
      Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute
      of Technology, Haifa, Israel.
AD  - Department of Cardiology, Rappaport Faculty of Medicine and Research Institute
      and Rambam Health Care Campus, Technion-Israel Institute of Technology, Haifa,
      Israel.
FAU - Keller, Gordon M
AU  - Keller GM
AD  - McEwen Centre for Regenerative Medicine and Princess Margaret Cancer Center,
      University Health Network, Toronto, Ontario, Canada.
AD  - Department of Medical Biophysics, University of Toronto, Ontario, Canada.
LA  - eng
PT  - Journal Article
DEP - 20161212
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Action Potentials/physiology
MH  - Biological Clocks/*physiology
MH  - Cell Differentiation/physiology
MH  - Cell Line
MH  - Cells, Cultured
MH  - Genetic Engineering
MH  - Humans
MH  - Myocytes, Cardiac/*cytology/*physiology
MH  - Pluripotent Stem Cells/*cytology/*physiology
MH  - Sinoatrial Node/cytology/*physiology
EDAT- 2016/12/13 06:00
MHDA- 2017/06/07 06:00
CRDT- 2016/12/13 06:00
PHST- 2016/06/20 00:00 [received]
PHST- 2016/11/10 00:00 [accepted]
PHST- 2016/12/13 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2016/12/13 06:00 [entrez]
AID - nbt.3745 [pii]
AID - 10.1038/nbt.3745 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jan;35(1):56-68. doi: 10.1038/nbt.3745. Epub 2016 Dec 12.

PMID- 27918548
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 1
DP  - 2017 Jan
TI  - Multiplex gene editing by CRISPR-Cpf1 using a single crRNA array.
PG  - 31-34
LID - 10.1038/nbt.3737 [doi]
AB  - Targeting of multiple genomic loci with Cas9 is limited by the need for multiple 
      or large expression constructs. Here we show that the ability of Cpf1 to process 
      its own CRISPR RNA (crRNA) can be used to simplify multiplexed genome editing.
      Using a single customized CRISPR array, we edit up to four genes in mammalian
      cells and three in the mouse brain, simultaneously.
FAU - Zetsche, Bernd
AU  - Zetsche B
AD  - Broad Institute of MIT and Harvard, Cambridge, MA 02142.
AD  - McGovern Institute for Brain Research, Massachusetts Institute of Technology,
      Cambridge, MA 02139.
AD  - Department of Brain and Cognitive Sciences, Massachusetts Institute of
      Technology, Cambridge, MA 02139.
AD  - Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge, MA 02139.
AD  - Department of Developmental Pathology, Institute of Pathology, Bonn Medical
      School, Sigmund Freud Street 25, 53127 Bonn, Germany.
FAU - Heidenreich, Matthias
AU  - Heidenreich M
AD  - Broad Institute of MIT and Harvard, Cambridge, MA 02142.
AD  - McGovern Institute for Brain Research, Massachusetts Institute of Technology,
      Cambridge, MA 02139.
AD  - Department of Brain and Cognitive Sciences, Massachusetts Institute of
      Technology, Cambridge, MA 02139.
AD  - Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge, MA 02139.
FAU - Mohanraju, Prarthana
AU  - Mohanraju P
AD  - Laboratory of Microbiology, Department of Agrotechnology and Food Sciences,
      Wageningen University, Stippeneng 4, 6708 WE Wageningen, Netherlands.
FAU - Fedorova, Iana
AU  - Fedorova I
AD  - Broad Institute of MIT and Harvard, Cambridge, MA 02142.
AD  - McGovern Institute for Brain Research, Massachusetts Institute of Technology,
      Cambridge, MA 02139.
AD  - Department of Brain and Cognitive Sciences, Massachusetts Institute of
      Technology, Cambridge, MA 02139.
AD  - Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge, MA 02139.
AD  - Skolkovo Institute of Science and Technology, Skolkovo, 143025, Russia.
AD  - Peter the Great St.Petersburg Polytechinc University, St. Petersburg, 195251,
      Russia.
FAU - Kneppers, Jeroen
AU  - Kneppers J
AD  - Broad Institute of MIT and Harvard, Cambridge, MA 02142.
AD  - Laboratory of Microbiology, Department of Agrotechnology and Food Sciences,
      Wageningen University, Stippeneng 4, 6708 WE Wageningen, Netherlands.
FAU - DeGennaro, Ellen M
AU  - DeGennaro EM
AD  - Broad Institute of MIT and Harvard, Cambridge, MA 02142.
AD  - Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute
      of Technology, Cambridge, MA 02139.
FAU - Winblad, Nerges
AU  - Winblad N
AD  - Broad Institute of MIT and Harvard, Cambridge, MA 02142.
AD  - McGovern Institute for Brain Research, Massachusetts Institute of Technology,
      Cambridge, MA 02139.
AD  - Department of Brain and Cognitive Sciences, Massachusetts Institute of
      Technology, Cambridge, MA 02139.
AD  - Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge, MA 02139.
FAU - Choudhury, Sourav R
AU  - Choudhury SR
AD  - Broad Institute of MIT and Harvard, Cambridge, MA 02142.
AD  - McGovern Institute for Brain Research, Massachusetts Institute of Technology,
      Cambridge, MA 02139.
AD  - Department of Brain and Cognitive Sciences, Massachusetts Institute of
      Technology, Cambridge, MA 02139.
AD  - Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge, MA 02139.
FAU - Abudayyeh, Omar O
AU  - Abudayyeh OO
AD  - Broad Institute of MIT and Harvard, Cambridge, MA 02142.
AD  - McGovern Institute for Brain Research, Massachusetts Institute of Technology,
      Cambridge, MA 02139.
AD  - Department of Brain and Cognitive Sciences, Massachusetts Institute of
      Technology, Cambridge, MA 02139.
AD  - Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge, MA 02139.
AD  - Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute
      of Technology, Cambridge, MA 02139.
FAU - Gootenberg, Jonathan S
AU  - Gootenberg JS
AD  - Broad Institute of MIT and Harvard, Cambridge, MA 02142.
AD  - McGovern Institute for Brain Research, Massachusetts Institute of Technology,
      Cambridge, MA 02139.
AD  - Department of Brain and Cognitive Sciences, Massachusetts Institute of
      Technology, Cambridge, MA 02139.
AD  - Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge, MA 02139.
AD  - Department of Systems Biology, Harvard Medical School, Boston, MA 02115.
FAU - Wu, Wen Y
AU  - Wu WY
AD  - Laboratory of Microbiology, Department of Agrotechnology and Food Sciences,
      Wageningen University, Stippeneng 4, 6708 WE Wageningen, Netherlands.
FAU - Scott, David A
AU  - Scott DA
AD  - Broad Institute of MIT and Harvard, Cambridge, MA 02142.
AD  - McGovern Institute for Brain Research, Massachusetts Institute of Technology,
      Cambridge, MA 02139.
FAU - Severinov, Konstantin
AU  - Severinov K
AD  - Skolkovo Institute of Science and Technology, Skolkovo, 143025, Russia.
AD  - Waksman Institute for Microbiology, Rutgers, The State University of New Jersey, 
      Piscataway, NJ 08854, USA.
AD  - Institute of Molecular Genetics, Russian Academy of Sciences, Moscow, 123182,
      Russia.
FAU - van der Oost, John
AU  - van der Oost J
AD  - Laboratory of Microbiology, Department of Agrotechnology and Food Sciences,
      Wageningen University, Stippeneng 4, 6708 WE Wageningen, Netherlands.
FAU - Zhang, Feng
AU  - Zhang F
AD  - Broad Institute of MIT and Harvard, Cambridge, MA 02142.
AD  - McGovern Institute for Brain Research, Massachusetts Institute of Technology,
      Cambridge, MA 02139.
AD  - Department of Brain and Cognitive Sciences, Massachusetts Institute of
      Technology, Cambridge, MA 02139.
AD  - Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge, MA 02139.
LA  - eng
GR  - DP1 MH100706/MH/NIMH NIH HHS/United States
GR  - R01 GM104071/GM/NIGMS NIH HHS/United States
GR  - R01 MH110049/MH/NIMH NIH HHS/United States
GR  - T32 EB001680/EB/NIBIB NIH HHS/United States
PT  - Journal Article
DEP - 20161205
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Bacterial Proteins)
RN  - 0 (CRISPR-Associated Proteins)
RN  - 0 (RNA, Bacterial)
SB  - IM
EIN - Nat Biotechnol. 2017 Feb 8;35(2):178. PMID: 28178246
MH  - Animals
MH  - Bacterial Proteins/*genetics
MH  - CRISPR-Associated Proteins/*genetics
MH  - CRISPR-Cas Systems/*genetics
MH  - Gene Editing/*methods
MH  - Mice
MH  - RNA, Bacterial/*genetics
MH  - Sequence Analysis, RNA/*methods
PMC - PMC5225075
MID - NIHMS827969
EDAT- 2016/12/06 06:00
MHDA- 2017/06/07 06:00
CRDT- 2016/12/06 06:00
PHST- 2016/03/04 00:00 [received]
PHST- 2016/11/03 00:00 [accepted]
PHST- 2016/12/06 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2016/12/06 06:00 [entrez]
AID - 10.1038/nbt.3737 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jan;35(1):31-34. doi: 10.1038/nbt.3737. Epub 2016 Dec 5.

PMID- 27918547
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 1
DP  - 2017 Jan
TI  - Optical inactivation of synaptic AMPA receptors erases fear memory.
PG  - 38-47
LID - 10.1038/nbt.3710 [doi]
AB  - The synaptic delivery of neurotransmitter receptors, such as GluA1 AMPA
      (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptors, mediates
      important processes in cognitive function, including memory acquisition and
      retention. Understanding the roles of these receptors has been hampered by the
      lack of a method to inactivate them in vivo with high spatiotemporal precision.
      We developed a technique to inactivate synaptic GluA1 AMPA receptors in vivo
      using chromophore-assisted light inactivation (CALI). We raised a monoclonal
      antibody specific for the extracellular domain of GluA1 that induced effective
      CALI when conjugated with a photosensitizer (eosin). Mice that had been injected 
      in the CA1 hippocampal region with the antibody conjugate underwent a fear memory
      task. Exposing the hippocampus to green light using an implanted cannula erased
      acquired fear memory in the animals by inactivation of synaptic GluA1. Our
      optical technique for inactivating synaptic proteins will enable elucidation of
      their physiological roles in cognition.
FAU - Takemoto, Kiwamu
AU  - Takemoto K
AD  - Yokohama City University Graduate School of Medicine, Department of Physiology,
      Yokohama, Japan.
AD  - Precursory Research for Embryonic Science and Technology, Japan Science and
      Technology Agency, Kawaguchi, Saitama, Japan.
FAU - Iwanari, Hiroko
AU  - Iwanari H
AD  - The University of Tokyo, Department of Quantitative Biology and Medicine,
      Research Center for Advanced Science and Technology (RCAST), Meguro-ku, Tokyo,
      Japan.
FAU - Tada, Hirobumi
AU  - Tada H
AD  - Yokohama City University Graduate School of Medicine, Department of Physiology,
      Yokohama, Japan.
FAU - Suyama, Kumiko
AU  - Suyama K
AD  - Yokohama City University Graduate School of Medicine, Department of Physiology,
      Yokohama, Japan.
FAU - Sano, Akane
AU  - Sano A
AD  - Yokohama City University Graduate School of Medicine, Department of Physiology,
      Yokohama, Japan.
FAU - Nagai, Takeharu
AU  - Nagai T
AD  - Osaka University, The Institute of Scientific and Industrial Research, Ibaraki,
      Osaka, Japan.
FAU - Hamakubo, Takao
AU  - Hamakubo T
AD  - The University of Tokyo, Department of Quantitative Biology and Medicine,
      Research Center for Advanced Science and Technology (RCAST), Meguro-ku, Tokyo,
      Japan.
FAU - Takahashi, Takuya
AU  - Takahashi T
AD  - Yokohama City University Graduate School of Medicine, Department of Physiology,
      Yokohama, Japan.
LA  - eng
PT  - Journal Article
DEP - 20161205
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Receptors, AMPA)
SB  - IM
MH  - Animals
MH  - Extinction, Psychological/*physiology/radiation effects
MH  - Fear/*physiology/radiation effects
MH  - Hippocampus/physiology/radiation effects
MH  - Light
MH  - Male
MH  - Memory/*physiology/radiation effects
MH  - Mice
MH  - Mice, Inbred ICR
MH  - Neural Inhibition/physiology/radiation effects
MH  - Photic Stimulation/*methods
MH  - Receptors, AMPA/*antagonists & inhibitors/metabolism/radiation effects
MH  - Synapses/*physiology/radiation effects
EDAT- 2016/12/06 06:00
MHDA- 2017/06/07 06:00
CRDT- 2016/12/06 06:00
PHST- 2016/06/29 00:00 [received]
PHST- 2016/09/26 00:00 [accepted]
PHST- 2016/12/06 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2016/12/06 06:00 [entrez]
AID - nbt.3710 [pii]
AID - 10.1038/nbt.3710 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jan;35(1):38-47. doi: 10.1038/nbt.3710. Epub 2016 Dec 5.

PMID- 27918546
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 1
DP  - 2017 Jan
TI  - MRI measurements of reporter-mediated increases in transmembrane water exchange
      enable detection of a gene reporter.
PG  - 75-80
LID - 10.1038/nbt.3714 [doi]
AB  - Non-invasive imaging of gene expression can be used to track implanted cells in
      vivo but often requires the addition of an exogenous contrast agent that may have
      limited tissue access. We show that the urea transporter (UT-B) can be used as a 
      gene reporter, where reporter expression is detected using (1)H MRI measurements 
      of UT-B-mediated increases in plasma membrane water exchange. HEK cells
      transfected with the reporter showed an increased apparent water exchange rate
      (AXR), which increased in line with UT-B expression. AXR values measured in vivo,
      in UT-B-expressing HEK cell xenografts, were significantly higher (about twofold,
      P < 0.0001), compared with non-expressing controls. Fluorescence imaging of a red
      fluorescent protein (mStrawberry), co-expressed with UT-B showed that UT-B
      expression correlated in a linear fashion with AXR. Transduction of rat brain
      cells in situ with a lentiviral vector expressing UT-B resulted in about a
      twofold increase in AXR at the site of virus injection.
FAU - Schilling, Franz
AU  - Schilling F
AD  - Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing
      Centre, Cambridge, UK.
FAU - Ros, Susana
AU  - Ros S
AD  - Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing
      Centre, Cambridge, UK.
FAU - Hu, De-En
AU  - Hu DE
AD  - Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing
      Centre, Cambridge, UK.
FAU - D'Santos, Paula
AU  - D'Santos P
AD  - Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing
      Centre, Cambridge, UK.
FAU - McGuire, Sarah
AU  - McGuire S
AD  - Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing
      Centre, Cambridge, UK.
FAU - Mair, Richard
AU  - Mair R
AD  - Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing
      Centre, Cambridge, UK.
FAU - Wright, Alan J
AU  - Wright AJ
AD  - Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing
      Centre, Cambridge, UK.
FAU - Mannion, Elizabeth
AU  - Mannion E
AD  - Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing
      Centre, Cambridge, UK.
FAU - Franklin, Robin J M
AU  - Franklin RJ
AD  - Wellcome Trust-Medical Research Council Stem Cell Institute and Department of
      Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus,
      Cambridge, UK.
FAU - Neves, Andre A
AU  - Neves AA
AUID- ORCID: http://orcid.org/0000-0003-2740-5166
AD  - Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing
      Centre, Cambridge, UK.
FAU - Brindle, Kevin M
AU  - Brindle KM
AD  - Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing
      Centre, Cambridge, UK.
AD  - Department of Biochemistry, University of Cambridge, Cambridge, UK.
LA  - eng
GR  - A10176/Cancer Research UK/United Kingdom
GR  - A16465/Cancer Research UK/United Kingdom
GR  - A17242/Cancer Research UK/United Kingdom
GR  - MC_PC_12009/Medical Research Council/United Kingdom
PT  - Journal Article
DEP - 20161205
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Membrane Transport Proteins)
RN  - 0 (urea transporter)
SB  - IM
MH  - Animals
MH  - Body Water/*metabolism
MH  - Cell Membrane/*metabolism
MH  - Female
MH  - Genes, Reporter/*genetics
MH  - HEK293 Cells
MH  - Humans
MH  - Magnetic Resonance Imaging/*methods
MH  - Membrane Transport Proteins/*genetics/*metabolism
MH  - Molecular Imaging/methods
MH  - Proton Magnetic Resonance Spectroscopy/methods
MH  - Rats
MH  - Reproducibility of Results
MH  - Sensitivity and Specificity
PMC - PMC5230773
MID - EMS70103
COIS- The authors declare no competing financial interests.
EDAT- 2016/12/06 06:00
MHDA- 2017/06/07 06:00
CRDT- 2016/12/06 06:00
PHST- 2016/03/06 00:00 [received]
PHST- 2016/09/29 00:00 [accepted]
PHST- 2016/12/06 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2016/12/06 06:00 [entrez]
AID - nbt.3714 [pii]
AID - 10.1038/nbt.3714 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jan;35(1):75-80. doi: 10.1038/nbt.3714. Epub 2016 Dec 5.

PMID- 27893703
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 1
DP  - 2017 Jan
TI  - Generation of genome-scale metabolic reconstructions for 773 members of the human
      gut microbiota.
PG  - 81-89
LID - 10.1038/nbt.3703 [doi]
AB  - Genome-scale metabolic models derived from human gut metagenomic data can be used
      as a framework to elucidate how microbial communities modulate human metabolism
      and health. We present AGORA (assembly of gut organisms through reconstruction
      and analysis), a resource of genome-scale metabolic reconstructions
      semi-automatically generated for 773 human gut bacteria. Using this resource, we 
      identified a defined growth medium for Bacteroides caccae ATCC 34185. We also
      showed that interactions among modeled species depend on both the metabolic
      potential of each species and the nutrients available. AGORA reconstructions can 
      integrate either metagenomic or 16S rRNA sequencing data sets to infer the
      metabolic diversity of microbial communities. AGORA reconstructions could provide
      a starting point for the generation of high-quality, manually curated metabolic
      reconstructions. AGORA is fully compatible with Recon 2, a comprehensive
      metabolic reconstruction of human metabolism, which will facilitate studies of
      host-microbiome interactions.
FAU - Magnusdottir, Stefania
AU  - Magnusdottir S
AD  - Luxembourg Centre for Systems Biomedicine, University of Luxembourg,
      Esch-sur-Alzette, Luxembourg.
FAU - Heinken, Almut
AU  - Heinken A
AD  - Luxembourg Centre for Systems Biomedicine, University of Luxembourg,
      Esch-sur-Alzette, Luxembourg.
FAU - Kutt, Laura
AU  - Kutt L
AD  - Luxembourg Centre for Systems Biomedicine, University of Luxembourg,
      Esch-sur-Alzette, Luxembourg.
FAU - Ravcheev, Dmitry A
AU  - Ravcheev DA
AD  - Luxembourg Centre for Systems Biomedicine, University of Luxembourg,
      Esch-sur-Alzette, Luxembourg.
FAU - Bauer, Eugen
AU  - Bauer E
AD  - Luxembourg Centre for Systems Biomedicine, University of Luxembourg,
      Esch-sur-Alzette, Luxembourg.
FAU - Noronha, Alberto
AU  - Noronha A
AD  - Luxembourg Centre for Systems Biomedicine, University of Luxembourg,
      Esch-sur-Alzette, Luxembourg.
FAU - Greenhalgh, Kacy
AU  - Greenhalgh K
AD  - Luxembourg Centre for Systems Biomedicine, University of Luxembourg,
      Esch-sur-Alzette, Luxembourg.
FAU - Jager, Christian
AU  - Jager C
AD  - Luxembourg Centre for Systems Biomedicine, University of Luxembourg,
      Esch-sur-Alzette, Luxembourg.
FAU - Baginska, Joanna
AU  - Baginska J
AD  - Luxembourg Centre for Systems Biomedicine, University of Luxembourg,
      Esch-sur-Alzette, Luxembourg.
FAU - Wilmes, Paul
AU  - Wilmes P
AD  - Luxembourg Centre for Systems Biomedicine, University of Luxembourg,
      Esch-sur-Alzette, Luxembourg.
FAU - Fleming, Ronan M T
AU  - Fleming RM
AUID- ORCID: http://orcid.org/0000-0001-5346-9812
AD  - Luxembourg Centre for Systems Biomedicine, University of Luxembourg,
      Esch-sur-Alzette, Luxembourg.
FAU - Thiele, Ines
AU  - Thiele I
AD  - Luxembourg Centre for Systems Biomedicine, University of Luxembourg,
      Esch-sur-Alzette, Luxembourg.
LA  - eng
PT  - Journal Article
DEP - 20161128
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Bacterial Proteins)
RN  - 0 (Proteome)
SB  - IM
MH  - Bacteria/classification/*genetics/isolation & purification
MH  - Bacterial Proteins/*genetics
MH  - Chromosome Mapping/*methods
MH  - Gastrointestinal Microbiome/*genetics
MH  - Genetic Variation/genetics
MH  - Genome, Bacterial/*genetics
MH  - High-Throughput Nucleotide Sequencing/methods
MH  - Metabolome/*genetics
MH  - Proteome/genetics
EDAT- 2016/11/29 06:00
MHDA- 2017/06/07 06:00
CRDT- 2016/11/29 06:00
PHST- 2016/04/15 00:00 [received]
PHST- 2016/09/20 00:00 [accepted]
PHST- 2016/11/29 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2016/11/29 06:00 [entrez]
AID - nbt.3703 [pii]
AID - 10.1038/nbt.3703 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jan;35(1):81-89. doi: 10.1038/nbt.3703. Epub 2016 Nov 28.

PMID- 27669166
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 1
DP  - 2017 Jan
TI  - Enhancing the pharmaceutical properties of protein drugs by ancestral sequence
      reconstruction.
PG  - 35-37
LID - 10.1038/nbt.3677 [doi]
AB  - Optimization of a protein's pharmaceutical properties is usually carried out by
      rational design and/or directed evolution. Here we test an alternative approach
      based on ancestral sequence reconstruction. Using available genomic sequence data
      on coagulation factor VIII and predictive models of molecular evolution, we
      engineer protein variants with improved activity, stability, and biosynthesis
      potential and reduced inhibition by anti-drug antibodies. In principle, this
      approach can be applied to any protein drug based on a conserved gene sequence.
FAU - Zakas, Philip M
AU  - Zakas PM
AUID- ORCID: http://orcid.org/0000-0002-4919-5182
AD  - Program in Molecular and Systems Pharmacology, Laney Graduate School, Emory
      University, Atlanta, Georgia, USA.
FAU - Brown, Harrison C
AU  - Brown HC
AD  - Program in Molecular and Systems Pharmacology, Laney Graduate School, Emory
      University, Atlanta, Georgia, USA.
FAU - Knight, Kristopher
AU  - Knight K
AD  - Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory
      University School of Medicine, Atlanta, Georgia, USA.
FAU - Meeks, Shannon L
AU  - Meeks SL
AUID- ORCID: http://orcid.org/0000-0002-3683-8644
AD  - Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory
      University School of Medicine, Atlanta, Georgia, USA.
FAU - Spencer, H Trent
AU  - Spencer HT
AD  - Program in Molecular and Systems Pharmacology, Laney Graduate School, Emory
      University, Atlanta, Georgia, USA.
AD  - Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory
      University School of Medicine, Atlanta, Georgia, USA.
FAU - Gaucher, Eric A
AU  - Gaucher EA
AD  - School of Biology, Institute for Bioengineering and Biosciences, Georgia
      Institute of Technology, Atlanta, Georgia, USA.
FAU - Doering, Christopher B
AU  - Doering CB
AD  - Program in Molecular and Systems Pharmacology, Laney Graduate School, Emory
      University, Atlanta, Georgia, USA.
AD  - Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory
      University School of Medicine, Atlanta, Georgia, USA.
LA  - eng
GR  - T32 GM008602/GM/NIGMS NIH HHS/United States
GR  - U54 HL112309/HL/NHLBI NIH HHS/United States
PT  - Journal Article
DEP - 20160926
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Proteins)
RN  - 9001-27-8 (Factor VIII)
SB  - IM
MH  - Conserved Sequence/*genetics
MH  - Drug Discovery/*methods
MH  - *Drug Synergism
MH  - Factor VIII/*genetics/therapeutic use
MH  - Protein Engineering/*methods
MH  - Proteins/*genetics/therapeutic use
MH  - Sequence Homology, Amino Acid
PMC - PMC5225049
MID - NIHMS812425
COIS- STATEMENT Drs. Doering, Gaucher, Spencer and Zakas are inventors on a patent
      application describing ancestral FVIII technology filed by Emory
      University/Children's Healthcare of Atlanta and Georgia Institute of Technology. 
      Drs. Doering and Spencer are co-founders Expression Therapeutics and own equity
      in the company. Expression Therapeutics owns the intellectual property associated
      with ET3. The terms of this arrangement have been reviewed and approved by Emory 
      University in accordance with its conflict of interest policies.
EDAT- 2016/11/01 06:00
MHDA- 2017/06/07 06:00
CRDT- 2016/11/08 06:00
PHST- 2016/02/01 00:00 [received]
PHST- 2016/08/22 00:00 [accepted]
PHST- 2016/11/01 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2016/11/08 06:00 [entrez]
AID - nbt.3677 [pii]
AID - 10.1038/nbt.3677 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2017 Jan;35(1):35-37. doi: 10.1038/nbt.3677. Epub 2016 Sep 26.

PMID- 27926727
OWN - NLM
STAT- In-Data-Review
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 12
DP  - 2016 Dec 7
TI  - Interactive and scalable biology cloud experimentation for scientific inquiry and
      education.
PG  - 1293-1298
LID - 10.1038/nbt.3747 [doi]
FAU - Hossain, Zahid
AU  - Hossain Z
AD  - Department of Bioengineering, Stanford University, Stanford, California, USA.
AD  - Department of Computer Science, Stanford University, Stanford, California, USA.
FAU - Bumbacher, Engin W
AU  - Bumbacher EW
AD  - Graduate School of Education, Stanford University, Stanford, California, USA.
FAU - Chung, Alice M
AU  - Chung AM
AD  - Department of Bioengineering, Stanford University, Stanford, California, USA.
FAU - Kim, Honesty
AU  - Kim H
AD  - Department of Bioengineering, Stanford University, Stanford, California, USA.
FAU - Litton, Casey
AU  - Litton C
AD  - Department of Bioengineering, Stanford University, Stanford, California, USA.
FAU - Walter, Ashley D
AU  - Walter AD
AD  - Northwestern University, Evanston, Illinois, USA.
FAU - Pradhan, Sachin N
AU  - Pradhan SN
AD  - Northwestern University, Evanston, Illinois, USA.
FAU - Jona, Kemi
AU  - Jona K
AD  - Northwestern University, Evanston, Illinois, USA.
FAU - Blikstein, Paulo
AU  - Blikstein P
AD  - Graduate School of Education, Stanford University, Stanford, California, USA.
FAU - Riedel-Kruse, Ingmar H
AU  - Riedel-Kruse IH
AD  - Department of Bioengineering, Stanford University, Stanford, California, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/12/08 06:00
MHDA- 2016/12/08 06:00
CRDT- 2016/12/08 06:00
PHST- 2016/12/08 06:00 [entrez]
PHST- 2016/12/08 06:00 [pubmed]
PHST- 2016/12/08 06:00 [medline]
AID - nbt.3747 [pii]
AID - 10.1038/nbt.3747 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Dec 7;34(12):1293-1298. doi: 10.1038/nbt.3747.

PMID- 27926726
OWN - NLM
STAT- In-Data-Review
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 12
DP  - 2016 Dec 7
TI  - Erratum: Rekindling cancer vaccines.
PG  - 1292
LID - 10.1038/nbt1216-1292c [doi]
FAU - Branca, Malorye Allison
AU  - Branca MA
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/12/08 06:00
MHDA- 2016/12/08 06:00
CRDT- 2016/12/08 06:00
PHST- 2016/12/08 06:00 [entrez]
PHST- 2016/12/08 06:00 [pubmed]
PHST- 2016/12/08 06:00 [medline]
AID - nbt1216-1292c [pii]
AID - 10.1038/nbt1216-1292c [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Dec 7;34(12):1292. doi: 10.1038/nbt1216-1292c.

PMID- 27926725
OWN - NLM
STAT- In-Data-Review
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 12
DP  - 2016 Dec 7
TI  - An update on obtaining and enforcing therapeutic antibody patent claims.
PG  - 1242-1244
LID - 10.1038/nbt.3735 [doi]
FAU - Gresl, Theresa
AU  - Gresl T
AD  - International Maize and Wheat Improvement Center (CIMMYT), El Batan, Texcoco,
      Mexico.
FAU - Storz, Ulrich
AU  - Storz U
AD  - Michalski Huttermann &Partner in Dusseldorf, Germany.
FAU - Sandercock, Colin
AU  - Sandercock C
AD  - Perkins Coie LLP, Washington, DC, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/12/08 06:00
MHDA- 2016/12/08 06:00
CRDT- 2016/12/08 06:00
PHST- 2016/12/08 06:00 [entrez]
PHST- 2016/12/08 06:00 [pubmed]
PHST- 2016/12/08 06:00 [medline]
AID - nbt.3735 [pii]
AID - 10.1038/nbt.3735 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Dec 7;34(12):1242-1244. doi: 10.1038/nbt.3735.

PMID- 27926724
OWN - NLM
STAT- In-Data-Review
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 12
DP  - 2016 Dec 7
TI  - New anti-IL-23 drugs raise hopes for psoriasis plaque clearance.
PG  - 1218-1219
LID - 10.1038/nbt1216-1218 [doi]
FAU - Dolgin, Elie
AU  - Dolgin E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/12/08 06:00
MHDA- 2016/12/08 06:00
CRDT- 2016/12/08 06:00
PHST- 2016/12/08 06:00 [entrez]
PHST- 2016/12/08 06:00 [pubmed]
PHST- 2016/12/08 06:00 [medline]
AID - nbt1216-1218 [pii]
AID - 10.1038/nbt1216-1218 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Dec 7;34(12):1218-1219. doi: 10.1038/nbt1216-1218.

PMID- 27926723
OWN - NLM
STAT- In-Data-Review
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 12
DP  - 2016 Dec 7
TI  - Imagining the future of bioimage analysis.
PG  - 1250-1255
LID - 10.1038/nbt.3722 [doi]
FAU - Meijering, Erik
AU  - Meijering E
AD  - Biomedical Imaging Group Rotterdam, Departments of Medical Informatics and
      Radiology, Erasmus University Medical Center, Rotterdam, the Netherlands.
FAU - Carpenter, Anne E
AU  - Carpenter AE
AD  - Imaging Platform, Broad Institute of Massachusetts Institute of Technology and
      Harvard, Cambridge, Massachusetts, USA.
FAU - Peng, Hanchuan
AU  - Peng H
AUID- ORCID: http://orcid.org/0000-0002-3478-3942
AD  - Allen Institute for Brain Science, Seattle, Washington, USA.
FAU - Hamprecht, Fred A
AU  - Hamprecht FA
AD  - Heidelberg Collaboratory for Image Processing, Heidelberg University, Heidelberg,
      Germany.
FAU - Olivo-Marin, Jean-Christophe
AU  - Olivo-Marin JC
AD  - Institut Pasteur, Unite d'Analyse d'Images Biologiques, Centre National de la
      Recherche Scientifique Unite de Recherche Mixte, Paris, France.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/12/08 06:00
MHDA- 2016/12/08 06:00
CRDT- 2016/12/08 06:00
PHST- 2015/10/31 00:00 [received]
PHST- 2016/11/10 00:00 [accepted]
PHST- 2016/12/08 06:00 [entrez]
PHST- 2016/12/08 06:00 [pubmed]
PHST- 2016/12/08 06:00 [medline]
AID - nbt.3722 [pii]
AID - 10.1038/nbt.3722 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Dec 7;34(12):1250-1255. doi: 10.1038/nbt.3722.

PMID- 27926722
OWN - NLM
STAT- In-Data-Review
LR  - 20161208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 12
DP  - 2016 Dec 7
TI  - Around the world in a month.
PG  - 1221
LID - 10.1038/nbt1216-1221 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/12/08 06:00
MHDA- 2016/12/08 06:00
CRDT- 2016/12/08 06:00
PHST- 2016/12/08 06:00 [entrez]
PHST- 2016/12/08 06:00 [pubmed]
PHST- 2016/12/08 06:00 [medline]
AID - nbt1216-1221 [pii]
AID - 10.1038/nbt1216-1221 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Dec 7;34(12):1221. doi: 10.1038/nbt1216-1221.

PMID- 27926721
OWN - NLM
STAT- In-Data-Review
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 12
DP  - 2016 Dec 7
TI  - Hacking rules for E. coli.
PG  - 1249
LID - 10.1038/nbt.3744 [doi]
FAU - Jarchum, Irene
AU  - Jarchum I
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/12/08 06:00
MHDA- 2016/12/08 06:00
CRDT- 2016/12/08 06:00
PHST- 2016/12/08 06:00 [entrez]
PHST- 2016/12/08 06:00 [pubmed]
PHST- 2016/12/08 06:00 [medline]
AID - nbt.3744 [pii]
AID - 10.1038/nbt.3744 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Dec 7;34(12):1249. doi: 10.1038/nbt.3744.

PMID- 27926720
OWN - NLM
STAT- In-Data-Review
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 12
DP  - 2016 Dec 7
TI  - Trump election sends aftershocks through biotech sector.
PG  - 1211-1212
LID - 10.1038/nbt1216-1211 [doi]
FAU - Morrison, Chris
AU  - Morrison C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/12/08 06:00
MHDA- 2016/12/08 06:00
CRDT- 2016/12/08 06:00
PHST- 2016/12/08 06:00 [entrez]
PHST- 2016/12/08 06:00 [pubmed]
PHST- 2016/12/08 06:00 [medline]
AID - nbt1216-1211 [pii]
AID - 10.1038/nbt1216-1211 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Dec 7;34(12):1211-1212. doi: 10.1038/nbt1216-1211.

PMID- 27926719
OWN - NLM
STAT- In-Data-Review
LR  - 20161208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 12
DP  - 2016 Dec 7
TI  - UK forms a pound1-billion life sciences powerhouse.
PG  - 1212
LID - 10.1038/nbt1216-1212 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/12/08 06:00
MHDA- 2016/12/08 06:00
CRDT- 2016/12/08 06:00
PHST- 2016/12/08 06:00 [entrez]
PHST- 2016/12/08 06:00 [pubmed]
PHST- 2016/12/08 06:00 [medline]
AID - nbt1216-1212 [pii]
AID - 10.1038/nbt1216-1212 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Dec 7;34(12):1212. doi: 10.1038/nbt1216-1212.

PMID- 27926718
OWN - NLM
STAT- In-Data-Review
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 12
DP  - 2016 Dec 7
TI  - Getting stem cell patients 'on the grid'.
PG  - 1228-1230
LID - 10.1038/nbt.3740 [doi]
FAU - Wicks, Paul
AU  - Wicks P
AUID- ORCID: http://orcid.org/0000-0002-2293-9284
AD  - PatientsLikeMe, Cambridge, Massachusetts, USA.
FAU - Heywood, Jamie
AU  - Heywood J
AD  - PatientsLikeMe, Cambridge, Massachusetts, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/12/08 06:00
MHDA- 2016/12/08 06:00
CRDT- 2016/12/08 06:00
PHST- 2016/12/08 06:00 [entrez]
PHST- 2016/12/08 06:00 [pubmed]
PHST- 2016/12/08 06:00 [medline]
AID - nbt.3740 [pii]
AID - 10.1038/nbt.3740 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Dec 7;34(12):1228-1230. doi: 10.1038/nbt.3740.

PMID- 27926717
OWN - NLM
STAT- In-Data-Review
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 12
DP  - 2016 Dec 7
TI  - Alnylam terminates revusiran program, stock plunges.
PG  - 1213-1214
LID - 10.1038/nbt1216-1213 [doi]
FAU - Garber, Ken
AU  - Garber K
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/12/08 06:00
MHDA- 2016/12/08 06:00
CRDT- 2016/12/08 06:00
PHST- 2016/12/08 06:00 [entrez]
PHST- 2016/12/08 06:00 [pubmed]
PHST- 2016/12/08 06:00 [medline]
AID - nbt1216-1213 [pii]
AID - 10.1038/nbt1216-1213 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Dec 7;34(12):1213-1214. doi: 10.1038/nbt1216-1213.

PMID- 27926716
OWN - NLM
STAT- In-Data-Review
LR  - 20180301
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 12
DP  - 2016 Dec 7
TI  - US National Academies report misses the mark.
PG  - 1226-1228
LID - 10.1038/nbt.3746 [doi]
FAU - Giddings, L Val
AU  - Giddings LV
AD  - Information Technology &Innovation Foundation (ITIF), Washington, DC, USA.
FAU - Miller, Henry
AU  - Miller H
AD  - The Hoover Institution, Stanford University, Stanford, California, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
CIN - Nat Biotechnol. 2017 Apr 11;35(4):302-304. PMID: 28398318
EDAT- 2016/12/08 06:00
MHDA- 2016/12/08 06:00
CRDT- 2016/12/08 06:00
PHST- 2016/12/08 06:00 [entrez]
PHST- 2016/12/08 06:00 [pubmed]
PHST- 2016/12/08 06:00 [medline]
AID - nbt.3746 [pii]
AID - 10.1038/nbt.3746 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Dec 7;34(12):1226-1228. doi: 10.1038/nbt.3746.

PMID- 27926715
OWN - NLM
STAT- In-Data-Review
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 12
DP  - 2016 Dec 7
TI  - Despite slow progress, bispecifics generate buzz.
PG  - 1215-1217
LID - 10.1038/nbt1216-1215 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/12/08 06:00
MHDA- 2016/12/08 06:00
CRDT- 2016/12/08 06:00
PHST- 2016/12/08 06:00 [entrez]
PHST- 2016/12/08 06:00 [pubmed]
PHST- 2016/12/08 06:00 [medline]
AID - nbt1216-1215 [pii]
AID - 10.1038/nbt1216-1215 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Dec 7;34(12):1215-1217. doi: 10.1038/nbt1216-1215.

PMID- 27926714
OWN - NLM
STAT- In-Data-Review
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 12
DP  - 2016 Dec 7
TI  - Pfizer drops phase 3 lipid-lowering antibody.
PG  - 1214
LID - 10.1038/nbt1216-1214 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/12/08 06:00
MHDA- 2016/12/08 06:00
CRDT- 2016/12/08 06:00
PHST- 2016/12/08 06:00 [entrez]
PHST- 2016/12/08 06:00 [pubmed]
PHST- 2016/12/08 06:00 [medline]
AID - nbt1216-1214 [pii]
AID - 10.1038/nbt1216-1214 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Dec 7;34(12):1214. doi: 10.1038/nbt1216-1214.

PMID- 27926712
OWN - NLM
STAT- In-Data-Review
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 12
DP  - 2016 Dec 7
TI  - Let there be light-at the right place.
PG  - 1246-1247
LID - 10.1038/nbt.3738 [doi]
FAU - Hufnagel, Lars
AU  - Hufnagel L
AD  - Cell Biology and Biophysics Unit, European Molecular Biology Laboratory,
      Heidelberg, Germany.
FAU - Pepperkok, Rainer
AU  - Pepperkok R
AD  - Cell Biology and Biophysics Unit, European Molecular Biology Laboratory,
      Heidelberg, Germany.
AD  - Advanced Light Microscopy Facility, European Molecular Biology Laboratory,
      Heidelberg, Germany.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/12/08 06:00
MHDA- 2016/12/08 06:00
CRDT- 2016/12/08 06:00
PHST- 2016/12/08 06:00 [entrez]
PHST- 2016/12/08 06:00 [pubmed]
PHST- 2016/12/08 06:00 [medline]
AID - nbt.3738 [pii]
AID - 10.1038/nbt.3738 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Dec 7;34(12):1246-1247. doi: 10.1038/nbt.3738.

PMID- 27926711
OWN - NLM
STAT- In-Data-Review
LR  - 20161208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 12
DP  - 2016 Dec 7
TI  - Closing the deal.
PG  - 1222-1225
LID - 10.1038/nbt.3687 [doi]
FAU - Chitale, Sadhana
AU  - Chitale S
AD  - Office of Industrial Liaison, NYU Langone Medical Center, New York, New York,
      USA.
FAU - Lawler, Colm
AU  - Lawler C
AD  - Partners HealthCare, Innovation, Cambridge, Massachusetts, USA.
FAU - Macfarlane, Scott
AU  - Macfarlane S
AD  - Technology Transfer, SUNY Upstate Medical University, Syracuse, New York, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/12/08 06:00
MHDA- 2016/12/08 06:00
CRDT- 2016/12/08 06:00
PHST- 2016/12/08 06:00 [entrez]
PHST- 2016/12/08 06:00 [pubmed]
PHST- 2016/12/08 06:00 [medline]
AID - nbt.3687 [pii]
AID - 10.1038/nbt.3687 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Dec 7;34(12):1222-1225. doi: 10.1038/nbt.3687.

PMID- 27926710
OWN - NLM
STAT- In-Data-Review
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 12
DP  - 2016 Dec 7
TI  - Erratum: A spark at the periphery.
PG  - 1292
LID - 10.1038/nbt1216-1292b [doi]
FAU - Waltz, Emily
AU  - Waltz E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/12/08 06:00
MHDA- 2016/12/08 06:00
CRDT- 2016/12/08 06:00
PHST- 2016/12/08 06:00 [entrez]
PHST- 2016/12/08 06:00 [pubmed]
PHST- 2016/12/08 06:00 [medline]
AID - nbt1216-1292b [pii]
AID - 10.1038/nbt1216-1292b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Dec 7;34(12):1292. doi: 10.1038/nbt1216-1292b.

PMID- 27926709
OWN - NLM
STAT- In-Data-Review
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 12
DP  - 2016 Dec 7
TI  - Are human oocytes from stem cells next?
PG  - 1247-1248
LID - 10.1038/nbt.3742 [doi]
FAU - Smitz, Johan E J
AU  - Smitz JE
AD  - Follicle Biology Laboratory, University Hospital UZBrussel, Medical School, Vrije
      Universiteit Brussel, Brussels, Belgium.
FAU - Gilchrist, Robert B
AU  - Gilchrist RB
AD  - Discipline of Obstetrics &Gynaecology, School of Women's &Children's Health,
      University of New South Wales, Sydney, New South Wales, Australia.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/12/08 06:00
MHDA- 2016/12/08 06:00
CRDT- 2016/12/08 06:00
PHST- 2016/12/08 06:00 [entrez]
PHST- 2016/12/08 06:00 [pubmed]
PHST- 2016/12/08 06:00 [medline]
AID - nbt.3742 [pii]
AID - 10.1038/nbt.3742 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Dec 7;34(12):1247-1248. doi: 10.1038/nbt.3742.

PMID- 27926708
OWN - NLM
STAT- In-Data-Review
LR  - 20161208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 12
DP  - 2016 Dec 7
TI  - Evolving fixes for drug pricing.
PG  - 1209
LID - 10.1038/nbt.3748 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/12/08 06:00
MHDA- 2016/12/08 06:00
CRDT- 2016/12/08 06:00
PHST- 2016/12/08 06:00 [entrez]
PHST- 2016/12/08 06:00 [pubmed]
PHST- 2016/12/08 06:00 [medline]
AID - nbt.3748 [pii]
AID - 10.1038/nbt.3748 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Dec 7;34(12):1209. doi: 10.1038/nbt.3748.

PMID- 27926707
OWN - NLM
STAT- In-Data-Review
LR  - 20161208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 12
DP  - 2016 Dec 7
TI  - Erratum: Top 20 translational researchers of 2015.
PG  - 1292
LID - 10.1038/nbt1216-1292a [doi]
FAU - Huggett, Brady
AU  - Huggett B
FAU - Paisner, Kathryn
AU  - Paisner K
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/12/08 06:00
MHDA- 2016/12/08 06:00
CRDT- 2016/12/08 06:00
PHST- 2016/12/08 06:00 [entrez]
PHST- 2016/12/08 06:00 [pubmed]
PHST- 2016/12/08 06:00 [medline]
AID - nbt1216-1292a [pii]
AID - 10.1038/nbt1216-1292a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Dec 7;34(12):1292. doi: 10.1038/nbt1216-1292a.

PMID- 27926706
OWN - NLM
STAT- In-Data-Review
LR  - 20161208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 12
DP  - 2016 Dec 7
TI  - First Rounders Podcast: Anu Acharya.
PG  - 1225
LID - 10.1038/nbt.3736 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/12/08 06:00
MHDA- 2016/12/08 06:00
CRDT- 2016/12/08 06:00
PHST- 2016/12/08 06:00 [entrez]
PHST- 2016/12/08 06:00 [pubmed]
PHST- 2016/12/08 06:00 [medline]
AID - nbt.3736 [pii]
AID - 10.1038/nbt.3736 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Dec 7;34(12):1225. doi: 10.1038/nbt.3736.

PMID- 27926704
OWN - NLM
STAT- In-Data-Review
LR  - 20161208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 12
DP  - 2016 Dec 7
TI  - Medtronic automated insulin delivery device gets FDA nod.
PG  - 1220
LID - 10.1038/nbt1216-1220 [doi]
FAU - Smalley, Eric
AU  - Smalley E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/12/08 06:00
MHDA- 2016/12/08 06:00
CRDT- 2016/12/08 06:00
PHST- 2016/12/08 06:00 [entrez]
PHST- 2016/12/08 06:00 [pubmed]
PHST- 2016/12/08 06:00 [medline]
AID - nbt1216-1220 [pii]
AID - 10.1038/nbt1216-1220 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Dec 7;34(12):1220. doi: 10.1038/nbt1216-1220.

PMID- 27926703
OWN - NLM
STAT- In-Data-Review
LR  - 20161208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 12
DP  - 2016 Dec 7
TI  - Recent patents in antibody engineering.
PG  - 1245
LID - 10.1038/nbt.3752 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/12/08 06:00
MHDA- 2016/12/08 06:00
CRDT- 2016/12/08 06:00
PHST- 2016/12/08 06:00 [entrez]
PHST- 2016/12/08 06:00 [pubmed]
PHST- 2016/12/08 06:00 [medline]
AID - nbt.3752 [pii]
AID - 10.1038/nbt.3752 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Dec 7;34(12):1245. doi: 10.1038/nbt.3752.

PMID- 27842061
OWN - NLM
STAT- In-Data-Review
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 12
DP  - 2016 Dec
TI  - America's drug problem.
PG  - 1231-1241
LID - 10.1038/nbt.3734 [doi]
FAU - Huggett, Brady
AU  - Huggett B
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
DEP - 20161114
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/11/15 06:00
MHDA- 2016/11/15 06:00
CRDT- 2016/11/15 06:00
PHST- 2016/11/15 06:00 [pubmed]
PHST- 2016/11/15 06:00 [medline]
PHST- 2016/11/15 06:00 [entrez]
AID - nbt.3734 [pii]
AID - 10.1038/nbt.3734 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Dec;34(12):1231-1241. doi: 10.1038/nbt.3734. Epub 2016 Nov
      14.

PMID- 27819664
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20170803
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 12
DP  - 2016 Dec
TI  - Measurement of bacterial replication rates in microbial communities.
PG  - 1256-1263
LID - 10.1038/nbt.3704 [doi]
AB  - Culture-independent microbiome studies have increased our understanding of the
      complexity and metabolic potential of microbial communities. However, to
      understand the contribution of individual microbiome members to community
      functions, it is important to determine which bacteria are actively replicating. 
      We developed an algorithm, iRep, that uses draft-quality genome sequences and
      single time-point metagenome sequencing to infer microbial population replication
      rates. The algorithm calculates an index of replication (iRep) based on the
      sequencing coverage trend that results from bi-directional genome replication
      from a single origin of replication. We apply this method to show that microbial 
      replication rates increase after antibiotic administration in human infants. We
      also show that uncultivated, groundwater-associated, Candidate Phyla Radiation
      bacteria only rarely replicate quickly in subsurface communities undergoing
      substantial changes in geochemistry. Our method can be applied to any
      genome-resolved microbiome study to track organism responses to varying
      conditions, identify actively growing populations and measure replication rates
      for use in modeling studies.
FAU - Brown, Christopher T
AU  - Brown CT
AUID- ORCID: http://orcid.org/0000-0002-7758-6447
AD  - Department of Plant and Microbial Biology, University of California, Berkeley,
      California, USA.
FAU - Olm, Matthew R
AU  - Olm MR
AD  - Department of Plant and Microbial Biology, University of California, Berkeley,
      California, USA.
FAU - Thomas, Brian C
AU  - Thomas BC
AD  - Department of Earth and Planetary Science, University of California, Berkeley,
      California, USA.
FAU - Banfield, Jillian F
AU  - Banfield JF
AD  - Department of Earth and Planetary Science, University of California, Berkeley,
      California, USA.
AD  - Department of Environmental Science, Policy, and Management, University of
      California, Berkeley, California, USA.
AD  - Earth Sciences Division, Lawrence Berkeley National Laboratory, Berkeley,
      California, USA.
LA  - eng
GR  - R01 AI092531/AI/NIAID NIH HHS/United States
PT  - Journal Article
DEP - 20161107
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Algorithms
MH  - Bacteria/*genetics/isolation & purification
MH  - Bacterial Load/*genetics/*methods
MH  - Cell Proliferation/genetics
MH  - Chromosome Mapping/*methods
MH  - Genome, Bacterial/genetics
MH  - Microbial Consortia/*physiology
MH  - Reproducibility of Results
MH  - Sensitivity and Specificity
PMC - PMC5538567
MID - NIHMS884305
EDAT- 2016/11/08 06:00
MHDA- 2017/06/07 06:00
CRDT- 2016/11/08 06:00
PHST- 2016/03/11 00:00 [received]
PHST- 2016/09/20 00:00 [accepted]
PHST- 2016/11/08 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2016/11/08 06:00 [entrez]
AID - nbt.3704 [pii]
AID - 10.1038/nbt.3704 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Dec;34(12):1256-1263. doi: 10.1038/nbt.3704. Epub 2016 Nov
      7.

PMID- 27798564
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20180404
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 12
DP  - 2016 Dec
TI  - Single-cell sequencing of the small-RNA transcriptome.
PG  - 1264-1266
LID - 10.1038/nbt.3701 [doi]
AB  - Little is known about the heterogeneity of small-RNA expression as small-RNA
      profiling has so far required large numbers of cells. Here we present a
      single-cell method for small-RNA sequencing and apply it to naive and primed
      human embryonic stem cells and cancer cells. Analysis of microRNAs and fragments 
      of tRNAs and small nucleolar RNAs (snoRNAs) reveals the potential of microRNAs as
      markers for different cell types and states.
FAU - Faridani, Omid R
AU  - Faridani OR
AD  - Ludwig Institute for Cancer Research, Stockholm, Sweden.
FAU - Abdullayev, Ilgar
AU  - Abdullayev I
AD  - Ludwig Institute for Cancer Research, Stockholm, Sweden.
AD  - Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm,
      Sweden.
FAU - Hagemann-Jensen, Michael
AU  - Hagemann-Jensen M
AD  - Ludwig Institute for Cancer Research, Stockholm, Sweden.
AD  - Respiratory Medicine Unit, Department of Medicine, Solna &Center for Molecular
      Medicine, Stockholm, Sweden.
FAU - Schell, John P
AU  - Schell JP
AD  - Department of Clinical Science, Intervention and Technology, Karolinska
      Institutet, Stockholm, Sweden.
AD  - Division of Obstetrics and Gynecology, Karolinska University Hospital, Stockholm,
      Sweden.
FAU - Lanner, Fredrik
AU  - Lanner F
AD  - Department of Clinical Science, Intervention and Technology, Karolinska
      Institutet, Stockholm, Sweden.
AD  - Division of Obstetrics and Gynecology, Karolinska University Hospital, Stockholm,
      Sweden.
FAU - Sandberg, Rickard
AU  - Sandberg R
AUID- ORCID: http://orcid.org/0000-0001-6473-1740
AD  - Ludwig Institute for Cancer Research, Stockholm, Sweden.
AD  - Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm,
      Sweden.
LA  - eng
PT  - Journal Article
DEP - 20161031
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (MicroRNAs)
SB  - IM
CIN - Sci Transl Med. 2016 Nov 16;8(365):365ec185. PMID: 27856794
MH  - Cell Line, Tumor
MH  - Cells, Cultured
MH  - High-Throughput Nucleotide Sequencing/*methods
MH  - Human Embryonic Stem Cells/*physiology
MH  - Humans
MH  - MicroRNAs/*genetics
MH  - Neoplasms, Experimental/*genetics
MH  - Sequence Analysis, RNA/*methods
MH  - Transcriptome/*genetics
EDAT- 2016/11/01 06:00
MHDA- 2017/06/07 06:00
CRDT- 2016/11/08 06:00
PHST- 2016/04/29 00:00 [received]
PHST- 2016/09/18 00:00 [accepted]
PHST- 2016/11/01 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2016/11/08 06:00 [entrez]
AID - nbt.3701 [pii]
AID - 10.1038/nbt.3701 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Dec;34(12):1264-1266. doi: 10.1038/nbt.3701. Epub 2016 Oct
      31.

PMID- 27798563
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20170912
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 12
DP  - 2016 Dec
TI  - Genome-scale deletion screening of human long non-coding RNAs using a
      paired-guide RNA CRISPR-Cas9 library.
PG  - 1279-1286
LID - 10.1038/nbt.3715 [doi]
AB  - CRISPR-Cas9 screens have been widely adopted to analyze coding-gene functions,
      but high-throughput screening of non-coding elements using this method is more
      challenging because indels caused by a single cut in non-coding regions are
      unlikely to produce a functional knockout. A high-throughput method to produce
      deletions of non-coding DNA is needed. We report a high-throughput genomic
      deletion strategy to screen for functional long non-coding RNAs (lncRNAs) that is
      based on a lentiviral paired-guide RNA (pgRNA) library. Applying our screening
      method, we identified 51 lncRNAs that can positively or negatively regulate human
      cancer cell growth. We validated 9 of 51 lncRNA hits using CRISPR-Cas9-mediated
      genomic deletion, functional rescue, CRISPR activation or inhibition and
      gene-expression profiling. Our high-throughput pgRNA genome deletion method will 
      enable rapid identification of functional mammalian non-coding elements.
FAU - Zhu, Shiyou
AU  - Zhu S
AD  - Biodynamic Optical Imaging Center (BIOPIC), Beijing Advanced Innovation Center
      for Genomics, Peking-Tsinghua Center for Life Sciences, State Key Laboratory of
      Protein and Plant Gene Research, School of Life Sciences, Peking University,
      Beijing, China.
AD  - Peking University-Tsinghua University-National Institute of Biological Sciences
      Joint Graduate Program (PTN), Peking University, China.
FAU - Li, Wei
AU  - Li W
AD  - Department of Biostatistics and Computational Biology, Dana-Farber Cancer
      Institute, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
AD  - Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston,
      Massachusetts, USA.
FAU - Liu, Jingze
AU  - Liu J
AD  - Biodynamic Optical Imaging Center (BIOPIC), Beijing Advanced Innovation Center
      for Genomics, Peking-Tsinghua Center for Life Sciences, State Key Laboratory of
      Protein and Plant Gene Research, School of Life Sciences, Peking University,
      Beijing, China.
AD  - Peking University-Tsinghua University-National Institute of Biological Sciences
      Joint Graduate Program (PTN), Peking University, China.
FAU - Chen, Chen-Hao
AU  - Chen CH
AD  - Department of Biostatistics and Computational Biology, Dana-Farber Cancer
      Institute, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
AD  - Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston,
      Massachusetts, USA.
FAU - Liao, Qi
AU  - Liao Q
AD  - Department of Prevention Medicine, School of Medicine, Ningbo University, Ningbo,
      Zhejiang, China.
FAU - Xu, Ping
AU  - Xu P
AD  - Biodynamic Optical Imaging Center (BIOPIC), Beijing Advanced Innovation Center
      for Genomics, Peking-Tsinghua Center for Life Sciences, State Key Laboratory of
      Protein and Plant Gene Research, School of Life Sciences, Peking University,
      Beijing, China.
FAU - Xu, Han
AU  - Xu H
AD  - Broad Institute of MIT and Harvard, Cambridge Center, Cambridge, Massachusetts,
      USA.
FAU - Xiao, Tengfei
AU  - Xiao T
AD  - Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston,
      Massachusetts, USA.
AD  - Division of Molecular and Cellular Oncology, Department of Medical Oncology,
      Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
FAU - Cao, Zhongzheng
AU  - Cao Z
AD  - Biodynamic Optical Imaging Center (BIOPIC), Beijing Advanced Innovation Center
      for Genomics, Peking-Tsinghua Center for Life Sciences, State Key Laboratory of
      Protein and Plant Gene Research, School of Life Sciences, Peking University,
      Beijing, China.
AD  - Academy for Advanced Interdisciplinary Studies, Peking University, Beijing,
      China.
FAU - Peng, Jingyu
AU  - Peng J
AD  - Biodynamic Optical Imaging Center (BIOPIC), Beijing Advanced Innovation Center
      for Genomics, Peking-Tsinghua Center for Life Sciences, State Key Laboratory of
      Protein and Plant Gene Research, School of Life Sciences, Peking University,
      Beijing, China.
FAU - Yuan, Pengfei
AU  - Yuan P
AD  - Biodynamic Optical Imaging Center (BIOPIC), Beijing Advanced Innovation Center
      for Genomics, Peking-Tsinghua Center for Life Sciences, State Key Laboratory of
      Protein and Plant Gene Research, School of Life Sciences, Peking University,
      Beijing, China.
FAU - Brown, Myles
AU  - Brown M
AD  - Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston,
      Massachusetts, USA.
AD  - Division of Molecular and Cellular Oncology, Department of Medical Oncology,
      Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
AD  - Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 
      Boston, Massachusetts, USA.
FAU - Liu, Xiaole Shirley
AU  - Liu XS
AD  - Department of Biostatistics and Computational Biology, Dana-Farber Cancer
      Institute, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
AD  - Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston,
      Massachusetts, USA.
FAU - Wei, Wensheng
AU  - Wei W
AD  - Biodynamic Optical Imaging Center (BIOPIC), Beijing Advanced Innovation Center
      for Genomics, Peking-Tsinghua Center for Life Sciences, State Key Laboratory of
      Protein and Plant Gene Research, School of Life Sciences, Peking University,
      Beijing, China.
LA  - eng
GR  - R01 HG008728/HG/NHGRI NIH HHS/United States
GR  - U01 CA180980/CA/NCI NIH HHS/United States
PT  - Journal Article
DEP - 20161031
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (RNA, Long Noncoding)
SB  - IM
MH  - CRISPR-Cas Systems/*genetics
MH  - Chromosome Mapping/*methods
MH  - Clustered Regularly Interspaced Short Palindromic Repeats/*genetics
MH  - *Gene Deletion
MH  - Genetic Testing/methods
MH  - Genome, Human/*genetics
MH  - High-Throughput Nucleotide Sequencing/methods
MH  - Humans
MH  - RNA, Long Noncoding/*genetics
MH  - Sequence Analysis, RNA/methods
PMC - PMC5592164
MID - NIHMS893054
EDAT- 2016/11/01 06:00
MHDA- 2017/06/07 06:00
CRDT- 2016/11/08 06:00
PHST- 2015/12/15 00:00 [received]
PHST- 2016/09/30 00:00 [accepted]
PHST- 2016/11/01 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2016/11/08 06:00 [entrez]
AID - nbt.3715 [pii]
AID - 10.1038/nbt.3715 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Dec;34(12):1279-1286. doi: 10.1038/nbt.3715. Epub 2016 Oct
      31.

PMID- 27798562
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 12
DP  - 2016 Dec
TI  - Adaptive light-sheet microscopy for long-term, high-resolution imaging in living 
      organisms.
PG  - 1267-1278
LID - 10.1038/nbt.3708 [doi]
AB  - Optimal image quality in light-sheet microscopy requires a perfect overlap
      between the illuminating light sheet and the focal plane of the detection
      objective. However, mismatches between the light-sheet and detection planes are
      common owing to the spatiotemporally varying optical properties of living
      specimens. Here we present the AutoPilot framework, an automated method for
      spatiotemporally adaptive imaging that integrates (i) a multi-view light-sheet
      microscope capable of digitally translating and rotating light-sheet and
      detection planes in three dimensions and (ii) a computational method that
      continuously optimizes spatial resolution across the specimen volume in real
      time. We demonstrate long-term adaptive imaging of entire developing zebrafish
      (Danio rerio) and Drosophila melanogaster embryos and perform adaptive
      whole-brain functional imaging in larval zebrafish. Our method improves spatial
      resolution and signal strength two to five-fold, recovers cellular and
      sub-cellular structures in many regions that are not resolved by non-adaptive
      imaging, adapts to spatiotemporal dynamics of genetically encoded fluorescent
      markers and robustly optimizes imaging performance during large-scale
      morphogenetic changes in living organisms.
FAU - Royer, Loic A
AU  - Royer LA
AUID- ORCID: http://orcid.org/0000-0002-9991-9724
AD  - Howard Hughes Medical Institute, Janelia Research Campus, Ashburn, Virginia, USA.
AD  - Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.
FAU - Lemon, William C
AU  - Lemon WC
AD  - Howard Hughes Medical Institute, Janelia Research Campus, Ashburn, Virginia, USA.
FAU - Chhetri, Raghav K
AU  - Chhetri RK
AD  - Howard Hughes Medical Institute, Janelia Research Campus, Ashburn, Virginia, USA.
FAU - Wan, Yinan
AU  - Wan Y
AD  - Howard Hughes Medical Institute, Janelia Research Campus, Ashburn, Virginia, USA.
FAU - Coleman, Michael
AU  - Coleman M
AD  - Coleman Technologies Incorporated, Newtown Square, Pennsylvania, USA.
FAU - Myers, Eugene W
AU  - Myers EW
AD  - Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.
FAU - Keller, Philipp J
AU  - Keller PJ
AD  - Howard Hughes Medical Institute, Janelia Research Campus, Ashburn, Virginia, USA.
LA  - eng
PT  - Journal Article
DEP - 20161031
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Algorithms
MH  - Animals
MH  - Drosophila
MH  - Embryo, Nonmammalian/*cytology
MH  - Equipment Design
MH  - Equipment Failure Analysis
MH  - Feedback
MH  - Image Enhancement/*instrumentation/*methods
MH  - Lasers
MH  - Lenses
MH  - Lighting/instrumentation/methods
MH  - Longitudinal Studies
MH  - Microscopy, Fluorescence/*instrumentation/*methods
MH  - Reproducibility of Results
MH  - Sensitivity and Specificity
MH  - Zebrafish
EDAT- 2016/11/01 06:00
MHDA- 2017/06/07 06:00
CRDT- 2016/11/08 06:00
PHST- 2016/03/25 00:00 [received]
PHST- 2016/09/16 00:00 [accepted]
PHST- 2016/11/01 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2016/11/08 06:00 [entrez]
AID - nbt.3708 [pii]
AID - 10.1038/nbt.3708 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Dec;34(12):1267-1278. doi: 10.1038/nbt.3708. Epub 2016 Oct
      31.

PMID- 27669167
OWN - NLM
STAT- MEDLINE
DCOM- 20170606
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 12
DP  - 2016 Dec
TI  - Modeling of RNA-seq fragment sequence bias reduces systematic errors in
      transcript abundance estimation.
PG  - 1287-1291
LID - 10.1038/nbt.3682 [doi]
AB  - We find that current computational methods for estimating transcript abundance
      from RNA-seq data can lead to hundreds of false-positive results. We show that
      these systematic errors stem largely from a failure to model fragment GC content 
      bias. Sample-specific biases associated with fragment sequence features lead to
      misidentification of transcript isoforms. We introduce alpine, a method for
      estimating sample-specific bias-corrected transcript abundance. By incorporating 
      fragment sequence features, alpine greatly increases the accuracy of transcript
      abundance estimates, enabling a fourfold reduction in the number of false
      positives for reported changes in expression compared with Cufflinks. Using
      simulated data, we also show that alpine retains the ability to discover true
      positives, similar to other approaches. The method is available as an
      R/Bioconductor package that includes data visualization tools useful for bias
      discovery.
FAU - Love, Michael I
AU  - Love MI
AUID- ORCID: http://orcid.org/0000-0001-8401-0545
AD  - Department of Biostatistics and Computational Biology, Dana-Farber Cancer
      Institute, Boston, Massachusetts, USA.
AD  - Department of Biostatistics, Harvard TH Chan School of Public Health, Boston,
      Massachusetts, USA.
FAU - Hogenesch, John B
AU  - Hogenesch JB
AUID- ORCID: http://orcid.org/0000-0002-9138-8973
AD  - Department of Pharmacology, Institute for Translational Medicine and
      Therapeutics, University of Pennsylvania School of Medicine, Philadelphia,
      Pennsylvania, USA.
FAU - Irizarry, Rafael A
AU  - Irizarry RA
AD  - Department of Biostatistics and Computational Biology, Dana-Farber Cancer
      Institute, Boston, Massachusetts, USA.
AD  - Department of Biostatistics, Harvard TH Chan School of Public Health, Boston,
      Massachusetts, USA.
LA  - eng
GR  - R01 HG005220/HG/NHGRI NIH HHS/United States
GR  - R01 NS054794/NS/NINDS NIH HHS/United States
GR  - T32 CA009337/CA/NCI NIH HHS/United States
PT  - Journal Article
DEP - 20160926
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Transcription Factors)
RN  - 63231-63-0 (RNA)
SB  - IM
MH  - Algorithms
MH  - *Artifacts
MH  - Base Composition/*genetics
MH  - Computer Simulation
MH  - *Models, Genetic
MH  - *Models, Statistical
MH  - RNA/*genetics
MH  - Reproducibility of Results
MH  - Sensitivity and Specificity
MH  - Sequence Analysis, RNA
MH  - Software
MH  - Transcription Factors/*genetics
PMC - PMC5143225
MID - NIHMS812426
EDAT- 2016/11/01 06:00
MHDA- 2017/06/07 06:00
CRDT- 2016/11/08 06:00
PHST- 2015/09/01 00:00 [received]
PHST- 2016/08/22 00:00 [accepted]
PHST- 2016/11/01 06:00 [pubmed]
PHST- 2017/06/07 06:00 [medline]
PHST- 2016/11/08 06:00 [entrez]
AID - nbt.3682 [pii]
AID - 10.1038/nbt.3682 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Dec;34(12):1287-1291. doi: 10.1038/nbt.3682. Epub 2016 Sep
      26.

PMID- 27893702
OWN - NLM
STAT- In-Data-Review
LR  - 20171101
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 35
IP  - 1
DP  - 2016 Nov 28
TI  - Failure to detect DNA-guided genome editing using Natronobacterium gregoryi
      Argonaute.
PG  - 17-18
LID - 10.1038/nbt.3753 [doi]
FAU - Lee, Seung Hwan
AU  - Lee SH
AD  - Center for Genome Engineering, Institute for Basic Science (IBS), Seoul, South
      Korea.
FAU - Turchiano, Giandomenico
AU  - Turchiano G
AUID- ORCID: http://orcid.org/0000-0001-9980-6810
AD  - Institute for Cell and Gene Therapy, Medical Center-University of Freiburg,
      Freiburg, Germany.
AD  - Center for Chronic Immunodeficiency, Medical Center-University of Freiburg,
      Freiburg, Germany.
FAU - Ata, Hirotaka
AU  - Ata H
AD  - Mayo Graduate School, Mayo Clinic, Rochester, Minnesota, USA.
FAU - Nowsheen, Somaira
AU  - Nowsheen S
AD  - Mayo Graduate School, Mayo Clinic, Rochester, Minnesota, USA.
FAU - Romito, Marianna
AU  - Romito M
AD  - Institute for Cell and Gene Therapy, Medical Center-University of Freiburg,
      Freiburg, Germany.
AD  - Center for Chronic Immunodeficiency, Medical Center-University of Freiburg,
      Freiburg, Germany.
AD  - Graduate School, Faculty of Biology, University of Freiburg, Freiburg, Germany.
FAU - Lou, Zhenkun
AU  - Lou Z
AD  - Division of Oncology Research, Mayo Clinic, Rochester, Minnesota, USA.
FAU - Ryu, Seuk-Min
AU  - Ryu SM
AD  - Center for Genome Engineering, Institute for Basic Science (IBS), Seoul, South
      Korea.
AD  - Department of Chemistry, Seoul National University, Seoul, South Korea.
FAU - Ekker, Stephen C
AU  - Ekker SC
AUID- ORCID: http://orcid.org/0000-0003-0726-4212
AD  - Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester,
      Minnesota, USA.
FAU - Cathomen, Toni
AU  - Cathomen T
AUID- ORCID: http://orcid.org/0000-0002-7757-4630
AD  - Institute for Cell and Gene Therapy, Medical Center-University of Freiburg,
      Freiburg, Germany.
AD  - Center for Chronic Immunodeficiency, Medical Center-University of Freiburg,
      Freiburg, Germany.
AD  - Faculty of Medicine, University of Freiburg, Freiburg, Germany.
FAU - Kim, Jin-Soo
AU  - Kim JS
AD  - Center for Genome Engineering, Institute for Basic Science (IBS), Seoul, South
      Korea.
AD  - Department of Chemistry, Seoul National University, Seoul, South Korea.
LA  - eng
GR  - R01 DA014546/DA/NIDA NIH HHS/United States
GR  - R01 GM063904/GM/NIGMS NIH HHS/United States
GR  - R01 HG006431/HG/NHGRI NIH HHS/United States
GR  - R56 GM063904/GM/NIGMS NIH HHS/United States
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
PMC - PMC5662444
MID - NIHMS867721
EDAT- 2016/11/29 06:00
MHDA- 2016/11/29 06:00
CRDT- 2016/11/29 06:00
PHST- 2016/11/29 06:00 [pubmed]
PHST- 2016/11/29 06:00 [medline]
PHST- 2016/11/29 06:00 [entrez]
AID - nbt.3753 [pii]
AID - 10.1038/nbt.3753 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov 28;35(1):17-18. doi: 10.1038/nbt.3753.

PMID- 27824856
OWN - NLM
STAT- In-Data-Review
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov 8
TI  - Amgen's migraine antibody advances.
PG  - 1084
LID - 10.1038/nbt1116-1084a [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/11/09 06:00
MHDA- 2016/11/09 06:00
CRDT- 2016/11/09 06:00
PHST- 2016/11/09 06:00 [entrez]
PHST- 2016/11/09 06:00 [pubmed]
PHST- 2016/11/09 06:00 [medline]
AID - nbt1116-1084a [pii]
AID - 10.1038/nbt1116-1084a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov 8;34(11):1084. doi: 10.1038/nbt1116-1084a.

PMID- 27824855
OWN - NLM
STAT- In-Data-Review
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov 8
TI  - Confounding factors in identification of disease-resilient individuals.
PG  - 1103-1104
LID - 10.1038/nbt.3684 [doi]
FAU - Rosenblatt, David S
AU  - Rosenblatt DS
AD  - Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
AD  - Research Institute, McGill University Health Centre, Montreal, Quebec, Canada.
FAU - Watkins, David
AU  - Watkins D
AD  - Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
AD  - Research Institute, McGill University Health Centre, Montreal, Quebec, Canada.
FAU - Rajabi, Farrah
AU  - Rajabi F
AD  - Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Levy, Harvey L
AU  - Levy HL
AD  - Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
AD  - Division of Genetics and Genomics, Boston Children's Hospital, Boston,
      Massachusetts, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/11/09 06:00
MHDA- 2016/11/09 06:00
CRDT- 2016/11/09 06:00
PHST- 2016/11/09 06:00 [entrez]
PHST- 2016/11/09 06:00 [pubmed]
PHST- 2016/11/09 06:00 [medline]
AID - nbt.3684 [pii]
AID - 10.1038/nbt.3684 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov 8;34(11):1103-1104. doi: 10.1038/nbt.3684.

PMID- 27824854
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20171109
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov 8
TI  - Revealing the vectors of cellular identity with single-cell genomics.
PG  - 1145-1160
LID - 10.1038/nbt.3711 [doi]
AB  - Single-cell genomics has now made it possible to create a comprehensive atlas of 
      human cells. At the same time, it has reopened definitions of a cell's identity
      and of the ways in which identity is regulated by the cell's molecular circuitry.
      Emerging computational analysis methods, especially in single-cell RNA sequencing
      (scRNA-seq), have already begun to reveal, in a data-driven way, the diverse
      simultaneous facets of a cell's identity, from discrete cell types to continuous 
      dynamic transitions and spatial locations. These developments will eventually
      allow a cell to be represented as a superposition of 'basis vectors', each
      determining a different (but possibly dependent) aspect of cellular organization 
      and function. However, computational methods must also overcome considerable
      challenges-from handling technical noise and data scale to forming new
      abstractions of biology. As the scale of single-cell experiments continues to
      increase, new computational approaches will be essential for constructing and
      characterizing a reference map of cell identities.
FAU - Wagner, Allon
AU  - Wagner A
AD  - Department of Electrical Engineering and Computer Science and the Center for
      Computational Biology, University of California, Berkeley, California, USA.
FAU - Regev, Aviv
AU  - Regev A
AD  - Howard Hughes Medical Institute, Department of Biology, Massachusetts Institute
      of Technology, Cambridge, Massachusetts, USA.
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
FAU - Yosef, Nir
AU  - Yosef N
AD  - Department of Electrical Engineering and Computer Science and the Center for
      Computational Biology, University of California, Berkeley, California, USA.
AD  - Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of
      Technology, and Harvard University, Boston, Massachusetts, USA.
LA  - eng
GR  - U24 CA180922/CA/NCI NIH HHS/United States
GR  - P30 CA014051/CA/NCI NIH HHS/United States
GR  - U01 MH105979/MH/NIMH NIH HHS/United States
GR  - U01 MH105960/MH/NIMH NIH HHS/United States
GR  - Howard Hughes Medical Institute/United States
GR  - P50 HG006193/HG/NHGRI NIH HHS/United States
GR  - U24 AI118672/AI/NIAID NIH HHS/United States
GR  - RM1 HG006193/HG/NHGRI NIH HHS/United States
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Proteome)
SB  - IM
MH  - Animals
MH  - Cell Physiological Phenomena/*physiology
MH  - Computer Simulation
MH  - Gene Expression Profiling/*methods
MH  - Gene Expression Regulation/*physiology
MH  - High-Throughput Nucleotide Sequencing/*methods
MH  - Humans
MH  - Models, Biological
MH  - Proteome/*metabolism
MH  - Signal Transduction/physiology
MH  - Transcriptome/*physiology
PMC - PMC5465644
MID - NIHMS857730
EDAT- 2016/11/09 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/11/09 06:00
PHST- 2016/11/09 06:00 [entrez]
PHST- 2016/11/09 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3711 [pii]
AID - 10.1038/nbt.3711 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov 8;34(11):1145-1160. doi: 10.1038/nbt.3711.

PMID- 27824853
OWN - NLM
STAT- In-Data-Review
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov 8
TI  - Microcantilevers track single-cell mass.
PG  - 1125-1126
LID - 10.1038/nbt.3725 [doi]
FAU - Bashir, Rashid
AU  - Bashir R
AD  - Department of Bioengineering, University of Illinois at Urbana-Champaign, Urbana,
      Illinois, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/11/09 06:00
MHDA- 2016/11/09 06:00
CRDT- 2016/11/09 06:00
PHST- 2016/11/09 06:00 [entrez]
PHST- 2016/11/09 06:00 [pubmed]
PHST- 2016/11/09 06:00 [medline]
AID - nbt.3725 [pii]
AID - 10.1038/nbt.3725 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov 8;34(11):1125-1126. doi: 10.1038/nbt.3725.

PMID- 27824851
OWN - NLM
STAT- In-Data-Review
LR  - 20161109
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov 8
TI  - Regulation of synthetic biology under the Nagoya Protocol.
PG  - 1104-1105
LID - 10.1038/nbt.3716 [doi]
FAU - Manheim, Bruce S
AU  - Manheim BS
AD  - WilmerHale, Washington, DC, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/11/09 06:00
MHDA- 2016/11/09 06:00
CRDT- 2016/11/09 06:00
PHST- 2016/11/09 06:00 [entrez]
PHST- 2016/11/09 06:00 [pubmed]
PHST- 2016/11/09 06:00 [medline]
AID - nbt.3716 [pii]
AID - 10.1038/nbt.3716 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov 8;34(11):1104-1105. doi: 10.1038/nbt.3716.

PMID- 27824850
OWN - NLM
STAT- In-Data-Review
LR  - 20161109
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov 8
TI  - The discombobulation of de-identification.
PG  - 1102-1103
LID - 10.1038/nbt.3696 [doi]
FAU - Phillips, Mark
AU  - Phillips M
AD  - Centre of Genomics and Policy, McGill University, Montreal, Quebec, Canada.
FAU - Knoppers, Bartha M
AU  - Knoppers BM
AD  - Centre of Genomics and Policy, McGill University, Montreal, Quebec, Canada.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/11/09 06:00
MHDA- 2016/11/09 06:00
CRDT- 2016/11/09 06:00
PHST- 2016/11/09 06:00 [entrez]
PHST- 2016/11/09 06:00 [pubmed]
PHST- 2016/11/09 06:00 [medline]
AID - nbt.3696 [pii]
AID - 10.1038/nbt.3696 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov 8;34(11):1102-1103. doi: 10.1038/nbt.3696.

PMID- 27824849
OWN - NLM
STAT- In-Data-Review
LR  - 20161109
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov 8
TI  - Recent patents in RNA-based therapies.
PG  - 1124
LID - 10.1038/nbt.3729 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/11/09 06:00
MHDA- 2016/11/09 06:00
CRDT- 2016/11/09 06:00
PHST- 2016/11/09 06:00 [entrez]
PHST- 2016/11/09 06:00 [pubmed]
PHST- 2016/11/09 06:00 [medline]
AID - nbt.3729 [pii]
AID - 10.1038/nbt.3729 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov 8;34(11):1124. doi: 10.1038/nbt.3729.

PMID- 27824848
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov 8
TI  - Challenges in long-term imaging and quantification of single-cell dynamics.
PG  - 1137-1144
LID - 10.1038/nbt.3713 [doi]
AB  - Continuous analysis of single cells, over several cell divisions and for up to
      weeks at a time, is crucial to deciphering rare, dynamic and heterogeneous cell
      responses, which would otherwise be missed by population or single-cell snapshot 
      analysis. Although the field of long-term single-cell imaging, tracking and
      analysis is constantly advancing, several technical challenges continue to hinder
      wider implementation of this important approach. This is a particular problem for
      mammalian cells, where in vitro observation usually remains the only possible
      option for uninterrupted long-term, single-cell observation. Efforts must focus
      not only on identifying and maintaining culture conditions that support normal
      cellular behavior while allowing high-resolution imaging over time, but also on
      developing computational methods that enable semiautomatic analysis of the data. 
      Solutions in microscopy hard- and software, computer vision and specialized
      theoretical methods for analysis of dynamic single-cell data will enable
      important discoveries in biology and beyond.
FAU - Skylaki, Stavroula
AU  - Skylaki S
AD  - Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
FAU - Hilsenbeck, Oliver
AU  - Hilsenbeck O
AD  - Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
FAU - Schroeder, Timm
AU  - Schroeder T
AD  - Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - Cell Physiological Phenomena/*physiology
MH  - Cell Tracking/*methods
MH  - Humans
MH  - Image Enhancement/*methods
MH  - Longitudinal Studies
MH  - Microscopy/*methods
MH  - Molecular Imaging/*methods
MH  - Pattern Recognition, Automated/*methods
EDAT- 2016/11/09 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/11/09 06:00
PHST- 2016/07/15 00:00 [received]
PHST- 2016/09/28 00:00 [accepted]
PHST- 2016/11/09 06:00 [entrez]
PHST- 2016/11/09 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3713 [pii]
AID - 10.1038/nbt.3713 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov 8;34(11):1137-1144. doi: 10.1038/nbt.3713.

PMID- 27824847
OWN - NLM
STAT- In-Data-Review
LR  - 20180301
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov 8
TI  - Railroading at the FDA.
PG  - 1078
LID - 10.1038/nbt.3733 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
CIN - Nat Biotechnol. 2017 Mar 7;35(3):207-209. PMID: 28267731
EDAT- 2016/11/09 06:00
MHDA- 2016/11/09 06:00
CRDT- 2016/11/09 06:00
PHST- 2016/11/09 06:00 [entrez]
PHST- 2016/11/09 06:00 [pubmed]
PHST- 2016/11/09 06:00 [medline]
AID - nbt.3733 [pii]
AID - 10.1038/nbt.3733 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov 8;34(11):1078. doi: 10.1038/nbt.3733.

PMID- 27824846
OWN - NLM
STAT- In-Data-Review
LR  - 20161109
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov 8
TI  - Third-quarter biotech job picture.
PG  - 1207
LID - 10.1038/nbt.3726 [doi]
FAU - Francisco, Michael
AU  - Francisco M
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/11/09 06:00
MHDA- 2016/11/09 06:00
CRDT- 2016/11/09 06:00
PHST- 2016/11/09 06:00 [entrez]
PHST- 2016/11/09 06:00 [pubmed]
PHST- 2016/11/09 06:00 [medline]
AID - nbt.3726 [pii]
AID - 10.1038/nbt.3726 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov 8;34(11):1207. doi: 10.1038/nbt.3726.

PMID- 27824845
OWN - NLM
STAT- In-Data-Review
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov 8
TI  - Venturing across the Atlantic.
PG  - 1095-1098
LID - 10.1038/nbt.3712 [doi]
FAU - Rooswinkel, Rogier W
AU  - Rooswinkel RW
AD  - Forbion Capital Partners, Naarden, the Netherlands.
FAU - Berbers, Daan S W
AU  - Berbers DS
AD  - Biogeneration Ventures, Naarden, the Netherlands.
FAU - Claassen, Eric H J H M
AU  - Claassen EH
AD  - Vrije Universiteit, Amsterdam, the Netherlands.
FAU - van Deventer, Sander
AU  - van Deventer S
AD  - Forbion Capital Partners, Naarden, the Netherlands.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/11/09 06:00
MHDA- 2016/11/09 06:00
CRDT- 2016/11/09 06:00
PHST- 2016/11/09 06:00 [entrez]
PHST- 2016/11/09 06:00 [pubmed]
PHST- 2016/11/09 06:00 [medline]
AID - nbt.3712 [pii]
AID - 10.1038/nbt.3712 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov 8;34(11):1095-1098. doi: 10.1038/nbt.3712.

PMID- 27824844
OWN - NLM
STAT- In-Data-Review
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov 8
TI  - Defining cell type with chromatin profiling.
PG  - 1126-1128
LID - 10.1038/nbt.3724 [doi]
FAU - Spivakov, Mikhail
AU  - Spivakov M
AUID- ORCID: http://orcid.org/0000-0002-0383-3943
AD  - Nuclear Dynamics Programme, The Babraham Institute, Cambridge, UK.
FAU - Fraser, Peter
AU  - Fraser P
AD  - Nuclear Dynamics Programme, The Babraham Institute, Cambridge, UK.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/11/09 06:00
MHDA- 2016/11/09 06:00
CRDT- 2016/11/09 06:00
PHST- 2016/11/09 06:00 [entrez]
PHST- 2016/11/09 06:00 [pubmed]
PHST- 2016/11/09 06:00 [medline]
AID - nbt.3724 [pii]
AID - 10.1038/nbt.3724 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov 8;34(11):1126-1128. doi: 10.1038/nbt.3724.

PMID- 27824843
OWN - NLM
STAT- In-Data-Review
LR  - 20161109
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov 8
TI  - Erratum: Defining digital medicine.
PG  - 1206
LID - 10.1038/nbt1116-1206 [doi]
FAU - Elenko, Eric
AU  - Elenko E
FAU - Underwood, Lindsay
AU  - Underwood L
FAU - Zohar, Daphne
AU  - Zohar D
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/11/09 06:00
MHDA- 2016/11/09 06:00
CRDT- 2016/11/09 06:00
PHST- 2016/11/09 06:00 [entrez]
PHST- 2016/11/09 06:00 [pubmed]
PHST- 2016/11/09 06:00 [medline]
AID - nbt1116-1206 [pii]
AID - 10.1038/nbt1116-1206 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov 8;34(11):1206. doi: 10.1038/nbt1116-1206.

PMID- 27824842
OWN - NLM
STAT- In-Data-Review
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov 8
TI  - CAR-T cells forge ahead, Novartis reorganizes.
PG  - 1079-1081
LID - 10.1038/nbt1116-1079 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/11/09 06:00
MHDA- 2016/11/09 06:00
CRDT- 2016/11/09 06:00
PHST- 2016/11/09 06:00 [entrez]
PHST- 2016/11/09 06:00 [pubmed]
PHST- 2016/11/09 06:00 [medline]
AID - nbt1116-1079 [pii]
AID - 10.1038/nbt1116-1079 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov 8;34(11):1079-1081. doi: 10.1038/nbt1116-1079.

PMID- 27824841
OWN - NLM
STAT- In-Data-Review
LR  - 20161109
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov 8
TI  - Single-cell microbiology.
PG  - 1077
LID - 10.1038/nbt.3728 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/11/09 06:00
MHDA- 2016/11/09 06:00
CRDT- 2016/11/09 06:00
PHST- 2016/11/09 06:00 [entrez]
PHST- 2016/11/09 06:00 [pubmed]
PHST- 2016/11/09 06:00 [medline]
AID - nbt.3728 [pii]
AID - 10.1038/nbt.3728 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov 8;34(11):1077. doi: 10.1038/nbt.3728.

PMID- 27824840
OWN - NLM
STAT- In-Data-Review
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov 8
TI  - Hope for anti-amyloid antibodies surges, yet again.
PG  - 1082-1083
LID - 10.1038/nbt1116-1082b [doi]
FAU - Morrison, Chris
AU  - Morrison C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/11/09 06:00
MHDA- 2016/11/09 06:00
CRDT- 2016/11/09 06:00
PHST- 2016/11/09 06:00 [entrez]
PHST- 2016/11/09 06:00 [pubmed]
PHST- 2016/11/09 06:00 [medline]
AID - nbt1116-1082b [pii]
AID - 10.1038/nbt1116-1082b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov 8;34(11):1082-1083. doi: 10.1038/nbt1116-1082b.

PMID- 27824838
OWN - NLM
STAT- In-Data-Review
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov 8
TI  - The cancer bloodhounds.
PG  - 1090-1094
LID - 10.1038/nbt.3717 [doi]
FAU - Webb, Sarah
AU  - Webb S
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EIN - Nat Biotechnol. 2017 Feb 8;35(2):178. PMID: 28178243
EDAT- 2016/11/09 06:00
MHDA- 2016/11/09 06:00
CRDT- 2016/11/09 06:00
PHST- 2016/11/09 06:00 [entrez]
PHST- 2016/11/09 06:00 [pubmed]
PHST- 2016/11/09 06:00 [medline]
AID - nbt.3717 [pii]
AID - 10.1038/nbt.3717 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov 8;34(11):1090-1094. doi: 10.1038/nbt.3717.

PMID- 27824837
OWN - NLM
STAT- In-Data-Review
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov 8
TI  - Sanofi and Google in type 2 diabetes smartphone tie-up.
PG  - 1087-1088
LID - 10.1038/nbt1116-1087 [doi]
FAU - Smalley, Eric
AU  - Smalley E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/11/09 06:00
MHDA- 2016/11/09 06:00
CRDT- 2016/11/09 06:00
PHST- 2016/11/09 06:00 [entrez]
PHST- 2016/11/09 06:00 [pubmed]
PHST- 2016/11/09 06:00 [medline]
AID - nbt1116-1087 [pii]
AID - 10.1038/nbt1116-1087 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov 8;34(11):1087-1088. doi: 10.1038/nbt1116-1087.

PMID- 27824836
OWN - NLM
STAT- In-Data-Review
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov 8
TI  - High-yield chemical synthesis by reprogramming central metabolism.
PG  - 1128-1129
LID - 10.1038/nbt.3723 [doi]
FAU - Yu, Vivian Y
AU  - Yu VY
AD  - Departments of Chemistry and Molecular &Cell Biology, University of California,
      Berkeley, USA.
FAU - Chang, Michelle C Y
AU  - Chang MC
AD  - Departments of Chemistry and Molecular &Cell Biology, University of California,
      Berkeley, USA.
AD  - Chemical Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/11/09 06:00
MHDA- 2016/11/09 06:00
CRDT- 2016/11/09 06:00
PHST- 2016/11/09 06:00 [entrez]
PHST- 2016/11/09 06:00 [pubmed]
PHST- 2016/11/09 06:00 [medline]
AID - nbt.3723 [pii]
AID - 10.1038/nbt.3723 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov 8;34(11):1128-1129. doi: 10.1038/nbt.3723.

PMID- 27824835
OWN - NLM
STAT- In-Data-Review
LR  - 20161109
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov 8
TI  - Corrections.
PG  - 1088
LID - 10.1038/nbt1116-1088 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/11/09 06:00
MHDA- 2016/11/09 06:00
CRDT- 2016/11/09 06:00
PHST- 2016/11/09 06:00 [entrez]
PHST- 2016/11/09 06:00 [pubmed]
PHST- 2016/11/09 06:00 [medline]
AID - nbt1116-1088 [pii]
AID - 10.1038/nbt1116-1088 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov 8;34(11):1088. doi: 10.1038/nbt1116-1088.

PMID- 27824834
OWN - NLM
STAT- In-Data-Review
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov 8
TI  - Single-cell analysis at the threshold.
PG  - 1111-1118
LID - 10.1038/nbt.3721 [doi]
FAU - Chen, Xi
AU  - Chen X
AD  - Wellcome Trust Sanger Institute, Cambridge, UK.
FAU - Love, J Christopher
AU  - Love JC
AD  - Koch Institute for Integrative Cancer Research, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
FAU - Navin, Nicholas E
AU  - Navin NE
AD  - Department of Genetics and Department of Bioinformatics and Computational
      Biology, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
FAU - Pachter, Lior
AU  - Pachter L
AD  - Department of Mathematics, University of California, Berkeley, California, USA.
FAU - Stubbington, Michael J T
AU  - Stubbington MJ
AD  - Wellcome Trust Sanger Institute, Cambridge, UK.
FAU - Svensson, Valentine
AU  - Svensson V
AD  - European Bioinformatics Institute, European Molecular Biology Laboratory,
      Cambridge, UK.
FAU - Sweedler, Jonathan V
AU  - Sweedler JV
AD  - Department of Chemistry, University of Illinois, Urbana, Illinois, USA.
FAU - Teichmann, Sarah A
AU  - Teichmann SA
AD  - Wellcome Trust Sanger Institute, Cambridge, UK.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/11/09 06:00
MHDA- 2016/11/09 06:00
CRDT- 2016/11/09 06:00
PHST- 2016/11/09 06:00 [entrez]
PHST- 2016/11/09 06:00 [pubmed]
PHST- 2016/11/09 06:00 [medline]
AID - nbt.3721 [pii]
AID - 10.1038/nbt.3721 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov 8;34(11):1111-1118. doi: 10.1038/nbt.3721.

PMID- 27824833
OWN - NLM
STAT- In-Data-Review
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov 8
TI  - 3D cancer cells library.
PG  - 1086
LID - 10.1038/nbt1116-1086 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/11/09 06:00
MHDA- 2016/11/09 06:00
CRDT- 2016/11/09 06:00
PHST- 2016/11/09 06:00 [entrez]
PHST- 2016/11/09 06:00 [pubmed]
PHST- 2016/11/09 06:00 [medline]
AID - nbt1116-1086 [pii]
AID - 10.1038/nbt1116-1086 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov 8;34(11):1086. doi: 10.1038/nbt1116-1086.

PMID- 27824832
OWN - NLM
STAT- In-Data-Review
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov 8
TI  - SPLASH, a hashed identifier for mass spectra.
PG  - 1099-1101
LID - 10.1038/nbt.3689 [doi]
FAU - Wohlgemuth, Gert
AU  - Wohlgemuth G
AD  - West Coast Metabolomics Center and Genome Center University of California Davis, 
      Davis, California, USA.
FAU - Mehta, Sajjan S
AU  - Mehta SS
AD  - West Coast Metabolomics Center and Genome Center University of California Davis, 
      Davis, California, USA.
FAU - Mejia, Ramon F
AU  - Mejia RF
AD  - RIKEN Center for Sustainable Resource Science, Yokohama, Kanagawa, Japan.
FAU - Neumann, Steffen
AU  - Neumann S
AD  - Department of Stress and Developmental Biology, Leibniz Institute of Plant
      Biochemistry, Halle, Germany.
FAU - Pedrosa, Diego
AU  - Pedrosa D
AD  - West Coast Metabolomics Center and Genome Center University of California Davis, 
      Davis, California, USA.
FAU - Pluskal, Tomas
AU  - Pluskal T
AUID- ORCID: http://orcid.org/0000-0002-6940-3006
AD  - Whitehead Institute for Biomedical Research, Nine Cambridge Center, Cambridge,
      Massachusetts, USA.
FAU - Schymanski, Emma L
AU  - Schymanski EL
AUID- ORCID: http://orcid.org/0000-0001-6868-8145
AD  - Eawag: Swiss Federal Institute of Aquatic Science and Technology, Dubendorf,
      Switzerland.
FAU - Willighagen, Egon L
AU  - Willighagen EL
AUID- ORCID: http://orcid.org/0000-0001-7542-0286
AD  - Department of Bioinformatics - BiGCaT, Maastricht University, Maastricht, the
      Netherlands.
FAU - Wilson, Michael
AU  - Wilson M
AD  - Department of Computing Science, University of Alberta, Edmonton, Alberta,
      Canada.
FAU - Wishart, David S
AU  - Wishart DS
AD  - Department of Computing Science, University of Alberta, Edmonton, Alberta,
      Canada.
FAU - Arita, Masanori
AU  - Arita M
AD  - RIKEN Center for Sustainable Resource Science, Yokohama, Kanagawa, Japan.
AD  - National Institute of Genetics, Mishima, Shizuoka, Japan.
FAU - Dorrestein, Pieter C
AU  - Dorrestein PC
AD  - Collaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and 
      Pharmaceutical Sciences, UC San Diego, La Jolla, California, USA.
AD  - Departments of Pharmacology and Pediatrics, School of Medicine, UC San Diego, La 
      Jolla, California, USA.
FAU - Bandeira, Nuno
AU  - Bandeira N
AD  - Collaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and 
      Pharmaceutical Sciences, UC San Diego, La Jolla, California, USA.
AD  - Computer Science and Engineering, UC San Diego, La Jolla, California, USA.
AD  - Center for Computational Mass Spectrometry, UC San Diego, La Jolla, California,
      USA.
FAU - Wang, Mingxun
AU  - Wang M
AD  - Computer Science and Engineering, UC San Diego, La Jolla, California, USA.
AD  - Center for Computational Mass Spectrometry, UC San Diego, La Jolla, California,
      USA.
FAU - Schulze, Tobias
AU  - Schulze T
AD  - Department of Effect-Directed Analysis, UFZ Helmholtz Centre for Environmental
      Research GmbH, Leipzig, Germany.
FAU - Salek, Reza M
AU  - Salek RM
AD  - European Molecular Biology Laboratory - European Bioinformatics Institute
      (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
FAU - Steinbeck, Christoph
AU  - Steinbeck C
AUID- ORCID: http://orcid.org/0000-0001-6966-0814
AD  - European Molecular Biology Laboratory - European Bioinformatics Institute
      (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
FAU - Nainala, Venkata Chandrasekhar
AU  - Nainala VC
AD  - European Molecular Biology Laboratory - European Bioinformatics Institute
      (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
FAU - Mistrik, Robert
AU  - Mistrik R
AD  - HighChem Ltd., Bratislava, Slovakia.
FAU - Nishioka, Takaaki
AU  - Nishioka T
AD  - Graduate School of Agriculture, Kyoto University, Kitashirakawa Oiwake-cho,
      Kyoto, Japan.
FAU - Fiehn, Oliver
AU  - Fiehn O
AUID- ORCID: http://orcid.org/0000-0002-6261-8928
AD  - West Coast Metabolomics Center and Genome Center University of California Davis, 
      Davis, California, USA.
AD  - Biochemistry Department, King Abdulaziz University, Jeddah, Saudi Arabia.
LA  - eng
GR  - MR/L01632X/1/Medical Research Council/United Kingdom
GR  - P41 GM103484/GM/NIGMS NIH HHS/United States
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
PMC - PMC5515539
MID - NIHMS871648
EDAT- 2016/11/09 06:00
MHDA- 2016/11/09 06:00
CRDT- 2016/11/09 06:00
PHST- 2016/11/09 06:00 [entrez]
PHST- 2016/11/09 06:00 [pubmed]
PHST- 2016/11/09 06:00 [medline]
AID - nbt.3689 [pii]
AID - 10.1038/nbt.3689 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov 8;34(11):1099-1101. doi: 10.1038/nbt.3689.

PMID- 27824831
OWN - NLM
STAT- In-Data-Review
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov 8
TI  - Myriad's impact on gene patents.
PG  - 1119-1123
LID - 10.1038/nbt.3719 [doi]
FAU - Aboy, Mateo
AU  - Aboy M
AD  - Centre of Law, Medicine, and Life Sciences (LML), Faculty of Law, University of
      Cambridge, Cambridge, UK.
AD  - College of Engineering, Technology and Management, Oregon Institute of
      Technology, Klamath Falls, Oregon, USA.
FAU - Liddell, Kathleen
AU  - Liddell K
AD  - Centre of Law, Medicine, and Life Sciences (LML), Faculty of Law, University of
      Cambridge, Cambridge, UK.
FAU - Liddicoat, Johnathon
AU  - Liddicoat J
AD  - Centre of Law, Medicine, and Life Sciences (LML), Faculty of Law, University of
      Cambridge, Cambridge, UK.
FAU - Crespo, Cristina
AU  - Crespo C
AD  - Centre of Law, Medicine, and Life Sciences (LML), Faculty of Law, University of
      Cambridge, Cambridge, UK.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/11/09 06:00
MHDA- 2016/11/09 06:00
CRDT- 2016/11/09 06:00
PHST- 2016/11/09 06:00 [entrez]
PHST- 2016/11/09 06:00 [pubmed]
PHST- 2016/11/09 06:00 [medline]
AID - nbt.3719 [pii]
AID - 10.1038/nbt.3719 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov 8;34(11):1119-1123. doi: 10.1038/nbt.3719.

PMID- 27824830
OWN - NLM
STAT- In-Data-Review
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov 8
TI  - Greener revolutions for all.
PG  - 1106-1110
LID - 10.1038/nbt.3709 [doi]
FAU - Flavell, Richard B
AU  - Flavell RB
AD  - Ceres, Inc., Thousand Oaks, California, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/11/09 06:00
MHDA- 2016/11/09 06:00
CRDT- 2016/11/09 06:00
PHST- 2016/11/09 06:00 [entrez]
PHST- 2016/11/09 06:00 [pubmed]
PHST- 2016/11/09 06:00 [medline]
AID - nbt.3709 [pii]
AID - 10.1038/nbt.3709 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov 8;34(11):1106-1110. doi: 10.1038/nbt.3709.

PMID- 27824829
OWN - NLM
STAT- In-Data-Review
LR  - 20161109
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov 8
TI  - Mutanome draws Genentech deal.
PG  - 1085
LID - 10.1038/nbt1116-1085 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/11/09 06:00
MHDA- 2016/11/09 06:00
CRDT- 2016/11/09 06:00
PHST- 2016/11/09 06:00 [entrez]
PHST- 2016/11/09 06:00 [pubmed]
PHST- 2016/11/09 06:00 [medline]
AID - nbt1116-1085 [pii]
AID - 10.1038/nbt1116-1085 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov 8;34(11):1085. doi: 10.1038/nbt1116-1085.

PMID- 27824828
OWN - NLM
STAT- In-Data-Review
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov 8
TI  - Zika pipeline progresses.
PG  - 1084-1086
LID - 10.1038/nbt1116-1084b [doi]
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/11/09 06:00
MHDA- 2016/11/09 06:00
CRDT- 2016/11/09 06:00
PHST- 2016/11/09 06:00 [entrez]
PHST- 2016/11/09 06:00 [pubmed]
PHST- 2016/11/09 06:00 [medline]
AID - nbt1116-1084b [pii]
AID - 10.1038/nbt1116-1084b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov 8;34(11):1084-1086. doi: 10.1038/nbt1116-1084b.

PMID- 27824827
OWN - NLM
STAT- In-Data-Review
LR  - 20161109
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov 8
TI  - Opdivo's lung cancer aspirations dashed.
PG  - 1082
LID - 10.1038/nbt1116-1082a [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/11/09 06:00
MHDA- 2016/11/09 06:00
CRDT- 2016/11/09 06:00
PHST- 2016/11/09 06:00 [entrez]
PHST- 2016/11/09 06:00 [pubmed]
PHST- 2016/11/09 06:00 [medline]
AID - nbt1116-1082a [pii]
AID - 10.1038/nbt1116-1082a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov 8;34(11):1082. doi: 10.1038/nbt1116-1082a.

PMID- 27824826
OWN - NLM
STAT- In-Data-Review
LR  - 20161109
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov 8
TI  - Drug pipeline: 3Q16.
PG  - 1089
LID - 10.1038/nbt.3731 [doi]
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/11/09 06:00
MHDA- 2016/11/09 06:00
CRDT- 2016/11/09 06:00
PHST- 2016/11/09 06:00 [entrez]
PHST- 2016/11/09 06:00 [pubmed]
PHST- 2016/11/09 06:00 [medline]
AID - nbt.3731 [pii]
AID - 10.1038/nbt.3731 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov 8;34(11):1089. doi: 10.1038/nbt.3731.

PMID- 27748755
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov
TI  - A proteomic atlas of the legume Medicago truncatula and its nitrogen-fixing
      endosymbiont Sinorhizobium meliloti.
PG  - 1198-1205
LID - 10.1038/nbt.3681 [doi]
AB  - Legumes are essential components of agricultural systems because they enrich the 
      soil in nitrogen and require little environmentally deleterious fertilizers. A
      complex symbiotic association between legumes and nitrogen-fixing soil bacteria
      called rhizobia culminates in the development of root nodules, where rhizobia fix
      atmospheric nitrogen and transfer it to their plant host. Here we describe a
      quantitative proteomic atlas of the model legume Medicago truncatula and its
      rhizobial symbiont Sinorhizobium meliloti, which includes more than 23,000
      proteins, 20,000 phosphorylation sites, and 700 lysine acetylation sites. Our
      analysis provides insight into mechanisms regulating symbiosis. We identify a
      calmodulin-binding protein as a key regulator in the host and assign putative
      roles and targets to host factors (bioactive peptides) that control gene
      expression in the symbiont. Further mining of this proteomic resource may enable 
      engineering of crops and their microbial partners to increase agricultural
      productivity and sustainability.
FAU - Marx, Harald
AU  - Marx H
AD  - Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin,
      USA.
FAU - Minogue, Catherine E
AU  - Minogue CE
AD  - Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin,
      USA.
FAU - Jayaraman, Dhileepkumar
AU  - Jayaraman D
AD  - Department of Agronomy, University of Wisconsin-Madison, Madison, Wisconsin, USA.
FAU - Richards, Alicia L
AU  - Richards AL
AD  - Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin,
      USA.
FAU - Kwiecien, Nicholas W
AU  - Kwiecien NW
AD  - Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin,
      USA.
FAU - Siahpirani, Alireza F
AU  - Siahpirani AF
AUID- ORCID: http://orcid.org/0000-0002-7804-4084
AD  - Department of Computer Sciences, University of Wisconsin-Madison, Madison,
      Wisconsin, USA.
FAU - Rajasekar, Shanmugam
AU  - Rajasekar S
AD  - Department of Agronomy, University of Wisconsin-Madison, Madison, Wisconsin, USA.
FAU - Maeda, Junko
AU  - Maeda J
AD  - Department of Bacteriology, University of Wisconsin-Madison, Madison, Wisconsin, 
      USA.
FAU - Garcia, Kevin
AU  - Garcia K
AD  - Department of Bacteriology, University of Wisconsin-Madison, Madison, Wisconsin, 
      USA.
FAU - Del Valle-Echevarria, Angel R
AU  - Del Valle-Echevarria AR
AD  - Department of Bacteriology, University of Wisconsin-Madison, Madison, Wisconsin, 
      USA.
FAU - Volkening, Jeremy D
AU  - Volkening JD
AD  - Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin, 
      USA.
FAU - Westphall, Michael S
AU  - Westphall MS
AD  - Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin,
      USA.
FAU - Roy, Sushmita
AU  - Roy S
AD  - Department of Biostatistics and Medical Informatics, University of
      Wisconsin-Madison, Madison, Wisconsin, USA.
AD  - Wisconsin Institute for Discovery, University of Wisconsin-Madison, Madison,
      Wisconsin, USA.
FAU - Sussman, Michael R
AU  - Sussman MR
AD  - Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin, 
      USA.
FAU - Ane, Jean-Michel
AU  - Ane JM
AD  - Department of Agronomy, University of Wisconsin-Madison, Madison, Wisconsin, USA.
AD  - Department of Bacteriology, University of Wisconsin-Madison, Madison, Wisconsin, 
      USA.
FAU - Coon, Joshua J
AU  - Coon JJ
AD  - Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin,
      USA.
AD  - Department of Biomolecular Chemistry, University of Wisconsin-Madison, Madison,
      Wisconsin, USA.
LA  - eng
PT  - Journal Article
DEP - 20161017
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Bacterial Proteins)
RN  - 0 (Plant Proteins)
RN  - 0 (Proteome)
SB  - IM
MH  - Bacterial Proteins/*metabolism
MH  - Databases, Protein
MH  - Medicago truncatula/*metabolism/*microbiology
MH  - Nitrogen Fixation/*physiology
MH  - Plant Proteins/*metabolism
MH  - Proteome/metabolism
MH  - Proteomics
MH  - Sinorhizobium meliloti/*physiology
MH  - Symbiosis/*physiology
EDAT- 2016/11/01 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/11/08 06:00
PHST- 2016/06/03 00:00 [received]
PHST- 2016/08/23 00:00 [accepted]
PHST- 2016/11/01 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
PHST- 2016/11/08 06:00 [entrez]
AID - nbt.3681 [pii]
AID - 10.1038/nbt.3681 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov;34(11):1198-1205. doi: 10.1038/nbt.3681. Epub 2016 Oct
      17.

PMID- 27748754
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20170605
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov
TI  - Differentiation of human embryonic stem cells to HOXA(+) hemogenic vasculature
      that resembles the aorta-gonad-mesonephros.
PG  - 1168-1179
LID - 10.1038/nbt.3702 [doi]
AB  - The ability to generate hematopoietic stem cells from human pluripotent cells
      would enable many biomedical applications. We find that hematopoietic CD34(+)
      cells in spin embryoid bodies derived from human embryonic stem cells (hESCs)
      lack HOXA expression compared with repopulation-competent human cord blood
      CD34(+) cells, indicating incorrect mesoderm patterning. Using reporter hESC
      lines to track the endothelial (SOX17) to hematopoietic (RUNX1C) transition that 
      occurs in development, we show that simultaneous modulation of WNT and ACTIVIN
      signaling yields CD34(+) hematopoietic cells with HOXA expression that more
      closely resembles that of cord blood. The cultures generate a network of
      aorta-like SOX17(+) vessels from which RUNX1C(+) blood cells emerge, similar to
      hematopoiesis in the aorta-gonad-mesonephros (AGM). Nascent CD34(+) hematopoietic
      cells and corresponding cells sorted from human AGM show similar expression of
      cell surface receptors, signaling molecules and transcription factors. Our
      findings provide an approach to mimic in vitro a key early stage in human
      hematopoiesis for the generation of AGM-derived hematopoietic lineages from
      hESCs.
FAU - Ng, Elizabeth S
AU  - Ng ES
AD  - Murdoch Childrens Research Institute, The Royal Children's Hospital, Parkville,
      Victoria, Australia.
AD  - Department of Anatomy and Developmental Biology, Faculty of Medicine, Nursing and
      Health Sciences, Monash University, Clayton, Victoria, Australia.
FAU - Azzola, Lisa
AU  - Azzola L
AD  - Murdoch Childrens Research Institute, The Royal Children's Hospital, Parkville,
      Victoria, Australia.
FAU - Bruveris, Freya F
AU  - Bruveris FF
AD  - Murdoch Childrens Research Institute, The Royal Children's Hospital, Parkville,
      Victoria, Australia.
AD  - Department of Anatomy and Developmental Biology, Faculty of Medicine, Nursing and
      Health Sciences, Monash University, Clayton, Victoria, Australia.
FAU - Calvanese, Vincenzo
AU  - Calvanese V
AD  - Department of Molecular, Cell and Developmental Biology, University of California
      Los Angeles, Los Angeles, California, USA.
AD  - Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research,
      University of California Los Angeles, Los Angeles, California, USA.
FAU - Phipson, Belinda
AU  - Phipson B
AD  - Murdoch Childrens Research Institute, The Royal Children's Hospital, Parkville,
      Victoria, Australia.
FAU - Vlahos, Katerina
AU  - Vlahos K
AD  - Murdoch Childrens Research Institute, The Royal Children's Hospital, Parkville,
      Victoria, Australia.
FAU - Hirst, Claire
AU  - Hirst C
AD  - Australian Regenerative Medicine Institute, Monash University, Clayton, Victoria,
      Australia.
FAU - Jokubaitis, Vanta J
AU  - Jokubaitis VJ
AD  - Department of Anatomy and Neuroscience, Faculty of Medicine, Dentistry and Health
      Sciences, University of Melbourne, Parkville, Victoria, Australia.
FAU - Yu, Qing C
AU  - Yu QC
AD  - Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological
      Sciences, Shanghai, P.R. China.
FAU - Maksimovic, Jovana
AU  - Maksimovic J
AD  - Murdoch Childrens Research Institute, The Royal Children's Hospital, Parkville,
      Victoria, Australia.
FAU - Liebscher, Simone
AU  - Liebscher S
AD  - Department of Women's Health, Research Institute for Women's Health, Eberhard
      Karls University Tubingen, Tubingen, Germany.
FAU - Januar, Vania
AU  - Januar V
AD  - Murdoch Childrens Research Institute, The Royal Children's Hospital, Parkville,
      Victoria, Australia.
FAU - Zhang, Zhen
AU  - Zhang Z
AD  - Commonwealth Scientific and Industrial Research Organisation (CSIRO),
      Manufacturing, Clayton, Victoria, Australia.
FAU - Williams, Brenda
AU  - Williams B
AD  - Australian Regenerative Medicine Institute, Monash University, Clayton, Victoria,
      Australia.
AD  - Commonwealth Scientific and Industrial Research Organisation (CSIRO),
      Manufacturing, Clayton, Victoria, Australia.
FAU - Conscience, Aude
AU  - Conscience A
AD  - Department of Anatomy and Developmental Biology, Faculty of Medicine, Nursing and
      Health Sciences, Monash University, Clayton, Victoria, Australia.
FAU - Durnall, Jennifer
AU  - Durnall J
AD  - Murdoch Childrens Research Institute, The Royal Children's Hospital, Parkville,
      Victoria, Australia.
FAU - Jackson, Steven
AU  - Jackson S
AD  - Wisconsin Institutes for Discovery, University of Wisconsin-Madison, Madison,
      Wisconsin, USA.
FAU - Costa, Magdaline
AU  - Costa M
AD  - Australian Centre for Blood Diseases, Monash University, Alfred Medical Research 
      Precinct, Melbourne, Victoria, Australia.
FAU - Elliott, David
AU  - Elliott D
AD  - Murdoch Childrens Research Institute, The Royal Children's Hospital, Parkville,
      Victoria, Australia.
FAU - Haylock, David N
AU  - Haylock DN
AD  - Australian Regenerative Medicine Institute, Monash University, Clayton, Victoria,
      Australia.
AD  - Commonwealth Scientific and Industrial Research Organisation (CSIRO),
      Manufacturing, Clayton, Victoria, Australia.
FAU - Nilsson, Susan K
AU  - Nilsson SK
AD  - Australian Regenerative Medicine Institute, Monash University, Clayton, Victoria,
      Australia.
AD  - Commonwealth Scientific and Industrial Research Organisation (CSIRO),
      Manufacturing, Clayton, Victoria, Australia.
FAU - Saffery, Richard
AU  - Saffery R
AUID- ORCID: http://orcid.org/0000-0002-9510-4181
AD  - Murdoch Childrens Research Institute, The Royal Children's Hospital, Parkville,
      Victoria, Australia.
FAU - Schenke-Layland, Katja
AU  - Schenke-Layland K
AD  - Department of Women's Health, Research Institute for Women's Health, Eberhard
      Karls University Tubingen, Tubingen, Germany.
AD  - Department of Cell and Tissue Engineering, Fraunhofer Institute for Interfacial
      Engineering and Biotechnology (IGB), Stuttgart, Germany.
AD  - Department of Medicine/Cardiology, Cardiovascular Research Laboratories, David
      Geffen School of Medicine at University of California Los Angeles, Los Angeles,
      California, USA.
FAU - Oshlack, Alicia
AU  - Oshlack A
AUID- ORCID: http://orcid.org/0000-0001-9788-5690
AD  - Murdoch Childrens Research Institute, The Royal Children's Hospital, Parkville,
      Victoria, Australia.
FAU - Mikkola, Hanna K A
AU  - Mikkola HK
AD  - Department of Molecular, Cell and Developmental Biology, University of California
      Los Angeles, Los Angeles, California, USA.
AD  - Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research,
      University of California Los Angeles, Los Angeles, California, USA.
AD  - Molecular Biology Institute, University of California Los Angeles, Los Angeles,
      California, USA.
FAU - Stanley, Edouard G
AU  - Stanley EG
AD  - Murdoch Childrens Research Institute, The Royal Children's Hospital, Parkville,
      Victoria, Australia.
AD  - Department of Anatomy and Developmental Biology, Faculty of Medicine, Nursing and
      Health Sciences, Monash University, Clayton, Victoria, Australia.
AD  - Department of Paediatrics, Faculty of Medicine, Dentistry and Health Sciences,
      University of Melbourne, Parkville, Victoria, Australia.
FAU - Elefanty, Andrew G
AU  - Elefanty AG
AD  - Murdoch Childrens Research Institute, The Royal Children's Hospital, Parkville,
      Victoria, Australia.
AD  - Department of Anatomy and Developmental Biology, Faculty of Medicine, Nursing and
      Health Sciences, Monash University, Clayton, Victoria, Australia.
AD  - Department of Paediatrics, Faculty of Medicine, Dentistry and Health Sciences,
      University of Melbourne, Parkville, Victoria, Australia.
LA  - eng
PT  - Journal Article
DEP - 20161017
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Homeodomain Proteins)
RN  - 157907-48-7 (HoxA protein)
SB  - IM
MH  - Aorta/cytology/embryology/growth & development
MH  - Cell Differentiation/physiology
MH  - Cells, Cultured
MH  - Embryonic Stem Cells/*cytology/physiology
MH  - Gonads/cytology/embryology/growth & development
MH  - Hematopoietic Stem Cells/*cytology/physiology
MH  - Homeodomain Proteins/*metabolism
MH  - Humans
MH  - Mesonephros/*cytology/*embryology/growth & development
MH  - Neovascularization, Physiologic/*physiology
EDAT- 2016/11/01 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/11/08 06:00
PHST- 2015/12/29 00:00 [received]
PHST- 2016/09/14 00:00 [accepted]
PHST- 2016/11/01 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
PHST- 2016/11/08 06:00 [entrez]
AID - nbt.3702 [pii]
AID - 10.1038/nbt.3702 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov;34(11):1168-1179. doi: 10.1038/nbt.3702. Epub 2016 Oct
      17.

PMID- 27723727
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20171102
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov
TI  - Drug sensitivity of single cancer cells is predicted by changes in mass
      accumulation rate.
PG  - 1161-1167
LID - 10.1038/nbt.3697 [doi]
AB  - Assays that can determine the response of tumor cells to cancer therapeutics
      could greatly aid the selection of drug regimens for individual patients.
      However, the utility of current functional assays is limited, and predictive
      genetic biomarkers are available for only a small fraction of cancer therapies.
      We found that the single-cell mass accumulation rate (MAR), profiled over many
      hours with a suspended microchannel resonator, accurately defined the drug
      sensitivity or resistance of glioblastoma and B-cell acute lymphocytic leukemia
      cells. MAR revealed heterogeneity in drug sensitivity not only between different 
      tumors, but also within individual tumors and tumor-derived cell lines. MAR
      measurement predicted drug response using samples as small as 25 mul of
      peripheral blood while maintaining cell viability and compatibility with
      downstream characterization. MAR measurement is a promising approach for directly
      assaying single-cell therapeutic responses and for identifying cellular
      subpopulations with phenotypic resistance in heterogeneous tumors.
FAU - Stevens, Mark M
AU  - Stevens MM
AD  - Koch Institute for Integrative Cancer Research, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Department of Biology, Massachusetts Institute of Technology, Cambridge,
      Massachusetts, USA.
FAU - Maire, Cecile L
AU  - Maire CL
AD  - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical
      School, Boston, Massachusetts, USA.
FAU - Chou, Nigel
AU  - Chou N
AD  - Koch Institute for Integrative Cancer Research, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Murakami, Mark A
AU  - Murakami MA
AD  - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical
      School, Boston, Massachusetts, USA.
FAU - Knoff, David S
AU  - Knoff DS
AD  - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical
      School, Boston, Massachusetts, USA.
FAU - Kikuchi, Yuki
AU  - Kikuchi Y
AD  - Koch Institute for Integrative Cancer Research, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Hitachi High-Technologies Corporation, Ibaraki-ken, Japan.
FAU - Kimmerling, Robert J
AU  - Kimmerling RJ
AD  - Koch Institute for Integrative Cancer Research, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Liu, Huiyun
AU  - Liu H
AD  - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical
      School, Boston, Massachusetts, USA.
FAU - Haidar, Samer
AU  - Haidar S
AD  - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical
      School, Boston, Massachusetts, USA.
FAU - Calistri, Nicholas L
AU  - Calistri NL
AD  - Koch Institute for Integrative Cancer Research, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
FAU - Cermak, Nathan
AU  - Cermak N
AD  - Program in Computational and Systems Biology, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
FAU - Olcum, Selim
AU  - Olcum S
AUID- ORCID: http://orcid.org/0000-0002-6417-1007
AD  - Koch Institute for Integrative Cancer Research, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
FAU - Cordero, Nicolas A
AU  - Cordero NA
AD  - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical
      School, Boston, Massachusetts, USA.
FAU - Idbaih, Ahmed
AU  - Idbaih A
AD  - Inserm U 1127, CNRS UMR 7225, Sorbonne Universites, UPMC Univ Paris 06 UMR S
      1127, Institut du Cerveau et de la Moelle epiniere, ICM, Paris, France.
AD  - AP-HP, Hopitaux Universitaires La Pitie Salpetriere - Charles Foix, Service de
      Neurologie 2-Mazarin, Paris, France.
FAU - Wen, Patrick Y
AU  - Wen PY
AD  - Center For Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 
      Boston, Massachusetts, USA.
FAU - Weinstock, David M
AU  - Weinstock DM
AD  - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical
      School, Boston, Massachusetts, USA.
AD  - Broad Institute, Cambridge, Massachusetts, USA.
FAU - Ligon, Keith L
AU  - Ligon KL
AD  - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical
      School, Boston, Massachusetts, USA.
AD  - Broad Institute, Cambridge, Massachusetts, USA.
AD  - Department of Pathology, Boston Children's Hospital, Boston, Massachusetts, USA.
AD  - Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts,
      USA.
FAU - Manalis, Scott R
AU  - Manalis SR
AD  - Koch Institute for Integrative Cancer Research, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
AD  - Department of Mechanical Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
LA  - eng
GR  - DP1 CA174420/CA/NCI NIH HHS/United States
GR  - R01 CA188228/CA/NCI NIH HHS/United States
GR  - R33 CA191143/CA/NCI NIH HHS/United States
GR  - P30 CA014051/CA/NCI NIH HHS/United States
GR  - P01 CA142536/CA/NCI NIH HHS/United States
GR  - T32 GM008334/GM/NIGMS NIH HHS/United States
GR  - T32 CA009172/CA/NCI NIH HHS/United States
GR  - T32 GM087237/GM/NIGMS NIH HHS/United States
GR  - U54 CA143874/CA/NCI NIH HHS/United States
GR  - R01 CA170592/CA/NCI NIH HHS/United States
GR  - P50 CA165962/CA/NCI NIH HHS/United States
PT  - Journal Article
DEP - 20161010
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antineoplastic Agents)
SB  - IM
MH  - Antineoplastic Agents/*administration & dosage
MH  - Cell Proliferation/drug effects
MH  - Cells, Cultured
MH  - Dose-Response Relationship, Drug
MH  - Drug Resistance, Neoplasm
MH  - Drug Screening Assays, Antitumor/*instrumentation/methods
MH  - Equipment Design
MH  - Equipment Failure Analysis
MH  - Humans
MH  - *Lab-On-A-Chip Devices
MH  - Micro-Electrical-Mechanical Systems/*instrumentation/methods
MH  - Neoplasms, Experimental/*drug therapy/pathology/*physiopathology
MH  - Treatment Outcome
PMC - PMC5142231
MID - NIHMS832140
COIS- SRM is a cofounder of Affinity Biosensors, which develops techniques relevant to 
      the research presented. SO and MMS anticipate employment at Affinity Biosensor.
      DMW is a consultant for and receives research support from Novartis.
EDAT- 2016/11/01 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/11/08 06:00
PHST- 2015/11/23 00:00 [received]
PHST- 2016/08/30 00:00 [accepted]
PHST- 2016/11/01 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
PHST- 2016/11/08 06:00 [entrez]
AID - nbt.3697 [pii]
AID - 10.1038/nbt.3697 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov;34(11):1161-1167. doi: 10.1038/nbt.3697. Epub 2016 Oct
      10.

PMID- 27701404
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov
TI  - A multicenter study benchmarks software tools for label-free proteome
      quantification.
PG  - 1130-1136
LID - 10.1038/nbt.3685 [doi]
AB  - Consistent and accurate quantification of proteins by mass spectrometry
      (MS)-based proteomics depends on the performance of instruments, acquisition
      methods and data analysis software. In collaboration with the software
      developers, we evaluated OpenSWATH, SWATH 2.0, Skyline, Spectronaut and
      DIA-Umpire, five of the most widely used software methods for processing data
      from sequential window acquisition of all theoretical fragment-ion spectra
      (SWATH)-MS, which uses data-independent acquisition (DIA) for label-free protein 
      quantification. We analyzed high-complexity test data sets from hybrid proteome
      samples of defined quantitative composition acquired on two different MS
      instruments using different SWATH isolation-window setups. For consistent
      evaluation, we developed LFQbench, an R package, to calculate metrics of
      precision and accuracy in label-free quantitative MS and report the
      identification performance, robustness and specificity of each software tool. Our
      reference data sets enabled developers to improve their software tools. After
      optimization, all tools provided highly convergent identification and reliable
      quantification performance, underscoring their robustness for label-free
      quantitative proteomics.
FAU - Navarro, Pedro
AU  - Navarro P
AD  - Institute for Immunology, University Medical Center of the Johannes-Gutenberg
      University Mainz, Mainz, Germany.
FAU - Kuharev, Jorg
AU  - Kuharev J
AD  - Institute for Immunology, University Medical Center of the Johannes-Gutenberg
      University Mainz, Mainz, Germany.
FAU - Gillet, Ludovic C
AU  - Gillet LC
AD  - Department of Biology, Institute of Molecular Systems Biology, Eidgenoessische
      Technische Hochschule (IMSB-ETH) Zurich, Zurich, Switzerland.
FAU - Bernhardt, Oliver M
AU  - Bernhardt OM
AD  - Biognosys AG, Schlieren, Switzerland.
FAU - MacLean, Brendan
AU  - MacLean B
AD  - Department of Genome Sciences, University of Washington, Seattle, Washington,
      USA.
FAU - Rost, Hannes L
AU  - Rost HL
AD  - Department of Biology, Institute of Molecular Systems Biology, Eidgenoessische
      Technische Hochschule (IMSB-ETH) Zurich, Zurich, Switzerland.
FAU - Tate, Stephen A
AU  - Tate SA
AD  - AB Sciex, Concord, Ontario, Canada.
FAU - Tsou, Chih-Chiang
AU  - Tsou CC
AD  - Department of Computational Medicine and Bioinformatics, University of Michigan, 
      Ann Arbor, Michigan, USA.
FAU - Reiter, Lukas
AU  - Reiter L
AD  - Biognosys AG, Schlieren, Switzerland.
FAU - Distler, Ute
AU  - Distler U
AD  - Institute for Immunology, University Medical Center of the Johannes-Gutenberg
      University Mainz, Mainz, Germany.
FAU - Rosenberger, George
AU  - Rosenberger G
AD  - Department of Biology, Institute of Molecular Systems Biology, Eidgenoessische
      Technische Hochschule (IMSB-ETH) Zurich, Zurich, Switzerland.
AD  - PhD Program in Systems Biology, University of Zurich and Eidgenoessische
      Technische Hochschule (ETH) Zurich, Zurich, Switzerland.
FAU - Perez-Riverol, Yasset
AU  - Perez-Riverol Y
AD  - European Molecular Biology Laboratory, European Bioinformatics Institute
      (EMBL-EBI), Hinxton, UK.
FAU - Nesvizhskii, Alexey I
AU  - Nesvizhskii AI
AD  - Department of Computational Medicine and Bioinformatics, University of Michigan, 
      Ann Arbor, Michigan, USA.
AD  - Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
FAU - Aebersold, Ruedi
AU  - Aebersold R
AD  - Department of Biology, Institute of Molecular Systems Biology, Eidgenoessische
      Technische Hochschule (IMSB-ETH) Zurich, Zurich, Switzerland.
AD  - Faculty of Science, University of Zurich, Zurich, Switzerland.
FAU - Tenzer, Stefan
AU  - Tenzer S
AD  - Institute for Immunology, University Medical Center of the Johannes-Gutenberg
      University Mainz, Mainz, Germany.
LA  - eng
GR  - 233226/European Research Council/International
GR  - 670821/European Research Council/International
GR  - R01 GM094231/GM/NIGMS NIH HHS/United States
PT  - Comparative Study
PT  - Evaluation Studies
PT  - Journal Article
PT  - Multicenter Study
DEP - 20161003
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Proteome)
SB  - IM
MH  - Algorithms
MH  - Benchmarking/*methods/*standards
MH  - Internationality
MH  - Mass Spectrometry/*standards
MH  - Proteome/analysis/*chemistry
MH  - Reproducibility of Results
MH  - Sensitivity and Specificity
MH  - Software/*classification/*standards
MH  - Staining and Labeling
PMC - PMC5120688
MID - EMS69887
COIS- The authors declare the following competing financial interests: S.A.T. is
      employed by SCIEX, O.M.B. and L.R. are employed by Biognosys AG.
EDAT- 2016/11/01 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/11/08 06:00
PHST- 2016/05/10 00:00 [received]
PHST- 2016/08/26 00:00 [accepted]
PHST- 2016/11/01 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
PHST- 2016/11/08 06:00 [entrez]
AID - 10.1038/nbt.3685 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov;34(11):1130-1136. doi: 10.1038/nbt.3685. Epub 2016 Oct
      3.

PMID- 27701403
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov
TI  - Genome-scale high-resolution mapping of activating and repressive nucleotides in 
      regulatory regions.
PG  - 1180-1190
LID - 10.1038/nbt.3678 [doi]
AB  - Massively parallel reporter assays (MPRAs) enable nucleotide-resolution
      dissection of transcriptional regulatory regions, such as enhancers, but only few
      regions at a time. Here we present a combined experimental and computational
      approach, Systematic high-resolution activation and repression profiling with
      reporter tiling using MPRA (Sharpr-MPRA), that allows high-resolution analysis of
      thousands of regions simultaneously. Sharpr-MPRA combines dense tiling of
      overlapping MPRA constructs with a probabilistic graphical model to recognize
      functional regulatory nucleotides, and to distinguish activating and repressive
      nucleotides, using their inferred contribution to reporter gene expression. We
      used Sharpr-MPRA to test 4.6 million nucleotides spanning 15,000 putative
      regulatory regions tiled at 5-nucleotide resolution in two human cell types. Our 
      results recovered known cell-type-specific regulatory motifs and evolutionarily
      conserved nucleotides, and distinguished known activating and repressive motifs. 
      Our results also showed that endogenous chromatin state and DNA accessibility are
      both predictive of regulatory function in reporter assays, identified retroviral 
      elements with activating roles, and uncovered 'attenuator' motifs with repressive
      roles in active chromatin.
FAU - Ernst, Jason
AU  - Ernst J
AD  - Department of Biological Chemistry, University of California, Los Angeles, Los
      Angeles, California, USA.
AD  - Computer Science Department, University of California, Los Angeles, Los Angeles, 
      California, USA.
AD  - Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at
      University of California, Los Angeles, Los Angeles, California, USA.
AD  - Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los
      Angeles, California, USA.
AD  - Molecular Biology Institute, University of California, Los Angeles, Los Angeles, 
      California, USA.
FAU - Melnikov, Alexandre
AU  - Melnikov A
AD  - Broad Institute of Massachusetts Institute of Technology and Harvard University, 
      Cambridge, Massachusetts, USA.
FAU - Zhang, Xiaolan
AU  - Zhang X
AD  - Broad Institute of Massachusetts Institute of Technology and Harvard University, 
      Cambridge, Massachusetts, USA.
FAU - Wang, Li
AU  - Wang L
AD  - Broad Institute of Massachusetts Institute of Technology and Harvard University, 
      Cambridge, Massachusetts, USA.
FAU - Rogov, Peter
AU  - Rogov P
AD  - Broad Institute of Massachusetts Institute of Technology and Harvard University, 
      Cambridge, Massachusetts, USA.
FAU - Mikkelsen, Tarjei S
AU  - Mikkelsen TS
AUID- ORCID: http://orcid.org/0000-0002-8133-3135
AD  - Broad Institute of Massachusetts Institute of Technology and Harvard University, 
      Cambridge, Massachusetts, USA.
FAU - Kellis, Manolis
AU  - Kellis M
AD  - Broad Institute of Massachusetts Institute of Technology and Harvard University, 
      Cambridge, Massachusetts, USA.
AD  - Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
LA  - eng
GR  - RF1 AG054012/AG/NIA NIH HHS/United States
GR  - R01 HG008155/HG/NHGRI NIH HHS/United States
GR  - R01 GM113708/GM/NIGMS NIH HHS/United States
GR  - R01 HG004037/HG/NHGRI NIH HHS/United States
GR  - U01 HG007610/HG/NHGRI NIH HHS/United States
GR  - R01 MH109978/MH/NIMH NIH HHS/United States
PT  - Journal Article
DEP - 20161003
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Nucleotides)
SB  - IM
MH  - Chromosome Mapping/*methods
MH  - Conserved Sequence/genetics
MH  - Epigenetic Repression/*genetics
MH  - Genome, Human/*genetics
MH  - High-Throughput Nucleotide Sequencing/*methods
MH  - Humans
MH  - Nucleotides/*genetics
MH  - Regulatory Sequences, Nucleic Acid/*genetics
MH  - Reproducibility of Results
MH  - Sensitivity and Specificity
PMC - PMC5125825
MID - NIHMS810263
EDAT- 2016/11/01 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/11/08 06:00
PHST- 2015/10/14 00:00 [received]
PHST- 2016/08/16 00:00 [accepted]
PHST- 2016/11/01 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
PHST- 2016/11/08 06:00 [entrez]
AID - nbt.3678 [pii]
AID - 10.1038/nbt.3678 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov;34(11):1180-1190. doi: 10.1038/nbt.3678. Epub 2016 Oct
      3.

PMID- 27669165
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20170803
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 11
DP  - 2016 Nov
TI  - Mitochondrial protein functions elucidated by multi-omic mass spectrometry
      profiling.
PG  - 1191-1197
LID - 10.1038/nbt.3683 [doi]
AB  - Mitochondrial dysfunction is associated with many human diseases, including
      cancer and neurodegeneration, that are often linked to proteins and pathways that
      are not well-characterized. To begin defining the functions of such poorly
      characterized proteins, we used mass spectrometry to map the proteomes,
      lipidomes, and metabolomes of 174 yeast strains, each lacking a single gene
      related to mitochondrial biology. 144 of these genes have human homologs, 60 of
      which are associated with disease and 39 of which are uncharacterized. We present
      a multi-omic data analysis and visualization tool that we use to find covariance 
      networks that can predict molecular functions, correlations between profiles of
      related gene deletions, gene-specific perturbations that reflect protein
      functions, and a global respiration deficiency response. Using this multi-omic
      approach, we link seven proteins including Hfd1p and its human homolog ALDH3A1 to
      mitochondrial coenzyme Q (CoQ) biosynthesis, an essential pathway disrupted in
      many human diseases. This Resource should provide molecular insights into
      mitochondrial protein functions.
FAU - Stefely, Jonathan A
AU  - Stefely JA
AD  - Morgridge Institute for Research, Madison, Wisconsin, USA.
AD  - Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin, 
      USA.
FAU - Kwiecien, Nicholas W
AU  - Kwiecien NW
AD  - Genome Center of Wisconsin, Madison, Wisconsin, USA.
AD  - Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin,
      USA.
FAU - Freiberger, Elyse C
AU  - Freiberger EC
AD  - Genome Center of Wisconsin, Madison, Wisconsin, USA.
AD  - Department of Biomolecular Chemistry, University of Wisconsin-Madison, Madison,
      Wisconsin, USA.
FAU - Richards, Alicia L
AU  - Richards AL
AD  - Genome Center of Wisconsin, Madison, Wisconsin, USA.
AD  - Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin,
      USA.
FAU - Jochem, Adam
AU  - Jochem A
AD  - Morgridge Institute for Research, Madison, Wisconsin, USA.
FAU - Rush, Matthew J P
AU  - Rush MJP
AD  - Genome Center of Wisconsin, Madison, Wisconsin, USA.
AD  - Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin,
      USA.
FAU - Ulbrich, Arne
AU  - Ulbrich A
AD  - Genome Center of Wisconsin, Madison, Wisconsin, USA.
AD  - Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin,
      USA.
FAU - Robinson, Kyle P
AU  - Robinson KP
AD  - Morgridge Institute for Research, Madison, Wisconsin, USA.
AD  - Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin, 
      USA.
FAU - Hutchins, Paul D
AU  - Hutchins PD
AD  - Genome Center of Wisconsin, Madison, Wisconsin, USA.
AD  - Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin,
      USA.
FAU - Veling, Mike T
AU  - Veling MT
AD  - Morgridge Institute for Research, Madison, Wisconsin, USA.
AD  - Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin, 
      USA.
FAU - Guo, Xiao
AU  - Guo X
AD  - Morgridge Institute for Research, Madison, Wisconsin, USA.
AD  - Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin,
      USA.
FAU - Kemmerer, Zachary A
AU  - Kemmerer ZA
AD  - Morgridge Institute for Research, Madison, Wisconsin, USA.
AD  - Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin, 
      USA.
FAU - Connors, Kyle J
AU  - Connors KJ
AD  - Genome Center of Wisconsin, Madison, Wisconsin, USA.
AD  - Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin,
      USA.
FAU - Trujillo, Edna A
AU  - Trujillo EA
AD  - Genome Center of Wisconsin, Madison, Wisconsin, USA.
AD  - Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin,
      USA.
FAU - Sokol, Jacob
AU  - Sokol J
AD  - Morgridge Institute for Research, Madison, Wisconsin, USA.
AD  - Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin, 
      USA.
FAU - Marx, Harald
AU  - Marx H
AD  - Genome Center of Wisconsin, Madison, Wisconsin, USA.
FAU - Westphall, Michael S
AU  - Westphall MS
AD  - Genome Center of Wisconsin, Madison, Wisconsin, USA.
FAU - Hebert, Alexander S
AU  - Hebert AS
AD  - Genome Center of Wisconsin, Madison, Wisconsin, USA.
FAU - Pagliarini, David J
AU  - Pagliarini DJ
AD  - Morgridge Institute for Research, Madison, Wisconsin, USA.
AD  - Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin, 
      USA.
FAU - Coon, Joshua J
AU  - Coon JJ
AD  - Genome Center of Wisconsin, Madison, Wisconsin, USA.
AD  - Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin,
      USA.
AD  - Department of Biomolecular Chemistry, University of Wisconsin-Madison, Madison,
      Wisconsin, USA.
LA  - eng
GR  - T32 GM007215/GM/NIGMS NIH HHS/United States
GR  - F30 AG043282/AG/NIA NIH HHS/United States
GR  - R01 GM112057/GM/NIGMS NIH HHS/United States
GR  - T32 GM008692/GM/NIGMS NIH HHS/United States
GR  - R01 DK098672/DK/NIDDK NIH HHS/United States
GR  - R35 GM118110/GM/NIGMS NIH HHS/United States
GR  - T32 HG002760/HG/NHGRI NIH HHS/United States
GR  - R01 GM115591/GM/NIGMS NIH HHS/United States
GR  - T32 DK007665/DK/NIDDK NIH HHS/United States
PT  - Journal Article
DEP - 20160926
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Mitochondrial Proteins)
RN  - 0 (Proteome)
SB  - IM
CIN - Cell Metab. 2016 Oct 11;24(4):525-526. PMID: 27732833
MH  - Cells, Cultured
MH  - Gene Expression Profiling/*methods
MH  - Humans
MH  - *Mass Spectrometry
MH  - Metabolome/physiology
MH  - Mitochondrial Diseases/genetics/*metabolism
MH  - Mitochondrial Proteins/genetics/*metabolism
MH  - Peptide Mapping
MH  - Proteome/genetics/*metabolism
MH  - Signal Transduction
PMC - PMC5101133
MID - NIHMS813406
EDAT- 2016/11/01 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/11/08 06:00
PHST- 2016/06/09 00:00 [received]
PHST- 2016/08/26 00:00 [accepted]
PHST- 2016/11/01 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
PHST- 2016/11/08 06:00 [entrez]
AID - 10.1038/nbt.3683 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Nov;34(11):1191-1197. doi: 10.1038/nbt.3683. Epub 2016 Sep
      26.

PMID- 27727231
OWN - NLM
STAT- In-Data-Review
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 10
DP  - 2016 Oct 11
TI  - Corrigendum: Genetic improvement of tomato by targeted control of fruit
      softening.
PG  - 1072
LID - 10.1038/nbt1016-1072d [doi]
FAU - Uluisik, Selman
AU  - Uluisik S
FAU - Chapman, Natalie H
AU  - Chapman NH
FAU - Smith, Rebecca
AU  - Smith R
FAU - Poole, Mervin
AU  - Poole M
FAU - Adams, Gary
AU  - Adams G
FAU - Gillis, Richard B
AU  - Gillis RB
FAU - Besong, Tabot M D
AU  - Besong TM
FAU - Sheldon, Judith
AU  - Sheldon J
FAU - Stiegelmeyer, Suzy
AU  - Stiegelmeyer S
FAU - Perez, Laura
AU  - Perez L
FAU - Samsulrizal, Nurul
AU  - Samsulrizal N
FAU - Wang, Duoduo
AU  - Wang D
FAU - Fisk, Ian D
AU  - Fisk ID
FAU - Yang, Ni
AU  - Yang N
FAU - Baxter, Charles
AU  - Baxter C
FAU - Rickett, Daniel
AU  - Rickett D
FAU - Fray, Rupert
AU  - Fray R
FAU - Blanco-Ulate, Barbara
AU  - Blanco-Ulate B
FAU - Powell, Ann L T
AU  - Powell AL
FAU - Harding, Stephen E
AU  - Harding SE
FAU - Craigon, Jim
AU  - Craigon J
FAU - Rose, Jocelyn K C
AU  - Rose JK
FAU - Fich, Eric A
AU  - Fich EA
FAU - Sun, Li
AU  - Sun L
FAU - Domozych, David S
AU  - Domozych DS
FAU - Fraser, Paul D
AU  - Fraser PD
FAU - Tucker, Gregory A
AU  - Tucker GA
FAU - Grierson, Don
AU  - Grierson D
FAU - Seymour, Graham B
AU  - Seymour GB
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/10/12 06:00
MHDA- 2016/10/12 06:00
CRDT- 2016/10/12 06:00
PHST- 2016/10/12 06:00 [entrez]
PHST- 2016/10/12 06:00 [pubmed]
PHST- 2016/10/12 06:00 [medline]
AID - nbt1016-1072d [pii]
AID - 10.1038/nbt1016-1072d [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Oct 11;34(10):1072. doi: 10.1038/nbt1016-1072d.

PMID- 27727229
OWN - NLM
STAT- In-Data-Review
LR  - 20161012
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 10
DP  - 2016 Oct 11
TI  - Top 20 translational researchers of 2015.
PG  - 1009
LID - 10.1038/nbt.3686 [doi]
FAU - Huggett, Brady
AU  - Huggett B
FAU - Paisner, Kathryn
AU  - Paisner K
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/10/12 06:00
MHDA- 2016/10/12 06:00
CRDT- 2016/10/12 06:00
PHST- 2016/10/12 06:00 [entrez]
PHST- 2016/10/12 06:00 [pubmed]
PHST- 2016/10/12 06:00 [medline]
AID - nbt.3686 [pii]
AID - 10.1038/nbt.3686 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Oct 11;34(10):1009. doi: 10.1038/nbt.3686.

PMID- 27727228
OWN - NLM
STAT- In-Data-Review
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 10
DP  - 2016 Oct 11
TI  - Erratum: Will Europe toast GM wheat for gluten sufferers?
PG  - 1072
LID - 10.1038/nbt1016-1072b [doi]
FAU - Laursen, Lucas
AU  - Laursen L
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/10/12 06:00
MHDA- 2016/10/12 06:00
CRDT- 2016/10/12 06:00
PHST- 2016/10/12 06:00 [entrez]
PHST- 2016/10/12 06:00 [pubmed]
PHST- 2016/10/12 06:00 [medline]
AID - nbt1016-1072b [pii]
AID - 10.1038/nbt1016-1072b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Oct 11;34(10):1072. doi: 10.1038/nbt1016-1072b.

PMID- 27727227
OWN - NLM
STAT- In-Data-Review
LR  - 20161012
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 10
DP  - 2016 Oct 11
TI  - An incredible fudge.
PG  - 997
LID - 10.1038/nbt.3705 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/10/12 06:00
MHDA- 2016/10/12 06:00
CRDT- 2016/10/12 06:00
PHST- 2016/10/12 06:00 [entrez]
PHST- 2016/10/12 06:00 [pubmed]
PHST- 2016/10/12 06:00 [medline]
AID - nbt.3705 [pii]
AID - 10.1038/nbt.3705 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Oct 11;34(10):997. doi: 10.1038/nbt.3705.

PMID- 27727226
OWN - NLM
STAT- In-Data-Review
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 10
DP  - 2016 Oct 11
TI  - Seres's pioneering microbiome drug fails mid-stage trial.
PG  - 1004-1005
LID - 10.1038/nbt1016-1004b [doi]
FAU - Ratner, Mark
AU  - Ratner M
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/10/12 06:00
MHDA- 2016/10/12 06:00
CRDT- 2016/10/12 06:00
PHST- 2016/10/12 06:00 [entrez]
PHST- 2016/10/12 06:00 [pubmed]
PHST- 2016/10/12 06:00 [medline]
AID - nbt1016-1004b [pii]
AID - 10.1038/nbt1016-1004b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Oct 11;34(10):1004-1005. doi: 10.1038/nbt1016-1004b.

PMID- 27727225
OWN - NLM
STAT- In-Data-Review
LR  - 20161012
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 10
DP  - 2016 Oct 11
TI  - Corrigendum: Secure cloud computing for genomic data.
PG  - 1072
LID - 10.1038/nbt1016-1072c [doi]
FAU - Datta, Somalee
AU  - Datta S
FAU - Bettinger, Keith
AU  - Bettinger K
FAU - Snyder, Michael
AU  - Snyder M
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/10/12 06:00
MHDA- 2016/10/12 06:00
CRDT- 2016/10/12 06:00
PHST- 2016/10/12 06:00 [entrez]
PHST- 2016/10/12 06:00 [pubmed]
PHST- 2016/10/12 06:00 [medline]
AID - nbt1016-1072c [pii]
AID - 10.1038/nbt1016-1072c [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Oct 11;34(10):1072. doi: 10.1038/nbt1016-1072c.

PMID- 27727224
OWN - NLM
STAT- In-Data-Review
LR  - 20161012
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 10
DP  - 2016 Oct 11
TI  - Bayer bids $66 billion for Monsanto.
PG  - 1003
LID - 10.1038/nbt1016-1003 [doi]
FAU - Waltz, Emily
AU  - Waltz E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/10/12 06:00
MHDA- 2016/10/12 06:00
CRDT- 2016/10/12 06:00
PHST- 2016/10/12 06:00 [entrez]
PHST- 2016/10/12 06:00 [pubmed]
PHST- 2016/10/12 06:00 [medline]
AID - nbt1016-1003 [pii]
AID - 10.1038/nbt1016-1003 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Oct 11;34(10):1003. doi: 10.1038/nbt1016-1003.

PMID- 27727223
OWN - NLM
STAT- In-Data-Review
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 10
DP  - 2016 Oct 11
TI  - Erratum: Stabilizing prospects for a universal flu vaccine.
PG  - 1072
LID - 10.1038/nbt1016-1072a [doi]
FAU - Elsner, Markus
AU  - Elsner M
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/10/12 06:00
MHDA- 2016/10/12 06:00
CRDT- 2016/10/12 06:00
PHST- 2016/10/12 06:00 [entrez]
PHST- 2016/10/12 06:00 [pubmed]
PHST- 2016/10/12 06:00 [medline]
AID - nbt1016-1072a [pii]
AID - 10.1038/nbt1016-1072a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Oct 11;34(10):1072. doi: 10.1038/nbt1016-1072a.

PMID- 27727222
OWN - NLM
STAT- In-Data-Review
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 10
DP  - 2016 Oct 11
TI  - BMS bets on targeting IL-8 to enhance cancer immunotherapies.
PG  - 1006-1007
LID - 10.1038/nbt1016-1006 [doi]
FAU - Dolgin, Elie
AU  - Dolgin E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/10/12 06:00
MHDA- 2016/10/12 06:00
CRDT- 2016/10/12 06:00
PHST- 2016/10/12 06:00 [entrez]
PHST- 2016/10/12 06:00 [pubmed]
PHST- 2016/10/12 06:00 [medline]
AID - nbt1016-1006 [pii]
AID - 10.1038/nbt1016-1006 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Oct 11;34(10):1006-1007. doi: 10.1038/nbt1016-1006.

PMID- 27727221
OWN - NLM
STAT- In-Data-Review
LR  - 20161012
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 10
DP  - 2016 Oct 11
TI  - First Rounders Podcast: Nancy J Kelley.
PG  - 1009
LID - 10.1038/nbt.3688 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/10/12 06:00
MHDA- 2016/10/12 06:00
CRDT- 2016/10/12 06:00
PHST- 2016/10/12 06:00 [entrez]
PHST- 2016/10/12 06:00 [pubmed]
PHST- 2016/10/12 06:00 [medline]
AID - nbt.3688 [pii]
AID - 10.1038/nbt.3688 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Oct 11;34(10):1009. doi: 10.1038/nbt.3688.

PMID- 27727220
OWN - NLM
STAT- In-Data-Review
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 10
DP  - 2016 Oct 11
TI  - DNA cages target quantum dots.
PG  - 1036
LID - 10.1038/nbt.3694 [doi]
FAU - Duarte, Joao H
AU  - Duarte JH
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/10/12 06:00
MHDA- 2016/10/12 06:00
CRDT- 2016/10/12 06:00
PHST- 2016/10/12 06:00 [entrez]
PHST- 2016/10/12 06:00 [pubmed]
PHST- 2016/10/12 06:00 [medline]
AID - nbt.3694 [pii]
AID - 10.1038/nbt.3694 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Oct 11;34(10):1036. doi: 10.1038/nbt.3694.

PMID- 27727219
OWN - NLM
STAT- In-Data-Review
LR  - 20161012
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 10
DP  - 2016 Oct 11
TI  - Recent patents in neurotechnology and neuroengineering.
PG  - 1032
LID - 10.1038/nbt.3706 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/10/12 06:00
MHDA- 2016/10/12 06:00
CRDT- 2016/10/12 06:00
PHST- 2016/10/12 06:00 [entrez]
PHST- 2016/10/12 06:00 [pubmed]
PHST- 2016/10/12 06:00 [medline]
AID - nbt.3706 [pii]
AID - 10.1038/nbt.3706 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Oct 11;34(10):1032. doi: 10.1038/nbt.3706.

PMID- 27727218
OWN - NLM
STAT- In-Data-Review
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 10
DP  - 2016 Oct 11
TI  - The emerging patent landscape of CRISPR-Cas gene editing technology.
PG  - 1025-1031
LID - 10.1038/nbt.3692 [doi]
FAU - Egelie, Knut J
AU  - Egelie KJ
AD  - Department of Biology, Norwegian University of Science and Technology, Trondheim,
      Norway.
AD  - Technology Transfer Office, Norwegian University of Science and Technology,
      Trondheim, Norway.
FAU - Graff, Gregory D
AU  - Graff GD
AD  - Department of Agricultural and Resource Economics, Colorado State University,
      Fort Collins, Colorado, USA, and the Department of Technology Management and
      Economics, Chalmers University of Technology, Gothenburg, Sweden.
FAU - Strand, Sabina P
AU  - Strand SP
AD  - Technology Transfer Office, Norwegian University of Science and Technology,
      Trondheim, Norway.
FAU - Johansen, Berit
AU  - Johansen B
AUID- ORCID: http://orcid.org/0000-0003-1901-7614
AD  - Department of Biology, Norwegian University of Science and Technology, Trondheim,
      Norway.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/10/12 06:00
MHDA- 2016/10/12 06:00
CRDT- 2016/10/12 06:00
PHST- 2016/10/12 06:00 [entrez]
PHST- 2016/10/12 06:00 [pubmed]
PHST- 2016/10/12 06:00 [medline]
AID - nbt.3692 [pii]
AID - 10.1038/nbt.3692 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Oct 11;34(10):1025-1031. doi: 10.1038/nbt.3692.

PMID- 27727217
OWN - NLM
STAT- In-Data-Review
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 10
DP  - 2016 Oct 11
TI  - Big win possible for Ionis/Biogen antisense drug in muscular atrophy.
PG  - 1002-1003
LID - 10.1038/nbt1016-1002 [doi]
FAU - Garber, Ken
AU  - Garber K
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/10/12 06:00
MHDA- 2016/10/12 06:00
CRDT- 2016/10/12 06:00
PHST- 2016/10/12 06:00 [entrez]
PHST- 2016/10/12 06:00 [pubmed]
PHST- 2016/10/12 06:00 [medline]
AID - nbt1016-1002 [pii]
AID - 10.1038/nbt1016-1002 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Oct 11;34(10):1002-1003. doi: 10.1038/nbt1016-1002.

PMID- 27727216
OWN - NLM
STAT- In-Data-Review
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 10
DP  - 2016 Oct 11
TI  - Rekindling cancer vaccines.
PG  - 1019-1024
LID - 10.1038/nbt.3690 [doi]
FAU - Branca, Malorye Allison
AU  - Branca MA
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/10/12 06:00
MHDA- 2016/10/12 06:00
CRDT- 2016/10/12 06:00
PHST- 2016/10/12 06:00 [entrez]
PHST- 2016/10/12 06:00 [pubmed]
PHST- 2016/10/12 06:00 [medline]
AID - nbt.3690 [pii]
AID - 10.1038/nbt.3690 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Oct 11;34(10):1019-1024. doi: 10.1038/nbt.3690.

PMID- 27727215
OWN - NLM
STAT- In-Data-Review
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 10
DP  - 2016 Oct 11
TI  - Early clinical data raise the bar for hemophilia gene therapies.
PG  - 999-1001
LID - 10.1038/nbt1016-999 [doi]
FAU - Dolgin, Elie
AU  - Dolgin E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/10/12 06:00
MHDA- 2016/10/12 06:00
CRDT- 2016/10/12 06:00
PHST- 2016/10/12 06:00 [entrez]
PHST- 2016/10/12 06:00 [pubmed]
PHST- 2016/10/12 06:00 [medline]
AID - nbt1016-999 [pii]
AID - 10.1038/nbt1016-999 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Oct 11;34(10):999-1001. doi: 10.1038/nbt1016-999.

PMID- 27727214
OWN - NLM
STAT- In-Data-Review
LR  - 20161012
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 10
DP  - 2016 Oct 11
TI  - Learn new languages to get ahead.
PG  - 1073-1074
LID - 10.1038/nbt.3698 [doi]
FAU - Birbrair, Alexander
AU  - Birbrair A
AD  - Department of Pathology, Federal University of Minas Gerais, Belo Horizonte,
      Minas Gerais, Brazil.
AD  - Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York,
      USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/10/12 06:00
MHDA- 2016/10/12 06:00
CRDT- 2016/10/12 06:00
PHST- 2016/10/12 06:00 [entrez]
PHST- 2016/10/12 06:00 [pubmed]
PHST- 2016/10/12 06:00 [medline]
AID - nbt.3698 [pii]
AID - 10.1038/nbt.3698 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Oct 11;34(10):1073-1074. doi: 10.1038/nbt.3698.

PMID- 27727213
OWN - NLM
STAT- In-Data-Review
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 10
DP  - 2016 Oct 11
TI  - Synthetic biology firms pivot from biofuels to cheap biologics.
PG  - 1008
LID - 10.1038/nbt1016-1008 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/10/12 06:00
MHDA- 2016/10/12 06:00
CRDT- 2016/10/12 06:00
PHST- 2016/10/12 06:00 [entrez]
PHST- 2016/10/12 06:00 [pubmed]
PHST- 2016/10/12 06:00 [medline]
AID - nbt1016-1008 [pii]
AID - 10.1038/nbt1016-1008 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Oct 11;34(10):1008. doi: 10.1038/nbt1016-1008.

PMID- 27727212
OWN - NLM
STAT- In-Data-Review
LR  - 20170825
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 10
DP  - 2016 Oct 11
TI  - Quantifying the human proteome.
PG  - 1033-1034
LID - 10.1038/nbt.3695 [doi]
FAU - Paulovich, Amanda G
AU  - Paulovich AG
AD  - Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle,
      Washington, USA.
FAU - Whiteaker, Jeffrey R
AU  - Whiteaker JR
AD  - Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle,
      Washington, USA.
LA  - eng
GR  - R50 CA211499/CA/NCI NIH HHS/United States
GR  - U24 CA160034/CA/NCI NIH HHS/United States
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
PMC - PMC5570441
MID - NIHMS892781
EDAT- 2016/10/12 06:00
MHDA- 2016/10/12 06:00
CRDT- 2016/10/12 06:00
PHST- 2016/10/12 06:00 [entrez]
PHST- 2016/10/12 06:00 [pubmed]
PHST- 2016/10/12 06:00 [medline]
AID - nbt.3695 [pii]
AID - 10.1038/nbt.3695 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Oct 11;34(10):1033-1034. doi: 10.1038/nbt.3695.

PMID- 27727211
OWN - NLM
STAT- In-Data-Review
LR  - 20161012
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 10
DP  - 2016 Oct 11
TI  - Surprise rejection for Amgen's D-peptide.
PG  - 1004
LID - 10.1038/nbt1016-1004a [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/10/12 06:00
MHDA- 2016/10/12 06:00
CRDT- 2016/10/12 06:00
PHST- 2016/10/12 06:00 [entrez]
PHST- 2016/10/12 06:00 [pubmed]
PHST- 2016/10/12 06:00 [medline]
AID - nbt1016-1004a [pii]
AID - 10.1038/nbt1016-1004a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Oct 11;34(10):1004. doi: 10.1038/nbt1016-1004a.

PMID- 27727210
OWN - NLM
STAT- In-Data-Review
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 10
DP  - 2016 Oct 11
TI  - Lost in the citation valley.
PG  - 1016-1018
LID - 10.1038/nbt.3691 [doi]
FAU - Pasterkamp, Gerard
AU  - Pasterkamp G
AD  - Laboratory of Experimental Cardiology, University Medical Center Utrecht,
      Utrecht, the Netherlands.
AD  - Laboratory of Clinical Chemistry, University Medical Center Utrecht, Utrecht, the
      Netherlands.
AD  - Eureka Institute for Translational Medicine, Siracusa, Italy.
FAU - Hoefer, Imo
AU  - Hoefer I
AD  - Laboratory of Clinical Chemistry, University Medical Center Utrecht, Utrecht, the
      Netherlands.
AD  - Eureka Institute for Translational Medicine, Siracusa, Italy.
FAU - Prakken, Berent
AU  - Prakken B
AD  - Department of Pediatrics, University Medical Center Utrecht, Utrecht, the
      Netherlands.
AD  - Eureka Institute for Translational Medicine, Siracusa, Italy.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/10/12 06:00
MHDA- 2016/10/12 06:00
CRDT- 2016/10/12 06:00
PHST- 2016/10/12 06:00 [entrez]
PHST- 2016/10/12 06:00 [pubmed]
PHST- 2016/10/12 06:00 [medline]
AID - nbt.3691 [pii]
AID - 10.1038/nbt.3691 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Oct 11;34(10):1016-1018. doi: 10.1038/nbt.3691.

PMID- 27727209
OWN - NLM
STAT- In-Data-Review
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 10
DP  - 2016 Oct 11
TI  - Bypassing GMO regulations with CRISPR gene editing.
PG  - 1014-1015
LID - 10.1038/nbt.3680 [doi]
FAU - Kim, Jungeun
AU  - Kim J
AD  - Department of Chemistry, Seoul National University, Seoul, South Korea.
FAU - Kim, Jin-Soo
AU  - Kim JS
AD  - Department of Chemistry, Seoul National University, Seoul, South Korea.
AD  - Center for Genome Engineering, Institute for Basic Science, Seoul, South Korea.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/10/12 06:00
MHDA- 2016/10/12 06:00
CRDT- 2016/10/12 06:00
PHST- 2016/10/12 06:00 [entrez]
PHST- 2016/10/12 06:00 [pubmed]
PHST- 2016/10/12 06:00 [medline]
AID - nbt.3680 [pii]
AID - 10.1038/nbt.3680 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Oct 11;34(10):1014-1015. doi: 10.1038/nbt.3680.

PMID- 27727208
OWN - NLM
STAT- In-Data-Review
LR  - 20161012
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 10
DP  - 2016 Oct 11
TI  - Allergan enriches skin portfolio.
PG  - 1005
LID - 10.1038/nbt1016-1005 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/10/12 06:00
MHDA- 2016/10/12 06:00
CRDT- 2016/10/12 06:00
PHST- 2016/10/12 06:00 [entrez]
PHST- 2016/10/12 06:00 [pubmed]
PHST- 2016/10/12 06:00 [medline]
AID - nbt1016-1005 [pii]
AID - 10.1038/nbt1016-1005 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Oct 11;34(10):1005. doi: 10.1038/nbt1016-1005.

PMID- 27727207
OWN - NLM
STAT- In-Data-Review
LR  - 20170826
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 10
DP  - 2016 Oct 11
TI  - Rewiring Escherichia coli for carbon-dioxide fixation.
PG  - 1035-1036
LID - 10.1038/nbt.3693 [doi]
FAU - Kerfeld, Cheryl A
AU  - Kerfeld CA
AUID- ORCID: http://orcid.org/0000-0002-9977-8482
AD  - MSU-DOE Plant Research Laboratory, Michigan State University, East Lansing,
      Michigan, USA.
AD  - Molecular Biophysics and Bioimaging Division, Lawrence Berkeley National
      Laboratory, Berkeley, California, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/10/12 06:00
MHDA- 2016/10/12 06:00
CRDT- 2016/10/12 06:00
PHST- 2016/10/12 06:00 [entrez]
PHST- 2016/10/12 06:00 [pubmed]
PHST- 2016/10/12 06:00 [medline]
AID - nbt.3693 [pii]
AID - 10.1038/nbt.3693 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Oct 11;34(10):1035-1036. doi: 10.1038/nbt.3693.

PMID- 27727205
OWN - NLM
STAT- In-Data-Review
LR  - 20161012
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 10
DP  - 2016 Oct 11
TI  - Around the world in a month.
PG  - 1007
LID - 10.1038/nbt1016-1007 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/10/12 06:00
MHDA- 2016/10/12 06:00
CRDT- 2016/10/12 06:00
PHST- 2016/10/12 06:00 [entrez]
PHST- 2016/10/12 06:00 [pubmed]
PHST- 2016/10/12 06:00 [medline]
AID - nbt1016-1007 [pii]
AID - 10.1038/nbt1016-1007 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Oct 11;34(10):1007. doi: 10.1038/nbt1016-1007.

PMID- 27617738
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20170719
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 10
DP  - 2016 Oct
TI  - Blood pressure regulation by CD4(+) lymphocytes expressing choline
      acetyltransferase.
PG  - 1066-1071
LID - 10.1038/nbt.3663 [doi]
AB  - Blood pressure regulation is known to be maintained by a neuro-endocrine circuit,
      but whether immune cells contribute to blood pressure homeostasis has not been
      determined. We previously showed that CD4(+) T lymphocytes that express choline
      acetyltransferase (ChAT), which catalyzes the synthesis of the vasorelaxant
      acetylcholine, relay neural signals. Here we show that these
      CD4(+)CD44(hi)CD62L(lo) T helper cells by gene expression are a distinct T-cell
      population defined by ChAT (CD4 TChAT). Mice lacking ChAT expression in CD4(+)
      cells have elevated arterial blood pressure, compared to littermate controls.
      Jurkat T cells overexpressing ChAT (JTChAT) decreased blood pressure when infused
      into mice. Co-incubation of JTChAT and endothelial cells increased endothelial
      cell levels of phosphorylated endothelial nitric oxide synthase, and of nitrates 
      and nitrites in conditioned media, indicating increased release of the potent
      vasorelaxant nitric oxide. The isolation and characterization of CD4 TChAT cells 
      will enable analysis of the role of these cells in hypotension and hypertension, 
      and may suggest novel therapeutic strategies by targeting cell-mediated
      vasorelaxation.
FAU - Olofsson, Peder S
AU  - Olofsson PS
AD  - Center for Bioelectronic Medicine, Department of Medicine, Center for Molecular
      Medicine, Solna, Karolinska Institutet, Karolinska University Hospital,
      Stockholm, Sweden.
AD  - Laboratory of Biomedical Science, The Feinstein Institute for Medical Research,
      Manhasset, New York, USA.
FAU - Steinberg, Benjamin E
AU  - Steinberg BE
AD  - Laboratory of Biomedical Science, The Feinstein Institute for Medical Research,
      Manhasset, New York, USA.
AD  - The Campbell Family Institute for Breast Cancer Research, University Health
      Network, Toronto, Ontario, Canada.
FAU - Sobbi, Roozbeh
AU  - Sobbi R
AD  - Division of Cardiology, Peter Munk Cardiac Centre, University Health Network,
      Toronto, Ontario, Canada.
FAU - Cox, Maureen A
AU  - Cox MA
AD  - The Campbell Family Institute for Breast Cancer Research, University Health
      Network, Toronto, Ontario, Canada.
FAU - Ahmed, Mohamed N
AU  - Ahmed MN
AD  - Center for Heart and Lung Research, The Feinstein Institute for Medical Research,
      Manhasset, New York, USA.
FAU - Oswald, Michaela
AU  - Oswald M
AD  - Robert S. Boas Center for Genomics and Human Genetics, Feinstein Institute for
      Medical Research, Manhasset, New York, USA.
FAU - Szekeres, Ferenc
AU  - Szekeres F
AD  - Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm,
      Sweden.
AD  - School of Health and Education, University of Skovde, Skovde, Sweden.
FAU - Hanes, William M
AU  - Hanes WM
AD  - Laboratory of Biomedical Science, The Feinstein Institute for Medical Research,
      Manhasset, New York, USA.
FAU - Introini, Andrea
AU  - Introini A
AUID- ORCID: http://orcid.org/0000-0002-9929-8964
AD  - Department of Medicine, Solna, Unit of Infectious Diseases, Center for Molecular 
      Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm,
      Sweden.
FAU - Liu, Shu Fang
AU  - Liu SF
AD  - Center for Heart and Lung Research, The Feinstein Institute for Medical Research,
      Manhasset, New York, USA.
FAU - Holodick, Nichol E
AU  - Holodick NE
AD  - Center for Oncology and Cell Biology, The Feinstein Institute for Medical
      Research, Manhasset, New York, USA.
FAU - Rothstein, Thomas L
AU  - Rothstein TL
AD  - Center for Oncology and Cell Biology, The Feinstein Institute for Medical
      Research, Manhasset, New York, USA.
FAU - Lovdahl, Cecilia
AU  - Lovdahl C
AD  - Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm,
      Sweden.
FAU - Chavan, Sangeeta S
AU  - Chavan SS
AD  - Laboratory of Biomedical Science, The Feinstein Institute for Medical Research,
      Manhasset, New York, USA.
FAU - Yang, Huan
AU  - Yang H
AD  - Laboratory of Biomedical Science, The Feinstein Institute for Medical Research,
      Manhasset, New York, USA.
FAU - Pavlov, Valentin A
AU  - Pavlov VA
AD  - Laboratory of Biomedical Science, The Feinstein Institute for Medical Research,
      Manhasset, New York, USA.
FAU - Broliden, Kristina
AU  - Broliden K
AUID- ORCID: http://orcid.org/0000-0003-2224-7664
AD  - Department of Medicine, Solna, Unit of Infectious Diseases, Center for Molecular 
      Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm,
      Sweden.
FAU - Andersson, Ulf
AU  - Andersson U
AD  - Department of Women's and Children's Health, Karolinska Institutet, Stockholm,
      Sweden.
FAU - Diamond, Betty
AU  - Diamond B
AUID- ORCID: http://orcid.org/0000-0002-3250-3804
AD  - The Center for Autoimmune and Musculoskeletal Diseases, The Feinstein Institute
      for Medical Research, Manhasset, New York, USA.
FAU - Miller, Edmund J
AU  - Miller EJ
AUID- ORCID: http://orcid.org/0000-0002-2131-0054
AD  - Center for Heart and Lung Research, The Feinstein Institute for Medical Research,
      Manhasset, New York, USA.
FAU - Arner, Anders
AU  - Arner A
AD  - Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm,
      Sweden.
FAU - Gregersen, Peter K
AU  - Gregersen PK
AD  - Robert S. Boas Center for Genomics and Human Genetics, Feinstein Institute for
      Medical Research, Manhasset, New York, USA.
FAU - Backx, Peter H
AU  - Backx PH
AD  - Division of Cardiology, Peter Munk Cardiac Centre, University Health Network,
      Toronto, Ontario, Canada.
AD  - Department of Biology, York University, Toronto, Ontario, Canada.
FAU - Mak, Tak W
AU  - Mak TW
AD  - The Campbell Family Institute for Breast Cancer Research, University Health
      Network, Toronto, Ontario, Canada.
FAU - Tracey, Kevin J
AU  - Tracey KJ
AD  - Laboratory of Biomedical Science, The Feinstein Institute for Medical Research,
      Manhasset, New York, USA.
AD  - Department of Women's and Children's Health, Karolinska Institutet, Stockholm,
      Sweden.
LA  - eng
GR  - R01 GM057226/GM/NIGMS NIH HHS/United States
GR  - P01 AI102852/AI/NIAID NIH HHS/United States
GR  - R01 GM098446/GM/NIGMS NIH HHS/United States
GR  - R35 GM118182/GM/NIGMS NIH HHS/United States
GR  - R01 AI029690/AI/NIAID NIH HHS/United States
GR  - R01 GM089807/GM/NIGMS NIH HHS/United States
PT  - Journal Article
DEP - 20160912
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - EC 2.3.1.6 (Choline O-Acetyltransferase)
SB  - IM
MH  - Animals
MH  - Blood Pressure/*physiology
MH  - CD4-Positive T-Lymphocytes/*physiology
MH  - Cells, Cultured
MH  - Choline O-Acetyltransferase/*metabolism
MH  - Feedback, Physiological/physiology
MH  - Female
MH  - Hemostasis/*physiology
MH  - Male
MH  - Mice
MH  - Mice, Inbred C57BL
PMC - PMC5513182
MID - NIHMS808619
EDAT- 2016/09/13 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/09/13 06:00
PHST- 2016/06/06 00:00 [received]
PHST- 2016/08/04 00:00 [accepted]
PHST- 2016/09/13 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
PHST- 2016/09/13 06:00 [entrez]
AID - nbt.3663 [pii]
AID - 10.1038/nbt.3663 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Oct;34(10):1066-1071. doi: 10.1038/nbt.3663. Epub 2016 Sep
      12.

PMID- 27617737
OWN - NLM
STAT- In-Data-Review
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 10
DP  - 2016 Oct
TI  - A community-based model of rapid autopsy in end-stage cancer patients.
PG  - 1010-1014
LID - 10.1038/nbt.3674 [doi]
FAU - Alsop, Kathryn
AU  - Alsop K
AD  - Cancer Genomics Program, Research Department, Peter MacCallum Cancer Centre,
      Melbourne, Victoria, Australia.
FAU - Thorne, Heather
AU  - Thorne H
AD  - Cancer Genomics Program, Research Department, Peter MacCallum Cancer Centre,
      Melbourne, Victoria, Australia.
AD  - kConFab, Research Department, Peter MacCallum Cancer Centre, Melbourne, Victoria,
      Australia.
FAU - Sandhu, Shahneen
AU  - Sandhu S
AD  - Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, 
      Australia.
FAU - Hamilton, Anne
AU  - Hamilton A
AD  - Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, 
      Australia.
AD  - Department of Oncology, the Royal Women's Hospital, Parkville, Victoria,
      Australia.
AD  - Department of Medicine, Dentistry and Health Sciences, the University of
      Melbourne, Parkville, Victoria, Australia.
FAU - Mintoff, Christopher
AU  - Mintoff C
AD  - Cancer Development and Treatment Laboratory, Research Department, Peter MacCallum
      Cancer, Melbourne, Victoria, Australia.
FAU - Christie, Elizabeth
AU  - Christie E
AUID- ORCID: http://orcid.org/0000-0002-9959-7024
AD  - Cancer Genomics Program, Research Department, Peter MacCallum Cancer Centre,
      Melbourne, Victoria, Australia.
AD  - Sir Peter MacCallum Department of Oncology, the University of Melbourne,
      Victoria, Australia.
FAU - Spruyt, Odette
AU  - Spruyt O
AD  - Department of Medicine, Dentistry and Health Sciences, the University of
      Melbourne, Parkville, Victoria, Australia.
AD  - Department of Pain and Palliative Care, Peter MacCallum Cancer Centre, Melbourne,
      Victoria, Australia.
FAU - Williams, Scott
AU  - Williams S
AD  - Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne,
      Victoria, Australia.
FAU - McNally, Orla
AU  - McNally O
AD  - Department of Oncology, the Royal Women's Hospital, Parkville, Victoria,
      Australia.
AD  - Department of Obstetrics and Gynaecology, the University of Melbourne, Parkville,
      Victoria, Australia.
FAU - Mileshkin, Linda
AU  - Mileshkin L
AD  - Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, 
      Australia.
AD  - Sir Peter MacCallum Department of Oncology, the University of Melbourne,
      Victoria, Australia.
FAU - Ananda, Sumitra
AU  - Ananda S
AD  - Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, 
      Australia.
AD  - Department of Oncology, the Royal Women's Hospital, Parkville, Victoria,
      Australia.
FAU - Hallo, Julene
AU  - Hallo J
AD  - Department of Oncology, the Royal Women's Hospital, Parkville, Victoria,
      Australia.
FAU - Loi, Sherene
AU  - Loi S
AD  - Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, 
      Australia.
AD  - Sir Peter MacCallum Department of Oncology, the University of Melbourne,
      Victoria, Australia.
AD  - Translational Breast Cancer Genomics and Therapeutics Laboratory, Research
      Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
FAU - Scott, Clare
AU  - Scott C
AD  - The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria,
      Australia.
FAU - Savas, Peter
AU  - Savas P
AD  - Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, 
      Australia.
AD  - Translational Breast Cancer Genomics and Therapeutics Laboratory, Research
      Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
FAU - Devereux, Lisa
AU  - Devereux L
AD  - Sir Peter MacCallum Department of Oncology, the University of Melbourne,
      Victoria, Australia.
FAU - O'Brien, Patricia
AU  - O'Brien P
AD  - The Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia.
FAU - Gunawardena, Sameera
AU  - Gunawardena S
AUID- ORCID: http://orcid.org/0000-0001-9562-0533
AD  - The Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia.
FAU - Hampson, Clare
AU  - Hampson C
AD  - The Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia.
FAU - Strachan, Kate
AU  - Strachan K
AD  - The Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia.
FAU - Jaravaza, Rufaro Diana
AU  - Jaravaza RD
AD  - The Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia.
FAU - Francis, Victoria
AU  - Francis V
AD  - The Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia.
FAU - Young, Gregory
AU  - Young G
AD  - The Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia.
FAU - Ranson, David
AU  - Ranson D
AD  - The Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia.
FAU - Samaranayake, Ravindra
AU  - Samaranayake R
AD  - The Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia.
FAU - Stevens, David
AU  - Stevens D
AD  - Tobin Brothers Funerals, Victoria, Australia.
FAU - Boyle, Samantha
AU  - Boyle S
AD  - Cancer Development and Treatment Laboratory, Research Department, Peter MacCallum
      Cancer, Melbourne, Victoria, Australia.
FAU - Fedele, Clare
AU  - Fedele C
AD  - Cancer Development and Treatment Laboratory, Research Department, Peter MacCallum
      Cancer, Melbourne, Victoria, Australia.
AD  - Sir Peter MacCallum Department of Oncology, the University of Melbourne,
      Victoria, Australia.
AD  - Department of Pathology, the University of Melbourne, Parkville, Victoria,
      Australia.
FAU - Topp, Monique
AU  - Topp M
AD  - The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria,
      Australia.
FAU - Ho, Gwo
AU  - Ho G
AD  - The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria,
      Australia.
FAU - Teo, Zhi Ling
AU  - Teo ZL
AD  - Sir Peter MacCallum Department of Oncology, the University of Melbourne,
      Victoria, Australia.
AD  - Translational Breast Cancer Genomics and Therapeutics Laboratory, Research
      Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
FAU - Taylor, Renea A
AU  - Taylor RA
AD  - Department of Physiology, Biomedicine Discovery Institute, Monash Partners
      Comprehensive Cancer Consortium, Monash University, Clayton, Victoria, Australia.
FAU - Papargiris, Melissa M
AU  - Papargiris MM
AD  - Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute,
      Monash Partners Comprehensive Cancer Consortium, Monash University, Clayton,
      Victoria, Australia.
FAU - Lawrence, Mitchell G
AU  - Lawrence MG
AD  - Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute,
      Monash Partners Comprehensive Cancer Consortium, Monash University, Clayton,
      Victoria, Australia.
FAU - Wang, Hong
AU  - Wang H
AD  - Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute,
      Monash Partners Comprehensive Cancer Consortium, Monash University, Clayton,
      Victoria, Australia.
FAU - Risbridger, Gail P
AU  - Risbridger GP
AD  - Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute,
      Monash Partners Comprehensive Cancer Consortium, Monash University, Clayton,
      Victoria, Australia.
FAU - Haynes, Nicole M
AU  - Haynes NM
AD  - Sir Peter MacCallum Department of Oncology, the University of Melbourne,
      Victoria, Australia.
AD  - Cancer Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, 
      Australia.
FAU - Medon, Mikolaj
AU  - Medon M
AD  - Cancer Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, 
      Australia.
AD  - Division of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne,
      Victoria, Australia.
FAU - Johnstone, Ricky W
AU  - Johnstone RW
AD  - Sir Peter MacCallum Department of Oncology, the University of Melbourne,
      Victoria, Australia.
AD  - Cancer Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, 
      Australia.
FAU - Vidacs, Eva
AU  - Vidacs E
AD  - Cancer Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, 
      Australia.
FAU - Arnau, Gisela Mir
AU  - Arnau GM
AD  - Molecular Genomics, Research Division, Peter MacCallum Cancer Centre, Melbourne, 
      Victoria, Australia.
FAU - Vergara, Ismael A
AU  - Vergara IA
AD  - The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria,
      Australia.
AD  - Bioinformatics and Cancer Genomics, Research Division, Peter MacCallum Cancer
      Centre, Melbourne, Victoria, Australia.
FAU - Papenfuss, Anthony T
AU  - Papenfuss AT
AD  - Sir Peter MacCallum Department of Oncology, the University of Melbourne,
      Victoria, Australia.
AD  - Cancer Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, 
      Australia.
AD  - Bioinformatics and Cancer Genomics, Research Division, Peter MacCallum Cancer
      Centre, Melbourne, Victoria, Australia.
FAU - McArthur, Grant
AU  - McArthur G
AD  - Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, 
      Australia.
AD  - Sir Peter MacCallum Department of Oncology, the University of Melbourne,
      Victoria, Australia.
FAU - Waring, Paul
AU  - Waring P
AD  - Department of Pathology, the University of Melbourne, Parkville, Victoria,
      Australia.
FAU - Carvosso, Shirley
AU  - Carvosso S
AD  - The Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
FAU - Angel, Christopher
AU  - Angel C
AD  - Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria,
      Australia.
FAU - Gyorki, David
AU  - Gyorki D
AD  - Division of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne,
      Victoria, Australia.
AD  - The Department of Surgery, the University of Melbourne, Parkville, Victoria,
      Australia.
FAU - Solomon, Benjamin
AU  - Solomon B
AD  - Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, 
      Australia.
AD  - Sir Peter MacCallum Department of Oncology, the University of Melbourne,
      Victoria, Australia.
FAU - Mitchell, Gillian
AU  - Mitchell G
AD  - Sir Peter MacCallum Department of Oncology, the University of Melbourne,
      Victoria, Australia.
AD  - The Jack Brockhoff Familial Cancer Centre, Peter MacCallum Cancer Centre,
      Melbourne, Victoria, Australia.
AD  - Hereditary Cancer Program, BC Cancer Agency, Vancouver, Canada.
FAU - Shanley, Sue
AU  - Shanley S
AD  - The Jack Brockhoff Familial Cancer Centre, Peter MacCallum Cancer Centre,
      Melbourne, Victoria, Australia.
FAU - Francis, Prudence A
AU  - Francis PA
AD  - Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, 
      Australia.
FAU - Dawson, Sarah-Jane
AU  - Dawson SJ
AD  - Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, 
      Australia.
AD  - Sir Peter MacCallum Department of Oncology, the University of Melbourne,
      Victoria, Australia.
AD  - Molecular Biomarkers and Translational Genomics Laboratory, Research Department, 
      Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
FAU - Haffenden, Amy
AU  - Haffenden A
AD  - Department of Nursing, the Peter MacCallum Cancer Centre, Melbourne, Victoria,
      Australia.
FAU - Tidball, Erin
AU  - Tidball E
AD  - Department of Nursing, the Peter MacCallum Cancer Centre, Melbourne, Victoria,
      Australia.
FAU - Volchek, Mila
AU  - Volchek M
AD  - Department of Pathology, the Royal Women's Hospital, Parkville, Victoria,
      Australia.
FAU - Pyman, Jan
AU  - Pyman J
AD  - Department of Pathology, the Royal Women's Hospital, Parkville, Victoria,
      Australia.
FAU - Madadin, Mohammed
AU  - Madadin M
AUID- ORCID: http://orcid.org/0000-0002-8594-5868
AD  - The Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia.
AD  - Department of Pathology, University of Dammam, Dammam, Saudi Arabia.
FAU - Leditschke, Jodie
AU  - Leditschke J
AD  - The Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia.
AD  - Department of Forensic Medicine, School of Public Health and Preventive Medicine,
      Monash University, Victoria, Australia.
FAU - Cordner, Stephen
AU  - Cordner S
AD  - The Victorian Institute of Forensic Medicine, Southbank, Victoria, Australia.
AD  - Department of Forensic Medicine, School of Public Health and Preventive Medicine,
      Monash University, Victoria, Australia.
CN  - Melbourne Melanoma Project
CN  - Australian Ovarian Cancer Study Group (AOCS)
CN  - Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer
      (kConFab)
FAU - Shackleton, Mark
AU  - Shackleton M
AUID- ORCID: http://orcid.org/0000-0002-7673-4655
AD  - Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, 
      Australia.
AD  - Cancer Development and Treatment Laboratory, Research Department, Peter MacCallum
      Cancer, Melbourne, Victoria, Australia.
AD  - Sir Peter MacCallum Department of Oncology, the University of Melbourne,
      Victoria, Australia.
FAU - Bowtell, David D
AU  - Bowtell DD
AD  - Cancer Genomics Program, Research Department, Peter MacCallum Cancer Centre,
      Melbourne, Victoria, Australia.
AD  - Sir Peter MacCallum Department of Oncology, the University of Melbourne,
      Victoria, Australia.
AD  - The Garvan Institute, Sydney, New South Wales, Australia.
LA  - eng
PT  - Journal Article
DEP - 20160912
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/09/13 06:00
MHDA- 2016/09/13 06:00
CRDT- 2016/09/13 06:00
PHST- 2016/09/13 06:00 [pubmed]
PHST- 2016/09/13 06:00 [medline]
PHST- 2016/09/13 06:00 [entrez]
AID - nbt.3674 [pii]
AID - 10.1038/nbt.3674 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Oct;34(10):1010-1014. doi: 10.1038/nbt.3674. Epub 2016 Sep
      12.

PMID- 27598230
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20171107
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 10
DP  - 2016 Oct
TI  - High-throughput measurement of single-cell growth rates using serial microfluidic
      mass sensor arrays.
PG  - 1052-1059
LID - 10.1038/nbt.3666 [doi]
AB  - Methods to rapidly assess cell growth would be useful for many applications,
      including drug susceptibility testing, but current technologies have limited
      sensitivity or throughput. Here we present an approach to precisely and rapidly
      measure growth rates of many individual cells simultaneously. We flow cells in
      suspension through a microfluidic channel with 10-12 resonant mass sensors
      distributed along its length, weighing each cell repeatedly over the 4-20 min it 
      spends in the channel. Because multiple cells traverse the channel at the same
      time, we obtain growth rates for >60 cells/h with a resolution of 0.2 pg/h for
      mammalian cells and 0.02 pg/h for bacteria. We measure the growth of single
      lymphocytic cells, mouse and human T cells, primary human leukemia cells, yeast, 
      Escherichia coli and Enterococcus faecalis. Our system reveals subpopulations of 
      cells with divergent growth kinetics and enables assessment of cellular responses
      to antibiotics and antimicrobial peptides within minutes.
FAU - Cermak, Nathan
AU  - Cermak N
AD  - Program in Computational and Systems Biology, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
FAU - Olcum, Selim
AU  - Olcum S
AUID- ORCID: http://orcid.org/0000-0002-6417-1007
AD  - Koch Institute for Integrative Cancer Research, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
FAU - Delgado, Francisco Feijo
AU  - Delgado FF
AD  - Koch Institute for Integrative Cancer Research, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Wasserman, Steven C
AU  - Wasserman SC
AD  - Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Payer, Kristofor R
AU  - Payer KR
AD  - Microsystems Technology Laboratories, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - A Murakami, Mark
AU  - A Murakami M
AD  - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical
      School, Boston, Massachusetts, USA.
FAU - Knudsen, Scott M
AU  - Knudsen SM
AD  - Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Kimmerling, Robert J
AU  - Kimmerling RJ
AD  - Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Stevens, Mark M
AU  - Stevens MM
AD  - Department of Biology, Massachusetts Institute of Technology, Cambridge,
      Massachusetts, USA.
FAU - Kikuchi, Yuki
AU  - Kikuchi Y
AD  - Microsystems Technology Laboratories, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Sandikci, Arzu
AU  - Sandikci A
AD  - Koch Institute for Integrative Cancer Research, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
FAU - Ogawa, Masaaki
AU  - Ogawa M
AD  - Innovative Micro Technology, Goleta, California, USA.
FAU - Agache, Vincent
AU  - Agache V
AD  - CEA-LETI, Minatec Campus, Grenoble, France.
FAU - Baleras, Francois
AU  - Baleras F
AD  - CEA-LETI, Minatec Campus, Grenoble, France.
FAU - Weinstock, David M
AU  - Weinstock DM
AD  - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical
      School, Boston, Massachusetts, USA.
AD  - Broad Institute, Cambridge, Massachusetts, USA.
FAU - Manalis, Scott R
AU  - Manalis SR
AD  - Program in Computational and Systems Biology, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Koch Institute for Integrative Cancer Research, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
AD  - Microsystems Technology Laboratories, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
AD  - Department of Mechanical Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
LA  - eng
GR  - DP1 CA174420/CA/NCI NIH HHS/United States
GR  - R33 CA191143/CA/NCI NIH HHS/United States
GR  - P30 CA014051/CA/NCI NIH HHS/United States
GR  - T32 GM008334/GM/NIGMS NIH HHS/United States
GR  - T32 CA009172/CA/NCI NIH HHS/United States
GR  - T32 GM087237/GM/NIGMS NIH HHS/United States
GR  - U54 CA143874/CA/NCI NIH HHS/United States
PT  - Evaluation Studies
PT  - Journal Article
DEP - 20160905
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Cell Proliferation/*drug effects/*physiology
MH  - Drug Evaluation, Preclinical/*instrumentation/methods
MH  - Equipment Design
MH  - Equipment Failure Analysis
MH  - High-Throughput Screening Assays/*instrumentation/methods
MH  - *Lab-On-A-Chip Devices
MH  - Micro-Electrical-Mechanical Systems/*instrumentation/methods
MH  - Reproducibility of Results
MH  - Sensitivity and Specificity
MH  - Transducers
PMC - PMC5064867
MID - NIHMS809992
EDAT- 2016/09/07 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/09/07 06:00
PHST- 2015/11/03 00:00 [received]
PHST- 2016/08/10 00:00 [accepted]
PHST- 2016/09/07 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
PHST- 2016/09/07 06:00 [entrez]
AID - nbt.3666 [pii]
AID - 10.1038/nbt.3666 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Oct;34(10):1052-1059. doi: 10.1038/nbt.3666. Epub 2016 Sep
      5.

PMID- 27598229
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20170605
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 10
DP  - 2016 Oct
TI  - Expression of an insecticidal fern protein in cotton protects against whitefly.
PG  - 1046-1051
LID - 10.1038/nbt.3665 [doi]
AB  - Whitefly (Bemisia tabaci) damages field crops by sucking sap and transmitting
      viral diseases. None of the insecticidal proteins used in genetically modified
      (GM) crop plants to date are effective against whitefly. We report the
      identification of a protein (Tma12) from an edible fern, Tectaria macrodonta
      (Fee) C. Chr., that is insecticidal to whitefly (median lethal concentration =
      1.49 mug/ml in in vitro feeding assays) and interferes with its life cycle at
      sublethal doses. Transgenic cotton lines that express Tma12 at approximately
      0.01% of total soluble leaf protein were resistant to whitefly infestation in
      contained field trials, with no detectable yield penalty. The transgenic cotton
      lines were also protected from whitefly-borne cotton leaf curl viral disease.
      Rats fed Tma12 showed no detectable histological or biochemical changes, and
      this, together with the predicted absence of allergenic domains in Tma12,
      indicates that Tma12 might be well suited for deployment in GM crops to control
      whitefly and the viruses it carries.
FAU - Shukla, Anoop Kumar
AU  - Shukla AK
AD  - Genetics and Plant Molecular Biology, Council of Scientific and Industrial
      Research (CSIR)-National Botanical Research Institute, Lucknow, India.
FAU - Upadhyay, Santosh Kumar
AU  - Upadhyay SK
AD  - Genetics and Plant Molecular Biology, Council of Scientific and Industrial
      Research (CSIR)-National Botanical Research Institute, Lucknow, India.
FAU - Mishra, Manisha
AU  - Mishra M
AD  - Genetics and Plant Molecular Biology, Council of Scientific and Industrial
      Research (CSIR)-National Botanical Research Institute, Lucknow, India.
AD  - Academy of Scientific and Innovative Research, New Delhi, India.
FAU - Saurabh, Sharad
AU  - Saurabh S
AD  - Genetics and Plant Molecular Biology, Council of Scientific and Industrial
      Research (CSIR)-National Botanical Research Institute, Lucknow, India.
FAU - Singh, Rahul
AU  - Singh R
AD  - Genetics and Plant Molecular Biology, Council of Scientific and Industrial
      Research (CSIR)-National Botanical Research Institute, Lucknow, India.
FAU - Singh, Harpal
AU  - Singh H
AD  - Genetics and Plant Molecular Biology, Council of Scientific and Industrial
      Research (CSIR)-National Botanical Research Institute, Lucknow, India.
FAU - Thakur, Nidhi
AU  - Thakur N
AD  - Genetics and Plant Molecular Biology, Council of Scientific and Industrial
      Research (CSIR)-National Botanical Research Institute, Lucknow, India.
AD  - Academy of Scientific and Innovative Research, New Delhi, India.
FAU - Rai, Preeti
AU  - Rai P
AD  - Genetics and Plant Molecular Biology, Council of Scientific and Industrial
      Research (CSIR)-National Botanical Research Institute, Lucknow, India.
FAU - Pandey, Paras
AU  - Pandey P
AD  - Genetics and Plant Molecular Biology, Council of Scientific and Industrial
      Research (CSIR)-National Botanical Research Institute, Lucknow, India.
AD  - Academy of Scientific and Innovative Research, New Delhi, India.
FAU - Hans, Aradhana L
AU  - Hans AL
AD  - Genetics and Plant Molecular Biology, Council of Scientific and Industrial
      Research (CSIR)-National Botanical Research Institute, Lucknow, India.
AD  - Academy of Scientific and Innovative Research, New Delhi, India.
FAU - Srivastava, Subhi
AU  - Srivastava S
AD  - Genetics and Plant Molecular Biology, Council of Scientific and Industrial
      Research (CSIR)-National Botanical Research Institute, Lucknow, India.
FAU - Rajapure, Vikram
AU  - Rajapure V
AD  - Genetics and Plant Molecular Biology, Council of Scientific and Industrial
      Research (CSIR)-National Botanical Research Institute, Lucknow, India.
FAU - Yadav, Sunil Kumar
AU  - Yadav SK
AD  - Genetics and Plant Molecular Biology, Council of Scientific and Industrial
      Research (CSIR)-National Botanical Research Institute, Lucknow, India.
AD  - Academy of Scientific and Innovative Research, New Delhi, India.
FAU - Singh, Mithlesh Kumar
AU  - Singh MK
AD  - Genetics and Plant Molecular Biology, Council of Scientific and Industrial
      Research (CSIR)-National Botanical Research Institute, Lucknow, India.
AD  - Academy of Scientific and Innovative Research, New Delhi, India.
FAU - Kumar, Jitendra
AU  - Kumar J
AD  - National Agri-Food Biotechnology Institute, Mohali, Punjab, India.
FAU - Chandrashekar, K
AU  - Chandrashekar K
AUID- ORCID: http://orcid.org/0000-0003-4937-8787
AD  - Genetics and Plant Molecular Biology, Council of Scientific and Industrial
      Research (CSIR)-National Botanical Research Institute, Lucknow, India.
FAU - Verma, Praveen C
AU  - Verma PC
AD  - Genetics and Plant Molecular Biology, Council of Scientific and Industrial
      Research (CSIR)-National Botanical Research Institute, Lucknow, India.
AD  - Academy of Scientific and Innovative Research, New Delhi, India.
FAU - Singh, Ajit Pratap
AU  - Singh AP
AD  - Academy of Scientific and Innovative Research, New Delhi, India.
AD  - Plant Diversity, Systematics and Herbarium Division, CSIR-National Botanical
      Research Institute, Lucknow, India.
FAU - Nair, K N
AU  - Nair KN
AD  - Academy of Scientific and Innovative Research, New Delhi, India.
AD  - Plant Diversity, Systematics and Herbarium Division, CSIR-National Botanical
      Research Institute, Lucknow, India.
FAU - Bhadauria, Smrati
AU  - Bhadauria S
AD  - Toxicology Division, CSIR-Central Drug Research Institute, Lucknow, India.
FAU - Wahajuddin, Muhammad
AU  - Wahajuddin M
AD  - Pharmacokinetics and Metabolism Division, CSIR-Central Drug Research Institute,
      Lucknow, India.
FAU - Singh, Sarika
AU  - Singh S
AD  - Toxicology Division, CSIR-Central Drug Research Institute, Lucknow, India.
FAU - Sharma, Sharad
AU  - Sharma S
AD  - Toxicology Division, CSIR-Central Drug Research Institute, Lucknow, India.
FAU - Omkar
AU  - Omkar
AD  - Ladybird Beetle Research Laboratory, Department of Zoology, University of
      Lucknow, Lucknow, India.
FAU - Upadhyay, Ram Sanmukh
AU  - Upadhyay RS
AD  - Department of Botany, Banaras Hindu University, Varanasi, India.
FAU - Ranade, Shirish A
AU  - Ranade SA
AD  - Genetics and Plant Molecular Biology, Council of Scientific and Industrial
      Research (CSIR)-National Botanical Research Institute, Lucknow, India.
AD  - Academy of Scientific and Innovative Research, New Delhi, India.
FAU - Tuli, Rakesh
AU  - Tuli R
AD  - Genetics and Plant Molecular Biology, Council of Scientific and Industrial
      Research (CSIR)-National Botanical Research Institute, Lucknow, India.
FAU - Singh, Pradhyumna Kumar
AU  - Singh PK
AD  - Genetics and Plant Molecular Biology, Council of Scientific and Industrial
      Research (CSIR)-National Botanical Research Institute, Lucknow, India.
AD  - Academy of Scientific and Innovative Research, New Delhi, India.
LA  - eng
PT  - Journal Article
DEP - 20160905
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Insecticides)
RN  - 0 (Plant Proteins)
RN  - 0 (Recombinant Proteins)
SB  - IM
MH  - Animals
MH  - Ferns/genetics/*metabolism
MH  - Genetic Enhancement/methods
MH  - Gossypium/*genetics/*parasitology/virology
MH  - Hemiptera/pathogenicity/*virology
MH  - Insecticides/*metabolism
MH  - Plant Proteins/genetics/*metabolism
MH  - Protein Engineering/methods
MH  - Recombinant Proteins/genetics/metabolism
EDAT- 2016/09/07 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/09/07 06:00
PHST- 2015/09/12 00:00 [received]
PHST- 2016/08/10 00:00 [accepted]
PHST- 2016/09/07 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
PHST- 2016/09/07 06:00 [entrez]
AID - nbt.3665 [pii]
AID - 10.1038/nbt.3665 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Oct;34(10):1046-1051. doi: 10.1038/nbt.3665. Epub 2016 Sep
      5.

PMID- 27571370
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20180118
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 10
DP  - 2016 Oct
TI  - Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers
      labeled with DNA barcodes.
PG  - 1037-1045
LID - 10.1038/nbt.3662 [doi]
AB  - Identification of the peptides recognized by individual T cells is important for 
      understanding and treating immune-related diseases. Current cytometry-based
      approaches are limited to the simultaneous screening of 10-100 distinct T-cell
      specificities in one sample. Here we use peptide-major histocompatibility complex
      (MHC) multimers labeled with individual DNA barcodes to screen >1,000 peptide
      specificities in a single sample, and detect low-frequency CD8 T cells specific
      for virus- or cancer-restricted antigens. When analyzing T-cell recognition of
      shared melanoma antigens before and after adoptive cell therapy in melanoma
      patients, we observe a greater number of melanoma-specific T-cell populations
      compared with cytometry-based approaches. Furthermore, we detect
      neoepitope-specific T cells in tumor-infiltrating lymphocytes and peripheral
      blood from patients with non-small cell lung cancer. Barcode-labeled pMHC
      multimers enable the combination of functional T-cell analysis with large-scale
      epitope recognition profiling for the characterization of T-cell recognition in
      various diseases, including in small clinical samples.
FAU - Bentzen, Amalie Kai
AU  - Bentzen AK
AD  - Section for Immunology and Vaccinology, National Veterinary Institute, Technical 
      University of Denmark, Copenhagen, Denmark.
FAU - Marquard, Andrea Marion
AU  - Marquard AM
AUID- ORCID: http://orcid.org/0000-0003-2928-6017
AD  - Center for Biological Sequence Analysis, Department of Systems Biology, Technical
      University of Denmark, Lyngby, Denmark.
FAU - Lyngaa, Rikke
AU  - Lyngaa R
AD  - Section for Immunology and Vaccinology, National Veterinary Institute, Technical 
      University of Denmark, Copenhagen, Denmark.
FAU - Saini, Sunil Kumar
AU  - Saini SK
AUID- ORCID: http://orcid.org/0000-0003-3382-9432
AD  - Section for Immunology and Vaccinology, National Veterinary Institute, Technical 
      University of Denmark, Copenhagen, Denmark.
FAU - Ramskov, Sofie
AU  - Ramskov S
AD  - Section for Immunology and Vaccinology, National Veterinary Institute, Technical 
      University of Denmark, Copenhagen, Denmark.
FAU - Donia, Marco
AU  - Donia M
AD  - Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital,
      University of Copenhagen, Copenhagen, Denmark.
AD  - Department of Oncology, Herlev Hospital, University of Copenhagen, Copenhagen,
      Denmark.
FAU - Such, Lina
AU  - Such L
AD  - Section for Immunology and Vaccinology, National Veterinary Institute, Technical 
      University of Denmark, Copenhagen, Denmark.
FAU - Furness, Andrew J S
AU  - Furness AJ
AD  - CRUK Lung Cancer Center of Excellence, UCL Cancer Institute, London, UK.
AD  - Cancer Immunology Unit, UCL Cancer Institute, University College London, London, 
      UK.
FAU - McGranahan, Nicholas
AU  - McGranahan N
AD  - CRUK Lung Cancer Center of Excellence, UCL Cancer Institute, London, UK.
AD  - Translational Cancer Therapeutics Laboratory, The Francis Crick Institute,
      London, UK.
FAU - Rosenthal, Rachel
AU  - Rosenthal R
AD  - CRUK Lung Cancer Center of Excellence, UCL Cancer Institute, London, UK.
AD  - Translational Cancer Therapeutics Laboratory, The Francis Crick Institute,
      London, UK.
FAU - Straten, Per Thor
AU  - Straten PT
AD  - Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital,
      University of Copenhagen, Copenhagen, Denmark.
AD  - Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, 
      Denmark.
FAU - Szallasi, Zoltan
AU  - Szallasi Z
AD  - Center for Biological Sequence Analysis, Department of Systems Biology, Technical
      University of Denmark, Lyngby, Denmark.
FAU - Svane, Inge Marie
AU  - Svane IM
AD  - Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital,
      University of Copenhagen, Copenhagen, Denmark.
AD  - Department of Oncology, Herlev Hospital, University of Copenhagen, Copenhagen,
      Denmark.
FAU - Swanton, Charles
AU  - Swanton C
AD  - CRUK Lung Cancer Center of Excellence, UCL Cancer Institute, London, UK.
AD  - Translational Cancer Therapeutics Laboratory, The Francis Crick Institute,
      London, UK.
FAU - Quezada, Sergio A
AU  - Quezada SA
AD  - CRUK Lung Cancer Center of Excellence, UCL Cancer Institute, London, UK.
AD  - Cancer Immunology Unit, UCL Cancer Institute, University College London, London, 
      UK.
FAU - Jakobsen, Soren Nyboe
AU  - Jakobsen SN
AD  - Section for Immunology and Vaccinology, National Veterinary Institute, Technical 
      University of Denmark, Copenhagen, Denmark.
AD  - Immudex, Copenhagen, Denmark.
FAU - Eklund, Aron Charles
AU  - Eklund AC
AUID- ORCID: http://orcid.org/0000-0003-0861-1001
AD  - Center for Biological Sequence Analysis, Department of Systems Biology, Technical
      University of Denmark, Lyngby, Denmark.
FAU - Hadrup, Sine Reker
AU  - Hadrup SR
AUID- ORCID: http://orcid.org/0000-0002-5937-4344
AD  - Section for Immunology and Vaccinology, National Veterinary Institute, Technical 
      University of Denmark, Copenhagen, Denmark.
LA  - eng
PT  - Journal Article
DEP - 20160829
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antigens)
RN  - 0 (Peptides)
SB  - IM
CIN - Transplantation. 2017 Feb;101(2):219-221. PMID: 28118315
MH  - Antigens/*genetics/*immunology
MH  - CD8-Positive T-Lymphocytes/*immunology
MH  - Cells, Cultured
MH  - DNA Barcoding, Taxonomic
MH  - Genes, MHC Class I/*genetics/immunology
MH  - High-Throughput Screening Assays/*methods
MH  - Humans
MH  - Immunoassay/*methods
MH  - Peptides/genetics/immunology
MH  - Protein Multimerization/genetics/immunology
MH  - Staining and Labeling/methods
EDAT- 2016/08/30 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/08/30 06:00
PHST- 2016/03/11 00:00 [received]
PHST- 2016/08/04 00:00 [accepted]
PHST- 2016/08/30 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
PHST- 2016/08/30 06:00 [entrez]
AID - nbt.3662 [pii]
AID - 10.1038/nbt.3662 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Oct;34(10):1037-1045. doi: 10.1038/nbt.3662. Epub 2016 Aug
      29.

PMID- 27571369
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20170605
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 10
DP  - 2016 Oct
TI  - Targeted DNA demethylation in vivo using dCas9-peptide repeat and scFv-TET1
      catalytic domain fusions.
PG  - 1060-1065
LID - 10.1038/nbt.3658 [doi]
AB  - Despite the importance of DNA methylation in health and disease, technologies to 
      readily manipulate methylation of specific sequences for functional analysis and 
      therapeutic purposes are lacking. Here we adapt the previously described
      dCas9-SunTag for efficient, targeted demethylation of specific DNA loci. The
      original SunTag consists of ten copies of the GCN4 peptide separated by
      5-amino-acid linkers. To achieve efficient recruitment of an anti-GCN4 scFv fused
      to the ten-eleven (TET) 1 hydroxylase, which induces demethylation, we changed
      the linker length to 22 amino acids. The system attains demethylation
      efficiencies >50% in seven out of nine loci tested. Four of these seven loci
      showed demethylation of >90%. We demonstrate targeted demethylation of CpGs in
      regulatory regions and demethylation-dependent 1.7- to 50-fold upregulation of
      associated genes both in cell culture (embryonic stem cells, cancer cell lines,
      primary neural precursor cells) and in vivo in mouse fetuses.
FAU - Morita, Sumiyo
AU  - Morita S
AD  - Institute for Molecular and Cellular Regulation, Gunma University, Maebashi,
      Japan.
FAU - Noguchi, Hirofumi
AU  - Noguchi H
AD  - Department of Stem Cell Biology and Medicine, Graduate School of Medical
      Sciences, Kyushu University, Fukuoka, Japan.
FAU - Horii, Takuro
AU  - Horii T
AD  - Institute for Molecular and Cellular Regulation, Gunma University, Maebashi,
      Japan.
FAU - Nakabayashi, Kazuhiko
AU  - Nakabayashi K
AD  - Department of Maternal-Fetal Biology, National Research Institute for Child
      Health and Development, Tokyo, Japan.
FAU - Kimura, Mika
AU  - Kimura M
AD  - Institute for Molecular and Cellular Regulation, Gunma University, Maebashi,
      Japan.
FAU - Okamura, Kohji
AU  - Okamura K
AUID- ORCID: http://orcid.org/0000-0001-9747-5069
AD  - Department of Systems BioMedicine, National Research Institute for Child Health
      and Development, Tokyo, Japan.
FAU - Sakai, Atsuhiko
AU  - Sakai A
AD  - Department of Stem Cell Biology and Medicine, Graduate School of Medical
      Sciences, Kyushu University, Fukuoka, Japan.
FAU - Nakashima, Hideyuki
AU  - Nakashima H
AD  - Department of Stem Cell Biology and Medicine, Graduate School of Medical
      Sciences, Kyushu University, Fukuoka, Japan.
FAU - Hata, Kenichiro
AU  - Hata K
AD  - Department of Maternal-Fetal Biology, National Research Institute for Child
      Health and Development, Tokyo, Japan.
FAU - Nakashima, Kinichi
AU  - Nakashima K
AD  - Department of Stem Cell Biology and Medicine, Graduate School of Medical
      Sciences, Kyushu University, Fukuoka, Japan.
FAU - Hatada, Izuho
AU  - Hatada I
AD  - Institute for Molecular and Cellular Regulation, Gunma University, Maebashi,
      Japan.
LA  - eng
PT  - Journal Article
DEP - 20160829
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Basic-Leucine Zipper Transcription Factors)
RN  - 0 (CRISPR-Associated Proteins)
RN  - 0 (GCN4 protein, S cerevisiae)
RN  - 0 (Proto-Oncogene Proteins)
RN  - 0 (Saccharomyces cerevisiae Proteins)
RN  - 0 (Single-Chain Antibodies)
RN  - EC 1.- (Mixed Function Oxygenases)
RN  - EC 1.- (TET1 protein, human)
SB  - IM
MH  - Animals
MH  - Basic-Leucine Zipper Transcription Factors/*genetics
MH  - CRISPR-Associated Proteins/*genetics
MH  - Catalysis
MH  - Clustered Regularly Interspaced Short Palindromic Repeats/*genetics
MH  - CpG Islands/genetics
MH  - DNA Methylation/*genetics
MH  - Gene Targeting/methods
MH  - Genetic Engineering/methods
MH  - Mice
MH  - Mixed Function Oxygenases/*genetics
MH  - Protein Domains
MH  - Proto-Oncogene Proteins/*genetics
MH  - Saccharomyces cerevisiae Proteins/*genetics
MH  - Single-Chain Antibodies/*genetics
EDAT- 2016/08/30 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/08/30 06:00
PHST- 2015/09/23 00:00 [received]
PHST- 2016/07/28 00:00 [accepted]
PHST- 2016/08/30 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
PHST- 2016/08/30 06:00 [entrez]
AID - nbt.3658 [pii]
AID - 10.1038/nbt.3658 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Oct;34(10):1060-1065. doi: 10.1038/nbt.3658. Epub 2016 Aug
      29.

PMID- 27606461
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 9
DP  - 2016 Sep 8
TI  - A survival guide for interdisciplinary PhD students.
PG  - 993-4
LID - 10.1038/nbt.3671 [doi]
FAU - Yu, Kun-Hsing
AU  - Yu KH
AD  - Biomedical Informatics Program, the Department of Genetics, and the Department of
      Computer Science, Stanford University, Stanford, California, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EDAT- 2016/09/09 06:00
MHDA- 2016/09/09 06:01
CRDT- 2016/09/09 06:00
PHST- 2016/09/09 06:00 [entrez]
PHST- 2016/09/09 06:00 [pubmed]
PHST- 2016/09/09 06:01 [medline]
AID - nbt.3671 [pii]
AID - 10.1038/nbt.3671 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Sep 8;34(9):993-4. doi: 10.1038/nbt.3671.

PMID- 27606460
OWN - NLM
STAT- MEDLINE
DCOM- 20180131
LR  - 20180201
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 9
DP  - 2016 Sep 8
TI  - Alighting on soft robot rays.
PG  - 932
LID - 10.1038/nbt.3672 [doi]
FAU - Jarchum, Irene
AU  - Jarchum I
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Science. 2016 Jul 8;353(6295):158-62. PMID: 27387948
MH  - *Equipment Design
MH  - *Robotics
EDAT- 2016/09/09 06:00
MHDA- 2018/02/01 06:00
CRDT- 2016/09/09 06:00
PHST- 2016/09/09 06:00 [entrez]
PHST- 2016/09/09 06:00 [pubmed]
PHST- 2018/02/01 06:00 [medline]
AID - nbt.3672 [pii]
AID - 10.1038/nbt.3672 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Sep 8;34(9):932. doi: 10.1038/nbt.3672.

PMID- 27606458
OWN - NLM
STAT- MEDLINE
DCOM- 20180131
LR  - 20180131
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 9
DP  - 2016 Sep 8
TI  - Precision medicine for autoimmune disease.
PG  - 930-2
LID - 10.1038/nbt.3670 [doi]
FAU - Chatenoud, Lucienne
AU  - Chatenoud L
AD  - Universite Paris Descartes, Sorbonne Paris Cite, Paris, France, and INSERM U1151,
      CNRS UMR 8253, INEM Hopital Necker-Enfants Malades, Paris, France.
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Science. 2016 Jul 8;353(6295):179-84. PMID: 27365313
MH  - *Autoimmune Diseases
MH  - Humans
MH  - *Precision Medicine
EDAT- 2016/09/09 06:00
MHDA- 2018/02/01 06:00
CRDT- 2016/09/09 06:00
PHST- 2016/09/09 06:00 [entrez]
PHST- 2016/09/09 06:00 [pubmed]
PHST- 2018/02/01 06:00 [medline]
AID - nbt.3670 [pii]
AID - 10.1038/nbt.3670 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Sep 8;34(9):930-2. doi: 10.1038/nbt.3670.

PMID- 27606457
OWN - NLM
STAT- MEDLINE
DCOM- 20180131
LR  - 20180201
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 9
DP  - 2016 Sep 8
TI  - Super-resolution microscopy writ large.
PG  - 928-30
LID - 10.1038/nbt.3669 [doi]
FAU - Engerer, Peter
AU  - Engerer P
AD  - Institute of Neuronal Cell Biology, Munich, Germany, the Center of Integrated
      Protein Science (CIPSM), Munich, Germany, the German Center for Neurodegenerative
      Diseases (DZNE), Munich, Germany, and the Munich Cluster of Systems Neurology
      (SyNergy), Munich, Germany.
FAU - Fecher, Caroline
AU  - Fecher C
AD  - Institute of Neuronal Cell Biology, Munich, Germany, the Center of Integrated
      Protein Science (CIPSM), Munich, Germany, the German Center for Neurodegenerative
      Diseases (DZNE), Munich, Germany, and the Munich Cluster of Systems Neurology
      (SyNergy), Munich, Germany.
FAU - Misgeld, Thomas
AU  - Misgeld T
AD  - Institute of Neuronal Cell Biology, Munich, Germany, the Center of Integrated
      Protein Science (CIPSM), Munich, Germany, the German Center for Neurodegenerative
      Diseases (DZNE), Munich, Germany, and the Munich Cluster of Systems Neurology
      (SyNergy), Munich, Germany.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Proteins)
SB  - IM
CON - Nat Biotechnol. 2016 Sep;34(9):987-92. PMID: 27376584
CON - Nat Biotechnol. 2016 Sep;34(9):973-81. PMID: 27454740
CON - Nat Methods. 2016 Jun;13(6):485-8. PMID: 27064647
MH  - Humans
MH  - *Microscopy, Fluorescence
MH  - Proteins/*analysis
EDAT- 2016/09/09 06:00
MHDA- 2018/02/01 06:00
CRDT- 2016/09/09 06:00
PHST- 2016/09/09 06:00 [entrez]
PHST- 2016/09/09 06:00 [pubmed]
PHST- 2018/02/01 06:00 [medline]
AID - nbt.3669 [pii]
AID - 10.1038/nbt.3669 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Sep 8;34(9):928-30. doi: 10.1038/nbt.3669.

PMID- 27606456
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 9
DP  - 2016 Sep 8
TI  - Recent patents in antimicrobials and infectious disease.
PG  - 927
LID - 10.1038/nbt.3675 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EDAT- 2016/09/09 06:00
MHDA- 2016/09/09 06:01
CRDT- 2016/09/09 06:00
PHST- 2016/09/09 06:00 [entrez]
PHST- 2016/09/09 06:00 [pubmed]
PHST- 2016/09/09 06:01 [medline]
AID - nbt.3675 [pii]
AID - 10.1038/nbt.3675 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Sep 8;34(9):927. doi: 10.1038/nbt.3675.

PMID- 27606455
OWN - NLM
STAT- MEDLINE
DCOM- 20180208
LR  - 20180208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 9
DP  - 2016 Sep 8
TI  - Which patent and where? Why international patent transparency by companies is
      needed for medicines.
PG  - 923-6
LID - 10.1038/nbt.3664 [doi]
FAU - Beall, Reed F
AU  - Beall RF
AD  - Population Health Program, Faculties of Law and of Medicine, University of
      Ottawa, Ottawa, Ontario, Canada.
FAU - Attaran, Amir
AU  - Attaran A
AD  - Population Health Program, Faculties of Law and of Medicine, University of
      Ottawa, Ottawa, Ontario, Canada.
LA  - eng
GR  - CIHR/Canada
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Drug Industry/*legislation & jurisprudence
MH  - Humans
MH  - Intellectual Property
MH  - Internationality/*legislation & jurisprudence
MH  - Patents as Topic/*legislation & jurisprudence
MH  - ROC Curve
EDAT- 2016/09/09 06:00
MHDA- 2018/02/09 06:00
CRDT- 2016/09/09 06:00
PHST- 2016/09/09 06:00 [entrez]
PHST- 2016/09/09 06:00 [pubmed]
PHST- 2018/02/09 06:00 [medline]
AID - nbt.3664 [pii]
AID - 10.1038/nbt.3664 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Sep 8;34(9):923-6. doi: 10.1038/nbt.3664.

PMID- 27606454
OWN - NLM
STAT- MEDLINE
DCOM- 20180208
LR  - 20180208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 9
DP  - 2016 Sep 8
TI  - Containment of transgenic trees by suppression of LEAFY.
PG  - 918-22
LID - 10.1038/nbt.3636 [doi]
FAU - Klocko, Amy L
AU  - Klocko AL
AD  - Department of Forest Ecosystems and Society, Oregon State University, Corvallis, 
      Oregon, USA.
FAU - Brunner, Amy M
AU  - Brunner AM
AD  - Department of Forest Ecosystems and Society, Oregon State University, Corvallis, 
      Oregon, USA.
FAU - Huang, Jian
AU  - Huang J
AD  - Department of Biological Sciences, University of Wisconsin-Milwaukee, Milwaukee, 
      Wisconsin, USA.
FAU - Meilan, Richard
AU  - Meilan R
AD  - Department of Forest Ecosystems and Society, Oregon State University, Corvallis, 
      Oregon, USA.
FAU - Lu, Haiwei
AU  - Lu H
AD  - Department of Forest Ecosystems and Society, Oregon State University, Corvallis, 
      Oregon, USA.
FAU - Ma, Cathleen
AU  - Ma C
AD  - Department of Forest Ecosystems and Society, Oregon State University, Corvallis, 
      Oregon, USA.
FAU - Morel, Alice
AU  - Morel A
AD  - Department of Forest Ecosystems and Society, Oregon State University, Corvallis, 
      Oregon, USA.
FAU - Zhao, Dazhong
AU  - Zhao D
AD  - Department of Biological Sciences, University of Wisconsin-Milwaukee, Milwaukee, 
      Wisconsin, USA.
FAU - Ault, Kori
AU  - Ault K
AD  - Department of Forest Ecosystems and Society, Oregon State University, Corvallis, 
      Oregon, USA.
FAU - Dow, Michael
AU  - Dow M
AD  - Department of Forest Ecosystems and Society, Oregon State University, Corvallis, 
      Oregon, USA.
FAU - Howe, Glenn
AU  - Howe G
AD  - Department of Forest Ecosystems and Society, Oregon State University, Corvallis, 
      Oregon, USA.
FAU - Shevchenko, Olga
AU  - Shevchenko O
AD  - Department of Forest Ecosystems and Society, Oregon State University, Corvallis, 
      Oregon, USA.
FAU - Strauss, Steven H
AU  - Strauss SH
AD  - Department of Forest Ecosystems and Society, Oregon State University, Corvallis, 
      Oregon, USA.
LA  - eng
PT  - Letter
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Plant Proteins)
RN  - 0 (Transcription Factors)
SB  - IM
MH  - Genetic Engineering/*methods/*standards
MH  - Phenotype
MH  - Plant Infertility/genetics
MH  - Plant Proteins/*genetics
MH  - Plants, Genetically Modified/*genetics
MH  - Populus/*genetics
MH  - RNA Interference
MH  - Transcription Factors/*genetics
EDAT- 2016/09/09 06:00
MHDA- 2018/02/09 06:00
CRDT- 2016/09/09 06:00
PHST- 2016/09/09 06:00 [entrez]
PHST- 2016/09/09 06:00 [pubmed]
PHST- 2018/02/09 06:00 [medline]
AID - nbt.3636 [pii]
AID - 10.1038/nbt.3636 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Sep 8;34(9):918-22. doi: 10.1038/nbt.3636.

PMID- 27606453
OWN - NLM
STAT- MEDLINE
DCOM- 20180208
LR  - 20180208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 9
DP  - 2016 Sep 8
TI  - The impact of personal genomics on risk perceptions and medical decision-making.
PG  - 912-8
LID - 10.1038/nbt.3661 [doi]
FAU - Krieger, Joshua L
AU  - Krieger JL
AD  - Sloan School of Management, Massachusetts Institute of Technology, Cambridge,
      Massachusetts, USA.
FAU - Murray, Fiona
AU  - Murray F
AD  - Sloan School of Management, Massachusetts Institute of Technology, Cambridge,
      Massachusetts, USA.
FAU - Roberts, J Scott
AU  - Roberts JS
AD  - Department of Health Behavior &Health Education, University of Michigan School of
      Public Health, Ann Arbor, Michigan, USA.
FAU - Green, Robert C
AU  - Green RC
AD  - Division of Genetics, Department of Medicine, Brigham and Women's Hospital,
      Partners HealthCare Personalized Medicine, the Broad Institute and Harvard
      Medical School, Boston, Massachusetts, USA.
LA  - eng
GR  - R01 HG005092/HG/NHGRI NIH HHS/United States
GR  - U01 HG006500/HG/NHGRI NIH HHS/United States
GR  - U19 HD077671/HD/NICHD NIH HHS/United States
GR  - U01 HG008685/HG/NHGRI NIH HHS/United States
GR  - U41 HG006834/HG/NHGRI NIH HHS/United States
PT  - Letter
PT  - Research Support, N.I.H., Extramural
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Decision Making
MH  - Direct-To-Consumer Screening and Testing/*psychology
MH  - Female
MH  - *Genomics
MH  - *Health Knowledge, Attitudes, Practice
MH  - *Health Risk Behaviors
MH  - Humans
MH  - Male
EDAT- 2016/09/09 06:00
MHDA- 2018/02/09 06:00
CRDT- 2016/09/09 06:00
PHST- 2016/09/09 06:00 [entrez]
PHST- 2016/09/09 06:00 [pubmed]
PHST- 2018/02/09 06:00 [medline]
AID - nbt.3661 [pii]
AID - 10.1038/nbt.3661 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Sep 8;34(9):912-8. doi: 10.1038/nbt.3661.

PMID- 27606452
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 9
DP  - 2016 Sep 8
TI  - Where the bodies lie.
PG  - 909-11
LID - 10.1038/nbt.3660 [doi]
FAU - Ben-Joseph, Oded
AU  - Ben-Joseph O
AD  - Outcome Capital, Boston, Massachusetts, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EDAT- 2016/09/09 06:00
MHDA- 2016/09/09 06:01
CRDT- 2016/09/09 06:00
PHST- 2016/09/09 06:00 [entrez]
PHST- 2016/09/09 06:00 [pubmed]
PHST- 2016/09/09 06:01 [medline]
AID - nbt.3660 [pii]
AID - 10.1038/nbt.3660 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Sep 8;34(9):909-11. doi: 10.1038/nbt.3660.

PMID- 27606451
OWN - NLM
STAT- MEDLINE
DCOM- 20180208
LR  - 20180208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 9
DP  - 2016 Sep 8
TI  - A spark at the periphery.
PG  - 904-8
LID - 10.1038/nbt.3667 [doi]
FAU - Waltz, Emily
AU  - Waltz E
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biomedical Engineering/*instrumentation
MH  - *Electric Stimulation Therapy
MH  - Humans
MH  - *Implantable Neurostimulators
MH  - *Peripheral Nerves
EDAT- 2016/09/09 06:00
MHDA- 2018/02/09 06:00
CRDT- 2016/09/09 06:00
PHST- 2016/09/09 06:00 [entrez]
PHST- 2016/09/09 06:00 [pubmed]
PHST- 2018/02/09 06:00 [medline]
AID - nbt.3667 [pii]
AID - 10.1038/nbt.3667 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Sep 8;34(9):904-8. doi: 10.1038/nbt.3667.

PMID- 27606450
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 9
DP  - 2016 Sep 8
TI  - Around the world in a month.
PG  - 903
LID - 10.1038/nbt0916-903 [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EDAT- 2016/09/09 06:00
MHDA- 2016/09/09 06:01
CRDT- 2016/09/09 06:00
PHST- 2016/09/09 06:00 [entrez]
PHST- 2016/09/09 06:00 [pubmed]
PHST- 2016/09/09 06:01 [medline]
AID - nbt0916-903 [pii]
AID - 10.1038/nbt0916-903 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Sep 8;34(9):903. doi: 10.1038/nbt0916-903.

PMID- 27606449
OWN - NLM
STAT- MEDLINE
DCOM- 20180208
LR  - 20180208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 9
DP  - 2016 Sep 8
TI  - Setbacks rattle allergy vaccine frontrunners, but hopes remain.
PG  - 901-2
LID - 10.1038/nbt0916-901 [doi]
FAU - Dolgin, Elie
AU  - Dolgin E
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Allergens)
RN  - 0 (Antigens, Plant)
RN  - 0 (Glycoproteins)
RN  - 0 (Plant Extracts)
RN  - 0 (Sweet Vernal, orchard, Perennial Rye, Timothy and Kentucky Blue Grass Mixed
      Pollens Allergen Extract)
RN  - G408EE88II (Fel d 1 protein, Felis domesticus)
SB  - IM
MH  - Allergens
MH  - Animals
MH  - Antigens, Plant
MH  - Cats
MH  - *Clinical Trials as Topic
MH  - *Desensitization, Immunologic
MH  - *Drug Industry
MH  - Europe
MH  - Glycoproteins
MH  - Humans
MH  - Hypersensitivity/*therapy
MH  - Plant Extracts
EDAT- 2016/09/09 06:00
MHDA- 2018/02/09 06:00
CRDT- 2016/09/09 06:00
PHST- 2016/09/09 06:00 [entrez]
PHST- 2016/09/09 06:00 [pubmed]
PHST- 2018/02/09 06:00 [medline]
AID - nbt0916-901 [pii]
AID - 10.1038/nbt0916-901 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Sep 8;34(9):901-2. doi: 10.1038/nbt0916-901.

PMID- 27606448
OWN - NLM
STAT- MEDLINE
DCOM- 20180208
LR  - 20180208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 9
DP  - 2016 Sep 8
TI  - Merck stakes out 'irritable' neuron territory with $1.25 billion.
PG  - 900
LID - 10.1038/nbt0916-900 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (AF-219)
RN  - 0 (Purinergic P2X Receptor Antagonists)
RN  - 0 (Pyrimidines)
SB  - IM
MH  - Clinical Trials as Topic
MH  - *Cough/drug therapy/physiopathology
MH  - *Drug Industry/economics/organization & administration
MH  - Humans
MH  - Neurons
MH  - *Purinergic P2X Receptor Antagonists/adverse effects/therapeutic use
MH  - *Pyrimidines/adverse effects/therapeutic use
MH  - Taste Disorders/chemically induced
EDAT- 2016/09/09 06:00
MHDA- 2018/02/09 06:00
CRDT- 2016/09/09 06:00
PHST- 2016/09/09 06:00 [entrez]
PHST- 2016/09/09 06:00 [pubmed]
PHST- 2018/02/09 06:00 [medline]
AID - nbt0916-900 [pii]
AID - 10.1038/nbt0916-900 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Sep 8;34(9):900. doi: 10.1038/nbt0916-900.

PMID- 27606447
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 9
DP  - 2016 Sep 8
TI  - Farmers' microbe aid.
PG  - 899
LID - 10.1038/nbt0916-899 [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EDAT- 2016/09/09 06:00
MHDA- 2016/09/09 06:01
CRDT- 2016/09/09 06:00
PHST- 2016/09/09 06:00 [entrez]
PHST- 2016/09/09 06:00 [pubmed]
PHST- 2016/09/09 06:01 [medline]
AID - nbt0916-899 [pii]
AID - 10.1038/nbt0916-899 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Sep 8;34(9):899. doi: 10.1038/nbt0916-899.

PMID- 27606446
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 9
DP  - 2016 Sep 8
TI  - Jounce checkpoint lures Celgene.
PG  - 898
LID - 10.1038/nbt0916-898 [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EDAT- 2016/09/09 06:00
MHDA- 2016/09/09 06:01
CRDT- 2016/09/09 06:00
PHST- 2016/09/09 06:00 [entrez]
PHST- 2016/09/09 06:00 [pubmed]
PHST- 2016/09/09 06:01 [medline]
AID - nbt0916-898 [pii]
AID - 10.1038/nbt0916-898 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Sep 8;34(9):898. doi: 10.1038/nbt0916-898.

PMID- 27606445
OWN - NLM
STAT- MEDLINE
DCOM- 20180208
LR  - 20180208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 9
DP  - 2016 Sep 8
TI  - Human-animal hybrid ban may end soon.
PG  - 897
LID - 10.1038/nbt0916-897b [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - Cell Differentiation
MH  - Cellular Reprogramming
MH  - *Chimera
MH  - Embryo Research
MH  - Humans
MH  - National Institutes of Health (U.S.)
MH  - Stem Cell Research/*legislation & jurisprudence
MH  - United States
EDAT- 2016/09/09 06:00
MHDA- 2018/02/09 06:00
CRDT- 2016/09/09 06:00
PHST- 2016/09/09 06:00 [entrez]
PHST- 2016/09/09 06:00 [pubmed]
PHST- 2018/02/09 06:00 [medline]
AID - nbt0916-897b [pii]
AID - 10.1038/nbt0916-897b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Sep 8;34(9):897. doi: 10.1038/nbt0916-897b.

PMID- 27606444
OWN - NLM
STAT- MEDLINE
DCOM- 20180208
LR  - 20180208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 9
DP  - 2016 Sep 8
TI  - Combined insulin/GLP-1 pens near market.
PG  - 897-9
LID - 10.1038/nbt0916-897a [doi]
FAU - von Schaper, Eva
AU  - von Schaper E
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Drug Combinations)
RN  - 0 (Hypoglycemic Agents)
RN  - 0 (Insulin)
RN  - 89750-14-1 (Glucagon-Like Peptide 1)
SB  - IM
MH  - Diabetes Mellitus, Type 2/drug therapy
MH  - Drug Approval
MH  - *Drug Combinations
MH  - *Glucagon-Like Peptide 1
MH  - Humans
MH  - *Hypoglycemic Agents
MH  - *Insulin
MH  - United States
MH  - United States Food and Drug Administration
EDAT- 2016/09/09 06:00
MHDA- 2018/02/09 06:00
CRDT- 2016/09/09 06:00
PHST- 2016/09/09 06:00 [entrez]
PHST- 2016/09/09 06:00 [pubmed]
PHST- 2018/02/09 06:00 [medline]
AID - nbt0916-897a [pii]
AID - 10.1038/nbt0916-897a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Sep 8;34(9):897-9. doi: 10.1038/nbt0916-897a.

PMID- 27606443
OWN - NLM
STAT- MEDLINE
DCOM- 20180208
LR  - 20180208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 9
DP  - 2016 Sep 8
TI  - Strata rolls out drug-matching service, offers free tumor profiling.
PG  - 895-6
LID - 10.1038/nbt0916-895 [doi]
FAU - Ratner, Mark
AU  - Ratner M
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Drug Industry/economics/methods/organization & administration
MH  - Early Detection of Cancer
MH  - Humans
MH  - Molecular Medicine/economics/methods/organization & administration
MH  - *Neoplasms/diagnosis/drug therapy
MH  - *Precision Medicine/economics/methods
EDAT- 2016/09/09 06:00
MHDA- 2018/02/09 06:00
CRDT- 2016/09/09 06:00
PHST- 2016/09/09 06:00 [entrez]
PHST- 2016/09/09 06:00 [pubmed]
PHST- 2018/02/09 06:00 [medline]
AID - nbt0916-895 [pii]
AID - 10.1038/nbt0916-895 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Sep 8;34(9):895-6. doi: 10.1038/nbt0916-895.

PMID- 27606442
OWN - NLM
STAT- MEDLINE
DCOM- 20180208
LR  - 20180208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 9
DP  - 2016 Sep 8
TI  - CRISPR mouse model boom, rat model renaissance.
PG  - 893-4
LID - 10.1038/nbt0916-893 [doi]
FAU - Smalley, Eric
AU  - Smalley E
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - *CRISPR-Cas Systems
MH  - *Gene Editing
MH  - Mice
MH  - Mice, Transgenic
MH  - *Models, Animal
MH  - Rats
MH  - Rats, Transgenic
EDAT- 2016/09/09 06:00
MHDA- 2018/02/09 06:00
CRDT- 2016/09/09 06:00
PHST- 2016/09/09 06:00 [entrez]
PHST- 2016/09/09 06:00 [pubmed]
PHST- 2018/02/09 06:00 [medline]
AID - nbt0916-893 [pii]
AID - 10.1038/nbt0916-893 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Sep 8;34(9):893-4. doi: 10.1038/nbt0916-893.

PMID- 27606441
OWN - NLM
STAT- MEDLINE
DCOM- 20180208
LR  - 20180208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 9
DP  - 2016 Sep 8
TI  - Off the grid.
PG  - 891
LID - 10.1038/nbt.3679 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Ambulatory Care Facilities/legislation & jurisprudence/standards
MH  - Humans
MH  - *Stem Cell Transplantation/legislation & jurisprudence/standards
MH  - Treatment Outcome
MH  - United States
MH  - United States Food and Drug Administration
EDAT- 2016/09/09 06:00
MHDA- 2018/02/09 06:00
CRDT- 2016/09/09 06:00
PHST- 2016/09/09 06:00 [entrez]
PHST- 2016/09/09 06:00 [pubmed]
PHST- 2018/02/09 06:00 [medline]
AID - nbt.3679 [pii]
AID - 10.1038/nbt.3679 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Sep 8;34(9):891. doi: 10.1038/nbt.3679.

PMID- 27606440
OWN - NLM
STAT- Publisher
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 9
DP  - 2016 Sep 8
TI  - Applications of CRISPR technologies in research and beyond.
PG  - 933-941
LID - 10.1038/nbt.3659 [doi]
AB  - Programmable DNA cleavage using CRISPR-Cas9 enables efficient, site-specific
      genome engineering in single cells and whole organisms. In the research arena,
      versatile CRISPR-enabled genome editing has been used in various ways, such as
      controlling transcription, modifying epigenomes, conducting genome-wide screens
      and imaging chromosomes. CRISPR systems are already being used to alleviate
      genetic disorders in animals and are likely to be employed soon in the clinic to 
      treat human diseases of the eye and blood. Two clinical trials using CRISPR-Cas9 
      for targeted cancer therapies have been approved in China and the United States. 
      Beyond biomedical applications, these tools are now being used to expedite crop
      and livestock breeding, engineer new antimicrobials and control disease-carrying 
      insects with gene drives.
FAU - Barrangou, Rodolphe
AU  - Barrangou R
AUID- ORCID: http://orcid.org/0000-0002-0648-3504
AD  - Department of Food, Bioprocessing and Nutrition Sciences, North Carolina State
      University, Raleigh, North Carolina, USA.
FAU - Doudna, Jennifer A
AU  - Doudna JA
AD  - Howard Hughes Medical Institute, Innovative Genomics Initiative, Department of
      Molecular and Cell Biology, University of California, Berkeley, California, USA.
AD  - Department of Chemistry, University of California, Berkeley, California, USA.
AD  - Physical Biosciences Division, Lawrence Berkeley National Laboratory, Berkeley,
      California, USA.
LA  - eng
PT  - Journal Article
DEP - 20160908
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/09/09 06:00
MHDA- 2016/09/09 06:00
CRDT- 2016/09/09 06:00
PHST- 2015/08/21 00:00 [received]
PHST- 2016/07/31 00:00 [accepted]
PHST- 2016/09/09 06:00 [entrez]
PHST- 2016/09/09 06:00 [pubmed]
PHST- 2016/09/09 06:00 [medline]
AID - nbt.3659 [pii]
AID - 10.1038/nbt.3659 [doi]
PST - aheadofprint
SO  - Nat Biotechnol. 2016 Sep 8;34(9):933-941. doi: 10.1038/nbt.3659.

PMID- 27479498
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 9
DP  - 2016 Sep
TI  - Engineered non-Mendelian inheritance of entire parental genomes in C. elegans.
PG  - 982-6
LID - 10.1038/nbt.3643 [doi]
AB  - The ability to rewrite the rules of genetic segregation would open new
      possibilities in diverse areas of biotechnology ranging from breeding to
      epigenetics. Here we engineer non-Mendelian inheritance of the entire maternal or
      paternal genome in Caenorhabditis elegans by changing the structure of the
      mitotic spindle during the first cell division of the zygote. Using
      germline-specific overexpression of a single protein, the conserved microtubule
      force regulator GPR-1, we increase forces that pull on spindle poles to convert
      the single bipolar mitotic spindle to two monopolar spindles. This generates
      two-cell embryos in which one cell contains only the maternal chromosomes and the
      other cell contains only the paternal chromosomes. As the embryo develops, each
      cell of the animal, including the germ cells, contains the genetic material of
      only one parent, resulting in hybrid F1 animals. Progeny of these animals (F2)
      inherit either only F0 maternal or only F0 paternal chromosomes, and thus descend
      from only either of their grandparents' gametes.
FAU - Besseling, Judith
AU  - Besseling J
AD  - Max Planck Institute for Biophysical Chemistry, Gottingen, Germany.
FAU - Bringmann, Henrik
AU  - Bringmann H
AD  - Max Planck Institute for Biophysical Chemistry, Gottingen, Germany.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20160801
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Caenorhabditis elegans Proteins)
RN  - 0 (G protein regulator 1, C elegans)
SB  - IM
MH  - Animals
MH  - Caenorhabditis elegans/*genetics
MH  - Caenorhabditis elegans Proteins/*genetics
MH  - Chromosome Segregation/*genetics
MH  - Female
MH  - Genetic Engineering/*methods
MH  - Genome/*genetics
MH  - Inheritance Patterns/*genetics
MH  - Male
MH  - Mendelian Randomization Analysis/methods
EDAT- 2016/08/02 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/08/02 06:00
PHST- 2015/11/13 00:00 [received]
PHST- 2016/07/05 00:00 [accepted]
PHST- 2016/08/02 06:00 [entrez]
PHST- 2016/08/02 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3643 [pii]
AID - 10.1038/nbt.3643 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Sep;34(9):982-6. doi: 10.1038/nbt.3643. Epub 2016 Aug 1.

PMID- 27479497
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 9
DP  - 2016 Sep
TI  - Analyzing tumor heterogeneity and driver genes in single myeloid leukemia cells
      with SBCapSeq.
PG  - 962-72
LID - 10.1038/nbt.3637 [doi]
AB  - A central challenge in oncology is how to kill tumors containing heterogeneous
      cell populations defined by different combinations of mutated genes. Identifying 
      these mutated genes and understanding how they cooperate requires single-cell
      analysis, but current single-cell analytic methods, such as PCR-based strategies 
      or whole-exome sequencing, are biased, lack sequencing depth or are cost
      prohibitive. Transposon-based mutagenesis allows the identification of early
      cancer drivers, but current sequencing methods have limitations that prevent
      single-cell analysis. We report a liquid-phase, capture-based sequencing and
      bioinformatics pipeline, Sleeping Beauty (SB) capture hybridization sequencing
      (SBCapSeq), that facilitates sequencing of transposon insertion sites from single
      tumor cells in a SB mouse model of myeloid leukemia (ML). SBCapSeq analysis of
      just 26 cells from one tumor revealed the tumor's major clonal subpopulations,
      enabled detection of clonal insertion events not detected by other sequencing
      methods and led to the identification of dominant subclones, each containing a
      unique pair of interacting gene drivers along with three to six cooperating
      cancer genes with SB-driven expression changes.
FAU - Mann, Karen M
AU  - Mann KM
AD  - Cancer Research Program, Houston Methodist Research Institute, Houston, Texas,
      USA.
AD  - Institute of Molecular and Cell Biology, Singapore, Republic of Singapore.
FAU - Newberg, Justin Y
AU  - Newberg JY
AD  - Cancer Research Program, Houston Methodist Research Institute, Houston, Texas,
      USA.
FAU - Black, Michael A
AU  - Black MA
AD  - Department of Biochemistry, University of Otago, Dunedin, New Zealand.
FAU - Jones, Devin J
AU  - Jones DJ
AUID- ORCID: 0000-0003-4364-1273
AD  - Cancer Research Program, Houston Methodist Research Institute, Houston, Texas,
      USA.
FAU - Amaya-Manzanares, Felipe
AU  - Amaya-Manzanares F
AD  - Cancer Research Program, Houston Methodist Research Institute, Houston, Texas,
      USA.
FAU - Guzman-Rojas, Liliana
AU  - Guzman-Rojas L
AD  - Cancer Research Program, Houston Methodist Research Institute, Houston, Texas,
      USA.
FAU - Kodama, Takahiro
AU  - Kodama T
AD  - Cancer Research Program, Houston Methodist Research Institute, Houston, Texas,
      USA.
FAU - Ward, Jerrold M
AU  - Ward JM
AD  - Institute of Molecular and Cell Biology, Singapore, Republic of Singapore.
FAU - Rust, Alistair G
AU  - Rust AG
AD  - Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton,
      Cambridge, UK.
FAU - van der Weyden, Louise
AU  - van der Weyden L
AD  - Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton,
      Cambridge, UK.
FAU - Yew, Christopher Chin Kuan
AU  - Yew CC
AD  - Institute of Molecular and Cell Biology, Singapore, Republic of Singapore.
FAU - Waters, Jill L
AU  - Waters JL
AD  - Department of Genetics, University of Texas MD Anderson Cancer Center, Houston,
      Texas, USA.
FAU - Leung, Marco L
AU  - Leung ML
AD  - Department of Genetics, University of Texas MD Anderson Cancer Center, Houston,
      Texas, USA.
FAU - Rogers, Keith
AU  - Rogers K
AD  - Institute of Molecular and Cell Biology, Singapore, Republic of Singapore.
FAU - Rogers, Susan M
AU  - Rogers SM
AD  - Institute of Molecular and Cell Biology, Singapore, Republic of Singapore.
FAU - McNoe, Leslie A
AU  - McNoe LA
AD  - Department of Biochemistry, University of Otago, Dunedin, New Zealand.
FAU - Selvanesan, Luxmanan
AU  - Selvanesan L
AD  - Department of Biochemistry, University of Otago, Dunedin, New Zealand.
FAU - Navin, Nicholas
AU  - Navin N
AD  - Department of Genetics, University of Texas MD Anderson Cancer Center, Houston,
      Texas, USA.
FAU - Jenkins, Nancy A
AU  - Jenkins NA
AD  - Cancer Research Program, Houston Methodist Research Institute, Houston, Texas,
      USA.
AD  - Institute of Molecular and Cell Biology, Singapore, Republic of Singapore.
FAU - Copeland, Neal G
AU  - Copeland NG
AD  - Cancer Research Program, Houston Methodist Research Institute, Houston, Texas,
      USA.
AD  - Institute of Molecular and Cell Biology, Singapore, Republic of Singapore.
FAU - Mann, Michael B
AU  - Mann MB
AUID- ORCID: 0000-0002-7515-6515
AD  - Cancer Research Program, Houston Methodist Research Institute, Houston, Texas,
      USA.
AD  - Institute of Molecular and Cell Biology, Singapore, Republic of Singapore.
LA  - eng
GR  - R01 CA169244/CA/NCI NIH HHS/United States
GR  - R21 CA174397/CA/NCI NIH HHS/United States
GR  - Medical Research Council/United Kingdom
GR  - Cancer Research UK/United Kingdom
GR  - Wellcome Trust/United Kingdom
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20160801
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Biomarkers, Tumor)
RN  - 0 (DNA Transposable Elements)
RN  - 0 (DNA, Neoplasm)
RN  - 0 (Neoplasm Proteins)
RN  - EC 2.7.7.- (Transposases)
RN  - EC 2.7.7.- (sleeping beauty transposase, human)
SB  - IM
MH  - Algorithms
MH  - Animals
MH  - Biomarkers, Tumor/genetics
MH  - DNA Transposable Elements
MH  - DNA, Neoplasm/*genetics
MH  - Female
MH  - Genes, Neoplasm/*genetics
MH  - High-Throughput Nucleotide Sequencing/methods
MH  - In Situ Hybridization/*methods
MH  - Leukemia, Myeloid/*genetics/pathology
MH  - Male
MH  - Mice
MH  - Mutagenesis, Insertional/*genetics
MH  - Neoplasm Proteins/genetics
MH  - Sequence Analysis, DNA/*methods
MH  - Software
MH  - Transposases/genetics
EDAT- 2016/08/02 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/08/02 06:00
PHST- 2015/10/28 00:00 [received]
PHST- 2016/06/20 00:00 [accepted]
PHST- 2016/08/02 06:00 [entrez]
PHST- 2016/08/02 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3637 [pii]
AID - 10.1038/nbt.3637 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Sep;34(9):962-72. doi: 10.1038/nbt.3637. Epub 2016 Aug 1.

PMID- 27454740
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 9
DP  - 2016 Sep
TI  - Multiplexed and scalable super-resolution imaging of three-dimensional protein
      localization in size-adjustable tissues.
PG  - 973-81
LID - 10.1038/nbt.3641 [doi]
AB  - The biology of multicellular organisms is coordinated across multiple size
      scales, from the subnanoscale of molecules to the macroscale, tissue-wide
      interconnectivity of cell populations. Here we introduce a method for
      super-resolution imaging of the multiscale organization of intact tissues. The
      method, called magnified analysis of the proteome (MAP), linearly expands entire 
      organs fourfold while preserving their overall architecture and three-dimensional
      proteome organization. MAP is based on the observation that preventing
      crosslinking within and between endogenous proteins during hydrogel-tissue
      hybridization allows for natural expansion upon protein denaturation and
      dissociation. The expanded tissue preserves its protein content, its fine
      subcellular details, and its organ-scale intercellular connectivity. We use
      off-the-shelf antibodies for multiple rounds of immunolabeling and imaging of a
      tissue's magnified proteome, and our experiments demonstrate a success rate of
      82% (100/122 antibodies tested). We show that specimen size can be reversibly
      modulated to image both inter-regional connections and fine synaptic
      architectures in the mouse brain.
FAU - Ku, Taeyun
AU  - Ku T
AUID- ORCID: 0000-0001-9447-7579
AD  - Institute for Medical Engineering and Science, Massachusetts Institute of
      Technology (MIT), Cambridge, Massachusetts, USA.
AD  - Picower Institute for Learning and Memory, MIT, Cambridge, Massachusetts, USA.
FAU - Swaney, Justin
AU  - Swaney J
AD  - Department of Chemical Engineering, MIT, Cambridge, Massachusetts, USA.
FAU - Park, Jeong-Yoon
AU  - Park JY
AD  - Institute for Medical Engineering and Science, Massachusetts Institute of
      Technology (MIT), Cambridge, Massachusetts, USA.
AD  - Picower Institute for Learning and Memory, MIT, Cambridge, Massachusetts, USA.
AD  - Department of Neurosurgery, Gangnam Severance Hospital, Spine and Spinal Cord
      Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
FAU - Albanese, Alexandre
AU  - Albanese A
AD  - Institute for Medical Engineering and Science, Massachusetts Institute of
      Technology (MIT), Cambridge, Massachusetts, USA.
FAU - Murray, Evan
AU  - Murray E
AD  - Institute for Medical Engineering and Science, Massachusetts Institute of
      Technology (MIT), Cambridge, Massachusetts, USA.
AD  - Department of Brain and Cognitive Sciences, MIT, Cambridge, Massachusetts, USA.
FAU - Cho, Jae Hun
AU  - Cho JH
AD  - Department of Chemical Engineering, MIT, Cambridge, Massachusetts, USA.
FAU - Park, Young-Gyun
AU  - Park YG
AD  - Institute for Medical Engineering and Science, Massachusetts Institute of
      Technology (MIT), Cambridge, Massachusetts, USA.
AD  - Picower Institute for Learning and Memory, MIT, Cambridge, Massachusetts, USA.
FAU - Mangena, Vamsi
AU  - Mangena V
AD  - Harvard-MIT Division of Health Sciences and Technology, MIT, Cambridge,
      Massachusetts, USA.
FAU - Chen, Jiapei
AU  - Chen J
AD  - Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA.
FAU - Chung, Kwanghun
AU  - Chung K
AD  - Institute for Medical Engineering and Science, Massachusetts Institute of
      Technology (MIT), Cambridge, Massachusetts, USA.
AD  - Picower Institute for Learning and Memory, MIT, Cambridge, Massachusetts, USA.
AD  - Department of Chemical Engineering, MIT, Cambridge, Massachusetts, USA.
AD  - Department of Brain and Cognitive Sciences, MIT, Cambridge, Massachusetts, USA.
AD  - Broad Institute of Harvard University and MIT, Cambridge, Massachusetts, USA.
LA  - eng
GR  - U01 NS090473/NS/NINDS NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20160725
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Nerve Tissue Proteins)
RN  - 0 (Proteome)
SB  - IM
CIN - Nat Biotechnol. 2016 Sep 8;34(9):928-30. PMID: 27606457
MH  - Animals
MH  - Brain/*metabolism/ultrastructure
MH  - Female
MH  - Gene Expression Profiling/methods
MH  - Image Enhancement/methods
MH  - Image Interpretation, Computer-Assisted/methods
MH  - Imaging, Three-Dimensional/*methods
MH  - Immunoassay/methods
MH  - Male
MH  - Mice
MH  - Molecular Imaging/*methods
MH  - Nerve Tissue Proteins/metabolism
MH  - Proteome/*metabolism/ultrastructure
MH  - Synapses/*metabolism/*ultrastructure
MH  - Tissue Distribution
PMC - PMC5070610
MID - NIHMS800446
EDAT- 2016/07/28 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/07/26 06:00
PHST- 2015/11/17 00:00 [received]
PHST- 2016/06/27 00:00 [accepted]
PHST- 2016/07/26 06:00 [entrez]
PHST- 2016/07/28 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3641 [pii]
AID - 10.1038/nbt.3641 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Sep;34(9):973-81. doi: 10.1038/nbt.3641. Epub 2016 Jul 25.

PMID- 27454739
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 9
DP  - 2016 Sep
TI  - Systematic improvement of amplicon marker gene methods for increased accuracy in 
      microbiome studies.
PG  - 942-9
LID - 10.1038/nbt.3601 [doi]
AB  - Amplicon-based marker gene surveys form the basis of most microbiome and other
      microbial community studies. Such PCR-based methods have multiple steps, each of 
      which is susceptible to error and bias. Variance in results has also arisen
      through the use of multiple methods of next-generation sequencing (NGS) amplicon 
      library preparation. Here we formally characterized errors and biases by
      comparing different methods of amplicon-based NGS library preparation. Using mock
      community standards, we analyzed the amplification process to reveal insights
      into sources of experimental error and bias in amplicon-based microbial community
      and microbiome experiments. We present a method that improves on the current best
      practices and enables the detection of taxonomic groups that often go undetected 
      with existing methods.
FAU - Gohl, Daryl M
AU  - Gohl DM
AUID- ORCID: 0000-0002-4434-2788
AD  - University of Minnesota Genomics Center, Minneapolis, Minnesota, USA.
FAU - Vangay, Pajau
AU  - Vangay P
AD  - Biomedical Informatics and Computational Biology, University of Minnesota,
      Minneapolis, Minnesota, USA.
FAU - Garbe, John
AU  - Garbe J
AD  - Minnesota Supercomputing Institute, University of Minnesota, Minneapolis,
      Minnesota, USA.
FAU - MacLean, Allison
AU  - MacLean A
AD  - University of Minnesota Genomics Center, Minneapolis, Minnesota, USA.
FAU - Hauge, Adam
AU  - Hauge A
AD  - University of Minnesota Genomics Center, Minneapolis, Minnesota, USA.
FAU - Becker, Aaron
AU  - Becker A
AD  - University of Minnesota Genomics Center, Minneapolis, Minnesota, USA.
FAU - Gould, Trevor J
AU  - Gould TJ
AD  - University of Minnesota Informatics Institute, Minneapolis, Minnesota, USA.
FAU - Clayton, Jonathan B
AU  - Clayton JB
AD  - Department of Veterinary and Biomedical Sciences, University of Minnesota, St.
      Paul, Minnesota, USA.
FAU - Johnson, Timothy J
AU  - Johnson TJ
AD  - Department of Veterinary and Biomedical Sciences, University of Minnesota, St.
      Paul, Minnesota, USA.
FAU - Hunter, Ryan
AU  - Hunter R
AD  - Department of Microbiology and Immunology, University of Minnesota, Minneapolis, 
      Minnesota, USA.
FAU - Knights, Dan
AU  - Knights D
AD  - Biotechnology Institute, University of Minnesota, St. Paul, Minnesota, USA.
AD  - Department of Computer Science and Engineering, University of Minnesota,
      Minneapolis, Minnesota, USA.
FAU - Beckman, Kenneth B
AU  - Beckman KB
AD  - University of Minnesota Genomics Center, Minneapolis, Minnesota, USA.
LA  - eng
GR  - T32 DA007097/DA/NIDA NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20160725
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Genetic Markers)
SB  - IM
MH  - DNA Replication/*genetics
MH  - *Gene Library
MH  - Genetic Markers/*genetics
MH  - High-Throughput Nucleotide Sequencing/methods/*standards
MH  - Microbiota/*genetics
MH  - Polymerase Chain Reaction/methods/*standards
MH  - Practice Guidelines as Topic
MH  - Reproducibility of Results
MH  - Sensitivity and Specificity
EDAT- 2016/07/28 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/07/26 06:00
PHST- 2015/11/09 00:00 [received]
PHST- 2016/05/11 00:00 [accepted]
PHST- 2016/07/26 06:00 [entrez]
PHST- 2016/07/28 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3601 [pii]
AID - 10.1038/nbt.3601 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Sep;34(9):942-9. doi: 10.1038/nbt.3601. Epub 2016 Jul 25.

PMID- 27454738
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 9
DP  - 2016 Sep
TI  - Co-ChIP enables genome-wide mapping of histone mark co-occurrence at
      single-molecule resolution.
PG  - 953-61
LID - 10.1038/nbt.3652 [doi]
AB  - Histone modifications play an important role in chromatin organization and
      transcriptional regulation, but despite the large amount of genome-wide histone
      modification data collected in different cells and tissues, little is known about
      co-occurrence of modifications on the same nucleosome. Here we present a
      genome-wide quantitative method for combinatorial indexed chromatin
      immunoprecipitation (co-ChIP) to characterize co-occurrence of histone
      modifications on nucleosomes. Using co-ChIP, we study the genome-wide
      co-occurrence of 14 chromatin marks (70 pairwise combinations), and find
      previously undescribed co-occurrence patterns, including the co-occurrence of
      H3K9me1 and H3K27ac in super-enhancers. Finally, we apply co-ChIP to measure the 
      distribution of the bivalent H3K4me3-H3K27me3 domains in two distinct mouse
      embryonic stem cell (mESC) states and in four adult tissues. We observe dynamic
      changes in 5,786 regions and discover both loss and de novo gain of bivalency in 
      key tissue-specific regulatory genes, suggesting a functional role for bivalent
      domains during different stages of development. These results show that co-ChIP
      can reveal the complex interactions between histone modifications.
FAU - Weiner, Assaf
AU  - Weiner A
AD  - The Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
FAU - Lara-Astiaso, David
AU  - Lara-Astiaso D
AD  - The Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
FAU - Krupalnik, Vladislav
AU  - Krupalnik V
AD  - The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot,
      Israel.
FAU - Gafni, Ohad
AU  - Gafni O
AD  - The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot,
      Israel.
FAU - David, Eyal
AU  - David E
AD  - The Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
FAU - Winter, Deborah R
AU  - Winter DR
AD  - The Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
FAU - Hanna, Jacob H
AU  - Hanna JH
AUID- ORCID: 0000-0003-2042-9974
AD  - The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot,
      Israel.
FAU - Amit, Ido
AU  - Amit I
AD  - The Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
LA  - eng
GR  - P50 HG006193/HG/NHGRI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20160725
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Histones)
SB  - IM
MH  - Animals
MH  - Binding Sites
MH  - Chromatin Immunoprecipitation/*methods
MH  - Chromosome Mapping/*methods
MH  - Combinatorial Chemistry Techniques/methods
MH  - Genome/*genetics
MH  - High-Throughput Nucleotide Sequencing
MH  - Histone Code/*genetics
MH  - Histones/*genetics
MH  - Mice
MH  - Microchemistry/*methods
MH  - Protein Binding
MH  - Reproducibility of Results
MH  - Sensitivity and Specificity
EDAT- 2016/07/28 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/07/26 06:00
PHST- 2016/04/29 00:00 [received]
PHST- 2016/07/18 00:00 [accepted]
PHST- 2016/07/26 06:00 [entrez]
PHST- 2016/07/28 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3652 [pii]
AID - 10.1038/nbt.3652 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Sep;34(9):953-61. doi: 10.1038/nbt.3652. Epub 2016 Jul 25.

PMID- 27454737
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 9
DP  - 2016 Sep
TI  - Genetic improvement of tomato by targeted control of fruit softening.
PG  - 950-2
LID - 10.1038/nbt.3602 [doi]
AB  - Controlling the rate of softening to extend shelf life was a key target for
      researchers engineering genetically modified (GM) tomatoes in the 1990s, but only
      modest improvements were achieved. Hybrids grown nowadays contain 'non-ripening
      mutations' that slow ripening and improve shelf life, but adversely affect flavor
      and color. We report substantial, targeted control of tomato softening, without
      affecting other aspects of ripening, by silencing a gene encoding a pectate
      lyase.
FAU - Uluisik, Selman
AU  - Uluisik S
AD  - School of Biosciences, University of Nottingham, Sutton Bonington Campus,
      Loughborough, UK.
FAU - Chapman, Natalie H
AU  - Chapman NH
AD  - School of Biosciences, University of Nottingham, Sutton Bonington Campus,
      Loughborough, UK.
FAU - Smith, Rebecca
AU  - Smith R
AD  - School of Biosciences, University of Nottingham, Sutton Bonington Campus,
      Loughborough, UK.
FAU - Poole, Mervin
AU  - Poole M
AD  - Heygates Ltd, Bugbrooke Mills, Bugbrooke, UK.
FAU - Adams, Gary
AU  - Adams G
AD  - School of Biosciences, University of Nottingham, Sutton Bonington Campus,
      Loughborough, UK.
AD  - School of Health Sciences, The University of Nottingham, Queen's Medical Centre, 
      Nottingham, UK.
FAU - Gillis, Richard B
AU  - Gillis RB
AD  - School of Biosciences, University of Nottingham, Sutton Bonington Campus,
      Loughborough, UK.
AD  - School of Health Sciences, The University of Nottingham, Queen's Medical Centre, 
      Nottingham, UK.
FAU - Besong, Tabot M D
AU  - Besong TM
AD  - School of Biosciences, University of Nottingham, Sutton Bonington Campus,
      Loughborough, UK.
FAU - Sheldon, Judith
AU  - Sheldon J
AD  - Syngenta Seeds, Jealott's Hill International Research Station, Bracknell, UK.
FAU - Stiegelmeyer, Suzy
AU  - Stiegelmeyer S
AD  - Syngenta Crop Protection, Research Triangle Park, North Carolina, USA.
FAU - Perez, Laura
AU  - Perez L
AD  - School of Biological Sciences, Royal Holloway University of London, Egham Hill,
      UK.
FAU - Samsulrizal, Nurul
AU  - Samsulrizal N
AD  - School of Biosciences, University of Nottingham, Sutton Bonington Campus,
      Loughborough, UK.
FAU - Wang, Duoduo
AU  - Wang D
AD  - School of Biosciences, University of Nottingham, Sutton Bonington Campus,
      Loughborough, UK.
FAU - Fisk, Ian D
AU  - Fisk ID
AUID- ORCID: 0000-0001-8448-3123
AD  - School of Biosciences, University of Nottingham, Sutton Bonington Campus,
      Loughborough, UK.
FAU - Yang, Ni
AU  - Yang N
AD  - School of Biosciences, University of Nottingham, Sutton Bonington Campus,
      Loughborough, UK.
FAU - Baxter, Charles
AU  - Baxter C
AD  - Syngenta Seeds, Jealott's Hill International Research Station, Bracknell, UK.
FAU - Rickett, Daniel
AU  - Rickett D
AD  - Syngenta Seeds, Jealott's Hill International Research Station, Bracknell, UK.
FAU - Fray, Rupert
AU  - Fray R
AD  - School of Biosciences, University of Nottingham, Sutton Bonington Campus,
      Loughborough, UK.
FAU - Blanco-Ulate, Barbara
AU  - Blanco-Ulate B
AD  - Plant Sciences Department, University of California, Davis, California, USA.
FAU - Powell, Ann L T
AU  - Powell AL
AD  - Plant Sciences Department, University of California, Davis, California, USA.
FAU - Harding, Stephen E
AU  - Harding SE
AD  - School of Biosciences, University of Nottingham, Sutton Bonington Campus,
      Loughborough, UK.
FAU - Craigon, Jim
AU  - Craigon J
AD  - School of Biosciences, University of Nottingham, Sutton Bonington Campus,
      Loughborough, UK.
FAU - Rose, Jocelyn K C
AU  - Rose JK
AD  - Plant Biology Section, School of Integrative Plant Science, Cornell University,
      Ithaca, New York, USA.
FAU - Fich, Eric A
AU  - Fich EA
AD  - Plant Biology Section, School of Integrative Plant Science, Cornell University,
      Ithaca, New York, USA.
FAU - Sun, Li
AU  - Sun L
AD  - Department of Biology and Skidmore Microscopy Imaging Center, Skidmore College,
      Saratoga Springs, New York, USA.
FAU - Domozych, David S
AU  - Domozych DS
AD  - Department of Biology and Skidmore Microscopy Imaging Center, Skidmore College,
      Saratoga Springs, New York, USA.
FAU - Fraser, Paul D
AU  - Fraser PD
AD  - School of Biological Sciences, Royal Holloway University of London, Egham Hill,
      UK.
FAU - Tucker, Gregory A
AU  - Tucker GA
AD  - School of Biosciences, University of Nottingham, Sutton Bonington Campus,
      Loughborough, UK.
FAU - Grierson, Don
AU  - Grierson D
AD  - School of Biosciences, University of Nottingham, Sutton Bonington Campus,
      Loughborough, UK.
FAU - Seymour, Graham B
AU  - Seymour GB
AUID- ORCID: 0000-0001-8365-4947
AD  - School of Biosciences, University of Nottingham, Sutton Bonington Campus,
      Loughborough, UK.
LA  - eng
GR  - BB/J015598/1/Biotechnology and Biological Sciences Research Council/United
      Kingdom
GR  - BB/J016071/1/Biotechnology and Biological Sciences Research Council/United
      Kingdom
PT  - Journal Article
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PT  - Research Support, Non-U.S. Gov't
DEP - 20160725
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - EC 4.2.2.- (Polysaccharide-Lyases)
RN  - EC 4.2.2.2 (pectate lyase)
SB  - IM
MH  - Fruit/*physiology
MH  - Gene Silencing/*physiology
MH  - Gene Targeting/methods
MH  - Genetic Enhancement/*methods
MH  - Lycopersicon esculentum/enzymology/*genetics
MH  - Plants, Genetically Modified/*genetics
MH  - Polysaccharide-Lyases/*genetics
EDAT- 2016/07/28 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/07/26 06:00
PHST- 2015/11/09 00:00 [received]
PHST- 2016/05/11 00:00 [accepted]
PHST- 2016/07/26 06:00 [entrez]
PHST- 2016/07/28 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3602 [pii]
AID - 10.1038/nbt.3602 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Sep;34(9):950-2. doi: 10.1038/nbt.3602. Epub 2016 Jul 25.

PMID- 27376584
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 9
DP  - 2016 Sep
TI  - Protein-retention expansion microscopy of cells and tissues labeled using
      standard fluorescent proteins and antibodies.
PG  - 987-92
LID - 10.1038/nbt.3625 [doi]
AB  - Expansion microscopy (ExM) enables imaging of preserved specimens with nanoscale 
      precision on diffraction-limited instead of specialized super-resolution
      microscopes. ExM works by physically separating fluorescent probes after
      anchoring them to a swellable gel. The first ExM method did not result in the
      retention of native proteins in the gel and relied on custom-made reagents that
      are not widely available. Here we describe protein retention ExM (proExM), a
      variant of ExM in which proteins are anchored to the swellable gel, allowing the 
      use of conventional fluorescently labeled antibodies and streptavidin, and
      fluorescent proteins. We validated and demonstrated the utility of proExM for
      multicolor super-resolution ( approximately 70 nm) imaging of cells and mammalian
      tissues on conventional microscopes.
FAU - Tillberg, Paul W
AU  - Tillberg PW
AD  - Department of Electrical Engineering and Computer Science, Massachusetts
      Institute of Technology, Cambridge, Massachusetts, USA.
AD  - Massachusetts Institute of Technology Media Lab, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
FAU - Chen, Fei
AU  - Chen F
AD  - Massachusetts Institute of Technology Media Lab, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Piatkevich, Kiryl D
AU  - Piatkevich KD
AD  - Massachusetts Institute of Technology Media Lab, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
FAU - Zhao, Yongxin
AU  - Zhao Y
AD  - Massachusetts Institute of Technology Media Lab, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
FAU - Yu, Chih-Chieh Jay
AU  - Yu CC
AD  - Massachusetts Institute of Technology Media Lab, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - English, Brian P
AU  - English BP
AUID- ORCID: 0000-0002-4037-6294
AD  - Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, Virginia, USA.
FAU - Gao, Linyi
AU  - Gao L
AUID- ORCID: 0000-0002-3579-0327
AD  - Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Martorell, Anthony
AU  - Martorell A
AD  - Department of Brain and Cognitive Sciences, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
FAU - Suk, Ho-Jun
AU  - Suk HJ
AD  - Massachusetts Institute of Technology Media Lab, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute
      of Technology, Cambridge, Massachusetts, USA.
FAU - Yoshida, Fumiaki
AU  - Yoshida F
AD  - Osaka University Medical School, Suita, Osaka, Japan.
AD  - McGovern Institute, Massachusetts Institute of Technology, Cambridge,
      Massachusetts, USA.
FAU - DeGennaro, Ellen M
AU  - DeGennaro EM
AUID- ORCID: 0000-0001-5506-6451
AD  - Department of Brain and Cognitive Sciences, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - McGovern Institute, Massachusetts Institute of Technology, Cambridge,
      Massachusetts, USA.
FAU - Roossien, Douglas H
AU  - Roossien DH
AD  - University of Michigan Medical School, Ann Arbor, Michigan, USA.
FAU - Gong, Guanyu
AU  - Gong G
AD  - Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Seneviratne, Uthpala
AU  - Seneviratne U
AD  - Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Tannenbaum, Steven R
AU  - Tannenbaum SR
AD  - Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Desimone, Robert
AU  - Desimone R
AD  - Department of Brain and Cognitive Sciences, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - McGovern Institute, Massachusetts Institute of Technology, Cambridge,
      Massachusetts, USA.
FAU - Cai, Dawen
AU  - Cai D
AD  - University of Michigan Medical School, Ann Arbor, Michigan, USA.
FAU - Boyden, Edward S
AU  - Boyden ES
AD  - Massachusetts Institute of Technology Media Lab, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
AD  - Department of Brain and Cognitive Sciences, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - McGovern Institute, Massachusetts Institute of Technology, Cambridge,
      Massachusetts, USA.
LA  - eng
GR  - DP1 NS087724/NS/NINDS NIH HHS/United States
GR  - R01 DA029639/DA/NIDA NIH HHS/United States
GR  - R01 EY023173/EY/NEI NIH HHS/United States
GR  - U01 MH106011/MH/NIMH NIH HHS/United States
GR  - HHMI/Howard Hughes Medical Institute/United States
GR  - R01 GM104948/GM/NIGMS NIH HHS/United States
GR  - T32 GM007484/GM/NIGMS NIH HHS/United States
PT  - Journal Article
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20160704
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antibodies, Monoclonal)
RN  - 0 (Luminescent Proteins)
SB  - IM
CIN - Nat Biotechnol. 2016 Sep 8;34(9):928-30. PMID: 27606457
MH  - Animals
MH  - *Antibodies, Monoclonal
MH  - Brain/*cytology/*metabolism
MH  - HEK293 Cells
MH  - HeLa Cells
MH  - Humans
MH  - Image Enhancement/*methods
MH  - *Luminescent Proteins
MH  - Macaca mulatta
MH  - Mice
MH  - Mice, Inbred C57BL
MH  - Microscopy, Fluorescence/*methods
MH  - Reproducibility of Results
MH  - Sensitivity and Specificity
MH  - Staining and Labeling/methods
PMC - PMC5068827
MID - NIHMS793136
COIS- PWT, FC, ESB, and CCY have filed for patent protection on a subset of the
      technologies here described. ESB has helped co-found a company to help
      disseminate kits to the community.
EDAT- 2016/07/05 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/07/05 06:00
PHST- 2015/11/17 00:00 [received]
PHST- 2016/05/30 00:00 [accepted]
PHST- 2016/07/05 06:00 [entrez]
PHST- 2016/07/05 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3625 [pii]
AID - 10.1038/nbt.3625 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Sep;34(9):987-92. doi: 10.1038/nbt.3625. Epub 2016 Jul 4.

PMID- 27504783
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug 9
TI  - Second-quarter biotech job picture.
PG  - 889
LID - 10.1038/nbt.3650 [doi]
FAU - Francisco, Michael
AU  - Francisco M
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EDAT- 2016/08/10 06:00
MHDA- 2016/08/10 06:01
CRDT- 2016/08/10 06:00
PHST- 2016/08/10 06:00 [entrez]
PHST- 2016/08/10 06:00 [pubmed]
PHST- 2016/08/10 06:01 [medline]
AID - nbt.3650 [pii]
AID - 10.1038/nbt.3650 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug 9;34(8):889. doi: 10.1038/nbt.3650.

PMID- 27504782
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug 9
TI  - Erratum: Nature Biotechnology's academic spinouts of 2015.
PG  - 888
LID - 10.1038/nbt0816-888c [doi]
FAU - Bouchie, Aaron
AU  - Bouchie A
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
LA  - eng
PT  - Journal Article
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EFR - Nat Biotechnol. 2016 May 6;34(5):484-92. PMID: 27153278
EDAT- 2016/08/10 06:00
MHDA- 2016/08/10 06:01
CRDT- 2016/08/10 06:00
PHST- 2016/08/10 06:00 [entrez]
PHST- 2016/08/10 06:00 [pubmed]
PHST- 2016/08/10 06:01 [medline]
AID - nbt0816-888c [pii]
AID - 10.1038/nbt0816-888c [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug 9;34(8):888. doi: 10.1038/nbt0816-888c.

PMID- 27504781
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug 9
TI  - Erratum: Genome-wide analysis reveals specificities of Cpf1 endonucleases in
      human cells.
PG  - 888
LID - 10.1038/nbt0816-888a [doi]
FAU - Kim, Daesik
AU  - Kim D
FAU - Kim, Jungeun
AU  - Kim J
FAU - Hur, Junho K
AU  - Hur JK
FAU - Been, Kyung Wook
AU  - Been KW
FAU - Yoon, Sun-Heui
AU  - Yoon SH
FAU - Kim, Jin-Soo
AU  - Kim JS
LA  - eng
PT  - Journal Article
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EFR - Nat Biotechnol. 2016 Aug;34(8):863-8. PMID: 27272384
EDAT- 2016/08/10 06:00
MHDA- 2016/08/10 06:01
CRDT- 2016/08/10 06:00
PHST- 2016/08/10 06:00 [entrez]
PHST- 2016/08/10 06:00 [pubmed]
PHST- 2016/08/10 06:01 [medline]
AID - nbt0816-888a [pii]
AID - 10.1038/nbt0816-888a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug 9;34(8):888. doi: 10.1038/nbt0816-888a.

PMID- 27504780
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug 9
TI  - Erratum: Near-optimal probabilistic RNA-seq quantification.
PG  - 888
LID - 10.1038/nbt0816-888d [doi]
FAU - Bray, Nicolas L
AU  - Bray NL
FAU - Pimentel, Harold
AU  - Pimentel H
FAU - Melsted, Pall
AU  - Melsted P
FAU - Pachter, Lior
AU  - Pachter L
LA  - eng
PT  - Journal Article
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EFR - Nat Biotechnol. 2016 May;34(5):525-7. PMID: 27043002
EDAT- 2016/08/10 06:00
MHDA- 2016/08/10 06:01
CRDT- 2016/08/10 06:00
PHST- 2016/08/10 06:00 [entrez]
PHST- 2016/08/10 06:00 [pubmed]
PHST- 2016/08/10 06:01 [medline]
AID - nbt0816-888d [pii]
AID - 10.1038/nbt0816-888d [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug 9;34(8):888. doi: 10.1038/nbt0816-888d.

PMID- 27504779
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug 9
TI  - Erratum: No longer going to waste.
PG  - 888
LID - 10.1038/nbt0816-888b [doi]
FAU - Garber, Ken
AU  - Garber K
LA  - eng
PT  - Journal Article
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EFR - Nat Biotechnol. 2016 May 6;34(5):458-61. PMID: 27153267
EDAT- 2016/08/10 06:00
MHDA- 2016/08/10 06:01
CRDT- 2016/08/10 06:00
PHST- 2016/08/10 06:00 [entrez]
PHST- 2016/08/10 06:00 [pubmed]
PHST- 2016/08/10 06:01 [medline]
AID - nbt0816-888b [pii]
AID - 10.1038/nbt0816-888b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug 9;34(8):888. doi: 10.1038/nbt0816-888b.

PMID- 27504778
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug 9
TI  - Sharing and community curation of mass spectrometry data with Global Natural
      Products Social Molecular Networking.
PG  - 828-837
LID - 10.1038/nbt.3597 [doi]
AB  - The potential of the diverse chemistries present in natural products (NP) for
      biotechnology and medicine remains untapped because NP databases are not
      searchable with raw data and the NP community has no way to share data other than
      in published papers. Although mass spectrometry (MS) techniques are well-suited
      to high-throughput characterization of NP, there is a pressing need for an
      infrastructure to enable sharing and curation of data. We present Global Natural 
      Products Social Molecular Networking (GNPS; http://gnps.ucsd.edu), an open-access
      knowledge base for community-wide organization and sharing of raw, processed or
      identified tandem mass (MS/MS) spectrometry data. In GNPS, crowdsourced curation 
      of freely available community-wide reference MS libraries will underpin improved 
      annotations. Data-driven social-networking should facilitate identification of
      spectra and foster collaborations. We also introduce the concept of 'living data'
      through continuous reanalysis of deposited data.
FAU - Wang, Mingxun
AU  - Wang M
AD  - Computer Science and Engineering, UC San Diego, La Jolla, United States.
AD  - Center for Computational Mass Spectrometry, UC San Diego, La Jolla, United
      States.
FAU - Carver, Jeremy J
AU  - Carver JJ
AD  - Computer Science and Engineering, UC San Diego, La Jolla, United States.
AD  - Center for Computational Mass Spectrometry, UC San Diego, La Jolla, United
      States.
FAU - Phelan, Vanessa V
AU  - Phelan VV
AD  - Collaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and 
      Pharmaceutical Sciences, UC San Diego, La Jolla, United States.
FAU - Sanchez, Laura M
AU  - Sanchez LM
AD  - Collaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and 
      Pharmaceutical Sciences, UC San Diego, La Jolla, United States.
FAU - Garg, Neha
AU  - Garg N
AD  - Collaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and 
      Pharmaceutical Sciences, UC San Diego, La Jolla, United States.
FAU - Peng, Yao
AU  - Peng Y
AD  - Department of Chemistry and Biochemistry, UC San Diego, La Jolla, United States.
FAU - Nguyen, Don Duy
AU  - Nguyen DD
AD  - Department of Chemistry and Biochemistry, UC San Diego, La Jolla, United States.
FAU - Watrous, Jeramie
AU  - Watrous J
AD  - Collaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and 
      Pharmaceutical Sciences, UC San Diego, La Jolla, United States.
FAU - Kapono, Clifford A
AU  - Kapono CA
AD  - Department of Chemistry and Biochemistry, UC San Diego, La Jolla, United States.
FAU - Luzzatto-Knaan, Tal
AU  - Luzzatto-Knaan T
AD  - Collaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and 
      Pharmaceutical Sciences, UC San Diego, La Jolla, United States.
FAU - Porto, Carla
AU  - Porto C
AD  - Collaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and 
      Pharmaceutical Sciences, UC San Diego, La Jolla, United States.
FAU - Bouslimani, Amina
AU  - Bouslimani A
AD  - Collaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and 
      Pharmaceutical Sciences, UC San Diego, La Jolla, United States.
FAU - Melnik, Alexey V
AU  - Melnik AV
AD  - Collaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and 
      Pharmaceutical Sciences, UC San Diego, La Jolla, United States.
FAU - Meehan, Michael J
AU  - Meehan MJ
AD  - Collaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and 
      Pharmaceutical Sciences, UC San Diego, La Jolla, United States.
FAU - Liu, Wei-Ting
AU  - Liu WT
AD  - Department of Microbiology and Immunology, Stanford University, Palo Alto, United
      States.
FAU - Crusemann, Max
AU  - Crusemann M
AD  - Center for Marine Biotechnology and Biomedicine, Scripps Institute of
      Oceanography, UC San Diego, La Jolla, United States.
FAU - Boudreau, Paul D
AU  - Boudreau PD
AD  - Center for Marine Biotechnology and Biomedicine, Scripps Institute of
      Oceanography, UC San Diego, La Jolla, United States.
FAU - Esquenazi, Eduardo
AU  - Esquenazi E
AD  - Sirenas Marine Discovery, San Diego, United States.
FAU - Sandoval-Calderon, Mario
AU  - Sandoval-Calderon M
AD  - Centro de Ciencias Genomicas, Universidad Nacional Autonoma de Mexico,
      Cuernavaca, Mexico.
FAU - Kersten, Roland D
AU  - Kersten RD
AD  - Salk Institute, Salk Institute, La Jolla, United States.
FAU - Pace, Laura A
AU  - Pace LA
AD  - Collaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and 
      Pharmaceutical Sciences, UC San Diego, La Jolla, United States.
FAU - Quinn, Robert A
AU  - Quinn RA
AD  - Biology Department, San Diego State University, San Diego, United States.
FAU - Duncan, Katherine R
AU  - Duncan KR
AD  - Scottish Association for Marine Science, Scottish Marine Institute, Oban, United 
      Kingdom.
AD  - Center for Marine Biotechnology and Biomedicine, Scripps Institute of
      Oceanography, UC San Diego, La Jolla, United States.
FAU - Hsu, Cheng-Chih
AU  - Hsu CC
AD  - Department of Chemistry and Biochemistry, UC San Diego, La Jolla, United States.
FAU - Floros, Dimitrios J
AU  - Floros DJ
AD  - Department of Chemistry and Biochemistry, UC San Diego, La Jolla, United States.
FAU - Gavilan, Ronnie G
AU  - Gavilan RG
AD  - Center for Drug Discovery and Biodiversity, INDICASAT, City of Knowledge, Panama.
FAU - Kleigrewe, Karin
AU  - Kleigrewe K
AD  - Center for Marine Biotechnology and Biomedicine, Scripps Institute of
      Oceanography, UC San Diego, La Jolla, United States.
FAU - Northen, Trent
AU  - Northen T
AD  - Genome Dynamics, Lawrence Berkeley National Laboratory, Berkeley, United States.
FAU - Dutton, Rachel J
AU  - Dutton RJ
AD  - FAS Center for Systems Biology, Harvard, Cambridge, United States.
FAU - Parrot, Delphine
AU  - Parrot D
AD  - Produits naturels - Syntheses - Chimie Medicinale, University of Rennes 1, Rennes
      Cedex, France.
FAU - Carlson, Erin E
AU  - Carlson EE
AD  - Chemistry, University of Minnesota, Minneapolis, United States.
FAU - Aigle, Bertrand
AU  - Aigle B
AD  - Dynamique des Genomes et Adaptation Microbienne, University of Lorraine,
      Vandoeuvre-les-Nancy, France.
FAU - Michelsen, Charlotte F
AU  - Michelsen CF
AD  - Department of Systems Biology, Technical University of Denmark, Lyngby, Denmark.
FAU - Jelsbak, Lars
AU  - Jelsbak L
AD  - Department of Systems Biology, Technical University of Denmark, Lyngby, Denmark.
FAU - Sohlenkamp, Christian
AU  - Sohlenkamp C
AD  - Centro de Ciencias Genomicas, Universidad Nacional Autonoma de Mexico,
      Cuernavaca, Mexico.
FAU - Pevzner, Pavel
AU  - Pevzner P
AD  - Center for Computational Mass Spectrometry, UC San Diego, La Jolla, United
      States.
AD  - Computer Science and Engineering, UC San Diego, La Jolla, United States.
FAU - Edlund, Anna
AU  - Edlund A
AD  - Microbial and Environmental Genomics, J. Craig Venter Institute, La Jolla, United
      States.
AD  - School of Dentistry, UC Los Angeles, Los Angeles, United States.
FAU - McLean, Jeffrey
AU  - McLean J
AD  - Department of Periodontics, University of Washington, Seattle, United States.
AD  - School of Dentistry, UC Los Angeles, Los Angeles, United States.
FAU - Piel, Jorn
AU  - Piel J
AD  - Institute of Microbiology, ETH Zurich, Zurich, Switzerland.
FAU - Murphy, Brian T
AU  - Murphy BT
AD  - Department of Medicinal Chemistry and Pharmacognosy, University of Illinois
      Chicago, Chicago, United States.
FAU - Gerwick, Lena
AU  - Gerwick L
AD  - Center for Marine Biotechnology and Biomedicine, Scripps Institute of
      Oceanography, UC San Diego, La Jolla, United States.
FAU - Liaw, Chih-Chuang
AU  - Liaw CC
AD  - Department of Marine Biotechnology and Resources, National Sun Yat-sen
      University, Kaohsiung, Taiwan.
FAU - Yang, Yu-Liang
AU  - Yang YL
AD  - Agricultural Biotechnology Research Center, Academia Sinica, Taipei, Taiwan.
FAU - Humpf, Hans-Ulrich
AU  - Humpf HU
AD  - Institute of Food Chemistry, University of Munster, Munster, Germany.
FAU - Maansson, Maria
AU  - Maansson M
AD  - Department of Systems Biology, Technical University of Denmark, Lyngby, Denmark.
FAU - Keyzers, Robert A
AU  - Keyzers RA
AD  - School of Chemical & Physical Sciences, and Centre for Biodiscovery, Victoria
      University of Wellington, Wellington, New Zealand.
FAU - Sims, Amy C
AU  - Sims AC
AD  - Gillings School of Global Public Health, Department of Epidemiology, UNC Chapel
      Hill, Chapel Hill, United States.
FAU - Johnson, Andrew R
AU  - Johnson AR
AD  - Department of Chemistry, Indiana University, Bloomington, United States.
FAU - Sidebottom, Ashley M
AU  - Sidebottom AM
AD  - Department of Chemistry, Indiana University, Bloomington, United States.
FAU - Sedio, Brian E
AU  - Sedio BE
AD  - Smithsonian Tropical Research Institute, Ancon, Panama.
AD  - Center for Drug Discovery and Biodiversity, INDICASAT, City of Knowledge, Panama.
FAU - Klitgaard, Andreas
AU  - Klitgaard A
AD  - Department of Systems Biology, Technical University of Denmark, Lyngby, Denmark.
FAU - Larson, Charles B
AU  - Larson CB
AD  - Center for Marine Biotechnology and Biomedicine, Scripps Institute of
      Oceanography, UC San Diego, La Jolla, United States.
AD  - Skaggs School of Pharmacy and Pharmaceutical Sciences, UC San Diego, La Jolla,
      United States.
FAU - P, Cristopher A Boya
AU  - P CAB
AD  - Center for Drug Discovery and Biodiversity, INDICASAT, City of Knowledge, Panama.
FAU - Torres-Mendoza, Daniel
AU  - Torres-Mendoza D
AD  - Center for Drug Discovery and Biodiversity, INDICASAT, City of Knowledge, Panama.
FAU - Gonzalez, David J
AU  - Gonzalez DJ
AD  - Skaggs School of Pharmacy and Pharmaceutical Sciences, UC San Diego, La Jolla,
      United States.
AD  - Collaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and 
      Pharmaceutical Sciences, UC San Diego, La Jolla, United States.
FAU - Silva, Denise B
AU  - Silva DB
AD  - School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Sao
      Paulo, Brazil.
AD  - Centro de Ciencias Biologicas e da Saude, Universidade Fderal de Mato Grosso do
      Sul, Campo Grande, Brazil.
FAU - Marques, Lucas M
AU  - Marques LM
AD  - School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Sao
      Paulo, Brazil.
FAU - Demarque, Daniel P
AU  - Demarque DP
AD  - School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Sao
      Paulo, Brazil.
FAU - Pociute, Egle
AU  - Pociute E
AD  - Sirenas Marine Discovery, San Diego, United States.
FAU - O'Neill, Ellis C
AU  - O'Neill EC
AD  - Center for Marine Biotechnology and Biomedicine, Scripps Institute of
      Oceanography, UC San Diego, La Jolla, United States.
FAU - Briand, Enora
AU  - Briand E
AD  - Center for Marine Biotechnology and Biomedicine, Scripps Institute of
      Oceanography, UC San Diego, La Jolla, United States.
AD  - UMR CNRS 6553 ECOBIO, University of Rennes 1, Rennes Cedex, France.
FAU - Helfrich, Eric J N
AU  - Helfrich EJN
AD  - Institute of Microbiology, ETH Zurich, Zurich, Switzerland.
FAU - Granatosky, Eve A
AU  - Granatosky EA
AD  - Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame,
      United States.
FAU - Glukhov, Evgenia
AU  - Glukhov E
AD  - Center for Marine Biotechnology and Biomedicine, Scripps Institute of
      Oceanography, UC San Diego, La Jolla, United States.
FAU - Ryffel, Florian
AU  - Ryffel F
AD  - Institute of Microbiology, ETH Zurich, Zurich, Switzerland.
FAU - Houson, Hailey
AU  - Houson H
AD  - Sirenas Marine Discovery, San Diego, United States.
FAU - Mohimani, Hosein
AU  - Mohimani H
AD  - Center for Computational Mass Spectrometry, UC San Diego, La Jolla, United
      States.
FAU - Kharbush, Jenan J
AU  - Kharbush JJ
AD  - Center for Marine Biotechnology and Biomedicine, Scripps Institute of
      Oceanography, UC San Diego, La Jolla, United States.
FAU - Zeng, Yi
AU  - Zeng Y
AD  - Department of Chemistry and Biochemistry, UC San Diego, La Jolla, United States.
FAU - Vorholt, Julia A
AU  - Vorholt JA
AD  - Institute of Microbiology, ETH Zurich, Zurich, Switzerland.
FAU - Kurita, Kenji L
AU  - Kurita KL
AD  - PBSci-Chemistry & Biochemistry Department, UC Santa Cruz, Santa Cruz, United
      States.
FAU - Charusanti, Pep
AU  - Charusanti P
AD  - Department of Bioengineering, UC San Diego, La Jolla, United States.
FAU - McPhail, Kerry L
AU  - McPhail KL
AD  - Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State
      University, Corvallis, United States.
FAU - Nielsen, Kristian Fog
AU  - Nielsen KF
AD  - Department of Systems Biology, Technical University of Denmark, Lyngby, Denmark.
FAU - Vuong, Lisa
AU  - Vuong L
AD  - Sirenas Marine Discovery, San Diego, United States.
FAU - Elfeki, Maryam
AU  - Elfeki M
AD  - Department of Medicinal Chemistry and Pharmacognosy, University of Illinois
      Chicago, Chicago, United States.
FAU - Traxler, Matthew F
AU  - Traxler MF
AD  - Department of Plant and Microbial Biology, UC Berkeley, Berkeley, United States.
FAU - Engene, Niclas
AU  - Engene N
AD  - Department of Biological Sciences, Florida International University, Miami,
      United States.
FAU - Koyama, Nobuhiro
AU  - Koyama N
AD  - Collaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and 
      Pharmaceutical Sciences, UC San Diego, La Jolla, United States.
FAU - Vining, Oliver B
AU  - Vining OB
AD  - Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State
      University, Corvallis, United States.
FAU - Baric, Ralph
AU  - Baric R
AD  - Gillings School of Global Public Health, Department of Epidemiology, UNC Chapel
      Hill, Chapel Hill, United States.
FAU - Silva, Ricardo R
AU  - Silva RR
AD  - School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Sao
      Paulo, Brazil.
FAU - Mascuch, Samantha J
AU  - Mascuch SJ
AD  - Center for Marine Biotechnology and Biomedicine, Scripps Institute of
      Oceanography, UC San Diego, La Jolla, United States.
FAU - Tomasi, Sophie
AU  - Tomasi S
AD  - Produits naturels - Syntheses - Chimie Medicinale, University of Rennes 1, Rennes
      Cedex, France.
FAU - Jenkins, Stefan
AU  - Jenkins S
AD  - Genome Dynamics, Lawrence Berkeley National Laboratory, Berkeley, United States.
FAU - Macherla, Venkat
AU  - Macherla V
AD  - Sirenas Marine Discovery, San Diego, United States.
FAU - Hoffman, Thomas
AU  - Hoffman T
AD  - Department of Pharmaceutical Biotechnology, Helmholtz Institute for
      Pharmaceutical Research Saarland, Saarbrucken, Germany.
FAU - Agarwal, Vinayak
AU  - Agarwal V
AD  - Center for Oceans and Human Health, Scripps Institute of Oceanography, UC San
      Diego, La Jolla, United States.
FAU - Williams, Philip G
AU  - Williams PG
AD  - Department of Chemistry, University of Hawaii at Manoa, Honolulu, United States.
FAU - Dai, Jingqui
AU  - Dai J
AD  - Department of Chemistry, University of Hawaii at Manoa, Honolulu, United States.
FAU - Neupane, Ram
AU  - Neupane R
AD  - Department of Chemistry, University of Hawaii at Manoa, Honolulu, United States.
FAU - Gurr, Joshua
AU  - Gurr J
AD  - Department of Chemistry, University of Hawaii at Manoa, Honolulu, United States.
FAU - Rodriguez, Andres M C
AU  - Rodriguez AMC
AD  - School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Sao
      Paulo, Brazil.
FAU - Lamsa, Anne
AU  - Lamsa A
AD  - Division of Biological Sciences, UC San Diego, La Jolla, United States.
FAU - Zhang, Chen
AU  - Zhang C
AD  - Department of Nanoengineering, UC San Diego, La Jolla, United States.
FAU - Dorrestein, Kathleen
AU  - Dorrestein K
AD  - Collaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and 
      Pharmaceutical Sciences, UC San Diego, La Jolla, United States.
FAU - Duggan, Brendan M
AU  - Duggan BM
AD  - Collaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and 
      Pharmaceutical Sciences, UC San Diego, La Jolla, United States.
FAU - Almaliti, Jehad
AU  - Almaliti J
AD  - Collaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and 
      Pharmaceutical Sciences, UC San Diego, La Jolla, United States.
FAU - Allard, Pierre-Marie
AU  - Allard PM
AD  - School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.
FAU - Phapale, Prasad
AU  - Phapale P
AD  - Structural and Computational Biology, European Molecular Biology Laboratory,
      Heidelberg, Germany.
FAU - Nothias, Louis-Felix
AU  - Nothias LF
AD  - Institut de Chimie des Substances Naturelles, CNRS-ICSN, UPR 2301, Labex CEBA,
      University of Paris-Saclay, Gif-sur-Yvette, France.
FAU - Alexandrov, Theodore
AU  - Alexandrov T
AD  - Structural and Computational Biology, European Molecular Biology Laboratory,
      Heidelberg, Germany.
FAU - Litaudon, Marc
AU  - Litaudon M
AD  - Institut de Chimie des Substances Naturelles, CNRS-ICSN, UPR 2301, Labex CEBA,
      University of Paris-Saclay, Gif-sur-Yvette, France.
FAU - Wolfender, Jean-Luc
AU  - Wolfender JL
AD  - School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.
FAU - Kyle, Jennifer E
AU  - Kyle JE
AD  - Biological Sciences, Pacific Northwest National Laboratory, Richland, United
      States.
FAU - Metz, Thomas O
AU  - Metz TO
AD  - Biological Sciences, Pacific Northwest National Laboratory, Richland, United
      States.
FAU - Peryea, Tyler
AU  - Peryea T
AD  - National Center for Advancing Translational Sciences, National Institute of
      Health, Rockville, United States.
FAU - Nguyen, Dac-Trung
AU  - Nguyen DT
AD  - National Center for Advancing Translational Sciences, National Institute of
      Health, Rockville, United States.
FAU - VanLeer, Danielle
AU  - VanLeer D
AD  - National Center for Advancing Translational Sciences, National Institute of
      Health, Rockville, United States.
FAU - Shinn, Paul
AU  - Shinn P
AD  - National Center for Advancing Translational Sciences, National Institute of
      Health, Rockville, United States.
FAU - Jadhav, Ajit
AU  - Jadhav A
AD  - National Center for Advancing Translational Sciences, National Institute of
      Health, Rockville, United States.
FAU - Muller, Rolf
AU  - Muller R
AD  - Department of Pharmaceutical Biotechnology, Helmholtz Institute for
      Pharmaceutical Research Saarland, Saarbrucken, Germany.
FAU - Waters, Katrina M
AU  - Waters KM
AD  - Biological Sciences, Pacific Northwest National Laboratory, Richland, United
      States.
FAU - Shi, Wenyuan
AU  - Shi W
AD  - School of Dentistry, UC Los Angeles, Los Angeles, United States.
FAU - Liu, Xueting
AU  - Liu X
AD  - Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
FAU - Zhang, Lixin
AU  - Zhang L
AD  - Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
FAU - Knight, Rob
AU  - Knight R
AD  - Department of Pediatrics, UC San Diego, La Jolla, United States.
FAU - Jensen, Paul R
AU  - Jensen PR
AD  - Center for Marine Biotechnology and Biomedicine, Scripps Institute of
      Oceanography, UC San Diego, La Jolla, United States.
FAU - Palsson, Bernhard O
AU  - Palsson BO
AD  - Department of Bioengineering, UC San Diego, La Jolla, United States.
FAU - Pogliano, Kit
AU  - Pogliano K
AD  - Division of Biological Sciences, UC San Diego, La Jolla, United States.
FAU - Linington, Roger G
AU  - Linington RG
AD  - PBSci-Chemistry & Biochemistry Department, UC Santa Cruz, Santa Cruz, United
      States.
FAU - Gutierrez, Marcelino
AU  - Gutierrez M
AD  - Center for Drug Discovery and Biodiversity, INDICASAT, City of Knowledge, Panama.
FAU - Lopes, Norberto P
AU  - Lopes NP
AD  - School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Sao
      Paulo, Brazil.
FAU - Gerwick, William H
AU  - Gerwick WH
AD  - Collaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and 
      Pharmaceutical Sciences, UC San Diego, La Jolla, United States.
AD  - Center for Marine Biotechnology and Biomedicine, Scripps Institute of
      Oceanography, UC San Diego, La Jolla, United States.
FAU - Moore, Bradley S
AU  - Moore BS
AD  - Collaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and 
      Pharmaceutical Sciences, UC San Diego, La Jolla, United States.
AD  - Center for Marine Biotechnology and Biomedicine, Scripps Institute of
      Oceanography, UC San Diego, La Jolla, United States.
AD  - Center for Oceans and Human Health, Scripps Institute of Oceanography, UC San
      Diego, La Jolla, United States.
FAU - Dorrestein, Pieter C
AU  - Dorrestein PC
AD  - Collaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and 
      Pharmaceutical Sciences, UC San Diego, La Jolla, United States.
AD  - Center for Marine Biotechnology and Biomedicine, Scripps Institute of
      Oceanography, UC San Diego, La Jolla, United States.
AD  - Skaggs School of Pharmacy and Pharmaceutical Sciences, UC San Diego, La Jolla,
      United States.
FAU - Bandeira, Nuno
AU  - Bandeira N
AD  - Center for Computational Mass Spectrometry, UC San Diego, La Jolla, United
      States.
AD  - Collaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and 
      Pharmaceutical Sciences, UC San Diego, La Jolla, United States.
AD  - Skaggs School of Pharmacy and Pharmaceutical Sciences, UC San Diego, La Jolla,
      United States.
LA  - eng
GR  - R01 DE023810/DE/NIDCR NIH HHS/United States
GR  - T32 GM075762/GM/NIGMS NIH HHS/United States
GR  - R01 GM094802/GM/NIGMS NIH HHS/United States
GR  - R00 DE024543/DE/NIDCR NIH HHS/United States
GR  - P41 GM103484/GM/NIGMS NIH HHS/United States
GR  - R01 GM097509/GM/NIGMS NIH HHS/United States
GR  - R01 DE020102/DE/NIDCR NIH HHS/United States
GR  - R01 GM085770/GM/NIGMS NIH HHS/United States
GR  - T32 DK007202/DK/NIDDK NIH HHS/United States
GR  - U19 TW007401/TW/FIC NIH HHS/United States
GR  - R01 GM095373/GM/NIGMS NIH HHS/United States
GR  - R01 AI095125/AI/NIAID NIH HHS/United States
GR  - U19 AI106772/AI/NIAID NIH HHS/United States
GR  - K01 GM103809/GM/NIGMS NIH HHS/United States
GR  - S10 RR029121/RR/NCRR NIH HHS/United States
GR  - UL1 RR031980/RR/NCRR NIH HHS/United States
GR  - HHSN272200800060C/AI/NIAID NIH HHS/United States
GR  - K12 GM068524/GM/NIGMS NIH HHS/United States
GR  - F32 GM089044/GM/NIGMS NIH HHS/United States
GR  - R21 AI085540/AI/NIAID NIH HHS/United States
GR  - U01 TW006634/TW/FIC NIH HHS/United States
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PT  - Research Support, N.I.H., Extramural
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Biological Products)
SB  - IM
MH  - Biological Products/*chemistry/*classification
MH  - Data Curation/*methods
MH  - Database Management Systems
MH  - *Databases, Chemical
MH  - Information Dissemination/*methods
MH  - Information Storage and Retrieval/methods
MH  - Internationality
MH  - Mass Spectrometry/*statistics & numerical data
PMC - PMC5321674
MID - NIHMS846480
EDAT- 2016/08/10 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/08/10 06:00
PHST- 2015/08/11 00:00 [received]
PHST- 2016/05/10 00:00 [accepted]
PHST- 2016/08/10 06:00 [entrez]
PHST- 2016/08/10 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - 10.1038/nbt.3597 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug 9;34(8):828-837. doi: 10.1038/nbt.3597.

PMID- 27504776
OWN - NLM
STAT- MEDLINE
DCOM- 20180104
LR  - 20180104
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug 9
TI  - Automated design of DNA origami.
PG  - 826-7
LID - 10.1038/nbt.3647 [doi]
FAU - Linko, Veikko
AU  - Linko V
AD  - Biohybrid Materials, Department of Biotechnology and Chemical Technology, Aalto
      University, Aalto, Finland.
FAU - Kostiainen, Mauri A
AU  - Kostiainen MA
AD  - Biohybrid Materials, Department of Biotechnology and Chemical Technology, Aalto
      University, Aalto, Finland.
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 9007-49-2 (DNA)
SB  - IM
CON - Science. 2016 Jun 24;352(6293):1534. PMID: 27229143
MH  - *DNA
MH  - Nanostructures
MH  - Nanotechnology
MH  - *Nucleic Acid Conformation
EDAT- 2016/08/10 06:00
MHDA- 2018/01/05 06:00
CRDT- 2016/08/10 06:00
PHST- 2016/08/10 06:00 [entrez]
PHST- 2016/08/10 06:00 [pubmed]
PHST- 2018/01/05 06:00 [medline]
AID - nbt.3647 [pii]
AID - 10.1038/nbt.3647 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug 9;34(8):826-7. doi: 10.1038/nbt.3647.

PMID- 27504775
OWN - NLM
STAT- MEDLINE
DCOM- 20180104
LR  - 20180104
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug 9
TI  - An edible switch for gene therapy.
PG  - 824-5
LID - 10.1038/nbt.3645 [doi]
FAU - Anguela, Xavier M
AU  - Anguela XM
AD  - Spark Therapeutics, Philadelphia, Pennsylvania, USA.
FAU - High, Katherine A
AU  - High KA
AD  - Spark Therapeutics, Philadelphia, Pennsylvania, USA.
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2016 Jul;34(7):746-51. PMID: 27272383
MH  - *Genetic Therapy
MH  - Humans
EDAT- 2016/08/10 06:00
MHDA- 2018/01/05 06:00
CRDT- 2016/08/10 06:00
PHST- 2016/08/10 06:00 [entrez]
PHST- 2016/08/10 06:00 [pubmed]
PHST- 2018/01/05 06:00 [medline]
AID - nbt.3645 [pii]
AID - 10.1038/nbt.3645 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug 9;34(8):824-5. doi: 10.1038/nbt.3645.

PMID- 27504774
OWN - NLM
STAT- MEDLINE
DCOM- 20180104
LR  - 20180105
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug 9
TI  - Deep phenotyping predicts Huntington's genotype.
PG  - 823-4
LID - 10.1038/nbt.3648 [doi]
FAU - Ruderfer, Douglas M
AU  - Ruderfer DM
AD  - Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New 
      York, USA.
FAU - Dudley, Joel T
AU  - Dudley JT
AD  - Department of Genetics and Genomics Sciences, Icahn Institute for Genomics and
      Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, New York, 
      USA.
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2016 Aug;34(8):838-44. PMID: 27376585
MH  - *Genotype
MH  - Humans
MH  - Huntington Disease/*genetics
MH  - *Phenotype
EDAT- 2016/08/10 06:00
MHDA- 2018/01/05 06:00
CRDT- 2016/08/10 06:00
PHST- 2016/08/10 06:00 [entrez]
PHST- 2016/08/10 06:00 [pubmed]
PHST- 2018/01/05 06:00 [medline]
AID - nbt.3648 [pii]
AID - 10.1038/nbt.3648 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug 9;34(8):823-4. doi: 10.1038/nbt.3648.

PMID- 27504773
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug 9
TI  - Recent patents in synthetic biology.
PG  - 822
LID - 10.1038/nbt.3656 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EDAT- 2016/08/10 06:00
MHDA- 2016/08/10 06:01
CRDT- 2016/08/10 06:00
PHST- 2016/08/10 06:00 [entrez]
PHST- 2016/08/10 06:00 [pubmed]
PHST- 2016/08/10 06:01 [medline]
AID - nbt.3656 [pii]
AID - 10.1038/nbt.3656 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug 9;34(8):822. doi: 10.1038/nbt.3656.

PMID- 27504772
OWN - NLM
STAT- MEDLINE
DCOM- 20180110
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug 9
TI  - The rise and fall of innovation in biofuels.
PG  - 814-21
LID - 10.1038/nbt.3644 [doi]
FAU - Albers, Stevan C
AU  - Albers SC
AD  - Cell and Molecular Biology Graduate Program, Colorado State University, Fort
      Collins, Colorado, USA, and CSU Ventures, Fort Collins, Colorado, USA.
FAU - Berklund, Annabelle M
AU  - Berklund AM
AD  - Department of Economics, Colorado State University, Fort Collins, Colorado, USA.
FAU - Graff, Gregory D
AU  - Graff GD
AD  - Department of Agricultural and Resource Economics, Colorado State University,
      Fort Collins, Colorado, USA, and the Department of Technology Management and
      Economics, Chalmers University of Technology, Gothenburg, Sweden.
LA  - eng
GR  - R01 HG004041/HG/NHGRI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Biofuels)
SB  - IM
MH  - Biofuels/*statistics & numerical data
MH  - Biotechnology/*statistics & numerical data/trends
MH  - Internationality
MH  - Inventions/*statistics & numerical data/trends
MH  - Patents as Topic/*statistics & numerical data
MH  - Private Sector/*statistics & numerical data/trends
MH  - Public Sector/economics/*statistics & numerical data/trends
EDAT- 2016/08/10 06:00
MHDA- 2018/01/11 06:00
CRDT- 2016/08/10 06:00
PHST- 2016/08/10 06:00 [entrez]
PHST- 2016/08/10 06:00 [pubmed]
PHST- 2018/01/11 06:00 [medline]
AID - nbt.3644 [pii]
AID - 10.1038/nbt.3644 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug 9;34(8):814-21. doi: 10.1038/nbt.3644.

PMID- 27504771
OWN - NLM
STAT- MEDLINE
DCOM- 20180110
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug 9
TI  - Rapid, semi-automated protein terminal characterization using ISDetect.
PG  - 811-3
LID - 10.1038/nbt.3621 [doi]
FAU - Bakalarski, Corey E
AU  - Bakalarski CE
AD  - Department of Protein Chemistry, Genentech, Inc., South San Francisco,
      California, USA.
AD  - Department of Bioinformatics and Computational Biology, Genentech, Inc., South
      San Francisco, California, USA.
FAU - Gan, Yutian
AU  - Gan Y
AD  - Department of Protein Chemistry, Genentech, Inc., South San Francisco,
      California, USA.
FAU - Wertz, Ingrid
AU  - Wertz I
AD  - Department of Early Discovery Biochemistry, Genentech, Inc., South San Francisco,
      California, USA.
FAU - Lill, Jennie R
AU  - Lill JR
AD  - Department of Protein Chemistry, Genentech, Inc., South San Francisco,
      California, USA.
FAU - Sandoval, Wendy
AU  - Sandoval W
AD  - Department of Protein Chemistry, Genentech, Inc., South San Francisco,
      California, USA.
LA  - eng
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Proteins)
SB  - IM
MH  - *Algorithms
MH  - High-Throughput Screening Assays
MH  - Pattern Recognition, Automated/*methods
MH  - Peptide Mapping/methods
MH  - Proteins/*chemistry/*isolation & purification
MH  - Sequence Analysis, Protein/*methods
MH  - *Software
MH  - Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/*methods
EDAT- 2016/08/10 06:00
MHDA- 2018/01/11 06:00
CRDT- 2016/08/10 06:00
PHST- 2016/08/10 06:00 [entrez]
PHST- 2016/08/10 06:00 [pubmed]
PHST- 2018/01/11 06:00 [medline]
AID - nbt.3621 [pii]
AID - 10.1038/nbt.3621 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug 9;34(8):811-3. doi: 10.1038/nbt.3621.

PMID- 27504770
OWN - NLM
STAT- MEDLINE
DCOM- 20180104
LR  - 20180104
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug 9
TI  - Nanopore development at Oxford Nanopore.
PG  - 810-1
LID - 10.1038/nbt.3622 [doi]
FAU - Brown, Clive G
AU  - Brown CG
AD  - Oxford Nanopore Technologies Ltd., Oxford, UK.
FAU - Clarke, James
AU  - Clarke J
AD  - Oxford Nanopore Technologies Ltd., Oxford, UK.
LA  - eng
PT  - Letter
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2016 May 6;34(5):481-2. PMID: 27153275
CON - Nat Biotechnol. 2016 May 6;34(5):518-24. PMID: 27153285
MH  - Humans
MH  - *Nanopores
MH  - *Sequence Analysis, DNA
EDAT- 2016/08/10 06:00
MHDA- 2018/01/05 06:00
CRDT- 2016/08/10 06:00
PHST- 2016/08/10 06:00 [entrez]
PHST- 2016/08/10 06:00 [pubmed]
PHST- 2018/01/05 06:00 [medline]
AID - nbt.3622 [pii]
AID - 10.1038/nbt.3622 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug 9;34(8):810-1. doi: 10.1038/nbt.3622.

PMID- 27504769
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug 9
TI  - First Rounders Podcast: David Baltimore.
PG  - 802
LID - 10.1038/nbt.3642 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EDAT- 2016/08/10 06:00
MHDA- 2016/08/10 06:01
CRDT- 2016/08/10 06:00
PHST- 2016/08/10 06:00 [entrez]
PHST- 2016/08/10 06:00 [pubmed]
PHST- 2016/08/10 06:01 [medline]
AID - nbt.3642 [pii]
AID - 10.1038/nbt.3642 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug 9;34(8):802. doi: 10.1038/nbt.3642.

PMID- 27504768
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug 9
TI  - Research biotech patenting 2015.
PG  - 801-2
LID - 10.1038/nbt.3646 [doi]
FAU - Huggett, Brady
AU  - Huggett B
AD  - Nature Biotechnology.
FAU - Paisner, Kathryn
AU  - Paisner K
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EDAT- 2016/08/10 06:00
MHDA- 2016/08/10 06:01
CRDT- 2016/08/10 06:00
PHST- 2016/08/10 06:00 [entrez]
PHST- 2016/08/10 06:00 [pubmed]
PHST- 2016/08/10 06:01 [medline]
AID - nbt.3646 [pii]
AID - 10.1038/nbt.3646 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug 9;34(8):801-2. doi: 10.1038/nbt.3646.

PMID- 27504767
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug 9
TI  - 2Q16-biotech claws back.
PG  - 800
LID - 10.1038/nbt.3654 [doi]
FAU - Edelson, Steve
AU  - Edelson S
AD  - BioCentury.
FAU - Wolfe, Meredith Durkin
AU  - Wolfe MD
AD  - BioCentury.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EDAT- 2016/08/10 06:00
MHDA- 2016/08/10 06:01
CRDT- 2016/08/10 06:00
PHST- 2016/08/10 06:00 [entrez]
PHST- 2016/08/10 06:00 [pubmed]
PHST- 2016/08/10 06:01 [medline]
AID - nbt.3654 [pii]
AID - 10.1038/nbt.3654 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug 9;34(8):800. doi: 10.1038/nbt.3654.

PMID- 27504766
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug 9
TI  - Drug pipeline: 2Q16.
PG  - 799
LID - 10.1038/nbt.3651 [doi]
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EDAT- 2016/08/10 06:00
MHDA- 2016/08/10 06:01
CRDT- 2016/08/10 06:00
PHST- 2016/08/10 06:00 [entrez]
PHST- 2016/08/10 06:00 [pubmed]
PHST- 2016/08/10 06:01 [medline]
AID - nbt.3651 [pii]
AID - 10.1038/nbt.3651 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug 9;34(8):799. doi: 10.1038/nbt.3651.

PMID- 27504765
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug 9
TI  - Around the world in a month.
PG  - 798
LID - 10.1038/nbt0816-798 [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EDAT- 2016/08/10 06:00
MHDA- 2016/08/10 06:01
CRDT- 2016/08/10 06:00
PHST- 2016/08/10 06:00 [entrez]
PHST- 2016/08/10 06:00 [pubmed]
PHST- 2016/08/10 06:01 [medline]
AID - nbt0816-798 [pii]
AID - 10.1038/nbt0816-798 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug 9;34(8):798. doi: 10.1038/nbt0816-798.

PMID- 27504764
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20180110
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug 9
TI  - Gilead's first pan-genotypic HCV cure.
PG  - 797
LID - 10.1038/nbt0816-797 [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/08/10 06:00
MHDA- 2016/08/10 06:01
CRDT- 2016/08/10 06:00
PHST- 2016/08/10 06:00 [entrez]
PHST- 2016/08/10 06:00 [pubmed]
PHST- 2016/08/10 06:01 [medline]
AID - nbt0816-797 [pii]
AID - 10.1038/nbt0816-797 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug 9;34(8):797. doi: 10.1038/nbt0816-797.

PMID- 27504763
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20180110
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug 9
TI  - Synthetic human genome set to spur applications.
PG  - 796-7
LID - 10.1038/nbt0816-796b [doi]
FAU - Dance, Amber
AU  - Dance A
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/08/10 06:00
MHDA- 2016/08/10 06:01
CRDT- 2016/08/10 06:00
PHST- 2016/08/10 06:00 [entrez]
PHST- 2016/08/10 06:00 [pubmed]
PHST- 2016/08/10 06:01 [medline]
AID - nbt0816-796b [pii]
AID - 10.1038/nbt0816-796b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug 9;34(8):796-7. doi: 10.1038/nbt0816-796b.

PMID- 27504762
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20180110
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug 9
TI  - First-in-human CRISPR trial.
PG  - 796
LID - 10.1038/nbt0816-796a [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/08/10 06:00
MHDA- 2016/08/10 06:01
CRDT- 2016/08/10 06:00
PHST- 2016/08/10 06:00 [entrez]
PHST- 2016/08/10 06:00 [pubmed]
PHST- 2016/08/10 06:01 [medline]
AID - nbt0816-796a [pii]
AID - 10.1038/nbt0816-796a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug 9;34(8):796. doi: 10.1038/nbt0816-796a.

PMID- 27504761
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20180110
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug 9
TI  - Cancer anabolic metabolism inhibitors move into clinic.
PG  - 794-5
LID - 10.1038/nbt0816-794 [doi]
FAU - Garber, Ken
AU  - Garber K
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/08/10 06:00
MHDA- 2016/08/10 06:01
CRDT- 2016/08/10 06:00
PHST- 2016/08/10 06:00 [entrez]
PHST- 2016/08/10 06:00 [pubmed]
PHST- 2016/08/10 06:01 [medline]
AID - nbt0816-794 [pii]
AID - 10.1038/nbt0816-794 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug 9;34(8):794-5. doi: 10.1038/nbt0816-794.

PMID- 27504760
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20180110
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug 9
TI  - Juno's wild ride.
PG  - 793
LID - 10.1038/nbt0816-793 [doi]
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/08/10 06:00
MHDA- 2016/08/10 06:01
CRDT- 2016/08/10 06:00
PHST- 2016/08/10 06:00 [entrez]
PHST- 2016/08/10 06:00 [pubmed]
PHST- 2016/08/10 06:01 [medline]
AID - nbt0816-793 [pii]
AID - 10.1038/nbt0816-793 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug 9;34(8):793. doi: 10.1038/nbt0816-793.

PMID- 27504759
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20180110
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug 9
TI  - Biogen and UPenn join forces to commercialize gene therapies.
PG  - 791-3
LID - 10.1038/nbt0816-791 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/08/10 06:00
MHDA- 2016/08/10 06:01
CRDT- 2016/08/10 06:00
PHST- 2016/08/10 06:00 [entrez]
PHST- 2016/08/10 06:00 [pubmed]
PHST- 2016/08/10 06:01 [medline]
AID - nbt0816-791 [pii]
AID - 10.1038/nbt0816-791 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug 9;34(8):791-3. doi: 10.1038/nbt0816-791.

PMID- 27504758
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20180110
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug 9
TI  - Genentech's PD-L1 agent approved for bladder cancer.
PG  - 789-90
LID - 10.1038/nbt0816-789 [doi]
FAU - Ratner, Mark
AU  - Ratner M
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/08/10 06:00
MHDA- 2016/08/10 06:01
CRDT- 2016/08/10 06:00
PHST- 2016/08/10 06:00 [entrez]
PHST- 2016/08/10 06:00 [pubmed]
PHST- 2016/08/10 06:01 [medline]
AID - nbt0816-789 [pii]
AID - 10.1038/nbt0816-789 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug 9;34(8):789-90. doi: 10.1038/nbt0816-789.

PMID- 27504757
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug 9
TI  - 'Brexit' stuns UK biotech into waiting game, but not all signals are red.
PG  - 787-8
LID - 10.1038/nbt0816-787 [doi]
FAU - Mitchell, Peter
AU  - Mitchell P
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EDAT- 2016/08/10 06:00
MHDA- 2016/08/10 06:01
CRDT- 2016/08/10 06:00
PHST- 2016/08/10 06:00 [entrez]
PHST- 2016/08/10 06:00 [pubmed]
PHST- 2016/08/10 06:01 [medline]
AID - nbt0816-787 [pii]
AID - 10.1038/nbt0816-787 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug 9;34(8):787-8. doi: 10.1038/nbt0816-787.

PMID- 27504756
OWN - NLM
STAT- MEDLINE
DCOM- 20180110
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug 9
TI  - What Brexit means for biotech.
PG  - 785
LID - 10.1038/nbt.3657 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biological Science Disciplines/*organization & administration
MH  - Biotechnology/*organization & administration
MH  - Clinical Trials as Topic/*organization & administration
MH  - *Emigration and Immigration
MH  - European Union/organization & administration
MH  - Industry/*organization & administration
MH  - *Public Policy
MH  - Research/*organization & administration
MH  - United Kingdom
EDAT- 2016/08/10 06:00
MHDA- 2018/01/11 06:00
CRDT- 2016/08/10 06:00
PHST- 2016/08/10 06:00 [entrez]
PHST- 2016/08/10 06:00 [pubmed]
PHST- 2018/01/11 06:00 [medline]
AID - nbt.3657 [pii]
AID - 10.1038/nbt.3657 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug 9;34(8):785. doi: 10.1038/nbt.3657.

PMID- 27398792
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug
TI  - A recellularized human colon model identifies cancer driver genes.
PG  - 845-51
LID - 10.1038/nbt.3586 [doi]
AB  - Refined cancer models are needed to bridge the gaps between cell line, animal and
      clinical research. Here we describe the engineering of an organotypic colon
      cancer model by recellularization of a native human matrix that contains
      cell-populated mucosa and an intact muscularis mucosa layer. This ex vivo system 
      recapitulates the pathophysiological progression from APC-mutant neoplasia to
      submucosal invasive tumor. We used it to perform a Sleeping Beauty transposon
      mutagenesis screen to identify genes that cooperate with mutant APC in driving
      invasive neoplasia. We identified 38 candidate invasion-driver genes, 17 of
      which, including TCF7L2, TWIST2, MSH2, DCC, EPHB1 and EPHB2 have been previously 
      implicated in colorectal cancer progression. Six invasion-driver genes that have 
      not, to our knowledge, been previously described were validated in vitro using
      cell proliferation, migration and invasion assays and ex vivo using
      recellularized human colon. These results demonstrate the utility of our organoid
      model for studying cancer biology.
FAU - Chen, Huanhuan Joyce
AU  - Chen HJ
AD  - Department of Biomedical Engineering, Cornell University, Ithaca, New York, USA.
FAU - Wei, Zhubo
AU  - Wei Z
AD  - Cancer Research Program, Houston Methodist Research Institute, Houston, Texas,
      USA.
FAU - Sun, Jian
AU  - Sun J
AD  - Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
AD  - Department of Genetic Medicine, Weill Cornell Medical College, New York, New
      York, USA.
FAU - Bhattacharya, Asmita
AU  - Bhattacharya A
AD  - Genetics, Genomics and Development, Cornell University, Ithaca, New York, USA.
FAU - Savage, David J
AU  - Savage DJ
AD  - University of Texas Medical School at Houston, Houston, Texas, USA.
FAU - Serda, Rita
AU  - Serda R
AD  - University of Texas Medical School at Houston, Houston, Texas, USA.
FAU - Mackeyev, Yuri
AU  - Mackeyev Y
AD  - Department of Chemistry, Rice University, Houston, Texas, USA.
FAU - Curley, Steven A
AU  - Curley SA
AD  - Department of Surgery, Baylor College of Medicine, Houston, Texas, USA.
FAU - Bu, Pengcheng
AU  - Bu P
AD  - Department of Biomedical Engineering, Cornell University, Ithaca, New York, USA.
FAU - Wang, Lihua
AU  - Wang L
AD  - Department of Biological and Environmental Engineering, Cornell University,
      Ithaca, New York, USA.
FAU - Chen, Shuibing
AU  - Chen S
AD  - Chemical Biology in Surgery, Weill Cornell Medical College, New York, New York,
      USA.
FAU - Cohen-Gould, Leona
AU  - Cohen-Gould L
AD  - Department of Biochemistry, Weill Cornell Medical College, New York, New York,
      USA.
FAU - Huang, Emina
AU  - Huang E
AD  - Department of Stem Cell Biology and Regenerative Medicine, Cleveland Clinic,
      Cleveland, Ohio, USA.
AD  - Department of Colorectal Surgery, Cleveland Clinic, Cleveland, Ohio, USA.
FAU - Shen, Xiling
AU  - Shen X
AD  - Department of Biomedical Engineering, Cornell University, Ithaca, New York, USA.
FAU - Lipkin, Steven M
AU  - Lipkin SM
AD  - Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
AD  - Department of Genetic Medicine, Weill Cornell Medical College, New York, New
      York, USA.
FAU - Copeland, Neal G
AU  - Copeland NG
AD  - Cancer Research Program, Houston Methodist Research Institute, Houston, Texas,
      USA.
FAU - Jenkins, Nancy A
AU  - Jenkins NA
AD  - Cancer Research Program, Houston Methodist Research Institute, Houston, Texas,
      USA.
FAU - Shuler, Michael L
AU  - Shuler ML
AD  - Department of Biomedical Engineering, Cornell University, Ithaca, New York, USA.
LA  - eng
GR  - R01 GM095990/GM/NIGMS NIH HHS/United States
GR  - R01 GM114254/GM/NIGMS NIH HHS/United States
GR  - UH2 TR000516/TR/NCATS NIH HHS/United States
GR  - UL1 TR001414/TR/NCATS NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20160711
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (APC protein, human)
RN  - 0 (Adenomatous Polyposis Coli Protein)
RN  - 0 (Neoplasm Proteins)
SB  - IM
CIN - Nat Rev Gastroenterol Hepatol. 2016 Sep;13(9):500. PMID: 27485789
MH  - Adenomatous Polyposis Coli Protein/*genetics
MH  - Carcinogenesis/genetics
MH  - Cell-Free System/metabolism
MH  - Cells, Cultured
MH  - Colon/*metabolism/pathology
MH  - Colonic Neoplasms/*metabolism/*pathology
MH  - Gene Expression Profiling/*methods
MH  - Genes, Neoplasm/genetics
MH  - Humans
MH  - Neoplasm Proteins/*metabolism
MH  - Organogenesis
MH  - Tissue Engineering/methods
PMC - PMC4980997
MID - NIHMS781893
EDAT- 2016/07/12 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/07/12 06:00
PHST- 2015/12/15 00:00 [received]
PHST- 2016/04/26 00:00 [accepted]
PHST- 2016/07/12 06:00 [entrez]
PHST- 2016/07/12 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3586 [pii]
AID - 10.1038/nbt.3586 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug;34(8):845-51. doi: 10.1038/nbt.3586. Epub 2016 Jul 11.

PMID- 27398791
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug
TI  - Translation efficiency of mRNAs is increased by antisense oligonucleotides
      targeting upstream open reading frames.
PG  - 875-80
LID - 10.1038/nbt.3589 [doi]
AB  - Increasing the levels of therapeutic proteins in vivo remains challenging.
      Antisense oligonucleotides (ASOs) are often used to downregulate gene expression 
      or to modify RNA splicing, but antisense technology has not previously been used 
      to directly increase the production of selected proteins. Here we used a class of
      modified ASOs that bind to mRNA sequences in upstream open reading frames (uORFs)
      to specifically increase the amounts of protein translated from a downstream
      primary ORF (pORF). Using ASO treatment, we increased the amount of proteins
      expressed from four genes by 30-150% in a dose-dependent manner in both human and
      mouse cells. Notably, systemic treatment of mice with ASO resulted in an
      approximately 80% protein increase of LRPPRC. The ASO-mediated increase in
      protein expression was sequence-specific, occurred at the level of translation
      and was dependent on helicase activity. We also found that the type of RNA
      modification and the position of modified nucleotides in ASOs affected
      translation of a pORF. ASOs are a useful class of therapeutic agents with broad
      utility.
FAU - Liang, Xue-Hai
AU  - Liang XH
AD  - Department of Core Antisense Research, Ionis Pharmaceuticals, Inc., Carlsbad,
      California, USA.
FAU - Shen, Wen
AU  - Shen W
AD  - Department of Core Antisense Research, Ionis Pharmaceuticals, Inc., Carlsbad,
      California, USA.
FAU - Sun, Hong
AU  - Sun H
AD  - Department of Core Antisense Research, Ionis Pharmaceuticals, Inc., Carlsbad,
      California, USA.
FAU - Migawa, Michael T
AU  - Migawa MT
AD  - Department of Medicinal Chemistry, Ionis Pharmaceuticals, Inc., Carlsbad,
      California, USA.
FAU - Vickers, Timothy A
AU  - Vickers TA
AD  - Department of Core Antisense Research, Ionis Pharmaceuticals, Inc., Carlsbad,
      California, USA.
FAU - Crooke, Stanley T
AU  - Crooke ST
AD  - Department of Core Antisense Research, Ionis Pharmaceuticals, Inc., Carlsbad,
      California, USA.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20160711
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Oligonucleotides, Antisense)
SB  - IM
MH  - Gene Expression Regulation/genetics
MH  - Gene Targeting/methods
MH  - Genetic Enhancement/*methods
MH  - Oligonucleotides, Antisense/*genetics
MH  - Open Reading Frames/*genetics
MH  - Protein Biosynthesis/*genetics
MH  - Protein Engineering/*methods
EDAT- 2016/07/12 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/07/12 06:00
PHST- 2015/06/04 00:00 [received]
PHST- 2016/05/02 00:00 [accepted]
PHST- 2016/07/12 06:00 [entrez]
PHST- 2016/07/12 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3589 [pii]
AID - 10.1038/nbt.3589 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug;34(8):875-80. doi: 10.1038/nbt.3589. Epub 2016 Jul 11.

PMID- 27398790
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug
TI  - Canola engineered with a microalgal polyketide synthase-like system produces oil 
      enriched in docosahexaenoic acid.
PG  - 881-7
LID - 10.1038/nbt.3585 [doi]
AB  - Dietary omega-3 long-chain polyunsaturated fatty acids (LC-PUFAs),
      docosahexaenoic acid (DHA, C22:6) and eicosapentaenoic acid (EPA, C20:5) are
      usually derived from marine fish. Although production of both EPA and DHA has
      been engineered into land plants, including Arabidopsis, Camelina sativa and
      Brassica juncea, neither has been produced in commercially relevant amounts in a 
      widely grown crop. We report expression of a microalgal polyketide synthase-like 
      PUFA synthase system, comprising three multidomain polypeptides and an accessory 
      enzyme, in canola (Brassica napus) seeds. This transgenic enzyme system is
      expressed in the cytoplasm, and synthesizes DHA and EPA de novo from malonyl-CoA 
      without substantially altering plastidial fatty acid production. Furthermore,
      there is no significant impact of DHA and EPA production on seed yield in either 
      the greenhouse or the field. Canola oil processed from field-grown grain contains
      3.7% DHA and 0.7% EPA, and can provide more than 600 mg of omega-3 LC-PUFAs in a 
      14 g serving.
FAU - Walsh, Terence A
AU  - Walsh TA
AUID- ORCID: 0000-0003-2640-8189
AD  - Dow AgroSciences LLC, Research and Development, Indianapolis, Indiana, USA.
FAU - Bevan, Scott A
AU  - Bevan SA
AD  - Dow AgroSciences LLC, Research and Development, Indianapolis, Indiana, USA.
FAU - Gachotte, Daniel J
AU  - Gachotte DJ
AD  - Dow AgroSciences LLC, Research and Development, Indianapolis, Indiana, USA.
FAU - Larsen, Cory M
AU  - Larsen CM
AD  - Dow AgroSciences LLC, Research and Development, Indianapolis, Indiana, USA.
FAU - Moskal, William A
AU  - Moskal WA
AD  - Dow AgroSciences LLC, Research and Development, Indianapolis, Indiana, USA.
FAU - Merlo, P A Owens
AU  - Merlo PA
AD  - Dow AgroSciences LLC, Research and Development, Indianapolis, Indiana, USA.
FAU - Sidorenko, Lyudmila V
AU  - Sidorenko LV
AD  - Dow AgroSciences LLC, Research and Development, Indianapolis, Indiana, USA.
FAU - Hampton, Ronnie E
AU  - Hampton RE
AD  - Dow AgroSciences LLC, Research and Development, Indianapolis, Indiana, USA.
FAU - Stoltz, Virginia
AU  - Stoltz V
AD  - Dow AgroSciences LLC, Research and Development, Indianapolis, Indiana, USA.
FAU - Pareddy, Dayakar
AU  - Pareddy D
AD  - Dow AgroSciences LLC, Research and Development, Indianapolis, Indiana, USA.
FAU - Anthony, Geny I
AU  - Anthony GI
AD  - Dow AgroSciences LLC, Research and Development, Indianapolis, Indiana, USA.
FAU - Bhaskar, Pudota B
AU  - Bhaskar PB
AD  - Dow AgroSciences LLC, Research and Development, Indianapolis, Indiana, USA.
FAU - Marri, Pradeep R
AU  - Marri PR
AD  - Dow AgroSciences LLC, Research and Development, Indianapolis, Indiana, USA.
FAU - Clark, Lauren M
AU  - Clark LM
AD  - Dow AgroSciences LLC, Research and Development, Indianapolis, Indiana, USA.
FAU - Chen, Wei
AU  - Chen W
AD  - Dow AgroSciences LLC, Research and Development, Indianapolis, Indiana, USA.
FAU - Adu-Peasah, Patrick S
AU  - Adu-Peasah PS
AD  - Dow AgroSciences LLC, Research and Development, Indianapolis, Indiana, USA.
FAU - Wensing, Steven T
AU  - Wensing ST
AD  - Dow AgroSciences LLC, Research and Development, Indianapolis, Indiana, USA.
FAU - Zirkle, Ross
AU  - Zirkle R
AD  - DSM Nutritional Products LLC, Columbia, Maryland, USA.
FAU - Metz, James G
AU  - Metz JG
AD  - DSM Nutritional Products LLC, Boulder, Colorado, USA.
LA  - eng
PT  - Journal Article
DEP - 20160711
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Canola Oil)
RN  - 0 (Plant Oils)
RN  - 25167-62-8 (Docosahexaenoic Acids)
RN  - 79956-01-7 (Polyketide Synthases)
SB  - IM
MH  - Brassica napus/genetics/*metabolism
MH  - Canola Oil
MH  - Docosahexaenoic Acids/*chemistry/isolation & purification/metabolism
MH  - Genetic Enhancement/*methods
MH  - Microalgae/*physiology
MH  - Plant Oils/analysis/chemistry/*metabolism
MH  - Plants, Genetically Modified/genetics/metabolism
MH  - Polyketide Synthases/genetics/*metabolism
MH  - Protein Engineering/methods
EDAT- 2016/07/12 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/07/12 06:00
PHST- 2015/11/10 00:00 [received]
PHST- 2016/04/27 00:00 [accepted]
PHST- 2016/07/12 06:00 [entrez]
PHST- 2016/07/12 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3585 [pii]
AID - 10.1038/nbt.3585 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug;34(8):881-7. doi: 10.1038/nbt.3585. Epub 2016 Jul 11.

PMID- 27376585
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug
TI  - Large-scale phenome analysis defines a behavioral signature for Huntington's
      disease genotype in mice.
PG  - 838-44
LID - 10.1038/nbt.3587 [doi]
AB  - Rapid technological advances for the frequent monitoring of health parameters
      have raised the intriguing possibility that an individual's genotype could be
      predicted from phenotypic data alone. Here we used a machine learning approach to
      analyze the phenotypic effects of polymorphic mutations in a mouse model of
      Huntington's disease that determine disease presentation and age of onset. The
      resulting model correlated variation across 3,086 behavioral traits with seven
      different CAG-repeat lengths in the huntingtin gene (Htt). We selected behavioral
      signatures for age and CAG-repeat length that most robustly distinguished between
      mouse lines and validated the model by correctly predicting the repeat length of 
      a blinded mouse line. Sufficient discriminatory power to accurately predict
      genotype required combined analysis of >200 phenotypic features. Our results
      suggest that autosomal dominant disease-causing mutations could be predicted
      through the use of subtle behavioral signatures that emerge in large-scale,
      combinatorial analyses. Our work provides an open data platform that we now share
      with the research community to aid efforts focused on understanding the pathways 
      that link behavioral consequences to genetic variation in Huntington's disease.
FAU - Alexandrov, Vadim
AU  - Alexandrov V
AD  - PsychoGenics Inc., Tarrytown, New York, USA.
FAU - Brunner, Dani
AU  - Brunner D
AD  - PsychoGenics Inc., Tarrytown, New York, USA.
FAU - Menalled, Liliana B
AU  - Menalled LB
AD  - PsychoGenics Inc., Tarrytown, New York, USA.
FAU - Kudwa, Andrea
AU  - Kudwa A
AD  - PsychoGenics Inc., Tarrytown, New York, USA.
FAU - Watson-Johnson, Judy
AU  - Watson-Johnson J
AD  - PsychoGenics Inc., Tarrytown, New York, USA.
FAU - Mazzella, Matthew
AU  - Mazzella M
AD  - PsychoGenics Inc., Tarrytown, New York, USA.
FAU - Russell, Ian
AU  - Russell I
AD  - PsychoGenics Inc., Tarrytown, New York, USA.
FAU - Ruiz, Melinda C
AU  - Ruiz MC
AD  - PsychoGenics Inc., Tarrytown, New York, USA.
FAU - Torello, Justin
AU  - Torello J
AD  - PsychoGenics Inc., Tarrytown, New York, USA.
FAU - Sabath, Emily
AU  - Sabath E
AD  - PsychoGenics Inc., Tarrytown, New York, USA.
FAU - Sanchez, Ana
AU  - Sanchez A
AD  - PsychoGenics Inc., Tarrytown, New York, USA.
FAU - Gomez, Miguel
AU  - Gomez M
AD  - PsychoGenics Inc., Tarrytown, New York, USA.
FAU - Filipov, Igor
AU  - Filipov I
AD  - PsychoGenics Inc., Tarrytown, New York, USA.
FAU - Cox, Kimberly
AU  - Cox K
AD  - PsychoGenics Inc., Tarrytown, New York, USA.
FAU - Kwan, Mei
AU  - Kwan M
AD  - PsychoGenics Inc., Tarrytown, New York, USA.
FAU - Ghavami, Afshin
AU  - Ghavami A
AD  - PsychoGenics Inc., Tarrytown, New York, USA.
FAU - Ramboz, Sylvie
AU  - Ramboz S
AD  - PsychoGenics Inc., Tarrytown, New York, USA.
FAU - Lager, Brenda
AU  - Lager B
AD  - CHDI Management/CHDI Foundation, Princeton, New Jersey, USA.
FAU - Wheeler, Vanessa C
AU  - Wheeler VC
AD  - Center for Human Genetic Research, Massachusetts General Hospital, Boston,
      Massachusetts, USA.
FAU - Aaronson, Jeff
AU  - Aaronson J
AD  - CHDI Management/CHDI Foundation, Princeton, New Jersey, USA.
FAU - Rosinski, Jim
AU  - Rosinski J
AD  - CHDI Management/CHDI Foundation, Princeton, New Jersey, USA.
FAU - Gusella, James F
AU  - Gusella JF
AD  - Center for Human Genetic Research, Massachusetts General Hospital, Boston,
      Massachusetts, USA.
FAU - MacDonald, Marcy E
AU  - MacDonald ME
AD  - Center for Human Genetic Research, Massachusetts General Hospital, Boston,
      Massachusetts, USA.
FAU - Howland, David
AU  - Howland D
AD  - CHDI Management/CHDI Foundation, Princeton, New Jersey, USA.
FAU - Kwak, Seung
AU  - Kwak S
AD  - CHDI Management/CHDI Foundation, Princeton, New Jersey, USA.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20160704
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Htt protein, mouse)
RN  - 0 (Huntingtin Protein)
SB  - IM
CIN - Nat Biotechnol. 2016 Aug 9;34(8):823-4. PMID: 27504774
MH  - Animals
MH  - *Behavior, Animal
MH  - Chromosome Mapping/methods
MH  - Genome/*genetics
MH  - Genome-Wide Association Study/methods
MH  - High-Throughput Nucleotide Sequencing/methods
MH  - Huntingtin Protein/*genetics
MH  - Huntington Disease/*genetics
MH  - Mice/classification/*genetics
MH  - *Phenotype
MH  - Polymorphism, Single Nucleotide/genetics
EDAT- 2016/07/05 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/07/05 06:00
PHST- 2015/03/11 00:00 [received]
PHST- 2016/04/28 00:00 [accepted]
PHST- 2016/07/05 06:00 [entrez]
PHST- 2016/07/05 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3587 [pii]
AID - 10.1038/nbt.3587 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug;34(8):838-44. doi: 10.1038/nbt.3587. Epub 2016 Jul 4.

PMID- 27347757
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug
TI  - Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells.
PG  - 869-74
LID - 10.1038/nbt.3620 [doi]
AB  - The activities and genome-wide specificities of CRISPR-Cas Cpf1 nucleases are not
      well defined. We show that two Cpf1 nucleases from Acidaminococcus sp. BV3L6 and 
      Lachnospiraceae bacterium ND2006 (AsCpf1 and LbCpf1, respectively) have on-target
      efficiencies in human cells comparable with those of the widely used
      Streptococcus pyogenes Cas9 (SpCas9). We also report that four to six bases at
      the 3' end of the short CRISPR RNA (crRNA) used to program Cpf1 nucleases are
      insensitive to single base mismatches, but that many of the other bases in this
      region of the crRNA are highly sensitive to single or double substitutions. Using
      GUIDE-seq and targeted deep sequencing analyses performed with both Cpf1
      nucleases, we were unable to detect off-target cleavage for more than half of 20 
      different crRNAs. Our results suggest that AsCpf1 and LbCpf1 are highly specific 
      in human cells.
FAU - Kleinstiver, Benjamin P
AU  - Kleinstiver BP
AD  - Molecular Pathology Unit, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Cancer Research, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Computational and Integrative Biology, Massachusetts General Hospital,
      Charlestown, Massachusetts, USA.
AD  - Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Tsai, Shengdar Q
AU  - Tsai SQ
AD  - Molecular Pathology Unit, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Cancer Research, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Computational and Integrative Biology, Massachusetts General Hospital,
      Charlestown, Massachusetts, USA.
AD  - Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Prew, Michelle S
AU  - Prew MS
AD  - Molecular Pathology Unit, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Cancer Research, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Computational and Integrative Biology, Massachusetts General Hospital,
      Charlestown, Massachusetts, USA.
FAU - Nguyen, Nhu T
AU  - Nguyen NT
AD  - Molecular Pathology Unit, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Cancer Research, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Computational and Integrative Biology, Massachusetts General Hospital,
      Charlestown, Massachusetts, USA.
FAU - Welch, Moira M
AU  - Welch MM
AD  - Molecular Pathology Unit, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Cancer Research, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Computational and Integrative Biology, Massachusetts General Hospital,
      Charlestown, Massachusetts, USA.
FAU - Lopez, Jose M
AU  - Lopez JM
AD  - Molecular Pathology Unit, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Cancer Research, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Computational and Integrative Biology, Massachusetts General Hospital,
      Charlestown, Massachusetts, USA.
AD  - Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA.
FAU - McCaw, Zachary R
AU  - McCaw ZR
AD  - Molecular Pathology Unit, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Cancer Research, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston,
      Massachusetts, USA.
FAU - Aryee, Martin J
AU  - Aryee MJ
AUID- ORCID: 0000-0002-6848-1344
AD  - Molecular Pathology Unit, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Cancer Research, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA.
AD  - Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston,
      Massachusetts, USA.
FAU - Joung, J Keith
AU  - Joung JK
AD  - Molecular Pathology Unit, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Cancer Research, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Computational and Integrative Biology, Massachusetts General Hospital,
      Charlestown, Massachusetts, USA.
AD  - Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA.
LA  - eng
GR  - DP1 GM105378/GM/NIGMS NIH HHS/United States
GR  - R01 GM107427/GM/NIGMS NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20160627
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Bacterial Proteins)
RN  - EC 3.1.- (Endonucleases)
SB  - IM
MH  - Bacterial Proteins/*genetics/*metabolism
MH  - Base Pair Mismatch
MH  - Binding Sites
MH  - CRISPR-Cas Systems/*genetics
MH  - Chromosome Mapping/methods
MH  - Clustered Regularly Interspaced Short Palindromic Repeats/physiology
MH  - Endonucleases/*genetics/*metabolism
MH  - Enzyme Activation
MH  - Genome, Human/*genetics
MH  - Humans
MH  - Protein Binding
MH  - Substrate Specificity
PMC - PMC4980201
MID - NIHMS789773
EDAT- 2016/06/28 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/06/28 06:00
PHST- 2016/03/02 00:00 [received]
PHST- 2016/05/24 00:00 [accepted]
PHST- 2016/06/28 06:00 [entrez]
PHST- 2016/06/28 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3620 [pii]
AID - 10.1038/nbt.3620 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug;34(8):869-74. doi: 10.1038/nbt.3620. Epub 2016 Jun 27.

PMID- 27347754
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug
TI  - Wide field-of-view, multi-region, two-photon imaging of neuronal activity in the 
      mammalian brain.
PG  - 857-62
LID - 10.1038/nbt.3594 [doi]
AB  - Two-photon calcium imaging provides an optical readout of neuronal activity in
      populations of neurons with subcellular resolution. However, conventional
      two-photon imaging systems are limited in their field of view to approximately 1 
      mm(2), precluding the visualization of multiple cortical areas simultaneously.
      Here, we demonstrate a two-photon microscope with an expanded field of view (>9.5
      mm(2)) for rapidly reconfigurable simultaneous scanning of widely separated
      populations of neurons. We custom designed and assembled an optimized scan
      engine, objective, and two independently positionable, temporally multiplexed
      excitation pathways. We used this new microscope to measure activity correlations
      between two cortical visual areas in mice during visual processing.
FAU - Stirman, Jeffrey N
AU  - Stirman JN
AD  - Neuroscience Center, University of North Carolina School of Medicine, Chapel
      Hill, North Carolina, USA.
AD  - Carolina Institute for Developmental Disabilities, University of North Carolina
      School of Medicine, Chapel Hill, North Carolina, USA.
FAU - Smith, Ikuko T
AU  - Smith IT
AD  - Neuroscience Center, University of North Carolina School of Medicine, Chapel
      Hill, North Carolina, USA.
AD  - Department of Pharmacology, University of North Carolina School of Medicine,
      Chapel Hill, North Carolina, USA.
FAU - Kudenov, Michael W
AU  - Kudenov MW
AD  - Department of Electrical and Computer Engineering, North Carolina State
      University, Raleigh, North Carolina, USA.
FAU - Smith, Spencer L
AU  - Smith SL
AD  - Neuroscience Center, University of North Carolina School of Medicine, Chapel
      Hill, North Carolina, USA.
AD  - Carolina Institute for Developmental Disabilities, University of North Carolina
      School of Medicine, Chapel Hill, North Carolina, USA.
AD  - Department of Cell Biology and Physiology, University of North Carolina School of
      Medicine, Chapel Hill, North Carolina, USA.
AD  - Neurobiology Curriculum, University of North Carolina School of Medicine, Chapel 
      Hill, North Carolina, USA.
LA  - eng
GR  - R01 EY024294/EY/NEI NIH HHS/United States
GR  - R01 NS091335/NS/NINDS NIH HHS/United States
GR  - P30 NS045892/NS/NINDS NIH HHS/United States
GR  - U54 HD079124/HD/NICHD NIH HHS/United States
GR  - P30 HD003110/HD/NICHD NIH HHS/United States
GR  - T32 HD040127/HD/NICHD NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20160627
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - Brain Mapping/*instrumentation/methods
MH  - Image Enhancement/instrumentation/methods
MH  - Mice
MH  - Mice, Inbred C57BL
MH  - Mice, Transgenic
MH  - Microscopy, Fluorescence, Multiphoton/*instrumentation/methods
MH  - Nerve Net/physiology
MH  - Neurons/cytology/*physiology
MH  - Reproducibility of Results
MH  - Sensitivity and Specificity
MH  - Visual Cortex/*physiology
MH  - Visual Perception/*physiology
MH  - Voltage-Sensitive Dye Imaging/*instrumentation/methods
PMC - PMC4980167
MID - NIHMS785666
EDAT- 2016/06/28 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/06/28 06:00
PHST- 2015/11/03 00:00 [received]
PHST- 2016/05/09 00:00 [accepted]
PHST- 2016/06/28 06:00 [entrez]
PHST- 2016/06/28 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3594 [pii]
AID - 10.1038/nbt.3594 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug;34(8):857-62. doi: 10.1038/nbt.3594. Epub 2016 Jun 27.

PMID- 27347753
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug
TI  - Single-cell 5hmC sequencing reveals chromosome-wide cell-to-cell variability and 
      enables lineage reconstruction.
PG  - 852-6
LID - 10.1038/nbt.3598 [doi]
AB  - The epigenetic DNA modification 5-hydroxymethylcytosine (5hmC) has crucial roles 
      in development and gene regulation. Quantifying the abundance of this epigenetic 
      mark at the single-cell level could enable us to understand its roles. We present
      a single-cell, genome-wide and strand-specific 5hmC sequencing technology, based 
      on 5hmC glucosylation and glucosylation-dependent digestion of DNA, that reveals 
      pronounced cell-to-cell variability in the abundance of 5hmC on the two DNA
      strands of a given chromosome. We develop a mathematical model that reproduces
      the strand bias and use this model to make two predictions. First, the variation 
      in strand bias should decrease when 5hmC turnover increases. Second, the strand
      bias of two sister cells should be strongly anti-correlated. We validate these
      predictions experimentally, and use our model to reconstruct lineages of two- and
      four-cell mouse embryos, showing that single-cell 5hmC sequencing can be used as 
      a lineage reconstruction tool.
FAU - Mooijman, Dylan
AU  - Mooijman D
AD  - Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences),
      Utrecht, the Netherlands.
AD  - University Medical Center Utrecht, Cancer Genomics Netherlands, Utrecht, the
      Netherlands.
FAU - Dey, Siddharth S
AU  - Dey SS
AD  - Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences),
      Utrecht, the Netherlands.
AD  - University Medical Center Utrecht, Cancer Genomics Netherlands, Utrecht, the
      Netherlands.
FAU - Boisset, Jean-Charles
AU  - Boisset JC
AD  - Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences),
      Utrecht, the Netherlands.
AD  - University Medical Center Utrecht, Cancer Genomics Netherlands, Utrecht, the
      Netherlands.
FAU - Crosetto, Nicola
AU  - Crosetto N
AD  - Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences),
      Utrecht, the Netherlands.
AD  - University Medical Center Utrecht, Cancer Genomics Netherlands, Utrecht, the
      Netherlands.
AD  - Science for Life Laboratory, Division of Translational Medicine and Chemical
      Biology, Department of Medical Biochemistry and Biophysics, Karolinska
      Institutet, Stockholm, Sweden.
FAU - van Oudenaarden, Alexander
AU  - van Oudenaarden A
AD  - Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences),
      Utrecht, the Netherlands.
AD  - University Medical Center Utrecht, Cancer Genomics Netherlands, Utrecht, the
      Netherlands.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20160627
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 1123-95-1 (5-hydroxymethylcytosine)
RN  - 6R795CQT4H (5-Methylcytosine)
SB  - IM
MH  - 5-Methylcytosine/*analogs & derivatives/chemistry
MH  - Animals
MH  - Cell Differentiation/genetics
MH  - Cell Lineage/*genetics
MH  - Chromosome Mapping/methods
MH  - Chromosomes/*chemistry/*genetics
MH  - Computer Simulation
MH  - Embryonic Development/*genetics
MH  - Epigenesis, Genetic/genetics
MH  - Genetic Variation/genetics
MH  - Male
MH  - Mice
MH  - Models, Chemical
MH  - Models, Genetic
MH  - Sequence Analysis, DNA/*methods
EDAT- 2016/06/28 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/06/28 06:00
PHST- 2015/07/23 00:00 [received]
PHST- 2016/05/11 00:00 [accepted]
PHST- 2016/06/28 06:00 [entrez]
PHST- 2016/06/28 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3598 [pii]
AID - 10.1038/nbt.3598 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug;34(8):852-6. doi: 10.1038/nbt.3598. Epub 2016 Jun 27.

PMID- 27323300
OWN - NLM
STAT- MEDLINE
DCOM- 20180110
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug
TI  - A crowdsourcing approach for reusing and meta-analyzing gene expression data.
PG  - 803-6
LID - 10.1038/nbt.3603 [doi]
FAU - Shah, Naisha
AU  - Shah N
AUID- ORCID: 0000-0003-0554-4835
AD  - Systems Genomics and Bioinformatics Unit, National Institute of Allergy and
      Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
FAU - Guo, Yongjian
AU  - Guo Y
AD  - Office of the Chief Laboratory of Systems Biology, National Institute of Allergy 
      and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
FAU - Wendelsdorf, Katherine V
AU  - Wendelsdorf KV
AD  - Systems Genomics and Bioinformatics Unit, National Institute of Allergy and
      Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
FAU - Lu, Yong
AU  - Lu Y
AUID- ORCID: 0000-0001-8541-6176
AD  - Systems Genomics and Bioinformatics Unit, National Institute of Allergy and
      Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
FAU - Sparks, Rachel
AU  - Sparks R
AD  - Systems Genomics and Bioinformatics Unit, National Institute of Allergy and
      Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
FAU - Tsang, John S
AU  - Tsang JS
AD  - Systems Genomics and Bioinformatics Unit, National Institute of Allergy and
      Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
LA  - eng
PT  - Letter
PT  - Research Support, N.I.H., Intramural
DEP - 20160620
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Algorithms
MH  - Crowdsourcing/*methods
MH  - Data Curation/*methods
MH  - *Databases, Genetic
MH  - Gene Expression Profiling/*methods
MH  - Humans
MH  - Information Storage and Retrieval/methods
MH  - *Meta-Analysis as Topic
MH  - *Software
EDAT- 2016/06/21 06:00
MHDA- 2018/01/11 06:00
CRDT- 2016/06/21 06:00
PHST- 2016/06/21 06:00 [entrez]
PHST- 2016/06/21 06:00 [pubmed]
PHST- 2018/01/11 06:00 [medline]
AID - nbt.3603 [pii]
AID - 10.1038/nbt.3603 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug;34(8):803-6. doi: 10.1038/nbt.3603. Epub 2016 Jun 20.

PMID- 27272387
OWN - NLM
STAT- MEDLINE
DCOM- 20180110
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug
TI  - Generation of knockout mice by Cpf1-mediated gene targeting.
PG  - 808-10
LID - 10.1038/nbt.3614 [doi]
FAU - Kim, Yongsub
AU  - Kim Y
AD  - Department of Biomedical Sciences, University of Ulsan College of Medicine, Asan 
      Medical Center, Seoul, Republic of Korea.
FAU - Cheong, Seung-A
AU  - Cheong SA
AD  - Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea.
FAU - Lee, Jong Geol
AU  - Lee JG
AD  - Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea.
AD  - College of Veterinary Medicine, Chungbuk National University, Cheongju, Republic 
      of Korea.
FAU - Lee, Sang-Wook
AU  - Lee SW
AD  - Department of Radiation Oncology, University of Ulsan College of Medicine, Asan
      Medical Center, Seoul, Republic of Korea.
FAU - Lee, Myeong Sup
AU  - Lee MS
AD  - Department of Biomedical Sciences, University of Ulsan College of Medicine, Asan 
      Medical Center, Seoul, Republic of Korea.
FAU - Baek, In-Jeoung
AU  - Baek IJ
AD  - Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea.
AD  - Department of Convergence Medicine, University of Ulsan College of Medicine,
      Seoul, Republic of Korea.
FAU - Sung, Young Hoon
AU  - Sung YH
AD  - Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea.
AD  - Department of Convergence Medicine, University of Ulsan College of Medicine,
      Seoul, Republic of Korea.
LA  - eng
PT  - Letter
PT  - Research Support, Non-U.S. Gov't
DEP - 20160606
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Ribonucleoproteins)
SB  - IM
MH  - Animals
MH  - Clustered Regularly Interspaced Short Palindromic Repeats/*genetics
MH  - Gene Editing/*methods
MH  - Gene Targeting/*methods
MH  - Mice
MH  - Mice, Knockout/*genetics
MH  - Mice, Transgenic
MH  - Mutagenesis, Site-Directed/methods
MH  - Ribonucleoproteins/*genetics
MH  - Transfection/*methods
EDAT- 2016/06/09 06:00
MHDA- 2018/01/11 06:00
CRDT- 2016/06/09 06:00
PHST- 2016/06/09 06:00 [entrez]
PHST- 2016/06/09 06:00 [pubmed]
PHST- 2018/01/11 06:00 [medline]
AID - nbt.3614 [pii]
AID - 10.1038/nbt.3614 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug;34(8):808-10. doi: 10.1038/nbt.3614. Epub 2016 Jun 6.

PMID- 27272385
OWN - NLM
STAT- MEDLINE
DCOM- 20180110
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug
TI  - Targeted mutagenesis in mice by electroporation of Cpf1 ribonucleoproteins.
PG  - 807-8
LID - 10.1038/nbt.3596 [doi]
FAU - Hur, Junho K
AU  - Hur JK
AUID- ORCID: 0000-0003-3794-1149
AD  - Center for Genome Engineering, Institute for Basic Science, Seoul, Republic of
      Korea.
FAU - Kim, Kyoungmi
AU  - Kim K
AD  - Center for Genome Engineering, Institute for Basic Science, Seoul, Republic of
      Korea.
FAU - Been, Kyung Wook
AU  - Been KW
AD  - Center for Genome Engineering, Institute for Basic Science, Seoul, Republic of
      Korea.
AD  - Department of Chemistry, Seoul National University, Seoul, Republic of Korea.
FAU - Baek, Gayoung
AU  - Baek G
AD  - Center for Genome Engineering, Institute for Basic Science, Seoul, Republic of
      Korea.
FAU - Ye, Sunghyeok
AU  - Ye S
AD  - Center for Genome Engineering, Institute for Basic Science, Seoul, Republic of
      Korea.
AD  - Basic Science, IBS School, Korea University of Science and Technology, Seoul,
      Republic of Korea.
FAU - Hur, Junseok W
AU  - Hur JW
AD  - Center for Genome Engineering, Institute for Basic Science, Seoul, Republic of
      Korea.
AD  - Department of Neurosurgery, Korea University College of Medicine, Seoul, Republic
      of Korea.
FAU - Ryu, Seuk-Min
AU  - Ryu SM
AD  - Center for Genome Engineering, Institute for Basic Science, Seoul, Republic of
      Korea.
AD  - Department of Chemistry, Seoul National University, Seoul, Republic of Korea.
FAU - Lee, Youn Su
AU  - Lee YS
AD  - Center for Genome Engineering, Institute for Basic Science, Seoul, Republic of
      Korea.
AD  - ToolGen, Seoul, Republic of Korea.
FAU - Kim, Jin-Soo
AU  - Kim JS
AD  - Center for Genome Engineering, Institute for Basic Science, Seoul, Republic of
      Korea.
AD  - Department of Chemistry, Seoul National University, Seoul, Republic of Korea.
LA  - eng
PT  - Letter
PT  - Research Support, Non-U.S. Gov't
DEP - 20160606
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Ribonucleoproteins)
SB  - IM
MH  - Animals
MH  - Clustered Regularly Interspaced Short Palindromic Repeats/*genetics
MH  - Electroporation/*methods
MH  - Gene Editing/*methods
MH  - Gene Targeting/*methods
MH  - Mice
MH  - Mice, Transgenic
MH  - Mutagenesis, Site-Directed/*methods
MH  - Ribonucleoproteins/*genetics
MH  - Transfection/*methods
EDAT- 2016/06/09 06:00
MHDA- 2018/01/11 06:00
CRDT- 2016/06/09 06:00
PHST- 2016/06/09 06:00 [entrez]
PHST- 2016/06/09 06:00 [pubmed]
PHST- 2018/01/11 06:00 [medline]
AID - nbt.3596 [pii]
AID - 10.1038/nbt.3596 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug;34(8):807-8. doi: 10.1038/nbt.3596. Epub 2016 Jun 6.

PMID- 27272384
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 8
DP  - 2016 Aug
TI  - Genome-wide analysis reveals specificities of Cpf1 endonucleases in human cells.
PG  - 863-8
LID - 10.1038/nbt.3609 [doi]
AB  - Programmable clustered regularly interspaced short palindromic repeats (CRISPR)
      Cpf1 endonucleases are single-RNA-guided (crRNA) enzymes that recognize
      thymidine-rich protospacer-adjacent motif (PAM) sequences and produce cohesive
      double-stranded breaks (DSBs). Genome editing with CRISPR-Cpf1 endonucleases
      could provide an alternative to CRISPR-Cas9 endonucleases, but the determinants
      of targeting specificity are not well understood. Using mismatched crRNAs we
      found that Cpf1 could tolerate single or double mismatches in the 3' PAM-distal
      region, but not in the 5' PAM-proximal region. Genome-wide analysis of cleavage
      sites in vitro for eight Cpf1 nucleases using Digenome-seq revealed that there
      were 6 (LbCpf1) and 12 (AsCpf1) cleavage sites per crRNA in the human genome,
      fewer than are present for Cas9 nucleases (>90). Most Cpf1 off-target cleavage
      sites did not produce mutations in cells. We found mismatches in either the 3'
      PAM-distal region or in the PAM sequence of 12 off-target sites that were
      validated in vivo. Off-target effects were completely abrogated by using
      preassembled, recombinant Cpf1 ribonucleoproteins.
FAU - Kim, Daesik
AU  - Kim D
AD  - Center for Genome Engineering, Institute for Basic Science (IBS), Seoul, Republic
      of Korea.
AD  - Department of Chemistry, Seoul National University, Seoul, Republic of Korea.
FAU - Kim, Jungeun
AU  - Kim J
AD  - Center for Genome Engineering, Institute for Basic Science (IBS), Seoul, Republic
      of Korea.
AD  - Department of Chemistry, Seoul National University, Seoul, Republic of Korea.
FAU - Hur, Junho K
AU  - Hur JK
AUID- ORCID: 0000-0003-3794-1149
AD  - Center for Genome Engineering, Institute for Basic Science (IBS), Seoul, Republic
      of Korea.
FAU - Been, Kyung Wook
AU  - Been KW
AD  - Center for Genome Engineering, Institute for Basic Science (IBS), Seoul, Republic
      of Korea.
AD  - Department of Chemistry, Seoul National University, Seoul, Republic of Korea.
FAU - Yoon, Sun-Heui
AU  - Yoon SH
AD  - Department of Chemistry, Seoul National University, Seoul, Republic of Korea.
FAU - Kim, Jin-Soo
AU  - Kim JS
AD  - Center for Genome Engineering, Institute for Basic Science (IBS), Seoul, Republic
      of Korea.
AD  - Department of Chemistry, Seoul National University, Seoul, Republic of Korea.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20160606
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Bacterial Proteins)
RN  - EC 3.1.- (Endonucleases)
SB  - IM
EIN - Nat Biotechnol. 2016 Aug 9;34(8):888. PMID: 27504781
MH  - Bacterial Proteins/*genetics/*metabolism
MH  - Base Pair Mismatch
MH  - Binding Sites
MH  - CRISPR-Cas Systems/*genetics
MH  - Chromosome Mapping/methods
MH  - Clustered Regularly Interspaced Short Palindromic Repeats/physiology
MH  - Endonucleases/*genetics/*metabolism
MH  - Enzyme Activation
MH  - Genome, Human/*genetics
MH  - Humans
MH  - Protein Binding
MH  - Substrate Specificity
EDAT- 2016/06/09 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/06/09 06:00
PHST- 2016/02/25 00:00 [received]
PHST- 2016/05/13 00:00 [accepted]
PHST- 2016/06/09 06:00 [entrez]
PHST- 2016/06/09 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3609 [pii]
AID - 10.1038/nbt.3609 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Aug;34(8):863-8. doi: 10.1038/nbt.3609. Epub 2016 Jun 6.

PMID- 27404886
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul 12
TI  - Boosting the career development of postdocs with a peer-to-peer mentor circles
      program.
PG  - 781-3
LID - 10.1038/nbt.3631 [doi]
FAU - Kuhn, Chantal
AU  - Kuhn C
AD  - Department of Neurology, Ann Romney Center for Neurologic Diseases, Brigham and
      Women's Hospital, Boston, Massachusetts, USA and at Harvard Medical School,
      Boston, Massachusetts, USA.
FAU - Castano, Zafira
AU  - Castano Z
AD  - Harvard Medical School, Boston, Massachusetts, USA; Division of Hematology,
      Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA;
      and the International Mentoring Foundation for the Advancement of Higher
      Education, Dedham, Massachusetts, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EDAT- 2016/07/13 06:00
MHDA- 2016/07/13 06:01
CRDT- 2016/07/13 06:00
PHST- 2016/07/13 06:00 [entrez]
PHST- 2016/07/13 06:00 [pubmed]
PHST- 2016/07/13 06:01 [medline]
AID - nbt.3631 [pii]
AID - 10.1038/nbt.3631 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul 12;34(7):781-3. doi: 10.1038/nbt.3631.

PMID- 27404885
OWN - NLM
STAT- MEDLINE
DCOM- 20180104
LR  - 20180104
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul 12
TI  - Tracing cell lineages with mutable barcodes.
PG  - 725
LID - 10.1038/nbt.3634 [doi]
FAU - Duarte, Joao H
AU  - Duarte JH
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Science. 2016 Jul 29;353(6298):aaf7907. PMID: 27229144
MH  - *Cell Lineage
MH  - *DNA Barcoding, Taxonomic
MH  - Humans
MH  - Phylogeny
EDAT- 2016/07/13 06:00
MHDA- 2018/01/05 06:00
CRDT- 2016/07/13 06:00
PHST- 2016/07/13 06:00 [entrez]
PHST- 2016/07/13 06:00 [pubmed]
PHST- 2018/01/05 06:00 [medline]
AID - nbt.3634 [pii]
AID - 10.1038/nbt.3634 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul 12;34(7):725. doi: 10.1038/nbt.3634.

PMID- 27404883
OWN - NLM
STAT- MEDLINE
DCOM- 20180104
LR  - 20180104
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul 12
TI  - Tracking translation one mRNA at a time.
PG  - 723-4
LID - 10.1038/nbt.3632 [doi]
FAU - Wu, Jiahui
AU  - Wu J
AUID- ORCID: 0000-0003-2406-6728
AD  - Department of Pharmacology, Weill Cornell Medical College, Cornell University,
      New York, NY, USA.
FAU - Jaffrey, Samie R
AU  - Jaffrey SR
AD  - Department of Pharmacology, Weill Cornell Medical College, Cornell University,
      New York, NY, USA.
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (RNA, Messenger)
SB  - IM
CON - Science. 2016 Jun 17;352(6292):1430-5. PMID: 27313041
CON - Science. 2016 Jun 17;352(6292):1425-9. PMID: 27313040
CON - Cell. 2016 May 5;165(4):976-89. PMID: 27153498
CON - Cell. 2016 May 5;165(4):990-1001. PMID: 27153499
MH  - Humans
MH  - *Protein Biosynthesis
MH  - RNA, Messenger/*genetics
EDAT- 2016/07/13 06:00
MHDA- 2018/01/05 06:00
CRDT- 2016/07/13 06:00
PHST- 2016/07/13 06:00 [entrez]
PHST- 2016/07/13 06:00 [pubmed]
PHST- 2018/01/05 06:00 [medline]
AID - nbt.3632 [pii]
AID - 10.1038/nbt.3632 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul 12;34(7):723-4. doi: 10.1038/nbt.3632.

PMID- 27404882
OWN - NLM
STAT- MEDLINE
DCOM- 20180104
LR  - 20180104
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul 12
TI  - Safer conditioning for blood stem cell transplants.
PG  - 721-3
LID - 10.1038/nbt.3629 [doi]
FAU - Aiuti, Alessandro
AU  - Aiuti A
AD  - San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Milan, Italy and
      Vita Salute San Raffaele University, Milan, Italy.
FAU - Naldini, Luigi
AU  - Naldini L
AD  - San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Milan, Italy and
      Vita Salute San Raffaele University, Milan, Italy.
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2016 Jul;34(7):738-45. PMID: 27272386
MH  - *Hematopoietic Stem Cell Transplantation
MH  - Humans
MH  - Stem Cell Transplantation
MH  - *Transplantation, Homologous
EDAT- 2016/07/13 06:00
MHDA- 2018/01/05 06:00
CRDT- 2016/07/13 06:00
PHST- 2016/07/13 06:00 [entrez]
PHST- 2016/07/13 06:00 [pubmed]
PHST- 2018/01/05 06:00 [medline]
AID - nbt.3629 [pii]
AID - 10.1038/nbt.3629 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul 12;34(7):721-3. doi: 10.1038/nbt.3629.

PMID- 27404881
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul 12
TI  - Recent patents in gene editing.
PG  - 720
LID - 10.1038/nbt.3638 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EDAT- 2016/07/13 06:00
MHDA- 2016/07/13 06:01
CRDT- 2016/07/13 06:00
PHST- 2016/07/13 06:00 [entrez]
PHST- 2016/07/13 06:00 [pubmed]
PHST- 2016/07/13 06:01 [medline]
AID - nbt.3638 [pii]
AID - 10.1038/nbt.3638 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul 12;34(7):720. doi: 10.1038/nbt.3638.

PMID- 27404880
OWN - NLM
STAT- MEDLINE
DCOM- 20180110
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul 12
TI  - Are reverse payments and pay-for-delay settlements business as usual or an
      anticompetitive practice?
PG  - 716-9
LID - 10.1038/nbt.3627 [doi]
FAU - Shah, Swati
AU  - Shah S
AD  - MCPHS University, Worcester, Massachusetts, USA.
FAU - Silva, Matthew A
AU  - Silva MA
AD  - MCPHS University, Worcester, Massachusetts, USA.
FAU - Malloy, Michael J
AU  - Malloy MJ
AD  - MCPHS University, Worcester, Massachusetts, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Drug Industry/*economics/*legislation & jurisprudence
MH  - Economic Competition/*economics/*legislation & jurisprudence
MH  - Legislation, Drug/*economics
MH  - Patents as Topic/*legislation & jurisprudence
MH  - United States
MH  - United States Federal Trade Commission/legislation & jurisprudence
EDAT- 2016/07/13 06:00
MHDA- 2018/01/11 06:00
CRDT- 2016/07/13 06:00
PHST- 2016/07/13 06:00 [entrez]
PHST- 2016/07/13 06:00 [pubmed]
PHST- 2018/01/11 06:00 [medline]
AID - nbt.3627 [pii]
AID - 10.1038/nbt.3627 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul 12;34(7):716-9. doi: 10.1038/nbt.3627.

PMID- 27404879
OWN - NLM
STAT- MEDLINE
DCOM- 20180110
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul 12
TI  - Public biotech in 2015 - the numbers.
PG  - 709-15
LID - 10.1038/nbt.3630 [doi]
FAU - Morrison, Chris
AU  - Morrison C
FAU - Lahteenmaki, Riku
AU  - Lahteenmaki R
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*economics
MH  - Drug Industry/*economics
MH  - Employment/*economics
MH  - Income/*statistics & numerical data
MH  - Public Sector/*economics
MH  - Research/*economics
EDAT- 2016/07/13 06:00
MHDA- 2018/01/11 06:00
CRDT- 2016/07/13 06:00
PHST- 2016/07/13 06:00 [entrez]
PHST- 2016/07/13 06:00 [pubmed]
PHST- 2018/01/11 06:00 [medline]
AID - nbt.3630 [pii]
AID - 10.1038/nbt.3630 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul 12;34(7):709-15. doi: 10.1038/nbt.3630.

PMID- 27404878
OWN - NLM
STAT- MEDLINE
DCOM- 20180104
LR  - 20180104
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul 12
TI  - Plant specific N-glycans do not have proven adverse effects in humans.
PG  - 706-8
LID - 10.1038/nbt.3556 [doi]
FAU - Shaaltiel, Yoseph
AU  - Shaaltiel Y
AD  - R&D Department, Protalix Ltd., Carmiel, Israel.
FAU - Tekoah, Yoram
AU  - Tekoah Y
AD  - R&D Department, Protalix Ltd., Carmiel, Israel.
LA  - eng
PT  - Letter
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Polysaccharides)
SB  - IM
CON - Nat Biotechnol. 2015 Nov;33(11):1135-7. PMID: 26544140
MH  - *Carbohydrate Sequence
MH  - Humans
MH  - Plants
MH  - *Polysaccharides
EDAT- 2016/07/13 06:00
MHDA- 2018/01/05 06:00
CRDT- 2016/07/13 06:00
PHST- 2016/07/13 06:00 [entrez]
PHST- 2016/07/13 06:00 [pubmed]
PHST- 2018/01/05 06:00 [medline]
AID - nbt.3556 [pii]
AID - 10.1038/nbt.3556 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul 12;34(7):706-8. doi: 10.1038/nbt.3556.

PMID- 27404877
OWN - NLM
STAT- MEDLINE
DCOM- 20180110
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul 12
TI  - Software tools for single-cell tracking and quantification of cellular and
      molecular properties.
PG  - 703-6
LID - 10.1038/nbt.3626 [doi]
FAU - Hilsenbeck, Oliver
AU  - Hilsenbeck O
AUID- ORCID: 0000-0002-9271-8815
AD  - Department of Biosystems Science and Engineering, Eidgenossische Technische
      Hochschule (ETH) Zurich, Basel, Switzerland.
AD  - Research Unit Stem Cell Dynamics, Helmholtz Zentrum Munchen - German Research
      Center for Environmental Health (GmbH), Neuherberg, Germany.
AD  - Institute of Computational Biology, Helmholtz Zentrum Munchen - German Research
      Center for Environmental Health (GmbH), Neuherberg, Germany.
FAU - Schwarzfischer, Michael
AU  - Schwarzfischer M
AD  - Institute of Computational Biology, Helmholtz Zentrum Munchen - German Research
      Center for Environmental Health (GmbH), Neuherberg, Germany.
FAU - Skylaki, Stavroula
AU  - Skylaki S
AD  - Department of Biosystems Science and Engineering, Eidgenossische Technische
      Hochschule (ETH) Zurich, Basel, Switzerland.
FAU - Schauberger, Bernhard
AU  - Schauberger B
AD  - Research Unit Stem Cell Dynamics, Helmholtz Zentrum Munchen - German Research
      Center for Environmental Health (GmbH), Neuherberg, Germany.
FAU - Hoppe, Philipp S
AU  - Hoppe PS
AD  - Department of Biosystems Science and Engineering, Eidgenossische Technische
      Hochschule (ETH) Zurich, Basel, Switzerland.
AD  - Research Unit Stem Cell Dynamics, Helmholtz Zentrum Munchen - German Research
      Center for Environmental Health (GmbH), Neuherberg, Germany.
FAU - Loeffler, Dirk
AU  - Loeffler D
AD  - Department of Biosystems Science and Engineering, Eidgenossische Technische
      Hochschule (ETH) Zurich, Basel, Switzerland.
AD  - Research Unit Stem Cell Dynamics, Helmholtz Zentrum Munchen - German Research
      Center for Environmental Health (GmbH), Neuherberg, Germany.
FAU - Kokkaliaris, Konstantinos D
AU  - Kokkaliaris KD
AD  - Department of Biosystems Science and Engineering, Eidgenossische Technische
      Hochschule (ETH) Zurich, Basel, Switzerland.
AD  - Research Unit Stem Cell Dynamics, Helmholtz Zentrum Munchen - German Research
      Center for Environmental Health (GmbH), Neuherberg, Germany.
FAU - Hastreiter, Simon
AU  - Hastreiter S
AD  - Department of Biosystems Science and Engineering, Eidgenossische Technische
      Hochschule (ETH) Zurich, Basel, Switzerland.
AD  - Research Unit Stem Cell Dynamics, Helmholtz Zentrum Munchen - German Research
      Center for Environmental Health (GmbH), Neuherberg, Germany.
FAU - Skylaki, Eleni
AU  - Skylaki E
AD  - Department of Biosystems Science and Engineering, Eidgenossische Technische
      Hochschule (ETH) Zurich, Basel, Switzerland.
FAU - Filipczyk, Adam
AU  - Filipczyk A
AD  - Research Unit Stem Cell Dynamics, Helmholtz Zentrum Munchen - German Research
      Center for Environmental Health (GmbH), Neuherberg, Germany.
FAU - Strasser, Michael
AU  - Strasser M
AD  - Institute of Computational Biology, Helmholtz Zentrum Munchen - German Research
      Center for Environmental Health (GmbH), Neuherberg, Germany.
FAU - Buggenthin, Felix
AU  - Buggenthin F
AD  - Institute of Computational Biology, Helmholtz Zentrum Munchen - German Research
      Center for Environmental Health (GmbH), Neuherberg, Germany.
FAU - Feigelman, Justin S
AU  - Feigelman JS
AD  - Institute of Computational Biology, Helmholtz Zentrum Munchen - German Research
      Center for Environmental Health (GmbH), Neuherberg, Germany.
FAU - Krumsiek, Jan
AU  - Krumsiek J
AUID- ORCID: 0000-0003-4734-3791
AD  - Institute of Computational Biology, Helmholtz Zentrum Munchen - German Research
      Center for Environmental Health (GmbH), Neuherberg, Germany.
FAU - van den Berg, Adrianus J J
AU  - van den Berg AJ
AD  - Research Unit Stem Cell Dynamics, Helmholtz Zentrum Munchen - German Research
      Center for Environmental Health (GmbH), Neuherberg, Germany.
FAU - Endele, Max
AU  - Endele M
AD  - Department of Biosystems Science and Engineering, Eidgenossische Technische
      Hochschule (ETH) Zurich, Basel, Switzerland.
AD  - Research Unit Stem Cell Dynamics, Helmholtz Zentrum Munchen - German Research
      Center for Environmental Health (GmbH), Neuherberg, Germany.
FAU - Etzrodt, Martin
AU  - Etzrodt M
AD  - Department of Biosystems Science and Engineering, Eidgenossische Technische
      Hochschule (ETH) Zurich, Basel, Switzerland.
FAU - Marr, Carsten
AU  - Marr C
AUID- ORCID: 0000-0003-2154-4552
AD  - Institute of Computational Biology, Helmholtz Zentrum Munchen - German Research
      Center for Environmental Health (GmbH), Neuherberg, Germany.
FAU - Theis, Fabian J
AU  - Theis FJ
AUID- ORCID: 0000-0002-2419-1943
AD  - Institute of Computational Biology, Helmholtz Zentrum Munchen - German Research
      Center for Environmental Health (GmbH), Neuherberg, Germany.
AD  - Department of Mathematics, Technische Universitat Munchen, Garching, Germany.
FAU - Schroeder, Timm
AU  - Schroeder T
AD  - Department of Biosystems Science and Engineering, Eidgenossische Technische
      Hochschule (ETH) Zurich, Basel, Switzerland.
AD  - Research Unit Stem Cell Dynamics, Helmholtz Zentrum Munchen - German Research
      Center for Environmental Health (GmbH), Neuherberg, Germany.
LA  - eng
PT  - Letter
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Algorithms
MH  - Cell Tracking/*methods
MH  - Image Enhancement/methods
MH  - Image Interpretation, Computer-Assisted/*methods
MH  - Machine Learning
MH  - Microscopy, Video/*methods
MH  - Molecular Imaging/*methods
MH  - Pattern Recognition, Automated/*methods
MH  - *Software
EDAT- 2016/07/13 06:00
MHDA- 2018/01/11 06:00
CRDT- 2016/07/13 06:00
PHST- 2016/07/13 06:00 [entrez]
PHST- 2016/07/13 06:00 [pubmed]
PHST- 2018/01/11 06:00 [medline]
AID - nbt.3626 [pii]
AID - 10.1038/nbt.3626 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul 12;34(7):703-6. doi: 10.1038/nbt.3626.

PMID- 27404876
OWN - NLM
STAT- MEDLINE
DCOM- 20180110
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul 12
TI  - CrispRVariants charts the mutation spectrum of genome engineering experiments.
PG  - 701-2
LID - 10.1038/nbt.3628 [doi]
FAU - Lindsay, Helen
AU  - Lindsay H
AD  - Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
AD  - SIB Swiss Insitute of Bioinformatics, University of Zurich, Zurich, Switzerland.
FAU - Burger, Alexa
AU  - Burger A
AD  - Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
FAU - Biyong, Berthin
AU  - Biyong B
AD  - Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
AD  - SIB Swiss Insitute of Bioinformatics, University of Zurich, Zurich, Switzerland.
FAU - Felker, Anastasia
AU  - Felker A
AD  - Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
FAU - Hess, Christopher
AU  - Hess C
AD  - Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
FAU - Zaugg, Jonas
AU  - Zaugg J
AD  - Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
FAU - Chiavacci, Elena
AU  - Chiavacci E
AD  - Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
FAU - Anders, Carolin
AU  - Anders C
AD  - Institute of Biochemistry, University of Zurich, Zurich, Switzerland.
FAU - Jinek, Martin
AU  - Jinek M
AD  - Institute of Biochemistry, University of Zurich, Zurich, Switzerland.
FAU - Mosimann, Christian
AU  - Mosimann C
AUID- ORCID: 0000-0002-0749-2576
AD  - Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
FAU - Robinson, Mark D
AU  - Robinson MD
AUID- ORCID: 0000-0002-3048-5518
AD  - Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.
AD  - SIB Swiss Insitute of Bioinformatics, University of Zurich, Zurich, Switzerland.
LA  - eng
PT  - Letter
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Algorithms
MH  - Clustered Regularly Interspaced Short Palindromic Repeats/*genetics
MH  - DNA Mutational Analysis/*methods
MH  - Gene Editing/*methods
MH  - Genome/*genetics
MH  - High-Throughput Nucleotide Sequencing/methods
MH  - Programming Languages
MH  - Sequence Analysis, DNA/*methods
MH  - *Software
EDAT- 2016/07/13 06:00
MHDA- 2018/01/11 06:00
CRDT- 2016/07/13 06:00
PHST- 2016/07/13 06:00 [entrez]
PHST- 2016/07/13 06:00 [pubmed]
PHST- 2018/01/11 06:00 [medline]
AID - nbt.3628 [pii]
AID - 10.1038/nbt.3628 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul 12;34(7):701-2. doi: 10.1038/nbt.3628.

PMID- 27404875
OWN - NLM
STAT- MEDLINE
DCOM- 20180110
LR  - 20180130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul 12
TI  - Data mining differential clinical outcomes associated with drug regimens using
      adverse event reporting data.
PG  - 697-700
LID - 10.1038/nbt.3623 [doi]
FAU - Sarangdhar, Mayur
AU  - Sarangdhar M
AD  - Division of Biomedical Informatics, Cincinnati Children's Hospital Medical
      Center, Cincinnati, Ohio, USA.
FAU - Tabar, Scott
AU  - Tabar S
AD  - Division of Biomedical Informatics, Cincinnati Children's Hospital Medical
      Center, Cincinnati, Ohio, USA.
FAU - Schmidt, Charles
AU  - Schmidt C
AUID- ORCID: 0000-0003-2622-8719
AD  - Division of Biomedical Informatics, Cincinnati Children's Hospital Medical
      Center, Cincinnati, Ohio, USA.
FAU - Kushwaha, Akash
AU  - Kushwaha A
AD  - Division of Biomedical Informatics, Cincinnati Children's Hospital Medical
      Center, Cincinnati, Ohio, USA.
FAU - Shah, Krish
AU  - Shah K
AD  - Division of Biomedical Informatics, Cincinnati Children's Hospital Medical
      Center, Cincinnati, Ohio, USA.
FAU - Dahlquist, Jeanine E
AU  - Dahlquist JE
AD  - Division of Biomedical Informatics, Cincinnati Children's Hospital Medical
      Center, Cincinnati, Ohio, USA.
FAU - Jegga, Anil G
AU  - Jegga AG
AUID- ORCID: 0000-0002-4881-7752
AD  - Division of Biomedical Informatics, Cincinnati Children's Hospital Medical
      Center, Cincinnati, Ohio, USA.
FAU - Aronow, Bruce J
AU  - Aronow BJ
AD  - Division of Biomedical Informatics, Cincinnati Children's Hospital Medical
      Center, Cincinnati, Ohio, USA.
AD  - Clinical and Translational Sciences Program, Cincinnati Children's Hospital
      Medical Center, Cincinnati, Ohio, USA.
LA  - eng
PT  - Letter
PT  - Research Support, N.I.H., Extramural
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Adverse Drug Reaction Reporting Systems/*organization & administration
MH  - Data Mining/*methods
MH  - Database Management Systems/organization & administration
MH  - *Databases, Factual
MH  - Drug-Related Side Effects and Adverse Reactions/*epidemiology
MH  - Electronic Health Records/organization & administration
MH  - Outcome Assessment (Health Care)/*methods
MH  - *Software
MH  - United States
MH  - *United States Food and Drug Administration
MH  - User-Computer Interface
EDAT- 2016/07/13 06:00
MHDA- 2018/01/11 06:00
CRDT- 2016/07/13 06:00
PHST- 2016/07/13 06:00 [entrez]
PHST- 2016/07/13 06:00 [pubmed]
PHST- 2018/01/11 06:00 [medline]
AID - nbt.3623 [pii]
AID - 10.1038/nbt.3623 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul 12;34(7):697-700. doi: 10.1038/nbt.3623.

PMID- 27404874
OWN - NLM
STAT- MEDLINE
DCOM- 20180110
LR  - 20180328
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul 12
TI  - Analyzing CRISPR genome-editing experiments with CRISPResso.
PG  - 695-7
LID - 10.1038/nbt.3583 [doi]
FAU - Pinello, Luca
AU  - Pinello L
AD  - Department of Biostatistics and Computational Biology, Dana-Farber Cancer
      Institute, Boston, Massachusetts, USA.
AD  - Department of Biostatistics, Harvard TH Chan School of Public Health, Boston,
      Massachusetts, USA.
FAU - Canver, Matthew C
AU  - Canver MC
AD  - Division of Hematology/Oncology, Boston Children's Hospital, Boston,
      Massachusetts, USA.
AD  - Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston,
      Massachusetts, USA.
AD  - Department of Pediatrics, Harvard Medical School and Harvard Stem Cell Institute,
      Harvard University, Boston, Massachusetts, USA.
FAU - Hoban, Megan D
AU  - Hoban MD
AUID- ORCID: 0000-0002-5011-9582
AD  - Department of Microbiology, Immunology, and Molecular Genetics, Eli &Edythe Broad
      Center of Regenerative Medicine &Stem Cell Research, University of California,
      Los Angeles, Los Angeles, California, USA.
FAU - Orkin, Stuart H
AU  - Orkin SH
AD  - Division of Hematology/Oncology, Boston Children's Hospital, Boston,
      Massachusetts, USA.
AD  - Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston,
      Massachusetts, USA.
AD  - Department of Pediatrics, Harvard Medical School and Harvard Stem Cell Institute,
      Harvard University, Boston, Massachusetts, USA.
AD  - Howard Hughes Medical Institute, Boston, Massachusetts, USA.
FAU - Kohn, Donald B
AU  - Kohn DB
AD  - Department of Microbiology, Immunology, and Molecular Genetics, Eli &Edythe Broad
      Center of Regenerative Medicine &Stem Cell Research, University of California,
      Los Angeles, Los Angeles, California, USA.
FAU - Bauer, Daniel E
AU  - Bauer DE
AD  - Division of Hematology/Oncology, Boston Children's Hospital, Boston,
      Massachusetts, USA.
AD  - Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston,
      Massachusetts, USA.
AD  - Department of Pediatrics, Harvard Medical School and Harvard Stem Cell Institute,
      Harvard University, Boston, Massachusetts, USA.
FAU - Yuan, Guo-Cheng
AU  - Yuan GC
AUID- ORCID: 0000-0002-2283-4714
AD  - Department of Biostatistics and Computational Biology, Dana-Farber Cancer
      Institute, Boston, Massachusetts, USA.
AD  - Department of Biostatistics, Harvard TH Chan School of Public Health, Boston,
      Massachusetts, USA.
LA  - eng
GR  - R01 HL119099/HL/NHLBI NIH HHS/United States
GR  - T32 HL007574/HL/NHLBI NIH HHS/United States
GR  - K08 DK093705/DK/NIDDK NIH HHS/United States
GR  - R01 HL032259/HL/NHLBI NIH HHS/United States
GR  - P30 DK049216/DK/NIDDK NIH HHS/United States
GR  - K99 HG008399/HG/NHGRI NIH HHS/United States
GR  - P01 HL032262/HL/NHLBI NIH HHS/United States
GR  - R01 HG005085/HG/NHGRI NIH HHS/United States
GR  - F30 DK103359/DK/NIDDK NIH HHS/United States
PT  - Letter
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Algorithms
MH  - Animals
MH  - CRISPR-Cas Systems/*genetics
MH  - Clustered Regularly Interspaced Short Palindromic Repeats/*genetics
MH  - Computer Simulation
MH  - Gene Editing/*methods
MH  - High-Throughput Nucleotide Sequencing/*methods
MH  - Humans
MH  - *Models, Genetic
MH  - Sequence Analysis, DNA/*methods
MH  - *Software
PMC - PMC5242601
MID - NIHMS808747
COIS- The authors declare no conflict of interest.
EDAT- 2016/07/13 06:00
MHDA- 2018/01/11 06:00
CRDT- 2016/07/13 06:00
PHST- 2016/07/13 06:00 [entrez]
PHST- 2016/07/13 06:00 [pubmed]
PHST- 2018/01/11 06:00 [medline]
AID - nbt.3583 [pii]
AID - 10.1038/nbt.3583 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul 12;34(7):695-7. doi: 10.1038/nbt.3583.

PMID- 27404873
OWN - NLM
STAT- MEDLINE
DCOM- 20180110
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul 12
TI  - European incoherence on GMO cultivation versus importation.
PG  - 694-5
LID - 10.1038/nbt.3588 [doi]
FAU - Tagliabue, Giovanni
AU  - Tagliabue G
LA  - eng
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Commerce/*legislation & jurisprudence
MH  - European Union/*organization & administration
MH  - Genetic Engineering/*legislation & jurisprudence
MH  - *Government Regulation
MH  - Organisms, Genetically Modified/*genetics
EDAT- 2016/07/13 06:00
MHDA- 2018/01/11 06:00
CRDT- 2016/07/13 06:00
PHST- 2016/07/13 06:00 [entrez]
PHST- 2016/07/13 06:00 [pubmed]
PHST- 2018/01/11 06:00 [medline]
AID - nbt.3588 [pii]
AID - 10.1038/nbt.3588 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul 12;34(7):694-5. doi: 10.1038/nbt.3588.

PMID- 27404872
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul 12
TI  - How China can enhance adoption of biotech crops.
PG  - 693
LID - 10.1038/nbt.3546 [doi]
FAU - Han, Fei
AU  - Han F
AD  - State Information Center, Beijing, China.
FAU - Shelton, Anthony M
AU  - Shelton AM
AD  - Department of Entomology, Cornell University/New York State Agricultural
      Experiment Station (NYSAES), Geneva, New York, USA.
FAU - Zhou, Dingyang
AU  - Zhou D
AD  - College of Resources Science and Technology, Beijing Normal University, Beijing, 
      China.
LA  - eng
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EDAT- 2016/07/13 06:00
MHDA- 2016/07/13 06:01
CRDT- 2016/07/13 06:00
PHST- 2016/07/13 06:00 [entrez]
PHST- 2016/07/13 06:00 [pubmed]
PHST- 2016/07/13 06:01 [medline]
AID - nbt.3546 [pii]
AID - 10.1038/nbt.3546 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul 12;34(7):693. doi: 10.1038/nbt.3546.

PMID- 27404871
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul 12
TI  - The value of royalty.
PG  - 685-90
LID - 10.1038/nbt.3624 [doi]
FAU - Reslinski, Michael A
AU  - Reslinski MA
AD  - DRI Capital, Toronto, Ontario, Canada.
FAU - Wu, Bernhard S
AU  - Wu BS
AD  - DRI Capital, Toronto, Ontario, Canada.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EDAT- 2016/07/13 06:00
MHDA- 2016/07/13 06:01
CRDT- 2016/07/13 06:00
PHST- 2016/07/13 06:00 [entrez]
PHST- 2016/07/13 06:00 [pubmed]
PHST- 2016/07/13 06:01 [medline]
AID - nbt.3624 [pii]
AID - 10.1038/nbt.3624 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul 12;34(7):685-90. doi: 10.1038/nbt.3624.

PMID- 27404870
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul 12
TI  - Organ delivery by 1,000 drones.
PG  - 684
LID - 10.1038/nbt0716-684a [doi]
FAU - Francisco, Michael
AU  - Francisco M
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EDAT- 2016/07/13 06:00
MHDA- 2016/07/13 06:01
CRDT- 2016/07/13 06:00
PHST- 2016/07/13 06:00 [entrez]
PHST- 2016/07/13 06:00 [pubmed]
PHST- 2016/07/13 06:01 [medline]
AID - nbt0716-684a [pii]
AID - 10.1038/nbt0716-684a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul 12;34(7):684. doi: 10.1038/nbt0716-684a.

PMID- 27404868
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20180110
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul 12
TI  - First EU PRIME designations.
PG  - 683
LID - 10.1038/nbt0716-683b [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/07/13 06:00
MHDA- 2016/07/13 06:01
CRDT- 2016/07/13 06:00
PHST- 2016/07/13 06:00 [entrez]
PHST- 2016/07/13 06:00 [pubmed]
PHST- 2016/07/13 06:01 [medline]
AID - nbt0716-683b [pii]
AID - 10.1038/nbt0716-683b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul 12;34(7):683. doi: 10.1038/nbt0716-683b.

PMID- 27404867
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20180110
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul 12
TI  - Stemcentrx bags $5.8 billion, even as Notch agent underwhelms.
PG  - 683
LID - 10.1038/nbt0716-683a [doi]
FAU - von Schaper, Eva
AU  - von Schaper E
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/07/13 06:00
MHDA- 2016/07/13 06:01
CRDT- 2016/07/13 06:00
PHST- 2016/07/13 06:00 [entrez]
PHST- 2016/07/13 06:00 [pubmed]
PHST- 2016/07/13 06:01 [medline]
AID - nbt0716-683a [pii]
AID - 10.1038/nbt0716-683a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul 12;34(7):683. doi: 10.1038/nbt0716-683a.

PMID- 27404866
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20180110
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul 12
TI  - Biogen's once-monthly MS injection gets FDA nod.
PG  - 681
LID - 10.1038/nbt0716-681b [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/07/13 06:00
MHDA- 2016/07/13 06:01
CRDT- 2016/07/13 06:00
PHST- 2016/07/13 06:00 [entrez]
PHST- 2016/07/13 06:00 [pubmed]
PHST- 2016/07/13 06:01 [medline]
AID - nbt0716-681b [pii]
AID - 10.1038/nbt0716-681b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul 12;34(7):681. doi: 10.1038/nbt0716-681b.

PMID- 27404865
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20180110
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul 12
TI  - FDA wades into sequencing-based diagnostics regulation.
PG  - 681-2
LID - 10.1038/nbt0716-681a [doi]
FAU - Petrone, Justin
AU  - Petrone J
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/07/13 06:00
MHDA- 2016/07/13 06:01
CRDT- 2016/07/13 06:00
PHST- 2016/07/13 06:00 [entrez]
PHST- 2016/07/13 06:00 [pubmed]
PHST- 2016/07/13 06:01 [medline]
AID - nbt0716-681a [pii]
AID - 10.1038/nbt0716-681a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul 12;34(7):681-2. doi: 10.1038/nbt0716-681a.

PMID- 27404864
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20180110
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul 12
TI  - Mayo Clinic to share 1 million.
PG  - 680
LID - 10.1038/nbt0716-680 [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/07/13 06:00
MHDA- 2016/07/13 06:01
CRDT- 2016/07/13 06:00
PHST- 2016/07/13 06:00 [entrez]
PHST- 2016/07/13 06:00 [pubmed]
PHST- 2016/07/13 06:01 [medline]
AID - nbt0716-680 [pii]
AID - 10.1038/nbt0716-680 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul 12;34(7):680. doi: 10.1038/nbt0716-680.

PMID- 27404863
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20180110
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul 12
TI  - Outlook for NGF inhibitor painkiller class brightens.
PG  - 679-80
LID - 10.1038/nbt0716-679 [doi]
FAU - Chi, Kelly Rae
AU  - Chi KR
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/07/13 06:00
MHDA- 2016/07/13 06:01
CRDT- 2016/07/13 06:00
PHST- 2016/07/13 06:00 [entrez]
PHST- 2016/07/13 06:00 [pubmed]
PHST- 2016/07/13 06:01 [medline]
AID - nbt0716-679 [pii]
AID - 10.1038/nbt0716-679 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul 12;34(7):679-80. doi: 10.1038/nbt0716-679.

PMID- 27404862
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20180110
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul 12
TI  - FDA snubs first smart pill.
PG  - 678
LID - 10.1038/nbt0716-678 [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/07/13 06:00
MHDA- 2016/07/13 06:01
CRDT- 2016/07/13 06:00
PHST- 2016/07/13 06:00 [entrez]
PHST- 2016/07/13 06:00 [pubmed]
PHST- 2016/07/13 06:01 [medline]
AID - nbt0716-678 [pii]
AID - 10.1038/nbt0716-678 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul 12;34(7):678. doi: 10.1038/nbt0716-678.

PMID- 27404861
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul 12
TI  - Neural stem cell trailblazer StemCells folds.
PG  - 677-8
LID - 10.1038/nbt0716-677 [doi]
FAU - Smalley, Eric
AU  - Smalley E
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EDAT- 2016/07/13 06:00
MHDA- 2016/07/13 06:01
CRDT- 2016/07/13 06:00
PHST- 2016/07/13 06:00 [entrez]
PHST- 2016/07/13 06:00 [pubmed]
PHST- 2016/07/13 06:01 [medline]
AID - nbt0716-677 [pii]
AID - 10.1038/nbt0716-677 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul 12;34(7):677-8. doi: 10.1038/nbt0716-677.

PMID- 27404860
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20180110
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul 12
TI  - Duchenne muscular dystrophy drugs at the crossroads, as newer agents advance.
PG  - 675-6
LID - 10.1038/nbt0716-675 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/07/13 06:00
MHDA- 2016/07/13 06:01
CRDT- 2016/07/13 06:00
PHST- 2016/07/13 06:00 [entrez]
PHST- 2016/07/13 06:00 [pubmed]
PHST- 2016/07/13 06:01 [medline]
AID - nbt0716-675 [pii]
AID - 10.1038/nbt0716-675 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul 12;34(7):675-6. doi: 10.1038/nbt0716-675.

PMID- 27404859
OWN - NLM
STAT- MEDLINE
DCOM- 20180110
LR  - 20180110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul 12
TI  - Rewriting our future.
PG  - 673
LID - 10.1038/nbt.3640 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Forecasting
MH  - Gene Editing/*trends
MH  - Genes, Synthetic/*genetics
MH  - Genome, Human/*genetics
MH  - Human Genome Project/*organization & administration
MH  - Humans
MH  - Synthetic Biology/*organization & administration
EDAT- 2016/07/13 06:00
MHDA- 2018/01/11 06:00
CRDT- 2016/07/13 06:00
PHST- 2016/07/13 06:00 [entrez]
PHST- 2016/07/13 06:00 [pubmed]
PHST- 2018/01/11 06:00 [medline]
AID - nbt.3640 [pii]
AID - 10.1038/nbt.3640 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul 12;34(7):673. doi: 10.1038/nbt.3640.

PMID- 27347756
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul
TI  - Quantitative comparison of DNA methylation assays for biomarker development and
      clinical applications.
PG  - 726-37
LID - 10.1038/nbt.3605 [doi]
AB  - DNA methylation patterns are altered in numerous diseases and often correlate
      with clinically relevant information such as disease subtypes, prognosis and drug
      response. With suitable assays and after validation in large cohorts, such
      associations can be exploited for clinical diagnostics and personalized treatment
      decisions. Here we describe the results of a community-wide benchmarking study
      comparing the performance of all widely used methods for DNA methylation analysis
      that are compatible with routine clinical use. We shipped 32 reference samples to
      18 laboratories in seven different countries. Researchers in those laboratories
      collectively contributed 21 locus-specific assays for an average of 27 predefined
      genomic regions, as well as six global assays. We evaluated assay sensitivity on 
      low-input samples and assessed the assays' ability to discriminate between cell
      types. Good agreement was observed across all tested methods, with amplicon
      bisulfite sequencing and bisulfite pyrosequencing showing the best all-round
      performance. Our technology comparison can inform the selection, optimization and
      use of DNA methylation assays in large-scale validation studies, biomarker
      development and clinical diagnostics.
CN  - BLUEPRINT consortium
LA  - eng
GR  - 095606/Wellcome Trust/United Kingdom
GR  - MR/J001597/1/Medical Research Council/United Kingdom
GR  - R01 GM097253/GM/NIGMS NIH HHS/United States
PT  - Comparative Study
PT  - Evaluation Studies
PT  - Journal Article
PT  - Multicenter Study
DEP - 20160627
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Genetic Markers)
RN  - 9007-49-2 (DNA)
RN  - EC 2.1.1.- (DNA Modification Methylases)
SB  - IM
MH  - *Algorithms
MH  - DNA/*genetics
MH  - DNA Methylation/*genetics
MH  - DNA Modification Methylases/genetics
MH  - Genetic Markers/*genetics
MH  - High-Throughput Nucleotide Sequencing/*methods
MH  - High-Throughput Screening Assays/*methods
MH  - Promoter Regions, Genetic/genetics
MH  - Reproducibility of Results
MH  - Sensitivity and Specificity
IR  - Bock C
FIR - Bock, Christoph
IR  - Halbritter F
FIR - Halbritter, Florian
IR  - Carmona FJ
FIR - Carmona, Francisco J
IR  - Tierling S
FIR - Tierling, Sascha
IR  - Datlinger P
FIR - Datlinger, Paul
IR  - Assenov Y
FIR - Assenov, Yassen
IR  - Berdasco M
FIR - Berdasco, Maria
IR  - Bergmann AK
FIR - Bergmann, Anke K
IR  - Booher K
FIR - Booher, Keith
IR  - Busato F
FIR - Busato, Florence
IR  - Campan M
FIR - Campan, Mihaela
IR  - Dahl C
FIR - Dahl, Christina
IR  - Dahmcke CM
FIR - Dahmcke, Christina M
IR  - Diep D
FIR - Diep, Dinh
IR  - Fernandez AF
FIR - Fernandez, Agustin F
IR  - Gerhauser C
FIR - Gerhauser, Clarissa
IR  - Haake A
FIR - Haake, Andrea
IR  - Heilmann K
FIR - Heilmann, Katharina
IR  - Holcomb T
FIR - Holcomb, Thomas
IR  - Hussmann D
FIR - Hussmann, Dianna
IR  - Ito M
FIR - Ito, Mitsuteru
IR  - Klaver R
FIR - Klaver, Ruth
IR  - Kreutz M
FIR - Kreutz, Martin
IR  - Kulis M
FIR - Kulis, Marta
IR  - Lopez V
FIR - Lopez, Virginia
IR  - Nair SS
FIR - Nair, Shalima S
IR  - Paul DS
FIR - Paul, Dirk S
IR  - Plongthongkum N
FIR - Plongthongkum, Nongluk
IR  - Qu W
FIR - Qu, Wenjia
IR  - Queiros AC
FIR - Queiros, Ana C
IR  - Reinicke F
FIR - Reinicke, Frank
IR  - Sauter G
FIR - Sauter, Guido
IR  - Schlomm T
FIR - Schlomm, Thorsten
IR  - Statham A
FIR - Statham, Aaron
IR  - Stirzaker C
FIR - Stirzaker, Clare
IR  - Strogantsev R
FIR - Strogantsev, Ruslan
IR  - Urdinguio RG
FIR - Urdinguio, Rocio G
IR  - Walter K
FIR - Walter, Kimberly
IR  - Weichenhan D
FIR - Weichenhan, Dieter
IR  - Weisenberger DJ
FIR - Weisenberger, Daniel J
IR  - Beck S
FIR - Beck, Stephan
IR  - Clark SJ
FIR - Clark, Susan J
IR  - Esteller M
FIR - Esteller, Manel
IR  - Ferguson-Smith AC
FIR - Ferguson-Smith, Anne C
IR  - Fraga MF
FIR - Fraga, Mario F
IR  - Guldberg P
FIR - Guldberg, Per
IR  - Hansen LL
FIR - Hansen, Lise Lotte
IR  - Laird PW
FIR - Laird, Peter W
IR  - Martin-Subero JI
FIR - Martin-Subero, Jose I
IR  - Nygren AO
FIR - Nygren, Anders O H
IR  - Peist R
FIR - Peist, Ralf
IR  - Plass C
FIR - Plass, Christoph
IR  - Shames DS
FIR - Shames, David S
IR  - Siebert R
FIR - Siebert, Reiner
IR  - Sun X
FIR - Sun, Xueguang
IR  - Tost J
FIR - Tost, Jorg
IR  - Walter J
FIR - Walter, Jorn
IR  - Zhang K
FIR - Zhang, Kun
EDAT- 2016/06/28 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/06/28 06:00
PHST- 2015/06/14 00:00 [received]
PHST- 2016/05/10 00:00 [accepted]
PHST- 2016/06/28 06:00 [entrez]
PHST- 2016/06/28 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3605 [pii]
AID - 10.1038/nbt.3605 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul;34(7):726-37. doi: 10.1038/nbt.3605. Epub 2016 Jun 27.

PMID- 27272386
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul
TI  - Non-genotoxic conditioning for hematopoietic stem cell transplantation using a
      hematopoietic-cell-specific internalizing immunotoxin.
PG  - 738-45
LID - 10.1038/nbt.3584 [doi]
AB  - Hematopoietic stem cell transplantation (HSCT) offers curative therapy for
      patients with hemoglobinopathies, congenital immunodeficiencies, and other
      conditions, possibly including AIDS. Autologous HSCT using genetically corrected 
      cells would avoid the risk of graft-versus-host disease (GVHD), but the
      genotoxicity of conditioning remains a substantial barrier to the development of 
      this approach. Here we report an internalizing immunotoxin targeting the
      hematopoietic-cell-restricted CD45 receptor that effectively conditions
      immunocompetent mice. A single dose of the immunotoxin, CD45-saporin (SAP),
      enabled efficient (>90%) engraftment of donor cells and full correction of a
      sickle-cell anemia model. In contrast to irradiation, CD45-SAP completely avoided
      neutropenia and anemia, spared bone marrow and thymic niches, enabling rapid
      recovery of T and B cells, preserved anti-fungal immunity, and had minimal
      overall toxicity. This non-genotoxic conditioning method may provide an
      attractive alternative to current conditioning regimens for HSCT in the treatment
      of non-malignant blood diseases.
FAU - Palchaudhuri, Rahul
AU  - Palchaudhuri R
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, 
      Massachusetts, USA.
AD  - Center for Regenerative Medicine, Massachusetts General Hospital, Boston,
      Massachusetts, USA.
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
AD  - Department of Chemistry and Chemical Biology, Harvard University, Cambridge,
      Massachusetts, USA.
FAU - Saez, Borja
AU  - Saez B
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, 
      Massachusetts, USA.
AD  - Center for Regenerative Medicine, Massachusetts General Hospital, Boston,
      Massachusetts, USA.
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
FAU - Hoggatt, Jonathan
AU  - Hoggatt J
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, 
      Massachusetts, USA.
AD  - Center for Regenerative Medicine, Massachusetts General Hospital, Boston,
      Massachusetts, USA.
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
FAU - Schajnovitz, Amir
AU  - Schajnovitz A
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, 
      Massachusetts, USA.
AD  - Center for Regenerative Medicine, Massachusetts General Hospital, Boston,
      Massachusetts, USA.
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
FAU - Sykes, David B
AU  - Sykes DB
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, 
      Massachusetts, USA.
AD  - Center for Regenerative Medicine, Massachusetts General Hospital, Boston,
      Massachusetts, USA.
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
FAU - Tate, Tiffany A
AU  - Tate TA
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, 
      Massachusetts, USA.
AD  - Center for Regenerative Medicine, Massachusetts General Hospital, Boston,
      Massachusetts, USA.
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
FAU - Czechowicz, Agnieszka
AU  - Czechowicz A
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, 
      Massachusetts, USA.
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
AD  - Program in Cellular and Molecular Medicine, Division of Hematology/Oncology,
      Boston Children's Hospital, Boston, Massachusetts, USA.
AD  - Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
AD  - Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston,
      Massachusetts, USA.
FAU - Kfoury, Youmna
AU  - Kfoury Y
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, 
      Massachusetts, USA.
AD  - Center for Regenerative Medicine, Massachusetts General Hospital, Boston,
      Massachusetts, USA.
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
FAU - Ruchika, Fnu
AU  - Ruchika F
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, 
      Massachusetts, USA.
AD  - Center for Regenerative Medicine, Massachusetts General Hospital, Boston,
      Massachusetts, USA.
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
FAU - Rossi, Derrick J
AU  - Rossi DJ
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, 
      Massachusetts, USA.
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
AD  - Program in Cellular and Molecular Medicine, Division of Hematology/Oncology,
      Boston Children's Hospital, Boston, Massachusetts, USA.
AD  - Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Verdine, Gregory L
AU  - Verdine GL
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, 
      Massachusetts, USA.
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
AD  - Department of Chemistry and Chemical Biology, Harvard University, Cambridge,
      Massachusetts, USA.
FAU - Mansour, Michael K
AU  - Mansour MK
AD  - Division of Infectious Diseases, Massachusetts General Hospital, Boston,
      Massachusetts, USA.
FAU - Scadden, David T
AU  - Scadden DT
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, 
      Massachusetts, USA.
AD  - Center for Regenerative Medicine, Massachusetts General Hospital, Boston,
      Massachusetts, USA.
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
LA  - eng
GR  - T32 HL007574/HL/NHLBI NIH HHS/United States
GR  - R01 HL044851/HL/NHLBI NIH HHS/United States
GR  - R01 HL107630/HL/NHLBI NIH HHS/United States
GR  - K08 AI110655/AI/NIAID NIH HHS/United States
GR  - K99 HL119559/HL/NHLBI NIH HHS/United States
GR  - U19 HL129903/HL/NHLBI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20160606
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antibodies, Monoclonal)
RN  - 0 (Immunotoxins)
RN  - 0 (Ribosome Inactivating Proteins, Type 1)
RN  - EC 3.1.3.48 (Leukocyte Common Antigens)
RN  - EC 3.1.3.48 (Ptprc protein, mouse)
RN  - EC 3.2.2.22 (saporin)
SB  - IM
CIN - Nat Biotechnol. 2016 Jul 12;34(7):721-3. PMID: 27404882
MH  - Animals
MH  - Antibodies, Monoclonal/genetics/immunology
MH  - Cell Differentiation/genetics/immunology
MH  - Cell Survival/genetics/immunology
MH  - Cells, Cultured
MH  - DNA Damage/genetics/*immunology
MH  - Female
MH  - Genetic Enhancement/methods
MH  - Hematopoietic Stem Cell Transplantation/*methods
MH  - Hematopoietic Stem Cells/*immunology
MH  - Immunogenetic Phenomena/genetics
MH  - Immunotoxins
MH  - Leukocyte Common Antigens/*immunology
MH  - Mice
MH  - Mice, Inbred C57BL
MH  - Ribosome Inactivating Proteins, Type 1/*genetics/*immunology
PMC - PMC5179034
MID - NIHMS821329
COIS- The authors declare competing financial interests: details are available in the
      online version of the paper.
EDAT- 2016/06/09 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/06/09 06:00
PHST- 2016/02/16 00:00 [received]
PHST- 2016/04/27 00:00 [accepted]
PHST- 2016/06/09 06:00 [entrez]
PHST- 2016/06/09 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3584 [pii]
AID - 10.1038/nbt.3584 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul;34(7):738-45. doi: 10.1038/nbt.3584. Epub 2016 Jun 6.

PMID- 27272383
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul
TI  - Regulating the expression of therapeutic transgenes by controlled intake of
      dietary essential amino acids.
PG  - 746-51
LID - 10.1038/nbt.3582 [doi]
AB  - Widespread application of gene therapy will depend on the development of simple
      methods to regulate the expression of therapeutic genes. Here we harness an
      endogenous signaling pathway to regulate therapeutic gene expression through
      diet. The GCN2-eIF2alpha signaling pathway is specifically activated by
      deficiencies in any essential amino acid (EAA); EAA deficiency leads to rapid
      expression of genes regulated by ATF4-binding cis elements. We found that
      therapeutic genes under the control of optimized amino acid response elements
      (AAREs) had low basal expression and high induced expression. We applied our
      system to regulate the expression of TNFSF10 (TRAIL) in the context of glioma
      therapy and found that intermittent activation of this gene by EEA-deficient
      meals retained its therapeutic efficacy while abrogating its toxic effects on
      normal tissue. The GCN2-eIF2alpha pathway is expressed in many tissues, including
      the brain, and is highly specific to EAA deficiency. Our system may be
      particularly well suited for intermittent regulation of therapeutic transgenes
      over short or long time periods.
FAU - Chaveroux, Cedric
AU  - Chaveroux C
AD  - Institut National de la Recherche Agronomique (INRA), UMR-1019 Nutrition Humaine,
      Genes-Nutrients team, Centre de Clermont-Theix, Universite Clermont-Ferrand 1,
      63122 Saint Genes Champanelle, France.
FAU - Bruhat, Alain
AU  - Bruhat A
AD  - Institut National de la Recherche Agronomique (INRA), UMR-1019 Nutrition Humaine,
      Genes-Nutrients team, Centre de Clermont-Theix, Universite Clermont-Ferrand 1,
      63122 Saint Genes Champanelle, France.
FAU - Carraro, Valerie
AU  - Carraro V
AD  - Institut National de la Recherche Agronomique (INRA), UMR-1019 Nutrition Humaine,
      Genes-Nutrients team, Centre de Clermont-Theix, Universite Clermont-Ferrand 1,
      63122 Saint Genes Champanelle, France.
FAU - Jousse, Celine
AU  - Jousse C
AD  - Institut National de la Recherche Agronomique (INRA), UMR-1019 Nutrition Humaine,
      Genes-Nutrients team, Centre de Clermont-Theix, Universite Clermont-Ferrand 1,
      63122 Saint Genes Champanelle, France.
FAU - Averous, Julien
AU  - Averous J
AD  - Institut National de la Recherche Agronomique (INRA), UMR-1019 Nutrition Humaine,
      Genes-Nutrients team, Centre de Clermont-Theix, Universite Clermont-Ferrand 1,
      63122 Saint Genes Champanelle, France.
FAU - Maurin, Anne-Catherine
AU  - Maurin AC
AD  - Institut National de la Recherche Agronomique (INRA), UMR-1019 Nutrition Humaine,
      Genes-Nutrients team, Centre de Clermont-Theix, Universite Clermont-Ferrand 1,
      63122 Saint Genes Champanelle, France.
FAU - Parry, Laurent
AU  - Parry L
AD  - Institut National de la Recherche Agronomique (INRA), UMR-1019 Nutrition Humaine,
      Genes-Nutrients team, Centre de Clermont-Theix, Universite Clermont-Ferrand 1,
      63122 Saint Genes Champanelle, France.
FAU - Mesclon, Florent
AU  - Mesclon F
AD  - Institut National de la Recherche Agronomique (INRA), UMR-1019 Nutrition Humaine,
      Genes-Nutrients team, Centre de Clermont-Theix, Universite Clermont-Ferrand 1,
      63122 Saint Genes Champanelle, France.
FAU - Muranishi, Yuki
AU  - Muranishi Y
AD  - Institut National de la Recherche Agronomique (INRA), UMR-1019 Nutrition Humaine,
      Genes-Nutrients team, Centre de Clermont-Theix, Universite Clermont-Ferrand 1,
      63122 Saint Genes Champanelle, France.
FAU - Cordelier, Pierre
AU  - Cordelier P
AD  - CRCT, Universite de Toulouse, Inserm, UPS, Toulouse, France.
FAU - Meulle, Aline
AU  - Meulle A
AD  - CRCT, Universite de Toulouse, Inserm, UPS, Toulouse, France.
FAU - Baril, Patrick
AU  - Baril P
AD  - Centre de Biophysique Moleculaire, Centre National de la Recherche Scientifique
      (CNRS) UPR4301, Universite d'Orleans and Institut National de la Sante Et de la
      Recherche Medicale (INSERM), Orleans, France.
FAU - Do Thi, Anh
AU  - Do Thi A
AD  - CNRS UMR7225, INSERM U1127, Universite Pierre et Marie Curie, Institut du Cerveau
      et de la Moelle (ICM), Biotechnology and Biotherapy Team, Paris, France.
FAU - Ravassard, Philippe
AU  - Ravassard P
AUID- ORCID: 0000-0002-0393-9262
AD  - CNRS UMR7225, INSERM U1127, Universite Pierre et Marie Curie, Institut du Cerveau
      et de la Moelle (ICM), Biotechnology and Biotherapy Team, Paris, France.
FAU - Mallet, Jacques
AU  - Mallet J
AD  - CNRS UMR7225, INSERM U1127, Universite Pierre et Marie Curie, Institut du Cerveau
      et de la Moelle (ICM), Biotechnology and Biotherapy Team, Paris, France.
AD  - Department of Neurological Surgery, University of California San Francisco, San
      Francisco, California, USA.
FAU - Fafournoux, Pierre
AU  - Fafournoux P
AD  - Institut National de la Recherche Agronomique (INRA), UMR-1019 Nutrition Humaine,
      Genes-Nutrients team, Centre de Clermont-Theix, Universite Clermont-Ferrand 1,
      63122 Saint Genes Champanelle, France.
AD  - Centre de Biophysique Moleculaire, Centre National de la Recherche Scientifique
      (CNRS) UPR4301, Universite d'Orleans and Institut National de la Sante Et de la
      Recherche Medicale (INSERM), Orleans, France.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20160606
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Amino Acids, Essential)
RN  - 0 (TNF-Related Apoptosis-Inducing Ligand)
RN  - 0 (Tnfsf10 protein, mouse)
SB  - IM
CIN - Nat Biotechnol. 2016 Aug 9;34(8):824-5. PMID: 27504775
MH  - Administration, Oral
MH  - Amino Acids, Essential/*administration & dosage/pharmacokinetics
MH  - Animals
MH  - Brain Neoplasms/*genetics/*therapy
MH  - Dietary Supplements
MH  - Dose-Response Relationship, Drug
MH  - Eating/genetics
MH  - Gene Expression Regulation/drug effects/genetics
MH  - Genetic Therapy/*methods
MH  - Male
MH  - Mice
MH  - TNF-Related Apoptosis-Inducing Ligand/*genetics/*therapeutic use
MH  - Transgenes/genetics
MH  - Treatment Outcome
EDAT- 2016/06/09 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/06/09 06:00
PHST- 2015/06/22 00:00 [received]
PHST- 2016/04/20 00:00 [accepted]
PHST- 2016/06/09 06:00 [entrez]
PHST- 2016/06/09 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3582 [pii]
AID - 10.1038/nbt.3582 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul;34(7):746-51. doi: 10.1038/nbt.3582. Epub 2016 Jun 6.

PMID- 27240197
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul
TI  - An artificial niche preserves the quiescence of muscle stem cells and enhances
      their therapeutic efficacy.
PG  - 752-9
LID - 10.1038/nbt.3576 [doi]
AB  - A promising therapeutic strategy for diverse genetic disorders involves
      transplantation of autologous stem cells that have been genetically corrected ex 
      vivo. A major challenge in such approaches is a loss of stem cell potency during 
      culture. Here we describe an artificial niche for maintaining muscle stem cells
      (MuSCs) in vitro in a potent, quiescent state. Using a machine learning method,
      we identified a molecular signature of quiescence and used it to screen for
      factors that could maintain mouse MuSC quiescence, thus defining a quiescence
      medium (QM). We also engineered muscle fibers that mimic the native myofiber of
      the MuSC niche. Mouse MuSCs maintained in QM on engineered fibers showed enhanced
      potential for engraftment, tissue regeneration and self-renewal after
      transplantation in mice. An artificial niche adapted to human cells similarly
      extended the quiescence of human MuSCs in vitro and enhanced their potency in
      vivo. Our approach for maintaining quiescence may be applicable to stem cells
      isolated from other tissues.
FAU - Quarta, Marco
AU  - Quarta M
AD  - Department of Neurology and Neurological Sciences, Stanford University School of 
      Medicine, Stanford, California, USA.
AD  - Paul F. Glenn Center for the Biology of Aging, Stanford University School of
      Medicine, Stanford, California, USA.
AD  - Center for Tissue Regeneration, Repair and Restoration, Veterans Affairs Palo
      Alto Health Care System, Palo Alto, California, USA.
FAU - Brett, Jamie O
AU  - Brett JO
AD  - Department of Neurology and Neurological Sciences, Stanford University School of 
      Medicine, Stanford, California, USA.
AD  - Paul F. Glenn Center for the Biology of Aging, Stanford University School of
      Medicine, Stanford, California, USA.
AD  - Institute for Stem Cell Biology and Regenerative Medicine, Stanford University
      School of Medicine, Stanford, California, USA.
FAU - DiMarco, Rebecca
AU  - DiMarco R
AD  - Department of Bioengineering, Stanford University, Stanford, California, USA.
FAU - De Morree, Antoine
AU  - De Morree A
AD  - Department of Neurology and Neurological Sciences, Stanford University School of 
      Medicine, Stanford, California, USA.
AD  - Paul F. Glenn Center for the Biology of Aging, Stanford University School of
      Medicine, Stanford, California, USA.
FAU - Boutet, Stephane C
AU  - Boutet SC
AD  - Department of Neurology and Neurological Sciences, Stanford University School of 
      Medicine, Stanford, California, USA.
AD  - Paul F. Glenn Center for the Biology of Aging, Stanford University School of
      Medicine, Stanford, California, USA.
FAU - Chacon, Robert
AU  - Chacon R
AD  - Department of Neurology and Neurological Sciences, Stanford University School of 
      Medicine, Stanford, California, USA.
AD  - Paul F. Glenn Center for the Biology of Aging, Stanford University School of
      Medicine, Stanford, California, USA.
AD  - Center for Tissue Regeneration, Repair and Restoration, Veterans Affairs Palo
      Alto Health Care System, Palo Alto, California, USA.
FAU - Gibbons, Michael C
AU  - Gibbons MC
AUID- ORCID: 0000-0002-3039-9839
AD  - Department of Neurology and Neurological Sciences, Stanford University School of 
      Medicine, Stanford, California, USA.
AD  - Paul F. Glenn Center for the Biology of Aging, Stanford University School of
      Medicine, Stanford, California, USA.
AD  - Center for Tissue Regeneration, Repair and Restoration, Veterans Affairs Palo
      Alto Health Care System, Palo Alto, California, USA.
FAU - Garcia, Victor A
AU  - Garcia VA
AD  - Department of Neurology and Neurological Sciences, Stanford University School of 
      Medicine, Stanford, California, USA.
AD  - Paul F. Glenn Center for the Biology of Aging, Stanford University School of
      Medicine, Stanford, California, USA.
AD  - Center for Tissue Regeneration, Repair and Restoration, Veterans Affairs Palo
      Alto Health Care System, Palo Alto, California, USA.
FAU - Su, James
AU  - Su J
AD  - Department of Materials Science and Engineering, Stanford University, Stanford,
      California, USA.
FAU - Shrager, Joseph B
AU  - Shrager JB
AD  - Division of Thoracic Surgery, Department of Cardiothoracic Surgery, Stanford
      University School of Medicine, Stanford, California, USA.
FAU - Heilshorn, Sarah
AU  - Heilshorn S
AD  - Department of Materials Science and Engineering, Stanford University, Stanford,
      California, USA.
FAU - Rando, Thomas A
AU  - Rando TA
AD  - Department of Neurology and Neurological Sciences, Stanford University School of 
      Medicine, Stanford, California, USA.
AD  - Paul F. Glenn Center for the Biology of Aging, Stanford University School of
      Medicine, Stanford, California, USA.
AD  - Center for Tissue Regeneration, Repair and Restoration, Veterans Affairs Palo
      Alto Health Care System, Palo Alto, California, USA.
LA  - eng
GR  - R01 AG047820/AG/NIA NIH HHS/United States
GR  - P01 AG036695/AG/NIA NIH HHS/United States
GR  - R01 AR062185/AR/NIAMS NIH HHS/United States
GR  - R37 AG023806/AG/NIA NIH HHS/United States
GR  - I21 RX002234/RX/RRD VA/United States
GR  - I01 RX001222/RX/RRD VA/United States
GR  - I01 BX002324/BX/BLRD VA/United States
GR  - P41 EB001046/EB/NIBIB NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20160530
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Muscle Proteins)
SB  - IM
MH  - Animals
MH  - Batch Cell Culture Techniques/*methods
MH  - Cells, Cultured
MH  - Mice
MH  - Mice, Inbred C57BL
MH  - Muscle Proteins/*metabolism
MH  - Myoblasts, Skeletal/cytology/*physiology/*transplantation
MH  - Stem Cell Niche/*physiology
MH  - Stem Cell Transplantation/methods
MH  - Tissue Preservation/*methods
MH  - Treatment Outcome
PMC - PMC4942359
MID - NIHMS779389
EDAT- 2016/05/31 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/05/31 06:00
PHST- 2016/01/18 00:00 [received]
PHST- 2016/04/15 00:00 [accepted]
PHST- 2016/05/31 06:00 [entrez]
PHST- 2016/05/31 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3576 [pii]
AID - 10.1038/nbt.3576 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul;34(7):752-9. doi: 10.1038/nbt.3576. Epub 2016 May 30.

PMID- 27240196
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul
TI  - A bright cyan-excitable orange fluorescent protein facilitates dual-emission
      microscopy and enhances bioluminescence imaging in vivo.
PG  - 760-7
LID - 10.1038/nbt.3550 [doi]
AB  - Orange-red fluorescent proteins (FPs) are widely used in biomedical research for 
      multiplexed epifluorescence microscopy with GFP-based probes, but their different
      excitation requirements make multiplexing with new advanced microscopy methods
      difficult. Separately, orange-red FPs are useful for deep-tissue imaging in
      mammals owing to the relative tissue transmissibility of orange-red light, but
      their dependence on illumination limits their sensitivity as reporters in deep
      tissues. Here we describe CyOFP1, a bright, engineered, orange-red FP that is
      excitable by cyan light. We show that CyOFP1 enables single-excitation
      multiplexed imaging with GFP-based probes in single-photon and two-photon
      microscopy, including time-lapse imaging in light-sheet systems. CyOFP1 also
      serves as an efficient acceptor for resonance energy transfer from the highly
      catalytic blue-emitting luciferase NanoLuc. An optimized fusion of CyOFP1 and
      NanoLuc, called Antares, functions as a highly sensitive bioluminescent reporter 
      in vivo, producing substantially brighter signals from deep tissues than firefly 
      luciferase and other bioluminescent proteins.
FAU - Chu, Jun
AU  - Chu J
AD  - Department of Bioengineering, Stanford University, Stanford, California, USA.
AD  - Department of Pediatrics, Stanford University, Stanford, California, USA.
FAU - Oh, Younghee
AU  - Oh Y
AD  - Department of Bioengineering, Stanford University, Stanford, California, USA.
AD  - Department of Pediatrics, Stanford University, Stanford, California, USA.
AD  - Department of Neurobiology, Stanford University, Stanford, California, USA.
FAU - Sens, Alex
AU  - Sens A
AD  - Department of Chemistry, University of Hawaii at Manoa, Honolulu, Hawaii, USA.
FAU - Ataie, Niloufar
AU  - Ataie N
AD  - Department of Chemistry, University of Hawaii at Manoa, Honolulu, Hawaii, USA.
FAU - Dana, Hod
AU  - Dana H
AD  - Howard Hughes Medical Institute, Janelia Research Campus, Ashburn, Virginia, USA.
FAU - Macklin, John J
AU  - Macklin JJ
AD  - Howard Hughes Medical Institute, Janelia Research Campus, Ashburn, Virginia, USA.
FAU - Laviv, Tal
AU  - Laviv T
AD  - Max Planck Florida Institute, Jupiter, Florida, USA.
FAU - Welf, Erik S
AU  - Welf ES
AD  - Department of Cell Biology, University of Texas Southwestern Medical Center,
      Dallas, Texas, USA.
FAU - Dean, Kevin M
AU  - Dean KM
AD  - Department of Cell Biology, University of Texas Southwestern Medical Center,
      Dallas, Texas, USA.
FAU - Zhang, Feijie
AU  - Zhang F
AD  - Department of Pediatrics, Stanford University, Stanford, California, USA.
AD  - Department of Genetics, Stanford University, Stanford, California, USA.
FAU - Kim, Benjamin B
AU  - Kim BB
AD  - Department of Bioengineering, Stanford University, Stanford, California, USA.
FAU - Tang, Clement Tran
AU  - Tang CT
AD  - Department of Chemistry, University of Hawaii at Manoa, Honolulu, Hawaii, USA.
FAU - Hu, Michelle
AU  - Hu M
AD  - Department of Chemistry, University of Hawaii at Manoa, Honolulu, Hawaii, USA.
FAU - Baird, Michelle A
AU  - Baird MA
AD  - Department of Biological Science, Florida State University, Tallahassee, Florida,
      USA.
AD  - National High Magnetic Field Laboratory, Florida State University, Tallahassee,
      Florida, USA.
FAU - Davidson, Michael W
AU  - Davidson MW
AD  - Department of Biological Science, Florida State University, Tallahassee, Florida,
      USA.
AD  - National High Magnetic Field Laboratory, Florida State University, Tallahassee,
      Florida, USA.
FAU - Kay, Mark A
AU  - Kay MA
AD  - Department of Pediatrics, Stanford University, Stanford, California, USA.
AD  - Department of Genetics, Stanford University, Stanford, California, USA.
FAU - Fiolka, Reto
AU  - Fiolka R
AD  - Department of Cell Biology, University of Texas Southwestern Medical Center,
      Dallas, Texas, USA.
FAU - Yasuda, Ryohei
AU  - Yasuda R
AD  - Max Planck Florida Institute, Jupiter, Florida, USA.
FAU - Kim, Douglas S
AU  - Kim DS
AD  - Howard Hughes Medical Institute, Janelia Research Campus, Ashburn, Virginia, USA.
FAU - Ng, Ho-Leung
AU  - Ng HL
AUID- ORCID: 0000-0002-6415-1938
AD  - Department of Chemistry, University of Hawaii at Manoa, Honolulu, Hawaii, USA.
AD  - University of Hawaii Cancer Center, Honolulu, Hawaii, USA.
FAU - Lin, Michael Z
AU  - Lin MZ
AD  - Department of Bioengineering, Stanford University, Stanford, California, USA.
AD  - Department of Pediatrics, Stanford University, Stanford, California, USA.
AD  - Department of Neurobiology, Stanford University, Stanford, California, USA.
LA  - eng
GR  - F32 GM117793/GM/NIGMS NIH HHS/United States
GR  - P50 GM107615/GM/NIGMS NIH HHS/United States
GR  - R01 HL064274/HL/NHLBI NIH HHS/United States
GR  - U01 NS090600/NS/NINDS NIH HHS/United States
GR  - R01 GM105404/GM/NIGMS NIH HHS/United States
GR  - R01 MH080047/MH/NIMH NIH HHS/United States
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PT  - Research Support, N.I.H., Extramural
DEP - 20160530
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Fluorescent Dyes)
RN  - 0 (Luminescent Proteins)
SB  - IM
MH  - Fluorescent Dyes/chemical synthesis/pharmacokinetics
MH  - Lighting/methods
MH  - Luminescent Measurements/*methods
MH  - Luminescent Proteins/*chemical synthesis/*pharmacokinetics
MH  - Microscopy, Fluorescence, Multiphoton/*methods
MH  - Molecular Imaging/*methods
MH  - Staining and Labeling
PMC - PMC4942401
MID - NIHMS772085
EDAT- 2016/05/31 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/05/31 06:00
PHST- 2015/12/25 00:00 [received]
PHST- 2016/03/22 00:00 [accepted]
PHST- 2016/05/31 06:00 [entrez]
PHST- 2016/05/31 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3550 [pii]
AID - 10.1038/nbt.3550 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul;34(7):760-7. doi: 10.1038/nbt.3550. Epub 2016 May 30.

PMID- 27240195
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul
TI  - A split horseradish peroxidase for the detection of intercellular protein-protein
      interactions and sensitive visualization of synapses.
PG  - 774-80
LID - 10.1038/nbt.3563 [doi]
AB  - Intercellular protein-protein interactions (PPIs) enable communication between
      cells in diverse biological processes, including cell proliferation, immune
      responses, infection, and synaptic transmission, but they are challenging to
      visualize because existing techniques have insufficient sensitivity and/or
      specificity. Here we report a split horseradish peroxidase (sHRP) as a sensitive 
      and specific tool for the detection of intercellular PPIs. The two sHRP
      fragments, engineered through screening of 17 cut sites in HRP followed by
      directed evolution, reconstitute into an active form when driven together by an
      intercellular PPI, producing bright fluorescence or contrast for electron
      microscopy. Fusing the sHRP fragments to the proteins neurexin (NRX) and
      neuroligin (NLG), which bind each other across the synaptic cleft, enabled
      sensitive visualization of synapses between specific sets of neurons, including
      two classes of synapses in the mouse visual system. sHRP should be widely
      applicable to studying mechanisms of communication between a variety of cell
      types.
FAU - Martell, Jeffrey D
AU  - Martell JD
AD  - Department of Chemistry, Massachusetts Institute of Technology, Cambridge,
      Massachusetts, USA.
FAU - Yamagata, Masahito
AU  - Yamagata M
AUID- ORCID: 0000-0001-8193-2931
AD  - Department of Molecular and Cellular Biology, Center for Brain Science, Harvard
      University, Cambridge, Massachusetts, USA.
FAU - Deerinck, Thomas J
AU  - Deerinck TJ
AD  - National Center for Microscopy and Imaging Research, Center for Research on
      Biological Systems, University of California at San Diego, La Jolla, San Diego,
      California, USA.
FAU - Phan, Sebastien
AU  - Phan S
AD  - National Center for Microscopy and Imaging Research, Center for Research on
      Biological Systems, University of California at San Diego, La Jolla, San Diego,
      California, USA.
FAU - Kwa, Carolyn G
AU  - Kwa CG
AD  - Department of Chemistry, Massachusetts Institute of Technology, Cambridge,
      Massachusetts, USA.
FAU - Ellisman, Mark H
AU  - Ellisman MH
AD  - National Center for Microscopy and Imaging Research, Center for Research on
      Biological Systems, University of California at San Diego, La Jolla, San Diego,
      California, USA.
AD  - Department of Neurosciences, University of California at San Diego, La Jolla, San
      Diego, California, USA.
AD  - Salk Institute for Biological Studies, La Jolla, San Diego, California, USA.
FAU - Sanes, Joshua R
AU  - Sanes JR
AD  - Department of Molecular and Cellular Biology, Center for Brain Science, Harvard
      University, Cambridge, Massachusetts, USA.
FAU - Ting, Alice Y
AU  - Ting AY
AD  - Department of Chemistry, Massachusetts Institute of Technology, Cambridge,
      Massachusetts, USA.
LA  - eng
GR  - P41 GM103412/GM/NIGMS NIH HHS/United States
GR  - R01 CA186568/CA/NCI NIH HHS/United States
GR  - R01 GM086197/GM/NIGMS NIH HHS/United States
GR  - HHMI/Howard Hughes Medical Institute/United States
GR  - R37 NS029169/NS/NINDS NIH HHS/United States
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, N.I.H., Extramural
DEP - 20160530
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Nerve Tissue Proteins)
RN  - EC 1.11.1.- (Horseradish Peroxidase)
SB  - IM
MH  - Animals
MH  - Horseradish Peroxidase/chemistry/genetics/*pharmacokinetics
MH  - Mice
MH  - Microscopy, Electron/*methods
MH  - Microscopy, Fluorescence/*methods
MH  - Nerve Tissue Proteins/metabolism
MH  - Protein Engineering/methods
MH  - Protein Interaction Mapping/*methods
MH  - Synapses/*metabolism/*ultrastructure
PMC - PMC4942342
MID - NIHMS776542
EDAT- 2016/05/31 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/05/31 06:00
PHST- 2015/10/21 00:00 [received]
PHST- 2016/04/07 00:00 [accepted]
PHST- 2016/05/31 06:00 [entrez]
PHST- 2016/05/31 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3563 [pii]
AID - 10.1038/nbt.3563 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul;34(7):774-80. doi: 10.1038/nbt.3563. Epub 2016 May 30.

PMID- 27136078
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 7
DP  - 2016 Jul
TI  - DNA-guided genome editing using the Natronobacterium gregoryi Argonaute.
PG  - 768-73
LID - 10.1038/nbt.3547 [doi]
AB  - The RNA-guided endonuclease Cas9 has made genome editing a widely accessible
      technique. Similar to Cas9, endonucleases from the Argonaute protein family also 
      use oligonucleotides as guides to degrade invasive genomes. Here we report that
      the Natronobacterium gregoryi Argonaute (NgAgo) is a DNA-guided endonuclease
      suitable for genome editing in human cells. NgAgo binds 5' phosphorylated
      single-stranded guide DNA (gDNA) of approximately 24 nucleotides, efficiently
      creates site-specific DNA double-strand breaks when loaded with the gDNA. The
      NgAgo-gDNA system does not require a protospacer-adjacent motif (PAM), as does
      Cas9, and preliminary characterization suggests a low tolerance to guide-target
      mismatches and high efficiency in editing (G+C)-rich genomic targets.
FAU - Gao, Feng
AU  - Gao F
AD  - Department of Bioscience and Bioengineering, Hebei University of Science and
      Technology, Shijiazhuang, Hebei, China.
FAU - Shen, Xiao Z
AU  - Shen XZ
AD  - Department of Physiology, Zhejiang University School of Medicine, Hangzhou,
      Zhejiang, China.
FAU - Jiang, Feng
AU  - Jiang F
AD  - Department of Bioscience and Bioengineering, Hebei University of Science and
      Technology, Shijiazhuang, Hebei, China.
FAU - Wu, Yongqiang
AU  - Wu Y
AD  - Department of Bioscience and Bioengineering, Hebei University of Science and
      Technology, Shijiazhuang, Hebei, China.
FAU - Han, Chunyu
AU  - Han C
AD  - Department of Bioscience and Bioengineering, Hebei University of Science and
      Technology, Shijiazhuang, Hebei, China.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Retracted Publication
DEP - 20160502
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (DNA, Bacterial)
RN  - EC 3.1.- (Deoxyribonucleases)
SB  - IM
CIN - Nature. 2017 Jan 20;541(7638):447. PMID: 28128269
EIN - Nat Biotechnol. 2017 May 9;35(5):481. PMID: 28486453
RIN - Nat Biotechnol. 2017 Aug 8;35(8):797. PMID: 28787423
MH  - DNA, Bacterial/*genetics
MH  - Deoxyribonucleases/*genetics
MH  - Gene Editing/*methods
MH  - Genome, Bacterial/*genetics
MH  - Natronobacterium/classification/*enzymology/*genetics
MH  - Species Specificity
EDAT- 2016/05/03 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/05/03 06:00
PHST- 2015/06/03 00:00 [received]
PHST- 2016/03/21 00:00 [accepted]
PHST- 2016/05/03 06:00 [entrez]
PHST- 2016/05/03 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3547 [pii]
AID - 10.1038/nbt.3547 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jul;34(7):768-73. doi: 10.1038/nbt.3547. Epub 2016 May 2.

PMID- 27347755
OWN - NLM
STAT- Publisher
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
DP  - 2016 Jun 27
TI  - Saturation analysis for whole-genome bisulfite sequencing data.
LID - 10.1038/nbt.3524 [doi]
FAU - Libertini, Emanuele
AU  - Libertini E
AD  - Medical Genomics, UCL Cancer Institute, University College London, London, UK.
FAU - Heath, Simon C
AU  - Heath SC
AUID- ORCID: http://orcid.org/0000-0002-9550-0897
AD  - Centro Nacional de Analisis Genomico (CNAG), Parc Cientific de Barcelona,
      Barcelona, Spain.
FAU - Hamoudi, Rifat A
AU  - Hamoudi RA
AD  - Division of Surgery and Interventional Science, University College London,
      London, UK.
FAU - Gut, Marta
AU  - Gut M
AD  - Centro Nacional de Analisis Genomico (CNAG), Parc Cientific de Barcelona,
      Barcelona, Spain.
FAU - Ziller, Michael J
AU  - Ziller MJ
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, 
      Massachusetts, USA.
FAU - Herrero, Javier
AU  - Herrero J
AUID- ORCID: http://orcid.org/0000-0001-7313-717X
AD  - Bill Lyons Informatics Centre, UCL Cancer Institute, University College London,
      London, UK.
FAU - Czyz, Agata
AU  - Czyz A
AD  - Illumina Inc., San Diego, California, USA.
FAU - Ruotti, Victor
AU  - Ruotti V
AD  - Illumina Inc., San Diego, California, USA.
FAU - Stunnenberg, Hendrik G
AU  - Stunnenberg HG
AD  - Department of Molecular Biology, Radboud University Nijmegen, Nijmegen,
      Netherlands.
FAU - Frontini, Mattia
AU  - Frontini M
AD  - Department of Haematology, University of Cambridge, Cambridge, United Kingdom.
AD  - National Health Service Blood and Transplant, Cambridge Biomedical Campus,
      Cambridge, UK.
AD  - British Heart Foundation Centre of Excellence, University of Cambridge,
      Cambridge, UK.
FAU - Ouwehand, Willem H
AU  - Ouwehand WH
AD  - Department of Haematology, University of Cambridge, Cambridge, United Kingdom.
AD  - National Health Service Blood and Transplant, Cambridge Biomedical Campus,
      Cambridge, UK.
AD  - British Heart Foundation Centre of Excellence, University of Cambridge,
      Cambridge, UK.
AD  - Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton,
      Cambridge, UK.
FAU - Meissner, Alexander
AU  - Meissner A
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, 
      Massachusetts, USA.
FAU - Gut, Ivo G
AU  - Gut IG
AD  - Centro Nacional de Analisis Genomico (CNAG), Parc Cientific de Barcelona,
      Barcelona, Spain.
FAU - Beck, Stephan
AU  - Beck S
AD  - Medical Genomics, UCL Cancer Institute, University College London, London, UK.
LA  - eng
GR  - RG/09/012/28096/British Heart Foundation/United Kingdom
GR  - RP-PG-0310-1002/Department of Health/United Kingdom
PT  - Journal Article
DEP - 20160627
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/06/28 06:00
MHDA- 2016/06/28 06:00
CRDT- 2016/06/28 06:00
PHST- 2016/06/28 06:00 [pubmed]
PHST- 2016/06/28 06:00 [medline]
PHST- 2016/06/28 06:00 [entrez]
AID - nbt.3524 [pii]
AID - 10.1038/nbt.3524 [doi]
PST - aheadofprint
SO  - Nat Biotechnol. 2016 Jun 27. pii: nbt.3524. doi: 10.1038/nbt.3524.

PMID- 27281430
OWN - NLM
STAT- MEDLINE
DCOM- 20171211
LR  - 20171211
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - Compensation inflation remains consistent at private life science companies.
PG  - 667-70
LID - 10.1038/nbt.3604 [doi]
FAU - Rychlik, Bruce
AU  - Rychlik B
AD  - Park Square Executive Search LLC, Boston, Massachusetts, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biological Science Disciplines/*economics/trends
MH  - Industry/*economics/trends
MH  - Inflation, Economic/*trends
MH  - Private Sector/*economics/trends
MH  - Salaries and Fringe Benefits/*statistics & numerical data/trends
MH  - Surveys and Questionnaires
MH  - United States
EDAT- 2016/06/10 06:00
MHDA- 2017/12/12 06:00
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2017/12/12 06:00 [medline]
AID - nbt.3604 [pii]
AID - 10.1038/nbt.3604 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):667-70. doi: 10.1038/nbt.3604.

PMID- 27281429
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20171206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - Erratum: When biotech goes bad.
PG  - 666
LID - 10.1038/nbt0616-666c [doi]
FAU - Hodgson, John
AU  - Hodgson J
LA  - eng
PT  - Journal Article
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EFR - Nat Biotechnol. 2016 Mar;34(3):284-91. PMID: 26963551
EDAT- 2016/06/10 06:00
MHDA- 2016/06/10 06:01
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2016/06/10 06:01 [medline]
AID - nbt0616-666c [pii]
AID - 10.1038/nbt0616-666c [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):666. doi: 10.1038/nbt0616-666c.

PMID- 27281428
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20171206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - Corrigendum: Combinatorial hydrogel library enables identification of materials
      that mitigate the foreign body response in primates.
PG  - 666
LID - 10.1038/nbt0616-666e [doi]
FAU - Vegas, Arturo J
AU  - Vegas AJ
FAU - Veiseh, Omid
AU  - Veiseh O
FAU - Doloff, Joshua C
AU  - Doloff JC
FAU - Ma, Minglin
AU  - Ma M
FAU - Tam, Hok Hei
AU  - Tam HH
FAU - Bratlie, Kaitlin
AU  - Bratlie K
FAU - Li, Jie
AU  - Li J
FAU - Bader, Andrew R
AU  - Bader AR
FAU - Langan, Erin
AU  - Langan E
FAU - Olejnik, Karsten
AU  - Olejnik K
FAU - Fenton, Patrick
AU  - Fenton P
FAU - Kang, Jeon Woong
AU  - Kang JW
FAU - Hollister-Locke, Jennifer
AU  - Hollister-Locke J
FAU - Bochenek, Matthew A
AU  - Bochenek MA
FAU - Chiu, Alan
AU  - Chiu A
FAU - Siebert, Sean
AU  - Siebert S
FAU - Tang, Katherine
AU  - Tang K
FAU - Jhunjhunwala, Siddharth
AU  - Jhunjhunwala S
FAU - Aresta-Dasilva, Stephanie
AU  - Aresta-Dasilva S
FAU - Dholakia, Nimit
AU  - Dholakia N
FAU - Thakrar, Raj
AU  - Thakrar R
FAU - Vietti, Thema
AU  - Vietti T
FAU - Chen, Michael
AU  - Chen M
FAU - Cohen, Josh
AU  - Cohen J
FAU - Siniakowicz, Karolina
AU  - Siniakowicz K
FAU - Qi, Meirigeng
AU  - Qi M
FAU - McGarrigle, James
AU  - McGarrigle J
FAU - Lyle, Stephen
AU  - Lyle S
FAU - Harlan, David M
AU  - Harlan DM
FAU - Greiner, Dale L
AU  - Greiner DL
FAU - Oberholzer, Jose
AU  - Oberholzer J
FAU - Weir, Gordon C
AU  - Weir GC
FAU - Langer, Robert
AU  - Langer R
FAU - Anderson, Daniel G
AU  - Anderson DG
LA  - eng
PT  - Journal Article
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EFR - Nat Biotechnol. 2016 Mar;34(3):345-52. PMID: 26807527
EDAT- 2016/06/10 06:00
MHDA- 2016/06/10 06:01
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2016/06/10 06:01 [medline]
AID - nbt0616-666e [pii]
AID - 10.1038/nbt0616-666e [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):666. doi: 10.1038/nbt0616-666e.

PMID- 27281427
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20171206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - Erratum: Community crystal gazing.
PG  - 666
LID - 10.1038/nbt0616-666d [doi]
FAU - Acharya, Anu
AU  - Acharya A
FAU - Bingham, Kate
AU  - Bingham K
FAU - Bradner, Jay
AU  - Bradner J
FAU - Burke, Wylie
AU  - Burke W
FAU - Charo, R Alta
AU  - Charo RA
FAU - Cherry, Joel
AU  - Cherry J
FAU - Choulika, Andre
AU  - Choulika A
FAU - Coles, Tony
AU  - Coles T
FAU - Cook-Deegan, Robert
AU  - Cook-Deegan R
FAU - Crook, Stanley T
AU  - Crook ST
FAU - Diaz, Emilia
AU  - Diaz E
FAU - Erickson, Brent
AU  - Erickson B
FAU - Giddings, L Val
AU  - Giddings LV
FAU - Giwa, Sebastian Eriksson
AU  - Giwa SE
FAU - Greenwood, James C
AU  - Greenwood JC
FAU - Gulati, Vishal
AU  - Gulati V
FAU - Hall, Sam
AU  - Hall S
FAU - Harris, John
AU  - Harris J
FAU - Heywood, Jamie
AU  - Heywood J
FAU - Hill, Colin
AU  - Hill C
FAU - Levin, Jeremy
AU  - Levin J
FAU - Mangubat, Adina
AU  - Mangubat A
FAU - Maraganore, John
AU  - Maraganore J
FAU - Mariggi, Giovanni
AU  - Mariggi G
FAU - Mazur, Barbara J
AU  - Mazur BJ
FAU - McGuire, Amy L
AU  - McGuire AL
FAU - Moll, Nathalie
AU  - Moll N
FAU - Moreno, Jonathan
AU  - Moreno J
FAU - Naughton, Gail
AU  - Naughton G
FAU - Nelsen, Lita
AU  - Nelsen L
FAU - Osbourn, Jane
AU  - Osbourn J
FAU - Perez, Daniel
AU  - Perez D
FAU - Reed, John
AU  - Reed J
FAU - Schmidt, Eric
AU  - Schmidt E
FAU - Seyfert-Margolis, Vicki
AU  - Seyfert-Margolis V
FAU - Stoffels, Paul
AU  - Stoffels P
FAU - Thorball, Jorgen
AU  - Thorball J
FAU - O'Toole, Tara
AU  - O'Toole T
FAU - Vainu, Indrek
AU  - Vainu I
FAU - van Deventer, Sander
AU  - van Deventer S
FAU - Zerhouni, Elias
AU  - Zerhouni E
FAU - Zohar, Daphne
AU  - Zohar D
LA  - eng
PT  - Journal Article
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EFR - Nat Biotechnol. 2016 Mar;34(3):276-83. PMID: 26963550
EDAT- 2016/06/10 06:00
MHDA- 2016/06/10 06:01
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2016/06/10 06:01 [medline]
AID - nbt0616-666d [pii]
AID - 10.1038/nbt0616-666d [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):666. doi: 10.1038/nbt0616-666d.

PMID- 27281426
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20171206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - Erratum: 20 years of Nature Biotechnology research tools.
PG  - 666
LID - 10.1038/nbt0616-666a [doi]
FAU - Azvolinsky, Anna
AU  - Azvolinsky A
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
FAU - Waltz, Emily
AU  - Waltz E
FAU - Webb, Sarah
AU  - Webb S
LA  - eng
PT  - Journal Article
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EFR - Nat Biotechnol. 2016 Mar;34(3):256-61. PMID: 26963546
EDAT- 2016/06/10 06:00
MHDA- 2016/06/10 06:01
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2016/06/10 06:01 [medline]
AID - nbt0616-666a [pii]
AID - 10.1038/nbt0616-666a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):666. doi: 10.1038/nbt0616-666a.

PMID- 27281425
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20171206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - Erratum: 20 years of Nature Biotechnology biomedical research.
PG  - 666
LID - 10.1038/nbt0616-666b [doi]
FAU - Azvolinsky, Anna
AU  - Azvolinsky A
FAU - Schmidt, Charles
AU  - Schmidt C
FAU - Waltz, Emily
AU  - Waltz E
FAU - Webb, Sarah
AU  - Webb S
LA  - eng
PT  - Journal Article
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EFR - Nat Biotechnol. 2016 Mar;34(3):262-6. PMID: 26963547
EDAT- 2016/06/10 06:00
MHDA- 2016/06/10 06:01
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2016/06/10 06:01 [medline]
AID - nbt0616-666b [pii]
AID - 10.1038/nbt0616-666b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):666. doi: 10.1038/nbt0616-666b.

PMID- 27281424
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20171206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - The US regulatory and pharmacopeia response to the global heparin contamination
      crisis.
PG  - 625-30
LID - 10.1038/nbt.3606 [doi]
AB  - The contamination of the widely used lifesaving anticoagulant drug heparin in
      2007 has drawn renewed attention to the challenges that are associated with the
      characterization, quality control and standardization of complex biological
      medicines from natural sources. Heparin is a linear, highly sulfated
      polysaccharide consisting of alternating glucosamine and uronic acid
      monosaccharide residues. Heparin has been used successfully as an injectable
      antithrombotic medicine since the 1930s, and its isolation from animal sources
      (primarily porcine intestine) as well as its manufacturing processes have not
      changed substantially since its introduction. The 2007 heparin contamination
      crisis resulted in several deaths in the United States and hundreds of adverse
      reactions worldwide, revealing the vulnerability of a complex global supply chain
      to sophisticated adulteration. This Perspective discusses how the US Food and
      Drug Administration (FDA), the United States Pharmacopeial Convention (USP) and
      international stakeholders collaborated to redefine quality expectations for
      heparin, thus making an important natural product better controlled and less
      susceptible to economically motivated adulteration.
FAU - Szajek, Anita Y
AU  - Szajek AY
AD  - Biologics and Biotechnology Department, US Pharmacopeia, Rockville, Maryland,
      USA.
FAU - Chess, Edward
AU  - Chess E
AD  - Structure Elucidation/Technology Resources, Baxter Healthcare Corporation, Round 
      Lake, Illinois, USA.
FAU - Johansen, Kristian
AU  - Johansen K
AD  - Sjolundsparken, Hellebaek, Denmark.
FAU - Gratzl, Gyongyi
AU  - Gratzl G
AD  - Boehringer Ingelheim, Ben Venue Laboratories, Inc., Bedford, Ohio, USA.
FAU - Gray, Elaine
AU  - Gray E
AD  - National Institute for Biological Standards and Control, South Mimms, Potters
      Bar, UK.
FAU - Keire, David
AU  - Keire D
AD  - US Food and Drug Administration/Division of Pharmaceutical Analysis, St. Louis,
      Missouri, USA.
FAU - Linhardt, Robert J
AU  - Linhardt RJ
AD  - Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic
      Institute, Troy, New York, USA.
FAU - Liu, Jian
AU  - Liu J
AD  - Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North
      Carolina, USA.
FAU - Morris, Tina
AU  - Morris T
AD  - Biologics and Biotechnology Department, US Pharmacopeia, Rockville, Maryland,
      USA.
FAU - Mulloy, Barbara
AU  - Mulloy B
AD  - National Institute for Biological Standards and Control, South Mimms, Potters
      Bar, UK.
AD  - Institute of Pharmaceutical Science King's College London, Franklin Wilkins
      Building, Waterloo Campus, London, UK.
FAU - Nasr, Moheb
AU  - Nasr M
AD  - R&D, GlaxoSmithKline, Collegeville, Pennsylvania, USA.
FAU - Shriver, Zachary
AU  - Shriver Z
AD  - Department of Biological Engineering, Harvard-MIT Division of Health Sciences
      &Technology, Koch institute for Integrative Cancer Research, Massachusetts
      Institute of Technology, Cambridge, Massachusetts, USA.
FAU - Torralba, Pearle
AU  - Torralba P
AD  - Product Development - Analytical Innovation and Development, Fresenius Kabi USA, 
      Skokie, Illinois, USA.
FAU - Viskov, Christian
AU  - Viskov C
AD  - Sanofi, Vitry sur Seine, France.
FAU - Williams, Roger
AU  - Williams R
AD  - US Pharmacopeia, Rockville, Maryland, USA.
FAU - Woodcock, Janet
AU  - Woodcock J
AD  - Center for Drug Evaluation and Research, US Food and Drug Administration, Silver 
      Spring, Maryland, USA.
FAU - Workman, Wesley
AU  - Workman W
AD  - Pfizer Quality Operations Biotech, Chesterfield, Missouri, USA.
FAU - Al-Hakim, Ali
AU  - Al-Hakim A
AD  - Center for Drug Evaluation and Research, US Food and Drug Administration, Silver 
      Spring, Maryland, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 9005-49-6 (Heparin)
SB  - IM
MH  - Drug Contamination/*legislation & jurisprudence/*prevention & control
MH  - Global Health/*legislation & jurisprudence/standards
MH  - Government Regulation
MH  - Heparin/*standards
MH  - Legislation, Drug
MH  - Pharmacopoeias as Topic/*standards
MH  - Practice Guidelines as Topic
MH  - Product Surveillance, Postmarketing/*standards
MH  - United States
MH  - United States Food and Drug Administration/legislation & jurisprudence
EDAT- 2016/06/10 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3606 [pii]
AID - 10.1038/nbt.3606 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):625-30. doi: 10.1038/nbt.3606.

PMID- 27281422
OWN - NLM
STAT- MEDLINE
DCOM- 20171207
LR  - 20171207
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - The minimal genome comes of age.
PG  - 623-4
LID - 10.1038/nbt.3593 [doi]
FAU - Vickers, Claudia E
AU  - Vickers CE
AUID- ORCID: 0000-0002-0792-050X
AD  - Australian Institute for Bioengineering and Nanotechnology, The University of
      Queensland, Brisbane, Australia.
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Science. 2016 Mar 25;351(6280):aad6253. PMID: 27013737
MH  - *Genome
MH  - *Genomics
MH  - Humans
EDAT- 2016/06/10 06:00
MHDA- 2017/12/08 06:00
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2017/12/08 06:00 [medline]
AID - nbt.3593 [pii]
AID - 10.1038/nbt.3593 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):623-4. doi: 10.1038/nbt.3593.

PMID- 27281421
OWN - NLM
STAT- MEDLINE
DCOM- 20171207
LR  - 20171207
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - Comparing CRISPR and RNAi-based screening technologies.
PG  - 621-3
LID - 10.1038/nbt.3599 [doi]
FAU - Housden, Benjamin E
AU  - Housden BE
AD  - Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Perrimon, Norbert
AU  - Perrimon N
AD  - Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.
AD  - Howard Hughes Medical Institute, Boston, Massachusetts, USA.
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (RNA, Small Interfering)
SB  - IM
CON - Nat Biotechnol. 2016 Jun;34(6):631-3. PMID: 27111720
CON - Nat Biotechnol. 2016 Jun;34(6):634-6. PMID: 27159373
MH  - CRISPR-Cas Systems
MH  - *Clustered Regularly Interspaced Short Palindromic Repeats
MH  - Humans
MH  - *RNA Interference
MH  - RNA, Small Interfering
EDAT- 2016/06/10 06:00
MHDA- 2017/12/08 06:00
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2017/12/08 06:00 [medline]
AID - nbt.3599 [pii]
AID - 10.1038/nbt.3599 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):621-3. doi: 10.1038/nbt.3599.

PMID- 27281420
OWN - NLM
STAT- MEDLINE
DCOM- 20171207
LR  - 20171208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - Resistance from relatives.
PG  - 620-1
LID - 10.1038/nbt.3591 [doi]
FAU - Bent, Andrew
AU  - Bent A
AUID- ORCID: 0000-0001-6610-9525
AD  - Department of Plant Pathology, University of Wisconsin-Madison, Madison,
      Wicsonsin, USA.
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2016 Jun;34(6):661-5. PMID: 27111723
CON - Nat Biotechnol. 2016 Jun;34(6):652-5. PMID: 27111722
CON - Nat Biotechnol. 2016 Jun;34(6):656-60. PMID: 27111721
MH  - Disease Resistance/*genetics
MH  - Plant Diseases/*genetics
EDAT- 2016/06/10 06:00
MHDA- 2017/12/08 06:00
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2017/12/08 06:00 [medline]
AID - nbt.3591 [pii]
AID - 10.1038/nbt.3591 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):620-1. doi: 10.1038/nbt.3591.

PMID- 27281418
OWN - NLM
STAT- MEDLINE
DCOM- 20171211
LR  - 20171211
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - The morality and ethics governing CRISPR-Cas9 patents in China.
PG  - 616-8
LID - 10.1038/nbt.3590 [doi]
FAU - Peng, Yaojin
AU  - Peng Y
AD  - Institute for Globalization and International Regulation, Maastricht University, 
      Maastricht, the Netherlands.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - China
MH  - Clinical Trials as Topic/ethics/legislation & jurisprudence
MH  - Clustered Regularly Interspaced Short Palindromic Repeats/*genetics
MH  - Gene Editing/*ethics/*legislation & jurisprudence
MH  - Genetic Therapy/*ethics/*legislation & jurisprudence
MH  - Government Regulation
MH  - Patents as Topic/*legislation & jurisprudence
MH  - Patient Rights/*ethics/legislation & jurisprudence
EDAT- 2016/06/10 06:00
MHDA- 2017/12/12 06:00
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2017/12/12 06:00 [medline]
AID - nbt.3590 [pii]
AID - 10.1038/nbt.3590 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):616-8. doi: 10.1038/nbt.3590.

PMID- 27281417
OWN - NLM
STAT- MEDLINE
DCOM- 20171211
LR  - 20171211
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - Biotech's wellspring-a survey of the health of the private sector in 2015.
PG  - 608-15
LID - 10.1038/nbt.3600 [doi]
FAU - Huggett, Brady
AU  - Huggett B
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*economics/*trends
MH  - Entrepreneurship/*economics/trends
MH  - Internationality
MH  - Investments/*economics/*trends
MH  - Private Sector/*economics/*trends
EDAT- 2016/06/10 06:00
MHDA- 2017/12/12 06:00
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2017/12/12 06:00 [medline]
AID - nbt.3600 [pii]
AID - 10.1038/nbt.3600 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):608-15. doi: 10.1038/nbt.3600.

PMID- 27281416
OWN - NLM
STAT- MEDLINE
DCOM- 20171211
LR  - 20171211
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - Gene therapy's out-of-body experience.
PG  - 600-7
LID - 10.1038/nbt.3592 [doi]
FAU - Scott, Christopher Thomas
AU  - Scott CT
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - EC 3.5.4.4 (Adenosine Deaminase)
RN  - Severe combined immunodeficiency due to adenosine deaminase deficiency
SB  - IM
MH  - Adenosine Deaminase/*deficiency/genetics
MH  - Agammaglobulinemia/*genetics/*therapy
MH  - *Clinical Trials as Topic
MH  - Evidence-Based Medicine
MH  - Genetic Therapy/*methods/*trends
MH  - Genetic Vectors/*therapeutic use
MH  - Humans
MH  - Severe Combined Immunodeficiency/*genetics/*therapy
MH  - Treatment Outcome
EDAT- 2016/06/10 06:00
MHDA- 2017/12/12 06:00
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2017/12/12 06:00 [medline]
AID - nbt.3592 [pii]
AID - 10.1038/nbt.3592 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):600-7. doi: 10.1038/nbt.3592.

PMID- 27281415
OWN - NLM
STAT- MEDLINE
DCOM- 20171211
LR  - 20171211
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - Cancer moonshot countdown.
PG  - 596-9
LID - 10.1038/nbt.3616 [doi]
FAU - Lowy, Douglas
AU  - Lowy D
AD  - Division of Cancer Biology, National Cancer Institute, Bethesda, Maryland, USA.
FAU - Singer, Dinah
AU  - Singer D
AD  - Division of Cancer Biology, National Cancer Institute, Bethesda, Maryland, USA.
FAU - DePinho, Ron
AU  - DePinho R
AD  - Department of Cancer Biology, University of Texas MD Anderson Cancer Center,
      Houston, Texas, USA.
FAU - Simon, Gregory C
AU  - Simon GC
AD  - White House Cancer Task Force, Washington, DC.
FAU - Soon-Shiong, Patrick
AU  - Soon-Shiong P
AD  - NantWorks LLC, Culver City, California, USA.
LA  - eng
PT  - Interview
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - Biomedical Research/*organization & administration
MH  - Government Programs/*organization & administration
MH  - Humans
MH  - *Interinstitutional Relations
MH  - Medical Oncology/*organization & administration
MH  - *Models, Organizational
MH  - Neoplasms/*therapy
MH  - *Organizational Objectives
EDAT- 2016/06/10 06:00
MHDA- 2017/12/12 06:00
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2017/12/12 06:00 [medline]
AID - nbt.3616 [pii]
AID - 10.1038/nbt.3616 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):596-9. doi: 10.1038/nbt.3616.

PMID- 27281413
OWN - NLM
STAT- MEDLINE
DCOM- 20171207
LR  - 20171207
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - The contribution of cell cycle to heterogeneity in single-cell RNA-seq data.
PG  - 591-3
LID - 10.1038/nbt.3498 [doi]
FAU - McDavid, Andrew
AU  - McDavid A
AD  - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, 
      Seattle, Washington, USA.
FAU - Finak, Greg
AU  - Finak G
AD  - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, 
      Seattle, Washington, USA.
FAU - Gottardo, Raphael
AU  - Gottardo R
AD  - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, 
      Seattle, Washington, USA.
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 63231-63-0 (RNA)
SB  - IM
CON - Nat Biotechnol. 2015 Feb;33(2):155-60. PMID: 25599176
CIN - Nat Biotechnol. 2016 May 6;34(6):593-5. PMID: 27281414
MH  - Cell Cycle
MH  - High-Throughput Nucleotide Sequencing
MH  - *RNA
MH  - *Sequence Analysis, RNA
EDAT- 2016/06/10 06:00
MHDA- 2017/12/08 06:00
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2017/12/08 06:00 [medline]
AID - nbt.3498 [pii]
AID - 10.1038/nbt.3498 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):591-3. doi: 10.1038/nbt.3498.

PMID- 27281412
OWN - NLM
STAT- MEDLINE
DCOM- 20171207
LR  - 20171207
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - Reply to Research that is fit to print.
PG  - 588
LID - 10.1038/nbt.3612 [doi]
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2016 Jun 9;34(6):587-8. PMID: 27281410
CON - Nat Biotechnol. 2016 Feb;34(2):115. PMID: 26849496
MH  - Humans
MH  - *Research
EDAT- 2016/06/10 06:00
MHDA- 2017/12/08 06:00
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2017/12/08 06:00 [medline]
AID - nbt.3612 [pii]
AID - 10.1038/nbt.3612 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):588. doi: 10.1038/nbt.3612.

PMID- 27281411
OWN - NLM
STAT- MEDLINE
DCOM- 20171211
LR  - 20171211
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - Secure cloud computing for genomic data.
PG  - 588-91
LID - 10.1038/nbt.3496 [doi]
FAU - Datta, Somalee
AU  - Datta S
AD  - Department of Genetics, Stanford School of Medicine, Stanford, California, USA.
FAU - Bettinger, Keith
AU  - Bettinger K
AD  - Department of Genetics, Stanford School of Medicine, Stanford, California, USA.
FAU - Snyder, Michael
AU  - Snyder M
AD  - Department of Genetics, Stanford School of Medicine, Stanford, California, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Cloud Computing
MH  - *Computer Security
MH  - *Confidentiality
MH  - *Databases, Genetic
MH  - Information Dissemination/*methods
MH  - Information Storage and Retrieval/*methods
EDAT- 2016/06/10 06:00
MHDA- 2017/12/12 06:00
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2017/12/12 06:00 [medline]
AID - nbt.3496 [pii]
AID - 10.1038/nbt.3496 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):588-91. doi: 10.1038/nbt.3496.

PMID- 27281410
OWN - NLM
STAT- MEDLINE
DCOM- 20171207
LR  - 20171207
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - Research that is fit to print.
PG  - 587-8
LID - 10.1038/nbt.3577 [doi]
FAU - Waksal, Harlan W
AU  - Waksal HW
AD  - Kadmon Corporation, New York, New York, USA.
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2016 Feb;34(2):115. PMID: 26849496
CIN - Nat Biotechnol. 2016 Jun 9;34(6):588. PMID: 27281412
MH  - Humans
MH  - *Research
EDAT- 2016/06/10 06:00
MHDA- 2017/12/08 06:00
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2017/12/08 06:00 [medline]
AID - nbt.3577 [pii]
AID - 10.1038/nbt.3577 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):587-8. doi: 10.1038/nbt.3577.

PMID- 27281409
OWN - NLM
STAT- MEDLINE
DCOM- 20171207
LR  - 20171207
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - Why patients shouldn't "own" their medical records.
PG  - 586
LID - 10.1038/nbt.3552 [doi]
FAU - Rumbold, John
AU  - Rumbold J
AD  - Kingston University London, Faculty of Science, Engineering and Computing,
      Penrhyn Road, London, UK.
FAU - Pierscionek, Barbara
AU  - Pierscionek B
AD  - Kingston University London, Faculty of Science, Engineering and Computing,
      Penrhyn Road, London, UK.
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2015 Sep;33(9):921-4. PMID: 26348958
CIN - Nat Biotechnol. 2016 Jun 9;34(6):586-7. PMID: 27281408
MH  - Humans
MH  - *Medical Records
EDAT- 2016/06/10 06:00
MHDA- 2017/12/08 06:00
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2017/12/08 06:00 [medline]
AID - nbt.3552 [pii]
AID - 10.1038/nbt.3552 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):586. doi: 10.1038/nbt.3552.

PMID- 27281408
OWN - NLM
STAT- MEDLINE
DCOM- 20171207
LR  - 20171207
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - Reply to Why patients shouldn't "own" their medical records.
PG  - 586-7
LID - 10.1038/nbt.3615 [doi]
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2016 Jun 9;34(6):586. PMID: 27281409
CON - Nat Biotechnol. 2015 Sep;33(9):921-4. PMID: 26348958
MH  - Humans
MH  - *Medical Records
EDAT- 2016/06/10 06:00
MHDA- 2017/12/08 06:00
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2017/12/08 06:00 [medline]
AID - nbt.3615 [pii]
AID - 10.1038/nbt.3615 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):586-7. doi: 10.1038/nbt.3615.

PMID- 27281407
OWN - NLM
STAT- MEDLINE
DCOM- 20171211
LR  - 20171211
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - The president says patients should own their genetic data. He's wrong.
PG  - 585-6
LID - 10.1038/nbt.3608 [doi]
FAU - Contreras, Jorge L
AU  - Contreras JL
AD  - University of Utah, Salt Lake City, Utah, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 9007-49-2 (DNA)
SB  - IM
MH  - Biomedical Research/*legislation & jurisprudence
MH  - DNA/*genetics
MH  - Databases, Genetic/*legislation & jurisprudence
MH  - Government Regulation
MH  - Ownership/*legislation & jurisprudence
MH  - Patient Rights/*legislation & jurisprudence
MH  - Population Dynamics
MH  - *Precision Medicine
MH  - United States
EDAT- 2016/06/10 06:00
MHDA- 2017/12/12 06:00
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2017/12/12 06:00 [medline]
AID - nbt.3608 [pii]
AID - 10.1038/nbt.3608 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):585-6. doi: 10.1038/nbt.3608.

PMID- 27281406
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20171211
LR  - 20171211
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - Research institute partnerships 2015.
PG  - 584
LID - 10.1038/nbt.3610 [doi]
FAU - Huggett, Brady
AU  - Huggett B
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/06/10 06:00
MHDA- 2016/06/10 06:01
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2016/06/10 06:01 [medline]
AID - nbt.3610 [pii]
AID - 10.1038/nbt.3610 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):584. doi: 10.1038/nbt.3610.

PMID- 27281405
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20171211
LR  - 20171211
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - First Rounders Podcast: Tom Maniatis.
PG  - 584
LID - 10.1038/nbt.3611 [doi]
FAU - Huggett, Brady
AU  - Huggett B
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/06/10 06:00
MHDA- 2016/06/10 06:01
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2016/06/10 06:01 [medline]
AID - nbt.3611 [pii]
AID - 10.1038/nbt.3611 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):584. doi: 10.1038/nbt.3611.

PMID- 27281404
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20171211
LR  - 20171211
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - AstraZeneca nabs genomics giants.
PG  - 583
LID - 10.1038/nbt0616-583b [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/06/10 06:00
MHDA- 2016/06/10 06:01
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2016/06/10 06:01 [medline]
AID - nbt0616-583b [pii]
AID - 10.1038/nbt0616-583b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):583. doi: 10.1038/nbt0616-583b.

PMID- 27281403
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20171211
LR  - 20171211
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - Tech billionaires fund new cancer centers.
PG  - 583
LID - 10.1038/nbt0616-583a [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/06/10 06:00
MHDA- 2016/06/10 06:01
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2016/06/10 06:01 [medline]
AID - nbt0616-583a [pii]
AID - 10.1038/nbt0616-583a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):583. doi: 10.1038/nbt0616-583a.

PMID- 27281402
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20171206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - Around the world in a month.
PG  - 583
LID - 10.1038/nbt0616-583c [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EDAT- 2016/06/10 06:00
MHDA- 2016/06/10 06:01
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2016/06/10 06:01 [medline]
AID - nbt0616-583c [pii]
AID - 10.1038/nbt0616-583c [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):583. doi: 10.1038/nbt0616-583c.

PMID- 27281401
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20171211
LR  - 20171211
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - CRISPR-edited crops free to enter market, skip regulation.
PG  - 582
LID - 10.1038/nbt0616-582 [doi]
FAU - Waltz, Emily
AU  - Waltz E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/06/10 06:00
MHDA- 2016/06/10 06:01
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2016/06/10 06:01 [medline]
AID - nbt0616-582 [pii]
AID - 10.1038/nbt0616-582 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):582. doi: 10.1038/nbt0616-582.

PMID- 27281400
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20171211
LR  - 20171211
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - White House unveils National Microbiome Initiative.
PG  - 580
LID - 10.1038/nbt0616-580a [doi]
FAU - Bouchie, Aaron
AU  - Bouchie A
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/06/10 06:00
MHDA- 2016/06/10 06:01
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2016/06/10 06:01 [medline]
AID - nbt0616-580a [pii]
AID - 10.1038/nbt0616-580a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):580. doi: 10.1038/nbt0616-580a.

PMID- 27281399
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20171211
LR  - 20171211
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - Amgen/UCB build on bone franchise with anti-sclerostin antibody.
PG  - 580-1
LID - 10.1038/nbt0616-580b [doi]
FAU - Elvidge, Suzanne
AU  - Elvidge S
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/06/10 06:00
MHDA- 2016/06/10 06:01
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2016/06/10 06:01 [medline]
AID - nbt0616-580b [pii]
AID - 10.1038/nbt0616-580b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):580-1. doi: 10.1038/nbt0616-580b.

PMID- 27281398
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20171211
LR  - 20171211
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - Matchmaker for NIH-rejected grants.
PG  - 579
LID - 10.1038/nbt0616-579 [doi]
FAU - Francisco, Michael
AU  - Francisco M
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/06/10 06:00
MHDA- 2016/06/10 06:01
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2016/06/10 06:01 [medline]
AID - nbt0616-579 [pii]
AID - 10.1038/nbt0616-579 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):579. doi: 10.1038/nbt0616-579.

PMID- 27281397
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20171211
LR  - 20171211
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - Consortium nurtures ex vivo gene therapy firm.
PG  - 578
LID - 10.1038/nbt0616-578 [doi]
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/06/10 06:00
MHDA- 2016/06/10 06:01
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2016/06/10 06:01 [medline]
AID - nbt0616-578 [pii]
AID - 10.1038/nbt0616-578 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):578. doi: 10.1038/nbt0616-578.

PMID- 27281396
OWN - NLM
STAT- MEDLINE
DCOM- 20171211
LR  - 20171211
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - Bristol-Myers Squibb locks into novel autoimmune strategy.
PG  - 577-9
LID - 10.1038/nbt0616-577 [doi]
FAU - Garber, Ken
AU  - Garber K
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Anti-Inflammatory Agents)
SB  - IM
MH  - Anti-Inflammatory Agents/*therapeutic use
MH  - *Drug Design
MH  - Drug Industry/*trends
MH  - Technology, Pharmaceutical/*trends
EDAT- 2016/06/10 06:00
MHDA- 2017/12/12 06:00
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2017/12/12 06:00 [medline]
AID - nbt0616-577 [pii]
AID - 10.1038/nbt0616-577 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):577-9. doi: 10.1038/nbt0616-577.

PMID- 27281395
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20171211
LR  - 20171211
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - Gilead bets big on Nimbus' fatty liver disease drug.
PG  - 575-6
LID - 10.1038/nbt0616-575 [doi]
FAU - Ratner, Mark
AU  - Ratner M
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/06/10 06:00
MHDA- 2016/06/10 06:01
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2016/06/10 06:01 [medline]
AID - nbt0616-575 [pii]
AID - 10.1038/nbt0616-575 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):575-6. doi: 10.1038/nbt0616-575.

PMID- 27281394
OWN - NLM
STAT- MEDLINE
DCOM- 20171211
LR  - 20171211
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun 9
TI  - No guarantees in translation.
PG  - 573
LID - 10.1038/nbt.3619 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Contracts/*economics
MH  - Drug Industry/*economics
MH  - *Interinstitutional Relations
MH  - Translational Medical Research/*economics
MH  - United States
MH  - Universities/*economics
EDAT- 2016/06/10 06:00
MHDA- 2017/12/12 06:00
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2017/12/12 06:00 [medline]
AID - nbt.3619 [pii]
AID - 10.1038/nbt.3619 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun 9;34(6):573. doi: 10.1038/nbt.3619.

PMID- 27159373
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20180206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun
TI  - Systematic comparison of CRISPR/Cas9 and RNAi screens for essential genes.
PG  - 634-6
LID - 10.1038/nbt.3567 [doi]
AB  - We compared the ability of short hairpin RNA (shRNA) and CRISPR/Cas9 screens to
      identify essential genes in the human chronic myelogenous leukemia cell line
      K562. We found that the precision of the two libraries in detecting essential
      genes was similar and that combining data from both screens improved performance.
      Notably, results from the two screens showed little correlation, which can be
      partially explained by the identification of distinct essential biological
      processes with each technology.
FAU - Morgens, David W
AU  - Morgens DW
AD  - Department of Genetics, Stanford University, Stanford, California, USA.
FAU - Deans, Richard M
AU  - Deans RM
AD  - Department of Genetics, Stanford University, Stanford, California, USA.
AD  - Department of Chemistry, Stanford University, Stanford, California, USA.
FAU - Li, Amy
AU  - Li A
AD  - Department of Genetics, Stanford University, Stanford, California, USA.
FAU - Bassik, Michael C
AU  - Bassik MC
AD  - Department of Genetics, Stanford University, Stanford, California, USA.
AD  - Stanford University Chemistry, Engineering, and Medicine for Human Health
      (ChEM-H), Stanford, California, USA.
LA  - eng
GR  - DP2 HD084069/HD/NICHD NIH HHS/United States
GR  - T32 GM007790/GM/NIGMS NIH HHS/United States
GR  - T32 HG000044/HG/NHGRI NIH HHS/United States
PT  - Comparative Study
PT  - Journal Article
DEP - 20160509
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (CRISPR-Associated Proteins)
RN  - 0 (RNA, Small Interfering)
SB  - IM
CIN - Nat Biotechnol. 2016 Jun 9;34(6):621-3. PMID: 27281421
MH  - CRISPR-Associated Proteins/*genetics
MH  - Clustered Regularly Interspaced Short Palindromic Repeats/*genetics
MH  - Genes, Essential/*genetics
MH  - Genetic Testing/methods
MH  - High-Throughput Nucleotide Sequencing/*methods
MH  - RNA, Small Interfering/*genetics
MH  - Reproducibility of Results
MH  - Sensitivity and Specificity
PMC - PMC4900911
MID - NIHMS777404
EDAT- 2016/05/10 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/05/10 06:00
PHST- 2015/11/16 00:00 [received]
PHST- 2016/04/11 00:00 [accepted]
PHST- 2016/05/10 06:00 [entrez]
PHST- 2016/05/10 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3567 [pii]
AID - 10.1038/nbt.3567 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun;34(6):634-6. doi: 10.1038/nbt.3567. Epub 2016 May 9.

PMID- 27136077
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20180124
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun
TI  - Profiling of engineering hotspots identifies an allosteric CRISPR-Cas9 switch.
PG  - 646-51
LID - 10.1038/nbt.3528 [doi]
AB  - The clustered, regularly interspaced, short palindromic repeats
      (CRISPR)-associated protein Cas9 from Streptococcus pyogenes is an RNA-guided DNA
      endonuclease with widespread utility for genome modification. However, the
      structural constraints limiting the engineering of Cas9 have not been determined.
      Here we experimentally profile Cas9 using randomized insertional mutagenesis and 
      delineate hotspots in the structure capable of tolerating insertions of a PDZ
      domain without disruption of the enzyme's binding and cleavage functions.
      Orthogonal domains or combinations of domains can be inserted into the identified
      sites with minimal functional consequence. To illustrate the utility of the
      identified sites, we construct an allosterically regulated Cas9 by insertion of
      the estrogen receptor-alpha ligand-binding domain. This protein showed robust,
      ligand-dependent activation in prokaryotic and eukaryotic cells, establishing a
      versatile one-component system for inducible and reversible Cas9 activation.
      Thus, domain insertion profiling facilitates the rapid generation of new Cas9
      functionalities and provides useful data for future engineering of Cas9.
FAU - Oakes, Benjamin L
AU  - Oakes BL
AD  - Department of Molecular and Cell Biology, University of California, Berkeley,
      Berkeley, California, USA.
FAU - Nadler, Dana C
AU  - Nadler DC
AUID- ORCID: 0000-0002-9792-145X
AD  - Department of Molecular and Cell Biology, University of California, Berkeley,
      Berkeley, California, USA.
FAU - Flamholz, Avi
AU  - Flamholz A
AD  - Department of Molecular and Cell Biology, University of California, Berkeley,
      Berkeley, California, USA.
FAU - Fellmann, Christof
AU  - Fellmann C
AD  - Department of Molecular and Cell Biology, University of California, Berkeley,
      Berkeley, California, USA.
FAU - Staahl, Brett T
AU  - Staahl BT
AD  - Department of Molecular and Cell Biology, University of California, Berkeley,
      Berkeley, California, USA.
FAU - Doudna, Jennifer A
AU  - Doudna JA
AD  - Department of Molecular and Cell Biology, University of California, Berkeley,
      Berkeley, California, USA.
AD  - Howard Hughes Medical Institute, University of California, Berkeley, Berkeley,
      California, USA.
AD  - Innovative Genomics Initiative, University of California, Berkeley, Berkeley,
      California, USA.
AD  - Physical Biosciences Division, Lawrence Berkeley National Laboratory, Berkeley,
      California, USA.
AD  - Department of Chemistry, University of California, Berkeley, Berkeley,
      California, USA.
FAU - Savage, David F
AU  - Savage DF
AUID- ORCID: 0000-0003-0042-2257
AD  - Department of Molecular and Cell Biology, University of California, Berkeley,
      Berkeley, California, USA.
AD  - Department of Chemistry, University of California, Berkeley, Berkeley,
      California, USA.
AD  - Energy Biosciences Institute, University of California, Berkeley, Berkeley,
      California, USA.
LA  - eng
GR  - DP2 EB018658/EB/NIBIB NIH HHS/United States
GR  - T32 GM066698/GM/NIGMS NIH HHS/United States
PT  - Journal Article
DEP - 20160502
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Bacterial Proteins)
RN  - EC 3.1.- (Cas9 endonuclease Streptococcus pyogenes)
RN  - EC 3.1.- (Endonucleases)
SB  - IM
MH  - Allosteric Regulation/genetics
MH  - Bacterial Proteins/*genetics
MH  - Binding Sites
MH  - Clustered Regularly Interspaced Short Palindromic Repeats/*genetics
MH  - Endonucleases/*genetics
MH  - Genes, Switch/*genetics
MH  - Mutagenesis, Insertional/*genetics/*methods
MH  - Mutagenesis, Site-Directed/methods
MH  - Protein Binding
MH  - Protein Domains
MH  - Protein Engineering/*methods
PMC - PMC4900928
MID - NIHMS766766
EDAT- 2016/05/03 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/05/03 06:00
PHST- 2015/07/24 00:00 [received]
PHST- 2016/03/07 00:00 [accepted]
PHST- 2016/05/03 06:00 [entrez]
PHST- 2016/05/03 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3528 [pii]
AID - 10.1038/nbt.3528 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun;34(6):646-51. doi: 10.1038/nbt.3528. Epub 2016 May 2.

PMID- 27136076
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20171206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun
TI  - Wishbone identifies bifurcating developmental trajectories from single-cell data.
PG  - 637-45
LID - 10.1038/nbt.3569 [doi]
AB  - Recent single-cell analysis technologies offer an unprecedented opportunity to
      elucidate developmental pathways. Here we present Wishbone, an algorithm for
      positioning single cells along bifurcating developmental trajectories with high
      resolution. Wishbone uses multi-dimensional single-cell data, such as mass
      cytometry or RNA-Seq data, as input and orders cells according to their
      developmental progression, and it pinpoints bifurcation points by labeling each
      cell as pre-bifurcation or as one of two post-bifurcation cell fates. Using
      30-channel mass cytometry data, we show that Wishbone accurately recovers the
      known stages of T-cell development in the mouse thymus, including the bifurcation
      point. We also apply the algorithm to mouse myeloid differentiation and
      demonstrate its generalization to additional lineages. A comparison of Wishbone
      to diffusion maps, SCUBA and Monocle shows that it outperforms these methods both
      in the accuracy of ordering cells and in the correct identification of branch
      points.
FAU - Setty, Manu
AU  - Setty M
AD  - Department of Biological Sciences, Department of Systems Biology, Columbia
      University, New York, New York, USA.
FAU - Tadmor, Michelle D
AU  - Tadmor MD
AD  - Department of Biological Sciences, Department of Systems Biology, Columbia
      University, New York, New York, USA.
FAU - Reich-Zeliger, Shlomit
AU  - Reich-Zeliger S
AD  - Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
FAU - Angel, Omer
AU  - Angel O
AD  - Department of Mathematics, University of British Columbia, Vancouver, British
      Columbia, Canada.
FAU - Salame, Tomer Meir
AU  - Salame TM
AD  - Biological Services Unit, Weizmann Institute of Science, Rehovot, Israel.
FAU - Kathail, Pooja
AU  - Kathail P
AD  - Department of Biological Sciences, Department of Systems Biology, Columbia
      University, New York, New York, USA.
FAU - Choi, Kristy
AU  - Choi K
AD  - Department of Biological Sciences, Department of Systems Biology, Columbia
      University, New York, New York, USA.
FAU - Bendall, Sean
AU  - Bendall S
AD  - Department of Pathology, Stanford University, Stanford, California, USA.
FAU - Friedman, Nir
AU  - Friedman N
AD  - Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
FAU - Pe'er, Dana
AU  - Pe'er D
AD  - Department of Biological Sciences, Department of Systems Biology, Columbia
      University, New York, New York, USA.
LA  - eng
GR  - DP1 HD084071/HD/NICHD NIH HHS/United States
GR  - R01 CA164729/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PT  - Research Support, Non-U.S. Gov't
DEP - 20160502
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Algorithms
MH  - Animals
MH  - Cell Differentiation/*physiology
MH  - Computer Simulation
MH  - Mice
MH  - *Models, Biological
MH  - Morphogenesis/*physiology
MH  - Software
MH  - T-Lymphocytes/*cytology/*physiology
PMC - PMC4900897
MID - NIHMS777794
EDAT- 2016/05/03 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/05/03 06:00
PHST- 2015/11/19 00:00 [received]
PHST- 2016/04/12 00:00 [accepted]
PHST- 2016/05/03 06:00 [entrez]
PHST- 2016/05/03 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3569 [pii]
AID - 10.1038/nbt.3569 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun;34(6):637-45. doi: 10.1038/nbt.3569. Epub 2016 May 2.

PMID- 27111723
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20171206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun
TI  - A pigeonpea gene confers resistance to Asian soybean rust in soybean.
PG  - 661-5
LID - 10.1038/nbt.3554 [doi]
AB  - Asian soybean rust (ASR), caused by the fungus Phakopsora pachyrhizi, is one of
      the most economically important crop diseases, but is only treatable with
      fungicides, which are becoming less effective owing to the emergence of fungicide
      resistance. There are no commercial soybean cultivars with durable resistance to 
      P. pachyrhizi, and although soybean resistance loci have been mapped, no
      resistance genes have been cloned. We report the cloning of a P. pachyrhizi
      resistance gene CcRpp1 (Cajanus cajan Resistance against Phakopsora pachyrhizi 1)
      from pigeonpea (Cajanus cajan) and show that CcRpp1 confers full resistance to P.
      pachyrhizi in soybean. Our findings show that legume species related to soybean
      such as pigeonpea, cowpea, common bean and others could provide a valuable and
      diverse pool of resistance traits for crop improvement.
FAU - Kawashima, Cintia G
AU  - Kawashima CG
AD  - The Sainsbury Laboratory, Norwich, U.K.
FAU - Guimaraes, Gustavo Augusto
AU  - Guimaraes GA
AD  - Dep. de Fitopatologia, Universidade Federal de Vicosa, Vicosa, Brazil.
FAU - Nogueira, Sonia Regina
AU  - Nogueira SR
AD  - Dep. de Fitopatologia, Universidade Federal de Vicosa, Vicosa, Brazil.
FAU - MacLean, Dan
AU  - MacLean D
AUID- ORCID: 0000-0003-1032-0887
AD  - The Sainsbury Laboratory, Norwich, U.K.
FAU - Cook, Doug R
AU  - Cook DR
AD  - Department of Plant Pathology, University of California Davis, Davis, California,
      USA.
FAU - Steuernagel, Burkhard
AU  - Steuernagel B
AD  - The Sainsbury Laboratory, Norwich, U.K.
FAU - Baek, Jongmin
AU  - Baek J
AD  - Department of Plant Pathology, University of California Davis, Davis, California,
      USA.
FAU - Bouyioukos, Costas
AU  - Bouyioukos C
AUID- ORCID: 0000-0002-7443-3736
AD  - The Sainsbury Laboratory, Norwich, U.K.
FAU - Melo, Bernardo do V A
AU  - Melo Bdo V
AD  - Dep. de Fitopatologia, Universidade Federal de Vicosa, Vicosa, Brazil.
FAU - Tristao, Gustavo
AU  - Tristao G
AD  - Dep. de Fitopatologia, Universidade Federal de Vicosa, Vicosa, Brazil.
FAU - de Oliveira, Jamile Camargos
AU  - de Oliveira JC
AD  - Dep. de Fitopatologia, Universidade Federal de Vicosa, Vicosa, Brazil.
FAU - Rauscher, Gilda
AU  - Rauscher G
AD  - Agricultural Biotechnology, DuPont-Pioneer, Wilmington, Delaware, USA.
FAU - Mittal, Shipra
AU  - Mittal S
AD  - Agricultural Biotechnology, DuPont-Pioneer, Wilmington, Delaware, USA.
FAU - Panichelli, Lisa
AU  - Panichelli L
AD  - Agricultural Biotechnology, DuPont-Pioneer, Wilmington, Delaware, USA.
FAU - Bacot, Karen
AU  - Bacot K
AD  - Agricultural Biotechnology, DuPont-Pioneer, Wilmington, Delaware, USA.
FAU - Johnson, Ebony
AU  - Johnson E
AD  - Agricultural Biotechnology, DuPont-Pioneer, Wilmington, Delaware, USA.
FAU - Iyer, Geeta
AU  - Iyer G
AD  - Agricultural Biotechnology, DuPont-Pioneer, Wilmington, Delaware, USA.
FAU - Tabor, Girma
AU  - Tabor G
AD  - Agricultural Biotechnology, DuPont-Pioneer, Wilmington, Delaware, USA.
FAU - Wulff, Brande B H
AU  - Wulff BB
AD  - The Sainsbury Laboratory, Norwich, U.K.
FAU - Ward, Eric
AU  - Ward E
AD  - 2Blades Foundation, Evanston, Illinois, USA.
FAU - Rairdan, Gregory J
AU  - Rairdan GJ
AD  - Agricultural Biotechnology, DuPont-Pioneer, Wilmington, Delaware, USA.
FAU - Broglie, Karen E
AU  - Broglie KE
AD  - Agricultural Biotechnology, DuPont-Pioneer, Wilmington, Delaware, USA.
FAU - Wu, Gusui
AU  - Wu G
AD  - Agricultural Biotechnology, DuPont-Pioneer, Wilmington, Delaware, USA.
FAU - van Esse, H Peter
AU  - van Esse HP
AUID- ORCID: 0000-0002-3667-060X
AD  - The Sainsbury Laboratory, Norwich, U.K.
FAU - Jones, Jonathan D G
AU  - Jones JD
AD  - The Sainsbury Laboratory, Norwich, U.K.
FAU - Brommonschenkel, Sergio H
AU  - Brommonschenkel SH
AD  - Dep. de Fitopatologia, Universidade Federal de Vicosa, Vicosa, Brazil.
LA  - eng
PT  - Journal Article
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PT  - Research Support, Non-U.S. Gov't
DEP - 20160425
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CIN - Nat Biotechnol. 2016 Jun 9;34(6):620-1. PMID: 27281420
MH  - Cajanus/*genetics
MH  - Cloning, Molecular/methods
MH  - Disease Resistance/*genetics
MH  - Genes, Plant/*genetics
MH  - Genetic Enhancement/methods
MH  - Phakopsora pachyrhizi/*physiology
MH  - Soybeans/*genetics/*microbiology
EDAT- 2016/04/26 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/04/26 06:00
PHST- 2015/08/28 00:00 [received]
PHST- 2016/03/24 00:00 [accepted]
PHST- 2016/04/26 06:00 [entrez]
PHST- 2016/04/26 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3554 [pii]
AID - 10.1038/nbt.3554 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun;34(6):661-5. doi: 10.1038/nbt.3554. Epub 2016 Apr 25.

PMID- 27111722
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20171206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun
TI  - Rapid cloning of disease-resistance genes in plants using mutagenesis and
      sequence capture.
PG  - 652-5
LID - 10.1038/nbt.3543 [doi]
AB  - Wild relatives of domesticated crop species harbor multiple, diverse, disease
      resistance (R) genes that could be used to engineer sustainable disease control. 
      However, breeding R genes into crop lines often requires long breeding timelines 
      of 5-15 years to break linkage between R genes and deleterious alleles (linkage
      drag). Further, when R genes are bred one at a time into crop lines, the
      protection that they confer is often overcome within a few seasons by pathogen
      evolution. If several cloned R genes were available, it would be possible to
      pyramid R genes in a crop, which might provide more durable resistance. We
      describe a three-step method (MutRenSeq)-that combines chemical mutagenesis with 
      exome capture and sequencing for rapid R gene cloning. We applied MutRenSeq to
      clone stem rust resistance genes Sr22 and Sr45 from hexaploid bread wheat.
      MutRenSeq can be applied to other commercially relevant crops and their
      relatives, including, for example, pea, bean, barley, oat, rye, rice and maize.
FAU - Steuernagel, Burkhard
AU  - Steuernagel B
AD  - The Sainsbury Laboratory, Norwich, UK.
AD  - John Innes Centre, Norwich, UK.
FAU - Periyannan, Sambasivam K
AU  - Periyannan SK
AD  - Commonwealth Scientific and Industrial Research Organization (CSIRO), Agriculture
      Flagship, Canberra, NSW, Australia.
FAU - Hernandez-Pinzon, Inmaculada
AU  - Hernandez-Pinzon I
AD  - The Sainsbury Laboratory, Norwich, UK.
FAU - Witek, Kamil
AU  - Witek K
AD  - The Sainsbury Laboratory, Norwich, UK.
FAU - Rouse, Matthew N
AU  - Rouse MN
AD  - USDA-ARS Cereal Disease Laboratory and Department of Plant Pathology, University 
      of Minnesota, St. Paul, Minnesota, USA.
FAU - Yu, Guotai
AU  - Yu G
AD  - John Innes Centre, Norwich, UK.
FAU - Hatta, Asyraf
AU  - Hatta A
AD  - John Innes Centre, Norwich, UK.
AD  - Department of Agriculture Technology, Universiti Putra Malaysia, Serdang,
      Malaysia.
FAU - Ayliffe, Mick
AU  - Ayliffe M
AD  - Commonwealth Scientific and Industrial Research Organization (CSIRO), Agriculture
      Flagship, Canberra, NSW, Australia.
FAU - Bariana, Harbans
AU  - Bariana H
AD  - University of Sydney, Plant Breeding Institute, Cobbitty, NSW, Australia.
FAU - Jones, Jonathan D G
AU  - Jones JD
AD  - The Sainsbury Laboratory, Norwich, UK.
FAU - Lagudah, Evans S
AU  - Lagudah ES
AD  - Commonwealth Scientific and Industrial Research Organization (CSIRO), Agriculture
      Flagship, Canberra, NSW, Australia.
FAU - Wulff, Brande B H
AU  - Wulff BB
AD  - The Sainsbury Laboratory, Norwich, UK.
AD  - John Innes Centre, Norwich, UK.
LA  - eng
GR  - Biotechnology and Biological Sciences Research Council/United Kingdom
PT  - Journal Article
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PT  - Research Support, Non-U.S. Gov't
DEP - 20160425
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CIN - Nat Biotechnol. 2016 Jun 9;34(6):620-1. PMID: 27281420
MH  - Cloning, Molecular/*methods
MH  - Disease Resistance/*genetics
MH  - Genes, Plant/*genetics
MH  - Genetic Enhancement/methods
MH  - Mutagenesis, Site-Directed/*methods
MH  - Plant Diseases/*genetics/prevention & control
MH  - Plants/*genetics
MH  - Plants, Genetically Modified/genetics
MH  - Sequence Analysis, DNA/methods
EDAT- 2016/04/26 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/04/26 06:00
PHST- 2015/08/19 00:00 [received]
PHST- 2016/03/16 00:00 [accepted]
PHST- 2016/04/26 06:00 [entrez]
PHST- 2016/04/26 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3543 [pii]
AID - 10.1038/nbt.3543 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun;34(6):652-5. doi: 10.1038/nbt.3543. Epub 2016 Apr 25.

PMID- 27111721
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20171206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun
TI  - Accelerated cloning of a potato late blight-resistance gene using RenSeq and SMRT
      sequencing.
PG  - 656-60
LID - 10.1038/nbt.3540 [doi]
AB  - Global yields of potato and tomato crops have fallen owing to potato late blight 
      disease, which is caused by Phytophthora infestans. Although most commercial
      potato varieties are susceptible to blight, many wild potato relatives show
      variation for resistance and are therefore a potential source of Resistance to P.
      infestans (Rpi) genes. Resistance breeding has exploited Rpi genes from closely
      related tuber-bearing potato relatives, but is laborious and slow. Here we report
      that the wild, diploid non-tuber-bearing Solanum americanum harbors multiple Rpi 
      genes. We combine resistance (R) gene sequence capture (RenSeq) with
      single-molecule real-time (SMRT) sequencing (SMRT RenSeq) to clone Rpi-amr3i.
      This technology should enable de novo assembly of complete nucleotide-binding,
      leucine-rich repeat receptor (NLR) genes, their regulatory elements and complex
      multi-NLR loci from uncharacterized germplasm. SMRT RenSeq can be applied to
      rapidly clone multiple R genes for engineering pathogen-resistant crops.
FAU - Witek, Kamil
AU  - Witek K
AD  - The Sainsbury Laboratory, Norwich Research Park, Norwich, UK.
FAU - Jupe, Florian
AU  - Jupe F
AD  - The Sainsbury Laboratory, Norwich Research Park, Norwich, UK.
FAU - Witek, Agnieszka I
AU  - Witek AI
AD  - The Sainsbury Laboratory, Norwich Research Park, Norwich, UK.
FAU - Baker, David
AU  - Baker D
AD  - The Genome Analysis Centre (TGAC), Norwich Research Park, Norwich, UK.
FAU - Clark, Matthew D
AU  - Clark MD
AD  - The Genome Analysis Centre (TGAC), Norwich Research Park, Norwich, UK.
FAU - Jones, Jonathan D G
AU  - Jones JD
AD  - The Sainsbury Laboratory, Norwich Research Park, Norwich, UK.
LA  - eng
GR  - BB/C007522/1/Biotechnology and Biological Sciences Research Council/United
      Kingdom
GR  - BB/G02197X/1/Biotechnology and Biological Sciences Research Council/United
      Kingdom
GR  - BB/H019820/1/Biotechnology and Biological Sciences Research Council/United
      Kingdom
GR  - BB/L011794/1/Biotechnology and Biological Sciences Research Council/United
      Kingdom
GR  - BB/L009757/1/Biotechnology and Biological Sciences Research Council/United
      Kingdom
GR  - BB/J010375/1 /Biotechnology and Biological Sciences Research Council/United
      Kingdom
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20160425
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Fungal Proteins)
SB  - IM
CIN - Nat Biotechnol. 2016 Jun 9;34(6):620-1. PMID: 27281420
MH  - Cloning, Molecular/methods
MH  - Computer Systems
MH  - Fungal Proteins/*genetics
MH  - High-Throughput Nucleotide Sequencing/methods
MH  - Phytophthora/*genetics
MH  - Plant Diseases/*genetics/*microbiology/prevention & control
MH  - Solanum tuberosum/*genetics/*microbiology
EDAT- 2016/04/26 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/04/26 06:00
PHST- 2015/08/19 00:00 [received]
PHST- 2016/03/15 00:00 [accepted]
PHST- 2016/04/26 06:00 [entrez]
PHST- 2016/04/26 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3540 [pii]
AID - 10.1038/nbt.3540 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun;34(6):656-60. doi: 10.1038/nbt.3540. Epub 2016 Apr 25.

PMID- 27111720
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20171206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 Jun
TI  - CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential 
      genes.
PG  - 631-3
LID - 10.1038/nbt.3536 [doi]
AB  - High-throughput genetic screens have become essential tools for studying a wide
      variety of biological processes. Here we experimentally compare systems based on 
      clustered regularly interspaced short palindromic repeat
      (CRISPR)/CRISPR-associated protein 9 (Cas9) or its transcriptionally repressive
      variant, CRISPR-interference (CRISPRi), with a traditional short hairpin RNA
      (shRNA)-based system for performing lethality screens. We find that the CRISPR
      technology performed best, with low noise, minimal off-target effects and
      consistent activity across reagents.
FAU - Evers, Bastiaan
AU  - Evers B
AD  - Division of Molecular Carcinogenesis, Cancer Systems Biology Centre and Cancer
      Genomics Centre Netherlands, The Netherlands Cancer Institute, Amsterdam, the
      Netherlands.
FAU - Jastrzebski, Katarzyna
AU  - Jastrzebski K
AD  - Division of Molecular Carcinogenesis, Cancer Systems Biology Centre and Cancer
      Genomics Centre Netherlands, The Netherlands Cancer Institute, Amsterdam, the
      Netherlands.
FAU - Heijmans, Jeroen P M
AU  - Heijmans JP
AD  - Division of Molecular Carcinogenesis, Cancer Systems Biology Centre and Cancer
      Genomics Centre Netherlands, The Netherlands Cancer Institute, Amsterdam, the
      Netherlands.
FAU - Grernrum, Wipawadee
AU  - Grernrum W
AD  - Division of Molecular Carcinogenesis, Cancer Systems Biology Centre and Cancer
      Genomics Centre Netherlands, The Netherlands Cancer Institute, Amsterdam, the
      Netherlands.
FAU - Beijersbergen, Roderick L
AU  - Beijersbergen RL
AD  - Division of Molecular Carcinogenesis, Cancer Systems Biology Centre and Cancer
      Genomics Centre Netherlands, The Netherlands Cancer Institute, Amsterdam, the
      Netherlands.
FAU - Bernards, Rene
AU  - Bernards R
AUID- ORCID: http://orcid.org/0000-0001-8677-3423
AD  - Division of Molecular Carcinogenesis, Cancer Systems Biology Centre and Cancer
      Genomics Centre Netherlands, The Netherlands Cancer Institute, Amsterdam, the
      Netherlands.
LA  - eng
PT  - Comparative Study
PT  - Evaluation Studies
PT  - Journal Article
DEP - 20160425
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Genetic Markers)
RN  - 0 (RNA, Small Interfering)
SB  - IM
CIN - Nat Biotechnol. 2016 Jun 9;34(6):621-3. PMID: 27281421
MH  - Clustered Regularly Interspaced Short Palindromic Repeats/*genetics
MH  - Gene Expression Profiling/*methods
MH  - Gene Knockout Techniques/*methods
MH  - Genetic Markers/*genetics
MH  - Genetic Testing/*methods
MH  - RNA, Small Interfering/*genetics
EDAT- 2016/04/26 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/04/26 06:00
PHST- 2015/10/12 00:00 [received]
PHST- 2016/03/11 00:00 [accepted]
PHST- 2016/04/26 06:00 [entrez]
PHST- 2016/04/26 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3536 [pii]
AID - 10.1038/nbt.3536 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jun;34(6):631-3. doi: 10.1038/nbt.3536. Epub 2016 Apr 25.

PMID- 27281414
OWN - NLM
STAT- MEDLINE
DCOM- 20171207
LR  - 20171207
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 6
DP  - 2016 May 6
TI  - Reply to The contribution of cell cycle to heterogeneity in single-cell RNA-seq
      data.
PG  - 593-5
LID - 10.1038/nbt.3607 [doi]
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 63231-63-0 (RNA)
SB  - IM
CON - Nat Biotechnol. 2016 Jun 9;34(6):591-3. PMID: 27281413
CON - Nat Biotechnol. 2015 Feb;33(2):155-60. PMID: 25599176
MH  - Cell Cycle
MH  - High-Throughput Nucleotide Sequencing
MH  - *RNA
MH  - *Sequence Analysis, RNA
EDAT- 2016/06/10 06:00
MHDA- 2017/12/08 06:00
CRDT- 2016/06/10 06:00
PHST- 2016/06/10 06:00 [entrez]
PHST- 2016/06/10 06:00 [pubmed]
PHST- 2017/12/08 06:00 [medline]
AID - nbt.3607 [pii]
AID - 10.1038/nbt.3607 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May 6;34(6):593-5. doi: 10.1038/nbt.3607.

PMID- 27153286
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20171208
LR  - 20171208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May 6
TI  - First-quarter biotech job picture.
PG  - 571
LID - 10.1038/nbt.3572 [doi]
FAU - Francisco, Michael
AU  - Francisco M
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/05/08 06:00
MHDA- 2016/05/08 06:01
CRDT- 2016/05/07 06:00
PHST- 2016/05/07 06:00 [entrez]
PHST- 2016/05/08 06:00 [pubmed]
PHST- 2016/05/08 06:01 [medline]
AID - nbt.3572 [pii]
AID - 10.1038/nbt.3572 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May 6;34(5):571. doi: 10.1038/nbt.3572.

PMID- 27153285
OWN - NLM
STAT- MEDLINE
DCOM- 20171208
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May 6
TI  - Three decades of nanopore sequencing.
PG  - 518-24
LID - 10.1038/nbt.3423 [doi]
FAU - Deamer, David
AU  - Deamer D
AD  - Department of Biomolecular Engineering, University of California, Santa Cruz,
      California, USA.
FAU - Akeson, Mark
AU  - Akeson M
AD  - Department of Biomolecular Engineering, University of California, Santa Cruz,
      California, USA.
FAU - Branton, Daniel
AU  - Branton D
AD  - Department of Molecular &Cellular Biology, Harvard University, Cambridge,
      Massachusetts, USA.
LA  - eng
GR  - R01 HG007827/HG/NHGRI NIH HHS/United States
GR  - R01 HG006321/HG/NHGRI NIH HHS/United States
GR  - R01 HG003703/HG/NHGRI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Review
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Lipid Bilayers)
RN  - 9007-49-2 (DNA)
SB  - IM
CIN - Nat Biotechnol. 2016 May 6;34(5):481-2. PMID: 27153275
CIN - Nat Biotechnol. 2016 May 6;34(5):482. PMID: 27153276
CIN - Nat Biotechnol. 2016 Aug 9;34(8):810-1. PMID: 27504770
MH  - Conductometry/*trends
MH  - DNA/chemistry/*genetics
MH  - High-Throughput Nucleotide Sequencing/*trends
MH  - Lipid Bilayers/*chemistry
MH  - Nanopores/*ultrastructure
MH  - Sequence Analysis, DNA/*trends
EDAT- 2016/05/08 06:00
MHDA- 2017/12/09 06:00
CRDT- 2016/05/07 06:00
PHST- 2016/05/07 06:00 [entrez]
PHST- 2016/05/08 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt.3423 [pii]
AID - 10.1038/nbt.3423 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May 6;34(5):518-24. doi: 10.1038/nbt.3423.

PMID- 27153283
OWN - NLM
STAT- MEDLINE
DCOM- 20171207
LR  - 20171207
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May 6
TI  - Inducing tolerance one antigen at a time.
PG  - 515-7
LID - 10.1038/nbt.3573 [doi]
FAU - Rezende, Rafael M
AU  - Rezende RM
AD  - Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard 
      Medical School, Boston, Massachusetts, USA.
FAU - Weiner, Howard L
AU  - Weiner HL
AD  - Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard 
      Medical School, Boston, Massachusetts, USA.
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antigens)
SB  - IM
CON - Nature. 2016 Feb 25;530(7591):434-40. PMID: 26886799
MH  - *Antigens
MH  - Humans
MH  - Immune Tolerance/*immunology
EDAT- 2016/05/08 06:00
MHDA- 2017/12/08 06:00
CRDT- 2016/05/07 06:00
PHST- 2016/05/07 06:00 [entrez]
PHST- 2016/05/08 06:00 [pubmed]
PHST- 2017/12/08 06:00 [medline]
AID - nbt.3573 [pii]
AID - 10.1038/nbt.3573 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May 6;34(5):515-7. doi: 10.1038/nbt.3573.

PMID- 27153282
OWN - NLM
STAT- MEDLINE
DCOM- 20171207
LR  - 20171207
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May 6
TI  - A microbial factory for diverse chemicals.
PG  - 513-5
LID - 10.1038/nbt.3565 [doi]
FAU - Ng, Chiam Yu
AU  - Ng CY
AD  - Department of Chemical Engineering, The Pennsylvania State University, University
      Park, Pennsylvania, USA.
FAU - Chowdhury, Anupam
AU  - Chowdhury A
AD  - Department of Chemical Engineering, The Pennsylvania State University, University
      Park, Pennsylvania, USA.
FAU - Maranas, Costas D
AU  - Maranas CD
AD  - Department of Chemical Engineering, The Pennsylvania State University, University
      Park, Pennsylvania, USA.
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Biofuels)
SB  - IM
CON - Nat Biotechnol. 2016 May;34(5):556-61. PMID: 27088721
MH  - *Biofuels
MH  - *Metabolic Engineering
EDAT- 2016/05/08 06:00
MHDA- 2017/12/08 06:00
CRDT- 2016/05/07 06:00
PHST- 2016/05/07 06:00 [entrez]
PHST- 2016/05/08 06:00 [pubmed]
PHST- 2017/12/08 06:00 [medline]
AID - nbt.3565 [pii]
AID - 10.1038/nbt.3565 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May 6;34(5):513-5. doi: 10.1038/nbt.3565.

PMID- 27153280
OWN - NLM
STAT- MEDLINE
DCOM- 20171208
LR  - 20171208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May 6
TI  - Intellectual property policies in early-phase research in public-private
      partnerships.
PG  - 504-10
LID - 10.1038/nbt.3562 [doi]
FAU - Stevens, Hilde
AU  - Stevens H
AD  - Department of Pharmaceutical and Pharmacological Sciences, Research Centre for
      Clinical Pharmacology and Pharmacotherapy, University of Leuven, Leuven, Belgium.
AD  - Centre for IT &IP Law (CiTiP), University of Leuven, Leuven, Belgium.
AD  - Institute for Interdisciplinary Innovation in healthcare (Ih), Universite libre
      de Bruxelles, Brussels, Belgium.
FAU - Van Overwalle, Geertrui
AU  - Van Overwalle G
AD  - Centre for IT &IP Law (CiTiP), University of Leuven, Leuven, Belgium.
AD  - Visiting professor, Tilburg University, Tilburg, the Netherlands.
FAU - Van Looy, Bart
AU  - Van Looy B
AD  - Department of Managerial Economics, Strategy and Innovation, University of
      Leuven, Leuven, Belgium.
AD  - Centre for Research and Development Monitoring, Leuven, Belgium.
FAU - Huys, Isabelle
AU  - Huys I
AD  - Department of Pharmaceutical and Pharmacological Sciences, Research Centre for
      Clinical Pharmacology and Pharmacotherapy, University of Leuven, Leuven, Belgium.
AD  - Centre for IT &IP Law (CiTiP), University of Leuven, Leuven, Belgium.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Drug Industry/*organization & administration
MH  - *Intellectual Property
MH  - *Models, Organizational
MH  - Organizational Policy
MH  - Ownership/*organization & administration
MH  - Private Sector/organization & administration
MH  - Public Sector/organization & administration
MH  - Public-Private Sector Partnerships/*organization & administration
MH  - Research/*organization & administration
EDAT- 2016/05/08 06:00
MHDA- 2017/12/09 06:00
CRDT- 2016/05/07 06:00
PHST- 2016/05/07 06:00 [entrez]
PHST- 2016/05/08 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt.3562 [pii]
AID - 10.1038/nbt.3562 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May 6;34(5):504-10. doi: 10.1038/nbt.3562.

PMID- 27153279
OWN - NLM
STAT- MEDLINE
DCOM- 20171208
LR  - 20171208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May 6
TI  - A risk-based approach to the regulation of genetically engineered organisms.
PG  - 493-503
LID - 10.1038/nbt.3568 [doi]
FAU - Conko, Gregory
AU  - Conko G
AD  - Competitive Enterprise Institute, Washington, DC, USA.
FAU - Kershen, Drew L
AU  - Kershen DL
AD  - Earl Sneed Centennial Professor of Law Emeritus at the University of Oklahoma
      College of Law, Norman, Oklahoma, USA.
FAU - Miller, Henry
AU  - Miller H
AD  - Robert Wesson Fellow in Scientific Philosophy and Public Policy at the Hoover
      Institution, Stanford University, Stanford, California, USA.
FAU - Parrott, Wayne A
AU  - Parrott WA
AD  - Institute for Plant Breeding Genetics &Genomics, University of Georgia, Athens,
      Georgia, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Agriculture/*legislation & jurisprudence
MH  - Crops, Agricultural/*genetics
MH  - Food, Genetically Modified
MH  - Genetic Engineering/*legislation & jurisprudence
MH  - *Government Regulation
MH  - Plants, Genetically Modified/*genetics
MH  - Risk Assessment/*legislation & jurisprudence/*methods
MH  - United States
EDAT- 2016/05/08 06:00
MHDA- 2017/12/09 06:00
CRDT- 2016/05/07 06:00
PHST- 2016/05/07 06:00 [entrez]
PHST- 2016/05/08 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt.3568 [pii]
AID - 10.1038/nbt.3568 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May 6;34(5):493-503. doi: 10.1038/nbt.3568.

PMID- 27153278
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20171208
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May 6
TI  - Nature Biotechnology's academic spinouts of 2015.
PG  - 484-92
LID - 10.1038/nbt.3564 [doi]
FAU - Bouchie, Aaron
AU  - Bouchie A
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EIN - Nat Biotechnol. 2016 Aug 9;34(8):888. PMID: 27504782
EDAT- 2016/05/08 06:00
MHDA- 2016/05/08 06:01
CRDT- 2016/05/07 06:00
PHST- 2016/05/07 06:00 [entrez]
PHST- 2016/05/08 06:00 [pubmed]
PHST- 2016/05/08 06:01 [medline]
AID - nbt.3564 [pii]
AID - 10.1038/nbt.3564 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May 6;34(5):484-92. doi: 10.1038/nbt.3564.

PMID- 27153277
OWN - NLM
STAT- MEDLINE
DCOM- 20171208
LR  - 20171208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May 6
TI  - Open-source guideseq software for analysis of GUIDE-seq data.
PG  - 483
LID - 10.1038/nbt.3534 [doi]
FAU - Tsai, Shengdar Q
AU  - Tsai SQ
AD  - Molecular Pathology Unit, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Cancer Research, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Computational and Integrative Biology, Massachusetts General Hospital,
      Charlestown, Massachusetts, USA.
AD  - Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Topkar, Ved V
AU  - Topkar VV
AD  - Molecular Pathology Unit, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Cancer Research, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Computational and Integrative Biology, Massachusetts General Hospital,
      Charlestown, Massachusetts, USA.
FAU - Joung, J Keith
AU  - Joung JK
AD  - Molecular Pathology Unit, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Cancer Research, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Computational and Integrative Biology, Massachusetts General Hospital,
      Charlestown, Massachusetts, USA.
AD  - Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Aryee, Martin J
AU  - Aryee MJ
AUID- ORCID: 0000-0002-6848-1344
AD  - Molecular Pathology Unit, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Cancer Research, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA.
AD  - Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston,
      Massachusetts, USA.
LA  - eng
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Access to Information
MH  - *Algorithms
MH  - *Clustered Regularly Interspaced Short Palindromic Repeats
MH  - High-Throughput Nucleotide Sequencing/*methods
MH  - Internet
MH  - *Programming Languages
MH  - Sequence Analysis, DNA/*methods
MH  - *Software
EDAT- 2016/05/08 06:00
MHDA- 2017/12/09 06:00
CRDT- 2016/05/07 06:00
PHST- 2016/05/07 06:00 [entrez]
PHST- 2016/05/08 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt.3534 [pii]
AID - 10.1038/nbt.3534 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May 6;34(5):483. doi: 10.1038/nbt.3534.

PMID- 27153276
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20171207
LR  - 20171207
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May 6
TI  - Author response to John Kasianowicz and Sergey Bezrukov.
PG  - 482
LID - 10.1038/nbt.3561 [doi]
FAU - Deamer, David
AU  - Deamer D
AD  - Department of Biomolecular Engineering, University of California, Santa Cruz,
      California, USA.
FAU - Akeson, Mark
AU  - Akeson M
AD  - Department of Biomolecular Engineering, University of California, Santa Cruz,
      California, USA.
FAU - Branton, Daniel
AU  - Branton D
AD  - Department of Molecular &Cellular Biology, Harvard University, Cambridge,
      Massachusetts, USA.
LA  - eng
GR  - R01 HG007827/HG/NHGRI NIH HHS/United States
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
CON - Nat Biotechnol. 2016 May 6;34(5):481-2. PMID: 27153275
CON - Nat Biotechnol. 2016 May 6;34(5):518-24. PMID: 27153285
PMC - PMC4926642
MID - NIHMS797630
EDAT- 2016/05/08 06:00
MHDA- 2016/05/08 06:01
CRDT- 2016/05/07 06:00
PHST- 2016/05/07 06:00 [entrez]
PHST- 2016/05/08 06:00 [pubmed]
PHST- 2016/05/08 06:01 [medline]
AID - nbt.3561 [pii]
AID - 10.1038/nbt.3561 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May 6;34(5):482. doi: 10.1038/nbt.3561.

PMID- 27153275
OWN - NLM
STAT- MEDLINE
DCOM- 20171207
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May 6
TI  - On 'three decades of nanopore sequencing'.
PG  - 481-2
LID - 10.1038/nbt.3570 [doi]
FAU - Kasianowicz, John J
AU  - Kasianowicz JJ
AD  - National Institute of Standards and Technology, Physical Measurement Laboratory, 
      Gaithersburg, Maryland, USA.
FAU - Bezrukov, Sergey M
AU  - Bezrukov SM
AD  - National Institutes of Health, Eunice Kennedy Shriver National Institute of Child
      Health and Human Development, Bethesda, Maryland, USA.
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2016 May 6;34(5):518-24. PMID: 27153285
CIN - Nat Biotechnol. 2016 May 6;34(5):482. PMID: 27153276
CIN - Nat Biotechnol. 2016 Aug 9;34(8):810-1. PMID: 27504770
MH  - Humans
MH  - *Nanopores
MH  - *Sequence Analysis, DNA
EDAT- 2016/05/08 06:00
MHDA- 2017/12/08 06:00
CRDT- 2016/05/07 06:00
PHST- 2016/05/07 06:00 [entrez]
PHST- 2016/05/08 06:00 [pubmed]
PHST- 2017/12/08 06:00 [medline]
AID - nbt.3570 [pii]
AID - 10.1038/nbt.3570 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May 6;34(5):481-2. doi: 10.1038/nbt.3570.

PMID- 27153274
OWN - NLM
STAT- MEDLINE
DCOM- 20171208
LR  - 20171208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May 6
TI  - Production of hornless dairy cattle from genome-edited cell lines.
PG  - 479-81
LID - 10.1038/nbt.3560 [doi]
FAU - Carlson, Daniel F
AU  - Carlson DF
AD  - Recombinetics, St. Paul, Minnesota, USA.
FAU - Lancto, Cheryl A
AU  - Lancto CA
AD  - Recombinetics, St. Paul, Minnesota, USA.
FAU - Zang, Bin
AU  - Zang B
AD  - Program in Scientific Computation, University of Minnesota, Minneapolis
      Minnesota, USA.
FAU - Kim, Eui-Soo
AU  - Kim ES
AD  - Recombinetics, St. Paul, Minnesota, USA.
FAU - Walton, Mark
AU  - Walton M
AD  - Recombinetics, St. Paul, Minnesota, USA.
FAU - Oldeschulte, David
AU  - Oldeschulte D
AUID- ORCID: 0000-0001-9704-7670
AD  - Department of Veterinary Pathobiology, College of Veterinary Medicine, Texas A&M 
      University, College Station, Texas, USA.
FAU - Seabury, Christopher
AU  - Seabury C
AD  - Department of Veterinary Pathobiology, College of Veterinary Medicine, Texas A&M 
      University, College Station, Texas, USA.
FAU - Sonstegard, Tad S
AU  - Sonstegard TS
AD  - Recombinetics, St. Paul, Minnesota, USA.
FAU - Fahrenkrug, Scott C
AU  - Fahrenkrug SC
AD  - Recombinetics, St. Paul, Minnesota, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CIN - Nat Biotechnol. 2016 May 6;34(5):477-9. PMID: 27153273
MH  - Animals
MH  - Animals, Genetically Modified/*genetics
MH  - Cattle/*genetics
MH  - Cell Line
MH  - Dairying/*methods
MH  - Female
MH  - Gene Editing/*methods
MH  - Genetic Enhancement/*methods
MH  - Horns/*growth & development
EDAT- 2016/05/08 06:00
MHDA- 2017/12/09 06:00
CRDT- 2016/05/07 06:00
PHST- 2016/05/07 06:00 [entrez]
PHST- 2016/05/08 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt.3560 [pii]
AID - 10.1038/nbt.3560 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May 6;34(5):479-81. doi: 10.1038/nbt.3560.

PMID- 27153273
OWN - NLM
STAT- MEDLINE
DCOM- 20171207
LR  - 20171207
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May 6
TI  - Regulate genome-edited products, not genome editing itself.
PG  - 477-9
LID - 10.1038/nbt.3566 [doi]
FAU - Carroll, Dana
AU  - Carroll D
AUID- ORCID: 0000-0002-3241-3331
AD  - Department of Biochemistry, University of Utah School of Medicine, Salt Lake
      City, Utah, USA.
FAU - Van Eenennaam, Alison L
AU  - Van Eenennaam AL
AD  - Department of Animal Science, University of California, Davis, California, USA.
FAU - Taylor, Jeremy F
AU  - Taylor JF
AD  - Division of Animal Sciences, University of Missouri, Columbia, Missouri, USA.
FAU - Seger, Jon
AU  - Seger J
AD  - Department of Biology, University of Utah, Salt Lake City, Utah, USA.
FAU - Voytas, Daniel F
AU  - Voytas DF
AD  - Department of Genetics, Cell Biology, and Development, University of Minnesota,
      Minneapolis, Minnesota, USA.
AD  - Center for Genome Engineering, University of Minnesota, Minneapolis, Minnesota,
      USA.
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2016 May 6;34(5):479-81. PMID: 27153274
MH  - Base Sequence
MH  - *Gene Editing
MH  - *Genome
MH  - Humans
MH  - RNA Editing
EDAT- 2016/05/08 06:00
MHDA- 2017/12/08 06:00
CRDT- 2016/05/07 06:00
PHST- 2016/05/07 06:00 [entrez]
PHST- 2016/05/08 06:00 [pubmed]
PHST- 2017/12/08 06:00 [medline]
AID - nbt.3566 [pii]
AID - 10.1038/nbt.3566 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May 6;34(5):477-9. doi: 10.1038/nbt.3566.

PMID- 27153272
OWN - NLM
STAT- MEDLINE
DCOM- 20171208
LR  - 20171208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May 6
TI  - Ending event-based regulation of GMO crops.
PG  - 474-7
LID - 10.1038/nbt.3541 [doi]
FAU - Strauss, Steven H
AU  - Strauss SH
AD  - Oregon State University, Forest Ecosystems &Society, Corvallis, Oregon, USA.
FAU - Sax, Joanna K
AU  - Sax JK
AD  - California Western School of Law, San Diego, California, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Agriculture/*legislation & jurisprudence
MH  - Crops, Agricultural/*genetics
MH  - European Union
MH  - Food, Genetically Modified/*standards
MH  - Genetic Engineering/*legislation & jurisprudence
MH  - *Government Regulation
MH  - Plants, Genetically Modified/*genetics
MH  - United States
EDAT- 2016/05/08 06:00
MHDA- 2017/12/09 06:00
CRDT- 2016/05/07 06:00
PHST- 2016/05/07 06:00 [entrez]
PHST- 2016/05/08 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt.3541 [pii]
AID - 10.1038/nbt.3541 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May 6;34(5):474-7. doi: 10.1038/nbt.3541.

PMID- 27153271
OWN - NLM
STAT- MEDLINE
DCOM- 20171208
LR  - 20171208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May 6
TI  - Cibus' herbicide-resistant canola in European limbo.
PG  - 473-4
LID - 10.1038/nbt.3558 [doi]
FAU - Fladung, Matthias
AU  - Fladung M
AD  - Thunen Institute of Forest Genetics, Grosshansdorf, Germany.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Agriculture/*legislation & jurisprudence
MH  - Brassicaceae/*genetics
MH  - European Union
MH  - Genetic Engineering/*legislation & jurisprudence
MH  - *Government Regulation
MH  - Herbicide Resistance/*genetics
MH  - Plants, Genetically Modified/*genetics
EDAT- 2016/05/08 06:00
MHDA- 2017/12/09 06:00
CRDT- 2016/05/07 06:00
PHST- 2016/05/07 06:00 [entrez]
PHST- 2016/05/08 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt.3558 [pii]
AID - 10.1038/nbt.3558 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May 6;34(5):473-4. doi: 10.1038/nbt.3558.

PMID- 27153270
OWN - NLM
STAT- MEDLINE
DCOM- 20171208
LR  - 20171208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May 6
TI  - Creating human germ cells for unmet reproductive needs.
PG  - 470-3
LID - 10.1038/nbt.3559 [doi]
FAU - Ishii, Tetsuya
AU  - Ishii T
AUID- ORCID: 0000-0002-7085-7750
AD  - Office of Health and Safety, Hokkaido University, Sapporo, Japan.
FAU - Pera, Renee A Reijo
AU  - Pera RA
AD  - Department of Cell Biology and Neurosciences and Department of Chemistry and
      Biochemistry, Montana State University, Bozeman, Montana, USA.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Batch Cell Culture Techniques/*trends
MH  - Female
MH  - Germ Cells/*cytology
MH  - Humans
MH  - Infertility/*therapy
MH  - Male
MH  - Reproductive Techniques, Assisted/*trends
MH  - *Stem Cell Research
MH  - Stem Cells/*cytology
EDAT- 2016/05/08 06:00
MHDA- 2017/12/09 06:00
CRDT- 2016/05/07 06:00
PHST- 2016/05/07 06:00 [entrez]
PHST- 2016/05/08 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt.3559 [pii]
AID - 10.1038/nbt.3559 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May 6;34(5):470-3. doi: 10.1038/nbt.3559.

PMID- 27153269
OWN - NLM
STAT- MEDLINE
DCOM- 20171208
LR  - 20171208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May 6
TI  - Developing context-specific next-generation sequencing policy.
PG  - 466-70
LID - 10.1038/nbt.3545 [doi]
FAU - Curnutte, Margaret Ann
AU  - Curnutte MA
AD  - Baylor College of Medicine, Center for Medical Ethics and Health Policy, Houston,
      Texas, USA.
FAU - Frumovitz, Karen L
AU  - Frumovitz KL
AD  - Baylor College of Medicine, Center for Medical Ethics and Health Policy, Houston,
      Texas, USA.
FAU - Bollinger, Juli M
AU  - Bollinger JM
AUID- ORCID: 0000-0001-6850-8562
AD  - Berman Institute of Bioethics, Johns Hopkins University, Baltimore, Maryland,
      USA.
FAU - Cook-Deegan, Robert M
AU  - Cook-Deegan RM
AD  - Sanford School of Public Policy, Duke University, Durham, North Carolina, USA.
AD  - School for the Future of Innovation in Society, Arizona State University, Tempe, 
      Arizona, USA.
FAU - McGuire, Amy L
AU  - McGuire AL
AD  - Baylor College of Medicine, Center for Medical Ethics and Health Policy, Houston,
      Texas, USA.
FAU - Majumder, Mary A
AU  - Majumder MA
AD  - Baylor College of Medicine, Center for Medical Ethics and Health Policy, Houston,
      Texas, USA.
LA  - eng
GR  - R01 HG006460/HG/NHGRI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Chromosome Mapping/*trends
MH  - Genetic Testing/*legislation & jurisprudence/trends
MH  - High-Throughput Nucleotide Sequencing/*trends
MH  - Public Policy/*legislation & jurisprudence
MH  - Sequence Analysis, DNA/*trends
MH  - United States
MH  - United States Food and Drug Administration/*organization & administration
PMC - PMC5117622
MID - NIHMS825740
EDAT- 2016/05/08 06:00
MHDA- 2017/12/09 06:00
CRDT- 2016/05/07 06:00
PHST- 2016/05/07 06:00 [entrez]
PHST- 2016/05/08 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt.3545 [pii]
AID - 10.1038/nbt.3545 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May 6;34(5):466-70. doi: 10.1038/nbt.3545.

PMID- 27153268
OWN - NLM
STAT- MEDLINE
DCOM- 20171208
LR  - 20171208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May 6
TI  - Protecting products versus platforms.
PG  - 462-5
LID - 10.1038/nbt.3553 [doi]
FAU - Sherkow, Jacob S
AU  - Sherkow JS
AD  - Innovation Center for Law and Technology, New York Law School, New York, New
      York, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology
MH  - Disclosure/*legislation & jurisprudence
MH  - *Intellectual Property
MH  - Ownership/*legislation & jurisprudence
MH  - Patents as Topic/*legislation & jurisprudence
MH  - United States
EDAT- 2016/05/08 06:00
MHDA- 2017/12/09 06:00
CRDT- 2016/05/07 06:00
PHST- 2016/05/07 06:00 [entrez]
PHST- 2016/05/08 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt.3553 [pii]
AID - 10.1038/nbt.3553 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May 6;34(5):462-5. doi: 10.1038/nbt.3553.

PMID- 27153267
OWN - NLM
STAT- MEDLINE
DCOM- 20171208
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May 6
TI  - No longer going to waste.
PG  - 458-61
LID - 10.1038/nbt.3557 [doi]
FAU - Garber, Ken
AU  - Garber K
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antibodies, Blocking)
RN  - 0 (Antibodies, Monoclonal)
RN  - N15SW1DIV8 (bimagrumab)
SB  - IM
EIN - Nat Biotechnol. 2016 Aug 9;34(8):888. PMID: 27504779
MH  - Antibodies, Blocking/*therapeutic use
MH  - Antibodies, Monoclonal/*therapeutic use
MH  - *Drug Approval
MH  - Europe
MH  - Evidence-Based Medicine
MH  - Humans
MH  - Muscular Atrophy/*drug therapy
MH  - Myositis/*drug therapy
MH  - *Orphan Drug Production
MH  - Treatment Outcome
MH  - United States
EDAT- 2016/05/08 06:00
MHDA- 2017/12/09 06:00
CRDT- 2016/05/07 06:00
PHST- 2016/05/07 06:00 [entrez]
PHST- 2016/05/08 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt.3557 [pii]
AID - 10.1038/nbt.3557 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May 6;34(5):458-61. doi: 10.1038/nbt.3557.

PMID- 27153266
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20171208
LR  - 20171208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May 6
TI  - Drug pipeline: 1Q16.
PG  - 457
LID - 10.1038/nbt.3571 [doi]
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/05/08 06:00
MHDA- 2016/05/08 06:01
CRDT- 2016/05/07 06:00
PHST- 2016/05/07 06:00 [entrez]
PHST- 2016/05/08 06:00 [pubmed]
PHST- 2016/05/08 06:01 [medline]
AID - nbt.3571 [pii]
AID - 10.1038/nbt.3571 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May 6;34(5):457. doi: 10.1038/nbt.3571.

PMID- 27153265
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20171208
LR  - 20171208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May 6
TI  - 1Q16-the biotech bear growls.
PG  - 456
LID - 10.1038/nbt.3574 [doi]
FAU - Yang, Walter
AU  - Yang W
AD  - BioCentury.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/05/08 06:00
MHDA- 2016/05/08 06:01
CRDT- 2016/05/07 06:00
PHST- 2016/05/07 06:00 [entrez]
PHST- 2016/05/08 06:00 [pubmed]
PHST- 2016/05/08 06:01 [medline]
AID - nbt.3574 [pii]
AID - 10.1038/nbt.3574 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May 6;34(5):456. doi: 10.1038/nbt.3574.

PMID- 27153264
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20171208
LR  - 20171208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May 6
TI  - Bento Lab.
PG  - 455
LID - 10.1038/nbt0516-455 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/05/08 06:00
MHDA- 2016/05/08 06:01
CRDT- 2016/05/07 06:00
PHST- 2016/05/07 06:00 [entrez]
PHST- 2016/05/08 06:00 [pubmed]
PHST- 2016/05/08 06:01 [medline]
AID - nbt0516-455 [pii]
AID - 10.1038/nbt0516-455 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May 6;34(5):455. doi: 10.1038/nbt0516-455.

PMID- 27153263
OWN - NLM
STAT- MEDLINE
DCOM- 20171208
LR  - 20171208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May 6
TI  - Celltrion's infliximab copy shows path to biosimilars in US.
PG  - 454-5
LID - 10.1038/nbt0516-454 [doi]
FAU - von Schaper, Eva
AU  - von Schaper E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Biosimilar Pharmaceuticals)
RN  - B72HH48FLU (Infliximab)
SB  - IM
MH  - *Biosimilar Pharmaceuticals
MH  - *Drug Approval
MH  - Humans
MH  - Infliximab/*classification/*therapeutic use
MH  - Republic of Korea
MH  - United States
EDAT- 2016/05/08 06:00
MHDA- 2017/12/09 06:00
CRDT- 2016/05/07 06:00
PHST- 2016/05/07 06:00 [entrez]
PHST- 2016/05/08 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt0516-454 [pii]
AID - 10.1038/nbt0516-454 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May 6;34(5):454-5. doi: 10.1038/nbt0516-454.

PMID- 27153262
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20171208
LR  - 20171208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May 6
TI  - Amgen's PCSK9 patents upheld.
PG  - 452
LID - 10.1038/nbt0516-452a [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/05/08 06:00
MHDA- 2016/05/08 06:01
CRDT- 2016/05/07 06:00
PHST- 2016/05/07 06:00 [entrez]
PHST- 2016/05/08 06:00 [pubmed]
PHST- 2016/05/08 06:01 [medline]
AID - nbt0516-452a [pii]
AID - 10.1038/nbt0516-452a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May 6;34(5):452. doi: 10.1038/nbt0516-452a.

PMID- 27153261
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20171208
LR  - 20171208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May 6
TI  - J&J incubators open in Belgium and Texas.
PG  - 452
LID - 10.1038/nbt0516-452b [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/05/08 06:00
MHDA- 2016/05/08 06:01
CRDT- 2016/05/07 06:00
PHST- 2016/05/07 06:00 [entrez]
PHST- 2016/05/08 06:00 [pubmed]
PHST- 2016/05/08 06:01 [medline]
AID - nbt0516-452b [pii]
AID - 10.1038/nbt0516-452b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May 6;34(5):452. doi: 10.1038/nbt0516-452b.

PMID- 27153260
OWN - NLM
STAT- MEDLINE
DCOM- 20171208
LR  - 20171208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May 6
TI  - Citizen science lures gamers into Sweden's Human Protein Atlas.
PG  - 452-3
LID - 10.1038/nbt0516-452c [doi]
FAU - Peplow, Mark
AU  - Peplow M
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Crowdsourcing/*methods
MH  - *Databases, Protein
MH  - Gene Expression Profiling/*methods
MH  - Information Storage and Retrieval/*methods
MH  - Sweden
MH  - Tissue Array Analysis/*methods
MH  - *Video Games
EDAT- 2016/05/08 06:00
MHDA- 2017/12/09 06:00
CRDT- 2016/05/07 06:00
PHST- 2016/05/07 06:00 [entrez]
PHST- 2016/05/08 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt0516-452c [pii]
AID - 10.1038/nbt0516-452c [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May 6;34(5):452-3. doi: 10.1038/nbt0516-452c.

PMID- 27153259
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20171208
LR  - 20171208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May 6
TI  - Merck, Ionis prevail in Gilead HCV suit.
PG  - 451
LID - 10.1038/nbt0516-451 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/05/08 06:00
MHDA- 2016/05/08 06:01
CRDT- 2016/05/07 06:00
PHST- 2016/05/07 06:00 [entrez]
PHST- 2016/05/08 06:00 [pubmed]
PHST- 2016/05/08 06:01 [medline]
AID - nbt0516-451 [pii]
AID - 10.1038/nbt0516-451 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May 6;34(5):451. doi: 10.1038/nbt0516-451.

PMID- 27153258
OWN - NLM
STAT- MEDLINE
DCOM- 20171208
LR  - 20171208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May 6
TI  - DNA-encoded drug libraries come of age.
PG  - 450-1
LID - 10.1038/nbt0516-450b [doi]
FAU - Mullard, Asher
AU  - Mullard A
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Small Molecule Libraries)
RN  - 9007-49-2 (DNA)
SB  - IM
MH  - DNA/*genetics
MH  - Drug Discovery/*trends
MH  - Drug Industry/*trends
MH  - Humans
MH  - Internationality
MH  - *Small Molecule Libraries
EDAT- 2016/05/08 06:00
MHDA- 2017/12/09 06:00
CRDT- 2016/05/07 06:00
PHST- 2016/05/07 06:00 [entrez]
PHST- 2016/05/08 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt0516-450b [pii]
AID - 10.1038/nbt0516-450b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May 6;34(5):450-1. doi: 10.1038/nbt0516-450b.

PMID- 27153257
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20171208
LR  - 20171208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May 6
TI  - Wellness 'omics in clinics.
PG  - 450
LID - 10.1038/nbt0516-450a [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2016/05/08 06:00
MHDA- 2016/05/08 06:01
CRDT- 2016/05/07 06:00
PHST- 2016/05/07 06:00 [entrez]
PHST- 2016/05/08 06:00 [pubmed]
PHST- 2016/05/08 06:01 [medline]
AID - nbt0516-450a [pii]
AID - 10.1038/nbt0516-450a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May 6;34(5):450. doi: 10.1038/nbt0516-450a.

PMID- 27153256
OWN - NLM
STAT- MEDLINE
DCOM- 20171208
LR  - 20171208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May 6
TI  - NIH dengue vaccine leaps into phase 3 studies.
PG  - 449
LID - 10.1038/nbt0516-449 [doi]
FAU - Perkel, Jeffrey M
AU  - Perkel JM
LA  - eng
PT  - Clinical Trial
PT  - Clinical Trial, Phase III
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Dengue Vaccines)
RN  - 0 (Vaccines, Attenuated)
SB  - IM
MH  - Brazil
MH  - Dengue/*immunology/*prevention & control
MH  - Dengue Vaccines/*administration & dosage/*immunology
MH  - Drug Design
MH  - Humans
MH  - *National Institutes of Health (U.S.)
MH  - Treatment Outcome
MH  - United States
MH  - Vaccines, Attenuated/*administration & dosage/*immunology
EDAT- 2016/05/08 06:00
MHDA- 2017/12/09 06:00
CRDT- 2016/05/07 06:00
PHST- 2016/05/07 06:00 [entrez]
PHST- 2016/05/08 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt0516-449 [pii]
AID - 10.1038/nbt0516-449 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May 6;34(5):449. doi: 10.1038/nbt0516-449.

PMID- 27153255
OWN - NLM
STAT- MEDLINE
DCOM- 20171208
LR  - 20171208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May 6
TI  - Fetal tissue probe unsettles scientific community.
PG  - 447-8
LID - 10.1038/nbt0516-447 [doi]
FAU - Maxmen, Amy
AU  - Maxmen A
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Abortion, Induced/*ethics/*legislation & jurisprudence
MH  - Fetal Research/*ethics/*legislation & jurisprudence
MH  - Fetal Tissue Transplantation/*ethics/*legislation & jurisprudence
MH  - Lobbying
MH  - Public Opinion
MH  - United States
EDAT- 2016/05/08 06:00
MHDA- 2017/12/09 06:00
CRDT- 2016/05/07 06:00
PHST- 2016/05/07 06:00 [entrez]
PHST- 2016/05/08 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt0516-447 [pii]
AID - 10.1038/nbt0516-447 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May 6;34(5):447-8. doi: 10.1038/nbt0516-447.

PMID- 27153254
OWN - NLM
STAT- MEDLINE
DCOM- 20171208
LR  - 20171208
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May 6
TI  - In harm's way.
PG  - 445
LID - 10.1038/nbt.3581 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Abortion, Induced/*ethics/*legislation & jurisprudence
MH  - Fetal Research/*ethics/*legislation & jurisprudence
MH  - *Lobbying
MH  - *Public Opinion
MH  - United States
EDAT- 2016/05/08 06:00
MHDA- 2017/12/09 06:00
CRDT- 2016/05/07 06:00
PHST- 2016/05/07 06:00 [entrez]
PHST- 2016/05/08 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - nbt.3581 [pii]
AID - 10.1038/nbt.3581 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May 6;34(5):445. doi: 10.1038/nbt.3581.

PMID- 27088724
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20180223
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May
TI  - Characterizing genomic alterations in cancer by complementary functional
      associations.
PG  - 539-46
LID - 10.1038/nbt.3527 [doi]
AB  - Systematic efforts to sequence the cancer genome have identified large numbers of
      mutations and copy number alterations in human cancers. However, elucidating the 
      functional consequences of these variants, and their interactions to drive or
      maintain oncogenic states, remains a challenge in cancer research. We developed
      REVEALER, a computational method that identifies combinations of mutually
      exclusive genomic alterations correlated with functional phenotypes, such as the 
      activation or gene dependency of oncogenic pathways or sensitivity to a drug
      treatment. We used REVEALER to uncover complementary genomic alterations
      associated with the transcriptional activation of beta-catenin and NRF2,
      MEK-inhibitor sensitivity, and KRAS dependency. REVEALER successfully identified 
      both known and new associations, demonstrating the power of combining functional 
      profiles with extensive characterization of genomic alterations in cancer
      genomes.
FAU - Kim, Jong Wook
AU  - Kim JW
AD  - Eli and Edythe Broad Institute of Harvard and Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Department of Medical Oncology, Dana-Farber Cancer Institute, Boston,
      Massachusetts, USA.
FAU - Botvinnik, Olga B
AU  - Botvinnik OB
AD  - Eli and Edythe Broad Institute of Harvard and Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Bioinformatics and Systems Biology Program, University of California at San
      Diego, La Jolla, California, USA.
AD  - Department of Cellular and Molecular Medicine, University of California at San
      Diego, La Jolla, California, USA.
AD  - Stem Cell Program and Institute for Genomic Medicine, University of California at
      San Diego, La Jolla, California, USA.
FAU - Abudayyeh, Omar
AU  - Abudayyeh O
AD  - Eli and Edythe Broad Institute of Harvard and Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Department of Medical Oncology, Dana-Farber Cancer Institute, Boston,
      Massachusetts, USA.
AD  - Harvard Medical School, Boston, Massachusetts, USA.
FAU - Birger, Chet
AU  - Birger C
AD  - Eli and Edythe Broad Institute of Harvard and Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
FAU - Rosenbluh, Joseph
AU  - Rosenbluh J
AD  - Eli and Edythe Broad Institute of Harvard and Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Department of Medical Oncology, Dana-Farber Cancer Institute, Boston,
      Massachusetts, USA.
FAU - Shrestha, Yashaswi
AU  - Shrestha Y
AD  - Eli and Edythe Broad Institute of Harvard and Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Department of Medical Oncology, Dana-Farber Cancer Institute, Boston,
      Massachusetts, USA.
FAU - Abazeed, Mohamed E
AU  - Abazeed ME
AD  - Eli and Edythe Broad Institute of Harvard and Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio, USA.
FAU - Hammerman, Peter S
AU  - Hammerman PS
AD  - Eli and Edythe Broad Institute of Harvard and Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Harvard Medical School, Boston, Massachusetts, USA.
AD  - Department of Medicine, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
FAU - DiCara, Daniel
AU  - DiCara D
AD  - Eli and Edythe Broad Institute of Harvard and Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
FAU - Konieczkowski, David J
AU  - Konieczkowski DJ
AD  - Eli and Edythe Broad Institute of Harvard and Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Department of Medical Oncology, Dana-Farber Cancer Institute, Boston,
      Massachusetts, USA.
FAU - Johannessen, Cory M
AU  - Johannessen CM
AD  - Eli and Edythe Broad Institute of Harvard and Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Department of Medical Oncology, Dana-Farber Cancer Institute, Boston,
      Massachusetts, USA.
FAU - Liberzon, Arthur
AU  - Liberzon A
AD  - Eli and Edythe Broad Institute of Harvard and Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
FAU - Alizad-Rahvar, Amir Reza
AU  - Alizad-Rahvar AR
AD  - Department of Electrical and Computer Engineering, University of Alberta,
      Edmonton, Alberta, Canada.
FAU - Alexe, Gabriela
AU  - Alexe G
AD  - Eli and Edythe Broad Institute of Harvard and Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston,
      Massachusetts, USA.
AD  - Boston Children's Hospital, Boston, Massachusetts, USA.
AD  - Bioinformatics Graduate Program, Boston University, Boston, Massachusetts, USA.
FAU - Aguirre, Andrew
AU  - Aguirre A
AD  - Eli and Edythe Broad Institute of Harvard and Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Department of Medical Oncology, Dana-Farber Cancer Institute, Boston,
      Massachusetts, USA.
FAU - Ghandi, Mahmoud
AU  - Ghandi M
AUID- ORCID: 0000-0003-1897-2265
AD  - Eli and Edythe Broad Institute of Harvard and Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
FAU - Greulich, Heidi
AU  - Greulich H
AD  - Eli and Edythe Broad Institute of Harvard and Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Department of Medical Oncology, Dana-Farber Cancer Institute, Boston,
      Massachusetts, USA.
AD  - Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
FAU - Vazquez, Francisca
AU  - Vazquez F
AD  - Eli and Edythe Broad Institute of Harvard and Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Department of Medical Oncology, Dana-Farber Cancer Institute, Boston,
      Massachusetts, USA.
FAU - Weir, Barbara A
AU  - Weir BA
AD  - Eli and Edythe Broad Institute of Harvard and Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
FAU - Van Allen, Eliezer M
AU  - Van Allen EM
AD  - Eli and Edythe Broad Institute of Harvard and Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Department of Medical Oncology, Dana-Farber Cancer Institute, Boston,
      Massachusetts, USA.
FAU - Tsherniak, Aviad
AU  - Tsherniak A
AUID- ORCID: 0000-0002-3797-1877
AD  - Eli and Edythe Broad Institute of Harvard and Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
FAU - Shao, Diane D
AU  - Shao DD
AD  - Eli and Edythe Broad Institute of Harvard and Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Department of Medical Oncology, Dana-Farber Cancer Institute, Boston,
      Massachusetts, USA.
FAU - Zack, Travis I
AU  - Zack TI
AD  - Eli and Edythe Broad Institute of Harvard and Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Department of Cancer Biology, Dana-Farber Cancer Institute, Boston,
      Massachusetts, USA.
AD  - Program in Biophysics, Harvard University, Boston, Massachusetts, USA.
FAU - Noble, Michael
AU  - Noble M
AD  - Eli and Edythe Broad Institute of Harvard and Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
FAU - Getz, Gad
AU  - Getz G
AD  - Eli and Edythe Broad Institute of Harvard and Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
FAU - Beroukhim, Rameen
AU  - Beroukhim R
AD  - Eli and Edythe Broad Institute of Harvard and Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Department of Medical Oncology, Dana-Farber Cancer Institute, Boston,
      Massachusetts, USA.
AD  - Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
AD  - Program in Biophysics, Harvard University, Boston, Massachusetts, USA.
FAU - Garraway, Levi A
AU  - Garraway LA
AD  - Eli and Edythe Broad Institute of Harvard and Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Department of Medical Oncology, Dana-Farber Cancer Institute, Boston,
      Massachusetts, USA.
AD  - Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
FAU - Ardakani, Masoud
AU  - Ardakani M
AD  - Department of Electrical and Computer Engineering, University of Alberta,
      Edmonton, Alberta, Canada.
FAU - Romualdi, Chiara
AU  - Romualdi C
AD  - Department of Biology, University of Padova, Padova, Italy.
FAU - Sales, Gabriele
AU  - Sales G
AD  - Department of Biology, University of Padova, Padova, Italy.
FAU - Barbie, David A
AU  - Barbie DA
AD  - Eli and Edythe Broad Institute of Harvard and Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Department of Medical Oncology, Dana-Farber Cancer Institute, Boston,
      Massachusetts, USA.
FAU - Boehm, Jesse S
AU  - Boehm JS
AUID- ORCID: 0000-0002-6795-6336
AD  - Eli and Edythe Broad Institute of Harvard and Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
FAU - Hahn, William C
AU  - Hahn WC
AD  - Eli and Edythe Broad Institute of Harvard and Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Department of Medical Oncology, Dana-Farber Cancer Institute, Boston,
      Massachusetts, USA.
AD  - Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
AD  - Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston,
      Massachusetts, USA.
FAU - Mesirov, Jill P
AU  - Mesirov JP
AD  - Eli and Edythe Broad Institute of Harvard and Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Department of Medicine, University of California San Diego, La Jolla, California,
      USA.
AD  - Moores Cancer Center, University of California San Diego, La Jolla, California,
      USA.
FAU - Tamayo, Pablo
AU  - Tamayo P
AUID- ORCID: 0000-0002-9360-4668
AD  - Eli and Edythe Broad Institute of Harvard and Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Department of Medicine, University of California San Diego, La Jolla, California,
      USA.
AD  - Moores Cancer Center, University of California San Diego, La Jolla, California,
      USA.
LA  - eng
GR  - R01 GM074024/GM/NIGMS NIH HHS/United States
GR  - U24 CA194107/CA/NCI NIH HHS/United States
GR  - T32 GM007753/GM/NIGMS NIH HHS/United States
GR  - U01 CA184898/CA/NCI NIH HHS/United States
GR  - U01 CA176058/CA/NCI NIH HHS/United States
GR  - R01 CA109467/CA/NCI NIH HHS/United States
GR  - P30 CA023100/CA/NCI NIH HHS/United States
GR  - U54 HD090255/HD/NICHD NIH HHS/United States
GR  - R01 CA154480/CA/NCI NIH HHS/United States
GR  - R01 CA121941/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20160418
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Biomarkers, Tumor)
RN  - 0 (Neoplasm Proteins)
SB  - IM
MH  - Biomarkers, Tumor/*genetics
MH  - Chromosome Mapping/*methods
MH  - Drug Resistance, Neoplasm/genetics
MH  - Genes, Neoplasm/genetics
MH  - Genetic Predisposition to Disease/genetics
MH  - Genome, Human/genetics
MH  - Genome-Wide Association Study/*methods
MH  - Humans
MH  - Mutation/genetics
MH  - Neoplasm Proteins/*genetics
MH  - Neoplasms/diagnosis/*genetics
MH  - Polymorphism, Single Nucleotide/*genetics
MH  - Signal Transduction/genetics
PMC - PMC4868596
MID - NIHMS766023
EDAT- 2016/04/19 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/04/19 06:00
PHST- 2015/10/10 00:00 [received]
PHST- 2016/03/03 00:00 [accepted]
PHST- 2016/04/19 06:00 [entrez]
PHST- 2016/04/19 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3527 [pii]
AID - 10.1038/nbt.3527 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May;34(5):539-46. doi: 10.1038/nbt.3527. Epub 2016 Apr 18.

PMID- 27088723
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20180124
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May
TI  - Multiplexed labeling of genomic loci with dCas9 and engineered sgRNAs using
      CRISPRainbow.
PG  - 528-30
LID - 10.1038/nbt.3526 [doi]
AB  - A lack of techniques to image multiple genomic loci in living cells has limited
      our ability to investigate chromosome dynamics. Here we describe CRISPRainbow, a 
      system for labeling DNA in living cells based on nuclease-dead (d) Cas9 combined 
      with engineered single guide RNA (sgRNA) scaffolds that bind sets of fluorescent 
      proteins. We demonstrate simultaneous imaging of up to six chromosomal loci in
      individual live cells and document large differences in the dynamic properties of
      different chromosomal loci.
FAU - Ma, Hanhui
AU  - Ma H
AD  - Department of Biochemistry and Molecular Pharmacology, University of
      Massachusetts Medical School, Worcester, Massachusetts, USA.
FAU - Tu, Li-Chun
AU  - Tu LC
AD  - RNA Therapeutics Institute, University of Massachusetts Medical School,
      Worcester, Massachusetts, USA.
FAU - Naseri, Ardalan
AU  - Naseri A
AD  - Department of Computer Science, University of Central Florida, Orlando, Florida, 
      USA.
FAU - Huisman, Maximiliaan
AU  - Huisman M
AD  - RNA Therapeutics Institute, University of Massachusetts Medical School,
      Worcester, Massachusetts, USA.
FAU - Zhang, Shaojie
AU  - Zhang S
AD  - Department of Computer Science, University of Central Florida, Orlando, Florida, 
      USA.
FAU - Grunwald, David
AU  - Grunwald D
AD  - RNA Therapeutics Institute, University of Massachusetts Medical School,
      Worcester, Massachusetts, USA.
FAU - Pederson, Thoru
AU  - Pederson T
AD  - Department of Biochemistry and Molecular Pharmacology, University of
      Massachusetts Medical School, Worcester, Massachusetts, USA.
LA  - eng
GR  - P50 GM082545/GM/NIGMS NIH HHS/United States
GR  - R01 GM102515/GM/NIGMS NIH HHS/United States
GR  - U01 EB021238/EB/NIBIB NIH HHS/United States
PT  - Journal Article
DEP - 20160418
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Bacterial Proteins)
RN  - 63231-63-0 (RNA)
RN  - EC 3.1.- (Cas9 endonuclease Streptococcus pyogenes)
RN  - EC 3.1.- (Endonucleases)
SB  - IM
MH  - Bacterial Proteins/*genetics
MH  - Clustered Regularly Interspaced Short Palindromic Repeats/*genetics
MH  - Endonucleases/*genetics
MH  - Gene Editing/*methods
MH  - Genetic Loci/genetics
MH  - Microscopy, Fluorescence/*methods
MH  - RNA/*genetics
MH  - Staining and Labeling
PMC - PMC4864854
MID - NIHMS781655
EDAT- 2016/04/19 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/04/19 06:00
PHST- 2015/10/19 00:00 [received]
PHST- 2016/03/04 00:00 [accepted]
PHST- 2016/04/19 06:00 [entrez]
PHST- 2016/04/19 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3526 [pii]
AID - 10.1038/nbt.3526 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May;34(5):528-30. doi: 10.1038/nbt.3526. Epub 2016 Apr 18.

PMID- 27088722
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20171206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May
TI  - Sequencing wild and cultivated cassava and related species reveals extensive
      interspecific hybridization and genetic diversity.
PG  - 562-70
LID - 10.1038/nbt.3535 [doi]
AB  - Cassava (Manihot esculenta) provides calories and nutrition for more than half a 
      billion people. It was domesticated by native Amazonian peoples through
      cultivation of the wild progenitor M. esculenta ssp. flabellifolia and is now
      grown in tropical regions worldwide. Here we provide a high-quality genome
      assembly for cassava with improved contiguity, linkage, and completeness; almost 
      97% of genes are anchored to chromosomes. We find that paleotetraploidy in
      cassava is shared with the related rubber tree Hevea, providing a resource for
      comparative studies. We also sequence a global collection of 58 Manihot
      accessions, including cultivated and wild cassava accessions and related species 
      such as Ceara or India rubber (M. glaziovii), and genotype 268 African cassava
      varieties. We find widespread interspecific admixture, and detect the genetic
      signature of past cassava breeding programs. As a clonally propagated crop,
      cassava is especially vulnerable to pathogens and abiotic stresses. This genomic 
      resource will inform future genome-enabled breeding efforts to improve this
      staple crop.
FAU - Bredeson, Jessen V
AU  - Bredeson JV
AD  - Department of Molecular and Cell Biology, University of California, Berkeley,
      California, USA.
FAU - Lyons, Jessica B
AU  - Lyons JB
AUID- ORCID: 0000-0002-3886-2146
AD  - Department of Molecular and Cell Biology, University of California, Berkeley,
      California, USA.
FAU - Prochnik, Simon E
AU  - Prochnik SE
AD  - United States Department of Energy Joint Genome Institute (DOE JGI), Walnut
      Creek, California, USA.
FAU - Wu, G Albert
AU  - Wu GA
AD  - United States Department of Energy Joint Genome Institute (DOE JGI), Walnut
      Creek, California, USA.
FAU - Ha, Cindy M
AU  - Ha CM
AD  - Department of Molecular and Cell Biology, University of California, Berkeley,
      California, USA.
FAU - Edsinger-Gonzales, Eric
AU  - Edsinger-Gonzales E
AD  - Department of Molecular and Cell Biology, University of California, Berkeley,
      California, USA.
FAU - Grimwood, Jane
AU  - Grimwood J
AD  - United States Department of Energy Joint Genome Institute (DOE JGI), Walnut
      Creek, California, USA.
AD  - HudsonAlpha Institute for Biotechnology, Huntsville, Alabama, USA.
FAU - Schmutz, Jeremy
AU  - Schmutz J
AD  - United States Department of Energy Joint Genome Institute (DOE JGI), Walnut
      Creek, California, USA.
AD  - HudsonAlpha Institute for Biotechnology, Huntsville, Alabama, USA.
FAU - Rabbi, Ismail Y
AU  - Rabbi IY
AD  - International Institute of Tropical Agriculture (IITA), Ibadan, Nigeria.
FAU - Egesi, Chiedozie
AU  - Egesi C
AD  - National Root Crops Research Institute (NRCRI), Umudike, Nigeria.
FAU - Nauluvula, Poasa
AU  - Nauluvula P
AD  - Department of Agriculture, Ministry of Primary Industries, Koronivia Research
      Station, Fiji.
FAU - Lebot, Vincent
AU  - Lebot V
AD  - Centre de cooperation Internationale en Recherche Agronomique pour le
      Developpement (CIRAD), Port-Vila, Vanuatu.
FAU - Ndunguru, Joseph
AU  - Ndunguru J
AD  - Mikocheni Agricultural Research Institute (MARI), Dar es Salaam, Tanzania.
FAU - Mkamilo, Geoffrey
AU  - Mkamilo G
AD  - Naliendele Agricultural Research Institute (NARI), Mtwara, Tanzania.
FAU - Bart, Rebecca S
AU  - Bart RS
AD  - Donald Danforth Plant Science Center, St. Louis, Missouri, USA.
FAU - Setter, Tim L
AU  - Setter TL
AD  - Section of Soil and Crop Sciences, School of Integrative Plant Science, Cornell
      University, Ithaca, New York, USA.
FAU - Gleadow, Roslyn M
AU  - Gleadow RM
AUID- ORCID: 0000-0003-4756-0411
AD  - School of Biological Sciences, Monash University, Melbourne, Victoria, Australia.
FAU - Kulakow, Peter
AU  - Kulakow P
AD  - International Institute of Tropical Agriculture (IITA), Ibadan, Nigeria.
FAU - Ferguson, Morag E
AU  - Ferguson ME
AD  - International Institute of Tropical Agriculture (IITA), Nairobi, Kenya.
FAU - Rounsley, Steve
AU  - Rounsley S
AUID- ORCID: 0000-0002-3016-6795
AD  - Dow AgroSciences, Indianapolis, Indiana, USA.
FAU - Rokhsar, Daniel S
AU  - Rokhsar DS
AD  - Department of Molecular and Cell Biology, University of California, Berkeley,
      California, USA.
AD  - United States Department of Energy Joint Genome Institute (DOE JGI), Walnut
      Creek, California, USA.
AD  - Molecular Genetics Unit, Okinawa Institute of Science and Technology Graduate
      University, Onna, Japan.
LA  - eng
GR  - S10 RR029668/RR/NCRR NIH HHS/United States
GR  - S10 RR027303/RR/NCRR NIH HHS/United States
PT  - Journal Article
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20160418
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (DNA, Plant)
SB  - IM
MH  - Chromosome Mapping/methods
MH  - Conserved Sequence/genetics
MH  - DNA, Plant/*genetics
MH  - Genetic Variation
MH  - Genome, Plant/genetics
MH  - Hybridization, Genetic/*genetics
MH  - Manihot/*classification/*genetics
MH  - Plant Breeding/*methods
MH  - Sequence Analysis, DNA/*methods
MH  - Species Specificity
EDAT- 2016/04/19 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/04/19 06:00
PHST- 2015/09/04 00:00 [received]
PHST- 2016/03/10 00:00 [accepted]
PHST- 2016/04/19 06:00 [entrez]
PHST- 2016/04/19 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3535 [pii]
AID - 10.1038/nbt.3535 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May;34(5):562-70. doi: 10.1038/nbt.3535. Epub 2016 Apr 18.

PMID- 27088721
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20171206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May
TI  - Energy- and carbon-efficient synthesis of functionalized small molecules in
      bacteria using non-decarboxylative Claisen condensation reactions.
PG  - 556-61
LID - 10.1038/nbt.3505 [doi]
AB  - Anabolic metabolism can produce an array of small molecules, but yields and
      productivities are low owing to carbon and energy inefficiencies and slow
      kinetics. Catabolic and fermentative pathways, on the other hand, are carbon and 
      energy efficient but support only a limited product range. We used carbon- and
      energy-efficient non-decarboxylative Claisen condensation reactions and
      subsequent beta-reduction reactions, which can accept a variety of functionalized
      primers and functionalized extender units and operate in an iterative manner, to 
      synthesize functionalized small molecules. Using different omega- and
      omega-1-functionalized primers and alpha-functionalized extender units in
      combination with various termination pathways, we demonstrate the synthesis of 18
      products from 10 classes, including omega-phenylalkanoic,
      alpha,omega-dicarboxylic, omega-hydroxy, omega-1-oxo, omega-1-methyl, 2-methyl,
      2-methyl-2-enolic and 2,3-dihydroxy acids, beta-hydroxy-omega-lactones, and
      omega-1-methyl alcohols.
FAU - Cheong, Seokjung
AU  - Cheong S
AUID- ORCID: 0000-0002-5699-2278
AD  - Department of Chemical and Biomolecular Engineering, Rice University, Houston,
      Texas, USA.
FAU - Clomburg, James M
AU  - Clomburg JM
AD  - Department of Chemical and Biomolecular Engineering, Rice University, Houston,
      Texas, USA.
FAU - Gonzalez, Ramon
AU  - Gonzalez R
AD  - Department of Chemical and Biomolecular Engineering, Rice University, Houston,
      Texas, USA.
AD  - Department of Bioengineering, Rice University, Houston, Texas, USA.
LA  - eng
PT  - Journal Article
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20160418
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Bacterial Proteins)
RN  - 0 (Biological Products)
RN  - 7440-44-0 (Carbon)
SB  - IM
CIN - Nat Biotechnol. 2016 May 6;34(5):513-5. PMID: 27153282
MH  - Bacterial Proteins/genetics/*metabolism
MH  - Biological Products/isolation & purification/*metabolism
MH  - Carbon/*metabolism
MH  - Energy Metabolism/*physiology
MH  - Escherichia coli/genetics/*metabolism
MH  - Genetic Enhancement/methods
MH  - Protein Engineering/*methods
EDAT- 2016/04/19 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/04/19 06:00
PHST- 2015/09/20 00:00 [received]
PHST- 2016/02/10 00:00 [accepted]
PHST- 2016/04/19 06:00 [entrez]
PHST- 2016/04/19 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3505 [pii]
AID - 10.1038/nbt.3505 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May;34(5):556-61. doi: 10.1038/nbt.3505. Epub 2016 Apr 18.

PMID- 27065010
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20171206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May
TI  - Analysis of 589,306 genomes identifies individuals resilient to severe Mendelian 
      childhood diseases.
PG  - 531-8
LID - 10.1038/nbt.3514 [doi]
AB  - Genetic studies of human disease have traditionally focused on the detection of
      disease-causing mutations in afflicted individuals. Here we describe a
      complementary approach that seeks to identify healthy individuals resilient to
      highly penetrant forms of genetic childhood disorders. A comprehensive screen of 
      874 genes in 589,306 genomes led to the identification of 13 adults harboring
      mutations for 8 severe Mendelian conditions, with no reported clinical
      manifestation of the indicated disease. Our findings demonstrate the promise of
      broadening genetic studies to systematically search for well individuals who are 
      buffering the effects of rare, highly penetrant, deleterious mutations. They also
      indicate that incomplete penetrance for Mendelian diseases is likely more common 
      than previously believed. The identification of resilient individuals may provide
      a first step toward uncovering protective genetic variants that could help
      elucidate the mechanisms of Mendelian diseases and new therapeutic strategies.
FAU - Chen, Rong
AU  - Chen R
AUID- ORCID: 0000-0001-6322-0340
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
AD  - Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at 
      Mount Sinai, New York, New York, USA.
FAU - Shi, Lisong
AU  - Shi L
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
AD  - Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at 
      Mount Sinai, New York, New York, USA.
FAU - Hakenberg, Jorg
AU  - Hakenberg J
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
AD  - Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at 
      Mount Sinai, New York, New York, USA.
FAU - Naughton, Brian
AU  - Naughton B
AD  - 23andMe, Mountain View, California, USA.
FAU - Sklar, Pamela
AU  - Sklar P
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
AD  - Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at 
      Mount Sinai, New York, New York, USA.
AD  - Friedman Brain Institute and Department of Psychiatry, Icahn School of Medicine
      at Mount Sinai, New York, New York, USA.
FAU - Zhang, Jianguo
AU  - Zhang J
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Zhou, Hanlin
AU  - Zhou H
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Tian, Lifeng
AU  - Tian L
AUID- ORCID: 0000-0003-1880-5811
AD  - Center for Applied Genomics, The Children's Hospital of Philadelphia,
      Philadelphia, Pennsylvania, USA.
FAU - Prakash, Om
AU  - Prakash O
AD  - Department of Clinical Sciences, Diabetes &Endocrinology, Lund University
      Diabetes Center, Skane University Hospital, Lund University, Malmo, Sweden.
FAU - Lemire, Mathieu
AU  - Lemire M
AD  - Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
FAU - Sleiman, Patrick
AU  - Sleiman P
AD  - Center for Applied Genomics, The Children's Hospital of Philadelphia,
      Philadelphia, Pennsylvania, USA.
FAU - Cheng, Wei-Yi
AU  - Cheng WY
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
AD  - Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at 
      Mount Sinai, New York, New York, USA.
FAU - Chen, Wanting
AU  - Chen W
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Shah, Hardik
AU  - Shah H
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
AD  - Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at 
      Mount Sinai, New York, New York, USA.
FAU - Shen, Yulan
AU  - Shen Y
AUID- ORCID: 0000-0002-2866-4146
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Fromer, Menachem
AU  - Fromer M
AUID- ORCID: 0000-0003-3749-4342
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
AD  - Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at 
      Mount Sinai, New York, New York, USA.
AD  - Friedman Brain Institute and Department of Psychiatry, Icahn School of Medicine
      at Mount Sinai, New York, New York, USA.
FAU - Omberg, Larsson
AU  - Omberg L
AD  - Sage Bionetworks, Seattle, Washington, USA.
FAU - Deardorff, Matthew A
AU  - Deardorff MA
AD  - Center for Applied Genomics, The Children's Hospital of Philadelphia,
      Philadelphia, Pennsylvania, USA.
FAU - Zackai, Elaine
AU  - Zackai E
AD  - Center for Applied Genomics, The Children's Hospital of Philadelphia,
      Philadelphia, Pennsylvania, USA.
FAU - Bobe, Jason R
AU  - Bobe JR
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
AD  - Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at 
      Mount Sinai, New York, New York, USA.
FAU - Levin, Elissa
AU  - Levin E
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
AD  - Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at 
      Mount Sinai, New York, New York, USA.
FAU - Hudson, Thomas J
AU  - Hudson TJ
AUID- ORCID: 0000-0002-1376-4849
AD  - Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
FAU - Groop, Leif
AU  - Groop L
AD  - Department of Clinical Sciences, Diabetes &Endocrinology, Lund University
      Diabetes Center, Skane University Hospital, Lund University, Malmo, Sweden.
FAU - Wang, Jun
AU  - Wang J
AD  - iCarbonX, Shenzhen, China.
FAU - Hakonarson, Hakon
AU  - Hakonarson H
AD  - Center for Applied Genomics, The Children's Hospital of Philadelphia,
      Philadelphia, Pennsylvania, USA.
FAU - Wojcicki, Anne
AU  - Wojcicki A
AD  - 23andMe, Mountain View, California, USA.
FAU - Diaz, George A
AU  - Diaz GA
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
AD  - Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at 
      Mount Sinai, New York, New York, USA.
FAU - Edelmann, Lisa
AU  - Edelmann L
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
AD  - Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at 
      Mount Sinai, New York, New York, USA.
FAU - Schadt, Eric E
AU  - Schadt EE
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
AD  - Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at 
      Mount Sinai, New York, New York, USA.
FAU - Friend, Stephen H
AU  - Friend SH
AUID- ORCID: 0000-0002-0830-7600
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
AD  - Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at 
      Mount Sinai, New York, New York, USA.
AD  - Sage Bionetworks, Seattle, Washington, USA.
LA  - eng
GR  - U54 HD086984/HD/NICHD NIH HHS/United States
PT  - Journal Article
DEP - 20160411
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CIN - Nat Biotechnol. 2016 May;34(5):512-3. PMID: 27065009
MH  - Child
MH  - Child, Preschool
MH  - Chromosome Mapping/*methods/statistics & numerical data
MH  - DNA Mutational Analysis/methods
MH  - Disease Resistance/*genetics
MH  - Female
MH  - Genetic Diseases, Inborn/*diagnosis/*genetics
MH  - Genetic Predisposition to Disease/genetics
MH  - Genetic Testing/methods
MH  - Genome, Human/*genetics
MH  - Humans
MH  - Infant
MH  - Infant, Newborn
MH  - Male
MH  - Mendelian Randomization Analysis/*methods/statistics & numerical data
MH  - Polymorphism, Single Nucleotide/genetics
MH  - Reproducibility of Results
MH  - Sensitivity and Specificity
EDAT- 2016/04/12 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/04/12 06:00
PHST- 2015/07/29 00:00 [received]
PHST- 2016/02/12 00:00 [accepted]
PHST- 2016/04/12 06:00 [entrez]
PHST- 2016/04/12 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3514 [pii]
AID - 10.1038/nbt.3514 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May;34(5):531-8. doi: 10.1038/nbt.3514. Epub 2016 Apr 11.

PMID- 27065009
OWN - NLM
STAT- MEDLINE
DCOM- 20171207
LR  - 20171207
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May
TI  - Superheroes of disease resistance.
PG  - 512-3
LID - 10.1038/nbt.3555 [doi]
FAU - MacArthur, Daniel
AU  - MacArthur D
AD  - Massachusetts General Hospital, Boston, Massachusetts, USA, and the Broad
      Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
LA  - eng
PT  - Journal Article
PT  - Comment
DEP - 20160411
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2016 May;34(5):531-8. PMID: 27065010
MH  - *Disease Resistance
MH  - Humans
EDAT- 2016/04/12 06:00
MHDA- 2017/12/08 06:00
CRDT- 2016/04/12 06:00
PHST- 2016/04/12 06:00 [entrez]
PHST- 2016/04/12 06:00 [pubmed]
PHST- 2017/12/08 06:00 [medline]
AID - nbt.3555 [pii]
AID - 10.1038/nbt.3555 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May;34(5):512-3. doi: 10.1038/nbt.3555. Epub 2016 Apr 11.

PMID- 27043002
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May
TI  - Near-optimal probabilistic RNA-seq quantification.
PG  - 525-7
LID - 10.1038/nbt.3519 [doi]
AB  - We present kallisto, an RNA-seq quantification program that is two orders of
      magnitude faster than previous approaches and achieves similar accuracy. Kallisto
      pseudoaligns reads to a reference, producing a list of transcripts that are
      compatible with each read while avoiding alignment of individual bases. We use
      kallisto to analyze 30 million unaligned paired-end RNA-seq reads in <10 min on a
      standard laptop computer. This removes a major computational bottleneck in
      RNA-seq analysis.
FAU - Bray, Nicolas L
AU  - Bray NL
AD  - Innovative Genomics Initiative, University of California, Berkeley, California,
      USA.
FAU - Pimentel, Harold
AU  - Pimentel H
AD  - Department of Computer Science, University of California, Berkeley, California,
      USA.
FAU - Melsted, Pall
AU  - Melsted P
AUID- ORCID: 0000-0002-8418-6724
AD  - Faculty of Industrial Engineering, Mechanical Engineering and Computer Science,
      University of Iceland, Reykjavik, Iceland.
FAU - Pachter, Lior
AU  - Pachter L
AD  - Department of Computer Science, University of California, Berkeley, California,
      USA.
AD  - Department of Mathematics, University of California, Berkeley, California, USA.
AD  - Department of Molecular &Cell Biology, University of California, Berkeley,
      California, USA.
LA  - eng
GR  - R01 HG006129/HG/NHGRI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20160404
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 63231-63-0 (RNA)
SB  - IM
EIN - Nat Biotechnol. 2016 Aug 9;34(8):888. PMID: 27504780
MH  - *Algorithms
MH  - Computer Simulation
MH  - Data Interpretation, Statistical
MH  - High-Throughput Nucleotide Sequencing/*methods
MH  - *Models, Statistical
MH  - Pattern Recognition, Automated/methods
MH  - RNA/*genetics
MH  - Reproducibility of Results
MH  - Sensitivity and Specificity
MH  - Sequence Alignment/methods
MH  - Sequence Analysis, RNA/*methods
MH  - *Software
EDAT- 2016/04/05 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/04/05 06:00
PHST- 2015/10/15 00:00 [received]
PHST- 2016/02/25 00:00 [accepted]
PHST- 2016/04/05 06:00 [entrez]
PHST- 2016/04/05 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - nbt.3519 [pii]
AID - 10.1038/nbt.3519 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May;34(5):525-7. doi: 10.1038/nbt.3519. Epub 2016 Apr 4.

PMID- 27018799
OWN - NLM
STAT- MEDLINE
DCOM- 20170605
LR  - 20180123
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 5
DP  - 2016 May
TI  - Integrated digital error suppression for improved detection of circulating tumor 
      DNA.
PG  - 547-555
LID - 10.1038/nbt.3520 [doi]
AB  - High-throughput sequencing of circulating tumor DNA (ctDNA) promises to
      facilitate personalized cancer therapy. However, low quantities of cell-free DNA 
      (cfDNA) in the blood and sequencing artifacts currently limit analytical
      sensitivity. To overcome these limitations, we introduce an approach for
      integrated digital error suppression (iDES). Our method combines in silico
      elimination of highly stereotypical background artifacts with a molecular
      barcoding strategy for the efficient recovery of cfDNA molecules. Individually,
      these two methods each improve the sensitivity of cancer personalized profiling
      by deep sequencing (CAPP-Seq) by about threefold, and synergize when combined to 
      yield approximately 15-fold improvements. As a result, iDES-enhanced CAPP-Seq
      facilitates noninvasive variant detection across hundreds of kilobases. Applied
      to non-small cell lung cancer (NSCLC) patients, our method enabled biopsy-free
      profiling of EGFR kinase domain mutations with 92% sensitivity and >99.99%
      specificity at the variant level, and with 90% sensitivity and 96% specificity at
      the patient level. In addition, our approach allowed monitoring of NSCLC ctDNA
      down to 4 in 10(5) cfDNA molecules. We anticipate that iDES will aid the
      noninvasive genotyping and detection of ctDNA in research and clinical settings.
FAU - Newman, Aaron M
AU  - Newman AM
AD  - Institute for Stem Cell Biology and Regenerative Medicine, Stanford University,
      Stanford, California, USA.
AD  - Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford
      University, Stanford, California, USA.
FAU - Lovejoy, Alexander F
AU  - Lovejoy AF
AD  - Institute for Stem Cell Biology and Regenerative Medicine, Stanford University,
      Stanford, California, USA.
AD  - Department of Radiation Oncology, Stanford University, Stanford, California, USA.
AD  - Stanford Cancer Institute, Stanford University, Stanford, California, USA.
FAU - Klass, Daniel M
AU  - Klass DM
AD  - Institute for Stem Cell Biology and Regenerative Medicine, Stanford University,
      Stanford, California, USA.
AD  - Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford
      University, Stanford, California, USA.
AD  - Stanford Cancer Institute, Stanford University, Stanford, California, USA.
FAU - Kurtz, David M
AU  - Kurtz DM
AD  - Institute for Stem Cell Biology and Regenerative Medicine, Stanford University,
      Stanford, California, USA.
AD  - Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford
      University, Stanford, California, USA.
AD  - Department of Bioengineering, Stanford University, Stanford, California, USA.
FAU - Chabon, Jacob J
AU  - Chabon JJ
AD  - Institute for Stem Cell Biology and Regenerative Medicine, Stanford University,
      Stanford, California, USA.
FAU - Scherer, Florian
AU  - Scherer F
AD  - Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford
      University, Stanford, California, USA.
FAU - Stehr, Henning
AU  - Stehr H
AD  - Stanford Cancer Institute, Stanford University, Stanford, California, USA.
FAU - Liu, Chih Long
AU  - Liu CL
AD  - Institute for Stem Cell Biology and Regenerative Medicine, Stanford University,
      Stanford, California, USA.
AD  - Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford
      University, Stanford, California, USA.
FAU - Bratman, Scott V
AU  - Bratman SV
AD  - Institute for Stem Cell Biology and Regenerative Medicine, Stanford University,
      Stanford, California, USA.
AD  - Department of Radiation Oncology, Stanford University, Stanford, California, USA.
FAU - Say, Carmen
AU  - Say C
AD  - Department of Radiation Oncology, Stanford University, Stanford, California, USA.
FAU - Zhou, Li
AU  - Zhou L
AD  - Stanford Cancer Institute, Stanford University, Stanford, California, USA.
FAU - Carter, Justin N
AU  - Carter JN
AD  - Department of Radiation Oncology, Stanford University, Stanford, California, USA.
FAU - West, Robert B
AU  - West RB
AD  - Department of Pathology, Stanford University, Stanford, California, USA.
FAU - Sledge, George W
AU  - Sledge GW
AD  - Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford
      University, Stanford, California, USA.
AD  - Stanford Cancer Institute, Stanford University, Stanford, California, USA.
FAU - Shrager, Joseph B
AU  - Shrager JB
AD  - Division of Thoracic Surgery, Department of Cardiothoracic Surgery, Stanford
      School of Medicine, Stanford University, Stanford, California, USA.
FAU - Loo, Billy W Jr
AU  - Loo BW Jr
AD  - Department of Radiation Oncology, Stanford University, Stanford, California, USA.
FAU - Neal, Joel W
AU  - Neal JW
AD  - Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford
      University, Stanford, California, USA.
FAU - Wakelee, Heather A
AU  - Wakelee HA
AD  - Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford
      University, Stanford, California, USA.
FAU - Diehn, Maximilian
AU  - Diehn M
AD  - Institute for Stem Cell Biology and Regenerative Medicine, Stanford University,
      Stanford, California, USA.
AD  - Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford
      University, Stanford, California, USA.
AD  - Department of Radiation Oncology, Stanford University, Stanford, California, USA.
FAU - Alizadeh, Ash A
AU  - Alizadeh AA
AD  - Institute for Stem Cell Biology and Regenerative Medicine, Stanford University,
      Stanford, California, USA.
AD  - Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford
      University, Stanford, California, USA.
AD  - Stanford Cancer Institute, Stanford University, Stanford, California, USA.
AD  - Division of Hematology, Department of Medicine, Stanford Cancer Institute,
      Stanford University, Stanford, California, USA.
LA  - eng
GR  - DP2 CA186569/CA/NCI NIH HHS/United States
GR  - T32 CA009302/CA/NCI NIH HHS/United States
GR  - CI-71-14/Damon Runyon Cancer Research Foundation/United States
GR  - U01 CA194389/CA/NCI NIH HHS/United States
GR  - U01 CA152662/CA/NCI NIH HHS/United States
GR  - K99 CA187192/CA/NCI NIH HHS/United States
GR  - U01 CA196405/CA/NCI NIH HHS/United States
GR  - R01 CA188298/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20160328
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Biomarkers, Tumor)
RN  - 0 (DNA, Neoplasm)
SB  - IM
MH  - Algorithms
MH  - *Artifacts
MH  - Biomarkers, Tumor/*blood/*genetics
MH  - DNA, Neoplasm/*blood/*genetics/isolation & purification
MH  - High-Throughput Nucleotide Sequencing/*methods
MH  - Humans
MH  - Neoplastic Cells, Circulating/metabolism
MH  - Reproducibility of Results
MH  - Sensitivity and Specificity
MH  - Signal Processing, Computer-Assisted
MH  - Systems Integration
PMC - PMC4907374
MID - NIHMS764326
EDAT- 2016/03/29 06:00
MHDA- 2017/06/06 06:00
CRDT- 2016/03/29 06:00
PHST- 2015/10/02 00:00 [received]
PHST- 2016/02/26 00:00 [accepted]
PHST- 2016/03/29 06:00 [entrez]
PHST- 2016/03/29 06:00 [pubmed]
PHST- 2017/06/06 06:00 [medline]
AID - 10.1038/nbt.3520 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 May;34(5):547-555. doi: 10.1038/nbt.3520. Epub 2016 Mar 28.

PMID- 27054999
OWN - NLM
STAT- MEDLINE
DCOM- 20160823
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 4
DP  - 2016 Apr
TI  - Biomedical research workforce summit makes strides in implementing change for
      postdocs.
PG  - 442-3
LID - 10.1038/nbt.3537 [doi]
FAU - Callier, Viviane
AU  - Callier V
AD  - Ronin Institute, Montclair, New Jersey, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Biomedical Research/economics/organization & administration
MH  - Humans
MH  - *Personnel Selection/economics/methods
MH  - *Research Personnel/economics/organization & administration
MH  - United States
EDAT- 2016/04/08 06:00
MHDA- 2016/08/24 06:00
CRDT- 2016/04/08 06:00
PHST- 2016/04/08 06:00 [entrez]
PHST- 2016/04/08 06:00 [pubmed]
PHST- 2016/08/24 06:00 [medline]
AID - nbt.3537 [pii]
AID - 10.1038/nbt.3537 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Apr;34(4):442-3. doi: 10.1038/nbt.3537.

PMID- 27054998
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20160815
LR  - 20160408
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 4
DP  - 2016 Apr
TI  - Erratum: Phosphoproteomics takes it easy.
PG  - 441
LID - 10.1038/nbt0416-441b [doi]
FAU - Picotti, Paola
AU  - Picotti P
LA  - eng
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2015 Sep;33(9):929-30. PMID: 26348962
EDAT- 2016/04/08 06:00
MHDA- 2016/04/08 06:01
CRDT- 2016/04/08 06:00
PHST- 2016/04/08 06:00 [entrez]
PHST- 2016/04/08 06:00 [pubmed]
PHST- 2016/04/08 06:01 [medline]
AID - nbt0416-441b [pii]
AID - 10.1038/nbt0416-441b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Apr;34(4):441. doi: 10.1038/nbt0416-441b.

PMID- 27054997
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20160815
LR  - 20160408
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 4
DP  - 2016 Apr
TI  - Corrigendum: Orthogonal gene knockout and activation with a catalytically active 
      Cas9 nuclease.
PG  - 441
LID - 10.1038/nbt0416-441a [doi]
FAU - Dahlman, James E
AU  - Dahlman JE
FAU - Abudayyeh, Omar O
AU  - Abudayyeh OO
FAU - Joung, Julia
AU  - Joung J
FAU - Gootenberg, Jonathan S
AU  - Gootenberg JS
FAU - Zhang, Feng
AU  - Zhang F
FAU - Konermann, Silvana
AU  - Konermann S
LA  - eng
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2015 Nov;33(11):1159-61. PMID: 26436575
EDAT- 2016/04/08 06:00
MHDA- 2016/04/08 06:01
CRDT- 2016/04/08 06:00
PHST- 2016/04/08 06:00 [entrez]
PHST- 2016/04/08 06:00 [pubmed]
PHST- 2016/04/08 06:01 [medline]
AID - nbt0416-441a [pii]
AID - 10.1038/nbt0416-441a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Apr;34(4):441. doi: 10.1038/nbt0416-441a.

PMID- 27054996
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20160815
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 4
DP  - 2016 Apr
TI  - Erratum: Resequencing 302 wild and cultivated accessions identifies genes related
      to domestication and improvement in soybean.
PG  - 441
LID - 10.1038/nbt0416-441c [doi]
FAU - Zhou, Zhengkui
AU  - Zhou Z
FAU - Jiang, Yu
AU  - Jiang Y
FAU - Wang, Zheng
AU  - Wang Z
FAU - Gou, Zhiheng
AU  - Gou Z
FAU - Lyu, Jun
AU  - Lyu J
FAU - Li, Weiyu
AU  - Li W
FAU - Yu, Yanjun
AU  - Yu Y
FAU - Shu, Liping
AU  - Shu L
FAU - Zhao, Yingjun
AU  - Zhao Y
FAU - Ma, Yanming
AU  - Ma Y
FAU - Fang, Chao
AU  - Fang C
FAU - Shen, Yanting
AU  - Shen Y
FAU - Liu, Tengfei
AU  - Liu T
FAU - Li, Congcong
AU  - Li C
FAU - Li, Qing
AU  - Li Q
FAU - Wu, Mian
AU  - Wu M
FAU - Wang, Min
AU  - Wang M
FAU - Wu, Yunshuai
AU  - Wu Y
FAU - Dong, Yang
AU  - Dong Y
FAU - Wan, Wenting
AU  - Wan W
FAU - Wang, Xiao
AU  - Wang X
FAU - Ding, Zhaoli
AU  - Ding Z
FAU - Gao, Yuedong
AU  - Gao Y
FAU - Xiang, Hui
AU  - Xiang H
FAU - Zhu, Baoge
AU  - Zhu B
FAU - Lee, Suk-Ha
AU  - Lee SH
FAU - Wang, Wen
AU  - Wang W
FAU - Tian, Zhixi
AU  - Tian Z
LA  - eng
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2015 Apr;33(4):408-14. PMID: 25643055
EDAT- 2016/04/08 06:00
MHDA- 2016/04/08 06:01
CRDT- 2016/04/08 06:00
PHST- 2016/04/08 06:00 [entrez]
PHST- 2016/04/08 06:00 [pubmed]
PHST- 2016/04/08 06:01 [medline]
AID - nbt0416-441c [pii]
AID - 10.1038/nbt0416-441c [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Apr;34(4):441. doi: 10.1038/nbt0416-441c.

PMID- 27054995
OWN - NLM
STAT- MEDLINE
DCOM- 20160823
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 4
DP  - 2016 Apr
TI  - Quality cell therapy manufacturing by design.
PG  - 393-400
LID - 10.1038/nbt.3525 [doi]
AB  - Transplantation of live cells as therapeutic agents is poised to offer new
      treatment options for a wide range of acute and chronic diseases. However, the
      biological complexity of cells has hampered the translation of laboratory-scale
      experiments into industrial processes for reliable, cost-effective manufacturing 
      of cell-based therapies. We argue here that a solution to this challenge is to
      design cell manufacturing processes according to quality-by-design (QbD)
      principles. QbD integrates scientific knowledge and risk analysis into
      manufacturing process development and is already being adopted by the
      biopharmaceutical industry. Many opportunities to incorporate QbD into cell
      therapy manufacturing exist, although further technology development is required 
      for full implementation. Linking measurable molecular and cellular
      characteristics of a cell population to final product quality through QbD is a
      crucial step in realizing the potential for cell therapies to transform
      healthcare.
FAU - Lipsitz, Yonatan Y
AU  - Lipsitz YY
AUID- ORCID: http://orcid.org/0000-0002-6022-8846
AD  - Institute of Biomaterials and Biomedical Engineering, University of Toronto,
      Toronto, Canada.
FAU - Timmins, Nicholas E
AU  - Timmins NE
AD  - Centre for Commercialization of Regenerative Medicine, Toronto, Ontario, Canada.
FAU - Zandstra, Peter W
AU  - Zandstra PW
AD  - Institute of Biomaterials and Biomedical Engineering, University of Toronto,
      Toronto, Canada.
AD  - Centre for Commercialization of Regenerative Medicine, Toronto, Ontario, Canada.
AD  - The Donnelly Centre for Cellular and Biomolecular Research, University of
      Toronto, Toronto, Canada.
AD  - Medicine by Design: A Canada First Research Excellence Fund Program, University
      of Toronto, Toronto, Canada.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Biopharmaceutics/methods/standards
MH  - *Cell- and Tissue-Based Therapy/methods/standards
MH  - Humans
MH  - Quality Control
MH  - *Research Design
MH  - Risk Assessment
MH  - *Technology, Pharmaceutical/methods/standards
EDAT- 2016/04/08 06:00
MHDA- 2016/08/24 06:00
CRDT- 2016/04/08 06:00
PHST- 2014/11/25 00:00 [received]
PHST- 2016/01/14 00:00 [accepted]
PHST- 2016/04/08 06:00 [entrez]
PHST- 2016/04/08 06:00 [pubmed]
PHST- 2016/08/24 06:00 [medline]
AID - nbt.3525 [pii]
AID - 10.1038/nbt.3525 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Apr;34(4):393-400. doi: 10.1038/nbt.3525.

PMID- 27054993
OWN - NLM
STAT- MEDLINE
DCOM- 20160815
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 4
DP  - 2016 Apr
TI  - Plant immunity switched from bacteria to virus.
PG  - 391-2
LID - 10.1038/nbt.3538 [doi]
FAU - Giannakopoulou, Artemis
AU  - Giannakopoulou A
AD  - The Sainsbury Laboratory, Norwich Research Park, Norwich, UK.
FAU - Bialas, Aleksandra
AU  - Bialas A
AD  - The Sainsbury Laboratory, Norwich Research Park, Norwich, UK.
FAU - Kamoun, Sophien
AU  - Kamoun S
AUID- ORCID: http://orcid.org/0000-0002-0290-0315
AD  - The Sainsbury Laboratory, Norwich Research Park, Norwich, UK.
FAU - Vleeshouwers, Vivianne G A A
AU  - Vleeshouwers VG
AD  - Wageningen UR Plant Breeding, Wageningen University and Research Centre,
      Wageningen, the Netherlands.
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Arabidopsis Proteins)
RN  - EC 2.7.11.1 (Protein-Serine-Threonine Kinases)
SB  - IM
CON - Science. 2016 Feb 12;351(6274):684-7. PMID: 26912853
MH  - *Arabidopsis
MH  - Arabidopsis Proteins/*metabolism
MH  - Disease Resistance/*genetics
MH  - Plant Diseases/*prevention & control
MH  - Protein-Serine-Threonine Kinases/*metabolism
MH  - *Proteolysis
EDAT- 2016/04/08 06:00
MHDA- 2016/08/16 06:00
CRDT- 2016/04/08 06:00
PHST- 2016/04/08 06:00 [entrez]
PHST- 2016/04/08 06:00 [pubmed]
PHST- 2016/08/16 06:00 [medline]
AID - nbt.3538 [pii]
AID - 10.1038/nbt.3538 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Apr;34(4):391-2. doi: 10.1038/nbt.3538.

PMID- 27054992
OWN - NLM
STAT- MEDLINE
DCOM- 20160815
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 4
DP  - 2016 Apr
TI  - Receptor combinations hone T-cell therapy.
PG  - 389-91
LID - 10.1038/nbt.3539 [doi]
FAU - Blankenstein, Thomas
AU  - Blankenstein T
AD  - Max-Delbrck-Center for Molecular Medicine, Berlin, Germany, and the Institute of 
      Immunology, Charite Campus Buch, Berlin, Germany.
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Cell. 2016 Feb 11;164(4):770-9. PMID: 26830879
MH  - Animals
MH  - Humans
MH  - Immunotherapy/*methods
MH  - Neoplasms/*immunology/*therapy
MH  - T-Lymphocytes/*metabolism
EDAT- 2016/04/08 06:00
MHDA- 2016/08/16 06:00
CRDT- 2016/04/08 06:00
PHST- 2016/04/08 06:00 [entrez]
PHST- 2016/04/08 06:00 [pubmed]
PHST- 2016/08/16 06:00 [medline]
AID - nbt.3539 [pii]
AID - 10.1038/nbt.3539 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Apr;34(4):389-91. doi: 10.1038/nbt.3539.

PMID- 27054991
OWN - NLM
STAT- MEDLINE
DCOM- 20160824
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 4
DP  - 2016 Apr
TI  - Genome editing for clinical HIV isolates.
PG  - 388-9
LID - 10.1038/nbt.3531 [doi]
FAU - Kim, Michelle
AU  - Kim M
AD  - Johns Hopkins University School of Medicine and Howard Hughes Medical Institute, 
      Baltimore, Maryland, USA.
FAU - Siliciano, Robert F
AU  - Siliciano RF
AD  - Johns Hopkins University School of Medicine and Howard Hughes Medical Institute, 
      Baltimore, Maryland, USA.
LA  - eng
GR  - Howard Hughes Medical Institute/United States
PT  - Comment
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2016 Apr;34(4):401-9. PMID: 26900663
MH  - *Genome
MH  - HIV Infections
MH  - *HIV-1
MH  - Humans
MH  - RNA Editing
EDAT- 2016/04/08 06:00
MHDA- 2016/08/25 06:00
CRDT- 2016/04/08 06:00
PHST- 2016/04/08 06:00 [entrez]
PHST- 2016/04/08 06:00 [pubmed]
PHST- 2016/08/25 06:00 [medline]
AID - nbt.3531 [pii]
AID - 10.1038/nbt.3531 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Apr;34(4):388-9. doi: 10.1038/nbt.3531.

PMID- 27054990
OWN - NLM
STAT- MEDLINE
DCOM- 20160823
LR  - 20160408
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 4
DP  - 2016 Apr
TI  - Recent patents in epigenetic targeting.
PG  - 387
LID - 10.1038/nbt.3549 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Epigenomics
MH  - Humans
MH  - *Patents as Topic
EDAT- 2016/04/08 06:00
MHDA- 2016/08/24 06:00
CRDT- 2016/04/08 06:00
PHST- 2016/04/08 06:00 [entrez]
PHST- 2016/04/08 06:00 [pubmed]
PHST- 2016/08/24 06:00 [medline]
AID - nbt.3549 [pii]
AID - 10.1038/nbt.3549 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Apr;34(4):387. doi: 10.1038/nbt.3549.

PMID- 27054989
OWN - NLM
STAT- MEDLINE
DCOM- 20160823
LR  - 20160408
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 4
DP  - 2016 Apr
TI  - Preparing for the next Zika.
PG  - 384-6
LID - 10.1038/nbt.3532 [doi]
FAU - Hoyt, Kendall
AU  - Hoyt K
AD  - Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
FAU - Hatchett, Richard
AU  - Hatchett R
AD  - Biomedical Advanced Research and Development Authority (HHS/ASPR/BARDA),
      Washington, DC, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Viral Vaccines)
SB  - IM
MH  - Biomedical Research/*economics/*organization & administration
MH  - Humans
MH  - Viral Vaccines/*economics
MH  - World Health Organization
MH  - *Zika Virus
MH  - Zika Virus Infection/*prevention & control
EDAT- 2016/04/08 06:00
MHDA- 2016/08/24 06:00
CRDT- 2016/04/08 06:00
PHST- 2016/04/08 06:00 [entrez]
PHST- 2016/04/08 06:00 [pubmed]
PHST- 2016/08/24 06:00 [medline]
AID - nbt.3532 [pii]
AID - 10.1038/nbt.3532 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Apr;34(4):384-6. doi: 10.1038/nbt.3532.

PMID- 27054988
OWN - NLM
STAT- MEDLINE
DCOM- 20160823
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 4
DP  - 2016 Apr
TI  - Accessing the accelerated approval pathway for rare disease therapeutics.
PG  - 380-3
LID - 10.1038/nbt.3530 [doi]
FAU - Kakkis, Emil D
AU  - Kakkis ED
AD  - EveryLife Foundation for Rare Diseases, Novato, California, USA.
FAU - Kowalcyk, Sara
AU  - Kowalcyk S
AD  - EveryLife Foundation for Rare Diseases, Novato, California, USA.
FAU - Bronstein, Max G
AU  - Bronstein MG
AD  - EveryLife Foundation for Rare Diseases, Novato, California, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Biomarkers)
SB  - IM
MH  - Biomarkers/analysis
MH  - Drug Approval/*legislation & jurisprudence/*statistics & numerical data
MH  - Humans
MH  - Rare Diseases/*diagnosis/*drug therapy
MH  - United States
MH  - United States Food and Drug Administration
EDAT- 2016/04/08 06:00
MHDA- 2016/08/24 06:00
CRDT- 2016/04/08 06:00
PHST- 2016/04/08 06:00 [entrez]
PHST- 2016/04/08 06:00 [pubmed]
PHST- 2016/08/24 06:00 [medline]
AID - nbt.3530 [pii]
AID - 10.1038/nbt.3530 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Apr;34(4):380-3. doi: 10.1038/nbt.3530.

PMID- 27054987
OWN - NLM
STAT- MEDLINE
DCOM- 20160823
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 4
DP  - 2016 Apr
TI  - Compressive mapping for next-generation sequencing.
PG  - 374-6
LID - 10.1038/nbt.3511 [doi]
FAU - Yorukoglu, Deniz
AU  - Yorukoglu D
AD  - Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
FAU - Yu, Yun William
AU  - Yu YW
AUID- ORCID: http://orcid.org/0000-0002-8275-9576
AD  - Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Mathematics, Massachusetts Institute of Technology, Cambridge,
      Massachusetts, USA.
FAU - Peng, Jian
AU  - Peng J
AD  - Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Mathematics, Massachusetts Institute of Technology, Cambridge,
      Massachusetts, USA.
AD  - Department of Computer Science, University of Illinois at Urbana-Champaign,
      Urbana, Illinois, USA.
FAU - Berger, Bonnie
AU  - Berger B
AD  - Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Mathematics, Massachusetts Institute of Technology, Cambridge,
      Massachusetts, USA.
LA  - eng
GR  - R01 GM108348/GM/NIGMS NIH HHS/United States
GR  - GM108348/GM/NIGMS NIH HHS/United States
GR  - Howard Hughes Medical Institute/United States
PT  - Letter
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - Chromosome Mapping/*methods
MH  - Computational Biology/*methods
MH  - High-Throughput Nucleotide Sequencing/*methods
MH  - Humans
MH  - Mice
MH  - Sequence Alignment
MH  - Sequence Analysis, DNA/*methods
MH  - *Software
PMC - PMC5080835
MID - NIHMS822731
EDAT- 2016/04/08 06:00
MHDA- 2016/08/24 06:00
CRDT- 2016/04/08 06:00
PHST- 2016/04/08 06:00 [entrez]
PHST- 2016/04/08 06:00 [pubmed]
PHST- 2016/08/24 06:00 [medline]
AID - nbt.3511 [pii]
AID - 10.1038/nbt.3511 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Apr;34(4):374-6. doi: 10.1038/nbt.3511.

PMID- 27054986
OWN - NLM
STAT- MEDLINE
DCOM- 20160823
LR  - 20160408
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 4
DP  - 2016 Apr
TI  - Ignore the Delaware director-compensation cases at your peril.
PG  - 373-4
LID - 10.1038/nbt.3529 [doi]
FAU - Lilienfeld, Doreen
AU  - Lilienfeld D
AD  - Shearman &Sterling LLP, New York, New York, USA.
FAU - Polovoy, Brian
AU  - Polovoy B
AD  - Shearman &Sterling LLP, New York, New York, USA.
FAU - Kessel, Mark
AU  - Kessel M
AD  - Shearman &Sterling LLP, New York, New York, USA.
LA  - eng
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*economics/*legislation & jurisprudence
MH  - Delaware
MH  - Drug Industry/*economics/*legislation & jurisprudence
MH  - Humans
MH  - Public Sector
EDAT- 2016/04/08 06:00
MHDA- 2016/08/24 06:00
CRDT- 2016/04/08 06:00
PHST- 2016/04/08 06:00 [entrez]
PHST- 2016/04/08 06:00 [pubmed]
PHST- 2016/08/24 06:00 [medline]
AID - nbt.3529 [pii]
AID - 10.1038/nbt.3529 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Apr;34(4):373-4. doi: 10.1038/nbt.3529.

PMID- 27054985
OWN - NLM
STAT- MEDLINE
DCOM- 20160823
LR  - 20160408
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 4
DP  - 2016 Apr
TI  - Academic partnerships 2015.
PG  - 372
LID - 10.1038/nbt.3522 [doi]
FAU - Huggett, Brady
AU  - Huggett B
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Academic Medical Centers/*organization & administration
MH  - Biotechnology/*organization & administration
MH  - Cooperative Behavior
MH  - Drug Industry/*organization & administration
MH  - Humans
EDAT- 2016/04/08 06:00
MHDA- 2016/08/24 06:00
CRDT- 2016/04/08 06:00
PHST- 2016/04/08 06:00 [entrez]
PHST- 2016/04/08 06:00 [pubmed]
PHST- 2016/08/24 06:00 [medline]
AID - nbt.3522 [pii]
AID - 10.1038/nbt.3522 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Apr;34(4):372. doi: 10.1038/nbt.3522.

PMID- 27054983
OWN - NLM
STAT- MEDLINE
DCOM- 20160823
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 4
DP  - 2016 Apr
TI  - Will Europe toast GM wheat for gluten sufferers?
PG  - 369-71
LID - 10.1038/nbt.3533 [doi]
FAU - Laursen, Lucas
AU  - Laursen L
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Edible Grain
MH  - Europe
MH  - Food Preferences
MH  - *Food, Genetically Modified/economics/standards
MH  - Humans
MH  - Marketing
MH  - *Plants, Genetically Modified
MH  - *Triticum
MH  - *Wheat Hypersensitivity
EDAT- 2016/04/08 06:00
MHDA- 2016/08/24 06:00
CRDT- 2016/04/08 06:00
PHST- 2016/04/08 06:00 [entrez]
PHST- 2016/04/08 06:00 [pubmed]
PHST- 2016/08/24 06:00 [medline]
AID - nbt.3533 [pii]
AID - 10.1038/nbt.3533 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Apr;34(4):369-71. doi: 10.1038/nbt.3533.

PMID- 27054982
OWN - NLM
STAT- MEDLINE
DCOM- 20160823
LR  - 20160408
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 4
DP  - 2016 Apr
TI  - Around the world in a month.
PG  - 368
LID - 10.1038/nbt0416-368b [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Biofuels)
RN  - 0 (Dengue Vaccines)
SB  - IM
MH  - *Biofuels
MH  - *Biotechnology
MH  - Brazil
MH  - *Dengue Vaccines
MH  - Humans
MH  - Kenya
MH  - *Plants, Genetically Modified
MH  - United Arab Emirates
EDAT- 2016/04/08 06:00
MHDA- 2016/08/24 06:00
CRDT- 2016/04/08 06:00
PHST- 2016/04/08 06:00 [entrez]
PHST- 2016/04/08 06:00 [pubmed]
PHST- 2016/08/24 06:00 [medline]
AID - nbt0416-368b [pii]
AID - 10.1038/nbt0416-368b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Apr;34(4):368. doi: 10.1038/nbt0416-368b.

PMID- 27054980
OWN - NLM
STAT- MEDLINE
DCOM- 20160823
LR  - 20160408
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 4
DP  - 2016 Apr
TI  - India's budget windfall for biotech entrepreneurs.
PG  - 367
LID - 10.1038/nbt0416-367 [doi]
FAU - Jayaraman, Killugudi
AU  - Jayaraman K
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*economics
MH  - Entrepreneurship/*economics
MH  - Humans
MH  - India
MH  - Industry/*economics
EDAT- 2016/04/08 06:00
MHDA- 2016/08/24 06:00
CRDT- 2016/04/08 06:00
PHST- 2016/04/08 06:00 [entrez]
PHST- 2016/04/08 06:00 [pubmed]
PHST- 2016/08/24 06:00 [medline]
AID - nbt0416-367 [pii]
AID - 10.1038/nbt0416-367 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Apr;34(4):367. doi: 10.1038/nbt0416-367.

PMID- 27054979
OWN - NLM
STAT- MEDLINE
DCOM- 20160823
LR  - 20160408
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 4
DP  - 2016 Apr
TI  - Biotech veteran wins Taiwan's presidential election.
PG  - 365-6
LID - 10.1038/nbt0416-365 [doi]
FAU - Cyranoski, David
AU  - Cyranoski D
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/economics/*organization & administration
MH  - Humans
MH  - *Politics
MH  - Taiwan
EDAT- 2016/04/08 06:00
MHDA- 2016/08/24 06:00
CRDT- 2016/04/08 06:00
PHST- 2016/04/08 06:00 [entrez]
PHST- 2016/04/08 06:00 [pubmed]
PHST- 2016/08/24 06:00 [medline]
AID - nbt0416-365 [pii]
AID - 10.1038/nbt0416-365 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Apr;34(4):365-6. doi: 10.1038/nbt0416-365.

PMID- 27054978
OWN - NLM
STAT- MEDLINE
DCOM- 20160823
LR  - 20160408
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 4
DP  - 2016 Apr
TI  - Autism DNA hub opens.
PG  - 364
LID - 10.1038/nbt0416-364 [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Autistic Disorder/*genetics
MH  - Biotechnology/*methods/*organization & administration
MH  - *Databases, Genetic
MH  - Genomics/*methods/*organization & administration
MH  - Humans
MH  - International Cooperation
EDAT- 2016/04/08 06:00
MHDA- 2016/08/24 06:00
CRDT- 2016/04/08 06:00
PHST- 2016/04/08 06:00 [entrez]
PHST- 2016/04/08 06:00 [pubmed]
PHST- 2016/08/24 06:00 [medline]
AID - nbt0416-364 [pii]
AID - 10.1038/nbt0416-364 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Apr;34(4):364. doi: 10.1038/nbt0416-364.

PMID- 27054977
OWN - NLM
STAT- MEDLINE
DCOM- 20160823
LR  - 20160408
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 4
DP  - 2016 Apr
TI  - DNA writers attract investors.
PG  - 363-4
LID - 10.1038/nbt0416-363 [doi]
FAU - Petrone, Justin
AU  - Petrone J
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 9007-49-2 (DNA)
SB  - IM
MH  - Biotechnology/*economics/*organization & administration
MH  - DNA/*chemical synthesis
MH  - Genetic Techniques/*economics
MH  - Humans
EDAT- 2016/04/08 06:00
MHDA- 2016/08/24 06:00
CRDT- 2016/04/08 06:00
PHST- 2016/04/08 06:00 [entrez]
PHST- 2016/04/08 06:00 [pubmed]
PHST- 2016/08/24 06:00 [medline]
AID - nbt0416-363 [pii]
AID - 10.1038/nbt0416-363 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Apr;34(4):363-4. doi: 10.1038/nbt0416-363.

PMID- 27054976
OWN - NLM
STAT- MEDLINE
DCOM- 20160823
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 4
DP  - 2016 Apr
TI  - Roche bets on bromodomains.
PG  - 361-2
LID - 10.1038/nbt0416-361 [doi]
FAU - von Schaper, Eva
AU  - von Schaper E
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Enzyme Inhibitors)
RN  - K3Z4F929H6 (Lysine)
SB  - IM
MH  - Acetylation
MH  - Biotechnology/*economics/*trends
MH  - *Enzyme Inhibitors
MH  - *Epigenesis, Genetic
MH  - Humans
MH  - Lysine
MH  - Massachusetts
MH  - *Protein Structure, Tertiary
EDAT- 2016/04/08 06:00
MHDA- 2016/08/24 06:00
CRDT- 2016/04/08 06:00
PHST- 2016/04/08 06:00 [entrez]
PHST- 2016/04/08 06:00 [pubmed]
PHST- 2016/08/24 06:00 [medline]
AID - nbt0416-361 [pii]
AID - 10.1038/nbt0416-361 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Apr;34(4):361-2. doi: 10.1038/nbt0416-361.

PMID- 27054975
OWN - NLM
STAT- MEDLINE
DCOM- 20160823
LR  - 20160408
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 4
DP  - 2016 Apr
TI  - Illumina sues Oxford Nanopore.
PG  - 360
LID - 10.1038/nbt0416-360 [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Porins)
RN  - 0 (mspA protein, Mycobacterium smegmatis)
SB  - IM
MH  - Biotechnology/*legislation & jurisprudence
MH  - Nanopores
MH  - Patents as Topic/*legislation & jurisprudence
MH  - Porins
EDAT- 2016/04/08 06:00
MHDA- 2016/08/24 06:00
CRDT- 2016/04/08 06:00
PHST- 2016/04/08 06:00 [entrez]
PHST- 2016/04/08 06:00 [pubmed]
PHST- 2016/08/24 06:00 [medline]
AID - nbt0416-360 [pii]
AID - 10.1038/nbt0416-360 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Apr;34(4):360. doi: 10.1038/nbt0416-360.

PMID- 27054974
OWN - NLM
STAT- MEDLINE
DCOM- 20160823
LR  - 20160408
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 4
DP  - 2016 Apr
TI  - Exosome cancer diagnostic reaches market.
PG  - 359-60
LID - 10.1038/nbt0416-359 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Biotechnology/economics/methods
MH  - *Exosomes
MH  - Humans
MH  - *Molecular Diagnostic Techniques/economics/methods
MH  - *Neoplasms/diagnosis/genetics
EDAT- 2016/04/08 06:00
MHDA- 2016/08/24 06:00
CRDT- 2016/04/08 06:00
PHST- 2016/04/08 06:00 [entrez]
PHST- 2016/04/08 06:00 [pubmed]
PHST- 2016/08/24 06:00 [medline]
AID - nbt0416-359 [pii]
AID - 10.1038/nbt0416-359 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Apr;34(4):359-60. doi: 10.1038/nbt0416-359.

PMID- 27054973
OWN - NLM
STAT- MEDLINE
DCOM- 20160823
LR  - 20160408
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 4
DP  - 2016 Apr
TI  - So long to the silos.
PG  - 357
LID - 10.1038/nbt.3544 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Biomedical Research
MH  - *Biotechnology
MH  - *Computational Biology
MH  - Humans
MH  - Periodicals as Topic
EDAT- 2016/04/08 06:00
MHDA- 2016/08/24 06:00
CRDT- 2016/04/08 06:00
PHST- 2016/04/08 06:00 [entrez]
PHST- 2016/04/08 06:00 [pubmed]
PHST- 2016/08/24 06:00 [medline]
AID - nbt.3544 [pii]
AID - 10.1038/nbt.3544 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Apr;34(4):357. doi: 10.1038/nbt.3544.

PMID- 26974511
OWN - NLM
STAT- MEDLINE
DCOM- 20160823
LR  - 20171130
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 4
DP  - 2016 Apr
TI  - An injectable nanoparticle generator enhances delivery of cancer therapeutics.
PG  - 414-8
LID - 10.1038/nbt.3506 [doi]
AB  - The efficacy of cancer drugs is often limited because only a small fraction of
      the administered dose accumulates in tumors. Here we report an injectable
      nanoparticle generator (iNPG) that overcomes multiple biological barriers to
      cancer drug delivery. The iNPG is a discoidal micrometer-sized particle that can 
      be loaded with chemotherapeutics. We conjugate doxorubicin to poly(L-glutamic
      acid) by means of a pH-sensitive cleavable linker, and load the polymeric drug
      (pDox) into iNPG to assemble iNPG-pDox. Once released from iNPG, pDox
      spontaneously forms nanometer-sized particles in aqueous solution. Intravenously 
      injected iNPG-pDox accumulates at tumors due to natural tropism and enhanced
      vascular dynamics and releases pDox nanoparticles that are internalized by tumor 
      cells. Intracellularly, pDox nanoparticles are transported to the perinuclear
      region and cleaved into Dox, thereby avoiding excretion by drug efflux pumps.
      Compared to its individual components or current therapeutic formulations,
      iNPG-pDox shows enhanced efficacy in MDA-MB-231 and 4T1 mouse models of
      metastatic breast cancer, including functional cures in 40-50% of treated mice.
FAU - Xu, Rong
AU  - Xu R
AD  - Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas,
      USA.
AD  - Department of Pharmacology, School of Basic Medicine, Tongji Medical College,
      Huazhong University of Science and Technology, Wuhan, China.
FAU - Zhang, Guodong
AU  - Zhang G
AD  - Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas,
      USA.
FAU - Mai, Junhua
AU  - Mai J
AUID- ORCID: http://orcid.org/0000-0001-8374-4352
AD  - Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas,
      USA.
FAU - Deng, Xiaoyong
AU  - Deng X
AD  - Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas,
      USA.
FAU - Segura-Ibarra, Victor
AU  - Segura-Ibarra V
AD  - Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas,
      USA.
FAU - Wu, Suhong
AU  - Wu S
AD  - Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas,
      USA.
FAU - Shen, Jianliang
AU  - Shen J
AD  - Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas,
      USA.
FAU - Liu, Haoran
AU  - Liu H
AD  - Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas,
      USA.
FAU - Hu, Zhenhua
AU  - Hu Z
AD  - Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas,
      USA.
FAU - Chen, Lingxiao
AU  - Chen L
AD  - Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas,
      USA.
FAU - Huang, Yi
AU  - Huang Y
AD  - Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas,
      USA.
FAU - Koay, Eugene
AU  - Koay E
AUID- ORCID: http://orcid.org/0000-0001-7675-3461
AD  - Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas,
      USA.
AD  - Division of Radiation Oncology, The University of Texas M.D. Anderson Cancer
      Center, Houston, Texas, USA.
FAU - Huang, Yu
AU  - Huang Y
AD  - Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas,
      USA.
FAU - Liu, Jun
AU  - Liu J
AD  - Department of Pathology and Laboratory Medicine, The University of Texas-Houston 
      Medical School, Houston, Texas, USA.
FAU - Ensor, Joe E
AU  - Ensor JE
AD  - Houston Methodist Cancer Center, Houston, Texas, USA.
FAU - Blanco, Elvin
AU  - Blanco E
AD  - Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas,
      USA.
FAU - Liu, Xuewu
AU  - Liu X
AD  - Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas,
      USA.
FAU - Ferrari, Mauro
AU  - Ferrari M
AD  - Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas,
      USA.
AD  - Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
FAU - Shen, Haifa
AU  - Shen H
AD  - Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas,
      USA.
AD  - Department of Cell and Developmental Biology, Weill Cornell Medical College, New 
      York, New York, USA.
LA  - eng
GR  - R01 CA193880/CA/NCI NIH HHS/United States
GR  - U54 CA151668/CA/NCI NIH HHS/United States
GR  - U54CA151668/CA/NCI NIH HHS/United States
GR  - U54 CA143837/CA/NCI NIH HHS/United States
GR  - NIH U54CA143837/CA/NCI NIH HHS/United States
GR  - 1R01CA193880-01A1/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20160314
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antineoplastic Agents)
RN  - 25513-46-6 (Polyglutamic Acid)
RN  - 80168379AG (Doxorubicin)
SB  - IM
CIN - Mol Ther. 2016 May;24(5):849-51. PMID: 27198852
MH  - Animals
MH  - *Antineoplastic Agents/administration & dosage/pharmacokinetics/therapeutic use
MH  - Cell Line, Tumor
MH  - *Doxorubicin/administration & dosage/pharmacokinetics/therapeutic use
MH  - Drug Delivery Systems/*methods
MH  - Female
MH  - Humans
MH  - Mice
MH  - Mice, Nude
MH  - Nanomedicine/*methods
MH  - *Nanoparticles/administration & dosage/therapeutic use
MH  - Neoplasms/*drug therapy
MH  - Polyglutamic Acid
MH  - Xenograft Model Antitumor Assays
PMC - PMC5070674
MID - NIHMS822072
COIS- All authors declare no conflict of interest.
EDAT- 2016/03/15 06:00
MHDA- 2016/08/24 06:00
CRDT- 2016/03/15 06:00
PHST- 2015/03/31 00:00 [received]
PHST- 2016/02/09 00:00 [accepted]
PHST- 2016/03/15 06:00 [entrez]
PHST- 2016/03/15 06:00 [pubmed]
PHST- 2016/08/24 06:00 [medline]
AID - nbt.3506 [pii]
AID - 10.1038/nbt.3506 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Apr;34(4):414-8. doi: 10.1038/nbt.3506. Epub 2016 Mar 14.

PMID- 26950749
OWN - NLM
STAT- MEDLINE
DCOM- 20160823
LR  - 20161203
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 4
DP  - 2016 Apr
TI  - Targeted gene addition in human CD34(+) hematopoietic cells for correction of
      X-linked chronic granulomatous disease.
PG  - 424-9
LID - 10.1038/nbt.3513 [doi]
AB  - Gene therapy with genetically modified human CD34(+) hematopoietic stem and
      progenitor cells (HSPCs) may be safer using targeted integration (TI) of
      transgenes into a genomic 'safe harbor' site rather than random viral
      integration. We demonstrate that temporally optimized delivery of zinc finger
      nuclease mRNA via electroporation and adeno-associated virus (AAV) 6 delivery of 
      donor constructs in human HSPCs approaches clinically relevant levels of TI into 
      the AAVS1 safe harbor locus. Up to 58% Venus(+) HSPCs with 6-16% human cell
      marking were observed following engraftment into mice. In HSPCs from patients
      with X-linked chronic granulomatous disease (X-CGD), caused by mutations in the
      gp91phox subunit of the NADPH oxidase, TI of a gp91phox transgene into AAVS1
      resulted in approximately 15% gp91phox expression and increased NADPH oxidase
      activity in ex vivo-derived neutrophils. In mice transplanted with corrected
      HSPCs, 4-11% of human cells in the bone marrow expressed gp91phox. This method
      for TI into AAVS1 may be broadly applicable to correction of other monogenic
      diseases.
FAU - De Ravin, Suk See
AU  - De Ravin SS
AD  - Laboratory of Host Defenses, National Institute of Allergy and Infectious
      Diseases, National Institutes of Health, Bethesda, Maryland, USA.
FAU - Reik, Andreas
AU  - Reik A
AD  - Sangamo BioSciences, Inc., Richmond, California, USA.
FAU - Liu, Pei-Qi
AU  - Liu PQ
AD  - Sangamo BioSciences, Inc., Richmond, California, USA.
FAU - Li, Linhong
AU  - Li L
AD  - MaxCyte, Inc., Gaithersburg, Maryland, USA.
FAU - Wu, Xiaolin
AU  - Wu X
AD  - Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick, 
      Maryland, USA.
FAU - Su, Ling
AU  - Su L
AD  - Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick, 
      Maryland, USA.
FAU - Raley, Castle
AU  - Raley C
AD  - Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick, 
      Maryland, USA.
FAU - Theobald, Narda
AU  - Theobald N
AD  - Laboratory of Host Defenses, National Institute of Allergy and Infectious
      Diseases, National Institutes of Health, Bethesda, Maryland, USA.
FAU - Choi, Uimook
AU  - Choi U
AD  - Laboratory of Host Defenses, National Institute of Allergy and Infectious
      Diseases, National Institutes of Health, Bethesda, Maryland, USA.
FAU - Song, Alexander H
AU  - Song AH
AD  - Sangamo BioSciences, Inc., Richmond, California, USA.
FAU - Chan, Andy
AU  - Chan A
AD  - Sangamo BioSciences, Inc., Richmond, California, USA.
FAU - Pearl, Jocelynn R
AU  - Pearl JR
AD  - Sangamo BioSciences, Inc., Richmond, California, USA.
FAU - Paschon, David E
AU  - Paschon DE
AD  - Sangamo BioSciences, Inc., Richmond, California, USA.
FAU - Lee, Janet
AU  - Lee J
AD  - Laboratory of Host Defenses, National Institute of Allergy and Infectious
      Diseases, National Institutes of Health, Bethesda, Maryland, USA.
FAU - Newcombe, Hannah
AU  - Newcombe H
AD  - Laboratory of Host Defenses, National Institute of Allergy and Infectious
      Diseases, National Institutes of Health, Bethesda, Maryland, USA.
FAU - Koontz, Sherry
AU  - Koontz S
AD  - Laboratory of Host Defenses, National Institute of Allergy and Infectious
      Diseases, National Institutes of Health, Bethesda, Maryland, USA.
FAU - Sweeney, Colin
AU  - Sweeney C
AD  - Laboratory of Host Defenses, National Institute of Allergy and Infectious
      Diseases, National Institutes of Health, Bethesda, Maryland, USA.
FAU - Shivak, David A
AU  - Shivak DA
AD  - Sangamo BioSciences, Inc., Richmond, California, USA.
FAU - Zarember, Kol A
AU  - Zarember KA
AD  - Laboratory of Host Defenses, National Institute of Allergy and Infectious
      Diseases, National Institutes of Health, Bethesda, Maryland, USA.
FAU - Peshwa, Madhusudan V
AU  - Peshwa MV
AD  - Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick, 
      Maryland, USA.
FAU - Gregory, Philip D
AU  - Gregory PD
AD  - Sangamo BioSciences, Inc., Richmond, California, USA.
FAU - Urnov, Fyodor D
AU  - Urnov FD
AD  - Sangamo BioSciences, Inc., Richmond, California, USA.
FAU - Malech, Harry L
AU  - Malech HL
AD  - Laboratory of Host Defenses, National Institute of Allergy and Infectious
      Diseases, National Institutes of Health, Bethesda, Maryland, USA.
LA  - eng
GR  - ZIA AI000644/AI/NIAID NIH HHS/United States
GR  - Z01-AI-00644/AI/NIAID NIH HHS/United States
GR  - Z01 AI000644-16/Intramural NIH HHS/United States
GR  - Z01-AI-00988/AI/NIAID NIH HHS/United States
GR  - Z01 AI000644-17/Intramural NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, N.I.H., Intramural
DEP - 20160307
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antigens, CD34)
RN  - Granulomatous Disease, Chronic, X-Linked
SB  - IM
MH  - Animals
MH  - Antigens, CD34/*chemistry
MH  - Cells, Cultured
MH  - Genetic Therapy/*methods
MH  - Granulomatous Disease, Chronic/*therapy
MH  - Hematopoietic Stem Cell Transplantation/*methods
MH  - Hematopoietic Stem Cells/*cytology
MH  - Humans
MH  - Mice
MH  - Mice, Transgenic
PMC - PMC4824656
MID - NIHMS761042
EDAT- 2016/03/08 06:00
MHDA- 2016/08/24 06:00
CRDT- 2016/03/08 06:00
PHST- 2015/06/16 00:00 [received]
PHST- 2016/02/16 00:00 [accepted]
PHST- 2016/03/08 06:00 [entrez]
PHST- 2016/03/08 06:00 [pubmed]
PHST- 2016/08/24 06:00 [medline]
AID - nbt.3513 [pii]
AID - 10.1038/nbt.3513 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Apr;34(4):424-9. doi: 10.1038/nbt.3513. Epub 2016 Mar 7.

PMID- 26950748
OWN - NLM
STAT- MEDLINE
DCOM- 20160823
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 4
DP  - 2016 Apr
TI  - One-step fermentative production of poly(lactate-co-glycolate) from carbohydrates
      in Escherichia coli.
PG  - 435-40
LID - 10.1038/nbt.3485 [doi]
AB  - Poly(lactate-co-glycolate) (PLGA) is a widely used biodegradable and
      biocompatible synthetic polymer. Here we report one-step fermentative production 
      of PLGA in engineered Escherichia coli harboring an evolved polyhydroxyalkanoate 
      (PHA) synthase that polymerizes D-lactyl-CoA and glycolyl-CoA into PLGA.
      Introduction of the Dahms pathway enables production of glycolate from xylose.
      Deletion of ptsG enables simultaneous utilization of glucose and xylose. An
      evolved propionyl-CoA transferase converts D-lactate and glycolate to
      D-lactyl-CoA and glycolyl-CoA, respectively. Deletion of adhE, frdB, pflB and
      poxB prevents by-product formation. We also demonstrate modulation of the monomer
      fractions in PLGA by overexpressing ldhA and deleting dld to increase the
      proportion of D-lactate or by deleting aceB, glcB, glcD, glcE, glcF and glcG to
      increase the proportion of glycolate. Incorporation of 2-hydroxybutyrate is
      prevented by deleting ilvA or feeding strains with L-isoleucine. The utility of
      our approach for generating diverse forms of PLGA is shown by the production of
      copolymers containing 3-hydroxybutyrate, 4-hydroxybutyrate or
      2-hydroxyisovalerate.
FAU - Choi, So Young
AU  - Choi SY
AD  - Metabolic and Biomolecular Engineering National Research Laboratory, Department
      of Chemical and Biomolecular Engineering (BK21 Plus Program), BioProcess
      Engineering Research Center, Center for Systems and Synthetic Biotechnology, and 
      Institute for the BioCentury, Korea Advanced Institute of Science and Technology,
      Daejeon, Republic of Korea.
FAU - Park, Si Jae
AU  - Park SJ
AD  - Department of Environmental Engineering and Energy, Myongji University, Yongin,
      Gyeonggido, Republic of Korea.
FAU - Kim, Won Jun
AU  - Kim WJ
AD  - Metabolic and Biomolecular Engineering National Research Laboratory, Department
      of Chemical and Biomolecular Engineering (BK21 Plus Program), BioProcess
      Engineering Research Center, Center for Systems and Synthetic Biotechnology, and 
      Institute for the BioCentury, Korea Advanced Institute of Science and Technology,
      Daejeon, Republic of Korea.
FAU - Yang, Jung Eun
AU  - Yang JE
AD  - Metabolic and Biomolecular Engineering National Research Laboratory, Department
      of Chemical and Biomolecular Engineering (BK21 Plus Program), BioProcess
      Engineering Research Center, Center for Systems and Synthetic Biotechnology, and 
      Institute for the BioCentury, Korea Advanced Institute of Science and Technology,
      Daejeon, Republic of Korea.
FAU - Lee, Hyuk
AU  - Lee H
AD  - Division of Drug Discovery Research, Korea Research Institute of Chemical
      Technology, Daejeon, Republic of Korea.
FAU - Shin, Jihoon
AU  - Shin J
AD  - Center for Bio-based Chemistry, Green Chemistry and Engineering Division, Korea
      Research Institute of Chemical Technology, Daejeon, Republic of Korea.
FAU - Lee, Sang Yup
AU  - Lee SY
AUID- ORCID: http://orcid.org/0000-0003-0599-3091
AD  - Metabolic and Biomolecular Engineering National Research Laboratory, Department
      of Chemical and Biomolecular Engineering (BK21 Plus Program), BioProcess
      Engineering Research Center, Center for Systems and Synthetic Biotechnology, and 
      Institute for the BioCentury, Korea Advanced Institute of Science and Technology,
      Daejeon, Republic of Korea.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20160307
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (polylactic acid-polyglycolic acid copolymer)
RN  - 26009-03-0 (Polyglycolic Acid)
RN  - 33X04XA5AT (Lactic Acid)
RN  - A1TA934AKO (Xylose)
RN  - IY9XDZ35W2 (Glucose)
SB  - IM
MH  - Escherichia coli/*genetics/*metabolism
MH  - Fermentation/*genetics
MH  - Gene Knockout Techniques
MH  - Genes, Bacterial/genetics
MH  - Glucose/*metabolism
MH  - Lactic Acid/*metabolism
MH  - Metabolic Engineering/*methods
MH  - Metabolic Networks and Pathways/genetics
MH  - Polyglycolic Acid/*metabolism
MH  - Xylose/*metabolism
EDAT- 2016/03/08 06:00
MHDA- 2016/08/24 06:00
CRDT- 2016/03/08 06:00
PHST- 2015/08/31 00:00 [received]
PHST- 2016/01/14 00:00 [accepted]
PHST- 2016/03/08 06:00 [entrez]
PHST- 2016/03/08 06:00 [pubmed]
PHST- 2016/08/24 06:00 [medline]
AID - nbt.3485 [pii]
AID - 10.1038/nbt.3485 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Apr;34(4):435-40. doi: 10.1038/nbt.3485. Epub 2016 Mar 7.

PMID- 26939011
OWN - NLM
STAT- MEDLINE
DCOM- 20160815
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 4
DP  - 2016 Apr
TI  - First, design for data sharing.
PG  - 377-9
LID - 10.1038/nbt.3516 [doi]
FAU - Wilbanks, John
AU  - Wilbanks J
AD  - Sage Bionetworks, Seattle, Washington, USA.
FAU - Friend, Stephen H
AU  - Friend SH
AD  - Sage Bionetworks, Seattle, Washington, USA.
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antineoplastic Agents)
RN  - 0 (Biomarkers, Tumor)
RN  - 0 (Homeodomain Proteins)
SB  - IM
CON - N Engl J Med. 2016 May 12;374(19):1896-7. PMID: 27168443
MH  - Antineoplastic Agents/*therapeutic use
MH  - Biomarkers, Tumor/*metabolism
MH  - Colonic Neoplasms/*genetics
MH  - Female
MH  - *Gene Expression
MH  - Homeodomain Proteins/*metabolism
MH  - Humans
MH  - Male
EDAT- 2016/03/05 06:00
MHDA- 2016/08/16 06:00
CRDT- 2016/03/04 06:00
PHST- 2016/03/04 06:00 [entrez]
PHST- 2016/03/05 06:00 [pubmed]
PHST- 2016/08/16 06:00 [medline]
AID - nbt.3516 [pii]
AID - 10.1038/nbt.3516 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Apr;34(4):377-9. doi: 10.1038/nbt.3516.

PMID- 26928769
OWN - NLM
STAT- MEDLINE
DCOM- 20160823
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 4
DP  - 2016 Apr
TI  - High-throughput identification of genotype-specific cancer vulnerabilities in
      mixtures of barcoded tumor cell lines.
PG  - 419-23
LID - 10.1038/nbt.3460 [doi]
AB  - Hundreds of genetically characterized cell lines are available for the discovery 
      of genotype-specific cancer vulnerabilities. However, screening large numbers of 
      compounds against large numbers of cell lines is currently impractical, and such 
      experiments are often difficult to control. Here we report a method called PRISM 
      that allows pooled screening of mixtures of cancer cell lines by labeling each
      cell line with 24-nucleotide barcodes. PRISM revealed the expected patterns of
      cell killing seen in conventional (unpooled) assays. In a screen of 102 cell
      lines across 8,400 compounds, PRISM led to the identification of BRD-7880 as a
      potent and highly specific inhibitor of aurora kinases B and C. Cell line pools
      also efficiently formed tumors as xenografts, and PRISM recapitulated the
      expected pattern of erlotinib sensitivity in vivo.
FAU - Yu, Channing
AU  - Yu C
AUID- ORCID: http://orcid.org/0000-0002-3231-2565
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
AD  - Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
AD  - Harvard Medical School, Boston, Massachusetts, USA.
FAU - Mannan, Aristotle M
AU  - Mannan AM
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Yvone, Griselda Metta
AU  - Yvone GM
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Ross, Kenneth N
AU  - Ross KN
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Zhang, Yan-Ling
AU  - Zhang YL
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Marton, Melissa A
AU  - Marton MA
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Taylor, Bradley R
AU  - Taylor BR
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Crenshaw, Andrew
AU  - Crenshaw A
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Gould, Joshua Z
AU  - Gould JZ
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Tamayo, Pablo
AU  - Tamayo P
AUID- ORCID: http://orcid.org/0000-0002-9360-4668
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Weir, Barbara A
AU  - Weir BA
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Tsherniak, Aviad
AU  - Tsherniak A
AUID- ORCID: http://orcid.org/0000-0002-3797-1877
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Wong, Bang
AU  - Wong B
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Garraway, Levi A
AU  - Garraway LA
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
AD  - Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
AD  - Harvard Medical School, Boston, Massachusetts, USA.
FAU - Shamji, Alykhan F
AU  - Shamji AF
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Palmer, Michelle A
AU  - Palmer MA
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Foley, Michael A
AU  - Foley MA
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Winckler, Wendy
AU  - Winckler W
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Schreiber, Stuart L
AU  - Schreiber SL
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
AD  - Harvard University, Cambridge, Massachusetts, USA.
AD  - Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.
FAU - Kung, Andrew L
AU  - Kung AL
AD  - Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
AD  - Harvard Medical School, Boston, Massachusetts, USA.
FAU - Golub, Todd R
AU  - Golub TR
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
AD  - Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
AD  - Harvard Medical School, Boston, Massachusetts, USA.
AD  - Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.
LA  - eng
GR  - UL1DE019585/DE/NIDCR NIH HHS/United States
GR  - UL1 DE019585/DE/NIDCR NIH HHS/United States
GR  - U54CA112962/CA/NCI NIH HHS/United States
GR  - RL1-GM084437/GM/NIGMS NIH HHS/United States
GR  - Howard Hughes Medical Institute/United States
GR  - RL1-CA133834/CA/NCI NIH HHS/United States
GR  - RL1 GM084437/GM/NIGMS NIH HHS/United States
GR  - RL1-HG004671/HG/NHGRI NIH HHS/United States
GR  - U54 CA112962/CA/NCI NIH HHS/United States
GR  - RL1 HG004671/HG/NHGRI NIH HHS/United States
GR  - RL1 CA133834/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20160229
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - Cell Line, Tumor
MH  - DNA Barcoding, Taxonomic/*methods
MH  - Drug Resistance, Neoplasm/*genetics
MH  - Genotyping Techniques/*methods
MH  - High-Throughput Nucleotide Sequencing/*methods
MH  - Humans
MH  - Mice
MH  - Neoplasms/*classification/*genetics
PMC - PMC5508574
MID - NIHMS744739
EDAT- 2016/03/02 06:00
MHDA- 2016/08/24 06:00
CRDT- 2016/03/02 06:00
PHST- 2015/08/31 00:00 [received]
PHST- 2015/12/14 00:00 [accepted]
PHST- 2016/03/02 06:00 [entrez]
PHST- 2016/03/02 06:00 [pubmed]
PHST- 2016/08/24 06:00 [medline]
AID - nbt.3460 [pii]
AID - 10.1038/nbt.3460 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Apr;34(4):419-23. doi: 10.1038/nbt.3460. Epub 2016 Feb 29.

PMID- 26900664
OWN - NLM
STAT- MEDLINE
DCOM- 20160823
LR  - 20170527
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 4
DP  - 2016 Apr
TI  - Inclusion of Strep-tag II in design of antigen receptors for T-cell
      immunotherapy.
PG  - 430-4
LID - 10.1038/nbt.3461 [doi]
AB  - Adoptive immunotherapy with genetically engineered T cells has the potential to
      treat cancer and other diseases. The introduction of Strep-tag II sequences into 
      specific sites in synthetic chimeric antigen receptors or natural T-cell
      receptors of diverse specificities provides engineered T cells with a marker for 
      identification and rapid purification, a method for tailoring spacer length of
      chimeric receptors for optimal function, and a functional element for selective
      antibody-coated, microbead-driven, large-scale expansion. These receptor designs 
      facilitate cGMP manufacturing of pure populations of engineered T cells for
      adoptive T-cell therapies and enable in vivo tracking and retrieval of
      transferred cells for downstream research applications.
FAU - Liu, Lingfeng
AU  - Liu L
AD  - Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle,
      Washington, USA.
FAU - Sommermeyer, Daniel
AU  - Sommermeyer D
AD  - Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle,
      Washington, USA.
FAU - Cabanov, Alexandra
AU  - Cabanov A
AD  - Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle,
      Washington, USA.
FAU - Kosasih, Paula
AU  - Kosasih P
AD  - Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle,
      Washington, USA.
FAU - Hill, Tyler
AU  - Hill T
AD  - Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle,
      Washington, USA.
FAU - Riddell, Stanley R
AU  - Riddell SR
AD  - Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle,
      Washington, USA.
AD  - Department of Medicine, University of Washington, Seattle, Washington, USA.
AD  - Institute for Advanced Study, Technical University of Munich, Munich, Germany.
LA  - eng
GR  - CA136551/CA/NCI NIH HHS/United States
GR  - P50 CA138293/CA/NCI NIH HHS/United States
GR  - R01 CA114536/CA/NCI NIH HHS/United States
GR  - R01 CA136551/CA/NCI NIH HHS/United States
GR  - U54 DK106829/DK/NIDDK NIH HHS/United States
GR  - CA114536/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20160222
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Oligopeptides)
RN  - 0 (Receptors, Antigen, T-Cell)
RN  - 0 (Trp-Ser- His-Pro-Gln-Phe-Glu-Lys)
SB  - IM
MH  - Animals
MH  - Cell Tracking
MH  - Female
MH  - Genetic Engineering/*methods
MH  - Humans
MH  - Immunotherapy, Adoptive/*methods
MH  - Mice
MH  - Mice, Transgenic
MH  - Oligopeptides/chemistry/*genetics/metabolism
MH  - *Receptors, Antigen, T-Cell/chemistry/genetics/metabolism
MH  - T-Lymphocytes/*chemistry/*cytology
PMC - PMC4940167
MID - NIHMS745560
EDAT- 2016/02/24 06:00
MHDA- 2016/08/24 06:00
CRDT- 2016/02/23 06:00
PHST- 2015/05/26 00:00 [received]
PHST- 2015/12/15 00:00 [accepted]
PHST- 2016/02/23 06:00 [entrez]
PHST- 2016/02/24 06:00 [pubmed]
PHST- 2016/08/24 06:00 [medline]
AID - nbt.3461 [pii]
AID - 10.1038/nbt.3461 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Apr;34(4):430-4. doi: 10.1038/nbt.3461. Epub 2016 Feb 22.

PMID- 26900663
OWN - NLM
STAT- MEDLINE
DCOM- 20160823
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 4
DP  - 2016 Apr
TI  - Directed evolution of a recombinase that excises the provirus of most HIV-1
      primary isolates with high specificity.
PG  - 401-9
LID - 10.1038/nbt.3467 [doi]
AB  - Current combination antiretroviral therapies (cART) efficiently suppress HIV-1
      reproduction in humans, but the virus persists as integrated proviral reservoirs 
      in small numbers of cells. To generate an antiviral agent capable of eradicating 
      the provirus from infected cells, we employed 145 cycles of substrate-linked
      directed evolution to evolve a recombinase (Brec1) that site-specifically
      recognizes a 34-bp sequence present in the long terminal repeats (LTRs) of the
      majority of the clinically relevant HIV-1 strains and subtypes. Brec1
      efficiently, precisely and safely removes the integrated provirus from infected
      cells and is efficacious on clinical HIV-1 isolates in vitro and in vivo,
      including in mice humanized with patient-derived cells. Our data suggest that
      Brec1 has potential for clinical application as a curative HIV-1 therapy.
FAU - Karpinski, Janet
AU  - Karpinski J
AD  - Medical Systems Biology, UCC, Medical Faculty Carl Gustav Carus, TU Dresden,
      Germany.
AD  - Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg,
      Germany.
FAU - Hauber, Ilona
AU  - Hauber I
AD  - Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg,
      Germany.
FAU - Chemnitz, Jan
AU  - Chemnitz J
AD  - Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg,
      Germany.
FAU - Schafer, Carola
AU  - Schafer C
AD  - Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg,
      Germany.
AD  - German Center for Infection Research (DZIF), partner site Hamburg, Germany.
FAU - Paszkowski-Rogacz, Maciej
AU  - Paszkowski-Rogacz M
AD  - Medical Systems Biology, UCC, Medical Faculty Carl Gustav Carus, TU Dresden,
      Germany.
FAU - Chakraborty, Deboyoti
AU  - Chakraborty D
AUID- ORCID: http://orcid.org/0000-0002-2300-4333
AD  - Medical Systems Biology, UCC, Medical Faculty Carl Gustav Carus, TU Dresden,
      Germany.
FAU - Beschorner, Niklas
AU  - Beschorner N
AD  - Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg,
      Germany.
FAU - Hofmann-Sieber, Helga
AU  - Hofmann-Sieber H
AD  - Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg,
      Germany.
AD  - German Center for Infection Research (DZIF), partner site Hamburg, Germany.
FAU - Lange, Ulrike C
AU  - Lange UC
AD  - Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg,
      Germany.
AD  - German Center for Infection Research (DZIF), partner site Hamburg, Germany.
AD  - Department of Anesthesiology, University Medical Center Hamburg-Eppendorf,
      Hamburg, Germany.
FAU - Grundhoff, Adam
AU  - Grundhoff A
AD  - Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg,
      Germany.
AD  - German Center for Infection Research (DZIF), partner site Hamburg, Germany.
FAU - Hackmann, Karl
AU  - Hackmann K
AD  - Institute for Clinical Genetics, University Hospital and Medical Faculty Carl
      Gustav Carus, TU Dresden, Germany.
FAU - Schrock, Evelin
AU  - Schrock E
AD  - Institute for Clinical Genetics, University Hospital and Medical Faculty Carl
      Gustav Carus, TU Dresden, Germany.
FAU - Abi-Ghanem, Josephine
AU  - Abi-Ghanem J
AD  - Structural Bioinformatics, BIOTEC TU Dresden, Germany.
FAU - Pisabarro, M Teresa
AU  - Pisabarro MT
AD  - Structural Bioinformatics, BIOTEC TU Dresden, Germany.
FAU - Surendranath, Vineeth
AU  - Surendranath V
AD  - Max Planck Institute for Molecular Cell Biology and Genetics, Dresden, Germany.
FAU - Schambach, Axel
AU  - Schambach A
AD  - Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.
FAU - Lindner, Christoph
AU  - Lindner C
AD  - Agaplesion Diakonieklinikum, Gynecology, Hamburg, Germany.
FAU - van Lunzen, Jan
AU  - van Lunzen J
AD  - Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg,
      Germany.
AD  - German Center for Infection Research (DZIF), partner site Hamburg, Germany.
AD  - Infectious Diseases Unit, University Medical Center Hamburg-Eppendorf, Hamburg,
      Germany.
FAU - Hauber, Joachim
AU  - Hauber J
AD  - Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg,
      Germany.
AD  - German Center for Infection Research (DZIF), partner site Hamburg, Germany.
FAU - Buchholz, Frank
AU  - Buchholz F
AD  - Medical Systems Biology, UCC, Medical Faculty Carl Gustav Carus, TU Dresden,
      Germany.
AD  - Max Planck Institute for Molecular Cell Biology and Genetics, Dresden, Germany.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20160222
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antiviral Agents)
RN  - 0 (Recombinases)
SB  - IM
CIN - Nat Biotechnol. 2016 Apr;34(4):388-9. PMID: 27054991
MH  - Animals
MH  - Antiviral Agents/metabolism/*pharmacology
MH  - Base Sequence
MH  - Cells, Cultured
MH  - Directed Molecular Evolution/*methods
MH  - HIV Infections/*virology
MH  - HIV-1/*drug effects/genetics
MH  - Humans
MH  - Mice
MH  - Molecular Sequence Data
MH  - Proviruses/*drug effects/genetics
MH  - Recombinases/metabolism/*pharmacology
MH  - Virus Integration/*drug effects/genetics
EDAT- 2016/02/24 06:00
MHDA- 2016/08/24 06:00
CRDT- 2016/02/23 06:00
PHST- 2015/04/30 00:00 [received]
PHST- 2015/12/21 00:00 [accepted]
PHST- 2016/02/23 06:00 [entrez]
PHST- 2016/02/24 06:00 [pubmed]
PHST- 2016/08/24 06:00 [medline]
AID - nbt.3467 [pii]
AID - 10.1038/nbt.3467 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Apr;34(4):401-9. doi: 10.1038/nbt.3467. Epub 2016 Feb 22.

PMID- 26900662
OWN - NLM
STAT- MEDLINE
DCOM- 20160823
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 4
DP  - 2016 Apr
TI  - Transcriptome-scale RNase-footprinting of RNA-protein complexes.
PG  - 410-3
LID - 10.1038/nbt.3441 [doi]
AB  - Ribosome profiling is widely used to study translation in vivo, but not all
      sequence reads correspond to ribosome-protected RNA. Here we describe Rfoot, a
      computational pipeline that analyzes ribosomal profiling data and identifies
      native, nonribosomal RNA-protein complexes. We use Rfoot to precisely map
      RNase-protected regions within small nucleolar RNAs, spliceosomal RNAs,
      microRNAs, tRNAs, long noncoding (lnc)RNAs and 3' untranslated regions of mRNAs
      in human cells. We show that RNAs of the same class can show differential complex
      association. Although only a subset of lncRNAs show RNase footprints, many of
      these have multiple footprints, and the protected regions are evolutionarily
      conserved, suggestive of biological functions.
FAU - Ji, Zhe
AU  - Ji Z
AD  - Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical
      School, Boston, Massachusetts, USA.
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
FAU - Song, Ruisheng
AU  - Song R
AUID- ORCID: http://orcid.org/0000-0002-6856-4721
AD  - Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical
      School, Boston, Massachusetts, USA.
FAU - Huang, Hailiang
AU  - Huang H
AUID- ORCID: http://orcid.org/0000-0003-1461-5762
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
AD  - Analytic and Translation Genetics Unit, Massachusetts General Hospital, Boston,
      Massachusetts, USA.
FAU - Regev, Aviv
AU  - Regev A
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
AD  - Department of Biology, Massachusetts Institute of Technology, Cambridge,
      Massachusetts, USA.
AD  - Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.
FAU - Struhl, Kevin
AU  - Struhl K
AD  - Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical
      School, Boston, Massachusetts, USA.
LA  - eng
GR  - U24 CA180922/CA/NCI NIH HHS/United States
GR  - CA 107486/CA/NCI NIH HHS/United States
GR  - Howard Hughes Medical Institute/United States
GR  - P50 HG006193/HG/NHGRI NIH HHS/United States
GR  - R01 CA107486/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20160222
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (RNA-Binding Proteins)
RN  - 63231-63-0 (RNA)
RN  - EC 3.1.- (Ribonucleases)
SB  - IM
MH  - Cell Line, Tumor
MH  - Computational Biology/*methods
MH  - Humans
MH  - RNA/analysis/*chemistry
MH  - RNA-Binding Proteins/*chemistry
MH  - Ribonucleases/*metabolism
MH  - Sequence Analysis, RNA/*methods
MH  - Transcriptome/*genetics
PMC - PMC4824641
MID - NIHMS741150
EDAT- 2016/02/24 06:00
MHDA- 2016/08/24 06:00
CRDT- 2016/02/23 06:00
PHST- 2015/04/25 00:00 [received]
PHST- 2015/11/25 00:00 [accepted]
PHST- 2016/02/23 06:00 [entrez]
PHST- 2016/02/24 06:00 [pubmed]
PHST- 2016/08/24 06:00 [medline]
AID - nbt.3441 [pii]
AID - 10.1038/nbt.3441 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Apr;34(4):410-3. doi: 10.1038/nbt.3441. Epub 2016 Feb 22.

PMID- 26963557
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20160311
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - Towards sustaining a culture of mental health and wellness for trainees in the
      biosciences.
PG  - 353-5
LID - 10.1038/nbt.3490 [doi]
FAU - Tsai, Jessica W
AU  - Tsai JW
AD  - Department of Medicine, Boston Children's Hospital, Boston, Massachusetts, USA,
      and the Department of Pediatrics, Boston Medical Center, Boston, Massachusetts,
      USA.
FAU - Muindi, Fanuel
AU  - Muindi F
AD  - Department of Molecular and Cellular Biology, Harvard University, Cambridge,
      Massachusetts, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biological Science Disciplines/education/*manpower
MH  - Education, Graduate/*manpower
MH  - Humans
MH  - *Mental Health
MH  - Stress, Psychological/*epidemiology/physiopathology
EDAT- 2016/03/11 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/03/11 06:00
PHST- 2016/03/11 06:00 [entrez]
PHST- 2016/03/11 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt.3490 [pii]
AID - 10.1038/nbt.3490 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):353-5. doi: 10.1038/nbt.3490.

PMID- 26963555
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - Cas9 loosens its grip on off-target sites.
PG  - 298-9
LID - 10.1038/nbt.3501 [doi]
FAU - Nelson, Christopher E
AU  - Nelson CE
AD  - Department of Biomedical Engineering, and at the Center for Genomic
      &Computational Biology, Duke University, Durham, North Carolina, USA.
FAU - Gersbach, Charles A
AU  - Gersbach CA
AD  - Department of Biomedical Engineering, and at the Center for Genomic
      &Computational Biology, Duke University, Durham, North Carolina, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Bacterial Proteins)
RN  - 9007-49-2 (DNA)
RN  - EC 3.1.- (Cas9 endonuclease Streptococcus pyogenes)
RN  - EC 3.1.- (Endonucleases)
SB  - IM
MH  - Bacterial Proteins/*genetics
MH  - DNA/*genetics
MH  - Endonucleases/*genetics
MH  - *Gene Targeting
MH  - Genome, Human
MH  - Humans
MH  - *RNA Editing
MH  - Streptococcus pyogenes/enzymology/genetics
EDAT- 2016/03/11 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/03/11 06:00
PHST- 2016/03/11 06:00 [entrez]
PHST- 2016/03/11 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt.3501 [pii]
AID - 10.1038/nbt.3501 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):298-9. doi: 10.1038/nbt.3501.

PMID- 26963554
OWN - NLM
STAT- MEDLINE
DCOM- 20160802
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - Haplotypes drop by drop.
PG  - 296-8
LID - 10.1038/nbt.3500 [doi]
FAU - Kitzman, Jacob O
AU  - Kitzman JO
AD  - Department of Human Genetics and Department of Computational Medicine
      &Bioinformatics, University of Michigan, Ann Arbor, Michigan, USA.
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2016 Mar;34(3):303-11. PMID: 26829319
MH  - Haplotypes/*genetics
MH  - High-Throughput Nucleotide Sequencing/*methods
MH  - Humans
MH  - Neoplasms/*genetics
MH  - Sequence Analysis, DNA/*methods
EDAT- 2016/03/11 06:00
MHDA- 2016/08/03 06:00
CRDT- 2016/03/11 06:00
PHST- 2016/03/11 06:00 [entrez]
PHST- 2016/03/11 06:00 [pubmed]
PHST- 2016/08/03 06:00 [medline]
AID - nbt.3500 [pii]
AID - 10.1038/nbt.3500 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):296-8. doi: 10.1038/nbt.3500.

PMID- 26963553
OWN - NLM
STAT- MEDLINE
DCOM- 20160802
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - From clinical imaging to implantation of 3D printed tissues.
PG  - 295-6
LID - 10.1038/nbt.3503 [doi]
FAU - Pashuck, E Thomas
AU  - Pashuck ET
AUID- ORCID: http://orcid.org/0000-0003-2881-4965
AD  - Department of Materials, Department of Bioengineering and Institute for
      Biomedical Engineering at Imperial College London, London, UK.
FAU - Stevens, Molly
AU  - Stevens M
AD  - Department of Materials, Department of Bioengineering and Institute for
      Biomedical Engineering at Imperial College London, London, UK.
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2016 Mar;34(3):312-9. PMID: 26878319
MH  - Bioprinting/*methods
MH  - Humans
MH  - *Printing, Three-Dimensional
MH  - Tissue Engineering/*methods
MH  - *Tissue Scaffolds
EDAT- 2016/03/11 06:00
MHDA- 2016/08/03 06:00
CRDT- 2016/03/11 06:00
PHST- 2016/03/11 06:00 [entrez]
PHST- 2016/03/11 06:00 [pubmed]
PHST- 2016/08/03 06:00 [medline]
AID - nbt.3503 [pii]
AID - 10.1038/nbt.3503 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):295-6. doi: 10.1038/nbt.3503.

PMID- 26963552
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - The changing life science patent landscape.
PG  - 292-4
LID - 10.1038/nbt.3504 [doi]
FAU - Rai, Arti K
AU  - Rai AK
AD  - Center for Innovation Policy, Duke University School of Law, Durham, North
      Carolina, USA.
FAU - Sherkow, Jacob S
AU  - Sherkow JS
AD  - Innovation Center for Law and Technology, New York Law School, New York, New
      York, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biological Science Disciplines/*legislation & jurisprudence/trends
MH  - Drug Industry/*legislation & jurisprudence
MH  - Humans
MH  - *Patents as Topic
MH  - Supreme Court Decisions
MH  - United States
EDAT- 2016/03/11 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/03/11 06:00
PHST- 2016/03/11 06:00 [entrez]
PHST- 2016/03/11 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt.3504 [pii]
AID - 10.1038/nbt.3504 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):292-4. doi: 10.1038/nbt.3504.

PMID- 26963551
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20171206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - When biotech goes bad.
PG  - 284-91
LID - 10.1038/nbt.3510 [doi]
FAU - Hodgson, John
AU  - Hodgson J
AD  - Pharma at Informa Business Information, London, UK, and Editor-at-Large, Nature
      Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EIN - Nat Biotechnol. 2016 Jun;34(6):666
EIN - Nat Biotechnol. 2016 Jun 9;34(6):666. PMID: 27281429
MH  - Biotechnology/ethics/*legislation & jurisprudence/trends
MH  - Drug Industry/ethics/*legislation & jurisprudence/trends
MH  - Humans
MH  - Scientific Misconduct/*legislation & jurisprudence
EDAT- 2016/03/11 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/03/11 06:00
PHST- 2016/03/11 06:00 [entrez]
PHST- 2016/03/11 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt.3510 [pii]
AID - 10.1038/nbt.3510 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):284-91. doi: 10.1038/nbt.3510.

PMID- 26963550
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20171206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - Community crystal gazing.
PG  - 276-83
LID - 10.1038/nbt.3515 [doi]
FAU - Acharya, Anu
AU  - Acharya A
AD  - Mapmygenome, Hyderabad, India.
FAU - Bingham, Kate
AU  - Bingham K
AD  - SV Life Sciences, London, UK.
FAU - Bradner, Jay
AU  - Bradner J
AD  - Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA.
FAU - Burke, Wylie
AU  - Burke W
AD  - University of Washington, Seattle, Washington, USA.
FAU - Charo, R Alta
AU  - Charo RA
AD  - University of Wisconsin, Madison, Wisconsin, USA.
FAU - Cherry, Joel
AU  - Cherry J
AD  - Amyris, Emeryville, California, USA.
FAU - Choulika, Andre
AU  - Choulika A
AD  - Cellectis, Paris, France.
FAU - Coles, Tony
AU  - Coles T
AD  - Yumanity Therapeutics, Cambridge, Massachusetts, USA.
FAU - Cook-Deegan, Robert
AU  - Cook-Deegan R
AD  - Duke University, Durham, North Carolina, USA.
FAU - Crooke, Stanley T
AU  - Crooke ST
AD  - Ionis Pharmaceuticals, Carlsbad, California, USA.
AD  - Ionis Pharmaceuticals, Carlsbad, California, USA.
FAU - Diaz, Emilia
AU  - Diaz E
AD  - Kaitek Labs, Santiago, Chile.
FAU - Erickson, Brent
AU  - Erickson B
AD  - Biotechnology Innovation Organization, Washington, DC, USA.
FAU - Giddings, L Val
AU  - Giddings LV
AD  - Information Technology and Innovation Foundation, Washington, DC, USA.
FAU - Giwa, Sebastian Eriksson
AU  - Giwa SE
AD  - Organ Preservation Alliance, Ossium and Sylvatica Biotech, New York, New York,
      USA.
FAU - Greenwood, James C
AU  - Greenwood JC
AD  - Biotechnology Innovation Organization, Washington, DC, USA.
FAU - Gulati, Vishal
AU  - Gulati V
AD  - Draper Espirit, London, UK.
FAU - Hall, Sam
AU  - Hall S
AD  - Apple Tree Partners, New York, New York, USA.
FAU - Harris, John
AU  - Harris J
AD  - University of Manchester, Manchester, UK.
FAU - Heywood, Jamie
AU  - Heywood J
AD  - PatientsLikeMe and AOBiome, Boston, Massachusetts, USA.
FAU - Hill, Colin
AU  - Hill C
AD  - GNS Healthcare, Cambridge, Massachusetts, USA.
FAU - Levin, Jeremy
AU  - Levin J
AD  - Ovid Therapeutics, New York, New York, USA.
FAU - Mangubat, Adina
AU  - Mangubat A
AD  - Spiral Genetics, Seattle, Washington, USA.
FAU - Maraganore, John
AU  - Maraganore J
AD  - Alnylam, Cambridge, Massachusetts, USA.
FAU - Mariggi, Giovanni
AU  - Mariggi G
AD  - Medicxi Ventures, Geneva, Switzerland.
FAU - Mazur, Barbara J
AU  - Mazur BJ
AD  - DuPont Pioneer, Wilmington, Delaware, USA.
FAU - McGuire, Amy L
AU  - McGuire AL
AD  - Baylor College of Medicine, Houston, Texas, USA.
FAU - Moll, Nathalie
AU  - Moll N
AD  - EuropaBio, Brussels, Belgium.
FAU - Moreno, Jonathan
AU  - Moreno J
AD  - University of Pennsylvania, Philadelphia, Pennsylvania, USA.
FAU - Naughton, Gail
AU  - Naughton G
AD  - Histogen, San Diego, California, USA.
FAU - Nelsen, Lita
AU  - Nelsen L
AD  - Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
FAU - Osbourn, Jane
AU  - Osbourn J
AD  - BioIndustry Association, London, UK.
FAU - Perez, Daniel
AU  - Perez D
AD  - Oxbridge Biotech Roundtable, London, UK.
FAU - Reed, John
AU  - Reed J
AD  - Roche, Basel, Switzerland.
FAU - Schmidt, Eric
AU  - Schmidt E
AD  - SG Cowan, New York, New York, USA.
FAU - Seyfert-Margolis, Vicki
AU  - Seyfert-Margolis V
AD  - MyOwnMed, Chevy Chase, Maryland, USA.
FAU - Stoffels, Paul
AU  - Stoffels P
AD  - Johnson &Johnson, New Brunswick, New Jersey, USA.
FAU - Thorball, Jorgen
AU  - Thorball J
AD  - XOventure International, Lucerne, Switzerland.
FAU - O'Toole, Tara
AU  - O'Toole T
AD  - In-Q-Tel, Arlington, Virginia, USA.
FAU - Vainu, Indrek
AU  - Vainu I
AD  - Xpressomics, Tallinn, Estonia.
FAU - van Deventer, Sander
AU  - van Deventer S
AD  - Forbion Capital Partners, Naarden, The Netherlands.
FAU - Zerhouni, Elias
AU  - Zerhouni E
AD  - Sanofi, Paris, France.
FAU - Zohar, Daphne
AU  - Zohar D
AD  - PureTech Health, Cambridge, Massachusetts, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EIN - Nat Biotechnol. 2016 Jun;34(6):666. Crook, Stanley T [Corrected to Crooke,
      Stanley T]
EIN - Nat Biotechnol. 2016 Jun 9;34(6):666. PMID: 27281427
MH  - Biomedical Research/*economics
MH  - Biotechnology/*economics
MH  - Drug Industry/*economics
MH  - Humans
MH  - Private Sector/economics
MH  - Research/*economics
EDAT- 2016/03/11 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/03/11 06:00
PHST- 2016/03/11 06:00 [entrez]
PHST- 2016/03/11 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt.3515 [pii]
AID - 10.1038/nbt.3515 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):276-83. doi: 10.1038/nbt.3515.

PMID- 26963549
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - Voices of biotech.
PG  - 270-5
LID - 10.1038/nbt.3502 [doi]
FAU - Amit, Ido
AU  - Amit I
AD  - Weizmann Institute of Science, Rehovot, Israel.
FAU - Baker, David
AU  - Baker D
AD  - University of Washington, Seattle, Washington, USA.
FAU - Barker, Roger
AU  - Barker R
AD  - University of Cambridge, Cambridge, UK.
FAU - Berger, Bonnie
AU  - Berger B
AD  - Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
FAU - Bertozzi, Carolyn
AU  - Bertozzi C
AD  - Stanford University, Stanford, California, USA.
FAU - Bhatia, Sangeeta
AU  - Bhatia S
AD  - Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
FAU - Biffi, Alessandra
AU  - Biffi A
AD  - Dana-Farber Cancer Institute, Cambridge, Massachusetts, USA.
AD  - Harvard University, Cambridge, Massachusetts, USA.
FAU - Demichelis, Francesca
AU  - Demichelis F
AD  - University of Trento, Trento, Italy.
FAU - Doudna, Jennifer
AU  - Doudna J
AD  - University of California, Berkeley, California, USA.
FAU - Dowdy, Steven F
AU  - Dowdy SF
AD  - University of California, San Diego, California, USA.
FAU - Endy, Drew
AU  - Endy D
AD  - Stanford University, Stanford, California, USA.
FAU - Helmstaedter, Moritz
AU  - Helmstaedter M
AD  - Max Planck Institute for Brain Research, Frankfurt, Germany.
FAU - Junca, Howard
AU  - Junca H
AD  - Microbiomas Foundation, Chia, Colombia.
FAU - June, Carl
AU  - June C
AD  - University of Pennsylvania, Philadelphia, Pennsylvania, USA.
FAU - Kamb, Sasha
AU  - Kamb S
AD  - Amgen, Thousand Oaks, California, USA.
FAU - Khvorova, Anastasia
AU  - Khvorova A
AD  - University of Massachusetts, Worcester, Massachusetts, USA.
FAU - Kim, Dae-Hyeong
AU  - Kim DH
AD  - Seoul National University, Seoul, Korea.
FAU - Kim, Jin-Soo
AU  - Kim JS
AD  - Seoul National University, Seoul, Korea.
FAU - Krishnan, Yamuna
AU  - Krishnan Y
AD  - University of Chicago, Chicago, Illinois, USA.
FAU - Lakadamyali, Melike
AU  - Lakadamyali M
AD  - The Institute of Photonic Sciences, Barcelona, Spain.
FAU - Lappalainen, Tuuli
AU  - Lappalainen T
AD  - New York Genome Center New York, New York, USA.
AD  - Columbia University, New York, New York, USA.
FAU - Lewin, Sharon
AU  - Lewin S
AD  - Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria,
      Australia.
FAU - Liao, James
AU  - Liao J
AD  - University of California, Los Angeles, California, USA.
FAU - Loman, Nick
AU  - Loman N
AD  - University of Birmingham, Birmingham, UK.
FAU - Lundberg, Emma
AU  - Lundberg E
AD  - KTH Royal Institute of Technology, Stockholm, Sweden.
FAU - Lynd, Lee
AU  - Lynd L
AD  - Dartmouth College, Hanover, New Hampshire, USA.
FAU - Martin, Cathie
AU  - Martin C
AD  - John Innes Centre, Norwich, UK.
FAU - Mellman, Ira
AU  - Mellman I
AD  - Genentech, S. San Francisco, California, USA.
FAU - Miyawaki, Atsushi
AU  - Miyawaki A
AD  - RIKEN Brain Science Institute, Wako, Japan.
FAU - Mummery, Christine
AU  - Mummery C
AD  - Leiden University Medical Center, Leiden, The Netherlands.
FAU - Nelson, Karen
AU  - Nelson K
AD  - J. Craig Venter Institute, La Jolla, California, USA.
AD  - Human Longevity, San Diego, California, USA.
FAU - Paz, Jeanne
AU  - Paz J
AD  - Gladstone Institutes, University of California San Francisco, San Francisco,
      California, USA.
FAU - Peralta-Yahya, Pamela
AU  - Peralta-Yahya P
AD  - Georgia Institute of Technology, Atlanta, Georgia, USA.
FAU - Picotti, Paola
AU  - Picotti P
AD  - ETH-Zurich, Zurich, Switzerland.
FAU - Polyak, Kornelia
AU  - Polyak K
AD  - Dana-Farber Cancer Institute, Cambridge, Massachusetts, USA.
AD  - Harvard University, Cambridge, Massachusetts, USA.
FAU - Prather, Kristala
AU  - Prather K
AD  - Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
FAU - Qin, Jun
AU  - Qin J
AD  - Beijing Proteome Research Center, Beijing, China.
AD  - Baylor College of Medicine, Houston, Texas, USA.
FAU - Quake, Stephen
AU  - Quake S
AD  - Stanford University, Stanford, California, USA.
FAU - Regev, Aviv
AU  - Regev A
AD  - Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
AD  - Harvard University, Cambridge, Massachusetts, USA.
FAU - Rogers, John A
AU  - Rogers JA
AD  - University of Illinois at Urbana-Champaign, Champaign, Illinois, USA.
FAU - Shetty, Reshma
AU  - Shetty R
AD  - Ginkgo Bioworks, Boston, Massachusetts, USA.
FAU - Sommer, Morten
AU  - Sommer M
AD  - Technical University of Denmark, Horsholm, Denmark.
FAU - Stevens, Molly
AU  - Stevens M
AD  - Imperial College London, London, UK.
FAU - Stolovitzky, Gustavo
AU  - Stolovitzky G
AD  - IBM Research, Yorktown Heights, New York, USA.
AD  - Icahn School of Medicine at Mount Sinai, New York, New York, USA.
FAU - Takahashi, Masayo
AU  - Takahashi M
AD  - RIKEN Center for Developmental Biology, Kobe, Japan.
FAU - Tang, Fuchou
AU  - Tang F
AD  - Biodynamic Optical Imaging Center, Peking University, Beijing, China.
FAU - Teichmann, Sarah
AU  - Teichmann S
AD  - Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.
FAU - Torres-Padilla, Maria-Elena
AU  - Torres-Padilla ME
AD  - Institut de Genetique et de Biologie Moleculaire et Cellulaire, Strasbourg,
      France.
AD  - Institute of Epigenetics and Stem Cells, Helmholtz Centre, Munich, Germany.
FAU - Tripathi, Leena
AU  - Tripathi L
AD  - International Institute of Tropical Agriculture, Ibadan, Kenya.
FAU - Vemula, Praveen
AU  - Vemula P
AD  - Institute for Stem Cell Biology and Regenerative Medicine, Bangalore, India.
FAU - Verdine, Greg
AU  - Verdine G
AD  - Harvard University, Cambridge, Massachusetts, USA.
AD  - Warp Drive Bio, Cambridge, Massachusetts, USA.
AD  - FogPharma, Gloucester, Massachusetts, USA.
FAU - Vollmer, Frank
AU  - Vollmer F
AD  - Max Planck Institute for the Science of Light, Erlangen, Germany.
FAU - Wang, Jun
AU  - Wang J
AD  - iCarbonX, Shenzhen, China.
FAU - Ying, Jackie Y
AU  - Ying JY
AD  - Institute of Bioengineering and Nanotechnology, Singapore.
FAU - Zhang, Feng
AU  - Zhang F
AD  - Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
FAU - Zhang, Tian
AU  - Zhang T
AD  - Technical University of Denmark, Horsholm, Denmark.
LA  - eng
GR  - BBS/E/J/00000153/Biotechnology and Biological Sciences Research Council/United
      Kingdom
GR  - MR/M501621/1/Medical Research Council/United Kingdom
GR  - R01 GM108803/GM/NIGMS NIH HHS/United States
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biomedical Research/*trends
MH  - *Biotechnology
MH  - *Forecasting
MH  - Humans
EDAT- 2016/03/11 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/03/11 06:00
PHST- 2016/03/11 06:00 [entrez]
PHST- 2016/03/11 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt.3502 [pii]
AID - 10.1038/nbt.3502 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):270-5. doi: 10.1038/nbt.3502.

PMID- 26963548
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - 20 years of Nature Biotechnology bioengineering research.
PG  - 267-9
LID - 10.1038/nbt.3508 [doi]
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
AD  - Nature Biotechnology.
FAU - Schmidt, Charles
AU  - Schmidt C
FAU - Waltz, Emily
AU  - Waltz E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Bioengineering
MH  - *Biotechnology
MH  - Humans
MH  - *Publishing
EDAT- 2016/03/11 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/03/11 06:00
PHST- 2016/03/11 06:00 [entrez]
PHST- 2016/03/11 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt.3508 [pii]
AID - 10.1038/nbt.3508 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):267-9. doi: 10.1038/nbt.3508.

PMID- 26963547
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20171206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - 20 years of Nature Biotechnology biomedical research.
PG  - 262-6
LID - 10.1038/nbt.3509 [doi]
FAU - Azvolinsky, Anna
AU  - Azvolinsky A
FAU - Schmidt, Charles
AU  - Schmidt C
FAU - Waltz, Emily
AU  - Waltz E
FAU - Webb, Sarah
AU  - Webb S
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EIN - Nat Biotechnol. 2016 Jun;34(6):666
EIN - Nat Biotechnol. 2016 Jun 9;34(6):666. PMID: 27281425
MH  - *Biomedical Research
MH  - *Biotechnology
MH  - Humans
MH  - *Publishing
EDAT- 2016/03/11 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/03/11 06:00
PHST- 2016/03/11 06:00 [entrez]
PHST- 2016/03/11 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt.3509 [pii]
AID - 10.1038/nbt.3509 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):262-6. doi: 10.1038/nbt.3509.

PMID- 26963546
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20171206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - 20 years of Nature Biotechnology research tools.
PG  - 256-61
LID - 10.1038/nbt.3507 [doi]
FAU - Azvolinsky, Anna
AU  - Azvolinsky A
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
AD  - Nature Biotechnology.
FAU - Waltz, Emily
AU  - Waltz E
FAU - Webb, Sarah
AU  - Webb S
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EIN - Nat Biotechnol. 2016 Jun;34(6):666
EIN - Nat Biotechnol. 2016 Jun 9;34(6):666. PMID: 27281426
MH  - *Biotechnology
MH  - Humans
MH  - *Publishing
MH  - *Research
EDAT- 2016/03/11 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/03/11 06:00
PHST- 2016/03/11 06:00 [entrez]
PHST- 2016/03/11 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt.3507 [pii]
AID - 10.1038/nbt.3507 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):256-61. doi: 10.1038/nbt.3507.

PMID- 26963545
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - Estimating the biotech sector's contribution to the US economy.
PG  - 247-55
LID - 10.1038/nbt.3491 [doi]
FAU - Carlson, Robert
AU  - Carlson R
AD  - Bioeconomy Capital LLC and Biodesic LLC, Seattle, Washington, USA.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*economics
MH  - Drug Industry/*economics
MH  - Humans
MH  - United States
EDAT- 2016/03/11 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/03/11 06:00
PHST- 2016/03/11 06:00 [entrez]
PHST- 2016/03/11 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt.3491 [pii]
AID - 10.1038/nbt.3491 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):247-55. doi: 10.1038/nbt.3491.

PMID- 26963544
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - Digital medicine's march on chronic disease.
PG  - 239-46
LID - 10.1038/nbt.3495 [doi]
FAU - Kvedar, Joseph C
AU  - Kvedar JC
AD  - Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts,
      USA, Harvard Medical School, Boston, Massachusetts, USA, and Partners Connected
      Health, Partners Healthcare, Boston, Massachusetts, USA.
FAU - Fogel, Alexander L
AU  - Fogel AL
AD  - Stanford University Graduate School of Business and the Stanford University
      School of Medicine, Stanford, California, USA.
FAU - Elenko, Eric
AU  - Elenko E
AD  - PureTech Health, Boston, Massachusetts, USA.
FAU - Zohar, Daphne
AU  - Zohar D
AD  - PureTech Health, Boston, Massachusetts, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Chronic Disease/*epidemiology/therapy
MH  - Humans
EDAT- 2016/03/11 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/03/11 06:00
PHST- 2016/03/11 06:00 [entrez]
PHST- 2016/03/11 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt.3495 [pii]
AID - 10.1038/nbt.3495 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):239-46. doi: 10.1038/nbt.3495.

PMID- 26963543
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - Marketplace response to GM animal products.
PG  - 236-8
LID - 10.1038/nbt.3494 [doi]
FAU - Mather, Damien
AU  - Mather D
AD  - University of Otago, Marketing, Dunedin, Otago, New Zealand.
FAU - Vikan, Rasmus
AU  - Vikan R
AD  - University of Otago, Marketing, Dunedin, Otago, New Zealand.
FAU - Knight, John
AU  - Knight J
AD  - University of Otago, Marketing, Dunedin, Otago, New Zealand.
LA  - eng
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - *Animals, Genetically Modified
MH  - Fisheries/legislation & jurisprudence
MH  - *Food, Genetically Modified
MH  - Norway
MH  - Salmon/*genetics
MH  - United States
MH  - United States Food and Drug Administration/legislation & jurisprudence
EDAT- 2016/03/11 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/03/11 06:00
PHST- 2016/03/11 06:00 [entrez]
PHST- 2016/03/11 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt.3494 [pii]
AID - 10.1038/nbt.3494 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):236-8. doi: 10.1038/nbt.3494.

PMID- 26963542
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - A call for industry to embrace green biopharma.
PG  - 234-5
LID - 10.1038/nbt.3493 [doi]
FAU - Budzinski, Kristi L
AU  - Budzinski KL
AD  - Environmental, Health, and Safety Department, Genentech, Inc., South San
      Francisco, California, USA.
FAU - Koenig, Stefan G
AU  - Koenig SG
AD  - Research and Early Development (gRED), Genentech, Inc., South San Francisco,
      California, USA.
FAU - O'Connor, Deborah A
AU  - O'Connor DA
AD  - Pharma Technical Development Operations, Genentech, Inc., South San Francisco,
      California, USA.
FAU - Wu, Tse-Sung
AU  - Wu TS
AD  - Process and Project Engineering, Production Technology, Genentech, Inc., South
      San Francisco, California, USA.
LA  - eng
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Drug Industry
MH  - *Environment
MH  - *Green Chemistry Technology
MH  - Humans
EDAT- 2016/03/11 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/03/11 06:00
PHST- 2016/03/11 06:00 [entrez]
PHST- 2016/03/11 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt.3493 [pii]
AID - 10.1038/nbt.3493 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):234-5. doi: 10.1038/nbt.3493.

PMID- 26963541
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - Deciphering the EU clinical trials regulation.
PG  - 231-3
LID - 10.1038/nbt.3492 [doi]
FAU - Abou-El-Enein, Mohamed
AU  - Abou-El-Enein M
AD  - Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charite University
      Medicine, Campus Virchow, Berlin, Germany.
FAU - Schneider, Christian K
AU  - Schneider CK
AD  - National Institute for Biological Standards and Control (NIBSC), Medicines and
      Healthcare Products Regulatory Agency, South Mimms, Hertfordshire, United
      Kingdom.
AD  - Twincore Centre for Experimental and Clinical Infection Research, Hannover,
      Germany.
LA  - eng
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Clinical Trials as Topic/*legislation & jurisprudence
MH  - *European Union
MH  - Government Agencies/*legislation & jurisprudence
MH  - Humans
EDAT- 2016/03/11 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/03/11 06:00
PHST- 2016/03/11 06:00 [entrez]
PHST- 2016/03/11 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt.3492 [pii]
AID - 10.1038/nbt.3492 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):231-3. doi: 10.1038/nbt.3492.

PMID- 26963540
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - Aligning needs.
PG  - 226-30
LID - 10.1038/nbt.3497 [doi]
FAU - Ford, Dennis
AU  - Ford D
AD  - Life Science Nation, Boston, Massachusetts, USA.
FAU - Kohlbrenner, William
AU  - Kohlbrenner W
AD  - Life Science Nation, Boston, Massachusetts, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Drug Industry/*economics
MH  - Humans
MH  - Investments/*economics
MH  - Regenerative Medicine/economics
MH  - Small Business/*economics
MH  - United States
EDAT- 2016/03/11 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/03/11 06:00
PHST- 2016/03/11 06:00 [entrez]
PHST- 2016/03/11 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt.3497 [pii]
AID - 10.1038/nbt.3497 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):226-30. doi: 10.1038/nbt.3497.

PMID- 26963538
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - Sanofi drops MannKind's inhaled insulin.
PG  - 224
LID - 10.1038/nbt0316-224 [doi]
FAU - Ratner, Mark
AU  - Ratner M
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Insulin)
SB  - IM
MH  - *Administration, Inhalation
MH  - Diabetes Mellitus, Type 1/drug therapy/*economics
MH  - Diabetes Mellitus, Type 2/drug therapy/*economics
MH  - Drug Industry/economics
MH  - France
MH  - Humans
MH  - Insulin/*economics/therapeutic use
EDAT- 2016/03/11 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/03/11 06:00
PHST- 2016/03/11 06:00 [entrez]
PHST- 2016/03/11 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt0316-224 [pii]
AID - 10.1038/nbt0316-224 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):224. doi: 10.1038/nbt0316-224.

PMID- 26963537
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - Seed spy pleads guilty.
PG  - 223
LID - 10.1038/nbt0316-223b [doi]
FAU - Waltz, Emily
AU  - Waltz E
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - China
MH  - Drug Industry/*legislation & jurisprudence
MH  - Government Agencies/*legislation & jurisprudence
MH  - Humans
MH  - *Intellectual Property
MH  - Seeds/*genetics
MH  - United States
EDAT- 2016/03/11 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/03/11 06:00
PHST- 2016/03/11 06:00 [entrez]
PHST- 2016/03/11 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt0316-223b [pii]
AID - 10.1038/nbt0316-223b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):223. doi: 10.1038/nbt0316-223b.

PMID- 26963536
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20161126
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - Bial incident raises FAAH suspicions.
PG  - 223
LID - 10.1038/nbt0316-223a [doi]
FAU - von Schaper, Eva
AU  - von Schaper E
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Arachidonic Acids)
RN  - 0 (Endocannabinoids)
RN  - 0 (Enzyme Inhibitors)
RN  - 0 (Polyunsaturated Alkamides)
RN  - EC 3.5.- (Amidohydrolases)
RN  - EC 3.5.1.- (fatty-acid amide hydrolase)
RN  - UR5G69TJKH (anandamide)
SB  - IM
MH  - Amidohydrolases/*antagonists & inhibitors
MH  - Arachidonic Acids/metabolism
MH  - *Clinical Trials as Topic
MH  - Endocannabinoids/metabolism
MH  - Enzyme Inhibitors/*adverse effects/therapeutic use
MH  - France
MH  - Humans
MH  - Polyunsaturated Alkamides/metabolism
MH  - Tourette Syndrome/drug therapy
EDAT- 2016/03/11 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/03/11 06:00
PHST- 2016/03/11 06:00 [entrez]
PHST- 2016/03/11 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt0316-223a [pii]
AID - 10.1038/nbt0316-223a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):223. doi: 10.1038/nbt0316-223a.

PMID- 26963535
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - GM mosquitoes fire first salvo against Zika virus.
PG  - 221-2
LID - 10.1038/nbt0316-221 [doi]
FAU - Waltz, Emily
AU  - Waltz E
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - *Animals, Genetically Modified
MH  - Brazil
MH  - China
MH  - Culicidae/genetics
MH  - Disease Outbreaks
MH  - Government Agencies
MH  - Humans
MH  - United States
MH  - Zika Virus/pathogenicity
MH  - Zika Virus Infection/genetics/*therapy/*transmission
EDAT- 2016/03/11 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/03/11 06:00
PHST- 2016/03/11 06:00 [entrez]
PHST- 2016/03/11 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt0316-221 [pii]
AID - 10.1038/nbt0316-221 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):221-2. doi: 10.1038/nbt0316-221.

PMID- 26963534
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - GM salmon shut out of US.
PG  - 220
LID - 10.1038/nbt0316-220b [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - Animals, Genetically Modified
MH  - Aquaculture
MH  - Food, Genetically Modified
MH  - Humans
MH  - Salmon/*genetics/growth & development
MH  - United States
MH  - United States Food and Drug Administration/*legislation & jurisprudence
EDAT- 2016/03/11 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/03/11 06:00
PHST- 2016/03/11 06:00 [entrez]
PHST- 2016/03/11 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt0316-220b [pii]
AID - 10.1038/nbt0316-220b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):220. doi: 10.1038/nbt0316-220b.

PMID- 26963533
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20160311
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - FDA head Califf spurned.
PG  - 220
LID - 10.1038/nbt0316-220a [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Government Agencies/*legislation & jurisprudence
MH  - Humans
MH  - United States
MH  - United States Food and Drug Administration/*legislation & jurisprudence/trends
EDAT- 2016/03/11 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/03/11 06:00
PHST- 2016/03/11 06:00 [entrez]
PHST- 2016/03/11 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt0316-220a [pii]
AID - 10.1038/nbt0316-220a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):220. doi: 10.1038/nbt0316-220a.

PMID- 26963532
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - Natural killer cells blaze into immuno-oncology.
PG  - 219-20
LID - 10.1038/nbt0316-219 [doi]
FAU - Garber, Ken
AU  - Garber K
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Drug Industry
MH  - Humans
MH  - Killer Cells, Natural/*immunology
MH  - Neoplasms/*immunology/therapy
EDAT- 2016/03/11 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/03/11 06:00
PHST- 2016/03/11 06:00 [entrez]
PHST- 2016/03/11 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt0316-219 [pii]
AID - 10.1038/nbt0316-219 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):219-20. doi: 10.1038/nbt0316-219.

PMID- 26963531
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - Drug developers refocus efforts on RAS.
PG  - 217-8
LID - 10.1038/nbt0316-217 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - EC 3.6.5.2 (ras Proteins)
SB  - IM
MH  - *Biotechnology
MH  - *Drug Discovery
MH  - Humans
MH  - Neoplasms/genetics/*therapy
MH  - ras Proteins/*genetics/therapeutic use
EDAT- 2016/03/11 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/03/11 06:00
PHST- 2016/03/11 06:00 [entrez]
PHST- 2016/03/11 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt0316-217 [pii]
AID - 10.1038/nbt0316-217 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):217-8. doi: 10.1038/nbt0316-217.

PMID- 26963530
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - Immune profiling players shift gear to guide cancer drug development.
PG  - 215-6
LID - 10.1038/nbt0316-215 [doi]
FAU - Eisenstein, Michael
AU  - Eisenstein M
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antineoplastic Agents)
SB  - IM
MH  - Antineoplastic Agents/*therapeutic use
MH  - *Drug Design
MH  - Humans
MH  - Neoplasms/*drug therapy
EDAT- 2016/03/11 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/03/11 06:00
PHST- 2016/03/11 06:00 [entrez]
PHST- 2016/03/11 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt0316-215 [pii]
AID - 10.1038/nbt0316-215 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):215-6. doi: 10.1038/nbt0316-215.

PMID- 26963529
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20160311
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - Breaking out of the bubble.
PG  - 213
LID - 10.1038/nbt.3517 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/economics/*trends
MH  - Human Genome Project
MH  - Humans
EDAT- 2016/03/11 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/03/11 06:00
PHST- 2016/03/11 06:00 [entrez]
PHST- 2016/03/11 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt.3517 [pii]
AID - 10.1038/nbt.3517 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):213. doi: 10.1038/nbt.3517.

PMID- 26878319
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20180126
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - A 3D bioprinting system to produce human-scale tissue constructs with structural 
      integrity.
PG  - 312-9
LID - 10.1038/nbt.3413 [doi]
AB  - A challenge for tissue engineering is producing three-dimensional (3D),
      vascularized cellular constructs of clinically relevant size, shape and
      structural integrity. We present an integrated tissue-organ printer (ITOP) that
      can fabricate stable, human-scale tissue constructs of any shape. Mechanical
      stability is achieved by printing cell-laden hydrogels together with
      biodegradable polymers in integrated patterns and anchored on sacrificial
      hydrogels. The correct shape of the tissue construct is achieved by representing 
      clinical imaging data as a computer model of the anatomical defect and
      translating the model into a program that controls the motions of the printer
      nozzles, which dispense cells to discrete locations. The incorporation of
      microchannels into the tissue constructs facilitates diffusion of nutrients to
      printed cells, thereby overcoming the diffusion limit of 100-200 mum for cell
      survival in engineered tissues. We demonstrate capabilities of the ITOP by
      fabricating mandible and calvarial bone, cartilage and skeletal muscle. Future
      development of the ITOP is being directed to the production of tissues for human 
      applications and to the building of more complex tissues and solid organs.
FAU - Kang, Hyun-Wook
AU  - Kang HW
AD  - Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, 
      Medical Center Boulevard, Winston-Salem, North Carolina, USA.
FAU - Lee, Sang Jin
AU  - Lee SJ
AUID- ORCID: http://orcid.org/0000-0002-3899-1909
AD  - Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, 
      Medical Center Boulevard, Winston-Salem, North Carolina, USA.
FAU - Ko, In Kap
AU  - Ko IK
AD  - Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, 
      Medical Center Boulevard, Winston-Salem, North Carolina, USA.
FAU - Kengla, Carlos
AU  - Kengla C
AD  - Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, 
      Medical Center Boulevard, Winston-Salem, North Carolina, USA.
FAU - Yoo, James J
AU  - Yoo JJ
AD  - Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, 
      Medical Center Boulevard, Winston-Salem, North Carolina, USA.
FAU - Atala, Anthony
AU  - Atala A
AD  - Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, 
      Medical Center Boulevard, Winston-Salem, North Carolina, USA.
LA  - eng
PT  - Journal Article
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20160215
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Biocompatible Materials)
RN  - 0 (Hydrogels)
RN  - 0 (Polymers)
SB  - IM
CIN - Nat Rev Rheumatol. 2016 Apr;12(4):191. PMID: 26935277
CIN - Nat Biotechnol. 2016 Mar;34(3):295-6. PMID: 26963553
CIN - Trends Biotechnol. 2016 May;34(5):356-7. PMID: 27038823
MH  - Biocompatible Materials/chemistry
MH  - Bioprinting/*methods
MH  - Humans
MH  - Hydrogels/chemistry
MH  - Mandible/physiology
MH  - Polymers/chemistry
MH  - *Printing, Three-Dimensional
MH  - Tissue Engineering/*methods
MH  - *Tissue Scaffolds
EDAT- 2016/02/16 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/02/16 06:00
PHST- 2015/07/27 00:00 [received]
PHST- 2015/10/19 00:00 [accepted]
PHST- 2016/02/16 06:00 [entrez]
PHST- 2016/02/16 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt.3413 [pii]
AID - 10.1038/nbt.3413 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):312-9. doi: 10.1038/nbt.3413. Epub 2016 Feb 15.

PMID- 26854477
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - Fast search of thousands of short-read sequencing experiments.
PG  - 300-2
LID - 10.1038/nbt.3442 [doi]
AB  - The amount of sequence information in public repositories is growing at a rapid
      rate. Although these data are likely to contain clinically important information 
      that has not yet been uncovered, our ability to effectively mine these
      repositories is limited. Here we introduce Sequence Bloom Trees (SBTs), a method 
      for querying thousands of short-read sequencing experiments by sequence, 162
      times faster than existing approaches. The approach searches large data archives 
      for all experiments that involve a given sequence. We use SBTs to search 2,652
      human blood, breast and brain RNA-seq experiments for all 214,293 known
      transcripts in under 4 days using less than 239 MB of RAM and a single CPU.
      Searching sequence archives at this scale and in this time frame is currently not
      possible using existing tools.
FAU - Solomon, Brad
AU  - Solomon B
AD  - Joint Carnegie Mellon University-University of Pittsburgh Ph.D. Program in
      Computational Biology, Computational Biology Department, School of Computer
      Science, Carnegie Mellon University, Pittsburgh, Pennsylvania, USA.
FAU - Kingsford, Carl
AU  - Kingsford C
AD  - Computational Biology Department, School of Computer Science, Carnegie Mellon
      University, Pittsburgh, Pennsylvania, USA.
LA  - eng
GR  - R01 HG007104/HG/NHGRI NIH HHS/United States
GR  - R21 HG006913/HG/NHGRI NIH HHS/United States
GR  - T32 EB009403/EB/NIBIB NIH HHS/United States
GR  - R01HG007104/HG/NHGRI NIH HHS/United States
GR  - R21HG006913/HG/NHGRI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20160208
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 63231-63-0 (RNA)
SB  - IM
MH  - Algorithms
MH  - *Data Mining
MH  - High-Throughput Nucleotide Sequencing/*methods
MH  - Humans
MH  - RNA/*genetics
MH  - Sequence Analysis, DNA/methods
MH  - Sequence Analysis, RNA/*methods
PMC - PMC4804353
MID - NIHMS740736
EDAT- 2016/02/09 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/02/09 06:00
PHST- 2015/04/28 00:00 [received]
PHST- 2015/11/23 00:00 [accepted]
PHST- 2016/02/09 06:00 [entrez]
PHST- 2016/02/09 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt.3442 [pii]
AID - 10.1038/nbt.3442 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):300-2. doi: 10.1038/nbt.3442. Epub 2016 Feb 8.

PMID- 26854476
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20171221
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - Minimally invasive endovascular stent-electrode array for high-fidelity, chronic 
      recordings of cortical neural activity.
PG  - 320-7
LID - 10.1038/nbt.3428 [doi]
AB  - High-fidelity intracranial electrode arrays for recording and stimulating brain
      activity have facilitated major advances in the treatment of neurological
      conditions over the past decade. Traditional arrays require direct implantation
      into the brain via open craniotomy, which can lead to inflammatory tissue
      responses, necessitating development of minimally invasive approaches that avoid 
      brain trauma. Here we demonstrate the feasibility of chronically recording brain 
      activity from within a vein using a passive stent-electrode recording array
      (stentrode). We achieved implantation into a superficial cortical vein overlying 
      the motor cortex via catheter angiography and demonstrate neural recordings in
      freely moving sheep for up to 190 d. Spectral content and bandwidth of vascular
      electrocorticography were comparable to those of recordings from epidural surface
      arrays. Venous internal lumen patency was maintained for the duration of
      implantation. Stentrodes may have wide ranging applications as a neural interface
      for treatment of a range of neurological conditions.
FAU - Oxley, Thomas J
AU  - Oxley TJ
AD  - Vascular Bionics Laboratory, Melbourne Brain Centre, Department of Medicine, The 
      University of Melbourne, Melbourne, Australia.
AD  - Departments of Medicine and Neurology, Melbourne Brain Centre at The Royal
      Melbourne Hospital, The University of Melbourne, Melbourne, Australia.
AD  - The Florey Institute of Neuroscience and Mental Health, The University of
      Melbourne, Melbourne, Australia.
AD  - NeuroEngineering Laboratory, Department of Electrical &Electronic Engineering,
      The University of Melbourne, Melbourne, Australia.
FAU - Opie, Nicholas L
AU  - Opie NL
AD  - Vascular Bionics Laboratory, Melbourne Brain Centre, Department of Medicine, The 
      University of Melbourne, Melbourne, Australia.
AD  - Departments of Medicine and Neurology, Melbourne Brain Centre at The Royal
      Melbourne Hospital, The University of Melbourne, Melbourne, Australia.
AD  - The Florey Institute of Neuroscience and Mental Health, The University of
      Melbourne, Melbourne, Australia.
AD  - NeuroEngineering Laboratory, Department of Electrical &Electronic Engineering,
      The University of Melbourne, Melbourne, Australia.
FAU - John, Sam E
AU  - John SE
AD  - Vascular Bionics Laboratory, Melbourne Brain Centre, Department of Medicine, The 
      University of Melbourne, Melbourne, Australia.
AD  - Departments of Medicine and Neurology, Melbourne Brain Centre at The Royal
      Melbourne Hospital, The University of Melbourne, Melbourne, Australia.
AD  - The Florey Institute of Neuroscience and Mental Health, The University of
      Melbourne, Melbourne, Australia.
AD  - NeuroEngineering Laboratory, Department of Electrical &Electronic Engineering,
      The University of Melbourne, Melbourne, Australia.
FAU - Rind, Gil S
AU  - Rind GS
AD  - Vascular Bionics Laboratory, Melbourne Brain Centre, Department of Medicine, The 
      University of Melbourne, Melbourne, Australia.
AD  - Departments of Medicine and Neurology, Melbourne Brain Centre at The Royal
      Melbourne Hospital, The University of Melbourne, Melbourne, Australia.
AD  - The Florey Institute of Neuroscience and Mental Health, The University of
      Melbourne, Melbourne, Australia.
FAU - Ronayne, Stephen M
AU  - Ronayne SM
AD  - Vascular Bionics Laboratory, Melbourne Brain Centre, Department of Medicine, The 
      University of Melbourne, Melbourne, Australia.
AD  - Departments of Medicine and Neurology, Melbourne Brain Centre at The Royal
      Melbourne Hospital, The University of Melbourne, Melbourne, Australia.
AD  - The Florey Institute of Neuroscience and Mental Health, The University of
      Melbourne, Melbourne, Australia.
FAU - Wheeler, Tracey L
AU  - Wheeler TL
AD  - Craig H. Neilsen Foundation, Encino, California, USA.
FAU - Judy, Jack W
AU  - Judy JW
AD  - Nanoscience Institute for Medical and Engineering Technology, University of
      Florida, Gainesville, Florida, USA.
FAU - McDonald, Alan J
AU  - McDonald AJ
AD  - The Florey Institute of Neuroscience and Mental Health, The University of
      Melbourne, Melbourne, Australia.
FAU - Dornom, Anthony
AU  - Dornom A
AD  - The Florey Institute of Neuroscience and Mental Health, The University of
      Melbourne, Melbourne, Australia.
FAU - Lovell, Timothy J H
AU  - Lovell TJ
AD  - Vascular Bionics Laboratory, Melbourne Brain Centre, Department of Medicine, The 
      University of Melbourne, Melbourne, Australia.
AD  - Departments of Medicine and Neurology, Melbourne Brain Centre at The Royal
      Melbourne Hospital, The University of Melbourne, Melbourne, Australia.
AD  - The Florey Institute of Neuroscience and Mental Health, The University of
      Melbourne, Melbourne, Australia.
FAU - Steward, Christopher
AU  - Steward C
AD  - Departments of Medicine and Neurology, Melbourne Brain Centre at The Royal
      Melbourne Hospital, The University of Melbourne, Melbourne, Australia.
AD  - Department of Radiology, Royal Melbourne Hospital, Melbourne Health, Melbourne,
      Australia.
AD  - Department of Radiology, The University of Melbourne, Melbourne, Australia.
FAU - Garrett, David J
AU  - Garrett DJ
AD  - School of Physics, The University of Melbourne, Melbourne, Australia.
AD  - The Bionics Institute, East Melbourne, Victoria, Australia.
FAU - Moffat, Bradford A
AU  - Moffat BA
AD  - Department of Radiology, Royal Melbourne Hospital, Melbourne Health, Melbourne,
      Australia.
AD  - Department of Radiology, The University of Melbourne, Melbourne, Australia.
AD  - Department of Anatomy and Neuroscience, The University of Melbourne, Melbourne,
      Australia.
FAU - Lui, Elaine H
AU  - Lui EH
AD  - Department of Radiology, Royal Melbourne Hospital, Melbourne Health, Melbourne,
      Australia.
AD  - Department of Radiology, The University of Melbourne, Melbourne, Australia.
FAU - Yassi, Nawaf
AU  - Yassi N
AD  - Departments of Medicine and Neurology, Melbourne Brain Centre at The Royal
      Melbourne Hospital, The University of Melbourne, Melbourne, Australia.
FAU - Campbell, Bruce C V
AU  - Campbell BC
AD  - Departments of Medicine and Neurology, Melbourne Brain Centre at The Royal
      Melbourne Hospital, The University of Melbourne, Melbourne, Australia.
FAU - Wong, Yan T
AU  - Wong YT
AD  - Vascular Bionics Laboratory, Melbourne Brain Centre, Department of Medicine, The 
      University of Melbourne, Melbourne, Australia.
AD  - NeuroEngineering Laboratory, Department of Electrical &Electronic Engineering,
      The University of Melbourne, Melbourne, Australia.
FAU - Fox, Kate E
AU  - Fox KE
AD  - School of Physics, The University of Melbourne, Melbourne, Australia.
AD  - Centre for Additive Manufacturing, School of Aerospace, Mechanical and
      Manufacturing Engineering, RMIT University, Melbourne, Australia.
FAU - Nurse, Ewan S
AU  - Nurse ES
AD  - Vascular Bionics Laboratory, Melbourne Brain Centre, Department of Medicine, The 
      University of Melbourne, Melbourne, Australia.
AD  - NeuroEngineering Laboratory, Department of Electrical &Electronic Engineering,
      The University of Melbourne, Melbourne, Australia.
FAU - Bennett, Iwan E
AU  - Bennett IE
AD  - Department of Surgery, Royal Melbourne Hospital, The University of Melbourne,
      Melbourne, Australia.
FAU - Bauquier, Sebastien H
AU  - Bauquier SH
AD  - Translational Research and Clinical Trials (TRACTs), Veterinary Hospital, Faculty
      of Veterinary and Agricultural Sciences, The University of Melbourne, Melbourne, 
      Australia.
FAU - Liyanage, Kishan A
AU  - Liyanage KA
AD  - Vascular Bionics Laboratory, Melbourne Brain Centre, Department of Medicine, The 
      University of Melbourne, Melbourne, Australia.
FAU - van der Nagel, Nicole R
AU  - van der Nagel NR
AD  - Vascular Bionics Laboratory, Melbourne Brain Centre, Department of Medicine, The 
      University of Melbourne, Melbourne, Australia.
FAU - Perucca, Piero
AU  - Perucca P
AD  - Departments of Medicine and Neurology, Melbourne Brain Centre at The Royal
      Melbourne Hospital, The University of Melbourne, Melbourne, Australia.
FAU - Ahnood, Arman
AU  - Ahnood A
AD  - School of Physics, The University of Melbourne, Melbourne, Australia.
FAU - Gill, Katherine P
AU  - Gill KP
AD  - Vascular Bionics Laboratory, Melbourne Brain Centre, Department of Medicine, The 
      University of Melbourne, Melbourne, Australia.
FAU - Yan, Bernard
AU  - Yan B
AD  - Departments of Medicine and Neurology, Melbourne Brain Centre at The Royal
      Melbourne Hospital, The University of Melbourne, Melbourne, Australia.
FAU - Churilov, Leonid
AU  - Churilov L
AD  - The Florey Institute of Neuroscience and Mental Health, The University of
      Melbourne, Melbourne, Australia.
AD  - School of Mathematics and Geospatial Sciences, RMIT University, Melbourne,
      Australia.
FAU - French, Christopher R
AU  - French CR
AD  - Departments of Medicine and Neurology, Melbourne Brain Centre at The Royal
      Melbourne Hospital, The University of Melbourne, Melbourne, Australia.
FAU - Desmond, Patricia M
AU  - Desmond PM
AD  - Department of Radiology, Royal Melbourne Hospital, Melbourne Health, Melbourne,
      Australia.
AD  - Department of Radiology, The University of Melbourne, Melbourne, Australia.
FAU - Horne, Malcolm K
AU  - Horne MK
AD  - The Florey Institute of Neuroscience and Mental Health, The University of
      Melbourne, Melbourne, Australia.
FAU - Kiers, Lynette
AU  - Kiers L
AD  - Departments of Medicine and Neurology, Melbourne Brain Centre at The Royal
      Melbourne Hospital, The University of Melbourne, Melbourne, Australia.
FAU - Prawer, Steven
AU  - Prawer S
AD  - School of Physics, The University of Melbourne, Melbourne, Australia.
FAU - Davis, Stephen M
AU  - Davis SM
AD  - Departments of Medicine and Neurology, Melbourne Brain Centre at The Royal
      Melbourne Hospital, The University of Melbourne, Melbourne, Australia.
FAU - Burkitt, Anthony N
AU  - Burkitt AN
AUID- ORCID: http://orcid.org/0000-0001-5672-2772
AD  - NeuroEngineering Laboratory, Department of Electrical &Electronic Engineering,
      The University of Melbourne, Melbourne, Australia.
AD  - The Bionics Institute, East Melbourne, Victoria, Australia.
FAU - Mitchell, Peter J
AU  - Mitchell PJ
AD  - Department of Radiology, Royal Melbourne Hospital, Melbourne Health, Melbourne,
      Australia.
AD  - Department of Radiology, The University of Melbourne, Melbourne, Australia.
FAU - Grayden, David B
AU  - Grayden DB
AD  - Vascular Bionics Laboratory, Melbourne Brain Centre, Department of Medicine, The 
      University of Melbourne, Melbourne, Australia.
AD  - NeuroEngineering Laboratory, Department of Electrical &Electronic Engineering,
      The University of Melbourne, Melbourne, Australia.
AD  - The Bionics Institute, East Melbourne, Victoria, Australia.
AD  - Centre for Neural Engineering, The University of Melbourne, Melbourne, Australia.
FAU - May, Clive N
AU  - May CN
AD  - Vascular Bionics Laboratory, Melbourne Brain Centre, Department of Medicine, The 
      University of Melbourne, Melbourne, Australia.
AD  - The Florey Institute of Neuroscience and Mental Health, The University of
      Melbourne, Melbourne, Australia.
FAU - O'Brien, Terence J
AU  - O'Brien TJ
AD  - Departments of Medicine and Neurology, Melbourne Brain Centre at The Royal
      Melbourne Hospital, The University of Melbourne, Melbourne, Australia.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20160208
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CIN - Neurosurgery. 2016 Aug;79(2):N22-3. PMID: 27428642
MH  - Animals
MH  - Catheters
MH  - Cerebral Angiography/methods
MH  - Electrodes
MH  - *Endovascular Procedures
MH  - Humans
MH  - Motor Cortex/*physiology
MH  - Neurons/*physiology
MH  - Sheep
MH  - *Stents
EDAT- 2016/02/09 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/02/09 06:00
PHST- 2015/04/18 00:00 [received]
PHST- 2015/11/09 00:00 [accepted]
PHST- 2016/02/09 06:00 [entrez]
PHST- 2016/02/09 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt.3428 [pii]
AID - 10.1038/nbt.3428 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):320-7. doi: 10.1038/nbt.3428. Epub 2016 Feb 8.

PMID- 26829319
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20161019
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - Haplotyping germline and cancer genomes with high-throughput linked-read
      sequencing.
PG  - 303-11
LID - 10.1038/nbt.3432 [doi]
AB  - Haplotyping of human chromosomes is a prerequisite for cataloguing the full
      repertoire of genetic variation. We present a microfluidics-based, linked-read
      sequencing technology that can phase and haplotype germline and cancer genomes
      using nanograms of input DNA. This high-throughput platform prepares barcoded
      libraries for short-read sequencing and computationally reconstructs long-range
      haplotype and structural variant information. We generate haplotype blocks in a
      nuclear trio that are concordant with expected inheritance patterns and phase a
      set of structural variants. We also resolve the structure of the EML4-ALK gene
      fusion in the NCI-H2228 cancer cell line using phased exome sequencing. Finally, 
      we assign genetic aberrations to specific megabase-scale haplotypes generated
      from whole-genome sequencing of a primary colorectal adenocarcinoma. This
      approach resolves haplotype information using up to 100 times less genomic DNA
      than some methods and enables the accurate detection of structural variants.
FAU - Zheng, Grace X Y
AU  - Zheng GX
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Lau, Billy T
AU  - Lau BT
AD  - Stanford Genome Technology Center, Stanford University, Palo Alto, California,
      USA.
FAU - Schnall-Levin, Michael
AU  - Schnall-Levin M
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Jarosz, Mirna
AU  - Jarosz M
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Bell, John M
AU  - Bell JM
AD  - Stanford Genome Technology Center, Stanford University, Palo Alto, California,
      USA.
FAU - Hindson, Christopher M
AU  - Hindson CM
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Kyriazopoulou-Panagiotopoulou, Sofia
AU  - Kyriazopoulou-Panagiotopoulou S
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Masquelier, Donald A
AU  - Masquelier DA
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Merrill, Landon
AU  - Merrill L
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Terry, Jessica M
AU  - Terry JM
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Mudivarti, Patrice A
AU  - Mudivarti PA
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Wyatt, Paul W
AU  - Wyatt PW
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Bharadwaj, Rajiv
AU  - Bharadwaj R
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Makarewicz, Anthony J
AU  - Makarewicz AJ
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Li, Yuan
AU  - Li Y
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Belgrader, Phillip
AU  - Belgrader P
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Price, Andrew D
AU  - Price AD
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Lowe, Adam J
AU  - Lowe AJ
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Marks, Patrick
AU  - Marks P
AUID- ORCID: http://orcid.org/0000-0002-3231-7163
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Vurens, Gerard M
AU  - Vurens GM
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Hardenbol, Paul
AU  - Hardenbol P
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Montesclaros, Luz
AU  - Montesclaros L
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Luo, Melissa
AU  - Luo M
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Greenfield, Lawrence
AU  - Greenfield L
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Wong, Alexander
AU  - Wong A
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Birch, David E
AU  - Birch DE
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Short, Steven W
AU  - Short SW
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Bjornson, Keith P
AU  - Bjornson KP
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Patel, Pranav
AU  - Patel P
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Hopmans, Erik S
AU  - Hopmans ES
AD  - Stanford Genome Technology Center, Stanford University, Palo Alto, California,
      USA.
FAU - Wood, Christina
AU  - Wood C
AD  - Division of Oncology, Department of Medicine, Stanford University School of
      Medicine, Stanford, California, USA.
FAU - Kaur, Sukhvinder
AU  - Kaur S
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Lockwood, Glenn K
AU  - Lockwood GK
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Stafford, David
AU  - Stafford D
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Delaney, Joshua P
AU  - Delaney JP
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Wu, Indira
AU  - Wu I
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Ordonez, Heather S
AU  - Ordonez HS
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Grimes, Susan M
AU  - Grimes SM
AD  - Stanford Genome Technology Center, Stanford University, Palo Alto, California,
      USA.
FAU - Greer, Stephanie
AU  - Greer S
AD  - Division of Oncology, Department of Medicine, Stanford University School of
      Medicine, Stanford, California, USA.
FAU - Lee, Josephine Y
AU  - Lee JY
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Belhocine, Kamila
AU  - Belhocine K
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Giorda, Kristina M
AU  - Giorda KM
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Heaton, William H
AU  - Heaton WH
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - McDermott, Geoffrey P
AU  - McDermott GP
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Bent, Zachary W
AU  - Bent ZW
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Meschi, Francesca
AU  - Meschi F
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Kondov, Nikola O
AU  - Kondov NO
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Wilson, Ryan
AU  - Wilson R
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Bernate, Jorge A
AU  - Bernate JA
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Gauby, Shawn
AU  - Gauby S
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Kindwall, Alex
AU  - Kindwall A
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Bermejo, Clara
AU  - Bermejo C
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Fehr, Adrian N
AU  - Fehr AN
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Chan, Adrian
AU  - Chan A
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Saxonov, Serge
AU  - Saxonov S
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Ness, Kevin D
AU  - Ness KD
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Hindson, Benjamin J
AU  - Hindson BJ
AD  - 10X Genomics, Pleasanton, California, USA.
FAU - Ji, Hanlee P
AU  - Ji HP
AD  - Stanford Genome Technology Center, Stanford University, Palo Alto, California,
      USA.
AD  - Division of Oncology, Department of Medicine, Stanford University School of
      Medicine, Stanford, California, USA.
LA  - eng
GR  - R01 HG006137/HG/NHGRI NIH HHS/United States
GR  - P01 HG000205/HG/NHGRI NIH HHS/United States
GR  - R01HG006137/HG/NHGRI NIH HHS/United States
GR  - R33CA174575/CA/NCI NIH HHS/United States
GR  - Howard Hughes Medical Institute/United States
GR  - R33 CA174575/CA/NCI NIH HHS/United States
GR  - P01HG000205/HG/NHGRI NIH HHS/United States
GR  - U01 CA151920/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20160201
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (EML4-ALK fusion protein, human)
RN  - 0 (Oncogene Proteins, Fusion)
RN  - 9007-49-2 (DNA)
SB  - IM
CIN - Nat Biotechnol. 2016 Mar;34(3):296-8. PMID: 26963554
MH  - DNA/genetics
MH  - Genome, Human
MH  - Genomic Structural Variation
MH  - Germ Cells
MH  - Haplotypes/*genetics
MH  - High-Throughput Nucleotide Sequencing/*methods
MH  - Humans
MH  - Neoplasms/*genetics
MH  - Nucleic Acid Conformation
MH  - Oncogene Proteins, Fusion/genetics
MH  - Polymorphism, Single Nucleotide
MH  - Sequence Analysis, DNA/*methods
PMC - PMC4786454
MID - NIHMS738063
EDAT- 2016/02/02 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/02/02 06:00
PHST- 2015/05/16 00:00 [received]
PHST- 2015/11/12 00:00 [accepted]
PHST- 2016/02/02 06:00 [entrez]
PHST- 2016/02/02 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt.3432 [pii]
AID - 10.1038/nbt.3432 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):303-11. doi: 10.1038/nbt.3432. Epub 2016 Feb 1.

PMID- 26829318
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20171101
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - Therapeutic genome editing by combined viral and non-viral delivery of CRISPR
      system components in vivo.
PG  - 328-33
LID - 10.1038/nbt.3471 [doi]
AB  - The combination of Cas9, guide RNA and repair template DNA can induce precise
      gene editing and the correction of genetic diseases in adult mammals. However,
      clinical implementation of this technology requires safe and effective delivery
      of all of these components into the nuclei of the target tissue. Here, we combine
      lipid nanoparticle-mediated delivery of Cas9 mRNA with adeno-associated viruses
      encoding a sgRNA and a repair template to induce repair of a disease gene in
      adult animals. We applied our delivery strategy to a mouse model of human
      hereditary tyrosinemia and show that the treatment generated fumarylacetoacetate 
      hydrolase (Fah)-positive hepatocytes by correcting the causative Fah-splicing
      mutation. Treatment rescued disease symptoms such as weight loss and liver
      damage. The efficiency of correction was >6% of hepatocytes after a single
      application, suggesting potential utility of Cas9-based therapeutic genome
      editing for a range of diseases.
FAU - Yin, Hao
AU  - Yin H
AD  - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
FAU - Song, Chun-Qing
AU  - Song CQ
AD  - RNA Therapeutics Institute, University of Massachusetts Medical School,
      Worcester, Massachusetts, USA.
AD  - Program in Molecular Medicine, University of Massachusetts Medical School,
      Worcester, Massachusetts, USA.
FAU - Dorkin, Joseph R
AU  - Dorkin JR
AD  - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Biology, Massachusetts Institute of Technology, Cambridge,
      Massachusetts, USA.
FAU - Zhu, Lihua J
AU  - Zhu LJ
AD  - Program in Molecular Medicine, University of Massachusetts Medical School,
      Worcester, Massachusetts, USA.
AD  - Department of Molecular, Cell and Cancer Biology, University of Massachusetts
      Medical School, Worcester, Massachusetts, USA.
AD  - Program in Bioinformatics and Integrative Biology, University of Massachusetts
      Medical School, Worcester, Massachusetts, USA.
FAU - Li, Yingxiang
AU  - Li Y
AUID- ORCID: http://orcid.org/0000-0003-0835-9280
AD  - Department of Bioinformatics, School of Life Science and Technology, Tongji
      University, Shanghai, P.R. China.
FAU - Wu, Qiongqiong
AU  - Wu Q
AD  - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
FAU - Park, Angela
AU  - Park A
AD  - RNA Therapeutics Institute, University of Massachusetts Medical School,
      Worcester, Massachusetts, USA.
FAU - Yang, Junghoon
AU  - Yang J
AD  - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
FAU - Suresh, Sneha
AU  - Suresh S
AD  - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
FAU - Bizhanova, Aizhan
AU  - Bizhanova A
AD  - RNA Therapeutics Institute, University of Massachusetts Medical School,
      Worcester, Massachusetts, USA.
FAU - Gupta, Ankit
AU  - Gupta A
AD  - Department of Molecular, Cell and Cancer Biology, University of Massachusetts
      Medical School, Worcester, Massachusetts, USA.
FAU - Bolukbasi, Mehmet F
AU  - Bolukbasi MF
AD  - Department of Molecular, Cell and Cancer Biology, University of Massachusetts
      Medical School, Worcester, Massachusetts, USA.
AD  - Department of Biochemistry and Molecular Pharmacology, University of
      Massachusetts Medical School, Worcester, Massachusetts, USA.
FAU - Walsh, Stephen
AU  - Walsh S
AD  - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
FAU - Bogorad, Roman L
AU  - Bogorad RL
AD  - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
FAU - Gao, Guangping
AU  - Gao G
AD  - Gene Therapy Center, University of Massachusetts Medical School, Worcester,
      Massachusetts, USA.
FAU - Weng, Zhiping
AU  - Weng Z
AD  - Program in Bioinformatics and Integrative Biology, University of Massachusetts
      Medical School, Worcester, Massachusetts, USA.
FAU - Dong, Yizhou
AU  - Dong Y
AD  - College of Pharmacy, the Ohio State University, Columbus, Ohio, USA.
FAU - Koteliansky, Victor
AU  - Koteliansky V
AD  - Skolkovo Institute of Science and Technology, Skolkovo, Russia.
AD  - Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory, 
      Russia.
FAU - Wolfe, Scot A
AU  - Wolfe SA
AD  - Department of Molecular, Cell and Cancer Biology, University of Massachusetts
      Medical School, Worcester, Massachusetts, USA.
AD  - Department of Biochemistry and Molecular Pharmacology, University of
      Massachusetts Medical School, Worcester, Massachusetts, USA.
FAU - Langer, Robert
AU  - Langer R
AD  - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Chemical Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
AD  - Harvard-MIT Division of Health Sciences &Technology, Cambridge, Massachusetts,
      USA.
AD  - Institute of Medical Engineering and Science, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
FAU - Xue, Wen
AU  - Xue W
AD  - RNA Therapeutics Institute, University of Massachusetts Medical School,
      Worcester, Massachusetts, USA.
AD  - Program in Molecular Medicine, University of Massachusetts Medical School,
      Worcester, Massachusetts, USA.
AD  - Department of Molecular, Cell and Cancer Biology, University of Massachusetts
      Medical School, Worcester, Massachusetts, USA.
FAU - Anderson, Daniel G
AU  - Anderson DG
AD  - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Chemical Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
AD  - Harvard-MIT Division of Health Sciences &Technology, Cambridge, Massachusetts,
      USA.
AD  - Institute of Medical Engineering and Science, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
LA  - eng
GR  - U54 CA151884/CA/NCI NIH HHS/United States
GR  - 5P30EY012196-17/EY/NEI NIH HHS/United States
GR  - 5R00CA169512/CA/NCI NIH HHS/United States
GR  - F32 EB017625/EB/NIBIB NIH HHS/United States
GR  - P30-CA14051/CA/NCI NIH HHS/United States
GR  - 5-U54-CA151884-04/CA/NCI NIH HHS/United States
GR  - P30 EY012196/EY/NEI NIH HHS/United States
GR  - R00 CA169512/CA/NCI NIH HHS/United States
GR  - 1F32EB017625/EB/NIBIB NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20160201
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Lipids)
SB  - IM
MH  - Animals
MH  - CRISPR-Cas Systems/*genetics
MH  - Disease Models, Animal
MH  - Gene Transfer Techniques
MH  - Genetic Vectors
MH  - *Genome, Human
MH  - Humans
MH  - Lipids/chemistry
MH  - Mice
MH  - Mutation
MH  - Nanoparticles/chemistry
MH  - *RNA Editing
MH  - Tyrosinemias/genetics/*therapy
MH  - Viruses/genetics
PMC - PMC5423356
MID - NIHMS843247
EDAT- 2016/02/02 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/02/02 06:00
PHST- 2015/06/18 00:00 [received]
PHST- 2016/01/05 00:00 [accepted]
PHST- 2016/02/02 06:00 [entrez]
PHST- 2016/02/02 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt.3471 [pii]
AID - 10.1038/nbt.3471 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):328-33. doi: 10.1038/nbt.3471. Epub 2016 Feb 1.

PMID- 26829317
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20161019
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - A dual AAV system enables the Cas9-mediated correction of a metabolic liver
      disease in newborn mice.
PG  - 334-8
LID - 10.1038/nbt.3469 [doi]
AB  - Many genetic liver diseases in newborns cause repeated, often lethal, metabolic
      crises. Gene therapy using nonintegrating viruses such as adeno-associated virus 
      (AAV) is not optimal in this setting because the nonintegrating genome is lost as
      developing hepatocytes proliferate. We reasoned that newborn liver may be an
      ideal setting for AAV-mediated gene correction using CRISPR-Cas9. Here we
      intravenously infuse two AAVs, one expressing Cas9 and the other expressing a
      guide RNA and the donor DNA, into newborn mice with a partial deficiency in the
      urea cycle disorder enzyme, ornithine transcarbamylase (OTC). This resulted in
      reversion of the mutation in 10% (6.7-20.1%) of hepatocytes and increased
      survival in mice challenged with a high-protein diet, which exacerbates disease. 
      Gene correction in adult OTC-deficient mice was lower and accompanied by larger
      deletions that ablated residual expression from the endogenous OTC gene, leading 
      to diminished protein tolerance and lethal hyperammonemia on a chow diet.
FAU - Yang, Yang
AU  - Yang Y
AD  - Gene Therapy Program, Department of Medicine, Perelman School of Medicine,
      University of Pennsylvania, Philadelphia, Pennsylvania, USA.
AD  - State Key Laboratory of Biotherapy and Cancer Center, West China Hospital,
      Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 
      Sichuan, China.
FAU - Wang, Lili
AU  - Wang L
AD  - Gene Therapy Program, Department of Pathology and Laboratory Medicine, Perelman
      School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
FAU - Bell, Peter
AU  - Bell P
AD  - Gene Therapy Program, Department of Medicine, Perelman School of Medicine,
      University of Pennsylvania, Philadelphia, Pennsylvania, USA.
FAU - McMenamin, Deirdre
AU  - McMenamin D
AD  - Gene Therapy Program, Department of Medicine, Perelman School of Medicine,
      University of Pennsylvania, Philadelphia, Pennsylvania, USA.
FAU - He, Zhenning
AU  - He Z
AD  - Gene Therapy Program, Department of Medicine, Perelman School of Medicine,
      University of Pennsylvania, Philadelphia, Pennsylvania, USA.
FAU - White, John
AU  - White J
AD  - Gene Therapy Program, Department of Medicine, Perelman School of Medicine,
      University of Pennsylvania, Philadelphia, Pennsylvania, USA.
FAU - Yu, Hongwei
AU  - Yu H
AD  - Gene Therapy Program, Department of Medicine, Perelman School of Medicine,
      University of Pennsylvania, Philadelphia, Pennsylvania, USA.
FAU - Xu, Chenyu
AU  - Xu C
AD  - Center for Genetic Medicine Research, Children's Research Institute, Children's
      National Health System, Washington, DC, USA.
FAU - Morizono, Hiroki
AU  - Morizono H
AD  - Center for Genetic Medicine Research, Children's Research Institute, Children's
      National Health System, Washington, DC, USA.
FAU - Musunuru, Kiran
AU  - Musunuru K
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Harvard
      Stem Cell Institute, Cambridge, Massachusetts, USA.
AD  - Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston,
      Massachusetts, USA.
FAU - Batshaw, Mark L
AU  - Batshaw ML
AD  - Center for Genetic Medicine Research, Children's Research Institute, Children's
      National Health System, Washington, DC, USA.
FAU - Wilson, James M
AU  - Wilson JM
AD  - Gene Therapy Program, Department of Medicine, Perelman School of Medicine,
      University of Pennsylvania, Philadelphia, Pennsylvania, USA.
LA  - eng
GR  - P01 HD057247/HD/NICHD NIH HHS/United States
GR  - P01-HD057247/HD/NICHD NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20160201
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - EC 2.1.3.3 (Ornithine Carbamoyltransferase)
SB  - IM
MH  - Animals
MH  - CRISPR-Cas Systems/*genetics
MH  - Dependovirus/genetics
MH  - Disease Models, Animal
MH  - Gene Transfer Techniques
MH  - Genetic Vectors
MH  - Humans
MH  - Mice
MH  - Ornithine Carbamoyltransferase/*genetics/therapeutic use
MH  - Ornithine Carbamoyltransferase Deficiency Disease/genetics/*therapy
MH  - *RNA Editing
MH  - Viruses/genetics
PMC - PMC4786489
MID - NIHMS748596
EDAT- 2016/02/02 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/02/02 06:00
PHST- 2015/09/23 00:00 [received]
PHST- 2015/12/30 00:00 [accepted]
PHST- 2016/02/02 06:00 [entrez]
PHST- 2016/02/02 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt.3469 [pii]
AID - 10.1038/nbt.3469 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):334-8. doi: 10.1038/nbt.3469. Epub 2016 Feb 1.

PMID- 26807527
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20171206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - Combinatorial hydrogel library enables identification of materials that mitigate 
      the foreign body response in primates.
PG  - 345-52
LID - 10.1038/nbt.3462 [doi]
AB  - The foreign body response is an immune-mediated reaction that can lead to the
      failure of implanted medical devices and discomfort for the recipient. There is a
      critical need for biomaterials that overcome this key challenge in the
      development of medical devices. Here we use a combinatorial approach for covalent
      chemical modification to generate a large library of variants of one of the most 
      widely used hydrogel biomaterials, alginate. We evaluated the materials in vivo
      and identified three triazole-containing analogs that substantially reduce
      foreign body reactions in both rodents and, for at least 6 months, in non-human
      primates. The distribution of the triazole modification creates a unique hydrogel
      surface that inhibits recognition by macrophages and fibrous deposition. In
      addition to the utility of the compounds reported here, our approach may enable
      the discovery of other materials that mitigate the foreign body response.
FAU - Vegas, Arturo J
AU  - Vegas AJ
AD  - David H Koch Institute for Integrative Cancer Research, Massachusetts Institute
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Anesthesiology, Boston Children's Hospital, Boston, Massachusetts, 
      USA.
FAU - Veiseh, Omid
AU  - Veiseh O
AD  - David H Koch Institute for Integrative Cancer Research, Massachusetts Institute
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Chemical Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Doloff, Joshua C
AU  - Doloff JC
AD  - David H Koch Institute for Integrative Cancer Research, Massachusetts Institute
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Anesthesiology, Boston Children's Hospital, Boston, Massachusetts, 
      USA.
FAU - Ma, Minglin
AU  - Ma M
AD  - David H Koch Institute for Integrative Cancer Research, Massachusetts Institute
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Anesthesiology, Boston Children's Hospital, Boston, Massachusetts, 
      USA.
FAU - Tam, Hok Hei
AU  - Tam HH
AD  - David H Koch Institute for Integrative Cancer Research, Massachusetts Institute
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Chemical Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Bratlie, Kaitlin
AU  - Bratlie K
AUID- ORCID: 0000-0002-5197-0176
AD  - David H Koch Institute for Integrative Cancer Research, Massachusetts Institute
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Chemical Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Li, Jie
AU  - Li J
AD  - David H Koch Institute for Integrative Cancer Research, Massachusetts Institute
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Anesthesiology, Boston Children's Hospital, Boston, Massachusetts, 
      USA.
FAU - Bader, Andrew R
AU  - Bader AR
AD  - David H Koch Institute for Integrative Cancer Research, Massachusetts Institute
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Anesthesiology, Boston Children's Hospital, Boston, Massachusetts, 
      USA.
FAU - Langan, Erin
AU  - Langan E
AD  - David H Koch Institute for Integrative Cancer Research, Massachusetts Institute
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Anesthesiology, Boston Children's Hospital, Boston, Massachusetts, 
      USA.
FAU - Olejnik, Karsten
AU  - Olejnik K
AD  - David H Koch Institute for Integrative Cancer Research, Massachusetts Institute
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Anesthesiology, Boston Children's Hospital, Boston, Massachusetts, 
      USA.
FAU - Fenton, Patrick
AU  - Fenton P
AD  - David H Koch Institute for Integrative Cancer Research, Massachusetts Institute
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Anesthesiology, Boston Children's Hospital, Boston, Massachusetts, 
      USA.
FAU - Kang, Jeon Woong
AU  - Kang JW
AD  - MIT Spectroscopy Lab, Massachusetts Institute of Technology, Cambridge,
      Massachusetts, USA.
FAU - Hollister-Locke, Jennifer
AU  - Hollister-Locke J
AD  - Section on Islet Cell and Regenerative Biology, Research Division, Joslin
      Diabetes Center, Boston, Massachusetts, USA.
FAU - Bochenek, Matthew A
AU  - Bochenek MA
AD  - Department of Surgery, Division of Transplantation, University of Illinois at
      Chicago, Chicago, Illinois, USA.
FAU - Chiu, Alan
AU  - Chiu A
AD  - David H Koch Institute for Integrative Cancer Research, Massachusetts Institute
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Anesthesiology, Boston Children's Hospital, Boston, Massachusetts, 
      USA.
FAU - Siebert, Sean
AU  - Siebert S
AD  - David H Koch Institute for Integrative Cancer Research, Massachusetts Institute
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Anesthesiology, Boston Children's Hospital, Boston, Massachusetts, 
      USA.
FAU - Tang, Katherine
AU  - Tang K
AD  - David H Koch Institute for Integrative Cancer Research, Massachusetts Institute
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Anesthesiology, Boston Children's Hospital, Boston, Massachusetts, 
      USA.
FAU - Jhunjhunwala, Siddharth
AU  - Jhunjhunwala S
AD  - David H Koch Institute for Integrative Cancer Research, Massachusetts Institute
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Anesthesiology, Boston Children's Hospital, Boston, Massachusetts, 
      USA.
FAU - Aresta-Dasilva, Stephanie
AU  - Aresta-Dasilva S
AD  - David H Koch Institute for Integrative Cancer Research, Massachusetts Institute
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Anesthesiology, Boston Children's Hospital, Boston, Massachusetts, 
      USA.
FAU - Dholakia, Nimit
AU  - Dholakia N
AD  - David H Koch Institute for Integrative Cancer Research, Massachusetts Institute
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Anesthesiology, Boston Children's Hospital, Boston, Massachusetts, 
      USA.
FAU - Thakrar, Raj
AU  - Thakrar R
AD  - David H Koch Institute for Integrative Cancer Research, Massachusetts Institute
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Anesthesiology, Boston Children's Hospital, Boston, Massachusetts, 
      USA.
FAU - Vietti, Thema
AU  - Vietti T
AD  - David H Koch Institute for Integrative Cancer Research, Massachusetts Institute
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Anesthesiology, Boston Children's Hospital, Boston, Massachusetts, 
      USA.
FAU - Chen, Michael
AU  - Chen M
AUID- ORCID: 0000-0002-1590-768X
AD  - David H Koch Institute for Integrative Cancer Research, Massachusetts Institute
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Anesthesiology, Boston Children's Hospital, Boston, Massachusetts, 
      USA.
FAU - Cohen, Josh
AU  - Cohen J
AD  - Section on Islet Cell and Regenerative Biology, Research Division, Joslin
      Diabetes Center, Boston, Massachusetts, USA.
FAU - Siniakowicz, Karolina
AU  - Siniakowicz K
AD  - Section on Islet Cell and Regenerative Biology, Research Division, Joslin
      Diabetes Center, Boston, Massachusetts, USA.
FAU - Qi, Meirigeng
AU  - Qi M
AD  - Department of Surgery, Division of Transplantation, University of Illinois at
      Chicago, Chicago, Illinois, USA.
FAU - McGarrigle, James
AU  - McGarrigle J
AD  - Department of Surgery, Division of Transplantation, University of Illinois at
      Chicago, Chicago, Illinois, USA.
FAU - Graham, Adam C
AU  - Graham AC
FAU - Lyle, Stephen
AU  - Lyle S
AD  - Department of Cancer Biology, University of Massachusetts Medical School,
      Worcester, Massachusetts, USA.
FAU - Harlan, David M
AU  - Harlan DM
AD  - Diabetes Center of Excellence, University of Massachusetts Medical School,
      Worcester, Massachusetts, USA.
FAU - Greiner, Dale L
AU  - Greiner DL
AD  - Diabetes Center of Excellence, University of Massachusetts Medical School,
      Worcester, Massachusetts, USA.
FAU - Oberholzer, Jose
AU  - Oberholzer J
AD  - Department of Surgery, Division of Transplantation, University of Illinois at
      Chicago, Chicago, Illinois, USA.
FAU - Weir, Gordon C
AU  - Weir GC
AD  - Section on Islet Cell and Regenerative Biology, Research Division, Joslin
      Diabetes Center, Boston, Massachusetts, USA.
FAU - Langer, Robert
AU  - Langer R
AD  - David H Koch Institute for Integrative Cancer Research, Massachusetts Institute
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Anesthesiology, Boston Children's Hospital, Boston, Massachusetts, 
      USA.
AD  - Department of Chemical Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
AD  - Institute for Medical Engineering and Science, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Division of Health Science Technology, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Anderson, Daniel G
AU  - Anderson DG
AD  - David H Koch Institute for Integrative Cancer Research, Massachusetts Institute
      of Technology, Cambridge, Massachusetts, USA.
AD  - Department of Anesthesiology, Boston Children's Hospital, Boston, Massachusetts, 
      USA.
AD  - Department of Chemical Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
AD  - Institute for Medical Engineering and Science, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Division of Health Science Technology, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
LA  - eng
GR  - R01DK091526/DK/NIDDK NIH HHS/United States
GR  - DE013023/DE/NIDCR NIH HHS/United States
GR  - R01 EB000244/EB/NIBIB NIH HHS/United States
GR  - U54 CA151884/CA/NCI NIH HHS/United States
GR  - R01 DK093909/DK/NIDDK NIH HHS/United States
GR  - P41EB015871-27/EB/NIBIB NIH HHS/United States
GR  - R01DK093909/DK/NIDDK NIH HHS/United States
GR  - P30 CA014051/CA/NCI NIH HHS/United States
GR  - P30-CA14051/CA/NCI NIH HHS/United States
GR  - P30 DK036836/DK/NIDDK NIH HHS/United States
GR  - R01 DE013023/DE/NIDCR NIH HHS/United States
GR  - EB000351/EB/NIBIB NIH HHS/United States
GR  - CA151884/CA/NCI NIH HHS/United States
GR  - R37 EB000244/EB/NIBIB NIH HHS/United States
GR  - R01 DK091526/DK/NIDDK NIH HHS/United States
GR  - P30DK036836/DK/NIDDK NIH HHS/United States
GR  - R01 EB000351/EB/NIBIB NIH HHS/United States
GR  - P41 EB015871/EB/NIBIB NIH HHS/United States
GR  - EB000244/EB/NIBIB NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20160125
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Biocompatible Materials)
RN  - 0 (Hydrogels)
SB  - IM
EIN - Nat Biotechnol. 2016 Jun;34(6):666
EIN - Nat Biotechnol. 2016 Jun 9;34(6):666. PMID: 27281428
MH  - Animals
MH  - Biocompatible Materials/adverse effects/therapeutic use
MH  - Foreign Bodies/*immunology
MH  - Foreign-Body Reaction/*immunology
MH  - Humans
MH  - Hydrogels/adverse effects/*therapeutic use
MH  - Macrophages/immunology
MH  - Primates/immunology
MH  - Prostheses and Implants/*adverse effects
PMC - PMC4904301
MID - NIHMS746011
EDAT- 2016/01/26 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/01/26 06:00
PHST- 2015/02/26 00:00 [received]
PHST- 2015/12/16 00:00 [accepted]
PHST- 2016/01/26 06:00 [entrez]
PHST- 2016/01/26 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt.3462 [pii]
AID - 10.1038/nbt.3462 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):345-52. doi: 10.1038/nbt.3462. Epub 2016 Jan 25.

PMID- 26789497
OWN - NLM
STAT- MEDLINE
DCOM- 20160801
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 3
DP  - 2016 Mar
TI  - Enhancing homology-directed genome editing by catalytically active and inactive
      CRISPR-Cas9 using asymmetric donor DNA.
PG  - 339-44
LID - 10.1038/nbt.3481 [doi]
AB  - Targeted genomic manipulation by Cas9 can efficiently generate knockout cells and
      organisms via error-prone nonhomologous end joining (NHEJ), but the efficiency of
      precise sequence replacement by homology-directed repair (HDR) is substantially
      lower. Here we investigate the interaction of Cas9 with target DNA and use our
      findings to improve HDR efficiency. We show that dissociation of Cas9 from
      double-stranded DNA (dsDNA) substrates is slow (lifetime approximately 6 h) but
      that, before complete dissociation, Cas9 asymmetrically releases the 3' end of
      the cleaved DNA strand that is not complementary to the sgRNA (nontarget strand).
      By rationally designing single-stranded DNA (ssDNA) donors of the optimal length 
      complementary to the strand that is released first, we increase the rate of HDR
      in human cells when using Cas9 or nickase variants to up to 60%. We also
      demonstrate HDR rates of up to 0.7% using a catalytically inactive Cas9 mutant
      (dCas9), which binds DNA without cleaving it.
FAU - Richardson, Christopher D
AU  - Richardson CD
AD  - Innovative Genomics Initiative, University of California, Berkeley, Berkeley,
      California, USA.
AD  - Department of Molecular and Cell Biology, University of California, Berkeley,
      Berkeley, California, USA.
FAU - Ray, Graham J
AU  - Ray GJ
AD  - Innovative Genomics Initiative, University of California, Berkeley, Berkeley,
      California, USA.
AD  - Department of Molecular and Cell Biology, University of California, Berkeley,
      Berkeley, California, USA.
FAU - DeWitt, Mark A
AU  - DeWitt MA
AD  - Innovative Genomics Initiative, University of California, Berkeley, Berkeley,
      California, USA.
AD  - Department of Molecular and Cell Biology, University of California, Berkeley,
      Berkeley, California, USA.
FAU - Curie, Gemma L
AU  - Curie GL
AD  - Innovative Genomics Initiative, University of California, Berkeley, Berkeley,
      California, USA.
AD  - Department of Molecular and Cell Biology, University of California, Berkeley,
      Berkeley, California, USA.
FAU - Corn, Jacob E
AU  - Corn JE
AUID- ORCID: http://orcid.org/0000-0002-7798-5309
AD  - Innovative Genomics Initiative, University of California, Berkeley, Berkeley,
      California, USA.
AD  - Department of Molecular and Cell Biology, University of California, Berkeley,
      Berkeley, California, USA.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20160120
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (DNA, Single-Stranded)
SB  - IM
CIN - Nat Methods. 2016 Apr;13(4):286-7. PMID: 27482569
MH  - CRISPR-Cas Systems/*genetics
MH  - Cell Line
MH  - *DNA Breaks, Double-Stranded
MH  - DNA End-Joining Repair/genetics
MH  - DNA, Single-Stranded/genetics
MH  - Genetic Engineering
MH  - Genome
MH  - Humans
MH  - RNA Editing/*genetics
MH  - Recombinational DNA Repair/*genetics
EDAT- 2016/01/21 06:00
MHDA- 2016/08/02 06:00
CRDT- 2016/01/21 06:00
PHST- 2015/09/04 00:00 [received]
PHST- 2016/01/13 00:00 [accepted]
PHST- 2016/01/21 06:00 [entrez]
PHST- 2016/01/21 06:00 [pubmed]
PHST- 2016/08/02 06:00 [medline]
AID - nbt.3481 [pii]
AID - 10.1038/nbt.3481 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Mar;34(3):339-44. doi: 10.1038/nbt.3481. Epub 2016 Jan 20.

PMID- 26849525
OWN - NLM
STAT- MEDLINE
DCOM- 20160621
LR  - 20160206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - Fourth-quarter biotech job picture.
PG  - 211
LID - 10.1038/nbt.3479 [doi]
FAU - Francisco, Michael
AU  - Francisco M
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*manpower
MH  - Drug Industry/*manpower
MH  - Humans
EDAT- 2016/02/06 06:00
MHDA- 2016/06/22 06:00
CRDT- 2016/02/06 06:00
PHST- 2016/02/06 06:00 [entrez]
PHST- 2016/02/06 06:00 [pubmed]
PHST- 2016/06/22 06:00 [medline]
AID - nbt.3479 [pii]
AID - 10.1038/nbt.3479 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):211. doi: 10.1038/nbt.3479.

PMID- 26849524
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20160609
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - Erratum: Analysis of intronic and exonic reads in RNA-seq data characterizes
      transcriptional and post-transcriptional regulation.
PG  - 210
LID - 10.1038/nbt0216-210a [doi]
FAU - Gaidatzis, Dimos
AU  - Gaidatzis D
FAU - Burger, Lukas
AU  - Burger L
FAU - Florescu, Maria
AU  - Florescu M
FAU - Stadler, Michael B
AU  - Stadler MB
LA  - eng
PT  - Journal Article
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2015 Jul;33(7):722-9. Florescu, Maria [Deleted]. PMID: 26098447
EDAT- 2016/02/06 06:00
MHDA- 2016/02/06 06:01
CRDT- 2016/02/06 06:00
PHST- 2016/02/06 06:00 [entrez]
PHST- 2016/02/06 06:00 [pubmed]
PHST- 2016/02/06 06:01 [medline]
AID - nbt0216-210a [pii]
AID - 10.1038/nbt0216-210a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):210. doi: 10.1038/nbt0216-210a.

PMID- 26849523
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20160609
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - Corrigendum: Increasing the efficiency of precise genome editing with CRISPR-Cas9
      by inhibition of nonhomologous end joining.
PG  - 210
LID - 10.1038/nbt0216-210c [doi]
FAU - Maruyama, Takeshi
AU  - Maruyama T
FAU - Dougan, Stephanie K
AU  - Dougan SK
FAU - Truttmann, Matthias C
AU  - Truttmann MC
FAU - Bilate, Angelina M
AU  - Bilate AM
FAU - Ingram, Jessica R
AU  - Ingram JR
FAU - Ploegh, Hidde L
AU  - Ploegh HL
LA  - eng
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2015 May;33(5):538-42. PMID: 25798939
EDAT- 2016/02/06 06:00
MHDA- 2016/02/06 06:01
CRDT- 2016/02/06 06:00
PHST- 2016/02/06 06:00 [entrez]
PHST- 2016/02/06 06:00 [pubmed]
PHST- 2016/02/06 06:01 [medline]
AID - nbt0216-210c [pii]
AID - 10.1038/nbt0216-210c [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):210. doi: 10.1038/nbt0216-210c.

PMID- 26849522
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20160609
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - Erratum: Share and share alike.
PG  - 210
LID - 10.1038/nbt0216-210b [doi]
FAU - Sia, Samuel K
AU  - Sia SK
FAU - Owens, Matthew P
AU  - Owens MP
LA  - eng
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2015 Dec 9;33(12):1224-8
EDAT- 2016/02/06 06:00
MHDA- 2016/02/06 06:01
CRDT- 2016/02/06 06:00
PHST- 2016/02/06 06:00 [entrez]
PHST- 2016/02/06 06:00 [pubmed]
PHST- 2016/02/06 06:01 [medline]
AID - nbt0216-210b [pii]
AID - 10.1038/nbt0216-210b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):210. doi: 10.1038/nbt0216-210b.

PMID- 26849520
OWN - NLM
STAT- MEDLINE
DCOM- 20160621
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - Personalized nutrition through big data.
PG  - 152-4
LID - 10.1038/nbt.3476 [doi]
FAU - McDonald, Daniel
AU  - McDonald D
AD  - Institute for Systems Biology, Seattle, Washington, USA.
FAU - Glusman, Gustavo
AU  - Glusman G
AD  - Institute for Systems Biology, Seattle, Washington, USA.
FAU - Price, Nathan D
AU  - Price ND
AD  - Institute for Systems Biology, Seattle, Washington, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Blood Glucose)
SB  - IM
MH  - Blood Glucose/*analysis
MH  - *Databases, Factual
MH  - Humans
MH  - *Nutritional Sciences
MH  - Phenotype
MH  - *Precision Medicine
MH  - *Systems Biology
EDAT- 2016/02/06 06:00
MHDA- 2016/06/22 06:00
CRDT- 2016/02/06 06:00
PHST- 2016/02/06 06:00 [entrez]
PHST- 2016/02/06 06:00 [pubmed]
PHST- 2016/06/22 06:00 [medline]
AID - nbt.3476 [pii]
AID - 10.1038/nbt.3476 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):152-4. doi: 10.1038/nbt.3476.

PMID- 26849519
OWN - NLM
STAT- MEDLINE
DCOM- 20160621
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - Mapping regulatory elements.
PG  - 151-2
LID - 10.1038/nbt.3477 [doi]
FAU - Zhou, Yuexin
AU  - Zhou Y
AD  - Biodynamic Optical Imaging Center (BIOPIC), Peking-Tsinghua Center for Life
      Sciences, the State Key Laboratory of Protein and Plant Gene Research, Beijing,
      China, and the School of Life Sciences, Peking University, Beijing, China.
FAU - Wei, Wensheng
AU  - Wei W
AD  - Biodynamic Optical Imaging Center (BIOPIC), Peking-Tsinghua Center for Life
      Sciences, the State Key Laboratory of Protein and Plant Gene Research, Beijing,
      China, and the School of Life Sciences, Peking University, Beijing, China.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - CRISPR-Cas Systems/*genetics
MH  - Chromosome Mapping/*methods
MH  - Gene Library
MH  - Genomics/*methods
MH  - Humans
MH  - Mice
MH  - Regulatory Sequences, Nucleic Acid/*genetics
EDAT- 2016/02/06 06:00
MHDA- 2016/06/22 06:00
CRDT- 2016/02/06 06:00
PHST- 2016/02/06 06:00 [entrez]
PHST- 2016/02/06 06:00 [pubmed]
PHST- 2016/06/22 06:00 [medline]
AID - nbt.3477 [pii]
AID - 10.1038/nbt.3477 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):151-2. doi: 10.1038/nbt.3477.

PMID- 26849518
OWN - NLM
STAT- MEDLINE
DCOM- 20160621
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - Can CRISPR-Cas9 gene drives curb malaria?
PG  - 149-50
LID - 10.1038/nbt.3473 [doi]
FAU - Alphey, Luke
AU  - Alphey L
AUID- ORCID: http://orcid.org/0000-0002-2916-3802
AD  - Pirbright Institute, Ash Road, Woking, UK, and the Department of Zoology,
      University of Oxford, Oxford, UK.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - *Anopheles/genetics/parasitology
MH  - CRISPR-Cas Systems/*genetics
MH  - Female
MH  - Genetic Engineering/*methods
MH  - Humans
MH  - *Insect Vectors/genetics/parasitology
MH  - *Malaria/prevention & control/transmission
MH  - Male
EDAT- 2016/02/06 06:00
MHDA- 2016/06/22 06:00
CRDT- 2016/02/06 06:00
PHST- 2016/02/06 06:00 [entrez]
PHST- 2016/02/06 06:00 [pubmed]
PHST- 2016/06/22 06:00 [medline]
AID - nbt.3473 [pii]
AID - 10.1038/nbt.3473 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):149-50. doi: 10.1038/nbt.3473.

PMID- 26849516
OWN - NLM
STAT- MEDLINE
DCOM- 20160621
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - Persistent confusion and controversy surrounding gene patents.
PG  - 145-7
LID - 10.1038/nbt.3470 [doi]
FAU - Guerrini, Christi J
AU  - Guerrini CJ
AD  - Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston,
      Texas, USA.
FAU - Majumder, Mary A
AU  - Majumder MA
AD  - Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston,
      Texas, USA.
FAU - McGuire, Amy L
AU  - McGuire AL
AD  - Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston,
      Texas, USA.
LA  - eng
GR  - R01 HG006460/HG/NHGRI NIH HHS/United States
GR  - R01-HG006460/HG/NHGRI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Genomics/*legislation & jurisprudence
MH  - *High-Throughput Nucleotide Sequencing
MH  - Humans
MH  - Patents as Topic/*legislation & jurisprudence
PMC - PMC5094359
MID - NIHMS825119
EDAT- 2016/02/06 06:00
MHDA- 2016/06/22 06:00
CRDT- 2016/02/06 06:00
PHST- 2016/02/06 06:00 [entrez]
PHST- 2016/02/06 06:00 [pubmed]
PHST- 2016/06/22 06:00 [medline]
AID - nbt.3470 [pii]
AID - 10.1038/nbt.3470 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):145-7. doi: 10.1038/nbt.3470.

PMID- 26849515
OWN - NLM
STAT- MEDLINE
DCOM- 20160621
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - Evolving Japanese regulations on companion diagnostics.
PG  - 141-4
LID - 10.1038/nbt.3478 [doi]
FAU - Nagai, Sumimasa
AU  - Nagai S
AD  - Companion Diagnostics Working Group, Pharmaceuticals and Medical Devices Agency, 
      Tokyo, Japan.
FAU - Urata, Masaaki
AU  - Urata M
AD  - Companion Diagnostics Working Group, Pharmaceuticals and Medical Devices Agency, 
      Tokyo, Japan.
FAU - Sato, Hiroyuki
AU  - Sato H
AD  - Companion Diagnostics Working Group, Pharmaceuticals and Medical Devices Agency, 
      Tokyo, Japan.
FAU - Mikami, Motoki
AU  - Mikami M
AD  - Companion Diagnostics Working Group, Pharmaceuticals and Medical Devices Agency, 
      Tokyo, Japan.
FAU - Kuga, Wataru
AU  - Kuga W
AD  - Companion Diagnostics Working Group, Pharmaceuticals and Medical Devices Agency, 
      Tokyo, Japan.
FAU - Yanagihara, Reiko
AU  - Yanagihara R
AD  - Companion Diagnostics Working Group, Pharmaceuticals and Medical Devices Agency, 
      Tokyo, Japan.
FAU - Miyamoto, Daisei
AU  - Miyamoto D
AD  - Companion Diagnostics Working Group, Pharmaceuticals and Medical Devices Agency, 
      Tokyo, Japan.
FAU - Suzuki, Yuka
AU  - Suzuki Y
AD  - Companion Diagnostics Working Group, Pharmaceuticals and Medical Devices Agency, 
      Tokyo, Japan.
FAU - Shikano, Mayumi
AU  - Shikano M
AD  - Companion Diagnostics Working Group, Pharmaceuticals and Medical Devices Agency, 
      Tokyo, Japan.
LA  - eng
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Biomarkers)
SB  - IM
MH  - Biomarkers/analysis
MH  - Delivery of Health Care/*legislation & jurisprudence
MH  - *Diagnostic Techniques and Procedures
MH  - Government Agencies/*legislation & jurisprudence/organization & administration
MH  - Humans
MH  - Japan
MH  - *Precision Medicine
EDAT- 2016/02/06 06:00
MHDA- 2016/06/22 06:00
CRDT- 2016/02/06 06:00
PHST- 2016/02/06 06:00 [entrez]
PHST- 2016/02/06 06:00 [pubmed]
PHST- 2016/06/22 06:00 [medline]
AID - nbt.3478 [pii]
AID - 10.1038/nbt.3478 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):141-4. doi: 10.1038/nbt.3478.

PMID- 26849514
OWN - NLM
STAT- MEDLINE
DCOM- 20160621
LR  - 20180123
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - Precision and robustness of 2D-NMR for structure assessment of filgrastim
      biosimilars.
PG  - 139-41
LID - 10.1038/nbt.3474 [doi]
FAU - Ghasriani, Houman
AU  - Ghasriani H
AD  - US Food and Drug Administration, Center for Drug Evaluation and Research,
      Division of Pharmaceutical Analysis, St. Louis, Missouri, USA.
FAU - Hodgson, Derek J
AU  - Hodgson DJ
AD  - Centre for Biologics Evaluation, Biologics and Genetic Therapies Directorate,
      Health Canada, Ottawa, Ontario, Canada.
FAU - Brinson, Robert G
AU  - Brinson RG
AD  - Institute for Bioscience and Biotechnology Research, National Institute of
      Standards and Technology, Rockville, Maryland, USA.
FAU - McEwen, Ian
AU  - McEwen I
AD  - Medical Products Agency of Sweden, Uppsala, Sweden.
FAU - Buhse, Lucinda F
AU  - Buhse LF
AD  - US Food and Drug Administration, Center for Drug Evaluation and Research,
      Division of Pharmaceutical Analysis, St. Louis, Missouri, USA.
FAU - Kozlowski, Steven
AU  - Kozlowski S
AD  - US Food and Drug Administration, Center for Drug Evaluation and Research, Office 
      of Biotechnology Products, Silver Spring, Maryland, USA.
FAU - Marino, John P
AU  - Marino JP
AD  - Institute for Bioscience and Biotechnology Research, National Institute of
      Standards and Technology, Rockville, Maryland, USA.
FAU - Aubin, Yves
AU  - Aubin Y
AD  - Centre for Biologics Evaluation, Biologics and Genetic Therapies Directorate,
      Health Canada, Ottawa, Ontario, Canada.
FAU - Keire, David A
AU  - Keire DA
AD  - US Food and Drug Administration, Center for Drug Evaluation and Research,
      Division of Pharmaceutical Analysis, St. Louis, Missouri, USA.
LA  - eng
GR  - 9999-NIST/Intramural NIST DOC/United States
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Biosimilar Pharmaceuticals)
RN  - PVI5M0M1GW (Filgrastim)
SB  - IM
MH  - *Biosimilar Pharmaceuticals/analysis/chemistry/standards
MH  - Chemistry, Pharmaceutical/*methods
MH  - *Filgrastim/analysis/chemistry/standards
MH  - Nuclear Magnetic Resonance, Biomolecular/*methods
MH  - Reproducibility of Results
PMC - PMC5218811
MID - NIHMS835356
EDAT- 2016/02/06 06:00
MHDA- 2016/06/22 06:00
CRDT- 2016/02/06 06:00
PHST- 2016/02/06 06:00 [entrez]
PHST- 2016/02/06 06:00 [pubmed]
PHST- 2016/06/22 06:00 [medline]
AID - nbt.3474 [pii]
AID - 10.1038/nbt.3474 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):139-41. doi: 10.1038/nbt.3474.

PMID- 26849513
OWN - NLM
STAT- MEDLINE
DCOM- 20160621
LR  - 20170228
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - Cas9-triggered chain ablation of cas9 as a gene drive brake.
PG  - 137-8
LID - 10.1038/nbt.3444 [doi]
FAU - Wu, Bing
AU  - Wu B
AD  - Howard Hughes Medical Institute and Department of Biology, Stanford University,
      Stanford, California, USA.
FAU - Luo, Liqun
AU  - Luo L
AD  - Howard Hughes Medical Institute and Department of Biology, Stanford University,
      Stanford, California, USA.
FAU - Gao, Xiaojing J
AU  - Gao XJ
AD  - Howard Hughes Medical Institute and Department of Biology, Stanford University,
      Stanford, California, USA.
LA  - eng
GR  - R01 DC005982/DC/NIDCD NIH HHS/United States
GR  - R01-DC005982/DC/NIDCD NIH HHS/United States
GR  - Howard Hughes Medical Institute/United States
PT  - Letter
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (RNA, Guide)
RN  - EC 3.1.- (Endonucleases)
SB  - IM
MH  - Animals
MH  - Animals, Genetically Modified
MH  - CRISPR-Cas Systems/*genetics
MH  - Drosophila
MH  - Endonucleases/*genetics
MH  - Female
MH  - *Genetic Techniques
MH  - Male
MH  - RNA, Guide/*genetics
MH  - Transgenes/*genetics
PMC - PMC5326742
MID - NIHMS850194
EDAT- 2016/02/06 06:00
MHDA- 2016/06/22 06:00
CRDT- 2016/02/06 06:00
PHST- 2016/02/06 06:00 [entrez]
PHST- 2016/02/06 06:00 [pubmed]
PHST- 2016/06/22 06:00 [medline]
AID - nbt.3444 [pii]
AID - 10.1038/nbt.3444 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):137-8. doi: 10.1038/nbt.3444.

PMID- 26849512
OWN - NLM
STAT- MEDLINE
DCOM- 20160621
LR  - 20160206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - Preparing for crises.
PG  - 133-6
LID - 10.1038/nbt.3475 [doi]
FAU - Kessel, Mark
AU  - Kessel M
AD  - Shearman and Sterling LLP, New York, New York, USA.
FAU - Masella, Robert
AU  - Masella R
AD  - Shearman and Sterling LLP, New York, New York, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Decision Making
MH  - Drug Industry/*organization & administration
MH  - *Emergencies
MH  - Humans
MH  - *Public Relations
EDAT- 2016/02/06 06:00
MHDA- 2016/06/22 06:00
CRDT- 2016/02/06 06:00
PHST- 2016/02/06 06:00 [entrez]
PHST- 2016/02/06 06:00 [pubmed]
PHST- 2016/06/22 06:00 [medline]
AID - nbt.3475 [pii]
AID - 10.1038/nbt.3475 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):133-6. doi: 10.1038/nbt.3475.

PMID- 26849511
OWN - NLM
STAT- MEDLINE
DCOM- 20160621
LR  - 20160206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - Fresh from the biotech pipeline--2015.
PG  - 129-32
LID - 10.1038/nbt.3472 [doi]
FAU - Morrison, Chris
AU  - Morrison C
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Drugs, Investigational)
SB  - IM
MH  - Biotechnology/*legislation & jurisprudence/organization & administration
MH  - Drug Industry/*legislation & jurisprudence/*organization & administration
MH  - Drugs, Investigational
MH  - Humans
MH  - United States
MH  - United States Food and Drug Administration
EDAT- 2016/02/06 06:00
MHDA- 2016/06/22 06:00
CRDT- 2016/02/06 06:00
PHST- 2016/02/06 06:00 [entrez]
PHST- 2016/02/06 06:00 [pubmed]
PHST- 2016/06/22 06:00 [medline]
AID - nbt.3472 [pii]
AID - 10.1038/nbt.3472 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):129-32. doi: 10.1038/nbt.3472.

PMID- 26849510
OWN - NLM
STAT- MEDLINE
DCOM- 20160621
LR  - 20160206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - Drug pipeline Q4 2015.
PG  - 128
LID - 10.1038/nbt.3484 [doi]
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*economics
MH  - Drug Industry/*economics
MH  - United States
EDAT- 2016/02/06 06:00
MHDA- 2016/06/22 06:00
CRDT- 2016/02/06 06:00
PHST- 2016/02/06 06:00 [entrez]
PHST- 2016/02/06 06:00 [pubmed]
PHST- 2016/06/22 06:00 [medline]
AID - nbt.3484 [pii]
AID - 10.1038/nbt.3484 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):128. doi: 10.1038/nbt.3484.

PMID- 26849509
OWN - NLM
STAT- MEDLINE
DCOM- 20160621
LR  - 20160206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - 2015--another banner year for biotech.
PG  - 127
LID - 10.1038/nbt.3480 [doi]
FAU - Yang, Walter
AU  - Yang W
AD  - BioCentury.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*economics
MH  - Drug Industry/*economics
EDAT- 2016/02/06 06:00
MHDA- 2016/06/22 06:00
CRDT- 2016/02/06 06:00
PHST- 2016/02/06 06:00 [entrez]
PHST- 2016/02/06 06:00 [pubmed]
PHST- 2016/06/22 06:00 [medline]
AID - nbt.3480 [pii]
AID - 10.1038/nbt.3480 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):127. doi: 10.1038/nbt.3480.

PMID- 26849508
OWN - NLM
STAT- MEDLINE
DCOM- 20160621
LR  - 20171116
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - FDA approves three different multiple myeloma drugs in one month.
PG  - 126
LID - 10.1038/nbt0216-126 [doi]
FAU - Ratner, Mark
AU  - Ratner M
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antibodies, Monoclonal)
RN  - 0 (Antibodies, Monoclonal, Humanized)
RN  - 0 (Boron Compounds)
RN  - 1351PE5UGS (elotuzumab)
RN  - 4Z63YK6E0E (daratumumab)
RN  - 71050168A2 (ixazomib)
RN  - TE7660XO1C (Glycine)
SB  - IM
MH  - *Antibodies, Monoclonal
MH  - *Antibodies, Monoclonal, Humanized
MH  - *Boron Compounds
MH  - Drug Approval
MH  - Drug Industry/*legislation & jurisprudence
MH  - Glycine/*analogs & derivatives
MH  - Humans
MH  - Multiple Myeloma/*drug therapy
MH  - United States
MH  - United States Food and Drug Administration
EDAT- 2016/02/06 06:00
MHDA- 2016/06/22 06:00
CRDT- 2016/02/06 06:00
PHST- 2016/02/06 06:00 [entrez]
PHST- 2016/02/06 06:00 [pubmed]
PHST- 2016/06/22 06:00 [medline]
AID - nbt0216-126 [pii]
AID - 10.1038/nbt0216-126 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):126. doi: 10.1038/nbt0216-126.

PMID- 26849507
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20160609
LR  - 20160206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - Corrections.
PG  - 125
LID - 10.1038/nbt0216-125a [doi]
LA  - eng
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2015 Nov;33(11):1115-7. PMID: 26544122
EDAT- 2016/02/06 06:00
MHDA- 2016/02/06 06:01
CRDT- 2016/02/06 06:00
PHST- 2016/02/06 06:00 [entrez]
PHST- 2016/02/06 06:00 [pubmed]
PHST- 2016/02/06 06:01 [medline]
AID - nbt0216-125a [pii]
AID - 10.1038/nbt0216-125a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):125. doi: 10.1038/nbt0216-125a.

PMID- 26849506
OWN - NLM
STAT- MEDLINE
DCOM- 20160621
LR  - 20160206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - Around the world in a month.
PG  - 125
LID - 10.1038/nbt0216-125b [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Asia
MH  - *Biotechnology/economics/legislation & jurisprudence/organization &
      administration
MH  - *Drug Industry/economics/legislation & jurisprudence/organization &
      administration
MH  - Food, Genetically Modified
MH  - Humans
MH  - Sweden
MH  - Zambia
EDAT- 2016/02/06 06:00
MHDA- 2016/06/22 06:00
CRDT- 2016/02/06 06:00
PHST- 2016/02/06 06:00 [entrez]
PHST- 2016/02/06 06:00 [pubmed]
PHST- 2016/06/22 06:00 [medline]
AID - nbt0216-125b [pii]
AID - 10.1038/nbt0216-125b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):125. doi: 10.1038/nbt0216-125b.

PMID- 26849505
OWN - NLM
STAT- MEDLINE
DCOM- 20160621
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - Chimera research under the spotlight.
PG  - 124-5
LID - 10.1038/nbt0216-124 [doi]
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - Biomedical Research/*legislation & jurisprudence/*organization & administration
MH  - *Chimera
MH  - Goats
MH  - Humans
MH  - National Institutes of Health (U.S.)
MH  - Sheep
MH  - United States
EDAT- 2016/02/06 06:00
MHDA- 2016/06/22 06:00
CRDT- 2016/02/06 06:00
PHST- 2016/02/06 06:00 [entrez]
PHST- 2016/02/06 06:00 [pubmed]
PHST- 2016/06/22 06:00 [medline]
AID - nbt0216-124 [pii]
AID - 10.1038/nbt0216-124 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):124-5. doi: 10.1038/nbt0216-124.

PMID- 26849504
OWN - NLM
STAT- MEDLINE
DCOM- 20160621
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - New partner for Galapagos JAK drug.
PG  - 123
LID - 10.1038/nbt0216-123 [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - EC 2.7.10.2 (Janus Kinase 1)
SB  - IM
MH  - Belgium
MH  - Drug Industry/*economics/*organization & administration
MH  - Humans
MH  - Janus Kinase 1/*antagonists & inhibitors
EDAT- 2016/02/06 06:00
MHDA- 2016/06/22 06:00
CRDT- 2016/02/06 06:00
PHST- 2016/02/06 06:00 [entrez]
PHST- 2016/02/06 06:00 [pubmed]
PHST- 2016/06/22 06:00 [medline]
AID - nbt0216-123 [pii]
AID - 10.1038/nbt0216-123 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):123. doi: 10.1038/nbt0216-123.

PMID- 26849503
OWN - NLM
STAT- MEDLINE
DCOM- 20160621
LR  - 20160206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - Direct Genomics revives Helicos sequencing system for China's hospitals.
PG  - 122-3
LID - 10.1038/nbt0216-122b [doi]
FAU - Cyranoski, David
AU  - Cyranoski D
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - China
MH  - *Genomics/economics/organization & administration
MH  - *Hospitals
MH  - Humans
MH  - *Precision Medicine
MH  - Sequence Analysis, DNA/economics
EDAT- 2016/02/06 06:00
MHDA- 2016/06/22 06:00
CRDT- 2016/02/06 06:00
PHST- 2016/02/06 06:00 [entrez]
PHST- 2016/02/06 06:00 [pubmed]
PHST- 2016/06/22 06:00 [medline]
AID - nbt0216-122b [pii]
AID - 10.1038/nbt0216-122b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):122-3. doi: 10.1038/nbt0216-122b.

PMID- 26849502
OWN - NLM
STAT- MEDLINE
DCOM- 20160621
LR  - 20160206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - Proteasome play C4 debuts.
PG  - 122
LID - 10.1038/nbt0216-122a [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - EC 3.4.25.1 (Proteasome Endopeptidase Complex)
SB  - IM
MH  - *Biomedical Research/economics/organization & administration
MH  - *Drug Industry/economics/organization & administration
MH  - Humans
MH  - Massachusetts
MH  - *Proteasome Endopeptidase Complex
EDAT- 2016/02/06 06:00
MHDA- 2016/06/22 06:00
CRDT- 2016/02/06 06:00
PHST- 2016/02/06 06:00 [entrez]
PHST- 2016/02/06 06:00 [pubmed]
PHST- 2016/06/22 06:00 [medline]
AID - nbt0216-122a [pii]
AID - 10.1038/nbt0216-122a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):122. doi: 10.1038/nbt0216-122a.

PMID- 26849501
OWN - NLM
STAT- MEDLINE
DCOM- 20160621
LR  - 20160206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - Bayer joins CRISPR.
PG  - 121
LID - 10.1038/nbt0216-121b [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *CRISPR-Cas Systems
MH  - Drug Industry/*economics/*organization & administration
MH  - Humans
MH  - Massachusetts
EDAT- 2016/02/06 06:00
MHDA- 2016/06/22 06:00
CRDT- 2016/02/06 06:00
PHST- 2016/02/06 06:00 [entrez]
PHST- 2016/02/06 06:00 [pubmed]
PHST- 2016/06/22 06:00 [medline]
AID - nbt0216-121b [pii]
AID - 10.1038/nbt0216-121b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):121. doi: 10.1038/nbt0216-121b.

PMID- 26849500
OWN - NLM
STAT- MEDLINE
DCOM- 20160621
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - CRISPR patents to go on trial.
PG  - 121
LID - 10.1038/nbt0216-121a [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*legislation & jurisprudence/*organization & administration
MH  - *CRISPR-Cas Systems
MH  - Humans
MH  - *Patents as Topic
EDAT- 2016/02/06 06:00
MHDA- 2016/06/22 06:00
CRDT- 2016/02/06 06:00
PHST- 2016/02/06 06:00 [entrez]
PHST- 2016/02/06 06:00 [pubmed]
PHST- 2016/06/22 06:00 [medline]
AID - nbt0216-121a [pii]
AID - 10.1038/nbt0216-121a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):121. doi: 10.1038/nbt0216-121a.

PMID- 26849499
OWN - NLM
STAT- MEDLINE
DCOM- 20160621
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - Biotechs target stagnant baldness market.
PG  - 120-1
LID - 10.1038/nbt0216-120 [doi]
FAU - Schmidt, Charles
AU  - Schmidt C
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Receptors, Androgen)
RN  - 08J2K08A3Y (Dihydrotestosterone)
SB  - IM
MH  - Alopecia/*drug therapy
MH  - Biotechnology
MH  - Dihydrotestosterone/metabolism/pharmacology
MH  - *Drug Discovery
MH  - *Drug Industry
MH  - Female
MH  - Hair Follicle/drug effects
MH  - Humans
MH  - Male
MH  - Receptors, Androgen/metabolism
EDAT- 2016/02/06 06:00
MHDA- 2016/06/22 06:00
CRDT- 2016/02/06 06:00
PHST- 2016/02/06 06:00 [entrez]
PHST- 2016/02/06 06:00 [pubmed]
PHST- 2016/06/22 06:00 [medline]
AID - nbt0216-120 [pii]
AID - 10.1038/nbt0216-120 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):120-1. doi: 10.1038/nbt0216-120.

PMID- 26849498
OWN - NLM
STAT- MEDLINE
DCOM- 20160621
LR  - 20160206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - Obama's cancer moonshot.
PG  - 119
LID - 10.1038/nbt0216-119 [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biomedical Research/*organization & administration
MH  - Humans
MH  - *Immunotherapy
MH  - Neoplasms/*therapy
MH  - Politics
MH  - United States
EDAT- 2016/02/06 06:00
MHDA- 2016/06/22 06:00
CRDT- 2016/02/06 06:00
PHST- 2016/02/06 06:00 [entrez]
PHST- 2016/02/06 06:00 [pubmed]
PHST- 2016/06/22 06:00 [medline]
AID - nbt0216-119 [pii]
AID - 10.1038/nbt0216-119 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):119. doi: 10.1038/nbt0216-119.

PMID- 26849497
OWN - NLM
STAT- MEDLINE
DCOM- 20160621
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - FDA approves 'farmaceutical' drug from transgenic chickens.
PG  - 117-9
LID - 10.1038/nbt0216-117 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Recombinant Proteins)
RN  - EC 3.1.1.13 (Sterol Esterase)
RN  - K4YTU42T8G (Sebelipase alfa)
SB  - IM
MH  - Animals
MH  - Animals, Genetically Modified/*metabolism
MH  - *Biotechnology/legislation & jurisprudence/methods
MH  - Chickens/*metabolism
MH  - Drug Approval/*legislation & jurisprudence
MH  - Eggs
MH  - *Recombinant Proteins
MH  - *Sterol Esterase
MH  - United States
MH  - United States Food and Drug Administration
EDAT- 2016/02/06 06:00
MHDA- 2016/06/22 06:00
CRDT- 2016/02/06 06:00
PHST- 2016/02/06 06:00 [entrez]
PHST- 2016/02/06 06:00 [pubmed]
PHST- 2016/06/22 06:00 [medline]
AID - nbt0216-117 [pii]
AID - 10.1038/nbt0216-117 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):117-9. doi: 10.1038/nbt0216-117.

PMID- 26849496
OWN - NLM
STAT- MEDLINE
DCOM- 20160621
LR  - 20171206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - Research not fit to print.
PG  - 115
LID - 10.1038/nbt.3488 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CIN - Nat Biotechnol. 2016 Jun 9;34(6):587-8. PMID: 27281410
CIN - Nat Biotechnol. 2016 Jun 9;34(6):588. PMID: 27281412
MH  - *Biomedical Research/economics/organization & administration
MH  - *Biotechnology/economics/organization & administration
MH  - Confidentiality
MH  - *Drug Industry/economics/organization & administration
MH  - Humans
MH  - *Publications/economics/statistics & numerical data
EDAT- 2016/02/06 06:00
MHDA- 2016/06/22 06:00
CRDT- 2016/02/06 06:00
PHST- 2016/02/06 06:00 [entrez]
PHST- 2016/02/06 06:00 [pubmed]
PHST- 2016/06/22 06:00 [medline]
AID - nbt.3488 [pii]
AID - 10.1038/nbt.3488 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):115. doi: 10.1038/nbt.3488.

PMID- 26829320
OWN - NLM
STAT- MEDLINE
DCOM- 20160621
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - Cre-dependent selection yields AAV variants for widespread gene transfer to the
      adult brain.
PG  - 204-9
LID - 10.1038/nbt.3440 [doi]
AB  - Recombinant adeno-associated viruses (rAAVs) are commonly used vehicles for in
      vivo gene transfer. However, the tropism repertoire of naturally occurring AAVs
      is limited, prompting a search for novel AAV capsids with desired
      characteristics. Here we describe a capsid selection method, called Cre
      recombination-based AAV targeted evolution (CREATE), that enables the development
      of AAV capsids that more efficiently transduce defined Cre-expressing cell
      populations in vivo. We use CREATE to generate AAV variants that efficiently and 
      widely transduce the adult mouse central nervous system (CNS) after intravenous
      injection. One variant, AAV-PHP.B, transfers genes throughout the CNS with an
      efficiency that is at least 40-fold greater than that of the current standard,
      AAV9 (refs. 14,15,16,17), and transduces the majority of astrocytes and neurons
      across multiple CNS regions. In vitro, it transduces human neurons and astrocytes
      more efficiently than does AAV9, demonstrating the potential of CREATE to produce
      customized AAV vectors for biomedical applications.
FAU - Deverman, Benjamin E
AU  - Deverman BE
AUID- ORCID: http://orcid.org/0000-0002-6223-9303
AD  - Division of Biology and Biological Engineering, California Institute of
      Technology, Pasadena, California, USA.
FAU - Pravdo, Piers L
AU  - Pravdo PL
AD  - Division of Biology and Biological Engineering, California Institute of
      Technology, Pasadena, California, USA.
FAU - Simpson, Bryan P
AU  - Simpson BP
AD  - Division of Biology and Biological Engineering, California Institute of
      Technology, Pasadena, California, USA.
FAU - Kumar, Sripriya Ravindra
AU  - Kumar SR
AD  - Division of Biology and Biological Engineering, California Institute of
      Technology, Pasadena, California, USA.
FAU - Chan, Ken Y
AU  - Chan KY
AD  - Division of Biology and Biological Engineering, California Institute of
      Technology, Pasadena, California, USA.
FAU - Banerjee, Abhik
AU  - Banerjee A
AD  - Division of Biology and Biological Engineering, California Institute of
      Technology, Pasadena, California, USA.
FAU - Wu, Wei-Li
AU  - Wu WL
AD  - Division of Biology and Biological Engineering, California Institute of
      Technology, Pasadena, California, USA.
FAU - Yang, Bin
AU  - Yang B
AD  - Division of Biology and Biological Engineering, California Institute of
      Technology, Pasadena, California, USA.
FAU - Huber, Nina
AU  - Huber N
AD  - Department of Psychiatry and Behavioral Sciences, Stanford University School of
      Medicine, Stanford, California, USA.
FAU - Pasca, Sergiu P
AU  - Pasca SP
AD  - Department of Psychiatry and Behavioral Sciences, Stanford University School of
      Medicine, Stanford, California, USA.
FAU - Gradinaru, Viviana
AU  - Gradinaru V
AUID- ORCID: http://orcid.org/0000-0001-5868-348X
AD  - Division of Biology and Biological Engineering, California Institute of
      Technology, Pasadena, California, USA.
LA  - eng
GR  - 1R21MH103824-01/MH/NIMH NIH HHS/United States
GR  - DP2 NS087949/NS/NINDS NIH HHS/United States
GR  - 1DP2NS087949/DP/NCCDPHP CDC HHS/United States
GR  - R21 MH103824/MH/NIMH NIH HHS/United States
GR  - 1R01MH100900/MH/NIMH NIH HHS/United States
GR  - R01MH107800/MH/NIMH NIH HHS/United States
GR  - R01 MH107800/MH/NIMH NIH HHS/United States
GR  - U01 NS090577/NS/NINDS NIH HHS/United States
GR  - R01 AG047664/AG/NIA NIH HHS/United States
GR  - R01 MH100900/MH/NIMH NIH HHS/United States
GR  - 1R01AG047664/AG/NIA NIH HHS/United States
GR  - 1U01NS090577/NS/NINDS NIH HHS/United States
GR  - 1R01MH100900-02S1/MH/NIMH NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20160201
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - EC 2.7.7.- (Cre recombinase)
RN  - EC 2.7.7.- (Integrases)
SB  - IM
MH  - Animals
MH  - Dependovirus/*genetics
MH  - Female
MH  - Genetic Engineering/*methods
MH  - Genetic Vectors/*genetics
MH  - HEK293 Cells
MH  - Humans
MH  - Integrases/*genetics/metabolism
MH  - Mice
MH  - Transfection/*methods
PMC - PMC5088052
MID - NIHMS740735
EDAT- 2016/02/02 06:00
MHDA- 2016/06/22 06:00
CRDT- 2016/02/02 06:00
PHST- 2015/01/09 00:00 [received]
PHST- 2015/11/23 00:00 [accepted]
PHST- 2016/02/02 06:00 [entrez]
PHST- 2016/02/02 06:00 [pubmed]
PHST- 2016/06/22 06:00 [medline]
AID - nbt.3440 [pii]
AID - 10.1038/nbt.3440 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):204-9. doi: 10.1038/nbt.3440. Epub 2016 Feb 1.

PMID- 26807528
OWN - NLM
STAT- MEDLINE
DCOM- 20160621
LR  - 20170513
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - High-throughput mapping of regulatory DNA.
PG  - 167-74
LID - 10.1038/nbt.3468 [doi]
AB  - Quantifying the effects of cis-regulatory DNA on gene expression is a major
      challenge. Here, we present the multiplexed editing regulatory assay (MERA), a
      high-throughput CRISPR-Cas9-based approach that analyzes the functional impact of
      the regulatory genome in its native context. MERA tiles thousands of mutations
      across approximately 40 kb of cis-regulatory genomic space and uses knock-in
      green fluorescent protein (GFP) reporters to read out gene activity. Using this
      approach, we obtain quantitative information on the contribution of
      cis-regulatory regions to gene expression. We identify proximal and distal
      regulatory elements necessary for expression of four embryonic stem cell-specific
      genes. We show a consistent contribution of neighboring gene promoters to gene
      expression and identify unmarked regulatory elements (UREs) that control gene
      expression but do not have typical enhancer epigenetic or chromatin features. We 
      compare thousands of functional and nonfunctional genotypes at a genomic location
      and identify the base pair-resolution functional motifs of regulatory elements.
FAU - Rajagopal, Nisha
AU  - Rajagopal N
AD  - Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
FAU - Srinivasan, Sharanya
AU  - Srinivasan S
AD  - Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
AD  - Division of Genetics, Department of Medicine, Brigham and Women's Hospital and
      Harvard Medical School, Boston, Massachusetts, USA.
FAU - Kooshesh, Kameron
AU  - Kooshesh K
AD  - Division of Genetics, Department of Medicine, Brigham and Women's Hospital and
      Harvard Medical School, Boston, Massachusetts, USA.
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, 
      Massachusetts, USA.
FAU - Guo, Yuchun
AU  - Guo Y
AUID- ORCID: http://orcid.org/0000-0003-2357-1546
AD  - Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
FAU - Edwards, Matthew D
AU  - Edwards MD
AD  - Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
FAU - Banerjee, Budhaditya
AU  - Banerjee B
AD  - Division of Genetics, Department of Medicine, Brigham and Women's Hospital and
      Harvard Medical School, Boston, Massachusetts, USA.
FAU - Syed, Tahin
AU  - Syed T
AD  - Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
FAU - Emons, Bart J M
AU  - Emons BJ
AD  - Division of Genetics, Department of Medicine, Brigham and Women's Hospital and
      Harvard Medical School, Boston, Massachusetts, USA.
AD  - Program in Cancer, Stem Cells, and Developmental Biology, University of Utrecht, 
      Utrecht, the Netherlands.
FAU - Gifford, David K
AU  - Gifford DK
AD  - Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
FAU - Sherwood, Richard I
AU  - Sherwood RI
AD  - Division of Genetics, Department of Medicine, Brigham and Women's Hospital and
      Harvard Medical School, Boston, Massachusetts, USA.
LA  - eng
GR  - K01 DK101684/DK/NIDDK NIH HHS/United States
GR  - 1U01HG007037/HG/NHGRI NIH HHS/United States
GR  - 1K01DK101684-01/DK/NIDDK NIH HHS/United States
GR  - R01 HG008363/HG/NHGRI NIH HHS/United States
GR  - R01 HG008754/HG/NHGRI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20160125
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - CRISPR-Cas Systems/*genetics
MH  - Chromosome Mapping/*methods
MH  - Gene Expression Regulation
MH  - Genomics/*methods
MH  - Mice
MH  - Regulatory Elements, Transcriptional/*genetics
MH  - Sequence Analysis, DNA/*methods
PMC - PMC5108523
MID - NIHMS827968
EDAT- 2016/01/26 06:00
MHDA- 2016/06/22 06:00
CRDT- 2016/01/26 06:00
PHST- 2015/05/11 00:00 [received]
PHST- 2015/12/24 00:00 [accepted]
PHST- 2016/01/26 06:00 [entrez]
PHST- 2016/01/26 06:00 [pubmed]
PHST- 2016/06/22 06:00 [medline]
AID - nbt.3468 [pii]
AID - 10.1038/nbt.3468 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):167-74. doi: 10.1038/nbt.3468. Epub 2016 Jan 25.

PMID- 26780180
OWN - NLM
STAT- MEDLINE
DCOM- 20160621
LR  - 20170718
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - Optimized sgRNA design to maximize activity and minimize off-target effects of
      CRISPR-Cas9.
PG  - 184-191
LID - 10.1038/nbt.3437 [doi]
AB  - CRISPR-Cas9-based genetic screens are a powerful new tool in biology. By simply
      altering the sequence of the single-guide RNA (sgRNA), one can reprogram Cas9 to 
      target different sites in the genome with relative ease, but the on-target
      activity and off-target effects of individual sgRNAs can vary widely. Here, we
      use recently devised sgRNA design rules to create human and mouse genome-wide
      libraries, perform positive and negative selection screens and observe that the
      use of these rules produced improved results. Additionally, we profile the
      off-target activity of thousands of sgRNAs and develop a metric to predict
      off-target sites. We incorporate these findings from large-scale, empirical data 
      to improve our computational design rules and create optimized sgRNA libraries
      that maximize on-target activity and minimize off-target effects to enable more
      effective and efficient genetic screens and genome engineering.
FAU - Doench, John G
AU  - Doench JG
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
FAU - Fusi, Nicolo
AU  - Fusi N
AD  - Microsoft Research New England, Cambridge, Massachusetts, USA.
FAU - Sullender, Meagan
AU  - Sullender M
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
FAU - Hegde, Mudra
AU  - Hegde M
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
FAU - Vaimberg, Emma W
AU  - Vaimberg EW
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
FAU - Donovan, Katherine F
AU  - Donovan KF
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
FAU - Smith, Ian
AU  - Smith I
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
FAU - Tothova, Zuzana
AU  - Tothova Z
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
AD  - Dana Farber Cancer Institute, Division of Hematologic Malignancies, Boston,
      Massachusetts, USA.
FAU - Wilen, Craig
AU  - Wilen C
AD  - Washington University School of Medicine, Department of Pathology and Immunology,
      St. Louis, Missouri, USA.
FAU - Orchard, Robert
AU  - Orchard R
AD  - Washington University School of Medicine, Department of Pathology and Immunology,
      St. Louis, Missouri, USA.
FAU - Virgin, Herbert W
AU  - Virgin HW
AD  - Washington University School of Medicine, Department of Pathology and Immunology,
      St. Louis, Missouri, USA.
FAU - Listgarten, Jennifer
AU  - Listgarten J
AD  - Microsoft Research New England, Cambridge, Massachusetts, USA.
FAU - Root, David E
AU  - Root DE
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
LA  - eng
GR  - K12 CA087723/CA/NCI NIH HHS/United States
GR  - T32 AI007163/AI/NIAID NIH HHS/United States
GR  - U19 AI109725/AI/NIAID NIH HHS/United States
GR  - 5K12CA087723-12/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20160118
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (RNA, Guide)
SB  - IM
MH  - Animals
MH  - CRISPR-Cas Systems/*genetics
MH  - Cell Line, Tumor
MH  - Drug Resistance/genetics
MH  - Gene Library
MH  - Genetic Engineering/*methods
MH  - Genome/genetics
MH  - Genomics/*methods
MH  - Humans
MH  - Mice
MH  - RNA, Guide/*genetics
PMC - PMC4744125
MID - NIHMS740733
EDAT- 2016/01/19 06:00
MHDA- 2016/06/22 06:00
CRDT- 2016/01/19 06:00
PHST- 2015/05/07 00:00 [received]
PHST- 2015/11/19 00:00 [accepted]
PHST- 2016/01/19 06:00 [entrez]
PHST- 2016/01/19 06:00 [pubmed]
PHST- 2016/06/22 06:00 [medline]
AID - 10.1038/nbt.3437 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):184-191. doi: 10.1038/nbt.3437. Epub 2016 Jan 18.

PMID- 26751173
OWN - NLM
STAT- MEDLINE
DCOM- 20160621
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - Functional genetic screens for enhancer elements in the human genome using
      CRISPR-Cas9.
PG  - 192-8
LID - 10.1038/nbt.3450 [doi]
AB  - Systematic identification of noncoding regulatory elements has, to date, mainly
      relied on large-scale reporter assays that do not reproduce endogenous
      conditions. We present two distinct CRISPR-Cas9 genetic screens to identify and
      characterize functional enhancers in their native context. Our strategy is to
      target Cas9 to transcription factor binding sites in enhancer regions. We
      identified several functional enhancer elements and characterized the role of two
      of them in mediating p53 (TP53) and ERalpha (ESR1) gene regulation. Moreover, we 
      show that a genomic CRISPR-Cas9 tiling screen can precisely map functional
      domains within enhancer elements. Our approach expands the utility of CRISPR-Cas9
      to elucidate the functions of the noncoding genome.
FAU - Korkmaz, Gozde
AU  - Korkmaz G
AD  - Division of Biological Stress Response, the Netherlands Cancer Institute,
      Amsterdam, the Netherlands.
FAU - Lopes, Rui
AU  - Lopes R
AD  - Division of Biological Stress Response, the Netherlands Cancer Institute,
      Amsterdam, the Netherlands.
FAU - Ugalde, Alejandro P
AU  - Ugalde AP
AD  - Division of Biological Stress Response, the Netherlands Cancer Institute,
      Amsterdam, the Netherlands.
FAU - Nevedomskaya, Ekaterina
AU  - Nevedomskaya E
AD  - Division of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, the
      Netherlands.
FAU - Han, Ruiqi
AU  - Han R
AD  - Division of Biological Stress Response, the Netherlands Cancer Institute,
      Amsterdam, the Netherlands.
FAU - Myacheva, Ksenia
AU  - Myacheva K
AD  - Division of Biological Stress Response, the Netherlands Cancer Institute,
      Amsterdam, the Netherlands.
FAU - Zwart, Wilbert
AU  - Zwart W
AD  - Division of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, the
      Netherlands.
FAU - Elkon, Ran
AU  - Elkon R
AD  - Division of Biological Stress Response, the Netherlands Cancer Institute,
      Amsterdam, the Netherlands.
FAU - Agami, Reuven
AU  - Agami R
AD  - Division of Biological Stress Response, the Netherlands Cancer Institute,
      Amsterdam, the Netherlands.
AD  - Erasmus MC, Rotterdam University, Rotterdam, the Netherlands.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20160111
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - CRISPR-Cas Systems/*genetics
MH  - Cell Line
MH  - Enhancer Elements, Genetic/*genetics
MH  - Gene Knockout Techniques
MH  - Genetic Engineering/*methods
MH  - Genome, Human/*genetics
MH  - Genomics/*methods
MH  - Humans
MH  - MCF-7 Cells
MH  - Mice
EDAT- 2016/01/12 06:00
MHDA- 2016/06/22 06:00
CRDT- 2016/01/12 06:00
PHST- 2015/08/11 00:00 [received]
PHST- 2015/12/08 00:00 [accepted]
PHST- 2016/01/12 06:00 [entrez]
PHST- 2016/01/12 06:00 [pubmed]
PHST- 2016/06/22 06:00 [medline]
AID - nbt.3450 [pii]
AID - 10.1038/nbt.3450 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):192-8. doi: 10.1038/nbt.3450. Epub 2016 Jan 11.

PMID- 26689544
OWN - NLM
STAT- MEDLINE
DCOM- 20160621
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - Integration of electrophysiological recordings with single-cell RNA-seq data
      identifies neuronal subtypes.
PG  - 175-183
LID - 10.1038/nbt.3443 [doi]
AB  - Traditionally, neuroscientists have defined the identity of neurons by the cells'
      location, morphology, connectivity and excitability. However, the direct
      relationship between these parameters and the molecular phenotypes has remained
      largely unexplored. Here, we present a method for obtaining full transcriptome
      data from single neocortical pyramidal cells and interneurons after whole-cell
      patch-clamp recordings in mouse brain slices. In our approach, termed Patch-seq, 
      a patch-clamp stimulus protocol is followed by the aspiration of the entire
      somatic compartment into the recording pipette, reverse transcription of RNA
      including addition of unique molecular identifiers, cDNA amplification, Illumina 
      library preparation and sequencing. We show that Patch-seq reveals a close link
      between electrophysiological characteristics, responses to acute chemical
      challenges and RNA expression of neurotransmitter receptors and channels.
      Moreover, it distinguishes neuronal subpopulations that correspond to both
      well-established and, to our knowledge, hitherto undescribed neuronal subtypes.
      Our findings demonstrate the ability of Patch-seq to precisely map neuronal
      subtypes and predict their network contributions in the brain.
FAU - Fuzik, Janos
AU  - Fuzik J
AD  - Department of Medical Biochemistry and Biophysics, Karolinska Institutet,
      Stockholm, Sweden.
AD  - Department of Molecular Neurosciences, Center for Brain Research, Medical
      University of Vienna, Vienna, Austria.
FAU - Zeisel, Amit
AU  - Zeisel A
AD  - Department of Medical Biochemistry and Biophysics, Karolinska Institutet,
      Stockholm, Sweden.
FAU - Mate, Zoltan
AU  - Mate Z
AD  - Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest,
      Hungary.
FAU - Calvigioni, Daniela
AU  - Calvigioni D
AD  - Department of Medical Biochemistry and Biophysics, Karolinska Institutet,
      Stockholm, Sweden.
AD  - Department of Molecular Neurosciences, Center for Brain Research, Medical
      University of Vienna, Vienna, Austria.
FAU - Yanagawa, Yuchio
AU  - Yanagawa Y
AD  - Department of Genetic and Behavioral Neuroscience, Gunma University Graduate
      School of Medicine, Maebashi, Japan.
FAU - Szabo, Gabor
AU  - Szabo G
AD  - Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest,
      Hungary.
FAU - Linnarsson, Sten
AU  - Linnarsson S
AD  - Department of Medical Biochemistry and Biophysics, Karolinska Institutet,
      Stockholm, Sweden.
FAU - Harkany, Tibor
AU  - Harkany T
AD  - Department of Medical Biochemistry and Biophysics, Karolinska Institutet,
      Stockholm, Sweden.
AD  - Department of Molecular Neurosciences, Center for Brain Research, Medical
      University of Vienna, Vienna, Austria.
LA  - eng
GR  - 261063/European Research Council/International
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20151221
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (RNA, Messenger)
SB  - IM
CIN - Nat Methods. 2016 Feb;13(2):114. PMID: 27243096
MH  - Animals
MH  - Electrophysiology
MH  - Gene Expression Profiling
MH  - Mice
MH  - Neurons/*cytology/*metabolism
MH  - Patch-Clamp Techniques/*methods
MH  - RNA, Messenger/analysis/metabolism
MH  - Sequence Analysis, RNA/*methods
MH  - Single-Cell Analysis/*methods
PMC - PMC4745137
MID - EMS66275
OID - NLM: EMS66275
EDAT- 2015/12/23 06:00
MHDA- 2016/06/22 06:00
CRDT- 2015/12/23 06:00
PHST- 2015/06/23 00:00 [received]
PHST- 2015/12/02 00:00 [accepted]
PHST- 2015/12/23 06:00 [entrez]
PHST- 2015/12/23 06:00 [pubmed]
PHST- 2016/06/22 06:00 [medline]
AID - 10.1038/nbt.3443 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):175-183. doi: 10.1038/nbt.3443. Epub 2015 Dec 21.

PMID- 26689543
OWN - NLM
STAT- MEDLINE
DCOM- 20160621
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - Electrophysiological, transcriptomic and morphologic profiling of single neurons 
      using Patch-seq.
PG  - 199-203
LID - 10.1038/nbt.3445 [doi]
AB  - Despite the importance of the mammalian neocortex for complex cognitive
      processes, we still lack a comprehensive description of its cellular components. 
      To improve the classification of neuronal cell types and the functional
      characterization of single neurons, we present Patch-seq, a method that combines 
      whole-cell electrophysiological patch-clamp recordings, single-cell
      RNA-sequencing and morphological characterization. Following electrophysiological
      characterization, cell contents are aspirated through the patch-clamp pipette and
      prepared for RNA-sequencing. Using this approach, we generate
      electrophysiological and molecular profiles of 58 neocortical cells and show that
      gene expression patterns can be used to infer the morphological and physiological
      properties such as axonal arborization and action potential amplitude of
      individual neurons. Our results shed light on the molecular underpinnings of
      neuronal diversity and suggest that Patch-seq can facilitate the classification
      of cell types in the nervous system.
FAU - Cadwell, Cathryn R
AU  - Cadwell CR
AUID- ORCID: http://orcid.org/0000-0003-1963-8285
AD  - Department of Neuroscience, Baylor College of Medicine, Houston, Texas, USA.
FAU - Palasantza, Athanasia
AU  - Palasantza A
AD  - Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm,
      Sweden.
AD  - Ludwig Institute for Cancer Research, Stockholm, Sweden.
FAU - Jiang, Xiaolong
AU  - Jiang X
AD  - Department of Neuroscience, Baylor College of Medicine, Houston, Texas, USA.
FAU - Berens, Philipp
AU  - Berens P
AD  - Department of Neuroscience, Baylor College of Medicine, Houston, Texas, USA.
AD  - Bernstein Center for Computational Neuroscience, Tubingen, Germany.
AD  - Institute for Ophthalmic Research, University of Tubingen, Tubingen, Germany.
AD  - Werner Reichardt Center for Integrative Neuroscience and Institute of Theoretical
      Physics, University of Tubingen, Tubingen, Germany.
FAU - Deng, Qiaolin
AU  - Deng Q
AD  - Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm,
      Sweden.
AD  - Ludwig Institute for Cancer Research, Stockholm, Sweden.
FAU - Yilmaz, Marlene
AU  - Yilmaz M
AD  - Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm,
      Sweden.
AD  - Ludwig Institute for Cancer Research, Stockholm, Sweden.
FAU - Reimer, Jacob
AU  - Reimer J
AD  - Department of Neuroscience, Baylor College of Medicine, Houston, Texas, USA.
FAU - Shen, Shan
AU  - Shen S
AD  - Department of Neuroscience, Baylor College of Medicine, Houston, Texas, USA.
FAU - Bethge, Matthias
AU  - Bethge M
AD  - Bernstein Center for Computational Neuroscience, Tubingen, Germany.
AD  - Werner Reichardt Center for Integrative Neuroscience and Institute of Theoretical
      Physics, University of Tubingen, Tubingen, Germany.
AD  - Max Planck Institute for Biological Cybernetics, Tubingen, Germany.
FAU - Tolias, Kimberley F
AU  - Tolias KF
AD  - Department of Neuroscience, Baylor College of Medicine, Houston, Texas, USA.
AD  - Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor
      College of Medicine, Houston, Texas, USA.
FAU - Sandberg, Rickard
AU  - Sandberg R
AUID- ORCID: http://orcid.org/0000-0001-6473-1740
AD  - Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm,
      Sweden.
AD  - Ludwig Institute for Cancer Research, Stockholm, Sweden.
FAU - Tolias, Andreas S
AU  - Tolias AS
AD  - Department of Neuroscience, Baylor College of Medicine, Houston, Texas, USA.
AD  - Bernstein Center for Computational Neuroscience, Tubingen, Germany.
LA  - eng
GR  - T32EY07001/EY/NEI NIH HHS/United States
GR  - R01MH103108/MH/NIMH NIH HHS/United States
GR  - R01NS062829/NS/NINDS NIH HHS/United States
GR  - F30 MH095440/MH/NIMH NIH HHS/United States
GR  - R01 MH103108/MH/NIMH NIH HHS/United States
GR  - F30MH095440/MH/NIMH NIH HHS/United States
GR  - DP1 OD008301/OD/NIH HHS/United States
GR  - DP1EY023176/DP/NCCDPHP CDC HHS/United States
GR  - T32 EY007001/EY/NEI NIH HHS/United States
GR  - T32GM007330/GM/NIGMS NIH HHS/United States
GR  - T32EB006350/EB/NIBIB NIH HHS/United States
GR  - R01 NS062829/NS/NINDS NIH HHS/United States
GR  - P30 EY002520/EY/NEI NIH HHS/United States
GR  - T32 EB006350/EB/NIBIB NIH HHS/United States
GR  - P30EY002520/EY/NEI NIH HHS/United States
GR  - T32 GM007330/GM/NIGMS NIH HHS/United States
GR  - DP1 EY023176/EY/NEI NIH HHS/United States
GR  - DP1OD008301/OD/NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20151221
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - Cell Shape/physiology
MH  - Female
MH  - Gene Expression Profiling/*methods
MH  - Male
MH  - Mice
MH  - Neocortex/cytology
MH  - Neurons/cytology/metabolism/*physiology
MH  - Patch-Clamp Techniques/*methods
MH  - Sequence Analysis, RNA/*methods
MH  - Transcriptome/*physiology
PMC - PMC4840019
MID - NIHMS775286
EDAT- 2015/12/23 06:00
MHDA- 2016/06/22 06:00
CRDT- 2015/12/23 06:00
PHST- 2015/06/24 00:00 [received]
PHST- 2015/12/02 00:00 [accepted]
PHST- 2015/12/23 06:00 [entrez]
PHST- 2015/12/23 06:00 [pubmed]
PHST- 2016/06/22 06:00 [medline]
AID - nbt.3445 [pii]
AID - 10.1038/nbt.3445 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):199-203. doi: 10.1038/nbt.3445. Epub 2015 Dec 21.

PMID- 26655495
OWN - NLM
STAT- MEDLINE
DCOM- 20160621
LR  - 20161019
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - Antisense oligonucleotide-directed inhibition of nonsense-mediated mRNA decay.
PG  - 164-6
LID - 10.1038/nbt.3427 [doi]
AB  - Nonsense-mediated mRNA decay (NMD) is a cellular quality-control mechanism that
      is thought to exacerbate the phenotype of certain pathogenic nonsense mutations
      by preventing the expression of semi-functional proteins. NMD also limits the
      efficacy of read-through compound (RTC)-based therapies. Here, we report a
      gene-specific method of NMD inhibition using antisense oligonucleotides (ASOs)
      and combine this approach with an RTC to effectively restore the expression of
      full-length protein from a nonsense-mutant allele.
FAU - Nomakuchi, Tomoki T
AU  - Nomakuchi TT
AD  - Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA.
AD  - Stony Brook University School of Medicine, Stony Brook, New York, USA.
FAU - Rigo, Frank
AU  - Rigo F
AD  - Isis Pharmaceuticals, Carslbad, California, USA.
FAU - Aznarez, Isabel
AU  - Aznarez I
AD  - Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA.
FAU - Krainer, Adrian R
AU  - Krainer AR
AD  - Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA.
LA  - eng
GR  - R37 GM042699/GM/NIGMS NIH HHS/United States
GR  - F31NS087747/NS/NINDS NIH HHS/United States
GR  - R21-NS081448/NS/NINDS NIH HHS/United States
GR  - T32GM008444/GM/NIGMS NIH HHS/United States
GR  - P30 CA045508/CA/NCI NIH HHS/United States
GR  - 5P30CA045508/CA/NCI NIH HHS/United States
GR  - R21 NS081448/NS/NINDS NIH HHS/United States
GR  - R37-GM042699/GM/NIGMS NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20151214
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Oligonucleotides, Antisense)
SB  - IM
MH  - Cell Line, Tumor
MH  - Gene Expression Regulation/*drug effects/genetics
MH  - Genetic Therapy/*methods
MH  - Humans
MH  - Nonsense Mediated mRNA Decay/*drug effects/*genetics
MH  - Oligonucleotides, Antisense/*genetics/*pharmacology
MH  - Reproducibility of Results
PMC - PMC4744113
MID - NIHMS736993
EDAT- 2015/12/15 06:00
MHDA- 2016/06/22 06:00
CRDT- 2015/12/15 06:00
PHST- 2015/06/08 00:00 [received]
PHST- 2015/11/09 00:00 [accepted]
PHST- 2015/12/15 06:00 [entrez]
PHST- 2015/12/15 06:00 [pubmed]
PHST- 2016/06/22 06:00 [medline]
AID - nbt.3427 [pii]
AID - 10.1038/nbt.3427 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):164-6. doi: 10.1038/nbt.3427. Epub 2015 Dec 14.

PMID- 26619011
OWN - NLM
STAT- MEDLINE
DCOM- 20160621
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 2
DP  - 2016 Feb
TI  - Identifying recurrent mutations in cancer reveals widespread lineage diversity
      and mutational specificity.
PG  - 155-63
LID - 10.1038/nbt.3391 [doi]
AB  - Mutational hotspots indicate selective pressure across a population of tumor
      samples, but their prevalence within and across cancer types is incompletely
      characterized. An approach to detect significantly mutated residues, rather than 
      methods that identify recurrently mutated genes, may uncover new biologically and
      therapeutically relevant driver mutations. Here, we developed a statistical
      algorithm to identify recurrently mutated residues in tumor samples. We applied
      the algorithm to 11,119 human tumors, spanning 41 cancer types, and identified
      470 somatic substitution hotspots in 275 genes. We find that half of all human
      tumors possess one or more mutational hotspots with widespread lineage-,
      position- and mutant allele-specific differences, many of which are likely
      functional. In total, 243 hotspots were novel and appeared to affect a broad
      spectrum of molecular function, including hotspots at paralogous residues of
      Ras-related small GTPases RAC1 and RRAS2. Redefining hotspots at mutant amino
      acid resolution will help elucidate the allele-specific differences in their
      function and could have important therapeutic implications.
FAU - Chang, Matthew T
AU  - Chang MT
AD  - Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, 
      New York, New York, USA.
AD  - Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer
      Center, New York, New York, USA.
AD  - Departments of Bioengineering and Therapeutic Sciences, University of California,
      San Francisco, California, USA.
FAU - Asthana, Saurabh
AU  - Asthana S
AD  - Department of Medicine, University of California, San Francisco, California, USA.
FAU - Gao, Sizhi Paul
AU  - Gao SP
AD  - Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, 
      New York, New York, USA.
FAU - Lee, Byron H
AU  - Lee BH
AD  - Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New
      York, USA.
FAU - Chapman, Jocelyn S
AU  - Chapman JS
AD  - Department of Obstetrics, Gynecology and Reproductive Sciences, University of
      California, San Francisco, California, USA.
FAU - Kandoth, Cyriac
AU  - Kandoth C
AUID- ORCID: http://orcid.org/0000-0002-1345-3573
AD  - Marie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan
      Kettering Cancer Center, New York, New York, USA.
FAU - Gao, JianJiong
AU  - Gao J
AD  - Marie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan
      Kettering Cancer Center, New York, New York, USA.
FAU - Socci, Nicholas D
AU  - Socci ND
AD  - Marie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan
      Kettering Cancer Center, New York, New York, USA.
AD  - Bioinformatics Core, Memorial Sloan Kettering Cancer Center, New York, New York, 
      USA.
FAU - Solit, David B
AU  - Solit DB
AD  - Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, 
      New York, New York, USA.
AD  - Marie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan
      Kettering Cancer Center, New York, New York, USA.
AD  - Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New
      York, USA.
AD  - Weill Cornel Medical College, Cornell University, New York, New York, USA.
FAU - Olshen, Adam B
AU  - Olshen AB
AD  - Epidemiology and Biostatistics, University of California, San Francisco,
      California, USA.
AD  - Helen Diller Family Comprehensive Cancer Center, University of California, San
      Francisco, California, USA.
FAU - Schultz, Nikolaus
AU  - Schultz N
AD  - Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer
      Center, New York, New York, USA.
AD  - Marie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan
      Kettering Cancer Center, New York, New York, USA.
FAU - Taylor, Barry S
AU  - Taylor BS
AD  - Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, 
      New York, New York, USA.
AD  - Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer
      Center, New York, New York, USA.
AD  - Marie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan
      Kettering Cancer Center, New York, New York, USA.
LA  - eng
GR  - P30 CA008748/CA/NCI NIH HHS/United States
GR  - P30 CA082103/CA/NCI NIH HHS/United States
GR  - T32 GM007175/GM/NIGMS NIH HHS/United States
GR  - P30 CA82103/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20151130
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Algorithms
MH  - Computational Biology
MH  - DNA Mutational Analysis/*methods
MH  - Humans
MH  - Mutation/*genetics
MH  - Neoplasms/*genetics
PMC - PMC4744099
MID - NIHMS726517
EDAT- 2015/12/01 06:00
MHDA- 2016/06/22 06:00
CRDT- 2015/12/01 06:00
PHST- 2015/03/11 00:00 [received]
PHST- 2015/09/25 00:00 [accepted]
PHST- 2015/12/01 06:00 [entrez]
PHST- 2015/12/01 06:00 [pubmed]
PHST- 2016/06/22 06:00 [medline]
AID - nbt.3391 [pii]
AID - 10.1038/nbt.3391 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Feb;34(2):155-63. doi: 10.1038/nbt.3391. Epub 2015 Nov 30.

PMID- 26744984
OWN - NLM
STAT- MEDLINE
DCOM- 20160511
LR  - 20170714
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - Preparing future professionals by enhancing workforce readiness.
PG  - 111-3
LID - 10.1038/nbt.3459 [doi]
FAU - Norman-Burgdolf, Heather L
AU  - Norman-Burgdolf HL
AD  - Department of Pharmacology and Nutritional Sciences, University of Kentucky
      College of Medicine, Lexington, Kentucky, USA.
FAU - Vanderford, Nathan L
AU  - Vanderford NL
AD  - Markey Cancer Center and Department of Toxicology and Cancer Biology, University 
      of Kentucky College of Medicine, Lexington, Kentucky, USA.
LA  - eng
GR  - T32 DK007778/DK/NIDDK NIH HHS/United States
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Career Choice
MH  - Education, Continuing/*organization & administration
MH  - Planning Techniques
PMC - PMC5500181
MID - NIHMS868025
EDAT- 2016/01/09 06:00
MHDA- 2016/05/12 06:00
CRDT- 2016/01/09 06:00
PHST- 2016/01/09 06:00 [entrez]
PHST- 2016/01/09 06:00 [pubmed]
PHST- 2016/05/12 06:00 [medline]
AID - nbt.3459 [pii]
AID - 10.1038/nbt.3459 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):111-3. doi: 10.1038/nbt.3459.

PMID- 26744983
OWN - NLM
STAT- MEDLINE
DCOM- 20160511
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - A reassessment of the PROPATRIA study and its implications for probiotic therapy.
PG  - 55-63
LID - 10.1038/nbt.3436 [doi]
AB  - The PROPATRIA (Probiotics in Pancreatitis Trial) study was a multicenter,
      double-blind, placebo-controlled clinical trial that aimed to reduce infectious
      complications in patients with predicted severe acute pancreatitis by the enteral
      use of a multispecies probiotic preparation. An unprecedented 24 of 152 patients 
      (16%) in the group receiving probiotics died versus 9 of 144 (6%) in the placebo 
      group. This high mortality rate in the probiotic-treated group contrasts strongly
      with observations from a previous smaller study and from our observations
      regarding the effects of abundant intestinal lactobacilli in patients with short 
      small bowel (SSB) syndrome. We argue here that a lethal combination of mainly
      proteolytic pancreas enzymes and probiotic therapy resulted in the high mortality
      rate of the PROPATRIA trial and that elevated levels of lactic acid produced by
      bacterial fermentation of carbohydrates were a key contributing factor. We
      suggest that probiotic therapy may not be counter-indicated for the prevention of
      secondary infections associated with acute pancreatitis, provided that future
      clinical studies (i) start probiotic therapy immediately after first onset of
      disease symptoms, (ii) limit the supply of fermentable carbohydrates, (iii)
      prevent bacterial (over)growth of patient's own intestinal flora and (iv)
      massively increase the dose of probiotic bacteria.
FAU - Bongaerts, Ger P A
AU  - Bongaerts GP
AD  - Laboratory of Pediatric Infectious Diseases, Department of Pediatrics, Radboud
      Institute for Molecular Life Sciences, Radboud University Medical Centre,
      Nijmegen, the Netherlands.
FAU - Severijnen, Rene S V M
AU  - Severijnen RS
AD  - Department of Surgery, Division of Pediatric Surgery, Radboud University Medical 
      Centre, Nijmegen, the Netherlands.
LA  - eng
PT  - Controlled Clinical Trial
PT  - Journal Article
PT  - Multicenter Study
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Placebos)
SB  - IM
MH  - Acute Disease
MH  - Chronic Disease
MH  - Double-Blind Method
MH  - Humans
MH  - Pancreatitis/therapy
MH  - Placebos
MH  - *Probiotics
EDAT- 2016/01/09 06:00
MHDA- 2016/05/12 06:00
CRDT- 2016/01/09 06:00
PHST- 2013/11/28 00:00 [received]
PHST- 2015/11/20 00:00 [accepted]
PHST- 2016/01/09 06:00 [entrez]
PHST- 2016/01/09 06:00 [pubmed]
PHST- 2016/05/12 06:00 [medline]
AID - nbt.3436 [pii]
AID - 10.1038/nbt.3436 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):55-63. doi: 10.1038/nbt.3436.

PMID- 26744982
OWN - NLM
STAT- MEDLINE
DCOM- 20160503
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - Getting rid of PERVs.
PG  - 46
LID - 10.1038/nbt.3448 [doi]
FAU - Jarchum, Irene
AU  - Jarchum I
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Science. 2015 Nov 27;350(6264):1101-4. PMID: 26456528
MH  - Animals
MH  - Endogenous Retroviruses/*genetics
MH  - Gene Targeting/*methods
MH  - Humans
MH  - Retroviridae Infections/*prevention & control
MH  - Swine/*virology
MH  - Transplantation, Heterologous/*methods
MH  - *Virus Inactivation
EDAT- 2016/01/09 06:00
MHDA- 2016/05/04 06:00
CRDT- 2016/01/09 06:00
PHST- 2016/01/09 06:00 [entrez]
PHST- 2016/01/09 06:00 [pubmed]
PHST- 2016/05/04 06:00 [medline]
AID - nbt.3448 [pii]
AID - 10.1038/nbt.3448 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):46. doi: 10.1038/nbt.3448.

PMID- 26744981
OWN - NLM
STAT- MEDLINE
DCOM- 20160503
LR  - 20170714
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - A systems approach to HIV-1 vaccines.
PG  - 44-6
LID - 10.1038/nbt.3456 [doi]
FAU - Ying, Tianlei
AU  - Ying T
AUID- ORCID: http://orcid.org/0000-0002-9597-2843
AD  - Key Laboratory of Medical Molecular Virology, Ministries of Education and Health,
      School of Basic Medical Sciences, Fudan University, Shanghai, China.
FAU - Prabakaran, Ponraj
AU  - Prabakaran P
AD  - Intrexon Corporation, Germantown, USA.
FAU - Dimitrov, Dimiter S
AU  - Dimitrov DS
AD  - Center for Cancer Research, National Cancer Institute, National Institutes of
      Health, USA.
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (AIDS Vaccines)
RN  - 0 (Antibodies, Viral)
RN  - 0 (Immunoglobulin G)
SB  - IM
CON - Cell. 2015 Nov 5;163(4):988-98. PMID: 26544943
MH  - AIDS Vaccines/*immunology
MH  - Animals
MH  - Antibodies, Viral/*immunology
MH  - Humans
MH  - Immunoglobulin G/*immunology
EDAT- 2016/01/09 06:00
MHDA- 2016/05/04 06:00
CRDT- 2016/01/09 06:00
PHST- 2016/01/09 06:00 [entrez]
PHST- 2016/01/09 06:00 [pubmed]
PHST- 2016/05/04 06:00 [medline]
AID - nbt.3456 [pii]
AID - 10.1038/nbt.3456 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):44-6. doi: 10.1038/nbt.3456.

PMID- 26744980
OWN - NLM
STAT- MEDLINE
DCOM- 20160511
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - Optogenetics unleashed.
PG  - 43-4
LID - 10.1038/nbt.3458 [doi]
FAU - Anikeeva, Polina
AU  - Anikeeva P
AD  - Department of Materials Science and Engineering and Research Laboratory of
      Electronics, Massachusetts Institute of Technology, Cambridge, Massachusetts,
      USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Humans
MH  - Miniaturization
MH  - *Optogenetics
MH  - Peripheral Nervous System/*physiopathology
MH  - *Prostheses and Implants
MH  - Radio Waves
MH  - Spinal Cord/*physiopathology
EDAT- 2016/01/09 06:00
MHDA- 2016/05/12 06:00
CRDT- 2016/01/09 06:00
PHST- 2016/01/09 06:00 [entrez]
PHST- 2016/01/09 06:00 [pubmed]
PHST- 2016/05/12 06:00 [medline]
AID - nbt.3458 [pii]
AID - 10.1038/nbt.3458 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):43-4. doi: 10.1038/nbt.3458.

PMID- 26744978
OWN - NLM
STAT- MEDLINE
DCOM- 20160512
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - Serotonin neurons in a dish.
PG  - 41-2
LID - 10.1038/nbt.3455 [doi]
FAU - Gaspar, Patricia
AU  - Gaspar P
AUID- ORCID: http://orcid.org/0000-0003-4217-5717
AD  - Institut du Fer a Moulin, INSERM UMRS-839, Paris, France.
FAU - Nedelec, Stephane
AU  - Nedelec S
AD  - Institut du Fer a Moulin, INSERM UMRS-839, Paris, France.
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 333DO1RDJY (Serotonin)
SB  - IM
CON - Nat Biotechnol. 2016 Jan;34(1):89-94. PMID: 26655496
MH  - Humans
MH  - Neurons/*cytology
MH  - Pluripotent Stem Cells/*cytology
MH  - Serotonin/*metabolism
EDAT- 2016/01/09 06:00
MHDA- 2016/05/14 06:00
CRDT- 2016/01/09 06:00
PHST- 2016/01/09 06:00 [entrez]
PHST- 2016/01/09 06:00 [pubmed]
PHST- 2016/05/14 06:00 [medline]
AID - nbt.3455 [pii]
AID - 10.1038/nbt.3455 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):41-2. doi: 10.1038/nbt.3455.

PMID- 26744976
OWN - NLM
STAT- MEDLINE
DCOM- 20160511
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - The patentability of human embryonic stem cell technology in China.
PG  - 37-9
LID - 10.1038/nbt.3417 [doi]
FAU - Peng, Yaojin
AU  - Peng Y
AD  - Institute for Globalization and International Regulation (IGIR), Maastricht
      University, the Netherlands.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - China
MH  - *Embryonic Stem Cells
MH  - Humans
MH  - *Patents as Topic
EDAT- 2016/01/09 06:00
MHDA- 2016/05/12 06:00
CRDT- 2016/01/09 06:00
PHST- 2016/01/09 06:00 [entrez]
PHST- 2016/01/09 06:00 [pubmed]
PHST- 2016/05/12 06:00 [medline]
AID - nbt.3417 [pii]
AID - 10.1038/nbt.3417 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):37-9. doi: 10.1038/nbt.3417.

PMID- 26744975
OWN - NLM
STAT- MEDLINE
DCOM- 20160511
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - The global pipeline of GM crops out to 2020.
PG  - 31-6
LID - 10.1038/nbt.3449 [doi]
FAU - Parisi, Claudia
AU  - Parisi C
AD  - European Commission, Joint Research Centre, Institute for Prospective
      Technological Studies, Seville, Spain.
FAU - Tillie, Pascal
AU  - Tillie P
AD  - European Commission, Joint Research Centre, Institute for Prospective
      Technological Studies, Seville, Spain.
FAU - Rodriguez-Cerezo, Emilio
AU  - Rodriguez-Cerezo E
AD  - European Commission, Joint Research Centre, Institute for Prospective
      Technological Studies, Seville, Spain.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Crops, Agricultural
MH  - Forecasting
MH  - Internationality
MH  - *Plants, Genetically Modified
EDAT- 2016/01/09 06:00
MHDA- 2016/05/12 06:00
CRDT- 2016/01/09 06:00
PHST- 2016/01/09 06:00 [entrez]
PHST- 2016/01/09 06:00 [pubmed]
PHST- 2016/05/12 06:00 [medline]
AID - nbt.3449 [pii]
AID - 10.1038/nbt.3449 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):31-6. doi: 10.1038/nbt.3449.

PMID- 26744974
OWN - NLM
STAT- MEDLINE
DCOM- 20160511
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - This time may be different.
PG  - 25-30
LID - 10.1038/nbt.3452 [doi]
FAU - Booth, Bruce L
AU  - Booth BL
AD  - Atlas Venture, Cambridge, Massachusetts, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Biotechnology
MH  - Investments
EDAT- 2016/01/09 06:00
MHDA- 2016/05/12 06:00
CRDT- 2016/01/09 06:00
PHST- 2016/01/09 06:00 [entrez]
PHST- 2016/01/09 06:00 [pubmed]
PHST- 2016/05/12 06:00 [medline]
AID - nbt.3452 [pii]
AID - 10.1038/nbt.3452 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):25-30. doi: 10.1038/nbt.3452.

PMID- 26744973
OWN - NLM
STAT- MEDLINE
DCOM- 20160503
LR  - 20160109
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - Reply to Standing up for transparency.
PG  - 24
LID - 10.1038/nbt0116-24 [doi]
LA  - eng
PT  - Comment
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2016 Jan;34(1):23. PMID: 26744972
MH  - *Food Safety
MH  - *Food, Genetically Modified
MH  - Plants, Genetically Modified/*genetics
MH  - *Public Opinion
MH  - Science/*organization & administration
EDAT- 2016/01/09 06:00
MHDA- 2016/05/04 06:00
CRDT- 2016/01/09 06:00
PHST- 2016/01/09 06:00 [entrez]
PHST- 2016/01/09 06:00 [pubmed]
PHST- 2016/05/04 06:00 [medline]
AID - nbt0116-24 [pii]
AID - 10.1038/nbt0116-24 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):24. doi: 10.1038/nbt0116-24.

PMID- 26744972
OWN - NLM
STAT- MEDLINE
DCOM- 20160503
LR  - 20160109
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - Standing up for transparency.
PG  - 23
LID - 10.1038/nbt.3453 [doi]
FAU - Malkan, Stacy
AU  - Malkan S
AD  - US Right to Know, Oakland, California, USA.
LA  - eng
PT  - Comment
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2015 Oct;33(10):1009. PMID: 26448065
CIN - Nat Biotechnol. 2016 Jan;34(1):23-4. PMID: 26744971
CIN - Nat Biotechnol. 2016 Jan;34(1):24. PMID: 26744973
MH  - *Food Safety
MH  - *Food, Genetically Modified
MH  - Plants, Genetically Modified/*genetics
MH  - *Public Opinion
MH  - Science/*organization & administration
EDAT- 2016/01/09 06:00
MHDA- 2016/05/04 06:00
CRDT- 2016/01/09 06:00
PHST- 2016/01/09 06:00 [entrez]
PHST- 2016/01/09 06:00 [pubmed]
PHST- 2016/05/04 06:00 [medline]
AID - nbt.3453 [pii]
AID - 10.1038/nbt.3453 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):23. doi: 10.1038/nbt.3453.

PMID- 26744971
OWN - NLM
STAT- MEDLINE
DCOM- 20160503
LR  - 20160109
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - Standing up for scientific consensus.
PG  - 23-4
LID - 10.1038/nbt.3454 [doi]
FAU - Payne, Jack M
AU  - Payne JM
AD  - University of Florida, Gainesville, Florida, USA.
LA  - eng
PT  - Comment
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2016 Jan;34(1):23. PMID: 26744972
MH  - *Food Safety
MH  - *Food, Genetically Modified
MH  - Plants, Genetically Modified/*genetics
MH  - *Public Opinion
MH  - Science/*organization & administration
EDAT- 2016/01/09 06:00
MHDA- 2016/05/04 06:00
CRDT- 2016/01/09 06:00
PHST- 2016/01/09 06:00 [entrez]
PHST- 2016/01/09 06:00 [pubmed]
PHST- 2016/05/04 06:00 [medline]
AID - nbt.3454 [pii]
AID - 10.1038/nbt.3454 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):23-4. doi: 10.1038/nbt.3454.

PMID- 26744970
OWN - NLM
STAT- MEDLINE
DCOM- 20160511
LR  - 20160109
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - Innovative academic startups 2015.
PG  - 19
LID - 10.1038/nbt.3447 [doi]
FAU - Huggett, Brady
AU  - Huggett B
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Biotechnology
MH  - *Internationality
EDAT- 2016/01/09 06:00
MHDA- 2016/05/12 06:00
CRDT- 2016/01/09 06:00
PHST- 2016/01/09 06:00 [entrez]
PHST- 2016/01/09 06:00 [pubmed]
PHST- 2016/05/12 06:00 [medline]
AID - nbt.3447 [pii]
AID - 10.1038/nbt.3447 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):19. doi: 10.1038/nbt.3447.

PMID- 26744969
OWN - NLM
STAT- MEDLINE
DCOM- 20160511
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - Drugs go wireless.
PG  - 15-8
LID - 10.1038/nbt.3446 [doi]
FAU - Waltz, Emily
AU  - Waltz E
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Drug Delivery Systems
MH  - *Drug Industry
MH  - Humans
MH  - *Mobile Applications
MH  - *Patient Compliance
EDAT- 2016/01/09 06:00
MHDA- 2016/05/12 06:00
CRDT- 2016/01/09 06:00
PHST- 2016/01/09 06:00 [entrez]
PHST- 2016/01/09 06:00 [pubmed]
PHST- 2016/05/12 06:00 [medline]
AID - nbt.3446 [pii]
AID - 10.1038/nbt.3446 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):15-8. doi: 10.1038/nbt.3446.

PMID- 26744967
OWN - NLM
STAT- MEDLINE
DCOM- 20160511
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - DuPont in CRISPR-Cas patent land grab.
PG  - 13
LID - 10.1038/nbt0116-13 [doi]
FAU - Grushkin, Daniel
AU  - Grushkin D
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Biotechnology
MH  - *Clustered Regularly Interspaced Short Palindromic Repeats
MH  - Drug Industry
MH  - *Patents as Topic
MH  - United States
EDAT- 2016/01/09 06:00
MHDA- 2016/05/12 06:00
CRDT- 2016/01/09 06:00
PHST- 2016/01/09 06:00 [entrez]
PHST- 2016/01/09 06:00 [pubmed]
PHST- 2016/05/12 06:00 [medline]
AID - nbt0116-13 [pii]
AID - 10.1038/nbt0116-13 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):13. doi: 10.1038/nbt0116-13.

PMID- 26744966
OWN - NLM
STAT- MEDLINE
DCOM- 20160511
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - Off-the-shelf CAR-T therapy induces remission in child with ALL.
PG  - 12
LID - 10.1038/nbt0116-12 [doi]
FAU - Ratner, Mark
AU  - Ratner M
LA  - eng
PT  - Case Reports
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Receptors, Antigen, T-Cell)
SB  - IM
MH  - Child
MH  - Female
MH  - Humans
MH  - Infant
MH  - Precursor Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy
MH  - Receptors, Antigen, T-Cell/*therapeutic use
MH  - *Remission Induction
EDAT- 2016/01/09 06:00
MHDA- 2016/05/12 06:00
CRDT- 2016/01/09 06:00
PHST- 2016/01/09 06:00 [entrez]
PHST- 2016/01/09 06:00 [pubmed]
PHST- 2016/05/12 06:00 [medline]
AID - nbt0116-12 [pii]
AID - 10.1038/nbt0116-12 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):12. doi: 10.1038/nbt0116-12.

PMID- 26744964
OWN - NLM
STAT- MEDLINE
DCOM- 20160511
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - Go-ahead for human genome editing with caveats.
PG  - 11
LID - 10.1038/nbt0116-11 [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Genome, Human
MH  - Humans
MH  - *RNA Editing
MH  - United Kingdom
MH  - United States
EDAT- 2016/01/09 06:00
MHDA- 2016/05/12 06:00
CRDT- 2016/01/09 06:00
PHST- 2016/01/09 06:00 [entrez]
PHST- 2016/01/09 06:00 [pubmed]
PHST- 2016/05/12 06:00 [medline]
AID - nbt0116-11 [pii]
AID - 10.1038/nbt0116-11 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):11. doi: 10.1038/nbt0116-11.

PMID- 26744963
OWN - NLM
STAT- MEDLINE
DCOM- 20160511
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - Severe asthma gets first biologic in decades.
PG  - 10-1
LID - 10.1038/nbt0116-10 [doi]
FAU - Azvolinsky, Anna
AU  - Azvolinsky A
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Biological Products)
SB  - IM
MH  - Asthma/*therapy
MH  - Biological Products/*therapeutic use
MH  - Humans
MH  - Severity of Illness Index
EDAT- 2016/01/09 06:00
MHDA- 2016/05/12 06:00
CRDT- 2016/01/09 06:00
PHST- 2016/01/09 06:00 [entrez]
PHST- 2016/01/09 06:00 [pubmed]
PHST- 2016/05/12 06:00 [medline]
AID - nbt0116-10 [pii]
AID - 10.1038/nbt0116-10 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):10-1. doi: 10.1038/nbt0116-10.

PMID- 26744962
OWN - NLM
STAT- MEDLINE
DCOM- 20160511
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - Mexico dengue vaccine first.
PG  - 8
LID - 10.1038/nbt0116-8b [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Viral Vaccines)
SB  - IM
MH  - Clinical Trials, Phase III as Topic
MH  - Dengue/*prevention & control
MH  - Mexico
MH  - Viral Vaccines/*therapeutic use
EDAT- 2016/01/09 06:00
MHDA- 2016/05/12 06:00
CRDT- 2016/01/09 06:00
PHST- 2016/01/09 06:00 [entrez]
PHST- 2016/01/09 06:00 [pubmed]
PHST- 2016/05/12 06:00 [medline]
AID - nbt0116-8b [pii]
AID - 10.1038/nbt0116-8b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):8. doi: 10.1038/nbt0116-8b.

PMID- 26744961
OWN - NLM
STAT- MEDLINE
DCOM- 20160511
LR  - 20160109
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - Gates champions CureVac.
PG  - 8
LID - 10.1038/nbt0116-8a [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Cancer Vaccines)
RN  - 0 (Vaccines)
SB  - IM
MH  - Biomedical Research/*economics
MH  - *Cancer Vaccines
MH  - *Drug Industry
MH  - Humans
MH  - Infection Control/*methods
MH  - *Vaccines
EDAT- 2016/01/09 06:00
MHDA- 2016/05/12 06:00
CRDT- 2016/01/09 06:00
PHST- 2016/01/09 06:00 [entrez]
PHST- 2016/01/09 06:00 [pubmed]
PHST- 2016/05/12 06:00 [medline]
AID - nbt0116-8a [pii]
AID - 10.1038/nbt0116-8a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):8. doi: 10.1038/nbt0116-8a.

PMID- 26744960
OWN - NLM
STAT- MEDLINE
DCOM- 20160511
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - GM salmon declared fit for dinner plates.
PG  - 7-9
LID - 10.1038/nbt0116-7a [doi]
FAU - Waltz, Emily
AU  - Waltz E
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - *Animals, Genetically Modified
MH  - Massachusetts
MH  - Salmon/*genetics
MH  - *Seafood
MH  - United Kingdom
EDAT- 2016/01/09 06:00
MHDA- 2016/05/12 06:00
CRDT- 2016/01/09 06:00
PHST- 2016/01/09 06:00 [entrez]
PHST- 2016/01/09 06:00 [pubmed]
PHST- 2016/05/12 06:00 [medline]
AID - nbt0116-7a [pii]
AID - 10.1038/nbt0116-7a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):7-9. doi: 10.1038/nbt0116-7a.

PMID- 26744959
OWN - NLM
STAT- MEDLINE
DCOM- 20160511
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - Shire bites deeper into rare disease space.
PG  - 7
LID - 10.1038/nbt0116-7b [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Angioedemas, Hereditary/*drug therapy
MH  - *Drug Industry
MH  - Humans
MH  - Ireland
EDAT- 2016/01/09 06:00
MHDA- 2016/05/12 06:00
CRDT- 2016/01/09 06:00
PHST- 2016/01/09 06:00 [entrez]
PHST- 2016/01/09 06:00 [pubmed]
PHST- 2016/05/12 06:00 [medline]
AID - nbt0116-7b [pii]
AID - 10.1038/nbt0116-7b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):7. doi: 10.1038/nbt0116-7b.

PMID- 26744958
OWN - NLM
STAT- MEDLINE
DCOM- 20160511
LR  - 20171116
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - Roche's immuno squeeze.
PG  - 6
LID - 10.1038/nbt0116-6 [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (B7-H1 Antigen)
RN  - 0 (CD274 protein, human)
SB  - IM
MH  - B7-H1 Antigen/immunology
MH  - *Drug Discovery
MH  - *Drug Industry
MH  - Humans
MH  - *Immunotherapy
MH  - Neoplasms/*therapy
EDAT- 2016/01/09 06:00
MHDA- 2016/05/12 06:00
CRDT- 2016/01/09 06:00
PHST- 2016/01/09 06:00 [entrez]
PHST- 2016/01/09 06:00 [pubmed]
PHST- 2016/05/12 06:00 [medline]
AID - nbt0116-6 [pii]
AID - 10.1038/nbt0116-6 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):6. doi: 10.1038/nbt0116-6.

PMID- 26744957
OWN - NLM
STAT- MEDLINE
DCOM- 20160511
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - CETP inhibitors boost 'good' cholesterol to no avail.
PG  - 5-6
LID - 10.1038/nbt0116-5 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - Clinical Trial, Phase III
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Cholesterol Ester Transfer Proteins)
RN  - 0 (Cholesterol, HDL)
SB  - IM
MH  - Cholesterol Ester Transfer Proteins/*antagonists & inhibitors
MH  - Cholesterol, HDL/*blood
MH  - Humans
EDAT- 2016/01/09 06:00
MHDA- 2016/05/12 06:00
CRDT- 2016/01/09 06:00
PHST- 2016/01/09 06:00 [entrez]
PHST- 2016/01/09 06:00 [pubmed]
PHST- 2016/05/12 06:00 [medline]
AID - nbt0116-5 [pii]
AID - 10.1038/nbt0116-5 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):5-6. doi: 10.1038/nbt0116-5.

PMID- 26744956
OWN - NLM
STAT- MEDLINE
DCOM- 20160511
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - Xenotransplantation makes a comeback.
PG  - 3-4
LID - 10.1038/nbt0116-3 [doi]
FAU - Perkel, Jeffrey M
AU  - Perkel JM
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - Biotechnology
MH  - Humans
MH  - Swine
MH  - *Transplantation, Heterologous
EDAT- 2016/01/09 06:00
MHDA- 2016/05/12 06:00
CRDT- 2016/01/09 06:00
PHST- 2016/01/09 06:00 [entrez]
PHST- 2016/01/09 06:00 [pubmed]
PHST- 2016/05/12 06:00 [medline]
AID - nbt0116-3 [pii]
AID - 10.1038/nbt0116-3 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):3-4. doi: 10.1038/nbt0116-3.

PMID- 26744955
OWN - NLM
STAT- MEDLINE
DCOM- 20160511
LR  - 20160109
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - Xenotransplantation 2.0.
PG  - 1
LID - 10.1038/nbt.3466 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Immunosuppressive Agents)
SB  - IM
MH  - Animals
MH  - *Genetic Engineering
MH  - Humans
MH  - Immunosuppressive Agents/*administration & dosage
MH  - Swine
MH  - *Transplantation, Heterologous
MH  - Waiting Lists
EDAT- 2016/01/09 06:00
MHDA- 2016/05/12 06:00
CRDT- 2016/01/09 06:00
PHST- 2016/01/09 06:00 [entrez]
PHST- 2016/01/09 06:00 [pubmed]
PHST- 2016/05/12 06:00 [medline]
AID - nbt.3466 [pii]
AID - 10.1038/nbt.3466 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):1. doi: 10.1038/nbt.3466.

PMID- 26655498
OWN - NLM
STAT- MEDLINE
DCOM- 20160511
LR  - 20180316
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - Synthetic long-read sequencing reveals intraspecies diversity in the human
      microbiome.
PG  - 64-9
LID - 10.1038/nbt.3416 [doi]
AB  - Identifying bacterial strains in metagenome and microbiome samples using
      computational analyses of short-read sequences remains a difficult problem. Here,
      we present an analysis of a human gut microbiome using TruSeq synthetic long
      reads combined with computational tools for metagenomic long-read assembly,
      variant calling and haplotyping (Nanoscope and Lens). Our analysis identifies 178
      bacterial species, of which 51 were not found using shotgun reads alone. We
      recover bacterial contigs that comprise multiple operons, including 22 contigs of
      >1 Mbp. Furthermore, we observe extensive intraspecies variation within microbial
      strains in the form of haplotypes that span up to hundreds of Kbp. Incorporation 
      of synthetic long-read sequencing technology with standard short-read approaches 
      enables more precise and comprehensive analyses of metagenomic samples.
FAU - Kuleshov, Volodymyr
AU  - Kuleshov V
AD  - Department of Computer Science, Stanford University, Stanford, California, USA.
AD  - Department of Genetics, Stanford University School of Medicine, Stanford,
      California, USA.
FAU - Jiang, Chao
AU  - Jiang C
AD  - Department of Genetics, Stanford University School of Medicine, Stanford,
      California, USA.
FAU - Zhou, Wenyu
AU  - Zhou W
AD  - Department of Genetics, Stanford University School of Medicine, Stanford,
      California, USA.
FAU - Jahanbani, Fereshteh
AU  - Jahanbani F
AD  - Department of Genetics, Stanford University School of Medicine, Stanford,
      California, USA.
FAU - Batzoglou, Serafim
AU  - Batzoglou S
AD  - Department of Computer Science, Stanford University, Stanford, California, USA.
FAU - Snyder, Michael
AU  - Snyder M
AD  - Department of Genetics, Stanford University School of Medicine, Stanford,
      California, USA.
LA  - eng
GR  - P50 HG007735/HG/NHGRI NIH HHS/United States
GR  - T32 HG000044/HG/NHGRI NIH HHS/United States
GR  - U54 DK102556/DK/NIDDK NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20151214
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *High-Throughput Nucleotide Sequencing
MH  - Humans
MH  - *Microbiota
MH  - *Species Specificity
PMC - PMC4884093
MID - NIHMS733257
EDAT- 2015/12/15 06:00
MHDA- 2016/05/12 06:00
CRDT- 2015/12/15 06:00
PHST- 2014/12/13 00:00 [received]
PHST- 2015/10/23 00:00 [accepted]
PHST- 2015/12/15 06:00 [entrez]
PHST- 2015/12/15 06:00 [pubmed]
PHST- 2016/05/12 06:00 [medline]
AID - nbt.3416 [pii]
AID - 10.1038/nbt.3416 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):64-9. doi: 10.1038/nbt.3416. Epub 2015 Dec 14.

PMID- 26655497
OWN - NLM
STAT- MEDLINE
DCOM- 20160511
LR  - 20170718
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - Improving drug discovery with high-content phenotypic screens by systematic
      selection of reporter cell lines.
PG  - 70-77
LID - 10.1038/nbt.3419 [doi]
AB  - High-content, image-based screens enable the identification of compounds that
      induce cellular responses similar to those of known drugs but through different
      chemical structures or targets. A central challenge in designing phenotypic
      screens is choosing suitable imaging biomarkers. Here we present a method for
      systematically identifying optimal reporter cell lines for annotating compound
      libraries (ORACLs), whose phenotypic profiles most accurately classify a training
      set of known drugs. We generate a library of fluorescently tagged reporter cell
      lines, and let analytical criteria determine which among them--the ORACL--best
      classifies compounds into multiple, diverse drug classes. We demonstrate that an 
      ORACL can functionally annotate large compound libraries across diverse drug
      classes in a single-pass screen and confirm high prediction accuracy by means of 
      orthogonal, secondary validation assays. Our approach will increase the
      efficiency, scale and accuracy of phenotypic screens by maximizing their
      discriminatory power.
FAU - Kang, Jungseog
AU  - Kang J
AD  - Green Center for Systems Biology, University of Texas Southwestern Medical
      Center, Dallas, TX 75390, USA.
AD  - Department of Biology, Arts and Science, New York University-Shanghai, Shanghai, 
      200122, China.
FAU - Hsu, Chien-Hsiang
AU  - Hsu CH
AD  - Green Center for Systems Biology, University of Texas Southwestern Medical
      Center, Dallas, TX 75390, USA.
AD  - Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas,
      TX 75390, USA.
AD  - Department of Pharmaceutical Chemistry, University of California, San Francisco, 
      San Francisco, CA 94158, USA.
FAU - Wu, Qi
AU  - Wu Q
AD  - Green Center for Systems Biology, University of Texas Southwestern Medical
      Center, Dallas, TX 75390, USA.
FAU - Liu, Shanshan
AU  - Liu S
AD  - Green Center for Systems Biology, University of Texas Southwestern Medical
      Center, Dallas, TX 75390, USA.
FAU - Coster, Adam D
AU  - Coster AD
AD  - Green Center for Systems Biology, University of Texas Southwestern Medical
      Center, Dallas, TX 75390, USA.
FAU - Posner, Bruce A
AU  - Posner BA
AD  - Department of Biochemistry, University of Texas Southwestern Medical Center,
      Dallas, TX 75390, USA.
FAU - Altschuler, Steven J
AU  - Altschuler SJ
AD  - Green Center for Systems Biology, University of Texas Southwestern Medical
      Center, Dallas, TX 75390, USA.
AD  - Department of Pharmaceutical Chemistry, University of California, San Francisco, 
      San Francisco, CA 94158, USA.
FAU - Wu, Lani F
AU  - Wu LF
AD  - Green Center for Systems Biology, University of Texas Southwestern Medical
      Center, Dallas, TX 75390, USA.
AD  - Department of Pharmaceutical Chemistry, University of California, San Francisco, 
      San Francisco, CA 94158, USA.
LA  - eng
GR  - P30 CA142543/CA/NCI NIH HHS/United States
GR  - R01 CA184984/CA/NCI NIH HHS/United States
GR  - R01CA184984/CA/NCI NIH HHS/United States
GR  - R01 CA133253/CA/NCI NIH HHS/United States
GR  - CA133253/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Validation Studies
DEP - 20151214
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - Cell Line
MH  - *Drug Discovery
MH  - Humans
MH  - Phenotype
PMC - PMC4844861
MID - NIHMS734579
EDAT- 2015/12/15 06:00
MHDA- 2016/05/12 06:00
CRDT- 2015/12/15 06:00
PHST- 2014/10/27 00:00 [received]
PHST- 2015/10/28 00:00 [accepted]
PHST- 2015/12/15 06:00 [entrez]
PHST- 2015/12/15 06:00 [pubmed]
PHST- 2016/05/12 06:00 [medline]
AID - 10.1038/nbt.3419 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):70-77. doi: 10.1038/nbt.3419. Epub 2015 Dec 14.

PMID- 26655496
OWN - NLM
STAT- MEDLINE
DCOM- 20160511
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - Generation of serotonin neurons from human pluripotent stem cells.
PG  - 89-94
LID - 10.1038/nbt.3435 [doi]
AB  - Serotonin neurons located in the raphe nucleus of the hindbrain have crucial
      roles in regulating brain functions and have been implicated in various
      psychiatric disorders. Yet functional human serotonin neurons are not available
      for in vitro studies. Through manipulation of the WNT pathway, we demonstrate
      efficient differentiation of human pluripotent stem cells (hPSCs) to cells
      resembling central serotonin neurons, primarily those located in the rhombomeric 
      segments 2-3 of the rostral raphe, which participate in high-order brain
      functions. The serotonin neurons express a series of molecules essential for
      serotonergic development, including tryptophan hydroxylase 2, exhibit typical
      electrophysiological properties and release serotonin in an activity-dependent
      manner. When treated with the FDA-approved drugs tramadol and escitalopram
      oxalate, they release or uptake serotonin in a dose- and time-dependent manner,
      suggesting the utility of these cells for the evaluation of drug candidates.
FAU - Lu, Jianfeng
AU  - Lu J
AD  - Waisman Center, University of Wisconsin, Madison, Wisconsin, USA.
FAU - Zhong, Xuefei
AU  - Zhong X
AD  - School of Pharmacy, University of Wisconsin, Madison, Wisconsin, USA.
FAU - Liu, Huisheng
AU  - Liu H
AD  - Waisman Center, University of Wisconsin, Madison, Wisconsin, USA.
FAU - Hao, Ling
AU  - Hao L
AD  - School of Pharmacy, University of Wisconsin, Madison, Wisconsin, USA.
FAU - Huang, Cindy Tzu-Ling
AU  - Huang CT
AD  - Waisman Center, University of Wisconsin, Madison, Wisconsin, USA.
FAU - Sherafat, Mohammad Amin
AU  - Sherafat MA
AD  - Waisman Center, University of Wisconsin, Madison, Wisconsin, USA.
FAU - Jones, Jeffrey
AU  - Jones J
AD  - Waisman Center, University of Wisconsin, Madison, Wisconsin, USA.
FAU - Ayala, Melvin
AU  - Ayala M
AD  - Waisman Center, University of Wisconsin, Madison, Wisconsin, USA.
FAU - Li, Lingjun
AU  - Li L
AD  - School of Pharmacy, University of Wisconsin, Madison, Wisconsin, USA.
AD  - Department of Chemistry, University of Wisconsin, Madison, Wisconsin, USA.
FAU - Zhang, Su-Chun
AU  - Zhang SC
AD  - Waisman Center, University of Wisconsin, Madison, Wisconsin, USA.
AD  - Department of Neuroscience and Department of Neurology, School of Medicine and
      Public Health, University of Wisconsin, Madison, Wisconsin, USA.
LA  - eng
GR  - S10RR029531/RR/NCRR NIH HHS/United States
GR  - MH100031/MH/NIMH NIH HHS/United States
GR  - P30 HD003352/HD/NICHD NIH HHS/United States
GR  - R01 MH099587/MH/NIMH NIH HHS/United States
GR  - P01 HD076892/HD/NICHD NIH HHS/United States
GR  - NS045926/NS/NINDS NIH HHS/United States
GR  - R01 NS045926/NS/NINDS NIH HHS/United States
GR  - R24 NS086604/NS/NINDS NIH HHS/United States
GR  - R01 NS076352/NS/NINDS NIH HHS/United States
GR  - S10 RR029531/RR/NCRR NIH HHS/United States
GR  - P30 HD03352/HD/NICHD NIH HHS/United States
GR  - P50 MH100031/MH/NIMH NIH HHS/United States
GR  - MH099587/MH/NIMH NIH HHS/United States
GR  - R01 DK071801/DK/NIDDK NIH HHS/United States
GR  - 1R01DK071801/DK/NIDDK NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20151214
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 333DO1RDJY (Serotonin)
SB  - IM
CIN - Nat Biotechnol. 2016 Jan;34(1):41-2. PMID: 26744978
MH  - Humans
MH  - Neurons/*cytology/metabolism
MH  - Pluripotent Stem Cells/*cytology
MH  - Serotonin/*metabolism
PMC - PMC4711820
MID - NIHMS749796
EDAT- 2015/12/15 06:00
MHDA- 2016/05/12 06:00
CRDT- 2015/12/15 06:00
PHST- 2015/01/28 00:00 [received]
PHST- 2015/11/20 00:00 [accepted]
PHST- 2015/12/15 06:00 [entrez]
PHST- 2015/12/15 06:00 [pubmed]
PHST- 2016/05/12 06:00 [medline]
AID - nbt.3435 [pii]
AID - 10.1038/nbt.3435 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):89-94. doi: 10.1038/nbt.3435. Epub 2015 Dec 14.

PMID- 26641533
OWN - NLM
STAT- MEDLINE
DCOM- 20160511
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - Gene-edited pigs are protected from porcine reproductive and respiratory syndrome
      virus.
PG  - 20-2
LID - 10.1038/nbt.3434 [doi]
FAU - Whitworth, Kristin M
AU  - Whitworth KM
AD  - Division of Animal Science, University of Missouri, Columbia, Missouri, USA.
FAU - Rowland, Raymond R R
AU  - Rowland RR
AD  - Department of Diagnostic Medicine and Pathobiology, Kansas State University,
      Manhattan, Kansas, USA.
FAU - Ewen, Catherine L
AU  - Ewen CL
AD  - Department of Diagnostic Medicine and Pathobiology, Kansas State University,
      Manhattan, Kansas, USA.
FAU - Trible, Benjamin R
AU  - Trible BR
AD  - Department of Diagnostic Medicine and Pathobiology, Kansas State University,
      Manhattan, Kansas, USA.
FAU - Kerrigan, Maureen A
AU  - Kerrigan MA
AD  - Department of Diagnostic Medicine and Pathobiology, Kansas State University,
      Manhattan, Kansas, USA.
FAU - Cino-Ozuna, Ada G
AU  - Cino-Ozuna AG
AD  - Department of Diagnostic Medicine and Pathobiology, Kansas State University,
      Manhattan, Kansas, USA.
FAU - Samuel, Melissa S
AU  - Samuel MS
AD  - Division of Animal Science, University of Missouri, Columbia, Missouri, USA.
FAU - Lightner, Jonathan E
AU  - Lightner JE
AD  - Genus plc, DeForest, Wisconsin, USA.
FAU - McLaren, David G
AU  - McLaren DG
AD  - Genus plc, DeForest, Wisconsin, USA.
FAU - Mileham, Alan J
AU  - Mileham AJ
AD  - Genus plc, DeForest, Wisconsin, USA.
FAU - Wells, Kevin D
AU  - Wells KD
AD  - Division of Animal Science, University of Missouri, Columbia, Missouri, USA.
FAU - Prather, Randall S
AU  - Prather RS
AUID- ORCID: http://orcid.org/0000-0002-6012-4035
AD  - Division of Animal Science, University of Missouri, Columbia, Missouri, USA.
LA  - eng
PT  - Letter
PT  - Research Support, Non-U.S. Gov't
DEP - 20151207
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - *Genes, Viral
MH  - Porcine Reproductive and Respiratory Syndrome/*prevention & control/virology
MH  - Porcine respiratory and reproductive syndrome virus/*genetics
MH  - Swine
EDAT- 2015/12/08 06:00
MHDA- 2016/05/12 06:00
CRDT- 2015/12/08 06:00
PHST- 2015/12/08 06:00 [entrez]
PHST- 2015/12/08 06:00 [pubmed]
PHST- 2016/05/12 06:00 [medline]
AID - nbt.3434 [pii]
AID - 10.1038/nbt.3434 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):20-2. doi: 10.1038/nbt.3434. Epub 2015 Dec 7.

PMID- 26641532
OWN - NLM
STAT- MEDLINE
DCOM- 20160511
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - The quantitative and condition-dependent Escherichia coli proteome.
PG  - 104-10
LID - 10.1038/nbt.3418 [doi]
AB  - Measuring precise concentrations of proteins can provide insights into biological
      processes. Here we use efficient protein extraction and sample fractionation, as 
      well as state-of-the-art quantitative mass spectrometry techniques to generate a 
      comprehensive, condition-dependent protein-abundance map for Escherichia coli. We
      measure cellular protein concentrations for 55% of predicted E. coli genes
      (>2,300 proteins) under 22 different experimental conditions and identify
      methylation and N-terminal protein acetylations previously not known to be
      prevalent in bacteria. We uncover system-wide proteome allocation, expression
      regulation and post-translational adaptations. These data provide a valuable
      resource for the systems biology and broader E. coli research communities.
FAU - Schmidt, Alexander
AU  - Schmidt A
AD  - Biozentrum, University of Basel, Basel, Switzerland.
FAU - Kochanowski, Karl
AU  - Kochanowski K
AD  - Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.
FAU - Vedelaar, Silke
AU  - Vedelaar S
AD  - Molecular Systems Biology, Groningen Biomolecular Sciences and Biotechnology
      Institute, University of Groningen, Groningen, the Netherlands.
FAU - Ahrne, Erik
AU  - Ahrne E
AD  - Biozentrum, University of Basel, Basel, Switzerland.
FAU - Volkmer, Benjamin
AU  - Volkmer B
AD  - Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.
FAU - Callipo, Luciano
AU  - Callipo L
AD  - Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.
FAU - Knoops, Kevin
AU  - Knoops K
AD  - Molecular Cell Biology, Groningen Biomolecular Sciences and Biotechnology
      Institute, University of Groningen, Groningen, the Netherlands.
FAU - Bauer, Manuel
AU  - Bauer M
AD  - Biozentrum, University of Basel, Basel, Switzerland.
FAU - Aebersold, Ruedi
AU  - Aebersold R
AD  - Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.
AD  - Faculty of Science, University of Zurich, Zurich, Switzerland.
FAU - Heinemann, Matthias
AU  - Heinemann M
AUID- ORCID: http://orcid.org/0000-0002-5512-9077
AD  - Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.
AD  - Molecular Systems Biology, Groningen Biomolecular Sciences and Biotechnology
      Institute, University of Groningen, Groningen, the Netherlands.
LA  - eng
GR  - 233226/European Research Council/International
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20151207
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Escherichia coli Proteins)
RN  - 0 (Proteome)
SB  - IM
MH  - Escherichia coli/*metabolism
MH  - Escherichia coli Proteins/*metabolism
MH  - Mass Spectrometry
MH  - *Proteome
PMC - PMC4888949
MID - EMS65833
OID - NLM: EMS65833
EDAT- 2015/12/08 06:00
MHDA- 2016/05/12 06:00
CRDT- 2015/12/08 06:00
PHST- 2015/04/28 00:00 [received]
PHST- 2015/10/28 00:00 [accepted]
PHST- 2015/12/08 06:00 [entrez]
PHST- 2015/12/08 06:00 [pubmed]
PHST- 2016/05/12 06:00 [medline]
AID - nbt.3418 [pii]
AID - 10.1038/nbt.3418 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):104-10. doi: 10.1038/nbt.3418. Epub 2015 Dec 7.

PMID- 26641531
OWN - NLM
STAT- MEDLINE
DCOM- 20160511
LR  - 20171116
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria
      mosquito vector Anopheles gambiae.
PG  - 78-83
LID - 10.1038/nbt.3439 [doi]
AB  - Gene drive systems that enable super-Mendelian inheritance of a transgene have
      the potential to modify insect populations over a timeframe of a few years. We
      describe CRISPR-Cas9 endonuclease constructs that function as gene drive systems 
      in Anopheles gambiae, the main vector for malaria. We identified three genes
      (AGAP005958, AGAP011377 and AGAP007280) that confer a recessive female-sterility 
      phenotype upon disruption, and inserted into each locus CRISPR-Cas9 gene drive
      constructs designed to target and edit each gene. For each targeted locus we
      observed a strong gene drive at the molecular level, with transmission rates to
      progeny of 91.4 to 99.6%. Population modeling and cage experiments indicate that 
      a CRISPR-Cas9 construct targeting one of these loci, AGAP007280, meets the
      minimum requirement for a gene drive targeting female reproduction in an insect
      population. These findings could expedite the development of gene drives to
      suppress mosquito populations to levels that do not support malaria transmission.
FAU - Hammond, Andrew
AU  - Hammond A
AD  - Department of Life Sciences, Imperial College London, London, UK.
FAU - Galizi, Roberto
AU  - Galizi R
AUID- ORCID: http://orcid.org/0000-0003-3134-7480
AD  - Department of Life Sciences, Imperial College London, London, UK.
FAU - Kyrou, Kyros
AU  - Kyrou K
AD  - Department of Life Sciences, Imperial College London, London, UK.
FAU - Simoni, Alekos
AU  - Simoni A
AD  - Department of Life Sciences, Imperial College London, London, UK.
FAU - Siniscalchi, Carla
AU  - Siniscalchi C
AD  - Dipartimento di Medicina Sperimentale Via Gambuli, Centro di Genomica Funzionale,
      University of Perugia, Perugia, Italy.
FAU - Katsanos, Dimitris
AU  - Katsanos D
AD  - Department of Life Sciences, Imperial College London, London, UK.
FAU - Gribble, Matthew
AU  - Gribble M
AD  - Department of Life Sciences, Imperial College London, London, UK.
FAU - Baker, Dean
AU  - Baker D
AD  - Department of Genetics, University of Cambridge, Cambridge, UK.
FAU - Marois, Eric
AU  - Marois E
AD  - INSERM U963, CNRS UPR9022, Universite de Strasbourg, Institut de Biologie
      Moleculaire et Cellulaire, Strasbourg, France.
FAU - Russell, Steven
AU  - Russell S
AD  - Department of Genetics, University of Cambridge, Cambridge, UK.
FAU - Burt, Austin
AU  - Burt A
AD  - Department of Life Sciences, Imperial College London, London, UK.
FAU - Windbichler, Nikolai
AU  - Windbichler N
AUID- ORCID: http://orcid.org/0000-0001-9896-1165
AD  - Department of Life Sciences, Imperial College London, London, UK.
FAU - Crisanti, Andrea
AU  - Crisanti A
AD  - Department of Life Sciences, Imperial College London, London, UK.
FAU - Nolan, Tony
AU  - Nolan T
AD  - Department of Life Sciences, Imperial College London, London, UK.
LA  - eng
GR  - 335724/European Research Council/International
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20151207
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - Anopheles/genetics/*physiology
MH  - *Clustered Regularly Interspaced Short Palindromic Repeats
MH  - Female
MH  - *Insect Vectors
MH  - Malaria/*transmission
PMC - PMC4913862
MID - EMS66155
OID - NLM: EMS66155
EDAT- 2015/12/08 06:00
MHDA- 2016/05/12 06:00
CRDT- 2015/12/08 06:00
PHST- 2015/09/12 00:00 [received]
PHST- 2015/11/23 00:00 [accepted]
PHST- 2015/12/08 06:00 [entrez]
PHST- 2015/12/08 06:00 [pubmed]
PHST- 2016/05/12 06:00 [medline]
AID - nbt.3439 [pii]
AID - 10.1038/nbt.3439 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):78-83. doi: 10.1038/nbt.3439. Epub 2015 Dec 7.

PMID- 26619012
OWN - NLM
STAT- MEDLINE
DCOM- 20160511
LR  - 20170511
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - Mapping the effects of drugs on the immune system.
PG  - 47-54
LID - 10.1038/nbt.3367 [doi]
AB  - Understanding how drugs affect the immune system has consequences for treating
      disease and minimizing unwanted side effects. Here we present an integrative
      computational approach for predicting interactions between drugs and immune cells
      in a system-wide manner. The approach matches gene sets between transcriptional
      signatures to determine their similarity. We apply the method to model the
      interactions between 1,309 drugs and 221 immune cell types and predict 69,995
      interactions. The resulting immune-cell pharmacology map is used to predict how
      five drugs influence four immune cell types in humans and mice. To validate the
      predictions, we analyzed patient records and examined cell population changes
      from in vivo experiments. Our method offers a tool for screening thousands of
      interactions to identify relationships between drugs and the immune system.
FAU - Kidd, Brian A
AU  - Kidd BA
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
AD  - Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at 
      Mount Sinai, New York, New York, USA.
FAU - Wroblewska, Aleksandra
AU  - Wroblewska A
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
FAU - Boland, Mary R
AU  - Boland MR
AD  - Department of Biomedical Informatics, Systems Biology and Medicine, Columbia
      University Medical Center, New York, New York, USA.
FAU - Agudo, Judith
AU  - Agudo J
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
FAU - Merad, Miriam
AU  - Merad M
AD  - Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New 
      York, New York, USA.
AD  - Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New
      York, USA.
AD  - Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New
      York, USA.
FAU - Tatonetti, Nicholas P
AU  - Tatonetti NP
AD  - Department of Biomedical Informatics, Systems Biology and Medicine, Columbia
      University Medical Center, New York, New York, USA.
FAU - Brown, Brian D
AU  - Brown BD
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
AD  - Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New
      York, USA.
AD  - Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New
      York, USA.
FAU - Dudley, Joel T
AU  - Dudley JT
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
AD  - Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at 
      Mount Sinai, New York, New York, USA.
LA  - eng
GR  - R01 DK098242/DK/NIDDK NIH HHS/United States
GR  - R01 AI104848/AI/NIAID NIH HHS/United States
GR  - R33CA182377/CA/NCI NIH HHS/United States
GR  - R01 AI113221/AI/NIAID NIH HHS/United States
GR  - R01 CA190400/CA/NCI NIH HHS/United States
GR  - R01AI104848/AI/NIAID NIH HHS/United States
GR  - P30 ES023515/ES/NIEHS NIH HHS/United States
GR  - R01 GM107145/GM/NIGMS NIH HHS/United States
GR  - R01DK098242/DK/NIDDK NIH HHS/United States
GR  - P30 DK020541/DK/NIDDK NIH HHS/United States
GR  - U54 CA189201/CA/NCI NIH HHS/United States
GR  - R33 CA182377/CA/NCI NIH HHS/United States
GR  - U54CA189201/CA/NCI NIH HHS/United States
GR  - R01AI113221/AI/NIAID NIH HHS/United States
GR  - P30 CA196521/CA/NCI NIH HHS/United States
GR  - R01 CA173861/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20151130
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - Humans
MH  - Immune System/*drug effects
MH  - Mice
MH  - Transcription, Genetic/drug effects
PMC - PMC4706827
MID - NIHMS715477
EDAT- 2015/12/01 06:00
MHDA- 2016/05/12 06:00
CRDT- 2015/12/01 06:00
PHST- 2015/02/07 00:00 [received]
PHST- 2015/08/11 00:00 [accepted]
PHST- 2015/12/01 06:00 [entrez]
PHST- 2015/12/01 06:00 [pubmed]
PHST- 2016/05/12 06:00 [medline]
AID - nbt.3367 [pii]
AID - 10.1038/nbt.3367 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):47-54. doi: 10.1038/nbt.3367. Epub 2015 Nov 30.

PMID- 26571101
OWN - NLM
STAT- MEDLINE
DCOM- 20160511
LR  - 20161019
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - Comprehensive analysis of protein glycosylation by solid-phase extraction of
      N-linked glycans and glycosite-containing peptides.
PG  - 84-8
LID - 10.1038/nbt.3403 [doi]
AB  - Comprehensive characterization of protein glycosylation is critical for
      understanding the structure and function of glycoproteins. However, due to the
      complexity and heterogeneity of glycoprotein conformations, current glycoprotein 
      analyses focus mainly on either the de-glycosylated glycosylation site
      (glycosite)-containing peptides or the released glycans. Here, we describe a
      chemoenzymatic method called solid phase extraction of N-linked glycans and
      glycosite-containing peptides (NGAG) for the comprehensive characterization of
      glycoproteins that is able to determine glycan heterogeneity for individual
      glycosites in addition to providing information about the total N-linked glycan, 
      glycosite-containing peptide and glycoprotein content of complex samples. The
      NGAG method can also be applied to quantitatively detect glycoprotein alterations
      in total and site-specific glycan occupancies.
FAU - Sun, Shisheng
AU  - Sun S
AD  - Department of Pathology, Johns Hopkins University, Baltimore, Maryland, USA.
FAU - Shah, Punit
AU  - Shah P
AD  - Department of Pathology, Johns Hopkins University, Baltimore, Maryland, USA.
FAU - Eshghi, Shadi Toghi
AU  - Eshghi ST
AD  - Department of Pathology, Johns Hopkins University, Baltimore, Maryland, USA.
FAU - Yang, Weiming
AU  - Yang W
AD  - Department of Pathology, Johns Hopkins University, Baltimore, Maryland, USA.
FAU - Trikannad, Namita
AU  - Trikannad N
AD  - Department of Pathology, Johns Hopkins University, Baltimore, Maryland, USA.
FAU - Yang, Shuang
AU  - Yang S
AD  - Department of Pathology, Johns Hopkins University, Baltimore, Maryland, USA.
FAU - Chen, Lijun
AU  - Chen L
AD  - Department of Pathology, Johns Hopkins University, Baltimore, Maryland, USA.
FAU - Aiyetan, Paul
AU  - Aiyetan P
AD  - Department of Pathology, Johns Hopkins University, Baltimore, Maryland, USA.
FAU - Hoti, Naseruddin
AU  - Hoti N
AD  - Department of Pathology, Johns Hopkins University, Baltimore, Maryland, USA.
FAU - Zhang, Zhen
AU  - Zhang Z
AD  - Department of Pathology, Johns Hopkins University, Baltimore, Maryland, USA.
FAU - Chan, Daniel W
AU  - Chan DW
AD  - Department of Pathology, Johns Hopkins University, Baltimore, Maryland, USA.
FAU - Zhang, Hui
AU  - Zhang H
AD  - Department of Pathology, Johns Hopkins University, Baltimore, Maryland, USA.
LA  - eng
GR  - U01 CA152813/CA/NCI NIH HHS/United States
GR  - U24 CA115102/CA/NCI NIH HHS/United States
GR  - R01CA112314/CA/NCI NIH HHS/United States
GR  - U24CA160036/CA/NCI NIH HHS/United States
GR  - R01 CA112314/CA/NCI NIH HHS/United States
GR  - U24 CA160036/CA/NCI NIH HHS/United States
GR  - N01-HV-00240/HV/NHLBI NIH HHS/United States
GR  - U24CA115102/CA/NCI NIH HHS/United States
GR  - P01 HL107153/HL/NHLBI NIH HHS/United States
GR  - U01CA152813/CA/NCI NIH HHS/United States
GR  - P01HL107153/HL/NHLBI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20151116
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Peptides)
RN  - 0 (Polysaccharides)
RN  - 0 (Proteins)
SB  - IM
MH  - Glycosylation
MH  - Peptides/*isolation & purification/metabolism
MH  - Polysaccharides/*isolation & purification/metabolism
MH  - Proteins/*metabolism
MH  - *Solid Phase Microextraction
PMC - PMC4872599
MID - NIHMS787134
EDAT- 2015/11/17 06:00
MHDA- 2016/05/12 06:00
CRDT- 2015/11/17 06:00
PHST- 2015/01/08 00:00 [received]
PHST- 2015/10/13 00:00 [accepted]
PHST- 2015/11/17 06:00 [entrez]
PHST- 2015/11/17 06:00 [pubmed]
PHST- 2016/05/12 06:00 [medline]
AID - nbt.3403 [pii]
AID - 10.1038/nbt.3403 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):84-8. doi: 10.1038/nbt.3403. Epub 2015 Nov 16.

PMID- 26501955
OWN - NLM
STAT- MEDLINE
DCOM- 20160511
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 34
IP  - 1
DP  - 2016 Jan
TI  - Comprehensive characterization of the Published Kinase Inhibitor Set.
PG  - 95-103
LID - 10.1038/nbt.3374 [doi]
AB  - Despite the success of protein kinase inhibitors as approved therapeutics, drug
      discovery has focused on a small subset of kinase targets. Here we provide a
      thorough characterization of the Published Kinase Inhibitor Set (PKIS), a set of 
      367 small-molecule ATP-competitive kinase inhibitors that was recently made
      freely available with the aim of expanding research in this field and as an
      experiment in open-source target validation. We screen the set in activity assays
      with 224 recombinant kinases and 24 G protein-coupled receptors and in cellular
      assays of cancer cell proliferation and angiogenesis. We identify chemical
      starting points for designing new chemical probes of orphan kinases and
      illustrate the utility of these leads by developing a selective inhibitor for the
      previously untargeted kinases LOK and SLK. Our cellular screens reveal compounds 
      that modulate cancer cell growth and angiogenesis in vitro. These reagents and
      associated data illustrate an efficient way forward to increasing understanding
      of the historically untargeted kinome.
FAU - Elkins, Jonathan M
AU  - Elkins JM
AUID- ORCID: http://orcid.org/0000-0003-2858-8929
AD  - Structural Genomics Consortium and Target Discovery Institute, Nuffield
      Department of Clinical Medicine, Old Road Campus, University of Oxford, Oxford,
      UK.
FAU - Fedele, Vita
AU  - Fedele V
AD  - Structural Genomics Consortium and Target Discovery Institute, Nuffield
      Department of Clinical Medicine, Old Road Campus, University of Oxford, Oxford,
      UK.
FAU - Szklarz, Marta
AU  - Szklarz M
AD  - Structural Genomics Consortium and Target Discovery Institute, Nuffield
      Department of Clinical Medicine, Old Road Campus, University of Oxford, Oxford,
      UK.
FAU - Abdul Azeez, Kamal R
AU  - Abdul Azeez KR
AD  - Structural Genomics Consortium and Target Discovery Institute, Nuffield
      Department of Clinical Medicine, Old Road Campus, University of Oxford, Oxford,
      UK.
FAU - Salah, Eidarus
AU  - Salah E
AD  - Structural Genomics Consortium and Target Discovery Institute, Nuffield
      Department of Clinical Medicine, Old Road Campus, University of Oxford, Oxford,
      UK.
FAU - Mikolajczyk, Jowita
AU  - Mikolajczyk J
AD  - Nanosyn, Inc., Santa Clara, California, USA.
FAU - Romanov, Sergei
AU  - Romanov S
AD  - Nanosyn, Inc., Santa Clara, California, USA.
FAU - Sepetov, Nikolai
AU  - Sepetov N
AD  - Nanosyn, Inc., Santa Clara, California, USA.
FAU - Huang, Xi-Ping
AU  - Huang XP
AD  - The National Institute of Mental Health Psychoactive Active Drug Screening
      Program, (NIMH PDSP), Department of Pharmacology and Division of Chemical Biology
      and Medicinal Chemistry, The University of North Carolina Chapel Hill School of
      Medicine, Chapel Hill, North Carolina, USA.
FAU - Roth, Bryan L
AU  - Roth BL
AD  - The National Institute of Mental Health Psychoactive Active Drug Screening
      Program, (NIMH PDSP), Department of Pharmacology and Division of Chemical Biology
      and Medicinal Chemistry, The University of North Carolina Chapel Hill School of
      Medicine, Chapel Hill, North Carolina, USA.
FAU - Al Haj Zen, Ayman
AU  - Al Haj Zen A
AD  - British Heart Foundation Centre of Research Excellence, Division of
      Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, 
      Oxford, UK.
FAU - Fourches, Denis
AU  - Fourches D
AD  - Laboratory for Molecular Modeling Division of Chemical Biology and Medicinal
      Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at
      Chapel Hill, Chapel Hill, North Carolina, USA.
FAU - Muratov, Eugene
AU  - Muratov E
AD  - Laboratory for Molecular Modeling Division of Chemical Biology and Medicinal
      Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at
      Chapel Hill, Chapel Hill, North Carolina, USA.
FAU - Tropsha, Alex
AU  - Tropsha A
AD  - Laboratory for Molecular Modeling Division of Chemical Biology and Medicinal
      Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at
      Chapel Hill, Chapel Hill, North Carolina, USA.
FAU - Morris, Joel
AU  - Morris J
AD  - Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville,
      Maryland, USA.
FAU - Teicher, Beverly A
AU  - Teicher BA
AD  - Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville,
      Maryland, USA.
FAU - Kunkel, Mark
AU  - Kunkel M
AD  - Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville,
      Maryland, USA.
FAU - Polley, Eric
AU  - Polley E
AD  - Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville,
      Maryland, USA.
FAU - Lackey, Karen E
AU  - Lackey KE
AD  - Medical University of South Carolina, Charleston, South Carolina, USA.
FAU - Atkinson, Francis L
AU  - Atkinson FL
AD  - European Molecular Biology Laboratory-European Bioinformatics Institute
      (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
FAU - Overington, John P
AU  - Overington JP
AUID- ORCID: http://orcid.org/0000-0002-5859-1064
AD  - European Molecular Biology Laboratory-European Bioinformatics Institute
      (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
FAU - Bamborough, Paul
AU  - Bamborough P
AD  - Chemical Sciences, GlaxoSmithKline, Stevenage, UK.
FAU - Muller, Susanne
AU  - Muller S
AD  - Structural Genomics Consortium and Target Discovery Institute, Nuffield
      Department of Clinical Medicine, Old Road Campus, University of Oxford, Oxford,
      UK.
FAU - Price, Daniel J
AU  - Price DJ
AD  - Chemical Sciences, GlaxoSmithKline, Research Triangle Park, North Carolina, USA.
FAU - Willson, Timothy M
AU  - Willson TM
AD  - Chemical Sciences, GlaxoSmithKline, Research Triangle Park, North Carolina, USA.
FAU - Drewry, David H
AU  - Drewry DH
AD  - Chemical Sciences, GlaxoSmithKline, Research Triangle Park, North Carolina, USA.
FAU - Knapp, Stefan
AU  - Knapp S
AD  - Structural Genomics Consortium and Target Discovery Institute, Nuffield
      Department of Clinical Medicine, Old Road Campus, University of Oxford, Oxford,
      UK.
AD  - Institute for Pharmaceutical Chemistry, Johann Wolfgang Goethe-University,
      Frankfurt am Main, Germany.
AD  - Buchmann Institute for Molecular Life Sciences (BMLS), Frankfurt am Main,
      Germany.
FAU - Zuercher, William J
AU  - Zuercher WJ
AD  - Chemical Sciences, GlaxoSmithKline, Research Triangle Park, North Carolina, USA.
LA  - eng
GR  - 104104/Wellcome Trust/United Kingdom
GR  - 106169/Wellcome Trust/United Kingdom
GR  - RE/13/1/30181/British Heart Foundation/United Kingdom
GR  - Wellcome Trust/United Kingdom
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20151026
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Protein Kinase Inhibitors)
RN  - EC 2.7.- (Phosphotransferases)
SB  - IM
MH  - Glycosylation
MH  - Phosphotransferases/*antagonists & inhibitors
MH  - Protein Kinase Inhibitors/*pharmacology
EDAT- 2015/10/27 06:00
MHDA- 2016/05/12 06:00
CRDT- 2015/10/27 06:00
PHST- 2013/10/03 00:00 [received]
PHST- 2015/08/31 00:00 [accepted]
PHST- 2015/10/27 06:00 [entrez]
PHST- 2015/10/27 06:00 [pubmed]
PHST- 2016/05/12 06:00 [medline]
AID - nbt.3374 [pii]
AID - 10.1038/nbt.3374 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2016 Jan;34(1):95-103. doi: 10.1038/nbt.3374. Epub 2015 Oct 26.

PMID- 26650011
OWN - NLM
STAT- Publisher
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 12
DP  - 2015 Dec 9
TI  - Cas9 gets a classmate.
PG  - 1240-1241
LID - 10.1038/nbt.3426 [doi]
FAU - Sontheimer, Erik J
AU  - Sontheimer EJ
AD  - RNA Therapeutics Institute, Program in Molecular Medicine, University of
      Massachusetts Medical School, Worcester, Massachusetts, USA.
FAU - Wolfe, Scot A
AU  - Wolfe SA
AD  - Department of Molecular, Cell and Cancer Biology, University of Massachusetts
      Medical School, Worcester, Massachusetts, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2015/12/10 06:00
MHDA- 2015/12/10 06:00
CRDT- 2015/12/10 06:00
PHST- 2015/12/10 06:00 [entrez]
PHST- 2015/12/10 06:00 [pubmed]
PHST- 2015/12/10 06:00 [medline]
AID - nbt.3426 [pii]
AID - 10.1038/nbt.3426 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Dec 9;33(12):1240-1241. doi: 10.1038/nbt.3426.

PMID- 26650010
OWN - NLM
STAT- Publisher
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 12
DP  - 2015 Dec 9
TI  - Your gut microbiome, deconstructed.
PG  - 1238-1240
LID - 10.1038/nbt.3431 [doi]
FAU - Dodd, Dylan
AU  - Dodd D
AD  - Department of Pathology and the Department of Microbiology &Immunology, Stanford 
      University School of Medicine, Stanford, California, USA.
FAU - Tropini, Carolina
AU  - Tropini C
AD  - Department of Microbiology &Immunology, Stanford University School of Medicine,
      Stanford, California, USA.
FAU - Sonnenburg, Justin L
AU  - Sonnenburg JL
AD  - Department of Microbiology &Immunology, Stanford University School of Medicine,
      Stanford, California, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2015/12/10 06:00
MHDA- 2015/12/10 06:00
CRDT- 2015/12/10 06:00
PHST- 2015/12/10 06:00 [entrez]
PHST- 2015/12/10 06:00 [pubmed]
PHST- 2015/12/10 06:00 [medline]
AID - nbt.3431 [pii]
AID - 10.1038/nbt.3431 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Dec 9;33(12):1238-1240. doi: 10.1038/nbt.3431.

PMID- 26650009
OWN - NLM
STAT- Publisher
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 12
DP  - 2015 Dec 9
TI  - Patching up hematopoietic stem cells.
PG  - 1236-1238
LID - 10.1038/nbt.3425 [doi]
FAU - Santilli, Giorgia
AU  - Santilli G
AD  - Department of Molecular and Cellular Immunology, Institute of Child Health,
      University College London, London, UK.
FAU - Thrasher, Adrian J
AU  - Thrasher AJ
AD  - Department of Molecular and Cellular Immunology, Institute of Child Health,
      University College London, London, UK.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2015/12/10 06:00
MHDA- 2015/12/10 06:00
CRDT- 2015/12/10 06:00
PHST- 2015/12/10 06:00 [entrez]
PHST- 2015/12/10 06:00 [pubmed]
PHST- 2015/12/10 06:00 [medline]
AID - nbt.3425 [pii]
AID - 10.1038/nbt.3425 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Dec 9;33(12):1236-1238. doi: 10.1038/nbt.3425.

PMID- 26650008
OWN - NLM
STAT- Publisher
LR  - 20151210
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 12
DP  - 2015 Dec 9
TI  - Recent patents in antibody engineering.
PG  - 1235
LID - 10.1038/nbt.3430 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2015/12/10 06:00
MHDA- 2015/12/10 06:00
CRDT- 2015/12/10 06:00
PHST- 2015/12/10 06:00 [entrez]
PHST- 2015/12/10 06:00 [pubmed]
PHST- 2015/12/10 06:00 [medline]
AID - nbt.3430 [pii]
AID - 10.1038/nbt.3430 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Dec 9;33(12):1235. doi: 10.1038/nbt.3430.

PMID- 26650007
OWN - NLM
STAT- Publisher
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 12
DP  - 2015 Dec 9
TI  - Patenting parthenotes in the US and Europe.
PG  - 1232-1234
LID - 10.1038/nbt.3421 [doi]
FAU - Senatore, Vincenzo
AU  - Senatore V
AD  - Guida Senatore &Associates Law Firm, Rome, Italy, and the Center for Biomedical
      Ethics, Stanford University, Stanford, California, USA.
FAU - Scott, Christopher Thomas
AU  - Scott CT
AD  - Center for Biomedical Ethics, Stanford University, Stanford, California, USA.
FAU - Sebastiano, Vittorio
AU  - Sebastiano V
AD  - Institute for Stem Cell Biology and Regenerative Medicine, Department of
      Obstetrics and Gynecology, Stanford University, Stanford, California, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2015/12/10 06:00
MHDA- 2015/12/10 06:00
CRDT- 2015/12/10 06:00
PHST- 2015/12/10 06:00 [entrez]
PHST- 2015/12/10 06:00 [pubmed]
PHST- 2015/12/10 06:00 [medline]
AID - nbt.3421 [pii]
AID - 10.1038/nbt.3421 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Dec 9;33(12):1232-1234. doi: 10.1038/nbt.3421.

PMID- 26650006
OWN - NLM
STAT- Publisher
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 12
DP  - 2015 Dec 9
TI  - Trade-sale exits in different biotech sectors.
PG  - 1229-1231
LID - 10.1038/nbt.3304 [doi]
FAU - Fernald, Kenneth
AU  - Fernald K
AD  - Athena Institute, Vrije Universiteit Amsterdam, Noord-Holland, the Netherlands.
FAU - Claassen, Eric
AU  - Claassen E
AD  - Athena Institute, Vrije Universiteit Amsterdam, Noord-Holland, the Netherlands.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2015/12/10 06:00
MHDA- 2015/12/10 06:00
CRDT- 2015/12/10 06:00
PHST- 2015/12/10 06:00 [entrez]
PHST- 2015/12/10 06:00 [pubmed]
PHST- 2015/12/10 06:00 [medline]
AID - nbt.3304 [pii]
AID - 10.1038/nbt.3304 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Dec 9;33(12):1229-1231. doi: 10.1038/nbt.3304.

PMID- 26650005
OWN - NLM
STAT- Publisher
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 12
DP  - 2015 Dec 9
TI  - Share and share alike.
PG  - 1224-1228
LID - 10.1038/nbt.3422 [doi]
FAU - Sia, Samuel K
AU  - Sia SK
AD  - Harlem Biospace and Synaptic.
FAU - Owens, Matthew P
AU  - Owens MP
AD  - Harlem Biospace and Synaptic.
AD  - Department of Biomedical Engineering at Columbia University.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2015/12/10 06:00
MHDA- 2015/12/10 06:00
CRDT- 2015/12/10 06:00
PHST- 2015/12/10 06:00 [entrez]
PHST- 2015/12/10 06:00 [pubmed]
PHST- 2015/12/10 06:00 [medline]
AID - nbt.3422 [pii]
AID - 10.1038/nbt.3422 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Dec 9;33(12):1224-1228. doi: 10.1038/nbt.3422.

PMID- 26650004
OWN - NLM
STAT- Publisher
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 12
DP  - 2015 Dec 9
TI  - Trade pact blow for innovative drug developers.
PG  - 1223
LID - 10.1038/nbt1215-1223 [doi]
FAU - Morrison, Chris
AU  - Morrison C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2015/12/10 06:00
MHDA- 2015/12/10 06:00
CRDT- 2015/12/10 06:00
PHST- 2015/12/10 06:00 [entrez]
PHST- 2015/12/10 06:00 [pubmed]
PHST- 2015/12/10 06:00 [medline]
AID - nbt1215-1223 [pii]
AID - 10.1038/nbt1215-1223 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Dec 9;33(12):1223. doi: 10.1038/nbt1215-1223.

PMID- 26650003
OWN - NLM
STAT- Publisher
LR  - 20151210
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 12
DP  - 2015 Dec 9
TI  - Tumor macrophage target fuels $1.7-billion deal.
PG  - 1222
LID - 10.1038/nbt1215-1222 [doi]
FAU - Garber, Ken
AU  - Garber K
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2015/12/10 06:00
MHDA- 2015/12/10 06:00
CRDT- 2015/12/10 06:00
PHST- 2015/12/10 06:00 [entrez]
PHST- 2015/12/10 06:00 [pubmed]
PHST- 2015/12/10 06:00 [medline]
AID - nbt1215-1222 [pii]
AID - 10.1038/nbt1215-1222 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Dec 9;33(12):1222. doi: 10.1038/nbt1215-1222.

PMID- 26650002
OWN - NLM
STAT- Publisher
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 12
DP  - 2015 Dec 9
TI  - A face-lift for biotech rules begins.
PG  - 1221-1222
LID - 10.1038/nbt1215-1221 [doi]
FAU - Waltz, Emily
AU  - Waltz E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2015/12/10 06:00
MHDA- 2015/12/10 06:00
CRDT- 2015/12/10 06:00
PHST- 2015/12/10 06:00 [entrez]
PHST- 2015/12/10 06:00 [pubmed]
PHST- 2015/12/10 06:00 [medline]
AID - nbt1215-1221 [pii]
AID - 10.1038/nbt1215-1221 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Dec 9;33(12):1221-1222. doi: 10.1038/nbt1215-1221.

PMID- 26650001
OWN - NLM
STAT- Publisher
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 12
DP  - 2015 Dec 9
TI  - 23andMe protects consumers' data.
PG  - 1220
LID - 10.1038/nbt1215-1220 [doi]
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2015/12/10 06:00
MHDA- 2015/12/10 06:00
CRDT- 2015/12/10 06:00
PHST- 2015/12/10 06:00 [entrez]
PHST- 2015/12/10 06:00 [pubmed]
PHST- 2015/12/10 06:00 [medline]
AID - nbt1215-1220 [pii]
AID - 10.1038/nbt1215-1220 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Dec 9;33(12):1220. doi: 10.1038/nbt1215-1220.

PMID- 26650000
OWN - NLM
STAT- Publisher
LR  - 20151210
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 12
DP  - 2015 Dec 9
TI  - IBM debuts hyped 'cognitive cloud' biotech HQ in Cambridge.
PG  - 1219-1220
LID - 10.1038/nbt1215-1219 [doi]
FAU - Laursen, Lucas
AU  - Laursen L
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2015/12/10 06:00
MHDA- 2015/12/10 06:00
CRDT- 2015/12/10 06:00
PHST- 2015/12/10 06:00 [entrez]
PHST- 2015/12/10 06:00 [pubmed]
PHST- 2015/12/10 06:00 [medline]
AID - nbt1215-1219 [pii]
AID - 10.1038/nbt1215-1219 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Dec 9;33(12):1219-1220. doi: 10.1038/nbt1215-1219.

PMID- 26649999
OWN - NLM
STAT- Publisher
LR  - 20151210
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 12
DP  - 2015 Dec 9
TI  - Predictive biomarkers for checkpoints, first tests approved.
PG  - 1217-1218
LID - 10.1038/nbt1215-1217 [doi]
FAU - Garber, Ken
AU  - Garber K
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2015/12/10 06:00
MHDA- 2015/12/10 06:00
CRDT- 2015/12/10 06:00
PHST- 2015/12/10 06:00 [entrez]
PHST- 2015/12/10 06:00 [pubmed]
PHST- 2015/12/10 06:00 [medline]
AID - nbt1215-1217 [pii]
AID - 10.1038/nbt1215-1217 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Dec 9;33(12):1217-1218. doi: 10.1038/nbt1215-1217.

PMID- 26649998
OWN - NLM
STAT- Publisher
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 12
DP  - 2015 Dec 9
TI  - Anti-CD20 antibody wows in multiple sclerosis.
PG  - 1215-1216
LID - 10.1038/nbt1215-1215 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2015/12/10 06:00
MHDA- 2015/12/10 06:00
CRDT- 2015/12/10 06:00
PHST- 2015/12/10 06:00 [entrez]
PHST- 2015/12/10 06:00 [pubmed]
PHST- 2015/12/10 06:00 [medline]
AID - nbt1215-1215 [pii]
AID - 10.1038/nbt1215-1215 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Dec 9;33(12):1215-1216. doi: 10.1038/nbt1215-1215.

PMID- 26649997
OWN - NLM
STAT- Publisher
LR  - 20151210
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 12
DP  - 2015 Dec 9
TI  - 20 years of bio-lox.
PG  - 1213
LID - 10.1038/nbt.3438 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2015/12/10 06:00
MHDA- 2015/12/10 06:00
CRDT- 2015/12/10 06:00
PHST- 2015/12/10 06:00 [entrez]
PHST- 2015/12/10 06:00 [pubmed]
PHST- 2015/12/10 06:00 [medline]
AID - nbt.3438 [pii]
AID - 10.1038/nbt.3438 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Dec 9;33(12):1213. doi: 10.1038/nbt.3438.

PMID- 26571100
OWN - NLM
STAT- Publisher
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 12
DP  - 2015 Dec
TI  - Safeguarding CRISPR-Cas9 gene drives in yeast.
PG  - 1250-1255
LID - 10.1038/nbt.3412 [doi]
AB  - RNA-guided gene drives capable of spreading genomic alterations made in
      laboratory organisms through wild populations could be used to address
      environmental and public health problems. However, the possibility of unintended 
      genome editing occurring through the escape of strains from laboratories, coupled
      with the prospect of unanticipated ecological change, demands caution. We report 
      the efficacy of CRISPR-Cas9 gene drive systems in wild and laboratory strains of 
      the yeast Saccharomyces cerevisiae. Furthermore, we address concerns surrounding 
      accidental genome editing by developing and validating methods of molecular
      confinement that minimize the risk of unwanted genome editing. We also present a 
      drive system capable of overwriting the changes introduced by an earlier gene
      drive. These molecular safeguards should enable the development of safe CRISPR
      gene drives for diverse organisms.
FAU - DiCarlo, James E
AU  - DiCarlo JE
AD  - Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.
AD  - Harvard Medical School, Boston, Massachusetts, USA.
AD  - Department of Biomedical Engineering, Boston University, Boston, Massachusetts,
      USA.
FAU - Chavez, Alejandro
AU  - Chavez A
AD  - Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.
AD  - Harvard Medical School, Boston, Massachusetts, USA.
AD  - Wyss Institute for Biologically Inspired Engineering, Boston, Massachusetts, USA.
AD  - Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts,
      USA.
FAU - Dietz, Sven L
AU  - Dietz SL
AD  - Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.
AD  - Harvard Medical School, Boston, Massachusetts, USA.
AD  - Wyss Institute for Biologically Inspired Engineering, Boston, Massachusetts, USA.
AD  - Department for Biosystems Science and Engineering, ETH Zurich, Basel,
      Switzerland.
FAU - Esvelt, Kevin M
AU  - Esvelt KM
AUID- ORCID: http://orcid.org/0000-0001-8797-3945
AD  - Harvard Medical School, Boston, Massachusetts, USA.
AD  - Wyss Institute for Biologically Inspired Engineering, Boston, Massachusetts, USA.
FAU - Church, George M
AU  - Church GM
AD  - Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.
AD  - Harvard Medical School, Boston, Massachusetts, USA.
AD  - Wyss Institute for Biologically Inspired Engineering, Boston, Massachusetts, USA.
LA  - eng
GR  - K99 DK102669/DK/NIDDK NIH HHS/United States
GR  - T32 CA009216/CA/NCI NIH HHS/United States
PT  - Journal Article
DEP - 20151116
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
PMC - PMC4675690
MID - NIHMS732217
EDAT- 2015/11/17 06:00
MHDA- 2015/11/17 06:00
CRDT- 2015/11/17 06:00
PHST- 2015/05/03 00:00 [received]
PHST- 2015/10/19 00:00 [accepted]
PHST- 2015/11/17 06:00 [entrez]
PHST- 2015/11/17 06:00 [pubmed]
PHST- 2015/11/17 06:00 [medline]
AID - nbt.3412 [pii]
AID - 10.1038/nbt.3412 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Dec;33(12):1250-1255. doi: 10.1038/nbt.3412. Epub 2015 Nov
      16.

PMID- 26571099
OWN - NLM
STAT- Publisher
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 12
DP  - 2015 Dec
TI  - Affinity regression predicts the recognition code of nucleic acid-binding
      proteins.
PG  - 1242-1249
LID - 10.1038/nbt.3343 [doi]
AB  - Predicting the affinity profiles of nucleic acid-binding proteins directly from
      the protein sequence is a challenging problem. We present a statistical approach 
      for learning the recognition code of a family of transcription factors or
      RNA-binding proteins (RBPs) from high-throughput binding data. Our method, called
      affinity regression, trains on protein binding microarray (PBM) or RNAcompete
      data to learn an interaction model between proteins and nucleic acids using only 
      protein domain and probe sequences as inputs. When trained on mouse homeodomain
      PBM profiles, our model correctly identifies residues that confer DNA-binding
      specificity and accurately predicts binding motifs for an independent set of
      divergent homeodomains. Similarly, when trained on RNAcompete profiles for
      diverse RBPs, our model correctly predicts the binding affinities of held-out
      proteins and identifies key RNA-binding residues, despite the high level of
      sequence divergence across RBPs. We expect that the method will be broadly
      applicable to modeling and predicting paired macromolecular interactions in
      settings where high-throughput affinity data are available.
FAU - Pelossof, Raphael
AU  - Pelossof R
AD  - Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, 
      New York, USA.
FAU - Singh, Irtisha
AU  - Singh I
AD  - Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, 
      New York, USA.
AD  - Tri-I Program in Computational Biology and Medicine, Weill Cornell Graduate
      College, New York, New York, USA.
FAU - Yang, Julie L
AU  - Yang JL
AD  - Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, 
      New York, USA.
AD  - Tri-I Program in Computational Biology and Medicine, Weill Cornell Graduate
      College, New York, New York, USA.
FAU - Weirauch, Matthew T
AU  - Weirauch MT
AD  - Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Children's
      Hospital Medical Center, Cincinnati, Ohio, USA.
AD  - Division of Biomedical Informatics, Cincinnati Children's Hospital Medical
      Center, Cincinnati, Ohio, USA.
AD  - Donnelly Centre, University of Toronto, Toronto, ON, Canada.
FAU - Hughes, Timothy R
AU  - Hughes TR
AD  - Donnelly Centre, University of Toronto, Toronto, ON, Canada.
FAU - Leslie, Christina S
AU  - Leslie CS
AD  - Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, 
      New York, USA.
LA  - eng
GR  - R01 HG006798/HG/NHGRI NIH HHS/United States
GR  - U24 CA143840/CA/NCI NIH HHS/United States
PT  - Journal Article
DEP - 20151116
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
PMC - PMC4871164
MID - NIHMS712501
EDAT- 2015/11/17 06:00
MHDA- 2015/11/17 06:00
CRDT- 2015/11/17 06:00
PHST- 2015/05/15 00:00 [received]
PHST- 2015/07/30 00:00 [accepted]
PHST- 2015/11/17 06:00 [entrez]
PHST- 2015/11/17 06:00 [pubmed]
PHST- 2015/11/17 06:00 [medline]
AID - nbt.3343 [pii]
AID - 10.1038/nbt.3343 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Dec;33(12):1242-1249. doi: 10.1038/nbt.3343. Epub 2015 Nov
      16.

PMID- 26571098
OWN - NLM
STAT- Publisher
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 12
DP  - 2015 Dec
TI  - Evolution of translation machinery in recoded bacteria enables multi-site
      incorporation of nonstandard amino acids.
PG  - 1272-1279
LID - 10.1038/nbt.3372 [doi]
AB  - Expansion of the genetic code with nonstandard amino acids (nsAAs) has enabled
      biosynthesis of proteins with diverse new chemistries. However, this technology
      has been largely restricted to proteins containing a single or few nsAA
      instances. Here we describe an in vivo evolution approach in a genomically
      recoded Escherichia coli strain for the selection of orthogonal translation
      systems capable of multi-site nsAA incorporation. We evolved chromosomal
      aminoacyl-tRNA synthetases (aaRSs) with up to 25-fold increased protein
      production for p-acetyl-L-phenylalanine and p-azido-L-phenylalanine (pAzF). We
      also evolved aaRSs with tunable specificities for 14 nsAAs, including an enzyme
      that efficiently charges pAzF while excluding 237 other nsAAs. These variants
      enabled production of elastin-like-polypeptides with 30 nsAA residues at high
      yields ( approximately 50 mg/L) and high accuracy of incorporation (>95%). This
      approach to aaRS evolution should accelerate and expand our ability to produce
      functionalized proteins and sequence-defined polymers with diverse chemistries.
FAU - Amiram, Miriam
AU  - Amiram M
AD  - Department of Molecular, Cellular, and Developmental Biology, Yale University,
      New Haven, Connecticut, USA.
AD  - Systems Biology Institute, Yale University, West Haven, Connecticut, USA.
FAU - Haimovich, Adrian D
AU  - Haimovich AD
AD  - Department of Molecular, Cellular, and Developmental Biology, Yale University,
      New Haven, Connecticut, USA.
AD  - Systems Biology Institute, Yale University, West Haven, Connecticut, USA.
FAU - Fan, Chenguang
AU  - Fan C
AD  - Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, 
      Connecticut, USA.
FAU - Wang, Yane-Shih
AU  - Wang YS
AUID- ORCID: http://orcid.org/0000-0003-2356-9577
AD  - Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, 
      Connecticut, USA.
FAU - Aerni, Hans-Rudolf
AU  - Aerni HR
AUID- ORCID: http://orcid.org/0000-0001-9477-2949
AD  - Systems Biology Institute, Yale University, West Haven, Connecticut, USA.
AD  - Department of Cellular and Molecular Physiology, Yale University, New Haven,
      Connecticut, USA.
FAU - Ntai, Ioanna
AU  - Ntai I
AD  - Department of Chemistry, Northwestern University, Evanston, Illinois, USA.
FAU - Moonan, Daniel W
AU  - Moonan DW
AD  - Department of Molecular, Cellular, and Developmental Biology, Yale University,
      New Haven, Connecticut, USA.
AD  - Systems Biology Institute, Yale University, West Haven, Connecticut, USA.
FAU - Ma, Natalie J
AU  - Ma NJ
AD  - Department of Molecular, Cellular, and Developmental Biology, Yale University,
      New Haven, Connecticut, USA.
AD  - Systems Biology Institute, Yale University, West Haven, Connecticut, USA.
FAU - Rovner, Alexis J
AU  - Rovner AJ
AD  - Department of Molecular, Cellular, and Developmental Biology, Yale University,
      New Haven, Connecticut, USA.
AD  - Systems Biology Institute, Yale University, West Haven, Connecticut, USA.
FAU - Hong, Seok Hoon
AU  - Hong SH
AUID- ORCID: http://orcid.org/0000-0003-2401-6368
AD  - Department of Chemical and Biological Engineering, Northwestern University,
      Evanston, Illinois, USA.
FAU - Kelleher, Neil L
AU  - Kelleher NL
AD  - Department of Chemistry, Northwestern University, Evanston, Illinois, USA.
FAU - Goodman, Andrew L
AU  - Goodman AL
AD  - Department of Microbial Pathogenesis and Microbial Sciences Institute, Yale
      University School of Medicine, New Haven, Connecticut, USA.
FAU - Jewett, Michael C
AU  - Jewett MC
AD  - Department of Chemical and Biological Engineering, Northwestern University,
      Evanston, Illinois, USA.
FAU - Soll, Dieter
AU  - Soll D
AD  - Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, 
      Connecticut, USA.
AD  - Department of Chemistry, Yale University, New Haven, Connecticut, USA.
FAU - Rinehart, Jesse
AU  - Rinehart J
AUID- ORCID: http://orcid.org/0000-0003-4839-4005
AD  - Systems Biology Institute, Yale University, West Haven, Connecticut, USA.
AD  - Department of Cellular and Molecular Physiology, Yale University, New Haven,
      Connecticut, USA.
FAU - Isaacs, Farren J
AU  - Isaacs FJ
AD  - Department of Molecular, Cellular, and Developmental Biology, Yale University,
      New Haven, Connecticut, USA.
AD  - Systems Biology Institute, Yale University, West Haven, Connecticut, USA.
LA  - eng
GR  - F30 CA196191/CA/NCI NIH HHS/United States
GR  - T32 GM007223/GM/NIGMS NIH HHS/United States
GR  - R37 GM022854/GM/NIGMS NIH HHS/United States
GR  - R01 GM022854/GM/NIGMS NIH HHS/United States
GR  - R01 GM067193/GM/NIGMS NIH HHS/United States
GR  - T32 GM007205/GM/NIGMS NIH HHS/United States
PT  - Journal Article
DEP - 20151116
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
PMC - PMC4784704
MID - NIHMS764859
EDAT- 2015/11/17 06:00
MHDA- 2015/11/17 06:00
CRDT- 2015/11/17 06:00
PHST- 2014/10/07 00:00 [received]
PHST- 2015/09/11 00:00 [accepted]
PHST- 2015/11/17 06:00 [entrez]
PHST- 2015/11/17 06:00 [pubmed]
PHST- 2015/11/17 06:00 [medline]
AID - nbt.3372 [pii]
AID - 10.1038/nbt.3372 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Dec;33(12):1272-1279. doi: 10.1038/nbt.3372. Epub 2015 Nov
      16.

PMID- 26551060
OWN - NLM
STAT- Publisher
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 12
DP  - 2015 Dec
TI  - Homology-driven genome editing in hematopoietic stem and progenitor cells using
      ZFN mRNA and AAV6 donors.
PG  - 1256-1263
LID - 10.1038/nbt.3408 [doi]
AB  - Genome editing with targeted nucleases and DNA donor templates homologous to the 
      break site has proven challenging in human hematopoietic stem and progenitor
      cells (HSPCs), and particularly in the most primitive, long-term repopulating
      cell population. Here we report that combining electroporation of zinc finger
      nuclease (ZFN) mRNA with donor template delivery by adeno-associated virus (AAV) 
      serotype 6 vectors directs efficient genome editing in HSPCs, achieving
      site-specific insertion of a GFP cassette at the CCR5 and AAVS1 loci in mobilized
      peripheral blood CD34(+) HSPCs at mean frequencies of 17% and 26%, respectively, 
      and in fetal liver HSPCs at 19% and 43%, respectively. Notably, this approach
      modified the CD34(+)CD133(+)CD90(+) cell population, a minor component of CD34(+)
      cells that contains long-term repopulating hematopoietic stem cells (HSCs).
      Genome-edited HSPCs also engrafted in immune-deficient mice long-term, confirming
      that HSCs are targeted by this approach. Our results provide a strategy for more 
      robust application of genome-editing technologies in HSPCs.
FAU - Wang, Jianbin
AU  - Wang J
AD  - Sangamo BioSciences, Inc., Richmond, California, USA.
FAU - Exline, Colin M
AU  - Exline CM
AD  - Department of Molecular Microbiology and Immunology, Keck School of Medicine,
      University of Southern California, Los Angeles, California, USA.
FAU - DeClercq, Joshua J
AU  - DeClercq JJ
AD  - Sangamo BioSciences, Inc., Richmond, California, USA.
FAU - Llewellyn, G Nicholas
AU  - Llewellyn GN
AD  - Department of Molecular Microbiology and Immunology, Keck School of Medicine,
      University of Southern California, Los Angeles, California, USA.
FAU - Hayward, Samuel B
AU  - Hayward SB
AD  - Sangamo BioSciences, Inc., Richmond, California, USA.
FAU - Li, Patrick Wai-Lun
AU  - Li PW
AD  - Sangamo BioSciences, Inc., Richmond, California, USA.
FAU - Shivak, David A
AU  - Shivak DA
AD  - Sangamo BioSciences, Inc., Richmond, California, USA.
FAU - Surosky, Richard T
AU  - Surosky RT
AD  - Sangamo BioSciences, Inc., Richmond, California, USA.
FAU - Gregory, Philip D
AU  - Gregory PD
AD  - Sangamo BioSciences, Inc., Richmond, California, USA.
FAU - Holmes, Michael C
AU  - Holmes MC
AD  - Sangamo BioSciences, Inc., Richmond, California, USA.
FAU - Cannon, Paula M
AU  - Cannon PM
AD  - Department of Molecular Microbiology and Immunology, Keck School of Medicine,
      University of Southern California, Los Angeles, California, USA.
LA  - eng
GR  - P01 HL073104/HL/NHLBI NIH HHS/United States
GR  - R01 DE025167/DE/NIDCR NIH HHS/United States
GR  - U19 HL129902/HL/NHLBI NIH HHS/United States
PT  - Journal Article
DEP - 20151109
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
PMC - PMC4842001
MID - NIHMS731486
EDAT- 2015/11/10 06:00
MHDA- 2015/11/10 06:00
CRDT- 2015/11/10 06:00
PHST- 2015/05/26 00:00 [received]
PHST- 2015/10/16 00:00 [accepted]
PHST- 2015/11/10 06:00 [entrez]
PHST- 2015/11/10 06:00 [pubmed]
PHST- 2015/11/10 06:00 [medline]
AID - nbt.3408 [pii]
AID - 10.1038/nbt.3408 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Dec;33(12):1256-1263. doi: 10.1038/nbt.3408. Epub 2015 Nov
      9.

PMID- 26551059
OWN - NLM
STAT- Publisher
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 12
DP  - 2015 Dec
TI  - Soft, stretchable, fully implantable miniaturized optoelectronic systems for
      wireless optogenetics.
PG  - 1280-1286
LID - 10.1038/nbt.3415 [doi]
AB  - Optogenetics allows rapid, temporally specific control of neuronal activity by
      targeted expression and activation of light-sensitive proteins. Implementation
      typically requires remote light sources and fiber-optic delivery schemes that
      impose considerable physical constraints on natural behaviors. In this report we 
      bypass these limitations using technologies that combine thin, mechanically soft 
      neural interfaces with fully implantable, stretchable wireless radio power and
      control systems. The resulting devices achieve optogenetic modulation of the
      spinal cord and peripheral nervous system. This is demonstrated with two form
      factors; stretchable film appliques that interface directly with peripheral
      nerves, and flexible filaments that insert into the narrow confines of the spinal
      epidural space. These soft, thin devices are minimally invasive, and histological
      tests suggest they can be used in chronic studies. We demonstrate the power of
      this technology by modulating peripheral and spinal pain circuitry, providing
      evidence for the potential widespread use of these devices in research and future
      clinical applications of optogenetics outside the brain.
FAU - Park, Sung Il
AU  - Park SI
AD  - Department of Materials Science and Engineering, University of Illinois at
      Urbana-Champaign, Urbana, Illinois, USA.
AD  - Frederick Seitz Materials Research Laboratory, University of Illinois at
      Urbana-Champaign, Urbana, Illinois, USA.
FAU - Brenner, Daniel S
AU  - Brenner DS
AD  - Washington University Pain Center and Department of Anesthesiology, Washington
      University School of Medicine, St. Louis, Missouri, USA.
FAU - Shin, Gunchul
AU  - Shin G
AD  - Department of Materials Science and Engineering, University of Illinois at
      Urbana-Champaign, Urbana, Illinois, USA.
AD  - Frederick Seitz Materials Research Laboratory, University of Illinois at
      Urbana-Champaign, Urbana, Illinois, USA.
FAU - Morgan, Clinton D
AU  - Morgan CD
AUID- ORCID: http://orcid.org/0000-0002-7511-0488
AD  - Washington University Pain Center and Department of Anesthesiology, Washington
      University School of Medicine, St. Louis, Missouri, USA.
FAU - Copits, Bryan A
AU  - Copits BA
AD  - Washington University Pain Center and Department of Anesthesiology, Washington
      University School of Medicine, St. Louis, Missouri, USA.
FAU - Chung, Ha Uk
AU  - Chung HU
AD  - Department of Materials Science and Engineering, University of Illinois at
      Urbana-Champaign, Urbana, Illinois, USA.
AD  - Frederick Seitz Materials Research Laboratory, University of Illinois at
      Urbana-Champaign, Urbana, Illinois, USA.
FAU - Pullen, Melanie Y
AU  - Pullen MY
AD  - Washington University Pain Center and Department of Anesthesiology, Washington
      University School of Medicine, St. Louis, Missouri, USA.
FAU - Noh, Kyung Nim
AU  - Noh KN
AD  - Department of Materials Science and Engineering, University of Illinois at
      Urbana-Champaign, Urbana, Illinois, USA.
AD  - Frederick Seitz Materials Research Laboratory, University of Illinois at
      Urbana-Champaign, Urbana, Illinois, USA.
FAU - Davidson, Steve
AU  - Davidson S
AD  - Washington University Pain Center and Department of Anesthesiology, Washington
      University School of Medicine, St. Louis, Missouri, USA.
FAU - Oh, Soong Ju
AU  - Oh SJ
AUID- ORCID: http://orcid.org/0000-0003-1434-8844
AD  - Department of Materials Science and Engineering, University of Illinois at
      Urbana-Champaign, Urbana, Illinois, USA.
AD  - Department of Materials Science and Engineering, Korea University, Seoul,
      Republic of Korea.
FAU - Yoon, Jangyeol
AU  - Yoon J
AD  - Department of Materials Science and Engineering, University of Illinois at
      Urbana-Champaign, Urbana, Illinois, USA.
AD  - Frederick Seitz Materials Research Laboratory, University of Illinois at
      Urbana-Champaign, Urbana, Illinois, USA.
AD  - Department of Chemical and Biological Engineering, Korea University, Seoul,
      Republic of Korea.
FAU - Jang, Kyung-In
AU  - Jang KI
AD  - Department of Materials Science and Engineering, University of Illinois at
      Urbana-Champaign, Urbana, Illinois, USA.
AD  - Frederick Seitz Materials Research Laboratory, University of Illinois at
      Urbana-Champaign, Urbana, Illinois, USA.
FAU - Samineni, Vijay K
AU  - Samineni VK
AD  - Washington University Pain Center and Department of Anesthesiology, Washington
      University School of Medicine, St. Louis, Missouri, USA.
FAU - Norman, Megan
AU  - Norman M
AD  - Washington University Pain Center and Department of Anesthesiology, Washington
      University School of Medicine, St. Louis, Missouri, USA.
FAU - Grajales-Reyes, Jose G
AU  - Grajales-Reyes JG
AD  - Washington University Pain Center and Department of Anesthesiology, Washington
      University School of Medicine, St. Louis, Missouri, USA.
FAU - Vogt, Sherri K
AU  - Vogt SK
AD  - Washington University Pain Center and Department of Anesthesiology, Washington
      University School of Medicine, St. Louis, Missouri, USA.
FAU - Sundaram, Saranya S
AU  - Sundaram SS
AD  - Washington University Pain Center and Department of Anesthesiology, Washington
      University School of Medicine, St. Louis, Missouri, USA.
FAU - Wilson, Kellie M
AU  - Wilson KM
AD  - Washington University Pain Center and Department of Anesthesiology, Washington
      University School of Medicine, St. Louis, Missouri, USA.
FAU - Ha, Jeong Sook
AU  - Ha JS
AD  - Department of Chemical and Biological Engineering, Korea University, Seoul,
      Republic of Korea.
FAU - Xu, Renxiao
AU  - Xu R
AD  - Department of Mechanical Engineering, Northwestern University, Chicago, Illinois,
      USA.
FAU - Pan, Taisong
AU  - Pan T
AUID- ORCID: http://orcid.org/0000-0003-1576-3409
AD  - Department of Mechanical Engineering, Northwestern University, Chicago, Illinois,
      USA.
FAU - Kim, Tae-Il
AU  - Kim TI
AD  - School of Chemical Engineering, Sungkyunkwan University (SKKU), Suwon, Republic
      of Korea.
FAU - Huang, Yonggang
AU  - Huang Y
AD  - Department of Mechanical Engineering, Northwestern University, Chicago, Illinois,
      USA.
FAU - Montana, Michael C
AU  - Montana MC
AD  - Washington University Pain Center and Department of Anesthesiology, Washington
      University School of Medicine, St. Louis, Missouri, USA.
FAU - Golden, Judith P
AU  - Golden JP
AD  - Washington University Pain Center and Department of Anesthesiology, Washington
      University School of Medicine, St. Louis, Missouri, USA.
FAU - Bruchas, Michael R
AU  - Bruchas MR
AD  - Washington University Pain Center and Department of Anesthesiology, Washington
      University School of Medicine, St. Louis, Missouri, USA.
FAU - Gereau, Robert W 4th
AU  - Gereau RW 4th
AUID- ORCID: http://orcid.org/0000-0002-5428-4251
AD  - Washington University Pain Center and Department of Anesthesiology, Washington
      University School of Medicine, St. Louis, Missouri, USA.
FAU - Rogers, John A
AU  - Rogers JA
AD  - Department of Materials Science and Engineering, University of Illinois at
      Urbana-Champaign, Urbana, Illinois, USA.
AD  - Frederick Seitz Materials Research Laboratory, University of Illinois at
      Urbana-Champaign, Urbana, Illinois, USA.
LA  - eng
GR  - F31 NS078852/NS/NINDS NIH HHS/United States
GR  - F32 NS076324/NS/NINDS NIH HHS/United States
GR  - R01 NS081707/NS/NINDS NIH HHS/United States
GR  - T32 GM108539/GM/NIGMS NIH HHS/United States
PT  - Journal Article
DEP - 20151109
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
PMC - PMC4880021
MID - NIHMS733252
EDAT- 2015/11/10 06:00
MHDA- 2015/11/10 06:00
CRDT- 2015/11/10 06:00
PHST- 2015/03/12 00:00 [received]
PHST- 2015/10/22 00:00 [accepted]
PHST- 2015/11/10 06:00 [entrez]
PHST- 2015/11/10 06:00 [pubmed]
PHST- 2015/11/10 06:00 [medline]
AID - nbt.3415 [pii]
AID - 10.1038/nbt.3415 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Dec;33(12):1280-1286. doi: 10.1038/nbt.3415. Epub 2015 Nov
      9.

PMID- 26524662
OWN - NLM
STAT- Publisher
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 12
DP  - 2015 Dec
TI  - Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying 
      PAM recognition.
PG  - 1293-1298
LID - 10.1038/nbt.3404 [doi]
AB  - CRISPR-Cas9 nucleases target specific DNA sequences using a guide RNA but also
      require recognition of a protospacer adjacent motif (PAM) by the Cas9 protein.
      Although longer PAMs can potentially improve the specificity of genome editing,
      they limit the range of sequences that Cas9 orthologs can target. One potential
      strategy to relieve this restriction is to relax the PAM recognition specificity 
      of Cas9. Here we used molecular evolution to modify the NNGRRT PAM of
      Staphylococcus aureus Cas9 (SaCas9). One variant we identified, referred to as
      KKH SaCas9, showed robust genome editing activities at endogenous human target
      sites with NNNRRT PAMs, thereby increasing SaCas9 targeting range by two- to
      fourfold. Using GUIDE-seq, we show that wild-type and KKH SaCas9 induce
      comparable numbers of off-target effects in human cells. Our strategy for
      evolving PAM specificity does not require structural information and therefore
      should be applicable to a wide range of Cas9 orthologs.
FAU - Kleinstiver, Benjamin P
AU  - Kleinstiver BP
AD  - Molecular Pathology Unit, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Cancer Research, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Computational and Integrative Biology, Massachusetts General Hospital,
      Charlestown, Massachusetts, USA.
AD  - Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Prew, Michelle S
AU  - Prew MS
AD  - Molecular Pathology Unit, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Cancer Research, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Computational and Integrative Biology, Massachusetts General Hospital,
      Charlestown, Massachusetts, USA.
FAU - Tsai, Shengdar Q
AU  - Tsai SQ
AD  - Molecular Pathology Unit, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Cancer Research, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Computational and Integrative Biology, Massachusetts General Hospital,
      Charlestown, Massachusetts, USA.
AD  - Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Nguyen, Nhu T
AU  - Nguyen NT
AD  - Molecular Pathology Unit, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Cancer Research, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Computational and Integrative Biology, Massachusetts General Hospital,
      Charlestown, Massachusetts, USA.
FAU - Topkar, Ved V
AU  - Topkar VV
AD  - Molecular Pathology Unit, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Cancer Research, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Computational and Integrative Biology, Massachusetts General Hospital,
      Charlestown, Massachusetts, USA.
FAU - Zheng, Zongli
AU  - Zheng Z
AD  - Department of Biomedical Sciences, City University of Hong Kong, Hong Kong,
      China.
FAU - Joung, J Keith
AU  - Joung JK
AD  - Molecular Pathology Unit, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Cancer Research, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA.
AD  - Center for Computational and Integrative Biology, Massachusetts General Hospital,
      Charlestown, Massachusetts, USA.
AD  - Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA.
LA  - eng
GR  - DP1 GM105378/GM/NIGMS NIH HHS/United States
GR  - R01 GM107427/GM/NIGMS NIH HHS/United States
PT  - Journal Article
DEP - 20151102
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
PMC - PMC4689141
MID - NIHMS744940
EDAT- 2015/11/03 06:00
MHDA- 2015/11/03 06:00
CRDT- 2015/11/03 06:00
PHST- 2015/09/01 00:00 [received]
PHST- 2015/10/14 00:00 [accepted]
PHST- 2015/11/03 06:00 [entrez]
PHST- 2015/11/03 06:00 [pubmed]
PHST- 2015/11/03 06:00 [medline]
AID - nbt.3404 [pii]
AID - 10.1038/nbt.3404 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Dec;33(12):1293-1298. doi: 10.1038/nbt.3404. Epub 2015 Nov
      2.

PMID- 26524661
OWN - NLM
STAT- Publisher
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 12
DP  - 2015 Dec
TI  - GFP-specific CD8 T cells enable targeted cell depletion and visualization of
      T-cell interactions.
PG  - 1287-1292
LID - 10.1038/nbt.3386 [doi]
AB  - There are numerous cell types with scarcely understood functions, whose
      interactions with the immune system are not well characterized. To facilitate
      their study, we generated a mouse bearing enhanced green fluorescent protein
      (EGFP)-specific CD8(+) T cells. Transfer of the T cells into EGFP reporter
      animals can be used to kill EGFP-expressing cells, allowing selective depletion
      of desired cell types, or to interrogate T-cell interactions with specific
      populations. Using this system, we eliminate a rare EGFP-expressing cell type in 
      the heart and demonstrate its role in cardiac function. We also show that naive T
      cells are recruited into the mouse brain by antigen-expressing microglia,
      providing evidence of an immune surveillance pathway in the central nervous
      system. The just EGFP death-inducing (Jedi) T cells enable visualization of a
      T-cell antigen. They also make it possible to utilize hundreds of existing
      EGFP-expressing mice, tumors, pathogens and other tools, to study T-cell
      interactions with many different cell types, to model disease states and to
      determine the functions of poorly characterized cell populations.
FAU - Agudo, Judith
AU  - Agudo J
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
FAU - Ruzo, Albert
AU  - Ruzo A
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
FAU - Park, Eun Sook
AU  - Park ES
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
FAU - Sweeney, Robert
AU  - Sweeney R
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
FAU - Kana, Veronika
AU  - Kana V
AD  - Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New 
      York, New York, USA.
FAU - Wu, Meng
AU  - Wu M
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
FAU - Zhao, Yong
AU  - Zhao Y
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
FAU - Egli, Dieter
AU  - Egli D
AD  - The New York Stem Cell Foundation Research Institute, New York, New York, USA.
FAU - Merad, Miriam
AU  - Merad M
AD  - Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New 
      York, New York, USA.
AD  - Mount Sinai Immunology Institute, Icahn School of Medicine at Mount Sinai, New
      York, New York, USA.
AD  - Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New
      York, USA.
FAU - Brown, Brian D
AU  - Brown BD
AD  - Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
AD  - Mount Sinai Immunology Institute, Icahn School of Medicine at Mount Sinai, New
      York, New York, USA.
AD  - Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New
      York, USA.
AD  - Diabetes Obesity and Metabolism Institute, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
LA  - eng
GR  - R01 AI104848/AI/NIAID NIH HHS/United States
GR  - R01 AI113221/AI/NIAID NIH HHS/United States
GR  - R01 CA190400/CA/NCI NIH HHS/United States
GR  - R01 HL107376/HL/NHLBI NIH HHS/United States
GR  - K02 HL103597/HL/NHLBI NIH HHS/United States
GR  - P30 DK026687/DK/NIDDK NIH HHS/United States
GR  - P30 CA196521/CA/NCI NIH HHS/United States
GR  - R01 CA173861/CA/NCI NIH HHS/United States
PT  - Journal Article
DEP - 20151102
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
PMC - PMC4675673
MID - NIHMS725822
EDAT- 2015/11/03 06:00
MHDA- 2015/11/03 06:00
CRDT- 2015/11/03 06:00
PHST- 2015/04/28 00:00 [received]
PHST- 2015/09/23 00:00 [accepted]
PHST- 2015/11/03 06:00 [entrez]
PHST- 2015/11/03 06:00 [pubmed]
PHST- 2015/11/03 06:00 [medline]
AID - nbt.3386 [pii]
AID - 10.1038/nbt.3386 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Dec;33(12):1287-1292. doi: 10.1038/nbt.3386. Epub 2015 Nov
      2.

PMID- 26501953
OWN - NLM
STAT- Publisher
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 12
DP  - 2015 Dec
TI  - Long-term culture and expansion of primary human hepatocytes.
PG  - 1264-1271
LID - 10.1038/nbt.3377 [doi]
AB  - Hepatocytes have a critical role in metabolism, but their study is limited by the
      inability to expand primary hepatocytes in vitro while maintaining proliferative 
      capacity and metabolic function. Here we describe the oncostatin M
      (OSM)-dependent expansion of primary human hepatocytes by low expression of the
      human papilloma virus (HPV) genes E6 and E7 coupled with inhibition of
      epithelial-to-mesenchymal transition. We show that E6 and E7 expression
      upregulates the OSM receptor gp130 and that OSM stimulation induces hepatocytes
      to expand for up to 40 population doublings, producing 10(13) to 10(16) cells
      from a single human hepatocyte isolate. OSM removal induces differentiation into 
      metabolically functional, polarized hepatocytes with functional bile canaliculi. 
      Differentiated hepatocytes show transcriptional and toxicity profiles and
      cytochrome P450 induction similar to those of primary human hepatocytes.
      Replication and infectivity of hepatitis C virus (HCV) in differentiated
      hepatocytes are similar to those of Huh7.5.1 human hepatoma cells. These results 
      offer a means of expanding human hepatocytes of different genetic backgrounds for
      research, clinical applications and pharmaceutical development.
FAU - Levy, Gahl
AU  - Levy G
AD  - Alexander Grass Center for Bioengineering, The Hebrew University of Jerusalem,
      Jerusalem, Israel.
FAU - Bomze, David
AU  - Bomze D
AD  - Alexander Grass Center for Bioengineering, The Hebrew University of Jerusalem,
      Jerusalem, Israel.
FAU - Heinz, Stefan
AU  - Heinz S
AD  - Upcyte Technologies GmbH, Hamburg, Germany.
FAU - Ramachandran, Sarada Devi
AU  - Ramachandran SD
AD  - Medicyte GmbH, Heidelberg, Germany.
FAU - Noerenberg, Astrid
AU  - Noerenberg A
AD  - Upcyte Technologies GmbH, Hamburg, Germany.
FAU - Cohen, Merav
AU  - Cohen M
AD  - Alexander Grass Center for Bioengineering, The Hebrew University of Jerusalem,
      Jerusalem, Israel.
AD  - Department of Cell and Developmental Biology, The Hebrew University of Jerusalem,
      Jerusalem, Israel.
FAU - Shibolet, Oren
AU  - Shibolet O
AD  - Liver Unit, Department of Gastroenterology, Tel Aviv Medical Center and Tel Aviv 
      University, Tel Aviv, Israel.
FAU - Sklan, Ella
AU  - Sklan E
AD  - Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, 
      Tel Aviv University, Tel Aviv, Israel.
FAU - Braspenning, Joris
AU  - Braspenning J
AD  - Medicyte GmbH, Heidelberg, Germany.
AD  - Fraunhofer Translational Center, Wurzburg, Germany.
FAU - Nahmias, Yaakov
AU  - Nahmias Y
AD  - Alexander Grass Center for Bioengineering, The Hebrew University of Jerusalem,
      Jerusalem, Israel.
AD  - Department of Cell and Developmental Biology, The Hebrew University of Jerusalem,
      Jerusalem, Israel.
LA  - eng
PT  - Journal Article
DEP - 20151026
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2015/10/27 06:00
MHDA- 2015/10/27 06:00
CRDT- 2015/10/27 06:00
PHST- 2014/03/27 00:00 [received]
PHST- 2015/09/16 00:00 [accepted]
PHST- 2015/10/27 06:00 [entrez]
PHST- 2015/10/27 06:00 [pubmed]
PHST- 2015/10/27 06:00 [medline]
AID - nbt.3377 [pii]
AID - 10.1038/nbt.3377 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Dec;33(12):1264-1271. doi: 10.1038/nbt.3377. Epub 2015 Oct
      26.

PMID- 26544148
OWN - NLM
STAT- MEDLINE
DCOM- 20160408
LR  - 20151107
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 11
DP  - 2015 Nov
TI  - Third-quarter biotech job picture.
PG  - 1211
LID - 10.1038/nbt.3406 [doi]
FAU - Francisco, Michael
AU  - Francisco M
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*economics/*manpower
MH  - Humans
EDAT- 2015/11/07 06:00
MHDA- 2016/04/09 06:00
CRDT- 2015/11/07 06:00
PHST- 2015/11/07 06:00 [entrez]
PHST- 2015/11/07 06:00 [pubmed]
PHST- 2016/04/09 06:00 [medline]
AID - nbt.3406 [pii]
AID - 10.1038/nbt.3406 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Nov;33(11):1211. doi: 10.1038/nbt.3406.

PMID- 26544146
OWN - NLM
STAT- MEDLINE
DCOM- 20160208
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 11
DP  - 2015 Nov
TI  - Scaling up phenotyping studies.
PG  - 1150-1
LID - 10.1038/nbt.3400 [doi]
FAU - Svenson, Karen L
AU  - Svenson KL
AD  - The Jackson Laboratory, Bar Harbor, Maine, USA.
LA  - eng
GR  - U54 HG006332/HG/NHGRI NIH HHS/United States
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Genet. 2015 Sep;47(9):969-78. PMID: 26214591
MH  - Animals
MH  - Female
MH  - *Genetic Association Studies
MH  - Humans
MH  - Male
EDAT- 2015/11/07 06:00
MHDA- 2016/02/09 06:00
CRDT- 2015/11/07 06:00
PHST- 2015/11/07 06:00 [entrez]
PHST- 2015/11/07 06:00 [pubmed]
PHST- 2016/02/09 06:00 [medline]
AID - nbt.3400 [pii]
AID - 10.1038/nbt.3400 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Nov;33(11):1150-1. doi: 10.1038/nbt.3400.

PMID- 26544145
OWN - NLM
STAT- MEDLINE
DCOM- 20160208
LR  - 20151107
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 11
DP  - 2015 Nov
TI  - Biological synthesis unbounded?
PG  - 1148-9
LID - 10.1038/nbt.3399 [doi]
FAU - Pfleger, Brian F
AU  - Pfleger BF
AUID- ORCID: http://orcid.org/0000-0002-9232-9959
AD  - University of Wisconsin-Madison, Madison, Wisconsin, USA.
FAU - Prather, Kristala L J
AU  - Prather KL
AUID- ORCID: http://orcid.org/0000-0003-0437-3157
AD  - Department of Chemical Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 2P9MKG8GX7 (Thebaine)
RN  - 6YKS4Y3WQ7 (Hydrocodone)
SB  - IM
CON - Science. 2015 Sep 4;349(6252):1095-100. PMID: 26272907
MH  - Animals
MH  - Genetic Engineering/*methods
MH  - Hydrocodone/*metabolism
MH  - Saccharomyces cerevisiae/*enzymology
MH  - Thebaine/*metabolism
EDAT- 2015/11/07 06:00
MHDA- 2016/02/09 06:00
CRDT- 2015/11/07 06:00
PHST- 2015/11/07 06:00 [entrez]
PHST- 2015/11/07 06:00 [pubmed]
PHST- 2016/02/09 06:00 [medline]
AID - nbt.3399 [pii]
AID - 10.1038/nbt.3399 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Nov;33(11):1148-9. doi: 10.1038/nbt.3399.

PMID- 26544144
OWN - NLM
STAT- MEDLINE
DCOM- 20160411
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 11
DP  - 2015 Nov
TI  - Big thinking for adjuvants.
PG  - 1146-8
LID - 10.1038/nbt.3398 [doi]
FAU - Dane, Eric L
AU  - Dane EL
AD  - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
FAU - Irvine, Darrell J
AU  - Irvine DJ
AD  - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Adjuvants, Immunologic)
RN  - 0 (Toll-Like Receptors)
RN  - 0 (Vaccines)
SB  - IM
CON - Nat Biotechnol. 2015 Nov;33(11):1201-10. PMID: 26501954
MH  - Adjuvants, Immunologic/*chemistry
MH  - Animals
MH  - Female
MH  - Male
MH  - Toll-Like Receptors/*agonists
MH  - Vaccines/*immunology
EDAT- 2015/11/07 06:00
MHDA- 2016/04/12 06:00
CRDT- 2015/11/07 06:00
PHST- 2015/11/07 06:00 [entrez]
PHST- 2015/11/07 06:00 [pubmed]
PHST- 2016/04/12 06:00 [medline]
AID - nbt.3398 [pii]
AID - 10.1038/nbt.3398 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Nov;33(11):1146-8. doi: 10.1038/nbt.3398.

PMID- 26544143
OWN - NLM
STAT- MEDLINE
DCOM- 20160411
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 11
DP  - 2015 Nov
TI  - Putting induced pluripotent stem cells to the test.
PG  - 1145-6
LID - 10.1038/nbt.3401 [doi]
FAU - Vallier, Ludovic
AU  - Vallier L
AD  - Wellcome Trust and MRC Stem Cell Institute and Wellcome Trust Sanger Institute,
      Department of Surgery, Cambridge University, Cambridge, UK.
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2015 Nov;33(11):1173-81. PMID: 26501951
MH  - Embryonic Stem Cells/*metabolism
MH  - Genes/*genetics
MH  - Humans
MH  - Induced Pluripotent Stem Cells/*metabolism
MH  - Male
EDAT- 2015/11/07 06:00
MHDA- 2016/04/12 06:00
CRDT- 2015/11/07 06:00
PHST- 2015/11/07 06:00 [entrez]
PHST- 2015/11/07 06:00 [pubmed]
PHST- 2016/04/12 06:00 [medline]
AID - nbt.3401 [pii]
AID - 10.1038/nbt.3401 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Nov;33(11):1145-6. doi: 10.1038/nbt.3401.

PMID- 26544141
OWN - NLM
STAT- MEDLINE
DCOM- 20160408
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 11
DP  - 2015 Nov
TI  - The ownership question of plant gene and genome intellectual properties.
PG  - 1138-43
LID - 10.1038/nbt.3393 [doi]
FAU - Jefferson, Osmat A
AU  - Jefferson OA
AD  - Queensland University of Technology, Brisbane, Australia, and at Cambia,
      Canberra, Australia.
FAU - Kollhofer, Deniz
AU  - Kollhofer D
AD  - Queensland University of Technology, Brisbane, Australia, and at Cambia,
      Canberra, Australia.
FAU - Ehrich, Thomas H
AU  - Ehrich TH
AD  - Queensland University of Technology, Brisbane, Australia, and at Cambia,
      Canberra, Australia.
FAU - Jefferson, Richard A
AU  - Jefferson RA
AD  - Queensland University of Technology, Brisbane, Australia, and at Cambia,
      Canberra, Australia.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*legislation & jurisprudence
MH  - *Genes, Plant
MH  - *Genome, Plant
MH  - Patents as Topic/*legislation & jurisprudence
EDAT- 2015/11/07 06:00
MHDA- 2016/04/09 06:00
CRDT- 2015/11/07 06:00
PHST- 2015/11/07 06:00 [entrez]
PHST- 2015/11/07 06:00 [pubmed]
PHST- 2016/04/09 06:00 [medline]
AID - nbt.3393 [pii]
AID - 10.1038/nbt.3393 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Nov;33(11):1138-43. doi: 10.1038/nbt.3393.

PMID- 26544140
OWN - NLM
STAT- MEDLINE
DCOM- 20160408
LR  - 20180103
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 11
DP  - 2015 Nov
TI  - Using GlycoDelete to produce proteins lacking plant-specific N-glycan
      modification in seeds.
PG  - 1135-7
LID - 10.1038/nbt.3359 [doi]
FAU - Piron, Robin
AU  - Piron R
AD  - Department of Plant Systems Biology, VIB, Ghent, Belgium.
AD  - Department of Plant Biotechnology and Bioinformatics, Ghent University, Ghent,
      Belgium.
FAU - Santens, Francis
AU  - Santens F
AD  - Medical Biotechnology Center, VIB, Ghent, Belgium.
AD  - Department of Biochemistry and Microbiology, Ghent University, Ghent, Belgium.
FAU - De Paepe, Annelies
AU  - De Paepe A
AD  - Department of Plant Systems Biology, VIB, Ghent, Belgium.
AD  - Department of Plant Biotechnology and Bioinformatics, Ghent University, Ghent,
      Belgium.
FAU - Depicker, Ann
AU  - Depicker A
AD  - Department of Plant Systems Biology, VIB, Ghent, Belgium.
AD  - Department of Plant Biotechnology and Bioinformatics, Ghent University, Ghent,
      Belgium.
FAU - Callewaert, Nico
AU  - Callewaert N
AD  - Medical Biotechnology Center, VIB, Ghent, Belgium.
AD  - Department of Biochemistry and Microbiology, Ghent University, Ghent, Belgium.
LA  - eng
PT  - Letter
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Glycoproteins)
RN  - 0 (Recombinant Proteins)
SB  - IM
CIN - Nat Biotechnol. 2016 Jul 12;34(7):706-8. PMID: 27404878
MH  - *Glycoproteins/chemistry/genetics/metabolism
MH  - Glycosylation
MH  - Protein Engineering/*methods
MH  - *Recombinant Proteins/chemistry/genetics/metabolism
MH  - Seeds/*metabolism
EDAT- 2015/11/07 06:00
MHDA- 2016/04/09 06:00
CRDT- 2015/11/07 06:00
PHST- 2015/11/07 06:00 [entrez]
PHST- 2015/11/07 06:00 [pubmed]
PHST- 2016/04/09 06:00 [medline]
AID - nbt.3359 [pii]
AID - 10.1038/nbt.3359 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Nov;33(11):1135-7. doi: 10.1038/nbt.3359.

PMID- 26544139
OWN - NLM
STAT- MEDLINE
DCOM- 20160408
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 11
DP  - 2015 Nov
TI  - Recasting Asilomar's lessons for human germline editing.
PG  - 1132-4
LID - 10.1038/nbt.3402 [doi]
FAU - Miller, Henry I
AU  - Miller HI
AD  - Hoover Institution, Stanford University, Stanford, California, USA.
LA  - eng
PT  - Historical Article
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Gene Transfer Techniques
MH  - *Genetic Research/history/legislation & jurisprudence
MH  - *Genetic Therapy/history/legislation & jurisprudence
MH  - Germ Cells
MH  - History, 20th Century
MH  - Humans
MH  - United States
EDAT- 2015/11/07 06:00
MHDA- 2016/04/09 06:00
CRDT- 2015/11/07 06:00
PHST- 2015/11/07 06:00 [entrez]
PHST- 2015/11/07 06:00 [pubmed]
PHST- 2016/04/09 06:00 [medline]
AID - nbt.3402 [pii]
AID - 10.1038/nbt.3402 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Nov;33(11):1132-4. doi: 10.1038/nbt.3402.

PMID- 26544138
OWN - NLM
STAT- MEDLINE
DCOM- 20160408
LR  - 20151107
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 11
DP  - 2015 Nov
TI  - Top US universities, institutes for life sciences in 2014.
PG  - 1131
LID - 10.1038/nbt.3394 [doi]
FAU - Huggett, Brady
AU  - Huggett B
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Academies and Institutes/economics/legislation & jurisprudence/statistics &
      numerical data
MH  - *Biological Science Disciplines/economics/legislation & jurisprudence/statistics 
      & numerical data
MH  - Biotechnology/economics/legislation & jurisprudence/statistics & numerical data
MH  - Humans
MH  - United States
MH  - *Universities/economics/legislation & jurisprudence/statistics & numerical data
EDAT- 2015/11/07 06:00
MHDA- 2016/04/09 06:00
CRDT- 2015/11/07 06:00
PHST- 2015/11/07 06:00 [entrez]
PHST- 2015/11/07 06:00 [pubmed]
PHST- 2016/04/09 06:00 [medline]
AID - nbt.3394 [pii]
AID - 10.1038/nbt.3394 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Nov;33(11):1131. doi: 10.1038/nbt.3394.

PMID- 26544137
OWN - NLM
STAT- MEDLINE
DCOM- 20160408
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 11
DP  - 2015 Nov
TI  - Breathing easier with combinations.
PG  - 1128-30
LID - 10.1038/nbt.3397 [doi]
FAU - Azvolinsky, Anna
AU  - Azvolinsky A
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Aminophenols)
RN  - 0 (Aminopyridines)
RN  - 0 (Benzodioxoles)
RN  - 0 (CFTR protein, human)
RN  - 0 (Quinolones)
RN  - 126880-72-6 (Cystic Fibrosis Transmembrane Conductance Regulator)
RN  - 1Y740ILL1Z (ivacaftor)
RN  - EGP8L81APK (lumacaftor)
SB  - IM
MH  - Aminophenols/pharmacology/therapeutic use
MH  - Aminopyridines/pharmacology/therapeutic use
MH  - Benzodioxoles/pharmacology/therapeutic use
MH  - Biomedical Research
MH  - *Cystic Fibrosis/drug therapy/genetics
MH  - Cystic Fibrosis Transmembrane Conductance Regulator/drug effects/genetics
MH  - Drug Industry
MH  - *Drug Therapy, Combination/economics/trends
MH  - Humans
MH  - Mutation/*genetics
MH  - Quinolones/pharmacology/therapeutic use
EDAT- 2015/11/07 06:00
MHDA- 2016/04/09 06:00
CRDT- 2015/11/07 06:00
PHST- 2015/11/07 06:00 [entrez]
PHST- 2015/11/07 06:00 [pubmed]
PHST- 2016/04/09 06:00 [medline]
AID - nbt.3397 [pii]
AID - 10.1038/nbt.3397 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Nov;33(11):1128-30. doi: 10.1038/nbt.3397.

PMID- 26544136
OWN - NLM
STAT- MEDLINE
DCOM- 20160408
LR  - 20151107
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 11
DP  - 2015 Nov
TI  - 3Q15--biotech in the balance.
PG  - 1127
LID - 10.1038/nbt.3407 [doi]
FAU - Yang, Walter
AU  - Yang W
AD  - BioCentury.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*economics/*statistics & numerical data
MH  - Industry/economics/statistics & numerical data
MH  - Public Sector
EDAT- 2015/11/07 06:00
MHDA- 2016/04/09 06:00
CRDT- 2015/11/07 06:00
PHST- 2015/11/07 06:00 [entrez]
PHST- 2015/11/07 06:00 [pubmed]
PHST- 2016/04/09 06:00 [medline]
AID - nbt.3407 [pii]
AID - 10.1038/nbt.3407 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Nov;33(11):1127. doi: 10.1038/nbt.3407.

PMID- 26544135
OWN - NLM
STAT- MEDLINE
DCOM- 20160408
LR  - 20151107
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 11
DP  - 2015 Nov
TI  - Drug pipeline: 3Q15.
PG  - 1126
LID - 10.1038/nbt.3405 [doi]
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Drugs, Investigational)
SB  - IM
MH  - *Drug Approval/economics/statistics & numerical data
MH  - Drug Industry/*economics
MH  - Drugs, Investigational/*economics
MH  - United States
MH  - United States Food and Drug Administration
EDAT- 2015/11/07 06:00
MHDA- 2016/04/09 06:00
CRDT- 2015/11/07 06:00
PHST- 2015/11/07 06:00 [entrez]
PHST- 2015/11/07 06:00 [pubmed]
PHST- 2016/04/09 06:00 [medline]
AID - nbt.3405 [pii]
AID - 10.1038/nbt.3405 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Nov;33(11):1126. doi: 10.1038/nbt.3405.

PMID- 26544133
OWN - NLM
STAT- MEDLINE
DCOM- 20160408
LR  - 20151107
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 11
DP  - 2015 Nov
TI  - Sexed-up beer.
PG  - 1125
LID - 10.1038/nbt1115-1125 [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Beer/*microbiology
MH  - *Fermentation
MH  - *Food Microbiology
MH  - Humans
MH  - *Saccharomyces
EDAT- 2015/11/07 06:00
MHDA- 2016/04/09 06:00
CRDT- 2015/11/07 06:00
PHST- 2015/11/07 06:00 [entrez]
PHST- 2015/11/07 06:00 [pubmed]
PHST- 2016/04/09 06:00 [medline]
AID - nbt1115-1125 [pii]
AID - 10.1038/nbt1115-1125 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Nov;33(11):1125. doi: 10.1038/nbt1115-1125.

PMID- 26544131
OWN - NLM
STAT- MEDLINE
DCOM- 20160408
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 11
DP  - 2015 Nov
TI  - Industrial biotechs turn greenhouse gas into feedstock opportunity.
PG  - 1123-5
LID - 10.1038/nbt1115-1123 [doi]
FAU - Peplow, Mark
AU  - Peplow M
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Biofuels)
RN  - 142M471B3J (Carbon Dioxide)
SB  - IM
MH  - *Biofuels
MH  - Bioreactors
MH  - *Biotechnology
MH  - *Carbon Dioxide
MH  - Cyanobacteria
MH  - *Industry
EDAT- 2015/11/07 06:00
MHDA- 2016/04/09 06:00
CRDT- 2015/11/07 06:00
PHST- 2015/11/07 06:00 [entrez]
PHST- 2015/11/07 06:00 [pubmed]
PHST- 2016/04/09 06:00 [medline]
AID - nbt1115-1123 [pii]
AID - 10.1038/nbt1115-1123 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Nov;33(11):1123-5. doi: 10.1038/nbt1115-1123.

PMID- 26544130
OWN - NLM
STAT- MEDLINE
DCOM- 20160408
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 11
DP  - 2015 Nov
TI  - Seek 1 million US citizens.
PG  - 1122
LID - 10.1038/nbt1115-1122b [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biomedical Research/*economics/*organization & administration
MH  - Humans
MH  - National Institutes of Health (U.S.)
MH  - *Precision Medicine
MH  - *Research Design
MH  - *Research Subjects
MH  - United States
EDAT- 2015/11/07 06:00
MHDA- 2016/04/09 06:00
CRDT- 2015/11/07 06:00
PHST- 2015/11/07 06:00 [entrez]
PHST- 2015/11/07 06:00 [pubmed]
PHST- 2016/04/09 06:00 [medline]
AID - nbt1115-1122b [pii]
AID - 10.1038/nbt1115-1122b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Nov;33(11):1122. doi: 10.1038/nbt1115-1122b.

PMID- 26544129
OWN - NLM
STAT- MEDLINE
DCOM- 20160408
LR  - 20151107
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 11
DP  - 2015 Nov
TI  - First moss-made drug.
PG  - 1122
LID - 10.1038/nbt1115-1122a [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Pharmaceutical Preparations)
RN  - 0 (Recombinant Proteins)
RN  - EC 3.2.1.22 (alpha-Galactosidase)
SB  - IM
MH  - Biotechnology/*methods
MH  - *Bryophyta/genetics/metabolism
MH  - Humans
MH  - *Pharmaceutical Preparations
MH  - *Recombinant Proteins
MH  - alpha-Galactosidase
EDAT- 2015/11/07 06:00
MHDA- 2016/04/09 06:00
CRDT- 2015/11/07 06:00
PHST- 2015/11/07 06:00 [entrez]
PHST- 2015/11/07 06:00 [pubmed]
PHST- 2016/04/09 06:00 [medline]
AID - nbt1115-1122a [pii]
AID - 10.1038/nbt1115-1122a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Nov;33(11):1122. doi: 10.1038/nbt1115-1122a.

PMID- 26544128
OWN - NLM
STAT- MEDLINE
DCOM- 20160408
LR  - 20151107
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 11
DP  - 2015 Nov
TI  - Hatteras rounds up $90 million to lead biotech rebound in North Carolina.
PG  - 1121-2
LID - 10.1038/nbt1115-1121 [doi]
FAU - Erickson, Deborah
AU  - Erickson D
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*economics/*organization & administration
MH  - Drug Industry/*economics/*organization & administration
MH  - Humans
MH  - North Carolina
MH  - Salaries and Fringe Benefits
EDAT- 2015/11/07 06:00
MHDA- 2016/04/09 06:00
CRDT- 2015/11/07 06:00
PHST- 2015/11/07 06:00 [entrez]
PHST- 2015/11/07 06:00 [pubmed]
PHST- 2016/04/09 06:00 [medline]
AID - nbt1115-1121 [pii]
AID - 10.1038/nbt1115-1121 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Nov;33(11):1121-2. doi: 10.1038/nbt1115-1121.

PMID- 26544127
OWN - NLM
STAT- MEDLINE
DCOM- 20160408
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 11
DP  - 2015 Nov
TI  - AbbVie buys last available priority voucher for $350 million.
PG  - 1120
LID - 10.1038/nbt1115-1120 [doi]
FAU - Morrison, Chris
AU  - Morrison C
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*economics/*organization & administration
MH  - Drug Industry/*economics/*organization & administration
MH  - Humans
EDAT- 2015/11/07 06:00
MHDA- 2016/04/09 06:00
CRDT- 2015/11/07 06:00
PHST- 2015/11/07 06:00 [entrez]
PHST- 2015/11/07 06:00 [pubmed]
PHST- 2016/04/09 06:00 [medline]
AID - nbt1115-1120 [pii]
AID - 10.1038/nbt1115-1120 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Nov;33(11):1120. doi: 10.1038/nbt1115-1120.

PMID- 26544126
OWN - NLM
STAT- MEDLINE
DCOM- 20160408
LR  - 20151107
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 11
DP  - 2015 Nov
TI  - MD Anderson catches immune-oncology wave.
PG  - 1119
LID - 10.1038/nbt1115-1119 [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antineoplastic Agents)
SB  - IM
MH  - *Antineoplastic Agents
MH  - Biotechnology/*economics
MH  - Drug Industry/*economics
MH  - Germany
MH  - Humans
MH  - *Immunotherapy
MH  - Neoplasms
MH  - United States
EDAT- 2015/11/07 06:00
MHDA- 2016/04/09 06:00
CRDT- 2015/11/07 06:00
PHST- 2015/11/07 06:00 [entrez]
PHST- 2015/11/07 06:00 [pubmed]
PHST- 2016/04/09 06:00 [medline]
AID - nbt1115-1119 [pii]
AID - 10.1038/nbt1115-1119 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Nov;33(11):1119. doi: 10.1038/nbt1115-1119.

PMID- 26544125
OWN - NLM
STAT- MEDLINE
DCOM- 20160408
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 11
DP  - 2015 Nov
TI  - UK funding agencies weigh in on human germline editing.
PG  - 1118-9
LID - 10.1038/nbt1115-1118b [doi]
FAU - Senior, Melanie
AU  - Senior M
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *CRISPR-Cas Systems
MH  - *Embryo Research/economics/legislation & jurisprudence
MH  - *Embryonic Germ Cells
MH  - *Genetic Techniques
MH  - *Genome, Human
MH  - Humans
MH  - United Kingdom
EDAT- 2015/11/07 06:00
MHDA- 2016/04/09 06:00
CRDT- 2015/11/07 06:00
PHST- 2015/11/07 06:00 [entrez]
PHST- 2015/11/07 06:00 [pubmed]
PHST- 2016/04/09 06:00 [medline]
AID - nbt1115-1118b [pii]
AID - 10.1038/nbt1115-1118b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Nov;33(11):1118-9. doi: 10.1038/nbt1115-1118b.

PMID- 26544124
OWN - NLM
STAT- MEDLINE
DCOM- 20160408
LR  - 20151107
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 11
DP  - 2015 Nov
TI  - Amgen bulks out cardio package.
PG  - 1118
LID - 10.1038/nbt1115-1118a [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Anticholesteremic Agents)
RN  - 0 (Cholesterol Ester Transfer Proteins)
RN  - 0 (Quinolines)
RN  - 0 (TA-8995)
SB  - IM
MH  - *Anticholesteremic Agents
MH  - Atherosclerosis/*drug therapy
MH  - Cholesterol Ester Transfer Proteins/*antagonists & inhibitors
MH  - Drug Industry/*economics
MH  - Humans
MH  - Netherlands
MH  - Quinolines
MH  - United States
EDAT- 2015/11/07 06:00
MHDA- 2016/04/09 06:00
CRDT- 2015/11/07 06:00
PHST- 2015/11/07 06:00 [entrez]
PHST- 2015/11/07 06:00 [pubmed]
PHST- 2016/04/09 06:00 [medline]
AID - nbt1115-1118a [pii]
AID - 10.1038/nbt1115-1118a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Nov;33(11):1118. doi: 10.1038/nbt1115-1118a.

PMID- 26544123
OWN - NLM
STAT- MEDLINE
DCOM- 20160408
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 11
DP  - 2015 Nov
TI  - FDA raps liquid biopsy firm.
PG  - 1117
LID - 10.1038/nbt1115-1117 [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/legislation & jurisprudence/organization & administration
MH  - *Genetic Techniques
MH  - Genomics/*legislation & jurisprudence
MH  - Humans
MH  - Medical Oncology
MH  - Patient Access to Records/*legislation & jurisprudence
MH  - *Precision Medicine
MH  - United States
MH  - United States Food and Drug Administration
EDAT- 2015/11/07 06:00
MHDA- 2016/04/09 06:00
CRDT- 2015/11/07 06:00
PHST- 2015/11/07 06:00 [entrez]
PHST- 2015/11/07 06:00 [pubmed]
PHST- 2016/04/09 06:00 [medline]
AID - nbt1115-1117 [pii]
AID - 10.1038/nbt1115-1117 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Nov;33(11):1117. doi: 10.1038/nbt1115-1117.

PMID- 26544122
OWN - NLM
STAT- MEDLINE
DCOM- 20160408
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 11
DP  - 2015 Nov
TI  - Drug makers target ubiquitin proteasome pathway anew.
PG  - 1115-7
LID - 10.1038/nbt1115-1115 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Ubiquitin)
RN  - EC 2.3.2.23 (Ubiquitin-Protein Ligase Complexes)
RN  - EC 3.4.25.1 (Proteasome Endopeptidase Complex)
SB  - IM
EIN - Nat Biotechnol. 2016 Feb;34(2):125. PMID: 26849507
MH  - *Drug Discovery
MH  - *Drug Industry
MH  - Humans
MH  - Parkinson Disease/drug therapy
MH  - *Proteasome Endopeptidase Complex
MH  - *Ubiquitin
MH  - *Ubiquitin-Protein Ligase Complexes
EDAT- 2015/11/07 06:00
MHDA- 2016/04/09 06:00
CRDT- 2015/11/07 06:00
PHST- 2015/11/07 06:00 [entrez]
PHST- 2015/11/07 06:00 [pubmed]
PHST- 2016/04/09 06:00 [medline]
AID - nbt1115-1115 [pii]
AID - 10.1038/nbt1115-1115 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Nov;33(11):1115-7. doi: 10.1038/nbt1115-1115.

PMID- 26544121
OWN - NLM
STAT- MEDLINE
DCOM- 20160408
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 11
DP  - 2015 Nov
TI  - An unusual business.
PG  - 1113
LID - 10.1038/nbt.3409 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Drug Industry/*economics
MH  - Drug Prescriptions/*economics
MH  - Humans
MH  - United States
EDAT- 2015/11/07 06:00
MHDA- 2016/04/09 06:00
CRDT- 2015/11/07 06:00
PHST- 2015/11/07 06:00 [entrez]
PHST- 2015/11/07 06:00 [pubmed]
PHST- 2016/04/09 06:00 [medline]
AID - nbt.3409 [pii]
AID - 10.1038/nbt.3409 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Nov;33(11):1113. doi: 10.1038/nbt.3409.

PMID- 26501954
OWN - NLM
STAT- MEDLINE
DCOM- 20160408
LR  - 20180309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 11
DP  - 2015 Nov
TI  - In vivo characterization of the physicochemical properties of polymer-linked TLR 
      agonists that enhance vaccine immunogenicity.
PG  - 1201-10
LID - 10.1038/nbt.3371 [doi]
AB  - The efficacy of vaccine adjuvants such as Toll-like receptor agonists (TLRa) can 
      be improved through formulation and delivery approaches. Here, we attached small 
      molecule TLR-7/8a to polymer scaffolds (polymer-TLR-7/8a) and evaluated how
      different physicochemical properties of the TLR-7/8a and polymer carrier
      influenced the location, magnitude and duration of innate immune activation in
      vivo. Particle formation by polymer-TLR-7/8a was the most important factor for
      restricting adjuvant distribution and prolonging activity in draining lymph
      nodes. The improved pharmacokinetic profile by particulate polymer-TLR-7/8a was
      also associated with reduced morbidity and enhanced vaccine immunogenicity for
      inducing antibodies and T cell immunity. We extended these findings to the
      development of a modular approach in which protein antigens are site-specifically
      linked to temperature-responsive polymer-TLR-7/8a adjuvants that self-assemble
      into immunogenic particles at physiologic temperatures in vivo. Our findings
      provide a chemical and structural basis for optimizing adjuvant design to elicit 
      broad-based antibody and T cell responses with protein antigens.
FAU - Lynn, Geoffrey M
AU  - Lynn GM
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases
      (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
AD  - Department of Oncology, University of Oxford, Oxford, UK.
FAU - Laga, Richard
AU  - Laga R
AD  - Department of Oncology, University of Oxford, Oxford, UK.
AD  - Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic,
      Prague, Czech Republic.
FAU - Darrah, Patricia A
AU  - Darrah PA
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases
      (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
FAU - Ishizuka, Andrew S
AU  - Ishizuka AS
AUID- ORCID: http://orcid.org/0000-0002-3024-7536
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases
      (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
FAU - Balaci, Alexandra J
AU  - Balaci AJ
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases
      (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
FAU - Dulcey, Andres E
AU  - Dulcey AE
AD  - Imaging Probe Development Center, National Heart, Lung, and Blood Institute, NIH,
      Rockville, Maryland, USA.
FAU - Pechar, Michal
AU  - Pechar M
AD  - Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic,
      Prague, Czech Republic.
FAU - Pola, Robert
AU  - Pola R
AD  - Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic,
      Prague, Czech Republic.
FAU - Gerner, Michael Y
AU  - Gerner MY
AD  - Lymphocyte Biology Section, Laboratory of Systems Biology, NIAID, NIH, Bethesda, 
      Maryland, USA.
FAU - Yamamoto, Ayako
AU  - Yamamoto A
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases
      (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
FAU - Buechler, Connor R
AU  - Buechler CR
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases
      (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
FAU - Quinn, Kylie M
AU  - Quinn KM
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases
      (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
FAU - Smelkinson, Margery G
AU  - Smelkinson MG
AD  - Biological Imaging Section, Research Technologies Branch, NIAID, NIH, Bethesda,
      Maryland, USA.
FAU - Vanek, Ondrej
AU  - Vanek O
AUID- ORCID: http://orcid.org/0000-0003-1190-8535
AD  - Department of Biochemistry, Faculty of Science, Charles University in Prague,
      Prague, Czech Republic.
FAU - Cawood, Ryan
AU  - Cawood R
AD  - Department of Oncology, University of Oxford, Oxford, UK.
FAU - Hills, Thomas
AU  - Hills T
AD  - Department of Oncology, University of Oxford, Oxford, UK.
FAU - Vasalatiy, Olga
AU  - Vasalatiy O
AD  - Imaging Probe Development Center, National Heart, Lung, and Blood Institute, NIH,
      Rockville, Maryland, USA.
FAU - Kastenmuller, Kathrin
AU  - Kastenmuller K
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases
      (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
FAU - Francica, Joseph R
AU  - Francica JR
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases
      (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
FAU - Stutts, Lalisa
AU  - Stutts L
AD  - Department of Chemistry, University of California, Irvine, Irvine, California,
      USA.
FAU - Tom, Janine K
AU  - Tom JK
AD  - Department of Chemistry, University of California, Irvine, Irvine, California,
      USA.
FAU - Ryu, Keun Ah
AU  - Ryu KA
AD  - Department of Chemistry, University of California, Irvine, Irvine, California,
      USA.
FAU - Esser-Kahn, Aaron P
AU  - Esser-Kahn AP
AD  - Department of Chemistry, University of California, Irvine, Irvine, California,
      USA.
FAU - Etrych, Tomas
AU  - Etrych T
AD  - Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic,
      Prague, Czech Republic.
FAU - Fisher, Kerry D
AU  - Fisher KD
AD  - Department of Oncology, University of Oxford, Oxford, UK.
FAU - Seymour, Leonard W
AU  - Seymour LW
AD  - Department of Oncology, University of Oxford, Oxford, UK.
FAU - Seder, Robert A
AU  - Seder RA
AD  - Vaccine Research Center, National Institute of Allergy and Infectious Diseases
      (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
LA  - eng
GR  - Z99 AI999999/Intramural NIH HHS/United States
GR  - C552/A17720/Cancer Research UK/United Kingdom
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20151026
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Adjuvants, Immunologic)
RN  - 0 (Drug Carriers)
RN  - 0 (Toll-Like Receptors)
RN  - 0 (Vaccines)
SB  - IM
CIN - Nat Biotechnol. 2015 Nov;33(11):1146-8. PMID: 26544144
MH  - Adjuvants, Immunologic/*chemistry
MH  - Animals
MH  - Drug Carriers/chemistry
MH  - Female
MH  - Male
MH  - Mice
MH  - Mice, Inbred C57BL
MH  - T-Lymphocytes/immunology
MH  - Toll-Like Receptors/*agonists
MH  - Vaccines/*immunology
PMC - PMC5842712
MID - NIHMS723239
EDAT- 2015/10/27 06:00
MHDA- 2016/04/09 06:00
CRDT- 2015/10/27 06:00
PHST- 2015/01/22 00:00 [received]
PHST- 2015/09/14 00:00 [accepted]
PHST- 2015/10/27 06:00 [entrez]
PHST- 2015/10/27 06:00 [pubmed]
PHST- 2016/04/09 06:00 [medline]
AID - nbt.3371 [pii]
AID - 10.1038/nbt.3371 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Nov;33(11):1201-10. doi: 10.1038/nbt.3371. Epub 2015 Oct 26.

PMID- 26501952
OWN - NLM
STAT- MEDLINE
DCOM- 20160408
LR  - 20161019
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 11
DP  - 2015 Nov
TI  - A qPCR ScoreCard quantifies the differentiation potential of human pluripotent
      stem cells.
PG  - 1182-92
LID - 10.1038/nbt.3387 [doi]
AB  - Research on human pluripotent stem cells has been hampered by the lack of a
      standardized, quantitative, scalable assay of pluripotency. We previously
      described an assay called ScoreCard that used gene expression signatures to
      quantify differentiation efficiency. Here we report an improved version of the
      assay based on qPCR that enables faster, more quantitative assessment of
      functional pluripotency. We provide an in-depth characterization of the revised
      signature panel (commercially available as the TaqMan hPSC Scorecard Assay)
      through embryoid body and directed differentiation experiments as well as a
      detailed comparison to the teratoma assay. We further show that the improved
      ScoreCard enables a wider range of applications, such as screening of small
      molecules, genetic perturbations and assessment of culture conditions. Our
      approach can be extended beyond stem cell applications to characterize and assess
      the utility of other cell types and lineages.
FAU - Tsankov, Alexander M
AU  - Tsankov AM
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, 
      Massachusetts, USA.
FAU - Akopian, Veronika
AU  - Akopian V
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, 
      Massachusetts, USA.
FAU - Pop, Ramona
AU  - Pop R
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, 
      Massachusetts, USA.
FAU - Chetty, Sundari
AU  - Chetty S
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, 
      Massachusetts, USA.
FAU - Gifford, Casey A
AU  - Gifford CA
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, 
      Massachusetts, USA.
FAU - Daheron, Laurence
AU  - Daheron L
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
FAU - Tsankova, Nadejda M
AU  - Tsankova NM
AD  - Department of Pathology and Cell Biology, Columbia University Medical Center, New
      York, New York, USA.
AD  - Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New
      York, USA.
AD  - Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York,
      New York, USA.
FAU - Meissner, Alexander
AU  - Meissner A
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, 
      Massachusetts, USA.
LA  - eng
SI  - GEO/GSE73211
GR  - F32 DK095537/DK/NIDDK NIH HHS/United States
GR  - 5F32DK095537/DK/NIDDK NIH HHS/United States
GR  - P01 GM099117/GM/NIGMS NIH HHS/United States
GR  - P01GM099117/GM/NIGMS NIH HHS/United States
GR  - P50 HG006193/HG/NHGRI NIH HHS/United States
GR  - 1P50HG006193/HG/NHGRI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20151026
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - Cell Differentiation/*genetics
MH  - Computational Biology/*methods
MH  - Embryoid Bodies/cytology/metabolism/*physiology
MH  - Humans
MH  - Mice
MH  - Neoplasms, Experimental/pathology
MH  - Pluripotent Stem Cells/cytology/metabolism/*physiology
MH  - Polymerase Chain Reaction/*methods
MH  - Teratoma/pathology
PMC - PMC4636964
MID - NIHMS725821
EDAT- 2015/10/27 06:00
MHDA- 2016/04/09 06:00
CRDT- 2015/10/27 06:00
PHST- 2015/09/18 00:00 [received]
PHST- 2015/09/24 00:00 [accepted]
PHST- 2015/10/27 06:00 [entrez]
PHST- 2015/10/27 06:00 [pubmed]
PHST- 2016/04/09 06:00 [medline]
AID - nbt.3387 [pii]
AID - 10.1038/nbt.3387 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Nov;33(11):1182-92. doi: 10.1038/nbt.3387. Epub 2015 Oct 26.

PMID- 26501951
OWN - NLM
STAT- MEDLINE
DCOM- 20160408
LR  - 20161019
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 11
DP  - 2015 Nov
TI  - A comparison of genetically matched cell lines reveals the equivalence of human
      iPSCs and ESCs.
PG  - 1173-81
LID - 10.1038/nbt.3388 [doi]
AB  - The equivalence of human induced pluripotent stem cells (hiPSCs) and human
      embryonic stem cells (hESCs) remains controversial. Here we use genetically
      matched hESC and hiPSC lines to assess the contribution of cellular origin (hESC 
      vs. hiPSC), the Sendai virus (SeV) reprogramming method and genetic background to
      transcriptional and DNA methylation patterns while controlling for cell line
      clonality and sex. We find that transcriptional and epigenetic variation
      originating from genetic background dominates over variation due to cellular
      origin or SeV infection. Moreover, the 49 differentially expressed genes we
      detect between genetically matched hESCs and hiPSCs neither predict functional
      outcome nor distinguish an independently derived, larger set of unmatched hESC
      and hiPSC lines. We conclude that hESCs and hiPSCs are molecularly and
      functionally equivalent and cannot be distinguished by a consistent gene
      expression signature. Our data further imply that genetic background variation is
      a major confounding factor for transcriptional and epigenetic comparisons of
      pluripotent cell lines, explaining some of the previously observed differences
      between genetically unmatched hESCs and hiPSCs.
FAU - Choi, Jiho
AU  - Choi J
AD  - Department of Molecular Biology, Cancer Center and Center for Regenerative
      Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
AD  - Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.
FAU - Lee, Soohyun
AU  - Lee S
AD  - Department of Biomedical Informatics, Harvard Medical School, Boston,
      Massachusetts, USA.
FAU - Mallard, William
AU  - Mallard W
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, 
      Massachusetts, USA.
FAU - Clement, Kendell
AU  - Clement K
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, 
      Massachusetts, USA.
FAU - Tagliazucchi, Guidantonio Malagoli
AU  - Tagliazucchi GM
AD  - Department of Biomedical Informatics, Harvard Medical School, Boston,
      Massachusetts, USA.
AD  - Center for Genome Research, Department of Life Sciences, University of Modena and
      Reggio Emilia, Modena, Italy.
FAU - Lim, Hotae
AU  - Lim H
AD  - Institute for Cell Engineering, Department of Neurology, The Solomon H. Snyder
      Department of Neuroscience, Johns Hopkins University School of Medicine,
      Baltimore, Maryland, USA.
FAU - Choi, In Young
AU  - Choi IY
AD  - Institute for Cell Engineering, Department of Neurology, The Solomon H. Snyder
      Department of Neuroscience, Johns Hopkins University School of Medicine,
      Baltimore, Maryland, USA.
FAU - Ferrari, Francesco
AU  - Ferrari F
AD  - Department of Biomedical Informatics, Harvard Medical School, Boston,
      Massachusetts, USA.
FAU - Tsankov, Alexander M
AU  - Tsankov AM
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, 
      Massachusetts, USA.
FAU - Pop, Ramona
AU  - Pop R
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, 
      Massachusetts, USA.
FAU - Lee, Gabsang
AU  - Lee G
AUID- ORCID: http://orcid.org/0000-0002-5052-5927
AD  - Institute for Cell Engineering, Department of Neurology, The Solomon H. Snyder
      Department of Neuroscience, Johns Hopkins University School of Medicine,
      Baltimore, Maryland, USA.
FAU - Rinn, John L
AU  - Rinn JL
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, 
      Massachusetts, USA.
AD  - Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
FAU - Meissner, Alexander
AU  - Meissner A
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, 
      Massachusetts, USA.
FAU - Park, Peter J
AU  - Park PJ
AUID- ORCID: http://orcid.org/0000-0001-9378-960X
AD  - Department of Biomedical Informatics, Harvard Medical School, Boston,
      Massachusetts, USA.
FAU - Hochedlinger, Konrad
AU  - Hochedlinger K
AD  - Department of Molecular Biology, Cancer Center and Center for Regenerative
      Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
AD  - Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.
LA  - eng
GR  - P01 GM099117/GM/NIGMS NIH HHS/United States
GR  - P01GM099117/GM/NIGMS NIH HHS/United States
GR  - Howard Hughes Medical Institute/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20151026
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CIN - Nat Biotechnol. 2015 Nov;33(11):1145-6. PMID: 26544143
MH  - Cluster Analysis
MH  - Computational Biology
MH  - Embryonic Stem Cells/*metabolism/physiology
MH  - Gene Expression Profiling
MH  - Genes/*genetics
MH  - Humans
MH  - Induced Pluripotent Stem Cells/*metabolism/physiology
MH  - Male
PMC - PMC4847940
MID - NIHMS726251
EDAT- 2015/10/27 06:00
MHDA- 2016/04/09 06:00
CRDT- 2015/10/27 06:00
PHST- 2015/07/14 00:00 [received]
PHST- 2015/09/24 00:00 [accepted]
PHST- 2015/10/27 06:00 [entrez]
PHST- 2015/10/27 06:00 [pubmed]
PHST- 2016/04/09 06:00 [medline]
AID - nbt.3388 [pii]
AID - 10.1038/nbt.3388 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Nov;33(11):1173-81. doi: 10.1038/nbt.3388. Epub 2015 Oct 26.

PMID- 26479191
OWN - NLM
STAT- MEDLINE
DCOM- 20160408
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 11
DP  - 2015 Nov
TI  - DNA-free genome editing in plants with preassembled CRISPR-Cas9
      ribonucleoproteins.
PG  - 1162-4
LID - 10.1038/nbt.3389 [doi]
AB  - Editing plant genomes without introducing foreign DNA into cells may alleviate
      regulatory concerns related to genetically modified plants. We transfected
      preassembled complexes of purified Cas9 protein and guide RNA into plant
      protoplasts of Arabidopsis thaliana, tobacco, lettuce and rice and achieved
      targeted mutagenesis in regenerated plants at frequencies of up to 46%. The
      targeted sites contained germline-transmissible small insertions or deletions
      that are indistinguishable from naturally occurring genetic variation.
FAU - Woo, Je Wook
AU  - Woo JW
AD  - Convergence Research Center for Functional Plant Products, Advanced Institutes of
      Convergence Technology, Yeongtong-gu, Suwon-si, Gyeonggi-do, Korea.
FAU - Kim, Jungeun
AU  - Kim J
AD  - Center for Genome Engineering, Institute for Basic Science, Seoul, South Korea.
AD  - Department of Chemistry, Seoul National University, Seoul, South Korea.
FAU - Kwon, Soon Il
AU  - Kwon SI
AD  - Convergence Research Center for Functional Plant Products, Advanced Institutes of
      Convergence Technology, Yeongtong-gu, Suwon-si, Gyeonggi-do, Korea.
FAU - Corvalan, Claudia
AU  - Corvalan C
AD  - School of Biological Sciences, College of Natural Sciences, Seoul National
      University, Seoul, South Korea.
FAU - Cho, Seung Woo
AU  - Cho SW
AD  - Department of Chemistry, Seoul National University, Seoul, South Korea.
FAU - Kim, Hyeran
AU  - Kim H
AD  - Center for Genome Engineering, Institute for Basic Science, Seoul, South Korea.
FAU - Kim, Sang-Gyu
AU  - Kim SG
AD  - Center for Genome Engineering, Institute for Basic Science, Seoul, South Korea.
FAU - Kim, Sang-Tae
AU  - Kim ST
AD  - Center for Genome Engineering, Institute for Basic Science, Seoul, South Korea.
FAU - Choe, Sunghwa
AU  - Choe S
AD  - Convergence Research Center for Functional Plant Products, Advanced Institutes of
      Convergence Technology, Yeongtong-gu, Suwon-si, Gyeonggi-do, Korea.
AD  - School of Biological Sciences, College of Natural Sciences, Seoul National
      University, Seoul, South Korea.
AD  - Plant Genomics and Breeding Institute, Seoul National University, Seoul, South
      Korea.
FAU - Kim, Jin-Soo
AU  - Kim JS
AD  - Center for Genome Engineering, Institute for Basic Science, Seoul, South Korea.
AD  - Department of Chemistry, Seoul National University, Seoul, South Korea.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20151019
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Plant Proteins)
RN  - 0 (Ribonucleoproteins)
SB  - IM
MH  - Arabidopsis/genetics/physiology
MH  - Base Sequence
MH  - CRISPR-Cas Systems/*genetics
MH  - Gene Knockout Techniques
MH  - Genetic Engineering/*methods
MH  - Genome, Plant/*genetics
MH  - Molecular Sequence Data
MH  - Oryza/genetics/physiology
MH  - Plant Proteins/genetics/metabolism
MH  - Plants, Genetically Modified/*genetics/physiology
MH  - Protoplasts
MH  - Ribonucleoproteins/*genetics/metabolism
MH  - Tobacco/genetics/physiology
EDAT- 2015/10/20 06:00
MHDA- 2016/04/09 06:00
CRDT- 2015/10/20 06:00
PHST- 2015/05/19 00:00 [received]
PHST- 2015/09/23 00:00 [accepted]
PHST- 2015/10/20 06:00 [entrez]
PHST- 2015/10/20 06:00 [pubmed]
PHST- 2016/04/09 06:00 [medline]
AID - nbt.3389 [pii]
AID - 10.1038/nbt.3389 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Nov;33(11):1162-4. doi: 10.1038/nbt.3389. Epub 2015 Oct 19.

PMID- 26458176
OWN - NLM
STAT- MEDLINE
DCOM- 20160408
LR  - 20161019
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 11
DP  - 2015 Nov
TI  - Nephron organoids derived from human pluripotent stem cells model kidney
      development and injury.
PG  - 1193-200
AB  - Kidney cells and tissues derived from human pluripotent stem cells (hPSCs) may
      enable organ regeneration, disease modeling and drug screening. We report an
      efficient, chemically defined protocol for differentiating hPSCs into multipotent
      nephron progenitor cells (NPCs) that can form nephron-like structures. By
      recapitulating metanephric kidney development in vitro, we generate SIX2+ SALL1+ 
      WT1+ PAX2+ NPCs with 90% efficiency within 9 days of differentiation. The NPCs
      possess the developmental potential of their in vivo counterparts and form PAX8+ 
      LHX1+ renal vesicles that self-organize into nephron structures. In both two- and
      three-dimensional culture, NPCs form kidney organoids containing epithelial
      nephron-like structures expressing markers of podocytes, proximal tubules, loops 
      of Henle and distal tubules in an organized, continuous arrangement that
      resembles the nephron in vivo. We also show that this organoid culture system can
      be used to study mechanisms of human kidney development and toxicity.
FAU - Morizane, Ryuji
AU  - Morizane R
FAU - Lam, Albert Q
AU  - Lam AQ
FAU - Freedman, Benjamin S
AU  - Freedman BS
FAU - Kishi, Seiji
AU  - Kishi S
FAU - Valerius, M Todd
AU  - Valerius MT
FAU - Bonventre, Joseph V
AU  - Bonventre JV
LA  - eng
GR  - K01 DK102826/DK/NIDDK NIH HHS/United States
GR  - R37 DK039773/DK/NIDDK NIH HHS/United States
GR  - DK102826/DK/NIDDK NIH HHS/United States
GR  - F32 DK092036/DK/NIDDK NIH HHS/United States
GR  - R01 DK072381/DK/NIDDK NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biomedical Research/methods
MH  - Cell Culture Techniques
MH  - Cell Differentiation
MH  - Humans
MH  - *Kidney/cytology/physiology
MH  - *Models, Biological
MH  - *Nephrons/cytology/metabolism
MH  - *Organoids/cytology/metabolism
MH  - *Pluripotent Stem Cells/cytology/metabolism
MH  - Tissue Culture Techniques
PMC - PMC4747858
MID - NIHMS728267
EDAT- 2015/10/13 06:00
MHDA- 2016/04/09 06:00
CRDT- 2015/10/13 06:00
PHST- 2015/06/09 00:00 [received]
PHST- 2015/10/06 00:00 [accepted]
PHST- 2015/10/13 06:00 [entrez]
PHST- 2015/10/13 06:00 [pubmed]
PHST- 2016/04/09 06:00 [medline]
AID - nbt.3392 [pii]
AID - 10.1038/nbt.3392 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Nov;33(11):1193-200. doi: 10.1038/nbt.3392.

PMID- 26458175
OWN - NLM
STAT- MEDLINE
DCOM- 20160408
LR  - 20161019
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 11
DP  - 2015 Nov
TI  - Single-cell ChIP-seq reveals cell subpopulations defined by chromatin state.
PG  - 1165-72
LID - 10.1038/nbt.3383 [doi]
AB  - Chromatin profiling provides a versatile means to investigate functional genomic 
      elements and their regulation. However, current methods yield ensemble profiles
      that are insensitive to cell-to-cell variation. Here we combine microfluidics,
      DNA barcoding and sequencing to collect chromatin data at single-cell resolution.
      We demonstrate the utility of the technology by assaying thousands of individual 
      cells and using the data to deconvolute a mixture of ES cells, fibroblasts and
      hematopoietic progenitors into high-quality chromatin state maps for each cell
      type. The data from each single cell are sparse, comprising on the order of 1,000
      unique reads. However, by assaying thousands of ES cells, we identify a spectrum 
      of subpopulations defined by differences in chromatin signatures of pluripotency 
      and differentiation priming. We corroborate these findings by comparison to
      orthogonal single-cell gene expression data. Our method for single-cell analysis 
      reveals aspects of epigenetic heterogeneity not captured by transcriptional
      analysis alone.
FAU - Rotem, Assaf
AU  - Rotem A
AD  - Department of Physics and School of Engineering and Applied Sciences, Harvard
      University, Cambridge, Massachusetts, USA.
AD  - Epigenomics Program, The Broad Institute of MIT and Harvard, Cambridge,
      Massachusetts, USA.
FAU - Ram, Oren
AU  - Ram O
AD  - Epigenomics Program, The Broad Institute of MIT and Harvard, Cambridge,
      Massachusetts, USA.
AD  - Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.
AD  - Department of Pathology, Massachusetts General Hospital and Harvard Medical
      School, Boston, Massachusetts, USA.
FAU - Shoresh, Noam
AU  - Shoresh N
AD  - Epigenomics Program, The Broad Institute of MIT and Harvard, Cambridge,
      Massachusetts, USA.
FAU - Sperling, Ralph A
AU  - Sperling RA
AD  - Department of Physics and School of Engineering and Applied Sciences, Harvard
      University, Cambridge, Massachusetts, USA.
FAU - Goren, Alon
AU  - Goren A
AD  - Broad Technology Labs, The Broad Institute of MIT and Harvard, Cambridge,
      Massachusetts, USA.
FAU - Weitz, David A
AU  - Weitz DA
AD  - Department of Physics and School of Engineering and Applied Sciences, Harvard
      University, Cambridge, Massachusetts, USA.
FAU - Bernstein, Bradley E
AU  - Bernstein BE
AD  - Epigenomics Program, The Broad Institute of MIT and Harvard, Cambridge,
      Massachusetts, USA.
AD  - Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.
AD  - Department of Pathology, Massachusetts General Hospital and Harvard Medical
      School, Boston, Massachusetts, USA.
LA  - eng
GR  - U54 HG006991/HG/NHGRI NIH HHS/United States
GR  - U01 HL100395/HL/NHLBI NIH HHS/United States
GR  - U54HG006991/HG/NHGRI NIH HHS/United States
GR  - P50 HG006193/HG/NHGRI NIH HHS/United States
GR  - Howard Hughes Medical Institute/United States
GR  - P50HG006193/HG/NHGRI NIH HHS/United States
GR  - U01HL100395/HL/NHLBI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20151012
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Chromatin)
SB  - IM
CIN - Nat Rev Genet. 2015 Dec;16(12):684-5. PMID: 26503794
MH  - Animals
MH  - Chromatin/genetics
MH  - Chromatin Immunoprecipitation/*methods
MH  - Computational Biology
MH  - DNA Barcoding, Taxonomic
MH  - Embryonic Stem Cells/*classification/*cytology
MH  - Humans
MH  - Mice
MH  - Microfluidic Analytical Techniques
MH  - Sequence Analysis, DNA
MH  - Single-Cell Analysis/*methods
PMC - PMC4636926
MID - NIHMS725498
EDAT- 2015/10/13 06:00
MHDA- 2016/04/09 06:00
CRDT- 2015/10/13 06:00
PHST- 2015/05/13 00:00 [received]
PHST- 2015/09/21 00:00 [accepted]
PHST- 2015/10/13 06:00 [entrez]
PHST- 2015/10/13 06:00 [pubmed]
PHST- 2016/04/09 06:00 [medline]
AID - nbt.3383 [pii]
AID - 10.1038/nbt.3383 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Nov;33(11):1165-72. doi: 10.1038/nbt.3383. Epub 2015 Oct 12.

PMID- 26436575
OWN - NLM
STAT- MEDLINE
DCOM- 20160408
LR  - 20161019
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 11
DP  - 2015 Nov
TI  - Orthogonal gene knockout and activation with a catalytically active Cas9
      nuclease.
PG  - 1159-61
AB  - We have developed a CRISPR-based method that uses catalytically active Cas9 and
      distinct single guide (sgRNA) constructs to knock out and activate different
      genes in the same cell. These sgRNAs, with 14- to 15-bp target sequences and MS2 
      binding loops, can activate gene expression using an active Streptococcus
      pyogenes Cas9 nuclease, without inducing double-stranded breaks. We use these
      'dead RNAs' to perform orthogonal gene knockout and transcriptional activation in
      human cells.
FAU - Dahlman, James E
AU  - Dahlman JE
FAU - Abudayyeh, Omar O
AU  - Abudayyeh OO
FAU - Joung, Julia
AU  - Joung J
FAU - Gootenberg, Jonathan S
AU  - Gootenberg JS
FAU - Zhang, Feng
AU  - Zhang F
FAU - Konermann, Silvana
AU  - Konermann S
LA  - eng
GR  - DP1 MH100706/MH/NIMH NIH HHS/United States
GR  - 1DP1-MH100706/DP/NCCDPHP CDC HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Bacterial Proteins)
RN  - 0 (RNA, Guide)
RN  - EC 3.1.- (Cas9 endonuclease Streptococcus pyogenes)
RN  - EC 3.1.- (Endonucleases)
SB  - IM
EIN - Nat Biotechnol. 2016 Apr;34(4):441. PMID: 27054997
MH  - Bacterial Proteins/*genetics
MH  - Endonucleases/*genetics
MH  - Gene Knockout Techniques/*methods
MH  - HEK293 Cells
MH  - Humans
MH  - RNA, Guide/*genetics
PMC - PMC4747789
MID - NIHMS726993
EDAT- 2015/10/06 06:00
MHDA- 2016/04/09 06:00
CRDT- 2015/10/06 06:00
PHST- 2015/08/30 00:00 [received]
PHST- 2015/09/28 00:00 [accepted]
PHST- 2015/10/06 06:00 [entrez]
PHST- 2015/10/06 06:00 [pubmed]
PHST- 2016/04/09 06:00 [medline]
AID - nbt.3390 [pii]
AID - 10.1038/nbt.3390 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Nov;33(11):1159-61. doi: 10.1038/nbt.3390.

PMID- 26372948
OWN - NLM
STAT- MEDLINE
DCOM- 20160408
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 11
DP  - 2015 Nov
TI  - Comprehensive analysis of cancer-associated somatic mutations in class I HLA
      genes.
PG  - 1152-8
AB  - Detection of somatic mutations in human leukocyte antigen (HLA) genes using
      whole-exome sequencing (WES) is hampered by the high polymorphism of the HLA
      loci, which prevents alignment of sequencing reads to the human reference genome.
      We describe a computational pipeline that enables accurate inference of germline 
      alleles of class I HLA-A, B and C genes and subsequent detection of mutations in 
      these genes using the inferred alleles as a reference. Analysis of WES data from 
      7,930 pairs of tumor and healthy tissue from the same patient revealed 298
      nonsilent HLA mutations in tumors from 266 patients. These 298 mutations are
      enriched for likely functional mutations, including putative loss-of-function
      events. Recurrence of mutations suggested that these 'hotspot' sites were
      positively selected. Cancers with recurrent somatic HLA mutations were associated
      with upregulation of signatures of cytolytic activity characteristic of tumor
      infiltration by effector lymphocytes, supporting immune evasion by altered HLA
      function as a contributory mechanism in cancer.
FAU - Shukla, Sachet A
AU  - Shukla SA
FAU - Rooney, Michael S
AU  - Rooney MS
FAU - Rajasagi, Mohini
AU  - Rajasagi M
FAU - Tiao, Grace
AU  - Tiao G
FAU - Dixon, Philip M
AU  - Dixon PM
FAU - Lawrence, Michael S
AU  - Lawrence MS
FAU - Stevens, Jonathan
AU  - Stevens J
FAU - Lane, William J
AU  - Lane WJ
FAU - Dellagatta, Jamie L
AU  - Dellagatta JL
FAU - Steelman, Scott
AU  - Steelman S
FAU - Sougnez, Carrie
AU  - Sougnez C
FAU - Cibulskis, Kristian
AU  - Cibulskis K
FAU - Kiezun, Adam
AU  - Kiezun A
FAU - Hacohen, Nir
AU  - Hacohen N
FAU - Brusic, Vladimir
AU  - Brusic V
FAU - Wu, Catherine J
AU  - Wu CJ
FAU - Getz, Gad
AU  - Getz G
LA  - eng
GR  - 1R01HL103532-01/HL/NHLBI NIH HHS/United States
GR  - R01 HL103532/HL/NHLBI NIH HHS/United States
GR  - U24 CA143845/CA/NCI NIH HHS/United States
GR  - R01 CA155010/CA/NCI NIH HHS/United States
GR  - 1R01CA155010-01A1/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Histocompatibility Antigens Class I)
SB  - IM
MH  - Computational Biology
MH  - DNA Mutational Analysis
MH  - Databases, Genetic
MH  - Histocompatibility Antigens Class I/*genetics
MH  - Humans
MH  - Mutation/*genetics
MH  - Neoplasms/*genetics
MH  - Software
PMC - PMC4747795
MID - NIHMS715480
EDAT- 2015/09/16 06:00
MHDA- 2016/04/09 06:00
CRDT- 2015/09/16 06:00
PHST- 2015/06/02 00:00 [received]
PHST- 2015/08/12 00:00 [accepted]
PHST- 2015/09/16 06:00 [entrez]
PHST- 2015/09/16 06:00 [pubmed]
PHST- 2016/04/09 06:00 [medline]
AID - nbt.3344 [pii]
AID - 10.1038/nbt.3344 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Nov;33(11):1152-8. doi: 10.1038/nbt.3344.

PMID- 26448094
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20151009
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - The right track for you in biotech and biomedical sciences.
PG  - 1110-1
LID - 10.1038/nbt.3376 [doi]
FAU - Iyer, Laxmi Ravi
AU  - Iyer LR
AD  - biotechin.asia, Biotech Media Pte. Ltd., Singapore.
FAU - Sriram, Sandhya
AU  - Sriram S
AD  - biotechin.asia, Biotech Media Pte. Ltd., Singapore.
AD  - Fat Metabolism and Stem Cell Group, Laboratory of Metabolic Medicine, Singapore
      Bioimaging Consortium, A*STAR, Singapore.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biomedical Research/*manpower
MH  - Biotechnology/*manpower
MH  - *Career Mobility
MH  - Science/*manpower
MH  - Singapore
EDAT- 2015/10/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/10/09 06:00
PHST- 2015/10/09 06:00 [entrez]
PHST- 2015/10/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3376 [pii]
AID - 10.1038/nbt.3376 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1110-1. doi: 10.1038/nbt.3376.

PMID- 26448093
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20160107
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - Corrigendum: Assembling large genomes with single-molecule sequencing and
      locality-sensitive hashing.
PG  - 1109
LID - 10.1038/nbt1015-1109c [doi]
FAU - Berlin, Konstantin
AU  - Berlin K
FAU - Koren, Sergey
AU  - Koren S
FAU - Chin, Chen-Shan
AU  - Chin CS
FAU - Drake, James P
AU  - Drake JP
FAU - Landolin, Jane M
AU  - Landolin JM
FAU - Phillippy, Adam M
AU  - Phillippy AM
LA  - eng
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2015 Jun;33(6):623-30. PMID: 26006009
EDAT- 2015/10/09 06:00
MHDA- 2015/10/09 06:01
CRDT- 2015/10/09 06:00
PHST- 2015/10/09 06:00 [entrez]
PHST- 2015/10/09 06:00 [pubmed]
PHST- 2015/10/09 06:01 [medline]
AID - nbt1015-1109c [pii]
AID - 10.1038/nbt1015-1109c [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1109. doi: 10.1038/nbt1015-1109c.

PMID- 26448092
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20160107
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - Erratum: Prediction of human population responses to toxic compounds by a
      collaborative competition.
PG  - 1109
LID - 10.1038/nbt1015-1109a [doi]
FAU - Eduati, Federica
AU  - Eduati F
FAU - Mangravite, Lara M
AU  - Mangravite LM
FAU - Wang, Tao
AU  - Wang T
FAU - Tang, Hao
AU  - Tang H
FAU - Bare, J Christopher
AU  - Bare JC
FAU - Huang, Ruili
AU  - Huang R
FAU - Norman, Thea
AU  - Norman T
FAU - Kellen, Mike
AU  - Kellen M
FAU - Menden, Michael P
AU  - Menden MP
FAU - Yang, Jichen
AU  - Yang J
FAU - Zhan, Xiaowei
AU  - Zhan X
FAU - Zhong, Rui
AU  - Zhong R
FAU - Xiao, Guanghua
AU  - Xiao G
FAU - Xia, Menghang
AU  - Xia M
FAU - Abdo, Nour
AU  - Abdo N
FAU - Kosyk, Oksana
AU  - Kosyk O
CN  - NIEHS-NCATS-UNC DREAM Toxicogenetics Collaboration
FAU - Friend, Stephen
AU  - Friend S
FAU - Dearry, Allen
AU  - Dearry A
FAU - Simeonov, Anton
AU  - Simeonov A
FAU - Tice, Raymond R
AU  - Tice RR
FAU - Rusyn, Ivan
AU  - Rusyn I
FAU - Wright, Fred A
AU  - Wright FA
FAU - Stolovitzky, Gustavo
AU  - Stolovitzky G
FAU - Xie, Yang
AU  - Xie Y
FAU - Saez-Rodriguez, Julio
AU  - Saez-Rodriguez J
LA  - eng
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2015 Sep;33(9):933-40. Friend, Stephen; Dearry, Allen; Simeonov, 
      Anton; Tice, Raymond R; Rusyn, Ivan; Wright, Fred A; Stolovitzky, Gustavo; Xie,
      Yang; and Saez-Rodriguez, Julio [Added]. PMID: 26258538
EDAT- 2015/10/09 06:00
MHDA- 2015/10/09 06:01
CRDT- 2015/10/09 06:00
PHST- 2015/10/09 06:00 [entrez]
PHST- 2015/10/09 06:00 [pubmed]
PHST- 2015/10/09 06:01 [medline]
AID - nbt1015-1109a [pii]
AID - 10.1038/nbt1015-1109a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1109. doi: 10.1038/nbt1015-1109a.

PMID- 26448091
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20160107
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - Erratum: Drug pipeline: 2Q15.
PG  - 1109
LID - 10.1038/nbt1015-1109b [doi]
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
LA  - eng
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2015 Aug;33(8):795. PMID: 26252129
EDAT- 2015/10/09 06:00
MHDA- 2015/10/09 06:01
CRDT- 2015/10/09 06:00
PHST- 2015/10/09 06:00 [entrez]
PHST- 2015/10/09 06:00 [pubmed]
PHST- 2015/10/09 06:01 [medline]
AID - nbt1015-1109b [pii]
AID - 10.1038/nbt1015-1109b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1109. doi: 10.1038/nbt1015-1109b.

PMID- 26448090
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - Systems strategies for developing industrial microbial strains.
PG  - 1061-72
LID - 10.1038/nbt.3365 [doi]
AB  - Industrial strain development requires system-wide engineering and optimization
      of cellular metabolism while considering industrially relevant fermentation and
      recovery processes. It can be conceptualized as several strategies, which may be 
      implemented in an iterative fashion and in different orders. The key challenges
      have been the time-, cost- and labor-intensive processes of strain development
      owing to the difficulties in understanding complex interactions among the
      metabolic, gene regulatory and signaling networks at the cell level, which are
      collectively represented as overall system performance under industrial
      fermentation conditions. These challenges can be overcome by taking systems
      approaches through the use of state-of-the-art tools of systems biology,
      synthetic biology and evolutionary engineering in the context of industrial
      bioprocess. Major systems metabolic engineering achievements in recent years
      include microbial production of amino acids (L-valine, L-threonine, L-lysine and 
      L-arginine), bulk chemicals (1,4-butanediol, 1,4-diaminobutane,
      1,5-diaminopentane, 1,3-propanediol, butanol, isobutanol and succinic acid) and
      drugs (artemisinin).
FAU - Lee, Sang Yup
AU  - Lee SY
AUID- ORCID: http://orcid.org/0000-0003-0599-3091
AD  - Metabolic and Biomolecular Engineering National Research Laboratory, Department
      of Chemical and Biomolecular Engineering (BK21 Plus Program), Center for Systems 
      and Synthetic Biotechnology, Institute for the BioCentury, Korea Advanced
      Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.
AD  - BioInformatics Research Center, KAIST, Daejeon, Republic of Korea.
AD  - BioProcess Engineering Research Center, KAIST, Daejeon, Republic of Korea.
AD  - The Novo Nordisk Foundation Center for Biosustainability, Technical University of
      Denmark, Horsholm, Denmark.
FAU - Kim, Hyun Uk
AU  - Kim HU
AUID- ORCID: http://orcid.org/0000-0001-7224-642X
AD  - Metabolic and Biomolecular Engineering National Research Laboratory, Department
      of Chemical and Biomolecular Engineering (BK21 Plus Program), Center for Systems 
      and Synthetic Biotechnology, Institute for the BioCentury, Korea Advanced
      Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.
AD  - BioInformatics Research Center, KAIST, Daejeon, Republic of Korea.
AD  - The Novo Nordisk Foundation Center for Biosustainability, Technical University of
      Denmark, Horsholm, Denmark.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Review
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Bacterial Proteins)
SB  - IM
MH  - Bacteria/*genetics
MH  - Bacterial Proteins/*genetics
MH  - Computer Simulation
MH  - Genetic Enhancement/*methods
MH  - Metabolic Engineering/*methods
MH  - *Models, Genetic
MH  - Systems Biology/*methods
EDAT- 2015/10/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/10/09 06:00
PHST- 2015/08/04 00:00 [received]
PHST- 2015/08/23 00:00 [accepted]
PHST- 2015/10/09 06:00 [entrez]
PHST- 2015/10/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3365 [pii]
AID - 10.1038/nbt.3365 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1061-72. doi: 10.1038/nbt.3365.

PMID- 26448088
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170603
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - Stabilizing prospects for a universal flu vaccine.
PG  - 1043-4
LID - 10.1038/nbt.3378 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Influenza Vaccines)
SB  - IM
MH  - *Drug Design
MH  - Drug Stability
MH  - Humans
MH  - Influenza Vaccines/*administration & dosage/*immunology
MH  - Influenza, Human/*immunology/*prevention & control
EDAT- 2015/10/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/10/09 06:00
PHST- 2015/10/09 06:00 [entrez]
PHST- 2015/10/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3378 [pii]
AID - 10.1038/nbt.3378 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1043-4. doi: 10.1038/nbt.3378.

PMID- 26448087
OWN - NLM
STAT- MEDLINE
DCOM- 20160330
LR  - 20170603
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - Strain recovery from metagenomes.
PG  - 1041-3
LID - 10.1038/nbt.3375 [doi]
FAU - Brown, C Titus
AU  - Brown CT
AUID- ORCID: http://orcid.org/0000-0001-6001-2677
AD  - School of Veterinary Medicine, University of California at Davis, Davis,
      California, USA.
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2015 Oct;33(10):1053-60. PMID: 26368049
MH  - Bacteria/*genetics
MH  - Epigenesis, Genetic/*genetics
MH  - Genome, Bacterial/*genetics
MH  - Metagenomics/*methods
MH  - Microbiota/*genetics
MH  - Sequence Analysis, DNA/*methods
EDAT- 2015/10/09 06:00
MHDA- 2016/03/31 06:00
CRDT- 2015/10/09 06:00
PHST- 2015/10/09 06:00 [entrez]
PHST- 2015/10/09 06:00 [pubmed]
PHST- 2016/03/31 06:00 [medline]
AID - nbt.3375 [pii]
AID - 10.1038/nbt.3375 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1041-3. doi: 10.1038/nbt.3375.

PMID- 26448086
OWN - NLM
STAT- MEDLINE
DCOM- 20160330
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - A BiTE from cancer's intracellular menu.
PG  - 1040-1
LID - 10.1038/nbt.3370 [doi]
FAU - Salter, Alexander I
AU  - Salter AI
AD  - Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle,
      Washington, USA.
AD  - University of Washington School of Medicine, Seattle, Washington, USA.
FAU - Riddell, Stanley R
AU  - Riddell SR
AD  - Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle,
      Washington, USA.
AD  - University of Washington School of Medicine, Seattle, Washington, USA.
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antibodies, Monoclonal)
RN  - 0 (Repressor Proteins)
SB  - IM
CON - Nat Biotechnol. 2015 Oct;33(10):1079-86. PMID: 26389576
MH  - Animals
MH  - Antibodies, Monoclonal/*therapeutic use
MH  - Humans
MH  - Neoplasms, Experimental/*immunology/*therapy
MH  - Repressor Proteins/*immunology
MH  - T-Lymphocytes/*immunology
EDAT- 2015/10/09 06:00
MHDA- 2016/03/31 06:00
CRDT- 2015/10/09 06:00
PHST- 2015/10/09 06:00 [entrez]
PHST- 2015/10/09 06:00 [pubmed]
PHST- 2016/03/31 06:00 [medline]
AID - nbt.3370 [pii]
AID - 10.1038/nbt.3370 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1040-1. doi: 10.1038/nbt.3370.

PMID- 26448084
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170603
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - Gene patent practice across plant and human genomes.
PG  - 1033-8
LID - 10.1038/nbt.3364 [doi]
FAU - Jefferson, Osmat A
AU  - Jefferson OA
AD  - Queensland University of Technology, Brisbane, Australia, and Cambia, Canberra,
      Australia.
FAU - Kollhofer, Deniz
AU  - Kollhofer D
AD  - Queensland University of Technology, Brisbane, Australia, and Cambia, Canberra,
      Australia.
FAU - Ehrich, Thomas H
AU  - Ehrich TH
AD  - Queensland University of Technology, Brisbane, Australia, and Cambia, Canberra,
      Australia.
FAU - Jefferson, Richard A
AU  - Jefferson RA
AD  - Queensland University of Technology, Brisbane, Australia, and Cambia, Canberra,
      Australia.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Genetic Structures/*genetics
MH  - Genome, Human/*genetics
MH  - Genome, Plant/*genetics
MH  - Genomics/legislation & jurisprudence/*statistics & numerical data
MH  - Humans
MH  - Patents as Topic/*legislation & jurisprudence/*statistics & numerical data
MH  - Species Specificity
EDAT- 2015/10/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/10/09 06:00
PHST- 2015/10/09 06:00 [entrez]
PHST- 2015/10/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3364 [pii]
AID - 10.1038/nbt.3364 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1033-8. doi: 10.1038/nbt.3364.

PMID- 26448083
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - Chinese government reaffirms backing for GM products.
PG  - 1029
LID - 10.1038/nbt.3362 [doi]
FAU - Li, Rongrong
AU  - Li R
AD  - School of Business Administration, Xinjiang University of Finance and Economics, 
      Urumqi, Xinjiang, P.R. China.
FAU - Wang, Qiang
AU  - Wang Q
AD  - Xinjiang Institute of Ecology and Geography, CAS, Urumqi, P.R. China.
AD  - China University of Petroleum (East China), Qingdao, P.R. China.
FAU - McHughen, Alan
AU  - McHughen A
AD  - Department of Botany &Plant Sciences, University of California-Riverside,
      California, USA.
LA  - eng
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Agriculture/*economics
MH  - China
MH  - Financing, Government/*economics
MH  - Food, Genetically Modified/*economics
MH  - Genetic Research/*economics
MH  - Public Policy
EDAT- 2015/10/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/10/09 06:00
PHST- 2015/10/09 06:00 [entrez]
PHST- 2015/10/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3362 [pii]
AID - 10.1038/nbt.3362 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1029. doi: 10.1038/nbt.3362.

PMID- 26448082
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - Increased bioavailable vitamin B6 in field-grown transgenic cassava for dietary
      sufficiency.
PG  - 1029-32
LID - 10.1038/nbt.3318 [doi]
FAU - Li, Kuan-Te
AU  - Li KT
AD  - Department of Biology, ETH Zurich, Zurich, Switzerland.
FAU - Moulin, Michael
AU  - Moulin M
AD  - Department of Botany and Plant Biology, University of Geneva, Geneva,
      Switzerland.
FAU - Mangel, Nathalie
AU  - Mangel N
AD  - Department of Biology, ETH Zurich, Zurich, Switzerland.
FAU - Albersen, Monique
AU  - Albersen M
AD  - Department of Medical Genetics, University Medical Center, Utrecht, the
      Netherlands.
FAU - Verhoeven-Duif, Nanda M
AU  - Verhoeven-Duif NM
AD  - Department of Medical Genetics, University Medical Center, Utrecht, the
      Netherlands.
FAU - Ma, Qiuxiang
AU  - Ma Q
AD  - SIBS-ETH Shanghai Center for Cassava Biotechnology, Institute of Plant Physiology
      and Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of
      Sciences, Shanghai, China.
FAU - Zhang, Peng
AU  - Zhang P
AUID- ORCID: http://orcid.org/0000-0002-4868-1306
AD  - SIBS-ETH Shanghai Center for Cassava Biotechnology, Institute of Plant Physiology
      and Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of
      Sciences, Shanghai, China.
FAU - Fitzpatrick, Teresa B
AU  - Fitzpatrick TB
AD  - Department of Botany and Plant Biology, University of Geneva, Geneva,
      Switzerland.
FAU - Gruissem, Wilhelm
AU  - Gruissem W
AD  - Department of Biology, ETH Zurich, Zurich, Switzerland.
AD  - SIBS-ETH Shanghai Center for Cassava Biotechnology, Institute of Plant Physiology
      and Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of
      Sciences, Shanghai, China.
FAU - Vanderschuren, Herve
AU  - Vanderschuren H
AUID- ORCID: http://orcid.org/0000-0003-2102-9737
AD  - Department of Biology, ETH Zurich, Zurich, Switzerland.
AD  - AgroBioChem Department, Gembloux Agro-Bio Tech, University of Liege, Liege,
      Belgium.
LA  - eng
PT  - Letter
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 8059-24-3 (Vitamin B 6)
SB  - IM
MH  - Biological Availability
MH  - *Dietary Supplements
MH  - *Food, Genetically Modified
MH  - Genetic Enhancement/methods
MH  - Humans
MH  - Manihot/*genetics
MH  - Plants, Genetically Modified/*genetics
MH  - Vitamin B 6/pharmacokinetics/*therapeutic use
MH  - Vitamin B 6 Deficiency/*diet therapy
EDAT- 2015/10/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/10/09 06:00
PHST- 2015/10/09 06:00 [entrez]
PHST- 2015/10/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3318 [pii]
AID - 10.1038/nbt.3318 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1029-32. doi: 10.1038/nbt.3318.

PMID- 26448081
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - Professionalism and ethics in animal research.
PG  - 1027-8
LID - 10.1038/nbt.3363 [doi]
FAU - Biller-Andorno, Nikola
AU  - Biller-Andorno N
AD  - Institute of Biomedical Ethics, University of Zurich, Switzerland.
FAU - Grimm, Herwig
AU  - Grimm H
AD  - Messerli Research Institute.
AD  - Veterinary University Vienna, Austria.
AD  - Medical University Vienna, Austria.
AD  - University Vienna, Vienna, Austria.
FAU - Walker, Rebecca L
AU  - Walker RL
AD  - Veterinary University Vienna, Austria.
AD  - Department of Social Medicine, University of North Carolina at Chapel Hill,
      Chapel Hill, North Carolina, USA.
LA  - eng
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animal Experimentation/*ethics/*legislation & jurisprudence
MH  - Animal Rights/*legislation & jurisprudence
MH  - Animals
MH  - Internationality
MH  - Professionalism/*ethics/*legislation & jurisprudence
EDAT- 2015/10/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/10/09 06:00
PHST- 2015/10/09 06:00 [entrez]
PHST- 2015/10/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3363 [pii]
AID - 10.1038/nbt.3363 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1027-8. doi: 10.1038/nbt.3363.

PMID- 26448080
OWN - NLM
STAT- MEDLINE
DCOM- 20160107
LR  - 20170603
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - Lessons in simplicity that should shape the future of drug delivery.
PG  - 1026-7
LID - 10.1038/nbt.3366 [doi]
FAU - Raemdonck, Koen
AU  - Raemdonck K
AD  - Ghent Research Group on Nanomedicines, Laboratory of General Biochemistry and
      Physical Pharmacy, Faculty of Pharmaceutical Sciences, Ghent University, Ghent,
      Belgium.
FAU - De Smedt, Stefaan C
AU  - De Smedt SC
AD  - Ghent Research Group on Nanomedicines, Laboratory of General Biochemistry and
      Physical Pharmacy, Faculty of Pharmaceutical Sciences, Ghent University, Ghent,
      Belgium.
LA  - eng
PT  - Comment
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2014 Oct;32(10):961. PMID: 25299892
MH  - *Drug Delivery Systems
EDAT- 2015/10/09 06:00
MHDA- 2016/01/08 06:00
CRDT- 2015/10/09 06:00
PHST- 2015/10/09 06:00 [entrez]
PHST- 2015/10/09 06:00 [pubmed]
PHST- 2016/01/08 06:00 [medline]
AID - nbt.3366 [pii]
AID - 10.1038/nbt.3366 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1026-7. doi: 10.1038/nbt.3366.

PMID- 26448079
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20151009
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - Philanthropy's role in translating scientific innovation.
PG  - 1022-5
LID - 10.1038/nbt.3369 [doi]
FAU - Parthasarathy, Hemai
AU  - Parthasarathy H
AD  - Breakout Labs, San Francisco, California, USA.
FAU - Fishburne, Lindy
AU  - Fishburne L
AD  - Breakout Labs, San Francisco, California, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Entrepreneurship/*economics
MH  - Foundations/*economics
MH  - Inventions/*economics
MH  - Models, Economic
MH  - *Models, Organizational
MH  - Science/*economics
MH  - Translational Medical Research/*economics
MH  - United States
EDAT- 2015/10/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/10/09 06:00
PHST- 2015/10/09 06:00 [entrez]
PHST- 2015/10/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3369 [pii]
AID - 10.1038/nbt.3369 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1022-5. doi: 10.1038/nbt.3369.

PMID- 26448078
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170603
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - Gene drive overdrive.
PG  - 1019-21
LID - 10.1038/nbt.3361 [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (CRISPR-Associated Proteins)
SB  - IM
MH  - CRISPR-Associated Proteins/*genetics
MH  - Clustered Regularly Interspaced Short Palindromic Repeats/*genetics
MH  - Genetic Engineering/*methods
MH  - Risk Assessment/*methods
EDAT- 2015/10/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/10/09 06:00
PHST- 2015/10/09 06:00 [entrez]
PHST- 2015/10/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3361 [pii]
AID - 10.1038/nbt.3361 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1019-21. doi: 10.1038/nbt.3361.

PMID- 26448077
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - Kirk, to boldly go into synthetic biology.
PG  - 1017-8
LID - 10.1038/nbt1015-1017 [doi]
FAU - Kirk, Randal J
AU  - Kirk RJ
FAU - Waltz, Emily
AU  - Waltz E
LA  - eng
PT  - Interview
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - Biotechnology/*organization & administration
MH  - *Genetic Research
MH  - Health Facility Merger/*organization & administration
MH  - Organisms, Genetically Modified/*genetics
MH  - Synthetic Biology/*organization & administration
EDAT- 2015/10/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/10/09 06:00
PHST- 2015/10/09 06:00 [entrez]
PHST- 2015/10/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt1015-1017 [pii]
AID - 10.1038/nbt1015-1017 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1017-8. doi: 10.1038/nbt1015-1017.

PMID- 26448076
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20151009
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - Around the world in a month.
PG  - 1016
LID - 10.1038/nbt1015-1016 [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*trends
MH  - Drug Industry/*trends
MH  - *Food, Genetically Modified
MH  - *Genetic Research
MH  - Genomics/*trends
MH  - Internationality
EDAT- 2015/10/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/10/09 06:00
PHST- 2015/10/09 06:00 [entrez]
PHST- 2015/10/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt1015-1016 [pii]
AID - 10.1038/nbt1015-1016 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1016. doi: 10.1038/nbt1015-1016.

PMID- 26448075
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - Landmark green light for Mosquirix malaria vaccine.
PG  - 1015-6
LID - 10.1038/nbt1015-1015 [doi]
FAU - Morrison, Chris
AU  - Morrison C
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Malaria Vaccines)
SB  - IM
MH  - *Clinical Trials as Topic
MH  - *Drug Approval
MH  - *Drug Design
MH  - Europe
MH  - Malaria Vaccines/*therapeutic use
MH  - Malaria, Falciparum/*drug therapy/*prevention & control
MH  - Treatment Outcome
EDAT- 2015/10/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/10/09 06:00
PHST- 2015/10/09 06:00 [entrez]
PHST- 2015/10/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt1015-1015 [pii]
AID - 10.1038/nbt1015-1015 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1015-6. doi: 10.1038/nbt1015-1015.

PMID- 26448074
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20151009
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - Syngenta rebuffs Monsanto, again.
PG  - 1014
LID - 10.1038/nbt1015-1014b [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Agriculture/*organization & administration
MH  - Biotechnology/*organization & administration
MH  - Drug Industry/*organization & administration
MH  - Health Facility Merger/*organization & administration
MH  - *Interinstitutional Relations
MH  - Internationality
EDAT- 2015/10/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/10/09 06:00
PHST- 2015/10/09 06:00 [entrez]
PHST- 2015/10/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt1015-1014b [pii]
AID - 10.1038/nbt1015-1014b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1014. doi: 10.1038/nbt1015-1014b.

PMID- 26448073
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20151009
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - Cat poop coffee goes biotech.
PG  - 1014
LID - 10.1038/nbt1015-1014c [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Coffee)
SB  - IM
MH  - Biomimetic Materials/*chemical synthesis
MH  - Coffea/chemistry/*microbiology
MH  - Coffee/*chemistry/*microbiology
MH  - Food Handling/*methods
MH  - Food Industry/methods
MH  - Food Microbiology/methods
MH  - Seeds/chemistry/*microbiology
EDAT- 2015/10/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/10/09 06:00
PHST- 2015/10/09 06:00 [entrez]
PHST- 2015/10/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt1015-1014c [pii]
AID - 10.1038/nbt1015-1014c [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1014. doi: 10.1038/nbt1015-1014c.

PMID- 26448072
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20151009
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - First 3D-printed pill.
PG  - 1014
LID - 10.1038/nbt1015-1014a [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Tablets)
RN  - 230447L0GL (etiracetam)
RN  - ZH516LNZ10 (Piracetam)
SB  - IM
MH  - Drug Compounding/*methods
MH  - Drug Design
MH  - Humans
MH  - Piracetam/administration & dosage/*analogs & derivatives/chemical synthesis
MH  - *Printing, Three-Dimensional
MH  - Seizures/*prevention & control
MH  - Tablets/administration & dosage/*chemical synthesis
EDAT- 2015/10/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/10/09 06:00
PHST- 2015/10/09 06:00 [entrez]
PHST- 2015/10/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt1015-1014a [pii]
AID - 10.1038/nbt1015-1014a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1014. doi: 10.1038/nbt1015-1014a.

PMID- 26448071
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - First US biosimilar launch.
PG  - 1013
LID - 10.1038/nbt1015-1013b [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antineoplastic Agents)
RN  - 0 (Biosimilar Pharmaceuticals)
SB  - IM
MH  - Antineoplastic Agents/chemical synthesis/therapeutic use
MH  - Biosimilar Pharmaceuticals/*chemical synthesis/*therapeutic use
MH  - Drug Approval
MH  - *Drug Design
MH  - Drug Industry/*organization & administration
MH  - Humans
MH  - Neoplasms/*drug therapy
MH  - United States
EDAT- 2015/10/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/10/09 06:00
PHST- 2015/10/09 06:00 [entrez]
PHST- 2015/10/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt1015-1013b [pii]
AID - 10.1038/nbt1015-1013b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1013. doi: 10.1038/nbt1015-1013b.

PMID- 26448070
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20151009
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - GSK collaborates with Apple on ResearchKit.
PG  - 1013-4
LID - 10.1038/nbt1015-1013a [doi]
FAU - Eisenstein, Michael
AU  - Eisenstein M
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*organization & administration
MH  - *Cooperative Behavior
MH  - Data Mining/*methods
MH  - Interinstitutional Relations
MH  - *Mobile Applications
MH  - Patient Participation/*methods
MH  - *User-Computer Interface
EDAT- 2015/10/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/10/09 06:00
PHST- 2015/10/09 06:00 [entrez]
PHST- 2015/10/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt1015-1013a [pii]
AID - 10.1038/nbt1015-1013a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1013-4. doi: 10.1038/nbt1015-1013a.

PMID- 26448069
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20151009
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - Illumina opens Helix genomics store.
PG  - 1012
LID - 10.1038/nbt1015-1012b [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Consumer Health Information/*organization & administration
MH  - Drug Industry/*organization & administration
MH  - Genomics/*organization & administration
MH  - Marketing of Health Services/*organization & administration
MH  - United States
EDAT- 2015/10/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/10/09 06:00
PHST- 2015/10/09 06:00 [entrez]
PHST- 2015/10/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt1015-1012b [pii]
AID - 10.1038/nbt1015-1012b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1012. doi: 10.1038/nbt1015-1012b.

PMID- 26448068
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20151009
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - Roche gobbles Smarticles.
PG  - 1012
LID - 10.1038/nbt1015-1012a [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Anti-Bacterial Agents)
SB  - IM
MH  - Anti-Bacterial Agents/*therapeutic use
MH  - Bacterial Physiological Phenomena/*drug effects
MH  - Biological Assay
MH  - Biotechnology/*organization & administration
MH  - Drug Design
MH  - Drug Industry/*organization & administration
MH  - Health Facility Merger/*organization & administration
MH  - *Molecular Diagnostic Techniques
MH  - United States
EDAT- 2015/10/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/10/09 06:00
PHST- 2015/10/09 06:00 [entrez]
PHST- 2015/10/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt1015-1012a [pii]
AID - 10.1038/nbt1015-1012a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1012. doi: 10.1038/nbt1015-1012a.

PMID- 26448067
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - Ebola vaccine trial falls short of homerun.
PG  - 1011-2
LID - 10.1038/nbt1015-1011 [doi]
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
LA  - eng
PT  - Clinical Trial
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Ebola Vaccines)
SB  - IM
MH  - *Drug Design
MH  - Ebola Vaccines/*administration & dosage
MH  - Evidence-Based Medicine
MH  - Hemorrhagic Fever, Ebola/*diagnosis/*prevention & control
MH  - Humans
MH  - Treatment Outcome
EDAT- 2015/10/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/10/09 06:00
PHST- 2015/10/09 06:00 [entrez]
PHST- 2015/10/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt1015-1011 [pii]
AID - 10.1038/nbt1015-1011 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1011-2. doi: 10.1038/nbt1015-1011.

PMID- 26448066
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20151009
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - No sample left behind.
PG  - 1010
LID - 10.1038/nbt.3381 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Humans
MH  - Immunoassay/*methods
MH  - Neoplasms/*immunology/*pathology/therapy
MH  - Specimen Handling/*methods
MH  - United States
EDAT- 2015/10/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/10/09 06:00
PHST- 2015/10/09 06:00 [entrez]
PHST- 2015/10/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3381 [pii]
AID - 10.1038/nbt.3381 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1010. doi: 10.1038/nbt.3381.

PMID- 26448065
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20160503
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - Standing up for science.
PG  - 1009
LID - 10.1038/nbt.3384 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CIN - Nat Biotechnol. 2016 Jan;34(1):23. PMID: 26744972
MH  - *Food Safety
MH  - *Food, Genetically Modified
MH  - Lobbying
MH  - Plants, Genetically Modified/*genetics
MH  - *Public Opinion
MH  - Risk Assessment/methods
MH  - Science/*organization & administration
MH  - United States
EDAT- 2015/10/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/10/09 06:00
PHST- 2015/10/09 06:00 [entrez]
PHST- 2015/10/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3384 [pii]
AID - 10.1038/nbt.3384 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1009. doi: 10.1038/nbt.3384.

PMID- 26414351
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - Subangstrom single-molecule measurements of motor proteins using a nanopore.
PG  - 1073-5
LID - 10.1038/nbt.3357 [doi]
AB  - Techniques for measuring the motion of single motor proteins, such as FRET and
      optical tweezers, are limited to a resolution of approximately 300 pm. We use ion
      current modulation through the protein nanopore MspA to observe translocation of 
      helicase Hel308 on DNA with up to approximately 40 pm sensitivity. This approach 
      should be applicable to any protein that translocates on DNA or RNA, including
      helicases, polymerases, recombinases and DNA repair enzymes.
FAU - Derrington, Ian M
AU  - Derrington IM
AD  - Department of Physics, University of Washington, Seattle, Washington, USA.
FAU - Craig, Jonathan M
AU  - Craig JM
AD  - Department of Physics, University of Washington, Seattle, Washington, USA.
FAU - Stava, Eric
AU  - Stava E
AD  - Illumina Inc., San Diego, California, USA.
FAU - Laszlo, Andrew H
AU  - Laszlo AH
AD  - Department of Physics, University of Washington, Seattle, Washington, USA.
FAU - Ross, Brian C
AU  - Ross BC
AD  - Department of Physics, University of Washington, Seattle, Washington, USA.
FAU - Brinkerhoff, Henry
AU  - Brinkerhoff H
AUID- ORCID: http://orcid.org/0000-0003-2735-8048
AD  - Department of Physics, University of Washington, Seattle, Washington, USA.
FAU - Nova, Ian C
AU  - Nova IC
AD  - Department of Physics, University of Washington, Seattle, Washington, USA.
FAU - Doering, Kenji
AU  - Doering K
AD  - Department of Physics, University of Washington, Seattle, Washington, USA.
FAU - Tickman, Benjamin I
AU  - Tickman BI
AD  - Department of Physics, University of Washington, Seattle, Washington, USA.
FAU - Ronaghi, Mostafa
AU  - Ronaghi M
AD  - Illumina Inc., San Diego, California, USA.
FAU - Mandell, Jeffrey G
AU  - Mandell JG
AD  - Illumina Inc., San Diego, California, USA.
FAU - Gunderson, Kevin L
AU  - Gunderson KL
AD  - Illumina Inc., San Diego, California, USA.
FAU - Gundlach, Jens H
AU  - Gundlach JH
AD  - Department of Physics, University of Washington, Seattle, Washington, USA.
LA  - eng
GR  - R01 HG005115/HG/NHGRI NIH HHS/United States
GR  - R01HG005115/HG/NHGRI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20150928
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Molecular Motor Proteins)
RN  - 9007-49-2 (DNA)
RN  - EC 3.6.4.- (DNA Helicases)
SB  - IM
CIN - Nat Methods. 2015 Dec;12(12):1119. PMID: 26962583
MH  - DNA/*chemistry/ultrastructure
MH  - DNA Helicases/*chemistry/ultrastructure
MH  - Elastic Modulus
MH  - Materials Testing/methods
MH  - Micromanipulation/*methods
MH  - Molecular Motor Proteins/*chemistry/ultrastructure
MH  - Motion
MH  - Nanopores/*ultrastructure
MH  - Nanotechnology/methods
MH  - Protein Binding
MH  - Stress, Mechanical
PMC - PMC4915380
MID - NIHMS718422
EDAT- 2015/09/29 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/29 06:00
PHST- 2015/06/01 00:00 [received]
PHST- 2015/08/24 00:00 [accepted]
PHST- 2015/09/29 06:00 [entrez]
PHST- 2015/09/29 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3357 [pii]
AID - 10.1038/nbt.3357 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1073-5. doi: 10.1038/nbt.3357. Epub 2015 Sep 28.

PMID- 26414350
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - A catalog of the mouse gut metagenome.
PG  - 1103-8
LID - 10.1038/nbt.3353 [doi]
AB  - We established a catalog of the mouse gut metagenome comprising approximately 2.6
      million nonredundant genes by sequencing DNA from fecal samples of 184 mice. To
      secure high microbiome diversity, we used mouse strains of diverse genetic
      backgrounds, from different providers, kept in different housing laboratories and
      fed either a low-fat or high-fat diet. Similar to the human gut microbiome, >99% 
      of the cataloged genes are bacterial. We identified 541 metagenomic species and
      defined a core set of 26 metagenomic species found in 95% of the mice. The mouse 
      gut microbiome is functionally similar to its human counterpart, with 95.2% of
      its Kyoto Encyclopedia of Genes and Genomes (KEGG) orthologous groups in common. 
      However, only 4.0% of the mouse gut microbial genes were shared (95% identity,
      90% coverage) with those of the human gut microbiome. This catalog provides a
      useful reference for future studies.
FAU - Xiao, Liang
AU  - Xiao L
AD  - Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China.
FAU - Feng, Qiang
AU  - Feng Q
AD  - Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China.
AD  - Laboratory of Genomics and Molecular Biomedicine, Department of Biology,
      University of Copenhagen, Copenhagen, Denmark.
FAU - Liang, Suisha
AU  - Liang S
AD  - Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China.
FAU - Sonne, Si Brask
AU  - Sonne SB
AD  - Laboratory of Genomics and Molecular Biomedicine, Department of Biology,
      University of Copenhagen, Copenhagen, Denmark.
FAU - Xia, Zhongkui
AU  - Xia Z
AD  - Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China.
FAU - Qiu, Xinmin
AU  - Qiu X
AD  - Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China.
FAU - Li, Xiaoping
AU  - Li X
AD  - Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China.
FAU - Long, Hua
AU  - Long H
AD  - Pfizer Experimental Medicine, Pfizer Inc., South San Francisco, California, USA.
FAU - Zhang, Jianfeng
AU  - Zhang J
AD  - Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China.
FAU - Zhang, Dongya
AU  - Zhang D
AD  - Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China.
FAU - Liu, Chuan
AU  - Liu C
AD  - Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China.
FAU - Fang, Zhiwei
AU  - Fang Z
AD  - Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China.
FAU - Chou, Joyce
AU  - Chou J
AD  - Pfizer Experimental Medicine, Pfizer Inc., South San Francisco, California, USA.
FAU - Glanville, Jacob
AU  - Glanville J
AD  - Pfizer Experimental Medicine, Pfizer Inc., South San Francisco, California, USA.
FAU - Hao, Qin
AU  - Hao Q
AD  - Laboratory of Genomics and Molecular Biomedicine, Department of Biology,
      University of Copenhagen, Copenhagen, Denmark.
FAU - Kotowska, Dorota
AU  - Kotowska D
AD  - Laboratory of Genomics and Molecular Biomedicine, Department of Biology,
      University of Copenhagen, Copenhagen, Denmark.
FAU - Colding, Camilla
AU  - Colding C
AD  - Laboratory of Genomics and Molecular Biomedicine, Department of Biology,
      University of Copenhagen, Copenhagen, Denmark.
FAU - Licht, Tine Rask
AU  - Licht TR
AUID- ORCID: http://orcid.org/0000-0002-6399-9574
AD  - National Food Institute, Technical University of Denmark, Soborg, Denmark.
FAU - Wu, Donghai
AU  - Wu D
AD  - Key Laboratory of Regenerative Biology, Guangzhou Institute of Biomedicine and
      Health, Chinese Academy of Sciences, Guangzhou, China.
FAU - Yu, Jun
AU  - Yu J
AD  - Institute of Digestive Disease and Department of Medicine and Therapeutics, State
      Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences
      (Chinese University Hong Kong), Shenzhen Research Institute, The Chinese
      University of Hong Kong, Hong Kong, China.
FAU - Sung, Joseph Jao Yiu
AU  - Sung JJ
AD  - Institute of Digestive Disease and Department of Medicine and Therapeutics, State
      Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences
      (Chinese University Hong Kong), Shenzhen Research Institute, The Chinese
      University of Hong Kong, Hong Kong, China.
FAU - Liang, Qiaoyi
AU  - Liang Q
AD  - Institute of Digestive Disease and Department of Medicine and Therapeutics, State
      Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences
      (Chinese University Hong Kong), Shenzhen Research Institute, The Chinese
      University of Hong Kong, Hong Kong, China.
FAU - Li, Junhua
AU  - Li J
AD  - Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China.
FAU - Jia, Huijue
AU  - Jia H
AUID- ORCID: http://orcid.org/0000-0002-3592-126X
AD  - Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China.
FAU - Lan, Zhou
AU  - Lan Z
AD  - Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China.
FAU - Tremaroli, Valentina
AU  - Tremaroli V
AD  - The Wallenberg Laboratory, Department of Molecular and Clinical Medicine,
      University of Gothenburg, Gothenburg, Sweden.
FAU - Dworzynski, Piotr
AU  - Dworzynski P
AD  - Department of Systems Biology, Technical University of Denmark, Kongens Lyngby,
      Denmark.
FAU - Nielsen, H Bjorn
AU  - Nielsen HB
AD  - Department of Systems Biology, Technical University of Denmark, Kongens Lyngby,
      Denmark.
FAU - Backhed, Fredrik
AU  - Backhed F
AD  - The Wallenberg Laboratory, Department of Molecular and Clinical Medicine,
      University of Gothenburg, Gothenburg, Sweden.
AD  - The Novo Nordisk Foundation Center for Basic Metabolic Research, University of
      Copenhagen, Copenhagen, Denmark.
FAU - Dore, Joel
AU  - Dore J
AD  - Institut National de la Recherche Agronomique (Microbiologie de l'Alimentation au
      Service de la Sante), Jouy en Josas, France.
AD  - Institut National de la Recherche Agronomique, Metagenopolis, Jouy en Josas,
      France.
FAU - Le Chatelier, Emmanuelle
AU  - Le Chatelier E
AD  - Institut National de la Recherche Agronomique, Metagenopolis, Jouy en Josas,
      France.
FAU - Ehrlich, S Dusko
AU  - Ehrlich SD
AD  - Institut National de la Recherche Agronomique, Metagenopolis, Jouy en Josas,
      France.
AD  - King's College London, Centre for Host-Microbiome Interactions, Dental Institute 
      Central Office, Guy's Hospital, London Bridge, UK.
FAU - Lin, John C
AU  - Lin JC
AD  - Pfizer Experimental Medicine, Pfizer Inc., South San Francisco, California, USA.
FAU - Arumugam, Manimozhiyan
AU  - Arumugam M
AUID- ORCID: http://orcid.org/0000-0002-0886-9101
AD  - Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China.
AD  - The Novo Nordisk Foundation Center for Basic Metabolic Research, University of
      Copenhagen, Copenhagen, Denmark.
FAU - Wang, Jun
AU  - Wang J
AD  - Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China.
AD  - Laboratory of Genomics and Molecular Biomedicine, Department of Biology,
      University of Copenhagen, Copenhagen, Denmark.
AD  - Princess Al Jawhara Albrahim Center of Excellence in the Research of Hereditary
      Disorders, King Abdulaziz University, Jeddah, Saudi Arabia.
AD  - Macau University of Science and Technology, Avenida Wai long, Taipa, Macau,
      China.
FAU - Madsen, Lise
AU  - Madsen L
AD  - Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China.
AD  - Laboratory of Genomics and Molecular Biomedicine, Department of Biology,
      University of Copenhagen, Copenhagen, Denmark.
AD  - National Institute of Nutrition and Seafood Research, Bergen, Norway.
FAU - Kristiansen, Karsten
AU  - Kristiansen K
AD  - Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China.
AD  - Laboratory of Genomics and Molecular Biomedicine, Department of Biology,
      University of Copenhagen, Copenhagen, Denmark.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150928
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Bacterial Proteins)
SB  - IM
MH  - Animals
MH  - Bacteria/*genetics
MH  - Bacterial Proteins/genetics
MH  - Catalogs as Topic
MH  - Chromosome Mapping/*methods
MH  - *Databases, Genetic
MH  - Genome, Bacterial/*genetics
MH  - Humans
MH  - Intestines/metabolism/*microbiology
MH  - Microbiota/*genetics
MH  - Species Specificity
EDAT- 2015/09/29 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/29 06:00
PHST- 2015/05/14 00:00 [received]
PHST- 2015/08/20 00:00 [accepted]
PHST- 2015/09/29 06:00 [entrez]
PHST- 2015/09/29 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3353 [pii]
AID - 10.1038/nbt.3353 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1103-8. doi: 10.1038/nbt.3353. Epub 2015 Sep 28.

PMID- 26389576
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20161019
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - Therapeutic bispecific T-cell engager antibody targeting the intracellular
      oncoprotein WT1.
PG  - 1079-86
LID - 10.1038/nbt.3349 [doi]
AB  - Intracellular tumor antigens presented on the cell surface in the context of
      human leukocyte antigen (HLA) molecules have been targeted by T cell-based
      therapies, but there has been little progress in developing small-molecule drugs 
      or antibodies directed to these antigens. Here we describe a bispecific T-cell
      engager (BiTE) antibody derived from a T-cell receptor (TCR)-mimic monoclonal
      antibody (mAb) ESK1, which binds a peptide derived from the intracellular
      oncoprotein WT1 presented on HLA-A*02:01. Despite the very low density of the
      complexes at the cell surface, ESK1-BiTE selectively activated and induced
      proliferation of cytolytic human T cells that killed cells from multiple
      leukemias and solid tumors in vitro and in mice. We also discovered that in an
      autologous in vitro setting, ESK1-BiTE induced a robust secondary CD8 T-cell
      response specific for tumor-associated antigens other than WT1. Our study
      provides an approach that targets tumor-specific intracellular antigens without
      using cell therapy and suggests that epitope spreading could contribute to the
      therapeutic efficacy of this BiTE.
FAU - Dao, Tao
AU  - Dao T
AD  - Memorial Sloan Kettering Cancer Center, New York, New York, USA.
FAU - Pankov, Dmitry
AU  - Pankov D
AD  - Memorial Sloan Kettering Cancer Center, New York, New York, USA.
FAU - Scott, Andrew
AU  - Scott A
AD  - Memorial Sloan Kettering Cancer Center, New York, New York, USA.
AD  - Weill Cornell Medical College, New York, New York, USA.
FAU - Korontsvit, Tatyana
AU  - Korontsvit T
AD  - Memorial Sloan Kettering Cancer Center, New York, New York, USA.
FAU - Zakhaleva, Victoriya
AU  - Zakhaleva V
AD  - Memorial Sloan Kettering Cancer Center, New York, New York, USA.
FAU - Xu, Yiyang
AU  - Xu Y
AD  - Eureka Therapeutics, Emeryville, California, USA.
FAU - Xiang, Jingyi
AU  - Xiang J
AD  - Eureka Therapeutics, Emeryville, California, USA.
FAU - Yan, Su
AU  - Yan S
AD  - Eureka Therapeutics, Emeryville, California, USA.
FAU - de Morais Guerreiro, Manuel Direito
AU  - de Morais Guerreiro MD
AD  - Memorial Sloan Kettering Cancer Center, New York, New York, USA.
FAU - Veomett, Nicholas
AU  - Veomett N
AD  - Memorial Sloan Kettering Cancer Center, New York, New York, USA.
AD  - Weill Cornell Medical College, New York, New York, USA.
FAU - Dubrovsky, Leonid
AU  - Dubrovsky L
AD  - Memorial Sloan Kettering Cancer Center, New York, New York, USA.
FAU - Curcio, Michael
AU  - Curcio M
AD  - Memorial Sloan Kettering Cancer Center, New York, New York, USA.
FAU - Doubrovina, Ekaterina
AU  - Doubrovina E
AD  - Memorial Sloan Kettering Cancer Center, New York, New York, USA.
FAU - Ponomarev, Vladimir
AU  - Ponomarev V
AD  - Memorial Sloan Kettering Cancer Center, New York, New York, USA.
FAU - Liu, Cheng
AU  - Liu C
AD  - Eureka Therapeutics, Emeryville, California, USA.
FAU - O'Reilly, Richard J
AU  - O'Reilly RJ
AD  - Memorial Sloan Kettering Cancer Center, New York, New York, USA.
AD  - Weill Cornell Medical College, New York, New York, USA.
FAU - Scheinberg, David A
AU  - Scheinberg DA
AD  - Memorial Sloan Kettering Cancer Center, New York, New York, USA.
AD  - Weill Cornell Medical College, New York, New York, USA.
LA  - eng
GR  - R01 CA055349/CA/NCI NIH HHS/United States
GR  - T32 CA062948/CA/NCI NIH HHS/United States
GR  - P01 CA023766/CA/NCI NIH HHS/United States
GR  - P30 CA008748/CA/NCI NIH HHS/United States
GR  - R01 CA 55349/CA/NCI NIH HHS/United States
GR  - P01 CA23766/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20150921
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antibodies, Monoclonal)
RN  - 0 (Antigens, Neoplasm)
RN  - 0 (Cancer Vaccines)
RN  - 0 (Oncogene Proteins)
RN  - 0 (Repressor Proteins)
RN  - 0 (WT1 protein, mouse)
SB  - IM
CIN - Nat Rev Drug Discov. 2015 Nov;14(11):749. PMID: 26514861
CIN - Nat Biotechnol. 2015 Oct;33(10):1040-1. PMID: 26448086
MH  - Animals
MH  - Antibodies, Monoclonal/immunology/*therapeutic use
MH  - Antigens, Neoplasm/immunology
MH  - Cancer Vaccines/immunology/therapeutic use
MH  - Cell Line, Tumor
MH  - Humans
MH  - Mice
MH  - Molecular Targeted Therapy/methods
MH  - Neoplasms, Experimental/*immunology/*therapy
MH  - Oncogene Proteins/immunology
MH  - Repressor Proteins/*immunology
MH  - T-Lymphocytes/*immunology
MH  - Treatment Outcome
PMC - PMC4600043
MID - NIHMS725861
EDAT- 2015/09/22 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/22 06:00
PHST- 2015/02/20 00:00 [received]
PHST- 2015/07/29 00:00 [accepted]
PHST- 2015/09/22 06:00 [entrez]
PHST- 2015/09/22 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3349 [pii]
AID - 10.1038/nbt.3349 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1079-86. doi: 10.1038/nbt.3349. Epub 2015 Sep 21.

PMID- 26389575
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - Improving folate (vitamin B9) stability in biofortified rice through metabolic
      engineering.
PG  - 1076-8
LID - 10.1038/nbt.3358 [doi]
AB  - Biofortification of staple crops could help to alleviate micronutrient
      deficiencies in humans. We show that folates in stored rice grains are unstable, 
      which reduces the potential benefits of folate biofortification. We obtain folate
      concentrations that are up to 150 fold higher than those of wild-type rice by
      complexing folate to folate-binding proteins to improve folate stability, thereby
      enabling long-term storage of biofortified high-folate rice grains.
FAU - Blancquaert, Dieter
AU  - Blancquaert D
AD  - Laboratory of Functional Plant Biology, Department of Physiology, Ghent
      University, Ghent, Belgium.
FAU - Van Daele, Jeroen
AU  - Van Daele J
AD  - Laboratory of Toxicology, Department of Bioanalysis, Ghent University, Ghent,
      Belgium.
FAU - Strobbe, Simon
AU  - Strobbe S
AD  - Laboratory of Functional Plant Biology, Department of Physiology, Ghent
      University, Ghent, Belgium.
FAU - Kiekens, Filip
AU  - Kiekens F
AD  - Laboratory of Toxicology, Department of Bioanalysis, Ghent University, Ghent,
      Belgium.
FAU - Storozhenko, Sergei
AU  - Storozhenko S
AD  - Laboratory of Functional Plant Biology, Department of Physiology, Ghent
      University, Ghent, Belgium.
FAU - De Steur, Hans
AU  - De Steur H
AD  - Division Agri-Food Marketing &Chain Management, Department of Agricultural
      Economics, Ghent University, Ghent, Belgium.
FAU - Gellynck, Xavier
AU  - Gellynck X
AD  - Division Agri-Food Marketing &Chain Management, Department of Agricultural
      Economics, Ghent University, Ghent, Belgium.
FAU - Lambert, Willy
AU  - Lambert W
AD  - Laboratory of Toxicology, Department of Bioanalysis, Ghent University, Ghent,
      Belgium.
FAU - Stove, Christophe
AU  - Stove C
AUID- ORCID: http://orcid.org/0000-0001-7126-348X
AD  - Laboratory of Toxicology, Department of Bioanalysis, Ghent University, Ghent,
      Belgium.
FAU - Van Der Straeten, Dominique
AU  - Van Der Straeten D
AUID- ORCID: http://orcid.org/0000-0002-7755-1420
AD  - Laboratory of Functional Plant Biology, Department of Physiology, Ghent
      University, Ghent, Belgium.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150921
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Plant Proteins)
RN  - 935E97BOY8 (Folic Acid)
SB  - IM
MH  - Dietary Supplements
MH  - Drug Stability
MH  - Folic Acid/*chemistry/*genetics
MH  - Genetic Enhancement/*methods
MH  - Metabolic Engineering/*methods
MH  - Oryza/*chemistry/*genetics
MH  - Plant Proteins/genetics
MH  - Plants, Genetically Modified/chemistry/genetics
EDAT- 2015/09/22 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/22 06:00
PHST- 2015/01/20 00:00 [received]
PHST- 2015/08/24 00:00 [accepted]
PHST- 2015/09/22 06:00 [entrez]
PHST- 2015/09/22 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3358 [pii]
AID - 10.1038/nbt.3358 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1076-8. doi: 10.1038/nbt.3358. Epub 2015 Sep 21.

PMID- 26368050
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170603
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - Optogenetic control of endogenous Ca(2+) channels in vivo.
PG  - 1092-6
LID - 10.1038/nbt.3350 [doi]
AB  - Calcium (Ca(2+)) signals that are precisely modulated in space and time mediate a
      myriad of cellular processes, including contraction, excitation, growth,
      differentiation and apoptosis. However, study of Ca(2+) responses has been
      hampered by technological limitations of existing Ca(2+)-modulating tools. Here
      we present OptoSTIM1, an optogenetic tool for manipulating intracellular Ca(2+)
      levels through activation of Ca(2+)-selective endogenous Ca(2+) release-activated
      Ca(2+) (CRAC) channels. Using OptoSTIM1, which combines a plant photoreceptor and
      the CRAC channel regulator STIM1 (ref. 4), we quantitatively and qualitatively
      controlled intracellular Ca(2+) levels in various biological systems, including
      zebrafish embryos and human embryonic stem cells. We demonstrate that activating 
      OptoSTIM1 in the CA1 hippocampal region of mice selectively reinforced contextual
      memory formation. The broad utility of OptoSTIM1 will expand our mechanistic
      understanding of numerous Ca(2+)-associated processes and facilitate screening
      for drug candidates that antagonize Ca(2+) signals.
FAU - Kyung, Taeyoon
AU  - Kyung T
AD  - Department of Biological Sciences, Korea Advanced Institute of Science and
      Technology (KAIST), Daejeon, Republic of Korea.
FAU - Lee, Sangkyu
AU  - Lee S
AD  - Center for Cognition and Sociality, Institute for Basic Science (IBS), Daejeon,
      Republic of Korea.
FAU - Kim, Jung Eun
AU  - Kim JE
AD  - Department of Biological Sciences, Korea Advanced Institute of Science and
      Technology (KAIST), Daejeon, Republic of Korea.
FAU - Cho, Taesup
AU  - Cho T
AD  - Center for Cognition and Sociality, Institute for Basic Science (IBS), Daejeon,
      Republic of Korea.
FAU - Park, Hyerim
AU  - Park H
AD  - Department of Biological Sciences, Korea Advanced Institute of Science and
      Technology (KAIST), Daejeon, Republic of Korea.
FAU - Jeong, Yun-Mi
AU  - Jeong YM
AD  - Department of Biology, Chungnam National University, Daejeon, Republic of Korea.
FAU - Kim, Dongkyu
AU  - Kim D
AD  - Department of Biological Sciences, Korea Advanced Institute of Science and
      Technology (KAIST), Daejeon, Republic of Korea.
FAU - Shin, Anna
AU  - Shin A
AD  - Department of Biological Sciences, Korea Advanced Institute of Science and
      Technology (KAIST), Daejeon, Republic of Korea.
FAU - Kim, Sungsoo
AU  - Kim S
AD  - Department of Biological Sciences, Korea Advanced Institute of Science and
      Technology (KAIST), Daejeon, Republic of Korea.
FAU - Baek, Jinhee
AU  - Baek J
AD  - Center for Cognition and Sociality, Institute for Basic Science (IBS), Daejeon,
      Republic of Korea.
AD  - Department of Bio and Brain Engineering, KAIST, Daejeon, Republic of Korea.
FAU - Kim, Jihoon
AU  - Kim J
AD  - Department of Biological Sciences, Korea Advanced Institute of Science and
      Technology (KAIST), Daejeon, Republic of Korea.
FAU - Kim, Na Yeon
AU  - Kim NY
AD  - Department of Biological Sciences, Korea Advanced Institute of Science and
      Technology (KAIST), Daejeon, Republic of Korea.
FAU - Woo, Doyeon
AU  - Woo D
AD  - Department of Biological Sciences, Korea Advanced Institute of Science and
      Technology (KAIST), Daejeon, Republic of Korea.
FAU - Chae, Sujin
AU  - Chae S
AD  - KAIST Institute for the BioCentury, KAIST, Daejeon, Republic of Korea.
FAU - Kim, Cheol-Hee
AU  - Kim CH
AD  - Department of Biology, Chungnam National University, Daejeon, Republic of Korea.
FAU - Shin, Hee-Sup
AU  - Shin HS
AD  - Center for Cognition and Sociality, Institute for Basic Science (IBS), Daejeon,
      Republic of Korea.
AD  - Department of Bio and Brain Engineering, KAIST, Daejeon, Republic of Korea.
FAU - Han, Yong-Mahn
AU  - Han YM
AD  - Department of Biological Sciences, Korea Advanced Institute of Science and
      Technology (KAIST), Daejeon, Republic of Korea.
FAU - Kim, Daesoo
AU  - Kim D
AD  - Department of Biological Sciences, Korea Advanced Institute of Science and
      Technology (KAIST), Daejeon, Republic of Korea.
FAU - Heo, Won Do
AU  - Heo WD
AD  - Department of Biological Sciences, Korea Advanced Institute of Science and
      Technology (KAIST), Daejeon, Republic of Korea.
AD  - Center for Cognition and Sociality, Institute for Basic Science (IBS), Daejeon,
      Republic of Korea.
AD  - KAIST Institute for the BioCentury, KAIST, Daejeon, Republic of Korea.
AD  - Cancer Metastasis Control Center, KAIST Institute for the BioCentury, KAIST,
      Daejeon, Republic of Korea.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150914
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Calcium Channels)
RN  - SY7Q814VUP (Calcium)
SB  - IM
MH  - Animals
MH  - Calcium/*metabolism
MH  - Calcium Channels/*genetics
MH  - Calcium Signaling/*genetics
MH  - Embryonic Stem Cells/cytology/*physiology
MH  - Genetic Engineering/methods
MH  - Hippocampus/cytology/*physiology
MH  - Humans
MH  - Mice
MH  - Optogenetics/*methods
EDAT- 2015/09/15 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/15 06:00
PHST- 2015/05/07 00:00 [received]
PHST- 2015/08/20 00:00 [accepted]
PHST- 2015/09/15 06:00 [entrez]
PHST- 2015/09/15 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3350 [pii]
AID - 10.1038/nbt.3350 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1092-6. doi: 10.1038/nbt.3350. Epub 2015 Sep 14.

PMID- 26368049
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - Detection of low-abundance bacterial strains in metagenomic datasets by
      eigengenome partitioning.
PG  - 1053-60
LID - 10.1038/nbt.3329 [doi]
AB  - Analyses of metagenomic datasets that are sequenced to a depth of billions or
      trillions of bases can uncover hundreds of microbial genomes, but naive assembly 
      of these data is computationally intensive, requiring hundreds of gigabytes to
      terabytes of RAM. We present latent strain analysis (LSA), a scalable, de novo
      pre-assembly method that separates reads into biologically informed partitions
      and thereby enables assembly of individual genomes. LSA is implemented with a
      streaming calculation of unobserved variables that we call eigengenomes.
      Eigengenomes reflect covariance in the abundance of short, fixed-length
      sequences, or k-mers. As the abundance of each genome in a sample is reflected in
      the abundance of each k-mer in that genome, eigengenome analysis can be used to
      partition reads from different genomes. This partitioning can be done in fixed
      memory using tens of gigabytes of RAM, which makes assembly and downstream
      analyses of terabytes of data feasible on commodity hardware. Using LSA, we
      assemble partial and near-complete genomes of bacterial taxa present at relative 
      abundances as low as 0.00001%. We also show that LSA is sensitive enough to
      separate reads from several strains of the same species.
FAU - Cleary, Brian
AU  - Cleary B
AD  - Computational and Systems Biology Program, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Brito, Ilana Lauren
AU  - Brito IL
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
AD  - Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
AD  - Center for Microbiome Informatics and Therapeutics, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
FAU - Huang, Katherine
AU  - Huang K
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Gevers, Dirk
AU  - Gevers D
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Shea, Terrance
AU  - Shea T
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Young, Sarah
AU  - Young S
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
FAU - Alm, Eric J
AU  - Alm EJ
AD  - Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
AD  - Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
AD  - Center for Microbiome Informatics and Therapeutics, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
LA  - eng
GR  - T32 GM087237/GM/NIGMS NIH HHS/United States
GR  - U54HG003067/HG/NHGRI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20150914
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CIN - Nat Biotechnol. 2015 Oct;33(10):1041-3. PMID: 26448087
MH  - Algorithms
MH  - Bacteria/classification/*genetics
MH  - Chromosome Mapping/methods
MH  - Databases, Genetic
MH  - Datasets as Topic
MH  - Epigenesis, Genetic/*genetics
MH  - Genome, Bacterial/*genetics
MH  - Metagenomics/*methods
MH  - Microbiota/*genetics
MH  - Sequence Analysis, DNA/*methods
MH  - Species Specificity
PMC - PMC4720164
MID - NIHMS750926
EDAT- 2015/09/15 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/15 06:00
PHST- 2014/10/26 00:00 [received]
PHST- 2015/07/28 00:00 [accepted]
PHST- 2015/09/15 06:00 [entrez]
PHST- 2015/09/15 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3329 [pii]
AID - 10.1038/nbt.3329 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1053-60. doi: 10.1038/nbt.3329. Epub 2015 Sep 14.

PMID- 26368048
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - Engineering pulmonary vasculature in decellularized rat and human lungs.
PG  - 1097-102
LID - 10.1038/nbt.3354 [doi]
AB  - Bioengineered lungs produced from patient-derived cells may one day provide an
      alternative to donor lungs for transplantation therapy. Here we report the
      regeneration of functional pulmonary vasculature by repopulating the vascular
      compartment of decellularized rat and human lung scaffolds with human cells,
      including endothelial and perivascular cells derived from induced pluripotent
      stem cells. We describe improved methods for delivering cells into the lung
      scaffold and for maturing newly formed endothelium through co-seeding of
      endothelial and perivascular cells and a two-phase culture protocol. Using these 
      methods we achieved approximately 75% endothelial coverage in the rat lung
      scaffold relative to that of native lung. The regenerated endothelium showed
      reduced vascular resistance and improved barrier function over the course of in
      vitro culture and remained patent for 3 days after orthotopic transplantation in 
      rats. Finally, we scaled our approach to the human lung lobe and achieved
      efficient cell delivery, maintenance of cell viability and establishment of
      perfusable vascular lumens.
FAU - Ren, Xi
AU  - Ren X
AD  - Center for Regenerative Medicine, Massachusetts General Hospital, Boston,
      Massachusetts, USA.
AD  - Harvard Medical School, Boston, Massachusetts, USA.
FAU - Moser, Philipp T
AU  - Moser PT
AD  - Center for Regenerative Medicine, Massachusetts General Hospital, Boston,
      Massachusetts, USA.
AD  - Harvard Medical School, Boston, Massachusetts, USA.
FAU - Gilpin, Sarah E
AU  - Gilpin SE
AD  - Center for Regenerative Medicine, Massachusetts General Hospital, Boston,
      Massachusetts, USA.
AD  - Harvard Medical School, Boston, Massachusetts, USA.
FAU - Okamoto, Tatsuya
AU  - Okamoto T
AD  - Center for Regenerative Medicine, Massachusetts General Hospital, Boston,
      Massachusetts, USA.
AD  - Harvard Medical School, Boston, Massachusetts, USA.
FAU - Wu, Tong
AU  - Wu T
AD  - Center for Regenerative Medicine, Massachusetts General Hospital, Boston,
      Massachusetts, USA.
AD  - Harvard Medical School, Boston, Massachusetts, USA.
FAU - Tapias, Luis F
AU  - Tapias LF
AD  - Center for Regenerative Medicine, Massachusetts General Hospital, Boston,
      Massachusetts, USA.
AD  - Harvard Medical School, Boston, Massachusetts, USA.
AD  - Division of Thoracic Surgery, Department of Surgery, Massachusetts General
      Hospital, Boston, Massachusetts, USA.
FAU - Mercier, Francois E
AU  - Mercier FE
AD  - Center for Regenerative Medicine, Massachusetts General Hospital, Boston,
      Massachusetts, USA.
AD  - Harvard Medical School, Boston, Massachusetts, USA.
FAU - Xiong, Linjie
AU  - Xiong L
AD  - Center for Regenerative Medicine, Massachusetts General Hospital, Boston,
      Massachusetts, USA.
AD  - Harvard Medical School, Boston, Massachusetts, USA.
FAU - Ghawi, Raja
AU  - Ghawi R
AD  - Center for Regenerative Medicine, Massachusetts General Hospital, Boston,
      Massachusetts, USA.
AD  - Harvard Medical School, Boston, Massachusetts, USA.
AD  - Harvard College, Cambridge, Massachusetts, USA.
FAU - Scadden, David T
AU  - Scadden DT
AD  - Center for Regenerative Medicine, Massachusetts General Hospital, Boston,
      Massachusetts, USA.
AD  - Harvard Medical School, Boston, Massachusetts, USA.
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
FAU - Mathisen, Douglas J
AU  - Mathisen DJ
AD  - Harvard Medical School, Boston, Massachusetts, USA.
AD  - Division of Thoracic Surgery, Department of Surgery, Massachusetts General
      Hospital, Boston, Massachusetts, USA.
FAU - Ott, Harald C
AU  - Ott HC
AD  - Center for Regenerative Medicine, Massachusetts General Hospital, Boston,
      Massachusetts, USA.
AD  - Harvard Medical School, Boston, Massachusetts, USA.
AD  - Division of Thoracic Surgery, Department of Surgery, Massachusetts General
      Hospital, Boston, Massachusetts, USA.
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
LA  - eng
GR  - DP2 OD008749/OD/NIH HHS/United States
GR  - DP2-OD008749-01/OD/NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20150914
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - Cell-Free System
MH  - Cells, Cultured
MH  - Endothelial Cells/cytology/*physiology
MH  - Equipment Design
MH  - Equipment Failure Analysis
MH  - Humans
MH  - Lung/*chemistry
MH  - Male
MH  - Neovascularization, Physiologic/physiology
MH  - Pulmonary Artery/*cytology/*growth & development
MH  - Rats
MH  - Rats, Sprague-Dawley
MH  - Regeneration/physiology
MH  - Species Specificity
MH  - Tissue Engineering/*instrumentation
MH  - *Tissue Scaffolds
EDAT- 2015/09/15 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/15 06:00
PHST- 2014/11/08 00:00 [received]
PHST- 2015/08/08 00:00 [accepted]
PHST- 2015/09/15 06:00 [entrez]
PHST- 2015/09/15 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3354 [pii]
AID - 10.1038/nbt.3354 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1097-102. doi: 10.1038/nbt.3354. Epub 2015 Sep
      14.

PMID- 26352647
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - De novo sequencing and variant calling with nanopores using PoreSeq.
PG  - 1087-91
LID - 10.1038/nbt.3360 [doi]
AB  - The accuracy of sequencing single DNA molecules with nanopores is continually
      improving, but de novo genome sequencing and assembly using only nanopore data
      remain challenging. Here we describe PoreSeq, an algorithm that identifies and
      corrects errors in nanopore sequencing data and improves the accuracy of de novo 
      genome assembly with increasing coverage depth. The approach relies on modeling
      the possible sources of uncertainty that occur as DNA transits through the
      nanopore and finds the sequence that best explains multiple reads of the same
      region. PoreSeq increases nanopore sequencing read accuracy of M13 bacteriophage 
      DNA from 85% to 99% at 100x coverage. We also use the algorithm to assemble
      Escherichia coli with 30x coverage and the lambda genome at a range of coverages 
      from 3x to 50x. Additionally, we classify sequence variants at an order of
      magnitude lower coverage than is possible with existing methods.
FAU - Szalay, Tamas
AU  - Szalay T
AUID- ORCID: http://orcid.org/0000-0002-6539-7497
AD  - School of Engineering and Applied Sciences, Harvard University, Cambridge,
      Massachusetts, USA.
FAU - Golovchenko, Jene A
AU  - Golovchenko JA
AD  - School of Engineering and Applied Sciences, Harvard University, Cambridge,
      Massachusetts, USA.
AD  - Department of Physics, Harvard University, Cambridge, Massachusetts, USA.
LA  - eng
GR  - R01 HG003703/HG/NHGRI NIH HHS/United States
GR  - R01HG003703/HG/NHGRI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20150909
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (DNA, Viral)
SB  - IM
MH  - *Algorithms
MH  - Base Sequence
MH  - Chromosome Mapping/*methods
MH  - DNA, Viral/*genetics/ultrastructure
MH  - Genetic Variation/*genetics
MH  - Molecular Sequence Data
MH  - Nanopores/*ultrastructure
MH  - Reproducibility of Results
MH  - Sensitivity and Specificity
MH  - Sequence Analysis, DNA/*methods
PMC - PMC4877053
MID - NIHMS719691
EDAT- 2015/09/10 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/10 06:00
PHST- 2015/02/19 00:00 [received]
PHST- 2015/08/28 00:00 [accepted]
PHST- 2015/09/10 06:00 [entrez]
PHST- 2015/09/10 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3360 [pii]
AID - 10.1038/nbt.3360 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1087-91. doi: 10.1038/nbt.3360. Epub 2015 Sep 9.

PMID- 26344404
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 10
DP  - 2015 Oct
TI  - ConStrains identifies microbial strains in metagenomic datasets.
PG  - 1045-52
LID - 10.1038/nbt.3319 [doi]
AB  - An important fraction of microbial diversity is harbored in strain individuality,
      so identification of conspecific bacterial strains is imperative for improved
      understanding of microbial community functions. Limitations in bioinformatics and
      sequencing technologies have to date precluded strain identification owing to
      difficulties in phasing short reads to faithfully recover the original
      strain-level genotypes, which have highly similar sequences. We present
      ConStrains, an open-source algorithm that identifies conspecific strains from
      metagenomic sequence data and reconstructs the phylogeny of these strains in
      microbial communities. The algorithm uses single-nucleotide polymorphism (SNP)
      patterns in a set of universal genes to infer within-species structures that
      represent strains. Applying ConStrains to simulated and host-derived datasets
      provides insights into microbial community dynamics.
FAU - Luo, Chengwei
AU  - Luo C
AD  - Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard,
      Cambridge, Massachusetts, USA.
AD  - Gastrointestinal Unit and Center for the Study of Inflammatory Bowel Disease,
      Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts,
      USA.
AD  - Center for Computational and Integrative Biology, Massachusetts General Hospital 
      and Harvard Medical School, Boston, Massachusetts, USA.
FAU - Knight, Rob
AU  - Knight R
AUID- ORCID: http://orcid.org/0000-0002-0975-9019
AD  - Department of Chemistry and Biochemistry, University of Colorado at Boulder,
      Boulder, Colorado, USA.
AD  - Howard Hughes Medical Institute, Boulder, Colorado, USA.
FAU - Siljander, Heli
AU  - Siljander H
AD  - Children's Hospital, University of Helsinki and Helsinki University Hospital,
      Helsinki, Finland.
AD  - Research Programs Unit, Diabetes and Obesity, University of Helsinki, Helsinki,
      Finland.
FAU - Knip, Mikael
AU  - Knip M
AUID- ORCID: http://orcid.org/0000-0003-0474-0033
AD  - Children's Hospital, University of Helsinki and Helsinki University Hospital,
      Helsinki, Finland.
AD  - Research Programs Unit, Diabetes and Obesity, University of Helsinki, Helsinki,
      Finland.
AD  - Folkhalsan Research Center, Helsinki, Finland.
AD  - Department of Pediatrics, Tampere University Hospital, Tampere, Finland.
FAU - Xavier, Ramnik J
AU  - Xavier RJ
AD  - Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard,
      Cambridge, Massachusetts, USA.
AD  - Gastrointestinal Unit and Center for the Study of Inflammatory Bowel Disease,
      Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts,
      USA.
AD  - Center for Computational and Integrative Biology, Massachusetts General Hospital 
      and Harvard Medical School, Boston, Massachusetts, USA.
AD  - Center for Microbiome Informatics and Therapeutics, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
FAU - Gevers, Dirk
AU  - Gevers D
AD  - Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard,
      Cambridge, Massachusetts, USA.
LA  - eng
GR  - U54 DK102557/DK/NIDDK NIH HHS/United States
GR  - P01 DK078669/DK/NIDDK NIH HHS/United States
GR  - P30 DK043351/DK/NIDDK NIH HHS/United States
GR  - R01 DK092405/DK/NIDDK NIH HHS/United States
GR  - R01 HG004872/HG/NHGRI NIH HHS/United States
GR  - Howard Hughes Medical Institute/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20150907
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Algorithms
MH  - Bacteria/classification/*genetics
MH  - Chromosome Mapping/methods
MH  - Databases, Genetic
MH  - Datasets as Topic
MH  - Genome, Bacterial/*genetics
MH  - Metagenomics/*methods
MH  - Microbiota/*genetics
MH  - Sequence Analysis, DNA/*methods
MH  - Species Specificity
PMC - PMC4676274
MID - NIHMS709471
EDAT- 2015/09/08 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/08 06:00
PHST- 2014/12/10 00:00 [received]
PHST- 2015/07/16 00:00 [accepted]
PHST- 2015/09/08 06:00 [entrez]
PHST- 2015/09/08 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3319 [pii]
AID - 10.1038/nbt.3319 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Oct;33(10):1045-52. doi: 10.1038/nbt.3319. Epub 2015 Sep 7.

PMID- 26349903
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20150909
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - Top 20 translational researchers of 2014.
PG  - 897
LID - 10.1038/nbt.3335 [doi]
FAU - Huggett, Brady
AU  - Huggett B
AD  - Nature Biotechnology.
FAU - Paisner, Kathryn
AU  - Paisner K
AD  - research and analytics at IP Checkups, Berkeley, California, USA.
LA  - eng
PT  - Journal Article
DEP - 20150820
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Entrepreneurship/*statistics & numerical data
MH  - Internationality
MH  - *Journal Impact Factor
MH  - Patents as Topic/*statistics & numerical data
MH  - Research/*statistics & numerical data
MH  - Research Personnel/*statistics & numerical data
MH  - Translational Medical Research/*manpower/statistics & numerical data
EDAT- 2015/09/10 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/10 06:00
PHST- 2015/09/10 06:00 [entrez]
PHST- 2015/09/10 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3335 [pii]
AID - 10.1038/nbt.3335 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):897. doi: 10.1038/nbt.3335. Epub 2015 Aug 20.

PMID- 26349902
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20150909
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - First Rounders Podcast: Stanley Crooke.
PG  - 897
LID - 10.1038/nbt.3336 [doi]
LA  - eng
PT  - Journal Article
PT  - Webcasts
DEP - 20150820
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (DNA, Antisense)
SB  - IM
MH  - Biotechnology/*organization & administration
MH  - DNA, Antisense/*genetics
MH  - Drug Industry/*organization & administration
MH  - Entrepreneurship/organization & administration
MH  - Genetic Engineering
MH  - *Genetic Research
MH  - *Leadership
MH  - *Models, Organizational
EDAT- 2015/09/10 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/10 06:00
PHST- 2015/09/10 06:00 [entrez]
PHST- 2015/09/10 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3336 [pii]
AID - 10.1038/nbt.3336 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):897. doi: 10.1038/nbt.3336. Epub 2015 Aug 20.

PMID- 26348966
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - MASS AWIS: Supporting women in science for over a decade.
PG  - 1005-6
LID - 10.1038/nbt.3347 [doi]
FAU - Cheema, Tooba
AU  - Cheema T
AD  - Unum Therapeutics, Cambridge, Massachusetts, USA.
FAU - Kamens, Joanne
AU  - Kamens J
AD  - Addgene, Cambridge, Massachusetts, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Employment/*statistics & numerical data
MH  - Science/*manpower
MH  - *Sexism
MH  - United States
MH  - Women, Working/*statistics & numerical data
EDAT- 2015/09/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/09 06:00
PHST- 2015/09/09 06:00 [entrez]
PHST- 2015/09/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3347 [pii]
AID - 10.1038/nbt.3347 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):1005-6. doi: 10.1038/nbt.3347.

PMID- 26348965
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - Principles of nanoparticle design for overcoming biological barriers to drug
      delivery.
PG  - 941-51
LID - 10.1038/nbt.3330 [doi]
AB  - Biological barriers to drug transport prevent successful accumulation of
      nanotherapeutics specifically at diseased sites, limiting efficacious responses
      in disease processes ranging from cancer to inflammation. Although substantial
      research efforts have aimed to incorporate multiple functionalities and moieties 
      within the overall nanoparticle design, many of these strategies fail to
      adequately address these barriers. Obstacles, such as nonspecific distribution
      and inadequate accumulation of therapeutics, remain formidable challenges to drug
      developers. A reimagining of conventional nanoparticles is needed to successfully
      negotiate these impediments to drug delivery. Site-specific delivery of
      therapeutics will remain a distant reality unless nanocarrier design takes into
      account the majority, if not all, of the biological barriers that a particle
      encounters upon intravenous administration. By successively addressing each of
      these barriers, innovative design features can be rationally incorporated that
      will create a new generation of nanotherapeutics, realizing a paradigmatic shift 
      in nanoparticle-based drug delivery.
FAU - Blanco, Elvin
AU  - Blanco E
AD  - Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas,
      USA.
FAU - Shen, Haifa
AU  - Shen H
AD  - Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas,
      USA.
AD  - Department of Cell and Developmental Biology, Weill Cornell Medical College, New 
      York, New York, USA.
FAU - Ferrari, Mauro
AU  - Ferrari M
AD  - Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas,
      USA.
AD  - Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
LA  - eng
GR  - U54 CA143837/CA/NCI NIH HHS/United States
GR  - U54 CA151668/CA/NCI NIH HHS/United States
GR  - U54CA143837/CA/NCI NIH HHS/United States
GR  - U54CA151668/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Biocompatible Materials)
RN  - 0 (Nanocapsules)
SB  - IM
MH  - Biocompatible Materials/*chemical synthesis/toxicity
MH  - Drug Compounding/*methods
MH  - *Drug Design
MH  - Nanocapsules/*chemistry/toxicity/*ultrastructure
MH  - Nanomedicine/*methods
PMC - PMC4978509
MID - NIHMS805388
EDAT- 2015/09/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/09 06:00
PHST- 2015/03/28 00:00 [received]
PHST- 2015/07/29 00:00 [accepted]
PHST- 2015/09/09 06:00 [entrez]
PHST- 2015/09/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3330 [pii]
AID - 10.1038/nbt.3330 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):941-51. doi: 10.1038/nbt.3330.

PMID- 26348963
OWN - NLM
STAT- MEDLINE
DCOM- 20151203
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - From mass cytometry to cancer prognosis.
PG  - 931-2
LID - 10.1038/nbt.3346 [doi]
FAU - Winter, Deborah R
AU  - Winter DR
AD  - Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
FAU - Ledergor, Guy
AU  - Ledergor G
AD  - Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
FAU - Amit, Ido
AU  - Amit I
AD  - Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Cell. 2015 Jul 2;162(1):184-97. PMID: 26095251
MH  - Computational Biology/*methods
MH  - Humans
MH  - Leukemia, Myeloid, Acute/*genetics/*physiopathology
MH  - Single-Cell Analysis/*methods
EDAT- 2015/09/09 06:00
MHDA- 2015/12/15 06:00
CRDT- 2015/09/09 06:00
PHST- 2015/09/09 06:00 [entrez]
PHST- 2015/09/09 06:00 [pubmed]
PHST- 2015/12/15 06:00 [medline]
AID - nbt.3346 [pii]
AID - 10.1038/nbt.3346 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):931-2. doi: 10.1038/nbt.3346.

PMID- 26348962
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - Phosphoproteomics takes it easy.
PG  - 929-30
LID - 10.1038/nbt.3345 [doi]
FAU - Picotti, Paola
AU  - Picotti P
AD  - Institute of Biochemistry, Department of Biology, ETH Zurich, Zurich,
      Switzerland.
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Plant Proteins)
RN  - EC 3.1.3.2 (Phosphoric Monoester Hydrolases)
SB  - IM
CON - Nat Biotechnol. 2015 Aug;33(8):862-9. PMID: 26473199
EIN - Nat Biotechnol. 2016 Apr;34(4):441. PMID: 27054998
MH  - Phosphoric Monoester Hydrolases/*metabolism
MH  - Plant Proteins/*metabolism
MH  - Plants, Genetically Modified/*genetics/*physiology
MH  - Zea mays/*genetics/*physiology
EDAT- 2015/09/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/09 06:00
PHST- 2015/09/09 06:00 [entrez]
PHST- 2015/09/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3345 [pii]
AID - 10.1038/nbt.3345 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):929-30. doi: 10.1038/nbt.3345.

PMID- 26348961
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - RNA structure from deep sequencing.
PG  - 928-9
LID - 10.1038/nbt.3338 [doi]
FAU - Westhof, Eric
AU  - Westhof E
AD  - Architecture &Reactivity of RNA, University of Strasbourg, Institute of Molecular
      and Cellular Biology of the CNRS, Strasbourg, France.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 63231-63-0 (RNA)
SB  - IM
MH  - Base Sequence
MH  - Computer Simulation
MH  - High-Throughput Nucleotide Sequencing/*methods
MH  - *Models, Chemical
MH  - Models, Genetic
MH  - *Models, Molecular
MH  - Molecular Sequence Data
MH  - Nucleic Acid Conformation
MH  - RNA/*genetics/*ultrastructure
MH  - Sequence Alignment/methods
MH  - Sequence Analysis, RNA/*methods
EDAT- 2015/09/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/09 06:00
PHST- 2015/09/09 06:00 [entrez]
PHST- 2015/09/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3338 [pii]
AID - 10.1038/nbt.3338 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):928-9. doi: 10.1038/nbt.3338.

PMID- 26348959
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20150909
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - Biotechnology patents under fire.
PG  - 925-6
LID - 10.1038/nbt.3334 [doi]
FAU - Royzman, Irena
AU  - Royzman I
AD  - Patterson Belknap Webb &Tyler LLP, New York, New York, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*legislation & jurisprudence
MH  - Cloning, Organism/*legislation & jurisprudence
MH  - Genetic Engineering/*legislation & jurisprudence
MH  - Liability, Legal
MH  - Ownership/*legislation & jurisprudence
MH  - Patents as Topic/*legislation & jurisprudence
MH  - *Supreme Court Decisions
MH  - United States
EDAT- 2015/09/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/09 06:00
PHST- 2015/09/09 06:00 [entrez]
PHST- 2015/09/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3334 [pii]
AID - 10.1038/nbt.3334 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):925-6. doi: 10.1038/nbt.3334.

PMID- 26348958
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20171206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - Unpatients-why patients should own their medical data.
PG  - 921-4
LID - 10.1038/nbt.3340 [doi]
FAU - Kish, Leonard J
AU  - Kish LJ
AD  - Unpatient.org, Denver, Colorado, USA.
FAU - Topol, Eric J
AU  - Topol EJ
AD  - The Scripps Research Institute, and Scripps Health, La Jolla, California, USA.
LA  - eng
GR  - UL1 TR001114/TR/NCATS NIH HHS/United States
GR  - 8 UL1 TR001114/TR/NCATS NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CIN - Nat Biotechnol. 2016 Jun 9;34(6):586. PMID: 27281409
CIN - Nat Biotechnol. 2016 Jun 9;34(6):586-7. PMID: 27281408
MH  - *Confidentiality
MH  - Electronic Health Records/*organization & administration
MH  - *Health Records, Personal
MH  - *Ownership
MH  - *Patient Access to Records
MH  - *Personal Autonomy
EDAT- 2015/09/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/09 06:00
PHST- 2015/09/09 06:00 [entrez]
PHST- 2015/09/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3340 [pii]
AID - 10.1038/nbt.3340 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):921-4. doi: 10.1038/nbt.3340.

PMID- 26348957
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - Building a business model in digital medicine.
PG  - 910-20
LID - 10.1038/nbt.3339 [doi]
FAU - Steinberg, David
AU  - Steinberg D
AD  - PureTech, Boston, Massachusetts, USA.
FAU - Horwitz, Geoffrey
AU  - Horwitz G
AD  - PureTech, Boston, Massachusetts, USA.
FAU - Zohar, Daphne
AU  - Zohar D
AD  - PureTech, Boston, Massachusetts, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*organization & administration
MH  - Commerce/*organization & administration
MH  - Drug Industry/*organization & administration
MH  - Health Care Sector/*organization & administration
MH  - *Models, Economic
MH  - *Models, Organizational
EDAT- 2015/09/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/09 06:00
PHST- 2015/09/09 06:00 [entrez]
PHST- 2015/09/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3339 [pii]
AID - 10.1038/nbt.3339 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):910-20. doi: 10.1038/nbt.3339.

PMID- 26348956
OWN - NLM
STAT- MEDLINE
DCOM- 20151203
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - Contesting estimates of cryopreserved embryos in the United States.
PG  - 909
LID - 10.1038/nbt.3342 [doi]
FAU - Snow, Dave
AU  - Snow D
AD  - Department of Political Science, University of Guelph, Guelph, Ontario, Canada.
FAU - Cattapan, Alana
AU  - Cattapan A
AD  - Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
FAU - Baylis, Francoise
AU  - Baylis F
AD  - Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
AD  - Faculty of Arts and Social Sciences, Dalhousie University, Halifax, Nova Scotia, 
      Canada.
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2013 Apr;31(4):288-90. PMID: 23563418
CIN - Nat Biotechnol. 2015 Sep;33(9):909. PMID: 26348955
MH  - Cryopreservation/*methods
MH  - *Embryo Research
MH  - Humans
MH  - *Knowledge
MH  - *Stem Cell Research
EDAT- 2015/09/09 06:00
MHDA- 2015/12/15 06:00
CRDT- 2015/09/09 06:00
PHST- 2015/09/09 06:00 [entrez]
PHST- 2015/09/09 06:00 [pubmed]
PHST- 2015/12/15 06:00 [medline]
AID - nbt.3342 [pii]
AID - 10.1038/nbt.3342 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):909. doi: 10.1038/nbt.3342.

PMID- 26348955
OWN - NLM
STAT- MEDLINE
DCOM- 20151203
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - Reply to Contesting estimates of cryopreserved embryos in the United States.
PG  - 909
LID - 10.1038/nbt.3348 [doi]
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2013 Apr;31(4):288-90. PMID: 23563418
CON - Nat Biotechnol. 2015 Sep;33(9):909. PMID: 26348956
MH  - Cryopreservation/*methods
MH  - *Embryo Research
MH  - Humans
MH  - *Knowledge
MH  - *Stem Cell Research
EDAT- 2015/09/09 06:00
MHDA- 2015/12/15 06:00
CRDT- 2015/09/09 06:00
PHST- 2015/09/09 06:00 [entrez]
PHST- 2015/09/09 06:00 [pubmed]
PHST- 2015/12/15 06:00 [medline]
AID - nbt.3348 [pii]
AID - 10.1038/nbt.3348 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):909. doi: 10.1038/nbt.3348.

PMID- 26348954
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20150909
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - The nonsensical GMO pseudo-category and a precautionary rabbit hole.
PG  - 907-8
LID - 10.1038/nbt.3333 [doi]
FAU - Tagliabue, Giovanni
AU  - Tagliabue G
AD  - Carugo, Como, Italy.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Crops, Agricultural/*classification/*genetics
MH  - Food, Genetically Modified/*classification
MH  - Internationality
MH  - Organisms, Genetically Modified/*classification/*genetics
MH  - *Terminology as Topic
EDAT- 2015/09/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/09 06:00
PHST- 2015/09/09 06:00 [entrez]
PHST- 2015/09/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3333 [pii]
AID - 10.1038/nbt.3333 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):907-8. doi: 10.1038/nbt.3333.

PMID- 26348953
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - Removing Bt eggplant from the face of Indian regulators.
PG  - 904-7
LID - 10.1038/nbt.3331 [doi]
FAU - Gupta, Pushpendra Kumar
AU  - Gupta PK
AD  - Department of Genetics and Plant Breeding, Chaudhary Charan Singh University,
      Meerut, India.
FAU - Choudhary, Bhagirath
AU  - Choudhary B
AD  - Department of Molecular Biotechnology, Faculty of Bioscience Engineering, Ghent
      University, Gent, Belgium.
AD  - Institute of Plant Biotechnology Outreach, Ghent University, Gent, Belgium.
FAU - Gheysen, Godelieve
AU  - Gheysen G
AD  - Department of Molecular Biotechnology, Faculty of Bioscience Engineering, Ghent
      University, Gent, Belgium.
AD  - Institute of Plant Biotechnology Outreach, Ghent University, Gent, Belgium.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Bacterial Proteins)
RN  - 0 (Endotoxins)
RN  - 0 (Hemolysin Proteins)
RN  - 0 (insecticidal crystal protein, Bacillus Thuringiensis)
SB  - IM
MH  - Bacterial Proteins/*genetics
MH  - Endotoxins/*genetics
MH  - *Food, Genetically Modified
MH  - *Government Regulation
MH  - Hemolysin Proteins/*genetics
MH  - India
MH  - *Legislation, Food
MH  - Pest Control, Biological/*legislation & jurisprudence
MH  - Plants, Genetically Modified/genetics
MH  - Solanum melongena/*genetics
EDAT- 2015/09/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/09 06:00
PHST- 2015/09/09 06:00 [entrez]
PHST- 2015/09/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3331 [pii]
AID - 10.1038/nbt.3331 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):904-7. doi: 10.1038/nbt.3331.

PMID- 26348952
OWN - NLM
STAT- MEDLINE
DCOM- 20151203
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - The payers' perspective on gene therapies.
PG  - 902-4
LID - 10.1038/nbt.3332 [doi]
FAU - Touchot, Nicolas
AU  - Touchot N
AD  - groupH, Strategy Consulting, London, UK.
FAU - Flume, Mathias
AU  - Flume M
AD  - Kassenarztliche Vereinigung Westfalen Lippe, Prescription Management, Dortmund,
      Germany.
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2014 Sep;32(9):874-6. PMID: 25203033
MH  - Genetic Therapy/*economics
MH  - Humans
EDAT- 2015/09/09 06:00
MHDA- 2015/12/15 06:00
CRDT- 2015/09/09 06:00
PHST- 2015/09/09 06:00 [entrez]
PHST- 2015/09/09 06:00 [pubmed]
PHST- 2015/12/15 06:00 [medline]
AID - nbt.3332 [pii]
AID - 10.1038/nbt.3332 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):902-4. doi: 10.1038/nbt.3332.

PMID- 26348951
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - Availability and payer coverage of BRCA1/2 tests and gene panels.
PG  - 900-2
LID - 10.1038/nbt.3322 [doi]
FAU - Clain, Elizabeth
AU  - Clain E
AD  - Albert Einstein College of Medicine, Bronx, New York, USA.
FAU - Trosman, Julia R
AU  - Trosman JR
AD  - Center for Business Models in Healthcare, Chicago, Illinois, USA.
AD  - University of California at San Francisco, Department of Clinical Pharmacy,
      Center for Translational and Policy Research on Personalized Medicine
      (TRANSPERS), San Francisco, California, USA.
FAU - Douglas, Michael P
AU  - Douglas MP
AUID- ORCID: http://orcid.org/0000-0001-8517-6678
AD  - University of California at San Francisco, Department of Clinical Pharmacy,
      Center for Translational and Policy Research on Personalized Medicine
      (TRANSPERS), San Francisco, California, USA.
FAU - Weldon, Christine B
AU  - Weldon CB
AD  - Center for Business Models in Healthcare, Chicago, Illinois, USA.
AD  - University of California at San Francisco, Department of Clinical Pharmacy,
      Center for Translational and Policy Research on Personalized Medicine
      (TRANSPERS), San Francisco, California, USA.
FAU - Phillips, Kathryn A
AU  - Phillips KA
AD  - University of California at San Francisco, Department of Clinical Pharmacy,
      Center for Translational and Policy Research on Personalized Medicine
      (TRANSPERS), San Francisco, California, USA.
AD  - UCSF Philip R. Lee Institute for Health Policy and UCSF Helen Diller Family
      Comprehensive Cancer Center, San Francisco, California, USA.
LA  - eng
GR  - R01 HG007063/HG/NHGRI NIH HHS/United States
GR  - 5P30CA082013-15/CA/NCI NIH HHS/United States
GR  - R01HG007063/HG/NHGRI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (BRCA1 Protein)
RN  - 0 (BRCA2 Protein)
RN  - 0 (BRCA2 protein, human)
RN  - 0 (Biomarkers, Tumor)
RN  - 0 (Genetic Markers)
SB  - IM
MH  - BRCA1 Protein/genetics
MH  - BRCA2 Protein/genetics
MH  - Biomarkers, Tumor/genetics
MH  - Genetic Markers/genetics
MH  - Health Services Accessibility/*economics/statistics & numerical data
MH  - High-Throughput Screening Assays/*economics/*utilization
MH  - Humans
MH  - Insurance, Health, Reimbursement/*economics
MH  - Multigene Family/genetics
MH  - Neoplasms/diagnosis/*economics/*genetics
MH  - Polymorphism, Single Nucleotide/genetics
MH  - United States
PMC - PMC4625918
MID - NIHMS732430
EDAT- 2015/09/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/09 06:00
PHST- 2015/09/09 06:00 [entrez]
PHST- 2015/09/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3322 [pii]
AID - 10.1038/nbt.3322 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):900-2. doi: 10.1038/nbt.3322.

PMID- 26348950
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - Why microbial diagnostics need more than money.
PG  - 898-900
LID - 10.1038/nbt.3328 [doi]
FAU - Kessel, Mark
AU  - Kessel M
AD  - FIND, Geneva, Switzerland.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Bacterial Infections/*diagnosis/*economics/microbiology
MH  - Bacterial Typing Techniques/*methods
MH  - Drug Industry/*economics
MH  - *Drug Resistance, Microbial
MH  - Molecular Diagnostic Techniques/*methods
MH  - United States
EDAT- 2015/09/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/09 06:00
PHST- 2015/09/09 06:00 [entrez]
PHST- 2015/09/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3328 [pii]
AID - 10.1038/nbt.3328 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):898-900. doi: 10.1038/nbt.3328.

PMID- 26348949
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20150909
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - 3D Printed clothing house microorganisms.
PG  - 896
LID - 10.1038/nbt0915-896a [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Bioartificial Organs
MH  - Biomimetic Materials/*chemical synthesis
MH  - Biomimetics/*instrumentation
MH  - *Clothing
MH  - Equipment Design
MH  - Humans
MH  - Intestines/*microbiology
MH  - *Printing, Three-Dimensional
EDAT- 2015/09/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/09 06:00
PHST- 2015/09/09 06:00 [entrez]
PHST- 2015/09/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt0915-896a [pii]
AID - 10.1038/nbt0915-896a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):896. doi: 10.1038/nbt0915-896a.

PMID- 26348948
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20150909
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - Around the world in a month.
PG  - 896
LID - 10.1038/nbt0915-896c [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Agriculture/*organization & administration
MH  - Biomedical Research/*organization & administration
MH  - Biotechnology/*organization & administration
MH  - Drug Industry/*organization & administration
MH  - *Genetic Engineering
MH  - Internationality
EDAT- 2015/09/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/09 06:00
PHST- 2015/09/09 06:00 [entrez]
PHST- 2015/09/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt0915-896c [pii]
AID - 10.1038/nbt0915-896c [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):896. doi: 10.1038/nbt0915-896c.

PMID- 26348947
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20151203
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - Corrections.
PG  - 896
LID - 10.1038/nbt0915-896b [doi]
LA  - eng
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2015 Aug;33(8):787-8. PMID: 26252119
EDAT- 2015/09/09 06:00
MHDA- 2015/09/09 06:01
CRDT- 2015/09/09 06:00
PHST- 2015/09/09 06:00 [entrez]
PHST- 2015/09/09 06:00 [pubmed]
PHST- 2015/09/09 06:01 [medline]
AID - nbt0915-896b [pii]
AID - 10.1038/nbt0915-896b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):896. doi: 10.1038/nbt0915-896b.

PMID- 26348946
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20171116
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - Suicidal thoughts end Amgen's blockbuster aspirations for psoriasis drug.
PG  - 894-5
LID - 10.1038/nbt0915-894b [doi]
FAU - Schmidt, Charlie
AU  - Schmidt C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antibodies, Monoclonal)
RN  - 0 (Dermatologic Agents)
RN  - 6ZA31Y954Z (brodalumab)
SB  - IM
MH  - Antibodies, Monoclonal/*adverse effects/therapeutic use
MH  - *Clinical Trials as Topic
MH  - Dermatologic Agents/adverse effects/therapeutic use
MH  - Drug Industry/*organization & administration
MH  - *Early Termination of Clinical Trials
MH  - Humans
MH  - Psoriasis/*drug therapy
MH  - *Suicidal Ideation
EDAT- 2015/09/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/09 06:00
PHST- 2015/09/09 06:00 [entrez]
PHST- 2015/09/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt0915-894b [pii]
AID - 10.1038/nbt0915-894b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):894-5. doi: 10.1038/nbt0915-894b.

PMID- 26348945
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20150909
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - Revamp biotech rules, says White House.
PG  - 894
LID - 10.1038/nbt0915-894a [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Biological Products)
SB  - IM
MH  - Biological Products/*classification
MH  - Biotechnology/*legislation & jurisprudence
MH  - *Federal Government
MH  - *Food, Genetically Modified
MH  - Genetic Engineering/*legislation & jurisprudence
MH  - *Government Regulation
MH  - United States
EDAT- 2015/09/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/09 06:00
PHST- 2015/09/09 06:00 [entrez]
PHST- 2015/09/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt0915-894a [pii]
AID - 10.1038/nbt0915-894a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):894. doi: 10.1038/nbt0915-894a.

PMID- 26348944
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20150909
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - Celgene samples from science smorgasbord.
PG  - 892-3
LID - 10.1038/nbt0915-892 [doi]
FAU - Mullard, Asher
AU  - Mullard A
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*organization & administration
MH  - *Drug Design
MH  - Drug Industry/*organization & administration
MH  - *Models, Organizational
MH  - New Jersey
MH  - *Organizational Objectives
MH  - Science/*organization & administration
EDAT- 2015/09/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/09 06:00
PHST- 2015/09/09 06:00 [entrez]
PHST- 2015/09/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt0915-892 [pii]
AID - 10.1038/nbt0915-892 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):892-3. doi: 10.1038/nbt0915-892.

PMID- 26348943
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20150909
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - 21st Century Cures Act wins in US House.
PG  - 891
LID - 10.1038/nbt0915-891 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biomedical Research/*economics/legislation & jurisprudence
MH  - Budgets/legislation & jurisprudence
MH  - *Federal Government
MH  - Financing, Government/*economics/*legislation & jurisprudence
MH  - National Institutes of Health (U.S.)/*economics/legislation & jurisprudence
MH  - United States
MH  - United States Food and Drug Administration/*economics/legislation & jurisprudence
EDAT- 2015/09/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/09 06:00
PHST- 2015/09/09 06:00 [entrez]
PHST- 2015/09/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt0915-891 [pii]
AID - 10.1038/nbt0915-891 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):891. doi: 10.1038/nbt0915-891.

PMID- 26348942
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20150909
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - RIKEN suspends first clinical trial involving induced pluripotent stem cells.
PG  - 890-1
LID - 10.1038/nbt0915-890 [doi]
FAU - Garber, Ken
AU  - Garber K
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Clinical Trials as Topic
MH  - Drug Approval
MH  - *Early Termination of Clinical Trials
MH  - Humans
MH  - Japan
MH  - Macular Degeneration/*therapy
MH  - Pluripotent Stem Cells/*transplantation
MH  - *Stem Cell Research
MH  - *Stem Cell Transplantation
EDAT- 2015/09/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/09 06:00
PHST- 2015/09/09 06:00 [entrez]
PHST- 2015/09/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt0915-890 [pii]
AID - 10.1038/nbt0915-890 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):890-1. doi: 10.1038/nbt0915-890.

PMID- 26348941
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20161125
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - UK biotech smashes financing record.
PG  - 889
LID - 10.1038/nbt0915-889a [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*economics
MH  - Drug Industry/*economics
MH  - *Healthcare Financing
MH  - Investments/*economics
MH  - United Kingdom
EDAT- 2015/09/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/09 06:00
PHST- 2015/09/09 06:00 [entrez]
PHST- 2015/09/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt0915-889a [pii]
AID - 10.1038/nbt0915-889a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):889. doi: 10.1038/nbt0915-889a.

PMID- 26348940
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20150909
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - BEAM to fight antimicrobial resistance.
PG  - 889
LID - 10.1038/nbt0915-889b [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Anti-Bacterial Agents)
SB  - IM
MH  - Anti-Bacterial Agents/administration & dosage/*chemical synthesis
MH  - Biotechnology/*organization & administration
MH  - *Drug Design
MH  - Drug Industry/*organization & administration
MH  - Drug Resistance, Microbial/*drug effects
MH  - *Interinstitutional Relations
EDAT- 2015/09/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/09 06:00
PHST- 2015/09/09 06:00 [entrez]
PHST- 2015/09/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt0915-889b [pii]
AID - 10.1038/nbt0915-889b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):889. doi: 10.1038/nbt0915-889b.

PMID- 26348939
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - Omics-driven startups challenge healthcare model.
PG  - 887-9
LID - 10.1038/nbt0915-887 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*organization & administration
MH  - Drug Industry/*organization & administration
MH  - Entrepreneurship/*organization & administration
MH  - Genomics/*organization & administration
MH  - Health Care Sector/*organization & administration
MH  - *Models, Organizational
MH  - Organizational Objectives
EDAT- 2015/09/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/09 06:00
PHST- 2015/09/09 06:00 [entrez]
PHST- 2015/09/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt0915-887 [pii]
AID - 10.1038/nbt0915-887 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):887-9. doi: 10.1038/nbt0915-887.

PMID- 26348938
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20150909
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - Incentivizing data donation.
PG  - 885
LID - 10.1038/nbt.3341 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Computer Security
MH  - *Confidentiality
MH  - Electronic Health Records/*organization & administration
MH  - Information Dissemination/*methods
MH  - Information Storage and Retrieval/*methods
MH  - Medical Record Linkage/*methods
MH  - Motivation
MH  - Software
EDAT- 2015/09/09 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/09/09 06:00
PHST- 2015/09/09 06:00 [entrez]
PHST- 2015/09/09 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3341 [pii]
AID - 10.1038/nbt.3341 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):885. doi: 10.1038/nbt.3341.

PMID- 26280413
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - Overexpression of receptor-like kinase ERECTA improves thermotolerance in rice
      and tomato.
PG  - 996-1003
LID - 10.1038/nbt.3321 [doi]
AB  - The detrimental effects of global warming on crop productivity threaten to reduce
      the world's food supply. Although plant responses to changes in temperature have 
      been studied, genetic modification of crops to improve thermotolerance has had
      little success to date. Here we demonstrate that overexpression of the
      Arabidopsis thaliana receptor-like kinase ERECTA (ER) in Arabidopsis, rice and
      tomato confers thermotolerance independent of water loss and that Arabidopsis er 
      mutants are hypersensitive to heat. A loss-of-function mutation of a rice ER
      homolog and reduced expression of a tomato ER allele decreased thermotolerance of
      both species. Transgenic tomato and rice lines overexpressing Arabidopsis ER
      showed improved heat tolerance in the greenhouse and in field tests at multiple
      locations in China during several seasons. Moreover, ER-overexpressing transgenic
      Arabidopsis, tomato and rice plants had increased biomass. Our findings could
      contribute to engineering or breeding thermotolerant crops with no growth
      penalty.
FAU - Shen, Hui
AU  - Shen H
AD  - National Key Laboratory of Plant Molecular Genetics and National Center of Plant 
      Gene Research, Institute of Plant Physiology &Ecology, Shanghai Institutes for
      Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
AD  - Shanghai Chenshan Plant Science Research Center, Chinese Academy of Sciences,
      Shanghai Chenshan Botanical Garden, Shanghai, China.
FAU - Zhong, Xiangbin
AU  - Zhong X
AD  - National Key Laboratory of Plant Molecular Genetics and National Center of Plant 
      Gene Research, Institute of Plant Physiology &Ecology, Shanghai Institutes for
      Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
FAU - Zhao, Fangfang
AU  - Zhao F
AD  - National Key Laboratory of Plant Molecular Genetics and National Center of Plant 
      Gene Research, Institute of Plant Physiology &Ecology, Shanghai Institutes for
      Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
FAU - Wang, Yanmei
AU  - Wang Y
AD  - National Key Laboratory of Plant Molecular Genetics and National Center of Plant 
      Gene Research, Institute of Plant Physiology &Ecology, Shanghai Institutes for
      Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
FAU - Yan, Bingxiao
AU  - Yan B
AD  - National Key Laboratory of Plant Molecular Genetics and National Center of Plant 
      Gene Research, Institute of Plant Physiology &Ecology, Shanghai Institutes for
      Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
FAU - Li, Qun
AU  - Li Q
AD  - National Key Laboratory of Plant Molecular Genetics and National Center of Plant 
      Gene Research, Institute of Plant Physiology &Ecology, Shanghai Institutes for
      Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
FAU - Chen, Genyun
AU  - Chen G
AD  - National Key Laboratory of Plant Molecular Genetics and National Center of Plant 
      Gene Research, Institute of Plant Physiology &Ecology, Shanghai Institutes for
      Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
FAU - Mao, Bizeng
AU  - Mao B
AD  - College of Agriculture and Biotechnology, Zhejiang University, Hangzhou, China.
FAU - Wang, Jianjun
AU  - Wang J
AD  - Zhejiang Academy of Agricultural Sciences, Hangzhou, China.
FAU - Li, Yangsheng
AU  - Li Y
AD  - College of Life Science, Wuhan University, Hubei, China.
FAU - Xiao, Guoying
AU  - Xiao G
AD  - Institute of Subtropical Agriculture, Chinese Academy of Sciences, Changsha,
      China.
FAU - He, Yuke
AU  - He Y
AUID- ORCID: http://orcid.org/0000-0001-6345-5115
AD  - National Key Laboratory of Plant Molecular Genetics and National Center of Plant 
      Gene Research, Institute of Plant Physiology &Ecology, Shanghai Institutes for
      Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
FAU - Xiao, Han
AU  - Xiao H
AD  - National Key Laboratory of Plant Molecular Genetics and National Center of Plant 
      Gene Research, Institute of Plant Physiology &Ecology, Shanghai Institutes for
      Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
FAU - Li, Jianming
AU  - Li J
AD  - Shanghai Center for Plant Stress Biology, Shanghai Institutes for Biological
      Sciences, Chinese Academy of Sciences, Shanghai, China.
FAU - He, Zuhua
AU  - He Z
AD  - National Key Laboratory of Plant Molecular Genetics and National Center of Plant 
      Gene Research, Institute of Plant Physiology &Ecology, Shanghai Institutes for
      Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
AD  - Collaborative Innovation Center of Genetics and Development, Institute of Plant
      Physiology &Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy
      of Sciences, Shanghai, China.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150817
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Arabidopsis Proteins)
RN  - 0 (Receptors, Cell Surface)
RN  - EC 2.7.1.- (ER protein, Arabidopsis)
RN  - EC 2.7.11.1 (Protein-Serine-Threonine Kinases)
SB  - IM
MH  - Adaptation, Physiological/genetics
MH  - Arabidopsis Proteins/*genetics
MH  - Genetic Enhancement/*methods
MH  - Heat-Shock Response/*physiology
MH  - Hot Temperature
MH  - Lycopersicon esculentum/*physiology
MH  - Oryza/*physiology
MH  - Plants, Genetically Modified/*physiology
MH  - Protein-Serine-Threonine Kinases/*genetics
MH  - Receptors, Cell Surface/*genetics
MH  - Up-Regulation/physiology
EDAT- 2015/08/19 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/08/18 06:00
PHST- 2015/02/10 00:00 [received]
PHST- 2015/07/21 00:00 [accepted]
PHST- 2015/08/18 06:00 [entrez]
PHST- 2015/08/19 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3321 [pii]
AID - 10.1038/nbt.3321 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):996-1003. doi: 10.1038/nbt.3321. Epub 2015 Aug 17.

PMID- 26280412
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - High-throughput phosphoproteomics reveals in vivo insulin signaling dynamics.
PG  - 990-5
LID - 10.1038/nbt.3327 [doi]
AB  - Mass spectrometry has enabled the study of cellular signaling on a systems-wide
      scale, through the quantification of post-translational modifications, such as
      protein phosphorylation. Here we describe EasyPhos, a scalable phosphoproteomics 
      platform that now allows rapid quantification of hundreds of phosphoproteomes in 
      diverse cells and tissues at a depth of >10,000 sites. We apply this technology
      to generate time-resolved maps of insulin signaling in the mouse liver. Our
      results reveal that insulin affects ~10% of the liver phosphoproteome and that
      many known functional phosphorylation sites, and an even larger number of unknown
      sites, are modified at very early time points (<15 s after insulin delivery). Our
      kinetic data suggest that the flow of signaling information from the cell surface
      to the nucleus can occur on very rapid timescales of less than 1 min in vivo.
      EasyPhos facilitates high-throughput phosphoproteomics studies, which should
      improve our understanding of dynamic cell signaling networks and how they are
      regulated and dysregulated in disease.
FAU - Humphrey, Sean J
AU  - Humphrey SJ
AD  - Department of Proteomics and Signal Transduction, Max Planck Institute of
      Biochemistry, Martinsried, Germany.
FAU - Azimifar, S Babak
AU  - Azimifar SB
AD  - Department of Proteomics and Signal Transduction, Max Planck Institute of
      Biochemistry, Martinsried, Germany.
FAU - Mann, Matthias
AU  - Mann M
AD  - Department of Proteomics and Signal Transduction, Max Planck Institute of
      Biochemistry, Martinsried, Germany.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150817
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Insulin)
RN  - 0 (Phosphoproteins)
RN  - 0 (Proteome)
SB  - IM
MH  - Animals
MH  - Cells, Cultured
MH  - Gene Expression Profiling/methods
MH  - High-Throughput Screening Assays/*methods
MH  - Insulin/*metabolism
MH  - Liver/*metabolism
MH  - Male
MH  - Mass Spectrometry/methods
MH  - Mice
MH  - Mice, Inbred C57BL
MH  - Phosphoproteins/*metabolism
MH  - Protein Interaction Mapping/methods
MH  - Proteome/*metabolism
MH  - Signal Transduction/*physiology
EDAT- 2015/08/19 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/08/18 06:00
PHST- 2015/02/17 00:00 [received]
PHST- 2015/07/27 00:00 [accepted]
PHST- 2015/08/18 06:00 [entrez]
PHST- 2015/08/19 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3327 [pii]
AID - 10.1038/nbt.3327 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):990-5. doi: 10.1038/nbt.3327. Epub 2015 Aug 17.

PMID- 26280411
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20161025
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - Massively parallel high-order combinatorial genetics in human cells.
PG  - 952-61
LID - 10.1038/nbt.3326 [doi]
AB  - The systematic functional analysis of combinatorial genetics has been limited by 
      the throughput that can be achieved and the order of complexity that can be
      studied. To enable massively parallel characterization of genetic combinations in
      human cells, we developed a technology for rapid, scalable assembly of high-order
      barcoded combinatorial genetic libraries that can be quantified with
      high-throughput sequencing. We applied this technology, combinatorial genetics en
      masse (CombiGEM), to create high-coverage libraries of 1,521 two-wise and 51,770 
      three-wise barcoded combinations of 39 human microRNA (miRNA) precursors. We
      identified miRNA combinations that synergistically sensitize drug-resistant
      cancer cells to chemotherapy and/or inhibit cancer cell proliferation, providing 
      insights into complex miRNA networks. More broadly, our method will enable
      high-throughput profiling of multifactorial genetic combinations that regulate
      phenotypes of relevance to biomedicine, biotechnology and basic science.
FAU - Wong, Alan S L
AU  - Wong AS
AD  - Synthetic Biology Group, MIT Synthetic Biology Center, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Research Laboratory of Electronics, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
AD  - Department of Biological Engineering and Electrical Engineering &Computer
      Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
FAU - Choi, Gigi C G
AU  - Choi GC
AD  - Synthetic Biology Group, MIT Synthetic Biology Center, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Research Laboratory of Electronics, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
AD  - Department of Biological Engineering and Electrical Engineering &Computer
      Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
FAU - Cheng, Allen A
AU  - Cheng AA
AD  - Synthetic Biology Group, MIT Synthetic Biology Center, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Research Laboratory of Electronics, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
AD  - Department of Biological Engineering and Electrical Engineering &Computer
      Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
FAU - Purcell, Oliver
AU  - Purcell O
AD  - Synthetic Biology Group, MIT Synthetic Biology Center, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Research Laboratory of Electronics, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
AD  - Department of Biological Engineering and Electrical Engineering &Computer
      Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
FAU - Lu, Timothy K
AU  - Lu TK
AD  - Synthetic Biology Group, MIT Synthetic Biology Center, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
AD  - Research Laboratory of Electronics, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
AD  - Department of Biological Engineering and Electrical Engineering &Computer
      Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
LA  - eng
GR  - DP2 OD008435/OD/NIH HHS/United States
GR  - P50 GM098792/GM/NIGMS NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20150817
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Biomarkers, Tumor)
RN  - 0 (Genetic Markers)
RN  - 0 (MicroRNAs)
SB  - IM
CIN - Nat Rev Genet. 2015 Oct;16(10):564-5. PMID: 26329501
MH  - Base Sequence
MH  - Biomarkers, Tumor/*genetics
MH  - Cell Line, Tumor
MH  - Combinatorial Chemistry Techniques/*methods
MH  - Genetic Markers/genetics
MH  - High-Throughput Nucleotide Sequencing/*methods
MH  - Humans
MH  - MicroRNAs/*genetics
MH  - Molecular Sequence Data
MH  - Neoplasms, Experimental/*genetics
MH  - Sequence Analysis, RNA/*methods
PMC - PMC4785103
MID - NIHMS734803
EDAT- 2015/08/19 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/08/18 06:00
PHST- 2015/05/27 00:00 [received]
PHST- 2015/07/16 00:00 [accepted]
PHST- 2015/08/18 06:00 [entrez]
PHST- 2015/08/19 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3326 [pii]
AID - 10.1038/nbt.3326 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):952-61. doi: 10.1038/nbt.3326. Epub 2015 Aug 17.

PMID- 26258538
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - Prediction of human population responses to toxic compounds by a collaborative
      competition.
PG  - 933-40
LID - 10.1038/nbt.3299 [doi]
AB  - The ability to computationally predict the effects of toxic compounds on humans
      could help address the deficiencies of current chemical safety testing. Here, we 
      report the results from a community-based DREAM challenge to predict toxicities
      of environmental compounds with potential adverse health effects for human
      populations. We measured the cytotoxicity of 156 compounds in 884 lymphoblastoid 
      cell lines for which genotype and transcriptional data are available as part of
      the Tox21 1000 Genomes Project. The challenge participants developed algorithms
      to predict interindividual variability of toxic response from genomic profiles
      and population-level cytotoxicity data from structural attributes of the
      compounds. 179 submitted predictions were evaluated against an experimental data 
      set to which participants were blinded. Individual cytotoxicity predictions were 
      better than random, with modest correlations (Pearson's r < 0.28), consistent
      with complex trait genomic prediction. In contrast, predictions of
      population-level response to different compounds were higher (r < 0.66). The
      results highlight the possibility of predicting health risks associated with
      unknown compounds, although risk estimation accuracy remains suboptimal.
FAU - Eduati, Federica
AU  - Eduati F
AUID- ORCID: http://orcid.org/0000-0002-7822-3867
AD  - European Molecular Biology Laboratory, European Bioinformatics Institute
      (EMBL-EBI), Wellcome Trust Genome Campus, Cambridge, UK.
FAU - Mangravite, Lara M
AU  - Mangravite LM
AD  - Sage Bionetworks, Seattle, Washington, USA.
FAU - Wang, Tao
AU  - Wang T
AUID- ORCID: http://orcid.org/0000-0002-4355-149X
AD  - Quantitative Biomedical Research Center, Department of Clinical Sciences,
      University of Texas Southwestern Medical Center, Dallas, Texas, USA.
FAU - Tang, Hao
AU  - Tang H
AD  - Quantitative Biomedical Research Center, Department of Clinical Sciences,
      University of Texas Southwestern Medical Center, Dallas, Texas, USA.
AD  - The Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical
      Center, Dallas, Texas, USA.
FAU - Bare, J Christopher
AU  - Bare JC
AD  - Sage Bionetworks, Seattle, Washington, USA.
FAU - Huang, Ruili
AU  - Huang R
AD  - Division of Preclinical Innovation, National Institutes of Health Chemical
      Genomics Center, National Center for Advancing Translational Sciences, Rockville,
      Maryland, USA.
FAU - Norman, Thea
AU  - Norman T
AD  - Sage Bionetworks, Seattle, Washington, USA.
FAU - Kellen, Mike
AU  - Kellen M
AD  - Sage Bionetworks, Seattle, Washington, USA.
FAU - Menden, Michael P
AU  - Menden MP
AD  - European Molecular Biology Laboratory, European Bioinformatics Institute
      (EMBL-EBI), Wellcome Trust Genome Campus, Cambridge, UK.
FAU - Yang, Jichen
AU  - Yang J
AD  - Quantitative Biomedical Research Center, Department of Clinical Sciences,
      University of Texas Southwestern Medical Center, Dallas, Texas, USA.
FAU - Zhan, Xiaowei
AU  - Zhan X
AD  - Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA.
FAU - Zhong, Rui
AU  - Zhong R
AD  - Quantitative Biomedical Research Center, Department of Clinical Sciences,
      University of Texas Southwestern Medical Center, Dallas, Texas, USA.
FAU - Xiao, Guanghua
AU  - Xiao G
AD  - Quantitative Biomedical Research Center, Department of Clinical Sciences,
      University of Texas Southwestern Medical Center, Dallas, Texas, USA.
FAU - Xia, Menghang
AU  - Xia M
AD  - Division of Preclinical Innovation, National Institutes of Health Chemical
      Genomics Center, National Center for Advancing Translational Sciences, Rockville,
      Maryland, USA.
FAU - Abdo, Nour
AU  - Abdo N
AD  - Department of Environmental Sciences and Engineering, University of North
      Carolina, Chapel Hill, North Carolina, USA.
AD  - Department of Public Health, Faculty of Medicine, Jordan University of Science
      and Technology, Irbid, Jordan.
FAU - Kosyk, Oksana
AU  - Kosyk O
AD  - Department of Environmental Sciences and Engineering, University of North
      Carolina, Chapel Hill, North Carolina, USA.
CN  - NIEHS-NCATS-UNC DREAM Toxicogenetics Collaboration
FAU - Friend, Stephen
AU  - Friend S
FAU - Dearry, Allen
AU  - Dearry A
FAU - Simeonov, Anton
AU  - Simeonov A
FAU - Tice, Raymond R
AU  - Tice RR
FAU - Rusyn, Ivan
AU  - Rusyn I
FAU - Wright, Fred A
AU  - Wright FA
FAU - Stolovitzky, Gustavo
AU  - Stolovitzky G
FAU - Xie, Yang
AU  - Xie Y
FAU - Saez-Rodriguez, Julio
AU  - Saez-Rodriguez J
LA  - eng
GR  - R01 HG006292/HG/NHGRI NIH HHS/United States
GR  - 1R01CA172211/CA/NCI NIH HHS/United States
GR  - R01 CA161608/CA/NCI NIH HHS/United States
GR  - G0902104/Medical Research Council/United Kingdom
GR  - R01CA161608/CA/NCI NIH HHS/United States
GR  - 5R01CA152301/CA/NCI NIH HHS/United States
GR  - R01 CA152301/CA/NCI NIH HHS/United States
GR  - R01HG006292/HG/NHGRI NIH HHS/United States
GR  - R01 CA172211/CA/NCI NIH HHS/United States
GR  - Y02 ES007020/ES/NIEHS NIH HHS/United States
GR  - P42 ES005948/ES/NIEHS NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20150810
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Hazardous Substances)
SB  - IM
EIN - Nat Biotechnol. 2015 Oct;33(10):1109. Friend, Stephen; Dearry, Allen; Simeonov,
      Anton; Tice, Raymond R; Rusyn, Ivan; Wright, Fred A; Stolovitzky, Gustavo; Xie,
      Yang; and Saez-Rodriguez, Julio [Added]. PMID: 26448092
MH  - Computer Simulation
MH  - Dose-Response Relationship, Drug
MH  - Genetic Predisposition to Disease/*genetics
MH  - Genetics, Population
MH  - Hazardous Substances/*toxicity
MH  - High-Throughput Screening Assays/*methods
MH  - Humans
MH  - Incidence
MH  - Lymphocytes/cytology/*drug effects/physiology
MH  - *Models, Genetic
MH  - Risk Assessment/methods
MH  - Toxicity Tests/methods
PMC - PMC4568441
MID - NIHMS703453
IR  - Eduati F
FIR - Eduati, Federica
IR  - Mangravite LM
FIR - Mangravite, Lara M
IR  - Bare JC
FIR - Bare, J Christopher
IR  - Norman T
FIR - Norman, Thea
IR  - Kellen M
FIR - Kellen, Mike
IR  - Menden MP
FIR - Menden, Michael P
IR  - Friend S
FIR - Friend, Stephen
IR  - Stolovitzky G
FIR - Stolovitzky, Gustavo
IR  - Dearry A
FIR - Dearry, Allen
IR  - Tice RR
FIR - Tice, Raymond R
IR  - Huang R
FIR - Huang, Ruili
IR  - Xia M
FIR - Xia, Menghang
IR  - Simeonov A
FIR - Simeonov, Anton
IR  - Abdo N
FIR - Abdo, Nour
IR  - Kosyk O
FIR - Kosyk, Oksana
IR  - Rusyn I
FIR - Rusyn, Ivan
IR  - Wright FA
FIR - Wright, Fred A
IR  - Wang T
FIR - Wang, Tao
IR  - Tang H
FIR - Tang, Hao
IR  - Zhan X
FIR - Zhan, Xiaowei
IR  - Yang J
FIR - Yang, Jichen
IR  - Zhong R
FIR - Zhong, Rui
IR  - Xiao G
FIR - Xiao, Guanghua
IR  - Xie Y
FIR - Xie, Yang
IR  - Tang H
FIR - Tang, Hao
IR  - Yang J
FIR - Yang, Jichen
IR  - Wang T
FIR - Wang, Tao
IR  - Xiao G
FIR - Xiao, Guanghua
IR  - Xie Y
FIR - Xie, Yang
IR  - Alaimo S
FIR - Alaimo, Salvatore
IR  - Amadoz A
FIR - Amadoz, Alicia
IR  - Ammad-Ud-Din M
FIR - Ammad-Ud-Din, Muhammad
IR  - Azencott CA
FIR - Azencott, Chloe-Agathe
IR  - Bacardit J
FIR - Bacardit, Jaume
IR  - Barron P
FIR - Barron, Pelham
IR  - Bernard E
FIR - Bernard, Elsa
IR  - Beyer A
FIR - Beyer, Andreas
IR  - Bin S
FIR - Bin, Shao
IR  - van Bommel A
FIR - van Bommel, Alena
IR  - Borgwardt K
FIR - Borgwardt, Karsten
IR  - Brys AM
FIR - Brys, April M
IR  - Caffrey B
FIR - Caffrey, Brian
IR  - Chang J
FIR - Chang, Jeffrey
IR  - Chang J
FIR - Chang, Jungsoo
IR  - Christodoulou EG
FIR - Christodoulou, Eleni G
IR  - Clement-Ziza M
FIR - Clement-Ziza, Mathieu
IR  - Cohen T
FIR - Cohen, Trevor
IR  - Cowherd M
FIR - Cowherd, Marianne
IR  - Demeyer S
FIR - Demeyer, Sofie
IR  - Dopazo J
FIR - Dopazo, Joaquin
IR  - Elhard JD
FIR - Elhard, Joel D
IR  - Falcao AO
FIR - Falcao, Andre O
IR  - Ferro A
FIR - Ferro, Alfredo
IR  - Friedenberg DA
FIR - Friedenberg, David A
IR  - Giugno R
FIR - Giugno, Rosalba
IR  - Gong Y
FIR - Gong, Yunguo
IR  - Gorospe JW
FIR - Gorospe, Jenni W
IR  - Granville CA
FIR - Granville, Courtney A
IR  - Grimm D
FIR - Grimm, Dominik
IR  - Heinig M
FIR - Heinig, Matthias
IR  - Hernansaiz RD
FIR - Hernansaiz, Rosa D
IR  - Hochreiter S
FIR - Hochreiter, Sepp
IR  - Huang LC
FIR - Huang, Liang-Chin
IR  - Huska M
FIR - Huska, Matthew
IR  - Jiao Y
FIR - Jiao, Yunlong
IR  - Klambauer G
FIR - Klambauer, Gunter
IR  - Kuhn M
FIR - Kuhn, Michael
IR  - Kursa MB
FIR - Kursa, Miron Bartosz
IR  - Kutum R
FIR - Kutum, Rintu
IR  - Lazzarini N
FIR - Lazzarini, Nicola
IR  - Lee I
FIR - Lee, Inhan
IR  - Leung MK
FIR - Leung, Michael K K
IR  - Lim WK
FIR - Lim, Weng Khong
IR  - Liu C
FIR - Liu, Charlie
IR  - Lopez FL
FIR - Lopez, Felipe Llinares
IR  - Mammana A
FIR - Mammana, Alessandro
IR  - Mayr A
FIR - Mayr, Andreas
IR  - Michoel T
FIR - Michoel, Tom
IR  - Mongiovi M
FIR - Mongiovi, Misael
IR  - Moore JD
FIR - Moore, Jonathan D
IR  - Narasimhan R
FIR - Narasimhan, Ravi
IR  - Opiyo SO
FIR - Opiyo, Stephen O
IR  - Pandey G
FIR - Pandey, Gaurav
IR  - Peabody AL
FIR - Peabody, Andrea L
IR  - Perner J
FIR - Perner, Juliane
IR  - Pulvirenti A
FIR - Pulvirenti, Alfredo
IR  - Rawlik K
FIR - Rawlik, Konrad
IR  - Reinhardt S
FIR - Reinhardt, Susanne
IR  - Riffle CG
FIR - Riffle, Carol G
IR  - Ruderfer D
FIR - Ruderfer, Douglas
IR  - Sander AJ
FIR - Sander, Aaron J
IR  - Savage RS
FIR - Savage, Richard S
IR  - Scornet E
FIR - Scornet, Erwan
IR  - Sebastian-Leon P
FIR - Sebastian-Leon, Patricia
IR  - Sharan R
FIR - Sharan, Roded
IR  - Simon-Gabriel CJ
FIR - Simon-Gabriel, Carl Johann
IR  - Stoven V
FIR - Stoven, Veronique
IR  - Sun J
FIR - Sun, Jingchun
IR  - Tang H
FIR - Tang, Hao
IR  - Teixeira AL
FIR - Teixeira, Ana L
IR  - Tenesa A
FIR - Tenesa, Albert
IR  - Vert JP
FIR - Vert, Jean-Philippe
IR  - Vingron M
FIR - Vingron, Martin
IR  - Wang T
FIR - Wang, Tao
IR  - Walter T
FIR - Walter, Thomas
IR  - Whalen S
FIR - Whalen, Sean
IR  - Wisniewska Z
FIR - Wisniewska, Zofia
IR  - Wu Y
FIR - Wu, Yonghui
IR  - Xiao G
FIR - Xiao, Guanghua
IR  - Xie Y
FIR - Xie, Yang
IR  - Xu H
FIR - Xu, Hua
IR  - Yang J
FIR - Yang, Jichen
IR  - Zhan X
FIR - Zhan, Xiaowei
IR  - Zhang S
FIR - Zhang, Shihua
IR  - Zhao J
FIR - Zhao, Junfei
IR  - Zheng WJ
FIR - Zheng, W Jim
IR  - Zhong R
FIR - Zhong, Rui
IR  - Ziwei D
FIR - Ziwei, Dai
IR  - Friend S
FIR - Friend, Stephen
IR  - Dearry A
FIR - Dearry, Allen
IR  - Simeonov A
FIR - Simeonov, Anton
IR  - Tice RR
FIR - Tice, Raymond R
IR  - Rusyn I
FIR - Rusyn, Ivan
IR  - Wright FA
FIR - Wright, Fred A
IR  - Stolovitzky G
FIR - Stolovitzky, Gustavo
IR  - Xie Y
FIR - Xie, Yang
IR  - Saez-Rodriguez J
FIR - Saez-Rodriguez, Julio
EDAT- 2015/08/11 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/08/11 06:00
PHST- 2014/11/17 00:00 [received]
PHST- 2015/06/25 00:00 [accepted]
PHST- 2015/08/11 06:00 [entrez]
PHST- 2015/08/11 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3299 [pii]
AID - 10.1038/nbt.3299 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):933-40. doi: 10.1038/nbt.3299. Epub 2015 Aug 10.

PMID- 26237517
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - Differentiation of pluripotent stem cells to muscle fiber to model Duchenne
      muscular dystrophy.
PG  - 962-9
LID - 10.1038/nbt.3297 [doi]
AB  - During embryonic development, skeletal muscles arise from somites, which derive
      from the presomitic mesoderm (PSM). Using PSM development as a guide, we
      establish conditions for the differentiation of monolayer cultures of mouse
      embryonic stem (ES) cells into PSM-like cells without the introduction of
      transgenes or cell sorting. We show that primary and secondary skeletal
      myogenesis can be recapitulated in vitro from the PSM-like cells, providing an
      efficient, serum-free protocol for the generation of striated, contractile fibers
      from mouse and human pluripotent cells. The mouse ES cells also differentiate
      into Pax7(+) cells with satellite cell characteristics, including the ability to 
      form dystrophin(+) fibers when grafted into muscles of dystrophin-deficient mdx
      mice, a model of Duchenne muscular dystrophy (DMD). Fibers derived from ES cells 
      of mdx mice exhibit an abnormal branched phenotype resembling that described in
      vivo, thus providing an attractive model to study the origin of the pathological 
      defects associated with DMD.
FAU - Chal, Jerome
AU  - Chal J
AD  - Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC), CNRS (UMR
      7104), Inserm U964, Universite de Strasbourg, Illkirch Graffenstaden, France.
AD  - Stowers Institute for Medical Research, Kansas City, Missouri, USA.
AD  - Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts,
      USA.
AD  - Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.
AD  - Harvard Stem Cell Institute, Boston, Massachusetts, USA.
FAU - Oginuma, Masayuki
AU  - Oginuma M
AD  - Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC), CNRS (UMR
      7104), Inserm U964, Universite de Strasbourg, Illkirch Graffenstaden, France.
FAU - Al Tanoury, Ziad
AU  - Al Tanoury Z
AD  - Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC), CNRS (UMR
      7104), Inserm U964, Universite de Strasbourg, Illkirch Graffenstaden, France.
FAU - Gobert, Benedicte
AU  - Gobert B
AD  - Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC), CNRS (UMR
      7104), Inserm U964, Universite de Strasbourg, Illkirch Graffenstaden, France.
FAU - Sumara, Olga
AU  - Sumara O
AD  - Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC), CNRS (UMR
      7104), Inserm U964, Universite de Strasbourg, Illkirch Graffenstaden, France.
FAU - Hick, Aurore
AU  - Hick A
AD  - Anagenesis Biotechnologies, Parc d'innovation, Illkirch Graffenstaden, France.
FAU - Bousson, Fanny
AU  - Bousson F
AD  - Anagenesis Biotechnologies, Parc d'innovation, Illkirch Graffenstaden, France.
FAU - Zidouni, Yasmine
AU  - Zidouni Y
AD  - Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC), CNRS (UMR
      7104), Inserm U964, Universite de Strasbourg, Illkirch Graffenstaden, France.
FAU - Mursch, Caroline
AU  - Mursch C
AD  - Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC), CNRS (UMR
      7104), Inserm U964, Universite de Strasbourg, Illkirch Graffenstaden, France.
FAU - Moncuquet, Philippe
AU  - Moncuquet P
AD  - Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC), CNRS (UMR
      7104), Inserm U964, Universite de Strasbourg, Illkirch Graffenstaden, France.
FAU - Tassy, Olivier
AU  - Tassy O
AD  - Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC), CNRS (UMR
      7104), Inserm U964, Universite de Strasbourg, Illkirch Graffenstaden, France.
FAU - Vincent, Stephane
AU  - Vincent S
AD  - Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC), CNRS (UMR
      7104), Inserm U964, Universite de Strasbourg, Illkirch Graffenstaden, France.
FAU - Miyanari, Ayako
AU  - Miyanari A
AD  - Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC), CNRS (UMR
      7104), Inserm U964, Universite de Strasbourg, Illkirch Graffenstaden, France.
FAU - Bera, Agata
AU  - Bera A
AD  - Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC), CNRS (UMR
      7104), Inserm U964, Universite de Strasbourg, Illkirch Graffenstaden, France.
FAU - Garnier, Jean-Marie
AU  - Garnier JM
AD  - Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC), CNRS (UMR
      7104), Inserm U964, Universite de Strasbourg, Illkirch Graffenstaden, France.
FAU - Guevara, Getzabel
AU  - Guevara G
AD  - Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts,
      USA.
AD  - Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.
AD  - Harvard Stem Cell Institute, Boston, Massachusetts, USA.
FAU - Hestin, Marie
AU  - Hestin M
AD  - Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts,
      USA.
AD  - Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.
AD  - Harvard Stem Cell Institute, Boston, Massachusetts, USA.
FAU - Kennedy, Leif
AU  - Kennedy L
AD  - Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC), CNRS (UMR
      7104), Inserm U964, Universite de Strasbourg, Illkirch Graffenstaden, France.
FAU - Hayashi, Shinichiro
AU  - Hayashi S
AD  - UPMC Paris 06, UMRS 787, INSERM, Avenir team, Pitie-Salpetriere, Paris, France.
AD  - Institut de Myologie, Paris, France.
FAU - Drayton, Bernadette
AU  - Drayton B
AD  - UPMC Paris 06, UMRS 787, INSERM, Avenir team, Pitie-Salpetriere, Paris, France.
AD  - Institut de Myologie, Paris, France.
FAU - Cherrier, Thomas
AU  - Cherrier T
AD  - Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC), CNRS (UMR
      7104), Inserm U964, Universite de Strasbourg, Illkirch Graffenstaden, France.
FAU - Gayraud-Morel, Barbara
AU  - Gayraud-Morel B
AD  - Institut Pasteur, CNRS URA 2578, Paris, France.
FAU - Gussoni, Emanuela
AU  - Gussoni E
AUID- ORCID: http://orcid.org/0000-0002-9915-3677
AD  - Division of Genetics and Genomics Boston Children's Hospital, Boston,
      Massachusetts, USA.
FAU - Relaix, Frederic
AU  - Relaix F
AD  - UPMC Paris 06, UMRS 787, INSERM, Avenir team, Pitie-Salpetriere, Paris, France.
AD  - Institut de Myologie, Paris, France.
FAU - Tajbakhsh, Shahragim
AU  - Tajbakhsh S
AD  - Institut Pasteur, CNRS URA 2578, Paris, France.
FAU - Pourquie, Olivier
AU  - Pourquie O
AD  - Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC), CNRS (UMR
      7104), Inserm U964, Universite de Strasbourg, Illkirch Graffenstaden, France.
AD  - Stowers Institute for Medical Research, Kansas City, Missouri, USA.
AD  - Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts,
      USA.
AD  - Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.
AD  - Harvard Stem Cell Institute, Boston, Massachusetts, USA.
AD  - Howard Hughes Medical Institute, Kansas City, Missouri, USA.
LA  - eng
GR  - Howard Hughes Medical Institute/United States
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150803
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CIN - Cell Stem Cell. 2015 Sep 3;17(3):255-7. PMID: 26340524
MH  - Animals
MH  - *Cell Differentiation
MH  - Cells, Cultured
MH  - *Disease Models, Animal
MH  - Mice
MH  - Mice, Transgenic
MH  - Muscle Fibers, Skeletal/*pathology
MH  - Muscular Dystrophy, Duchenne/*pathology
MH  - Pluripotent Stem Cells/*pathology
EDAT- 2015/08/04 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/08/04 06:00
PHST- 2015/02/09 00:00 [received]
PHST- 2015/06/23 00:00 [accepted]
PHST- 2015/08/04 06:00 [entrez]
PHST- 2015/08/04 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3297 [pii]
AID - 10.1038/nbt.3297 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):962-9. doi: 10.1038/nbt.3297. Epub 2015 Aug 3.

PMID- 26237516
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - High-throughput determination of RNA structure by proximity ligation.
PG  - 980-4
LID - 10.1038/nbt.3289 [doi]
AB  - We present an unbiased method to globally resolve RNA structures through pairwise
      contact measurements between interacting regions. RNA proximity ligation (RPL)
      uses proximity ligation of native RNA followed by deep sequencing to yield
      chimeric reads with ligation junctions in the vicinity of structurally proximate 
      bases. We apply RPL in both baker's yeast (Saccharomyces cerevisiae) and human
      cells and generate contact probability maps for ribosomal and other abundant
      RNAs, including yeast snoRNAs, the RNA subunit of the signal recognition particle
      and the yeast U2 spliceosomal RNA homolog. RPL measurements correlate with
      established secondary structures for these RNA molecules, including stem-loop
      structures and long-range pseudoknots. We anticipate that RPL will complement the
      current repertoire of computational and experimental approaches in enabling the
      high-throughput determination of secondary and tertiary RNA structures.
FAU - Ramani, Vijay
AU  - Ramani V
AD  - Department of Genome Sciences, University of Washington, Seattle, Washington,
      USA.
FAU - Qiu, Ruolan
AU  - Qiu R
AD  - Department of Genome Sciences, University of Washington, Seattle, Washington,
      USA.
FAU - Shendure, Jay
AU  - Shendure J
AD  - Department of Genome Sciences, University of Washington, Seattle, Washington,
      USA.
LA  - eng
SI  - GEO/GSE69472
GR  - DP1 HG007811/HG/NHGRI NIH HHS/United States
GR  - T32 HG000035/HG/NHGRI NIH HHS/United States
GR  - 1DP1HG007811/DP/NCCDPHP CDC HHS/United States
GR  - 5T32HG000035/HG/NHGRI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20150803
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 63231-63-0 (RNA)
SB  - IM
CIN - Nat Methods. 2015 Oct;12(10):906-7. PMID: 26688884
MH  - Base Sequence
MH  - Computer Simulation
MH  - High-Throughput Nucleotide Sequencing/*methods
MH  - *Models, Chemical
MH  - Models, Genetic
MH  - *Models, Molecular
MH  - Molecular Sequence Data
MH  - Nucleic Acid Conformation
MH  - RNA/*genetics/*ultrastructure
MH  - Real-Time Polymerase Chain Reaction/methods
MH  - Sequence Alignment/methods
MH  - Sequence Analysis, RNA/*methods
PMC - PMC4564351
MID - NIHMS700917
EDAT- 2015/08/04 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/08/04 06:00
PHST- 2015/04/08 00:00 [received]
PHST- 2015/06/15 00:00 [accepted]
PHST- 2015/08/04 06:00 [entrez]
PHST- 2015/08/04 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):980-4. Epub 2015 Aug 3.

PMID- 26192318
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - Expansion and patterning of cardiovascular progenitors derived from human
      pluripotent stem cells.
PG  - 970-9
LID - 10.1038/nbt.3271 [doi]
AB  - The inability of multipotent cardiovascular progenitor cells (CPCs) to undergo
      multiple divisions in culture has precluded stable expansion of precursors of
      cardiomyocytes and vascular cells. This contrasts with neural progenitors, which 
      can be expanded robustly and are a renewable source of their derivatives. Here we
      use human pluripotent stem cells bearing a cardiac lineage reporter to show that 
      regulated MYC expression enables robust expansion of CPCs with insulin-like
      growth factor-1 (IGF-1) and a hedgehog pathway agonist. The CPCs can be patterned
      with morphogens, recreating features of heart field assignment, and controllably 
      differentiated to relatively pure populations of pacemaker-like or
      ventricular-like cardiomyocytes. The cells are clonogenic and can be expanded for
      >40 population doublings while retaining the ability to differentiate into
      cardiomyocytes and vascular cells. Access to CPCs will allow precise recreation
      of elements of heart development in vitro and facilitate investigation of the
      molecular basis of cardiac fate determination. This technology is applicable for 
      cardiac disease modeling, toxicology studies and tissue engineering.
FAU - Birket, Matthew J
AU  - Birket MJ
AD  - Leiden University Medical Center, Leiden, the Netherlands.
FAU - Ribeiro, Marcelo C
AU  - Ribeiro MC
AUID- ORCID: http://orcid.org/0000-0003-0583-7443
AD  - Leiden University Medical Center, Leiden, the Netherlands.
FAU - Verkerk, Arie O
AU  - Verkerk AO
AD  - Amsterdam Medical Center, Amsterdam, the Netherlands.
FAU - Ward, Dorien
AU  - Ward D
AD  - Leiden University Medical Center, Leiden, the Netherlands.
FAU - Leitoguinho, Ana Rita
AU  - Leitoguinho AR
AD  - Leiden University Medical Center, Leiden, the Netherlands.
FAU - den Hartogh, Sabine C
AU  - den Hartogh SC
AD  - Leiden University Medical Center, Leiden, the Netherlands.
FAU - Orlova, Valeria V
AU  - Orlova VV
AD  - Leiden University Medical Center, Leiden, the Netherlands.
FAU - Devalla, Harsha D
AU  - Devalla HD
AUID- ORCID: http://orcid.org/0000-0001-5343-1021
AD  - Leiden University Medical Center, Leiden, the Netherlands.
FAU - Schwach, Verena
AU  - Schwach V
AD  - Leiden University Medical Center, Leiden, the Netherlands.
FAU - Bellin, Milena
AU  - Bellin M
AD  - Leiden University Medical Center, Leiden, the Netherlands.
FAU - Passier, Robert
AU  - Passier R
AD  - Leiden University Medical Center, Leiden, the Netherlands.
FAU - Mummery, Christine L
AU  - Mummery CL
AD  - Leiden University Medical Center, Leiden, the Netherlands.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150720
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Hedgehog Proteins)
SB  - IM
MH  - Batch Cell Culture Techniques/*methods
MH  - Cell Differentiation/physiology
MH  - Cell Proliferation/physiology
MH  - Cells, Cultured
MH  - Hedgehog Proteins/metabolism
MH  - Humans
MH  - Myocytes, Cardiac/*cytology/*physiology
MH  - Pluripotent Stem Cells/*cytology/*physiology
MH  - Tissue Engineering/*methods
EDAT- 2015/07/21 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/07/21 06:00
PHST- 2015/01/23 00:00 [received]
PHST- 2015/06/02 00:00 [accepted]
PHST- 2015/07/21 06:00 [entrez]
PHST- 2015/07/21 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3271 [pii]
AID - 10.1038/nbt.3271 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):970-9. doi: 10.1038/nbt.3271. Epub 2015 Jul 20.

PMID- 26121415
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170718
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 9
DP  - 2015 Sep
TI  - Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary
      cells.
PG  - 985-989
LID - 10.1038/nbt.3290 [doi]
AB  - CRISPR-Cas-mediated genome editing relies on guide RNAs that direct site-specific
      DNA cleavage facilitated by the Cas endonuclease. Here we report that chemical
      alterations to synthesized single guide RNAs (sgRNAs) enhance genome editing
      efficiency in human primary T cells and CD34(+) hematopoietic stem and progenitor
      cells. Co-delivering chemically modified sgRNAs with Cas9 mRNA or protein is an
      efficient RNA- or ribonucleoprotein (RNP)-based delivery method for the
      CRISPR-Cas system, without the toxicity associated with DNA delivery. This
      approach is a simple and effective way to streamline the development of genome
      editing with the potential to accelerate a wide array of biotechnological and
      therapeutic applications of the CRISPR-Cas technology.
FAU - Hendel, Ayal
AU  - Hendel A
AD  - Department of Pediatrics, Stanford University, Stanford, California, USA.
FAU - Bak, Rasmus O
AU  - Bak RO
AD  - Department of Pediatrics, Stanford University, Stanford, California, USA.
FAU - Clark, Joseph T
AU  - Clark JT
AD  - Department of Pediatrics, Stanford University, Stanford, California, USA.
FAU - Kennedy, Andrew B
AU  - Kennedy AB
AD  - Agilent Research Laboratories, Santa Clara, California, USA.
FAU - Ryan, Daniel E
AU  - Ryan DE
AD  - Agilent Research Laboratories, Santa Clara, California, USA.
FAU - Roy, Subhadeep
AU  - Roy S
AD  - Agilent Research Laboratories, Boulder, Colorado, USA.
FAU - Steinfeld, Israel
AU  - Steinfeld I
AD  - Agilent Research Laboratories, Tel Aviv, Israel.
FAU - Lunstad, Benjamin D
AU  - Lunstad BD
AD  - Agilent Research Laboratories, Boulder, Colorado, USA.
FAU - Kaiser, Robert J
AU  - Kaiser RJ
AD  - Agilent Research Laboratories, Santa Clara, California, USA.
FAU - Wilkens, Alec B
AU  - Wilkens AB
AD  - Department of Pediatrics, Stanford University, Stanford, California, USA.
FAU - Bacchetta, Rosa
AU  - Bacchetta R
AD  - Department of Pediatrics, Stanford University, Stanford, California, USA.
FAU - Tsalenko, Anya
AU  - Tsalenko A
AD  - Agilent Research Laboratories, Santa Clara, California, USA.
FAU - Dellinger, Douglas
AU  - Dellinger D
AD  - Agilent Research Laboratories, Boulder, Colorado, USA.
FAU - Bruhn, Laurakay
AU  - Bruhn L
AD  - Agilent Research Laboratories, Santa Clara, California, USA.
FAU - Porteus, Matthew H
AU  - Porteus MH
AD  - Department of Pediatrics, Stanford University, Stanford, California, USA.
LA  - eng
GR  - R01 AI120766/AI/NIAID NIH HHS/United States
GR  - R01 AI097320/AI/NIAID NIH HHS/United States
GR  - PN2EY018244/EY/NEI NIH HHS/United States
GR  - PN2 EY018244/EY/NEI NIH HHS/United States
GR  - R01-AI097320/AI/NIAID NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20150629
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (RNA, Guide)
SB  - IM
MH  - CRISPR-Cas Systems/*genetics
MH  - Clustered Regularly Interspaced Short Palindromic Repeats/*genetics
MH  - Genetic Engineering/*methods
MH  - Genome, Human/*genetics
MH  - Humans
MH  - RNA, Guide/*chemistry/*genetics
PMC - PMC4729442
MID - NIHMS752360
EDAT- 2015/06/30 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/06/30 06:00
PHST- 2015/03/06 00:00 [received]
PHST- 2015/06/17 00:00 [accepted]
PHST- 2015/06/30 06:00 [entrez]
PHST- 2015/06/30 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - 10.1038/nbt.3290 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Sep;33(9):985-989. doi: 10.1038/nbt.3290. Epub 2015 Jun 29.

PMID- 26473199
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20161125
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - Expression of trehalose-6-phosphate phosphatase in maize ears improves yield in
      well-watered and drought conditions.
PG  - 862-9
AB  - Maize, the highest-yielding cereal crop worldwide, is particularly susceptible to
      drought during its 2- to 3-week flowering period. Many genetic engineering
      strategies for drought tolerance impinge on plant development, reduce maximum
      yield potential or do not translate from laboratory conditions to the field. We
      overexpressed a gene encoding a rice trehalose-6-phosphate phosphatase (TPP) in
      developing maize ears using a floral promoter. This reduced the concentration of 
      trehalose-6-phosphate (T6P), a sugar signal that regulates growth and
      development, and increased the concentration of sucrose in ear spikelets.
      Overexpression of TPP increased both kernel set and harvest index. Field data at 
      several sites and over multiple seasons showed that the engineered trait improved
      yields from 9% to 49% under non-drought or mild drought conditions, and from 31% 
      to 123% under more severe drought conditions, relative to yields from
      nontransgenic controls.
FAU - Nuccio, Michael L
AU  - Nuccio ML
FAU - Wu, Jeff
AU  - Wu J
FAU - Mowers, Ron
AU  - Mowers R
FAU - Zhou, Hua-Ping
AU  - Zhou HP
FAU - Meghji, Moez
AU  - Meghji M
FAU - Primavesi, Lucia F
AU  - Primavesi LF
FAU - Paul, Matthew J
AU  - Paul MJ
FAU - Chen, Xi
AU  - Chen X
FAU - Gao, Yan
AU  - Gao Y
FAU - Haque, Emdadul
AU  - Haque E
FAU - Basu, Shib Sankar
AU  - Basu SS
FAU - Lagrimini, L Mark
AU  - Lagrimini LM
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Plant Proteins)
RN  - 0 (Recombinant Proteins)
RN  - EC 3.1.3.12 (trehalose-phosphatase)
RN  - EC 3.1.3.2 (Phosphoric Monoester Hydrolases)
SB  - IM
CIN - Nat Biotechnol. 2015 Sep;33(9):929-30. PMID: 26348962
MH  - Adaptation, Biological/genetics
MH  - Biotechnology
MH  - Droughts
MH  - Phosphoric Monoester Hydrolases/genetics/*metabolism
MH  - Plant Proteins/genetics/*metabolism
MH  - Plants, Genetically Modified/*genetics/metabolism/*physiology
MH  - Recombinant Proteins/genetics/metabolism
MH  - Zea mays/*genetics/metabolism/*physiology
EDAT- 2015/10/17 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/10/17 06:00
PHST- 2015/10/17 06:00 [entrez]
PHST- 2015/10/17 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):862-9.

PMID- 26252149
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20150808
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - Second-quarter biotech job picture.
PG  - 883
LID - 10.1038/nbt.3314 [doi]
FAU - Francisco, Michael
AU  - Francisco M
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*manpower/*organization & administration
MH  - Drug Industry/*manpower/*organization & administration
MH  - Humans
EDAT- 2015/08/08 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/08/08 06:00
PHST- 2015/08/08 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - nbt.3314 [pii]
AID - 10.1038/nbt.3314 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):883. doi: 10.1038/nbt.3314.

PMID- 26252148
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20151022
LR  - 20150808
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - Erratum: A mass-tolerant database search identifies a large proportion of
      unassigned spectra in shotgun proteomics as modified peptides.
PG  - 882
LID - 10.1038/nbt0815-882d [doi]
FAU - Chick, Joel M
AU  - Chick JM
FAU - Kolippakkam, Deepak
AU  - Kolippakkam D
FAU - Nusinow, David P
AU  - Nusinow DP
FAU - Zhai, Bo
AU  - Zhai B
FAU - Rad, Ramin
AU  - Rad R
FAU - Huttlin, Edward L
AU  - Huttlin EL
FAU - Gygi, Steven P
AU  - Gygi SP
LA  - eng
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2015 Jul;33(7):743-9. PMID: 26076430
EDAT- 2015/08/08 06:00
MHDA- 2015/08/08 06:01
CRDT- 2015/08/08 06:00
PHST- 2015/08/08 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2015/08/08 06:01 [medline]
AID - nbt0815-882d [pii]
AID - 10.1038/nbt0815-882d [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):882. doi: 10.1038/nbt0815-882d.

PMID- 26252147
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20151022
LR  - 20150808
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - Corrigendum: Long-term persistence and development of induced pancreatic beta
      cells generated by lineage conversion of acinar cells.
PG  - 882
LID - 10.1038/nbt0815-882a [doi]
FAU - Li, Weida
AU  - Li W
FAU - Cavelti-Weder, Claudia
AU  - Cavelti-Weder C
FAU - Zhang, Yinying
AU  - Zhang Y
FAU - Clement, Kendell
AU  - Clement K
FAU - Donovan, Scott
AU  - Donovan S
FAU - Gonzalez, Gabriel
AU  - Gonzalez G
FAU - Zhu, Jiang
AU  - Zhu J
FAU - Stemann, Marianne
AU  - Stemann M
FAU - Xu, Ke
AU  - Xu K
FAU - Hashimoto, Tatsu
AU  - Hashimoto T
FAU - Yamada, Takatsugu
AU  - Yamada T
FAU - Nakanishi, Mio
AU  - Nakanishi M
FAU - Zhang, Yuemei
AU  - Zhang Y
FAU - Zeng, Samuel
AU  - Zeng S
FAU - Gifford, David
AU  - Gifford D
FAU - Meissner, Alexander
AU  - Meissner A
FAU - Weir, Gordon
AU  - Weir G
FAU - Zhou, Qiao
AU  - Zhou Q
LA  - eng
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2014 Dec;32(12):1223-30. Zhang, Yinying [corrected to Zhang,
      Yingying]. PMID: 25402613
EDAT- 2015/08/08 06:00
MHDA- 2015/08/08 06:01
CRDT- 2015/08/08 06:00
PHST- 2015/08/08 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2015/08/08 06:01 [medline]
AID - nbt0815-882a [pii]
AID - 10.1038/nbt0815-882a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):882. doi: 10.1038/nbt0815-882a.

PMID- 26252146
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20151022
LR  - 20150808
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - Corrigendum: Suppression of vascular permeability and inflammation by targeting
      of the transcription factor c-Jun.
PG  - 882
LID - 10.1038/nbt0815-882c [doi]
FAU - Fahmy, Roger G
AU  - Fahmy RG
FAU - Waldman, Alla
AU  - Waldman A
FAU - Zhang, Guishui
AU  - Zhang G
FAU - Mitchell, Ainslie
AU  - Mitchell A
FAU - Tedla, Nicodemus
AU  - Tedla N
FAU - Cai, Hong
AU  - Cai H
FAU - Geczy, Carolyn R
AU  - Geczy CR
FAU - Chesterman, Colin N
AU  - Chesterman CN
FAU - Perry, Michael
AU  - Perry M
FAU - Khachigian, Levon M
AU  - Khachigian LM
LA  - eng
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2006 Jul;24(7):856-63. PMID: 16823369
EDAT- 2015/08/08 06:00
MHDA- 2015/08/08 06:01
CRDT- 2015/08/08 06:00
PHST- 2015/08/08 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2015/08/08 06:01 [medline]
AID - nbt0815-882c [pii]
AID - 10.1038/nbt0815-882c [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):882. doi: 10.1038/nbt0815-882c.

PMID- 26252145
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20151022
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - Corrigendum: The ethics of publishing human germline research.
PG  - 882
LID - 10.1038/nbt0815-882b [doi]
FAU - Sharma, Arun
AU  - Sharma A
FAU - Thomas Scott, Christopher
AU  - Thomas Scott C
LA  - eng
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2015 Jun;33(6):590-2. PMID: 26057973
EDAT- 2015/08/08 06:00
MHDA- 2015/08/08 06:01
CRDT- 2015/08/08 06:00
PHST- 2015/08/08 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2015/08/08 06:01 [medline]
AID - nbt0815-882b [pii]
AID - 10.1038/nbt0815-882b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):882. doi: 10.1038/nbt0815-882b.

PMID- 26252144
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20151022
LR  - 20150808
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - Erratum: Public biotech 2013-the numbers.
PG  - 882
LID - 10.1038/nbt0815-882e [doi]
FAU - Lawrence, Stacy
AU  - Lawrence S
FAU - Lahteenmaki, Riku
AU  - Lahteenmaki R
LA  - eng
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2014 Jul;32(7):626-32. PMID: 25004227
EDAT- 2015/08/08 06:00
MHDA- 2015/08/08 06:01
CRDT- 2015/08/08 06:00
PHST- 2015/08/08 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2015/08/08 06:01 [medline]
AID - nbt0815-882e [pii]
AID - 10.1038/nbt0815-882e [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):882. doi: 10.1038/nbt0815-882e.

PMID- 26252143
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - A flexible mesh to record the brain.
PG  - 830
LID - 10.1038/nbt.3316 [doi]
FAU - Jarchum, Irene
AU  - Jarchum I
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - Biotechnology/*instrumentation
MH  - *Electrodes, Implanted
MH  - Mice
MH  - Monitoring, Physiologic/*instrumentation
MH  - Nanomedicine
MH  - *Neural Prostheses
EDAT- 2015/08/08 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/08/08 06:00
PHST- 2015/08/08 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - nbt.3316 [pii]
AID - 10.1038/nbt.3316 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):830. doi: 10.1038/nbt.3316.

PMID- 26252142
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - New PAMs for Cas.
PG  - 829
LID - 10.1038/nbt.3317 [doi]
FAU - Elsner, Markus
AU  - Elsner M
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Bacterial Proteins)
RN  - 0 (DNA, Bacterial)
RN  - EC 3.1.- (Endonucleases)
SB  - IM
MH  - Bacterial Proteins/chemistry/genetics/metabolism
MH  - CRISPR-Cas Systems/*genetics
MH  - DNA, Bacterial/chemistry/genetics/metabolism
MH  - Endonucleases/chemistry/genetics/metabolism
MH  - Mutation/genetics
MH  - Nucleotide Motifs/*genetics
EDAT- 2015/08/08 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/08/08 06:00
PHST- 2015/08/08 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - nbt.3317 [pii]
AID - 10.1038/nbt.3317 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):829. doi: 10.1038/nbt.3317.

PMID- 26252140
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - A time and a place for sugar in your ears.
PG  - 827-8
LID - 10.1038/nbt.3315 [doi]
FAU - Guan, Jiahn-Chou
AU  - Guan JC
AD  - University of Florida, Department of Horticultural Sciences, Gainesville,
      Florida, USA.
FAU - Koch, Karen E
AU  - Koch KE
AD  - University of Florida, Department of Horticultural Sciences, Gainesville,
      Florida, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - B8WCK70T7I (Trehalose)
SB  - IM
MH  - Biotechnology
MH  - Droughts
MH  - *Genetic Engineering
MH  - Plants, Genetically Modified/chemistry/genetics/*metabolism/*physiology
MH  - Stress, Physiological
MH  - Trehalose/*metabolism
MH  - Zea mays/chemistry/genetics/*metabolism/*physiology
EDAT- 2015/08/08 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/08/08 06:00
PHST- 2015/08/08 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - nbt.3315 [pii]
AID - 10.1038/nbt.3315 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):827-8. doi: 10.1038/nbt.3315.

PMID- 26252139
OWN - NLM
STAT- MEDLINE
DCOM- 20160329
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - Deep learning for regulatory genomics.
PG  - 825-6
LID - 10.1038/nbt.3313 [doi]
FAU - Park, Yongjin
AU  - Park Y
AD  - Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
FAU - Kellis, Manolis
AU  - Kellis M
AD  - Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (DNA-Binding Proteins)
RN  - 0 (RNA-Binding Proteins)
SB  - IM
CON - Nat Biotechnol. 2015 Aug;33(8):831-8. PMID: 26213851
MH  - Computational Biology/*methods
MH  - DNA-Binding Proteins/*chemistry
MH  - RNA-Binding Proteins/*chemistry
MH  - Sequence Analysis, Protein/*methods
MH  - *Software
EDAT- 2015/08/08 06:00
MHDA- 2016/03/30 06:00
CRDT- 2015/08/08 06:00
PHST- 2015/08/08 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2016/03/30 06:00 [medline]
AID - nbt.3313 [pii]
AID - 10.1038/nbt.3313 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):825-6. doi: 10.1038/nbt.3313.

PMID- 26252137
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - The emergence of agbiogenerics.
PG  - 819-23
LID - 10.1038/nbt.3306 [doi]
FAU - Jefferson, David J
AU  - Jefferson DJ
AD  - PIPRA (Public-Sector Intellectual Property Resource for Agriculture), Department 
      of Plant Sciences, University of California, Davis, Davis, California, USA.
FAU - Graff, Gregory D
AU  - Graff GD
AD  - 1] PIPRA (Public-Sector Intellectual Property Resource for Agriculture),
      Department of Plant Sciences, University of California, Davis, Davis, California,
      USA. [2] Department of Agricultural and Resource Economics, Colorado State
      University, Fort Collins, Colorado, USA.
FAU - Chi-Ham, Cecilia L
AU  - Chi-Ham CL
AD  - PIPRA (Public-Sector Intellectual Property Resource for Agriculture), Department 
      of Plant Sciences, University of California, Davis, Davis, California, USA.
FAU - Bennett, Alan B
AU  - Bennett AB
AD  - PIPRA (Public-Sector Intellectual Property Resource for Agriculture), Department 
      of Plant Sciences, University of California, Davis, Davis, California, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 4632WW1X5A (glyphosate)
RN  - TE7660XO1C (Glycine)
SB  - IM
MH  - *Agriculture
MH  - *Biotechnology
MH  - *Crops, Agricultural
MH  - Glycine/analogs & derivatives
MH  - *Herbicide Resistance
MH  - *Patents as Topic
MH  - Plants, Genetically Modified
EDAT- 2015/08/08 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/08/08 06:00
PHST- 2015/08/08 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - nbt.3306 [pii]
AID - 10.1038/nbt.3306 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):819-23. doi: 10.1038/nbt.3306.

PMID- 26252136
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - The smart and gentle microscope.
PG  - 815-8
LID - 10.1038/nbt.3310 [doi]
FAU - Scherf, Nico
AU  - Scherf N
AUID- ORCID: 0000000340039121
AD  - 1] Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.
      [2] Institute for Medical Informatics and Biometry, Faculty of Medicine Carl
      Gustav Carus, TU Dresden, Dresden, Germany.
FAU - Huisken, Jan
AU  - Huisken J
AUID- ORCID: 0000000172503756
AD  - Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Computational Biology
MH  - Humans
MH  - Image Processing, Computer-Assisted
MH  - *Microscopy/instrumentation/trends
EDAT- 2015/08/08 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/08/08 06:00
PHST- 2015/08/08 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - nbt.3310 [pii]
AID - 10.1038/nbt.3310 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):815-8. doi: 10.1038/nbt.3310.

PMID- 26252135
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - What does the current biotech stock market value?
PG  - 813-4
LID - 10.1038/nbt.3303 [doi]
FAU - McNamee, Laura
AU  - McNamee L
AD  - Center for Integration of Science and Industry, Bentley University, Waltham, MA, 
      USA.
FAU - Ledley, Fred
AU  - Ledley F
AD  - Center for Integration of Science and Industry, Bentley University, Waltham, MA, 
      USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*economics
MH  - Drug Industry/*economics
MH  - Investments/economics
EDAT- 2015/08/08 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/08/08 06:00
PHST- 2015/08/08 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - nbt.3303 [pii]
AID - 10.1038/nbt.3303 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):813-4. doi: 10.1038/nbt.3303.

PMID- 26252134
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - Benchmarking the scientific output of the Innovative Medicines Initiative.
PG  - 811-2
LID - 10.1038/nbt.3305 [doi]
FAU - Gunn, Magda
AU  - Gunn M
AD  - Innovative Medicines Initiative, Brussels, Belgium.
FAU - Lim, Mark
AU  - Lim M
AD  - Fastercures, Center of the Milken Institute, Washington, DC, USA.
FAU - Cross, Didi
AU  - Cross D
AD  - Thomson Reuters, New York, New York, USA.
FAU - Goldman, Michel
AU  - Goldman M
AD  - Universite Libre de Bruxelles, Brussels, Belgium.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Belgium
MH  - Benchmarking/*methods
MH  - *Bibliometrics
MH  - Biomedical Research/*standards
MH  - Drug Industry/*standards
MH  - Humans
MH  - Models, Theoretical
MH  - Translational Medical Research/standards
EDAT- 2015/08/08 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/08/08 06:00
PHST- 2015/08/08 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - nbt.3305 [pii]
AID - 10.1038/nbt.3305 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):811-2. doi: 10.1038/nbt.3305.

PMID- 26252133
OWN - NLM
STAT- MEDLINE
DCOM- 20151022
LR  - 20180310
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - Health ROI as a measure of misalignment of biomedical needs and resources.
PG  - 807-11
LID - 10.1038/nbt.3276 [doi]
FAU - Yao, Lixia
AU  - Yao L
AD  - Department of Software and Information Systems, the University of North Carolina 
      at Charlotte, Charlotte, North Carolina, USA.
FAU - Li, Ying
AU  - Li Y
AD  - Department of Biomedical Informatics, Columbia University, New York, New York,
      USA.
FAU - Ghosh, Soumitra
AU  - Ghosh S
AD  - Department of Genetics, GlaxoSmithKline R&D, King of Prussia, Pennsylvania, USA.
FAU - Evans, James A
AU  - Evans JA
AD  - 1] Department of Sociology, the University of Chicago, Chicago, Illinois, USA.
      [2] Computational Institute, the University of Chicago, Chicago, Illinois, USA.
FAU - Rzhetsky, Andrey
AU  - Rzhetsky A
AD  - 1] Computational Institute, the University of Chicago, Chicago, Illinois, USA.
      [2] Departments of Medicine and Human Genetics, Institute for Genomics and
      Systems Biology, the University of Chicago, Chicago, Illinois, USA.
LA  - eng
GR  - R01 HL122712/HL/NHLBI NIH HHS/United States
GR  - R01 GM061372/GM/NIGMS NIH HHS/United States
GR  - K12 HL119995/HL/NHLBI NIH HHS/United States
GR  - R01 MH110905/MH/NIMH NIH HHS/United States
GR  - P50 MH094267/MH/NIMH NIH HHS/United States
GR  - 1P50MH094267/MH/NIMH NIH HHS/United States
GR  - U01 HL108634/HL/NHLBI NIH HHS/United States
GR  - R01 LM010132/LM/NLM NIH HHS/United States
GR  - T32 MH020065/MH/NIMH NIH HHS/United States
GR  - U01HL108634-01/HL/NHLBI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Biomedical Research
MH  - *Cost of Illness
MH  - Disease/*classification/*economics
MH  - Female
MH  - Health Care Rationing/*statistics & numerical data
MH  - Humans
MH  - Male
MH  - National Institutes of Health (U.S.)/*economics/*organization & administration
MH  - Research/*economics
MH  - Research Support as Topic/*economics/*organization & administration/*statistics &
      numerical data
MH  - *Resource Allocation
PMC - PMC5843469
MID - NIHMS946768
EDAT- 2015/08/08 06:00
MHDA- 2015/10/23 06:00
CRDT- 2015/08/08 06:00
PHST- 2015/08/08 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2015/10/23 06:00 [medline]
AID - nbt.3276 [pii]
AID - 10.1038/nbt.3276 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):807-11. doi: 10.1038/nbt.3276.

PMID- 26252132
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20150808
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - First Rounders Podcast.
PG  - 804
LID - 10.1038/nbt0815-804 [doi]
FAU - King, Rachel
AU  - King R
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Biotechnology
MH  - Humans
MH  - *Webcasts as Topic
EDAT- 2015/08/08 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/08/08 06:00
PHST- 2015/08/08 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - nbt0815-804 [pii]
AID - 10.1038/nbt0815-804 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):804. doi: 10.1038/nbt0815-804.

PMID- 26252131
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20150808
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - In house expertise.
PG  - 801-4
LID - 10.1038/nbt.3302 [doi]
FAU - Herskowitz, Orin
AU  - Herskowitz O
AD  - Tech Transfer and Intellectual Property at Columbia Technology Ventures at
      Columbia University, New York, New York, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*organization & administration
MH  - Entrepreneurship/*organization & administration
MH  - Humans
MH  - *Mentors
MH  - Professional Competence
EDAT- 2015/08/08 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/08/08 06:00
PHST- 2015/08/08 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - nbt.3302 [pii]
AID - 10.1038/nbt.3302 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):801-4. doi: 10.1038/nbt.3302.

PMID- 26252130
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - To share is human.
PG  - 796-800
LID - 10.1038/nbt.3309 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biomedical Research
MH  - *Confidentiality
MH  - *Electronic Health Records
MH  - Humans
MH  - *Information Dissemination
MH  - *Internet
MH  - Social Media
EDAT- 2015/08/08 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/08/08 06:00
PHST- 2015/08/08 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - nbt.3309 [pii]
AID - 10.1038/nbt.3309 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):796-800. doi: 10.1038/nbt.3309.

PMID- 26252129
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20150808
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - Drug pipeline: 2Q15.
PG  - 795
LID - 10.1038/nbt.3312 [doi]
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EIN - Nat Biotechnol. 2015 Oct;33(10):1109. PMID: 26448091
MH  - Clinical Trials as Topic
MH  - Drug Industry/*legislation & jurisprudence/*statistics & numerical data
MH  - Humans
MH  - *Legislation, Drug
MH  - United States
MH  - United States Food and Drug Administration
EDAT- 2015/08/08 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/08/08 06:00
PHST- 2015/08/08 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - nbt.3312 [pii]
AID - 10.1038/nbt.3312 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):795. doi: 10.1038/nbt.3312.

PMID- 26252128
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20150808
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - 2Q15-Running of the biotech bulls.
PG  - 794
LID - 10.1038/nbt.3311 [doi]
FAU - Yang, Walter
AU  - Yang W
AD  - BioCentury.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*economics
EDAT- 2015/08/08 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/08/08 06:00
PHST- 2015/08/08 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - nbt.3311 [pii]
AID - 10.1038/nbt.3311 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):794. doi: 10.1038/nbt.3311.

PMID- 26252127
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20150808
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - Around the world in a month.
PG  - 793
LID - 10.1038/nbt0815-793 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antimalarials)
SB  - IM
MH  - Antimalarials
MH  - *Biotechnology
MH  - China
MH  - *Global Health
MH  - Humans
MH  - Iran
MH  - Slovenia
MH  - South Africa
MH  - Stem Cell Research
EDAT- 2015/08/08 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/08/08 06:00
PHST- 2015/08/08 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - nbt0815-793 [pii]
AID - 10.1038/nbt0815-793 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):793. doi: 10.1038/nbt0815-793.

PMID- 26252126
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20150808
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - PureTech floats away.
PG  - 792
LID - 10.1038/nbt0815-792a [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biomedical Research/*economics
MH  - Biotechnology/*economics
MH  - Boston
MH  - Humans
MH  - Public Sector
EDAT- 2015/08/08 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/08/08 06:00
PHST- 2015/08/08 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - nbt0815-792a [pii]
AID - 10.1038/nbt0815-792a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):792. doi: 10.1038/nbt0815-792a.

PMID- 26252125
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20150808
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - BGI goes head-to-head with Illumina.
PG  - 792
LID - 10.1038/nbt0815-792b [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology
MH  - California
MH  - China
MH  - *Genome, Human
MH  - *Genomics
MH  - *High-Throughput Nucleotide Sequencing
MH  - Humans
MH  - *Sequence Analysis, DNA
EDAT- 2015/08/08 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/08/08 06:00
PHST- 2015/08/08 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - nbt0815-792b [pii]
AID - 10.1038/nbt0815-792b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):792. doi: 10.1038/nbt0815-792b.

PMID- 26252124
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - Oxitec trials GM sterile moth to combat agricultural infestations.
PG  - 792-3
LID - 10.1038/nbt0815-792c [doi]
FAU - Waltz, Emily
AU  - Waltz E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - *Animals, Genetically Modified/genetics/physiology
MH  - Biotechnology
MH  - Crops, Agricultural
MH  - Female
MH  - Male
MH  - *Moths/genetics/physiology
MH  - *Pest Control, Biological
EDAT- 2015/08/08 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/08/08 06:00
PHST- 2015/08/08 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - nbt0815-792c [pii]
AID - 10.1038/nbt0815-792c [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):792-3. doi: 10.1038/nbt0815-792c.

PMID- 26252123
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - Court invalidates Sequenom's prenatal test patent.
PG  - 791
LID - 10.1038/nbt0815-791b [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*legislation & jurisprudence
MH  - Female
MH  - Humans
MH  - Patents as Topic/*legislation & jurisprudence
MH  - Pregnancy
MH  - *Prenatal Diagnosis
MH  - United States
EDAT- 2015/08/08 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/08/08 06:00
PHST- 2015/08/08 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - nbt0815-791b [pii]
AID - 10.1038/nbt0815-791b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):791. doi: 10.1038/nbt0815-791b.

PMID- 26252122
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20150808
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - Alnylam, Dicerna tussle over RNAi tech.
PG  - 791
LID - 10.1038/nbt0815-791a [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*legislation & jurisprudence
MH  - Drug Industry/*legislation & jurisprudence
MH  - Humans
MH  - *Intellectual Property
MH  - *RNA Interference
EDAT- 2015/08/08 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/08/08 06:00
PHST- 2015/08/08 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - nbt0815-791a [pii]
AID - 10.1038/nbt0815-791a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):791. doi: 10.1038/nbt0815-791a.

PMID- 26252121
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - NCI-MATCH pairs tumor mutations with matching drugs.
PG  - 790-1
LID - 10.1038/nbt0815-790 [doi]
FAU - Brower, Vicki
AU  - Brower V
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antineoplastic Agents)
SB  - IM
MH  - *Antineoplastic Agents/classification/therapeutic use
MH  - Humans
MH  - Mutation/*genetics
MH  - National Cancer Institute (U.S.)
MH  - *Neoplasms/classification/genetics
MH  - *Patient Selection
MH  - Pharmacogenetics
MH  - Research Subjects/classification
MH  - Sequence Analysis, DNA
MH  - United States
EDAT- 2015/08/08 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/08/08 06:00
PHST- 2015/08/08 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - nbt0815-790 [pii]
AID - 10.1038/nbt0815-790 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):790-1. doi: 10.1038/nbt0815-790.

PMID- 26252120
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - Blockbuster expectations for hepatitis B therapeutic vaccine.
PG  - 789
LID - 10.1038/nbt0815-789 [doi]
FAU - Elvidge, Suzanne
AU  - Elvidge S
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Hepatitis B Vaccines)
RN  - 0 (Vaccines, Synthetic)
SB  - IM
MH  - Biotechnology
MH  - Clinical Trials, Phase III as Topic
MH  - Colorado
MH  - France
MH  - Hepatitis B/*prevention & control
MH  - *Hepatitis B Vaccines
MH  - Humans
MH  - *Vaccines, Synthetic
EDAT- 2015/08/08 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/08/08 06:00
PHST- 2015/08/08 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - nbt0815-789 [pii]
AID - 10.1038/nbt0815-789 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):789. doi: 10.1038/nbt0815-789.

PMID- 26252119
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - Microbial cocktails join fecal transplants in IBD treatment trials.
PG  - 787-8
LID - 10.1038/nbt0815-787 [doi]
FAU - Ratner, Mark
AU  - Ratner M
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EIN - Nat Biotechnol. 2015 Sep;33(9):896. PMID: 26348947
MH  - Biomedical Research
MH  - Clinical Trials as Topic
MH  - *Fecal Microbiota Transplantation
MH  - Humans
MH  - Inflammatory Bowel Diseases/*therapy
EDAT- 2015/08/08 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/08/08 06:00
PHST- 2015/08/08 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - nbt0815-787 [pii]
AID - 10.1038/nbt0815-787 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):787-8. doi: 10.1038/nbt0815-787.

PMID- 26252118
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - New class PCSK9 blockers stride into cholesterol market.
PG  - 785-6
LID - 10.1038/nbt0815-785 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Anticholesteremic Agents)
RN  - 97C5T2UQ7J (Cholesterol)
RN  - EC 3.4.21.- (PCSK9 protein, human)
RN  - EC 3.4.21.- (Proprotein Convertase 9)
RN  - EC 3.4.21.- (Proprotein Convertases)
RN  - EC 3.4.21.- (Serine Endopeptidases)
SB  - IM
MH  - *Anticholesteremic Agents/economics/pharmacology/therapeutic use
MH  - Cardiovascular Diseases/drug therapy/prevention & control
MH  - Cholesterol/*blood
MH  - Drug Industry
MH  - Humans
MH  - Proprotein Convertase 9
MH  - Proprotein Convertases/*antagonists & inhibitors
MH  - Serine Endopeptidases
EDAT- 2015/08/08 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/08/08 06:00
PHST- 2015/08/08 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - nbt0815-785 [pii]
AID - 10.1038/nbt0815-785 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):785-6. doi: 10.1038/nbt0815-785.

PMID- 26252117
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20150808
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - 'Financial toxicity' looms as cancer combinations proliferate.
PG  - 783-4
LID - 10.1038/nbt0815-783 [doi]
FAU - Morrison, Chris
AU  - Morrison C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antineoplastic Agents)
SB  - IM
MH  - Antineoplastic Agents/*economics/therapeutic use
MH  - Antineoplastic Combined Chemotherapy Protocols/*economics/therapeutic use
MH  - Drug Industry/*economics
MH  - Humans
MH  - Neoplasms/*drug therapy/*economics
EDAT- 2015/08/08 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/08/08 06:00
PHST- 2015/08/08 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - nbt0815-783 [pii]
AID - 10.1038/nbt0815-783 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):783-4. doi: 10.1038/nbt0815-783.

PMID- 26252116
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20150808
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - Old boy biotech.
PG  - 781
LID - 10.1038/nbt.3308 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Biotechnology/organization & administration/statistics & numerical data
MH  - Humans
MH  - Male
MH  - *Sexism
EDAT- 2015/08/08 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/08/08 06:00
PHST- 2015/08/08 06:00 [entrez]
PHST- 2015/08/08 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - nbt.3308 [pii]
AID - 10.1038/nbt.3308 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):781. doi: 10.1038/nbt.3308.

PMID- 26237515
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20161019
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - Mammalian synthetic circuits with RNA binding proteins for RNA-only delivery.
PG  - 839-41
LID - 10.1038/nbt.3301 [doi]
AB  - Synthetic regulatory circuits encoded in RNA rather than DNA could provide a
      means to control cell behavior while avoiding potentially harmful genomic
      integration in therapeutic applications. We create post-transcriptional circuits 
      using RNA-binding proteins, which can be wired in a plug-and-play fashion to
      create networks of higher complexity. We show that the circuits function in
      mammalian cells when encoded in modified mRNA or self-replicating RNA.
FAU - Wroblewska, Liliana
AU  - Wroblewska L
AD  - Department of Biological Engineering, Synthetic Biology Center, Massachusetts
      Institute of Technology, Cambridge, Massachusetts, USA.
FAU - Kitada, Tasuku
AU  - Kitada T
AUID- ORCID: 0000000322653363
AD  - Department of Biological Engineering, Synthetic Biology Center, Massachusetts
      Institute of Technology, Cambridge, Massachusetts, USA.
FAU - Endo, Kei
AU  - Endo K
AD  - Department of Life Science Frontiers, Center for iPS Cell Research and
      Application, Kyoto University, Kyoto, Japan.
FAU - Siciliano, Velia
AU  - Siciliano V
AD  - Department of Biological Engineering, Synthetic Biology Center, Massachusetts
      Institute of Technology, Cambridge, Massachusetts, USA.
FAU - Stillo, Breanna
AU  - Stillo B
AD  - Department of Biological Engineering, Synthetic Biology Center, Massachusetts
      Institute of Technology, Cambridge, Massachusetts, USA.
FAU - Saito, Hirohide
AU  - Saito H
AD  - 1] Department of Life Science Frontiers, Center for iPS Cell Research and
      Application, Kyoto University, Kyoto, Japan. [2] The Hakubi Center for Advanced
      Research, Kyoto University, Kyoto, Japan.
FAU - Weiss, Ron
AU  - Weiss R
AD  - Department of Biological Engineering, Synthetic Biology Center, Massachusetts
      Institute of Technology, Cambridge, Massachusetts, USA.
LA  - eng
GR  - HHSN261201200058C/CA/NCI NIH HHS/United States
GR  - R01 CA155320/CA/NCI NIH HHS/United States
GR  - P50 GM098792/GM/NIGMS NIH HHS/United States
GR  - R01 CA173712/CA/NCI NIH HHS/United States
GR  - P50-GM098792/GM/NIGMS NIH HHS/United States
GR  - 5-R01-CA155320-03/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20150803
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (RNA-Binding Proteins)
RN  - 63231-63-0 (RNA)
SB  - IM
MH  - Animals
MH  - Cell Line
MH  - Cricetinae
MH  - Gene Regulatory Networks/*genetics
MH  - HEK293 Cells
MH  - Humans
MH  - RNA/*genetics/metabolism
MH  - RNA-Binding Proteins/*genetics/metabolism
MH  - Synthetic Biology/*methods
PMC - PMC4532950
MID - NIHMS703452
EDAT- 2015/08/04 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/08/04 06:00
PHST- 2015/04/21 00:00 [received]
PHST- 2015/06/25 00:00 [accepted]
PHST- 2015/08/04 06:00 [entrez]
PHST- 2015/08/04 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - nbt.3301 [pii]
AID - 10.1038/nbt.3301 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):839-41. doi: 10.1038/nbt.3301. Epub 2015 Aug 3.

PMID- 26213851
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - Predicting the sequence specificities of DNA- and RNA-binding proteins by deep
      learning.
PG  - 831-8
LID - 10.1038/nbt.3300 [doi]
AB  - Knowing the sequence specificities of DNA- and RNA-binding proteins is essential 
      for developing models of the regulatory processes in biological systems and for
      identifying causal disease variants. Here we show that sequence specificities can
      be ascertained from experimental data with 'deep learning' techniques, which
      offer a scalable, flexible and unified computational approach for pattern
      discovery. Using a diverse array of experimental data and evaluation metrics, we 
      find that deep learning outperforms other state-of-the-art methods, even when
      training on in vitro data and testing on in vivo data. We call this approach
      DeepBind and have built a stand-alone software tool that is fully automatic and
      handles millions of sequences per experiment. Specificities determined by
      DeepBind are readily visualized as a weighted ensemble of position weight
      matrices or as a 'mutation map' that indicates how variations affect binding
      within a specific sequence.
FAU - Alipanahi, Babak
AU  - Alipanahi B
AD  - 1] Department of Electrical and Computer Engineering, University of Toronto,
      Toronto, Ontario, Canada. [2] Donnelly Centre for Cellular and Biomolecular
      Research, University of Toronto, Toronto, Ontario, Canada.
FAU - Delong, Andrew
AU  - Delong A
AD  - Department of Electrical and Computer Engineering, University of Toronto,
      Toronto, Ontario, Canada.
FAU - Weirauch, Matthew T
AU  - Weirauch MT
AD  - 1] Canadian Institute for Advanced Research, Programs on Genetic Networks and
      Neural Computation, Toronto, Ontario, Canada. [2] Center for Autoimmune Genomics 
      and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio,
      USA. [3] Divisions of Biomedical Informatics and Developmental Biology,
      Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
FAU - Frey, Brendan J
AU  - Frey BJ
AD  - 1] Department of Electrical and Computer Engineering, University of Toronto,
      Toronto, Ontario, Canada. [2] Donnelly Centre for Cellular and Biomolecular
      Research, University of Toronto, Toronto, Ontario, Canada. [3] Canadian Institute
      for Advanced Research, Programs on Genetic Networks and Neural Computation,
      Toronto, Ontario, Canada.
LA  - eng
GR  - OGP-106690/Canadian Institutes of Health Research/Canada
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150727
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (DNA-Binding Proteins)
RN  - 0 (RNA-Binding Proteins)
SB  - IM
CIN - Nat Biotechnol. 2015 Aug;33(8):825-6. PMID: 26252139
MH  - Computational Biology/*methods
MH  - DNA-Binding Proteins/*chemistry
MH  - Position-Specific Scoring Matrices
MH  - RNA-Binding Proteins/*chemistry
MH  - Sequence Analysis, Protein/*methods
MH  - *Software
EDAT- 2015/07/28 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/07/28 06:00
PHST- 2014/11/28 00:00 [received]
PHST- 2015/06/25 00:00 [accepted]
PHST- 2015/07/28 06:00 [entrez]
PHST- 2015/07/28 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - nbt.3300 [pii]
AID - 10.1038/nbt.3300 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):831-8. doi: 10.1038/nbt.3300. Epub 2015 Jul 27.

PMID- 26192320
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - Visualizing lipid-formulated siRNA release from endosomes and target gene
      knockdown.
PG  - 870-6
LID - 10.1038/nbt.3298 [doi]
AB  - A central hurdle in developing small interfering RNAs (siRNAs) as therapeutics is
      the inefficiency of their delivery across the plasma and endosomal membranes to
      the cytosol, where they interact with the RNA interference machinery. With the
      aim of improving endosomal release, a poorly understood and inefficient process, 
      we studied the uptake and cytosolic release of siRNAs, formulated in lipoplexes
      or lipid nanoparticles, by live-cell imaging and correlated it with knockdown of 
      a target GFP reporter. siRNA release occurred invariably from maturing endosomes 
      within ~5-15 min of endocytosis. Cytosolic galectins immediately recognized the
      damaged endosome and targeted it for autophagy. However, inhibiting autophagy did
      not enhance cytosolic siRNA release. Gene knockdown occurred within a few hours
      of release and required <2,000 copies of cytosolic siRNAs. The ability to detect 
      cytosolic release of siRNAs and understand how it is regulated will facilitate
      the development of rational strategies for improving the cytosolic delivery of
      candidate drugs.
FAU - Wittrup, Anders
AU  - Wittrup A
AD  - 1] Program in Cellular and Molecular Medicine, Boston Children's Hospital,
      Harvard Medical School, Boston, Massachusetts, USA. [2] Department of Clinical
      Sciences, Section for Oncology and Pathology, Lund University, Lund, Sweden.
FAU - Ai, Angela
AU  - Ai A
AD  - Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard
      Medical School, Boston, Massachusetts, USA.
FAU - Liu, Xing
AU  - Liu X
AD  - Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard
      Medical School, Boston, Massachusetts, USA.
FAU - Hamar, Peter
AU  - Hamar P
AUID- ORCID: 0000000210953564
AD  - 1] Program in Cellular and Molecular Medicine, Boston Children's Hospital,
      Harvard Medical School, Boston, Massachusetts, USA. [2] Institute of
      Pathophysiology, Semmelweis University, Budapest, Hungary.
FAU - Trifonova, Radiana
AU  - Trifonova R
AD  - Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard
      Medical School, Boston, Massachusetts, USA.
FAU - Charisse, Klaus
AU  - Charisse K
AD  - Alnylam Pharmaceuticals, Cambridge, Massachusetts, USA.
FAU - Manoharan, Muthiah
AU  - Manoharan M
AD  - Alnylam Pharmaceuticals, Cambridge, Massachusetts, USA.
FAU - Kirchhausen, Tomas
AU  - Kirchhausen T
AD  - 1] Program in Cellular and Molecular Medicine, Boston Children's Hospital,
      Harvard Medical School, Boston, Massachusetts, USA. [2] Department of Cell
      Biology, Harvard Medical School, Boston, Massachusetts, USA. [3] Department of
      Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Lieberman, Judy
AU  - Lieberman J
AD  - 1] Program in Cellular and Molecular Medicine, Boston Children's Hospital,
      Harvard Medical School, Boston, Massachusetts, USA. [2] Department of Pediatrics,
      Harvard Medical School, Boston, Massachusetts, USA.
LA  - eng
GR  - GM075252/GM/NIGMS NIH HHS/United States
GR  - U54 AI057159/AI/NIAID NIH HHS/United States
GR  - AI090671/AI/NIAID NIH HHS/United States
GR  - CA139444/CA/NCI NIH HHS/United States
GR  - R01 GM075252/GM/NIGMS NIH HHS/United States
GR  - AI057159/AI/NIAID NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20150720
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Lipids)
RN  - 0 (Luminescent Proteins)
RN  - 0 (RNA, Small Interfering)
SB  - IM
MH  - Endosomes/*metabolism
MH  - Gene Knockdown Techniques/*methods
MH  - HeLa Cells
MH  - Humans
MH  - Lipids/chemistry
MH  - Luminescent Proteins/genetics/metabolism/*pharmacokinetics
MH  - Nanoparticles/chemistry
MH  - *RNA Interference
MH  - RNA, Small Interfering/*genetics/metabolism/*pharmacokinetics
PMC - PMC4663660
MID - NIHMS736725
EDAT- 2015/07/21 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/07/21 06:00
PHST- 2014/11/26 00:00 [received]
PHST- 2015/06/22 00:00 [accepted]
PHST- 2015/07/21 06:00 [entrez]
PHST- 2015/07/21 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - nbt.3298 [pii]
AID - 10.1038/nbt.3298 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):870-6. doi: 10.1038/nbt.3298. Epub 2015 Jul 20.

PMID- 26192319
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - Engineered CHO cells for production of diverse, homogeneous glycoproteins.
PG  - 842-4
LID - 10.1038/nbt.3280 [doi]
AB  - Production of glycoprotein therapeutics in Chinese hamster ovary (CHO) cells is
      limited by the cells' generic capacity for N-glycosylation, and production of
      glycoproteins with desirable homogeneous glycoforms remains a challenge. We
      conducted a comprehensive knockout screen of glycosyltransferase genes
      controlling N-glycosylation in CHO cells and constructed a design matrix that
      facilitates the generation of desired glycosylation, such as human-like
      alpha2,6-linked sialic acid capping. This engineering approach will aid the
      production of glycoproteins with improved properties and therapeutic potential.
FAU - Yang, Zhang
AU  - Yang Z
AD  - 1] Center for Glycomics, Cellular and Molecular Medicine and Odontology, Faculty 
      of Health Sciences, University of Copenhagen, Copenhagen N, Denmark. [2] The Novo
      Nordisk Foundation Center for Biosustainability, The Danish Technical University,
      Denmark.
FAU - Wang, Shengjun
AU  - Wang S
AD  - 1] Center for Glycomics, Cellular and Molecular Medicine and Odontology, Faculty 
      of Health Sciences, University of Copenhagen, Copenhagen N, Denmark. [2] The Novo
      Nordisk Foundation Center for Biosustainability, The Danish Technical University,
      Denmark.
FAU - Halim, Adnan
AU  - Halim A
AD  - 1] Center for Glycomics, Cellular and Molecular Medicine and Odontology, Faculty 
      of Health Sciences, University of Copenhagen, Copenhagen N, Denmark. [2] The Novo
      Nordisk Foundation Center for Biosustainability, The Danish Technical University,
      Denmark.
FAU - Schulz, Morten Alder
AU  - Schulz MA
AD  - Center for Glycomics, Cellular and Molecular Medicine and Odontology, Faculty of 
      Health Sciences, University of Copenhagen, Copenhagen N, Denmark.
FAU - Frodin, Morten
AU  - Frodin M
AD  - Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen,
      Denmark.
FAU - Rahman, Shamim H
AU  - Rahman SH
AD  - 1] Center for Glycomics, Cellular and Molecular Medicine and Odontology, Faculty 
      of Health Sciences, University of Copenhagen, Copenhagen N, Denmark. [2] Novo
      Nordisk A/S, Malov, Denmark.
FAU - Vester-Christensen, Malene B
AU  - Vester-Christensen MB
AD  - 1] Center for Glycomics, Cellular and Molecular Medicine and Odontology, Faculty 
      of Health Sciences, University of Copenhagen, Copenhagen N, Denmark. [2] Novo
      Nordisk A/S, Malov, Denmark.
FAU - Behrens, Carsten
AU  - Behrens C
AD  - Novo Nordisk A/S, Malov, Denmark.
FAU - Kristensen, Claus
AU  - Kristensen C
AD  - Center for Glycomics, Cellular and Molecular Medicine and Odontology, Faculty of 
      Health Sciences, University of Copenhagen, Copenhagen N, Denmark.
FAU - Vakhrushev, Sergey Y
AU  - Vakhrushev SY
AD  - Center for Glycomics, Cellular and Molecular Medicine and Odontology, Faculty of 
      Health Sciences, University of Copenhagen, Copenhagen N, Denmark.
FAU - Bennett, Eric Paul
AU  - Bennett EP
AD  - Center for Glycomics, Cellular and Molecular Medicine and Odontology, Faculty of 
      Health Sciences, University of Copenhagen, Copenhagen N, Denmark.
FAU - Wandall, Hans H
AU  - Wandall HH
AD  - Center for Glycomics, Cellular and Molecular Medicine and Odontology, Faculty of 
      Health Sciences, University of Copenhagen, Copenhagen N, Denmark.
FAU - Clausen, Henrik
AU  - Clausen H
AD  - 1] Center for Glycomics, Cellular and Molecular Medicine and Odontology, Faculty 
      of Health Sciences, University of Copenhagen, Copenhagen N, Denmark. [2] The Novo
      Nordisk Foundation Center for Biosustainability, The Danish Technical University,
      Denmark.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150720
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Glycoproteins)
RN  - 0 (Recombinant Proteins)
SB  - IM
MH  - Animals
MH  - CHO Cells
MH  - Cricetinae
MH  - Cricetulus
MH  - *Glycoproteins/chemistry/genetics/metabolism
MH  - Protein Engineering/*methods
MH  - *Recombinant Proteins/chemistry/genetics/metabolism
EDAT- 2015/07/21 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/07/21 06:00
PHST- 2014/10/22 00:00 [received]
PHST- 2015/06/10 00:00 [accepted]
PHST- 2015/07/21 06:00 [entrez]
PHST- 2015/07/21 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - nbt.3280 [pii]
AID - 10.1038/nbt.3280 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):842-4. doi: 10.1038/nbt.3280. Epub 2015 Jul 20.

PMID- 26192317
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20171110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - High-throughput sequencing of DNA G-quadruplex structures in the human genome.
PG  - 877-81
LID - 10.1038/nbt.3295 [doi]
AB  - G-quadruplexes (G4s) are nucleic acid secondary structures that form within
      guanine-rich DNA or RNA sequences. G4 formation can affect chromatin architecture
      and gene regulation and has been associated with genomic instability, genetic
      diseases and cancer progression. Here we present a high-resolution
      sequencing-based method to detect G4s in the human genome. We identified 716,310 
      distinct G4 structures, 451,646 of which were not predicted by computational
      methods. These included previously uncharacterized noncanonical long loop and
      bulged structures. We observed a high G4 density in functional regions, such as
      5' untranslated regions and splicing sites, as well as in genes previously not
      predicted to contain these structures (such as BRCA2). G4 formation was
      significantly associated with oncogenes, tumor suppressors and somatic copy
      number alterations related to cancer development. The G4s identified in this
      study may therefore represent promising targets for cancer intervention.
FAU - Chambers, Vicki S
AU  - Chambers VS
AUID- ORCID: 0000000333391813
AD  - Department of Chemistry, University of Cambridge, Cambridge, UK.
FAU - Marsico, Giovanni
AU  - Marsico G
AD  - Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, 
      UK.
FAU - Boutell, Jonathan M
AU  - Boutell JM
AD  - Illumina Cambridge Ltd., Chesterford Research Park, Little Chesterford, Saffron
      Walden, UK.
FAU - Di Antonio, Marco
AU  - Di Antonio M
AD  - 1] Department of Chemistry, University of Cambridge, Cambridge, UK. [2] Cancer
      Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK.
FAU - Smith, Geoffrey P
AU  - Smith GP
AD  - Illumina Cambridge Ltd., Chesterford Research Park, Little Chesterford, Saffron
      Walden, UK.
FAU - Balasubramanian, Shankar
AU  - Balasubramanian S
AD  - 1] Department of Chemistry, University of Cambridge, Cambridge, UK. [2] Cancer
      Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK. [3]
      School of Clinical Medicine, University of Cambridge, Cambridge, UK.
LA  - eng
GR  - 11961/Cancer Research UK/United Kingdom
GR  - 12488/Cancer Research UK/United Kingdom
GR  - BB/I015477/1/Biotechnology and Biological Sciences Research Council/United
      Kingdom
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150720
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 9007-49-2 (DNA)
SB  - IM
CIN - Nat Methods. 2015 Sep;12(9):806-7. PMID: 26554089
MH  - DNA/*genetics
MH  - *G-Quadruplexes
MH  - Genome, Human/*genetics
MH  - Genomics
MH  - High-Throughput Nucleotide Sequencing/*methods
MH  - Humans
MH  - Sequence Analysis, DNA/*methods
EDAT- 2015/07/21 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/07/21 06:00
PHST- 2015/01/12 00:00 [received]
PHST- 2015/06/19 00:00 [accepted]
PHST- 2015/07/21 06:00 [entrez]
PHST- 2015/07/21 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - nbt.3295 [pii]
AID - 10.1038/nbt.3295 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):877-81. doi: 10.1038/nbt.3295. Epub 2015 Jul 20.

PMID- 26167630
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - Directed differentiation of cholangiocytes from human pluripotent stem cells.
PG  - 853-61
LID - 10.1038/nbt.3294 [doi]
AB  - Although bile duct disorders are well-recognized causes of liver disease, the
      molecular and cellular events leading to biliary dysfunction are poorly
      understood. To enable modeling and drug discovery for biliary disease, we
      describe a protocol that achieves efficient differentiation of biliary epithelial
      cells (cholangiocytes) from human pluripotent stem cells (hPSCs) through delivery
      of developmentally relevant cues, including NOTCH signaling. Using
      three-dimensional culture, the protocol yields cystic and/or ductal structures
      that express mature biliary markers, including apical sodium-dependent bile acid 
      transporter, secretin receptor, cilia and cystic fibrosis transmembrane
      conductance regulator (CFTR). We demonstrate that hPSC-derived cholangiocytes
      possess epithelial functions, including rhodamine efflux and CFTR-mediated fluid 
      secretion. Furthermore, we show that functionally impaired hPSC-derived
      cholangiocytes from cystic fibrosis patients are rescued by CFTR correctors.
      These findings demonstrate that mature cholangiocytes can be differentiated from 
      hPSCs and used for studies of biliary development and disease.
FAU - Ogawa, Mina
AU  - Ogawa M
AD  - 1] McEwen Centre for Regenerative Medicine, University Health Network, Toronto,
      Ontario, Canada. [2] Toronto General Research Institute, University Health
      Network, Toronto, Ontario, Canada.
FAU - Ogawa, Shinichiro
AU  - Ogawa S
AD  - McEwen Centre for Regenerative Medicine, University Health Network, Toronto,
      Ontario, Canada.
FAU - Bear, Christine E
AU  - Bear CE
AD  - Program in Molecular Structure &Function, The Hospital for Sick Children Research
      Institute, Toronto, Ontario, Canada.
FAU - Ahmadi, Saumel
AU  - Ahmadi S
AD  - Program in Molecular Structure &Function, The Hospital for Sick Children Research
      Institute, Toronto, Ontario, Canada.
FAU - Chin, Stephanie
AU  - Chin S
AD  - Program in Molecular Structure &Function, The Hospital for Sick Children Research
      Institute, Toronto, Ontario, Canada.
FAU - Li, Bin
AU  - Li B
AD  - Department of Pediatrics, Oregon Health and Science University, Portland, Oregon,
      USA.
FAU - Grompe, Markus
AU  - Grompe M
AD  - Department of Pediatrics, Oregon Health and Science University, Portland, Oregon,
      USA.
FAU - Keller, Gordon
AU  - Keller G
AD  - 1] McEwen Centre for Regenerative Medicine, University Health Network, Toronto,
      Ontario, Canada. [2] Princess Margaret Cancer Centre, University Health Network, 
      Toronto, Ontario, Canada. [3] Department of Medical Biophysics, University of
      Toronto, Toronto, Ontario, Canada.
FAU - Kamath, Binita M
AU  - Kamath BM
AD  - 1] Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick 
      Children, Toronto, Ontario, Canada. [2] Department of Pediatrics, University of
      Toronto, Toronto, Ontario, Canada.
FAU - Ghanekar, Anand
AU  - Ghanekar A
AD  - 1] Toronto General Research Institute, University Health Network, Toronto,
      Ontario, Canada. [2] Division of General Surgery, University Health Network,
      Toronto, Ontario, Canada. [3] Department of Surgery, University of Toronto,
      Toronto, Ontario, Canada.
LA  - eng
GR  - GPG102171/Canadian Institutes of Health Research/Canada
GR  - MOP133620/Canadian Institutes of Health Research/Canada
GR  - MOP97954/Canadian Institutes of Health Research/Canada
GR  - U01 DK062453/DK/NIDDK NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20150713
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Receptors, Notch)
SB  - IM
CIN - Nat Rev Gastroenterol Hepatol. 2015 Sep;12(9):490. PMID: 26215387
MH  - Bile Ducts/*cytology
MH  - Cell Culture Techniques/*methods
MH  - Cell Differentiation/*physiology
MH  - Cells, Cultured
MH  - Epithelial Cells/cytology/physiology
MH  - Humans
MH  - *Pluripotent Stem Cells/cytology/physiology
MH  - Receptors, Notch/metabolism
MH  - Signal Transduction/physiology
MH  - Stem Cell Research
EDAT- 2015/07/15 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/07/14 06:00
PHST- 2015/02/02 00:00 [received]
PHST- 2015/06/19 00:00 [accepted]
PHST- 2015/07/14 06:00 [entrez]
PHST- 2015/07/15 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - nbt.3294 [pii]
AID - 10.1038/nbt.3294 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):853-61. doi: 10.1038/nbt.3294. Epub 2015 Jul 13.

PMID- 26167629
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - Cholangiocytes derived from human induced pluripotent stem cells for disease
      modeling and drug validation.
PG  - 845-852
LID - 10.1038/nbt.3275 [doi]
AB  - The study of biliary disease has been constrained by a lack of primary human
      cholangiocytes. Here we present an efficient, serum-free protocol for directed
      differentiation of human induced pluripotent stem cells into cholangiocyte-like
      cells (CLCs). CLCs show functional characteristics of cholangiocytes, including
      bile acids transfer, alkaline phosphatase activity, gamma-glutamyl-transpeptidase
      activity and physiological responses to secretin, somatostatin and vascular
      endothelial growth factor. We use CLCs to model in vitro key features of Alagille
      syndrome, polycystic liver disease and cystic fibrosis (CF)-associated
      cholangiopathy. Furthermore, we use CLCs generated from healthy individuals and
      patients with polycystic liver disease to reproduce the effects of the drugs
      verapamil and octreotide, and we show that the experimental CF drug VX809 rescues
      the disease phenotype of CF cholangiopathy in vitro. Our differentiation protocol
      will facilitate the study of biological mechanisms controlling biliary
      development, as well as disease modeling and drug screening.
FAU - Sampaziotis, Fotios
AU  - Sampaziotis F
AD  - Wellcome Trust-Medical Research Council Stem Cell Institute, Anne McLaren
      Laboratory for Regenerative Medicine, Department of Surgery, University of
      Cambridge, Cambridge, UK.
AD  - Wellcome Trust Sanger Institute, Hinxton, United Kingdom.
FAU - de Brito, Miguel Cardoso
AU  - de Brito MC
AD  - Wellcome Trust-Medical Research Council Stem Cell Institute, Anne McLaren
      Laboratory for Regenerative Medicine, Department of Surgery, University of
      Cambridge, Cambridge, UK.
FAU - Madrigal, Pedro
AU  - Madrigal P
AD  - Wellcome Trust-Medical Research Council Stem Cell Institute, Anne McLaren
      Laboratory for Regenerative Medicine, Department of Surgery, University of
      Cambridge, Cambridge, UK.
AD  - Wellcome Trust Sanger Institute, Hinxton, United Kingdom.
FAU - Bertero, Alessandro
AU  - Bertero A
AD  - Wellcome Trust-Medical Research Council Stem Cell Institute, Anne McLaren
      Laboratory for Regenerative Medicine, Department of Surgery, University of
      Cambridge, Cambridge, UK.
FAU - Saeb-Parsy, Kourosh
AU  - Saeb-Parsy K
AD  - Department of Surgery, University of Cambridge and NIHR Cambridge Biomedical
      Research Centre, Cambridge, UK.
FAU - Soares, Filipa A C
AU  - Soares FAC
AD  - Wellcome Trust-Medical Research Council Stem Cell Institute, Anne McLaren
      Laboratory for Regenerative Medicine, Department of Surgery, University of
      Cambridge, Cambridge, UK.
FAU - Schrumpf, Elisabeth
AU  - Schrumpf E
AD  - Norwegian PSC Research Center, Division of Cancer, Surgery and Transplantation,
      Oslo University Hospital, Rikshospitalet, Oslo, Norway.
AD  - K.G. Jebsen Inflammation Research Centre, Research Institute of Internal
      Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
AD  - Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
FAU - Melum, Espen
AU  - Melum E
AD  - Norwegian PSC Research Center, Division of Cancer, Surgery and Transplantation,
      Oslo University Hospital, Rikshospitalet, Oslo, Norway.
AD  - K.G. Jebsen Inflammation Research Centre, Research Institute of Internal
      Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
FAU - Karlsen, Tom H
AU  - Karlsen TH
AD  - Norwegian PSC Research Center, Division of Cancer, Surgery and Transplantation,
      Oslo University Hospital, Rikshospitalet, Oslo, Norway.
AD  - K.G. Jebsen Inflammation Research Centre, Research Institute of Internal
      Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
AD  - Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
FAU - Bradley, J Andrew
AU  - Bradley JA
AD  - Department of Surgery, University of Cambridge and NIHR Cambridge Biomedical
      Research Centre, Cambridge, UK.
FAU - Gelson, William Th
AU  - Gelson WT
AD  - Department of Hepatology, Cambridge University Hospitals NHS Foundation Trust,
      Cambridge, UK.
FAU - Davies, Susan
AU  - Davies S
AD  - Department of Histopathology, Cambridge University Hospitals NHS Foundation
      Trust, Cambridge, UK.
FAU - Baker, Alastair
AU  - Baker A
AD  - Child Health Clinical Academic Grouping, King's Health Partners, Denmark Hill
      Campus, London, United Kingdom.
FAU - Kaser, Arthur
AU  - Kaser A
AD  - Division of Gastroenterology and Hepatology, Department of Medicine, University
      of Cambridge, Cambridge CB2 0QQ, United Kingdom.
FAU - Alexander, Graeme J
AU  - Alexander GJ
AD  - Department of Medicine, School of Clinical Medicine, University of Cambridge,
      Cambridge, United Kingdom.
FAU - Hannan, Nicholas R F
AU  - Hannan NRF
AD  - Wellcome Trust-Medical Research Council Stem Cell Institute, Anne McLaren
      Laboratory for Regenerative Medicine, Department of Surgery, University of
      Cambridge, Cambridge, UK.
FAU - Vallier, Ludovic
AU  - Vallier L
AD  - Wellcome Trust-Medical Research Council Stem Cell Institute, Anne McLaren
      Laboratory for Regenerative Medicine, Department of Surgery, University of
      Cambridge, Cambridge, UK.
AD  - Wellcome Trust Sanger Institute, Hinxton, United Kingdom.
LA  - eng
GR  - G0800784/Medical Research Council/United Kingdom
GR  - Medical Research Council/United Kingdom
GR  - 281335/European Research Council/International
GR  - MR/L016761/1/Medical Research Council/United Kingdom
GR  - G1000847/Medical Research Council/United Kingdom
GR  - Wellcome Trust/United Kingdom
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150713
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CIN - Nat Rev Gastroenterol Hepatol. 2015 Sep;12(9):490. PMID: 26215387
MH  - Biliary Tract/*cytology
MH  - Biomedical Research
MH  - Cells, Cultured
MH  - *Drug Discovery
MH  - Humans
MH  - *Induced Pluripotent Stem Cells/cytology/drug effects/metabolism/physiology
MH  - Liver Diseases
MH  - *Models, Biological
PMC - PMC4768345
MID - EMS63736
OID - NLM: EMS63736
EDAT- 2015/07/15 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/07/14 06:00
PHST- 2015/04/02 00:00 [received]
PHST- 2015/06/05 00:00 [accepted]
PHST- 2015/07/14 06:00 [entrez]
PHST- 2015/07/15 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - 10.1038/nbt.3275 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):845-852. doi: 10.1038/nbt.3275. Epub 2015 Jul 13.

PMID- 26121414
OWN - NLM
STAT- MEDLINE
DCOM- 20160328
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 8
DP  - 2015 Aug
TI  - Flexible guide-RNA design for CRISPR applications using Protospacer Workbench.
PG  - 805-6
LID - 10.1038/nbt.3291 [doi]
FAU - MacPherson, Cameron Ross
AU  - MacPherson CR
AUID- ORCID: 0000000289459736
AD  - 1] Biology of Host-Parasite Interactions Unit, Institut Pasteur, Paris, France.
      [2] CNRS, ERL 9195, Paris, France. [3] INSERM, Unit U1201, Paris, France.
FAU - Scherf, Artur
AU  - Scherf A
AD  - 1] Biology of Host-Parasite Interactions Unit, Institut Pasteur, Paris, France.
      [2] CNRS, ERL 9195, Paris, France. [3] INSERM, Unit U1201, Paris, France.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150629
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (RNA, Guide)
SB  - IM
MH  - Biotechnology/*methods
MH  - *CRISPR-Cas Systems
MH  - Computational Biology
MH  - Databases, Genetic
MH  - High-Throughput Nucleotide Sequencing
MH  - Humans
MH  - *RNA, Guide
MH  - *Sequence Analysis, DNA
MH  - *Software
EDAT- 2015/06/30 06:00
MHDA- 2016/03/29 06:00
CRDT- 2015/06/30 06:00
PHST- 2015/06/30 06:00 [entrez]
PHST- 2015/06/30 06:00 [pubmed]
PHST- 2016/03/29 06:00 [medline]
AID - nbt.3291 [pii]
AID - 10.1038/nbt.3291 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Aug;33(8):805-6. doi: 10.1038/nbt.3291. Epub 2015 Jun 29.

PMID- 26154014
OWN - NLM
STAT- MEDLINE
DCOM- 20160107
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 7
DP  - 2015 Jul
TI  - Emerging network of resources for exploring paths beyond academia.
PG  - 775-8
LID - 10.1038/nbt.3282 [doi]
FAU - Muindi, Fanuel
AU  - Muindi F
AD  - Department of Brain and Cognitive Sciences, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
FAU - Keller, Joseph B
AU  - Keller JB
AD  - Department of Brain and Cognitive Sciences, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biomedical Research/*organization & administration
MH  - *Career Choice
MH  - Employment
MH  - Humans
MH  - *Industry
MH  - Research Personnel
MH  - *Universities
EDAT- 2015/07/15 06:00
MHDA- 2016/01/08 06:00
CRDT- 2015/07/09 06:00
PHST- 2015/07/09 06:00 [entrez]
PHST- 2015/07/15 06:00 [pubmed]
PHST- 2016/01/08 06:00 [medline]
AID - nbt.3282 [pii]
AID - 10.1038/nbt.3282 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jul;33(7):775-8. doi: 10.1038/nbt.3282.

PMID- 26154012
OWN - NLM
STAT- MEDLINE
DCOM- 20150914
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 7
DP  - 2015 Jul
TI  - Molecular networks in context.
PG  - 720-1
LID - 10.1038/nbt.3283 [doi]
FAU - Gross, Andrew M
AU  - Gross AM
AD  - Bioinformatics Program and Department of Medicine, University of California, San 
      Diego, San Diego, California, USA.
FAU - Ideker, Trey
AU  - Ideker T
AD  - Bioinformatics Program and Department of Medicine, University of California, San 
      Diego, San Diego, California, USA.
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Genet. 2015 Jun;47(6):569-76. PMID: 25915600
MH  - *Gene Regulatory Networks
MH  - Humans
MH  - *Protein Interaction Maps
EDAT- 2015/07/15 06:00
MHDA- 2015/09/15 06:00
CRDT- 2015/07/09 06:00
PHST- 2015/07/09 06:00 [entrez]
PHST- 2015/07/15 06:00 [pubmed]
PHST- 2015/09/15 06:00 [medline]
AID - nbt.3283 [pii]
AID - 10.1038/nbt.3283 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jul;33(7):720-1. doi: 10.1038/nbt.3283.

PMID- 26154011
OWN - NLM
STAT- MEDLINE
DCOM- 20160127
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 7
DP  - 2015 Jul
TI  - Reigning in regulatory T-cell function.
PG  - 718-9
LID - 10.1038/nbt.3285 [doi]
FAU - Konopacki, Catherine
AU  - Konopacki C
AD  - Howard Hughes Medical Institute and Immunology Program, Ludwig Center.
FAU - Plitas, George
AU  - Plitas G
AD  - 1] Howard Hughes Medical Institute and Immunology Program, Ludwig Center [2]
      Breast Cancer Service, Department of Surgery, Memorial Sloan Kettering Cancer
      Center, New York, New York, USA.
FAU - Rudensky, Alexander
AU  - Rudensky A
AD  - Howard Hughes Medical Institute and Immunology Program, Ludwig Center.
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antibodies, Monoclonal)
RN  - 0 (Immunosuppressive Agents)
RN  - 0 (Membrane Proteins)
RN  - 0 (Transforming Growth Factor beta1)
SB  - IM
CON - Sci Transl Med. 2015 Apr 22;7(284):284ra56. PMID: 25904740
MH  - Animals
MH  - Antibodies, Monoclonal/*chemistry
MH  - Humans
MH  - Immunosuppressive Agents/*chemistry
MH  - Membrane Proteins/*chemistry
MH  - T-Lymphocytes, Regulatory/*immunology
MH  - Transforming Growth Factor beta1/*chemistry
EDAT- 2015/07/15 06:00
MHDA- 2016/01/28 06:00
CRDT- 2015/07/09 06:00
PHST- 2015/07/09 06:00 [entrez]
PHST- 2015/07/15 06:00 [pubmed]
PHST- 2016/01/28 06:00 [medline]
AID - nbt.3285 [pii]
AID - 10.1038/nbt.3285 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jul;33(7):718-9. doi: 10.1038/nbt.3285.

PMID- 26154010
OWN - NLM
STAT- MEDLINE
DCOM- 20160108
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 7
DP  - 2015 Jul
TI  - Illuminating the dark matter of shotgun proteomics.
PG  - 717-8
LID - 10.1038/nbt.3287 [doi]
FAU - Skinner, Owen S
AU  - Skinner OS
AD  - Department of Chemistry, Northwestern University, Evanston, Illinois, USA.
FAU - Kelleher, Neil L
AU  - Kelleher NL
AD  - 1] Department of Chemistry, Northwestern University, Evanston, Illinois, USA. [2]
      Department of Molecular Biosciences, Northwestern University, Evanston, Illinois,
      USA.
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Peptides)
SB  - IM
CON - Nat Biotechnol. 2015 Jul;33(7):743-9. PMID: 26076430
MH  - *Databases, Protein
MH  - Humans
MH  - Peptide Mapping/*methods
MH  - Peptides/*analysis
MH  - Proteomics/*methods
MH  - *Tandem Mass Spectrometry
EDAT- 2015/07/15 06:00
MHDA- 2016/01/09 06:00
CRDT- 2015/07/09 06:00
PHST- 2015/07/09 06:00 [entrez]
PHST- 2015/07/15 06:00 [pubmed]
PHST- 2016/01/09 06:00 [medline]
AID - nbt.3287 [pii]
AID - 10.1038/nbt.3287 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jul;33(7):717-8. doi: 10.1038/nbt.3287.

PMID- 26154008
OWN - NLM
STAT- MEDLINE
DCOM- 20160107
LR  - 20150709
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 7
DP  - 2015 Jul
TI  - Safe harbors in Europe: an update on the research and Bolar exemptions to patent 
      infringement.
PG  - 710-5
LID - 10.1038/nbt.3273 [doi]
FAU - Kupecz, Andras
AU  - Kupecz A
AD  - Kupecz Intellectual Property, Amsterdam, the Netherlands.
FAU - Roox, Kristof
AU  - Roox K
AD  - Crowell &Moring LLP, Brussels, Belgium.
FAU - Dekoninck, Christian
AU  - Dekoninck C
AD  - Crowell &Moring LLP, Brussels, Belgium.
FAU - Schertenleib, Denis
AU  - Schertenleib D
AD  - Cabinet Schertenleib, Paris, France.
FAU - Stief, Marco
AU  - Stief M
AD  - Maiwald Partnerschaftsgesellschaft Patentanwalte Rechtsanwalte, Munich, Germany.
FAU - Sanna, Fabrizio
AU  - Sanna F
AD  - Orsingher Avvocati Associati, Milan, Italy.
FAU - Orsingher, Matteo
AU  - Orsingher M
AD  - Orsingher Avvocati Associati, Milan, Italy.
FAU - Miralles, Sergio
AU  - Miralles S
AD  - Intangibles Legal SLP, Barcelona, Spain.
FAU - Molina, Elena
AU  - Molina E
AD  - Intangibles Legal SLP, Barcelona, Spain.
FAU - Crosse, Trevor
AU  - Crosse T
AD  - Marks &Clerk Solicitors LLP, London, UK.
FAU - Gilbert, Mike
AU  - Gilbert M
AD  - Marks &Clerk Solicitors LLP, London, UK.
FAU - James, Will
AU  - James W
AD  - Marks &Clerk Solicitors LLP, London, UK.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biomedical Research/*legislation & jurisprudence
MH  - Drug Industry/*legislation & jurisprudence
MH  - Europe
MH  - Humans
MH  - Patents as Topic/*legislation & jurisprudence
EDAT- 2015/07/15 06:00
MHDA- 2016/01/08 06:00
CRDT- 2015/07/09 06:00
PHST- 2015/07/09 06:00 [entrez]
PHST- 2015/07/15 06:00 [pubmed]
PHST- 2016/01/08 06:00 [medline]
AID - nbt.3273 [pii]
AID - 10.1038/nbt.3273 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jul;33(7):710-5. doi: 10.1038/nbt.3273.

PMID- 26154007
OWN - NLM
STAT- MEDLINE
DCOM- 20160107
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 7
DP  - 2015 Jul
TI  - Public biotech in 2014--the numbers.
PG  - 703-9
LID - 10.1038/nbt.3278 [doi]
FAU - Morrison, Chris
AU  - Morrison C
FAU - Lahteenmaki, Riku
AU  - Lahteenmaki R
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*economics
MH  - Drug Industry/*economics
MH  - Humans
MH  - Public Sector/*economics
EDAT- 2015/07/15 06:00
MHDA- 2016/01/08 06:00
CRDT- 2015/07/09 06:00
PHST- 2015/07/09 06:00 [entrez]
PHST- 2015/07/15 06:00 [pubmed]
PHST- 2016/01/08 06:00 [medline]
AID - nbt.3278 [pii]
AID - 10.1038/nbt.3278 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jul;33(7):703-9. doi: 10.1038/nbt.3278.

PMID- 26154006
OWN - NLM
STAT- MEDLINE
DCOM- 20160107
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 7
DP  - 2015 Jul
TI  - A regulatory framework emerges for digital medicine.
PG  - 697-702
LID - 10.1038/nbt.3284 [doi]
FAU - Elenko, Eric
AU  - Elenko E
AD  - PureTech, Boston, Massachusetts, USA.
FAU - Speier, Austin
AU  - Speier A
AD  - Precision for Medicine, Bethesda, Maryland, USA.
FAU - Zohar, Daphne
AU  - Zohar D
AD  - PureTech, Boston, Massachusetts, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Delivery of Health Care/legislation & jurisprudence/standards
MH  - Equipment Safety
MH  - Humans
MH  - *Medical Informatics/instrumentation/standards
MH  - Medical Informatics Applications
MH  - *Monitoring, Physiologic/instrumentation/standards
MH  - *Software
EDAT- 2015/07/15 06:00
MHDA- 2016/01/08 06:00
CRDT- 2015/07/09 06:00
PHST- 2015/07/09 06:00 [entrez]
PHST- 2015/07/15 06:00 [pubmed]
PHST- 2016/01/08 06:00 [medline]
AID - nbt.3284 [pii]
AID - 10.1038/nbt.3284 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jul;33(7):697-702. doi: 10.1038/nbt.3284.

PMID- 26154005
OWN - NLM
STAT- MEDLINE
DCOM- 20160107
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 7
DP  - 2015 Jul
TI  - Site-specific conjugation improves therapeutic index of antibody drug conjugates 
      with high drug loading.
PG  - 694-6
LID - 10.1038/nbt.3274 [doi]
FAU - Strop, Pavel
AU  - Strop P
AD  - Rinat Laboratories, Pfizer Inc., South San Francisco, California, USA.
FAU - Delaria, Kathy
AU  - Delaria K
AD  - Rinat Laboratories, Pfizer Inc., South San Francisco, California, USA.
FAU - Foletti, Davide
AU  - Foletti D
AD  - Rinat Laboratories, Pfizer Inc., South San Francisco, California, USA.
FAU - Witt, Jody Melton
AU  - Witt JM
AD  - Rinat Laboratories, Pfizer Inc., South San Francisco, California, USA.
FAU - Hasa-Moreno, Adela
AU  - Hasa-Moreno A
AD  - Rinat Laboratories, Pfizer Inc., South San Francisco, California, USA.
FAU - Poulsen, Kris
AU  - Poulsen K
AD  - Rinat Laboratories, Pfizer Inc., South San Francisco, California, USA.
FAU - Casas, Meritxell Galindo
AU  - Casas MG
AUID- ORCID: 0000000250341722
AD  - Rinat Laboratories, Pfizer Inc., South San Francisco, California, USA.
FAU - Dorywalska, Magdalena
AU  - Dorywalska M
AD  - Rinat Laboratories, Pfizer Inc., South San Francisco, California, USA.
FAU - Farias, Santiago
AU  - Farias S
AD  - Rinat Laboratories, Pfizer Inc., South San Francisco, California, USA.
FAU - Pios, Ariel
AU  - Pios A
AD  - Rinat Laboratories, Pfizer Inc., South San Francisco, California, USA.
FAU - Lui, Victor
AU  - Lui V
AD  - Rinat Laboratories, Pfizer Inc., South San Francisco, California, USA.
FAU - Dushin, Russell
AU  - Dushin R
AD  - Worldwide Medicinal Chemistry, Pfizer Inc., Groton, Connecticut, USA.
FAU - Zhou, Dahui
AU  - Zhou D
AD  - Worldwide Medicinal Chemistry, Pfizer Inc., Groton, Connecticut, USA.
FAU - Navaratnam, Thayalan
AU  - Navaratnam T
AD  - Worldwide Medicinal Chemistry, Pfizer Inc., Groton, Connecticut, USA.
FAU - Tran, Thomas-Toan
AU  - Tran TT
AD  - Rinat Laboratories, Pfizer Inc., South San Francisco, California, USA.
FAU - Sutton, Janette
AU  - Sutton J
AD  - Rinat Laboratories, Pfizer Inc., South San Francisco, California, USA.
FAU - Lindquist, Kevin C
AU  - Lindquist KC
AD  - Rinat Laboratories, Pfizer Inc., South San Francisco, California, USA.
FAU - Han, Bora
AU  - Han B
AD  - Drug Safety Research and Development, Pfizer Inc., San Diego, California, USA.
FAU - Liu, Shu-Hui
AU  - Liu SH
AD  - Rinat Laboratories, Pfizer Inc., South San Francisco, California, USA.
FAU - Shelton, David L
AU  - Shelton DL
AD  - Rinat Laboratories, Pfizer Inc., South San Francisco, California, USA.
FAU - Pons, Jaume
AU  - Pons J
AD  - Rinat Laboratories, Pfizer Inc., South San Francisco, California, USA.
FAU - Rajpal, Arvind
AU  - Rajpal A
AD  - Rinat Laboratories, Pfizer Inc., South San Francisco, California, USA.
LA  - eng
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Immunoconjugates)
SB  - IM
MH  - Animals
MH  - Cell Line, Tumor
MH  - Chemistry, Pharmaceutical
MH  - Humans
MH  - Hydrophobic and Hydrophilic Interactions
MH  - *Immunoconjugates/administration & dosage/chemistry/pharmacology/therapeutic use
MH  - Mice
MH  - Models, Molecular
MH  - Rats
MH  - Xenograft Model Antitumor Assays
EDAT- 2015/07/15 06:00
MHDA- 2016/01/08 06:00
CRDT- 2015/07/09 06:00
PHST- 2015/07/09 06:00 [entrez]
PHST- 2015/07/15 06:00 [pubmed]
PHST- 2016/01/08 06:00 [medline]
AID - nbt.3274 [pii]
AID - 10.1038/nbt.3274 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jul;33(7):694-6. doi: 10.1038/nbt.3274.

PMID- 26154004
OWN - NLM
STAT- MEDLINE
DCOM- 20160107
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 7
DP  - 2015 Jul
TI  - Good laboratory practice for clinical next-generation sequencing informatics
      pipelines.
PG  - 689-93
LID - 10.1038/nbt.3237 [doi]
FAU - Gargis, Amy S
AU  - Gargis AS
AD  - Division of Laboratory Systems, Centers for Disease Control and Prevention,
      Atlanta, Georgia, USA.
FAU - Kalman, Lisa
AU  - Kalman L
AD  - Division of Laboratory Systems, Centers for Disease Control and Prevention,
      Atlanta, Georgia, USA.
FAU - Bick, David P
AU  - Bick DP
AD  - Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin,
      USA.
FAU - da Silva, Cristina
AU  - da Silva C
AD  - Department of Human Genetics, Emory University School of Medicine, Atlanta,
      Georgia, USA.
FAU - Dimmock, David P
AU  - Dimmock DP
AUID- ORCID: 0000000166902523
AD  - Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin,
      USA.
FAU - Funke, Birgit H
AU  - Funke BH
AD  - 1] Laboratory for Molecular Medicine, Partners Healthcare Personalized Medicine, 
      Cambridge, Massachusetts, USA. [2] Department of Pathology, Harvard Medical
      School, Boston, Massachusetts, USA.
FAU - Gowrisankar, Sivakumar
AU  - Gowrisankar S
AD  - 1] Laboratory for Molecular Medicine, Partners Healthcare Personalized Medicine, 
      Cambridge, Massachusetts, USA. [2] Department of Pathology, Harvard Medical
      School, Boston, Massachusetts, USA.
FAU - Hegde, Madhuri R
AU  - Hegde MR
AD  - Department of Human Genetics, Emory University School of Medicine, Atlanta,
      Georgia, USA.
FAU - Kulkarni, Shashikant
AU  - Kulkarni S
AD  - 1] Department of Genetics, Washington University School of Medicine, St. Louis,
      Missouri, USA. [2] Department of Pediatrics, Washington University School of
      Medicine, St. Louis, Missouri, USA. [3] Department of Pathology and Immunology,
      Washington University School of Medicine, St. Louis, Missouri, USA.
FAU - Mason, Christopher E
AU  - Mason CE
AD  - Department of Physiology and Biophysics, Cornell University, New York, New York, 
      USA.
FAU - Nagarajan, Rakesh
AU  - Nagarajan R
AD  - Department of Pathology and Immunology, Washington University School of Medicine,
      St. Louis, Missouri, USA.
FAU - Voelkerding, Karl V
AU  - Voelkerding KV
AD  - 1] Department of Pathology, University of Utah, Salt Lake City, Utah, USA. [2]
      Institute for Clinical and Experimental Pathology, Associated Regional and
      University Pathologists (ARUP) Laboratories, Salt Lake City, Utah, USA.
FAU - Worthey, Elizabeth A
AU  - Worthey EA
AD  - Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin,
      USA.
FAU - Aziz, Nazneen
AU  - Aziz N
AD  - College of American Pathologists, Northfield, Illinois, USA.
FAU - Barnes, John
AU  - Barnes J
AD  - National Center for Immunization and Respiratory Diseases, Centers for Disease
      Control and Prevention, Atlanta, Georgia, USA.
FAU - Bennett, Sarah F
AU  - Bennett SF
AD  - Division of Laboratory Services, Centers for Medicare and Medicaid Services,
      Baltimore, Maryland, USA.
FAU - Bisht, Himani
AU  - Bisht H
AD  - Center for Devices and Radiological Health, Food and Drug Administration, Silver 
      Spring, Maryland, USA.
FAU - Church, Deanna M
AU  - Church DM
AD  - National Center for Biotechnology Information, National Institutes of Health,
      Bethesda, Maryland, USA.
FAU - Dimitrova, Zoya
AU  - Dimitrova Z
AD  - Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta,
      Georgia, USA.
FAU - Gargis, Shaw R
AU  - Gargis SR
AD  - Division of Select Agents and Toxins, Centers for Disease Control and Prevention,
      Atlanta, Georgia, USA.
FAU - Hafez, Nabil
AU  - Hafez N
AD  - GenomeQuest, Westborough, Massachusetts, USA.
FAU - Hambuch, Tina
AU  - Hambuch T
AD  - Clinical Services, Illumina, San Diego, California, USA.
FAU - Hyland, Fiona C L
AU  - Hyland FC
AD  - Thermo Fisher Scientific, South San Francisco, California, USA.
FAU - Luna, Ruth Ann
AU  - Luna RA
AD  - Texas Children's Microbiome Center, Texas Children's Hospital and Department of
      Pathology &Immunology, Baylor College of Medicine, Houston, Texas, USA.
FAU - MacCannell, Duncan
AU  - MacCannell D
AD  - National Center for Emerging and Zoonotic Infectious Diseases, Centers for
      Disease Control and Prevention, Atlanta, Georgia USA.
FAU - Mann, Tobias
AU  - Mann T
AD  - Illumina, San Diego, California, USA.
FAU - McCluskey, Megan R
AU  - McCluskey MR
AD  - SoftGenetics, State College, Pennsylvania, USA.
FAU - McDaniel, Timothy K
AU  - McDaniel TK
AD  - Oncology, Illumina, San Diego, California, USA.
FAU - Ganova-Raeva, Lilia M
AU  - Ganova-Raeva LM
AD  - Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta,
      Georgia, USA.
FAU - Rehm, Heidi L
AU  - Rehm HL
AD  - 1] Laboratory for Molecular Medicine, Partners Healthcare Personalized Medicine, 
      Cambridge, Massachusetts, USA. [2] Department of Pathology, Harvard Medical
      School, Boston, Massachusetts, USA.
FAU - Reid, Jeffrey
AU  - Reid J
AD  - Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, 
      Texas, USA.
FAU - Campo, David S
AU  - Campo DS
AD  - Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta,
      Georgia, USA.
FAU - Resnick, Richard B
AU  - Resnick RB
AD  - GenomeQuest, Westborough, Massachusetts, USA.
FAU - Ridge, Perry G
AU  - Ridge PG
AD  - Department of Pathology, University of Utah, Salt Lake City, Utah, USA.
FAU - Salit, Marc L
AU  - Salit ML
AD  - Material Measurement Laboratory, National Institute of Standards and Technology, 
      Gaithersburg, Maryland, USA.
FAU - Skums, Pavel
AU  - Skums P
AD  - Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta,
      Georgia, USA.
FAU - Wong, Lee-Jun C
AU  - Wong LJ
AD  - Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, 
      Texas, USA.
FAU - Zehnbauer, Barbara A
AU  - Zehnbauer BA
AD  - Division of Laboratory Systems, Centers for Disease Control and Prevention,
      Atlanta, Georgia, USA.
FAU - Zook, Justin M
AU  - Zook JM
AD  - Material Measurement Laboratory, National Institute of Standards and Technology, 
      Gaithersburg, Maryland, USA.
FAU - Lubin, Ira M
AU  - Lubin IM
AD  - Division of Laboratory Systems, Centers for Disease Control and Prevention,
      Atlanta, Georgia, USA.
LA  - eng
GR  - U01HG006500/HG/NHGRI NIH HHS/United States
GR  - U41HG006834/HG/NHGRI NIH HHS/United States
PT  - Letter
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PT  - Research Support, U.S. Gov't, P.H.S.
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Databases, Genetic/*standards
MH  - High-Throughput Nucleotide Sequencing/methods/*standards
MH  - Humans
MH  - Laboratories/standards
MH  - Medical Informatics/methods/*standards
MH  - Molecular Diagnostic Techniques/methods/*standards
MH  - Sequence Analysis, DNA/methods/*standards
EDAT- 2015/07/15 06:00
MHDA- 2016/01/08 06:00
CRDT- 2015/07/09 06:00
PHST- 2015/07/09 06:00 [entrez]
PHST- 2015/07/15 06:00 [pubmed]
PHST- 2016/01/08 06:00 [medline]
AID - nbt.3237 [pii]
AID - 10.1038/nbt.3237 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jul;33(7):689-93. doi: 10.1038/nbt.3237.

PMID- 26154003
OWN - NLM
STAT- MEDLINE
DCOM- 20160107
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 7
DP  - 2015 Jul
TI  - The constrained prescription, interchangeability and substitution of biosimilars.
PG  - 688-9
LID - 10.1038/nbt.3272 [doi]
FAU - Minghetti, Paola
AU  - Minghetti P
AD  - Department of Pharmaceutical Sciences, Universita degli Studi di Milano, Milan,
      Italy.
FAU - Rocco, Paolo
AU  - Rocco P
AD  - Department of Pharmaceutical Sciences, Universita degli Studi di Milano, Milan,
      Italy.
FAU - Schellekens, Huub
AU  - Schellekens H
AD  - Department of Pharmaceutical Sciences and Department of Innovation Studies,
      Utrecht University, Utrecht, the Netherlands.
LA  - eng
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Biosimilar Pharmaceuticals)
SB  - IM
MH  - *Biosimilar Pharmaceuticals
MH  - Drug Industry
MH  - *Drug Prescriptions
MH  - *Drug Substitution
MH  - Europe
MH  - Humans
MH  - United States
MH  - United States Food and Drug Administration
EDAT- 2015/07/15 06:00
MHDA- 2016/01/08 06:00
CRDT- 2015/07/09 06:00
PHST- 2015/07/09 06:00 [entrez]
PHST- 2015/07/15 06:00 [pubmed]
PHST- 2016/01/08 06:00 [medline]
AID - nbt.3272 [pii]
AID - 10.1038/nbt.3272 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jul;33(7):688-9. doi: 10.1038/nbt.3272.

PMID- 26154002
OWN - NLM
STAT- MEDLINE
DCOM- 20150914
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 7
DP  - 2015 Jul
TI  - Toward effective software solutions for big biology.
PG  - 686-7
LID - 10.1038/nbt.3240 [doi]
FAU - Prins, Pjotr
AU  - Prins P
AD  - 1] Department of Medical Genetics, University Medical Centre, Utrecht, the
      Netherlands. [2] Hubrecht Institute, Royal Netherlands Academy of Arts and
      Sciences (KNAW), CancerGenomics. nl, Utrecht, the Netherlands. [3] Department of 
      Nematology, Wageningen University, the Netherlands.
FAU - de Ligt, Joep
AU  - de Ligt J
AD  - Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW),
      CancerGenomics. nl, Utrecht, the Netherlands.
FAU - Tarasov, Artem
AU  - Tarasov A
AD  - St. Petersburg State University, St. Petersburg, Russia.
FAU - Jansen, Ritsert C
AU  - Jansen RC
AUID- ORCID: 0000000329779110
AD  - University of Groningen, Groningen Bioinformatics Centre, Groningen, the
      Netherlands.
FAU - Cuppen, Edwin
AU  - Cuppen E
AUID- ORCID: 0000000204009542
AD  - 1] Department of Medical Genetics, University Medical Centre, Utrecht, the
      Netherlands. [2] Hubrecht Institute, Royal Netherlands Academy of Arts and
      Sciences (KNAW), CancerGenomics. nl, Utrecht, the Netherlands.
FAU - Bourne, Philip E
AU  - Bourne PE
AD  - Office of the Director, The National Institutes of Health, Bethesda, Maryland,
      USA.
LA  - eng
PT  - Comment
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2014 Aug;32(8):755-9. PMID: 25101748
MH  - *Allergy and Immunology
EDAT- 2015/07/15 06:00
MHDA- 2015/09/15 06:00
CRDT- 2015/07/09 06:00
PHST- 2015/07/09 06:00 [entrez]
PHST- 2015/07/15 06:00 [pubmed]
PHST- 2015/09/15 06:00 [medline]
AID - nbt.3240 [pii]
AID - 10.1038/nbt.3240 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jul;33(7):686-7. doi: 10.1038/nbt.3240.

PMID- 26154001
OWN - NLM
STAT- MEDLINE
DCOM- 20160107
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 7
DP  - 2015 Jul
TI  - Will clinical trial data disclosure reduce incentives to develop new uses of
      drugs?
PG  - 685-6
LID - 10.1038/nbt.3243 [doi]
FAU - Price, W Nicholson 2nd
AU  - Price WN 2nd
AD  - University of New Hampshire School of Law, Concord, New Hampshire, USA.
FAU - Minssen, Timo
AU  - Minssen T
AUID- ORCID: 0000000232864888
AD  - Centre for Information and Innovation Law, University of Copenhagen, Denmark.
LA  - eng
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Clinical Trials as Topic/economics/legislation & jurisprudence
MH  - *Disclosure
MH  - *Drug Discovery/economics/legislation & jurisprudence
MH  - Drug Industry/economics/legislation & jurisprudence
MH  - Europe
MH  - Humans
MH  - Patents as Topic
EDAT- 2015/07/15 06:00
MHDA- 2016/01/08 06:00
CRDT- 2015/07/09 06:00
PHST- 2015/07/09 06:00 [entrez]
PHST- 2015/07/15 06:00 [pubmed]
PHST- 2016/01/08 06:00 [medline]
AID - nbt.3243 [pii]
AID - 10.1038/nbt.3243 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jul;33(7):685-6. doi: 10.1038/nbt.3243.

PMID- 26154000
OWN - NLM
STAT- MEDLINE
DCOM- 20160107
LR  - 20150709
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 7
DP  - 2015 Jul
TI  - Research biotech patenting 2014.
PG  - 684
LID - 10.1038/nbt.3288 [doi]
FAU - Huggett, Brady
AU  - Huggett B
AD  - Nature Biotechnology.
FAU - Paisner, Kathryn
AU  - Paisner K
AD  - IP Checkups Inc., Berkeley, California, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Academies and Institutes/statistics & numerical data
MH  - Biomedical Research/*statistics & numerical data
MH  - Biotechnology/*statistics & numerical data
MH  - Humans
MH  - Patents as Topic/*statistics & numerical data
MH  - United States
MH  - Universities/statistics & numerical data
EDAT- 2015/07/15 06:00
MHDA- 2016/01/08 06:00
CRDT- 2015/07/09 06:00
PHST- 2015/07/09 06:00 [entrez]
PHST- 2015/07/15 06:00 [pubmed]
PHST- 2016/01/08 06:00 [medline]
AID - nbt.3288 [pii]
AID - 10.1038/nbt.3288 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jul;33(7):684. doi: 10.1038/nbt.3288.

PMID- 26153999
OWN - NLM
STAT- MEDLINE
DCOM- 20160107
LR  - 20150709
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 7
DP  - 2015 Jul
TI  - Saving rhinos with 3D printed horns.
PG  - 683
LID - 10.1038/nbt0715-683a [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 68238-35-7 (Keratins)
SB  - IM
MH  - Animals
MH  - Biotechnology/methods
MH  - Extinction, Biological
MH  - Horns/*injuries
MH  - Keratins/therapeutic use
MH  - Perissodactyla/*injuries
MH  - *Printing, Three-Dimensional
MH  - Prostheses and Implants/*veterinary
MH  - Prosthesis Design/veterinary
MH  - *Wounds and Injuries/therapy/veterinary
EDAT- 2015/07/15 06:00
MHDA- 2016/01/08 06:00
CRDT- 2015/07/09 06:00
PHST- 2015/07/09 06:00 [entrez]
PHST- 2015/07/15 06:00 [pubmed]
PHST- 2016/01/08 06:00 [medline]
AID - nbt0715-683a [pii]
AID - 10.1038/nbt0715-683a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jul;33(7):683. doi: 10.1038/nbt0715-683a.

PMID- 26153997
OWN - NLM
STAT- MEDLINE
DCOM- 20160107
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 7
DP  - 2015 Jul
TI  - First stress-tolerant soybean gets go-ahead in Argentina.
PG  - 682
LID - 10.1038/nbt0715-682 [doi]
FAU - Waltz, Emily
AU  - Waltz E
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Adaptation, Biological/genetics/physiology
MH  - Argentina
MH  - Plants, Genetically Modified/genetics/*physiology
MH  - Soybeans/genetics/*physiology
MH  - Stress, Physiological
EDAT- 2015/07/15 06:00
MHDA- 2016/01/08 06:00
CRDT- 2015/07/09 06:00
PHST- 2015/07/09 06:00 [entrez]
PHST- 2015/07/15 06:00 [pubmed]
PHST- 2016/01/08 06:00 [medline]
AID - nbt0715-682 [pii]
AID - 10.1038/nbt0715-682 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jul;33(7):682. doi: 10.1038/nbt0715-682.

PMID- 26153996
OWN - NLM
STAT- MEDLINE
DCOM- 20160107
LR  - 20150709
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 7
DP  - 2015 Jul
TI  - Biotechs recoil at hedge fund manager's patent attacks.
PG  - 680-1
LID - 10.1038/nbt0715-680b [doi]
FAU - Senior, Melanie
AU  - Senior M
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Pharmaceutical Preparations)
SB  - IM
MH  - Biotechnology/*economics
MH  - *Capital Financing/economics/methods/organization & administration
MH  - Drug Industry/*economics
MH  - Humans
MH  - *Patents as Topic
MH  - Pharmaceutical Preparations/economics
EDAT- 2015/07/15 06:00
MHDA- 2016/01/08 06:00
CRDT- 2015/07/09 06:00
PHST- 2015/07/09 06:00 [entrez]
PHST- 2015/07/15 06:00 [pubmed]
PHST- 2016/01/08 06:00 [medline]
AID - nbt0715-680b [pii]
AID - 10.1038/nbt0715-680b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jul;33(7):680-1. doi: 10.1038/nbt0715-680b.

PMID- 26153994
OWN - NLM
STAT- MEDLINE
DCOM- 20160107
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 7
DP  - 2015 Jul
TI  - Alexion pays big for Synageva's rare disease drug candidate.
PG  - 679
LID - 10.1038/nbt0715-679 [doi]
FAU - Ratner, Mark
AU  - Ratner M
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - EC 3.1.1.13 (Sterol Esterase)
RN  - K4YTU42T8G (Sebelipase alfa)
RN  - Lysosomal acid lipase deficiency
SB  - IM
MH  - Connecticut
MH  - Drug Industry/*economics
MH  - Humans
MH  - Massachusetts
MH  - Non-alcoholic Fatty Liver Disease/*drug therapy
MH  - Rare Diseases/drug therapy
MH  - *Sterol Esterase/economics/therapeutic use
MH  - Wolman Disease/drug therapy
EDAT- 2015/07/15 06:00
MHDA- 2016/01/08 06:00
CRDT- 2015/07/09 06:00
PHST- 2015/07/09 06:00 [entrez]
PHST- 2015/07/15 06:00 [pubmed]
PHST- 2016/01/08 06:00 [medline]
AID - nbt0715-679 [pii]
AID - 10.1038/nbt0715-679 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jul;33(7):679. doi: 10.1038/nbt0715-679.

PMID- 26153993
OWN - NLM
STAT- MEDLINE
DCOM- 20160107
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 7
DP  - 2015 Jul
TI  - Gene therapy 'cure' for blindness wanes.
PG  - 678
LID - 10.1038/nbt0715-678 [doi]
FAU - Azvolinsky, Anna
AU  - Azvolinsky A
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - EC 3.1.1.64 (retinoid isomerohydrolase)
RN  - EC 5.2.- (cis-trans-Isomerases)
SB  - IM
MH  - Blindness/*therapy
MH  - Clinical Trials as Topic
MH  - *Genetic Therapy/economics/methods/trends
MH  - Humans
MH  - *Injections, Intraocular
MH  - London
MH  - Philadelphia
MH  - cis-trans-Isomerases/*genetics
EDAT- 2015/07/15 06:00
MHDA- 2016/01/08 06:00
CRDT- 2015/07/09 06:00
PHST- 2015/07/09 06:00 [entrez]
PHST- 2015/07/15 06:00 [pubmed]
PHST- 2016/01/08 06:00 [medline]
AID - nbt0715-678 [pii]
AID - 10.1038/nbt0715-678 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jul;33(7):678. doi: 10.1038/nbt0715-678.

PMID- 26153991
OWN - NLM
STAT- MEDLINE
DCOM- 20160107
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 7
DP  - 2015 Jul
TI  - Migraine mAbs crowd into late-stage trials.
PG  - 676-7
LID - 10.1038/nbt0715-676c [doi]
FAU - Sinha, Gunjan
AU  - Sinha G
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antibodies, Monoclonal)
RN  - 83652-28-2 (Calcitonin Gene-Related Peptide)
SB  - IM
MH  - Antibodies, Monoclonal/*therapeutic use
MH  - Calcitonin Gene-Related Peptide/*antagonists & inhibitors
MH  - Clinical Trials as Topic
MH  - Drug Industry
MH  - Humans
MH  - Migraine Disorders/*drug therapy
EDAT- 2015/07/15 06:00
MHDA- 2016/01/08 06:00
CRDT- 2015/07/09 06:00
PHST- 2015/07/09 06:00 [entrez]
PHST- 2015/07/15 06:00 [pubmed]
PHST- 2016/01/08 06:00 [medline]
AID - nbt0715-676c [pii]
AID - 10.1038/nbt0715-676c [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jul;33(7):676-7. doi: 10.1038/nbt0715-676c.

PMID- 26153987
OWN - NLM
STAT- MEDLINE
DCOM- 20160107
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 7
DP  - 2015 Jul
TI  - Immuno-oncology moves beyond PD-1.
PG  - 673-5
LID - 10.1038/nbt0715-673 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antibodies, Monoclonal)
RN  - 0 (Antibodies, Monoclonal, Humanized)
RN  - 0 (Antineoplastic Agents)
RN  - 0 (Programmed Cell Death 1 Receptor)
RN  - 31YO63LBSN (nivolumab)
RN  - DPT0O3T46P (pembrolizumab)
SB  - IM
MH  - Animals
MH  - *Antibodies, Monoclonal/immunology/therapeutic use
MH  - Antibodies, Monoclonal, Humanized
MH  - *Antineoplastic Agents/immunology/therapeutic use
MH  - Dendritic Cells/immunology
MH  - Drug Industry
MH  - Humans
MH  - Immunotherapy/*trends
MH  - Lymphocytes/immunology
MH  - Mice
MH  - *Neoplasms/drug therapy/immunology
MH  - Programmed Cell Death 1 Receptor/antagonists & inhibitors
MH  - Signal Transduction/immunology
EDAT- 2015/07/15 06:00
MHDA- 2016/01/08 06:00
CRDT- 2015/07/09 06:00
PHST- 2015/07/09 06:00 [entrez]
PHST- 2015/07/15 06:00 [pubmed]
PHST- 2016/01/08 06:00 [medline]
AID - nbt0715-673 [pii]
AID - 10.1038/nbt0715-673 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jul;33(7):673-5. doi: 10.1038/nbt0715-673.

PMID- 26153986
OWN - NLM
STAT- MEDLINE
DCOM- 20160107
LR  - 20150709
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 7
DP  - 2015 Jul
TI  - Modeling credentials.
PG  - 671
LID - 10.1038/nbt.3279 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antineoplastic Agents)
SB  - IM
MH  - Animals
MH  - *Antineoplastic Agents/pharmacology/therapeutic use
MH  - Antineoplastic Protocols/*standards
MH  - *Disease Models, Animal
MH  - Humans
MH  - Mice
MH  - Neoplasms/physiopathology/*therapy
MH  - *Treatment Outcome
EDAT- 2015/07/15 06:00
MHDA- 2016/01/08 06:00
CRDT- 2015/07/09 06:00
PHST- 2015/07/09 06:00 [entrez]
PHST- 2015/07/15 06:00 [pubmed]
PHST- 2016/01/08 06:00 [medline]
AID - nbt.3279 [pii]
AID - 10.1038/nbt.3279 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jul;33(7):671. doi: 10.1038/nbt.3279.

PMID- 26098451
OWN - NLM
STAT- MEDLINE
DCOM- 20160107
LR  - 20161019
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 7
DP  - 2015 Jul
TI  - Kinetic fingerprinting to identify and count single nucleic acids.
PG  - 730-2
LID - 10.1038/nbt.3246 [doi]
AB  - MicroRNAs (miRNAs) have emerged as promising diagnostic biomarkers. We introduce 
      a kinetic fingerprinting approach called single-molecule recognition through
      equilibrium Poisson sampling (SiMREPS) for the amplification-free counting of
      single unlabeled miRNA molecules, which circumvents thermodynamic limits of
      specificity and virtually eliminates false positives. We demonstrate
      high-confidence, single-molecule detection of synthetic and endogenous miRNAs in 
      both buffer and minimally treated biofluids, as well as >500-fold discrimination 
      between single nucleotide polymorphisms.
FAU - Johnson-Buck, Alexander
AU  - Johnson-Buck A
AD  - Single Molecule Analysis Group, Department of Chemistry, University of Michigan, 
      Ann Arbor, Michigan, USA.
FAU - Su, Xin
AU  - Su X
AD  - Beijing National Laboratory for Molecular Sciences, MOE Key Laboratory of
      Bioorganic Chemistry and Molecular Engineering, College of Chemistry and
      Molecular Engineering, Peking University, Beijing, China.
FAU - Giraldez, Maria D
AU  - Giraldez MD
AD  - Department of Internal Medicine, Division of Hematology/Oncology, University of
      Michigan, Ann Arbor, Michigan, USA.
FAU - Zhao, Meiping
AU  - Zhao M
AD  - Beijing National Laboratory for Molecular Sciences, MOE Key Laboratory of
      Bioorganic Chemistry and Molecular Engineering, College of Chemistry and
      Molecular Engineering, Peking University, Beijing, China.
FAU - Tewari, Muneesh
AU  - Tewari M
AD  - 1] Department of Internal Medicine, Division of Hematology/Oncology, University
      of Michigan, Ann Arbor, Michigan, USA. [2] Department of Internal Medicine,
      Division of Molecular Medicine and Genetics, University of Michigan, Ann Arbor,
      Michigan, USA. [3] Department of Biomedical Engineering, University of Michigan, 
      Ann Arbor, Michigan, USA. [4] Center for Computational Medicine and
      Bioinformatics, University of Michigan, Ann Arbor, Michigan, USA. [5]
      Biointerfaces Institute, University of Michigan, Ann Arbor, Michigan, USA.
FAU - Walter, Nils G
AU  - Walter NG
AD  - Single Molecule Analysis Group, Department of Chemistry, University of Michigan, 
      Ann Arbor, Michigan, USA.
LA  - eng
GR  - R01 DK085714/DK/NIDDK NIH HHS/United States
GR  - R01DK085714/DK/NIDDK NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20150622
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Fluorescent Dyes)
RN  - 0 (MicroRNAs)
SB  - IM
MH  - Fluorescent Dyes/chemistry
MH  - Humans
MH  - Limit of Detection
MH  - MicroRNAs/*analysis/chemistry
MH  - Sequence Analysis, RNA/*methods
PMC - PMC4559481
MID - NIHMS718232
EDAT- 2015/06/23 06:00
MHDA- 2016/01/08 06:00
CRDT- 2015/06/23 06:00
PHST- 2015/03/22 00:00 [received]
PHST- 2015/05/07 00:00 [accepted]
PHST- 2015/06/23 06:00 [entrez]
PHST- 2015/06/23 06:00 [pubmed]
PHST- 2016/01/08 06:00 [medline]
AID - nbt.3246 [pii]
AID - 10.1038/nbt.3246 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jul;33(7):730-2. doi: 10.1038/nbt.3246. Epub 2015 Jun 22.

PMID- 26098450
OWN - NLM
STAT- MEDLINE
DCOM- 20160107
LR  - 20161019
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 7
DP  - 2015 Jul
TI  - Lineage conversion induced by pluripotency factors involves transient passage
      through an iPSC stage.
PG  - 761-8
LID - 10.1038/nbt.3247 [doi]
AB  - Brief expression of pluripotency-associated factors such as Oct4, Klf4, Sox2 and 
      c-Myc (OKSM), in combination with differentiation-inducing signals, has been
      reported to trigger transdifferentiation of fibroblasts into other cell types.
      Here we show that OKSM expression in mouse fibroblasts gives rise to both induced
      pluripotent stem cells (iPSCs) and induced neural stem cells (iNSCs) under
      conditions previously shown to induce only iNSCs. Fibroblast-derived iNSC
      colonies silenced retroviral transgenes and reactivated silenced X chromosomes,
      both hallmarks of pluripotent stem cells. Moreover, lineage tracing with an
      Oct4-CreER labeling system demonstrated that virtually all iNSC colonies
      originated from cells transiently expressing Oct4, whereas ablation of Oct4(+)
      cells prevented iNSC formation. Lastly, an alternative transdifferentiation
      cocktail that lacks Oct4 and was reportedly unable to support induced
      pluripotency yielded iPSCs and iNSCs carrying the Oct4-CreER-derived lineage
      label. Together, these data suggest that iNSC generation from fibroblasts using
      OKSM and other pluripotency-related reprogramming factors requires passage
      through a transient iPSC state.
FAU - Bar-Nur, Ori
AU  - Bar-Nur O
AD  - 1] Center for Regenerative Medicine, Massachusetts General Hospital, Boston,
      Massachusetts, USA. [2] Department of Molecular Biology, Massachusetts General
      Hospital, Boston, Massachusetts, USA. [3] Department of Stem Cell and
      Regenerative Biology, Harvard University, Cambridge, Massachusetts, USA. [4]
      Howard Hughes Medical Institute, Chevy Chase, Maryland, USA. [5] Harvard Stem
      Cell Institute, Cambridge, Massachusetts, USA.
FAU - Verheul, Cassandra
AU  - Verheul C
AD  - 1] Center for Regenerative Medicine, Massachusetts General Hospital, Boston,
      Massachusetts, USA. [2] Department of Molecular Biology, Massachusetts General
      Hospital, Boston, Massachusetts, USA. [3] Department of Stem Cell and
      Regenerative Biology, Harvard University, Cambridge, Massachusetts, USA. [4]
      Howard Hughes Medical Institute, Chevy Chase, Maryland, USA. [5] Harvard Stem
      Cell Institute, Cambridge, Massachusetts, USA.
FAU - Sommer, Andreia G
AU  - Sommer AG
AD  - 1] Center for Regenerative Medicine (CReM), Boston University School of Medicine,
      Boston, Massachusetts, USA. [2] Boston Medical Center, Boston, Massachusetts,
      USA.
FAU - Brumbaugh, Justin
AU  - Brumbaugh J
AD  - 1] Center for Regenerative Medicine, Massachusetts General Hospital, Boston,
      Massachusetts, USA. [2] Department of Molecular Biology, Massachusetts General
      Hospital, Boston, Massachusetts, USA. [3] Department of Stem Cell and
      Regenerative Biology, Harvard University, Cambridge, Massachusetts, USA. [4]
      Howard Hughes Medical Institute, Chevy Chase, Maryland, USA. [5] Harvard Stem
      Cell Institute, Cambridge, Massachusetts, USA.
FAU - Schwarz, Benjamin A
AU  - Schwarz BA
AD  - 1] Center for Regenerative Medicine, Massachusetts General Hospital, Boston,
      Massachusetts, USA. [2] Department of Molecular Biology, Massachusetts General
      Hospital, Boston, Massachusetts, USA. [3] Department of Stem Cell and
      Regenerative Biology, Harvard University, Cambridge, Massachusetts, USA. [4]
      Howard Hughes Medical Institute, Chevy Chase, Maryland, USA. [5] Harvard Stem
      Cell Institute, Cambridge, Massachusetts, USA.
FAU - Lipchina, Inna
AU  - Lipchina I
AD  - 1] Center for Regenerative Medicine, Massachusetts General Hospital, Boston,
      Massachusetts, USA. [2] Department of Molecular Biology, Massachusetts General
      Hospital, Boston, Massachusetts, USA. [3] Department of Stem Cell and
      Regenerative Biology, Harvard University, Cambridge, Massachusetts, USA. [4]
      Howard Hughes Medical Institute, Chevy Chase, Maryland, USA. [5] Harvard Stem
      Cell Institute, Cambridge, Massachusetts, USA.
FAU - Huebner, Aaron J
AU  - Huebner AJ
AD  - 1] Center for Regenerative Medicine, Massachusetts General Hospital, Boston,
      Massachusetts, USA. [2] Department of Molecular Biology, Massachusetts General
      Hospital, Boston, Massachusetts, USA. [3] Department of Stem Cell and
      Regenerative Biology, Harvard University, Cambridge, Massachusetts, USA. [4]
      Howard Hughes Medical Institute, Chevy Chase, Maryland, USA. [5] Harvard Stem
      Cell Institute, Cambridge, Massachusetts, USA.
FAU - Mostoslavsky, Gustavo
AU  - Mostoslavsky G
AD  - 1] Center for Regenerative Medicine (CReM), Boston University School of Medicine,
      Boston, Massachusetts, USA. [2] Boston Medical Center, Boston, Massachusetts,
      USA.
FAU - Hochedlinger, Konrad
AU  - Hochedlinger K
AD  - 1] Center for Regenerative Medicine, Massachusetts General Hospital, Boston,
      Massachusetts, USA. [2] Department of Molecular Biology, Massachusetts General
      Hospital, Boston, Massachusetts, USA. [3] Department of Stem Cell and
      Regenerative Biology, Harvard University, Cambridge, Massachusetts, USA. [4]
      Howard Hughes Medical Institute, Chevy Chase, Maryland, USA. [5] Harvard Stem
      Cell Institute, Cambridge, Massachusetts, USA.
LA  - eng
SI  - GEO/GSE65951
GR  - 1F32HD078029-01A1/HD/NICHD NIH HHS/United States
GR  - R01HD058013/HD/NICHD NIH HHS/United States
GR  - 1F32HD079225-01A1/HD/NICHD NIH HHS/United States
GR  - F32 HD079225/HD/NICHD NIH HHS/United States
GR  - 5-T32-CA-9216-33/CA/NCI NIH HHS/United States
GR  - T32 CA009216/CA/NCI NIH HHS/United States
GR  - Howard Hughes Medical Institute/United States
GR  - R01 HD058013/HD/NICHD NIH HHS/United States
GR  - F32 HD078029/HD/NICHD NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20150622
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Transcription Factors)
SB  - IM
CIN - Nat Methods. 2015 Aug;12(8):701. PMID: 26451422
MH  - Animals
MH  - Cell Transdifferentiation/*physiology
MH  - Cells, Cultured
MH  - Female
MH  - Fibroblasts/physiology
MH  - Gene Silencing
MH  - Induced Pluripotent Stem Cells/*physiology
MH  - Male
MH  - Mice
MH  - Mice, Transgenic
MH  - Transcription Factors/*metabolism
MH  - Transgenes
PMC - PMC4840929
MID - NIHMS681927
EDAT- 2015/06/23 06:00
MHDA- 2016/01/08 06:00
CRDT- 2015/06/23 06:00
PHST- 2015/01/14 00:00 [received]
PHST- 2015/04/16 00:00 [accepted]
PHST- 2015/06/23 06:00 [entrez]
PHST- 2015/06/23 06:00 [pubmed]
PHST- 2016/01/08 06:00 [medline]
AID - nbt.3247 [pii]
AID - 10.1038/nbt.3247 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jul;33(7):761-8. doi: 10.1038/nbt.3247. Epub 2015 Jun 22.

PMID- 26098449
OWN - NLM
STAT- MEDLINE
DCOM- 20160107
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 7
DP  - 2015 Jul
TI  - Optogenetics for in vivo cardiac pacing and resynchronization therapies.
PG  - 750-4
LID - 10.1038/nbt.3268 [doi]
AB  - Abnormalities in the specialized cardiac conduction system may result in slow
      heart rate or mechanical dyssynchrony. Here we apply optogenetics, widely used to
      modulate neuronal excitability, for cardiac pacing and resynchronization. We used
      adeno-associated virus (AAV) 9 to express the Channelrhodopsin-2 (ChR2) transgene
      at one or more ventricular sites in rats. This allowed optogenetic pacing of the 
      hearts at different beating frequencies with blue-light illumination both in vivo
      and in isolated perfused hearts. Optical mapping confirmed that the source of the
      new pacemaker activity was the site of ChR2 transgene delivery. Notably, diffuse 
      illumination of hearts where the ChR2 transgene was delivered to several
      ventricular sites resulted in electrical synchronization and significant
      shortening of ventricular activation times. These findings highlight the unique
      potential of optogenetics for cardiac pacing and resynchronization therapies.
FAU - Nussinovitch, Udi
AU  - Nussinovitch U
AD  - 1] The Sohnis Laboratory for Cardiac Electrophysiology and Regenerative Medicine,
      Rappaport Faculty of Medicine and Research Institute, Technion-Institute of
      Technology, Haifa, Israel. [2] Rambam Health Care Campus, Haifa, Israel.
FAU - Gepstein, Lior
AU  - Gepstein L
AD  - 1] The Sohnis Laboratory for Cardiac Electrophysiology and Regenerative Medicine,
      Rappaport Faculty of Medicine and Research Institute, Technion-Institute of
      Technology, Haifa, Israel. [2] Rambam Health Care Campus, Haifa, Israel.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150622
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 9009-81-8 (Rhodopsin)
SB  - IM
MH  - Animals
MH  - Cardiac Resynchronization Therapy/*methods
MH  - Dependovirus/genetics
MH  - Female
MH  - Heart/*physiology
MH  - Image Processing, Computer-Assisted
MH  - Male
MH  - Optical Imaging
MH  - Optogenetics/*methods
MH  - Rats
MH  - Rhodopsin/genetics/metabolism
EDAT- 2015/06/23 06:00
MHDA- 2016/01/08 06:00
CRDT- 2015/06/23 06:00
PHST- 2014/02/28 00:00 [received]
PHST- 2015/05/22 00:00 [accepted]
PHST- 2015/06/23 06:00 [entrez]
PHST- 2015/06/23 06:00 [pubmed]
PHST- 2016/01/08 06:00 [medline]
AID - nbt.3268 [pii]
AID - 10.1038/nbt.3268 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jul;33(7):750-4. doi: 10.1038/nbt.3268. Epub 2015 Jun 22.

PMID- 26098448
OWN - NLM
STAT- MEDLINE
DCOM- 20160107
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 7
DP  - 2015 Jul
TI  - Transient acquisition of pluripotency during somatic cell transdifferentiation
      with iPSC reprogramming factors.
PG  - 769-74
LID - 10.1038/nbt.3270 [doi]
AB  - Somatic cells can be transdifferentiated to other cell types without passing
      through a pluripotent state by ectopic expression of appropriate transcription
      factors. Recent reports have proposed an alternative transdifferentiation method 
      in which fibroblasts are directly converted to various mature somatic cell types 
      by brief expression of the induced pluripotent stem cell (iPSC) reprogramming
      factors Oct4, Sox2, Klf4 and c-Myc (OSKM) followed by cell expansion in media
      that promote lineage differentiation. Here we test this method using genetic
      lineage tracing for expression of endogenous Nanog and Oct4 and for X chromosome 
      reactivation, as these events mark acquisition of pluripotency. We show that the 
      vast majority of reprogrammed cardiomyocytes or neural stem cells obtained from
      mouse fibroblasts by OSKM-induced 'transdifferentiation' pass through a transient
      pluripotent state, and that their derivation is molecularly coupled to iPSC
      formation mechanisms. Our findings underscore the importance of defining
      trajectories during cell reprogramming by various methods.
FAU - Maza, Itay
AU  - Maza I
AD  - 1] The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, 
      Israel. [2] The Department of Gastroenterology, Rambam Health Care Campus &Bruce 
      Rappaport School of Medicine, Technion Institute of Technology, Haifa, Israel.
FAU - Caspi, Inbal
AU  - Caspi I
AD  - The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot,
      Israel.
FAU - Zviran, Asaf
AU  - Zviran A
AD  - The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot,
      Israel.
FAU - Chomsky, Elad
AU  - Chomsky E
AD  - The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot,
      Israel.
FAU - Rais, Yoach
AU  - Rais Y
AD  - The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot,
      Israel.
FAU - Viukov, Sergey
AU  - Viukov S
AD  - The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot,
      Israel.
FAU - Geula, Shay
AU  - Geula S
AD  - The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot,
      Israel.
FAU - Buenrostro, Jason D
AU  - Buenrostro JD
AD  - Department of Genetics, Stanford University School of Medicine, Stanford,
      California, USA.
FAU - Weinberger, Leehee
AU  - Weinberger L
AD  - The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot,
      Israel.
FAU - Krupalnik, Vladislav
AU  - Krupalnik V
AD  - The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot,
      Israel.
FAU - Hanna, Suhair
AU  - Hanna S
AD  - 1] The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, 
      Israel. [2] The Department of Pediatrics and the Pediatric Immunology Unit,
      Rambam Health Care Campus &Bruce Rappaport School of Medicine, Technion Institute
      of Technology, Haifa, Israel.
FAU - Zerbib, Mirie
AU  - Zerbib M
AD  - The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot,
      Israel.
FAU - Dutton, James R
AU  - Dutton JR
AD  - Stem Cell Institute, University of Minnesota, Minneapolis, Minnesota, USA.
FAU - Greenleaf, William J
AU  - Greenleaf WJ
AD  - The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot,
      Israel.
FAU - Massarwa, Rada
AU  - Massarwa R
AD  - The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot,
      Israel.
FAU - Novershtern, Noa
AU  - Novershtern N
AD  - The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot,
      Israel.
FAU - Hanna, Jacob H
AU  - Hanna JH
AUID- ORCID: 0000000320429974
AD  - The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot,
      Israel.
LA  - eng
GR  - 281906/European Research Council/International
GR  - T32 GM007790/GM/NIGMS NIH HHS/United States
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150622
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Transcription Factors)
SB  - IM
CIN - Nat Methods. 2015 Aug;12(8):701. PMID: 26451422
MH  - Animals
MH  - Cell Transdifferentiation/*genetics
MH  - Cells, Cultured
MH  - Cellular Reprogramming/*genetics
MH  - Female
MH  - Induced Pluripotent Stem Cells/*physiology
MH  - Male
MH  - Mice
MH  - Mice, Transgenic
MH  - Transcription Factors/*metabolism
PMC - PMC4500825
MID - EMS63686
OID - NLM: EMS63686
EDAT- 2015/06/23 06:00
MHDA- 2016/01/08 06:00
CRDT- 2015/06/23 06:00
PHST- 2014/06/27 00:00 [received]
PHST- 2015/06/01 00:00 [accepted]
PHST- 2015/06/23 06:00 [entrez]
PHST- 2015/06/23 06:00 [pubmed]
PHST- 2016/01/08 06:00 [medline]
AID - nbt.3270 [pii]
AID - 10.1038/nbt.3270 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jul;33(7):769-74. doi: 10.1038/nbt.3270. Epub 2015 Jun 22.

PMID- 26098447
OWN - NLM
STAT- MEDLINE
DCOM- 20160107
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 7
DP  - 2015 Jul
TI  - Analysis of intronic and exonic reads in RNA-seq data characterizes
      transcriptional and post-transcriptional regulation.
PG  - 722-9
LID - 10.1038/nbt.3269 [doi]
AB  - RNA-seq experiments generate reads derived not only from mature RNA transcripts
      but also from pre-mRNA. Here we present a computational approach called
      exon-intron split analysis (EISA) that measures changes in mature RNA and
      pre-mRNA reads across different experimental conditions to quantify
      transcriptional and post-transcriptional regulation of gene expression. We apply 
      EISA to 17 diverse data sets to show that most intronic reads arise from nuclear 
      RNA and changes in intronic read counts accurately predict changes in
      transcriptional activity. Furthermore, changes in post-transcriptional regulation
      can be predicted from differences between exonic and intronic changes. EISA
      reveals both transcriptional and post-transcriptional contributions to expression
      changes, increasing the amount of information that can be gained from RNA-seq
      data sets.
FAU - Gaidatzis, Dimos
AU  - Gaidatzis D
AD  - 1] Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland. [2] 
      Swiss Institute of Bioinformatics, Basel, Switzerland.
FAU - Burger, Lukas
AU  - Burger L
AD  - 1] Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland. [2] 
      Swiss Institute of Bioinformatics, Basel, Switzerland.
FAU - Florescu, Maria
AU  - Florescu M
AD  - 1] Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland. [2] 
      Swiss Institute of Bioinformatics, Basel, Switzerland.
FAU - Stadler, Michael B
AU  - Stadler MB
AUID- ORCID: 0000000222694934
AD  - 1] Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland. [2] 
      Swiss Institute of Bioinformatics, Basel, Switzerland.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150622
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 63231-63-0 (RNA)
SB  - IM
EIN - Nat Biotechnol. 2016 Feb;34(2):210. Florescu, Maria [Deleted]. PMID: 26849524
MH  - Animals
MH  - Cell Line
MH  - Computational Biology
MH  - Exons/*genetics
MH  - Gene Expression Profiling
MH  - Gene Expression Regulation/*genetics
MH  - Humans
MH  - Introns/*genetics
MH  - Mice
MH  - Organ Specificity
MH  - *RNA/genetics/metabolism
MH  - Sequence Analysis, RNA/*methods
MH  - Transcription, Genetic/genetics
EDAT- 2015/06/23 06:00
MHDA- 2016/01/08 06:00
CRDT- 2015/06/23 06:00
PHST- 2014/04/10 00:00 [received]
PHST- 2015/05/22 00:00 [accepted]
PHST- 2015/06/23 06:00 [entrez]
PHST- 2015/06/23 06:00 [pubmed]
PHST- 2016/01/08 06:00 [medline]
AID - nbt.3269 [pii]
AID - 10.1038/nbt.3269 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jul;33(7):722-9. doi: 10.1038/nbt.3269. Epub 2015 Jun 22.

PMID- 26076431
OWN - NLM
STAT- MEDLINE
DCOM- 20160107
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 7
DP  - 2015 Jul
TI  - Photoactivatable CRISPR-Cas9 for optogenetic genome editing.
PG  - 755-60
LID - 10.1038/nbt.3245 [doi]
AB  - We describe an engineered photoactivatable Cas9 (paCas9) that enables optogenetic
      control of CRISPR-Cas9 genome editing in human cells. paCas9 consists of split
      Cas9 fragments and photoinducible dimerization domains named Magnets. In response
      to blue light irradiation, paCas9 expressed in human embryonic kidney 293T cells 
      induces targeted genome sequence modifications through both nonhomologous end
      joining and homology-directed repair pathways. Genome editing activity can be
      switched off simply by extinguishing the light. We also demonstrate activation of
      paCas9 in spatial patterns determined by the sites of irradiation. Optogenetic
      control of targeted genome editing should facilitate improved understanding of
      complex gene networks and could prove useful in biomedical applications.
FAU - Nihongaki, Yuta
AU  - Nihongaki Y
AD  - Graduate School of Arts and Sciences, The University of Tokyo, Komaba, Meguro-ku,
      Tokyo, Japan.
FAU - Kawano, Fuun
AU  - Kawano F
AD  - Graduate School of Arts and Sciences, The University of Tokyo, Komaba, Meguro-ku,
      Tokyo, Japan.
FAU - Nakajima, Takahiro
AU  - Nakajima T
AD  - Graduate School of Arts and Sciences, The University of Tokyo, Komaba, Meguro-ku,
      Tokyo, Japan.
FAU - Sato, Moritoshi
AU  - Sato M
AD  - Graduate School of Arts and Sciences, The University of Tokyo, Komaba, Meguro-ku,
      Tokyo, Japan.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150615
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Base Sequence
MH  - CRISPR-Cas Systems/*genetics/*radiation effects
MH  - Genetic Engineering/*methods
MH  - HEK293 Cells
MH  - Humans
MH  - Models, Genetic
MH  - Molecular Sequence Data
MH  - Optogenetics/*methods
MH  - RNA Interference
EDAT- 2015/06/16 06:00
MHDA- 2016/01/08 06:00
CRDT- 2015/06/16 06:00
PHST- 2015/02/21 00:00 [received]
PHST- 2015/05/05 00:00 [accepted]
PHST- 2015/06/16 06:00 [entrez]
PHST- 2015/06/16 06:00 [pubmed]
PHST- 2016/01/08 06:00 [medline]
AID - nbt.3245 [pii]
AID - 10.1038/nbt.3245 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jul;33(7):755-60. doi: 10.1038/nbt.3245. Epub 2015 Jun 15.

PMID- 26076430
OWN - NLM
STAT- MEDLINE
DCOM- 20160107
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 7
DP  - 2015 Jul
TI  - A mass-tolerant database search identifies a large proportion of unassigned
      spectra in shotgun proteomics as modified peptides.
PG  - 743-9
LID - 10.1038/nbt.3267 [doi]
AB  - Fewer than half of all tandem mass spectrometry (MS/MS) spectra acquired in
      shotgun proteomics experiments are typically matched to a peptide with high
      confidence. Here we determine the identity of unassigned peptides using an
      ultra-tolerant Sequest database search that allows peptide matching even with
      modifications of unknown masses up to +/- 500 Da. In a proteome-wide data set on 
      HEK293 cells (9,513 proteins and 396,736 peptides), this approach matched an
      additional 184,000 modified peptides, which were linked to biological and
      chemical modifications representing 523 distinct mass bins, including
      phosphorylation, glycosylation and methylation. We localized all unknown
      modification masses to specific regions within a peptide. Known modifications
      were assigned to the correct amino acids with frequencies >90%. We conclude that 
      at least one-third of unassigned spectra arise from peptides with
      substoichiometric modifications.
FAU - Chick, Joel M
AU  - Chick JM
AD  - Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Kolippakkam, Deepak
AU  - Kolippakkam D
AD  - Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Nusinow, David P
AU  - Nusinow DP
AUID- ORCID: 0000000278195261
AD  - Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Zhai, Bo
AU  - Zhai B
AUID- ORCID: 0000000251203241
AD  - Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Rad, Ramin
AU  - Rad R
AD  - Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Huttlin, Edward L
AU  - Huttlin EL
AD  - Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.
FAU - Gygi, Steven P
AU  - Gygi SP
AD  - Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.
LA  - eng
GR  - R01 GM067945/GM/NIGMS NIH HHS/United States
GR  - R01 HG003456/HG/NHGRI NIH HHS/United States
GR  - GM67945/GM/NIGMS NIH HHS/United States
GR  - HG3456/HG/NHGRI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20150615
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Peptides)
RN  - 0 (Proteins)
SB  - IM
CIN - Nat Biotechnol. 2015 Jul;33(7):717-8. PMID: 26154010
EIN - Nat Biotechnol. 2015 Aug;33(8):882
EIN - Nat Biotechnol. 2015 Aug;33(8):882. PMID: 26252148
MH  - Amino Acid Sequence
MH  - *Databases, Protein
MH  - HEK293 Cells
MH  - Humans
MH  - Molecular Sequence Data
MH  - Peptide Mapping/*methods
MH  - Peptides/*analysis/chemistry
MH  - Proteins/analysis/chemistry
MH  - Proteomics/*methods
MH  - *Tandem Mass Spectrometry
PMC - PMC4515955
MID - NIHMS690171
EDAT- 2015/06/16 06:00
MHDA- 2016/01/08 06:00
CRDT- 2015/06/16 06:00
PHST- 2014/10/28 00:00 [received]
PHST- 2015/05/11 00:00 [accepted]
PHST- 2015/06/16 06:00 [entrez]
PHST- 2015/06/16 06:00 [pubmed]
PHST- 2016/01/08 06:00 [medline]
AID - nbt.3267 [pii]
AID - 10.1038/nbt.3267 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jul;33(7):743-9. doi: 10.1038/nbt.3267. Epub 2015 Jun 15.

PMID- 26076429
OWN - NLM
STAT- MEDLINE
DCOM- 20160107
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 7
DP  - 2015 Jul
TI  - Reducing hydrophobicity of homogeneous antibody-drug conjugates improves
      pharmacokinetics and therapeutic index.
PG  - 733-5
LID - 10.1038/nbt.3212 [doi]
AB  - The in vitro potency of antibody-drug conjugates (ADCs) increases with the
      drug-to-antibody ratio (DAR); however, ADC plasma clearance also increases with
      DAR, reducing exposure and in vivo efficacy. Here we show that accelerated
      clearance arises from ADC hydrophobicity, which can be modulated through
      drug-linker design. We exemplify this using hydrophilic auristatin drug linkers
      and PEGylated ADCs that yield uniform, high-DAR ADCs with superior in vivo
      performance.
FAU - Lyon, Robert P
AU  - Lyon RP
AD  - Department of Chemistry, Seattle Genetics, Bothell, Washington, USA.
FAU - Bovee, Tim D
AU  - Bovee TD
AD  - Department of Chemistry, Seattle Genetics, Bothell, Washington, USA.
FAU - Doronina, Svetlana O
AU  - Doronina SO
AD  - Department of Chemistry, Seattle Genetics, Bothell, Washington, USA.
FAU - Burke, Patrick J
AU  - Burke PJ
AD  - Department of Chemistry, Seattle Genetics, Bothell, Washington, USA.
FAU - Hunter, Joshua H
AU  - Hunter JH
AD  - Department of Chemistry, Seattle Genetics, Bothell, Washington, USA.
FAU - Neff-LaFord, Haley D
AU  - Neff-LaFord HD
AD  - Department of Pharmacology and Toxicology, Seattle Genetics, Bothell, Washington,
      USA.
FAU - Jonas, Mechthild
AU  - Jonas M
AD  - Department of Translational Research, Seattle Genetics, Bothell, Washington, USA.
FAU - Anderson, Martha E
AU  - Anderson ME
AD  - Department of Preclinical Research, Seattle Genetics, Bothell, Washington, USA.
FAU - Setter, Jocelyn R
AU  - Setter JR
AD  - Department of Chemistry, Seattle Genetics, Bothell, Washington, USA.
FAU - Senter, Peter D
AU  - Senter PD
AD  - Department of Chemistry, Seattle Genetics, Bothell, Washington, USA.
LA  - eng
PT  - Journal Article
DEP - 20150615
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Immunoconjugates)
RN  - 0 (Pharmaceutical Preparations)
SB  - IM
MH  - Animals
MH  - Cell Line
MH  - *Chemistry, Pharmaceutical
MH  - Humans
MH  - Hydrophobic and Hydrophilic Interactions
MH  - *Immunoconjugates/chemistry/pharmacokinetics
MH  - Mice
MH  - Mice, SCID
MH  - Models, Chemical
MH  - Models, Molecular
MH  - *Pharmaceutical Preparations/chemistry
EDAT- 2015/06/16 06:00
MHDA- 2016/01/08 06:00
CRDT- 2015/06/16 06:00
PHST- 2014/09/09 00:00 [received]
PHST- 2015/03/31 00:00 [accepted]
PHST- 2015/06/16 06:00 [entrez]
PHST- 2015/06/16 06:00 [pubmed]
PHST- 2016/01/08 06:00 [medline]
AID - nbt.3212 [pii]
AID - 10.1038/nbt.3212 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jul;33(7):733-5. doi: 10.1038/nbt.3212. Epub 2015 Jun 15.

PMID- 25985263
OWN - NLM
STAT- MEDLINE
DCOM- 20160107
LR  - 20171116
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 7
DP  - 2015 Jul
TI  - Comprehensive transcriptome analysis using synthetic long-read sequencing reveals
      molecular co-association of distant splicing events.
PG  - 736-42
LID - 10.1038/nbt.3242 [doi]
AB  - Alternative splicing shapes mammalian transcriptomes, with many RNA molecules
      undergoing multiple distant alternative splicing events. Comprehensive
      transcriptome analysis, including analysis of exon co-association in the same
      molecule, requires deep, long-read sequencing. Here we introduce an RNA
      sequencing method, synthetic long-read RNA sequencing (SLR-RNA-seq), in which
      small pools (</=1,000 molecules/pool, </=1 molecule/gene for most genes) of
      full-length cDNAs are amplified, fragmented and short-read-sequenced. We
      demonstrate that these RNA sequences reconstructed from the short reads from each
      of the pools are mostly close to full length and contain few insertion and
      deletion errors. We report many previously undescribed isoforms (human brain:
      approximately 13,800 affected genes, 14.5% of molecules; mouse brain
      approximately 8,600 genes, 18% of molecules) and up to 165 human distant
      molecularly associated exon pairs (dMAPs) and distant molecularly and mutually
      exclusive pairs (dMEPs). Of 16 associated pairs detected in the mouse brain, 9
      are conserved in human. Our results indicate conserved mechanisms that can
      produce distant but phased features on transcript and proteome isoforms.
FAU - Tilgner, Hagen
AU  - Tilgner H
AD  - Department of Genetics, Stanford University, Stanford, California, USA.
FAU - Jahanbani, Fereshteh
AU  - Jahanbani F
AD  - Department of Genetics, Stanford University, Stanford, California, USA.
FAU - Blauwkamp, Tim
AU  - Blauwkamp T
AD  - Illumina Inc., San Francisco, California, USA.
FAU - Moshrefi, Ali
AU  - Moshrefi A
AD  - Illumina Inc., San Francisco, California, USA.
FAU - Jaeger, Erich
AU  - Jaeger E
AD  - Illumina Inc., San Francisco, California, USA.
FAU - Chen, Feng
AU  - Chen F
AD  - Illumina Inc., San Francisco, California, USA.
FAU - Harel, Itamar
AU  - Harel I
AD  - Department of Genetics, Stanford University, Stanford, California, USA.
FAU - Bustamante, Carlos D
AU  - Bustamante CD
AD  - Department of Genetics, Stanford University, Stanford, California, USA.
FAU - Rasmussen, Morten
AU  - Rasmussen M
AD  - Department of Genetics, Stanford University, Stanford, California, USA.
FAU - Snyder, Michael P
AU  - Snyder MP
AD  - Department of Genetics, Stanford University, Stanford, California, USA.
LA  - eng
GR  - U54 HG006996/HG/NHGRI NIH HHS/United States
GR  - 1P50HG007735-01/HG/NHGRI NIH HHS/United States
GR  - P01 GM099130/GM/NIGMS NIH HHS/United States
GR  - P50 HG007735/HG/NHGRI NIH HHS/United States
GR  - 5P01GM09913004/GM/NIGMS NIH HHS/United States
GR  - 5U01HL10739304/HL/NHLBI NIH HHS/United States
GR  - U01 HL107393/HL/NHLBI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20150518
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (RNA Isoforms)
SB  - IM
MH  - Alternative Splicing/*genetics
MH  - Animals
MH  - Brain Chemistry
MH  - Computational Biology
MH  - Gene Expression Profiling/*methods
MH  - High-Throughput Nucleotide Sequencing/methods
MH  - Humans
MH  - Male
MH  - Mice
MH  - Mice, Inbred C57BL
MH  - RNA Isoforms/genetics
MH  - Sequence Analysis, RNA/*methods
PMC - PMC4832928
MID - NIHMS746125
EDAT- 2015/05/20 06:00
MHDA- 2016/01/08 06:00
CRDT- 2015/05/19 06:00
PHST- 2014/10/23 00:00 [received]
PHST- 2015/04/21 00:00 [accepted]
PHST- 2015/05/19 06:00 [entrez]
PHST- 2015/05/20 06:00 [pubmed]
PHST- 2016/01/08 06:00 [medline]
AID - nbt.3242 [pii]
AID - 10.1038/nbt.3242 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jul;33(7):736-42. doi: 10.1038/nbt.3242. Epub 2015 May 18.

PMID- 26057981
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20150610
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - Career coaching for scientists.
PG  - 668-9
LID - 10.1038/nbt.3259 [doi]
FAU - Kamens, Joanne
AU  - Kamens J
AD  - Addgene, Cambridge, Massachusetts, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*manpower
MH  - Commerce/manpower
MH  - Humans
MH  - *Mentors
MH  - Occupations
EDAT- 2015/06/10 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/06/10 06:00
PHST- 2015/06/10 06:00 [entrez]
PHST- 2015/06/10 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt.3259 [pii]
AID - 10.1038/nbt.3259 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):668-9. doi: 10.1038/nbt.3259.

PMID- 26057979
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - The heritable immune system.
PG  - 608-9
LID - 10.1038/nbt.3256 [doi]
FAU - Cho, Judy
AU  - Cho J
AD  - Icahn School of Medicine at Mount Sinai, New York, New York, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Genome-Wide Association Study
MH  - *Genotype
MH  - Humans
MH  - Immunity/*genetics
MH  - *Immunophenotyping
MH  - Twins, Dizygotic/genetics
MH  - Twins, Monozygotic/genetics
EDAT- 2015/06/10 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/06/10 06:00
PHST- 2015/06/10 06:00 [entrez]
PHST- 2015/06/10 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt.3256 [pii]
AID - 10.1038/nbt.3256 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):608-9. doi: 10.1038/nbt.3256.

PMID- 26057978
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - Epigenome editing made easy.
PG  - 606-7
LID - 10.1038/nbt.3248 [doi]
FAU - Zentner, Gabriel E
AU  - Zentner GE
AD  - Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle,
      Washington, USA.
FAU - Henikoff, Steven
AU  - Henikoff S
AD  - Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle,
      Washington, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Chromatin)
SB  - IM
MH  - CRISPR-Cas Systems/*genetics
MH  - Chromatin/*genetics
MH  - *Epigenomics
MH  - Gene Targeting
MH  - *Genome
MH  - RNA Editing
EDAT- 2015/06/10 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/06/10 06:00
PHST- 2015/06/10 06:00 [entrez]
PHST- 2015/06/10 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt.3248 [pii]
AID - 10.1038/nbt.3248 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):606-7. doi: 10.1038/nbt.3248.

PMID- 26057977
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - Beyond the reference genome.
PG  - 605-6
LID - 10.1038/nbt.3249 [doi]
FAU - Bustamante, Carlos D
AU  - Bustamante CD
AD  - Department of Genetics, Stanford University School of Medicine, Stanford,
      California, USA.
FAU - Rasmussen, Morten
AU  - Rasmussen M
AD  - Department of Genetics, Stanford University School of Medicine, Stanford,
      California, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Genome, Human
MH  - *High-Throughput Nucleotide Sequencing
MH  - Humans
EDAT- 2015/06/10 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/06/10 06:00
PHST- 2015/06/10 06:00 [entrez]
PHST- 2015/06/10 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt.3249 [pii]
AID - 10.1038/nbt.3249 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):605-6. doi: 10.1038/nbt.3249.

PMID- 26057975
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - Access to new technologies in multipatented vaccines: challenges for Brazil.
PG  - 599-603
LID - 10.1038/nbt.3244 [doi]
FAU - Possas, Cristina
AU  - Possas C
AD  - 1] Bio-Manguinhos, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil; [2]
      Evandro Chagas National Institute of Infectology, FIOCRUZ, Rio de Janeiro,
      Brazil; and.
FAU - de Souza Antunes, Adelaide Maria
AU  - de Souza Antunes AM
AD  - 1] School of Chemistry, Federal University of Rio de Janeiro, Rio de Janeiro,
      Brazil; [2] National Institute of Industrial Property, Rio de Janeiro, Brazil.
FAU - Mendes, Flavia Maria Lins
AU  - Mendes FM
AD  - School of Chemistry, Federal University of Rio de Janeiro, Rio de Janeiro,
      Brazil;
FAU - de Oliveira Rodrigues Schumacher, Suzanne
AU  - de Oliveira Rodrigues Schumacher S
AD  - School of Chemistry, Federal University of Rio de Janeiro, Rio de Janeiro,
      Brazil;
FAU - Martins, Reinaldo Menezes
AU  - Martins RM
AD  - Bio-Manguinhos, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil;
FAU - Homma, Akira
AU  - Homma A
AD  - Bio-Manguinhos, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil;
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Vaccines)
SB  - IM
MH  - Brazil
MH  - Humans
MH  - *Intellectual Property
MH  - Patents as Topic/legislation & jurisprudence
MH  - Public Health/*legislation & jurisprudence
MH  - *Vaccines
EDAT- 2015/06/10 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/06/10 06:00
PHST- 2015/06/10 06:00 [entrez]
PHST- 2015/06/10 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt.3244 [pii]
AID - 10.1038/nbt.3244 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):599-603. doi: 10.1038/nbt.3244.

PMID- 26057974
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - Alexander Rich 1924-2015.
PG  - 593-8
LID - 10.1038/nbt.3262 [doi]
FAU - Zhang, Shuguang
AU  - Zhang S
AD  - Center for Bits &Atoms of the Media Lab at MIT, Cambridge, Massachusetts, USA.
FAU - Wittig, Burghardt
AU  - Wittig B
AD  - Foundation Institute Molecular Biology and Bioinformatics, Freie Universitaet
      Berlin, Berlin, Germany.
LA  - eng
PT  - Biography
PT  - Historical Article
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - History, 20th Century
MH  - History, 21st Century
MH  - Humans
MH  - Molecular Biology/*history
PS  - Rich A
FPS - Rich, Alexander
EDAT- 2015/06/10 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/06/10 06:00
PHST- 2015/06/10 06:00 [entrez]
PHST- 2015/06/10 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt.3262 [pii]
AID - 10.1038/nbt.3262 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):593-8. doi: 10.1038/nbt.3262.

PMID- 26057973
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - The ethics of publishing human germline research.
PG  - 590-2
LID - 10.1038/nbt.3252 [doi]
FAU - Sharma, Arun
AU  - Sharma A
AD  - Institute for Stem Cell Biology and Regenerative Medicine and the Stanford
      Cardiovascular Institute, Stanford, California, USA.
FAU - Scott, Christopher Thomas
AU  - Scott CT
AD  - Center for Biomedical Ethics, Stanford University, Stanford, California, USA.
LA  - eng
GR  - 2U54TR000123/TR/NCATS NIH HHS/United States
PT  - Letter
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (beta-Globins)
SB  - IM
EIN - Nat Biotechnol. 2015 Aug;33(8):882. PMID: 26252145
EIN - Nat Biotechnol. 26252145
MH  - CRISPR-Cas Systems/genetics
MH  - Fertilization in Vitro/*ethics
MH  - Genetic Therapy/*ethics
MH  - *Germ Cells
MH  - Humans
MH  - beta-Globins/genetics/therapeutic use
EDAT- 2015/06/10 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/06/10 06:00
PHST- 2015/06/10 06:00 [entrez]
PHST- 2015/06/10 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt.3252 [pii]
AID - 10.1038/nbt.3252 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):590-2. doi: 10.1038/nbt.3252.

PMID- 26057972
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - Accelerating innovation in rapid diagnostics and targeted antibacterials.
PG  - 589-90
LID - 10.1038/nbt.3251 [doi]
FAU - Hwang, Thomas J
AU  - Hwang TJ
AD  - 1] Faculty of Arts and Sciences, Harvard University, Cambridge, Massachusetts,
      USA. [2] The Blackstone Group, London, UK.
FAU - Powers, John H
AU  - Powers JH
AD  - George Washington University School of Medicine, Washington, DC, USA.
FAU - Carpenter, Daniel
AU  - Carpenter D
AD  - 1] Faculty of Arts and Sciences, Harvard University, Cambridge, Massachusetts,
      USA. [2] Radcliffe Institute for Advanced Study, Harvard University, Cambridge,
      Massachusetts, USA.
FAU - Kesselheim, Aaron S
AU  - Kesselheim AS
AD  - Program on Regulation, Therapeutics, and Law (PORTAL), Division of
      Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and
      Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
LA  - eng
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Bacterial Infections/epidemiology/*therapy
MH  - Drug Discovery/*legislation & jurisprudence
MH  - *Drug Resistance, Bacterial
MH  - Humans
MH  - United States
MH  - United States Food and Drug Administration/legislation & jurisprudence
MH  - United States Government Agencies/legislation & jurisprudence
EDAT- 2015/06/10 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/06/10 06:00
PHST- 2015/06/10 06:00 [entrez]
PHST- 2015/06/10 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt.3251 [pii]
AID - 10.1038/nbt.3251 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):589-90. doi: 10.1038/nbt.3251.

PMID- 26057971
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20150610
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - Biological products and GAIN Act eligibility.
PG  - 588-9
LID - 10.1038/nbt.3253 [doi]
FAU - da Silveira, Samareh Azeredo
AU  - da Silveira SA
AD  - Lascco SA, Geneva, Switzerland.
LA  - eng
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Biological Products)
SB  - IM
MH  - Bacterial Infections/epidemiology/*therapy
MH  - Biological Products/*therapeutic use
MH  - *Drug Resistance, Bacterial
MH  - Humans
MH  - United States
MH  - United States Government Agencies
EDAT- 2015/06/10 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/06/10 06:00
PHST- 2015/06/10 06:00 [entrez]
PHST- 2015/06/10 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt.3253 [pii]
AID - 10.1038/nbt.3253 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):588-9. doi: 10.1038/nbt.3253.

PMID- 26057970
OWN - NLM
STAT- MEDLINE
DCOM- 20150811
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - Response to cardiac regeneration validated.
PG  - 587
LID - 10.1038/nbt.3257 [doi]
FAU - Naumova, Anna V
AU  - Naumova AV
AD  - 1] Department of Radiology, University of Washington, Seattle, Washington, USA.
      [2] Center for Cardiovascular Biology, University of Washington, Seattle,
      Washington, USA. [3] Institute for Stem Cell and Regenerative Medicine,
      University of Washington, Seattle, Washington, USA.
FAU - Modo, Michel
AU  - Modo M
AD  - 1] McGowan Institute for Regenerative Medicine, University of Pittsburgh,
      Pittsburgh, Pennsylvania, USA. [2] Centre for the Neural Basis of Cognition,
      University of Pittsburgh, Pittsburgh, Pennsylvania, USA. [3] Department of
      Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. [4]
      Department of Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania,
      USA.
FAU - Moore, Anna
AU  - Moore A
AD  - Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology,
      Massachusetts General Hospital, Charlestown, Massachusetts, USA.
FAU - Frank, Joseph A
AU  - Frank JA
AD  - 1] Radiology and Imaging Sciences, Clinical, National Institutes of Health,
      Bethesda, Maryland, USA. [2] National Institutes of Biomedical Imaging and
      Bioengineering, National Institutes of Health Bethesda, Maryland, USA.
FAU - Murry, Charles E
AU  - Murry CE
AD  - 1] Center for Cardiovascular Biology, University of Washington, Seattle,
      Washington, USA. [2] Institute for Stem Cell and Regenerative Medicine,
      University of Washington, Seattle, Washington, USA. [3] Department of Pathology, 
      University of Washington, Seattle, Washington, USA. [4] Department of
      Bioengineering, University of Washington, Seattle, Washington, USA. [5]
      Department of Medicine/Cardiology, University of Washington, Seattle, Washington,
      USA.
LA  - eng
PT  - Comment
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2014 Aug;32(8):804-18. PMID: 25093889
CON - Nat Biotechnol. 2015 Jun;33(6):587. PMID: 26057969
MH  - Animals
MH  - *Diagnostic Imaging
MH  - *Regenerative Medicine
EDAT- 2015/06/10 06:00
MHDA- 2015/08/12 06:00
CRDT- 2015/06/10 06:00
PHST- 2015/06/10 06:00 [entrez]
PHST- 2015/06/10 06:00 [pubmed]
PHST- 2015/08/12 06:00 [medline]
AID - nbt.3257 [pii]
AID - 10.1038/nbt.3257 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):587. doi: 10.1038/nbt.3257.

PMID- 26057969
OWN - NLM
STAT- MEDLINE
DCOM- 20150811
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - Cardiac regeneration validated.
PG  - 587
LID - 10.1038/nbt.3254 [doi]
FAU - Malliaras, Konstantinos
AU  - Malliaras K
AD  - Cedars-Sinai Heart Institute, Los Angeles, California, USA.
FAU - Marban, Eduardo
AU  - Marban E
AD  - Cedars-Sinai Heart Institute, Los Angeles, California, USA.
LA  - eng
PT  - Comment
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2014 Aug;32(8):804-18. PMID: 25093889
CIN - Nat Biotechnol. 2015 Jun;33(6):587. PMID: 26057970
MH  - Animals
MH  - *Diagnostic Imaging
MH  - *Regenerative Medicine
EDAT- 2015/06/10 06:00
MHDA- 2015/08/12 06:00
CRDT- 2015/06/10 06:00
PHST- 2015/06/10 06:00 [entrez]
PHST- 2015/06/10 06:00 [pubmed]
PHST- 2015/08/12 06:00 [medline]
AID - nbt.3254 [pii]
AID - 10.1038/nbt.3254 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):587. doi: 10.1038/nbt.3254.

PMID- 26057967
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20150610
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - Bridging tech and biotech.
PG  - 581-3
LID - 10.1038/nbt.3260 [doi]
FAU - van Rooyen, Pieter
AU  - van Rooyen P
AD  - Edico Genome, La Jolla, California, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*trends
MH  - Drug Industry/trends
MH  - Humans
MH  - Medical Informatics/*trends
EDAT- 2015/06/10 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/06/10 06:00
PHST- 2015/06/10 06:00 [entrez]
PHST- 2015/06/10 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt.3260 [pii]
AID - 10.1038/nbt.3260 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):581-3. doi: 10.1038/nbt.3260.

PMID- 26057966
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20150610
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - Drug pipeline: 1Q15.
PG  - 580
LID - 10.1038/nbt.3261 [doi]
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Clinical Trials as Topic
MH  - *Drug Approval
MH  - Humans
MH  - United States
MH  - United States Food and Drug Administration/*trends
EDAT- 2015/06/10 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/06/10 06:00
PHST- 2015/06/10 06:00 [entrez]
PHST- 2015/06/10 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt.3261 [pii]
AID - 10.1038/nbt.3261 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):580. doi: 10.1038/nbt.3261.

PMID- 26057965
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20150610
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - Around the world in a month.
PG  - 579
LID - 10.1038/nbt0615-579 [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Australia
MH  - *Biomedical Research/economics/trends
MH  - Brazil
MH  - Cuba
MH  - Humans
MH  - Ireland
MH  - Japan
EDAT- 2015/06/10 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/06/10 06:00
PHST- 2015/06/10 06:00 [entrez]
PHST- 2015/06/10 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt0615-579 [pii]
AID - 10.1038/nbt0615-579 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):579. doi: 10.1038/nbt0615-579.

PMID- 26057964
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - Medtronic deal flurry raises artificial pancreas prospects.
PG  - 578-9
LID - 10.1038/nbt0615-578a [doi]
FAU - Waltz, Emily
AU  - Waltz E
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Insulin)
SB  - IM
MH  - Diabetes Mellitus/pathology/*therapy
MH  - Humans
MH  - Insulin/*therapeutic use
MH  - *Pancreas, Artificial
EDAT- 2015/06/10 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/06/10 06:00
PHST- 2015/06/10 06:00 [entrez]
PHST- 2015/06/10 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt0615-578a [pii]
AID - 10.1038/nbt0615-578a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):578-9. doi: 10.1038/nbt0615-578a.

PMID- 26057963
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20150610
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - EC approves long overdue GM plants.
PG  - 578
LID - 10.1038/nbt0615-578b [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Europe
MH  - Gossypium/*genetics
MH  - Humans
MH  - *Plants, Genetically Modified
MH  - Soybeans/*genetics
MH  - Zea mays/*genetics
EDAT- 2015/06/10 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/06/10 06:00
PHST- 2015/06/10 06:00 [entrez]
PHST- 2015/06/10 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt0615-578b [pii]
AID - 10.1038/nbt0615-578b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):578. doi: 10.1038/nbt0615-578b.

PMID- 26057962
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - Backlog cripples China's drug regulator.
PG  - 577
LID - 10.1038/nbt0615-577b [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - China
MH  - *Drug Approval
MH  - *Drug and Narcotic Control
MH  - Humans
MH  - United States
MH  - *United States Food and Drug Administration
EDAT- 2015/06/10 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/06/10 06:00
PHST- 2015/06/10 06:00 [entrez]
PHST- 2015/06/10 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt0615-577b [pii]
AID - 10.1038/nbt0615-577b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):577. doi: 10.1038/nbt0615-577b.

PMID- 26057961
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20150610
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - Brazil approves transgenic eucalyptus.
PG  - 577
LID - 10.1038/nbt0615-577c [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Arabidopsis/genetics
MH  - Brazil
MH  - Eucalyptus/*genetics/growth & development
MH  - Plants, Genetically Modified/*genetics/growth & development
EDAT- 2015/06/10 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/06/10 06:00
PHST- 2015/06/10 06:00 [entrez]
PHST- 2015/06/10 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt0615-577c [pii]
AID - 10.1038/nbt0615-577c [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):577. doi: 10.1038/nbt0615-577c.

PMID- 26057960
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - Alnylam's RNAi therapy targets amyloid disease.
PG  - 577
LID - 10.1038/nbt0615-577a [doi]
FAU - Garber, Ken
AU  - Garber K
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (RNA, Small Interfering)
SB  - IM
MH  - Amyloid Neuropathies/genetics/*therapy
MH  - Humans
MH  - RNA, Small Interfering/*therapeutic use
MH  - *RNAi Therapeutics
EDAT- 2015/06/10 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/06/10 06:00
PHST- 2015/06/10 06:00 [entrez]
PHST- 2015/06/10 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt0615-577a [pii]
AID - 10.1038/nbt0615-577a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):577. doi: 10.1038/nbt0615-577a.

PMID- 26057959
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20150610
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - Cold Spring Harbor in translation.
PG  - 576
LID - 10.1038/nbt0615-576 [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Academies and Institutes
MH  - Community Health Planning
MH  - Humans
MH  - Neoplasms/genetics/*therapy
MH  - *Translational Medical Research
EDAT- 2015/06/10 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/06/10 06:00
PHST- 2015/06/10 06:00 [entrez]
PHST- 2015/06/10 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt0615-576 [pii]
AID - 10.1038/nbt0615-576 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):576. doi: 10.1038/nbt0615-576.

PMID- 26057958
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - Industry chases pan-genotypic and shorter HCV treatments.
PG  - 575-6
LID - 10.1038/nbt0615-575 [doi]
FAU - Azvolinsky, Anna
AU  - Azvolinsky A
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (NS-5 protein, hepatitis C virus)
RN  - 0 (Viral Nonstructural Proteins)
SB  - IM
MH  - Drug Industry
MH  - Genome, Human
MH  - Hepacivirus/drug effects/pathogenicity
MH  - Hepatitis C/*drug therapy/genetics/virology
MH  - Humans
MH  - Viral Nonstructural Proteins/*antagonists & inhibitors/therapeutic use
EDAT- 2015/06/10 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/06/10 06:00
PHST- 2015/06/10 06:00 [entrez]
PHST- 2015/06/10 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt0615-575 [pii]
AID - 10.1038/nbt0615-575 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):575-6. doi: 10.1038/nbt0615-575.

PMID- 26057957
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20150610
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - Biogen's anti-LINGO promises nerve repair.
PG  - 573
LID - 10.1038/nbt0615-573b [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antibodies, Anti-Idiotypic)
RN  - 0 (LINGO1 protein, human)
RN  - 0 (Membrane Proteins)
RN  - 0 (Nerve Tissue Proteins)
SB  - IM
MH  - Antibodies, Anti-Idiotypic/immunology/*therapeutic use
MH  - Humans
MH  - Membrane Proteins/immunology/*therapeutic use
MH  - Multiple Sclerosis/immunology/*therapy
MH  - Nerve Regeneration/immunology
MH  - Nerve Tissue Proteins/immunology/*therapeutic use
MH  - Neurons/immunology/pathology
EDAT- 2015/06/10 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/06/10 06:00
PHST- 2015/06/10 06:00 [entrez]
PHST- 2015/06/10 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt0615-573b [pii]
AID - 10.1038/nbt0615-573b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):573. doi: 10.1038/nbt0615-573b.

PMID- 26057956
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - Heart failure gene therapy disappoints but experts keep the faith.
PG  - 573-4
LID - 10.1038/nbt0615-573a [doi]
FAU - Ratner, Mark
AU  - Ratner M
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Genetic Therapy
MH  - Heart Failure/genetics/*therapy
MH  - Humans
EDAT- 2015/06/10 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/06/10 06:00
PHST- 2015/06/10 06:00 [entrez]
PHST- 2015/06/10 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt0615-573a [pii]
AID - 10.1038/nbt0615-573a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):573-4. doi: 10.1038/nbt0615-573a.

PMID- 26057955
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - Takeda moves into stem cells.
PG  - 573
LID - 10.1038/nbt0615-573c [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Drug Industry
MH  - Humans
MH  - *Induced Pluripotent Stem Cells
MH  - *Stem Cell Research
EDAT- 2015/06/10 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/06/10 06:00
PHST- 2015/06/10 06:00 [entrez]
PHST- 2015/06/10 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt0615-573c [pii]
AID - 10.1038/nbt0615-573c [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):573. doi: 10.1038/nbt0615-573c.

PMID- 26057954
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - CAR-T field booms as next-generation platforms attract big players.
PG  - 571-2
LID - 10.1038/nbt0615-571 [doi]
FAU - Morrison, Chris
AU  - Morrison C
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Receptors, Antigen, T-Cell)
SB  - IM
MH  - Drug Industry
MH  - Humans
MH  - *Immunotherapy, Adoptive
MH  - Neoplasms/immunology/*therapy
MH  - Receptors, Antigen, T-Cell/immunology/*therapeutic use
EDAT- 2015/06/10 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/06/10 06:00
PHST- 2015/06/10 06:00 [entrez]
PHST- 2015/06/10 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt0615-571 [pii]
AID - 10.1038/nbt0615-571 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):571-2. doi: 10.1038/nbt0615-571.

PMID- 26057953
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - First oncolytic virus edges towards approval in surprise vote.
PG  - 569-70
LID - 10.1038/nbt0615-569 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Drug Approval
MH  - Humans
MH  - *Immunotherapy
MH  - Melanoma/genetics/immunology/*therapy
MH  - *Oncolytic Virotherapy
MH  - Oncolytic Viruses/genetics
MH  - United States
MH  - United States Food and Drug Administration
EDAT- 2015/06/10 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/06/10 06:00
PHST- 2015/06/10 06:00 [entrez]
PHST- 2015/06/10 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt0615-569 [pii]
AID - 10.1038/nbt0615-569 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):569-70. doi: 10.1038/nbt0615-569.

PMID- 26057952
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20150610
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - The coming era of human phenotyping.
PG  - 567
LID - 10.1038/nbt.3266 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Genetics, Population
MH  - Humans
MH  - *Phenotype
EDAT- 2015/06/10 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/06/10 06:00
PHST- 2015/06/10 06:00 [entrez]
PHST- 2015/06/10 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt.3266 [pii]
AID - 10.1038/nbt.3266 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):567. doi: 10.1038/nbt.3266.

PMID- 26006009
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - Assembling large genomes with single-molecule sequencing and locality-sensitive
      hashing.
PG  - 623-30
LID - 10.1038/nbt.3238 [doi]
AB  - Long-read, single-molecule real-time (SMRT) sequencing is routinely used to
      finish microbial genomes, but available assembly methods have not scaled well to 
      larger genomes. We introduce the MinHash Alignment Process (MHAP) for overlapping
      noisy, long reads using probabilistic, locality-sensitive hashing. Integrating
      MHAP with the Celera Assembler enabled reference-grade de novo assemblies of
      Saccharomyces cerevisiae, Arabidopsis thaliana, Drosophila melanogaster and a
      human hydatidiform mole cell line (CHM1) from SMRT sequencing. The resulting
      assemblies are highly continuous, include fully resolved chromosome arms and
      close persistent gaps in these reference genomes. Our assembly of D. melanogaster
      revealed previously unknown heterochromatic and telomeric transition sequences,
      and we assembled low-complexity sequences from CHM1 that fill gaps in the human
      GRCh38 reference. Using MHAP and the Celera Assembler, single-molecule sequencing
      can produce de novo near-complete eukaryotic assemblies that are 99.99% accurate 
      when compared with available reference genomes.
FAU - Berlin, Konstantin
AU  - Berlin K
AD  - 1] Department of Chemistry and Biochemistry, University of Maryland, College
      Park, Maryland, USA. [2] Institute for Advanced Computer Studies, University of
      Maryland, College Park, Maryland, USA. [3] Invincea Labs, Arlington, Virginia,
      USA.
FAU - Koren, Sergey
AU  - Koren S
AD  - National Biodefense Analysis and Countermeasures Center, Frederick, Maryland,
      USA.
FAU - Chin, Chen-Shan
AU  - Chin CS
AUID- ORCID: 0000000343942455
AD  - Pacific Biosciences of California, Inc., Menlo Park, California, USA.
FAU - Drake, James P
AU  - Drake JP
AD  - Pacific Biosciences of California, Inc., Menlo Park, California, USA.
FAU - Landolin, Jane M
AU  - Landolin JM
AD  - Pacific Biosciences of California, Inc., Menlo Park, California, USA.
FAU - Phillippy, Adam M
AU  - Phillippy AM
AD  - National Biodefense Analysis and Countermeasures Center, Frederick, Maryland,
      USA.
LA  - eng
PT  - Journal Article
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20150525
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Heterochromatin)
SB  - IM
EIN - Nat Biotechnol. 2015 Oct;33(10):1109. PMID: 26448093
MH  - Animals
MH  - Arabidopsis/genetics
MH  - Base Sequence
MH  - Chromosomes/genetics
MH  - Drosophila melanogaster/genetics
MH  - *Genome, Fungal
MH  - *Genome, Human
MH  - *Genome, Insect
MH  - *Genome, Plant
MH  - Heterochromatin
MH  - High-Throughput Nucleotide Sequencing/methods
MH  - Humans
MH  - Saccharomyces cerevisiae/genetics
MH  - Sequence Alignment
MH  - *Sequence Analysis, DNA
EDAT- 2015/05/26 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/05/26 06:00
PHST- 2014/08/14 00:00 [received]
PHST- 2015/04/08 00:00 [accepted]
PHST- 2015/05/26 06:00 [entrez]
PHST- 2015/05/26 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt.3238 [pii]
AID - 10.1038/nbt.3238 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):623-30. doi: 10.1038/nbt.3238. Epub 2015 May 25.

PMID- 26006008
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20161215
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - COMPASS identifies T-cell subsets correlated with clinical outcomes.
PG  - 610-6
LID - 10.1038/nbt.3187 [doi]
AB  - Advances in flow cytometry and other single-cell technologies have enabled
      high-dimensional, high-throughput measurements of individual cells as well as the
      interrogation of cell population heterogeneity. However, in many instances,
      computational tools to analyze the wealth of data generated by these technologies
      are lacking. Here, we present a computational framework for unbiased
      combinatorial polyfunctionality analysis of antigen-specific T-cell subsets
      (COMPASS). COMPASS uses a Bayesian hierarchical framework to model all observed
      cell subsets and select those most likely to have antigen-specific responses.
      Cell-subset responses are quantified by posterior probabilities, and human
      subject-level responses are quantified by two summary statistics that describe
      the quality of an individual's polyfunctional response and can be correlated
      directly with clinical outcome. Using three clinical data sets of cytokine
      production, we demonstrate how COMPASS improves characterization of
      antigen-specific T cells and reveals cellular 'correlates of protection/immunity'
      in the RV144 HIV vaccine efficacy trial that are missed by other methods. COMPASS
      is available as open-source software.
FAU - Lin, Lin
AU  - Lin L
AD  - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, 
      Seattle, Washington, USA.
FAU - Finak, Greg
AU  - Finak G
AD  - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, 
      Seattle, Washington, USA.
FAU - Ushey, Kevin
AU  - Ushey K
AD  - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, 
      Seattle, Washington, USA.
FAU - Seshadri, Chetan
AU  - Seshadri C
AD  - Division of Allergy and Infectious Diseases, University of Washington, Seattle,
      Washington, USA.
FAU - Hawn, Thomas R
AU  - Hawn TR
AD  - Division of Allergy and Infectious Diseases, University of Washington, Seattle,
      Washington, USA.
FAU - Frahm, Nicole
AU  - Frahm N
AUID- ORCID: 0000000312983676
AD  - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, 
      Seattle, Washington, USA.
FAU - Scriba, Thomas J
AU  - Scriba TJ
AD  - South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease
      and Molecular Medicine and School of Child and Adolescent Health, University of
      Cape Town, Cape Town, South Africa.
FAU - Mahomed, Hassan
AU  - Mahomed H
AD  - South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease
      and Molecular Medicine and School of Child and Adolescent Health, University of
      Cape Town, Cape Town, South Africa.
FAU - Hanekom, Willem
AU  - Hanekom W
AD  - South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease
      and Molecular Medicine and School of Child and Adolescent Health, University of
      Cape Town, Cape Town, South Africa.
FAU - Bart, Pierre-Alexandre
AU  - Bart PA
AD  - Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
FAU - Pantaleo, Giuseppe
AU  - Pantaleo G
AD  - Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
FAU - Tomaras, Georgia D
AU  - Tomaras GD
AD  - Duke Human Vaccine Institute, Duke University Medical Center, Durham, North
      Carolina, USA.
FAU - Rerks-Ngarm, Supachai
AU  - Rerks-Ngarm S
AD  - Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand.
FAU - Kaewkungwal, Jaranit
AU  - Kaewkungwal J
AD  - Data Management Unit, Faculty of Tropical Medicine, Mahidol University,
      Ratchathewi, Bangkok, Thailand.
FAU - Nitayaphan, Sorachai
AU  - Nitayaphan S
AD  - Thai Component, Armed Forces Research Institute of Medical Sciences, Bangkok,
      Ratchathewi, Bangkok, Thailand.
FAU - Pitisuttithum, Punnee
AU  - Pitisuttithum P
AD  - Vaccine Trials Center, Faculty of Tropical Medicine, Mahidol University,
      Ratchathewi, Bangkok, Thailand.
FAU - Michael, Nelson L
AU  - Michael NL
AD  - US Military HIV Research Program, Walter Reed Army Institute of Research, Silver 
      Spring, Maryland, USA.
FAU - Kim, Jerome H
AU  - Kim JH
AD  - US Military HIV Research Program, Walter Reed Army Institute of Research, Silver 
      Spring, Maryland, USA.
FAU - Robb, Merlin L
AU  - Robb ML
AD  - US Army Military HIV Research Program, Walter Reed Army Institute of Research;
      Henry M. Jackson Foundation, Bethesda, Maryland, USA.
FAU - O'Connell, Robert J
AU  - O'Connell RJ
AD  - US Army Medical Component, Armed Forces Research Institute of Medical Sciences,
      Ratchathewi, Bangkok, Thailand.
FAU - Karasavvas, Nicos
AU  - Karasavvas N
AD  - US Army Medical Component, Armed Forces Research Institute of Medical Sciences,
      Ratchathewi, Bangkok, Thailand.
FAU - Gilbert, Peter
AU  - Gilbert P
AD  - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, 
      Seattle, Washington, USA.
FAU - C De Rosa, Stephen
AU  - C De Rosa S
AD  - 1] Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research
      Center, Seattle, Washington, USA. [2] Department of Laboratory Medicine,
      University of Washington, Seattle, Washington, USA.
FAU - McElrath, M Juliana
AU  - McElrath MJ
AD  - 1] Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research
      Center, Seattle, Washington, USA. [2] Division of Allergy and Infectious
      Diseases, University of Washington, Seattle, Washington, USA. [3] Department of
      Laboratory Medicine, University of Washington, Seattle, Washington, USA.
FAU - Gottardo, Raphael
AU  - Gottardo R
AD  - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, 
      Seattle, Washington, USA.
LA  - eng
GR  - Y01 AI2642-12/AI/NIAID NIH HHS/United States
GR  - U19 AI089986/AI/NIAID NIH HHS/United States
GR  - UM1 AI068614/AI/NIAID NIH HHS/United States
GR  - UM1 AI068618/AI/NIAID NIH HHS/United States
GR  - UM1 AI068635/AI/NIAID NIH HHS/United States
GR  - R01 EB008400/EB/NIBIB NIH HHS/United States
PT  - Clinical Trial, Phase I
PT  - Journal Article
PT  - Randomized Controlled Trial
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20150525
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (AIDS Vaccines)
RN  - 0 (Cytokines)
RN  - 0 (Gene Products, env)
RN  - 0 (Immunoglobulin A)
SB  - IM
MH  - AIDS Vaccines/*administration & dosage/immunology
MH  - Case-Control Studies
MH  - Cytokines/biosynthesis/blood/*immunology
MH  - Female
MH  - Flow Cytometry
MH  - Gene Products, env/immunology/therapeutic use
MH  - HIV Infections/blood/*drug therapy/immunology/virology
MH  - HIV-1/immunology/pathogenicity
MH  - Healthy Volunteers
MH  - Humans
MH  - *Immunity, Cellular
MH  - Immunoglobulin A/blood
MH  - Male
MH  - Single-Cell Analysis
MH  - T-Lymphocyte Subsets/*immunology
MH  - Treatment Outcome
PMC - PMC4569006
MID - NIHMS721011
EDAT- 2015/05/26 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/05/26 06:00
PHST- 2014/04/17 00:00 [received]
PHST- 2015/03/04 00:00 [accepted]
PHST- 2015/05/26 06:00 [entrez]
PHST- 2015/05/26 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt.3187 [pii]
AID - 10.1038/nbt.3187 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):610-6. doi: 10.1038/nbt.3187. Epub 2015 May 25.

PMID- 26006007
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20180204
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - Comprehensive models of human primary and metastatic colorectal tumors in
      immunodeficient and immunocompetent mice by chemokine targeting.
PG  - 656-60
LID - 10.1038/nbt.3239 [doi]
AB  - Current orthotopic xenograft models of human colorectal cancer (CRC) require
      surgery and do not robustly form metastases in the liver, the most common site
      clinically. CCR9 traffics lymphocytes to intestine and colorectum. We engineered 
      use of the chemokine receptor CCR9 in CRC cell lines and patient-derived cells to
      create primary gastrointestinal (GI) tumors in immunodeficient mice by tail-vein 
      injection rather than surgery. The tumors metastasize inducibly and robustly to
      the liver. Metastases have higher DKK4 and NOTCH signaling levels and are more
      chemoresistant than paired subcutaneous xenografts. Using this approach, we
      generated 17 chemokine-targeted mouse models (CTMMs) that recapitulate the
      majority of common human somatic CRC mutations. We also show that primary tumors 
      can be modeled in immunocompetent mice by microinjecting CCR9-expressing cancer
      cell lines into early-stage mouse blastocysts, which induces central immune
      tolerance. We expect that CTMMs will facilitate investigation of the biology of
      CRC metastasis and drug screening.
FAU - Chen, Huanhuan Joyce
AU  - Chen HJ
AD  - 1] Department of Biomedical Engineering, Cornell University, Ithaca, New York,
      USA. [2] Department of Medicine, Weill Cornell Medical College, New York, New
      York, USA.
FAU - Sun, Jian
AU  - Sun J
AD  - Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
FAU - Huang, Zhiliang
AU  - Huang Z
AD  - Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
FAU - Hou, Harry Jr
AU  - Hou H Jr
AD  - Department of Cell Biology, Albert Einstein College of Medicine, New York, New
      York, USA.
FAU - Arcilla, Myra
AU  - Arcilla M
AD  - Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
FAU - Rakhilin, Nikolai
AU  - Rakhilin N
AD  - Department of Biomedical Engineering, Cornell University, Ithaca, New York, USA.
FAU - Joe, Daniel J
AU  - Joe DJ
AUID- ORCID: 0000000219458236
AD  - Department of Biomedical Engineering, Cornell University, Ithaca, New York, USA.
FAU - Choi, Jiahn
AU  - Choi J
AD  - Department of Biomedical Engineering, Cornell University, Ithaca, New York, USA.
FAU - Gadamsetty, Poornima
AU  - Gadamsetty P
AD  - Department of Biomedical Engineering, Cornell University, Ithaca, New York, USA.
FAU - Milsom, Jeff
AU  - Milsom J
AD  - Department of Surgery, Weill Cornell Medical College, New York, New York, USA.
FAU - Nandakumar, Govind
AU  - Nandakumar G
AD  - Department of Surgery, Weill Cornell Medical College, New York, New York, USA.
FAU - Longman, Randy
AU  - Longman R
AD  - Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
FAU - Zhou, Xi Kathy
AU  - Zhou XK
AUID- ORCID: 000000028942439X
AD  - Department of Healthcare Policy and Research, Weill Cornell Medical College, New 
      York, New York, USA.
FAU - Edwards, Robert
AU  - Edwards R
AD  - Department of Pathology, University of California, Irvine, Irvine, California,
      USA.
FAU - Chen, Jonlin
AU  - Chen J
AD  - School of Electrical and Computer Engineering, Cornell University, Ithaca, New
      York, USA.
FAU - Chen, Kai Yuan
AU  - Chen KY
AD  - School of Electrical and Computer Engineering, Cornell University, Ithaca, New
      York, USA.
FAU - Bu, Pengcheng
AU  - Bu P
AD  - 1] Department of Biomedical Engineering, Cornell University, Ithaca, New York,
      USA. [2] School of Electrical and Computer Engineering, Cornell University,
      Ithaca, New York, USA.
FAU - Wang, Lihua
AU  - Wang L
AD  - Department of Biomedical Engineering, Cornell University, Ithaca, New York, USA.
FAU - Xu, Yitian
AU  - Xu Y
AD  - Department of Biomedical Engineering, Cornell University, Ithaca, New York, USA.
FAU - Munroe, Robert
AU  - Munroe R
AD  - College of Veterinary Medicine and Biological Sciences, Cornell University,
      Ithaca, New York, USA.
FAU - Abratte, Christian
AU  - Abratte C
AD  - College of Veterinary Medicine and Biological Sciences, Cornell University,
      Ithaca, New York, USA.
FAU - Miller, Andrew D
AU  - Miller AD
AD  - College of Veterinary Medicine and Biological Sciences, Cornell University,
      Ithaca, New York, USA.
FAU - Gumus, Zeynep H
AU  - Gumus ZH
AUID- ORCID: 0000000273642202
AD  - 1] Department of Medicine, Weill Cornell Medical College, New York, New York,
      USA. [2] Department of Genetics and Genomic Sciences, Icahn School of Medicine at
      Mount Sinai, New York, New York, USA.
FAU - Shuler, Michael
AU  - Shuler M
AD  - Department of Biomedical Engineering, Cornell University, Ithaca, New York, USA.
FAU - Nishimura, Nozomi
AU  - Nishimura N
AD  - Department of Biomedical Engineering, Cornell University, Ithaca, New York, USA.
FAU - Edelmann, Winfried
AU  - Edelmann W
AD  - Department of Cell Biology, Albert Einstein College of Medicine, New York, New
      York, USA.
FAU - Shen, Xiling
AU  - Shen X
AD  - 1] Department of Biomedical Engineering, Cornell University, Ithaca, New York,
      USA. [2] School of Electrical and Computer Engineering, Cornell University,
      Ithaca, New York, USA.
FAU - Lipkin, Steven M
AU  - Lipkin SM
AD  - Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
LA  - eng
GR  - UH2 TR000516/TR/NCATS NIH HHS/United States
GR  - R01 CA098626/CA/NCI NIH HHS/United States
GR  - UL1 RR024996/RR/NCRR NIH HHS/United States
GR  - R01 GM114254/GM/NIGMS NIH HHS/United States
GR  - 2UL1-RR024996/RR/NCRR NIH HHS/United States
GR  - R01 GM095990/GM/NIGMS NIH HHS/United States
GR  - R01 CA076329/CA/NCI NIH HHS/United States
GR  - CA098626/CA/NCI NIH HHS/United States
GR  - K08 DK099381/DK/NIDDK NIH HHS/United States
GR  - UL1 TR001414/TR/NCATS NIH HHS/United States
GR  - R56 CA098626/CA/NCI NIH HHS/United States
GR  - UH2TR000516/TR/NCATS NIH HHS/United States
GR  - P30 CA013330/CA/NCI NIH HHS/United States
GR  - UL1 TR000457/TR/NCATS NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20150525
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (CC chemokine receptor 9)
RN  - 0 (DKK4 protein, human)
RN  - 0 (Intercellular Signaling Peptides and Proteins)
RN  - 0 (Receptors, CCR)
RN  - 0 (Receptors, Notch)
SB  - IM
MH  - Animals
MH  - Blastocyst/pathology
MH  - Cell Line, Tumor
MH  - Colorectal Neoplasms/*genetics/pathology
MH  - *Disease Models, Animal
MH  - Gene Expression Regulation, Neoplastic
MH  - Humans
MH  - Intercellular Signaling Peptides and Proteins/biosynthesis
MH  - Liver Neoplasms, Experimental/*genetics/secondary
MH  - Mice
MH  - Neoplasm Metastasis
MH  - Receptors, CCR/administration & dosage/biosynthesis/*genetics
MH  - Receptors, Notch/biosynthesis
MH  - Signal Transduction
MH  - Xenograft Model Antitumor Assays
PMC - PMC4532544
MID - NIHMS681926
EDAT- 2015/05/26 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/05/26 06:00
PHST- 2015/02/14 00:00 [received]
PHST- 2015/04/15 00:00 [accepted]
PHST- 2015/05/26 06:00 [entrez]
PHST- 2015/05/26 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt.3239 [pii]
AID - 10.1038/nbt.3239 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):656-60. doi: 10.1038/nbt.3239. Epub 2015 May 25.

PMID- 26006006
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - De novo assembly of a haplotype-resolved human genome.
PG  - 617-22
LID - 10.1038/nbt.3200 [doi]
AB  - The human genome is diploid, and knowledge of the variants on each chromosome is 
      important for the interpretation of genomic information. Here we report the
      assembly of a haplotype-resolved diploid genome without using a reference genome.
      Our pipeline relies on fosmid pooling together with whole-genome shotgun
      strategies, based solely on next-generation sequencing and hierarchical assembly 
      methods. We applied our sequencing method to the genome of an Asian individual
      and generated a 5.15-Gb assembled genome with a haplotype N50 of 484 kb. Our
      analysis identified previously undetected indels and 7.49 Mb of novel coding
      sequences that could not be aligned to the human reference genome, which include 
      at least six predicted genes. This haplotype-resolved genome represents the most 
      complete de novo human genome assembly to date. Application of our approach to
      identify individual haplotype differences should aid in translating genotypes to 
      phenotypes for the development of personalized medicine.
FAU - Cao, Hongzhi
AU  - Cao H
AD  - 1] BGI-Shenzhen, Shenzhen, China. [2] BGI-Tianjin, Tianjin, China. [3] Department
      of Biology, University of Copenhagen, Copenhagen, Denmark.
FAU - Wu, Honglong
AU  - Wu H
AD  - 1] BGI-Shenzhen, Shenzhen, China. [2] BGI-Tianjin, Tianjin, China.
FAU - Luo, Ruibang
AU  - Luo R
AD  - 1] BGI-Shenzhen, Shenzhen, China. [2] HKU-BGI Bioinformatics Algorithms and Core 
      Technology Research Laboratory, Hong Kong, China.
FAU - Huang, Shujia
AU  - Huang S
AD  - 1] BGI-Shenzhen, Shenzhen, China. [2] School of Bioscience and Bioengineering,
      South China University of Technology, Guangzhou, China.
FAU - Sun, Yuhui
AU  - Sun Y
AD  - 1] BGI-Shenzhen, Shenzhen, China. [2] School of Bioscience and Bioengineering,
      South China University of Technology, Guangzhou, China.
FAU - Tong, Xin
AU  - Tong X
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Xie, Yinlong
AU  - Xie Y
AD  - 1] BGI-Shenzhen, Shenzhen, China. [2] HKU-BGI Bioinformatics Algorithms and Core 
      Technology Research Laboratory, Hong Kong, China. [3] School of Bioscience and
      Bioengineering, South China University of Technology, Guangzhou, China.
FAU - Liu, Binghang
AU  - Liu B
AD  - 1] BGI-Shenzhen, Shenzhen, China. [2] HKU-BGI Bioinformatics Algorithms and Core 
      Technology Research Laboratory, Hong Kong, China.
FAU - Yang, Hailong
AU  - Yang H
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Zheng, Hancheng
AU  - Zheng H
AD  - 1] BGI-Shenzhen, Shenzhen, China. [2] Department of Biology, University of
      Copenhagen, Copenhagen, Denmark.
FAU - Li, Jian
AU  - Li J
AD  - 1] BGI-Shenzhen, Shenzhen, China. [2] Department of Biology, University of
      Copenhagen, Copenhagen, Denmark.
FAU - Li, Bo
AU  - Li B
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Wang, Yu
AU  - Wang Y
AD  - 1] BGI-Shenzhen, Shenzhen, China. [2] School of Bioscience and Bioengineering,
      South China University of Technology, Guangzhou, China.
FAU - Yang, Fang
AU  - Yang F
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Sun, Peng
AU  - Sun P
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Liu, Siyang
AU  - Liu S
AD  - 1] BGI-Shenzhen, Shenzhen, China. [2] Department of Biology, University of
      Copenhagen, Copenhagen, Denmark.
FAU - Gao, Peng
AU  - Gao P
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Huang, Haodong
AU  - Huang H
AD  - 1] BGI-Shenzhen, Shenzhen, China. [2] School of Bioscience and Bioengineering,
      South China University of Technology, Guangzhou, China.
FAU - Sun, Jing
AU  - Sun J
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Chen, Dan
AU  - Chen D
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - He, Guangzhu
AU  - He G
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Huang, Weihua
AU  - Huang W
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Huang, Zheng
AU  - Huang Z
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Li, Yue
AU  - Li Y
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Tellier, Laurent C A M
AU  - Tellier LC
AD  - 1] BGI-Shenzhen, Shenzhen, China. [2] Department of Biology, University of
      Copenhagen, Copenhagen, Denmark.
FAU - Liu, Xiao
AU  - Liu X
AD  - 1] BGI-Shenzhen, Shenzhen, China. [2] Department of Biology, University of
      Copenhagen, Copenhagen, Denmark.
FAU - Feng, Qiang
AU  - Feng Q
AD  - 1] BGI-Shenzhen, Shenzhen, China. [2] Department of Biology, University of
      Copenhagen, Copenhagen, Denmark.
FAU - Xu, Xun
AU  - Xu X
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Zhang, Xiuqing
AU  - Zhang X
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Bolund, Lars
AU  - Bolund L
AD  - 1] BGI-Shenzhen, Shenzhen, China. [2] Institute of Biomedicine, University of
      Aarhus, Aarhus, Denmark. [3] Danish Center for Translational Breast Cancer
      Research, Copenhagen, Denmark.
FAU - Krogh, Anders
AU  - Krogh A
AUID- ORCID: 0000000251476282
AD  - Department of Biology, University of Copenhagen, Copenhagen, Denmark.
FAU - Kristiansen, Karsten
AU  - Kristiansen K
AD  - 1] BGI-Shenzhen, Shenzhen, China. [2] Department of Biology, University of
      Copenhagen, Copenhagen, Denmark.
FAU - Drmanac, Radoje
AU  - Drmanac R
AD  - Complete Genomics Inc., Mountain View, California, USA.
FAU - Drmanac, Snezana
AU  - Drmanac S
AD  - Complete Genomics Inc., Mountain View, California, USA.
FAU - Nielsen, Rasmus
AU  - Nielsen R
AD  - 1] BGI-Shenzhen, Shenzhen, China. [2] Department of Integrative Biology,
      University of California, Berkeley, California, USA. [3] Department of
      Statistics, University of California, Berkeley, California, USA.
FAU - Li, Songgang
AU  - Li S
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Wang, Jian
AU  - Wang J
AD  - 1] BGI-Shenzhen, Shenzhen, China. [2] James D. Watson Institute of Genome
      Sciences, Hangzhou, China.
FAU - Yang, Huanming
AU  - Yang H
AD  - 1] BGI-Shenzhen, Shenzhen, China. [2] James D. Watson Institute of Genome
      Sciences, Hangzhou, China. [3] Princess Al Jawhara Albrahim Center of Excellence 
      in the Research of Hereditary Disorders, King Abdulaziz University, Jeddah, Saudi
      Arabia.
FAU - Li, Yingrui
AU  - Li Y
AD  - 1] BGI-Shenzhen, Shenzhen, China. [2] Institute for Molecular Bioscience, The
      University of Queensland, Brisbane, Queensland, Australia.
FAU - Wong, Gane Ka-Shu
AU  - Wong GK
AD  - 1] BGI-Shenzhen, Shenzhen, China. [2] Department of Biological Sciences,
      University of Alberta, Edmonton, Alberta, Canada. [3] Department of Medicine,
      University of Alberta, Edmonton, Alberta, Canada.
FAU - Wang, Jun
AU  - Wang J
AD  - 1] BGI-Shenzhen, Shenzhen, China. [2] Department of Biology, University of
      Copenhagen, Copenhagen, Denmark. [3] Princess Al Jawhara Albrahim Center of
      Excellence in the Research of Hereditary Disorders, King Abdulaziz University,
      Jeddah, Saudi Arabia. [4] Macau University of Science and Technology, Taipa,
      Macau, China. [5] Department of Medicine and State Key Laboratory of
      Pharmaceutical Biotechnology, University of Hong Kong, Hong Kong, China.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150525
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Asian Continental Ancestry Group/genetics
MH  - Base Sequence
MH  - Chromosome Mapping
MH  - Diploidy
MH  - *Genome, Human
MH  - Genotype
MH  - Haplotypes/*genetics
MH  - High-Throughput Nucleotide Sequencing/*methods
MH  - Humans
MH  - Phenotype
MH  - Polymorphism, Single Nucleotide
MH  - *Precision Medicine
MH  - Sequence Analysis, DNA
EDAT- 2015/05/26 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/05/26 06:00
PHST- 2014/10/14 00:00 [received]
PHST- 2015/03/16 00:00 [accepted]
PHST- 2015/05/26 06:00 [entrez]
PHST- 2015/05/26 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt.3200 [pii]
AID - 10.1038/nbt.3200 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):617-22. doi: 10.1038/nbt.3200. Epub 2015 May 25.

PMID- 25985262
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - In vivo genome editing using nuclease-encoding mRNA corrects SP-B deficiency.
PG  - 584-6
LID - 10.1038/nbt.3241 [doi]
FAU - Mahiny, Azita J
AU  - Mahiny AJ
AD  - Department of Pediatrics I-Pediatric Infectiology and Immunology, Translational
      Genomics and Gene Therapy, University of Tubingen, Tubingen, Germany.
FAU - Dewerth, Alexander
AU  - Dewerth A
AD  - Department of Pediatrics I-Pediatric Infectiology and Immunology, Translational
      Genomics and Gene Therapy, University of Tubingen, Tubingen, Germany.
FAU - Mays, Lauren E
AU  - Mays LE
AD  - Department of Pediatrics I-Pediatric Infectiology and Immunology, Translational
      Genomics and Gene Therapy, University of Tubingen, Tubingen, Germany.
FAU - Alkhaled, Mohammed
AU  - Alkhaled M
AD  - Department of Pediatrics I-Pediatric Infectiology and Immunology, Translational
      Genomics and Gene Therapy, University of Tubingen, Tubingen, Germany.
FAU - Mothes, Benedikt
AU  - Mothes B
AD  - 1] Department of Pharmacology and Experimental Therapy, University of Tubingen,
      Tubingen, Germany. [2] ICePha, University of Tubingen, Tubingen, Germany.
FAU - Malaeksefat, Emad
AU  - Malaeksefat E
AD  - Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Center
      for Infection Research (HZI), Saarbrucken, Germany.
FAU - Loretz, Brigitta
AU  - Loretz B
AD  - Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Center
      for Infection Research (HZI), Saarbrucken, Germany.
FAU - Rottenberger, Jennifer
AU  - Rottenberger J
AD  - Department of Pediatrics I-Pediatric Infectiology and Immunology, Translational
      Genomics and Gene Therapy, University of Tubingen, Tubingen, Germany.
FAU - Brosch, Darina M
AU  - Brosch DM
AD  - Department of Pediatrics I-Pediatric Infectiology and Immunology, Translational
      Genomics and Gene Therapy, University of Tubingen, Tubingen, Germany.
FAU - Reautschnig, Philipp
AU  - Reautschnig P
AD  - Department of Pediatrics I-Pediatric Infectiology and Immunology, Translational
      Genomics and Gene Therapy, University of Tubingen, Tubingen, Germany.
FAU - Surapolchai, Pacharapan
AU  - Surapolchai P
AD  - Department of Pediatrics I-Pediatric Infectiology and Immunology, Translational
      Genomics and Gene Therapy, University of Tubingen, Tubingen, Germany.
FAU - Zeyer, Franziska
AU  - Zeyer F
AD  - Department of Pediatrics I-Pediatric Infectiology and Immunology, Translational
      Genomics and Gene Therapy, University of Tubingen, Tubingen, Germany.
FAU - Schams, Andrea
AU  - Schams A
AD  - 1] Department of Pediatric Pulmonology, Dr. von Hauner Children's Hospital,
      Ludwig Maximilians University, Munich, Germany. [2] Member of the German Center
      for Lung Research (DZL), Munich, Germany.
FAU - Carevic, Melanie
AU  - Carevic M
AD  - Department of Pediatrics I-Pediatric Infectiology and Immunology, Translational
      Genomics and Gene Therapy, University of Tubingen, Tubingen, Germany.
FAU - Bakele, Martina
AU  - Bakele M
AD  - Department of Pediatrics I-Pediatric Infectiology and Immunology, Translational
      Genomics and Gene Therapy, University of Tubingen, Tubingen, Germany.
FAU - Griese, Matthias
AU  - Griese M
AD  - 1] Department of Pediatric Pulmonology, Dr. von Hauner Children's Hospital,
      Ludwig Maximilians University, Munich, Germany. [2] Member of the German Center
      for Lung Research (DZL), Munich, Germany.
FAU - Schwab, Matthias
AU  - Schwab M
AD  - 1] ICePha, University of Tubingen, Tubingen, Germany. [2] Department of Clinical 
      Pharmacology, University of Tubingen, Tubingen, Germany. [3] Dr. Margarete
      Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
FAU - Nurnberg, Bernd
AU  - Nurnberg B
AD  - Department of Pharmacology and Experimental Therapy, University of Tubingen,
      Tubingen, Germany.
FAU - Beer-Hammer, Sandra
AU  - Beer-Hammer S
AD  - Department of Pharmacology and Experimental Therapy, University of Tubingen,
      Tubingen, Germany.
FAU - Handgretinger, Rupert
AU  - Handgretinger R
AD  - Department of Pediatrics I-Pediatric Infectiology and Immunology, Translational
      Genomics and Gene Therapy, University of Tubingen, Tubingen, Germany.
FAU - Hartl, Dominik
AU  - Hartl D
AD  - Department of Pediatrics I-Pediatric Infectiology and Immunology, Translational
      Genomics and Gene Therapy, University of Tubingen, Tubingen, Germany.
FAU - Lehr, Claus-Michael
AU  - Lehr CM
AD  - 1] Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz
      Center for Infection Research (HZI), Saarbrucken, Germany. [2] Department of
      Pharmacy, Saarland University, Saarbrucken, Germany.
FAU - Kormann, Michael S D
AU  - Kormann MS
AD  - Department of Pediatrics I-Pediatric Infectiology and Immunology, Translational
      Genomics and Gene Therapy, University of Tubingen, Tubingen, Germany.
LA  - eng
PT  - Letter
PT  - Research Support, Non-U.S. Gov't
DEP - 20150518
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Pulmonary Surfactant-Associated Protein B)
RN  - 0 (RNA, Messenger)
RN  - 9012-76-4 (Chitosan)
RN  - Congenital Deficiency of Pulmonary Surfactant Protein B
SB  - IM
MH  - Animals
MH  - Asthma/genetics/*therapy
MH  - Chitosan/therapeutic use
MH  - Disease Models, Animal
MH  - Humans
MH  - Mice
MH  - Mice, Transgenic
MH  - Nanoparticles/therapeutic use
MH  - Pulmonary Alveolar Proteinosis/*congenital/genetics/therapy
MH  - Pulmonary Surfactant-Associated Protein B/*deficiency/genetics
MH  - RNA Editing/*genetics
MH  - RNA, Messenger/genetics/*therapeutic use
EDAT- 2015/05/20 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/05/19 06:00
PHST- 2015/05/19 06:00 [entrez]
PHST- 2015/05/20 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt.3241 [pii]
AID - 10.1038/nbt.3241 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):584-6. doi: 10.1038/nbt.3241. Epub 2015 May 18.

PMID- 25961409
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - Generation of articular chondrocytes from human pluripotent stem cells.
PG  - 638-45
LID - 10.10.38/nbt.3210 [doi]
AB  - The replacement of articular cartilage through transplantation of chondrogenic
      cells or preformed cartilage tissue represents a potential new avenue for the
      treatment of degenerative joint diseases. Although many studies have described
      differentiation of human pluripotent stem cells (hPSCs) to the chondrogenic
      lineage, the generation of chondrocytes able to produce stable articular
      cartilage in vivo has not been demonstrated. Here we show that activation of the 
      TGFbeta pathway in hPSC-derived chondrogenic progenitors promotes the efficient
      development of articular chondrocytes that can form stable cartilage tissue in
      vitro and in vivo. In contrast, chondrocytes specified by BMP4 signaling display 
      characteristics of hypertrophy and give rise to cartilage tissues that initiate
      the endochondral ossification process in vivo. These findings provide a simple
      serum-free and efficient approach for the routine generation of hPSC-derived
      articular chondrocytes for modeling diseases of the joint and developing cell
      therapy approaches to treat them.
FAU - Craft, April M
AU  - Craft AM
AD  - 1] McEwen Centre for Regenerative Medicine, University Health Network, Toronto,
      Ontario, Canada. [2] Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
FAU - Rockel, Jason S
AU  - Rockel JS
AD  - Developmental and Stem Cell Biology, Hospital for Sick Children, Toronto,
      Ontario, Canada.
FAU - Nartiss, Yulia
AU  - Nartiss Y
AD  - 1] McEwen Centre for Regenerative Medicine, University Health Network, Toronto,
      Ontario, Canada. [2] Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
FAU - Kandel, Rita A
AU  - Kandel RA
AD  - Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario,
      Canada.
FAU - Alman, Benjamin A
AU  - Alman BA
AD  - Developmental and Stem Cell Biology, Hospital for Sick Children, Toronto,
      Ontario, Canada.
FAU - Keller, Gordon M
AU  - Keller GM
AD  - 1] McEwen Centre for Regenerative Medicine, University Health Network, Toronto,
      Ontario, Canada. [2] Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
      [3] Department of Medical Biophysics, University of Toronto, Toronto, Ontario,
      Canada.
LA  - eng
GR  - MOP 219710/Canadian Institutes of Health Research/Canada
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150511
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (BMP4 protein, human)
RN  - 0 (Bone Morphogenetic Protein 4)
SB  - IM
MH  - Bone Morphogenetic Protein 4/genetics/metabolism
MH  - Cartilage, Articular/*cytology/growth & development
MH  - Cell Differentiation/*genetics
MH  - Chondrocytes/cytology
MH  - Humans
MH  - Joint Diseases/pathology/*therapy
MH  - Mesenchymal Stromal Cells/cytology
MH  - Pluripotent Stem Cells/cytology/*transplantation
MH  - Signal Transduction/genetics
EDAT- 2015/05/12 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/05/12 06:00
PHST- 2014/11/08 00:00 [received]
PHST- 2015/03/25 00:00 [accepted]
PHST- 2015/05/12 06:00 [entrez]
PHST- 2015/05/12 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt.3210 [pii]
AID - 10.1038/nbt.3210 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):638-45. doi: 10.1038/nbt.3210. Epub 2015 May 11.

PMID- 25961408
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20161019
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains.
PG  - 661-7
LID - 10.1038/nbt.3235 [doi]
AB  - CRISPR-Cas9 genome editing technology holds great promise for discovering
      therapeutic targets in cancer and other diseases. Current screening strategies
      target CRISPR-Cas9-induced mutations to the 5' exons of candidate genes, but this
      approach often produces in-frame variants that retain functionality, which can
      obscure even strong genetic dependencies. Here we overcome this limitation by
      targeting CRISPR-Cas9 mutagenesis to exons encoding functional protein domains.
      This generates a higher proportion of null mutations and substantially increases 
      the potency of negative selection. We also show that the magnitude of negative
      selection can be used to infer the functional importance of individual protein
      domains of interest. A screen of 192 chromatin regulatory domains in murine acute
      myeloid leukemia cells identifies six known drug targets and 19 additional
      dependencies. A broader application of this approach may allow comprehensive
      identification of protein domains that sustain cancer cells and are suitable for 
      drug targeting.
FAU - Shi, Junwei
AU  - Shi J
AD  - 1] Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA. [2]
      Molecular and Cellular Biology Program, Stony Brook University, Stony Brook, New 
      York, USA.
FAU - Wang, Eric
AU  - Wang E
AD  - Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA.
FAU - Milazzo, Joseph P
AU  - Milazzo JP
AD  - Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA.
FAU - Wang, Zihua
AU  - Wang Z
AD  - Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA.
FAU - Kinney, Justin B
AU  - Kinney JB
AD  - Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA.
FAU - Vakoc, Christopher R
AU  - Vakoc CR
AD  - Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA.
LA  - eng
GR  - P30 CA045508/CA/NCI NIH HHS/United States
GR  - R01 CA174793/CA/NCI NIH HHS/United States
GR  - CA174793/CA/NCI NIH HHS/United States
GR  - CA45508/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20150511
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Neoplasm Proteins)
SB  - IM
MH  - Animals
MH  - CRISPR-Cas Systems/*genetics
MH  - Cell Line, Tumor
MH  - *Drug Discovery
MH  - Exons/genetics
MH  - Humans
MH  - Leukemia, Myeloid, Acute/drug therapy/*genetics
MH  - Mice
MH  - Molecular Targeted Therapy
MH  - Mutagenesis/genetics
MH  - Neoplasm Proteins/biosynthesis/*genetics
MH  - Protein Structure, Tertiary/genetics
MH  - RNA Editing/genetics
PMC - PMC4529991
MID - NIHMS683307
EDAT- 2015/05/12 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/05/12 06:00
PHST- 2014/12/02 00:00 [received]
PHST- 2015/04/20 00:00 [accepted]
PHST- 2015/05/12 06:00 [entrez]
PHST- 2015/05/12 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt.3235 [pii]
AID - 10.1038/nbt.3235 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):661-7. doi: 10.1038/nbt.3235. Epub 2015 May 11.

PMID- 25798938
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - Functional analysis of a chromosomal deletion associated with myelodysplastic
      syndromes using isogenic human induced pluripotent stem cells.
PG  - 646-55
LID - 10.1038/nbt.3178 [doi]
AB  - Chromosomal deletions associated with human diseases, such as cancer, are common,
      but synteny issues complicate modeling of these deletions in mice. We use
      cellular reprogramming and genome engineering to functionally dissect the loss of
      chromosome 7q (del(7q)), a somatic cytogenetic abnormality present in
      myelodysplastic syndromes (MDS). We derive del(7q)- and isogenic karyotypically
      normal induced pluripotent stem cells (iPSCs) from hematopoietic cells of MDS
      patients and show that the del(7q) iPSCs recapitulate disease-associated
      phenotypes, including impaired hematopoietic differentiation. These disease
      phenotypes are rescued by spontaneous dosage correction and can be reproduced in 
      karyotypically normal cells by engineering hemizygosity of defined chr7q segments
      in a 20-Mb region. We use a phenotype-rescue screen to identify candidate
      haploinsufficient genes that might mediate the del(7q)- hematopoietic defect. Our
      approach highlights the utility of human iPSCs both for functional mapping of
      disease-associated large-scale chromosomal deletions and for discovery of
      haploinsufficient genes.
FAU - Kotini, Andriana G
AU  - Kotini AG
AD  - 1] Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai,
      New York, New York, USA. [2] The Tisch Cancer Institute, Icahn School of Medicine
      at Mount Sinai, New York, New York, USA. [3] The Black Family Stem Cell
      Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
FAU - Chang, Chan-Jung
AU  - Chang CJ
AD  - 1] Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai,
      New York, New York, USA. [2] The Tisch Cancer Institute, Icahn School of Medicine
      at Mount Sinai, New York, New York, USA. [3] The Black Family Stem Cell
      Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
FAU - Boussaad, Ibrahim
AU  - Boussaad I
AD  - 1] Division of Hematology, Department of Medicine, University of Washington,
      Seattle, Washington, USA. [2] Institute for Stem Cell and Regenerative Medicine, 
      University of Washington, Seattle, Washington, USA.
FAU - Delrow, Jeffrey J
AU  - Delrow JJ
AD  - Genomics Resource, Fred Hutchinson Cancer Research Center, Seattle, Washington,
      USA.
FAU - Dolezal, Emily K
AU  - Dolezal EK
AD  - Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of
      Miami, Miami, Florida, USA.
FAU - Nagulapally, Abhinav B
AU  - Nagulapally AB
AD  - 1] Institute for Stem Cell and Regenerative Medicine, University of Washington,
      Seattle, Washington, USA. [2] Division of Medical Genetics, Department of
      Medicine, University of Washington, Seattle, Washington, USA.
FAU - Perna, Fabiana
AU  - Perna F
AD  - Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer
      Center, New York, New York, USA.
FAU - Fishbein, Gregory A
AU  - Fishbein GA
AD  - 1] Institute for Stem Cell and Regenerative Medicine, University of Washington,
      Seattle, Washington, USA. [2] Department of Pathology and Laboratory Medicine,
      David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
FAU - Klimek, Virginia M
AU  - Klimek VM
AD  - Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New
      York, USA.
FAU - Hawkins, R David
AU  - Hawkins RD
AD  - 1] Institute for Stem Cell and Regenerative Medicine, University of Washington,
      Seattle, Washington, USA. [2] Division of Medical Genetics, Department of
      Medicine, University of Washington, Seattle, Washington, USA.
FAU - Huangfu, Danwei
AU  - Huangfu D
AD  - Developmental Biology Program, Sloan-Kettering Institute, New York, New York,
      USA.
FAU - Murry, Charles E
AU  - Murry CE
AD  - 1] Institute for Stem Cell and Regenerative Medicine, University of Washington,
      Seattle, Washington, USA. [2] Department of Pathology, University of Washington, 
      Seattle, Washington, USA. [3] Center for Cardiovascular Biology, University of
      Washington, Seattle, Washington, USA. [4] Department of Bioengineering University
      of Washington, Seattle, Washington, USA. [5] Division of Cardiology, Department
      of Medicine, University of Washington, Seattle, Washington, USA.
FAU - Graubert, Timothy
AU  - Graubert T
AD  - MGH Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
FAU - Nimer, Stephen D
AU  - Nimer SD
AD  - Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of
      Miami, Miami, Florida, USA.
FAU - Papapetrou, Eirini P
AU  - Papapetrou EP
AD  - 1] Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai,
      New York, New York, USA. [2] The Tisch Cancer Institute, Icahn School of Medicine
      at Mount Sinai, New York, New York, USA. [3] The Black Family Stem Cell
      Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA. [4] 
      Division of Hematology, Department of Medicine, University of Washington,
      Seattle, Washington, USA. [5] Institute for Stem Cell and Regenerative Medicine, 
      University of Washington, Seattle, Washington, USA. [6] Department of Pathology, 
      University of Washington, Seattle, Washington, USA. [7] Division of Hematology
      and Medical Oncology, Department of Medicine, Icahn School of Medicine at Mount
      Sinai, New York, New York, USA.
LA  - eng
GR  - P30 CA15704/CA/NCI NIH HHS/United States
GR  - R01 CA166835/CA/NCI NIH HHS/United States
GR  - P30 CA015704/CA/NCI NIH HHS/United States
GR  - R00 DK087923/DK/NIDDK NIH HHS/United States
GR  - P30 CA008748/CA/NCI NIH HHS/United States
GR  - R01 HL121570/HL/NHLBI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20150323
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - *Chromosome Deletion
MH  - Chromosomes, Human, Pair 7/genetics
MH  - *Genetic Engineering
MH  - Humans
MH  - Induced Pluripotent Stem Cells/*cytology
MH  - Karyotyping
MH  - Mice
MH  - Myelodysplastic Syndromes/*genetics/therapy
PMC - PMC4464949
MID - NIHMS664590
EDAT- 2015/03/24 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/03/24 06:00
PHST- 2014/11/06 00:00 [received]
PHST- 2015/02/13 00:00 [accepted]
PHST- 2015/03/24 06:00 [entrez]
PHST- 2015/03/24 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt.3178 [pii]
AID - 10.1038/nbt.3178 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):646-55. doi: 10.1038/nbt.3178. Epub 2015 Mar 23.

PMID- 25798935
OWN - NLM
STAT- MEDLINE
DCOM- 20160301
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 6
DP  - 2015 Jun
TI  - Multiplexed tracking of combinatorial genomic mutations in engineered cell
      populations.
PG  - 631-7
LID - 10.1038/nbt.3177 [doi]
AB  - Multiplexed genome engineering approaches can be used to generate targeted
      genetic diversity in cell populations on laboratory timescales, but methods to
      track mutations and link them to phenotypes have been lacking. We present an
      approach for tracking combinatorial engineered libraries (TRACE) through the
      simultaneous mapping of millions of combinatorially engineered genomes at
      single-cell resolution. Distal genomic sites are assembled into individual DNA
      constructs that are compatible with next-generation sequencing strategies. We
      used TRACE to map growth selection dynamics for Escherichia coli combinatorial
      libraries created by recursive multiplex recombineering at a depth 10(4)-fold
      greater than before. TRACE was used to identify genotype-to-phenotype
      correlations and to map the evolutionary trajectory of two individual
      combinatorial mutants in E. coli. Combinatorial mutations in the human ES2
      ovarian carcinoma cell line were also assessed with TRACE. TRACE completes the
      combinatorial engineering cycle and enables more sophisticated approaches to
      genome engineering in both bacteria and eukaryotic cells than are currently
      possible.
FAU - Zeitoun, Ramsey I
AU  - Zeitoun RI
AD  - Department of Chemical and Biological Engineering, University of Colorado
      Boulder, Boulder, Colorado, USA.
FAU - Garst, Andrew D
AU  - Garst AD
AD  - Department of Chemical and Biological Engineering, University of Colorado
      Boulder, Boulder, Colorado, USA.
FAU - Degen, George D
AU  - Degen GD
AD  - Department of Chemical Engineering, Carnegie Mellon University, Pittsburgh,
      Pennsylvania, USA.
FAU - Pines, Gur
AU  - Pines G
AD  - Department of Chemical and Biological Engineering, University of Colorado
      Boulder, Boulder, Colorado, USA.
FAU - Mansell, Thomas J
AU  - Mansell TJ
AUID- ORCID: 0000000188074570
AD  - Department of Chemical and Biological Engineering, University of Colorado
      Boulder, Boulder, Colorado, USA.
FAU - Glebes, Tirzah Y
AU  - Glebes TY
AD  - Department of Chemical and Biological Engineering, University of Colorado
      Boulder, Boulder, Colorado, USA.
FAU - Boyle, Nanette R
AU  - Boyle NR
AD  - Department of Chemical and Biological Engineering, Colorado School of Mines,
      Golden, Colorado, USA.
FAU - Gill, Ryan T
AU  - Gill RT
AD  - Department of Chemical and Biological Engineering, University of Colorado
      Boulder, Boulder, Colorado, USA.
LA  - eng
PT  - Journal Article
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20150323
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Escherichia coli/*genetics
MH  - Genetic Association Studies
MH  - *Genetic Engineering
MH  - *Genetic Variation
MH  - Genome, Bacterial
MH  - Genomics
MH  - High-Throughput Nucleotide Sequencing
MH  - Humans
MH  - Mutation/*genetics
MH  - Single-Cell Analysis
EDAT- 2015/03/24 06:00
MHDA- 2016/03/02 06:00
CRDT- 2015/03/24 06:00
PHST- 2014/11/14 00:00 [received]
PHST- 2015/02/13 00:00 [accepted]
PHST- 2015/03/24 06:00 [entrez]
PHST- 2015/03/24 06:00 [pubmed]
PHST- 2016/03/02 06:00 [medline]
AID - nbt.3177 [pii]
AID - 10.1038/nbt.3177 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jun;33(6):631-7. doi: 10.1038/nbt.3177. Epub 2015 Mar 23.

PMID- 25965763
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20160427
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - Erratum: Modeling the course of amyotrophic lateral sclerosis.
PG  - 563
LID - 10.1038/nbt0515-563a [doi]
FAU - Fournier, Christina
AU  - Fournier C
FAU - Glass, Jonathan D
AU  - Glass JD
LA  - eng
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2015 Jan;33(1):45-7. PMID: 25574636
EDAT- 2015/05/13 06:00
MHDA- 2015/05/13 06:01
CRDT- 2015/05/13 06:00
PHST- 2015/05/13 06:00 [entrez]
PHST- 2015/05/13 06:00 [pubmed]
PHST- 2015/05/13 06:01 [medline]
AID - nbt0515-563a [pii]
AID - 10.1038/nbt0515-563a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):563. doi: 10.1038/nbt0515-563a.

PMID- 25965762
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20160427
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - Erratum: Selling long life.
PG  - 563
LID - 10.1038/nbt0515-563b [doi]
FAU - Scott, Christopher Thomas
AU  - Scott CT
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
LA  - eng
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2015 Jan;33(1):31-40. PMID: 25574633
EDAT- 2015/05/13 06:00
MHDA- 2015/05/13 06:01
CRDT- 2015/05/13 06:00
PHST- 2015/05/13 06:00 [entrez]
PHST- 2015/05/13 06:00 [pubmed]
PHST- 2015/05/13 06:01 [medline]
AID - nbt0515-563b [pii]
AID - 10.1038/nbt0515-563b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):563. doi: 10.1038/nbt0515-563b.

PMID- 25965761
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20160427
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - Corrigendum: Taking charge of siRNA delivery.
PG  - 563
LID - 10.1038/nbt0515-563c [doi]
FAU - Khvorova, Anastasia
AU  - Khvorova A
FAU - Osborn, Maire F
AU  - Osborn MF
FAU - Hassler, Matthew R
AU  - Hassler MR
LA  - eng
GR  - R01 GM108803/GM/NIGMS NIH HHS/United States
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2014 Dec;32(12):1197-8. PMID: 25489835
EDAT- 2015/05/13 06:00
MHDA- 2015/05/13 06:01
CRDT- 2015/05/13 06:00
PHST- 2015/05/13 06:00 [entrez]
PHST- 2015/05/13 06:00 [pubmed]
PHST- 2015/05/13 06:01 [medline]
AID - nbt0515-563c [pii]
AID - 10.1038/nbt0515-563c [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):563. doi: 10.1038/nbt0515-563c.

PMID- 25965759
OWN - NLM
STAT- MEDLINE
DCOM- 20160427
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - Islet implantation in a pocket.
PG  - 493-4
LID - 10.1038/nbt.3216 [doi]
FAU - Bromberg, Jonathan S
AU  - Bromberg JS
AD  - Departments of Surgery and Microbiology and Immunology, Center for Inflammatory
      and Vascular Diseases, University of Maryland School of Medicine, Baltimore,
      Maryland, USA.
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2015 May;33(5):518-23. PMID: 25893782
MH  - Animals
MH  - *Cell- and Tissue-Based Therapy
MH  - Diabetes Mellitus, Experimental/*therapy
MH  - Humans
MH  - *Islets of Langerhans Transplantation
MH  - Neovascularization, Pathologic/*therapy
EDAT- 2015/05/13 06:00
MHDA- 2016/04/28 06:00
CRDT- 2015/05/13 06:00
PHST- 2015/05/13 06:00 [entrez]
PHST- 2015/05/13 06:00 [pubmed]
PHST- 2016/04/28 06:00 [medline]
AID - nbt.3216 [pii]
AID - 10.1038/nbt.3216 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):493-4. doi: 10.1038/nbt.3216.

PMID- 25965758
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - Unraveling the fabric of polyploidy.
PG  - 491-3
LID - 10.1038/nbt.3217 [doi]
FAU - Paterson, Andrew H
AU  - Paterson AH
AD  - University of Georgia, Athens, Georgia, USA, and.
FAU - Wendel, Jonathan F
AU  - Wendel JF
AD  - Iowa State University, Ames, Iowa, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Cotton Fiber
MH  - Genome, Plant
MH  - Gossypium/*genetics
MH  - *Polyploidy
EDAT- 2015/05/13 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/05/13 06:00
PHST- 2015/05/13 06:00 [entrez]
PHST- 2015/05/13 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - nbt.3217 [pii]
AID - 10.1038/nbt.3217 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):491-3. doi: 10.1038/nbt.3217.

PMID- 25965757
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20170603
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - Putting cells in their place.
PG  - 490-1
LID - 10.1038/nbt.3219 [doi]
FAU - Faridani, Omid R
AU  - Faridani OR
AD  - Ludwig Institute for Cancer Research, Stockholm, Sweden.
FAU - Sandberg, Rickard
AU  - Sandberg R
AUID- ORCID: 0000000164731740
AD  - Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm,
      Sweden.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - Gene Expression Regulation, Developmental
MH  - High-Throughput Nucleotide Sequencing
MH  - Image Processing, Computer-Assisted
MH  - In Situ Hybridization, Fluorescence/*methods
MH  - Single-Cell Analysis/*methods
MH  - Transcriptome/genetics
MH  - Zebrafish/genetics/*growth & development
EDAT- 2015/05/13 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/05/13 06:00
PHST- 2015/05/13 06:00 [entrez]
PHST- 2015/05/13 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - nbt.3219 [pii]
AID - 10.1038/nbt.3219 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):490-1. doi: 10.1038/nbt.3219.

PMID- 25965755
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20150513
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - A solution to the controversy on plant variety protection in Africa.
PG  - 487-8
LID - 10.1038/nbt.3213 [doi]
FAU - De Jonge, Bram
AU  - De Jonge B
AD  - Law and Governance Group, Wageningen University, Wageningen, the Netherlands.
FAU - Louwaars, Niels P
AU  - Louwaars NP
AD  - 1] Law and Governance Group, Wageningen University, Wageningen, the Netherlands. 
      [2] Plantum NL, Gouda, the Netherlands.
FAU - Kinderlerer, Julian
AU  - Kinderlerer J
AD  - Department of Private Law, University of Cape Town, Cape Town, South Africa.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Africa
MH  - Agriculture/legislation & jurisprudence
MH  - Conservation of Natural Resources/*legislation & jurisprudence
MH  - *Genetic Variation
MH  - Humans
MH  - Intellectual Property
MH  - Plants/*genetics
EDAT- 2015/05/13 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/05/13 06:00
PHST- 2015/05/13 06:00 [entrez]
PHST- 2015/05/13 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - nbt.3213 [pii]
AID - 10.1038/nbt.3213 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):487-8. doi: 10.1038/nbt.3213.

PMID- 25965754
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20171110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - CRISPR germline engineering--the community speaks.
PG  - 478-86
LID - 10.1038/nbt.3227 [doi]
FAU - Bosley, Katrine S
AU  - Bosley KS
AD  - Editas Medicine, Cambridge, Massachusetts, USA.
FAU - Botchan, Michael
AU  - Botchan M
AD  - Department of Molecular and Cell Biology, University of California, Berkeley,
      Berkeley, California, USA.
FAU - Bredenoord, Annelien L
AU  - Bredenoord AL
AD  - Department of Medical Humanities, University Medical Center, Utrecht, the
      Netherlands.
FAU - Carroll, Dana
AU  - Carroll D
AD  - Department of Biochemistry, University of Utah School of Medicine, Salt Lake
      City, Utah, USA.
FAU - Charo, R Alta
AU  - Charo RA
AD  - School of Law, and Department of Medical History and Bioethics, University of
      Wisconsin School of Medicine &Public Health, Madison, Wisconsin, USA.
FAU - Charpentier, Emmanuelle
AU  - Charpentier E
AD  - Department of Regulation in Infection Biology, Helmholtz Centre for Infection
      Research, Braunschweig, Germany.
FAU - Cohen, Ron
AU  - Cohen R
AD  - Acorda Therapeutics, Ardsley, New York, USA.
FAU - Corn, Jacob
AU  - Corn J
AD  - Innovative Genomics Initiative, Berkeley, California, USA.
FAU - Doudna, Jennifer
AU  - Doudna J
AD  - Department of Molecular &Cell Biology and Chemistry, University of California,
      Berkeley, Berkeley, California, USA.
FAU - Feng, Guoping
AU  - Feng G
AD  - Department of Brain and Cognitive Sciences, Massachusetts Institute of
      Technology, Stanley Center for Psychiatric Research, Broad Institute of MIT and
      Harvard University, Cambridge, Massachusetts, USA.
FAU - Greely, Henry T
AU  - Greely HT
AD  - Stanford Law School, Stanford, California, USA.
FAU - Isasi, Rosario
AU  - Isasi R
AD  - Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
FAU - Ji, Weihzi
AU  - Ji W
AD  - Kunming Biomed International and National Engineering Research Center of
      Biomedicine and Animal Science, Kunming, China.
FAU - Kim, Jin-Soo
AU  - Kim JS
AD  - Center for Genome Engineering, Institute for Basic Science and Department of
      Chemistry, Seoul National University, Seoul, Korea.
FAU - Knoppers, Bartha
AU  - Knoppers B
AD  - Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
FAU - Lanphier, Edward
AU  - Lanphier E
AD  - Sangamo Biosciences, Richmond, California, USA.
FAU - Li, Jinsong
AU  - Li J
AD  - Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological
      Sciences, Chinese Academy of Sciences, Shanghai, China.
FAU - Lovell-Badge, Robin
AU  - Lovell-Badge R
AD  - The Francis Crick Institute, London, UK.
FAU - Martin, G Steven
AU  - Martin GS
AD  - Department of Molecular and Cell Biology, University of California, Berkeley,
      Berkeley, California, USA.
FAU - Moreno, Jonathan
AU  - Moreno J
AD  - University of Pennsylvania, Philadelphia, Pennsylvania, USA.
FAU - Naldini, Luigi
AU  - Naldini L
AD  - San Raffaele Telethon Institute for Gene Therapy, Milan, Italy.
FAU - Pera, Martin
AU  - Pera M
AD  - Department of Anatomy and Neuroscience, University of Melbourne, Melbourne,
      Australia.
FAU - Perry, Anthony C F
AU  - Perry AC
AD  - Department of Biology and Biochemistry, University of Bath, Bath, UK.
FAU - Venter, J Craig
AU  - Venter JC
AD  - J. Craig Venter Institute in La Jolla, California, USA.
FAU - Zhang, Feng
AU  - Zhang F
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
FAU - Zhou, Qi
AU  - Zhou Q
AD  - State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese
      Academy of Sciences, Beijing, China.
LA  - eng
GR  - G1000839/Medical Research Council/United Kingdom
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - CRISPR-Cas Systems/*genetics
MH  - *Genetic Engineering/ethics/methods
MH  - Genome, Human
MH  - *Germ Cells
MH  - Humans
MH  - RNA Editing/*genetics
EDAT- 2015/05/13 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/05/13 06:00
PHST- 2015/05/13 06:00 [entrez]
PHST- 2015/05/13 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - nbt.3227 [pii]
AID - 10.1038/nbt.3227 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):478-86. doi: 10.1038/nbt.3227.

PMID- 25965753
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20150513
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - Biotech's wellspring--a survey of the health of the private sector in 2014.
PG  - 470-7
LID - 10.1038/nbt.3218 [doi]
FAU - Huggett, Brady
AU  - Huggett B
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Capital Financing/economics
MH  - Drug Industry/*economics
MH  - Humans
MH  - Private Sector/*economics
EDAT- 2015/05/13 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/05/13 06:00
PHST- 2015/05/13 06:00 [entrez]
PHST- 2015/05/13 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - nbt.3218 [pii]
AID - 10.1038/nbt.3218 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):470-7. doi: 10.1038/nbt.3218.

PMID- 25965752
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - What Ebola tells us about outbreak diagnostic readiness.
PG  - 464-9
LID - 10.1038/nbt.3215 [doi]
FAU - Perkins, Mark D
AU  - Perkins MD
AD  - FIND (Foundation for Innovative New Diagnostics), Geneva, Switzerland.
FAU - Kessel, Mark
AU  - Kessel M
AD  - FIND (Foundation for Innovative New Diagnostics), Geneva, Switzerland.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Disease Outbreaks
MH  - Ebolavirus/pathogenicity
MH  - Hemorrhagic Fever, Ebola/diagnosis/*epidemiology/virology
MH  - Humans
EDAT- 2015/05/13 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/05/13 06:00
PHST- 2015/05/13 06:00 [entrez]
PHST- 2015/05/13 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - nbt.3215 [pii]
AID - 10.1038/nbt.3215 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):464-9. doi: 10.1038/nbt.3215.

PMID- 25965751
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20170603
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - The digital phenotype.
PG  - 462-3
LID - 10.1038/nbt.3223 [doi]
FAU - Jain, Sachin H
AU  - Jain SH
AD  - 1] Caremore Health System, Cerritos, California, USA [2] Boston-Virginia Medical 
      Center, Boston, Massachusetts, USA, and Merck and Co., Inc., Boston,
      Massachusetts, USA.
FAU - Powers, Brian W
AU  - Powers BW
AD  - Harvard Medical School, Boston, Massachusetts, USA.
FAU - Hawkins, Jared B
AU  - Hawkins JB
AD  - 1] Harvard Medical School, Boston, Massachusetts, USA [2] Children's Hospital
      Boston, Boston, Massachusetts, USA.
FAU - Brownstein, John S
AU  - Brownstein JS
AD  - 1] Harvard Medical School, Boston, Massachusetts, USA [2] Children's Hospital
      Boston, Boston, Massachusetts, USA.
LA  - eng
GR  - 1U54HG007963-01/HG/NHGRI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Biosensing Techniques
MH  - Humans
MH  - Phenotype
MH  - *Precision Medicine
EDAT- 2015/05/13 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/05/13 06:00
PHST- 2015/05/13 06:00 [entrez]
PHST- 2015/05/13 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - nbt.3223 [pii]
AID - 10.1038/nbt.3223 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):462-3. doi: 10.1038/nbt.3223.

PMID- 25965750
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - Defining digital medicine.
PG  - 456-61
LID - 10.1038/nbt.3222 [doi]
FAU - Elenko, Eric
AU  - Elenko E
AD  - PureTech, Boston, Massachusetts, USA.
FAU - Underwood, Lindsay
AU  - Underwood L
AD  - PureTech, Boston, Massachusetts, USA.
FAU - Zohar, Daphne
AU  - Zohar D
AD  - PureTech, Boston, Massachusetts, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Biotechnology
MH  - *Drug Industry
MH  - Genome, Human
MH  - Humans
MH  - Medicine
MH  - *Research
EDAT- 2015/05/13 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/05/13 06:00
PHST- 2015/05/13 06:00 [entrez]
PHST- 2015/05/13 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - nbt.3222 [pii]
AID - 10.1038/nbt.3222 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):456-61. doi: 10.1038/nbt.3222.

PMID- 25965749
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - Oversight of human inheritable genome modification.
PG  - 454-5
LID - 10.1038/nbt.3231 [doi]
FAU - Isasi, Rosario
AU  - Isasi R
AD  - Centre of Genomics and Policy, McGill University and Genome Quebec Innovation
      Centre, Montreal, Quebec, Canada.
FAU - Knoppers, Bartha M
AU  - Knoppers BM
AD  - Centre of Genomics and Policy, McGill University and Genome Quebec Innovation
      Centre, Montreal, Quebec, Canada.
LA  - eng
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Genetic Diseases, Inborn/*therapy
MH  - Genetic Therapy/ethics/*legislation & jurisprudence
MH  - *Genome, Human
MH  - Humans
MH  - Legislation, Medical
EDAT- 2015/05/13 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/05/13 06:00
PHST- 2015/05/13 06:00 [entrez]
PHST- 2015/05/13 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - nbt.3231 [pii]
AID - 10.1038/nbt.3231 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):454-5. doi: 10.1038/nbt.3231.

PMID- 25965748
OWN - NLM
STAT- MEDLINE
DCOM- 20160427
LR  - 20170603
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - Transparency in GM food labeling.
PG  - 453
LID - 10.1038/nbt.3220 [doi]
FAU - Melchett, Peter
AU  - Melchett P
AD  - Soil Association UK, Bristol, UK.
LA  - eng
PT  - Comment
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2014 Dec;32(12):1169. PMID: 25489816
CIN - Nat Biotechnol. 2015 May;33(5):453-4. PMID: 25965747
MH  - *Food Labeling
MH  - *Food, Genetically Modified
MH  - Humans
EDAT- 2015/05/13 06:00
MHDA- 2016/04/28 06:00
CRDT- 2015/05/13 06:00
PHST- 2015/05/13 06:00 [entrez]
PHST- 2015/05/13 06:00 [pubmed]
PHST- 2016/04/28 06:00 [medline]
AID - nbt.3220 [pii]
AID - 10.1038/nbt.3220 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):453. doi: 10.1038/nbt.3220.

PMID- 25965747
OWN - NLM
STAT- MEDLINE
DCOM- 20160427
LR  - 20150513
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - Nature biotechnology responds to Melchett correspondence.
PG  - 453-4
LID - 10.1038/nbt.3224 [doi]
LA  - eng
PT  - Comment
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2015 May;33(5):451-3. PMID: 25965746
CON - Nat Biotechnol. 2015 May;33(5):453. PMID: 25965748
MH  - *Food Labeling
MH  - *Food, Genetically Modified
MH  - Humans
EDAT- 2015/05/13 06:00
MHDA- 2016/04/28 06:00
CRDT- 2015/05/13 06:00
PHST- 2015/05/13 06:00 [entrez]
PHST- 2015/05/13 06:00 [pubmed]
PHST- 2016/04/28 06:00 [medline]
AID - nbt.3224 [pii]
AID - 10.1038/nbt.3224 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):453-4. doi: 10.1038/nbt.3224.

PMID- 25965746
OWN - NLM
STAT- MEDLINE
DCOM- 20160427
LR  - 20170603
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - What's behind a 'genetically engineered' label?
PG  - 451-3
LID - 10.1038/nbt.3225 [doi]
FAU - Brookes, Graham
AU  - Brookes G
AD  - PG Economics Limited, Dorchester, UK.
FAU - Miller, Henry I
AU  - Miller HI
AD  - Hoover Institution, Stanford University, Stanford, California, USA.
LA  - eng
PT  - Comment
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2014 Dec;32(12):1169. PMID: 25489816
CIN - Nat Biotechnol. 2015 May;33(5):453-4. PMID: 25965747
MH  - *Food Labeling
MH  - *Food, Genetically Modified
MH  - Humans
EDAT- 2015/05/13 06:00
MHDA- 2016/04/28 06:00
CRDT- 2015/05/13 06:00
PHST- 2015/05/13 06:00 [entrez]
PHST- 2015/05/13 06:00 [pubmed]
PHST- 2016/04/28 06:00 [medline]
AID - nbt.3225 [pii]
AID - 10.1038/nbt.3225 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):451-3. doi: 10.1038/nbt.3225.

PMID- 25965745
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - Precision medicine and the FDA's draft guidance on laboratory-developed tests.
PG  - 449-51
LID - 10.1038/nbt.3221 [doi]
FAU - Hwang, Thomas J
AU  - Hwang TJ
AD  - 1] Faculty of Arts and Sciences, Harvard University, Cambridge, Massachusetts,
      USA. [2] The Blackstone Group, London, United Kingdom.
FAU - Lehmann, Lisa Soleymani
AU  - Lehmann LS
AD  - Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 
      Boston, Massachusetts, USA.
FAU - Kesselheim, Aaron S
AU  - Kesselheim AS
AD  - Program on Regulation, Therapeutics and Law (PORTAL), Division of
      Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and
      Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
LA  - eng
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Government Regulation
MH  - Humans
MH  - *Precision Medicine
MH  - United States
MH  - United States Food and Drug Administration/legislation & jurisprudence
EDAT- 2015/05/13 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/05/13 06:00
PHST- 2015/05/13 06:00 [entrez]
PHST- 2015/05/13 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - nbt.3221 [pii]
AID - 10.1038/nbt.3221 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):449-51. doi: 10.1038/nbt.3221.

PMID- 25965744
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20150513
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - Startups on the menu: Atreca.
PG  - 444
LID - 10.1038/nbt.3226 [doi]
FAU - Steinman, Lawrence
AU  - Steinman L
LA  - eng
PT  - Interview
DEP - 20140423
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Drug Industry
MH  - Humans
EDAT- 2015/05/13 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/05/13 06:00
PHST- 2015/05/13 06:00 [entrez]
PHST- 2015/05/13 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - nbt.3226 [pii]
AID - 10.1038/nbt.3226 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):444. doi: 10.1038/nbt.3226. Epub 2014 Apr 23.

PMID- 25965740
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - Lilly pays $50 million for Korean BTK.
PG  - 440
LID - 10.1038/nbt0515-440a [doi]
FAU - Proffitt, Allison
AU  - Proffitt A
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Protein Kinase Inhibitors)
SB  - IM
MH  - Drug Industry/*economics
MH  - Humans
MH  - Protein Kinase Inhibitors/economics/*therapeutic use
MH  - Republic of Korea
MH  - Research/*economics
MH  - United States
EDAT- 2015/05/13 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/05/13 06:00
PHST- 2015/05/13 06:00 [entrez]
PHST- 2015/05/13 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - nbt0515-440a [pii]
AID - 10.1038/nbt0515-440a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):440. doi: 10.1038/nbt0515-440a.

PMID- 25965738
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20150513
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - First-in-class HIV drug enters phase 3 trials.
PG  - 439
LID - 10.1038/nbt0515-439a [doi]
FAU - Azvolinsky, Anna
AU  - Azvolinsky A
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Anti-HIV Agents)
RN  - 0 (BMS-663068)
RN  - 0 (Organophosphates)
RN  - 0 (Piperazines)
SB  - IM
MH  - Anti-HIV Agents/*therapeutic use
MH  - Clinical Trials, Phase III as Topic
MH  - HIV Infections/*drug therapy
MH  - HIV-1/drug effects/pathogenicity
MH  - Humans
MH  - Organophosphates/*therapeutic use
MH  - Piperazines/*therapeutic use
EDAT- 2015/05/13 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/05/13 06:00
PHST- 2015/05/13 06:00 [entrez]
PHST- 2015/05/13 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - nbt0515-439a [pii]
AID - 10.1038/nbt0515-439a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):439. doi: 10.1038/nbt0515-439a.

PMID- 25965737
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20160427
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - Corrections.
PG  - 439
LID - 10.1038/nbt0515-439b [doi]
LA  - eng
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2015 Jan;33(1):12-3. PMID: 25574623
EFR - Nat Biotechnol. 2015 Mar;33(3):219-21. PMID: 25748895
EFR - Nat Biotechnol. 2015 Mar;33(3):222-3. PMID: 25748898
EDAT- 2015/05/13 06:00
MHDA- 2015/05/13 06:01
CRDT- 2015/05/13 06:00
PHST- 2015/05/13 06:00 [entrez]
PHST- 2015/05/13 06:00 [pubmed]
PHST- 2015/05/13 06:01 [medline]
AID - nbt0515-439b [pii]
AID - 10.1038/nbt0515-439b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):439. doi: 10.1038/nbt0515-439b.

PMID- 25965736
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20171116
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - Biogen's early Alzheimer's data raise hopes, some eyebrows.
PG  - 438
LID - 10.1038/nbt0515-438 [doi]
FAU - Ratner, Mark
AU  - Ratner M
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antibodies, Monoclonal, Humanized)
RN  - 105J35OE21 (aducanumab)
SB  - IM
MH  - Alzheimer Disease/*drug therapy
MH  - Antibodies, Monoclonal, Humanized/*therapeutic use
MH  - Clinical Trials, Phase I as Topic
MH  - *Drug Industry
MH  - Humans
EDAT- 2015/05/13 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/05/13 06:00
PHST- 2015/05/13 06:00 [entrez]
PHST- 2015/05/13 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - nbt0515-438 [pii]
AID - 10.1038/nbt0515-438 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):438. doi: 10.1038/nbt0515-438.

PMID- 25965735
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - Keytruda UK's first early-access drug.
PG  - 437
LID - 10.1038/nbt0515-437a [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antibodies, Monoclonal, Humanized)
RN  - DPT0O3T46P (pembrolizumab)
SB  - IM
MH  - Antibodies, Monoclonal, Humanized/*therapeutic use
MH  - *Drug Approval
MH  - Humans
MH  - Melanoma/*drug therapy
MH  - United Kingdom
EDAT- 2015/05/13 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/05/13 06:00
PHST- 2015/05/13 06:00 [entrez]
PHST- 2015/05/13 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - nbt0515-437a [pii]
AID - 10.1038/nbt0515-437a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):437. doi: 10.1038/nbt0515-437a.

PMID- 25965734
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20150513
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - Epigenome drug approved after setback.
PG  - 437
LID - 10.1038/nbt0515-437b [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Hydroxamic Acids)
RN  - 0 (Indoles)
RN  - 9647FM7Y3Z (panobinostat)
SB  - IM
MH  - *Drug Approval
MH  - *Epigenomics
MH  - Humans
MH  - Hydroxamic Acids/therapeutic use
MH  - Indoles/therapeutic use
MH  - Multiple Myeloma/drug therapy
EDAT- 2015/05/13 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/05/13 06:00
PHST- 2015/05/13 06:00 [entrez]
PHST- 2015/05/13 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - nbt0515-437b [pii]
AID - 10.1038/nbt0515-437b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):437. doi: 10.1038/nbt0515-437b.

PMID- 25965733
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - Human cell assays for new medicines now open access.
PG  - 436-7
LID - 10.1038/nbt0515-436 [doi]
FAU - Mullard, Asher
AU  - Mullard A
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Drug Discovery/*legislation & jurisprudence
MH  - Drug Industry/*legislation & jurisprudence
MH  - Epigenesis, Genetic/genetics
MH  - Genome, Human
MH  - Genomics
MH  - Humans
MH  - Molecular Targeted Therapy
MH  - Protein Conformation/drug effects
EDAT- 2015/05/13 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/05/13 06:00
PHST- 2015/05/13 06:00 [entrez]
PHST- 2015/05/13 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - nbt0515-436 [pii]
AID - 10.1038/nbt0515-436 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):436-7. doi: 10.1038/nbt0515-436.

PMID- 25965732
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20171116
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - FDA approves 23andMe gene carrier test.
PG  - 435
LID - 10.1038/nbt0515-435a [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Drug Industry/*legislation & jurisprudence
MH  - Genetic Carrier Screening/*methods
MH  - *Genetic Testing
MH  - Humans
MH  - United States
MH  - United States Food and Drug Administration/legislation & jurisprudence
EDAT- 2015/05/13 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/05/13 06:00
PHST- 2015/05/13 06:00 [entrez]
PHST- 2015/05/13 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - nbt0515-435a [pii]
AID - 10.1038/nbt0515-435a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):435. doi: 10.1038/nbt0515-435a.

PMID- 25965731
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20150513
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - Court sides with Sandoz over Neupogen biosimilar.
PG  - 435
LID - 10.1038/nbt0515-435b [doi]
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Drug Industry/*legislation & jurisprudence
MH  - Humans
MH  - *Judicial Role
MH  - United States
EDAT- 2015/05/13 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/05/13 06:00
PHST- 2015/05/13 06:00 [entrez]
PHST- 2015/05/13 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - nbt0515-435b [pii]
AID - 10.1038/nbt0515-435b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):435. doi: 10.1038/nbt0515-435b.

PMID- 25965730
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - Startups use short-read data to expand long-read sequencing market.
PG  - 433-5
LID - 10.1038/nbt0515-433 [doi]
FAU - Eisenstein, Michael
AU  - Eisenstein M
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Drug Industry/economics/*instrumentation
MH  - Genome, Human
MH  - High-Throughput Nucleotide Sequencing/economics/*instrumentation
MH  - Humans
MH  - *Sequence Analysis, DNA
EDAT- 2015/05/13 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/05/13 06:00
PHST- 2015/05/13 06:00 [entrez]
PHST- 2015/05/13 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - nbt0515-433 [pii]
AID - 10.1038/nbt0515-433 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):433-5. doi: 10.1038/nbt0515-433.

PMID- 25965729
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - CRISPR germline editing reverberates through biotech industry.
PG  - 431-2
LID - 10.1038/nbt0515-431 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Biotechnology
MH  - CRISPR-Cas Systems/*genetics
MH  - *Genetic Therapy
MH  - Genome, Human
MH  - Humans
MH  - RNA Editing/*genetics
EDAT- 2015/05/13 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/05/13 06:00
PHST- 2015/05/13 06:00 [entrez]
PHST- 2015/05/13 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - nbt0515-431 [pii]
AID - 10.1038/nbt0515-431 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):431-2. doi: 10.1038/nbt0515-431.

PMID- 25965728
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - Next-generation genome editing.
PG  - 429
LID - 10.1038/nbt.3234 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Biotechnology
MH  - CRISPR-Cas Systems/*genetics
MH  - *Genetic Therapy
MH  - Genome, Human
MH  - Humans
MH  - RNA Editing/*genetics
EDAT- 2015/05/13 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/05/13 06:00
PHST- 2015/05/13 06:00 [entrez]
PHST- 2015/05/13 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - nbt.3234 [pii]
AID - 10.1038/nbt.3234 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):429. doi: 10.1038/nbt.3234.

PMID- 25893782
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - A prevascularized subcutaneous device-less site for islet and cellular
      transplantation.
PG  - 518-23
LID - 10.1038/nbt.3211 [doi]
AB  - Transplantation of donor-derived islets into the liver is a successful cellular
      replacement therapy for individuals with diabetes. However, the hepatic
      vasculature is not an optimal transplant site for several reasons, including
      graft attrition and the inability to retrieve or image the islets. Here we
      describe islet transplantation into a prevascularized, subcutaneous site created 
      by temporary placement of a medically approved vascular access catheter. In mice 
      with streptozotocin (STZ)-induced diabetes, transplantation of approximately 500 
      syngeneic islets into the resulting 'device-less' space reversed diabetes in 91% 
      of mice and maintained normoglycemia for >100 days. The approach was also
      effective in mice with pre-existing diabetes, in another mouse strain that mounts
      a more vigorous inflammatory response, and across an allogeneic barrier. These
      results demonstrate that transient priming of a subcutaneous site supports
      diabetes-reversing islet transplantation in mouse models without the need for a
      permanent cell-encapsulation device.
FAU - Pepper, Andrew R
AU  - Pepper AR
AD  - Clinical Islet Transplant Program, Alberta Diabetes Institute, University of
      Alberta, Edmonton, Alberta, Canada.
FAU - Gala-Lopez, Boris
AU  - Gala-Lopez B
AD  - Clinical Islet Transplant Program, Alberta Diabetes Institute, University of
      Alberta, Edmonton, Alberta, Canada.
FAU - Pawlick, Rena
AU  - Pawlick R
AD  - Clinical Islet Transplant Program, Alberta Diabetes Institute, University of
      Alberta, Edmonton, Alberta, Canada.
FAU - Merani, Shaheed
AU  - Merani S
AD  - Clinical Islet Transplant Program, Alberta Diabetes Institute, University of
      Alberta, Edmonton, Alberta, Canada.
FAU - Kin, Tatsuya
AU  - Kin T
AUID- ORCID: 0000000251796067
AD  - 1] Clinical Islet Transplant Program, Alberta Diabetes Institute, University of
      Alberta, Edmonton, Alberta, Canada. [2] Department of Surgery, University of
      Alberta, Edmonton, Alberta, Canada.
FAU - Shapiro, A M James
AU  - Shapiro AM
AD  - 1] Clinical Islet Transplant Program, Alberta Diabetes Institute, University of
      Alberta, Edmonton, Alberta, Canada. [2] Department of Surgery, University of
      Alberta, Edmonton, Alberta, Canada.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150420
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Blood Glucose)
SB  - IM
CIN - Nat Biotechnol. 2015 May;33(5):493-4. PMID: 25965759
MH  - Animals
MH  - Blood Glucose
MH  - *Cell- and Tissue-Based Therapy
MH  - Diabetes Mellitus, Experimental/blood/pathology/*therapy
MH  - Graft Survival
MH  - Humans
MH  - *Islets of Langerhans Transplantation
MH  - Liver
MH  - Mice
MH  - Neovascularization, Pathologic/blood/pathology/*therapy
MH  - Translational Medical Research
EDAT- 2015/04/22 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/04/21 06:00
PHST- 2014/10/06 00:00 [received]
PHST- 2015/03/12 00:00 [accepted]
PHST- 2015/04/21 06:00 [entrez]
PHST- 2015/04/22 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - nbt.3211 [pii]
AID - 10.1038/nbt.3211 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):518-23. doi: 10.1038/nbt.3211. Epub 2015 Apr 20.

PMID- 25893781
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - Sequencing of allotetraploid cotton (Gossypium hirsutum L. acc. TM-1) provides a 
      resource for fiber improvement.
PG  - 531-7
LID - 10.1038/nbt.3207 [doi]
AB  - Upland cotton is a model for polyploid crop domestication and transgenic
      improvement. Here we sequenced the allotetraploid Gossypium hirsutum L. acc. TM-1
      genome by integrating whole-genome shotgun reads, bacterial artificial chromosome
      (BAC)-end sequences and genotype-by-sequencing genetic maps. We assembled and
      annotated 32,032 A-subgenome genes and 34,402 D-subgenome genes. Structural
      rearrangements, gene loss, disrupted genes and sequence divergence were more
      common in the A subgenome than in the D subgenome, suggesting asymmetric
      evolution. However, no genome-wide expression dominance was found between the
      subgenomes. Genomic signatures of selection and domestication are associated with
      positively selected genes (PSGs) for fiber improvement in the A subgenome and for
      stress tolerance in the D subgenome. This draft genome sequence provides a
      resource for engineering superior cotton lines.
FAU - Zhang, Tianzhen
AU  - Zhang T
AD  - State Key Laboratory of Crop Genetics and Germplasm Enhancement, Cotton Hybrid R 
      &D Engineering Center (the Ministry of Education), Nanjing Agricultural
      University, Nanjing, Jiangsu, China.
FAU - Hu, Yan
AU  - Hu Y
AD  - State Key Laboratory of Crop Genetics and Germplasm Enhancement, Cotton Hybrid R 
      &D Engineering Center (the Ministry of Education), Nanjing Agricultural
      University, Nanjing, Jiangsu, China.
FAU - Jiang, Wenkai
AU  - Jiang W
AD  - Novogene Bioinformatics Institute, Beijing, China.
FAU - Fang, Lei
AU  - Fang L
AD  - 1] State Key Laboratory of Crop Genetics and Germplasm Enhancement, Cotton Hybrid
      R &D Engineering Center (the Ministry of Education), Nanjing Agricultural
      University, Nanjing, Jiangsu, China. [2] Department of Molecular Biosciences,
      Center for Computational Biology and Bioinformatics, and Institute for Cellular
      and Molecular Biology, The University of Texas at Austin, Austin, Texas, USA.
FAU - Guan, Xueying
AU  - Guan X
AD  - 1] State Key Laboratory of Crop Genetics and Germplasm Enhancement, Cotton Hybrid
      R &D Engineering Center (the Ministry of Education), Nanjing Agricultural
      University, Nanjing, Jiangsu, China. [2] Department of Molecular Biosciences,
      Center for Computational Biology and Bioinformatics, and Institute for Cellular
      and Molecular Biology, The University of Texas at Austin, Austin, Texas, USA.
FAU - Chen, Jiedan
AU  - Chen J
AUID- ORCID: 0000000252238243
AD  - State Key Laboratory of Crop Genetics and Germplasm Enhancement, Cotton Hybrid R 
      &D Engineering Center (the Ministry of Education), Nanjing Agricultural
      University, Nanjing, Jiangsu, China.
FAU - Zhang, Jinbo
AU  - Zhang J
AD  - Novogene Bioinformatics Institute, Beijing, China.
FAU - Saski, Christopher A
AU  - Saski CA
AD  - Clemson University Genomics Institute, Clemson University, Clemson, South
      Carolina, USA.
FAU - Scheffler, Brian E
AU  - Scheffler BE
AD  - US Department of Agriculture (USDA), Agricultural Research Service (ARS), Middle 
      Southern Area (MSA) Genomics Laboratory, Stoneville, Mississippi, USA.
FAU - Stelly, David M
AU  - Stelly DM
AD  - Department of Soil and Crop Sciences, Texas A&M University, College Station,
      Texas, USA.
FAU - Hulse-Kemp, Amanda M
AU  - Hulse-Kemp AM
AD  - Department of Soil and Crop Sciences, Texas A&M University, College Station,
      Texas, USA.
FAU - Wan, Qun
AU  - Wan Q
AD  - State Key Laboratory of Crop Genetics and Germplasm Enhancement, Cotton Hybrid R 
      &D Engineering Center (the Ministry of Education), Nanjing Agricultural
      University, Nanjing, Jiangsu, China.
FAU - Liu, Bingliang
AU  - Liu B
AD  - State Key Laboratory of Crop Genetics and Germplasm Enhancement, Cotton Hybrid R 
      &D Engineering Center (the Ministry of Education), Nanjing Agricultural
      University, Nanjing, Jiangsu, China.
FAU - Liu, Chunxiao
AU  - Liu C
AD  - State Key Laboratory of Crop Genetics and Germplasm Enhancement, Cotton Hybrid R 
      &D Engineering Center (the Ministry of Education), Nanjing Agricultural
      University, Nanjing, Jiangsu, China.
FAU - Wang, Sen
AU  - Wang S
AD  - State Key Laboratory of Crop Genetics and Germplasm Enhancement, Cotton Hybrid R 
      &D Engineering Center (the Ministry of Education), Nanjing Agricultural
      University, Nanjing, Jiangsu, China.
FAU - Pan, Mengqiao
AU  - Pan M
AD  - State Key Laboratory of Crop Genetics and Germplasm Enhancement, Cotton Hybrid R 
      &D Engineering Center (the Ministry of Education), Nanjing Agricultural
      University, Nanjing, Jiangsu, China.
FAU - Wang, Yangkun
AU  - Wang Y
AD  - State Key Laboratory of Crop Genetics and Germplasm Enhancement, Cotton Hybrid R 
      &D Engineering Center (the Ministry of Education), Nanjing Agricultural
      University, Nanjing, Jiangsu, China.
FAU - Wang, Dawei
AU  - Wang D
AD  - Novogene Bioinformatics Institute, Beijing, China.
FAU - Ye, Wenxue
AU  - Ye W
AD  - State Key Laboratory of Crop Genetics and Germplasm Enhancement, Cotton Hybrid R 
      &D Engineering Center (the Ministry of Education), Nanjing Agricultural
      University, Nanjing, Jiangsu, China.
FAU - Chang, Lijing
AU  - Chang L
AD  - State Key Laboratory of Crop Genetics and Germplasm Enhancement, Cotton Hybrid R 
      &D Engineering Center (the Ministry of Education), Nanjing Agricultural
      University, Nanjing, Jiangsu, China.
FAU - Zhang, Wenpan
AU  - Zhang W
AD  - State Key Laboratory of Crop Genetics and Germplasm Enhancement, Cotton Hybrid R 
      &D Engineering Center (the Ministry of Education), Nanjing Agricultural
      University, Nanjing, Jiangsu, China.
FAU - Song, Qingxin
AU  - Song Q
AD  - Department of Molecular Biosciences, Center for Computational Biology and
      Bioinformatics, and Institute for Cellular and Molecular Biology, The University 
      of Texas at Austin, Austin, Texas, USA.
FAU - Kirkbride, Ryan C
AU  - Kirkbride RC
AD  - Department of Molecular Biosciences, Center for Computational Biology and
      Bioinformatics, and Institute for Cellular and Molecular Biology, The University 
      of Texas at Austin, Austin, Texas, USA.
FAU - Chen, Xiaoya
AU  - Chen X
AD  - National Key Laboratory of Plant Molecular Genetics, National Plant Gene Research
      Center, Institute of Plant Physiology and Ecology, Shanghai Institutes for
      Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
FAU - Dennis, Elizabeth
AU  - Dennis E
AD  - The Commonwealth Scientific and Industrial Research Organisation, Plant Industry,
      Black Mountain, Australia.
FAU - Llewellyn, Danny J
AU  - Llewellyn DJ
AD  - The Commonwealth Scientific and Industrial Research Organisation, Plant Industry,
      Black Mountain, Australia.
FAU - Peterson, Daniel G
AU  - Peterson DG
AD  - Department of Plant and Soil Sciences, Mississippi State University, Starkville, 
      Mississippi, USA.
FAU - Thaxton, Peggy
AU  - Thaxton P
AD  - Delta Research and Extension Center, Mississippi State University, Stoneville,
      Mississippi, USA.
FAU - Jones, Don C
AU  - Jones DC
AD  - Cotton Incorporated, Cary, North Carolina, USA.
FAU - Wang, Qiong
AU  - Wang Q
AD  - State Key Laboratory of Crop Genetics and Germplasm Enhancement, Cotton Hybrid R 
      &D Engineering Center (the Ministry of Education), Nanjing Agricultural
      University, Nanjing, Jiangsu, China.
FAU - Xu, Xiaoyang
AU  - Xu X
AD  - State Key Laboratory of Crop Genetics and Germplasm Enhancement, Cotton Hybrid R 
      &D Engineering Center (the Ministry of Education), Nanjing Agricultural
      University, Nanjing, Jiangsu, China.
FAU - Zhang, Hua
AU  - Zhang H
AD  - State Key Laboratory of Crop Genetics and Germplasm Enhancement, Cotton Hybrid R 
      &D Engineering Center (the Ministry of Education), Nanjing Agricultural
      University, Nanjing, Jiangsu, China.
FAU - Wu, Huaitong
AU  - Wu H
AD  - State Key Laboratory of Crop Genetics and Germplasm Enhancement, Cotton Hybrid R 
      &D Engineering Center (the Ministry of Education), Nanjing Agricultural
      University, Nanjing, Jiangsu, China.
FAU - Zhou, Lei
AU  - Zhou L
AD  - State Key Laboratory of Crop Genetics and Germplasm Enhancement, Cotton Hybrid R 
      &D Engineering Center (the Ministry of Education), Nanjing Agricultural
      University, Nanjing, Jiangsu, China.
FAU - Mei, Gaofu
AU  - Mei G
AD  - State Key Laboratory of Crop Genetics and Germplasm Enhancement, Cotton Hybrid R 
      &D Engineering Center (the Ministry of Education), Nanjing Agricultural
      University, Nanjing, Jiangsu, China.
FAU - Chen, Shuqi
AU  - Chen S
AD  - State Key Laboratory of Crop Genetics and Germplasm Enhancement, Cotton Hybrid R 
      &D Engineering Center (the Ministry of Education), Nanjing Agricultural
      University, Nanjing, Jiangsu, China.
FAU - Tian, Yue
AU  - Tian Y
AD  - State Key Laboratory of Crop Genetics and Germplasm Enhancement, Cotton Hybrid R 
      &D Engineering Center (the Ministry of Education), Nanjing Agricultural
      University, Nanjing, Jiangsu, China.
FAU - Xiang, Dan
AU  - Xiang D
AD  - State Key Laboratory of Crop Genetics and Germplasm Enhancement, Cotton Hybrid R 
      &D Engineering Center (the Ministry of Education), Nanjing Agricultural
      University, Nanjing, Jiangsu, China.
FAU - Li, Xinghe
AU  - Li X
AD  - State Key Laboratory of Crop Genetics and Germplasm Enhancement, Cotton Hybrid R 
      &D Engineering Center (the Ministry of Education), Nanjing Agricultural
      University, Nanjing, Jiangsu, China.
FAU - Ding, Jian
AU  - Ding J
AD  - State Key Laboratory of Crop Genetics and Germplasm Enhancement, Cotton Hybrid R 
      &D Engineering Center (the Ministry of Education), Nanjing Agricultural
      University, Nanjing, Jiangsu, China.
FAU - Zuo, Qiyang
AU  - Zuo Q
AD  - Novogene Bioinformatics Institute, Beijing, China.
FAU - Tao, Linna
AU  - Tao L
AD  - Novogene Bioinformatics Institute, Beijing, China.
FAU - Liu, Yunchao
AU  - Liu Y
AD  - Novogene Bioinformatics Institute, Beijing, China.
FAU - Li, Ji
AU  - Li J
AD  - Novogene Bioinformatics Institute, Beijing, China.
FAU - Lin, Yu
AU  - Lin Y
AD  - Novogene Bioinformatics Institute, Beijing, China.
FAU - Hui, Yuanyuan
AU  - Hui Y
AD  - Novogene Bioinformatics Institute, Beijing, China.
FAU - Cao, Zhisheng
AU  - Cao Z
AD  - Novogene Bioinformatics Institute, Beijing, China.
FAU - Cai, Caiping
AU  - Cai C
AD  - State Key Laboratory of Crop Genetics and Germplasm Enhancement, Cotton Hybrid R 
      &D Engineering Center (the Ministry of Education), Nanjing Agricultural
      University, Nanjing, Jiangsu, China.
FAU - Zhu, Xiefei
AU  - Zhu X
AD  - State Key Laboratory of Crop Genetics and Germplasm Enhancement, Cotton Hybrid R 
      &D Engineering Center (the Ministry of Education), Nanjing Agricultural
      University, Nanjing, Jiangsu, China.
FAU - Jiang, Zhi
AU  - Jiang Z
AD  - Novogene Bioinformatics Institute, Beijing, China.
FAU - Zhou, Baoliang
AU  - Zhou B
AD  - State Key Laboratory of Crop Genetics and Germplasm Enhancement, Cotton Hybrid R 
      &D Engineering Center (the Ministry of Education), Nanjing Agricultural
      University, Nanjing, Jiangsu, China.
FAU - Guo, Wangzhen
AU  - Guo W
AD  - State Key Laboratory of Crop Genetics and Germplasm Enhancement, Cotton Hybrid R 
      &D Engineering Center (the Ministry of Education), Nanjing Agricultural
      University, Nanjing, Jiangsu, China.
FAU - Li, Ruiqiang
AU  - Li R
AD  - Novogene Bioinformatics Institute, Beijing, China.
FAU - Chen, Z Jeffrey
AU  - Chen ZJ
AD  - 1] State Key Laboratory of Crop Genetics and Germplasm Enhancement, Cotton Hybrid
      R &D Engineering Center (the Ministry of Education), Nanjing Agricultural
      University, Nanjing, Jiangsu, China. [2] Department of Molecular Biosciences,
      Center for Computational Biology and Bioinformatics, and Institute for Cellular
      and Molecular Biology, The University of Texas at Austin, Austin, Texas, USA.
LA  - eng
SI  - SRA/PRJNA248163
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150420
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Plant Proteins)
SB  - IM
MH  - Base Sequence
MH  - Chromosome Mapping
MH  - *Cotton Fiber
MH  - *Genome, Plant
MH  - Gossypium/*genetics
MH  - High-Throughput Nucleotide Sequencing
MH  - Plant Proteins/biosynthesis/*genetics
MH  - Sequence Analysis, DNA
MH  - Tetraploidy
EDAT- 2015/04/22 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/04/21 06:00
PHST- 2014/09/18 00:00 [received]
PHST- 2015/03/15 00:00 [accepted]
PHST- 2015/04/21 06:00 [entrez]
PHST- 2015/04/22 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - nbt.3207 [pii]
AID - 10.1038/nbt.3207 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):531-7. doi: 10.1038/nbt.3207. Epub 2015 Apr 20.

PMID- 25893780
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - Genome sequence of cultivated Upland cotton (Gossypium hirsutum TM-1) provides
      insights into genome evolution.
PG  - 524-30
LID - 10.1038/nbt.3208 [doi]
AB  - Gossypium hirsutum has proven difficult to sequence owing to its complex
      allotetraploid (AtDt) genome. Here we produce a draft genome using 181-fold
      paired-end sequences assisted by fivefold BAC-to-BAC sequences and a
      high-resolution genetic map. In our assembly 88.5% of the 2,173-Mb scaffolds,
      which cover 89.6% approximately 96.7% of the AtDt genome, are anchored and
      oriented to 26 pseudochromosomes. Comparison of this G. hirsutum AtDt genome with
      the already sequenced diploid Gossypium arboreum (AA) and Gossypium raimondii
      (DD) genomes revealed conserved gene order. Repeated sequences account for 67.2% 
      of the AtDt genome, and transposable elements (TEs) originating from Dt seem more
      active than from At. Reduction in the AtDt genome size occurred after
      allopolyploidization. The A or At genome may have undergone positive selection
      for fiber traits. Concerted evolution of different regulatory mechanisms for
      Cellulose synthase (CesA) and 1-Aminocyclopropane-1-carboxylic acid oxidase1 and 
      3 (ACO1,3) may be important for enhanced fiber production in G. hirsutum.
FAU - Li, Fuguang
AU  - Li F
AD  - State Key Laboratory of Cotton Biology, Institute of Cotton Research of the
      Chinese Academy of Agricultural Sciences, Anyang, China.
FAU - Fan, Guangyi
AU  - Fan G
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Lu, Cairui
AU  - Lu C
AD  - State Key Laboratory of Cotton Biology, Institute of Cotton Research of the
      Chinese Academy of Agricultural Sciences, Anyang, China.
FAU - Xiao, Guanghui
AU  - Xiao G
AD  - 1] State Key Laboratory of Protein and Plant Gene Research, College of Life
      Sciences, Peking University, Beijing, China. [2] Institute for Advanced Studies
      and College of Life Sciences, Wuhan University, Wuhan, China.
FAU - Zou, Changsong
AU  - Zou C
AD  - State Key Laboratory of Cotton Biology, Institute of Cotton Research of the
      Chinese Academy of Agricultural Sciences, Anyang, China.
FAU - Kohel, Russell J
AU  - Kohel RJ
AD  - Crop Germplasm Research Unit, Southern Plains Agricultural Research Center, US
      Department of Agriculture-Agricultural Research Service (USDA-ARS), College
      Station, Texas, USA.
FAU - Ma, Zhiying
AU  - Ma Z
AD  - Key Laboratory for Crop Germplasm Resources of Hebei, Agricultural University of 
      Hebei, Baoding, China.
FAU - Shang, Haihong
AU  - Shang H
AD  - State Key Laboratory of Cotton Biology, Institute of Cotton Research of the
      Chinese Academy of Agricultural Sciences, Anyang, China.
FAU - Ma, Xiongfeng
AU  - Ma X
AD  - State Key Laboratory of Cotton Biology, Institute of Cotton Research of the
      Chinese Academy of Agricultural Sciences, Anyang, China.
FAU - Wu, Jianyong
AU  - Wu J
AD  - State Key Laboratory of Cotton Biology, Institute of Cotton Research of the
      Chinese Academy of Agricultural Sciences, Anyang, China.
FAU - Liang, Xinming
AU  - Liang X
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Huang, Gai
AU  - Huang G
AD  - 1] State Key Laboratory of Protein and Plant Gene Research, College of Life
      Sciences, Peking University, Beijing, China. [2] Institute for Advanced Studies
      and College of Life Sciences, Wuhan University, Wuhan, China.
FAU - Percy, Richard G
AU  - Percy RG
AD  - Crop Germplasm Research Unit, Southern Plains Agricultural Research Center, US
      Department of Agriculture-Agricultural Research Service (USDA-ARS), College
      Station, Texas, USA.
FAU - Liu, Kun
AU  - Liu K
AD  - State Key Laboratory of Cotton Biology, Institute of Cotton Research of the
      Chinese Academy of Agricultural Sciences, Anyang, China.
FAU - Yang, Weihua
AU  - Yang W
AD  - State Key Laboratory of Cotton Biology, Institute of Cotton Research of the
      Chinese Academy of Agricultural Sciences, Anyang, China.
FAU - Chen, Wenbin
AU  - Chen W
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Du, Xiongming
AU  - Du X
AD  - State Key Laboratory of Cotton Biology, Institute of Cotton Research of the
      Chinese Academy of Agricultural Sciences, Anyang, China.
FAU - Shi, Chengcheng
AU  - Shi C
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Yuan, Youlu
AU  - Yuan Y
AD  - State Key Laboratory of Cotton Biology, Institute of Cotton Research of the
      Chinese Academy of Agricultural Sciences, Anyang, China.
FAU - Ye, Wuwei
AU  - Ye W
AD  - State Key Laboratory of Cotton Biology, Institute of Cotton Research of the
      Chinese Academy of Agricultural Sciences, Anyang, China.
FAU - Liu, Xin
AU  - Liu X
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Zhang, Xueyan
AU  - Zhang X
AD  - State Key Laboratory of Cotton Biology, Institute of Cotton Research of the
      Chinese Academy of Agricultural Sciences, Anyang, China.
FAU - Liu, Weiqing
AU  - Liu W
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Wei, Hengling
AU  - Wei H
AD  - State Key Laboratory of Cotton Biology, Institute of Cotton Research of the
      Chinese Academy of Agricultural Sciences, Anyang, China.
FAU - Wei, Shoujun
AU  - Wei S
AD  - State Key Laboratory of Cotton Biology, Institute of Cotton Research of the
      Chinese Academy of Agricultural Sciences, Anyang, China.
FAU - Huang, Guodong
AU  - Huang G
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Zhang, Xianlong
AU  - Zhang X
AD  - National Key Laboratory of Crop Genetic Improvement, Huazhong Agricultural
      University, Wuhan, China.
FAU - Zhu, Shuijin
AU  - Zhu S
AD  - Department of Agronomy, Zhejiang University, Hangzhou, China.
FAU - Zhang, He
AU  - Zhang H
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Sun, Fengming
AU  - Sun F
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Wang, Xingfen
AU  - Wang X
AD  - Key Laboratory for Crop Germplasm Resources of Hebei, Agricultural University of 
      Hebei, Baoding, China.
FAU - Liang, Jie
AU  - Liang J
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Wang, Jiahao
AU  - Wang J
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - He, Qiang
AU  - He Q
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Huang, Leihuan
AU  - Huang L
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Wang, Jun
AU  - Wang J
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Cui, Jinjie
AU  - Cui J
AD  - State Key Laboratory of Cotton Biology, Institute of Cotton Research of the
      Chinese Academy of Agricultural Sciences, Anyang, China.
FAU - Song, Guoli
AU  - Song G
AD  - State Key Laboratory of Cotton Biology, Institute of Cotton Research of the
      Chinese Academy of Agricultural Sciences, Anyang, China.
FAU - Wang, Kunbo
AU  - Wang K
AD  - State Key Laboratory of Cotton Biology, Institute of Cotton Research of the
      Chinese Academy of Agricultural Sciences, Anyang, China.
FAU - Xu, Xun
AU  - Xu X
AD  - BGI-Shenzhen, Shenzhen, China.
FAU - Yu, John Z
AU  - Yu JZ
AD  - Crop Germplasm Research Unit, Southern Plains Agricultural Research Center, US
      Department of Agriculture-Agricultural Research Service (USDA-ARS), College
      Station, Texas, USA.
FAU - Zhu, Yuxian
AU  - Zhu Y
AD  - 1] State Key Laboratory of Protein and Plant Gene Research, College of Life
      Sciences, Peking University, Beijing, China. [2] Institute for Advanced Studies
      and College of Life Sciences, Wuhan University, Wuhan, China.
FAU - Yu, Shuxun
AU  - Yu S
AD  - State Key Laboratory of Cotton Biology, Institute of Cotton Research of the
      Chinese Academy of Agricultural Sciences, Anyang, China.
LA  - eng
SI  - BioProject/PRJNA259930
SI  - SRA/SRA180756
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150420
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (DNA Transposable Elements)
RN  - EC 1.4.- (Amino Acid Oxidoreductases)
RN  - EC 1.4.3.- (1-aminocyclopropane-1-carboxylic acid oxidase)
RN  - EC 2.4.1.- (Glucosyltransferases)
RN  - EC 2.4.1.- (cellulose synthase)
SB  - IM
MH  - Amino Acid Oxidoreductases/genetics
MH  - Base Sequence
MH  - Chromosome Mapping
MH  - Cotton Fiber
MH  - DNA Transposable Elements/genetics
MH  - *Evolution, Molecular
MH  - *Genome, Plant
MH  - Glucosyltransferases/genetics
MH  - Gossypium/*genetics
MH  - Phylogeny
MH  - Polyploidy
MH  - *Sequence Analysis, DNA
EDAT- 2015/04/22 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/04/21 06:00
PHST- 2014/10/08 00:00 [received]
PHST- 2015/03/15 00:00 [accepted]
PHST- 2015/04/21 06:00 [entrez]
PHST- 2015/04/22 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - nbt.3208 [pii]
AID - 10.1038/nbt.3208 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):524-30. doi: 10.1038/nbt.3208. Epub 2015 Apr 20.

PMID- 25867923
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - Spatial reconstruction of single-cell gene expression data.
PG  - 495-502
LID - 10.1038/nbt.3192 [doi]
AB  - Spatial localization is a key determinant of cellular fate and behavior, but
      methods for spatially resolved, transcriptome-wide gene expression profiling
      across complex tissues are lacking. RNA staining methods assay only a small
      number of transcripts, whereas single-cell RNA-seq, which measures global gene
      expression, separates cells from their native spatial context. Here we present
      Seurat, a computational strategy to infer cellular localization by integrating
      single-cell RNA-seq data with in situ RNA patterns. We applied Seurat to
      spatially map 851 single cells from dissociated zebrafish (Danio rerio) embryos
      and generated a transcriptome-wide map of spatial patterning. We confirmed
      Seurat's accuracy using several experimental approaches, then used the strategy
      to identify a set of archetypal expression patterns and spatial markers. Seurat
      correctly localizes rare subpopulations, accurately mapping both spatially
      restricted and scattered groups. Seurat will be applicable to mapping cellular
      localization within complex patterned tissues in diverse systems.
FAU - Satija, Rahul
AU  - Satija R
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
FAU - Farrell, Jeffrey A
AU  - Farrell JA
AD  - Department of Molecular and Cellular Biology, Harvard University, Cambridge,
      Massachusetts, USA.
FAU - Gennert, David
AU  - Gennert D
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
FAU - Schier, Alexander F
AU  - Schier AF
AD  - 1] Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2]
      Department of Molecular and Cellular Biology, Harvard University, Cambridge,
      Massachusetts, USA. [3] Center for Brain Science, Harvard University, Cambridge, 
      Massachusetts, USA. [4] Harvard Stem Cell Institute, Harvard University,
      Cambridge, Massachusetts, USA. [5] Center for Systems Biology, Harvard
      University, Cambridge, Massachusetts, USA.
FAU - Regev, Aviv
AU  - Regev A
AD  - 1] Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Howard 
      Hughes Medical Institute, Department of Biology, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
LA  - eng
SI  - GEO/GSE66688
GR  - F32 HD075541/HD/NICHD NIH HHS/United States
GR  - Howard Hughes Medical Institute/United States
GR  - P50 HG006193/HG/NHGRI NIH HHS/United States
GR  - R01 GM056211/GM/NIGMS NIH HHS/United States
GR  - 1P50HG006193/HG/NHGRI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20150413
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CIN - Nat Rev Genet. 2015 Jun;16(6):319. PMID: 25948245
MH  - Animals
MH  - Gene Expression Regulation, Developmental
MH  - High-Throughput Nucleotide Sequencing
MH  - Image Processing, Computer-Assisted
MH  - In Situ Hybridization, Fluorescence/*methods
MH  - Single-Cell Analysis/*methods
MH  - Transcriptome/genetics
MH  - Zebrafish/genetics/*growth & development
PMC - PMC4430369
MID - NIHMS660791
EDAT- 2015/04/14 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/04/14 06:00
PHST- 2014/09/08 00:00 [received]
PHST- 2015/02/02 00:00 [accepted]
PHST- 2015/04/14 06:00 [entrez]
PHST- 2015/04/14 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - nbt.3192 [pii]
AID - 10.1038/nbt.3192 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):495-502. doi: 10.1038/nbt.3192. Epub 2015 Apr 13.

PMID- 25867922
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - High-throughput spatial mapping of single-cell RNA-seq data to tissue of origin.
PG  - 503-9
LID - 10.1038/nbt.3209 [doi]
AB  - Understanding cell type identity in a multicellular organism requires the
      integration of gene expression profiles from individual cells with their spatial 
      location in a particular tissue. Current technologies allow whole-transcriptome
      sequencing of spatially identified cells but lack the throughput needed to
      characterize complex tissues. Here we present a high-throughput method to
      identify the spatial origin of cells assayed by single-cell RNA-sequencing within
      a tissue of interest. Our approach is based on comparing complete,
      specificity-weighted mRNA profiles of a cell with positional gene expression
      profiles derived from a gene expression atlas. We show that this method allocates
      cells to precise locations in the brain of the marine annelid Platynereis
      dumerilii with a success rate of 81%. Our method is applicable to any system that
      has a reference gene expression database of sufficiently high resolution.
FAU - Achim, Kaia
AU  - Achim K
AUID- ORCID: 0000000337234065
AD  - 1] European Bioinformatics Institute, European Molecular Biology Laboratory
      (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, UK. [2]
      Developmental Biology Unit, European Molecular Biology Laboratory (EMBL),
      Heidelberg, Germany.
FAU - Pettit, Jean-Baptiste
AU  - Pettit JB
AD  - European Bioinformatics Institute, European Molecular Biology Laboratory
      (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, UK.
FAU - Saraiva, Luis R
AU  - Saraiva LR
AUID- ORCID: 0000000340790396
AD  - 1] European Bioinformatics Institute, European Molecular Biology Laboratory
      (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, UK. [2]
      Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton,
      Cambridgeshire, UK.
FAU - Gavriouchkina, Daria
AU  - Gavriouchkina D
AD  - Developmental Biology Unit, European Molecular Biology Laboratory (EMBL),
      Heidelberg, Germany.
FAU - Larsson, Tomas
AU  - Larsson T
AD  - Developmental Biology Unit, European Molecular Biology Laboratory (EMBL),
      Heidelberg, Germany.
FAU - Arendt, Detlev
AU  - Arendt D
AD  - Developmental Biology Unit, European Molecular Biology Laboratory (EMBL),
      Heidelberg, Germany.
FAU - Marioni, John C
AU  - Marioni JC
AD  - 1] European Bioinformatics Institute, European Molecular Biology Laboratory
      (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, UK. [2]
      Developmental Biology Unit, European Molecular Biology Laboratory (EMBL),
      Heidelberg, Germany. [3] Wellcome Trust Sanger Institute, Wellcome Trust Genome
      Campus, Hinxton, Cambridgeshire, UK.
LA  - eng
GR  - Wellcome Trust/United Kingdom
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150413
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CIN - Nat Rev Genet. 2015 Jun;16(6):319. PMID: 25948245
MH  - Animals
MH  - *Gene Expression Regulation, Developmental
MH  - High-Throughput Nucleotide Sequencing/*methods
MH  - Organ Specificity/genetics
MH  - Polychaeta/*genetics/growth & development
MH  - Single-Cell Analysis/*methods
MH  - Transcriptome/genetics
EDAT- 2015/04/14 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/04/14 06:00
PHST- 2014/09/01 00:00 [received]
PHST- 2015/03/13 00:00 [accepted]
PHST- 2015/04/14 06:00 [entrez]
PHST- 2015/04/14 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - nbt.3209 [pii]
AID - 10.1038/nbt.3209 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):503-9. doi: 10.1038/nbt.3209. Epub 2015 Apr 13.

PMID- 25849900
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20170826
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from
      promoters and enhancers.
PG  - 510-7
LID - 10.1038/nbt.3199 [doi]
AB  - Technologies that enable targeted manipulation of epigenetic marks could be used 
      to precisely control cell phenotype or interrogate the relationship between the
      epigenome and transcriptional control. Here we describe a programmable,
      CRISPR-Cas9-based acetyltransferase consisting of the nuclease-null dCas9 protein
      fused to the catalytic core of the human acetyltransferase p300. The fusion
      protein catalyzes acetylation of histone H3 lysine 27 at its target sites,
      leading to robust transcriptional activation of target genes from promoters and
      both proximal and distal enhancers. Gene activation by the targeted
      acetyltransferase was highly specific across the genome. In contrast to previous 
      dCas9-based activators, the acetyltransferase activates genes from enhancer
      regions and with an individual guide RNA. We also show that the core p300 domain 
      can be fused to other programmable DNA-binding proteins. These results support
      targeted acetylation as a causal mechanism of transactivation and provide a
      robust tool for manipulating gene regulation.
FAU - Hilton, Isaac B
AU  - Hilton IB
AUID- ORCID: 0000000230648532
AD  - 1] Department of Biomedical Engineering, Duke University, Durham, North Carolina,
      USA. [2] Center for Genomic &Computational Biology, Duke University, Durham,
      North Carolina, USA.
FAU - D'Ippolito, Anthony M
AU  - D'Ippolito AM
AD  - 1] Center for Genomic &Computational Biology, Duke University, Durham, North
      Carolina, USA. [2] University Program in Genetics and Genomics, Duke University
      Medical Center, Durham, North Carolina, USA.
FAU - Vockley, Christopher M
AU  - Vockley CM
AD  - 1] Center for Genomic &Computational Biology, Duke University, Durham, North
      Carolina, USA. [2] Department of Cell Biology, Duke University Medical Center,
      Durham, North Carolina, USA.
FAU - Thakore, Pratiksha I
AU  - Thakore PI
AD  - 1] Department of Biomedical Engineering, Duke University, Durham, North Carolina,
      USA. [2] Center for Genomic &Computational Biology, Duke University, Durham,
      North Carolina, USA.
FAU - Crawford, Gregory E
AU  - Crawford GE
AD  - 1] Center for Genomic &Computational Biology, Duke University, Durham, North
      Carolina, USA. [2] Department of Pediatrics, Division of Medical Genetics, Duke
      University Medical Center, Durham, North Carolina, USA.
FAU - Reddy, Timothy E
AU  - Reddy TE
AUID- ORCID: 000000027629061X
AD  - 1] Center for Genomic &Computational Biology, Duke University, Durham, North
      Carolina, USA. [2] Department of Biostatistics &Bioinformatics, Duke University
      Medical Center, Durham, North Carolina, USA.
FAU - Gersbach, Charles A
AU  - Gersbach CA
AD  - 1] Department of Biomedical Engineering, Duke University, Durham, North Carolina,
      USA. [2] Center for Genomic &Computational Biology, Duke University, Durham,
      North Carolina, USA. [3] Department of Orthopaedic Surgery, Duke University
      Medical Center, Durham, North Carolina, USA.
LA  - eng
SI  - GEO/GSE66742
GR  - DP2OD008586/OD/NIH HHS/United States
GR  - T32 HD040372/HD/NICHD NIH HHS/United States
GR  - DP2 OD008586/OD/NIH HHS/United States
GR  - T32 GM007754/GM/NIGMS NIH HHS/United States
GR  - R01 DA036865/DA/NIDA NIH HHS/United States
GR  - U01 HG007900/HG/NHGRI NIH HHS/United States
GR  - P30AR066527/AR/NIAMS NIH HHS/United States
GR  - U01HG007900/HG/NHGRI NIH HHS/United States
GR  - P30 AR066527/AR/NIAMS NIH HHS/United States
GR  - R01DA036865/DA/NIDA NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20150406
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (RNA, Guide)
RN  - EC 2.3.1.- (Acetyltransferases)
RN  - EC 2.3.1.48 (E1A-Associated p300 Protein)
RN  - EC 2.3.1.48 (EP300 protein, human)
SB  - IM
CIN - Nat Rev Mol Cell Biol. 2015 May;16(5):266-7. PMID: 25874740
MH  - Acetyltransferases/genetics
MH  - CRISPR-Cas Systems/*genetics
MH  - E1A-Associated p300 Protein/genetics
MH  - *Enhancer Elements, Genetic
MH  - Epigenomics/*methods
MH  - HEK293 Cells
MH  - Humans
MH  - Promoter Regions, Genetic
MH  - RNA Editing/genetics
MH  - RNA, Guide/genetics
MH  - Transcriptional Activation
PMC - PMC4430400
MID - NIHMS672873
EDAT- 2015/04/08 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/04/08 06:00
PHST- 2014/12/23 00:00 [received]
PHST- 2015/03/16 00:00 [accepted]
PHST- 2015/04/08 06:00 [entrez]
PHST- 2015/04/08 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - nbt.3199 [pii]
AID - 10.1038/nbt.3199 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):510-7. doi: 10.1038/nbt.3199. Epub 2015 Apr 6.

PMID- 25803306
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced
      precise gene editing in mammalian cells.
PG  - 543-8
LID - 10.1038/nbt.3198 [doi]
AB  - The insertion of precise genetic modifications by genome editing tools such as
      CRISPR-Cas9 is limited by the relatively low efficiency of homology-directed
      repair (HDR) compared with the higher efficiency of the nonhomologous end-joining
      (NHEJ) pathway. To enhance HDR, enabling the insertion of precise genetic
      modifications, we suppressed the NHEJ key molecules KU70, KU80 or DNA ligase IV
      by gene silencing, the ligase IV inhibitor SCR7 or the coexpression of adenovirus
      4 E1B55K and E4orf6 proteins in a 'traffic light' and other reporter systems.
      Suppression of KU70 and DNA ligase IV promotes the efficiency of HDR 4-5-fold.
      When co-expressed with the Cas9 system, E1B55K and E4orf6 improved the efficiency
      of HDR up to eightfold and essentially abolished NHEJ activity in both human and 
      mouse cell lines. Our findings provide useful tools to improve the frequency of
      precise gene modifications in mammalian cells.
FAU - Chu, Van Trung
AU  - Chu VT
AD  - Max-Delbruck-Center for Molecular Medicine, Berlin, Germany.
FAU - Weber, Timm
AU  - Weber T
AD  - Max-Delbruck-Center for Molecular Medicine, Berlin, Germany.
FAU - Wefers, Benedikt
AU  - Wefers B
AUID- ORCID: 0000000224929389
AD  - 1] Helmholtz Zentrum Munchen, German Research Center for Environmental Health,
      Neuherberg, Germany. [2] Deutsches Zentrum fur Neurodegenerative Erkrankungen
      e.V., Munich, Germany.
FAU - Wurst, Wolfgang
AU  - Wurst W
AD  - 1] Helmholtz Zentrum Munchen, German Research Center for Environmental Health,
      Neuherberg, Germany. [2] Deutsches Zentrum fur Neurodegenerative Erkrankungen
      e.V., Munich, Germany. [3] Munich Cluster for Systems Neurology (SyNergy),
      Ludwig-Maximilians-Universitat Munchen, Munich, Germany.
FAU - Sander, Sandrine
AU  - Sander S
AD  - Max-Delbruck-Center for Molecular Medicine, Berlin, Germany.
FAU - Rajewsky, Klaus
AU  - Rajewsky K
AD  - Max-Delbruck-Center for Molecular Medicine, Berlin, Germany.
FAU - Kuhn, Ralf
AU  - Kuhn R
AD  - 1] Max-Delbruck-Center for Molecular Medicine, Berlin, Germany. [2] Helmholtz
      Zentrum Munchen, German Research Center for Environmental Health, Neuherberg,
      Germany. [3] Berlin Institute of Health, Berlin, Germany.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150324
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Adenovirus E4 Proteins)
RN  - 0 (E1B55K protein, adenovirus)
RN  - 0 (E4orf6 protein, adenovirus)
RN  - 0 (LIG4 protein, human)
RN  - 0 (Viral Proteins)
RN  - EC 6.5.1.- (DNA Ligases)
RN  - EC 6.5.1.1 (DNA Ligase ATP)
SB  - IM
MH  - Adenoviridae/genetics
MH  - Adenovirus E4 Proteins/biosynthesis/genetics
MH  - Animals
MH  - CRISPR-Cas Systems/*genetics
MH  - Cell Line
MH  - DNA Breaks, Double-Stranded
MH  - DNA End-Joining Repair/*genetics
MH  - DNA Ligase ATP
MH  - DNA Ligases/genetics
MH  - Gene Expression Regulation
MH  - Genetic Engineering/*methods
MH  - Genome, Human
MH  - Homologous Recombination/genetics
MH  - Humans
MH  - Mice
MH  - Viral Proteins/biosynthesis/genetics
EDAT- 2015/03/25 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/03/25 06:00
PHST- 2015/02/13 00:00 [received]
PHST- 2015/03/18 00:00 [accepted]
PHST- 2015/03/25 06:00 [entrez]
PHST- 2015/03/25 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - nbt.3198 [pii]
AID - 10.1038/nbt.3198 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):543-8. doi: 10.1038/nbt.3198. Epub 2015 Mar 24.

PMID- 25798939
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - Increasing the efficiency of precise genome editing with CRISPR-Cas9 by
      inhibition of nonhomologous end joining.
PG  - 538-42
LID - 10.1038/nbt.3190 [doi]
AB  - Methods to introduce targeted double-strand breaks (DSBs) into DNA enable precise
      genome editing by increasing the rate at which externally supplied DNA fragments 
      are incorporated into the genome through homologous recombination. The efficiency
      of these methods is limited by nonhomologous end joining (NHEJ), an alternative
      DNA repair pathway that competes with homology-directed repair (HDR). To promote 
      HDR at the expense of NHEJ, we targeted DNA ligase IV, a key enzyme in the NHEJ
      pathway, using the inhibitor Scr7. Scr7 treatment increased the efficiency of
      HDR-mediated genome editing, using Cas9 in mammalian cell lines and in mice for
      all four genes examined, up to 19-fold. This approach should be applicable to
      other customizable endonucleases, such as zinc finger nucleases and transcription
      activator-like effector nucleases, and to nonmammalian cells with sufficiently
      conserved mechanisms of NHEJ and HDR.
FAU - Maruyama, Takeshi
AU  - Maruyama T
AD  - Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA.
FAU - Dougan, Stephanie K
AU  - Dougan SK
AD  - Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA.
FAU - Truttmann, Matthias C
AU  - Truttmann MC
AD  - Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA.
FAU - Bilate, Angelina M
AU  - Bilate AM
AD  - Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA.
FAU - Ingram, Jessica R
AU  - Ingram JR
AD  - Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA.
FAU - Ploegh, Hidde L
AU  - Ploegh HL
AD  - 1] Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA.
      [2] Department of Biology, Massachusetts Institute of Technology, Cambridge,
      Massachusetts, USA.
LA  - eng
SI  - SRA/SRX950186
SI  - SRA/SRX950215
GR  - R01 AI087879/AI/NIAID NIH HHS/United States
GR  - R01 AI087879-01/AI/NIAID NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20150323
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (5,6-bis(benzylideneamino)-2-mercaptopyrimidin-4-ol)
RN  - 0 (Pyrimidines)
RN  - 0 (Schiff Bases)
RN  - EC 6.5.1.- (DNA Ligases)
RN  - EC 6.5.1.1 (DNA Ligase ATP)
SB  - IM
EIN - Nat Biotechnol. 2016 Feb;34(2):210. PMID: 26849523
MH  - Animals
MH  - CRISPR-Cas Systems/*genetics
MH  - Cell Line
MH  - DNA Breaks, Double-Stranded/drug effects
MH  - DNA End-Joining Repair/*genetics
MH  - DNA Ligase ATP
MH  - DNA Ligases/*genetics
MH  - DNA Repair/genetics
MH  - Genetic Engineering/*methods
MH  - Genome
MH  - Homologous Recombination/genetics
MH  - Mice
MH  - Pyrimidines/administration & dosage
MH  - Schiff Bases/administration & dosage
MH  - Zinc Fingers/genetics
PMC - PMC4618510
MID - NIHMS670952
EDAT- 2015/03/24 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/03/24 06:00
PHST- 2014/07/11 00:00 [received]
PHST- 2015/03/09 00:00 [accepted]
PHST- 2015/03/24 06:00 [entrez]
PHST- 2015/03/24 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - nbt.3190 [pii]
AID - 10.1038/nbt.3190 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):538-42. doi: 10.1038/nbt.3190. Epub 2015 Mar 23.

PMID- 25798937
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - Clearance of persistent hepatitis C virus infection in humanized mice using a
      claudin-1-targeting monoclonal antibody.
PG  - 549-554
LID - 10.1038/nbt.3179 [doi]
AB  - Hepatitis C virus (HCV) infection is a leading cause of liver cirrhosis and
      cancer. Cell entry of HCV and other pathogens is mediated by tight junction (TJ) 
      proteins, but successful therapeutic targeting of TJ proteins has not been
      reported yet. Using a human liver-chimeric mouse model, we show that a monoclonal
      antibody specific for the TJ protein claudin-1 (ref. 7) eliminates chronic HCV
      infection without detectable toxicity. This antibody inhibits HCV entry,
      cell-cell transmission and virus-induced signaling events. Antibody treatment
      reduces the number of HCV-infected hepatocytes in vivo, highlighting the need for
      de novo infection by means of host entry factors to maintain chronic infection.
      In summary, we demonstrate that an antibody targeting a virus receptor can cure
      chronic viral infection and uncover TJ proteins as targets for antiviral therapy.
FAU - Mailly, Laurent
AU  - Mailly L
AD  - Institut National de la Sante et de la Recherche Medicale, U1110, Strasbourg,
      France.
AD  - Universite de Strasbourg, Strasbourg, France.
FAU - Xiao, Fei
AU  - Xiao F
AD  - Institut National de la Sante et de la Recherche Medicale, U1110, Strasbourg,
      France.
AD  - Universite de Strasbourg, Strasbourg, France.
FAU - Lupberger, Joachim
AU  - Lupberger J
AD  - Institut National de la Sante et de la Recherche Medicale, U1110, Strasbourg,
      France.
AD  - Universite de Strasbourg, Strasbourg, France.
FAU - Wilson, Garrick K
AU  - Wilson GK
AD  - Hepatitis C Research Group, Institute for Biomedical Research, University of
      Birmingham, Birmingham, United Kingdom.
FAU - Aubert, Philippe
AU  - Aubert P
AD  - Institut National de la Sante et de la Recherche Medicale, U913, Nantes, France.
AD  - Universite de Nantes, Nantes, France.
AD  - Institut des Maladies de l'Appareil Digestif, CHU Nantes, Hopital Hotel-Dieu,
      Nantes, France.
FAU - Duong, Francois H T
AU  - Duong FHT
AD  - Department of Biomedicine, Hepatology Laboratory, University of Basel, Basel,
      Switzerland.
FAU - Calabrese, Diego
AU  - Calabrese D
AD  - Department of Biomedicine, Hepatology Laboratory, University of Basel, Basel,
      Switzerland.
FAU - Leboeuf, Celine
AU  - Leboeuf C
AD  - Institut National de la Sante et de la Recherche Medicale, U1110, Strasbourg,
      France.
AD  - Universite de Strasbourg, Strasbourg, France.
FAU - Fofana, Isabel
AU  - Fofana I
AD  - Institut National de la Sante et de la Recherche Medicale, U1110, Strasbourg,
      France.
AD  - Universite de Strasbourg, Strasbourg, France.
FAU - Thumann, Christine
AU  - Thumann C
AD  - Institut National de la Sante et de la Recherche Medicale, U1110, Strasbourg,
      France.
AD  - Universite de Strasbourg, Strasbourg, France.
FAU - Bandiera, Simonetta
AU  - Bandiera S
AD  - Institut National de la Sante et de la Recherche Medicale, U1110, Strasbourg,
      France.
AD  - Universite de Strasbourg, Strasbourg, France.
FAU - Lutgehetmann, Marc
AU  - Lutgehetmann M
AD  - I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, 
      Hamburg, Germany.
FAU - Volz, Tassilo
AU  - Volz T
AD  - I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, 
      Hamburg, Germany.
FAU - Davis, Christopher
AU  - Davis C
AD  - Hepatitis C Research Group, Institute for Biomedical Research, University of
      Birmingham, Birmingham, United Kingdom.
FAU - Harris, Helen J
AU  - Harris HJ
AD  - Hepatitis C Research Group, Institute for Biomedical Research, University of
      Birmingham, Birmingham, United Kingdom.
FAU - Mee, Christopher J
AU  - Mee CJ
AD  - Hepatitis C Research Group, Institute for Biomedical Research, University of
      Birmingham, Birmingham, United Kingdom.
FAU - Girardi, Erika
AU  - Girardi E
AD  - Universite de Strasbourg, Strasbourg, France.
AD  - Architecture et Reactivite de l'ARN, Institut de Biologie Moleculaire et
      Cellulaire du CNRS - UPR 9002, Strasbourg, France.
FAU - Chane-Woon-Ming, Beatrice
AU  - Chane-Woon-Ming B
AD  - Universite de Strasbourg, Strasbourg, France.
AD  - Architecture et Reactivite de l'ARN, Institut de Biologie Moleculaire et
      Cellulaire du CNRS - UPR 9002, Strasbourg, France.
FAU - Ericsson, Maria
AU  - Ericsson M
AD  - Electron Microscopy Facility, Harvard Medical School, Boston, USA.
FAU - Fletcher, Nicola
AU  - Fletcher N
AD  - Universite de Nantes, Nantes, France.
FAU - Bartenschlager, Ralf
AU  - Bartenschlager R
AD  - Department of Infectious Diseases, Molecular Virology, Heidelberg University,
      Heidelberg, Germany.
AD  - German Centre for Infection Research, Heidelberg University, Heidelberg, Germany.
FAU - Pessaux, Patrick
AU  - Pessaux P
AD  - Institut National de la Sante et de la Recherche Medicale, U1110, Strasbourg,
      France.
AD  - Universite de Strasbourg, Strasbourg, France.
AD  - Pole Hepato-Digestif, Institut Hopitalo-Universitaire, Hopitaux Universitaires de
      Strasbourg, Strasbourg, France.
FAU - Vercauteren, Koen
AU  - Vercauteren K
AD  - Center for Vaccinology, Ghent University, Ghent, Belgium.
FAU - Meuleman, Philip
AU  - Meuleman P
AD  - Center for Vaccinology, Ghent University, Ghent, Belgium.
FAU - Villa, Pascal
AU  - Villa P
AD  - Universite de Strasbourg, Strasbourg, France.
AD  - Plateforme de Chimie Biologique Integrative de Strasbourg, UMS 3286 CNRS-UdS &
      FMTS, Illkirch, France.
FAU - Kaderali, Lars
AU  - Kaderali L
AD  - Institute for Medical Informatics and Biometry, Medical Faculty, Technische
      Universitat Dresden, Dresden, Germany.
FAU - Pfeffer, Sebastien
AU  - Pfeffer S
AD  - Universite de Strasbourg, Strasbourg, France.
AD  - Architecture et Reactivite de l'ARN, Institut de Biologie Moleculaire et
      Cellulaire du CNRS - UPR 9002, Strasbourg, France.
FAU - Heim, Markus H
AU  - Heim MH
AD  - Department of Biomedicine, Hepatology Laboratory, University of Basel, Basel,
      Switzerland.
FAU - Neunlist, Michel
AU  - Neunlist M
AD  - Institut National de la Sante et de la Recherche Medicale, U913, Nantes, France.
AD  - Universite de Nantes, Nantes, France.
AD  - Institut des Maladies de l'Appareil Digestif, CHU Nantes, Hopital Hotel-Dieu,
      Nantes, France.
FAU - Zeisel, Mirjam B
AU  - Zeisel MB
AD  - Institut National de la Sante et de la Recherche Medicale, U1110, Strasbourg,
      France.
AD  - Universite de Strasbourg, Strasbourg, France.
FAU - Dandri, Maura
AU  - Dandri M
AD  - I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, 
      Hamburg, Germany.
FAU - McKeating, Jane A
AU  - McKeating JA
AD  - Hepatitis C Research Group, Institute for Biomedical Research, University of
      Birmingham, Birmingham, United Kingdom.
FAU - Robinet, Eric
AU  - Robinet E
AD  - Institut National de la Sante et de la Recherche Medicale, U1110, Strasbourg,
      France.
AD  - Universite de Strasbourg, Strasbourg, France.
FAU - Baumert, Thomas F
AU  - Baumert TF
AD  - Institut National de la Sante et de la Recherche Medicale, U1110, Strasbourg,
      France.
AD  - Universite de Strasbourg, Strasbourg, France.
AD  - Pole Hepato-Digestif, Institut Hopitalo-Universitaire, Hopitaux Universitaires de
      Strasbourg, Strasbourg, France.
LA  - eng
GR  - 260767/European Research Council/International
GR  - G1100247/Medical Research Council/United Kingdom
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150323
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antibodies, Monoclonal)
RN  - 0 (Antibodies, Monoclonal, Humanized)
RN  - 0 (Claudin-1)
SB  - IM
CIN - Nat Rev Gastroenterol Hepatol. 2015 May;12(5):249. PMID: 25850009
MH  - Animals
MH  - Antibodies, Monoclonal/*administration & dosage/immunology
MH  - Antibodies, Monoclonal, Humanized/administration & dosage/immunology
MH  - Claudin-1/*immunology/therapeutic use
MH  - Hepacivirus/immunology/pathogenicity
MH  - Hepatitis C/immunology/*therapy/virology
MH  - Hepatocytes/immunology
MH  - Humans
MH  - Liver Cirrhosis/*immunology/therapy/virology
MH  - Mice
PMC - PMC4430301
MID - EMS61960
OID - NLM: EMS61960
EDAT- 2015/03/24 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/03/24 06:00
PHST- 2014/10/01 00:00 [received]
PHST- 2014/12/22 00:00 [accepted]
PHST- 2015/03/24 06:00 [entrez]
PHST- 2015/03/24 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - 10.1038/nbt.3179 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):549-554. doi: 10.1038/nbt.3179. Epub 2015 Mar 23.

PMID- 25798936
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20170603
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - MutMap accelerates breeding of a salt-tolerant rice cultivar.
PG  - 445-9
LID - 10.1038/nbt.3188 [doi]
FAU - Takagi, Hiroki
AU  - Takagi H
AD  - Iwate Biotechnology Research Center, Kitakami, Iwate, Japan.
FAU - Tamiru, Muluneh
AU  - Tamiru M
AD  - Iwate Biotechnology Research Center, Kitakami, Iwate, Japan.
FAU - Abe, Akira
AU  - Abe A
AD  - Iwate Biotechnology Research Center, Kitakami, Iwate, Japan.
FAU - Yoshida, Kentaro
AU  - Yoshida K
AD  - The Sainsbury Laboratory, Norwich Research Park, Norwich, UK.
FAU - Uemura, Aiko
AU  - Uemura A
AD  - Iwate Biotechnology Research Center, Kitakami, Iwate, Japan.
FAU - Yaegashi, Hiroki
AU  - Yaegashi H
AD  - Iwate Biotechnology Research Center, Kitakami, Iwate, Japan.
FAU - Obara, Tsutomu
AU  - Obara T
AD  - Iwate Biotechnology Research Center, Kitakami, Iwate, Japan.
FAU - Oikawa, Kaori
AU  - Oikawa K
AD  - Iwate Biotechnology Research Center, Kitakami, Iwate, Japan.
FAU - Utsushi, Hiroe
AU  - Utsushi H
AD  - Iwate Biotechnology Research Center, Kitakami, Iwate, Japan.
FAU - Kanzaki, Eiko
AU  - Kanzaki E
AD  - Iwate Biotechnology Research Center, Kitakami, Iwate, Japan.
FAU - Mitsuoka, Chikako
AU  - Mitsuoka C
AD  - Iwate Biotechnology Research Center, Kitakami, Iwate, Japan.
FAU - Natsume, Satoshi
AU  - Natsume S
AD  - Iwate Biotechnology Research Center, Kitakami, Iwate, Japan.
FAU - Kosugi, Shunichi
AU  - Kosugi S
AD  - Kazusa DNA Research Institute, Kisarazu, Chiba, Japan.
FAU - Kanzaki, Hiroyuki
AU  - Kanzaki H
AD  - Iwate Biotechnology Research Center, Kitakami, Iwate, Japan.
FAU - Matsumura, Hideo
AU  - Matsumura H
AD  - Gene Research Center, Shinshu University, Ueda, Nagano, Japan.
FAU - Urasaki, Naoya
AU  - Urasaki N
AD  - Okinawa Prefectural Agricultural Research Center, Itoman, Okinawa, Japan.
FAU - Kamoun, Sophien
AU  - Kamoun S
AUID- ORCID: 0000000202900315
AD  - The Sainsbury Laboratory, Norwich Research Park, Norwich, UK.
FAU - Terauchi, Ryohei
AU  - Terauchi R
AD  - Iwate Biotechnology Research Center, Kitakami, Iwate, Japan.
LA  - eng
GR  - Biotechnology and Biological Sciences Research Council/United Kingdom
PT  - Letter
PT  - Research Support, Non-U.S. Gov't
DEP - 20150323
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 451W47IQ8X (Sodium Chloride)
SB  - IM
MH  - Agriculture
MH  - *Breeding
MH  - Humans
MH  - Oryza/*genetics/growth & development/metabolism
MH  - Salt-Tolerance/*genetics
MH  - Sodium Chloride/toxicity
EDAT- 2015/03/24 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/03/24 06:00
PHST- 2015/03/24 06:00 [entrez]
PHST- 2015/03/24 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - nbt.3188 [pii]
AID - 10.1038/nbt.3188 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):445-9. doi: 10.1038/nbt.3188. Epub 2015 Mar 23.

PMID- 25690854
OWN - NLM
STAT- MEDLINE
DCOM- 20160211
LR  - 20170603
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 5
DP  - 2015 May
TI  - C2H2 zinc finger proteins greatly expand the human regulatory lexicon.
PG  - 555-62
LID - 10.1038/nbt.3128 [doi]
AB  - Cys2-His2 zinc finger (C2H2-ZF) proteins represent the largest class of putative 
      human transcription factors. However, for most C2H2-ZF proteins it is unknown
      whether they even bind DNA or, if they do, to which sequences. Here, by combining
      data from a modified bacterial one-hybrid system with protein-binding microarray 
      and chromatin immunoprecipitation analyses, we show that natural C2H2-ZFs encoded
      in the human genome bind DNA both in vitro and in vivo, and we infer the DNA
      recognition code using DNA-binding data for thousands of natural C2H2-ZF domains.
      In vivo binding data are generally consistent with our recognition code and
      indicate that C2H2-ZF proteins recognize more motifs than all other human
      transcription factors combined. We provide direct evidence that most
      KRAB-containing C2H2-ZF proteins bind specific endogenous retroelements (EREs),
      ranging from currently active to ancient families. The majority of C2H2-ZF
      proteins, including KRAB proteins, also show widespread binding to regulatory
      regions, indicating that the human genome contains an extensive and largely
      unstudied adaptive C2H2-ZF regulatory network that targets a diverse range of
      genes and pathways.
FAU - Najafabadi, Hamed S
AU  - Najafabadi HS
AD  - Donnelly Centre for Cellular and Biomolecular Research, University of Toronto,
      Toronto, Ontario, Canada.
FAU - Mnaimneh, Sanie
AU  - Mnaimneh S
AD  - Donnelly Centre for Cellular and Biomolecular Research, University of Toronto,
      Toronto, Ontario, Canada.
FAU - Schmitges, Frank W
AU  - Schmitges FW
AD  - Donnelly Centre for Cellular and Biomolecular Research, University of Toronto,
      Toronto, Ontario, Canada.
FAU - Garton, Michael
AU  - Garton M
AD  - Donnelly Centre for Cellular and Biomolecular Research, University of Toronto,
      Toronto, Ontario, Canada.
FAU - Lam, Kathy N
AU  - Lam KN
AD  - Department of Molecular Genetics, University of Toronto, Toronto, Ontario,
      Canada.
FAU - Yang, Ally
AU  - Yang A
AUID- ORCID: 0000000286780946
AD  - Donnelly Centre for Cellular and Biomolecular Research, University of Toronto,
      Toronto, Ontario, Canada.
FAU - Albu, Mihai
AU  - Albu M
AD  - Donnelly Centre for Cellular and Biomolecular Research, University of Toronto,
      Toronto, Ontario, Canada.
FAU - Weirauch, Matthew T
AU  - Weirauch MT
AD  - 1] Center for Autoimmune Genomics and Etiology (CAGE) and Divisions of Biomedical
      Informatics and Developmental Biology, Cincinnati Children's Hospital Medical
      Center, Cincinnati, Ohio, USA. [2] Canadian Institutes for Advanced Research,
      Toronto, Ontario, Canada.
FAU - Radovani, Ernest
AU  - Radovani E
AD  - Department of Molecular Genetics, University of Toronto, Toronto, Ontario,
      Canada.
FAU - Kim, Philip M
AU  - Kim PM
AD  - 1] Donnelly Centre for Cellular and Biomolecular Research, University of Toronto,
      Toronto, Ontario, Canada. [2] Department of Molecular Genetics, University of
      Toronto, Toronto, Ontario, Canada. [3] Department of Computer Science, University
      of Toronto, Toronto, Ontario, Canada.
FAU - Greenblatt, Jack
AU  - Greenblatt J
AD  - 1] Donnelly Centre for Cellular and Biomolecular Research, University of Toronto,
      Toronto, Ontario, Canada. [2] Department of Molecular Genetics, University of
      Toronto, Toronto, Ontario, Canada.
FAU - Frey, Brendan J
AU  - Frey BJ
AD  - 1] Donnelly Centre for Cellular and Biomolecular Research, University of Toronto,
      Toronto, Ontario, Canada. [2] Canadian Institutes for Advanced Research, Toronto,
      Ontario, Canada. [3] Department of Computer Science, University of Toronto,
      Toronto, Ontario, Canada. [4] Department of Electrical and Computer Engineering, 
      University of Toronto, Toronto, Ontario, Canada.
FAU - Hughes, Timothy R
AU  - Hughes TR
AD  - 1] Donnelly Centre for Cellular and Biomolecular Research, University of Toronto,
      Toronto, Ontario, Canada. [2] Department of Molecular Genetics, University of
      Toronto, Toronto, Ontario, Canada. [3] Canadian Institutes for Advanced Research,
      Toronto, Ontario, Canada.
LA  - eng
SI  - GEO/GSE52523
GR  - MOP-111007/Canadian Institutes of Health Research/Canada
GR  - MOP-272138/Canadian Institutes of Health Research/Canada
GR  - MOP-77721/Canadian Institutes of Health Research/Canada
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150218
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (BCL11A protein, human)
RN  - 0 (Carrier Proteins)
RN  - 0 (Chromatin)
RN  - 0 (DNA-Binding Proteins)
RN  - 0 (Nuclear Proteins)
RN  - 0 (Repressor Proteins)
RN  - 0 (Retroelements)
RN  - 0 (ZNF350 protein, human)
SB  - IM
MH  - Carrier Proteins/genetics/*metabolism
MH  - Chromatin/metabolism
MH  - DNA-Binding Proteins/genetics
MH  - Gene Expression Regulation
MH  - *Genome, Human
MH  - Humans
MH  - Nuclear Proteins/genetics/*metabolism
MH  - Protein Binding
MH  - Regulatory Sequences, Nucleic Acid
MH  - Repressor Proteins/genetics/*metabolism
MH  - Retroelements/*genetics
EDAT- 2015/02/19 06:00
MHDA- 2016/02/13 06:00
CRDT- 2015/02/19 06:00
PHST- 2014/07/12 00:00 [received]
PHST- 2014/12/15 00:00 [accepted]
PHST- 2015/02/19 06:00 [entrez]
PHST- 2015/02/19 06:00 [pubmed]
PHST- 2016/02/13 06:00 [medline]
AID - nbt.3128 [pii]
AID - 10.1038/nbt.3128 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 May;33(5):555-62. doi: 10.1038/nbt.3128. Epub 2015 Feb 18.

PMID- 26042230
OWN - NLM
STAT- MEDLINE
DCOM- 20160321
LR  - 20150603
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 4
DP  - 2015 Apr
TI  - Dogs, humans and lymphoma therapy.
PG  - 324
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 4F4X42SYQ6 (Rituximab)
SB  - IM
MH  - Animals
MH  - Dog Diseases/*drug therapy
MH  - Dogs
MH  - Drug Approval
MH  - Drug Design
MH  - Drug Industry/*trends
MH  - Humans
MH  - Lymphoma/drug therapy/*veterinary
MH  - Rituximab/*therapeutic use
MH  - Species Specificity
MH  - Treatment Outcome
MH  - United States
MH  - United States Department of Agriculture
EDAT- 2015/06/05 06:00
MHDA- 2016/03/22 06:00
CRDT- 2015/06/05 06:00
PHST- 2015/06/05 06:00 [entrez]
PHST- 2015/06/05 06:00 [pubmed]
PHST- 2016/03/22 06:00 [medline]
PST - ppublish
SO  - Nat Biotechnol. 2015 Apr;33(4):324.

PMID- 25850063
OWN - NLM
STAT- MEDLINE
DCOM- 20160321
LR  - 20170603
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 4
DP  - 2015 Apr
TI  - Expanding ELSI to all areas of innovative science and technology.
PG  - 425-6
LID - 10.1038/nbt.3193 [doi]
AB  - New curricula in the study of the ethical, legal and social implications of
      scientific research aims to further the conversation among all stakeholders in
      the interactions between science, technology and society.
FAU - Greenbaum, Dov
AU  - Greenbaum D
AD  - Zvi Meitar Institute for Legal Implications of Emerging Technologies, Radzyner
      Law School, Interdisciplinary Center, Herzliya, Israel, and the Department of
      Molecular Biophysics and Biochemistry, Yale University School of Medicine, New
      Haven, Connecticut, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Academies and Institutes/*organization & administration
MH  - Bioethics/*education
MH  - Biotechnology/*education
MH  - Curriculum
MH  - *Inventions
MH  - Israel
MH  - Science/*education
EDAT- 2015/04/08 06:00
MHDA- 2016/03/22 06:00
CRDT- 2015/04/08 06:00
PHST- 2015/04/08 06:00 [entrez]
PHST- 2015/04/08 06:00 [pubmed]
PHST- 2016/03/22 06:00 [medline]
AID - nbt.3193 [pii]
AID - 10.1038/nbt.3193 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Apr;33(4):425-6. doi: 10.1038/nbt.3193.

PMID- 25850062
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20150903
LR  - 20150408
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 4
DP  - 2015 Apr
TI  - Corrigendum: Network deconvolution as a general method to distinguish direct
      dependencies in networks.
PG  - 424
LID - 10.1038/nbt0415-424 [doi]
FAU - Feizi, Soheil
AU  - Feizi S
FAU - Marbach, Daniel
AU  - Marbach D
FAU - Medard, Muriel
AU  - Medard M
FAU - Kellis, Manolis
AU  - Kellis M
LA  - eng
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2013 Aug;31(8):726-33. PMID: 23851448
EDAT- 2015/04/08 06:00
MHDA- 2015/04/08 06:01
CRDT- 2015/04/08 06:00
PHST- 2015/04/08 06:00 [entrez]
PHST- 2015/04/08 06:00 [pubmed]
PHST- 2015/04/08 06:01 [medline]
AID - nbt0415-424 [pii]
AID - 10.1038/nbt0415-424 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Apr;33(4):424. doi: 10.1038/nbt0415-424.

PMID- 25850061
OWN - NLM
STAT- MEDLINE
DCOM- 20160321
LR  - 20161025
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 4
DP  - 2015 Apr
TI  - Federalist principles for healthcare data networks.
PG  - 360-3
LID - 10.1038/nbt.3180 [doi]
AB  - Applying federalist principles to networked health record data could facilitate
      realization of the potential of shared health data.
FAU - Mandl, Kenneth D
AU  - Mandl KD
AD  - Boston Children's Hospital, Boston and Harvard Medical School, Boston,
      Massachusetts, USA.
FAU - Kohane, Isaac S
AU  - Kohane IS
AD  - Boston Children's Hospital, Boston and Harvard Medical School, Boston,
      Massachusetts, USA.
LA  - eng
GR  - R01 GM104303/GM/NIGMS NIH HHS/United States
GR  - R01 LM011185/LM/NLM NIH HHS/United States
GR  - U01 HL121518/HL/NHLBI NIH HHS/United States
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Computer Communication Networks/*organization & administration
MH  - Confidentiality
MH  - Electronic Health Records/*organization & administration
MH  - Information Storage and Retrieval/*methods
MH  - Internet/*organization & administration
MH  - Medical Record Linkage/*methods
MH  - *Models, Organizational
PMC - PMC4392383
MID - NIHMS672480
EDAT- 2015/04/08 06:00
MHDA- 2016/03/22 06:00
CRDT- 2015/04/08 06:00
PHST- 2015/04/08 06:00 [entrez]
PHST- 2015/04/08 06:00 [pubmed]
PHST- 2016/03/22 06:00 [medline]
AID - nbt.3180 [pii]
AID - 10.1038/nbt.3180 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Apr;33(4):360-3. doi: 10.1038/nbt.3180.

PMID- 25850059
OWN - NLM
STAT- MEDLINE
DCOM- 20150903
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 4
DP  - 2015 Apr
TI  - Genetic variation and alternative splicing.
PG  - 357-9
LID - 10.1038/nbt.3195 [doi]
FAU - Estivill, Xavier
AU  - Estivill X
AD  - Center for Genomic Regulation (CRG), Pompeu Fabra University (UPF), and Dexeus
      Women's Health, Quiron-Dexeus University Institute, Barcelona, Spain.
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Science. 2015 Jan 9;347(6218):1254806. PMID: 25525159
MH  - *Artificial Intelligence
MH  - Child Development Disorders, Pervasive/*genetics
MH  - Colorectal Neoplasms, Hereditary Nonpolyposis/*genetics
MH  - Genome-Wide Association Study/*methods
MH  - Humans
MH  - Molecular Sequence Annotation/*methods
MH  - Muscular Atrophy, Spinal/*genetics
MH  - RNA Splicing/*genetics
EDAT- 2015/04/08 06:00
MHDA- 2015/09/04 06:00
CRDT- 2015/04/08 06:00
PHST- 2015/04/08 06:00 [entrez]
PHST- 2015/04/08 06:00 [pubmed]
PHST- 2015/09/04 06:00 [medline]
AID - nbt.3195 [pii]
AID - 10.1038/nbt.3195 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Apr;33(4):357-9. doi: 10.1038/nbt.3195.

PMID- 25850058
OWN - NLM
STAT- MEDLINE
DCOM- 20160322
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 4
DP  - 2015 Apr
TI  - A dynamic picture of protein behavior in cells.
PG  - 356-7
LID - 10.1038/nbt.3196 [doi]
FAU - Teruel, Mary N
AU  - Teruel MN
AD  - Department of Chemical and Systems Biology, Stanford University, Stanford,
      California, USA.
FAU - Gu, Bo
AU  - Gu B
AD  - Department of Chemical and Systems Biology, Stanford University, Stanford,
      California, USA.
FAU - Zhao, Michael L
AU  - Zhao ML
AD  - Department of Chemical and Systems Biology, Stanford University, Stanford,
      California, USA.
LA  - eng
GR  - P50 GM107615/GM/NIGMS NIH HHS/United States
GR  - R01 DK101743/DK/NIDDK NIH HHS/United States
GR  - R01 DK106241/DK/NIDDK NIH HHS/United States
GR  - T32 HG000044/HG/NHGRI NIH HHS/United States
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Proteome)
SB  - IM
CON - Nat Biotechnol. 2015 Apr;33(4):384-9. PMID: 25774713
MH  - High-Throughput Screening Assays/*methods
MH  - Protein Interaction Mapping/*methods
MH  - Proteome/*metabolism
MH  - Spectrometry, Fluorescence/*methods
MH  - Subcellular Fractions/*metabolism
PMC - PMC4947550
MID - NIHMS741644
EDAT- 2015/04/08 06:00
MHDA- 2016/03/24 06:00
CRDT- 2015/04/08 06:00
PHST- 2015/04/08 06:00 [entrez]
PHST- 2015/04/08 06:00 [pubmed]
PHST- 2016/03/24 06:00 [medline]
AID - nbt.3196 [pii]
AID - 10.1038/nbt.3196 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Apr;33(4):356-7. doi: 10.1038/nbt.3196.

PMID- 25850057
OWN - NLM
STAT- MEDLINE
DCOM- 20160322
LR  - 20170603
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 4
DP  - 2015 Apr
TI  - Improving reference epigenome catalogs by computational prediction.
PG  - 354-5
LID - 10.1038/nbt.3194 [doi]
FAU - Ebert, Peter
AU  - Ebert P
AD  - 1] Max Planck Institute for Informatics, Saarbrucken, Germany. [2] Graduate
      School of Computer Science, Saarland University, Saarbrucken, Germany.
FAU - Bock, Christoph
AU  - Bock C
AD  - 1] Max Planck Institute for Informatics, Saarbrucken, Germany. [2] CeMM Research 
      Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna,
      Austria, and the Department of Laboratory Medicine, Medical University of Vienna,
      Vienna, Austria.
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2015 Apr;33(4):364-76. PMID: 25690853
MH  - Chromosome Mapping/*methods
MH  - Data Curation/*methods
MH  - *Database Management Systems
MH  - *Databases, Genetic
MH  - Epigenesis, Genetic/*physiology
MH  - Genome, Human/*genetics
MH  - Humans
EDAT- 2015/04/08 06:00
MHDA- 2016/03/24 06:00
CRDT- 2015/04/08 06:00
PHST- 2015/04/08 06:00 [entrez]
PHST- 2015/04/08 06:00 [pubmed]
PHST- 2016/03/24 06:00 [medline]
AID - nbt.3194 [pii]
AID - 10.1038/nbt.3194 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Apr;33(4):354-5. doi: 10.1038/nbt.3194.

PMID- 25850055
OWN - NLM
STAT- MEDLINE
DCOM- 20160321
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 4
DP  - 2015 Apr
TI  - Are the gene-patent storm clouds dissipating? A global snapshot.
PG  - 347-52
LID - 10.1038/nbt.3182 [doi]
AB  - In genetic diagnostics testing, what are the boundaries of the global patent
      problem, and is there a real risk that patents and licensing practices could
      impede access to tests?
FAU - Liddicoat, Johnathon
AU  - Liddicoat J
AD  - Centre for Law and Genetics, Faculty of Law, University of Tasmania, Hobart,
      Tasmania, Australia.
FAU - Whitton, Tess
AU  - Whitton T
AD  - Centre for Law and Genetics, Faculty of Law, University of Tasmania, Hobart,
      Tasmania, Australia.
FAU - Nicol, Dianne
AU  - Nicol D
AUID- ORCID: 0000000265532839
AD  - Centre for Law and Genetics, Faculty of Law, University of Tasmania, Hobart,
      Tasmania, Australia.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Cytogenetics/*legislation & jurisprudence
MH  - Genetic Testing/*legislation & jurisprudence
MH  - Genetics/*legislation & jurisprudence
MH  - *Internationality
MH  - Patents as Topic/*legislation & jurisprudence
MH  - United States
EDAT- 2015/04/08 06:00
MHDA- 2016/03/22 06:00
CRDT- 2015/04/08 06:00
PHST- 2015/04/08 06:00 [entrez]
PHST- 2015/04/08 06:00 [pubmed]
PHST- 2016/03/22 06:00 [medline]
AID - nbt.3182 [pii]
AID - 10.1038/nbt.3182 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Apr;33(4):347-52. doi: 10.1038/nbt.3182.

PMID- 25850054
OWN - NLM
STAT- MEDLINE
DCOM- 20150903
LR  - 20180316
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 4
DP  - 2015 Apr
TI  - Opportunities for drug repositioning from phenome-wide association studies.
PG  - 342-5
LID - 10.1038/nbt.3183 [doi]
FAU - Rastegar-Mojarad, Majid
AU  - Rastegar-Mojarad M
AUID- ORCID: 0000000169623554
AD  - 1] Biomedical Informatics Research Center, Marshfield Clinic Research Foundation,
      Marshfield, Wisconsin, USA. [2] Biomedical Statistics and Bioinformatics, Mayo
      Clinic, Rochester, Minnesota, USA and Nationwide Children's Hospital, Columbus,
      Ohio, USA.
FAU - Ye, Zhan
AU  - Ye Z
AUID- ORCID: 0000000204260382
AD  - Biomedical Informatics Research Center, Marshfield Clinic Research Foundation,
      Marshfield, Wisconsin, USA.
FAU - Kolesar, Jill M
AU  - Kolesar JM
AD  - School of Pharmacy, University of Wisconsin, Madison, Wisconsin, USA.
FAU - Hebbring, Scott J
AU  - Hebbring SJ
AD  - Center for Human Genetics, Marshfield Clinic Research Foundation, Marshfield,
      Wisconsin, USA.
FAU - Lin, Simon M
AU  - Lin SM
AD  - 1] Biomedical Informatics Research Center, Marshfield Clinic Research Foundation,
      Marshfield, Wisconsin, USA. [2] Biomedical Statistics and Bioinformatics, Mayo
      Clinic, Rochester, Minnesota, USA and Nationwide Children's Hospital, Columbus,
      Ohio, USA.
LA  - eng
GR  - 1K22LM011938/LM/NLM NIH HHS/United States
GR  - UL1TR000427/TR/NCATS NIH HHS/United States
PT  - Comment
PT  - Letter
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2013 Dec;31(12):1102-10. PMID: 24270849
MH  - Electronic Health Records/*statistics & numerical data
MH  - Genetic Predisposition to Disease/*epidemiology/*genetics
MH  - Genome-Wide Association Study/*methods/*statistics & numerical data
MH  - Humans
MH  - Medical Record Linkage/*methods
MH  - Polymorphism, Single Nucleotide/*genetics
EDAT- 2015/04/08 06:00
MHDA- 2015/09/04 06:00
CRDT- 2015/04/08 06:00
PHST- 2015/04/08 06:00 [entrez]
PHST- 2015/04/08 06:00 [pubmed]
PHST- 2015/09/04 06:00 [medline]
AID - nbt.3183 [pii]
AID - 10.1038/nbt.3183 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Apr;33(4):342-5. doi: 10.1038/nbt.3183.

PMID- 25850053
OWN - NLM
STAT- MEDLINE
DCOM- 20150903
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 4
DP  - 2015 Apr
TI  - Response to letter of correspondence - Bastiaens et al.
PG  - 339-42
LID - 10.1038/nbt.3184 [doi]
FAU - Barzel, Baruch
AU  - Barzel B
AD  - 1] Center for Complex Network Research and Departments of Physics, Computer
      Science and Biology, Northeastern University, Boston, Massachusetts, USA. [2]
      Center for Cancer Systems Biology, Dana-Farber Cancer Institute, Harvard Medical 
      School, Boston, Massachusetts, USA.
FAU - Barabasi, Albert-Laszlo
AU  - Barabasi AL
AD  - 1] Center for Complex Network Research and Departments of Physics, Computer
      Science and Biology, Northeastern University, Boston, Massachusetts, USA. [2]
      Center for Cancer Systems Biology, Dana-Farber Cancer Institute, Harvard Medical 
      School, Boston, Massachusetts, USA. [3] Department of Medicine, Brigham and
      Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
LA  - eng
PT  - Comment
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2013 Aug;31(8):720-5. PMID: 23851447
CON - Nat Biotechnol. 2015 Apr;33(4):336-9. PMID: 25850052
MH  - *Gene Regulatory Networks
MH  - *Models, Theoretical
EDAT- 2015/04/08 06:00
MHDA- 2015/09/04 06:00
CRDT- 2015/04/08 06:00
PHST- 2015/04/08 06:00 [entrez]
PHST- 2015/04/08 06:00 [pubmed]
PHST- 2015/09/04 06:00 [medline]
AID - nbt.3184 [pii]
AID - 10.1038/nbt.3184 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Apr;33(4):339-42. doi: 10.1038/nbt.3184.

PMID- 25850052
OWN - NLM
STAT- MEDLINE
DCOM- 20150903
LR  - 20171118
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 4
DP  - 2015 Apr
TI  - Silence on the relevant literature and errors in implementation.
PG  - 336-9
LID - 10.1038/nbt.3185 [doi]
FAU - Bastiaens, Philippe
AU  - Bastiaens P
AD  - Department of Systemic Cell Biology, Max Planck Institute of Molecular
      Physiology, Dortmund, Germany.
FAU - Birtwistle, Marc R
AU  - Birtwistle MR
AD  - Icahn School of Medicine at Mount Sinai, Dept. of Pharmacology and Systems
      Therapeutics, New York, New York, USA.
FAU - Bluthgen, Nils
AU  - Bluthgen N
AD  - 1] Institut fur Pathologie Charite, Universitatsmedizin Berlin, Campus Mitte,
      Berlin, Germany. [2] Integrative Research Institute for the Life Sciences,
      Humboldt University Berlin, Berlin, Germany.
FAU - Bruggeman, Frank J
AU  - Bruggeman FJ
AD  - Systems Bioinformatics, VU University, Amsterdam, The Netherlands.
FAU - Cho, Kwang-Hyun
AU  - Cho KH
AD  - Department of Bio and Brain Engineering, Korea Advanced Institute of Science and 
      Technology (KAIST), Yuseong-gu, Daejeon, Republic of Korea.
FAU - Cosentino, Carlo
AU  - Cosentino C
AUID- ORCID: 0000000157681829
AD  - Department of Experimental and Clinical Medicine, Magna Graecia University of
      Catanzaro, Campus Salvatore Venuta, Catanzaro, Italy.
FAU - de la Fuente, Alberto
AU  - de la Fuente A
AD  - Department of Biomathematics and Bioinformatics, Institute for Genetics and
      Biometry, Leibniz Institute for Farm Animal Biology, Dummerstorf,
      Mecklenburg-Vorpommern, Germany.
FAU - Hoek, Jan B
AU  - Hoek JB
AD  - Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University,
      Philadelphia, Pennsylvania, USA.
FAU - Kiyatkin, Anatoly
AU  - Kiyatkin A
AUID- ORCID: 0000000250606081
AD  - Department of Physiology, Perelman School of Medicine, University of
      Pennsylvania, Philadelphia, Pennsylvania, USA.
FAU - Klamt, Steffen
AU  - Klamt S
AD  - Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg,
      Germany.
FAU - Kolch, Walter
AU  - Kolch W
AUID- ORCID: 0000000157775016
AD  - 1] Systems Biology Ireland, University College Dublin, Belfield, Dublin, Ireland.
      [2] Conway Institute of Biomolecular and Biomedical Research, University College 
      Dublin, Belfield, Dublin, Ireland. [3] School of Medicine and Medical Science,
      University College Dublin, Belfield, Dublin, Ireland.
FAU - Legewie, Stefan
AU  - Legewie S
AD  - Institute of Molecular Biology (IMB), Mainz, Germany.
FAU - Mendes, Pedro
AU  - Mendes P
AUID- ORCID: 0000000165079168
AD  - 1] Manchester Centre for Integrative Systems Biology, Manchester Institute of
      Biotechnology, The University of Manchester, Manchester, UK. [2] School of
      Computer Science, Manchester Institute of Biotechnology, The University of
      Manchester, Manchester, UK. [3] Center for Quantitative Medicine, University of
      Connecticut Health Center, Farmington, Connecticut, USA.
FAU - Naka, Takashi
AU  - Naka T
AD  - Faculty of Information Science, Kyushu Sangyo University, Higashi-ku, Fukuoka,
      Japan.
FAU - Santra, Tapesh
AU  - Santra T
AD  - Systems Biology Ireland, University College Dublin, Belfield, Dublin, Ireland.
FAU - Sontag, Eduardo
AU  - Sontag E
AD  - Department of Mathematics and Cancer Institute of New Jersey, Rutgers University,
      Piscataway, New Jersey, USA.
FAU - Westerhoff, Hans V
AU  - Westerhoff HV
AD  - 1] Manchester Centre for Integrative Systems Biology, Manchester Institute of
      Biotechnology, The University of Manchester, Manchester, UK. [2] Molecular Cell
      Physiology, VU University, Amsterdam, The Netherlands. [3] Synthetic Systems
      Biology, Swammerdam Institute for Life Sciences, Faculty of Science, University
      of Amsterdam, Amsterdam, The Netherlands.
FAU - Kholodenko, Boris N
AU  - Kholodenko BN
AD  - 1] Systems Biology Ireland, University College Dublin, Belfield, Dublin, Ireland.
      [2] Conway Institute of Biomolecular and Biomedical Research, University College 
      Dublin, Belfield, Dublin, Ireland. [3] School of Medicine and Medical Science,
      University College Dublin, Belfield, Dublin, Ireland.
LA  - eng
GR  - BB/C008219/1/Biotechnology and Biological Sciences Research Council/United
      Kingdom
GR  - BB/F003528/1/Biotechnology and Biological Sciences Research Council/United
      Kingdom
GR  - P50 GM071558/GM/NIGMS NIH HHS/United States
PT  - Comment
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2013 Aug;31(8):720-5. PMID: 23851447
CIN - Nat Biotechnol. 2015 Apr;33(4):339-42. PMID: 25850053
MH  - *Gene Regulatory Networks
MH  - *Models, Theoretical
EDAT- 2015/04/08 06:00
MHDA- 2015/09/04 06:00
CRDT- 2015/04/08 06:00
PHST- 2015/04/08 06:00 [entrez]
PHST- 2015/04/08 06:00 [pubmed]
PHST- 2015/09/04 06:00 [medline]
AID - nbt.3185 [pii]
AID - 10.1038/nbt.3185 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Apr;33(4):336-9. doi: 10.1038/nbt.3185.

PMID- 25850051
OWN - NLM
STAT- MEDLINE
DCOM- 20160321
LR  - 20170603
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 4
DP  - 2015 Apr
TI  - The quintessence of immunogenicity reporting for biotherapeutics.
PG  - 334-6
LID - 10.1038/nbt.3181 [doi]
FAU - Shankar, Gopi
AU  - Shankar G
AD  - Janssen Research &Development, LLC (Johnson &Johnson), Spring House,
      Pennsylvania, USA.
FAU - Arkin, Steven
AU  - Arkin S
AD  - Pfizer Worldwide Research &Development, Cambridge, Massachusetts, USA.
FAU - Devanarayan, Viswanath
AU  - Devanarayan V
AD  - AbbVie, Inc., Chicago, Illinois, USA.
FAU - Kromminga, Arno
AU  - Kromminga A
AD  - IPM Biotech GmbH, Hamburg, Germany.
FAU - Quarmby, Valerie
AU  - Quarmby V
AD  - Genentech, South San Francisco, California, USA.
FAU - Richards, Susan
AU  - Richards S
AD  - Sanofi, Framingham, Massachusetts, USA.
FAU - Subramanyam, Meena
AU  - Subramanyam M
AD  - Biogen Idec, Cambridge, Massachusetts, USA.
FAU - Swanson, Steven
AU  - Swanson S
AD  - Amgen Inc., Thousand Oaks, California, USA.
LA  - eng
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Biological Products)
SB  - IM
MH  - Biological Products/*adverse effects/*immunology
MH  - Biopharmaceutics/*methods
MH  - *Disclosure
MH  - Drug Labeling/methods
MH  - Humans
MH  - Immune System Diseases/*chemically induced/*immunology
EDAT- 2015/04/08 06:00
MHDA- 2016/03/22 06:00
CRDT- 2015/04/08 06:00
PHST- 2015/04/08 06:00 [entrez]
PHST- 2015/04/08 06:00 [pubmed]
PHST- 2016/03/22 06:00 [medline]
AID - nbt.3181 [pii]
AID - 10.1038/nbt.3181 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Apr;33(4):334-6. doi: 10.1038/nbt.3181.

PMID- 25850050
OWN - NLM
STAT- MEDLINE
DCOM- 20160321
LR  - 20150408
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 4
DP  - 2015 Apr
TI  - First rounders podcast: Kari Stefansson.
PG  - 333
LID - 10.1038/nbt.3186 [doi]
FAU - Stefansson, Kari
AU  - Stefansson K
LA  - eng
PT  - Journal Article
PT  - Webcasts
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*organization & administration
MH  - *Chromosome Mapping
MH  - *Genetic Research
MH  - Iceland
MH  - *Leadership
EDAT- 2015/04/08 06:00
MHDA- 2016/03/22 06:00
CRDT- 2015/04/08 06:00
PHST- 2015/04/08 06:00 [entrez]
PHST- 2015/04/08 06:00 [pubmed]
PHST- 2016/03/22 06:00 [medline]
AID - nbt.3186 [pii]
AID - 10.1038/nbt.3186 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Apr;33(4):333. doi: 10.1038/nbt.3186.

PMID- 25850049
OWN - NLM
STAT- MEDLINE
DCOM- 20160321
LR  - 20150408
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 4
DP  - 2015 Apr
TI  - Academic partnerships 2014.
PG  - 333
LID - 10.1038/nbt.3189 [doi]
FAU - Huggett, Brady
AU  - Huggett B
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*statistics & numerical data
MH  - Drug Industry/*statistics & numerical data
MH  - *Interinstitutional Relations
MH  - Internationality
MH  - Public-Private Sector Partnerships/*statistics & numerical data
MH  - Universities/*statistics & numerical data
EDAT- 2015/04/08 06:00
MHDA- 2016/03/22 06:00
CRDT- 2015/04/08 06:00
PHST- 2015/04/08 06:00 [entrez]
PHST- 2015/04/08 06:00 [pubmed]
PHST- 2016/03/22 06:00 [medline]
AID - nbt.3189 [pii]
AID - 10.1038/nbt.3189 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Apr;33(4):333. doi: 10.1038/nbt.3189.

PMID- 25850048
OWN - NLM
STAT- MEDLINE
DCOM- 20160321
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 4
DP  - 2015 Apr
TI  - Engineers of scent.
PG  - 329-32
LID - 10.1038/nbt.3191 [doi]
AB  - Companies exploring biotech approaches to flavor and fragrance production must
      navigate challenges in regulations, market dynamics and public perception. Emily 
      Waltz investigates.
FAU - Waltz, Emily
AU  - Waltz E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Biological Products)
RN  - 0 (Food Additives)
SB  - IM
MH  - Bacteria/chemistry/*genetics
MH  - Biological Products/*chemical synthesis
MH  - *Food Additives
MH  - *Genetic Engineering
MH  - Government Regulation
MH  - *Odorants
MH  - *Public Opinion
MH  - United States
EDAT- 2015/04/08 06:00
MHDA- 2016/03/22 06:00
CRDT- 2015/04/08 06:00
PHST- 2015/04/08 06:00 [entrez]
PHST- 2015/04/08 06:00 [pubmed]
PHST- 2016/03/22 06:00 [medline]
AID - nbt.3191 [pii]
AID - 10.1038/nbt.3191 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Apr;33(4):329-32. doi: 10.1038/nbt.3191.

PMID- 25850047
OWN - NLM
STAT- MEDLINE
DCOM- 20160321
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 4
DP  - 2015 Apr
TI  - Monsanto adds dicamba to its cache to counter weed threat.
PG  - 328
LID - 10.1038/nbt0415-328 [doi]
FAU - Waltz, Emily
AU  - Waltz E
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Herbicides)
RN  - SJG3M6RY6H (Dicamba)
SB  - IM
MH  - Agriculture/*trends
MH  - Chemical Industry/*trends
MH  - Dicamba/*pharmacology
MH  - Drug Design
MH  - Herbicides/*pharmacology
MH  - Plant Weeds/*drug effects
EDAT- 2015/04/08 06:00
MHDA- 2016/03/22 06:00
CRDT- 2015/04/08 06:00
PHST- 2015/04/08 06:00 [entrez]
PHST- 2015/04/08 06:00 [pubmed]
PHST- 2016/03/22 06:00 [medline]
AID - nbt0415-328 [pii]
AID - 10.1038/nbt0415-328 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Apr;33(4):328. doi: 10.1038/nbt0415-328.

PMID- 25850045
OWN - NLM
STAT- MEDLINE
DCOM- 20160321
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 4
DP  - 2015 Apr
TI  - Nonbrowning GM apple cleared for market.
PG  - 326-7
LID - 10.1038/nbt0415-326c [doi]
FAU - Waltz, Emily
AU  - Waltz E
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Color
MH  - *Food, Genetically Modified
MH  - Fruit/*genetics
MH  - *Genetic Enhancement
MH  - Malus/*genetics
MH  - *Marketing
MH  - Plants, Genetically Modified/*genetics
MH  - United States
MH  - United States Department of Agriculture
EDAT- 2015/04/08 06:00
MHDA- 2016/03/22 06:00
CRDT- 2015/04/08 06:00
PHST- 2015/04/08 06:00 [entrez]
PHST- 2015/04/08 06:00 [pubmed]
PHST- 2016/03/22 06:00 [medline]
AID - nbt0415-326c [pii]
AID - 10.1038/nbt0415-326c [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Apr;33(4):326-7. doi: 10.1038/nbt0415-326c.

PMID- 25850042
OWN - NLM
STAT- MEDLINE
DCOM- 20160321
LR  - 20150408
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 4
DP  - 2015 Apr
TI  - Obama catapults patient-empowered Precision Medicine.
PG  - 325
LID - 10.1038/nbt0415-325 [doi]
FAU - Fox, Jeffrey L
AU  - Fox JL
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Crowdsourcing/*methods
MH  - *Databases, Genetic
MH  - *Government Programs
MH  - Humans
MH  - Patient Participation/*methods
MH  - Precision Medicine/*methods
MH  - *Social Media
MH  - United States
EDAT- 2015/04/08 06:00
MHDA- 2016/03/22 06:00
CRDT- 2015/04/08 06:00
PHST- 2015/04/08 06:00 [entrez]
PHST- 2015/04/08 06:00 [pubmed]
PHST- 2016/03/22 06:00 [medline]
AID - nbt0415-325 [pii]
AID - 10.1038/nbt0415-325 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Apr;33(4):325. doi: 10.1038/nbt0415-325.

PMID- 25850040
OWN - NLM
STAT- MEDLINE
DCOM- 20160321
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 4
DP  - 2015 Apr
TI  - Pfizer's CDK4/6 inhibitor approved for advanced breast cancer.
PG  - 323-4
LID - 10.1038/nbt0415-323 [doi]
FAU - Morrison, Chris
AU  - Morrison C
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antineoplastic Agents)
RN  - 0 (Protein Kinase Inhibitors)
RN  - EC 2.7.11.22 (CDK4 protein, human)
RN  - EC 2.7.11.22 (CDK6 protein, human)
RN  - EC 2.7.11.22 (Cyclin-Dependent Kinase 4)
RN  - EC 2.7.11.22 (Cyclin-Dependent Kinase 6)
SB  - IM
MH  - Administration, Oral
MH  - Antineoplastic Agents/administration & dosage
MH  - Breast Neoplasms/*drug therapy/*enzymology
MH  - Cyclin-Dependent Kinase 4/*antagonists & inhibitors/metabolism
MH  - Cyclin-Dependent Kinase 6/*antagonists & inhibitors/metabolism
MH  - *Drug Approval
MH  - Drug Industry/*trends
MH  - Evidence-Based Medicine
MH  - Humans
MH  - Protein Kinase Inhibitors/administration & dosage
MH  - Treatment Outcome
MH  - United States
MH  - United States Food and Drug Administration
EDAT- 2015/04/08 06:00
MHDA- 2016/03/22 06:00
CRDT- 2015/04/08 06:00
PHST- 2015/04/08 06:00 [entrez]
PHST- 2015/04/08 06:00 [pubmed]
PHST- 2016/03/22 06:00 [medline]
AID - nbt0415-323 [pii]
AID - 10.1038/nbt0415-323 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Apr;33(4):323-4. doi: 10.1038/nbt0415-323.

PMID- 25850038
OWN - NLM
STAT- MEDLINE
DCOM- 20160321
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 4
DP  - 2015 Apr
TI  - IDO inhibitors move center stage in immuno-oncology.
PG  - 321-2
LID - 10.1038/nbt0415-321 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antineoplastic Agents)
RN  - 0 (Enzyme Inhibitors)
RN  - 0 (Indoleamine-Pyrrole 2,3,-Dioxygenase)
SB  - IM
MH  - Animals
MH  - Antineoplastic Agents/immunology/therapeutic use
MH  - *Drug Design
MH  - Drug Industry/trends
MH  - Enzyme Inhibitors/immunology/therapeutic use
MH  - Humans
MH  - Immunotherapy/*methods
MH  - Indoleamine-Pyrrole 2,3,-Dioxygenase/*antagonists & inhibitors/*immunology
MH  - Neoplasms/*drug therapy/*immunology
EDAT- 2015/04/08 06:00
MHDA- 2016/03/22 06:00
CRDT- 2015/04/08 06:00
PHST- 2015/04/08 06:00 [entrez]
PHST- 2015/04/08 06:00 [pubmed]
PHST- 2016/03/22 06:00 [medline]
AID - nbt0415-321 [pii]
AID - 10.1038/nbt0415-321 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Apr;33(4):321-2. doi: 10.1038/nbt0415-321.

PMID- 25850037
OWN - NLM
STAT- MEDLINE
DCOM- 20160321
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 4
DP  - 2015 Apr
TI  - Rebooting review.
PG  - 319
LID - 10.1038/nbt.3202 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*trends
MH  - *Computational Biology
MH  - *Disclosure
MH  - *Editorial Policies
MH  - Peer Review, Research/*methods/trends
MH  - Periodicals as Topic/*trends
EDAT- 2015/04/08 06:00
MHDA- 2016/03/22 06:00
CRDT- 2015/04/08 06:00
PHST- 2015/04/08 06:00 [entrez]
PHST- 2015/04/08 06:00 [pubmed]
PHST- 2016/03/22 06:00 [medline]
AID - nbt.3202 [pii]
AID - 10.1038/nbt.3202 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Apr;33(4):319. doi: 10.1038/nbt.3202.

PMID- 25774714
OWN - NLM
STAT- MEDLINE
DCOM- 20160321
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 4
DP  - 2015 Apr
TI  - Identification of human T-cell receptors with optimal affinity to cancer antigens
      using antigen-negative humanized mice.
PG  - 402-7
LID - 10.1038/nbt.3147 [doi]
AB  - Identifying T-cell receptors (TCRs) that bind tumor-associated antigens (TAAs)
      with optimal affinity is a key bottleneck in the development of adoptive T-cell
      therapy of cancer. TAAs are unmutated self proteins, and T cells bearing
      high-affinity TCRs specific for such antigens are commonly deleted in the thymus.
      To identify optimal-affinity TCRs, we generated antigen-negative humanized mice
      with a diverse human TCR repertoire restricted to the human leukocyte antigen
      (HLA) A*02:01 (ref. 3). These mice were immunized with human TAAs, for which they
      are not tolerant, allowing induction of CD8(+) T cells with optimal-affinity
      TCRs. We isolate TCRs specific for the cancer/testis (CT) antigen MAGE-A1 (ref.
      4) and show that two of them have an anti-tumor effect in vivo. By comparison,
      human-derived TCRs have lower affinity and do not mediate substantial therapeutic
      effects. We also identify optimal-affinity TCRs specific for the CT antigen
      NY-ESO. Our humanized mouse model provides a useful tool for the generation of
      optimal-affinity TCRs for T-cell therapy.
FAU - Obenaus, Matthias
AU  - Obenaus M
AUID- ORCID: 0000000250909162
AD  - Max-Delbruck-Center for Molecular Medicine, Berlin, Germany.
FAU - Leitao, Catarina
AU  - Leitao C
AUID- ORCID: 0000000198842983
AD  - Max-Delbruck-Center for Molecular Medicine, Berlin, Germany.
FAU - Leisegang, Matthias
AU  - Leisegang M
AD  - Max-Delbruck-Center for Molecular Medicine, Berlin, Germany.
FAU - Chen, Xiaojing
AU  - Chen X
AD  - Max-Delbruck-Center for Molecular Medicine, Berlin, Germany.
FAU - Gavvovidis, Ioannis
AU  - Gavvovidis I
AD  - Max-Delbruck-Center for Molecular Medicine, Berlin, Germany.
FAU - van der Bruggen, Pierre
AU  - van der Bruggen P
AD  - 1] Ludwig Institute for Cancer Research and WELBIO, Brussels, Belgium. [2] De
      Duve Institute, Universite Catholique de Louvain, Brussels, Belgium.
FAU - Uckert, Wolfgang
AU  - Uckert W
AD  - 1] Max-Delbruck-Center for Molecular Medicine, Berlin, Germany. [2] Institute of 
      Biology, Humboldt University, Berlin, Germany.
FAU - Schendel, Dolores J
AU  - Schendel DJ
AD  - Medigene AG, Planegg/Martinsried, Germany.
FAU - Blankenstein, Thomas
AU  - Blankenstein T
AD  - 1] Max-Delbruck-Center for Molecular Medicine, Berlin, Germany. [2] Institute of 
      Immunology, Charite Campus Buch, Berlin, Germany.
LA  - eng
SI  - GENBANK/KM501069
SI  - GENBANK/KM501070
SI  - GENBANK/KM501071
SI  - GENBANK/KM501072
SI  - GENBANK/KM501073
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150316
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antibodies, Monoclonal, Humanized)
RN  - 0 (Antigens, Neoplasm)
RN  - 0 (Receptors, Antigen, T-Cell)
SB  - IM
MH  - Animals
MH  - Antibodies, Monoclonal, Humanized/*immunology
MH  - Antigens, Neoplasm/*immunology
MH  - Binding Sites
MH  - Cell Line, Tumor
MH  - Female
MH  - Humans
MH  - Immunoassay/*methods
MH  - Immunotherapy, Adoptive/methods
MH  - Mice
MH  - Molecular Sequence Data
MH  - Neoplasms, Experimental/*immunology/*therapy
MH  - Protein Binding
MH  - Protein Interaction Mapping/instrumentation/methods
MH  - Receptors, Antigen, T-Cell/*immunology
MH  - Species Specificity
EDAT- 2015/03/17 06:00
MHDA- 2016/03/22 06:00
CRDT- 2015/03/17 06:00
PHST- 2014/08/28 00:00 [received]
PHST- 2015/01/12 00:00 [accepted]
PHST- 2015/03/17 06:00 [entrez]
PHST- 2015/03/17 06:00 [pubmed]
PHST- 2016/03/22 06:00 [medline]
AID - nbt.3147 [pii]
AID - 10.1038/nbt.3147 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Apr;33(4):402-7. doi: 10.1038/nbt.3147. Epub 2015 Mar 16.

PMID- 25774713
OWN - NLM
STAT- MEDLINE
DCOM- 20160321
LR  - 20170603
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 4
DP  - 2015 Apr
TI  - High-throughput fluorescence correlation spectroscopy enables analysis of
      proteome dynamics in living cells.
PG  - 384-9
LID - 10.1038/nbt.3146 [doi]
AB  - To understand the function of cellular protein networks, spatial and temporal
      context is essential. Fluorescence correlation spectroscopy (FCS) is a
      single-molecule method to study the abundance, mobility and interactions of
      fluorescence-labeled biomolecules in living cells. However, manual acquisition
      and analysis procedures have restricted live-cell FCS to short-term experiments
      of a few proteins. Here, we present high-throughput (HT)-FCS, which automates
      screening and time-lapse acquisition of FCS data at specific subcellular
      locations and subsequent data analysis. We demonstrate its utility by studying
      the dynamics of 53 nuclear proteins. We made 60,000 measurements in 10,000 living
      human cells, to obtain biophysical parameters that allowed us to classify
      proteins according to their chromatin binding and complex formation. We also
      analyzed the cell-cycle-dependent dynamics of the mitotic kinase complex Aurora
      B/INCENP and showed how a rise in Aurora concentration triggers two-step complex 
      formation. We expect that throughput and robustness will make HT-FCS a broadly
      applicable technology for characterizing protein network dynamics in cells.
FAU - Wachsmuth, Malte
AU  - Wachsmuth M
AD  - Cell Biology and Biophysics Unit, European Molecular Biology Laboratory,
      Heidelberg, Germany.
FAU - Conrad, Christian
AU  - Conrad C
AD  - 1] Advanced Light Microscopy Facility, European Molecular Biology Laboratory,
      Heidelberg, Germany. [2] Theoretical Bioinformatics, German Cancer Research
      Center/BioQuant, Heidelberg, Germany.
FAU - Bulkescher, Jutta
AU  - Bulkescher J
AD  - Advanced Light Microscopy Facility, European Molecular Biology Laboratory,
      Heidelberg, Germany.
FAU - Koch, Birgit
AU  - Koch B
AUID- ORCID: 0000000296108854
AD  - Cell Biology and Biophysics Unit, European Molecular Biology Laboratory,
      Heidelberg, Germany.
FAU - Mahen, Robert
AU  - Mahen R
AD  - Cell Biology and Biophysics Unit, European Molecular Biology Laboratory,
      Heidelberg, Germany.
FAU - Isokane, Mayumi
AU  - Isokane M
AD  - Cell Biology and Biophysics Unit, European Molecular Biology Laboratory,
      Heidelberg, Germany.
FAU - Pepperkok, Rainer
AU  - Pepperkok R
AD  - 1] Cell Biology and Biophysics Unit, European Molecular Biology Laboratory,
      Heidelberg, Germany. [2] Advanced Light Microscopy Facility, European Molecular
      Biology Laboratory, Heidelberg, Germany.
FAU - Ellenberg, Jan
AU  - Ellenberg J
AD  - Cell Biology and Biophysics Unit, European Molecular Biology Laboratory,
      Heidelberg, Germany.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150316
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Proteome)
SB  - IM
CIN - Nat Methods. 2015 May;12(5):389. PMID: 26120631
CIN - Nat Biotechnol. 2015 Apr;33(4):356-7. PMID: 25850058
MH  - High-Throughput Screening Assays/*methods
MH  - Molecular Imaging/methods
MH  - Protein Interaction Mapping/*methods
MH  - Proteome/*metabolism
MH  - Spectrometry, Fluorescence/*methods
MH  - Subcellular Fractions/*metabolism
EDAT- 2015/03/17 06:00
MHDA- 2016/03/22 06:00
CRDT- 2015/03/17 06:00
PHST- 2014/10/06 00:00 [received]
PHST- 2014/12/24 00:00 [accepted]
PHST- 2015/03/17 06:00 [entrez]
PHST- 2015/03/17 06:00 [pubmed]
PHST- 2016/03/22 06:00 [medline]
AID - nbt.3146 [pii]
AID - 10.1038/nbt.3146 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Apr;33(4):384-9. doi: 10.1038/nbt.3146. Epub 2015 Mar 16.

PMID- 25751058
OWN - NLM
STAT- MEDLINE
DCOM- 20160321
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 4
DP  - 2015 Apr
TI  - Acetylation site specificities of lysine deacetylase inhibitors in human cells.
PG  - 415-23
LID - 10.1038/nbt.3130 [doi]
AB  - Lysine deacetylases inhibitors (KDACIs) are used in basic research, and many are 
      being investigated in clinical trials for treatment of cancer and other diseases.
      However, their specificities in cells are incompletely characterized. Here we
      used quantitative mass spectrometry (MS) to obtain acetylation signatures for 19 
      different KDACIs, covering all 18 human lysine deacetylases. Most KDACIs
      increased acetylation of a small, specific subset of the acetylome, including
      sites on histones and other chromatin-associated proteins. Inhibitor treatment
      combined with genetic deletion showed that the effects of the pan-sirtuin
      inhibitor nicotinamide are primarily mediated by SIRT1 inhibition. Furthermore,
      we confirmed that the effects of tubacin and bufexamac on cytoplasmic proteins
      result from inhibition of HDAC6. Bufexamac also triggered an HDAC6-independent,
      hypoxia-like response by stabilizing HIF1-alpha, providing a possible mechanistic
      explanation of its adverse, pro-inflammatory effects. Our results offer a systems
      view of KDACI specificities, providing a framework for studying function of
      acetylation and deacetylases.
FAU - Scholz, Christian
AU  - Scholz C
AUID- ORCID: 0000000216332072
AD  - Department of Proteomics, The Novo Nordisk Foundation Center for Protein
      Research, Faculty of Health and Medical Sciences, University of Copenhagen,
      Copenhagen, Denmark.
FAU - Weinert, Brian T
AU  - Weinert BT
AD  - Department of Proteomics, The Novo Nordisk Foundation Center for Protein
      Research, Faculty of Health and Medical Sciences, University of Copenhagen,
      Copenhagen, Denmark.
FAU - Wagner, Sebastian A
AU  - Wagner SA
AD  - Department of Proteomics, The Novo Nordisk Foundation Center for Protein
      Research, Faculty of Health and Medical Sciences, University of Copenhagen,
      Copenhagen, Denmark.
FAU - Beli, Petra
AU  - Beli P
AD  - Department of Proteomics, The Novo Nordisk Foundation Center for Protein
      Research, Faculty of Health and Medical Sciences, University of Copenhagen,
      Copenhagen, Denmark.
FAU - Miyake, Yasuyuki
AU  - Miyake Y
AD  - Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
FAU - Qi, Jun
AU  - Qi J
AD  - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical
      School, Boston, Massachusetts, USA.
FAU - Jensen, Lars J
AU  - Jensen LJ
AD  - Department of Protein Science and Technology, The Novo Nordisk Foundation Center 
      for Protein Research, Faculty of Health Sciences, University of Copenhagen,
      Copenhagen, Denmark.
FAU - Streicher, Werner
AU  - Streicher W
AD  - Department of Disease Systems Biology, The Novo Nordisk Foundation Center for
      Protein Research, Faculty of Health Sciences, University of Copenhagen,
      Copenhagen, Denmark.
FAU - McCarthy, Anna R
AU  - McCarthy AR
AD  - Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet,
      Stockholm, Sweden.
FAU - Westwood, Nicholas J
AU  - Westwood NJ
AD  - School of Chemistry and Biomedical Sciences Research Complex, EaStCHEM,
      University of St. Andrews, St. Andrews, Scotland, UK.
FAU - Lain, Sonia
AU  - Lain S
AD  - Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet,
      Stockholm, Sweden.
FAU - Cox, Jurgen
AU  - Cox J
AD  - Department of Proteomics and Signal Transduction, Max Planck Institute for
      Biochemistry, Martinsried, Germany.
FAU - Matthias, Patrick
AU  - Matthias P
AD  - Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
FAU - Mann, Matthias
AU  - Mann M
AD  - Department of Proteomics and Signal Transduction, Max Planck Institute for
      Biochemistry, Martinsried, Germany.
FAU - Bradner, James E
AU  - Bradner JE
AD  - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical
      School, Boston, Massachusetts, USA.
FAU - Choudhary, Chunaram
AU  - Choudhary C
AD  - Department of Proteomics, The Novo Nordisk Foundation Center for Protein
      Research, Faculty of Health and Medical Sciences, University of Copenhagen,
      Copenhagen, Denmark.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150309
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Enzyme Inhibitors)
RN  - 0 (Histone Deacetylase Inhibitors)
RN  - EC 3.5.1.98 (Histone Deacetylases)
SB  - IM
MH  - Acetylation
MH  - Amino Acid Sequence
MH  - Binding Sites
MH  - Cells, Cultured
MH  - Enzyme Inhibitors/*chemistry
MH  - Histone Deacetylase Inhibitors/*chemistry
MH  - Histone Deacetylases/*chemistry
MH  - Humans
MH  - Mass Spectrometry/*methods
MH  - Molecular Sequence Data
MH  - Peptide Mapping/*methods
MH  - Protein Binding
MH  - Protein Interaction Mapping/*methods
EDAT- 2015/03/10 06:00
MHDA- 2016/03/22 06:00
CRDT- 2015/03/10 06:00
PHST- 2014/07/31 00:00 [received]
PHST- 2014/12/11 00:00 [accepted]
PHST- 2015/03/10 06:00 [entrez]
PHST- 2015/03/10 06:00 [pubmed]
PHST- 2016/03/22 06:00 [medline]
AID - nbt.3130 [pii]
AID - 10.1038/nbt.3130 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Apr;33(4):415-23. doi: 10.1038/nbt.3130. Epub 2015 Mar 9.

PMID- 25751057
OWN - NLM
STAT- MEDLINE
DCOM- 20160321
LR  - 20161019
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 4
DP  - 2015 Apr
TI  - ChIP-nexus enables improved detection of in vivo transcription factor binding
      footprints.
PG  - 395-401
LID - 10.1038/nbt.3121 [doi]
AB  - Understanding how eukaryotic enhancers are bound and regulated by specific
      combinations of transcription factors is still a major challenge. To better map
      transcription factor binding genome-wide at nucleotide resolution in vivo, we
      have developed a robust ChIP-exo protocol called ChIP-nexus (chromatin
      immunoprecipitation experiments with nucleotide resolution through exonuclease,
      unique barcode and single ligation), which utilizes an efficient DNA
      self-circularization step during library preparation. Application of ChIP-nexus
      to four proteins--human TBP and Drosophila NFkB, Twist and Max--shows that it
      outperforms existing ChIP protocols in resolution and specificity, pinpoints
      relevant binding sites within enhancers containing multiple binding motifs, and
      allows for the analysis of in vivo binding specificities. Notably, we show that
      Max frequently interacts with DNA sequences next to its motif, and that this
      binding pattern correlates with local DNA-sequence features such as DNA shape.
      ChIP-nexus will be broadly applicable to the study of in vivo transcription
      factor binding specificity and its relationship to cis-regulatory changes in
      humans and model organisms.
FAU - He, Qiye
AU  - He Q
AD  - Stowers Institute for Medical Research, Kansas City, Missouri, USA.
FAU - Johnston, Jeff
AU  - Johnston J
AUID- ORCID: 0000000289626186
AD  - Stowers Institute for Medical Research, Kansas City, Missouri, USA.
FAU - Zeitlinger, Julia
AU  - Zeitlinger J
AD  - 1] Stowers Institute for Medical Research, Kansas City, Missouri, USA. [2]
      Department of Pathology, Kansas University Medical Center, Kansas City, Kansas,
      USA.
LA  - eng
SI  - GEO/GSE55306
GR  - DP2 OD004561/OD/NIH HHS/United States
GR  - 1DP2 OD004561/OD/NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20150309
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Transcription Factors)
RN  - 9007-49-2 (DNA)
SB  - IM
MH  - Base Sequence
MH  - Binding Sites
MH  - Chromatin Immunoprecipitation/*methods
MH  - DNA/*chemistry/*genetics
MH  - Molecular Sequence Data
MH  - Protein Binding
MH  - Protein Interaction Mapping/*methods
MH  - Reproducibility of Results
MH  - Sensitivity and Specificity
MH  - Transcription Factors/*chemistry/*genetics
PMC - PMC4390430
MID - NIHMS647911
EDAT- 2015/03/10 06:00
MHDA- 2016/03/22 06:00
CRDT- 2015/03/10 06:00
PHST- 2014/03/11 00:00 [received]
PHST- 2014/12/08 00:00 [accepted]
PHST- 2015/03/10 06:00 [entrez]
PHST- 2015/03/10 06:00 [pubmed]
PHST- 2016/03/22 06:00 [medline]
AID - nbt.3121 [pii]
AID - 10.1038/nbt.3121 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Apr;33(4):395-401. doi: 10.1038/nbt.3121. Epub 2015 Mar 9.

PMID- 25690853
OWN - NLM
STAT- MEDLINE
DCOM- 20160321
LR  - 20161019
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 4
DP  - 2015 Apr
TI  - Large-scale imputation of epigenomic datasets for systematic annotation of
      diverse human tissues.
PG  - 364-76
LID - 10.1038/nbt.3157 [doi]
AB  - With hundreds of epigenomic maps, the opportunity arises to exploit the
      correlated nature of epigenetic signals, across both marks and samples, for
      large-scale prediction of additional datasets. Here, we undertake epigenome
      imputation by leveraging such correlations through an ensemble of regression
      trees. We impute 4,315 high-resolution signal maps, of which 26% are also
      experimentally observed. Imputed signal tracks show overall similarity to
      observed signals and surpass experimental datasets in consistency, recovery of
      gene annotations and enrichment for disease-associated variants. We use the
      imputed data to detect low-quality experimental datasets, to find genomic sites
      with unexpected epigenomic signals, to define high-priority marks for new
      experiments and to delineate chromatin states in 127 reference epigenomes
      spanning diverse tissues and cell types. Our imputed datasets provide the most
      comprehensive human regulatory region annotation to date, and our approach and
      the ChromImpute software constitute a useful complement to large-scale
      experimental mapping of epigenomic information.
FAU - Ernst, Jason
AU  - Ernst J
AD  - 1] Department of Biological Chemistry, University of California, Los Angeles,
      California, USA. [2] Computer Science Department, University of California, Los
      Angeles, California, USA. [3] Eli and Edythe Broad Center of Regenerative
      Medicine and Stem Cell Research at UCLA, Los Angeles, California, USA. [4]
      Jonsson Comprehensive Cancer Center, University of California, Los Angeles,
      California, USA. [5] Molecular Biology Institute, University of California, Los
      Angeles, California, USA.
FAU - Kellis, Manolis
AU  - Kellis M
AD  - 1] MIT Computer Science and Artificial Intelligence Laboratory, Cambridge,
      Massachusetts, USA. [2] Broad Institute of MIT and Harvard, Cambridge,
      Massachusetts, USA.
LA  - eng
GR  - R01 GM113708/GM/NIGMS NIH HHS/United States
GR  - R01 HG004037/HG/NHGRI NIH HHS/United States
GR  - U01 HG007610/HG/NHGRI NIH HHS/United States
GR  - R01HG004037/HG/NHGRI NIH HHS/United States
GR  - U54 HG004570/HG/NHGRI NIH HHS/United States
GR  - RC1 HG005334/HG/NHGRI NIH HHS/United States
GR  - U41 HG007000/HG/NHGRI NIH HHS/United States
GR  - RC1HG005334/HG/NHGRI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20150218
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CIN - Nat Biotechnol. 2015 Apr;33(4):354-5. PMID: 25850057
MH  - Chromosome Mapping/*methods
MH  - Data Curation/*methods
MH  - *Database Management Systems
MH  - *Databases, Genetic
MH  - Datasets as Topic
MH  - Epigenesis, Genetic/*physiology
MH  - Genetic Variation/genetics
MH  - Genome, Human/*genetics
MH  - Humans
MH  - Information Storage and Retrieval/methods
MH  - Organ Specificity/genetics
MH  - Software
MH  - User-Computer Interface
PMC - PMC4512306
MID - NIHMS660789
EDAT- 2015/02/19 06:00
MHDA- 2016/03/22 06:00
CRDT- 2015/02/19 06:00
PHST- 2014/05/13 00:00 [received]
PHST- 2015/02/02 00:00 [accepted]
PHST- 2015/02/19 06:00 [entrez]
PHST- 2015/02/19 06:00 [pubmed]
PHST- 2016/03/22 06:00 [medline]
AID - nbt.3157 [pii]
AID - 10.1038/nbt.3157 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Apr;33(4):364-76. doi: 10.1038/nbt.3157. Epub 2015 Feb 18.

PMID- 25690852
OWN - NLM
STAT- MEDLINE
DCOM- 20160321
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 4
DP  - 2015 Apr
TI  - Inducible in vivo genome editing with CRISPR-Cas9.
PG  - 390-394
LID - 10.1038/nbt.3155 [doi]
AB  - CRISPR-Cas9-based genome editing enables the rapid genetic manipulation of any
      genomic locus without the need for gene targeting by homologous recombination.
      Here we describe a conditional transgenic approach that allows temporal control
      of CRISPR-Cas9 activity for inducible genome editing in adult mice. We show that 
      doxycycline-regulated Cas9 induction enables widespread gene disruption in
      multiple tissues and that limiting the duration of Cas9 expression or using a
      Cas9(D10A) (Cas9n) variant can regulate the frequency and size of target gene
      modifications, respectively. Further, we show that this inducible CRISPR
      (iCRISPR) system can be used effectively to create biallelic mutation in multiple
      target loci and, thus, provides a flexible and fast platform to study
      loss-of-function phenotypes in vivo.
FAU - Dow, Lukas E
AU  - Dow LE
AD  - Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New 
      York, NY.
AD  - Hematology / Medical Oncology Division, Department of Medicine, Weill-Cornell
      Medical College, New York, NY.
FAU - Fisher, Jonathan
AU  - Fisher J
AD  - Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New 
      York, NY.
FAU - O'Rourke, Kevin P
AU  - O'Rourke KP
AD  - Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New 
      York, NY.
AD  - Weill-Cornell / Rockefeller / Sloan Kettering Tri-Institutional MD-PhD program,
      New York, NY.
FAU - Muley, Ashlesha
AU  - Muley A
AD  - Hematology / Medical Oncology Division, Department of Medicine, Weill-Cornell
      Medical College, New York, NY.
FAU - Kastenhuber, Edward R
AU  - Kastenhuber ER
AD  - Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New 
      York, NY.
AD  - Gerstner Sloan Kettering Graduate School of Biomedical Sciences, New York, NY.
FAU - Livshits, Geulah
AU  - Livshits G
AD  - Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New 
      York, NY.
FAU - Tschaharganeh, Darjus F
AU  - Tschaharganeh DF
AD  - Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New 
      York, NY.
FAU - Socci, Nicholas D
AU  - Socci ND
AD  - Bioinformatics Core facility, Memorial Sloan Kettering Cancer Center, New York,
      NY.
FAU - Lowe, Scott W
AU  - Lowe SW
AD  - Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New 
      York, NY.
AD  - Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New
      York, NY.
LA  - eng
GR  - T32GM07739/GM/NIGMS NIH HHS/United States
GR  - F31 CA192835/CA/NCI NIH HHS/United States
GR  - F32 CA177072/CA/NCI NIH HHS/United States
GR  - P30 CA008748/CA/NCI NIH HHS/United States
GR  - Howard Hughes Medical Institute/United States
GR  - P01 CA087497/CA/NCI NIH HHS/United States
GR  - 1K22CA181280-01/CA/NCI NIH HHS/United States
GR  - P01 CA013106/CA/NCI NIH HHS/United States
GR  - T32 GM007739/GM/NIGMS NIH HHS/United States
GR  - R01 CA195787/CA/NCI NIH HHS/United States
GR  - P01 CA129243/CA/NCI NIH HHS/United States
GR  - 1F32CA177072-01/CA/NCI NIH HHS/United States
GR  - CA-013106/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20150218
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - CRISPR-Cas Systems/*genetics
MH  - Clustered Regularly Interspaced Short Palindromic Repeats/*genetics
MH  - Genome/*genetics
MH  - Mice
MH  - Mutagenesis, Site-Directed/*methods
MH  - Recombination, Genetic/genetics
PMC - PMC4390466
MID - NIHMS658413
EDAT- 2015/02/19 06:00
MHDA- 2016/03/22 06:00
CRDT- 2015/02/19 06:00
PHST- 2014/11/23 00:00 [received]
PHST- 2015/01/22 00:00 [accepted]
PHST- 2015/02/19 06:00 [entrez]
PHST- 2015/02/19 06:00 [pubmed]
PHST- 2016/03/22 06:00 [medline]
AID - 10.1038/nbt.3155 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Apr;33(4):390-394. doi: 10.1038/nbt.3155. Epub 2015 Feb 18.

PMID- 25690851
OWN - NLM
STAT- MEDLINE
DCOM- 20160321
LR  - 20161025
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 4
DP  - 2015 Apr
TI  - Epigenomic annotation of genetic variants using the Roadmap Epigenome Browser.
PG  - 345-6
FAU - Zhou, Xin
AU  - Zhou X
FAU - Li, Daofeng
AU  - Li D
FAU - Zhang, Bo
AU  - Zhang B
FAU - Lowdon, Rebecca F
AU  - Lowdon RF
FAU - Rockweiler, Nicole B
AU  - Rockweiler NB
FAU - Sears, Renee L
AU  - Sears RL
FAU - Madden, Pamela A F
AU  - Madden PA
FAU - Smirnov, Ivan
AU  - Smirnov I
FAU - Costello, Joseph F
AU  - Costello JF
FAU - Wang, Ting
AU  - Wang T
LA  - eng
GR  - U01 ES017154/ES/NIEHS NIH HHS/United States
GR  - R01 HG007175/HG/NHGRI NIH HHS/United States
GR  - R01 ES024992/ES/NIEHS NIH HHS/United States
GR  - T32 GM081739/GM/NIGMS NIH HHS/United States
GR  - R25 DA027995/DA/NIDA NIH HHS/United States
GR  - R01 HG007354/HG/NHGRI NIH HHS/United States
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Chromosome Mapping/*methods
MH  - *Database Management Systems
MH  - *Databases, Genetic
MH  - Epigenesis, Genetic/*genetics
MH  - Genetic Variation/genetics
MH  - Genome, Human/*genetics
MH  - Humans
MH  - Polymorphism, Single Nucleotide/genetics
MH  - User-Computer Interface
MH  - *Web Browser
PMC - PMC4467764
MID - NIHMS697122
EDAT- 2015/02/19 06:00
MHDA- 2016/03/22 06:00
CRDT- 2015/02/19 06:00
PHST- 2015/02/19 06:00 [entrez]
PHST- 2015/02/19 06:00 [pubmed]
PHST- 2016/03/22 06:00 [medline]
AID - nbt.3158 [pii]
AID - 10.1038/nbt.3158 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Apr;33(4):345-6. doi: 10.1038/nbt.3158.

PMID- 25643055
OWN - NLM
STAT- MEDLINE
DCOM- 20160321
LR  - 20170603
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 4
DP  - 2015 Apr
TI  - Resequencing 302 wild and cultivated accessions identifies genes related to
      domestication and improvement in soybean.
PG  - 408-14
LID - 10.1038/nbt.3096 [doi]
AB  - Understanding soybean (Glycine max) domestication and improvement at a genetic
      level is important to inform future efforts to further improve a crop that
      provides the world's main source of oilseed. We detect 230 selective sweeps and
      162 selected copy number variants by analysis of 302 resequenced wild, landrace
      and improved soybean accessions at >11x depth. A genome-wide association study
      using these new sequences reveals associations between 10 selected regions and 9 
      domestication or improvement traits, and identifies 13 previously uncharacterized
      loci for agronomic traits including oil content, plant height and pubescence
      form. Combined with previous quantitative trait loci (QTL) information, we find
      that, of the 230 selected regions, 96 correlate with reported oil QTLs and 21
      contain fatty acid biosynthesis genes. Moreover, we observe that some traits and 
      loci are associated with geographical regions, which shows that soybean
      populations are structured geographically. This study provides resources for
      genomics-enabled improvements in soybean breeding.
FAU - Zhou, Zhengkui
AU  - Zhou Z
AD  - State Key Laboratory of Plant Cell and Chromosome Engineering, Institute of
      Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China.
FAU - Jiang, Yu
AU  - Jiang Y
AUID- ORCID: 0000000348213585
AD  - 1] State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of 
      Zoology, Chinese Academy of Sciences, Kunming, China. [2] College of Animal
      Science and Technology, Northwest A&F University, Yangling, China.
FAU - Wang, Zheng
AU  - Wang Z
AD  - State Key Laboratory of Plant Cell and Chromosome Engineering, Institute of
      Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China.
FAU - Gou, Zhiheng
AU  - Gou Z
AD  - 1] State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of 
      Zoology, Chinese Academy of Sciences, Kunming, China. [2] University of Chinese
      Academy of Sciences, Beijing, China.
FAU - Lyu, Jun
AU  - Lyu J
AD  - State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of
      Zoology, Chinese Academy of Sciences, Kunming, China.
FAU - Li, Weiyu
AU  - Li W
AD  - State Key Laboratory of Plant Cell and Chromosome Engineering, Institute of
      Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China.
FAU - Yu, Yanjun
AU  - Yu Y
AD  - Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
FAU - Shu, Liping
AU  - Shu L
AD  - State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of
      Zoology, Chinese Academy of Sciences, Kunming, China.
FAU - Zhao, Yingjun
AU  - Zhao Y
AD  - 1] State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of 
      Zoology, Chinese Academy of Sciences, Kunming, China. [2] University of Chinese
      Academy of Sciences, Beijing, China.
FAU - Ma, Yanming
AU  - Ma Y
AD  - State Key Laboratory of Plant Cell and Chromosome Engineering, Institute of
      Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China.
FAU - Fang, Chao
AU  - Fang C
AD  - 1] State Key Laboratory of Plant Cell and Chromosome Engineering, Institute of
      Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China. 
      [2] University of Chinese Academy of Sciences, Beijing, China.
FAU - Shen, Yanting
AU  - Shen Y
AD  - 1] State Key Laboratory of Plant Cell and Chromosome Engineering, Institute of
      Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China. 
      [2] University of Chinese Academy of Sciences, Beijing, China.
FAU - Liu, Tengfei
AU  - Liu T
AD  - 1] State Key Laboratory of Plant Cell and Chromosome Engineering, Institute of
      Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China. 
      [2] University of Chinese Academy of Sciences, Beijing, China.
FAU - Li, Congcong
AU  - Li C
AD  - 1] State Key Laboratory of Plant Cell and Chromosome Engineering, Institute of
      Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China. 
      [2] University of Chinese Academy of Sciences, Beijing, China.
FAU - Li, Qing
AU  - Li Q
AD  - 1] State Key Laboratory of Plant Cell and Chromosome Engineering, Institute of
      Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China. 
      [2] University of Chinese Academy of Sciences, Beijing, China.
FAU - Wu, Mian
AU  - Wu M
AD  - State Key Laboratory of Plant Cell and Chromosome Engineering, Institute of
      Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China.
FAU - Wang, Min
AU  - Wang M
AD  - 1] State Key Laboratory of Plant Cell and Chromosome Engineering, Institute of
      Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China. 
      [2] University of Chinese Academy of Sciences, Beijing, China.
FAU - Wu, Yunshuai
AU  - Wu Y
AD  - State Key Laboratory of Plant Cell and Chromosome Engineering, Institute of
      Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China.
FAU - Dong, Yang
AU  - Dong Y
AD  - State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of
      Zoology, Chinese Academy of Sciences, Kunming, China.
FAU - Wan, Wenting
AU  - Wan W
AD  - State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of
      Zoology, Chinese Academy of Sciences, Kunming, China.
FAU - Wang, Xiao
AU  - Wang X
AD  - 1] State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of 
      Zoology, Chinese Academy of Sciences, Kunming, China. [2] University of Chinese
      Academy of Sciences, Beijing, China.
FAU - Ding, Zhaoli
AU  - Ding Z
AD  - State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of
      Zoology, Chinese Academy of Sciences, Kunming, China.
FAU - Gao, Yuedong
AU  - Gao Y
AD  - State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of
      Zoology, Chinese Academy of Sciences, Kunming, China.
FAU - Xiang, Hui
AU  - Xiang H
AD  - State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of
      Zoology, Chinese Academy of Sciences, Kunming, China.
FAU - Zhu, Baoge
AU  - Zhu B
AD  - State Key Laboratory of Plant Cell and Chromosome Engineering, Institute of
      Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China.
FAU - Lee, Suk-Ha
AU  - Lee SH
AD  - Department of Plant Science and Research Institute for Agriculture and Life
      Sciences, Seoul National University, Seoul, Korea.
FAU - Wang, Wen
AU  - Wang W
AD  - State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of
      Zoology, Chinese Academy of Sciences, Kunming, China.
FAU - Tian, Zhixi
AU  - Tian Z
AD  - State Key Laboratory of Plant Cell and Chromosome Engineering, Institute of
      Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China.
LA  - eng
SI  - SRA/SRP045129
SI  - dbSNP/1061960
SI  - dbSNP/1061961
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150202
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EIN - Nat Biotechnol. 2016 Apr;34(4):441. PMID: 27054996
MH  - Chromosome Mapping/*methods
MH  - DNA Copy Number Variations/*genetics
MH  - Genetic Enhancement/*methods
MH  - Genome, Plant/*genetics
MH  - Quantitative Trait Loci
MH  - Sequence Analysis, DNA/*methods
MH  - Soybeans/*genetics
EDAT- 2015/02/03 06:00
MHDA- 2016/03/22 06:00
CRDT- 2015/02/03 06:00
PHST- 2014/04/10 00:00 [received]
PHST- 2014/11/11 00:00 [accepted]
PHST- 2015/02/03 06:00 [entrez]
PHST- 2015/02/03 06:00 [pubmed]
PHST- 2016/03/22 06:00 [medline]
AID - nbt.3096 [pii]
AID - 10.1038/nbt.3096 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Apr;33(4):408-14. doi: 10.1038/nbt.3096. Epub 2015 Feb 2.

PMID- 25558867
OWN - NLM
STAT- MEDLINE
DCOM- 20160321
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 4
DP  - 2015 Apr
TI  - Distributing a metabolic pathway among a microbial consortium enhances production
      of natural products.
PG  - 377-83
LID - 10.1038/nbt.3095 [doi]
AB  - Metabolic engineering of microorganisms such as Escherichia coli and
      Saccharomyces cerevisiae to produce high-value natural metabolites is often done 
      through functional reconstitution of long metabolic pathways. Problems arise when
      parts of pathways require specialized environments or compartments for optimal
      function. Here we solve this problem through co-culture of engineered organisms, 
      each of which contains the part of the pathway that it is best suited to hosting.
      In one example, we divided the synthetic pathway for the acetylated diol
      paclitaxel precursor into two modules, expressed in either S. cerevisiae or E.
      coli, neither of which can produce the paclitaxel precursor on their own. Stable 
      co-culture in the same bioreactor was achieved by designing a mutualistic
      relationship between the two species in which a metabolic intermediate produced
      by E. coli was used and functionalized by yeast. This synthetic consortium
      produced 33 mg/L oxygenated taxanes, including a monoacetylated dioxygenated
      taxane. The same method was also used to produce tanshinone precursors and
      functionalized sesquiterpenes.
FAU - Zhou, Kang
AU  - Zhou K
AD  - Department of Chemical Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Qiao, Kangjian
AU  - Qiao K
AD  - Department of Chemical Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Edgar, Steven
AU  - Edgar S
AD  - Department of Chemical Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Stephanopoulos, Gregory
AU  - Stephanopoulos G
AD  - Department of Chemical Engineering, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
LA  - eng
GR  - R01 GM085323/GM/NIGMS NIH HHS/United States
GR  - 1-R01-GM085323-01A1/GM/NIGMS NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20150105
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Bacterial Proteins)
RN  - 0 (Biological Products)
RN  - 0 (Taxoids)
SB  - IM
MH  - Bacterial Proteins/genetics
MH  - Biological Products/isolation & purification/metabolism
MH  - Escherichia coli/genetics
MH  - Genetic Enhancement/*methods
MH  - Metabolic Engineering/*methods
MH  - Microbial Consortia/*genetics
MH  - Microbial Interactions/*genetics
MH  - Saccharomyces cerevisiae/genetics
MH  - Taxoids/*metabolism
PMC - PMC4867547
MID - NIHMS641842
EDAT- 2015/01/07 06:00
MHDA- 2016/03/22 06:00
CRDT- 2015/01/07 06:00
PHST- 2014/06/25 00:00 [received]
PHST- 2014/11/10 00:00 [accepted]
PHST- 2015/01/07 06:00 [entrez]
PHST- 2015/01/07 06:00 [pubmed]
PHST- 2016/03/22 06:00 [medline]
AID - nbt.3095 [pii]
AID - 10.1038/nbt.3095 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Apr;33(4):377-83. doi: 10.1038/nbt.3095. Epub 2015 Jan 5.

PMID- 25748919
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 3
DP  - 2015 Mar
TI  - Total target cash compensation shows a healthy increase at private life-science
      companies.
PG  - 313-6
LID - 10.1038/nbt.3166 [doi]
FAU - Rychlik, Bruce
AU  - Rychlik B
AD  - Park Square Executive Search, LLC, Cambridge, Massachusetts, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biological Science Disciplines/*economics
MH  - Private Sector/*economics
MH  - *Salaries and Fringe Benefits
MH  - Surveys and Questionnaires
EDAT- 2015/03/10 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/03/10 06:00
PHST- 2015/03/10 06:00 [entrez]
PHST- 2015/03/10 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3166 [pii]
AID - 10.1038/nbt.3166 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Mar;33(3):313-6. doi: 10.1038/nbt.3166.

PMID- 25748918
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20170607
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 3
DP  - 2015 Mar
TI  - A systems approach to traditional oriental medicine.
PG  - 264-8
LID - 10.1038/nbt.3167 [doi]
FAU - Kim, Hyun Uk
AU  - Kim HU
AUID- ORCID: 000000017224642X
AD  - 1] Metabolic and Biomolecular Engineering National Research Laboratory,
      Department of Chemical and Biomolecular Engineering (BK21 Plus Program), Center
      for Systems and Synthetic Biotechnology, Institute for the BioCentury, Korea
      Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.
      [2] BioInformatics Research Center, KAIST, Daejeon, Republic of Korea. [3] The
      Novo Nordisk Foundation Center for Biosustainability, Technical University of
      Denmark, Horsholm, Denmark.
FAU - Ryu, Jae Yong
AU  - Ryu JY
AD  - Metabolic and Biomolecular Engineering National Research Laboratory, Department
      of Chemical and Biomolecular Engineering (BK21 Plus Program), Center for Systems 
      and Synthetic Biotechnology, Institute for the BioCentury, Korea Advanced
      Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.
FAU - Lee, Jong Ok
AU  - Lee JO
AD  - 1] Metabolic and Biomolecular Engineering National Research Laboratory,
      Department of Chemical and Biomolecular Engineering (BK21 Plus Program), Center
      for Systems and Synthetic Biotechnology, Institute for the BioCentury, Korea
      Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.
      [2] BioInformatics Research Center, KAIST, Daejeon, Republic of Korea.
FAU - Lee, Sang Yup
AU  - Lee SY
AUID- ORCID: 0000000305993091
AD  - 1] Metabolic and Biomolecular Engineering National Research Laboratory,
      Department of Chemical and Biomolecular Engineering (BK21 Plus Program), Center
      for Systems and Synthetic Biotechnology, Institute for the BioCentury, Korea
      Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.
      [2] BioInformatics Research Center, KAIST, Daejeon, Republic of Korea. [3]
      BioProcess Engineering Research Center, KAIST, Daejeon, Republic of Korea. [4]
      The Novo Nordisk Foundation Center for Biosustainability, Technical University of
      Denmark, Horsholm, Denmark.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Drugs, Chinese Herbal)
SB  - IM
MH  - Drug Synergism
MH  - Drugs, Chinese Herbal/chemistry
MH  - Humans
MH  - *Medicine, East Asian Traditional
MH  - Metabolome
MH  - *Systems Analysis
EDAT- 2015/03/10 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/03/10 06:00
PHST- 2015/03/10 06:00 [entrez]
PHST- 2015/03/10 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3167 [pii]
AID - 10.1038/nbt.3167 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Mar;33(3):264-8. doi: 10.1038/nbt.3167.

PMID- 25748917
OWN - NLM
STAT- MEDLINE
DCOM- 20160114
LR  - 20171116
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 3
DP  - 2015 Mar
TI  - Engineering insect-free cereals.
PG  - 262-3
LID - 10.1038/nbt.3162 [doi]
FAU - Hogenhout, Saskia A
AU  - Hogenhout SA
AD  - Department of Cell and Developmental Biology, John Innes Centre, Norwich Research
      Park, Norwich, UK.
FAU - Zipfel, Cyril
AU  - Zipfel C
AD  - The Sainsbury Laboratory, Norwich Research Park, Norwich, UK.
LA  - eng
GR  - BB/G024936/1/Biotechnology and Biological Sciences Research Council/United
      Kingdom
GR  - BBS/E/J/000C0623/Biotechnology and Biological Sciences Research Council/United
      Kingdom
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Receptors, Mitogen)
RN  - EC 2.7.- (Protein Kinases)
SB  - IM
CON - Nat Biotechnol. 2015 Mar;33(3):301-5. PMID: 25485617
MH  - Animals
MH  - Disease Resistance/*genetics
MH  - Insecta/*physiology
MH  - *Multigene Family
MH  - Oryza/*genetics
MH  - Plant Diseases/*parasitology
MH  - Protein Kinases/*genetics
MH  - Receptors, Mitogen/*genetics
EDAT- 2015/03/10 06:00
MHDA- 2016/01/15 06:00
CRDT- 2015/03/10 06:00
PHST- 2015/03/10 06:00 [entrez]
PHST- 2015/03/10 06:00 [pubmed]
PHST- 2016/01/15 06:00 [medline]
AID - nbt.3162 [pii]
AID - 10.1038/nbt.3162 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Mar;33(3):262-3. doi: 10.1038/nbt.3162.

PMID- 25748916
OWN - NLM
STAT- MEDLINE
DCOM- 20160114
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 3
DP  - 2015 Mar
TI  - Singling out blood development.
PG  - 260-1
LID - 10.1038/nbt.3168 [doi]
FAU - Fast, Eva M
AU  - Fast EM
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, 
      Massachusetts, USA.
FAU - Zon, Len I
AU  - Zon LI
AD  - Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, 
      Massachusetts, USA.
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2015 Mar;33(3):269-76. PMID: 25664528
MH  - Animals
MH  - Blood Cells/*metabolism
MH  - Female
MH  - *Gene Expression Regulation
MH  - *Gene Regulatory Networks
MH  - Male
MH  - Single-Cell Analysis/*methods
EDAT- 2015/03/10 06:00
MHDA- 2016/01/15 06:00
CRDT- 2015/03/10 06:00
PHST- 2015/03/10 06:00 [entrez]
PHST- 2015/03/10 06:00 [pubmed]
PHST- 2016/01/15 06:00 [medline]
AID - nbt.3168 [pii]
AID - 10.1038/nbt.3168 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Mar;33(3):260-1. doi: 10.1038/nbt.3168.

PMID- 25748915
OWN - NLM
STAT- MEDLINE
DCOM- 20160114
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 3
DP  - 2015 Mar
TI  - An integrated microprobe for the brain.
PG  - 259-60
LID - 10.1038/nbt.3169 [doi]
FAU - Herrera, Carolina Gutierrez
AU  - Herrera CG
AD  - University of Bern, Department of Neurology, Inselspital University Hospital,
      Bern, Switzerland.
FAU - Adamantidis, Antoine R
AU  - Adamantidis AR
AD  - 1] University of Bern, Department of Neurology, Inselspital University Hospital, 
      Bern, Switzerland. [2] McGill University, Department of Psychiatry, Douglas
      Institute, Montreal, Quebec, Canada.
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2015 Mar;33(3):277-84. PMID: 25599177
MH  - Animals
MH  - *Electrophysiological Phenomena
MH  - Male
MH  - Nerve Net/*physiology
MH  - *Optical Fibers
EDAT- 2015/03/10 06:00
MHDA- 2016/01/15 06:00
CRDT- 2015/03/10 06:00
PHST- 2015/03/10 06:00 [entrez]
PHST- 2015/03/10 06:00 [pubmed]
PHST- 2016/01/15 06:00 [medline]
AID - nbt.3169 [pii]
AID - 10.1038/nbt.3169 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Mar;33(3):259-60. doi: 10.1038/nbt.3169.

PMID- 25748913
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 3
DP  - 2015 Mar
TI  - Law, history and lessons in the CRISPR patent conflict.
PG  - 256-7
LID - 10.1038/nbt.3160 [doi]
FAU - Sherkow, Jacob S
AU  - Sherkow JS
AD  - Institute for Information Law and Policy, New York Law School, New York, New
      York, USA.
LA  - eng
PT  - Historical Article
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Clustered Regularly Interspaced Short Palindromic Repeats/*genetics
MH  - History, 21st Century
MH  - Patents as Topic/*history/*legislation & jurisprudence
EDAT- 2015/03/10 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/03/10 06:00
PHST- 2015/03/10 06:00 [entrez]
PHST- 2015/03/10 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3160 [pii]
AID - 10.1038/nbt.3160 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Mar;33(3):256-7. doi: 10.1038/nbt.3160.

PMID- 25748912
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20170607
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 3
DP  - 2015 Mar
TI  - Nature Biotechnology's academic spinouts of 2014.
PG  - 247-55
LID - 10.1038/nbt.3163 [doi]
FAU - Bouchie, Aaron
AU  - Bouchie A
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Transforming Growth Factor beta)
RN  - EC 2.7.1.1 (TOR Serine-Threonine Kinases)
SB  - IM
MH  - *Academies and Institutes
MH  - *Biotechnology
MH  - Clustered Regularly Interspaced Short Palindromic Repeats
MH  - Drug Industry
MH  - Genetic Therapy
MH  - Humans
MH  - Immunotherapy
MH  - *Periodicals as Topic
MH  - TOR Serine-Threonine Kinases/metabolism
MH  - Transforming Growth Factor beta/metabolism
EDAT- 2015/03/10 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/03/10 06:00
PHST- 2015/03/10 06:00 [entrez]
PHST- 2015/03/10 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3163 [pii]
AID - 10.1038/nbt.3163 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Mar;33(3):247-55. doi: 10.1038/nbt.3163.

PMID- 25748911
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20170505
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 3
DP  - 2015 Mar
TI  - Ballgown bridges the gap between transcriptome assembly and expression analysis.
PG  - 243-6
LID - 10.1038/nbt.3172 [doi]
FAU - Frazee, Alyssa C
AU  - Frazee AC
AD  - 1] Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, 
      Baltimore, Maryland, USA. [2] Center for Computational Biology, Johns Hopkins
      University, Baltimore, Maryland, USA.
FAU - Pertea, Geo
AU  - Pertea G
AD  - 1] Center for Computational Biology, Johns Hopkins University, Baltimore,
      Maryland, USA. [2] McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins 
      University School of Medicine, Baltimore, Maryland, USA.
FAU - Jaffe, Andrew E
AU  - Jaffe AE
AUID- ORCID: 0000000168861454
AD  - 1] Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, 
      Baltimore, Maryland, USA. [2] Center for Computational Biology, Johns Hopkins
      University, Baltimore, Maryland, USA. [3] Lieber Institute for Brain Development,
      Johns Hopkins Medical Campus, Baltimore, Maryland, USA.
FAU - Langmead, Ben
AU  - Langmead B
AD  - 1] Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, 
      Baltimore, Maryland, USA. [2] Center for Computational Biology, Johns Hopkins
      University, Baltimore, Maryland, USA. [3] Department of Computer Science, Johns
      Hopkins University, Baltimore, Maryland, USA.
FAU - Salzberg, Steven L
AU  - Salzberg SL
AUID- ORCID: 0000000288597432
AD  - 1] Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, 
      Baltimore, Maryland, USA. [2] Center for Computational Biology, Johns Hopkins
      University, Baltimore, Maryland, USA. [3] McKusick-Nathans Institute of Genetic
      Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. 
      [4] Department of Computer Science, Johns Hopkins University, Baltimore,
      Maryland, USA.
FAU - Leek, Jeffrey T
AU  - Leek JT
AD  - 1] Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, 
      Baltimore, Maryland, USA. [2] Center for Computational Biology, Johns Hopkins
      University, Baltimore, Maryland, USA.
LA  - eng
GR  - R01 GM105705/GM/NIGMS NIH HHS/United States
GR  - R01 HG006677/HG/NHGRI NIH HHS/United States
GR  - 1R01GM105705/GM/NIGMS NIH HHS/United States
PT  - Letter
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (RNA, Messenger)
SB  - IM
MH  - Female
MH  - Gene Expression Profiling/*methods
MH  - *Gene Expression Regulation
MH  - Humans
MH  - Male
MH  - Quantitative Trait Loci/genetics
MH  - RNA, Messenger/genetics/metabolism
MH  - *Software
MH  - Transcriptome/*genetics
PMC - PMC4792117
MID - NIHMS764978
EDAT- 2015/03/10 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/03/10 06:00
PHST- 2015/03/10 06:00 [entrez]
PHST- 2015/03/10 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3172 [pii]
AID - 10.1038/nbt.3172 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Mar;33(3):243-6. doi: 10.1038/nbt.3172.

PMID- 25748910
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20161019
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 3
DP  - 2015 Mar
TI  - Quality score compression improves genotyping accuracy.
PG  - 240-3
LID - 10.1038/nbt.3170 [doi]
FAU - Yu, Y William
AU  - Yu YW
AUID- ORCID: 0000000282759576
AD  - 1] Computer Science and Artificial Intelligence Laboratory, Massachusetts
      Institute of Technology, Cambridge, Massachusetts, USA. [2] Department of
      Mathematics, Massachusetts Institute of Technology, Cambridge, Massachusetts,
      USA.
FAU - Yorukoglu, Deniz
AU  - Yorukoglu D
AD  - Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute 
      of Technology, Cambridge, Massachusetts, USA.
FAU - Peng, Jian
AU  - Peng J
AD  - 1] Computer Science and Artificial Intelligence Laboratory, Massachusetts
      Institute of Technology, Cambridge, Massachusetts, USA. [2] Department of
      Mathematics, Massachusetts Institute of Technology, Cambridge, Massachusetts,
      USA.
FAU - Berger, Bonnie
AU  - Berger B
AD  - 1] Computer Science and Artificial Intelligence Laboratory, Massachusetts
      Institute of Technology, Cambridge, Massachusetts, USA. [2] Department of
      Mathematics, Massachusetts Institute of Technology, Cambridge, Massachusetts,
      USA.
LA  - eng
GR  - R01 GM108348/GM/NIGMS NIH HHS/United States
GR  - GM108348/GM/NIGMS NIH HHS/United States
PT  - Letter
PT  - Research Support, N.I.H., Extramural
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Algorithms
MH  - *Data Compression
MH  - Genotyping Techniques/*standards
MH  - High-Throughput Nucleotide Sequencing
MH  - Humans
MH  - ROC Curve
PMC - PMC4439189
MID - NIHMS689880
EDAT- 2015/03/10 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/03/10 06:00
PHST- 2015/03/10 06:00 [entrez]
PHST- 2015/03/10 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3170 [pii]
AID - 10.1038/nbt.3170 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Mar;33(3):240-3. doi: 10.1038/nbt.3170.

PMID- 25748909
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20150309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 3
DP  - 2015 Mar
TI  - How to set up collaborations between academia and industrial biotech companies.
PG  - 237-40
LID - 10.1038/nbt.3171 [doi]
FAU - Pronk, Jack T
AU  - Pronk JT
AD  - Department of Biotechnology, Delft University of Technology, Delft, The
      Netherlands.
FAU - Lee, Sang Yup
AU  - Lee SY
AUID- ORCID: 0000000305993091
AD  - 1] Department of Chemical and Biomolecular Engineering, KAIST, Daejeon, Korea.
      [2] Novo Nordisk Foundation Center for Biosustainability, Technical University of
      Denmark, Horsholm, Denmark.
FAU - Lievense, Jeff
AU  - Lievense J
AD  - Genomatica, San Diego, California, USA.
FAU - Pierce, John
AU  - Pierce J
AD  - BP, Cambridge, Massachusetts, USA.
FAU - Palsson, Bernhard
AU  - Palsson B
AD  - 1] Novo Nordisk Foundation Center for Biosustainability, Technical University of 
      Denmark, Horsholm, Denmark. [2] Department of Bioengineering, University of
      California, San Diego, La Jolla, California, USA.
FAU - Uhlen, Mathias
AU  - Uhlen M
AD  - 1] Novo Nordisk Foundation Center for Biosustainability, Technical University of 
      Denmark, Horsholm, Denmark. [2] Science for Life Laboratory, Royal Institute of
      Technology, Stockholm, Sweden.
FAU - Nielsen, Jens
AU  - Nielsen J
AD  - 1] Novo Nordisk Foundation Center for Biosustainability, Technical University of 
      Denmark, Horsholm, Denmark. [2] Department of Chemical and Biological
      Engineering, Chalmers University of Technology, Gothenburg, Sweden.
LA  - eng
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Academies and Institutes
MH  - *Biotechnology
MH  - *Cooperative Behavior
MH  - Decision Making
MH  - *Drug Industry
MH  - Intellectual Property
MH  - Models, Theoretical
MH  - Public-Private Sector Partnerships
EDAT- 2015/03/10 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/03/10 06:00
PHST- 2015/03/10 06:00 [entrez]
PHST- 2015/03/10 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3171 [pii]
AID - 10.1038/nbt.3171 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Mar;33(3):237-40. doi: 10.1038/nbt.3171.

PMID- 25748908
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20161125
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 3
DP  - 2015 Mar
TI  - Keys to the kingdom.
PG  - 232-6
LID - 10.1038/nbt.3159 [doi]
FAU - Wong, Sybil C K
AU  - Wong SC
AD  - Oxbridge Biotech Roundtable, London, UK.
FAU - Sasportas, Laura S
AU  - Sasportas LS
AD  - Departments of Bioengineering and Radiology, Stanford University, Stanford,
      California, USA.
FAU - Richardson, Katie
AU  - Richardson K
AD  - Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.
FAU - Gordon, Brian R
AU  - Gordon BR
AD  - BRGordon Partners, San Francisco, California, USA.
FAU - Jayatunga, Madura K P
AU  - Jayatunga MK
AD  - Department of Organic Chemistry, Chemistry Research Laboratory, University of
      Oxford, Oxford, UK.
FAU - Shalizi, Aryaman
AU  - Shalizi A
AD  - Department of Pathology, Stanford University, Stanford, California, USA.
FAU - Pfister, Sophia X
AU  - Pfister SX
AD  - CRUK MRC Oxford Institute for Radiation Oncology, UK.
FAU - Stanzl, Erika G
AU  - Stanzl EG
AD  - Department of Chemistry, Stanford University, California, USA.
FAU - Chui, Cecilia
AU  - Chui C
AD  - NDM Research Building, University of Oxford, Oxford, UK.
FAU - Mathur, Melina
AU  - Mathur M
AD  - Department of Bioengineering, Stanford University, Stanford, California, USA.
FAU - Thomsen, Soren K
AU  - Thomsen SK
AD  - Oxford Centre for Diabetes, Endocrinology &Metabolism, University of Oxford,
      Oxford, UK.
FAU - Shetty, Charvi
AU  - Shetty C
AD  - KNOX Medical Diagnostics, Inc., San Francisco, California, USA.
FAU - Pliuskys, Laurynas
AU  - Pliuskys L
AD  - Doctoral Training Centre, University of Oxford, Oxford, UK.
FAU - Mehra, Akhil
AU  - Mehra A
AD  - Department of Anthropology, History, and Social Medicine University of
      California, San Francisco, California, USA.
FAU - Bahar, Hila
AU  - Bahar H
AD  - Endocrine Unit, Massachusetts General Hospital and Harvard Medical School,
      Boston, Massachusetts, USA.
FAU - Godec, Jernej
AU  - Godec J
AD  - 1] Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston,
      Massachusetts, USA. [2] Department of Microbiology and Immunobiology, Harvard
      Medical School, Boston, Massachusetts, USA.
FAU - Jong, Simcha
AU  - Jong S
AD  - Department of Management Science &Innovation, University College London, London, 
      UK.
FAU - Perez, Daniel A
AU  - Perez DA
AD  - 1] Oxbridge Biotech Roundtable, London, UK. [2] Department of Biochemistry,
      Glycobiology Institute, University of Oxford, UK.
LA  - eng
PT  - Journal Article
DEP - 20150226
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Conflict of Interest
MH  - Financial Statements
MH  - Guidelines as Topic
MH  - Legislation as Topic
MH  - Licensure
MH  - *Technology Transfer
MH  - United Kingdom
MH  - United States
MH  - Universities
EDAT- 2015/03/10 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/03/10 06:00
PHST- 2015/03/10 06:00 [entrez]
PHST- 2015/03/10 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3159 [pii]
AID - 10.1038/nbt.3159 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Mar;33(3):232-6. doi: 10.1038/nbt.3159. Epub 2015 Feb 26.

PMID- 25748907
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20180329
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 3
DP  - 2015 Mar
TI  - Drugging the gut microbiome.
PG  - 228-31
LID - 10.1038/nbt.3161 [doi]
AB  - Using conventional drug discovery and novel synthetic biology approaches, some
      investigators and companies are mining our resident microbes and their
      metabolites for targets in small-molecule drug programs. Ken Garber reports.
FAU - Garber, Ken
AU  - Garber K
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EIN - Nat Biotechnol. 2017 May 9;35(5):481. PMID: 28486466
MH  - Cardiovascular Diseases/therapy
MH  - *Drug Discovery
MH  - Fermentation
MH  - *Gastrointestinal Microbiome
MH  - Genetic Engineering
MH  - Humans
MH  - Metabolome
EDAT- 2015/03/10 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/03/10 06:00
PHST- 2015/03/10 06:00 [entrez]
PHST- 2015/03/10 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3161 [pii]
AID - 10.1038/nbt.3161 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Mar;33(3):228-31. doi: 10.1038/nbt.3161.

PMID- 25748904
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20150309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 3
DP  - 2015 Mar
TI  - Shire bags NPS, including newly approved biologic for hypoparathyroidism.
PG  - 226
LID - 10.1038/nbt0315-226c [doi]
FAU - Ratner, Mark
AU  - Ratner M
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Biological Products)
RN  - 0 (Parathyroid Hormone)
SB  - IM
MH  - Biological Products/*therapeutic use
MH  - Clinical Trials as Topic
MH  - *Drug Industry
MH  - Humans
MH  - Hypoparathyroidism/*drug therapy
MH  - Parathyroid Hormone/therapeutic use
EDAT- 2015/03/10 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/03/10 06:00
PHST- 2015/03/10 06:00 [entrez]
PHST- 2015/03/10 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt0315-226c [pii]
AID - 10.1038/nbt0315-226c [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Mar;33(3):226. doi: 10.1038/nbt0315-226c.

PMID- 25748903
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20150616
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 3
DP  - 2015 Mar
TI  - Correction.
PG  - 226
LID - 10.1038/nbt0315-227b [doi]
LA  - eng
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2015 Jan;33(1):8-9. PMID: 25574617
EFR - Nat Biotechnol. 2014 Dec;32(12):1175. PMID: 25489819
EDAT- 2015/03/10 06:00
MHDA- 2015/03/10 06:01
CRDT- 2015/03/10 06:00
PHST- 2015/03/10 06:00 [entrez]
PHST- 2015/03/10 06:00 [pubmed]
PHST- 2015/03/10 06:01 [medline]
AID - nbt0315-227b [pii]
AID - 10.1038/nbt0315-227b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Mar;33(3):226. doi: 10.1038/nbt0315-227b.

PMID- 25748902
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20150309
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 3
DP  - 2015 Mar
TI  - Weight loss 'electroceutical' device wins FDA okay.
PG  - 226
LID - 10.1038/nbt0315-227a [doi]
FAU - Sinha, Gunjan
AU  - Sinha G
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Device Approval
MH  - Electric Stimulation
MH  - Humans
MH  - Obesity/therapy
MH  - Prostheses and Implants/*economics
MH  - United States
MH  - *United States Food and Drug Administration
MH  - *Weight Loss
EDAT- 2015/03/10 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/03/10 06:00
PHST- 2015/03/10 06:00 [entrez]
PHST- 2015/03/10 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt0315-227a [pii]
AID - 10.1038/nbt0315-227a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Mar;33(3):226. doi: 10.1038/nbt0315-227a.

PMID- 25748900
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20170607
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 3
DP  - 2015 Mar
TI  - Next-generation stem cell therapy poised to enter EU market.
PG  - 224-5
LID - 10.1038/nbt0315-224 [doi]
FAU - Dolgin, Elie
AU  - Dolgin E
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Clinical Trials as Topic
MH  - *European Union
MH  - Humans
MH  - Limbus Corneae/cytology
MH  - *Marketing
MH  - *Stem Cell Transplantation
MH  - Stem Cells/cytology
MH  - Transplantation, Autologous
EDAT- 2015/03/10 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/03/10 06:00
PHST- 2015/03/10 06:00 [entrez]
PHST- 2015/03/10 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt0315-224 [pii]
AID - 10.1038/nbt0315-224 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Mar;33(3):224-5. doi: 10.1038/nbt0315-224.

PMID- 25748899
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20170607
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 3
DP  - 2015 Mar
TI  - Scotts' GM grass grows free from regulation.
PG  - 223
LID - 10.1038/nbt0315-223 [doi]
FAU - Waltz, Emily
AU  - Waltz E
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Genetic Engineering
MH  - Plants, Genetically Modified
MH  - Poaceae/*genetics/*growth & development
MH  - Social Control, Formal
MH  - United States
EDAT- 2015/03/10 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/03/10 06:00
PHST- 2015/03/10 06:00 [entrez]
PHST- 2015/03/10 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt0315-223 [pii]
AID - 10.1038/nbt0315-223 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Mar;33(3):223. doi: 10.1038/nbt0315-223.

PMID- 25748898
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20170607
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 3
DP  - 2015 Mar
TI  - First US biosimilar edges towards market.
PG  - 222-3
LID - 10.1038/nbt0315-222 [doi]
FAU - Senior, Melanie
AU  - Senior M
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Biosimilar Pharmaceuticals)
SB  - IM
EIN - Nat Biotechnol. 2015 May;33(5):439. PMID: 25965737
MH  - Biosimilar Pharmaceuticals/*pharmacology
MH  - Drug Approval
MH  - Drug Industry
MH  - Humans
MH  - *Marketing
MH  - United States
MH  - United States Food and Drug Administration
EDAT- 2015/03/10 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/03/10 06:00
PHST- 2015/03/10 06:00 [entrez]
PHST- 2015/03/10 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt0315-222 [pii]
AID - 10.1038/nbt0315-222 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Mar;33(3):222-3. doi: 10.1038/nbt0315-222.

PMID- 25748895
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20170607
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 3
DP  - 2015 Mar
TI  - Amgen's bispecific antibody puffs across finish line.
PG  - 219-21
LID - 10.1038/nbt0315-219 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antibodies, Bispecific)
SB  - IM
EIN - Nat Biotechnol. 2015 May;33(5):439. PMID: 25965737
MH  - Antibodies, Bispecific/*immunology
MH  - Clinical Trials as Topic
MH  - *Drug Industry
MH  - Humans
MH  - Killer Cells, Natural/immunology
EDAT- 2015/03/10 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/03/10 06:00
PHST- 2015/03/10 06:00 [entrez]
PHST- 2015/03/10 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt0315-219 [pii]
AID - 10.1038/nbt0315-219 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Mar;33(3):219-21. doi: 10.1038/nbt0315-219.

PMID- 25748892
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20170607
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 3
DP  - 2015 Mar
TI  - $1-million price tag set for Glybera gene therapy.
PG  - 217-8
LID - 10.1038/nbt0315-217 [doi]
FAU - Morrison, Chris
AU  - Morrison C
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Commerce/*economics
MH  - Drug Industry/economics
MH  - Europe
MH  - Genetic Therapy/adverse effects/*economics
MH  - Humans
MH  - Insurance, Health/economics
MH  - Treatment Outcome
MH  - United States
EDAT- 2015/03/10 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/03/10 06:00
PHST- 2015/03/10 06:00 [entrez]
PHST- 2015/03/10 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt0315-217 [pii]
AID - 10.1038/nbt0315-217 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Mar;33(3):217-8. doi: 10.1038/nbt0315-217.

PMID- 25748890
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20170607
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 3
DP  - 2015 Mar
TI  - Roche spends $1 billion on Foundation Medicine's tumor profiling.
PG  - 215-6
LID - 10.1038/nbt0315-215 [doi]
FAU - Ratner, Mark
AU  - Ratner M
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Genomics/*economics
MH  - Humans
MH  - Laboratories/*economics
MH  - Neoplasms/*economics/*genetics
MH  - Precision Medicine/economics
MH  - Research/economics
EDAT- 2015/03/10 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/03/10 06:00
PHST- 2015/03/10 06:00 [entrez]
PHST- 2015/03/10 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt0315-215 [pii]
AID - 10.1038/nbt0315-215 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Mar;33(3):215-6. doi: 10.1038/nbt0315-215.

PMID- 25748889
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20170607
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 3
DP  - 2015 Mar
TI  - Double-blind peer review.
PG  - 213
LID - 10.1038/nbt.3173 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Double-Blind Method
MH  - *Peer Review, Research
MH  - Periodicals as Topic
EDAT- 2015/03/10 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/03/10 06:00
PHST- 2015/03/10 06:00 [entrez]
PHST- 2015/03/10 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3173 [pii]
AID - 10.1038/nbt.3173 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Mar;33(3):213. doi: 10.1038/nbt.3173.

PMID- 25690850
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20170607
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 3
DP  - 2015 Mar
TI  - StringTie enables improved reconstruction of a transcriptome from RNA-seq reads.
PG  - 290-5
LID - 10.1038/nbt.3122 [doi]
AB  - Methods used to sequence the transcriptome often produce more than 200 million
      short sequences. We introduce StringTie, a computational method that applies a
      network flow algorithm originally developed in optimization theory, together with
      optional de novo assembly, to assemble these complex data sets into transcripts. 
      When used to analyze both simulated and real data sets, StringTie produces more
      complete and accurate reconstructions of genes and better estimates of expression
      levels, compared with other leading transcript assembly programs including
      Cufflinks, IsoLasso, Scripture and Traph. For example, on 90 million reads from
      human blood, StringTie correctly assembled 10,990 transcripts, whereas the next
      best assembly was of 7,187 transcripts by Cufflinks, which is a 53% increase in
      transcripts assembled. On a simulated data set, StringTie correctly assembled
      7,559 transcripts, which is 20% more than the 6,310 assembled by Cufflinks. As
      well as producing a more complete transcriptome assembly, StringTie runs faster
      on all data sets tested to date compared with other assembly software, including 
      Cufflinks.
FAU - Pertea, Mihaela
AU  - Pertea M
AD  - 1] Center for Computational Biology, Johns Hopkins University, Baltimore,
      Maryland, USA. [2] McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins 
      University, Baltimore, Maryland, USA.
FAU - Pertea, Geo M
AU  - Pertea GM
AD  - 1] Center for Computational Biology, Johns Hopkins University, Baltimore,
      Maryland, USA. [2] McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins 
      University, Baltimore, Maryland, USA.
FAU - Antonescu, Corina M
AU  - Antonescu CM
AD  - 1] Center for Computational Biology, Johns Hopkins University, Baltimore,
      Maryland, USA. [2] McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins 
      University, Baltimore, Maryland, USA.
FAU - Chang, Tsung-Cheng
AU  - Chang TC
AD  - 1] Department of Molecular Biology, The University of Texas Southwestern Medical 
      Center, Dallas, Texas, USA. [2] Center for Regenerative Science and Medicine, The
      University of Texas Southwestern Medical Center, Dallas, Texas, USA.
FAU - Mendell, Joshua T
AU  - Mendell JT
AD  - 1] Department of Molecular Biology, The University of Texas Southwestern Medical 
      Center, Dallas, Texas, USA. [2] Center for Regenerative Science and Medicine, The
      University of Texas Southwestern Medical Center, Dallas, Texas, USA. [3] Simmons 
      Cancer Center, The University of Texas Southwestern Medical Center, Dallas,
      Texas, USA.
FAU - Salzberg, Steven L
AU  - Salzberg SL
AUID- ORCID: 0000000288597432
AD  - 1] Center for Computational Biology, Johns Hopkins University, Baltimore,
      Maryland, USA. [2] McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins 
      University, Baltimore, Maryland, USA. [3] Department of Biomedical Engineering,
      Johns Hopkins University, Baltimore, Maryland, USA. [4] Department of Computer
      Science, Johns Hopkins University, Baltimore, Maryland, USA.
LA  - eng
SI  - SRA/SRP041943
GR  - R01 HG006677/HG/NHGRI NIH HHS/United States
GR  - R01-HG006102/HG/NHGRI NIH HHS/United States
GR  - R01-HG006677/HG/NHGRI NIH HHS/United States
GR  - R01-GM105705/GM/NIGMS NIH HHS/United States
GR  - R01 CA120185/CA/NCI NIH HHS/United States
GR  - P01 CA134292/CA/NCI NIH HHS/United States
GR  - R01-CA120185/CA/NCI NIH HHS/United States
GR  - P01-CA134292/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20150218
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (RNA, Messenger)
SB  - IM
MH  - Algorithms
MH  - HEK293 Cells
MH  - Humans
MH  - RNA, Messenger/genetics/metabolism
MH  - Sequence Analysis, RNA/*methods
MH  - *Software
MH  - Transcriptome/*genetics
PMC - PMC4643835
MID - NIHMS736717
EDAT- 2015/02/19 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/02/19 06:00
PHST- 2014/04/15 00:00 [received]
PHST- 2014/12/09 00:00 [accepted]
PHST- 2015/02/19 06:00 [entrez]
PHST- 2015/02/19 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3122 [pii]
AID - 10.1038/nbt.3122 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Mar;33(3):290-5. doi: 10.1038/nbt.3122. Epub 2015 Feb 18.

PMID- 25664528
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 3
DP  - 2015 Mar
TI  - Decoding the regulatory network of early blood development from single-cell gene 
      expression measurements.
PG  - 269-276
LID - 10.1038/nbt.3154 [doi]
AB  - Reconstruction of the molecular pathways controlling organ development has been
      hampered by a lack of methods to resolve embryonic progenitor cells. Here we
      describe a strategy to address this problem that combines gene expression
      profiling of large numbers of single cells with data analysis based on diffusion 
      maps for dimensionality reduction and network synthesis from state transition
      graphs. Applying the approach to hematopoietic development in the mouse embryo,
      we map the progression of mesoderm toward blood using single-cell gene expression
      analysis of 3,934 cells with blood-forming potential captured at four time points
      between E7.0 and E8.5. Transitions between individual cellular states are then
      used as input to develop a single-cell network synthesis toolkit to generate a
      computationally executable transcriptional regulatory network model of blood
      development. Several model predictions concerning the roles of Sox and Hox
      factors are validated experimentally. Our results demonstrate that single-cell
      analysis of a developing organ coupled with computational approaches can reveal
      the transcriptional programs that underpin organogenesis.
FAU - Moignard, Victoria
AU  - Moignard V
AD  - Department of Haematology, Cambridge Institute for Medical Research, University
      of Cambridge, UK.
AD  - Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute,
      University of Cambridge, Cambridge, UK.
FAU - Woodhouse, Steven
AU  - Woodhouse S
AD  - Department of Haematology, Cambridge Institute for Medical Research, University
      of Cambridge, UK.
AD  - Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute,
      University of Cambridge, Cambridge, UK.
FAU - Haghverdi, Laleh
AU  - Haghverdi L
AD  - Institute of Computational Biology, Helmholtz Zentrum Munchen, Neuherberg,
      Germany.
AD  - Department of Mathematics, Technische Universitat Munchen, Garching, Germany.
FAU - Lilly, Andrew J
AU  - Lilly AJ
AD  - Cancer Research UK Stem Cell Haematopoiesis Group, Paterson Institute for Cancer 
      Research, University of Manchester, Manchester, UK.
FAU - Tanaka, Yosuke
AU  - Tanaka Y
AD  - Department of Haematology, Cambridge Institute for Medical Research, University
      of Cambridge, UK.
AD  - Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute,
      University of Cambridge, Cambridge, UK.
AD  - Laboratory for Stem Cell Biology, RIKEN Center for Developmental Biology,
      Chuo-ku, Kobe, Japan.
FAU - Wilkinson, Adam C
AU  - Wilkinson AC
AD  - Department of Haematology, Cambridge Institute for Medical Research, University
      of Cambridge, UK.
AD  - Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute,
      University of Cambridge, Cambridge, UK.
FAU - Buettner, Florian
AU  - Buettner F
AD  - Institute of Computational Biology, Helmholtz Zentrum Munchen, Neuherberg,
      Germany.
FAU - Macaulay, Iain C
AU  - Macaulay IC
AD  - Sanger Institute-EBI Single Cell Genomics Centre, Wellcome Trust Sanger
      Institute, Hinxton, Cambridge, UK.
FAU - Jawaid, Wajid
AU  - Jawaid W
AD  - Department of Haematology, Cambridge Institute for Medical Research, University
      of Cambridge, UK.
FAU - Diamanti, Evangelia
AU  - Diamanti E
AD  - Department of Haematology, Cambridge Institute for Medical Research, University
      of Cambridge, UK.
AD  - Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute,
      University of Cambridge, Cambridge, UK.
FAU - Nishikawa, Shin-Ichi
AU  - Nishikawa SI
AD  - Laboratory for Stem Cell Biology, RIKEN Center for Developmental Biology,
      Chuo-ku, Kobe, Japan.
FAU - Piterman, Nir
AU  - Piterman N
AD  - Department of Computer Science, University of Leicester, Leicester, UK.
FAU - Kouskoff, Valerie
AU  - Kouskoff V
AD  - Cancer Research UK Stem Cell Haematopoiesis Group, Paterson Institute for Cancer 
      Research, University of Manchester, Manchester, UK.
FAU - Theis, Fabian J
AU  - Theis FJ
AD  - Institute of Computational Biology, Helmholtz Zentrum Munchen, Neuherberg,
      Germany.
AD  - Department of Mathematics, Technische Universitat Munchen, Garching, Germany.
FAU - Fisher, Jasmin
AU  - Fisher J
AD  - Microsoft Research Cambridge, Cambridge, UK.
AD  - Department of Biochemistry, University of Cambridge, Cambridge, UK.
FAU - Gottgens, Berthold
AU  - Gottgens B
AD  - Department of Haematology, Cambridge Institute for Medical Research, University
      of Cambridge, UK.
AD  - Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute,
      University of Cambridge, Cambridge, UK.
LA  - eng
SI  - GEO/GSE61470
GR  - Medical Research Council/United Kingdom
GR  - Biotechnology and Biological Sciences Research Council/United Kingdom
GR  - 12765/Cancer Research UK/United Kingdom
GR  - G0900951/Medical Research Council/United Kingdom
GR  - 097922/Wellcome Trust/United Kingdom
GR  - MR/M008975/1/Medical Research Council/United Kingdom
GR  - 100140/Wellcome Trust/United Kingdom
GR  - MC_PC_12009/Medical Research Council/United Kingdom
GR  - Wellcome Trust/United Kingdom
GR  - BB/I00050X/1/Biotechnology and Biological Sciences Research Council/United
      Kingdom
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150209
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CIN - Nat Biotechnol. 2015 Mar;33(3):260-1. PMID: 25748916
MH  - Animals
MH  - Base Sequence
MH  - Blood Cells/*metabolism
MH  - Computer Simulation
MH  - Diffusion
MH  - Female
MH  - Gastrulation
MH  - Gene Expression Profiling
MH  - *Gene Expression Regulation
MH  - *Gene Regulatory Networks
MH  - Male
MH  - Mice, Inbred ICR
MH  - Models, Genetic
MH  - Molecular Sequence Data
MH  - Single-Cell Analysis/*methods
MH  - Transcription, Genetic
PMC - PMC4374163
MID - EMS61867
OID - NLM: EMS61867
EDAT- 2015/02/11 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/02/10 06:00
PHST- 2014/08/15 00:00 [received]
PHST- 2015/01/16 00:00 [accepted]
PHST- 2015/02/10 06:00 [entrez]
PHST- 2015/02/11 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - 10.1038/nbt.3154 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Mar;33(3):269-276. doi: 10.1038/nbt.3154. Epub 2015 Feb 9.

PMID- 25599178
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 3
DP  - 2015 Mar
TI  - Integrated genome and transcriptome sequencing of the same cell.
PG  - 285-289
LID - 10.1038/nbt.3129 [doi]
AB  - Single-cell genomics and single-cell transcriptomics have emerged as powerful
      tools to study the biology of single cells at a genome-wide scale. However, a
      major challenge is to sequence both genomic DNA and mRNA from the same cell,
      which would allow direct comparison of genomic variation and transcriptome
      heterogeneity. We describe a quasilinear amplification strategy to quantify
      genomic DNA and mRNA from the same cell without physically separating the nucleic
      acids before amplification. We show that the efficiency of our integrated
      approach is similar to existing methods for single-cell sequencing of either
      genomic DNA or mRNA. Further, we find that genes with high cell-to-cell
      variability in transcript numbers generally have lower genomic copy numbers, and 
      vice versa, suggesting that copy number variations may drive variability in gene 
      expression among individual cells. Applications of our integrated sequencing
      approach could range from gaining insights into cancer evolution and
      heterogeneity to understanding the transcriptional consequences of copy number
      variations in healthy and diseased tissues.
FAU - Dey, Siddharth S
AU  - Dey SS
AD  - Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences),
      Utrecht, The Netherlands.
AD  - University Medical Center Utrecht, Cancer Genomics Netherlands, Utrecht, The
      Netherlands.
FAU - Kester, Lennart
AU  - Kester L
AD  - Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences),
      Utrecht, The Netherlands.
AD  - University Medical Center Utrecht, Cancer Genomics Netherlands, Utrecht, The
      Netherlands.
FAU - Spanjaard, Bastiaan
AU  - Spanjaard B
AD  - Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences),
      Utrecht, The Netherlands.
AD  - University Medical Center Utrecht, Cancer Genomics Netherlands, Utrecht, The
      Netherlands.
FAU - Bienko, Magda
AU  - Bienko M
AD  - Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences),
      Utrecht, The Netherlands.
AD  - University Medical Center Utrecht, Cancer Genomics Netherlands, Utrecht, The
      Netherlands.
FAU - van Oudenaarden, Alexander
AU  - van Oudenaarden A
AD  - Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences),
      Utrecht, The Netherlands.
AD  - University Medical Center Utrecht, Cancer Genomics Netherlands, Utrecht, The
      Netherlands.
LA  - eng
SI  - GEO/GSE62952
GR  - 294325/European Research Council/International
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150119
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (RNA, Messenger)
RN  - 9007-49-2 (DNA)
SB  - IM
MH  - Cell Line, Tumor
MH  - DNA/genetics
MH  - Gene Expression Regulation
MH  - *Genome
MH  - High-Throughput Nucleotide Sequencing/*methods
MH  - Humans
MH  - RNA, Messenger/genetics/metabolism
MH  - *Single-Cell Analysis
MH  - Transcriptome/*genetics
PMC - PMC4374170
MID - EMS61543
OID - NLM: EMS61543
EDAT- 2015/01/20 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/01/20 06:00
PHST- 2014/04/25 00:00 [received]
PHST- 2014/12/12 00:00 [accepted]
PHST- 2015/01/20 06:00 [entrez]
PHST- 2015/01/20 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - 10.1038/nbt.3129 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Mar;33(3):285-289. doi: 10.1038/nbt.3129. Epub 2015 Jan 19.

PMID- 25599177
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20170607
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 3
DP  - 2015 Mar
TI  - Multifunctional fibers for simultaneous optical, electrical and chemical
      interrogation of neural circuits in vivo.
PG  - 277-84
LID - 10.1038/nbt.3093 [doi]
AB  - Brain function depends on simultaneous electrical, chemical and mechanical
      signaling at the cellular level. This multiplicity has confounded efforts to
      simultaneously measure or modulate these diverse signals in vivo. Here we present
      fiber probes that allow for simultaneous optical stimulation, neural recording
      and drug delivery in behaving mice with high resolution. These fibers are
      fabricated from polymers by means of a thermal drawing process that allows for
      the integration of multiple materials and interrogation modalities into neural
      probes. Mechanical, electrical, optical and microfluidic measurements revealed
      high flexibility and functionality of the probes under bending deformation.
      Long-term in vivo recordings, optogenetic stimulation, drug perturbation and
      analysis of tissue response confirmed that our probes can form stable
      brain-machine interfaces for at least 2 months. We expect that our
      multifunctional fibers will permit more detailed manipulation and analysis of
      neural circuits deep in the brain of behaving animals than achievable before.
FAU - Canales, Andres
AU  - Canales A
AD  - Department of Materials Science and Engineering, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
FAU - Jia, Xiaoting
AU  - Jia X
AD  - Research Laboratory of Electronics, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Froriep, Ulrich P
AU  - Froriep UP
AD  - 1] Research Laboratory of Electronics, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA. [2] Simons Center for the Social Brain,
      Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
FAU - Koppes, Ryan A
AU  - Koppes RA
AD  - Research Laboratory of Electronics, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Tringides, Christina M
AU  - Tringides CM
AD  - Department of Materials Science and Engineering, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
FAU - Selvidge, Jennifer
AU  - Selvidge J
AD  - Department of Materials Science and Engineering, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
FAU - Lu, Chi
AU  - Lu C
AD  - Department of Materials Science and Engineering, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
FAU - Hou, Chong
AU  - Hou C
AD  - Department of Materials Science and Engineering, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA.
FAU - Wei, Lei
AU  - Wei L
AD  - Research Laboratory of Electronics, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA.
FAU - Fink, Yoel
AU  - Fink Y
AD  - 1] Department of Materials Science and Engineering, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA. [2] Research Laboratory of
      Electronics, Massachusetts Institute of Technology, Cambridge, Massachusetts,
      USA.
FAU - Anikeeva, Polina
AU  - Anikeeva P
AD  - 1] Department of Materials Science and Engineering, Massachusetts Institute of
      Technology, Cambridge, Massachusetts, USA. [2] Research Laboratory of
      Electronics, Massachusetts Institute of Technology, Cambridge, Massachusetts,
      USA.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20150119
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Metals)
SB  - IM
CIN - Nat Biotechnol. 2015 Mar;33(3):259-60. PMID: 25748915
MH  - Animals
MH  - Blood-Brain Barrier/drug effects
MH  - Drug Delivery Systems
MH  - Electrodes
MH  - *Electrophysiological Phenomena/drug effects
MH  - Foreign-Body Reaction/pathology
MH  - Implants, Experimental
MH  - Male
MH  - Metals/pharmacology
MH  - Mice, Inbred C57BL
MH  - Mice, Transgenic
MH  - Nerve Net/drug effects/*physiology
MH  - *Optical Fibers
MH  - Optogenetics
EDAT- 2015/01/20 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/01/20 06:00
PHST- 2014/08/04 00:00 [received]
PHST- 2014/11/10 00:00 [accepted]
PHST- 2015/01/20 06:00 [entrez]
PHST- 2015/01/20 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3093 [pii]
AID - 10.1038/nbt.3093 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Mar;33(3):277-84. doi: 10.1038/nbt.3093. Epub 2015 Jan 19.

PMID- 25485619
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20170606
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 3
DP  - 2015 Mar
TI  - A comprehensive transcriptional portrait of human cancer cell lines.
PG  - 306-12
LID - 10.1038/nbt.3080 [doi]
AB  - Tumor-derived cell lines have served as vital models to advance our understanding
      of oncogene function and therapeutic responses. Although substantial effort has
      been made to define the genomic constitution of cancer cell line panels, the
      transcriptome remains understudied. Here we describe RNA sequencing and
      single-nucleotide polymorphism (SNP) array analysis of 675 human cancer cell
      lines. We report comprehensive analyses of transcriptome features including gene 
      expression, mutations, gene fusions and expression of non-human sequences. Of the
      2,200 gene fusions catalogued, 1,435 consist of genes not previously found in
      fusions, providing many leads for further investigation. We combine multiple
      genome and transcriptome features in a pathway-based approach to enhance
      prediction of response to targeted therapeutics. Our results provide a valuable
      resource for studies that use cancer cell lines.
FAU - Klijn, Christiaan
AU  - Klijn C
AD  - Department of Bioinformatics and Computational Biology, Genentech Inc., South San
      Francisco, California, USA.
FAU - Durinck, Steffen
AU  - Durinck S
AD  - 1] Department of Bioinformatics and Computational Biology, Genentech Inc., South 
      San Francisco, California, USA. [2] Department of Molecular Biology, Genentech
      Inc., South San Francisco, California, USA.
FAU - Stawiski, Eric W
AU  - Stawiski EW
AD  - 1] Department of Bioinformatics and Computational Biology, Genentech Inc., South 
      San Francisco, California, USA. [2] Department of Molecular Biology, Genentech
      Inc., South San Francisco, California, USA.
FAU - Haverty, Peter M
AU  - Haverty PM
AD  - Department of Bioinformatics and Computational Biology, Genentech Inc., South San
      Francisco, California, USA.
FAU - Jiang, Zhaoshi
AU  - Jiang Z
AD  - Department of Bioinformatics and Computational Biology, Genentech Inc., South San
      Francisco, California, USA.
FAU - Liu, Hanbin
AU  - Liu H
AD  - Department of Bioinformatics and Computational Biology, Genentech Inc., South San
      Francisco, California, USA.
FAU - Degenhardt, Jeremiah
AU  - Degenhardt J
AD  - Department of Bioinformatics and Computational Biology, Genentech Inc., South San
      Francisco, California, USA.
FAU - Mayba, Oleg
AU  - Mayba O
AD  - Department of Bioinformatics and Computational Biology, Genentech Inc., South San
      Francisco, California, USA.
FAU - Gnad, Florian
AU  - Gnad F
AD  - Department of Bioinformatics and Computational Biology, Genentech Inc., South San
      Francisco, California, USA.
FAU - Liu, Jinfeng
AU  - Liu J
AUID- ORCID: 0000000203438222
AD  - Department of Bioinformatics and Computational Biology, Genentech Inc., South San
      Francisco, California, USA.
FAU - Pau, Gregoire
AU  - Pau G
AD  - Department of Bioinformatics and Computational Biology, Genentech Inc., South San
      Francisco, California, USA.
FAU - Reeder, Jens
AU  - Reeder J
AD  - Department of Bioinformatics and Computational Biology, Genentech Inc., South San
      Francisco, California, USA.
FAU - Cao, Yi
AU  - Cao Y
AD  - 1] Department of Bioinformatics and Computational Biology, Genentech Inc., South 
      San Francisco, California, USA. [2] Department of Discovery Oncology, Genentech
      Inc., South San Francisco, California, USA.
FAU - Mukhyala, Kiran
AU  - Mukhyala K
AD  - Department of Bioinformatics and Computational Biology, Genentech Inc., South San
      Francisco, California, USA.
FAU - Selvaraj, Suresh K
AU  - Selvaraj SK
AD  - Department of Discovery Oncology, Genentech Inc., South San Francisco,
      California, USA.
FAU - Yu, Mamie
AU  - Yu M
AD  - Department of Discovery Oncology, Genentech Inc., South San Francisco,
      California, USA.
FAU - Zynda, Gregory J
AU  - Zynda GJ
AD  - Department of Bioinformatics and Computational Biology, Genentech Inc., South San
      Francisco, California, USA.
FAU - Brauer, Matthew J
AU  - Brauer MJ
AD  - Department of Bioinformatics and Computational Biology, Genentech Inc., South San
      Francisco, California, USA.
FAU - Wu, Thomas D
AU  - Wu TD
AD  - Department of Bioinformatics and Computational Biology, Genentech Inc., South San
      Francisco, California, USA.
FAU - Gentleman, Robert C
AU  - Gentleman RC
AD  - Department of Bioinformatics and Computational Biology, Genentech Inc., South San
      Francisco, California, USA.
FAU - Manning, Gerard
AU  - Manning G
AUID- ORCID: 0000000250879151
AD  - Department of Bioinformatics and Computational Biology, Genentech Inc., South San
      Francisco, California, USA.
FAU - Yauch, Robert L
AU  - Yauch RL
AD  - Department of Discovery Oncology, Genentech Inc., South San Francisco,
      California, USA.
FAU - Bourgon, Richard
AU  - Bourgon R
AUID- ORCID: 0000000258904374
AD  - Department of Bioinformatics and Computational Biology, Genentech Inc., South San
      Francisco, California, USA.
FAU - Stokoe, David
AU  - Stokoe D
AD  - Department of Discovery Oncology, Genentech Inc., South San Francisco,
      California, USA.
FAU - Modrusan, Zora
AU  - Modrusan Z
AD  - Department of Molecular Biology, Genentech Inc., South San Francisco, California,
      USA.
FAU - Neve, Richard M
AU  - Neve RM
AD  - Department of Discovery Oncology, Genentech Inc., South San Francisco,
      California, USA.
FAU - de Sauvage, Frederic J
AU  - de Sauvage FJ
AD  - Department of Molecular Biology, Genentech Inc., South San Francisco, California,
      USA.
FAU - Settleman, Jeffrey
AU  - Settleman J
AD  - Department of Discovery Oncology, Genentech Inc., South San Francisco,
      California, USA.
FAU - Seshagiri, Somasekar
AU  - Seshagiri S
AD  - Department of Molecular Biology, Genentech Inc., South San Francisco, California,
      USA.
FAU - Zhang, Zemin
AU  - Zhang Z
AD  - Department of Bioinformatics and Computational Biology, Genentech Inc., South San
      Francisco, California, USA.
LA  - eng
PT  - Journal Article
DEP - 20141208
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Base Sequence
MH  - Cell Line, Tumor
MH  - Cluster Analysis
MH  - Gene Expression Regulation, Neoplastic
MH  - Gene Regulatory Networks
MH  - Humans
MH  - Mutation/genetics
MH  - Neoplasms/*genetics
MH  - Oncogene Fusion/genetics
MH  - Organ Specificity/genetics
MH  - Polymorphism, Single Nucleotide/genetics
MH  - *Transcription, Genetic
EDAT- 2014/12/09 06:00
MHDA- 2016/01/14 06:00
CRDT- 2014/12/09 06:00
PHST- 2014/04/11 00:00 [received]
PHST- 2014/10/15 00:00 [accepted]
PHST- 2014/12/09 06:00 [entrez]
PHST- 2014/12/09 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3080 [pii]
AID - 10.1038/nbt.3080 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Mar;33(3):306-12. doi: 10.1038/nbt.3080. Epub 2014 Dec 8.

PMID- 25485618
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20170607
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 3
DP  - 2015 Mar
TI  - MinION nanopore sequencing identifies the position and structure of a bacterial
      antibiotic resistance island.
PG  - 296-300
LID - 10.1038/nbt.3103 [doi]
AB  - Short-read, high-throughput sequencing technology cannot identify the chromosomal
      position of repetitive insertion sequences that typically flank horizontally
      acquired genes such as bacterial virulence genes and antibiotic resistance genes.
      The MinION nanopore sequencer can produce long sequencing reads on a device
      similar in size to a USB memory stick. Here we apply a MinION sequencer to
      resolve the structure and chromosomal insertion site of a composite antibiotic
      resistance island in Salmonella Typhi Haplotype 58. Nanopore sequencing data from
      a single 18-h run was used to create a scaffold for an assembly generated from
      short-read Illumina data. Our results demonstrate the potential of the MinION
      device in clinical laboratories to fully characterize the epidemic spread of
      bacterial pathogens.
FAU - Ashton, Philip M
AU  - Ashton PM
AD  - Gastrointestinal Bacteria Reference Unit, Public Health England, Colindale,
      London, UK.
FAU - Nair, Satheesh
AU  - Nair S
AD  - Gastrointestinal Bacteria Reference Unit, Public Health England, Colindale,
      London, UK.
FAU - Dallman, Tim
AU  - Dallman T
AD  - Gastrointestinal Bacteria Reference Unit, Public Health England, Colindale,
      London, UK.
FAU - Rubino, Salvatore
AU  - Rubino S
AD  - 1] Department of Biomedical Sciences, University of Sassari, Sassari, Italy. [2] 
      Department of Infection and Immunity, King Faisal Specialist Hospital and
      Research Center, Riyadh, Saudi Arabia.
FAU - Rabsch, Wolfgang
AU  - Rabsch W
AD  - National Reference Centre for Salmonellae and other Enterics, Robert Koch
      Institute, Wernigerode, Germany.
FAU - Mwaigwisya, Solomon
AU  - Mwaigwisya S
AD  - Norwich Medical School, University of East Anglia, Norwich, UK.
FAU - Wain, John
AU  - Wain J
AD  - Norwich Medical School, University of East Anglia, Norwich, UK.
FAU - O'Grady, Justin
AU  - O'Grady J
AUID- ORCID: 0000000154127152
AD  - Norwich Medical School, University of East Anglia, Norwich, UK.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20141208
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Base Composition/genetics
MH  - Chromosomes, Bacterial/genetics
MH  - CpG Islands/*genetics
MH  - Drug Resistance, Bacterial/*genetics
MH  - High-Throughput Nucleotide Sequencing/*instrumentation/*methods
MH  - *Nanopores
MH  - Plasmids/genetics
MH  - Salmonella typhi/genetics
EDAT- 2014/12/09 06:00
MHDA- 2016/01/14 06:00
CRDT- 2014/12/09 06:00
PHST- 2014/09/07 00:00 [received]
PHST- 2014/11/21 00:00 [accepted]
PHST- 2014/12/09 06:00 [entrez]
PHST- 2014/12/09 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3103 [pii]
AID - 10.1038/nbt.3103 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Mar;33(3):296-300. doi: 10.1038/nbt.3103. Epub 2014 Dec 8.

PMID- 25485617
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20171116
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 3
DP  - 2015 Mar
TI  - A gene cluster encoding lectin receptor kinases confers broad-spectrum and
      durable insect resistance in rice.
PG  - 301-5
LID - 10.1038/nbt.3069 [doi]
FAU - Liu, Yuqiang
AU  - Liu Y
AD  - National Key Laboratory for Crop Genetics and Germplasm Enhancement, Jiangsu
      Plant Gene Engineering Research Center, Nanjing Agricultural University, Nanjing,
      China.
FAU - Wu, Han
AU  - Wu H
AD  - National Key Laboratory for Crop Genetics and Germplasm Enhancement, Jiangsu
      Plant Gene Engineering Research Center, Nanjing Agricultural University, Nanjing,
      China.
FAU - Chen, Hong
AU  - Chen H
AD  - National Key Laboratory for Crop Genetics and Germplasm Enhancement, Jiangsu
      Plant Gene Engineering Research Center, Nanjing Agricultural University, Nanjing,
      China.
FAU - Liu, Yanling
AU  - Liu Y
AD  - National Key Laboratory for Crop Genetics and Germplasm Enhancement, Jiangsu
      Plant Gene Engineering Research Center, Nanjing Agricultural University, Nanjing,
      China.
FAU - He, Jun
AU  - He J
AD  - National Key Laboratory for Crop Genetics and Germplasm Enhancement, Jiangsu
      Plant Gene Engineering Research Center, Nanjing Agricultural University, Nanjing,
      China.
FAU - Kang, Haiyan
AU  - Kang H
AD  - National Key Laboratory for Crop Genetics and Germplasm Enhancement, Jiangsu
      Plant Gene Engineering Research Center, Nanjing Agricultural University, Nanjing,
      China.
FAU - Sun, Zhiguang
AU  - Sun Z
AD  - National Key Laboratory for Crop Genetics and Germplasm Enhancement, Jiangsu
      Plant Gene Engineering Research Center, Nanjing Agricultural University, Nanjing,
      China.
FAU - Pan, Gen
AU  - Pan G
AD  - National Key Laboratory for Crop Genetics and Germplasm Enhancement, Jiangsu
      Plant Gene Engineering Research Center, Nanjing Agricultural University, Nanjing,
      China.
FAU - Wang, Qi
AU  - Wang Q
AD  - National Key Laboratory for Crop Genetics and Germplasm Enhancement, Jiangsu
      Plant Gene Engineering Research Center, Nanjing Agricultural University, Nanjing,
      China.
FAU - Hu, Jinlong
AU  - Hu J
AD  - National Key Laboratory for Crop Genetics and Germplasm Enhancement, Jiangsu
      Plant Gene Engineering Research Center, Nanjing Agricultural University, Nanjing,
      China.
FAU - Zhou, Feng
AU  - Zhou F
AD  - National Key Laboratory for Crop Genetics and Germplasm Enhancement, Jiangsu
      Plant Gene Engineering Research Center, Nanjing Agricultural University, Nanjing,
      China.
FAU - Zhou, Kunneng
AU  - Zhou K
AD  - National Key Laboratory for Crop Genetics and Germplasm Enhancement, Jiangsu
      Plant Gene Engineering Research Center, Nanjing Agricultural University, Nanjing,
      China.
FAU - Zheng, Xiaoming
AU  - Zheng X
AD  - National Key Facility for Crop Gene Resources and Genetic Improvement, Institute 
      of Crop Science, Chinese Academy of Agricultural Sciences, Beijing, China.
FAU - Ren, Yulong
AU  - Ren Y
AD  - National Key Laboratory for Crop Genetics and Germplasm Enhancement, Jiangsu
      Plant Gene Engineering Research Center, Nanjing Agricultural University, Nanjing,
      China.
FAU - Chen, Liangming
AU  - Chen L
AD  - National Key Laboratory for Crop Genetics and Germplasm Enhancement, Jiangsu
      Plant Gene Engineering Research Center, Nanjing Agricultural University, Nanjing,
      China.
FAU - Wang, Yihua
AU  - Wang Y
AD  - National Key Laboratory for Crop Genetics and Germplasm Enhancement, Jiangsu
      Plant Gene Engineering Research Center, Nanjing Agricultural University, Nanjing,
      China.
FAU - Zhao, Zhigang
AU  - Zhao Z
AD  - National Key Laboratory for Crop Genetics and Germplasm Enhancement, Jiangsu
      Plant Gene Engineering Research Center, Nanjing Agricultural University, Nanjing,
      China.
FAU - Lin, Qibing
AU  - Lin Q
AD  - National Key Facility for Crop Gene Resources and Genetic Improvement, Institute 
      of Crop Science, Chinese Academy of Agricultural Sciences, Beijing, China.
FAU - Wu, Fuqing
AU  - Wu F
AD  - National Key Facility for Crop Gene Resources and Genetic Improvement, Institute 
      of Crop Science, Chinese Academy of Agricultural Sciences, Beijing, China.
FAU - Zhang, Xin
AU  - Zhang X
AD  - National Key Facility for Crop Gene Resources and Genetic Improvement, Institute 
      of Crop Science, Chinese Academy of Agricultural Sciences, Beijing, China.
FAU - Guo, Xiuping
AU  - Guo X
AD  - National Key Facility for Crop Gene Resources and Genetic Improvement, Institute 
      of Crop Science, Chinese Academy of Agricultural Sciences, Beijing, China.
FAU - Cheng, Xianian
AU  - Cheng X
AD  - National Key Laboratory for Crop Genetics and Germplasm Enhancement, Jiangsu
      Plant Gene Engineering Research Center, Nanjing Agricultural University, Nanjing,
      China.
FAU - Jiang, Ling
AU  - Jiang L
AD  - National Key Laboratory for Crop Genetics and Germplasm Enhancement, Jiangsu
      Plant Gene Engineering Research Center, Nanjing Agricultural University, Nanjing,
      China.
FAU - Wu, Chuanyin
AU  - Wu C
AD  - National Key Facility for Crop Gene Resources and Genetic Improvement, Institute 
      of Crop Science, Chinese Academy of Agricultural Sciences, Beijing, China.
FAU - Wang, Haiyang
AU  - Wang H
AD  - National Key Facility for Crop Gene Resources and Genetic Improvement, Institute 
      of Crop Science, Chinese Academy of Agricultural Sciences, Beijing, China.
FAU - Wan, Jianmin
AU  - Wan J
AD  - 1] National Key Laboratory for Crop Genetics and Germplasm Enhancement, Jiangsu
      Plant Gene Engineering Research Center, Nanjing Agricultural University, Nanjing,
      China. [2] National Key Facility for Crop Gene Resources and Genetic Improvement,
      Institute of Crop Science, Chinese Academy of Agricultural Sciences, Beijing,
      China.
LA  - eng
SI  - GENBANK/KF748957
SI  - GENBANK/KF748958
SI  - GENBANK/KF748959
SI  - GENBANK/KF748960
SI  - GENBANK/KF748961
SI  - GENBANK/KF748962
SI  - GENBANK/KF748963
SI  - GENBANK/KF748964
SI  - GENBANK/KF748965
SI  - GENBANK/KF748966
SI  - GENBANK/KF748967
SI  - GENBANK/KF748968
SI  - GENBANK/KF748969
SI  - GENBANK/KF748970
SI  - GENBANK/KF748971
SI  - GENBANK/KF748972
SI  - GENBANK/KF748973
SI  - GENBANK/KF748974
SI  - GENBANK/KF748975
SI  - GENBANK/KF748976
SI  - GENBANK/KF748977
SI  - GENBANK/KF748978
SI  - GENBANK/KF748979
SI  - GENBANK/KF748980
SI  - GENBANK/KF748981
SI  - GENBANK/KF748982
SI  - GENBANK/KF748983
SI  - GENBANK/KF748984
SI  - GENBANK/KF748985
SI  - GENBANK/KF748986
SI  - GENBANK/KF748987
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20141208
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Genetic Markers)
RN  - 0 (Receptors, Mitogen)
RN  - EC 2.7.- (Protein Kinases)
SB  - IM
CIN - Nat Biotechnol. 2015 Mar;33(3):262-3. PMID: 25748917
MH  - Animals
MH  - Disease Resistance/*genetics
MH  - Genes, Plant
MH  - Genetic Markers
MH  - Insecta/*physiology
MH  - Molecular Sequence Data
MH  - *Multigene Family
MH  - Oryza/*genetics/parasitology
MH  - Physical Chromosome Mapping
MH  - Plant Diseases/*parasitology
MH  - Polymorphism, Genetic
MH  - Protein Kinases/*genetics
MH  - Receptors, Mitogen/*genetics
EDAT- 2014/12/09 06:00
MHDA- 2016/01/14 06:00
CRDT- 2014/12/09 06:00
PHST- 2013/09/07 00:00 [received]
PHST- 2014/10/15 00:00 [accepted]
PHST- 2014/12/09 06:00 [entrez]
PHST- 2014/12/09 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3069 [pii]
AID - 10.1038/nbt.3069 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Mar;33(3):301-5. doi: 10.1038/nbt.3069. Epub 2014 Dec 8.

PMID- 25658288
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20150608
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - Corrigendum: Selling long life.
PG  - 210
LID - 10.1038/nbt0215-210d [doi]
FAU - Scott, Christopher Thomas
AU  - Scott CT
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
LA  - eng
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2015 Jan;33(1):31-40. PMID: 25574633
EDAT- 2015/02/07 06:00
MHDA- 2015/02/07 06:01
CRDT- 2015/02/07 06:00
PHST- 2015/02/07 06:00 [entrez]
PHST- 2015/02/07 06:00 [pubmed]
PHST- 2015/02/07 06:01 [medline]
AID - nbt0215-210d [pii]
AID - 10.1038/nbt0215-210d [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):210. doi: 10.1038/nbt0215-210d.

PMID- 25658287
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20150608
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - Erratum: Reinventing tech transfer.
PG  - 210
LID - 10.1038/nbt0215-210a [doi]
FAU - Huggett, Brady
AU  - Huggett B
LA  - eng
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2014 Dec;32(12):1184-91. PMID: 25489831
EDAT- 2015/02/07 06:00
MHDA- 2015/02/07 06:01
CRDT- 2015/02/07 06:00
PHST- 2015/02/07 06:00 [entrez]
PHST- 2015/02/07 06:00 [pubmed]
PHST- 2015/02/07 06:01 [medline]
AID - nbt0215-210a [pii]
AID - 10.1038/nbt0215-210a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):210. doi: 10.1038/nbt0215-210a.

PMID- 25658286
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20180322
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - Corrigendum: Linking T-cell receptor sequence to functional phenotype at the
      single-cell level.
PG  - 210
LID - 10.1038/nbt0215-210c [doi]
FAU - Han, Arnold
AU  - Han A
FAU - Glanville, Jacob
AU  - Glanville J
FAU - Hansmann, Leo
AU  - Hansmann L
FAU - Davis, Mark M
AU  - Davis MM
LA  - eng
GR  - T32 DK007056/DK/NIDDK NIH HHS/United States
GR  - U19 AI057229/AI/NIAID NIH HHS/United States
GR  - R37 AI022511/AI/NIAID NIH HHS/United States
GR  - L30 AI113847/AI/NIAID NIH HHS/United States
GR  - L30 DK089634/DK/NIDDK NIH HHS/United States
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Receptors, Antigen, T-Cell)
SB  - IM
EFR - Nat Biotechnol. 2014 Jul;32(7):684-92. PMID: 24952902
MH  - Receptors, Antigen, T-Cell/*genetics
MH  - Single-Cell Analysis
PMC - PMC5800857
MID - NIHMS936959
EDAT- 2015/02/07 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/02/07 06:00
PHST- 2015/02/07 06:00 [entrez]
PHST- 2015/02/07 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt0215-210c [pii]
AID - 10.1038/nbt0215-210c [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):210. doi: 10.1038/nbt0215-210c.

PMID- 25658285
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20150608
LR  - 20150209
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - Erratum: Bring out your dead.
PG  - 210
LID - 10.1038/nbt0215-210b [doi]
LA  - eng
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2015 Jan;33(1):1. PMID: 25574611
EDAT- 2015/02/07 06:00
MHDA- 2015/02/07 06:01
CRDT- 2015/02/07 06:00
PHST- 2015/02/07 06:00 [entrez]
PHST- 2015/02/07 06:00 [pubmed]
PHST- 2015/02/07 06:01 [medline]
AID - nbt0215-210b [pii]
AID - 10.1038/nbt0215-210b [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):210. doi: 10.1038/nbt0215-210b.

PMID- 25658284
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20150608
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - Corrigendum: Status and market potential of transgenic biofortified crops.
PG  - 210
LID - 10.1038/nbt0215-210e [doi]
FAU - De Steur, Hans
AU  - De Steur H
FAU - Blancquaert, Dieter
AU  - Blancquaert D
FAU - Strobbe, Simon
AU  - Strobbe S
FAU - Lambert, Willy
AU  - Lambert W
FAU - Gellynck, Xavier
AU  - Gellynck X
FAU - Van Der Straeten, Dominique
AU  - Van Der Straeten D
LA  - eng
PT  - Published Erratum
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EFR - Nat Biotechnol. 2015 Jan;33(1):25-9. PMID: 25574631
EDAT- 2015/02/07 06:00
MHDA- 2015/02/07 06:01
CRDT- 2015/02/07 06:00
PHST- 2015/02/07 06:00 [entrez]
PHST- 2015/02/07 06:00 [pubmed]
PHST- 2015/02/07 06:01 [medline]
AID - nbt0215-210e [pii]
AID - 10.1038/nbt0215-210e [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):210. doi: 10.1038/nbt0215-210e.

PMID- 25658282
OWN - NLM
STAT- MEDLINE
DCOM- 20150608
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - Tracing the potential of lung progenitors.
PG  - 152-4
LID - 10.1038/nbt.3139 [doi]
FAU - Mahoney, John E
AU  - Mahoney JE
AD  - Stem Cell Program at Boston Children's Hospital and the Department of Genetics at
      Harvard Medical School, Boston, Massachusetts, USA.
FAU - Kim, Carla F
AU  - Kim CF
AD  - Stem Cell Program at Boston Children's Hospital and the Department of Genetics at
      Harvard Medical School, Boston, Massachusetts, USA.
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Keratin-5)
RN  - 0 (Phosphoproteins)
RN  - 0 (Trans-Activators)
SB  - IM
CON - Nature. 2015 Jan 29;517(7536):621-5. PMID: 25533958
CON - Nature. 2015 Jan 29;517(7536):616-20. PMID: 25383540
MH  - Animals
MH  - Epithelial Cells/*cytology/*pathology
MH  - Female
MH  - Humans
MH  - Keratin-5/*metabolism
MH  - Lung/*cytology/*pathology/*physiology
MH  - Lung Injury/*pathology
MH  - Male
MH  - Phosphoproteins/*metabolism
MH  - *Re-Epithelialization
MH  - *Regeneration
MH  - Stem Cells/*cytology/*metabolism
MH  - Trans-Activators/*metabolism
EDAT- 2015/02/07 06:00
MHDA- 2015/06/09 06:00
CRDT- 2015/02/07 06:00
PHST- 2015/02/07 06:00 [entrez]
PHST- 2015/02/07 06:00 [pubmed]
PHST- 2015/06/09 06:00 [medline]
AID - nbt.3139 [pii]
AID - 10.1038/nbt.3139 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):152-4. doi: 10.1038/nbt.3139.

PMID- 25658281
OWN - NLM
STAT- MEDLINE
DCOM- 20150608
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - Mapping the precision of genome editing.
PG  - 150-2
LID - 10.1038/nbt.3142 [doi]
FAU - Gabriel, Richard
AU  - Gabriel R
AD  - National Center for Tumor Diseases and German Cancer Research Center, Heidelberg,
      Germany.
FAU - von Kalle, Christof
AU  - von Kalle C
AD  - National Center for Tumor Diseases and German Cancer Research Center, Heidelberg,
      Germany.
FAU - Schmidt, Manfred
AU  - Schmidt M
AD  - National Center for Tumor Diseases and German Cancer Research Center, Heidelberg,
      Germany.
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (CRISPR-Associated Proteins)
RN  - EC 3.1.- (Endonucleases)
SB  - IM
CON - Nat Biotechnol. 2013 Sep;31(9):822-6. PMID: 23792628
CON - Nat Biotechnol. 2015 Feb;33(2):187-97. PMID: 25513782
CON - Nat Biotechnol. 2015 Feb;33(2):179-86. PMID: 25503383
CON - Nat Biotechnol. 2015 Feb;33(2):175-8. PMID: 25599175
MH  - CRISPR-Associated Proteins/*genetics
MH  - Endonucleases/*genetics
MH  - Genetic Engineering/*methods
MH  - Humans
MH  - Mutagenesis/*genetics
EDAT- 2015/02/07 06:00
MHDA- 2015/06/09 06:00
CRDT- 2015/02/07 06:00
PHST- 2015/02/07 06:00 [entrez]
PHST- 2015/02/07 06:00 [pubmed]
PHST- 2015/06/09 06:00 [medline]
AID - nbt.3142 [pii]
AID - 10.1038/nbt.3142 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):150-2. doi: 10.1038/nbt.3142.

PMID- 25658280
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20161025
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - Illuminating Parkinson's therapy with optogenetics.
PG  - 149-50
LID - 10.1038/nbt.3140 [doi]
FAU - Chen, Yuejun
AU  - Chen Y
AD  - Waisman Center, University of Wisconsin, Madison, Wisconsin, USA.
FAU - Xiong, Man
AU  - Xiong M
AD  - Waisman Center, University of Wisconsin, Madison, Wisconsin, USA.
FAU - Zhang, Su-Chun
AU  - Zhang SC
AD  - Waisman Center, University of Wisconsin, Madison, Wisconsin, USA.
LA  - eng
GR  - P51 OD011106/OD/NIH HHS/United States
GR  - R01 NS076352/NS/NINDS NIH HHS/United States
GR  - R24 NS086604/NS/NINDS NIH HHS/United States
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Halorhodopsins)
SB  - IM
MH  - Cell Differentiation/genetics
MH  - Dopaminergic Neurons/*transplantation
MH  - Embryonic Stem Cells/metabolism/transplantation
MH  - Halorhodopsins/therapeutic use
MH  - Humans
MH  - Optogenetics/*methods
MH  - Parkinson Disease/genetics/*therapy
PMC - PMC4339091
MID - NIHMS664097
EDAT- 2015/02/07 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/02/07 06:00
PHST- 2015/02/07 06:00 [entrez]
PHST- 2015/02/07 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3140 [pii]
AID - 10.1038/nbt.3140 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):149-50. doi: 10.1038/nbt.3140.

PMID- 25658279
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20150209
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - Recent patent applications in single cell analysis.
PG  - 148
LID - 10.1038/nbt.3152 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*legislation & jurisprudence
MH  - Humans
MH  - Patents as Topic
MH  - *Single-Cell Analysis
EDAT- 2015/02/07 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/02/07 06:00
PHST- 2015/02/07 06:00 [entrez]
PHST- 2015/02/07 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3152 [pii]
AID - 10.1038/nbt.3152 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):148. doi: 10.1038/nbt.3152.

PMID- 25658278
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - Keeping score, strengthening policy and fighting bad actors over access to
      research tools.
PG  - 143-7
LID - 10.1038/nbt.3131 [doi]
FAU - Bubela, Tania
AU  - Bubela T
AD  - School of Public Health, University of Alberta, Edmonton, Alberta, Canada.
FAU - Cook-Deegan, Robert
AU  - Cook-Deegan R
AD  - Sanford School of Public Policy, Duke University, Durham, North Carolina, USA and
      a Senior Fellow at FasterCures, a Center of the Milken Institute in Washington,
      DC.
LA  - eng
GR  - P50 HG003391/HG/NHGRI NIH HHS/United States
GR  - R01 HG006460/HG/NHGRI NIH HHS/United States
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*legislation & jurisprudence
MH  - Humans
MH  - *Intellectual Property
MH  - Licensure/*legislation & jurisprudence
MH  - Patents as Topic
MH  - Translational Medical Research/*legislation & jurisprudence
MH  - United States
PMC - PMC4332873
MID - NIHMS662723
EDAT- 2015/02/07 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/02/07 06:00
PHST- 2015/02/07 06:00 [entrez]
PHST- 2015/02/07 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3131 [pii]
AID - 10.1038/nbt.3131 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):143-7. doi: 10.1038/nbt.3131.

PMID- 25658277
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - Multi-omic data analysis using Galaxy.
PG  - 137-9
LID - 10.1038/nbt.3134 [doi]
FAU - Boekel, Jorrit
AU  - Boekel J
AD  - 1] Department of Oncology-Pathology, Science for Life Laboratory, Karolinska
      Institute, Stockholm, Sweden. [2] Bioinformatics Infrastructure for Life Sciences
      (BILS), Stockholm, Sweden.
FAU - Chilton, John M
AU  - Chilton JM
AD  - 1] Minnesota Supercomputing Institute, University of Minnesota, Minneapolis, USA.
      [2] Department of Biochemistry and Molecular Biology, Pennsylvania State
      University, State College, Pennsylvania, USA.
FAU - Cooke, Ira R
AU  - Cooke IR
AUID- ORCID: 0000000165201397
AD  - 1] Department of Biochemistry, La Trobe Institute for Molecular Science, La Trobe
      University, Melbourne, Australia. [2] Life Sciences Computation Centre, Victorian
      Life Sciences Computation Initiative, Melbourne, Australia.
FAU - Horvatovich, Peter L
AU  - Horvatovich PL
AUID- ORCID: 0000000322181140
AD  - Analytical Biochemistry, Department of Pharmacy, University of Groningen,
      Groningen, The Netherlands.
FAU - Jagtap, Pratik D
AU  - Jagtap PD
AD  - 1] Minnesota Supercomputing Institute, University of Minnesota, Minneapolis, USA.
      [2] Department of Biochemistry, Molecular Biology and Biophysics, University of
      Minnesota, Minneapolis, USA.
FAU - Kall, Lukas
AU  - Kall L
AD  - School of Biotechnology, Science for Life Laboratory, Royal Institute of
      Technology - KTH, Stockholm, Sweden.
FAU - Lehtio, Janne
AU  - Lehtio J
AD  - Department of Oncology-Pathology, Science for Life Laboratory, Karolinska
      Institute, Stockholm, Sweden.
FAU - Lukasse, Pieter
AU  - Lukasse P
AD  - Plant Research International, Wageningen University and Research Center,
      Wageningen, The Netherlands.
FAU - Moerland, Perry D
AU  - Moerland PD
AUID- ORCID: 0000000223573659
AD  - Bioinformatics Laboratory, Department of Clinical Epidemiology, Biostatistics and
      Bioinformatics, Academic Medical Center, University of Amsterdam, Amsterdam, The 
      Netherlands.
FAU - Griffin, Timothy J
AU  - Griffin TJ
AD  - Department of Biochemistry, Molecular Biology and Biophysics, University of
      Minnesota, Minneapolis, USA.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Computational Biology
MH  - Humans
MH  - Proteomics/*methods
MH  - *Software
MH  - Statistics as Topic/*methods
EDAT- 2015/02/07 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/02/07 06:00
PHST- 2015/02/07 06:00 [entrez]
PHST- 2015/02/07 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3134 [pii]
AID - 10.1038/nbt.3134 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):137-9. doi: 10.1038/nbt.3134.

PMID- 25658276
OWN - NLM
STAT- MEDLINE
DCOM- 20150608
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - Conflict of interests and evidence base for GM crops food/feed safety research.
PG  - 135-7
LID - 10.1038/nbt.3133 [doi]
FAU - Sanchez, Miguel A
AU  - Sanchez MA
AD  - ChileBio, Santiago, Chile.
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Crit Rev Biotechnol. 2014 Mar;34(1):77-88. PMID: 24041244
CON - Nat Biotechnol. 2007 Jun;25(6):624-6. PMID: 17557092
MH  - *Biomedical Research
MH  - Biotechnology/*trends
MH  - *Crops, Agricultural
MH  - *Databases, Genetic
MH  - *Food Safety
MH  - *Food, Genetically Modified
MH  - *Genes, Plant
MH  - *Genetic Engineering
MH  - *Plants, Genetically Modified
EDAT- 2015/02/07 06:00
MHDA- 2015/06/09 06:00
CRDT- 2015/02/07 06:00
PHST- 2015/02/07 06:00 [entrez]
PHST- 2015/02/07 06:00 [pubmed]
PHST- 2015/06/09 06:00 [medline]
AID - nbt.3133 [pii]
AID - 10.1038/nbt.3133 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):135-7. doi: 10.1038/nbt.3133.

PMID- 25658275
OWN - NLM
STAT- MEDLINE
DCOM- 20150928
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - Increasing patient participation in drug development.
PG  - 134-5
LID - 10.1038/nbt.3145 [doi]
FAU - Wicks, Paul
AU  - Wicks P
AD  - PatientsLikeMe, 155 2nd Street, Cambridge MA, 02141, USA.
FAU - Lowe, Maria
AU  - Lowe M
AD  - PatientsLikeMe, 155 2nd Street, Cambridge MA, 02141, USA.
FAU - Gabriel, Susan
AU  - Gabriel S
AD  - Novartis, Health Economics &Outcomes Research, One Health Plaza, East Hanover,
      NJ, 07936, USA.
FAU - Sikirica, Slaven
AU  - Sikirica S
AD  - Novartis, Health Economics &Outcomes Research, One Health Plaza, East Hanover,
      NJ, 07936, USA.
FAU - Sasane, Rahul
AU  - Sasane R
AD  - Novartis, Health Economics &Outcomes Research, One Health Plaza, East Hanover,
      NJ, 07936, USA.
FAU - Arcona, Stephen
AU  - Arcona S
AD  - Novartis, Health Economics &Outcomes Research, One Health Plaza, East Hanover,
      NJ, 07936, USA.
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2015 Jan;33(1):14-7. PMID: 25574625
MH  - *Drug Industry
MH  - *Social Media
EDAT- 2015/02/07 06:00
MHDA- 2015/09/29 06:00
CRDT- 2015/02/07 06:00
PHST- 2015/02/07 06:00 [entrez]
PHST- 2015/02/07 06:00 [pubmed]
PHST- 2015/09/29 06:00 [medline]
AID - nbt.3145 [pii]
AID - 10.1038/nbt.3145 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):134-5. doi: 10.1038/nbt.3145.

PMID- 25658274
OWN - NLM
STAT- MEDLINE
DCOM- 20151030
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - Response to Rosier correspondence.
PG  - 134
LID - 10.1038/nbt.3135 [doi]
FAU - Langer, Lynn Johnson
AU  - Langer LJ
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2015 Feb;33(2):133-4. PMID: 25658273
CON - Nat Biotechnol. 2014 Sep;32(9):863-5. PMID: 25203028
MH  - *Biotechnology
MH  - *Curriculum
MH  - *Entrepreneurship
EDAT- 2015/02/07 06:00
MHDA- 2015/10/31 06:00
CRDT- 2015/02/07 06:00
PHST- 2015/02/07 06:00 [entrez]
PHST- 2015/02/07 06:00 [pubmed]
PHST- 2015/10/31 06:00 [medline]
AID - nbt.3135 [pii]
AID - 10.1038/nbt.3135 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):134. doi: 10.1038/nbt.3135.

PMID- 25658273
OWN - NLM
STAT- MEDLINE
DCOM- 20151030
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - Nuances in the entrepreneurship training tool box.
PG  - 133-4
LID - 10.1038/nbt.3132 [doi]
FAU - Rosier, Jan
AU  - Rosier J
AD  - 1] University College Dublin Michael Smurfit Graduate School of Business, Dublin,
      Ireland. [2] University College Dublin School of Biomolecular &Biomedical
      Science, Dublin, Ireland.
FAU - O'Connell, David
AU  - O'Connell D
AD  - University College Dublin School of Biomolecular &Biomedical Science, Dublin,
      Ireland.
LA  - eng
PT  - Comment
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2014 Sep;32(9):863-5. PMID: 25203028
CIN - Nat Biotechnol. 2015 Feb;33(2):134. PMID: 25658274
MH  - *Biotechnology
MH  - *Curriculum
MH  - *Entrepreneurship
EDAT- 2015/02/07 06:00
MHDA- 2015/10/31 06:00
CRDT- 2015/02/07 06:00
PHST- 2015/02/07 06:00 [entrez]
PHST- 2015/02/07 06:00 [pubmed]
PHST- 2015/10/31 06:00 [medline]
AID - nbt.3132 [pii]
AID - 10.1038/nbt.3132 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):133-4. doi: 10.1038/nbt.3132.

PMID- 25658272
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20150209
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - First rounders podcast: Carl Feldbaum.
PG  - 132
LID - 10.1038/nbt.3138 [doi]
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Biological Science Disciplines
MH  - *Biotechnology
MH  - *Drug Industry
MH  - Humans
EDAT- 2015/02/07 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/02/07 06:00
PHST- 2015/02/07 06:00 [entrez]
PHST- 2015/02/07 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3138 [pii]
AID - 10.1038/nbt.3138 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):132. doi: 10.1038/nbt.3138.

PMID- 25658271
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20150209
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - Incubators for innovators.
PG  - 129-32
LID - 10.1038/nbt.3137 [doi]
FAU - Kirkpatrick, Lynn
AU  - Kirkpatrick L
AD  - PHusis Therapeutics, San Diego, California, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Capital Financing/*economics
MH  - Drug Industry/*economics
MH  - Humans
EDAT- 2015/02/07 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/02/07 06:00
PHST- 2015/02/07 06:00 [entrez]
PHST- 2015/02/07 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3137 [pii]
AID - 10.1038/nbt.3137 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):129-32. doi: 10.1038/nbt.3137.

PMID- 25658270
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - Fresh from the biotech pipeline-2014.
PG  - 125-8
LID - 10.1038/nbt.3136 [doi]
FAU - Morrison, Chris
AU  - Morrison C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Biotechnology
MH  - Drug Approval/*legislation & jurisprudence
MH  - Humans
MH  - United States
MH  - United States Food and Drug Administration/*legislation & jurisprudence
EDAT- 2015/02/07 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/02/07 06:00
PHST- 2015/02/07 06:00 [entrez]
PHST- 2015/02/07 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3136 [pii]
AID - 10.1038/nbt.3136 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):125-8. doi: 10.1038/nbt.3136.

PMID- 25658269
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20150209
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - Drug pipeline: 4Q14.
PG  - 124
LID - 10.1038/nbt.3143 [doi]
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Drug Approval/*legislation & jurisprudence
MH  - Humans
MH  - United States
MH  - United States Food and Drug Administration/*legislation & jurisprudence
EDAT- 2015/02/07 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/02/07 06:00
PHST- 2015/02/07 06:00 [entrez]
PHST- 2015/02/07 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3143 [pii]
AID - 10.1038/nbt.3143 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):124. doi: 10.1038/nbt.3143.

PMID- 25658268
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20150209
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - 2014-the biotech bull rages on.
PG  - 123
LID - 10.1038/nbt.3151 [doi]
FAU - Yang, Walter
AU  - Yang W
AD  - BioCentury.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*economics
MH  - Drug Industry/*economics
MH  - Humans
EDAT- 2015/02/07 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/02/07 06:00
PHST- 2015/02/07 06:00 [entrez]
PHST- 2015/02/07 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3151 [pii]
AID - 10.1038/nbt.3151 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):123. doi: 10.1038/nbt.3151.

PMID- 25658267
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - Agricultural probiotics enter spotlight.
PG  - 122
LID - 10.1038/nbt0215-122 [doi]
FAU - Fox, Jeffrey L
AU  - Fox JL
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Agriculture
MH  - Drug Industry/*economics
MH  - Humans
MH  - Plant Development/drug effects
MH  - Probiotics/*economics
EDAT- 2015/02/07 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/02/07 06:00
PHST- 2015/02/07 06:00 [entrez]
PHST- 2015/02/07 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt0215-122 [pii]
AID - 10.1038/nbt0215-122 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):122. doi: 10.1038/nbt0215-122.

PMID- 25658265
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - Merck splashes on Cubist, antibiotics prospects brighten.
PG  - 120-1
LID - 10.1038/nbt0215-120 [doi]
FAU - Morrison, Chris
AU  - Morrison C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Anti-Bacterial Agents)
SB  - IM
MH  - Anti-Bacterial Agents/*economics/therapeutic use
MH  - Drug Industry/*economics
MH  - Humans
EDAT- 2015/02/07 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/02/07 06:00
PHST- 2015/02/07 06:00 [entrez]
PHST- 2015/02/07 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt0215-120 [pii]
AID - 10.1038/nbt0215-120 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):120-1. doi: 10.1038/nbt0215-120.

PMID- 25658262
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - 23andMe sets sights on UK/Canada, signs up Genentech.
PG  - 119
LID - 10.1038/nbt0215-119a [doi]
FAU - Mullard, Asher
AU  - Mullard A
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Drug Industry/*economics
MH  - *Genealogy and Heraldry
MH  - Genetics, Medical/*economics
MH  - Humans
MH  - United Kingdom
EDAT- 2015/02/07 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/02/07 06:00
PHST- 2015/02/07 06:00 [entrez]
PHST- 2015/02/07 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt0215-119a [pii]
AID - 10.1038/nbt0215-119a [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):119. doi: 10.1038/nbt0215-119a.

PMID- 25658260
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - Antidotes progress for new oral clotbusters.
PG  - 117-8
LID - 10.1038/nbt0215-117 [doi]
FAU - Dolgin, Elie
AU  - Dolgin E
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Anticoagulants)
RN  - 0 (Antidotes)
SB  - IM
MH  - Administration, Oral
MH  - Anticoagulants/*therapeutic use
MH  - Antidotes/*therapeutic use
MH  - Drug Industry
MH  - Hemorrhage/*drug therapy
MH  - Humans
MH  - United States
MH  - United States Food and Drug Administration
EDAT- 2015/02/07 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/02/07 06:00
PHST- 2015/02/07 06:00 [entrez]
PHST- 2015/02/07 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt0215-117 [pii]
AID - 10.1038/nbt0215-117 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):117-8. doi: 10.1038/nbt0215-117.

PMID- 25658256
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20171116
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - Pivotal trials for beta-secretase inhibitors in Alzheimer's.
PG  - 115-6
LID - 10.1038/nbt0215-115 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antibodies, Monoclonal, Humanized)
RN  - 0 (Enzyme Inhibitors)
RN  - 0 (Protein Aggregates)
RN  - 5D6PWO0333 (solanezumab)
RN  - EC 3.4.- (Amyloid Precursor Protein Secretases)
SB  - IM
MH  - Alzheimer Disease/*drug therapy
MH  - Amyloid Precursor Protein Secretases/antagonists & inhibitors
MH  - Antibodies, Monoclonal, Humanized/therapeutic use
MH  - Clinical Trials as Topic
MH  - *Drug Industry
MH  - Enzyme Inhibitors/*therapeutic use
MH  - Humans
MH  - Protein Aggregates/*drug effects
EDAT- 2015/02/07 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/02/07 06:00
PHST- 2015/02/07 06:00 [entrez]
PHST- 2015/02/07 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt0215-115 [pii]
AID - 10.1038/nbt0215-115 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):115-6. doi: 10.1038/nbt0215-115.

PMID- 25658255
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - Roche swallows Ariosa, grabs slice of prenatal test market.
PG  - 113-4
LID - 10.1038/nbt0215-113 [doi]
FAU - Ratner, Mark
AU  - Ratner M
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Drug Industry/*economics
MH  - Humans
MH  - Prenatal Diagnosis/*economics/methods
MH  - Sequence Analysis, DNA/*economics
MH  - United States
EDAT- 2015/02/07 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/02/07 06:00
PHST- 2015/02/07 06:00 [entrez]
PHST- 2015/02/07 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt0215-113 [pii]
AID - 10.1038/nbt0215-113 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):113-4. doi: 10.1038/nbt0215-113.

PMID- 25658254
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20150209
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - Kicking the can.
PG  - 111
LID - 10.1038/nbt.3148 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*legislation & jurisprudence
MH  - European Union
MH  - Genetic Engineering/*legislation & jurisprudence
MH  - Government Agencies
MH  - Humans
MH  - *Organisms, Genetically Modified
EDAT- 2015/02/07 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/02/07 06:00
PHST- 2015/02/07 06:00 [entrez]
PHST- 2015/02/07 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3148 [pii]
AID - 10.1038/nbt.3148 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):111. doi: 10.1038/nbt.3148.

PMID- 25643054
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20161025
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - A split-Cas9 architecture for inducible genome editing and transcription
      modulation.
PG  - 139-42
LID - 10.1038/nbt.3149 [doi]
FAU - Zetsche, Bernd
AU  - Zetsche B
AD  - 1] Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2]
      McGovern Institute for Brain Research, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA. [3] Department of Brain and Cognitive Sciences,
      Massachusetts Institute of Technology, Cambridge Massachusetts, USA. [4]
      Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge Massachusetts, USA. [5] Department of Developmental Pathology,
      Institute of Pathology, Bonn Medical School, Bonn, Germany.
FAU - Volz, Sara E
AU  - Volz SE
AD  - 1] Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2]
      McGovern Institute for Brain Research, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA. [3] Department of Brain and Cognitive Sciences,
      Massachusetts Institute of Technology, Cambridge Massachusetts, USA. [4]
      Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge Massachusetts, USA.
FAU - Zhang, Feng
AU  - Zhang F
AD  - 1] Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2]
      McGovern Institute for Brain Research, Massachusetts Institute of Technology,
      Cambridge, Massachusetts, USA. [3] Department of Brain and Cognitive Sciences,
      Massachusetts Institute of Technology, Cambridge Massachusetts, USA. [4]
      Department of Biological Engineering, Massachusetts Institute of Technology,
      Cambridge Massachusetts, USA.
LA  - eng
GR  - DP1 MH100706/MH/NIMH NIH HHS/United States
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - EC 3.4.22.- (Caspase 9)
SB  - IM
MH  - Caspase 9/*genetics
MH  - *Genome, Human
MH  - Humans
MH  - Organ Specificity
MH  - Promoter Regions, Genetic
MH  - RNA Editing/genetics
MH  - *Transcription, Genetic
PMC - PMC4503468
MID - NIHMS702628
EDAT- 2015/02/03 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/02/03 06:00
PHST- 2015/02/03 06:00 [entrez]
PHST- 2015/02/03 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3149 [pii]
AID - 10.1038/nbt.3149 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):139-42. doi: 10.1038/nbt.3149.

PMID- 25599179
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20171116
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - Optimizing pyramided transgenic Bt crops for sustainable pest management.
PG  - 161-8
LID - 10.1038/nbt.3099 [doi]
AB  - Transgenic crop pyramids producing two or more Bacillus thuringiensis (Bt) toxins
      that kill the same insect pest have been widely used to delay evolution of pest
      resistance. To assess the potential of pyramids to achieve this goal, we analyze 
      data from 38 studies that report effects of ten Bt toxins used in transgenic
      crops against 15 insect pests. We find that compared with optimal low levels of
      insect survival, survival on currently used pyramids is often higher for both
      susceptible insects and insects resistant to one of the toxins in the pyramid.
      Furthermore, we find that cross-resistance and antagonism between toxins used in 
      pyramids are common, and that these problems are associated with the similarity
      of the amino acid sequences of domains II and III of the toxins, respectively.
      This analysis should assist in future pyramid design and the development of
      sustainable resistance management strategies.
FAU - Carriere, Yves
AU  - Carriere Y
AD  - Department of Entomology, The University of Arizona, Tucson, Arizona, USA.
FAU - Crickmore, Neil
AU  - Crickmore N
AD  - School of Life Sciences, University of Sussex, Brighton, UK.
FAU - Tabashnik, Bruce E
AU  - Tabashnik BE
AD  - Department of Entomology, The University of Arizona, Tucson, Arizona, USA.
LA  - eng
PT  - Journal Article
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20150119
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Bacterial Toxins)
SB  - IM
MH  - Amino Acid Sequence/genetics
MH  - Animals
MH  - Bacillus thuringiensis/genetics
MH  - Bacterial Toxins/biosynthesis/*genetics
MH  - Crops, Agricultural/genetics/*growth & development
MH  - Insecta/pathogenicity
MH  - Insecticide Resistance/*genetics
MH  - *Pest Control, Biological
MH  - Plants, Genetically Modified/genetics/growth & development
EDAT- 2015/01/20 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/01/20 06:00
PHST- 2013/11/11 00:00 [received]
PHST- 2014/11/10 00:00 [accepted]
PHST- 2015/01/20 06:00 [entrez]
PHST- 2015/01/20 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3099 [pii]
AID - 10.1038/nbt.3099 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):161-8. doi: 10.1038/nbt.3099. Epub 2015 Jan 19.

PMID- 25599176
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20171206
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - Computational analysis of cell-to-cell heterogeneity in single-cell
      RNA-sequencing data reveals hidden subpopulations of cells.
PG  - 155-60
LID - 10.1038/nbt.3102 [doi]
AB  - Recent technical developments have enabled the transcriptomes of hundreds of
      cells to be assayed in an unbiased manner, opening up the possibility that new
      subpopulations of cells can be found. However, the effects of potential
      confounding factors, such as the cell cycle, on the heterogeneity of gene
      expression and therefore on the ability to robustly identify subpopulations
      remain unclear. We present and validate a computational approach that uses latent
      variable models to account for such hidden factors. We show that our single-cell 
      latent variable model (scLVM) allows the identification of otherwise undetectable
      subpopulations of cells that correspond to different stages during the
      differentiation of naive T cells into T helper 2 cells. Our approach can be used 
      not only to identify cellular subpopulations but also to tease apart different
      sources of gene expression heterogeneity in single-cell transcriptomes.
FAU - Buettner, Florian
AU  - Buettner F
AD  - 1] Helmholtz Zentrum Munchen-German Research Center for Environmental Health,
      Institute of Computational Biology, Neuherberg, Germany. [2] European Molecular
      Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome
      Campus, Hinxton, Cambridge, UK.
FAU - Natarajan, Kedar N
AU  - Natarajan KN
AD  - 1] European Molecular Biology Laboratory, European Bioinformatics Institute,
      Wellcome Trust Genome Campus, Hinxton, Cambridge, UK. [2] Wellcome Trust Sanger
      Institute, Hinxton, UK.
FAU - Casale, F Paolo
AU  - Casale FP
AD  - European Molecular Biology Laboratory, European Bioinformatics Institute,
      Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
FAU - Proserpio, Valentina
AU  - Proserpio V
AD  - 1] European Molecular Biology Laboratory, European Bioinformatics Institute,
      Wellcome Trust Genome Campus, Hinxton, Cambridge, UK. [2] Wellcome Trust Sanger
      Institute, Hinxton, UK.
FAU - Scialdone, Antonio
AU  - Scialdone A
AD  - 1] European Molecular Biology Laboratory, European Bioinformatics Institute,
      Wellcome Trust Genome Campus, Hinxton, Cambridge, UK. [2] Wellcome Trust Sanger
      Institute, Hinxton, UK.
FAU - Theis, Fabian J
AU  - Theis FJ
AUID- ORCID: 0000000224191943
AD  - 1] Helmholtz Zentrum Munchen-German Research Center for Environmental Health,
      Institute of Computational Biology, Neuherberg, Germany. [2] Department of
      Mathematics, Technische Universitat Munchen, Munich, Germany.
FAU - Teichmann, Sarah A
AU  - Teichmann SA
AD  - 1] European Molecular Biology Laboratory, European Bioinformatics Institute,
      Wellcome Trust Genome Campus, Hinxton, Cambridge, UK. [2] Wellcome Trust Sanger
      Institute, Hinxton, UK.
FAU - Marioni, John C
AU  - Marioni JC
AD  - 1] European Molecular Biology Laboratory, European Bioinformatics Institute,
      Wellcome Trust Genome Campus, Hinxton, Cambridge, UK. [2] Wellcome Trust Sanger
      Institute, Hinxton, UK.
FAU - Stegle, Oliver
AU  - Stegle O
AUID- ORCID: 0000000288187193
AD  - European Molecular Biology Laboratory, European Bioinformatics Institute,
      Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150119
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 63231-63-0 (RNA)
SB  - IM
CIN - Nat Methods. 2015 Mar;12(3):170-1. PMID: 25879100
CIN - Nat Biotechnol. 2016 Jun 9;34(6):591-3. PMID: 27281413
CIN - Nat Biotechnol. 2016 May 6;34(6):593-5. PMID: 27281414
MH  - Animals
MH  - Cell Differentiation/*genetics
MH  - Cell Lineage/*genetics
MH  - Computational Biology
MH  - Gene Expression Regulation, Developmental
MH  - *Genetic Heterogeneity
MH  - Mice
MH  - Models, Theoretical
MH  - Mouse Embryonic Stem Cells
MH  - RNA/genetics
MH  - Sequence Analysis, RNA
MH  - Single-Cell Analysis
MH  - Th2 Cells/*cytology
MH  - Transcriptome/genetics
EDAT- 2015/01/20 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/01/20 06:00
PHST- 2014/01/26 00:00 [received]
PHST- 2014/11/05 00:00 [accepted]
PHST- 2015/01/20 06:00 [entrez]
PHST- 2015/01/20 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3102 [pii]
AID - 10.1038/nbt.3102 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):155-60. doi: 10.1038/nbt.3102. Epub 2015 Jan 19.

PMID- 25599175
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using
      integrase-defective lentiviral vectors.
PG  - 175-8
LID - 10.1038/nbt.3127 [doi]
AB  - The utility of CRISPR-Cas9 and TALENs for genome editing may be compromised by
      their off-target activity. We show that integrase-defective lentiviral vectors
      (IDLVs) can detect such off-target cleavage with a frequency as low as 1%. In the
      case of Cas9, we find frequent off-target sites with a one-base bulge or up to 13
      mismatches between the single guide RNA (sgRNA) and its genomic target, which
      refines sgRNA design.
FAU - Wang, Xiaoling
AU  - Wang X
AD  - Department of Virology, Beckman Research Institute of City of Hope, Duarte,
      California, USA.
FAU - Wang, Yebo
AU  - Wang Y
AD  - 1] Department of Virology, Beckman Research Institute of City of Hope, Duarte,
      California, USA. [2] Bone Marrow Transplantation Center, The First Affiliated
      Hospital, Zhejiang University, Hangzhou, Zhejiang, China.
FAU - Wu, Xiwei
AU  - Wu X
AD  - Department of Molecular and Cellular Biology, Beckman Research Institute of City 
      of Hope, Duarte, California, USA.
FAU - Wang, Jinhui
AU  - Wang J
AD  - Department of Molecular and Cellular Biology, Beckman Research Institute of City 
      of Hope, Duarte, California, USA.
FAU - Wang, Yingjia
AU  - Wang Y
AD  - 1] Department of Virology, Beckman Research Institute of City of Hope, Duarte,
      California, USA. [2] Bone Marrow Transplantation Center, The First Affiliated
      Hospital, Zhejiang University, Hangzhou, Zhejiang, China.
FAU - Qiu, Zhaojun
AU  - Qiu Z
AD  - Department of Molecular and Cellular Biology, Beckman Research Institute of City 
      of Hope, Duarte, California, USA.
FAU - Chang, Tammy
AU  - Chang T
AD  - Department of Virology, Beckman Research Institute of City of Hope, Duarte,
      California, USA.
FAU - Huang, He
AU  - Huang H
AD  - Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang
      University, Hangzhou, Zhejiang, China.
FAU - Lin, Ren-Jang
AU  - Lin RJ
AD  - Department of Molecular and Cellular Biology, Beckman Research Institute of City 
      of Hope, Duarte, California, USA.
FAU - Yee, Jiing-Kuan
AU  - Yee JK
AD  - Department of Virology, Beckman Research Institute of City of Hope, Duarte,
      California, USA.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150119
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - EC 2.7.7.- (Integrases)
SB  - IM
CIN - Nat Biotechnol. 2015 Feb;33(2):150-2. PMID: 25658281
MH  - CRISPR-Cas Systems/*genetics
MH  - Genetic Vectors
MH  - Genome, Human
MH  - HEK293 Cells
MH  - High-Throughput Nucleotide Sequencing
MH  - Humans
MH  - Integrases/genetics
MH  - Lentivirus/enzymology/*genetics
MH  - RNA Editing/*genetics
EDAT- 2015/01/20 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/01/20 06:00
PHST- 2014/08/26 00:00 [received]
PHST- 2014/12/17 00:00 [accepted]
PHST- 2015/01/20 06:00 [entrez]
PHST- 2015/01/20 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3127 [pii]
AID - 10.1038/nbt.3127 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):175-8. doi: 10.1038/nbt.3127. Epub 2015 Jan 19.

PMID- 25580598
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - Optogenetics enables functional analysis of human embryonic stem cell-derived
      grafts in a Parkinson's disease model.
PG  - 204-9
LID - 10.1038/nbt.3124 [doi]
AB  - Recent studies have shown evidence of behavioral recovery after transplantation
      of human pluripotent stem cell (PSC)-derived neural cells in animal models of
      neurological disease. However, little is known about the mechanisms underlying
      graft function. Here we use optogenetics to modulate in real time
      electrophysiological and neurochemical properties of mesencephalic dopaminergic
      (mesDA) neurons derived from human embryonic stem cells (hESCs). In mice that had
      recovered from lesion-induced Parkinsonian motor deficits, light-induced
      selective silencing of graft activity rapidly and reversibly re-introduced the
      motor deficits. The re-introduction of motor deficits was prevented by the
      dopamine agonist apomorphine. These results suggest that functionality depends on
      graft neuronal activity and dopamine release. Combining optogenetics, slice
      electrophysiology and pharmacological approaches, we further show that mesDA-rich
      grafts modulate host glutamatergic synaptic transmission onto striatal medium
      spiny neurons in a manner reminiscent of endogenous mesDA neurons. Thus,
      application of optogenetics in cell therapy can link transplantation, animal
      behavior and postmortem analysis to enable the identification of mechanisms that 
      drive recovery.
FAU - Steinbeck, Julius A
AU  - Steinbeck JA
AD  - 1] Center for Stem Cell Biology, Sloan-Kettering Institute for Cancer Research,
      New York, New York, USA. [2] Developmental Biology Program, Sloan-Kettering
      Institute for Cancer Research, New York, New York, USA.
FAU - Choi, Se Joon
AU  - Choi SJ
AD  - Department of Neurology, Columbia University Medical Center, New York, New York, 
      USA.
FAU - Mrejeru, Ana
AU  - Mrejeru A
AD  - Department of Neurology, Columbia University Medical Center, New York, New York, 
      USA.
FAU - Ganat, Yosif
AU  - Ganat Y
AD  - 1] Center for Stem Cell Biology, Sloan-Kettering Institute for Cancer Research,
      New York, New York, USA. [2] Developmental Biology Program, Sloan-Kettering
      Institute for Cancer Research, New York, New York, USA.
FAU - Deisseroth, Karl
AU  - Deisseroth K
AD  - 1] Department of Bioengineering, Stanford University, Stanford, California, USA. 
      [2] Department of Psychiatry, Stanford University, Stanford, California, USA. [3]
      Howard Hughes Medical Institute, Stanford University, Stanford, California, USA.
FAU - Sulzer, David
AU  - Sulzer D
AD  - 1] Department of Neurology, Columbia University Medical Center, New York, New
      York, USA. [2] Department of Psychiatry, Columbia University Medical Center, New 
      York, New York, USA. [3] Department of Pharmacology, Columbia University Medical 
      Center, New York, New York, USA.
FAU - Mosharov, Eugene V
AU  - Mosharov EV
AD  - Department of Neurology, Columbia University Medical Center, New York, New York, 
      USA.
FAU - Studer, Lorenz
AU  - Studer L
AD  - 1] Center for Stem Cell Biology, Sloan-Kettering Institute for Cancer Research,
      New York, New York, USA. [2] Developmental Biology Program, Sloan-Kettering
      Institute for Cancer Research, New York, New York, USA.
LA  - eng
GR  - P01 DA010154/DA/NIDA NIH HHS/United States
GR  - R01 NS052671/NS/NINDS NIH HHS/United States
GR  - NS052671/NS/NINDS NIH HHS/United States
GR  - P30 CA008748/CA/NCI NIH HHS/United States
GR  - R01 AA019801/AA/NIAAA NIH HHS/United States
GR  - NS075222/NS/NINDS NIH HHS/United States
GR  - T32 MH015174/MH/NIMH NIH HHS/United States
GR  - R01 DA007418/DA/NIDA NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20150112
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - Cell Differentiation/*genetics
MH  - Disease Models, Animal
MH  - Dopaminergic Neurons/cytology/*transplantation
MH  - Human Embryonic Stem Cells/cytology
MH  - Humans
MH  - Mesencephalon/cytology/transplantation
MH  - Mice
MH  - Neural Stem Cells/transplantation
MH  - Optogenetics/*methods
MH  - Parkinson Disease/*genetics/pathology/therapy
MH  - Synaptic Transmission/genetics
PMC - PMC5117952
MID - NIHMS691315
COIS- The authors declare competing financial interests: details are available in the
      online version of the paper.
EDAT- 2015/01/13 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/01/13 06:00
PHST- 2014/09/03 00:00 [received]
PHST- 2014/12/15 00:00 [accepted]
PHST- 2015/01/13 06:00 [entrez]
PHST- 2015/01/13 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3124 [pii]
AID - 10.1038/nbt.3124 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):204-9. doi: 10.1038/nbt.3124. Epub 2015 Jan 12.

PMID- 25580597
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20171116
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - Genomic discovery of potent chromatin insulators for human gene therapy.
PG  - 198-203
LID - 10.1038/nbt.3062 [doi]
AB  - Insertional mutagenesis and genotoxicity, which usually manifest as hematopoietic
      malignancy, represent major barriers to realizing the promise of gene therapy.
      Although insulator sequences that block transcriptional enhancers could mitigate 
      or eliminate these risks, so far no human insulators with high functional potency
      have been identified. Here we describe a genomic approach for the identification 
      of compact sequence elements that function as insulators. These elements are
      highly occupied by the insulator protein CTCF, are DNase I hypersensitive and
      represent only a small minority of the CTCF recognition sequences in the human
      genome. We show that the elements identified acted as potent enhancer blockers
      and substantially decreased the risk of tumor formation in a cancer-prone animal 
      model. The elements are small, can be efficiently accommodated by viral vectors
      and have no detrimental effects on viral titers. The insulators we describe here 
      are expected to increase the safety of gene therapy for genetic diseases.
FAU - Liu, Mingdong
AU  - Liu M
AD  - Division of Medical Genetics, University of Washington, Seattle, Washington, USA.
FAU - Maurano, Matthew T
AU  - Maurano MT
AD  - Department of Genome Sciences, University of Washington, Seattle, Washington,
      USA.
FAU - Wang, Hao
AU  - Wang H
AD  - Department of Genome Sciences, University of Washington, Seattle, Washington,
      USA.
FAU - Qi, Heyuan
AU  - Qi H
AD  - 1] Division of Medical Genetics, University of Washington, Seattle, Washington,
      USA. [2] Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing,
      China.
FAU - Song, Chao-Zhong
AU  - Song CZ
AD  - 1] Division of Medical Genetics, University of Washington, Seattle, Washington,
      USA. [2] Institute for Stem Cell and Regenerative Medicine, University of
      Washington, Seattle, Washington, USA.
FAU - Navas, Patrick A
AU  - Navas PA
AD  - Division of Medical Genetics, University of Washington, Seattle, Washington, USA.
FAU - Emery, David W
AU  - Emery DW
AD  - 1] Division of Medical Genetics, University of Washington, Seattle, Washington,
      USA. [2] Institute for Stem Cell and Regenerative Medicine, University of
      Washington, Seattle, Washington, USA.
FAU - Stamatoyannopoulos, John A
AU  - Stamatoyannopoulos JA
AD  - 1] Department of Genome Sciences, University of Washington, Seattle, Washington, 
      USA. [2] Department of Medicine, University of Washington, Seattle, Washington,
      USA.
FAU - Stamatoyannopoulos, George
AU  - Stamatoyannopoulos G
AD  - 1] Division of Medical Genetics, University of Washington, Seattle, Washington,
      USA. [2] Department of Genome Sciences, University of Washington, Seattle,
      Washington, USA.
LA  - eng
GR  - F31 MH 094073/MH/NIMH NIH HHS/United States
GR  - P01 HL53750/HL/NHLBI NIH HHS/United States
GR  - R90 HG004152/HG/NHGRI NIH HHS/United States
GR  - U01 ES017156/ES/NIEHS NIH HHS/United States
GR  - U54 HG007010/HG/NHGRI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
DEP - 20150112
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (CCCTC-Binding Factor)
RN  - 0 (CTCF protein, human)
RN  - 0 (Chromatin)
RN  - 0 (Repressor Proteins)
SB  - IM
CIN - Nat Rev Genet. 2015 Mar;16(3):130-1. PMID: 25628218
MH  - Binding Sites/genetics
MH  - CCCTC-Binding Factor
MH  - Chromatin/*genetics
MH  - Computational Biology
MH  - Enhancer Elements, Genetic
MH  - Gene Expression Regulation
MH  - *Genetic Therapy
MH  - Genetic Vectors
MH  - Genome, Human
MH  - Genomics
MH  - Humans
MH  - Insulator Elements/*genetics
MH  - Repressor Proteins/*genetics/metabolism
MH  - Sequence Analysis, DNA
EDAT- 2015/01/13 06:00
MHDA- 2016/01/14 06:00
CRDT- 2015/01/13 06:00
PHST- 2014/01/07 00:00 [received]
PHST- 2014/10/09 00:00 [accepted]
PHST- 2015/01/13 06:00 [entrez]
PHST- 2015/01/13 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3062 [pii]
AID - 10.1038/nbt.3062 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):198-203. doi: 10.1038/nbt.3062. Epub 2015 Jan 12.

PMID- 25513782
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas
      nucleases.
PG  - 187-197
LID - 10.1038/nbt.3117 [doi]
AB  - CRISPR RNA-guided nucleases (RGNs) are widely used genome-editing reagents, but
      methods to delineate their genome-wide, off-target cleavage activities have been 
      lacking. Here we describe an approach for global detection of DNA double-stranded
      breaks (DSBs) introduced by RGNs and potentially other nucleases. This method,
      called genome-wide, unbiased identification of DSBs enabled by sequencing
      (GUIDE-seq), relies on capture of double-stranded oligodeoxynucleotides into
      DSBs. Application of GUIDE-seq to 13 RGNs in two human cell lines revealed wide
      variability in RGN off-target activities and unappreciated characteristics of
      off-target sequences. The majority of identified sites were not detected by
      existing computational methods or chromatin immunoprecipitation sequencing
      (ChIP-seq). GUIDE-seq also identified RGN-independent genomic breakpoint
      'hotspots'. Finally, GUIDE-seq revealed that truncated guide RNAs exhibit
      substantially reduced RGN-induced, off-target DSBs. Our experiments define the
      most rigorous framework for genome-wide identification of RGN off-target effects 
      to date and provide a method for evaluating the safety of these nucleases before 
      clinical use.
FAU - Tsai, Shengdar Q
AU  - Tsai SQ
AD  - Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, MA USA.
AD  - Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA USA.
AD  - Department of Pathology, Harvard Medical School, Boston, MA USA.
FAU - Zheng, Zongli
AU  - Zheng Z
AD  - Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, MA USA.
AD  - Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA USA.
AD  - Department of Pathology, Harvard Medical School, Boston, MA USA.
AD  - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet,
      Stockholm, Sweden.
FAU - Nguyen, Nhu T
AU  - Nguyen NT
AD  - Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, MA USA.
AD  - Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA USA.
FAU - Liebers, Matthew
AU  - Liebers M
AD  - Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, MA USA.
AD  - Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA USA.
FAU - Topkar, Ved V
AU  - Topkar VV
AD  - Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, MA USA.
AD  - Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA USA.
FAU - Thapar, Vishal
AU  - Thapar V
AD  - Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, MA USA.
AD  - Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA USA.
FAU - Wyvekens, Nicolas
AU  - Wyvekens N
AD  - Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, MA USA.
AD  - Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA USA.
FAU - Khayter, Cyd
AU  - Khayter C
AD  - Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, MA USA.
AD  - Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA USA.
FAU - Iafrate, A John
AU  - Iafrate AJ
AD  - Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, MA USA.
AD  - Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA USA.
AD  - Department of Pathology, Harvard Medical School, Boston, MA USA.
FAU - Le, Long P
AU  - Le LP
AD  - Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, MA USA.
AD  - Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA USA.
AD  - Department of Pathology, Harvard Medical School, Boston, MA USA.
FAU - Aryee, Martin J
AU  - Aryee MJ
AD  - Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, MA USA.
AD  - Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA USA.
AD  - Department of Pathology, Harvard Medical School, Boston, MA USA.
FAU - Joung, J Keith
AU  - Joung JK
AD  - Molecular Pathology Unit, Massachusetts General Hospital, Charlestown, MA USA.
AD  - Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA USA.
AD  - Department of Pathology, Harvard Medical School, Boston, MA USA.
LA  - eng
GR  - DP1 GM105378/GM/NIGMS NIH HHS/United States
GR  - DP1 GM105378/DP/NCCDPHP CDC HHS/United States
GR  - R01 GM088040/GM/NIGMS NIH HHS/United States
GR  - F32 GM105189/GM/NIGMS NIH HHS/United States
GR  - R01 AR063070/AR/NIAMS NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20141216
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Oligodeoxyribonucleotides)
RN  - 0 (RNA, Guide)
SB  - IM
CIN - Nat Biotechnol. 2015 Feb;33(2):150-2. PMID: 25658281
MH  - CRISPR-Cas Systems/*genetics
MH  - Cell Line
MH  - *DNA Breaks, Double-Stranded
MH  - Genome, Human
MH  - High-Throughput Nucleotide Sequencing
MH  - Humans
MH  - Oligodeoxyribonucleotides/genetics
MH  - RNA Editing/genetics
MH  - RNA, Guide/*genetics
PMC - PMC4320685
MID - NIHMS647337
EDAT- 2014/12/17 06:00
MHDA- 2016/01/14 06:00
CRDT- 2014/12/17 06:00
PHST- 2014/11/11 00:00 [received]
PHST- 2014/12/04 00:00 [accepted]
PHST- 2014/12/17 06:00 [entrez]
PHST- 2014/12/17 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - 10.1038/nbt.3117 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):187-197. doi: 10.1038/nbt.3117. Epub 2014 Dec 16.

PMID- 25503384
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20171116
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - Large-scale test of the natural refuge strategy for delaying insect resistance to
      transgenic Bt crops.
PG  - 169-74
LID - 10.1038/nbt.3100 [doi]
AB  - The 'natural refuge strategy" for delaying insect resistance to transgenic cotton
      that produces insecticidal proteins from Bacillus thuringiensis (Bt) relies on
      refuges of host plants other than cotton that do not make Bt toxins. We tested
      this widely adopted strategy by comparing predictions from modeling with data
      from a four-year field study of cotton bollworm (Helicoverpa armigera) resistance
      to transgenic cotton producing Bt toxin Cry1Ac in six provinces of northern
      China. Bioassay data revealed that the percentage of resistant insects increased 
      from 0.93% in 2010 to 5.5% in 2013. Modeling predicted that the percentage of
      resistant insects would exceed 98% in 2013 without natural refuges, but would
      increase to only 1.1% if natural refuges were as effective as non-Bt cotton
      refuges. Therefore, the results imply that natural refuges delayed resistance,
      but were not as effective as an equivalent area of non-Bt cotton refuges. The
      percentage of resistant insects with nonrecessive inheritance of resistance
      increased from 37% in 2010 to 84% in 2013. Switching to Bt cotton producing two
      or more toxins and integrating other control tactics could slow further increases
      in resistance.
FAU - Jin, Lin
AU  - Jin L
AD  - College of Plant Protection, Nanjing Agricultural University, Nanjing, China.
FAU - Zhang, Haonan
AU  - Zhang H
AD  - College of Plant Protection, Nanjing Agricultural University, Nanjing, China.
FAU - Lu, Yanhui
AU  - Lu Y
AD  - State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of
      Plant Protection, Chinese Academy of Agricultural Sciences, Beijing, China.
FAU - Yang, Yihua
AU  - Yang Y
AD  - College of Plant Protection, Nanjing Agricultural University, Nanjing, China.
FAU - Wu, Kongming
AU  - Wu K
AD  - State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of
      Plant Protection, Chinese Academy of Agricultural Sciences, Beijing, China.
FAU - Tabashnik, Bruce E
AU  - Tabashnik BE
AD  - Department of Entomology, University of Arizona, Tucson, Arizona, USA.
FAU - Wu, Yidong
AU  - Wu Y
AD  - College of Plant Protection, Nanjing Agricultural University, Nanjing, China.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20141215
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Bacterial Proteins)
RN  - 0 (Endotoxins)
RN  - 0 (Hemolysin Proteins)
RN  - 0 (insecticidal crystal protein, Bacillus Thuringiensis)
SB  - IM
MH  - Animals
MH  - Bacillus thuringiensis/genetics
MH  - Bacterial Proteins/biosynthesis/*genetics
MH  - Endotoxins/biosynthesis/*genetics
MH  - Gossypium/*genetics/growth & development
MH  - Hemolysin Proteins/biosynthesis/*genetics
MH  - Insecta/pathogenicity
MH  - Insecticide Resistance/genetics
MH  - Lepidoptera/pathogenicity
MH  - *Pest Control, Biological
MH  - Plants, Genetically Modified/genetics/*growth & development
EDAT- 2014/12/17 06:00
MHDA- 2016/01/14 06:00
CRDT- 2014/12/16 06:00
PHST- 2014/04/23 00:00 [received]
PHST- 2014/11/10 00:00 [accepted]
PHST- 2014/12/16 06:00 [entrez]
PHST- 2014/12/17 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3100 [pii]
AID - 10.1038/nbt.3100 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):169-74. doi: 10.1038/nbt.3100. Epub 2014 Dec 15.

PMID- 25503383
OWN - NLM
STAT- MEDLINE
DCOM- 20160113
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 2
DP  - 2015 Feb
TI  - Genome-wide detection of DNA double-stranded breaks induced by engineered
      nucleases.
PG  - 179-86
LID - 10.1038/nbt.3101 [doi]
AB  - Although great progress has been made in the characterization of the off-target
      effects of engineered nucleases, sensitive and unbiased genome-wide methods for
      the detection of off-target cleavage events and potential collateral damage are
      still lacking. Here we describe a linear amplification-mediated modification of a
      previously published high-throughput, genome-wide, translocation sequencing
      (HTGTS) method that robustly detects DNA double-stranded breaks (DSBs) generated 
      by engineered nucleases across the human genome based on their translocation to
      other endogenous or ectopic DSBs. HTGTS with different Cas9:sgRNA or TALEN
      nucleases revealed off-target hotspot numbers for given nucleases that ranged
      from a few or none to dozens or more, and extended the number of known
      off-targets for certain previously characterized nucleases more than tenfold. We 
      also identified translocations between bona fide nuclease targets on homologous
      chromosomes, an undesired collateral effect that has not been described
      previously. Finally, HTGTS confirmed that the Cas9D10A paired nickase approach
      suppresses off-target cleavage genome-wide.
FAU - Frock, Richard L
AU  - Frock RL
AD  - 1] Program in Cellular and Molecular Medicine, Boston Children's Hospital,
      Boston, Massachusetts, USA. [2] Department of Genetics, Harvard Medical School,
      Boston, Massachusetts, USA. [3] Howard Hughes Medical Institute, Boston,
      Massachusetts, USA.
FAU - Hu, Jiazhi
AU  - Hu J
AD  - 1] Program in Cellular and Molecular Medicine, Boston Children's Hospital,
      Boston, Massachusetts, USA. [2] Department of Genetics, Harvard Medical School,
      Boston, Massachusetts, USA. [3] Howard Hughes Medical Institute, Boston,
      Massachusetts, USA.
FAU - Meyers, Robin M
AU  - Meyers RM
AD  - 1] Program in Cellular and Molecular Medicine, Boston Children's Hospital,
      Boston, Massachusetts, USA. [2] Department of Genetics, Harvard Medical School,
      Boston, Massachusetts, USA. [3] Howard Hughes Medical Institute, Boston,
      Massachusetts, USA.
FAU - Ho, Yu-Jui
AU  - Ho YJ
AD  - 1] Program in Cellular and Molecular Medicine, Boston Children's Hospital,
      Boston, Massachusetts, USA. [2] Department of Genetics, Harvard Medical School,
      Boston, Massachusetts, USA. [3] Howard Hughes Medical Institute, Boston,
      Massachusetts, USA.
FAU - Kii, Erina
AU  - Kii E
AUID- ORCID: 0000000279078067
AD  - 1] Program in Cellular and Molecular Medicine, Boston Children's Hospital,
      Boston, Massachusetts, USA. [2] Department of Genetics, Harvard Medical School,
      Boston, Massachusetts, USA. [3] Howard Hughes Medical Institute, Boston,
      Massachusetts, USA.
FAU - Alt, Frederick W
AU  - Alt FW
AD  - 1] Program in Cellular and Molecular Medicine, Boston Children's Hospital,
      Boston, Massachusetts, USA. [2] Department of Genetics, Harvard Medical School,
      Boston, Massachusetts, USA. [3] Howard Hughes Medical Institute, Boston,
      Massachusetts, USA.
LA  - eng
GR  - P01 CA109901/CA/NCI NIH HHS/United States
GR  - T32 CA070083/CA/NCI NIH HHS/United States
GR  - T32 AI007512/AI/NIAID NIH HHS/United States
GR  - Howard Hughes Medical Institute/United States
GR  - P01CA109901/CA/NCI NIH HHS/United States
GR  - P01AI076210/AI/NIAID NIH HHS/United States
GR  - P01 AI076210/AI/NIAID NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20141215
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Homeodomain Proteins)
RN  - 0 (RNA, Guide)
RN  - 128559-51-3 (RAG-1 protein)
RN  - 9007-49-2 (DNA)
RN  - EC 3.1.- (Endonucleases)
SB  - IM
CIN - Nat Biotechnol. 2015 Feb;33(2):150-2. PMID: 25658281
CIN - Mol Cell. 2015 May 21;58(4):565-7. PMID: 26000841
MH  - CRISPR-Cas Systems/*genetics
MH  - DNA/*genetics
MH  - *DNA Breaks, Double-Stranded
MH  - Endonucleases/biosynthesis/*genetics
MH  - Genome, Human
MH  - High-Throughput Nucleotide Sequencing
MH  - Homeodomain Proteins/genetics
MH  - Humans
MH  - Protein Engineering
MH  - RNA Editing/genetics
MH  - RNA, Guide/genetics
PMC - PMC4320661
MID - NIHMS643651
EDAT- 2014/12/17 06:00
MHDA- 2016/01/14 06:00
CRDT- 2014/12/16 06:00
PHST- 2014/09/02 00:00 [received]
PHST- 2014/11/14 00:00 [accepted]
PHST- 2014/12/16 06:00 [entrez]
PHST- 2014/12/17 06:00 [pubmed]
PHST- 2016/01/14 06:00 [medline]
AID - nbt.3101 [pii]
AID - 10.1038/nbt.3101 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Feb;33(2):179-86. doi: 10.1038/nbt.3101. Epub 2014 Dec 15.

PMID- 25574640
OWN - NLM
STAT- MEDLINE
DCOM- 20150925
LR  - 20150110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 1
DP  - 2015 Jan
TI  - Life sciences workforce trends evolve with the industry.
PG  - 107-9
LID - 10.1038/nbt.3116 [doi]
FAU - Nugent, Kathy L
AU  - Nugent KL
AD  - Institute for Innovation and Entrepreneurship, University of Alabama at
      Birmingham, Birmingham, Alabama, USA, BioAlabama and the Coalition of State
      Bioscience Institutes.
FAU - Lindburg, Lori
AU  - Lindburg L
AD  - BayBio Institute, South San Francisco, California, USA, and the Coalition of
      State Bioscience Institutes.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Biotechnology
MH  - Employment/*statistics & numerical data
MH  - United States
EDAT- 2015/01/13 06:00
MHDA- 2015/09/26 06:00
CRDT- 2015/01/10 06:00
PHST- 2015/01/10 06:00 [entrez]
PHST- 2015/01/13 06:00 [pubmed]
PHST- 2015/09/26 06:00 [medline]
AID - nbt.3116 [pii]
AID - 10.1038/nbt.3116 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jan;33(1):107-9. doi: 10.1038/nbt.3116.

PMID- 25574639
OWN - NLM
STAT- MEDLINE
DCOM- 20150925
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 1
DP  - 2015 Jan
TI  - DREAMing of benchmarks.
PG  - 49-50
LID - 10.1038/nbt.3115 [doi]
FAU - Jarchum, Irene
AU  - Jarchum I
FAU - Jones, Susan
AU  - Jones S
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Benchmarking
MH  - Biotechnology
EDAT- 2015/01/13 06:00
MHDA- 2015/09/26 06:00
CRDT- 2015/01/10 06:00
PHST- 2015/01/10 06:00 [entrez]
PHST- 2015/01/13 06:00 [pubmed]
PHST- 2015/09/26 06:00 [medline]
AID - nbt.3115 [pii]
AID - 10.1038/nbt.3115 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jan;33(1):49-50. doi: 10.1038/nbt.3115.

PMID- 25574637
OWN - NLM
STAT- MEDLINE
DCOM- 20150521
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 1
DP  - 2015 Jan
TI  - Systematic discovery of probiotics.
PG  - 47-9
LID - 10.1038/nbt.3111 [doi]
FAU - Forster, Samuel C
AU  - Forster SC
AD  - Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
FAU - Lawley, Trevor D
AU  - Lawley TD
AD  - Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Bile Acids and Salts)
SB  - IM
CON - Nature. 2015 Jan 8;517(7533):205-8. PMID: 25337874
MH  - Animals
MH  - Bile Acids and Salts/*metabolism
MH  - Clostridium difficile/*physiology
MH  - Disease Susceptibility/*microbiology
MH  - Female
MH  - Humans
MH  - Intestines/*metabolism/*microbiology
MH  - Microbiota/*physiology
EDAT- 2015/01/13 06:00
MHDA- 2015/05/23 06:00
CRDT- 2015/01/10 06:00
PHST- 2015/01/10 06:00 [entrez]
PHST- 2015/01/13 06:00 [pubmed]
PHST- 2015/05/23 06:00 [medline]
AID - nbt.3111 [pii]
AID - 10.1038/nbt.3111 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jan;33(1):47-9. doi: 10.1038/nbt.3111.

PMID- 25574636
OWN - NLM
STAT- MEDLINE
DCOM- 20150928
LR  - 20171013
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 1
DP  - 2015 Jan
TI  - Modeling the course of amyotrophic lateral sclerosis.
PG  - 45-7
LID - 10.1038/nbt.3118 [doi]
FAU - Fournier, Christina
AU  - Fournier C
AD  - Emory University School of Medicine, Atlanta, Georgia, USA.
FAU - Glass, Jonathan D
AU  - Glass JD
AD  - Emory University School of Medicine, Atlanta, Georgia, USA.
LA  - eng
PT  - Comment
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2015 Jan;33(1):51-7. PMID: 25362243
EIN - Nat Biotechnol. 2015 May;33(5):563. PMID: 25965763
MH  - Amyotrophic Lateral Sclerosis/*pathology
MH  - *Clinical Trials as Topic
MH  - *Crowdsourcing
MH  - Humans
EDAT- 2015/01/13 06:00
MHDA- 2015/09/29 06:00
CRDT- 2015/01/10 06:00
PHST- 2015/01/10 06:00 [entrez]
PHST- 2015/01/13 06:00 [pubmed]
PHST- 2015/09/29 06:00 [medline]
AID - nbt.3118 [pii]
AID - 10.1038/nbt.3118 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jan;33(1):45-7. doi: 10.1038/nbt.3118.

PMID- 25574635
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20150521
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 1
DP  - 2015 Jan
TI  - Cancer immunotherapy meets biomaterials.
PG  - 44-5
LID - 10.1038/nbt.3119 [doi]
FAU - Weber, Jeffrey S
AU  - Weber JS
AD  - Moffitt Cancer Center, Tampa, Florida, USA.
FAU - Mule, James J
AU  - Mule JJ
AD  - Moffitt Cancer Center, Tampa, Florida, USA.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
EDAT- 2015/01/13 06:00
MHDA- 2015/01/13 06:01
CRDT- 2015/01/10 06:00
PHST- 2015/01/10 06:00 [entrez]
PHST- 2015/01/13 06:00 [pubmed]
PHST- 2015/01/13 06:01 [medline]
AID - nbt.3119 [pii]
AID - 10.1038/nbt.3119 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jan;33(1):44-5. doi: 10.1038/nbt.3119.

PMID- 25574634
OWN - NLM
STAT- MEDLINE
DCOM- 20150925
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 1
DP  - 2015 Jan
TI  - The impact of European embryonic stem cell patent decisions on research
      strategies.
PG  - 41-3
LID - 10.1038/nbt.3105 [doi]
FAU - Mahalatchimy, Aurelie
AU  - Mahalatchimy A
AD  - 1] UMR1027, INSERM and Universite Toulouse III-Paul Sabatier, Toulouse, France
      [2] Center for Global Health Policy, School of Global Studies, University of
      Sussex, Brighton, UK, and IRDEIC, Universite Toulouse 1 Capitole, Toulouse,
      France.
FAU - Rial-Sebbag, Emmanuelle
AU  - Rial-Sebbag E
AD  - UMR1027, INSERM and Universite Toulouse III-Paul Sabatier, Toulouse, France.
FAU - Duguet, Anne-Marie
AU  - Duguet AM
AD  - UMR1027, INSERM and Universite Toulouse III-Paul Sabatier, Toulouse, France.
FAU - Taboulet, Florence
AU  - Taboulet F
AD  - UMR1027, INSERM and Universite Toulouse III-Paul Sabatier, Toulouse, France.
FAU - Cambon-Thomsen, Anne
AU  - Cambon-Thomsen A
AUID- ORCID: 0000000187933644
AD  - UMR1027, INSERM and Universite Toulouse III-Paul Sabatier, Toulouse, France.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Biomedical Research
MH  - Embryonic Stem Cells/*cytology
MH  - European Union
MH  - Humans
MH  - *Patents as Topic
EDAT- 2015/01/13 06:00
MHDA- 2015/09/26 06:00
CRDT- 2015/01/10 06:00
PHST- 2015/01/10 06:00 [entrez]
PHST- 2015/01/13 06:00 [pubmed]
PHST- 2015/09/26 06:00 [medline]
AID - nbt.3105 [pii]
AID - 10.1038/nbt.3105 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jan;33(1):41-3. doi: 10.1038/nbt.3105.

PMID- 25574633
OWN - NLM
STAT- MEDLINE
DCOM- 20150925
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 1
DP  - 2015 Jan
TI  - Selling long life.
PG  - 31-40
LID - 10.1038/nbt.3108 [doi]
FAU - Scott, Christopher Thomas
AU  - Scott CT
AD  - Nature Biotechnology.
FAU - DeFrancesco, Laura
AU  - DeFrancesco L
AD  - Nature Biotechnology.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - EC 2.7.1.1 (MTOR protein, human)
RN  - EC 2.7.1.1 (TOR Serine-Threonine Kinases)
SB  - IM
EIN - Nat Biotechnol. 2015 May;33(5):563. PMID: 25965762
EIN - Nat Biotechnol. 2015 Feb;33(2):210. PMID: 25658288
MH  - *Aging
MH  - Genome, Human
MH  - Humans
MH  - *Longevity
MH  - TOR Serine-Threonine Kinases/physiology
EDAT- 2015/01/13 06:00
MHDA- 2015/09/26 06:00
CRDT- 2015/01/10 06:00
PHST- 2015/01/10 06:00 [entrez]
PHST- 2015/01/13 06:00 [pubmed]
PHST- 2015/09/26 06:00 [medline]
AID - nbt.3108 [pii]
AID - 10.1038/nbt.3108 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jan;33(1):31-40. doi: 10.1038/nbt.3108.

PMID- 25574632
OWN - NLM
STAT- MEDLINE
DCOM- 20150521
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 1
DP  - 2015 Jan
TI  - Reply to Intellectual property issues and synthetic biology standards.
PG  - 25
LID - 10.1038/nbt.3114 [doi]
FAU - Galdzicki, Michal
AU  - Galdzicki M
FAU - Kahl, Linda J
AU  - Kahl LJ
FAU - Endy, Drew
AU  - Endy D
FAU - Sauro, Herbert M
AU  - Sauro HM
LA  - eng
PT  - Comment
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2015 Jan;33(1):24-5. PMID: 25574630
CON - Nat Biotechnol. 2014 Jun;32(6):545-50. PMID: 24911500
MH  - Information Dissemination/*methods
MH  - Research Design/*standards
MH  - Software/*standards
MH  - Synthetic Biology/*standards
MH  - *Terminology as Topic
MH  - *Vocabulary, Controlled
EDAT- 2015/01/13 06:00
MHDA- 2015/05/23 06:00
CRDT- 2015/01/10 06:00
PHST- 2015/01/10 06:00 [entrez]
PHST- 2015/01/13 06:00 [pubmed]
PHST- 2015/05/23 06:00 [medline]
AID - nbt.3114 [pii]
AID - 10.1038/nbt.3114 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jan;33(1):25. doi: 10.1038/nbt.3114.

PMID- 25574631
OWN - NLM
STAT- MEDLINE
DCOM- 20150925
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 1
DP  - 2015 Jan
TI  - Status and market potential of transgenic biofortified crops.
PG  - 25-9
LID - 10.1038/nbt.3110 [doi]
FAU - De Steur, Hans
AU  - De Steur H
AD  - Ghent University, Department of Agricultural Economics, Ghent, Belgium.
FAU - Blancquaert, Dieter
AU  - Blancquaert D
AD  - Ghent University Department of Physiology, Laboratory of Functional Plant
      Biology, Ghent, Belgium.
FAU - Strobbe, Simon
AU  - Strobbe S
AD  - Ghent University Department of Physiology, Laboratory of Functional Plant
      Biology, Ghent, Belgium.
FAU - Lambert, Willy
AU  - Lambert W
AD  - Ghent University Department of Bioanalysis, Laboratory of Toxicology, Ghent,
      Belgium.
FAU - Gellynck, Xavier
AU  - Gellynck X
AD  - Ghent University, Department of Agricultural Economics, Ghent, Belgium.
FAU - Van Der Straeten, Dominique
AU  - Van Der Straeten D
AD  - Ghent University Department of Physiology, Laboratory of Functional Plant
      Biology, Ghent, Belgium.
LA  - eng
PT  - Letter
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EIN - Nat Biotechnol. 2015 Feb;33(2):210. PMID: 25658284
MH  - Crops, Agricultural/*genetics
MH  - *Plants, Genetically Modified
EDAT- 2015/01/13 06:00
MHDA- 2015/09/26 06:00
CRDT- 2015/01/10 06:00
PHST- 2015/01/10 06:00 [entrez]
PHST- 2015/01/13 06:00 [pubmed]
PHST- 2015/09/26 06:00 [medline]
AID - nbt.3110 [pii]
AID - 10.1038/nbt.3110 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jan;33(1):25-9. doi: 10.1038/nbt.3110.

PMID- 25574630
OWN - NLM
STAT- MEDLINE
DCOM- 20150521
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 1
DP  - 2015 Jan
TI  - Intellectual property issues and synthetic biology standards.
PG  - 24-5
LID - 10.1038/nbt.3107 [doi]
FAU - Contreras, Jorge L
AU  - Contreras JL
AD  - S.J. Quinney College of Law and Department of Human Genetics, University of Utah,
      Salt Lake City, Utah, USA.
FAU - Rai, Arti K
AU  - Rai AK
AD  - School of Law, Duke University, Durham, North Carolina, USA.
FAU - Torrance, Andrew W
AU  - Torrance AW
AD  - 1] School of Law, University of Kansas, Lawrence, Kansas, USA. [2] MIT Sloan
      School of Management, Cambridge, Massachusetts, USA.
LA  - eng
GR  - P50 HG003391/HG/NHGRI NIH HHS/United States
GR  - P50 G003391002/PHS HHS/United States
PT  - Comment
PT  - Letter
PT  - Research Support, N.I.H., Extramural
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CON - Nat Biotechnol. 2014 Jun;32(6):545-50. PMID: 24911500
CIN - Nat Biotechnol. 2015 Jan;33(1):25. PMID: 25574632
MH  - Information Dissemination/*methods
MH  - Research Design/*standards
MH  - Software/*standards
MH  - Synthetic Biology/*standards
MH  - *Terminology as Topic
MH  - *Vocabulary, Controlled
EDAT- 2015/01/13 06:00
MHDA- 2015/05/23 06:00
CRDT- 2015/01/10 06:00
PHST- 2015/01/10 06:00 [entrez]
PHST- 2015/01/13 06:00 [pubmed]
PHST- 2015/05/23 06:00 [medline]
AID - nbt.3107 [pii]
AID - 10.1038/nbt.3107 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jan;33(1):24-5. doi: 10.1038/nbt.3107.

PMID- 25574629
OWN - NLM
STAT- MEDLINE
DCOM- 20150925
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 1
DP  - 2015 Jan
TI  - PeptideShaker enables reanalysis of MS-derived proteomics data sets.
PG  - 22-4
LID - 10.1038/nbt.3109 [doi]
FAU - Vaudel, Marc
AU  - Vaudel M
AD  - 1] Leibniz-Institut fur Analytische Wissenschaften-ISAS-e.V., Dortmund, Germany. 
      [2] Proteomics Unit, Department of Biomedicine, University of Bergen, Bergen,
      Norway.
FAU - Burkhart, Julia M
AU  - Burkhart JM
AD  - Leibniz-Institut fur Analytische Wissenschaften-ISAS-e.V., Dortmund, Germany.
FAU - Zahedi, Rene P
AU  - Zahedi RP
AD  - Leibniz-Institut fur Analytische Wissenschaften-ISAS-e.V., Dortmund, Germany.
FAU - Oveland, Eystein
AU  - Oveland E
AD  - 1] Proteomics Unit, Department of Biomedicine, University of Bergen, Bergen,
      Norway. [2] Department of Clinical Medicine, University of Bergen, Bergen,
      Norway. [3] The KG Jebsen Centre for MS Research, Department of Clinical
      Medicine, University of Bergen, Bergen, Norway.
FAU - Berven, Frode S
AU  - Berven FS
AD  - 1] Proteomics Unit, Department of Biomedicine, University of Bergen, Bergen,
      Norway. [2] The KG Jebsen Centre for MS Research, Department of Clinical
      Medicine, University of Bergen, Bergen, Norway. [3] The Norwegian Multiple
      Sclerosis Competence Centre, Department of Neurology, Haukeland University
      Hospital, Bergen, Norway.
FAU - Sickmann, Albert
AU  - Sickmann A
AD  - Leibniz-Institut fur Analytische Wissenschaften-ISAS-e.V., Dortmund, Germany.
FAU - Martens, Lennart
AU  - Martens L
AD  - 1] Department of Medical Protein Research, VIB, Ghent, Belgium. [2] Department of
      Biochemistry, Ghent University, Ghent, Belgium.
FAU - Barsnes, Harald
AU  - Barsnes H
AD  - 1] Proteomics Unit, Department of Biomedicine, University of Bergen, Bergen,
      Norway. [2] Computational Biology Unit, University of Bergen, Norway.
LA  - eng
PT  - Letter
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Peptides)
SB  - IM
MH  - Amino Acid Sequence
MH  - Mass Spectrometry/*methods
MH  - Molecular Sequence Data
MH  - Peptides/*chemistry
MH  - *Proteomics
EDAT- 2015/01/13 06:00
MHDA- 2015/09/26 06:00
CRDT- 2015/01/10 06:00
PHST- 2015/01/10 06:00 [entrez]
PHST- 2015/01/13 06:00 [pubmed]
PHST- 2015/09/26 06:00 [medline]
AID - nbt.3109 [pii]
AID - 10.1038/nbt.3109 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jan;33(1):22-4. doi: 10.1038/nbt.3109.

PMID- 25574628
OWN - NLM
STAT- MEDLINE
DCOM- 20150925
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 1
DP  - 2015 Jan
TI  - Outcubation--where incubation meets outsourcing.
PG  - 20-1
LID - 10.1038/nbt.3112 [doi]
FAU - Betz, Ulrich A K
AU  - Betz UA
AD  - Merck Serono, Darmstadt, Germany.
FAU - Tidona, Christian A
AU  - Tidona CA
AUID- ORCID: 0000000212096033
LA  - eng
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Contract Services/*organization & administration
MH  - Decision Making, Organizational
MH  - Drug Industry
EDAT- 2015/01/13 06:00
MHDA- 2015/09/26 06:00
CRDT- 2015/01/10 06:00
PHST- 2015/01/10 06:00 [entrez]
PHST- 2015/01/13 06:00 [pubmed]
PHST- 2015/09/26 06:00 [medline]
AID - nbt.3112 [pii]
AID - 10.1038/nbt.3112 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jan;33(1):20-1. doi: 10.1038/nbt.3112.

PMID- 25574627
OWN - NLM
STAT- MEDLINE
DCOM- 20150925
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 1
DP  - 2015 Jan
TI  - Biosimilars or semi-similars?
PG  - 19-20
LID - 10.1038/nbt.3083 [doi]
FAU - Schellekens, Huub
AU  - Schellekens H
AD  - Department of Innovation, Utrecht University, Utrecht, the Netherlands, and
      Department of Pharmaceutical Sciences, Utrecht University, Utrecht, the
      Netherlands.
FAU - Moors, Ellen
AU  - Moors E
AD  - Department of Innovation, Utrecht University, Utrecht, the Netherlands, and
      Department of Pharmaceutical Sciences, Utrecht University, Utrecht, the
      Netherlands.
LA  - eng
PT  - Letter
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antibodies, Monoclonal)
SB  - IM
MH  - Antibodies, Monoclonal/immunology/*therapeutic use
MH  - Drug Approval/legislation & jurisprudence
EDAT- 2015/01/13 06:00
MHDA- 2015/09/26 06:00
CRDT- 2015/01/10 06:00
PHST- 2015/01/10 06:00 [entrez]
PHST- 2015/01/13 06:00 [pubmed]
PHST- 2015/09/26 06:00 [medline]
AID - nbt.3083 [pii]
AID - 10.1038/nbt.3083 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jan;33(1):19-20. doi: 10.1038/nbt.3083.

PMID- 25574625
OWN - NLM
STAT- MEDLINE
DCOM- 20150925
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 1
DP  - 2015 Jan
TI  - Social storm.
PG  - 14-7
LID - 10.1038/nbt.3106 [doi]
FAU - Hughes, Virginia
AU  - Hughes V
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CIN - Nat Biotechnol. 2015 Feb;33(2):134-5. PMID: 25658275
MH  - *Drug Industry
MH  - *Social Media
MH  - United States
MH  - United States Food and Drug Administration
EDAT- 2015/01/13 06:00
MHDA- 2015/09/26 06:00
CRDT- 2015/01/10 06:00
PHST- 2015/01/10 06:00 [entrez]
PHST- 2015/01/13 06:00 [pubmed]
PHST- 2015/09/26 06:00 [medline]
AID - nbt.3106 [pii]
AID - 10.1038/nbt.3106 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jan;33(1):14-7. doi: 10.1038/nbt.3106.

PMID- 25574623
OWN - NLM
STAT- MEDLINE
DCOM- 20150925
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 1
DP  - 2015 Jan
TI  - USDA approves next-generation GM potato.
PG  - 12-3
LID - 10.1038/nbt0115-12 [doi]
FAU - Waltz, Emily
AU  - Waltz E
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EIN - Nat Biotechnol. 2015 May;33(5):439. PMID: 25965737
MH  - *Plants, Genetically Modified
MH  - Solanum tuberosum/*genetics
MH  - United States
MH  - United States Department of Agriculture
EDAT- 2015/01/13 06:00
MHDA- 2015/09/26 06:00
CRDT- 2015/01/10 06:00
PHST- 2015/01/10 06:00 [entrez]
PHST- 2015/01/13 06:00 [pubmed]
PHST- 2015/09/26 06:00 [medline]
AID - nbt0115-12 [pii]
AID - 10.1038/nbt0115-12 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jan;33(1):12-3. doi: 10.1038/nbt0115-12.

PMID- 25574622
OWN - NLM
STAT- MEDLINE
DCOM- 20150925
LR  - 20150110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 1
DP  - 2015 Jan
TI  - How frothy is this IPO window?
PG  - 11
LID - 10.1038/nbt0115-11 [doi]
FAU - Orelli, Brian
AU  - Orelli B
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Biotechnology/*economics
MH  - *Investments
MH  - United States
EDAT- 2015/01/13 06:00
MHDA- 2015/09/26 06:00
CRDT- 2015/01/10 06:00
PHST- 2015/01/10 06:00 [entrez]
PHST- 2015/01/13 06:00 [pubmed]
PHST- 2015/09/26 06:00 [medline]
AID - nbt0115-11 [pii]
AID - 10.1038/nbt0115-11 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jan;33(1):11. doi: 10.1038/nbt0115-11.

PMID- 25574621
OWN - NLM
STAT- MEDLINE
DCOM- 20150925
LR  - 20150110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 1
DP  - 2015 Jan
TI  - IBM's Watson Group signs up genomics partners.
PG  - 10-1
LID - 10.1038/nbt0115-10 [doi]
FAU - Ratner, Mark
AU  - Ratner M
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Genomics
MH  - Humans
MH  - Neoplasms/genetics/therapy
MH  - United States
EDAT- 2015/01/13 06:00
MHDA- 2015/09/26 06:00
CRDT- 2015/01/10 06:00
PHST- 2015/01/10 06:00 [entrez]
PHST- 2015/01/13 06:00 [pubmed]
PHST- 2015/09/26 06:00 [medline]
AID - nbt0115-10 [pii]
AID - 10.1038/nbt0115-10 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jan;33(1):10-1. doi: 10.1038/nbt0115-10.

PMID- 25574617
OWN - NLM
STAT- MEDLINE
DCOM- 20150925
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 1
DP  - 2015 Jan
TI  - Foundation receives $3.3-billion windfall for Kalydeco.
PG  - 8-9
LID - 10.1038/nbt0115-8 [doi]
FAU - Senior, Melanie
AU  - Senior M
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Aminophenols)
RN  - 0 (Quinolones)
RN  - 126880-72-6 (Cystic Fibrosis Transmembrane Conductance Regulator)
RN  - 1Y740ILL1Z (ivacaftor)
SB  - IM
EIN - Nat Biotechnol. 2015 Mar;33(3):226. PMID: 25748903
MH  - Aminophenols/*economics/therapeutic use
MH  - Cystic Fibrosis/drug therapy
MH  - Cystic Fibrosis Transmembrane Conductance Regulator/*economics/therapeutic use
MH  - *Financing, Organized
MH  - *Foundations
MH  - Humans
MH  - Quinolones/*economics/therapeutic use
EDAT- 2015/01/13 06:00
MHDA- 2015/09/26 06:00
CRDT- 2015/01/10 06:00
PHST- 2015/01/10 06:00 [entrez]
PHST- 2015/01/13 06:00 [pubmed]
PHST- 2015/09/26 06:00 [medline]
AID - nbt0115-8 [pii]
AID - 10.1038/nbt0115-8 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jan;33(1):8-9. doi: 10.1038/nbt0115-8.

PMID- 25574616
OWN - NLM
STAT- MEDLINE
DCOM- 20150925
LR  - 20171116
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 1
DP  - 2015 Jan
TI  - Clinuvel's tanning agent nears approval for porphyria.
PG  - 7
LID - 10.1038/nbt0115-7 [doi]
FAU - Mullard, Asher
AU  - Mullard A
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Placebos)
RN  - 581-05-5 (alpha-MSH)
RN  - QW68W3J66U (afamelanotide)
SB  - IM
MH  - Clinical Trials, Phase III as Topic
MH  - Humans
MH  - Placebos
MH  - Porphyrias/*drug therapy
MH  - alpha-MSH/*analogs & derivatives/therapeutic use
EDAT- 2015/01/13 06:00
MHDA- 2015/09/26 06:00
CRDT- 2015/01/10 06:00
PHST- 2015/01/10 06:00 [entrez]
PHST- 2015/01/13 06:00 [pubmed]
PHST- 2015/09/26 06:00 [medline]
AID - nbt0115-7 [pii]
AID - 10.1038/nbt0115-7 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jan;33(1):7. doi: 10.1038/nbt0115-7.

PMID- 25574615
OWN - NLM
STAT- MEDLINE
DCOM- 20150925
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 1
DP  - 2015 Jan
TI  - Amgen's angiopoietin blocker fails in ovarian cancer.
PG  - 5-6
LID - 10.1038/nbt0115-5 [doi]
FAU - Sheridan, Cormac
AU  - Sheridan C
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (ANGPT1 protein, human)
RN  - 0 (ANGPT2 protein, human)
RN  - 0 (Angiopoietin-1)
RN  - 0 (Angiopoietin-2)
RN  - 0 (Recombinant Fusion Proteins)
RN  - X8Y5U6NC7E (trebananib)
SB  - IM
MH  - Angiopoietin-1/*antagonists & inhibitors
MH  - Angiopoietin-2/*antagonists & inhibitors
MH  - Female
MH  - Humans
MH  - Ovarian Neoplasms/*drug therapy
MH  - Recombinant Fusion Proteins/pharmacology/*therapeutic use
EDAT- 2015/01/13 06:00
MHDA- 2015/09/26 06:00
CRDT- 2015/01/10 06:00
PHST- 2015/01/10 06:00 [entrez]
PHST- 2015/01/13 06:00 [pubmed]
PHST- 2015/09/26 06:00 [medline]
AID - nbt0115-5 [pii]
AID - 10.1038/nbt0115-5 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jan;33(1):5-6. doi: 10.1038/nbt0115-5.

PMID- 25574612
OWN - NLM
STAT- MEDLINE
DCOM- 20150925
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 1
DP  - 2015 Jan
TI  - IL-17-targeting biologics aim to become standard of care in psoriasis.
PG  - 3-4
LID - 10.1038/nbt0115-3 [doi]
FAU - Ratner, Mark
AU  - Ratner M
LA  - eng
PT  - News
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Antibodies, Monoclonal, Humanized)
RN  - 0 (Interleukin-17)
RN  - BTY153760O (ixekizumab)
SB  - IM
MH  - Antibodies, Monoclonal, Humanized/*therapeutic use
MH  - Humans
MH  - Interleukin-17/*antagonists & inhibitors
MH  - Psoriasis/*drug therapy
MH  - United States
MH  - United States Food and Drug Administration
EDAT- 2015/01/13 06:00
MHDA- 2015/09/26 06:00
CRDT- 2015/01/10 06:00
PHST- 2015/01/10 06:00 [entrez]
PHST- 2015/01/13 06:00 [pubmed]
PHST- 2015/09/26 06:00 [medline]
AID - nbt0115-3 [pii]
AID - 10.1038/nbt0115-3 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jan;33(1):3-4. doi: 10.1038/nbt0115-3.

PMID- 25574611
OWN - NLM
STAT- MEDLINE
DCOM- 20150925
LR  - 20161125
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 1
DP  - 2015 Jan
TI  - Bring out your dead.
PG  - 1
LID - 10.1038/nbt.3123 [doi]
LA  - eng
PT  - Editorial
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
EIN - Nat Biotechnol. 2015 Feb;33(2):210. PMID: 25658285
MH  - *Biomedical Research
MH  - Cooperative Behavior
MH  - *Drug Industry
MH  - United Kingdom
EDAT- 2015/01/13 06:00
MHDA- 2015/09/26 06:00
CRDT- 2015/01/10 06:00
PHST- 2015/01/10 06:00 [entrez]
PHST- 2015/01/13 06:00 [pubmed]
PHST- 2015/09/26 06:00 [medline]
AID - nbt.3123 [pii]
AID - 10.1038/nbt.3123 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jan;33(1):1. doi: 10.1038/nbt.3123.

PMID- 25503382
OWN - NLM
STAT- MEDLINE
DCOM- 20150925
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 1
DP  - 2015 Jan
TI  - Biopolymer implants enhance the efficacy of adoptive T-cell therapy.
PG  - 97-101
LID - 10.1038/nbt.3104 [doi]
AB  - Although adoptive T-cell therapy holds promise for the treatment of many cancers,
      its clinical utility has been limited by problems in delivering targeted
      lymphocytes to tumor sites, and the cells' inefficient expansion in the
      immunosuppressive tumor microenvironment. Here we describe a bioactive polymer
      implant capable of delivering, expanding and dispersing tumor-reactive T cells.
      The approach can be used to treat inoperable or incompletely removed tumors by
      situating implants near them or at resection sites. Using a mouse breast cancer
      resection model, we show that the implants effectively support tumor-targeting T 
      cells throughout resection beds and associated lymph nodes, and reduce tumor
      relapse compared to conventional delivery modalities. In a multifocal ovarian
      cancer model, we demonstrate that polymer-delivered T cells trigger regression,
      whereas injected tumor-reactive lymphocytes have little curative effect.
      Scaffold-based T-cell delivery may provide a viable treatment option for
      inoperable tumors and reduce the rate of metastatic relapse after surgery.
FAU - Stephan, Sirkka B
AU  - Stephan SB
AD  - Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle,
      Washington, USA.
FAU - Taber, Alexandria M
AU  - Taber AM
AD  - Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle,
      Washington, USA.
FAU - Jileaeva, Ilona
AU  - Jileaeva I
AD  - Technology Access Foundation (TAF) Academy, Fred Hutchinson Cancer Research
      Center, Seattle, Washington, USA.
FAU - Pegues, Ericka P
AU  - Pegues EP
AD  - Technology Access Foundation (TAF) Academy, Fred Hutchinson Cancer Research
      Center, Seattle, Washington, USA.
FAU - Sentman, Charles L
AU  - Sentman CL
AD  - Department of Microbiology and Immunology, The Geisel School of Medicine at
      Dartmouth, Lebanon, New Hampshire, USA.
FAU - Stephan, Matthias T
AU  - Stephan MT
AD  - 1] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle,
      Washington, USA. [2] Technology Access Foundation (TAF) Academy, Fred Hutchinson 
      Cancer Research Center, Seattle, Washington, USA. [3] Department of
      Bioengineering and Molecular Engineering &Sciences Institute, University of
      Washington, Seattle, Washington, USA. [4] Department of Medicine, Division of
      Medical Oncology, University of Washington, Seattle, Washington, USA.
LA  - eng
GR  - P50 CA083636/CA/NCI NIH HHS/United States
GR  - P50 CA138293/CA/NCI NIH HHS/United States
GR  - R01 CA181413/CA/NCI NIH HHS/United States
GR  - P50 CA83636/CA/NCI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20141215
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Biopolymers)
SB  - IM
MH  - *Adoptive Transfer
MH  - *Biopolymers
MH  - *Prostheses and Implants
MH  - T-Lymphocytes/*immunology
PMC - PMC4289408
MID - NIHMS644838
EDAT- 2014/12/17 06:00
MHDA- 2015/09/26 06:00
CRDT- 2014/12/16 06:00
PHST- 2014/08/05 00:00 [received]
PHST- 2014/11/24 00:00 [accepted]
PHST- 2014/12/16 06:00 [entrez]
PHST- 2014/12/17 06:00 [pubmed]
PHST- 2015/09/26 06:00 [medline]
AID - nbt.3104 [pii]
AID - 10.1038/nbt.3104 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jan;33(1):97-101. doi: 10.1038/nbt.3104. Epub 2014 Dec 15.

PMID- 25485616
OWN - NLM
STAT- MEDLINE
DCOM- 20150925
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 1
DP  - 2015 Jan
TI  - Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells
      in vivo and increase vaccine efficacy.
PG  - 64-72
LID - 10.1038/nbt.3071 [doi]
AB  - Implanting materials in the body to program host immune cells is a promising
      alternative to transplantation of cells manipulated ex vivo to direct an immune
      response, but doing so requires a surgical procedure. Here we demonstrate that
      high-aspect-ratio, mesoporous silica rods (MSRs) injected with a needle
      spontaneously assemble in vivo to form macroporous structures that provide a 3D
      cellular microenvironment for host immune cells. In mice, substantial numbers of 
      dendritic cells are recruited to the pores between the scaffold rods. The
      recruitment of dendritic cells and their subsequent homing to lymph nodes can be 
      modulated by sustained release of inflammatory signals and adjuvants from the
      scaffold. Moreover, injection of an MSR-based vaccine formulation enhances
      systemic helper T cells TH1 and TH2 serum antibody and cytotoxic T-cell levels
      compared to bolus controls. These findings suggest that injectable MSRs may serve
      as a multifunctional vaccine platform to modulate host immune cell function and
      provoke adaptive immune responses.
FAU - Kim, Jaeyun
AU  - Kim J
AD  - 1] School of Engineering and Applied Sciences, Harvard University, Cambridge,
      Massachusetts, USA. [2] The Wyss Institute for Biologically Inspired Engineering,
      Harvard University, Boston, Massachusetts, USA. [3] School of Chemical
      Engineering, Sungkyunkwan University, Suwon, Korea.
FAU - Li, Weiwei Aileen
AU  - Li WA
AD  - 1] School of Engineering and Applied Sciences, Harvard University, Cambridge,
      Massachusetts, USA. [2] The Wyss Institute for Biologically Inspired Engineering,
      Harvard University, Boston, Massachusetts, USA.
FAU - Choi, Youngjin
AU  - Choi Y
AD  - School of Chemical Engineering, Sungkyunkwan University, Suwon, Korea.
FAU - Lewin, Sarah A
AU  - Lewin SA
AD  - The Wyss Institute for Biologically Inspired Engineering, Harvard University,
      Boston, Massachusetts, USA.
FAU - Verbeke, Catia S
AU  - Verbeke CS
AD  - 1] School of Engineering and Applied Sciences, Harvard University, Cambridge,
      Massachusetts, USA. [2] The Wyss Institute for Biologically Inspired Engineering,
      Harvard University, Boston, Massachusetts, USA.
FAU - Dranoff, Glenn
AU  - Dranoff G
AD  - Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts,
      USA.
FAU - Mooney, David J
AU  - Mooney DJ
AD  - 1] School of Engineering and Applied Sciences, Harvard University, Cambridge,
      Massachusetts, USA. [2] The Wyss Institute for Biologically Inspired Engineering,
      Harvard University, Boston, Massachusetts, USA.
LA  - eng
GR  - R01 EB015498/EB/NIBIB NIH HHS/United States
GR  - UL1 TR001102/TR/NCATS NIH HHS/United States
GR  - 1R01EB015498/EB/NIBIB NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20141208
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Vaccines)
SB  - IM
MH  - Animals
MH  - Immune System/*cytology
MH  - Mice
MH  - *Tissue Scaffolds
MH  - Vaccines/*immunology
PMC - PMC4318563
MID - NIHMS635669
EDAT- 2014/12/09 06:00
MHDA- 2015/09/26 06:00
CRDT- 2014/12/09 06:00
PHST- 2014/04/25 00:00 [received]
PHST- 2014/10/14 00:00 [accepted]
PHST- 2014/12/09 06:00 [entrez]
PHST- 2014/12/09 06:00 [pubmed]
PHST- 2015/09/26 06:00 [medline]
AID - nbt.3071 [pii]
AID - 10.1038/nbt.3071 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jan;33(1):64-72. doi: 10.1038/nbt.3071. Epub 2014 Dec 8.

PMID- 25437882
OWN - NLM
STAT- MEDLINE
DCOM- 20150925
LR  - 20180131
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 1
DP  - 2015 Jan
TI  - A comparison of non-integrating reprogramming methods.
PG  - 58-63
LID - 10.1038/nbt.3070 [doi]
AB  - Human induced pluripotent stem cells (hiPSCs) are useful in disease modeling and 
      drug discovery, and they promise to provide a new generation of cell-based
      therapeutics. To date there has been no systematic evaluation of the most widely 
      used techniques for generating integration-free hiPSCs. Here we compare
      Sendai-viral (SeV), episomal (Epi) and mRNA transfection mRNA methods using a
      number of criteria. All methods generated high-quality hiPSCs, but significant
      differences existed in aneuploidy rates, reprogramming efficiency, reliability
      and workload. We discuss the advantages and shortcomings of each approach, and
      present and review the results of a survey of a large number of human
      reprogramming laboratories on their independent experiences and preferences. Our 
      analysis provides a valuable resource to inform the use of specific reprogramming
      methods for different laboratories and different applications, including clinical
      translation.
FAU - Schlaeger, Thorsten M
AU  - Schlaeger TM
AD  - 1] Division of Pediatric Hematology/Oncology, Boston Children's Hospital,
      Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Harvard Stem Cell
      Institute, Cambridge, Massachusetts, USA.
FAU - Daheron, Laurence
AU  - Daheron L
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
FAU - Brickler, Thomas R
AU  - Brickler TR
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
FAU - Entwisle, Samuel
AU  - Entwisle S
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
FAU - Chan, Karrie
AU  - Chan K
AD  - Division of Pediatric Hematology/Oncology, Boston Children's Hospital,
      Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
FAU - Cianci, Amelia
AU  - Cianci A
AD  - Division of Pediatric Hematology/Oncology, Boston Children's Hospital,
      Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
FAU - DeVine, Alexander
AU  - DeVine A
AD  - Division of Pediatric Hematology/Oncology, Boston Children's Hospital,
      Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
FAU - Ettenger, Andrew
AU  - Ettenger A
AUID- ORCID: 0000000322584329
AD  - Division of Pediatric Hematology/Oncology, Boston Children's Hospital,
      Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
FAU - Fitzgerald, Kelly
AU  - Fitzgerald K
AD  - Division of Pediatric Hematology/Oncology, Boston Children's Hospital,
      Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
FAU - Godfrey, Michelle
AU  - Godfrey M
AD  - Division of Pediatric Hematology/Oncology, Boston Children's Hospital,
      Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
FAU - Gupta, Dipti
AU  - Gupta D
AD  - Division of Pediatric Hematology/Oncology, Boston Children's Hospital,
      Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
FAU - McPherson, Jade
AU  - McPherson J
AD  - Division of Pediatric Hematology/Oncology, Boston Children's Hospital,
      Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
FAU - Malwadkar, Prerana
AU  - Malwadkar P
AD  - Division of Pediatric Hematology/Oncology, Boston Children's Hospital,
      Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
FAU - Gupta, Manav
AU  - Gupta M
AD  - Division of Pediatric Hematology/Oncology, Boston Children's Hospital,
      Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
FAU - Bell, Blair
AU  - Bell B
AD  - Division of Pediatric Hematology/Oncology, Boston Children's Hospital,
      Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
FAU - Doi, Akiko
AU  - Doi A
AD  - 1] Center for Epigenetics and Department of Medicine, Johns Hopkins University
      School of Medicine, Baltimore, Maryland, USA. [2] Department of Biology,
      Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
FAU - Jung, Namyoung
AU  - Jung N
AD  - Center for Epigenetics and Department of Medicine, Johns Hopkins University
      School of Medicine, Baltimore, Maryland, USA.
FAU - Li, Xin
AU  - Li X
AD  - Center for Epigenetics and Department of Medicine, Johns Hopkins University
      School of Medicine, Baltimore, Maryland, USA.
FAU - Lynes, Maureen S
AU  - Lynes MS
AD  - Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
FAU - Brookes, Emily
AU  - Brookes E
AD  - Division of Pediatric Hematology/Oncology, Boston Children's Hospital,
      Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
FAU - Cherry, Anne B C
AU  - Cherry AB
AD  - 1] Division of Pediatric Hematology/Oncology, Boston Children's Hospital,
      Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Department of
      Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, 
      Massachusetts, USA.
FAU - Demirbas, Didem
AU  - Demirbas D
AD  - The Manton Center for Orphan Disease Research, Division of Genetics and Genomics,
      Boston Children's Hospital, Boston, Massachusetts, USA.
FAU - Tsankov, Alexander M
AU  - Tsankov AM
AD  - 1] Harvard Stem Cell Institute, Cambridge, Massachusetts, USA. [2] Broad
      Institute, Cambridge, Massachusetts, USA.
FAU - Zon, Leonard I
AU  - Zon LI
AD  - 1] Division of Pediatric Hematology/Oncology, Boston Children's Hospital,
      Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Harvard Stem Cell
      Institute, Cambridge, Massachusetts, USA.
FAU - Rubin, Lee L
AU  - Rubin LL
AD  - 1] Harvard Stem Cell Institute, Cambridge, Massachusetts, USA. [2] Department of 
      Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts,
      USA.
FAU - Feinberg, Andrew P
AU  - Feinberg AP
AD  - Center for Epigenetics and Department of Medicine, Johns Hopkins University
      School of Medicine, Baltimore, Maryland, USA.
FAU - Meissner, Alexander
AU  - Meissner A
AD  - 1] Harvard Stem Cell Institute, Cambridge, Massachusetts, USA. [2] Broad
      Institute, Cambridge, Massachusetts, USA.
FAU - Cowan, Chad A
AU  - Cowan CA
AD  - 1] Harvard Stem Cell Institute, Cambridge, Massachusetts, USA. [2] Broad
      Institute, Cambridge, Massachusetts, USA. [3] Department of Stem Cell and
      Regenerative Biology, Harvard University, Cambridge, Massachusetts, USA. [4]
      Center for Regenerative Medicine, Massachusetts General Hospital, Boston,
      Massachusetts, USA.
FAU - Daley, George Q
AU  - Daley GQ
AD  - 1] Division of Pediatric Hematology/Oncology, Boston Children's Hospital,
      Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Harvard Stem Cell
      Institute, Cambridge, Massachusetts, USA. [3] Department of Biological Chemistry 
      and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA.
      [4] Howard Hughes Medical Institute, Children's Hospital Boston and Dana Farber
      Cancer Institute, Boston, Massachusetts, USA.
LA  - eng
GR  - P01 NS066888/NS/NINDS NIH HHS/United States
GR  - R01HL75737/HL/NHLBI NIH HHS/United States
GR  - R24DK092760/DK/NIDDK NIH HHS/United States
GR  - U01-HL100001/HL/NHLBI NIH HHS/United States
GR  - U01 HL100408/HL/NHLBI NIH HHS/United States
GR  - F32 DK095537/DK/NIDDK NIH HHS/United States
GR  - U01HL87402/HL/NHLBI NIH HHS/United States
GR  - U01 HL100001/HL/NHLBI NIH HHS/United States
GR  - R01 GM107536/GM/NIGMS NIH HHS/United States
GR  - U01HL100408/HL/NHLBI NIH HHS/United States
GR  - R24 DK092760/DK/NIDDK NIH HHS/United States
GR  - R01 CA054358/CA/NCI NIH HHS/United States
GR  - P01NS066888/NS/NINDS NIH HHS/United States
GR  - UL1 RR025758/RR/NCRR NIH HHS/United States
GR  - U01HL107440/HL/NHLBI NIH HHS/United States
GR  - U01 HL107440/HL/NHLBI NIH HHS/United States
PT  - Comparative Study
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20141201
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - *Cellular Reprogramming
MH  - Humans
MH  - Induced Pluripotent Stem Cells/*cytology
PMC - PMC4329913
MID - NIHMS661021
EDAT- 2014/12/02 06:00
MHDA- 2015/09/26 06:00
CRDT- 2014/12/02 06:00
PHST- 2014/06/11 00:00 [received]
PHST- 2014/10/14 00:00 [accepted]
PHST- 2014/12/02 06:00 [entrez]
PHST- 2014/12/02 06:00 [pubmed]
PHST- 2015/09/26 06:00 [medline]
AID - nbt.3070 [pii]
AID - 10.1038/nbt.3070 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jan;33(1):58-63. doi: 10.1038/nbt.3070. Epub 2014 Dec 1.

PMID- 25383599
OWN - NLM
STAT- MEDLINE
DCOM- 20150925
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 1
DP  - 2015 Jan
TI  - Combinatorial analysis of developmental cues efficiently converts human
      pluripotent stem cells into multiple neuronal subtypes.
PG  - 89-96
LID - 10.1038/nbt.3049 [doi]
AB  - Specification of cell identity during development depends on exposure of cells to
      sequences of extrinsic cues delivered at precise times and concentrations.
      Identification of combinations of patterning molecules that control cell fate is 
      essential for the effective use of human pluripotent stem cells (hPSCs) for basic
      and translational studies. Here we describe a scalable, automated approach to
      systematically test the combinatorial actions of small molecules for the targeted
      differentiation of hPSCs. Applied to the generation of neuronal subtypes, this
      analysis revealed an unappreciated role for canonical Wnt signaling in specifying
      motor neuron diversity from hPSCs and allowed us to define rapid (14 days),
      efficient procedures to generate spinal and cranial motor neurons as well as
      spinal interneurons and sensory neurons. Our systematic approach to improving
      hPSC-targeted differentiation should facilitate disease modeling studies and drug
      screening assays.
FAU - Maury, Yves
AU  - Maury Y
AD  - CECS, I-STEM (Institute for Stem Cell Therapy and Exploration of Monogenic
      Diseases), AFM, Evry, France.
FAU - Come, Julien
AU  - Come J
AD  - CECS, I-STEM (Institute for Stem Cell Therapy and Exploration of Monogenic
      Diseases), AFM, Evry, France.
FAU - Piskorowski, Rebecca A
AU  - Piskorowski RA
AD  - CNRS UMR 8118, Universite Paris Descartes Sorbonne Paris Cite, Paris, France.
FAU - Salah-Mohellibi, Nouzha
AU  - Salah-Mohellibi N
AD  - INSERM/UEVE UMR 861, I-STEM, AFM, Evry, France.
FAU - Chevaleyre, Vivien
AU  - Chevaleyre V
AD  - CNRS UMR 8118, Universite Paris Descartes Sorbonne Paris Cite, Paris, France.
FAU - Peschanski, Marc
AU  - Peschanski M
AD  - INSERM/UEVE UMR 861, I-STEM, AFM, Evry, France.
FAU - Martinat, Cecile
AU  - Martinat C
AD  - INSERM/UEVE UMR 861, I-STEM, AFM, Evry, France.
FAU - Nedelec, Stephane
AU  - Nedelec S
AD  - INSERM/UEVE UMR 861, I-STEM, AFM, Evry, France.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20141110
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Cell Differentiation
MH  - *Combinatorial Chemistry Techniques
MH  - Humans
MH  - Neurons/*cytology
MH  - Pluripotent Stem Cells/*cytology
EDAT- 2014/11/11 06:00
MHDA- 2015/09/26 06:00
CRDT- 2014/11/11 06:00
PHST- 2014/04/10 00:00 [received]
PHST- 2014/09/19 00:00 [accepted]
PHST- 2014/11/11 06:00 [entrez]
PHST- 2014/11/11 06:00 [pubmed]
PHST- 2015/09/26 06:00 [medline]
AID - nbt.3049 [pii]
AID - 10.1038/nbt.3049 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jan;33(1):89-96. doi: 10.1038/nbt.3049. Epub 2014 Nov 10.

PMID- 25362245
OWN - NLM
STAT- MEDLINE
DCOM- 20150925
LR  - 20171110
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 1
DP  - 2015 Jan
TI  - Engineered liposomes sequester bacterial exotoxins and protect from severe
      invasive infections in mice.
PG  - 81-8
LID - 10.1038/nbt.3037 [doi]
AB  - Gram-positive bacterial pathogens that secrete cytotoxic pore-forming toxins,
      such as Staphylococcus aureus and Streptococcus pneumoniae, cause a substantial
      burden of disease. Inspired by the principles that govern natural toxin-host
      interactions, we have engineered artificial liposomes that are tailored to
      effectively compete with host cells for toxin binding. Liposome-bound toxins are 
      unable to lyse mammalian cells in vitro. We use these artificial liposomes as
      decoy targets to sequester bacterial toxins that are produced during active
      infection in vivo. Administration of artificial liposomes within 10 h after
      infection rescues mice from septicemia caused by S. aureus and S. pneumoniae,
      whereas untreated mice die within 24-33 h. Furthermore, liposomes protect mice
      against invasive pneumococcal pneumonia. Composed exclusively of naturally
      occurring lipids, tailored liposomes are not bactericidal and could be used
      therapeutically either alone or in conjunction with antibiotics to combat
      bacterial infections and to minimize toxin-induced tissue damage that occurs
      during bacterial clearance.
FAU - Henry, Brian D
AU  - Henry BD
AD  - 1] Institute of Molecular Biology, University of Duisburg-Essen, Essen, Germany. 
      [2] Department of Surgery, University of Cincinnati, Cincinnati, Ohio, USA.
FAU - Neill, Daniel R
AU  - Neill DR
AD  - Department of Clinical Infection Microbiology &Immunology, Institute of Infection
      &Global Health, University of Liverpool, Liverpool, UK.
FAU - Becker, Katrin Anne
AU  - Becker KA
AD  - Institute of Molecular Biology, University of Duisburg-Essen, Essen, Germany.
FAU - Gore, Suzanna
AU  - Gore S
AD  - Department of Clinical Infection Microbiology &Immunology, Institute of Infection
      &Global Health, University of Liverpool, Liverpool, UK.
FAU - Bricio-Moreno, Laura
AU  - Bricio-Moreno L
AD  - Department of Clinical Infection Microbiology &Immunology, Institute of Infection
      &Global Health, University of Liverpool, Liverpool, UK.
FAU - Ziobro, Regan
AU  - Ziobro R
AD  - 1] Institute of Molecular Biology, University of Duisburg-Essen, Essen, Germany. 
      [2] Department of Surgery, University of Cincinnati, Cincinnati, Ohio, USA.
FAU - Edwards, Michael J
AU  - Edwards MJ
AD  - Department of Surgery, University of Cincinnati, Cincinnati, Ohio, USA.
FAU - Muhlemann, Kathrin
AU  - Muhlemann K
AD  - Institute for Infectious Diseases, University of Bern, Bern, Switzerland.
FAU - Steinmann, Jorg
AU  - Steinmann J
AD  - Institute of Medical Microbiology, University of Duisburg-Essen, Essen, Germany.
FAU - Kleuser, Burkhard
AU  - Kleuser B
AD  - Department of Toxicology, Institute of Nutritional Science, University of
      Potsdam, Potsdam, Germany.
FAU - Japtok, Lukasz
AU  - Japtok L
AD  - Department of Toxicology, Institute of Nutritional Science, University of
      Potsdam, Potsdam, Germany.
FAU - Luginbuhl, Miriam
AU  - Luginbuhl M
AD  - Institute of Anatomy, University of Bern, Bern, Switzerland.
FAU - Wolfmeier, Heidi
AU  - Wolfmeier H
AD  - Institute of Anatomy, University of Bern, Bern, Switzerland.
FAU - Scherag, Andre
AU  - Scherag A
AD  - Clinical Epidemiology, Integrated Research and Treatment Center, Center for
      Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.
FAU - Gulbins, Erich
AU  - Gulbins E
AD  - 1] Institute of Molecular Biology, University of Duisburg-Essen, Essen, Germany. 
      [2] Department of Surgery, University of Cincinnati, Cincinnati, Ohio, USA.
FAU - Kadioglu, Aras
AU  - Kadioglu A
AD  - Department of Clinical Infection Microbiology &Immunology, Institute of Infection
      &Global Health, University of Liverpool, Liverpool, UK.
FAU - Draeger, Annette
AU  - Draeger A
AD  - Institute of Anatomy, University of Bern, Bern, Switzerland.
FAU - Babiychuk, Eduard B
AU  - Babiychuk EB
AD  - Institute of Anatomy, University of Bern, Bern, Switzerland.
LA  - eng
GR  - MC_PC_13068/Medical Research Council/United Kingdom
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20141102
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Bacterial Toxins)
RN  - 0 (Exotoxins)
RN  - 0 (Liposomes)
SB  - IM
MH  - Animals
MH  - Bacterial Infections/*prevention & control
MH  - Bacterial Toxins/*chemistry
MH  - Exotoxins/*chemistry
MH  - *Genetic Engineering
MH  - Liposomes/*chemistry
MH  - Mice
EDAT- 2014/11/05 06:00
MHDA- 2015/09/26 06:00
CRDT- 2014/11/03 06:00
PHST- 2013/08/28 00:00 [received]
PHST- 2014/09/09 00:00 [accepted]
PHST- 2014/11/03 06:00 [entrez]
PHST- 2014/11/05 06:00 [pubmed]
PHST- 2015/09/26 06:00 [medline]
AID - nbt.3037 [pii]
AID - 10.1038/nbt.3037 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jan;33(1):81-8. doi: 10.1038/nbt.3037. Epub 2014 Nov 2.

PMID- 25362243
OWN - NLM
STAT- MEDLINE
DCOM- 20150925
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 1
DP  - 2015 Jan
TI  - Crowdsourced analysis of clinical trial data to predict amyotrophic lateral
      sclerosis progression.
PG  - 51-7
LID - 10.1038/nbt.3051 [doi]
AB  - Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with
      substantial heterogeneity in its clinical presentation. This makes diagnosis and 
      effective treatment difficult, so better tools for estimating disease progression
      are needed. Here, we report results from the DREAM-Phil Bowen ALS Prediction
      Prize4Life challenge. In this crowdsourcing competition, competitors developed
      algorithms for the prediction of disease progression of 1,822 ALS patients from
      standardized, anonymized phase 2/3 clinical trials. The two best algorithms
      outperformed a method designed by the challenge organizers as well as predictions
      by ALS clinicians. We estimate that using both winning algorithms in future trial
      designs could reduce the required number of patients by at least 20%. The
      DREAM-Phil Bowen ALS Prediction Prize4Life challenge also identified several
      potential nonstandard predictors of disease progression including uric acid,
      creatinine and surprisingly, blood pressure, shedding light on ALS pathobiology. 
      This analysis reveals the potential of a crowdsourcing competition that uses
      clinical trial data for accelerating ALS research and development.
FAU - Kuffner, Robert
AU  - Kuffner R
AD  - 1] Institute of Bioinformatics and Systems Biology, German Research Center for
      Environmental Health, Munich, Germany. [2] Department of Informatics,
      Ludwig-Maximilians-University, Munich, Germany.
FAU - Zach, Neta
AU  - Zach N
AD  - Prize4Life, Tel Aviv, Israel and Cambridge, Massachusetts, USA.
FAU - Norel, Raquel
AU  - Norel R
AUID- ORCID: 0000000177374172
AD  - IBM T.J. Watson Research Center, Yorktown Heights, New York, USA.
FAU - Hawe, Johann
AU  - Hawe J
AD  - Department of Informatics, Ludwig-Maximilians-University, Munich, Germany.
FAU - Schoenfeld, David
AU  - Schoenfeld D
AD  - 1] MGH Biostatistics Center, Massachusetts General Hospital, Boston,
      Massachusetts, USA. [2] Harvard Medical School, Charlestown, Massachusetts, USA.
FAU - Wang, Liuxia
AU  - Wang L
AD  - Sentrana Inc., Washington, DC, USA.
FAU - Li, Guang
AU  - Li G
AD  - Sentrana Inc., Washington, DC, USA.
FAU - Fang, Lilly
AU  - Fang L
AD  - Latham&Watkins LLP, Silicon Valley, California, USA.
FAU - Mackey, Lester
AU  - Mackey L
AD  - Department of Statistics, Stanford University, Stanford, California, USA.
FAU - Hardiman, Orla
AU  - Hardiman O
AD  - Department of Neuroscience, Beaumont Hospital and Trinity College Dublin, Dublin,
      Ireland.
FAU - Cudkowicz, Merit
AU  - Cudkowicz M
AD  - Neurological Clinical Research Institute, Massachusetts General Hospital,
      Charlestown, Massachusetts, USA.
FAU - Sherman, Alexander
AU  - Sherman A
AD  - Neurological Clinical Research Institute, Massachusetts General Hospital,
      Charlestown, Massachusetts, USA.
FAU - Ertaylan, Gokhan
AU  - Ertaylan G
AD  - Luxembourg Centre for Systems Biomedicine, University of Luxembourg,
      Esch/Alzette, Luxembourg.
FAU - Grosse-Wentrup, Moritz
AU  - Grosse-Wentrup M
AD  - Max Planck Institute for Intelligent Systems, Tubingen, Germany.
FAU - Hothorn, Torsten
AU  - Hothorn T
AD  - Institute of Social- and Preventive Medicine, University of Zurich, Zurich,
      Switzerland.
FAU - van Ligtenberg, Jules
AU  - van Ligtenberg J
AD  - Orca XL Problem Solvers, Amsterdam, the Netherlands.
FAU - Macke, Jakob H
AU  - Macke JH
AD  - Max Planck Institute for Biological Cybernetics and Bernstein Center for
      Computational Neuroscience, Tubingen, Germany.
FAU - Meyer, Timm
AU  - Meyer T
AD  - Max Planck Institute for Intelligent Systems, Tubingen, Germany.
FAU - Scholkopf, Bernhard
AU  - Scholkopf B
AD  - Max Planck Institute for Intelligent Systems, Tubingen, Germany.
FAU - Tran, Linh
AU  - Tran L
AD  - Berkeley School of Public Health, University of California, Berkeley, California,
      USA.
FAU - Vaughan, Rubio
AU  - Vaughan R
AD  - Orca XL Problem Solvers, Amsterdam, the Netherlands.
FAU - Stolovitzky, Gustavo
AU  - Stolovitzky G
AD  - IBM T.J. Watson Research Center, Yorktown Heights, New York, USA.
FAU - Leitner, Melanie L
AU  - Leitner ML
AD  - 1] Prize4Life, Tel Aviv, Israel and Cambridge, Massachusetts, USA. [2] ALS
      Innovation Hub, Biogen Idec, Cambridge, Massachusetts, USA.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20141102
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
CIN - Nat Biotechnol. 2015 Jan;33(1):45-7. PMID: 25574636
MH  - Algorithms
MH  - Amyotrophic Lateral Sclerosis/*pathology
MH  - *Clinical Trials as Topic
MH  - *Crowdsourcing
MH  - Disease Progression
MH  - Humans
EDAT- 2014/11/05 06:00
MHDA- 2015/09/26 06:00
CRDT- 2014/11/03 06:00
PHST- 2014/07/17 00:00 [received]
PHST- 2014/09/23 00:00 [accepted]
PHST- 2014/11/03 06:00 [entrez]
PHST- 2014/11/05 06:00 [pubmed]
PHST- 2015/09/26 06:00 [medline]
AID - nbt.3051 [pii]
AID - 10.1038/nbt.3051 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jan;33(1):51-7. doi: 10.1038/nbt.3051. Epub 2014 Nov 2.

PMID- 25357182
OWN - NLM
STAT- MEDLINE
DCOM- 20150925
LR  - 20170922
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 1
DP  - 2015 Jan
TI  - Cationic lipid-mediated delivery of proteins enables efficient protein-based
      genome editing in vitro and in vivo.
PG  - 73-80
LID - 10.1038/nbt.3081 [doi]
AB  - Efficient intracellular delivery of proteins is needed to fully realize the
      potential of protein therapeutics. Current methods of protein delivery commonly
      suffer from low tolerance for serum, poor endosomal escape and limited in vivo
      efficacy. Here we report that common cationic lipid nucleic acid transfection
      reagents can potently deliver proteins that are fused to negatively supercharged 
      proteins, that contain natural anionic domains or that natively bind to anionic
      nucleic acids. This approach mediates the potent delivery of nM concentrations of
      Cre recombinase, TALE- and Cas9-based transcription activators, and Cas9:sgRNA
      nuclease complexes into cultured human cells in media containing 10% serum.
      Delivery of unmodified Cas9:sgRNA complexes resulted in up to 80% genome
      modification with substantially higher specificity compared to DNA transfection. 
      This approach also mediated efficient delivery of Cre recombinase and Cas9:sgRNA 
      complexes into the mouse inner ear in vivo, achieving 90% Cre-mediated
      recombination and 20% Cas9-mediated genome modification in hair cells.
FAU - Zuris, John A
AU  - Zuris JA
AD  - 1] Department of Chemistry &Chemical Biology, Harvard University, Cambridge,
      Massachusetts, USA. [2] Howard Hughes Medical Institute, Harvard University,
      Cambridge, Massachusetts, USA.
FAU - Thompson, David B
AU  - Thompson DB
AD  - 1] Department of Chemistry &Chemical Biology, Harvard University, Cambridge,
      Massachusetts, USA. [2] Howard Hughes Medical Institute, Harvard University,
      Cambridge, Massachusetts, USA.
FAU - Shu, Yilai
AU  - Shu Y
AD  - 1] Department of Otology and Laryngology, Harvard Medical School, Boston,
      Massachusetts, USA. [2] Eaton-Peabody Laboratory, Massachusetts Eye and Ear
      Infirmary, Boston, Massachusetts, USA. [3] Department of Otology and Skull Base
      Surgery, Eye, Ear, Nose and Throat Hospital, Shanghai Medical College, Fudan
      University, Shanghai, China. [4] Key Laboratory of Health Ministry for Hearing
      Medicine, Shanghai, China.
FAU - Guilinger, John P
AU  - Guilinger JP
AD  - 1] Department of Chemistry &Chemical Biology, Harvard University, Cambridge,
      Massachusetts, USA. [2] Howard Hughes Medical Institute, Harvard University,
      Cambridge, Massachusetts, USA.
FAU - Bessen, Jeffrey L
AU  - Bessen JL
AD  - 1] Department of Chemistry &Chemical Biology, Harvard University, Cambridge,
      Massachusetts, USA. [2] Howard Hughes Medical Institute, Harvard University,
      Cambridge, Massachusetts, USA.
FAU - Hu, Johnny H
AU  - Hu JH
AD  - 1] Department of Chemistry &Chemical Biology, Harvard University, Cambridge,
      Massachusetts, USA. [2] Howard Hughes Medical Institute, Harvard University,
      Cambridge, Massachusetts, USA.
FAU - Maeder, Morgan L
AU  - Maeder ML
AD  - 1] Molecular Pathology Unit, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA. [2] Center for Cancer Research, Massachusetts General
      Hospital, Charlestown, Massachusetts, USA. [3] Center for Computational and
      Integrative Biology, Massachusetts General Hospital, Charlestown, Massachusetts, 
      USA. [4] Department of Pathology, Harvard Medical School, Boston, Massachusetts, 
      USA.
FAU - Joung, J Keith
AU  - Joung JK
AD  - 1] Molecular Pathology Unit, Massachusetts General Hospital, Charlestown,
      Massachusetts, USA. [2] Center for Cancer Research, Massachusetts General
      Hospital, Charlestown, Massachusetts, USA. [3] Center for Computational and
      Integrative Biology, Massachusetts General Hospital, Charlestown, Massachusetts, 
      USA. [4] Department of Pathology, Harvard Medical School, Boston, Massachusetts, 
      USA.
FAU - Chen, Zheng-Yi
AU  - Chen ZY
AD  - 1] Department of Otology and Laryngology, Harvard Medical School, Boston,
      Massachusetts, USA. [2] Eaton-Peabody Laboratory, Massachusetts Eye and Ear
      Infirmary, Boston, Massachusetts, USA.
FAU - Liu, David R
AU  - Liu DR
AD  - 1] Department of Chemistry &Chemical Biology, Harvard University, Cambridge,
      Massachusetts, USA. [2] Howard Hughes Medical Institute, Harvard University,
      Cambridge, Massachusetts, USA.
LA  - eng
SI  - SRA/SRP049127
SI  - SRA/SRP049131
GR  - F32 GM 106601-2/GM/NIGMS NIH HHS/United States
GR  - Howard Hughes Medical Institute/United States
GR  - DP1 GM105378/DP/NCCDPHP CDC HHS/United States
GR  - R01 GM095501/GM/NIGMS NIH HHS/United States
GR  - R01 DC006908/DC/NIDCD NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, Non-P.H.S.
DEP - 20141030
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
RN  - 0 (Cations)
RN  - 0 (Lipids)
RN  - 0 (Proteins)
RN  - 0 (Trans-Activators)
SB  - IM
MH  - Cations
MH  - In Vitro Techniques
MH  - Lipids/*administration & dosage
MH  - Proteins/*administration & dosage
MH  - Trans-Activators/administration & dosage
MH  - Transfection
PMC - PMC4289409
MID - NIHMS637767
EDAT- 2014/10/31 06:00
MHDA- 2015/09/26 06:00
CRDT- 2014/10/31 06:00
PHST- 2014/07/22 00:00 [received]
PHST- 2014/10/23 00:00 [accepted]
PHST- 2014/10/31 06:00 [entrez]
PHST- 2014/10/31 06:00 [pubmed]
PHST- 2015/09/26 06:00 [medline]
AID - nbt.3081 [pii]
AID - 10.1038/nbt.3081 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jan;33(1):73-80. doi: 10.1038/nbt.3081. Epub 2014 Oct 30.

PMID- 25326897
OWN - NLM
STAT- MEDLINE
DCOM- 20150925
LR  - 20170220
IS  - 1546-1696 (Electronic)
IS  - 1087-0156 (Linking)
VI  - 33
IP  - 1
DP  - 2015 Jan
TI  - In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9.
PG  - 102-6
LID - 10.1038/nbt.3055 [doi]
AB  - Probing gene function in the mammalian brain can be greatly assisted with methods
      to manipulate the genome of neurons in vivo. The clustered, regularly
      interspaced, short palindromic repeats (CRISPR)-associated endonuclease (Cas)9
      from Streptococcus pyogenes (SpCas9) can be used to edit single or multiple genes
      in replicating eukaryotic cells, resulting in frame-shifting insertion/deletion
      (indel) mutations and subsequent protein depletion. Here, we delivered SpCas9 and
      guide RNAs using adeno-associated viral (AAV) vectors to target single (Mecp2) as
      well as multiple genes (Dnmt1, Dnmt3a and Dnmt3b) in the adult mouse brain in
      vivo. We characterized the effects of genome modifications in postmitotic neurons
      using biochemical, genetic, electrophysiological and behavioral readouts. Our
      results demonstrate that AAV-mediated SpCas9 genome editing can enable reverse
      genetic studies of gene function in the brain.
FAU - Swiech, Lukasz
AU  - Swiech L
AD  - 1] Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2]
      McGovern Institute for Brain Research, Department of Brain and Cognitive
      Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
      [3] McGovern Institute for Brain Research, Department of Biological Engineering, 
      Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
FAU - Heidenreich, Matthias
AU  - Heidenreich M
AD  - 1] Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2]
      McGovern Institute for Brain Research, Department of Brain and Cognitive
      Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
      [3] McGovern Institute for Brain Research, Department of Biological Engineering, 
      Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
FAU - Banerjee, Abhishek
AU  - Banerjee A
AD  - Picower Institute for Learning and Memory, Department of Brain and Cognitive
      Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
FAU - Habib, Naomi
AU  - Habib N
AD  - 1] Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2]
      McGovern Institute for Brain Research, Department of Brain and Cognitive
      Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
      [3] McGovern Institute for Brain Research, Department of Biological Engineering, 
      Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
FAU - Li, Yinqing
AU  - Li Y
AD  - 1] Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2]
      McGovern Institute for Brain Research, Department of Brain and Cognitive
      Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
      [3] Department of Electrical Engineering and Computer Science, Massachusetts
      Institute of Technology, Cambridge, Massachusetts, USA.
FAU - Trombetta, John
AU  - Trombetta J
AD  - Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
FAU - Sur, Mriganka
AU  - Sur M
AD  - Picower Institute for Learning and Memory, Department of Brain and Cognitive
      Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
FAU - Zhang, Feng
AU  - Zhang F
AD  - 1] Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2]
      McGovern Institute for Brain Research, Department of Brain and Cognitive
      Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
      [3] McGovern Institute for Brain Research, Department of Biological Engineering, 
      Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
LA  - eng
SI  - SRA/PRJNA262918
GR  - 5DP1-MH100706/DP/NCCDPHP CDC HHS/United States
GR  - R01 EY007023/EY/NEI NIH HHS/United States
GR  - R01 MH085802/MH/NIMH NIH HHS/United States
GR  - R01MH085802/MH/NIMH NIH HHS/United States
GR  - R01EY007023/EY/NEI NIH HHS/United States
GR  - DP1 MH100706/MH/NIMH NIH HHS/United States
GR  - R01 NS073124/NS/NINDS NIH HHS/United States
GR  - 5R01-NS073124/NS/NINDS NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20141019
PL  - United States
TA  - Nat Biotechnol
JT  - Nature biotechnology
JID - 9604648
SB  - IM
MH  - Animals
MH  - Clustered Regularly Interspaced Short Palindromic Repeats/*physiology
MH  - Streptococcus pyogenes/*genetics
PMC - PMC4492112
MID - NIHMS701422
EDAT- 2014/10/20 06:00
MHDA- 2015/09/26 06:00
CRDT- 2014/10/20 06:00
PHST- 2014/05/27 00:00 [received]
PHST- 2014/10/02 00:00 [accepted]
PHST- 2014/10/20 06:00 [entrez]
PHST- 2014/10/20 06:00 [pubmed]
PHST- 2015/09/26 06:00 [medline]
AID - nbt.3055 [pii]
AID - 10.1038/nbt.3055 [doi]
PST - ppublish
SO  - Nat Biotechnol. 2015 Jan;33(1):102-6. doi: 10.1038/nbt.3055. Epub 2014 Oct 19.
